Citrus Sinensis ID: 006460
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 644 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LHI7 | 571 | Serine/threonine-protein | no | no | 0.864 | 0.975 | 0.448 | 1e-137 | |
| Q9LT35 | 416 | Serine/threonine-protein | yes | no | 0.425 | 0.658 | 0.778 | 1e-136 | |
| Q6YY75 | 534 | Serine/threonine-protein | yes | no | 0.470 | 0.567 | 0.713 | 1e-133 | |
| A2ZMH2 | 591 | Serine/threonine-protein | N/A | no | 0.871 | 0.949 | 0.424 | 1e-132 | |
| Q2QMH1 | 591 | Serine/threonine-protein | yes | no | 0.871 | 0.949 | 0.422 | 1e-131 | |
| Q60DG4 | 943 | Serine/threonine-protein | no | no | 0.448 | 0.306 | 0.696 | 1e-127 | |
| Q9CAU7 | 606 | Serine/threonine-protein | no | no | 0.891 | 0.947 | 0.421 | 1e-126 | |
| Q0WPH8 | 956 | Serine/threonine-protein | no | no | 0.411 | 0.277 | 0.735 | 1e-125 | |
| Q94CU5 | 943 | Serine/threonine-protein | no | no | 0.409 | 0.279 | 0.757 | 1e-124 | |
| Q10GB1 | 599 | Serine/threonine-protein | no | no | 0.624 | 0.671 | 0.503 | 1e-118 |
| >sp|Q9LHI7|NEK7_ARATH Serine/threonine-protein kinase Nek7 OS=Arabidopsis thaliana GN=NEK7 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 489 bits (1258), Expect = e-137, Method: Compositional matrix adjust.
Identities = 287/640 (44%), Positives = 378/640 (59%), Gaps = 83/640 (12%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLI 66
+ K L++Y V+EQ+ RG + F+VLH IE KKY +KKI LAK T+K K+TALQEM L+
Sbjct: 11 EHKFTLDNYHVVEQVRRGKSSSDFVVLHDIEDKKYAMKKICLAKHTDKLKQTALQEMKLL 70
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
S L NPYIV Y+D+W+D N CI T Y EGG+MA IKKARG FPEE++ KWL QLLL
Sbjct: 71 SSLKNPYIVHYEDSWIDNDNNACIFTAYYEGGNMANAIKKARGKLFPEERIFKWLAQLLL 130
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
AV+YLHSNRV+H DL CSNIFL KD+ ++LG++GLAKL+N E S V G N MCPE+L
Sbjct: 131 AVNYLHSNRVVHMDLTCSNIFLPKDDHVQLGNYGLAKLINPEKPVSMVSGISNSMCPEVL 190
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
D PYGYKSDIWSLGCCM+EI AHQPAF+APDMAGLINKINRS +SPLPIVYSST+KQ+I
Sbjct: 191 EDQPYGYKSDIWSLGCCMYEITAHQPAFKAPDMAGLINKINRSLMSPLPIVYSSTLKQMI 250
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLP---IKPTNIMKEKTRKSPSSK 303
K MLRK PE+RPTA +LLR+P LQPYLL+CQN S +YLP IKP N K+K R++
Sbjct: 251 KLMLRKKPEYRPTACELLRNPSLQPYLLQCQNLSPIYLPVFPIKPVNSPKDKARRNSLPG 310
Query: 304 HNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKVDPTS 363
++ ++ LEN+ N + + +S+ ED LETK++DP+
Sbjct: 311 KFGKERVSREKSEVSRSLENLYPFWTN--TETGSSSSSQPASSTNGAEDKLETKRIDPSC 368
Query: 364 YTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHV 423
T+++S E ++Q S S + +I S + PA+ +
Sbjct: 369 DTLKIS-------EFTSQK---------------SDESLIDPDIAVYS---TETPAEENA 403
Query: 424 QPAEEIDVETVKSKDQNPFSDRVIEEADIEGESAVPLDCGKMTPSSAGCNGNNESPDDKS 483
P E +N FS EE+ + +D G ++ C S
Sbjct: 404 LPKE----------TENIFS----EESQLRD-----VDVGVVSAQEVAC----------S 434
Query: 484 SSSAIYEPEVAPGSCSPKINSDNAQNGEAHMGNLSSASNDALPCKDEAQTKPDNTSCSMQ 543
AI E E PK + AH +A+ D L S
Sbjct: 435 PPRAIEEAETQEALPKPKEQITVPISSVAHSSTEVAAAKDHL---------------SGS 479
Query: 544 TEKDDSRAFNLAPSDIS-LLSTVTGISCDEIRAEWENPTQQRADALESLLELCARLLKQD 602
E D ++ L S++S +LS +T + + +++RADALE LLE CA L+KQ+
Sbjct: 480 LEGDKAKMVKLTASEMSSVLSKLTKLGPPQ--------SKERADALECLLEKCAGLVKQE 531
Query: 603 KLDELAGVLRPFGEETVSSRETAIWLTKSLVSAQKFNGGT 642
K +ELAG+L PFGE+ VS+R+TAIW K+L+S+ K N GT
Sbjct: 532 KYEELAGLLTPFGEDGVSARDTAIWFAKTLLSSDKLNQGT 571
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LT35|NEK6_ARATH Serine/threonine-protein kinase Nek6 OS=Arabidopsis thaliana GN=NEK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1253), Expect = e-136, Method: Compositional matrix adjust.
Identities = 214/275 (77%), Positives = 254/275 (92%), Gaps = 1/275 (0%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
++DYEV+EQIGRGAFG+AFLV+HK ER+KYV+KKIRLAKQTE+ K A+QEM LISKL +
Sbjct: 1 MDDYEVVEQIGRGAFGSAFLVIHKSERRKYVVKKIRLAKQTERCKLAAIQEMSLISKLKS 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
PYIV+YKD+WV+K +CVCIVT YCEGGDM ++IKK+RG EEKLC+W+ QLLLA+DYL
Sbjct: 61 PYIVEYKDSWVEK-DCVCIVTSYCEGGDMTQMIKKSRGVFASEEKLCRWMVQLLLAIDYL 119
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
H+NRVLHRDLKCSNIFLTK+N++RLGDFGLAKLL +DLASS+VGTPNYMCPELLADIPY
Sbjct: 120 HNNRVLHRDLKCSNIFLTKENEVRLGDFGLAKLLGKDDLASSMVGTPNYMCPELLADIPY 179
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
GYKSDIWSLGCCMFE+AAHQPAF+APDMA LINKINRSS+SPLP++YSS++K++IKSMLR
Sbjct: 180 GYKSDIWSLGCCMFEVAAHQPAFKAPDMAALINKINRSSLSPLPVMYSSSLKRLIKSMLR 239
Query: 252 KNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPI 286
KNPEHRPTA++LLRHPHLQPYL +CQN S V+ P+
Sbjct: 240 KNPEHRPTAAELLRHPHLQPYLAQCQNLSPVFKPV 274
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6YY75|NEK6_ORYSJ Serine/threonine-protein kinase Nek6 OS=Oryza sativa subsp. japonica GN=NEK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 476 bits (1226), Expect = e-133, Method: Compositional matrix adjust.
Identities = 219/307 (71%), Positives = 260/307 (84%), Gaps = 4/307 (1%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+E YEV+EQIGRGA+G+A+LV+HK ERK+YV+KKIRL+KQ +KF+RTA QEM L++ L+N
Sbjct: 1 MEQYEVVEQIGRGAYGSAYLVVHKGERKRYVMKKIRLSKQNDKFQRTAYQEMSLMASLSN 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
PYIV+YKD WVD+G CIVT YCEGGDMAE IKKARG F EE++C+W TQLLLA+DYL
Sbjct: 61 PYIVEYKDGWVDEGTSACIVTSYCEGGDMAERIKKARGVLFSEERVCRWFTQLLLALDYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
H NRVLHRDLKCSNI LTKDN+IRL DFGLAKLL EDLAS++VGTPNYMCPE+LADIPY
Sbjct: 121 HCNRVLHRDLKCSNILLTKDNNIRLADFGLAKLL-MEDLASTIVGTPNYMCPEILADIPY 179
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
GYKSDIWSLGCCMFEI AH+PAF+A DMA LINKINRSSISP+P +YSS++KQI+KSMLR
Sbjct: 180 GYKSDIWSLGCCMFEILAHRPAFKAADMASLINKINRSSISPMPPIYSSSLKQIVKSMLR 239
Query: 252 KNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPT--NIM-KEKTRKSPSSKHNSRK 308
KNPEHRPTA +LLRHP+LQPYL + S +YLP+KPT N+ K+++RK S + K
Sbjct: 240 KNPEHRPTAGELLRHPYLQPYLAESCSCSPIYLPVKPTKSNLGDKQQSRKPGSGRKRIIK 299
Query: 309 DKGEREA 315
G EA
Sbjct: 300 TNGSSEA 306
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2ZMH2|NEK2_ORYSI Serine/threonine-protein kinase Nek2 OS=Oryza sativa subsp. indica GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1212), Expect = e-132, Method: Compositional matrix adjust.
Identities = 274/646 (42%), Positives = 368/646 (56%), Gaps = 85/646 (13%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
++ YEV+EQIG+GAFG+A LV HK+E+KKYVLKKIRLA+QT++ +R+A QEM LI+ + N
Sbjct: 1 MDQYEVLEQIGKGAFGSALLVRHKLEKKKYVLKKIRLARQTDRTRRSAHQEMQLIATVRN 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P+IV+YKD+WV+KG VCIV GYCEGGDMAE IK+A G F EEKLCKWL QLL+A+DYL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCEGGDMAEAIKRANGTYFSEEKLCKWLVQLLMALDYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
H+N +LHRD+KCSNIF+ +D IRLGDFGLAK+L ++DLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFIARDQSIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
G KSDIWSLGCC++E+ A +PAF+A DM LINKI +S +SPLP YS + +IKSMLR
Sbjct: 181 GTKSDIWSLGCCIYEMTALRPAFKAFDMQALINKITKSIVSPLPTKYSGAFRGLIKSMLR 240
Query: 252 KNPEHRPTASDLLRHPHLQPYLLRCQ---NPSSVYLPIKPTNIMKEKTRKSPSSKHNSRK 308
K+PEHRP+A+ LL+HP LQPY+L+ Q +P+ LPI + K K PS
Sbjct: 241 KSPEHRPSAAQLLKHPQLQPYVLQVQLKSSPTRNILPIHQSLTDKVKKMTFPSDV----V 296
Query: 309 DKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKVDPTSYTMEV 368
D R A N L N R+V + N + +T ++E VD + EV
Sbjct: 297 DSARRRMARRNSLGNERTVTFSKPSPERNSVSSTRSIKEYTTTQSVEGLSVDSSEAGDEV 356
Query: 369 SSSINDSKERST-QTETSDCSRDKQAH---------FNGSTGSDLTSEITANSQNEIQEP 418
+S +K S +T S ++ A +N + S+L S+ T N+I P
Sbjct: 357 TSKAIITKTSSILRTPKSLPAKTYTARNQLEPPKTSYNRTYRSELPSKTTP---NKIARP 413
Query: 419 ADAHVQPAEEIDVETVKSKD------------QNPFSDRVIEEADIEGESAVPLDCGKMT 466
A P + T +S P DR+ E E + K++
Sbjct: 414 ARRASLPLSTYETPTKRSISILEQLDSPDVSVNAPRIDRIAEFPLASSEDPLLPIHNKLS 473
Query: 467 PSSAGCNGNNESPDDKSSSSAIYEPEVAPGSCSPKINSDNAQNGEAHMGNLSSASNDALP 526
P C S+ + C+ ++ + NG G ++A
Sbjct: 474 PGHGSC-----------STPPFINRSITKDKCTIQVLRTDGDNGSDSSGRNATA------ 516
Query: 527 CKDEAQTKPDNTSCSMQTEKDDSRAFNLAPSDISLLSTVTGISCDEIRAEWENPTQQRAD 586
A ++ N S + ++ D+ +F QQRA+
Sbjct: 517 ----ASSRGSNDS---RQQRFDTSSF-----------------------------QQRAE 540
Query: 587 ALESLLELCARLLKQDKLDELAGVLRPFGEETVSSRETAIWLTKSL 632
ALE LLE A+LL+Q++ +EL +L+PFG E S RETAIWLTKS
Sbjct: 541 ALEGLLEFSAQLLQQERYEELGILLKPFGPEKASPRETAIWLTKSF 586
|
May be involved in plant development processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QMH1|NEK2_ORYSJ Serine/threonine-protein kinase Nek2 OS=Oryza sativa subsp. japonica GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 469 bits (1208), Expect = e-131, Method: Compositional matrix adjust.
Identities = 273/646 (42%), Positives = 368/646 (56%), Gaps = 85/646 (13%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
++ YEV+EQIG+GAFG+A LV HK+E+KKYVLKKIRLA+QT++ +R+A QEM LI+ + N
Sbjct: 1 MDQYEVLEQIGKGAFGSALLVRHKLEKKKYVLKKIRLARQTDRTRRSAHQEMQLIATVRN 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P+IV+YKD+WV+KG VCIV GYCEGGDMAE IK+A G F EEKLCKWL QLL+A+DYL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCEGGDMAEAIKRANGTYFSEEKLCKWLVQLLMALDYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
H+N +LHRD+KCSNIF+ +D IRLGDFGLAK+L ++DLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFIARDQSIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
G KSDIWSLGCC++E+ A +PAF+A DM LINKI +S +SPLP YS + +IKSMLR
Sbjct: 181 GTKSDIWSLGCCIYEMTALRPAFKAFDMQALINKITKSIVSPLPTKYSGAFRGLIKSMLR 240
Query: 252 KNPEHRPTASDLLRHPHLQPYLLRCQ---NPSSVYLPIKPTNIMKEKTRKSPSSKHNSRK 308
K+PEHRP+A+ LL+HP LQPY+L+ Q +P+ LPI + K K PS
Sbjct: 241 KSPEHRPSAAQLLKHPQLQPYVLQVQLKSSPTRNILPIHQSLTDKVKKMTFPSDV----V 296
Query: 309 DKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKVDPTSYTMEV 368
D R A N L N R+V + N + +T +++ VD + EV
Sbjct: 297 DSARRRMARRNSLGNERTVTFSKPSPERNSVSSTRSIKEYTTTQSVKGLSVDSSEAGDEV 356
Query: 369 SSSINDSKERST-QTETSDCSRDKQAH---------FNGSTGSDLTSEITANSQNEIQEP 418
+S +K S +T S ++ A +N + S+L S+ T N+I P
Sbjct: 357 TSKAIITKTSSILRTPKSLPAKTYTARNQLEPPKTSYNRTYRSELPSKTTP---NKIARP 413
Query: 419 ADAHVQPAEEIDVETVKSKD------------QNPFSDRVIEEADIEGESAVPLDCGKMT 466
A P + T +S P DR+ E E + K++
Sbjct: 414 ARRASLPLSTYETPTKRSISILEQLDSPDVSVNAPRIDRIAEFPLASSEDPLLPIHNKLS 473
Query: 467 PSSAGCNGNNESPDDKSSSSAIYEPEVAPGSCSPKINSDNAQNGEAHMGNLSSASNDALP 526
P C S+ + C+ ++ + NG G ++A
Sbjct: 474 PGHGSC-----------STPPFINRSITKDKCTIQVLRTDGDNGSDSSGRNATA------ 516
Query: 527 CKDEAQTKPDNTSCSMQTEKDDSRAFNLAPSDISLLSTVTGISCDEIRAEWENPTQQRAD 586
A ++ N S + ++ D+ +F QQRA+
Sbjct: 517 ----ASSRGSNDS---RQQRFDTSSF-----------------------------QQRAE 540
Query: 587 ALESLLELCARLLKQDKLDELAGVLRPFGEETVSSRETAIWLTKSL 632
ALE LLE A+LL+Q++ +EL +L+PFG E S RETAIWLTKS
Sbjct: 541 ALEGLLEFSAQLLQQERYEELGILLKPFGPEKASPRETAIWLTKSF 586
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60DG4|NEK4_ORYSJ Serine/threonine-protein kinase Nek4 OS=Oryza sativa subsp. japonica GN=NEK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1173), Expect = e-127, Method: Compositional matrix adjust.
Identities = 204/293 (69%), Positives = 249/293 (84%), Gaps = 4/293 (1%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
+S+++ YE++EQ+GRGAFGAA LV HKIERKKYVLKKIRLA+QTE+ +++A QEM LI++
Sbjct: 2 ESRMDQYEIMEQVGRGAFGAAILVNHKIERKKYVLKKIRLARQTERCRKSAHQEMALIAR 61
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
L +PYIV++K+AWV+KG VCIVTGYCEGGDM E++KK G FPEEKL KW QL+LAV
Sbjct: 62 LQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMDELMKKLNGTYFPEEKLLKWFAQLVLAV 121
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD 188
DYLHSN VLHRDLKCSNIFLTKD DIRLGDFGLAK L +DL SSVVGTPNYMCPELL D
Sbjct: 122 DYLHSNYVLHRDLKCSNIFLTKDQDIRLGDFGLAKTLKEDDLTSSVVGTPNYMCPELLTD 181
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248
IPYG+KSDIWSLGCCM+E+AAH+PAF+A DMAGLI+KINRSSI PLP YSS+MK +IKS
Sbjct: 182 IPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPACYSSSMKTLIKS 241
Query: 249 MLRKNPEHRPTASDLLRHPHLQPYLLRCQ----NPSSVYLPIKPTNIMKEKTR 297
MLRK+PEHRPTAS++L++P+LQPY+ +C+ P+ + +P KP + + R
Sbjct: 242 MLRKSPEHRPTASEILKNPYLQPYVNQCRPLSDAPTPIRMPEKPLSTSRSNQR 294
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAU7|NEK2_ARATH Serine/threonine-protein kinase Nek2 OS=Arabidopsis thaliana GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-126, Method: Compositional matrix adjust.
Identities = 271/643 (42%), Positives = 380/643 (59%), Gaps = 69/643 (10%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+E+YEV+EQIG+G+FG+A LV HK E+K YVLKKIRLA+QT + +R+A QEM+LISK++N
Sbjct: 1 MENYEVLEQIGKGSFGSALLVRHKHEKKLYVLKKIRLARQTGRTRRSAHQEMELISKIHN 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P+IV+YKD+WV+KG VCI+ GYC+GGDMAE IKK G F EEKLCKWL Q+LLA++YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCKGGDMAEAIKKTNGVHFTEEKLCKWLVQILLALEYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
H+N +LHRD+KCSNIFLTKD DIRLGDFGLAK+L ++DLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKVLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
G KSDIWSLGCCM+E+ A +PAF+A DM GLIN+INRS + PLP YS+ + ++KSMLR
Sbjct: 181 GSKSDIWSLGCCMYEMTAMKPAFKAFDMQGLINRINRSIVPPLPAQYSAAFRGLVKSMLR 240
Query: 252 KNPEHRPTASDLLRHPHLQPYL----LRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNS- 306
KNPE RP+A++LLR P LQPY+ L+ +P S N++ + +S S++ NS
Sbjct: 241 KNPELRPSAAELLRQPLLQPYIQKIHLKVNDPGS--------NVLPAQWPESESARRNSF 292
Query: 307 ----RKDKGEREAAAPNQL-----ENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNL-ET 356
R+ G+ + P++ ++V S+ K + LN D T ++ + T
Sbjct: 293 PEQRRRPAGKSHSFGPSRFRGNLEDSVSSIKKTVPAYLNRERQVDLSTDASGDGTVVRRT 352
Query: 357 KKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQ 416
+ +S + V +S + + R +++ Q N + + +S+ +
Sbjct: 353 SEASKSSRYVPVRASASPVRPRQPRSDLGQLPVSSQLK-NRKPAALIRRASMPSSRKPAK 411
Query: 417 EPADAHVQPAEEIDVETVKSKDQN---PFSDRV-IEEADIEGESAVPLDCGKMTPSSAGC 472
E D+ + ++ + + S D + P D++ A E E VP+ GK
Sbjct: 412 EIKDS-LYISKTSFLHQINSPDVSMNAPRIDKIEFPLASYEEEPFVPVVRGK-------- 462
Query: 473 NGNNESPDDKSSSSAIYEPEVAPG-SCSPKINSDNAQNGEAHMGNLSSASNDALPCKDEA 531
K+SS Y P P CS + + G+ G + A +
Sbjct: 463 -------KKKASSRGSYSPPPEPPLDCSITKDKFTLEPGQNREGAIMKAVYE-------- 507
Query: 532 QTKPDNTSCSMQTEKDDSRAFNLAPSDISLLSTVTGISCDEIRAEWENPTQQRADA--LE 589
++ ++E D A A S S +G+ R + +P+ + A LE
Sbjct: 508 ----EDAYLEDRSESSDQNATAGASSRAS-----SGV-----RRQRFDPSSYQQRAEALE 553
Query: 590 SLLELCARLLKQDKLDELAGVLRPFGEETVSSRETAIWLTKSL 632
LLE ARLL+ ++ DEL +LRPFG VS RETAIWL+KS
Sbjct: 554 GLLEFSARLLQDERYDELNVLLRPFGPGKVSPRETAIWLSKSF 596
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WPH8|NEK5_ARATH Serine/threonine-protein kinase Nek5 OS=Arabidopsis thaliana GN=NEK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-125, Method: Compositional matrix adjust.
Identities = 195/265 (73%), Positives = 237/265 (89%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
+S+++ YE++EQIGRGAFGAA LV HK ERKKYVLKKIRLA+QTE+ +R+A QEM LI++
Sbjct: 2 ESRMDQYELMEQIGRGAFGAAILVHHKAERKKYVLKKIRLARQTERCRRSAHQEMSLIAR 61
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
+ +PYIV++K+AWV+KG VCIVTGYCEGGDMAE++KK+ G FPEEKLCKW TQLLLAV
Sbjct: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGVYFPEEKLCKWFTQLLLAV 121
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD 188
+YLHSN VLHRDLKCSNIFLTKD D+RLGDFGLAK L +DL SSVVGTPNYMCPELLAD
Sbjct: 122 EYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLTSSVVGTPNYMCPELLAD 181
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248
IPYG+KSDIWSLGCC++E+AA++PAF+A DMAGLI+K+NRSSI PLP YS ++K +IK
Sbjct: 182 IPYGFKSDIWSLGCCIYEMAAYRPAFKAFDMAGLISKVNRSSIGPLPPCYSPSLKALIKG 241
Query: 249 MLRKNPEHRPTASDLLRHPHLQPYL 273
MLRKNPE+RP AS++L+HP+LQPY+
Sbjct: 242 MLRKNPEYRPNASEILKHPYLQPYV 266
|
Involved in epidermal-cell morphogenesis in hypocotyls and roots. May act on the microtubule function. May have a secondary role in trichome branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94CU5|NEK5_ORYSJ Serine/threonine-protein kinase Nek5 OS=Oryza sativa subsp. japonica GN=NEK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 447 bits (1150), Expect = e-124, Method: Compositional matrix adjust.
Identities = 200/264 (75%), Positives = 234/264 (88%)
Query: 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL 69
S+++ YEV+EQIGRGAFGAA LV HK E+KKYVLKKIRLA+QTE+ +++A QEM LI++L
Sbjct: 3 SRMDQYEVMEQIGRGAFGAAILVNHKTEKKKYVLKKIRLARQTERCRKSAHQEMALIARL 62
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
+PYIV++K+AWV+KG VCIVTGYCEGGDMAE++KKA G FPEEKL KW QL LAVD
Sbjct: 63 QHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKANGTYFPEEKLLKWFAQLALAVD 122
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI 189
YLHSN VLHRDLKCSNIFLTKD DIRLGDFGLAK L +DL SSVVGTPNYMCPELLADI
Sbjct: 123 YLHSNFVLHRDLKCSNIFLTKDQDIRLGDFGLAKTLKADDLTSSVVGTPNYMCPELLADI 182
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249
PYG+KSDIWSLGCCM+E+AAH+PAF+A DMAGLI+KINRSSI PLP YS +MK +IKSM
Sbjct: 183 PYGFKSDIWSLGCCMYEMAAHRPAFKAFDMAGLISKINRSSIGPLPPCYSPSMKSLIKSM 242
Query: 250 LRKNPEHRPTASDLLRHPHLQPYL 273
LRK+PEHRPTAS++L+ P+LQPY+
Sbjct: 243 LRKSPEHRPTASEILKSPYLQPYV 266
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10GB1|NEK1_ORYSJ Serine/threonine-protein kinase Nek1 OS=Oryza sativa subsp. japonica GN=NEK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1091), Expect = e-118, Method: Compositional matrix adjust.
Identities = 207/411 (50%), Positives = 282/411 (68%), Gaps = 9/411 (2%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+E YEV+EQIG+GAFG+A LV HK+E+KKYVLKKIRLA+QT++ +R+A QEM LI+ + N
Sbjct: 1 MEQYEVLEQIGKGAFGSALLVRHKVEKKKYVLKKIRLARQTDRTRRSAHQEMQLIATVRN 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P+IV+YKD+WV+KG VCI+ GYCEGGDMAE IK+A G F EEKLCKWL QLL+A+DYL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKRATGDHFSEEKLCKWLVQLLMALDYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
H+N +LHRD+KCSNIFLT+D IRLGDFGLAK+L ++DLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTRDQSIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
G KSDIWSLGCC++E+ A +PAF+A DM LI+KI +S +SPLP YS + +IKSMLR
Sbjct: 181 GTKSDIWSLGCCIYEMTALRPAFKAFDMQALISKITKSIVSPLPTRYSGAFRGLIKSMLR 240
Query: 252 KNPEHRPTASDLLRHPHLQPYLLRCQ---NPSSVYLPIKPTNIMKEKTRKSPSSKHNSRK 308
K+PEHRP+A++LL+HPHLQPY+L+ +P+ +P + I K K P+ +
Sbjct: 241 KSPEHRPSAAELLKHPHLQPYVLQVHLKSSPARNIIPSHQSPIDKVKKMTFPTESMC--R 298
Query: 309 DKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKVD----PTSY 364
KG R + ++ + + + D T+ + + +++ V+ T++
Sbjct: 299 SKGRRNSLGNERIVTFSKPSPERKFTSSIQSIKDYSTTRSVKDLSIDVSLVEEVSSKTTF 358
Query: 365 TMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEI 415
T SS + K ++T T+ + +N S+L S N +
Sbjct: 359 TTRTSSIVKTPKRTPSKTITTPQLEPPKVSYNRVNRSELLSRTPVNRSARV 409
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 644 | ||||||
| 147843683 | 973 | hypothetical protein VITISV_040411 [Viti | 0.992 | 0.656 | 0.645 | 0.0 | |
| 225441728 | 662 | PREDICTED: serine/threonine-protein kina | 0.992 | 0.965 | 0.647 | 0.0 | |
| 255571602 | 700 | ATP binding protein, putative [Ricinus c | 0.976 | 0.898 | 0.653 | 0.0 | |
| 356503464 | 647 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.978 | 0.611 | 0.0 | |
| 356572052 | 643 | PREDICTED: serine/threonine-protein kina | 0.976 | 0.978 | 0.600 | 0.0 | |
| 449453832 | 691 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.911 | 0.571 | 0.0 | |
| 359478747 | 597 | PREDICTED: serine/threonine-protein kina | 0.925 | 0.998 | 0.574 | 0.0 | |
| 297739704 | 613 | unnamed protein product [Vitis vinifera] | 0.597 | 0.628 | 0.762 | 1e-172 | |
| 449518318 | 629 | PREDICTED: serine/threonine-protein kina | 0.881 | 0.903 | 0.546 | 1e-166 | |
| 356498521 | 1040 | PREDICTED: uncharacterized protein LOC10 | 0.720 | 0.446 | 0.624 | 1e-162 |
| >gi|147843683|emb|CAN81991.1| hypothetical protein VITISV_040411 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2147), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/663 (64%), Positives = 502/663 (75%), Gaps = 24/663 (3%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
METE D++ K+EDYEVIEQIGRGAFG+AFLVL+K E+KKYVLKKIR+AKQTEKFKRTA
Sbjct: 312 METEESDTRLKMEDYEVIEQIGRGAFGSAFLVLNKTEKKKYVLKKIRVAKQTEKFKRTAH 371
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
QEM+LI++L+NPYIV+YKDAWVDKG VCIVTGYCEGGDMA IKKARGA FPEEKLCKW
Sbjct: 372 QEMELIARLDNPYIVEYKDAWVDKGCSVCIVTGYCEGGDMAGAIKKARGALFPEEKLCKW 431
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNY 180
LTQLLLAVDYLHSNRVLHRDLKCSNIFLTK++DIRLGDFGLAKLL+TEDLASSVVGTPNY
Sbjct: 432 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKESDIRLGDFGLAKLLSTEDLASSVVGTPNY 491
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240
MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS
Sbjct: 492 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 551
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSP 300
T+KQIIKSMLRKNPEHRPTA++LLRHPHLQPYL+RC+N SS++LP+K +I K+KT + P
Sbjct: 552 TLKQIIKSMLRKNPEHRPTAAELLRHPHLQPYLVRCRNTSSIFLPVKSEHISKDKTPRKP 611
Query: 301 SS-KHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKV 359
S KH++ KD ++E +V + +N VQ NL KPT TE+ LETK+V
Sbjct: 612 SPIKHSAGKDNRDKEGRVLKMAGSVEPLEENANVQPRNLQNKAKPTPIXQTEEXLETKRV 671
Query: 360 DPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNG-------------STGSDLTSE 406
DPTSY EVS+++ SK ST T+ + D+Q NG STGS S+
Sbjct: 672 DPTSYPEEVSNAVESSKGGSTSCATTITNEDEQV--NGILLAQKESLDTETSTGSTPNSQ 729
Query: 407 ITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSD-RVIEEADIEGESAVPLDCGKM 465
+ + E A H ++ D++ V S+D S+ +V A+ E +S P + G M
Sbjct: 730 PGDEKEQDESESAPKHFAQIQDGDIKNVTSEDDAMESNTQVPAGAETESKSLQPGNHGAM 789
Query: 466 TPSSAGCNGNNESPDDKSSSSAI------YEPEVAPGSCSPKINSDNAQ-NGEAHMGNLS 518
SSA S DD+SS+S+ YEP P C K+ S ++Q G A + +S
Sbjct: 790 ATSSANSTDKGGSLDDESSNSSSATQGIEYEPNAEPSCCLQKMESPDSQAEGGAQIDYIS 849
Query: 519 SASNDALPCKDEAQTKPDNTSCSMQTEKDDSRAFNLAPSDISLLSTVTGISCDEIRAEWE 578
S SND LPCKDEA K DNTSCSM KDD N APS++SLLST+T + DE + EW+
Sbjct: 850 SESNDILPCKDEAGAKTDNTSCSMVMAKDDMNTMNKAPSEVSLLSTLTAVGGDETKGEWD 909
Query: 579 NPTQQRADALESLLELCARLLKQDKLDELAGVLRPFGEETVSSRETAIWLTKSLVSAQKF 638
NP+QQRADALESLLELCARLL+QDKL+ELAGVL+PFGEE VSSRETAIWLTKSL++AQKF
Sbjct: 910 NPSQQRADALESLLELCARLLQQDKLEELAGVLKPFGEEAVSSRETAIWLTKSLMTAQKF 969
Query: 639 NGG 641
GG
Sbjct: 970 LGG 972
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225441728|ref|XP_002277339.1| PREDICTED: serine/threonine-protein kinase Nek6-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2147), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/663 (64%), Positives = 503/663 (75%), Gaps = 24/663 (3%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
METE D++ K+EDYEVIEQIGRGAFG+AFLVL+K E+KKYVLKKIR+AKQTEKFKRTA
Sbjct: 1 METEESDTRLKMEDYEVIEQIGRGAFGSAFLVLNKTEKKKYVLKKIRVAKQTEKFKRTAH 60
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
QEM+LI++L+NPYIV+YKDAWVDKG VCIVTGYCEGGDMA IKKARGA FPEEKLCKW
Sbjct: 61 QEMELIARLDNPYIVEYKDAWVDKGCSVCIVTGYCEGGDMAGAIKKARGALFPEEKLCKW 120
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNY 180
LTQLLLAVDYLHSNRVLHRDLKCSNIFLTK++DIRLGDFGLAKLL+TEDLASSVVGTPNY
Sbjct: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKESDIRLGDFGLAKLLSTEDLASSVVGTPNY 180
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240
MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS
Sbjct: 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSP 300
T+KQIIKSMLRKNPEHRPTA++LLRHPHLQPYL+RC+N SS++LP+K +I K+KT + P
Sbjct: 241 TLKQIIKSMLRKNPEHRPTAAELLRHPHLQPYLVRCRNTSSIFLPVKSEHISKDKTPRKP 300
Query: 301 SS-KHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKV 359
S KH++ KD ++E +V + +N VQ NL KPT TE+NLETK+V
Sbjct: 301 SPIKHSAGKDNRDKEGRVLKMAGSVEPLEENANVQPRNLQNKAKPTPIVQTEENLETKRV 360
Query: 360 DPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNG-------------STGSDLTSE 406
DPTSY EVS+++ SK ST T+ + D+Q NG STGS S+
Sbjct: 361 DPTSYPEEVSNAVESSKGGSTSCATTITNEDEQ--VNGILLAQKESLDTETSTGSTPNSQ 418
Query: 407 ITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSD-RVIEEADIEGESAVPLDCGKM 465
+ + E A H ++ D++ V S+D S+ +V A+ E +S P + G M
Sbjct: 419 PGDEKEQDESESAPKHFAQIQDGDIKNVTSEDDAMESNTQVPAGAETESKSLQPGNHGAM 478
Query: 466 TPSSAGCNGNNESPDDKSSSSAI------YEPEVAPGSCSPKINSDNAQ-NGEAHMGNLS 518
SSA S DD+SS+S+ YEP P C K+ S ++Q G A + +S
Sbjct: 479 ATSSANSTDKGGSLDDESSNSSSATQGIEYEPNAEPSCCLQKMESPDSQAEGGAQIDYIS 538
Query: 519 SASNDALPCKDEAQTKPDNTSCSMQTEKDDSRAFNLAPSDISLLSTVTGISCDEIRAEWE 578
S SND LPCKDEA K DNTSCSM KDD N APS++SLLST+T + DE + EW+
Sbjct: 539 SESNDILPCKDEAGAKTDNTSCSMVMAKDDMNTMNKAPSEVSLLSTLTAVGGDETKGEWD 598
Query: 579 NPTQQRADALESLLELCARLLKQDKLDELAGVLRPFGEETVSSRETAIWLTKSLVSAQKF 638
NP+QQRADALESLLELCARLL+QDKL+ELAGVL+PFGEE VSSRETAIWLTKSL++AQKF
Sbjct: 599 NPSQQRADALESLLELCARLLQQDKLEELAGVLKPFGEEAVSSRETAIWLTKSLMTAQKF 658
Query: 639 NGG 641
GG
Sbjct: 659 LGG 661
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255571602|ref|XP_002526747.1| ATP binding protein, putative [Ricinus communis] gi|223533936|gb|EEF35661.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 814 bits (2102), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/656 (65%), Positives = 487/656 (74%), Gaps = 27/656 (4%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
ME +NG+ KSK+EDYEVIEQIGRGA FL +YVLKKIRLAKQTEKFKRTA
Sbjct: 58 MEADNGEVKSKMEDYEVIEQIGRGA--XXFL--------QYVLKKIRLAKQTEKFKRTAH 107
Query: 61 QE-------MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFP 113
QE D ++ PYIV+YKD+WVDKGNCVCIVTGYCEGGDMA IIKKARG FP
Sbjct: 108 QEETLLICTADGVNAQXXPYIVEYKDSWVDKGNCVCIVTGYCEGGDMAAIIKKARGIYFP 167
Query: 114 EEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS 173
EEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND+RLGDFGLAKLLNTEDLASS
Sbjct: 168 EEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDVRLGDFGLAKLLNTEDLASS 227
Query: 174 VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP 233
VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH PAFRAPDMAGLINKINRSSISP
Sbjct: 228 VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHHPAFRAPDMAGLINKINRSSISP 287
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMK 293
LPIVYSS++KQIIKSMLRKNPEHRPTAS+LLRHPHLQ YLLRC+N SSVYLPIKP K
Sbjct: 288 LPIVYSSSLKQIIKSMLRKNPEHRPTASELLRHPHLQSYLLRCRNASSVYLPIKPITNSK 347
Query: 294 EKT-RKSPSSKHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTED 352
+KT RKS K + KD +RE NQ EN +N+ Q + + D PTS++S ED
Sbjct: 348 DKTKRKSLLGKPSGIKDNRDREVRPLNQPENDHPFQRNVVQQRKSSHI-DIPTSTSSAED 406
Query: 353 NLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHF-----NGSTGSDLTSEI 407
NLETK+VDPTSYT+E+S S+ K+ ST +ETS C+ +KQ+ N T + T E
Sbjct: 407 NLETKRVDPTSYTVELSDSMTGPKDSSTDSETSVCNGEKQSDSSPLAQNDGTEIEFTLES 466
Query: 408 TANSQNEIQEPADAHVQPAEEIDVETVKSKDQ-NPFSDRVIEEADIEGESAVPLDCGKMT 466
T SQ+E+ EP H Q E+DV+ V +KDQ +P +VIEEA IE A D +
Sbjct: 467 TLTSQHEV-EPTSKHSQQLREVDVKIVTTKDQLHPCDQKVIEEAQIEEGGATTEDSRNLA 525
Query: 467 PSSAGCNGNNESPDDKSSSSAIYEPEVAPGSCSPKINSDNAQNGEAHMGNLSSASNDALP 526
S C + S DDK S +AI EP + P C K S + HM LSS + D LP
Sbjct: 526 VPSLDCIDKDTSNDDKGSPTAINEPYIEPERCLQKPESPDVYTEGTHMDYLSSDNIDILP 585
Query: 527 CKDEAQTKPDNTSCSMQTEKDDSRAFNLAPSDISLLSTVTGISCDEIRAEWENPTQQRAD 586
CKDE+ KPDN +CS++ EKDDS S ISLL+T+ + +E + EWENP QQRAD
Sbjct: 586 CKDESVAKPDN-NCSLELEKDDSHGMKPTASQISLLNTLAAMHANETKNEWENPGQQRAD 644
Query: 587 ALESLLELCARLLKQDKLDELAGVLRPFGEETVSSRETAIWLTKSLVSAQKFNGGT 642
ALESLLELCARLL+QDK+DELAGVL+PFGEE VSSRETAIWLTKSL+S KFNGGT
Sbjct: 645 ALESLLELCARLLRQDKIDELAGVLKPFGEEVVSSRETAIWLTKSLMSQHKFNGGT 700
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503464|ref|XP_003520528.1| PREDICTED: serine/threonine-protein kinase Nek6-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1962), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/652 (61%), Positives = 492/652 (75%), Gaps = 19/652 (2%)
Query: 1 METENGDSKSK-LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTA 59
ME ENGD++SK +E+Y+VIEQIGRGAFG+AFLVLHK E+K+YVLKKIRLAKQTEKFKRTA
Sbjct: 1 MEIENGDTRSKKMEEYQVIEQIGRGAFGSAFLVLHKSEKKRYVLKKIRLAKQTEKFKRTA 60
Query: 60 LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
QEMDLI+KLNNPYIV+YKDAWV+K + +CI+TGYCEGGDMAE IKKARG+ FPEEK+CK
Sbjct: 61 FQEMDLIAKLNNPYIVEYKDAWVEKDH-ICIITGYCEGGDMAENIKKARGSFFPEEKVCK 119
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN 179
WLTQLL+AVDYLHSNRV+HRDLKCSNIFLTKDN+IRLGDFGLAK LN EDLASSVVGTPN
Sbjct: 120 WLTQLLIAVDYLHSNRVIHRDLKCSNIFLTKDNNIRLGDFGLAKRLNAEDLASSVVGTPN 179
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS 239
YMCPELLADIPYGYKSD+WSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS
Sbjct: 180 YMCPELLADIPYGYKSDMWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS 239
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKS 299
ST+KQ+IKSMLRKNPEHRPTA++LLRHP LQPY+LRC N SS LP+ P K+KTR+
Sbjct: 240 STLKQLIKSMLRKNPEHRPTAAELLRHPLLQPYVLRCHNASSNVLPVYPLVNPKDKTRR- 298
Query: 300 PSSKHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKV 359
S+K + KD ++EA+ N+LE + + N +Q++NLP +D T STS EDNLET+
Sbjct: 299 -SNKSSGGKDHKDKEASLVNRLERIHPIEGNGDIQISNLP-NDAVTISTSAEDNLETRMA 356
Query: 360 DPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNG-----STGSDLTSEITANSQNE 414
D TSY +E +SI+ SK+ ST +E++ CS K+ F + ++++S+ T NS +E
Sbjct: 357 DLTSYIVESCTSISGSKDGSTTSESTICSVCKE-DFKSRPARETANNEISSKSTQNSMHE 415
Query: 415 IQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIEGESAVPLDCGKMTPSSAGCNG 474
Q A H EE ++ ++ ++ + ++ A+ + E + D GK T SSAG +
Sbjct: 416 KQRFAAKHFHKLEEDNINVATTEVEDASCNEGLDSAEAQREDSNFEDSGKSTMSSAGSST 475
Query: 475 NNESPDDKSSSSAIYEP-----EVAPGSCSPKINSDNAQNGEAHMGNLSSASNDALPCKD 529
+ + ++ SSS I P + G+ S K + + +HM L+S SNDALP KD
Sbjct: 476 DKDKSINEESSSLIMHPIRVEHDTESGNHSKKSKTPDVFTEVSHMNCLTSFSNDALPVKD 535
Query: 530 EAQTKPDNTSCSMQTEKDDSRAFNLAPSDISLLSTVTGISCDE-IRAEWENPTQQRADAL 588
+ + CS E D++ + AP +S LS +T + DE I+ ++P QQRADAL
Sbjct: 536 DDMANV-HILCSTHKEDDNAVEVDQAPRGVS-LSVITEVDGDETIKTPVDSPCQQRADAL 593
Query: 589 ESLLELCARLLKQDKLDELAGVLRPFGEETVSSRETAIWLTKSLVSAQKFNG 640
ESLLELCA+LLKQDKLDELAGVLRPFG+E VSSRETAIWL KSL+SAQKFN
Sbjct: 594 ESLLELCAQLLKQDKLDELAGVLRPFGKEAVSSRETAIWLAKSLMSAQKFNA 645
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572052|ref|XP_003554184.1| PREDICTED: serine/threonine-protein kinase Nek6-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1857), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/656 (60%), Positives = 485/656 (73%), Gaps = 27/656 (4%)
Query: 1 METENGDSKSK-LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTA 59
METENGD++SK +E+YEVIEQIGRGAFG+AFLVLHK YVLKKIRLAKQTEKFKRTA
Sbjct: 1 METENGDTRSKKMEEYEVIEQIGRGAFGSAFLVLHK-----YVLKKIRLAKQTEKFKRTA 55
Query: 60 LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
QEM+LI+KLNNPYIV YKDAWV+K + +CI+TGYCEGGDMAE IKKARG+ FPEEK+CK
Sbjct: 56 HQEMNLIAKLNNPYIVDYKDAWVEKEDHICIITGYCEGGDMAENIKKARGSFFPEEKVCK 115
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN 179
WLTQLL+AVDYLHSNRV+HRDLKCSNIFLTKDN+IRLGDFGLAK LN EDLASSVVGTPN
Sbjct: 116 WLTQLLIAVDYLHSNRVIHRDLKCSNIFLTKDNNIRLGDFGLAKRLNAEDLASSVVGTPN 175
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS 239
YMCPELLADIPYGYKSD+WSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS
Sbjct: 176 YMCPELLADIPYGYKSDMWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS 235
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKS 299
ST+KQ+IKSMLRKNPEHRPTA++LLRHP LQPY+LRC N SS LP+ P K+K R+
Sbjct: 236 STLKQLIKSMLRKNPEHRPTAAELLRHPLLQPYVLRCHNASSNVLPVYPLVNPKDKARR- 294
Query: 300 PSSKHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKV 359
+K + KD ++EA N LE + + N +Q++NLP +D T STS EDNLET+
Sbjct: 295 -PNKSSGGKDHKDKEAGLVNCLERIHPIEGNADIQISNLP-NDVVTISTSAEDNLETRMA 352
Query: 360 DPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGS-----TGSDLTSEITANSQNE 414
+ TSY +E S+SI+ SK+ ST +E++ CS K+ F T ++++S+ T +S +E
Sbjct: 353 NLTSYIVESSTSISGSKDGSTTSESTICSVCKE-DFKSRPAREMTNNEISSKSTQDSLHE 411
Query: 415 IQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIEGESAVPLDCGK--MTPSSAGC 472
Q A H E+ D+ V ++ ++ + ++ A+ + E + D GK M+ +
Sbjct: 412 EQRFAAKHFHKLEDDDINAVTAEVEDASCNGGLDNAEAQREDSNLEDSGKSTMSSEGSSS 471
Query: 473 NGNNESPDDKSSSSAIY----EPEVAPGSCSPKINSDNAQNGEAHMGNLSSASNDALPCK 528
++S +++ SS ++ E + G+ K + + HM L S SNDALP K
Sbjct: 472 TDKDKSINEERSSLIVHPIRVENDTESGNRLKKSENPDVYTEVPHMNCLMSVSNDALPVK 531
Query: 529 DEAQTKPDNTSCSMQTEKDDSRA-FNLAPSDISLLSTVTGISCDE-IRAEWENPTQQRAD 586
D+ + CS T KDD+ + APS IS LS +T + DE I+ ++P QQRAD
Sbjct: 532 DD-DIANGHILCS--THKDDNVVEVDQAPSGIS-LSVITEVDGDETIKTPLDSPCQQRAD 587
Query: 587 ALESLLELCARLLKQDKLDELAGVLRPFGEETVSSRETAIWLTKSLVSAQKFNGGT 642
ALESLLELCA+LLKQDKL+ELAGVLRPFG+E VSSRETAIWL KSL+S+QKFN T
Sbjct: 588 ALESLLELCAQLLKQDKLEELAGVLRPFGKEAVSSRETAIWLAKSLISSQKFNPET 643
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449453832|ref|XP_004144660.1| PREDICTED: serine/threonine-protein kinase Nek7-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/702 (57%), Positives = 478/702 (68%), Gaps = 72/702 (10%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
ME++NGD K+++EDYEVIEQIGRGAFG+AFLV HK E+KKYVLKKIRLAKQTEKFKRTA
Sbjct: 1 MESDNGDMKTRMEDYEVIEQIGRGAFGSAFLVYHKTEKKKYVLKKIRLAKQTEKFKRTAH 60
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
QEM+LI+KLNNPYIV YKD+WVDKG+C+CIVTGYCEGGDM+E+IKKARG FPEEKLCKW
Sbjct: 61 QEMNLIAKLNNPYIVDYKDSWVDKGDCICIVTGYCEGGDMSELIKKARGTYFPEEKLCKW 120
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNY 180
L QLLLAVDYLHSNRVLHRDLKCSNIFLTK NDIRLGDFGLAKLLNTEDLASSVVGTPNY
Sbjct: 121 LAQLLLAVDYLHSNRVLHRDLKCSNIFLTKGNDIRLGDFGLAKLLNTEDLASSVVGTPNY 180
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240
MCPELLADIPYGYKSDIWSLGCCMFEI+AHQPAFRAPDMA LINKINRSSISPLPIVYSS
Sbjct: 181 MCPELLADIPYGYKSDIWSLGCCMFEISAHQPAFRAPDMASLINKINRSSISPLPIVYSS 240
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNI-MKEKT-RK 298
T+KQIIKSMLRKNPEHRPTA++LLRHPH+QPY+L+C+N S+ LPI P I K+KT RK
Sbjct: 241 TLKQIIKSMLRKNPEHRPTAAELLRHPHMQPYVLQCRNASANILPIYPLPINSKDKTPRK 300
Query: 299 SPSSKHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKK 358
SPS+K N + + + A N LEN+ V + + +N D+ + + +ED LETK
Sbjct: 301 SPSNKLNGGHEIRAKPSIAFNLLENIDLVGGSGDIHNSNSSTDENMSLTAISEDILETKM 360
Query: 359 VDPTSYTMEVSSSINDSKERSTQTETSDCS------RDKQAHFNGSTGSDLTS----EIT 408
VDPTS+ E+S+S D+ + T TS S DKQ NG + T +I+
Sbjct: 361 VDPTSFPDEISTS--DAVDSGTDGLTSSLSPTLTSNGDKQ---NGGIAVECTEPPAIKIS 415
Query: 409 -ANSQNEIQEPADA-HVQPAEEIDVETVK--------SKDQNPF----------SDRVIE 448
NS N +Q DA + Q E D++TV SK + S+R +E
Sbjct: 416 PENSPNYLQREPDAENFQQLREFDIKTVNLHEPKISCSKQTSNVTVTGMKPEETSERKVE 475
Query: 449 ------------------------EADIEGESAVPLDCGKMTPSSAGCNGNNESPDDKSS 484
+ ++E S+V + K P AGC+ S +
Sbjct: 476 LLMSSVGIAEKSSSDDKCLLNSADQLNVELRSSVNQESFKEHP-EAGCSSCLTSEKATTG 534
Query: 485 SSAI-YEPEVAPGSCSPKINSDNAQNGEAHMGNLSSASNDALPCKDEAQTKPDNTSCSMQ 543
+ E E C P ++ G LS +++ L KDE D TSC+ Q
Sbjct: 535 MELVSSEKESVRTDCLP------SEKGSHTDCTLSEITSNILSRKDEIHVNSDGTSCATQ 588
Query: 544 TEKDDS-RAFNLAPSDISLLSTVT--GISCDEIRAEWENPTQQRADALESLLELCARLLK 600
+++ + A SD+S +ST T G D E E P+Q+RADALESLLELCARLLK
Sbjct: 589 MITNENIHQHHRAGSDVSEISTQTASGGGDDTKSTESEYPSQRRADALESLLELCARLLK 648
Query: 601 QDKLDELAGVLRPFGEETVSSRETAIWLTKSLVSAQKFNGGT 642
QDKL+ELAGVL PFGEE VSSRETAIWLTKSL+S+QK N G+
Sbjct: 649 QDKLEELAGVLSPFGEEAVSSRETAIWLTKSLMSSQKSNDGS 690
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478747|ref|XP_002282977.2| PREDICTED: serine/threonine-protein kinase Nek6-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1752), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/632 (57%), Positives = 438/632 (69%), Gaps = 36/632 (5%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+EDYEVIEQIGRGAFGAAFLVLHK E+KKYVLKKIRLAKQTEKFKRTA QEM+LISKLNN
Sbjct: 1 MEDYEVIEQIGRGAFGAAFLVLHKTEKKKYVLKKIRLAKQTEKFKRTAHQEMNLISKLNN 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
PYIV YK+AWV+KG CVCIVT YCEGGDMAE+IKKARG PEEKLCKW+ QLLLAVDYL
Sbjct: 61 PYIVGYKEAWVEKGCCVCIVTSYCEGGDMAEMIKKARGTLLPEEKLCKWMAQLLLAVDYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
HSNRVLHRDLKCSNIFLTK+NDIRLGDFGLAKLL+T+DLASS+VGTPNYMCPELLADIPY
Sbjct: 121 HSNRVLHRDLKCSNIFLTKNNDIRLGDFGLAKLLSTDDLASSIVGTPNYMCPELLADIPY 180
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
GYKSDIWSLGCCMFE+AAH PAFRAPDMAGLINKINRSS+S LP VYSST+KQ+IKSMLR
Sbjct: 181 GYKSDIWSLGCCMFEMAAHHPAFRAPDMAGLINKINRSSMSLLPTVYSSTLKQLIKSMLR 240
Query: 252 KNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNS-RKDK 310
KNPEHRPTA++LLRHPHLQPY+ +CQN V+LPIK +KT + SS +S KD
Sbjct: 241 KNPEHRPTAAELLRHPHLQPYVAQCQNIPPVFLPIKSEYNSNDKTSGTRSSNKSSIDKDS 300
Query: 311 GEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKVDPTSYTMEVSS 370
++ +LENV+ V N V N + PTSS S E + TK+VDPT
Sbjct: 301 KGGKSRLRKELENVQLVKGNTDVHKQNPAYNQMPTSSDSLEARVHTKRVDPT-------- 352
Query: 371 SINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEID 430
S D ++ + D + +Q ++ ++ S T+++ E EP + + A+++
Sbjct: 353 SCYDQMPKANKGLVVDPNFTEQTE---NSNAETASVRTSSTHQEDVEPDELISECAQKVK 409
Query: 431 VETVKSKDQNPFSDRVIEEADIEGESAVPLDCGKMTPSSAGCNGNNESPDDKSSSSAIYE 490
E +V +EAD E E L G + PS A A E
Sbjct: 410 KE-----------GQVTDEADTEEERLETLYAGPIPPSEA-------------MKIAKQE 445
Query: 491 PEVAPGSCSPKINSDNAQNGEAHMGNLSSASNDALPCKDEAQTKPDNTSCSMQTEKDDSR 550
E+ P C + + ++ MGN S S LP ++E + K D QT K +R
Sbjct: 446 REIVPSCCLHTMENLSSYPANTSMGNSSMESTVTLPSENEQEAKTDTLIIPFQTPKKGAR 505
Query: 551 AFNLAPSDISLLSTVTGISCDEIRAEWENPTQQRADALESLLELCARLLKQDKLDELAGV 610
N A SDIS + T + ++ + + ++ QQRA+ALESLLELCARLL+Q++L+ELAGV
Sbjct: 506 ELNRAVSDISSIITPSMLNSNNRSIDLDHLNQQRAEALESLLELCARLLRQERLEELAGV 565
Query: 611 LRPFGEETVSSRETAIWLTKSLVSAQKFNGGT 642
L+PFGEE VSSRETAIWLTKS+ S K NGG+
Sbjct: 566 LKPFGEEAVSSRETAIWLTKSIASLGKHNGGS 597
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297739704|emb|CBI29886.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1576), Expect = e-172, Method: Compositional matrix adjust.
Identities = 296/388 (76%), Positives = 335/388 (86%), Gaps = 3/388 (0%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
METE D++ K+EDYEVIEQIGRGAFG+AFLVL+K E+KKYVLKKIR+AKQTEKFKRTA
Sbjct: 115 METEESDTRLKMEDYEVIEQIGRGAFGSAFLVLNKTEKKKYVLKKIRVAKQTEKFKRTAH 174
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
QEM+LI++L+NPYIV+YKDAWVDKG VCIVTGYCEGGDMA IKKARGA FPEEKLCKW
Sbjct: 175 QEMELIARLDNPYIVEYKDAWVDKGCSVCIVTGYCEGGDMAGAIKKARGALFPEEKLCKW 234
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNY 180
LTQLLLAVDYLHSNRVLHRDLKCSNIFLTK++DIRLGDFGLAKLL+TEDLASSVVGTPNY
Sbjct: 235 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKESDIRLGDFGLAKLLSTEDLASSVVGTPNY 294
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240
MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS
Sbjct: 295 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 354
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSP 300
T+KQIIKSMLRKNPEHRPTA++LLRHPHLQPYL+RC+N SS++LP+K +I K+KT + P
Sbjct: 355 TLKQIIKSMLRKNPEHRPTAAELLRHPHLQPYLVRCRNTSSIFLPVKSEHISKDKTPRKP 414
Query: 301 SS-KHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKV 359
S KH++ KD ++E +V + +N VQ NL KPT TE+NLETK+V
Sbjct: 415 SPIKHSAGKDNRDKEGRVLKMAGSVEPLEENANVQPRNLQNKAKPTPIVQTEENLETKRV 474
Query: 360 DPTSYTMEVSSSINDSK--ERSTQTETS 385
DPTSY EVS+++ SK + S TETS
Sbjct: 475 DPTSYPEEVSNAVESSKAQKESLDTETS 502
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449518318|ref|XP_004166189.1| PREDICTED: serine/threonine-protein kinase Nek7-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1528), Expect = e-166, Method: Compositional matrix adjust.
Identities = 350/640 (54%), Positives = 420/640 (65%), Gaps = 72/640 (11%)
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
M+LI+KLNNPYIV YKD+WVDKG+C+CIVTGYCEGGDM+E+IKKARG FPEEKLCKWL
Sbjct: 1 MNLIAKLNNPYIVDYKDSWVDKGDCICIVTGYCEGGDMSELIKKARGTYFPEEKLCKWLA 60
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMC 182
QLLLAVDYLHSNRVLHRDLKCSNIFLTK NDIRLGDFGLAKLLNTEDLASSVVGTPNYMC
Sbjct: 61 QLLLAVDYLHSNRVLHRDLKCSNIFLTKGNDIRLGDFGLAKLLNTEDLASSVVGTPNYMC 120
Query: 183 PELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242
PELLADIPYGYKSDIWSLGCCMFEI+AHQPAFRAPDMA LINKINRSSISPLPIVYSST+
Sbjct: 121 PELLADIPYGYKSDIWSLGCCMFEISAHQPAFRAPDMASLINKINRSSISPLPIVYSSTL 180
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNI-MKEKT-RKSP 300
KQIIKSMLRKNPEHRPTA++LLRHPH+QPY+L+C+N S+ LPI P I K+KT RKSP
Sbjct: 181 KQIIKSMLRKNPEHRPTAAELLRHPHMQPYVLQCRNASANILPIYPLPINSKDKTPRKSP 240
Query: 301 SSKHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKVD 360
S+K N + + + A N LEN+ V + + +N D+ + + +ED LETK VD
Sbjct: 241 SNKLNGGHEIRAKPSIAFNLLENIDLVGGSGDIHNSNSSTDENMSLTAISEDILETKMVD 300
Query: 361 PTSYTMEVSSSINDSKERSTQTETSDCS------RDKQAHFNGSTGSDLTS----EITA- 409
PTS+ E+S+S D+ + T TS S DKQ NG + T +I+
Sbjct: 301 PTSFPDEISTS--DAVDSGTDGLTSSLSPTLTSNGDKQ---NGGIAVECTEPPAIKISPE 355
Query: 410 NSQNEIQEPADA-HVQPAEEIDVETVK--------SKDQNPF----------SDRVIE-- 448
NS N +Q DA + Q E D++TV SK + S+R +E
Sbjct: 356 NSPNYLQREPDAENFQQLREFDIKTVNLHEPKISCSKQTSNVTVTGMKPEETSERKVELL 415
Query: 449 ----------------------EADIEGESAVPLDCGKMTPSSAGCNGNNESPDDKSSSS 486
+ ++E S+V + K P AGC+ S +
Sbjct: 416 MSSVGIAEKSSSDDKCLLNSADQLNVELRSSVNQESFKEHP-EAGCSSCLTSEKATTGME 474
Query: 487 AI-YEPEVAPGSCSPKINSDNAQNGEAHMGNLSSASNDALPCKDEAQTKPDNTSCSMQTE 545
+ E E C P ++ G LS +++ L KDE D TSC+ Q
Sbjct: 475 LVSSEKESVRTDCLP------SEKGSHTDCTLSEITSNILSRKDEIHVNSDGTSCATQMI 528
Query: 546 KDDS-RAFNLAPSDISLLSTVT--GISCDEIRAEWENPTQQRADALESLLELCARLLKQD 602
+++ + A SD+S +ST T G D E E P+Q+RADALESLLELCARLLKQD
Sbjct: 529 TNENIHQHHRAGSDVSEISTQTASGGGDDTKSTESEYPSQRRADALESLLELCARLLKQD 588
Query: 603 KLDELAGVLRPFGEETVSSRETAIWLTKSLVSAQKFNGGT 642
KL+ELAGVL PFGEE VSSRETAIWLTKSL+S+QK N G+
Sbjct: 589 KLEELAGVLSPFGEEAVSSRETAIWLTKSLMSSQKSNDGS 628
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498521|ref|XP_003518099.1| PREDICTED: uncharacterized protein LOC100796658 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1493), Expect = e-162, Method: Compositional matrix adjust.
Identities = 299/479 (62%), Positives = 357/479 (74%), Gaps = 15/479 (3%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLI 66
+S K+EDYEVI+QIGRGA GA FLVLHKIE K+YVLKKIRLAKQ +K K TA QEMDLI
Sbjct: 2 ESSGKMEDYEVIQQIGRGALGATFLVLHKIENKRYVLKKIRLAKQADKSKVTAQQEMDLI 61
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
+KL+ PYIV+YKDAWV+K + +CI+TGYCEGGDMA IKKARG+ F EEK+CKWLTQLLL
Sbjct: 62 AKLHYPYIVEYKDAWVEKDDYICIITGYCEGGDMAANIKKARGSYFSEEKVCKWLTQLLL 121
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
AVDYLHSNRVLHRD+KCSNIFLTK+N+IRLG+FGLAKLLNTEDL S VVGT NYMCPE
Sbjct: 122 AVDYLHSNRVLHRDIKCSNIFLTKENNIRLGEFGLAKLLNTEDLTSPVVGTLNYMCPEAF 181
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
A +PYGYKSD+WSLGCCMFEI AHQPAFRAPD AGLINKINRSSISPLPIVYSST+KQ+I
Sbjct: 182 AGMPYGYKSDMWSLGCCMFEIVAHQPAFRAPDRAGLINKINRSSISPLPIVYSSTLKQLI 241
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNI-MKEKTRKSPSSKHN 305
KSMLRKNPEHRPTAS+LL++PHLQPY+LRC+N SS++LP+ N K+KT+ SS
Sbjct: 242 KSMLRKNPEHRPTASELLKNPHLQPYVLRCRNASSIFLPVHLINSNSKDKTKTKSSS--- 298
Query: 306 SRKDKGEREAAAP---NQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKVDPT 362
KD EREAA N+L+ + + N VQ N D K STS EDNLETK VD T
Sbjct: 299 GSKDHWEREAALAGLVNRLDRLYPLEGNGDVQSRNWHNDGKLAVSTSAEDNLETKMVDLT 358
Query: 363 SYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNG-----STGSDLTSEITANSQNEIQE 417
SYT+E S+SI+ SK+ ST +E++ CS K+ + S++TS+ T +S E ++
Sbjct: 359 SYTVEFSTSISGSKDGSTTSESTVCSVCKEGDSKNRLTRDTADSEITSKSTMDSGLE-EQ 417
Query: 418 PADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIEGESAVPLDCGKMTPSSAGCNGNN 476
D H A ID+ TV +K ++ FS+ + E P D K SS NGN+
Sbjct: 418 GLDCHKSYA--IDINTVINKVEDTFSNEDFNTDEALSEGVKPEDSSKSIMSSEDSNGND 474
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 644 | ||||||
| TAIR|locus:2081383 | 956 | NEK6 ""NIMA (never in mitosis, | 0.468 | 0.315 | 0.671 | 1.5e-128 | |
| TAIR|locus:2114885 | 606 | NEK2 "NIMA-related kinase 2" [ | 0.740 | 0.787 | 0.458 | 4.2e-115 | |
| TAIR|locus:2077274 | 555 | NEK4 "NIMA-related kinase 4" [ | 0.475 | 0.551 | 0.597 | 1.6e-113 | |
| TAIR|locus:2020148 | 612 | NEK1 "NIMA-related serine/thre | 0.607 | 0.638 | 0.520 | 5.5e-113 | |
| TAIR|locus:2185314 | 568 | NEK3 "NIMA-related kinase 3" [ | 0.504 | 0.572 | 0.589 | 9e-111 | |
| UNIPROTKB|E1C5S2 | 786 | NEK4 "Uncharacterized protein" | 0.402 | 0.329 | 0.411 | 1.8e-64 | |
| ZFIN|ZDB-GENE-040426-1392 | 849 | nek4 "NIMA (never in mitosis g | 0.628 | 0.477 | 0.326 | 1.2e-63 | |
| UNIPROTKB|E1BWZ5 | 838 | NEK4 "Uncharacterized protein" | 0.402 | 0.309 | 0.411 | 1.1e-62 | |
| MGI|MGI:1344404 | 792 | Nek4 "NIMA (never in mitosis g | 0.631 | 0.513 | 0.326 | 4.8e-62 | |
| RGD|1304995 | 309 | Nek4 "NIMA-related kinase 4" [ | 0.402 | 0.838 | 0.419 | 1.3e-61 |
| TAIR|locus:2081383 NEK6 ""NIMA (never in mitosis, gene A)-related 6"" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 1.5e-128, Sum P(3) = 1.5e-128
Identities = 204/304 (67%), Positives = 252/304 (82%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
+S+++ YE++EQIGRGAFGAA LV HK ERKKYVLKKIRLA+QTE+ +R+A QEM LI++
Sbjct: 2 ESRMDQYELMEQIGRGAFGAAILVHHKAERKKYVLKKIRLARQTERCRRSAHQEMSLIAR 61
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
+ +PYIV++K+AWV+KG VCIVTGYCEGGDMAE++KK+ G FPEEKLCKW TQLLLAV
Sbjct: 62 VQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDMAELMKKSNGVYFPEEKLCKWFTQLLLAV 121
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD 188
+YLHSN VLHRDLKCSNIFLTKD D+RLGDFGLAK L +DL SSVVGTPNYMCPELLAD
Sbjct: 122 EYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFGLAKTLKADDLTSSVVGTPNYMCPELLAD 181
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248
IPYG+KSDIWSLGCC++E+AA++PAF+A DMAGLI+K+NRSSI PLP YS ++K +IK
Sbjct: 182 IPYGFKSDIWSLGCCIYEMAAYRPAFKAFDMAGLISKVNRSSIGPLPPCYSPSLKALIKG 241
Query: 249 MLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSV--YLPIKPTNIMKEKTRKSPSSKHNS 306
MLRKNPE+RP AS++L+HP+LQPY+ + + S P KP N + + + S NS
Sbjct: 242 MLRKNPEYRPNASEILKHPYLQPYVEQYRPTLSAASITPEKPLNSREGRRSMAESQNSNS 301
Query: 307 RKDK 310
+K
Sbjct: 302 SSEK 305
|
|
| TAIR|locus:2114885 NEK2 "NIMA-related kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 4.2e-115, Sum P(2) = 4.2e-115
Identities = 230/502 (45%), Positives = 324/502 (64%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+E+YEV+EQIG+G+FG+A LV HK E+K YVLKKIRLA+QT + +R+A QEM+LISK++N
Sbjct: 1 MENYEVLEQIGKGSFGSALLVRHKHEKKLYVLKKIRLARQTGRTRRSAHQEMELISKIHN 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P+IV+YKD+WV+KG VCI+ GYC+GGDMAE IKK G F EEKLCKWL Q+LLA++YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIIIGYCKGGDMAEAIKKTNGVHFTEEKLCKWLVQILLALEYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
H+N +LHRD+KCSNIFLTKD DIRLGDFGLAK+L ++DLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HANHILHRDVKCSNIFLTKDQDIRLGDFGLAKVLTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
G KSDIWSLGCCM+E+ A +PAF+A DM GLIN+INRS + PLP YS+ + ++KSMLR
Sbjct: 181 GSKSDIWSLGCCMYEMTAMKPAFKAFDMQGLINRINRSIVPPLPAQYSAAFRGLVKSMLR 240
Query: 252 KNPEHRPTASDLLRHPHLQPYL----LRCQNPSSVYLPIK-PTNIMKEKTRKSPSSKHNS 306
KNPE RP+A++LLR P LQPY+ L+ +P S LP + P + E R++ S
Sbjct: 241 KNPELRPSAAELLRQPLLQPYIQKIHLKVNDPGSNVLPAQWPES---ESARRN-SFPEQR 296
Query: 307 RKDKGEREAAAPNQL-----ENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLE-TKKVD 360
R+ G+ + P++ ++V S+ K + LN D T ++ + T +
Sbjct: 297 RRPAGKSHSFGPSRFRGNLEDSVSSIKKTVPAYLNRERQVDLSTDASGDGTVVRRTSEAS 356
Query: 361 PTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPAD 420
+S + V +S + + R +++ Q N + + +S+ +E D
Sbjct: 357 KSSRYVPVRASASPVRPRQPRSDLGQLPVSSQLK-NRKPAALIRRASMPSSRKPAKEIKD 415
Query: 421 AHVQPAEEIDVETVKSKDQNPFSDRV--IEE--ADIEGESAVPLDCGKMTPSSAGCNGNN 476
+ + ++ + + S D + + R+ IE A E E VP+ GK +S+ G+
Sbjct: 416 S-LYISKTSFLHQINSPDVSMNAPRIDKIEFPLASYEEEPFVPVVRGKKKKASS--RGSY 472
Query: 477 ESPDDKSSSSAIYEPE--VAPG 496
P + +I + + + PG
Sbjct: 473 SPPPEPPLDCSITKDKFTLEPG 494
|
|
| TAIR|locus:2077274 NEK4 "NIMA-related kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1013 (361.7 bits), Expect = 1.6e-113, Sum P(2) = 1.6e-113
Identities = 187/313 (59%), Positives = 247/313 (78%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+E YEV+EQIG+G+FG+A LV HK ERKKYVLKKIRLA+Q+++ +R+A QEM+LIS + N
Sbjct: 1 MERYEVLEQIGKGSFGSALLVRHKQERKKYVLKKIRLARQSDRARRSAHQEMELISTVRN 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P++V+YKD+WV+KG VCIV GYC+GGDM + IK+A G FPEEKLC+WL QLL+A+DYL
Sbjct: 61 PFVVEYKDSWVEKGCYVCIVIGYCQGGDMTDTIKRACGVHFPEEKLCQWLVQLLMALDYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
HSN +LHRD+KCSNIFLTK+ DIRLGDFGLAK+L ++DL SSVVGTP+YMCPELLADIPY
Sbjct: 121 HSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
G KSDIWSLGCCM+E+AAH+P F+A D+ LI KI++ + P+P +YS + + +IKSMLR
Sbjct: 181 GSKSDIWSLGCCMYEMAAHKPPFKASDVQTLITKIHKLIMDPIPAMYSGSFRGLIKSMLR 240
Query: 252 KNPEHRPTASDLLRHPHLQPYL----LRCQNPSSVYLPIKPTN---IMKEKTRKSPSSKH 304
KNPE RP+A++LL HPHLQPY+ ++ ++P P++ + +KE+ R S S+
Sbjct: 241 KNPELRPSANELLNHPHLQPYISMVYMKLESPRRSTFPLQFSERDATLKERRRSSFSNDR 300
Query: 305 NSRKDKGEREAAA 317
+ EA +
Sbjct: 301 RLNPSVSDTEAGS 313
|
|
| TAIR|locus:2020148 NEK1 "NIMA-related serine/threonine kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 5.5e-113, Sum P(2) = 5.5e-113
Identities = 215/413 (52%), Positives = 286/413 (69%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+E YE +EQIG+G+FG+A LV HK E+KKYVLKKIRLA+QT++ +R+A QEM+LISK+ +
Sbjct: 1 MEQYEFLEQIGKGSFGSALLVRHKHEKKKYVLKKIRLARQTQRTRRSAHQEMELISKMRH 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P+IV+YKD+WV+K VCIV GYCEGGDMA+ IKK+ G F EEKLCKWL QLL+ ++YL
Sbjct: 61 PFIVEYKDSWVEKACYVCIVIGYCEGGDMAQAIKKSNGVHFQEEKLCKWLVQLLMGLEYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
HSN +LHRD+KCSNIFLTK+ DIRLGDFGLAK+L ++DL SSVVGTP+YMCPELLADIPY
Sbjct: 121 HSNHILHRDVKCSNIFLTKEQDIRLGDFGLAKILTSDDLTSSVVGTPSYMCPELLADIPY 180
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
G KSDIWSLGCC++E+A +PAF+A DM LINKIN++ +SPLP YS + ++KSMLR
Sbjct: 181 GSKSDIWSLGCCIYEMAYLKPAFKAFDMQALINKINKTIVSPLPAKYSGPFRGLVKSMLR 240
Query: 252 KNPEHRPTASDLLRHPHLQPYLL----RCQNPSSVYLPIK-PTN--IMK-----EKTRKS 299
KNPE RP+ASDLLRHPHLQPY+L R N LP + P++ IMK E
Sbjct: 241 KNPEVRPSASDLLRHPHLQPYVLDVKLRLNNLRRKTLPPELPSSKRIMKKAHFSEPAVTC 300
Query: 300 PSSKHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKV 359
P+ + A P E+ S K I+ ++++L ++ +S++ L K+V
Sbjct: 301 PAFGERQHRSLWNDRALNPEAEEDTASSIKCISRRISDLSIE------SSSKGTLICKQV 354
Query: 360 DPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQ 412
+S +VS +K T + R + H + +G TS+I +++
Sbjct: 355 --SSSACKVSK-YPLAKSSVTSRRIMETGR-RSDHLHPVSGGGTTSKIIPSAR 403
|
|
| TAIR|locus:2185314 NEK3 "NIMA-related kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 9.0e-111, Sum P(2) = 9.0e-111
Identities = 198/336 (58%), Positives = 258/336 (76%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+E YEV+EQIG+G+FG+A LV HK E+K YVLKKIRLA+QT + +R+A QEM+LISK+ N
Sbjct: 1 MEHYEVLEQIGKGSFGSALLVRHKHEKKLYVLKKIRLARQTGRTRRSAHQEMELISKIRN 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P+IV+YKD+WV+KG VCIV GYC+GGDMAE IKKA G F EEKLCKWL QLL+A++YL
Sbjct: 61 PFIVEYKDSWVEKGCYVCIVIGYCKGGDMAEAIKKANGVEFSEEKLCKWLVQLLMALEYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
H++ +LHRD+KCSNIFLTKD DIRLGDFGLAK+L ++DLASSVVGTP+YMCPELLADIPY
Sbjct: 121 HASHILHRDVKCSNIFLTKDQDIRLGDFGLAKILTSDDLASSVVGTPSYMCPELLADIPY 180
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
G KSDIWSLGCCM+E+ A +PAF+A DM GLIN+INRS ++PLP YS+ + ++KSMLR
Sbjct: 181 GSKSDIWSLGCCMYEMTALKPAFKAFDMQGLINRINRSIVAPLPAQYSTAFRSLVKSMLR 240
Query: 252 KNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNSRKDKG 311
KNPE RP+ASDLLR P LQPY+ + + L + + + ++ + S ++ G
Sbjct: 241 KNPELRPSASDLLRQPLLQPYVQKVL----LKLSFREHDTLPSESERRSSYPQQRKRTSG 296
Query: 312 EREAAAPN-----QLENVRSVAKNIAVQLN-NLPLD 341
+ + P+ Q ++V SV K + L+ + P+D
Sbjct: 297 KSVSFGPSRFGVDQEDSVSSV-KPVHTYLHRHRPVD 331
|
|
| UNIPROTKB|E1C5S2 NEK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 1.8e-64, Sum P(2) = 1.8e-64
Identities = 107/260 (41%), Positives = 174/260 (66%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
L Y + +G+G++G LV H+ + K+YV+KK+ L + + ++ A QE L+S+L +
Sbjct: 3 LAAYCFLRAVGKGSYGEVSLVRHRQDSKQYVIKKLNLKHASSRERKAAEQEAQLLSQLKH 62
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P IV Y+++W + + IV G+CEGGD+ +K+ +G PE ++ +W Q+ +A+ YL
Sbjct: 63 PNIVAYRESWQGEDGLLYIVMGFCEGGDLYHRLKEQKGKLLPENQVVEWFVQIAMALQYL 122
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPNYMCPELLADIP 190
H +LHRDLK N+FLT+ N I++GD G+A++L + D+AS+++GTP YM PEL ++ P
Sbjct: 123 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP 182
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
Y YKSD+W+LGCC++E+A + AF A DM L+ +I + P+P YS + +II++ML
Sbjct: 183 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPQLVEIIQTML 242
Query: 251 RKNPEHRPTASDLLRHPHLQ 270
K PE RP+ +LR P+++
Sbjct: 243 SKRPEQRPSVKSILRQPYIK 262
|
|
| ZFIN|ZDB-GENE-040426-1392 nek4 "NIMA (never in mitosis gene a)-related kinase 4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 649 (233.5 bits), Expect = 1.2e-63, P = 1.2e-63
Identities = 138/423 (32%), Positives = 238/423 (56%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
++ Y + +G+G++G LV HK +RK+YV+KK+ L + + +R A QE L+S+L +
Sbjct: 1 MDGYLFVRVVGKGSYGEVNLVRHKSDRKQYVIKKLNLRTSSRRERRAAEQEAQLLSQLKH 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P IV Y+++W + + IV G+CEGGD+ +K+ +G PE ++ +W Q+ +A+ YL
Sbjct: 61 PNIVMYRESWEGEDCQLYIVMGFCEGGDLYHRLKQQKGELLPERQVVEWFVQIAMALQYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTPNYMCPELLADIP 190
H +LHRDLK NIFLTK N I++GD G+A++L N D+AS+++GTP YM PEL ++ P
Sbjct: 121 HEKHILHRDLKTQNIFLTKTNIIKVGDLGIARVLENQNDMASTLIGTPYYMSPELFSNKP 180
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
Y YKSD+W+LGCC++E+A + AF A DM L+ +I + +P Y + ++IK ML
Sbjct: 181 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIVEGKLPQMPSKYDPQLGELIKRML 240
Query: 251 RKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNSRKDK 310
K PE RP +LR QPY+ ++ S++L KEKT KS + N + +
Sbjct: 241 CKKPEDRPDVKHILR----QPYI---KHQISMFL-----EATKEKTAKSRKNAANGKLNS 288
Query: 311 GEREAAA-PNQL---ENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKVDPTSYTM 366
+A+ PNQ+ + + S +K + + L+ + + + E+ + P S T
Sbjct: 289 AGSDASTKPNQVVQPQCLNSESKTCGKKAEEIYLNRQKPCNGAWENVAPKHHMPPKSPTR 348
Query: 367 EVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPA 426
++ +S S + + + + ++A + + + + + E ++P P
Sbjct: 349 DIHNSTGQSIATISNIDI-EIQKQRKAKPPKPSSHQNNNLPSVSKRREKEDPGAPQTHPH 407
Query: 427 EEI 429
+++
Sbjct: 408 KQV 410
|
|
| UNIPROTKB|E1BWZ5 NEK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 1.1e-62, Sum P(2) = 1.1e-62
Identities = 107/260 (41%), Positives = 174/260 (66%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
L Y + +G+G++G LV H+ + K+YV+KK+ L + + ++ A QE L+S+L +
Sbjct: 3 LAAYCFLRAVGKGSYGEVSLVRHRQDSKQYVIKKLNLKHASSRERKAAEQEAQLLSQLKH 62
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P IV Y+++W + + IV G+CEGGD+ +K+ +G PE ++ +W Q+ +A+ YL
Sbjct: 63 PNIVAYRESWQGEDGLLYIVMGFCEGGDLYHRLKEQKGKLLPENQVVEWFVQIAMALQYL 122
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPNYMCPELLADIP 190
H +LHRDLK N+FLT+ N I++GD G+A++L + D+AS+++GTP YM PEL ++ P
Sbjct: 123 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP 182
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
Y YKSD+W+LGCC++E+A + AF A DM L+ +I + P+P YS + +II++ML
Sbjct: 183 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPQLVEIIQTML 242
Query: 251 RKNPEHRPTASDLLRHPHLQ 270
K PE RP+ +LR P+++
Sbjct: 243 SKRPEQRPSVKSILRQPYIK 262
|
|
| MGI|MGI:1344404 Nek4 "NIMA (never in mitosis gene a)-related expressed kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 634 (228.2 bits), Expect = 4.8e-62, P = 4.8e-62
Identities = 137/420 (32%), Positives = 229/420 (54%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y + +GRG++G LV H+ + K+YV+KK+ L + + +R A QE L+S+L +P I
Sbjct: 6 YCYMRVVGRGSYGEVTLVKHRRDGKQYVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNI 65
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V YK++W + IV G+CEGGD+ +K+ +G PE ++ +W Q+ +A+ YLH
Sbjct: 66 VTYKESWEGGDGLLYIVMGFCEGGDLYRKLKEQKGQLLPESQVVEWFVQIAMALQYLHEK 125
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTPNYMCPELLADIPYGY 193
+LHRDLK N+FLT+ N I++GD G+A++L N D+AS+++GTP YM PEL ++ PY Y
Sbjct: 126 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENHGDMASTLIGTPYYMSPELFSNKPYNY 185
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
KSD+W+LGCC++E+A + AF A DM L+ +I + P+P VYS+ + ++I++ML +
Sbjct: 186 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKVYSTELAELIRTMLSRR 245
Query: 254 PEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNSRKDKGER 313
PE RP+ +LR P+++ ++ + N+ +R P + SRK++
Sbjct: 246 PEERPSVRSILRQPYIKHHISLFLEATKA--KTSKNNVKNCDSRAKPVAAVVSRKEESNT 303
Query: 314 EAA--APNQLE-NVRSVAKNIAVQLNNLPLDDKPTSS-TSTEDNLETKKVDPTSYTMEVS 369
+ P E + V P+D P S S E + + ++ T +
Sbjct: 304 DVIHYQPRSSEGSALHVMGEDKCLSQEKPVDIGPLRSPASLEGHTGKQDMNNTGESCATI 363
Query: 370 SSIN-D--SKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNE-IQEPADAHVQP 425
S IN D ER + H + + ++ S+ + + + E +Q + QP
Sbjct: 364 SRINIDILPAERRDSANAGVVQESQPQHVDAA--DEVDSQCSISQEKERLQGNTKSSDQP 421
|
|
| RGD|1304995 Nek4 "NIMA-related kinase 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 109/260 (41%), Positives = 176/260 (67%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y + +GRG++G LV H+ + K+YV+KK+ L + + +R A QE L+S+L +P I
Sbjct: 6 YCYLRVVGRGSYGEVTLVKHRRDGKQYVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNI 65
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V YK++W + IV G+CEGGD+ +K+ +G PE ++ +W Q+ +A+ YLH
Sbjct: 66 VTYKESWEGGDGLLYIVMGFCEGGDLYRKLKEQKGQLLPESQVVEWFVQIAMALQYLHEK 125
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTPNYMCPELLADIPYGY 193
+LHRDLK N+FLT+ N I++GD G+A++L N D+AS+++GTP YM PEL ++ PY Y
Sbjct: 126 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENHSDMASTLIGTPYYMSPELFSNKPYNY 185
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
KSD+W+LGCC++E+A + AF A DM L+ +I + P+P VYS+ + ++I++ML +
Sbjct: 186 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKVYSAELAELIRTMLSRR 245
Query: 254 PEHRPTASDLLRHPHLQPYL 273
PE RP+ +LR P+++ ++
Sbjct: 246 PEERPSVRSILRQPYIKHHI 265
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LT35 | NEK6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7781 | 0.4254 | 0.6586 | yes | no |
| Q2QMH1 | NEK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.4226 | 0.8711 | 0.9492 | yes | no |
| Q6YY75 | NEK6_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7133 | 0.4704 | 0.5674 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 644 | |||
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-125 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-92 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-86 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-79 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-76 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-75 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-73 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-70 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-69 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-69 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-69 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-67 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-66 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-62 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-62 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-59 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-58 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-58 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-55 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-54 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-54 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-51 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-50 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-49 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-49 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-49 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-48 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-48 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-48 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-46 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-46 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-46 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-46 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-45 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-44 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-44 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-43 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-43 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-42 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-41 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-41 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-41 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-40 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-40 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-40 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-38 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-38 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-38 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-37 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-37 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-37 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-36 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-36 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-36 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-36 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-36 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-35 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-35 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-34 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-34 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-33 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-33 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-32 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-32 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-32 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-32 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-32 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-32 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-32 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-32 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-31 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-31 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-31 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-31 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-30 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-30 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-30 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-30 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-30 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-30 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-30 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-30 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-30 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-30 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-29 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-29 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-29 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-29 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-29 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-29 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-29 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-29 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-29 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-29 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-28 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-28 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-28 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-28 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-28 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-28 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-28 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-28 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-28 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-27 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-27 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-27 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-27 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-27 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-27 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-27 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-27 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-27 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-27 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-27 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-27 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-27 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-26 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-26 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-26 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-26 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-25 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-25 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-25 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-25 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-25 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-25 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-25 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-24 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-24 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-23 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-23 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-22 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-22 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-21 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-21 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-20 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-20 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-20 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-20 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-20 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-20 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-19 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-19 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-18 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-16 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-16 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-16 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 6e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 8e-04 | |
| TIGR00600 | 1034 | TIGR00600, rad2, DNA excision repair protein (rad2 | 0.001 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 371 bits (955), Expect = e-125
Identities = 117/259 (45%), Positives = 178/259 (68%), Gaps = 4/259 (1%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
YE+I+QIG+G+FG +LV K + K YVLK+I L+ +EK + AL E+ ++ KLN+P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGAC--FPEEKLCKWLTQLLLAVDYL 131
I+KY +++ +KG +CIV Y +GGD+++ IKK + FPEE++ W QL LA+ YL
Sbjct: 61 IIKYYESFEEKG-KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTPNYMCPELLADIP 190
HS ++LHRD+K NIFLT + ++LGDFG++K+L+ T DLA +VVGTP Y+ PEL + P
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
Y YKSDIWSLGC ++E+ + F ++ L KI + P+P YSS ++ ++ S+L
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239
Query: 251 RKNPEHRPTASDLLRHPHL 269
+K+PE RP+ + +L+ P +
Sbjct: 240 QKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 4e-92
Identities = 95/256 (37%), Positives = 149/256 (58%), Gaps = 7/256 (2%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
YE++E++G G+FG +L K K +K I+ K + +R L+E+ ++ KL +P I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNI 59
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V+ D + D+ + + +V YCEGGD+ +++KK E++ +L Q+L A++YLHS
Sbjct: 60 VRLYDVFEDE-DKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSK 116
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYK 194
++HRDLK NI L +D ++L DFGLA+ L+ + ++ VGTP YM PE+L YG
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 195 SDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINRSSISPLP--IVYSSTMKQIIKSMLR 251
DIWSLG ++E+ +P F D + L KI + P S K +I+ +L
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 252 KNPEHRPTASDLLRHP 267
K+PE R TA + L+HP
Sbjct: 237 KDPEKRLTAEEALQHP 252
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 271 bits (694), Expect = 1e-86
Identities = 115/263 (43%), Positives = 163/263 (61%), Gaps = 9/263 (3%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
DYEV+E IG+G+FG V K + K V K+I TEK K+ + E++++ +L +P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 74 IVKYKDAWVDKGN-CVCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDY 130
IV+Y D +D+ N + IV YCEGGD+A++I+K + EE + + LTQLLLA+
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 131 LH-----SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPNYMCPE 184
H N VLHRDLK +NIFL +N+++LGDFGLAK+L + A + VGTP YM PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244
L + Y KSDIWSLGC ++E+ A P F A + L +KI +P YSS + +
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNE 240
Query: 245 IIKSMLRKNPEHRPTASDLLRHP 267
+IKSML +P+ RP+ +LL+ P
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 254 bits (649), Expect = 4e-80
Identities = 106/256 (41%), Positives = 171/256 (66%), Gaps = 1/256 (0%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y + +G+G++G LV H+ + K+YV+KK+ L + + ++ A QE L+S+L +P I
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V Y+++W + + IV G+CEGGD+ +K+ +G PE ++ +W Q+ +A+ YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTPNYMCPELLADIPYGY 193
+LHRDLK N+FLT+ N I++GD G+A++L N D+AS+++GTP YM PEL ++ PY Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
KSD+W+LGCC++E+A + AF A DM L+ +I + P+P YS + ++I +ML K
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKR 241
Query: 254 PEHRPTASDLLRHPHL 269
PE RP+ +LR P++
Sbjct: 242 PEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 252 bits (647), Expect = 1e-79
Identities = 90/261 (34%), Positives = 145/261 (55%), Gaps = 11/261 (4%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
YE++ ++G G+FG + HK K +K ++ + K +TA +E+ ++ +L++P I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V+ DA+ DK + + +V YCEGGD+ + + + E++ K Q+L ++YLHSN
Sbjct: 61 VRLIDAFEDKDH-LYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSN 117
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPNYMCPELLAD-IPYG 192
++HRDLK NI L ++ +++ DFGLAK L ++ VGTP YM PE+L YG
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR------SSISPLPIVYSSTMKQII 246
K D+WSLG ++E+ +P F ++ + I R P S K +I
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 247 KSMLRKNPEHRPTASDLLRHP 267
K L K+P RPTA ++L+HP
Sbjct: 238 KKCLNKDPSKRPTAEEILQHP 258
|
Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 7e-76
Identities = 101/254 (39%), Positives = 167/254 (65%), Gaps = 2/254 (0%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y +++IG G+FG A LV K + K+YV+K+I ++K + K + + +E+ ++S + +P I
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V+Y++++ + G + IV YCEGGD+ + I RG FPE+++ W Q+ LA+ ++H
Sbjct: 62 VQYQESFEENG-NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTPNYMCPELLADIPYGY 193
++LHRD+K NIFLTKD I+LGDFG+A++LN T +LA + +GTP Y+ PE+ + PY
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
KSDIW+LGC ++E+ + AF A +M L+ KI R S P+ YS ++ ++ + ++N
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN 240
Query: 254 PEHRPTASDLLRHP 267
P RP+ + +L
Sbjct: 241 PRDRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 3e-75
Identities = 97/257 (37%), Positives = 164/257 (63%), Gaps = 2/257 (0%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
D+E++ +IG+G+FG F V+ K +++ Y +K+I L+K + + A+ E +++KL++ Y
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
I++Y ++++DKG + IV Y E GD+ +++K RG PE+++ ++ Q+LL + +LHS
Sbjct: 61 IIRYYESFLDKGK-LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPNYMCPELLADIPYG 192
++LHRD+K N+FL +++++GD G+AKLL+ A+++VGTP Y+ PEL D PY
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252
KSD+W+LG ++E + F A + LI KI R P+ +YS + Q+I L K
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239
Query: 253 NPEHRPTASDLLRHPHL 269
+ RP LLR+P L
Sbjct: 240 DYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 236 bits (603), Expect = 2e-73
Identities = 104/252 (41%), Positives = 160/252 (63%), Gaps = 3/252 (1%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
Y V+ +G G+FG A LV H +KY +K+IRL K + + + +E L++K+ +P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVE-DSRKEAVLLAKMKHPN 59
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
IV +K+++ G+ + IV YC+GGD+ + IK RG FPE+ + +W Q+ L V ++H
Sbjct: 60 IVAFKESFEADGH-LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTPNYMCPELLADIPYG 192
RVLHRD+K NIFLT++ ++LGDFG A+LL + A + VGTP Y+ PE+ ++PY
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252
KSDIWSLGC ++E+ + F+A LI K+ + S PLP YS ++ +IK M ++
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238
Query: 253 NPEHRPTASDLL 264
NP RP+A+ +L
Sbjct: 239 NPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 1e-70
Identities = 102/256 (39%), Positives = 159/256 (62%), Gaps = 2/256 (0%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y I +G+GAFG A L + V K++ L + +EK +R AL E+ ++S L +P I
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
+ Y + ++D N + I Y GG + + I + +G F EE + +L Q++ AV Y+H
Sbjct: 62 IAYYNHFMDD-NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPNYMCPELLADIPYGY 193
+LHRD+K NIFLTK I+LGDFG++K+L +E +A +VVGTP YM PEL + Y +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
KSDIW+LGC ++E+ + F A + L+ KI + + +P+ VYSS + ++ S+L+++
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240
Query: 254 PEHRPTASDLLRHPHL 269
PE RPTA ++L P L
Sbjct: 241 PEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 224 bits (574), Expect = 1e-69
Identities = 88/250 (35%), Positives = 137/250 (54%), Gaps = 38/250 (15%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDA 80
+G G FG +L K KK +K I+ + + L+E++++ KLN+P IVK
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK-EDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 81 WVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRD 140
+ D+ N + +V YCEGG + +++K+ G E+++ + L Q+L ++YLHSN ++HRD
Sbjct: 60 FEDE-NHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 141 LKCSNIFLTKDND-IRLGDFGLAKLL-NTEDLASSVVGTPNYMCPELLADIP-YGYKSDI 197
LK NI L DN ++L DFGL+KLL + + L ++VGTP YM PE+L Y KSDI
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 198 WSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHR 257
WSLG ++E+ +K +I+ ML+K+PE R
Sbjct: 178 WSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKR 205
Query: 258 PTASDLLRHP 267
P+A ++L H
Sbjct: 206 PSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 2e-69
Identities = 93/258 (36%), Positives = 163/258 (63%), Gaps = 4/258 (1%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
D++V++++G+G++G+ + V + + Y LK++ L ++K + A+ E+ +++ +N+P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKK--ARGACFPEEKLCKWLTQLLLAVDYL 131
I+ YK+A++D GN +CIV Y GD+++ I K + PE+++ + QLL + L
Sbjct: 61 IISYKEAFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
H ++LHRDLK +NI L ++ +++GD G++K+L +++A + +GTP+YM PE+ PY
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL-KKNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
YKSDIWSLGC ++E+A P F A M L K+ R P+P +YS ++ I+SML+
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238
Query: 252 KNPEHRPTASDLLRHPHL 269
P+ RP +L P +
Sbjct: 239 VKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 5e-69
Identities = 89/260 (34%), Positives = 142/260 (54%), Gaps = 8/260 (3%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
++ E +GRG+FG+ +L L K + +K + L+ +E+ +E+ ++S L +P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 74 IVKYKDAWVDK-GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IV+Y + D+ N + I Y GG ++ ++KK PE + K+ Q+L + YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAYLH 118
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA---SSVVGTPNYMCPELLADI 189
SN ++HRD+K +NI + D ++L DFG AK L + SV GTP +M PE++
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 190 PYGYKSDIWSLGCCMFEIA-AHQPAFRAPDMAGLINKINRSSISP-LPIVYSSTMKQIIK 247
YG +DIWSLGC + E+A P + + KI S P +P S K ++
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 248 SMLRKNPEHRPTASDLLRHP 267
LR++P+ RPTA +LL+HP
Sbjct: 239 KCLRRDPKKRPTADELLQHP 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 1e-67
Identities = 90/256 (35%), Positives = 146/256 (57%), Gaps = 6/256 (2%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
+E++E+IG+G FG + HK K+ +K I+L + +K + E+ ++ K +P
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK--EKIINEIQILKKCKHPN 58
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
IVKY +++ K + IV +C GG + +++K + E ++ +LL ++YLHS
Sbjct: 59 IVKYYGSYLKKDE-LWIVMEFCSGGSLKDLLK-STNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGY 193
N ++HRD+K +NI LT D +++L DFGL+ L+ +++VGTP +M PE++ PY Y
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI--VYSSTMKQIIKSMLR 251
K+DIWSLG E+A +P + + KI + L +S K +K L+
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236
Query: 252 KNPEHRPTASDLLRHP 267
KNPE RPTA LL+HP
Sbjct: 237 KNPEKRPTAEQLLKHP 252
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 217 bits (553), Expect = 4e-66
Identities = 93/254 (36%), Positives = 155/254 (61%), Gaps = 2/254 (0%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
YE I +GRGAFG L K ++K ++K+I + + T+ + A E ++ L++P I
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
++Y + +++ + IV Y GG +AE I+K + E+ + + Q+LLA+ ++H+
Sbjct: 62 IEYYENFLED-KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 135 RVLHRDLKCSNIFLTKDNDI-RLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGY 193
+LHRDLK NI L K + ++GDFG++K+L+++ A +VVGTP Y+ PEL PY
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
KSDIW+LGC ++E+A+ + AF A ++ L+ KI + +P+ YS ++Q+I SML +
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLD 240
Query: 254 PEHRPTASDLLRHP 267
P RP S ++ P
Sbjct: 241 PSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 207 bits (527), Expect = 3e-62
Identities = 106/262 (40%), Positives = 161/262 (61%), Gaps = 10/262 (3%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKI----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
Y + +++G+G+FG +LV K ER K VLK+I + + A QE L+SKL+
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLK-VLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK--KARGACFPEEKLCKWLTQLLLAV 128
+P IVK+ +++++ CI+T YCEG D+ ++ K G E ++C+W QLLL V
Sbjct: 61 HPAIVKFHASFLERDA-FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTPNYMCPELLA 187
Y+H R+LHRDLK NIFL K+N +++GDFG+++LL + DLA++ GTP YM PE L
Sbjct: 120 HYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247
Y KSDIWSLGC ++E+ AF + ++ +I LP YS + I++
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238
Query: 248 SMLRKNPEHRPTASDLLRHPHL 269
SML K+P RP+A+++LR+P +
Sbjct: 239 SMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 9e-62
Identities = 82/254 (32%), Positives = 135/254 (53%), Gaps = 13/254 (5%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKR---TALQEMDLISKLNNPYIVKY 77
+G+G+FG LV K K Y +K ++ K+ ++ L E +++S++N+P+IVK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK--KKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
A+ + + +V Y GG++ + K F EE+ + +++LA++YLHS ++
Sbjct: 59 HYAFQTEEK-LYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGII 115
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLAK-LLNTEDLASSVVGTPNYMCPELLADIPYGYKSD 196
+RDLK NI L D I+L DFGLAK L + ++ GTP Y+ PE+L YG D
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVD 175
Query: 197 IWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEH 256
WSLG ++E+ +P F A D + KI + + P S + +I +L+K+P
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR-FPEFLSPEARDLISGLLQKDPTK 234
Query: 257 RPT---ASDLLRHP 267
R A ++ HP
Sbjct: 235 RLGSGGAEEIKAHP 248
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 6e-59
Identities = 91/257 (35%), Positives = 160/257 (62%), Gaps = 3/257 (1%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
YE+I++IG G+FG +L K + + V+K+I L K K K + +E+ L++K+ +P I
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V + ++ + G + IV YC+GGD+ + I + RG F E+++ W Q+ L + ++H
Sbjct: 62 VTFFASFQENGR-LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 135 RVLHRDLKCSNIFLTKDNDI-RLGDFGLAKLLN-TEDLASSVVGTPNYMCPELLADIPYG 192
++LHRD+K NIFL+K+ + +LGDFG+A+ LN + +LA + VGTP Y+ PE+ + PY
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN 180
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252
K+DIWSLGC ++E+ + F ++ L+ KI + +P+ +S ++ +I + +
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV 240
Query: 253 NPEHRPTASDLLRHPHL 269
+P RP+ + +L+ P L
Sbjct: 241 SPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 1e-58
Identities = 92/267 (34%), Positives = 147/267 (55%), Gaps = 12/267 (4%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
D E ++ +G+G+ G + V HK K Y LKKI + E F++ L+E+ + +P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE-FRKQLLRELKTLRSCESP 59
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
Y+VK A+ +G + IV Y +GG +A+++KK PE L Q+L +DYLH
Sbjct: 60 YVVKCYGAFYKEGE-ISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLH 116
Query: 133 SNR-VLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTPNYMCPELLADIP 190
+ R ++HRD+K SN+ + ++++ DFG++K+L NT D ++ VGT YM PE +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 191 YGYKSDIWSLGCCMFEIA-AHQPAFRAPDMAG---LINKINRSSISPLP-IVYSSTMKQI 245
Y Y +DIWSLG + E A P F P L+ I LP +S +
Sbjct: 177 YSYAADIWSLGLTLLECALGKFP-FLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235
Query: 246 IKSMLRKNPEHRPTASDLLRHPHLQPY 272
I + L+K+P+ RP+A++LL+HP ++
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 2e-58
Identities = 97/258 (37%), Positives = 144/258 (55%), Gaps = 10/258 (3%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+Y++ + IGRGAFG + L+ E +V +K+I L K E+ ++ +QE+DL+ L +P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IVKY + ++ + + I+ Y E G + +IIKK FPE + ++ Q+L + YLH
Sbjct: 60 NIVKYIGS-IETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH 116
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS-SVVGTPNYMCPELLADIPY 191
V+HRD+K +NI TKD ++L DFG+A LN SVVGTP +M PE++
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 192 GYKSDIWSLGCCMFEIAAHQPAF--RAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249
SDIWSLGC + E+ P + P MA L + PLP S +K +
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNP-MAALFRIVQDDHP-PLPEGISPELKDFLMQC 234
Query: 250 LRKNPEHRPTASDLLRHP 267
+K+P RPTA LL+HP
Sbjct: 235 FQKDPNLRPTAKQLLKHP 252
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 1e-55
Identities = 85/260 (32%), Positives = 156/260 (60%), Gaps = 8/260 (3%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLN 70
L ++++ ++IG+G F + + ++ + LKK+++ + + K ++ L+E+DL+ +L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAV 128
+P ++KY ++++ N + IV + GD++ +IK + PE + K+ QL A+
Sbjct: 61 HPNVIKYLASFIEN-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS-SVVGTPNYMCPELLA 187
+++HS R++HRD+K +N+F+T ++LGD GL + +++ A+ S+VGTP YM PE +
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA--GLINKINRSSISPLPI-VYSSTMKQ 244
+ Y +KSDIWSLGC ++E+AA Q F M L KI + PLP YS ++
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239
Query: 245 IIKSMLRKNPEHRPTASDLL 264
++ + +PE RP S +L
Sbjct: 240 LVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 2e-54
Identities = 85/284 (29%), Positives = 129/284 (45%), Gaps = 35/284 (12%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
YE +E++G G +G + K + LKKIRL + E TAL+E+ L+ +L +P I
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
VK D + + +V YC+ D+ + + K G + + QLL + Y HS+
Sbjct: 61 VKLLDVIHTE-RKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCHSH 117
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPE-LLADIPYG 192
R+LHRDLK NI + +D ++L DFGLA+ + V T Y PE LL Y
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYS 177
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR----------SSISPLPIVYSSTM 242
DIWS+GC E+ +P F + KI + ++ LP Y T
Sbjct: 178 TAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKPTF 236
Query: 243 KQ-------------------IIKSMLRKNPEHRPTASDLLRHP 267
+ ++ ML+ NP R +A + L+HP
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 4e-54
Identities = 85/289 (29%), Positives = 140/289 (48%), Gaps = 45/289 (15%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK---KIRLAKQTEKFKRTALQEMDLISKL 69
+D++ + IG G+F L K K+Y +K K +L K EK + E +++++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRL 58
Query: 70 N-NPYIVK----YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT-Q 123
N +P I+K ++D + V Y G++ + I+K E K ++ +
Sbjct: 59 NGHPGIIKLYYTFQDE-----ENLYFVLEYAPNGELLQYIRKY--GSLDE-KCTRFYAAE 110
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL------------- 170
+LLA++YLHS ++HRDLK NI L KD I++ DFG AK+L+
Sbjct: 111 ILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 171 --------ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL 222
+S VGT Y+ PELL + P G SD+W+LGC ++++ +P FR +
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 223 INKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASD----LLRHP 267
KI + S P + K +I+ +L +P+ R ++ L HP
Sbjct: 231 FQKILKLEYS-FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 5e-51
Identities = 94/260 (36%), Positives = 142/260 (54%), Gaps = 10/260 (3%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y+ +E+IG GA G + + K+ +KK+RL KQ K + E+ ++ +P I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN---KELIINEILIMKDCKHPNI 77
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V Y D+++ G+ + +V Y +GG + +II + E ++ ++L ++YLHS
Sbjct: 78 VDYYDSYLV-GDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPNYMCPELLADIPYGY 193
V+HRD+K NI L+KD ++L DFG A L E +SVVGTP +M PE++ YG
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 194 KSDIWSLGCCMFEIAAHQPA-FRAPDMAGLINKINRSSISPL--PIVYSSTMKQIIKSML 250
K DIWSLG E+A +P R P + L I I PL P +S K + L
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGIPPLKNPEKWSPEFKDFLNKCL 254
Query: 251 RKNPEHRPTASDLLRHPHLQ 270
K+PE RP+A +LL+HP L+
Sbjct: 255 VKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 9e-50
Identities = 87/254 (34%), Positives = 144/254 (56%), Gaps = 8/254 (3%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFK---RTALQEMDLISKLNNPYIV 75
E +G G+FG+ + L+ + + +K++ LA + + + QE+ L+SKL +P IV
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR 135
+Y ++ N + I GG +A+++KK G+ FPE + + Q+LL ++YLH
Sbjct: 66 QYLGTEREEDN-LYIFLELVPGGSLAKLLKKY-GS-FPEPVIRLYTRQILLGLEYLHDRN 122
Query: 136 VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI-PYGYK 194
+HRD+K +NI + + ++L DFG+AK + A S G+P +M PE++A YG
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182
Query: 195 SDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-SISPLPIVYSSTMKQIIKSMLRKN 253
+DIWSLGC + E+A +P + + + KI RS + P+P S K I L+++
Sbjct: 183 ADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRD 242
Query: 254 PEHRPTASDLLRHP 267
P RPTA++LL HP
Sbjct: 243 PSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 1e-49
Identities = 89/254 (35%), Positives = 157/254 (61%), Gaps = 8/254 (3%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLN 70
L ++++ ++IGRG F + ++RK LKK+++ + + K ++ ++E+DL+ +LN
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK--KARGACFPEEKLCKWLTQLLLAV 128
+P ++KY D++++ N + IV + GD++++IK K + PE + K+ QL AV
Sbjct: 61 HPNVIKYLDSFIED-NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS-SVVGTPNYMCPELLA 187
+++HS RV+HRD+K +N+F+T ++LGD GL + +++ A+ S+VGTP YM PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA--GLINKINRSSISPLPIV-YSSTMKQ 244
+ Y +KSDIWSLGC ++E+AA Q F M L KI + PLP YS +++
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239
Query: 245 IIKSMLRKNPEHRP 258
++ + +P+ RP
Sbjct: 240 LVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 4e-49
Identities = 82/267 (30%), Positives = 146/267 (54%), Gaps = 27/267 (10%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E ++++E++G G++G+ + +HK + +K + + + ++ + E+ ++ + ++P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK----EISILKQCDSP 58
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
YIVKY ++ + IV YC G +++I+K EE++ L Q L ++YLH
Sbjct: 59 YIVKYYGSYFKNTDLW-IVMEYCGAGSVSDIMK-ITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLA-KLLNTEDLASSVVGTPNYMCPELLADIPY 191
SN+ +HRD+K NI L ++ +L DFG++ +L +T ++V+GTP +M PE++ +I Y
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 192 GYKSDIWSLGCCMFEIA------AHQPAFRAPDMAGLINKINRSSISPLPIV-----YSS 240
K+DIWSLG E+A + RA + + NK P P + +S
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMIPNK-------PPPTLSDPEKWSP 227
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHP 267
+K L K+PE RP+A LL+HP
Sbjct: 228 EFNDFVKKCLVKDPEERPSAIQLLQHP 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-49
Identities = 83/286 (29%), Positives = 137/286 (47%), Gaps = 34/286 (11%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y+ + +IG G +G + K+ + +KKI+L ++E +TAL+E+ L+ +LN+P I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
+K D + KG+ + +V + + D+ ++IK + PE + +L QLL + + HS+
Sbjct: 61 IKLLDVFRHKGD-LYLVFEFMDT-DLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSH 117
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPNYMCPE-LLADIPYG 192
+LHRDLK N+ + + ++L DFGLA+ + + V T Y PE LL D Y
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY-------------- 238
DIWS+GC E+ + +P F + KI R+ +P P V+
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 239 ---------------SSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
S ++ ML +P R TA L HP+
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 87/258 (33%), Positives = 140/258 (54%), Gaps = 15/258 (5%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRL--------AKQTEKFKRTALQEMDL 65
Y V+E +G GAFG + V K + + LK+I + ++ +K + E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 66 ISK-LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK--KARGACFPEEKLCKWLT 122
I + L +P IV+Y +++ + + IV EG + E K + F EE++
Sbjct: 62 IKEQLRHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 123 QLLLAVDYLH-SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYM 181
Q++LA+ YLH R++HRDL +NI L +D+ + + DFGLAK E +SVVGT Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 182 CPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP-IVYSS 240
CPE++ + PYG K+D+W+ GC ++++ QP F + +M L KI + PLP +YS
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240
Query: 241 TMKQIIKSMLRKNPEHRP 258
+ +I S L + E RP
Sbjct: 241 DVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 3e-48
Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 17/261 (6%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLA-KQTEKFKRTALQEMDLISKLNNPYIVKYKD 79
I +GA+G FL K Y +K I+ A + L E D++S+ +PY+VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHR 139
++ K N + +V Y GGD+A +++ E+ ++ +++LA++YLHSN ++HR
Sbjct: 61 SFQGKKN-LYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHR 117
Query: 140 DLKCSNIFLTKDNDIRLGDFGLAK---------LLNTEDLASSVVGTPNYMCPELLADIP 190
DLK NI + + ++L DFGL+K L + E +VGTP+Y+ PE++
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS-TMKQIIKSM 249
+ D WSLGC ++E P F + I I V S +I +
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237
Query: 250 LRKNPEHRPTA---SDLLRHP 267
L +PE R A ++ HP
Sbjct: 238 LVPDPEKRLGAKSIEEIKNHP 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 81/262 (30%), Positives = 146/262 (55%), Gaps = 17/262 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E + ++E IG+G+FG + + K + +K I L + ++ + QE+ +S+ +P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSP 59
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
YI KY +++ KG+ + I+ YC GG +++K + E + L ++LL ++YLH
Sbjct: 60 YITKYYGSFL-KGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLH 115
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLA-KLLNTEDLASSVVGTPNYMCPELLADIPY 191
+HRD+K +NI L+++ D++L DFG++ +L +T ++ VGTP +M PE++ Y
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL-----INKINRSSISPLP-IVYSSTMKQI 245
K+DIWSLG E+A +P P ++ L + I +++ L +S K
Sbjct: 176 DEKADIWSLGITAIELAKGEP----P-LSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDF 230
Query: 246 IKSMLRKNPEHRPTASDLLRHP 267
+ L K+P+ RP+A +LL+H
Sbjct: 231 VSLCLNKDPKERPSAKELLKHK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 3e-46
Identities = 89/267 (33%), Positives = 156/267 (58%), Gaps = 11/267 (4%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLN 70
L ++ + ++IGRG F + ++ LKK+++ + K + ++E+DL+ +LN
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK--KARGACFPEEKLCKWLTQLLLAV 128
+P ++KY ++++ N + IV + GD++ +IK K + PE+ + K+ QL A+
Sbjct: 61 HPNVIKYYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS-SVVGTPNYMCPELLA 187
+++HS RV+HRD+K +N+F+T ++LGD GL + +++ A+ S+VGTP YM PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA--GLINKINRSSISPLPI-VYSSTMKQ 244
+ Y +KSDIWSLGC ++E+AA Q F M L KI + PLP YS ++Q
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239
Query: 245 IIKSMLRKNPEHRPTAS---DLLRHPH 268
++ + +PE RP + D+ + H
Sbjct: 240 LVNMCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 6e-46
Identities = 91/267 (34%), Positives = 137/267 (51%), Gaps = 11/267 (4%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+D E + ++G G G VLH+ K +K IRL K+ L+E+D++ K N+P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI-LRELDILHKCNSP 59
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
YIV + A+ + G+ I Y +GG + +I+K+ +G PE L K +L + YLH
Sbjct: 60 YIVGFYGAFYNNGDIS-ICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLH 117
Query: 133 SNR-VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
++HRD+K SNI + I+L DFG++ L LA + VGT +YM PE + Y
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFVGTSSYMAPERIQGNDY 176
Query: 192 GYKSDIWSLGCCMFEIAAHQ----PAFRAPDMA-GLINKINRSSISPLPI-VYSSTMKQI 245
KSDIWSLG + E+A + P PD L+ I LP +S +
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236
Query: 246 IKSMLRKNPEHRPTASDLLRHPHLQPY 272
+ L K+P RP+ +LL HP ++ Y
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 7e-46
Identities = 86/269 (31%), Positives = 137/269 (50%), Gaps = 18/269 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+DYE+IE IG GA A + + V +K+I L K +E+ +S+ N+
Sbjct: 1 DDYELIEVIGVGA-TAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNH 58
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK-KARGACFPEEKLCKWLTQLLLAVDY 130
P +VKY ++V G+ + +V Y GG + +I+K E + L ++L ++Y
Sbjct: 59 PNVVKYYTSFVV-GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLAS----SVVGTPNYMCPEL 185
LHSN +HRD+K NI L +D +++ DFG+ A L + D + VGTP +M PE+
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 186 LA-DIPYGYKSDIWSLGCCMFEIA-AHQPAFRAPDMAGLINKINRSSISPLPI-----VY 238
+ Y +K+DIWS G E+A P + P M L+ + L Y
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PSLETGADYKKY 236
Query: 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
S + +++I L+K+P RPTA +LL+H
Sbjct: 237 SKSFRKMISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 8e-46
Identities = 90/293 (30%), Positives = 135/293 (46%), Gaps = 48/293 (16%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
YE I QIG G +G + +K + LKKIR+ + E F TA++E+ L+ KL +P I
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 75 VKYKDAWVDKG-NCVCIVTGYCEGGDMAEIIKKARGACFPEEKL----CKWLT-QLLLAV 128
V+ K+ KG + +V Y + D+ ++ PE K K QLL +
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS------PEVKFTESQIKCYMKQLLEGL 113
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE---DLASSVVGTPNYMCPEL 185
YLHSN +LHRD+K SNI + D ++L DFGLA+ D + V+ T Y PEL
Sbjct: 114 QYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPEL 172
Query: 186 L-ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI----------NRSSISPL 234
L YG + D+WS+GC + E+ +P F+ + KI N +S L
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232
Query: 235 P--------IVYSSTMKQIIKS------------MLRKNPEHRPTASDLLRHP 267
P Y +++ K +L +P+ R +A L+H
Sbjct: 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 92/268 (34%), Positives = 153/268 (57%), Gaps = 16/268 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL--AKQTEKFKRTALQEMDLISKLN 70
+ +E+I ++G GAFG + HK K I++ ++ E F + E+D++S+
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDF----MVEIDILSECK 60
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+P IV +A+ + + I+ +C+GG + I+ + E ++ Q+L A+++
Sbjct: 61 HPNIVGLYEAYFYENK-LWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNF 118
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLA-- 187
LHS++V+HRDLK NI LT D D++L DFG+ AK +T + +GTP +M PE++A
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 188 ---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL--PIVYSSTM 242
D PY YK+DIWSLG + E+A +P + ++ KI +S L P +SS+
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
+KS L K+P+ RPTA++LL+HP +
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 1e-44
Identities = 106/395 (26%), Positives = 169/395 (42%), Gaps = 38/395 (9%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLN-N 71
Y ++ ++G G+FG +L + K LK + + K L+E+ +++ LN
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKK-ARGACFPEEKLCKWLTQLLLAVDY 130
P IVK D + D+G+ +V Y +GG + +++KK R E + L Q+L A++Y
Sbjct: 58 PNIVKLYDFFQDEGSLY-LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 131 LHSNRVLHRDLKCSNIFLTKDND-IRLGDFGLAKLLNTED-------LASSVVGTPNYMC 182
LHS ++HRD+K NI L +D ++L DFGLAKLL L S+ VGTP YM
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 183 PELLADI---PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLIN---KINRSSISP--- 233
PE+L + SDIWSLG ++E+ P F + + KI +P
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 234 ------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIK 287
P + S ++K +L K+P++R ++S L H LL L
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD-----LLAHLKLKESDLSDL 291
Query: 288 PTNIMKEKTRKSPSSKHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSS 347
R S + A + + L+ S N + +L + P +S
Sbjct: 292 LKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDS---NFSKELAPNGVSSSPHNS 348
Query: 348 TSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQT 382
+S + + K SS + S Q
Sbjct: 349 SSLLLSTASSKRSSLPKISARSSPSSLSSSSRQQA 383
|
Length = 384 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 7e-44
Identities = 87/289 (30%), Positives = 135/289 (46%), Gaps = 36/289 (12%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL---NN 71
YE + +IG GA+G + + LKK+R+ E + L+E+ L+ +L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 72 PYIVKYKDAW----VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT-QLLL 126
P IV+ D D+ + +V + + D+A + K P E + K L QLL
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETI-KDLMRQLLR 118
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
VD+LHS+R++HRDLK NI +T D +++ DFGLA++ + E +SVV T Y PE+L
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI------------------NR 228
Y D+WS+GC E+ +P FR A ++KI R
Sbjct: 179 LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238
Query: 229 SSISPLPIVYSSTM--------KQIIKSMLRKNPEHRPTASDLLRHPHL 269
SS + ++K ML NP R +A + L+HP+
Sbjct: 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 87/266 (32%), Positives = 138/266 (51%), Gaps = 16/266 (6%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
EDYE+I++IG G +G + + +K I+L + F+ QE+ ++ + +
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFE-IIQQEISMLKECRH 59
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT-QLLLAVDY 130
P IV Y +++ + + + IV YC GG + +I + RG E ++ + L + Y
Sbjct: 60 PNIVAYFGSYL-RRDKLWIVMEYCGGGSLQDIYQVTRGPL--SELQIAYVCRETLKGLAY 116
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLA-- 187
LH +HRD+K +NI LT+D D++L DFG+ A+L T S +GTP +M PE+ A
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 188 -DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV-----YSST 241
Y K DIW+LG E+A QP + I++S+ P P + +S
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-PKLKDKEKWSPV 235
Query: 242 MKQIIKSMLRKNPEHRPTASDLLRHP 267
IK L K+P+ RPTA+ LL+HP
Sbjct: 236 FHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 76/262 (29%), Positives = 133/262 (50%), Gaps = 12/262 (4%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFK-RTALQEMDLISKLNNPY 73
+E++ IG+GAFG +V + +K + +K + K EK R L E ++ +LN+P+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMA-EIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+V ++ D+ N +V GGD+ + +K + F EE++ W+ +++LA++YLH
Sbjct: 62 LVNLWYSFQDEENMY-LVVDLLLGGDLRYHLSQKVK---FSEEQVKFWICEIVLALEYLH 117
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYG 192
S ++HRD+K NI L + + + DF +A + + L +S GTP YM PE+L Y
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS---SISPLPIVYSSTMKQIIKSM 249
D WSLG +E + +R + ++I + P +S+ I +
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADVLYPATWSTEAIDAINKL 236
Query: 250 LRKNPEHR--PTASDLLRHPHL 269
L ++P+ R DL HP+
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 3e-42
Identities = 88/267 (32%), Positives = 138/267 (51%), Gaps = 23/267 (8%)
Query: 19 EQIGRGAFGAAFLVL----HKIERKKYVL---KKIRLAKQTEKFKRTALQEMDLISKLNN 71
E +G+GA+G + L I K+ L + K+ EK + +E+DL+ L +
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQ----EEVDLLKSLKH 61
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
IV+Y +D N + I + GG ++ I+ R PE CK+ Q+L V YL
Sbjct: 62 VNIVQYLGTCLDD-NTISIFMEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYL 118
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-------NTEDLASSVVGTPNYMCPE 184
H+N V+HRD+K +N+ L + I+L DFG A+ L ++ S+ GTP +M PE
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI--NRSSISPLPIVYSSTM 242
++ + YG KSDIWS+GC +FE+A +P + D + I +R + LP +S+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHPHL 269
+ S L ++ RP+A LLRH L
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 79/290 (27%), Positives = 136/290 (46%), Gaps = 39/290 (13%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
Y+++ +IG GA G F E + V LKK+ L + AL+E+ + +P
Sbjct: 1 RYKILGRIGEGAHGIVFKAKD-RETGETVALKKVALRRLEGGIPNQALREIKALQACQHP 59
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
Y+VK D + G+ +V Y D++E+++ PE ++ ++ LL V Y+H
Sbjct: 60 YVVKLLDVFPH-GSGFVLVMEYM-PSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--LASSVVGTPNYMCPELLADIP 190
+N ++HRDLK +N+ ++ D +++ DFGLA+L + E+ L S V T Y PELL
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 191 -YGYKSDIWSLGCCMFEIAAHQPAFR-APDMAGLINKINRSSISPLPIVYS--------- 239
Y D+W++GC E+ P F D+ L + R+ +P +
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL-AIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 240 ---------STMKQI-----------IKSMLRKNPEHRPTASDLLRHPHL 269
+++I +K +L +P R +A++ LRHP+
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 91/295 (30%), Positives = 142/295 (48%), Gaps = 49/295 (16%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR----LAKQTEKFKRTALQEMDLISK 68
+D+EVI+ IGRGAFG +LV K + Y +K +R + + R E D+++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRA---ERDILAD 57
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGD-MAEIIKKARGACFPEEKLCKW-LTQLLL 126
++P+IVK ++ D+ + + +V Y GGD M +I+K FPEE ++ + +L+L
Sbjct: 58 ADSPWIVKLYYSFQDEEH-LYLVMEYMPGGDLMNLLIRKD---VFPEE-TARFYIAELVL 112
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED----------------- 169
A+D +H +HRD+K NI + D I+L DFGL K +N
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 170 -------------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRA 216
A+S VGTP+Y+ PE+L PYG + D WSLG ++E+ P F +
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232
Query: 217 PDMAGLINKINRSSIS---PLPIVYSSTMKQIIKSMLRKNPEHR-PTASDLLRHP 267
+ NKI S P S +I +L +PE R + ++ HP
Sbjct: 233 DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 2e-41
Identities = 95/265 (35%), Positives = 151/265 (56%), Gaps = 16/265 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E +E+I ++G GAFG + +K E K+ K E+ + + E+++++ N+P
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELE-DYMVEIEILATCNHP 69
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDM-AEIIKKARGACFPEEK-LCKWLTQLLLAVDY 130
YIVK A+ G + I+ +C GG + A +++ RG P+ + +C+ Q+L A+ Y
Sbjct: 70 YIVKLLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR---QMLEALQY 125
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPEL---- 185
LHS +++HRDLK N+ LT D DI+L DFG+ AK + T S +GTP +M PE+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 186 -LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL--PIVYSSTM 242
+ D PY YK+DIWSLG + E+A +P + ++ KI +S L P +S
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHP 267
+ +K+ L K+PE RP+A+ LL HP
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLEHP 270
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 79/267 (29%), Positives = 134/267 (50%), Gaps = 24/267 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKY----VLKK---IRLAKQTEKFKRTALQEMDL 65
+D+E I+ +G G+FG LV HK KY +L K ++L KQ E E +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK-GSGKYYALKILSKAKIVKL-KQVEHVLN----EKRI 54
Query: 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ + +P++V ++ D N +V Y GG++ ++K+ FPE + Q++
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLY-LVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVV 111
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPEL 185
LA++YLHS +++RDLK N+ L D I++ DFG AK + + ++ GTP Y+ PE+
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV--KGRTYTLCGTPEYLAPEI 169
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245
+ YG D W+LG ++E+ A P F + + KI P +S K +
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-LEGKVRFPSFFSPDAKDL 228
Query: 246 IKSMLRKNPEHR-----PTASDLLRHP 267
I+++L+ + R +D+ HP
Sbjct: 229 IRNLLQVDLTKRLGNLKNGVNDIKNHP 255
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 84/258 (32%), Positives = 140/258 (54%), Gaps = 13/258 (5%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISKLNN-- 71
Y+ +E IGRGA+GA + H + LK I L T + +Q E+ L+S+L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL--DTPDDDVSDIQREVALLSQLRQSQ 60
Query: 72 -PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
P I KY +++ KG + I+ Y EGG + ++K E+ + + ++L+A+ Y
Sbjct: 61 PPNITKYYGSYL-KGPRLWIIMEYAEGGSVRTLMK---AGPIAEKYISVIIREVLVALKY 116
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPELLAD- 188
+H V+HRD+K +NI +T +++L DFG+A LLN S+ VGTP +M PE++ +
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI-VYSSTMKQIIK 247
Y K+DIWSLG ++E+A P + D + I +S L YS +++ +
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236
Query: 248 SMLRKNPEHRPTASDLLR 265
+ L + P+ R +A +LL+
Sbjct: 237 ACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 88/267 (32%), Positives = 130/267 (48%), Gaps = 32/267 (11%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK-FKRTALQEMDLISKLNNPYIVKYKD 79
IG G FG + ++ + +K+IR+ K K A EM ++ L +P +VKY
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA-DEMKVLELLKHPNLVKYYG 66
Query: 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHR 139
V + V I YC GG + E+++ G E + + QLL + YLHS+ ++HR
Sbjct: 67 VEVHR-EKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 140 DLKCSNIFLTKDNDIRLGDFGLAKLL--NTEDLAS---SVVGTPNYMCPELLADIP---Y 191
D+K +NIFL + I+LGDFG A L NT + S+ GTP YM PE++ +
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-----------PLPIVYSS 240
G +DIWSLGC + E+A + + D N I P + S
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWSELD--------NEFQIMFHVGAGHKPPIPDSLQLSP 235
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHP 267
K + L +P+ RPTAS+LL+HP
Sbjct: 236 EGKDFLDRCLESDPKKRPTASELLQHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 6e-40
Identities = 74/243 (30%), Positives = 124/243 (51%), Gaps = 11/243 (4%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKD 79
+G G FG LV K + + + LK ++ E + E +++ + N+P+IVK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT-QLLLAVDYLHSNRVLH 138
+ DK + ++ YC GG++ I++ RG F E ++ ++LA +YLH+ +++
Sbjct: 61 TFKDKKY-IYMLMEYCLGGELWTILRD-RGL-FDEYT-ARFYIACVVLAFEYLHNRGIIY 116
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIW 198
RDLK N+ L + ++L DFG AK L + + GTP Y+ PE++ + Y + D W
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 199 SLGCCMFEIAAHQPAFRAPDMAGLI--NKINRSSISPL--PIVYSSTMKQIIKSMLRKNP 254
SLG ++E+ +P F D + N I + L P K +IK +LR+NP
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILK-GNGKLEFPNYIDKAAKDLIKQLLRRNP 235
Query: 255 EHR 257
E R
Sbjct: 236 EER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 89/270 (32%), Positives = 134/270 (49%), Gaps = 18/270 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E + ++G GA G+ K K ++ L+E+++ +P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSP 59
Query: 73 YIVKYKDAWVDKGNC-VCIVTGYCEGGDMAEIIKK--ARGACFPEEKLCKWLTQLLLAVD 129
YIVKY A++D+ + + I YCEGG + I KK RG E+ L K +L +
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA-KLLNTEDLASSVVGTPNYMCPELLAD 188
YLHS +++HRD+K SNI LT+ ++L DFG++ +L+N+ LA + GT YM PE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--LAGTFTGTSFYMAPERIQG 177
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQ---PAFRAPDMA--GLINKINRSSISPLP------IV 237
PY SD+WSLG + E+A ++ P P + L++ I L I
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237
Query: 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+S K IK L K+P RPT D+L HP
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 7e-40
Identities = 80/255 (31%), Positives = 130/255 (50%), Gaps = 11/255 (4%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKI---RLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
+G+GAFG +L ++ +K++ + +T+K E+ L+ L + IV+Y
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
D + I Y GG + + +K A G E K+ Q+L V+YLHSN ++
Sbjct: 70 YGCLRDDET-LSIFMEYMPGGSVKDQLK-AYG-ALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLAKLLNT----EDLASSVVGTPNYMCPELLADIPYGY 193
HRD+K +NI +++LGDFG +K L T SV GTP +M PE+++ YG
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-LPIVYSSTMKQIIKSMLRK 252
K+D+WS+GC + E+ +P + + I KI +P LP S + ++ +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVE 246
Query: 253 NPEHRPTASDLLRHP 267
N + RP+A +LLRH
Sbjct: 247 NAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 86/274 (31%), Positives = 137/274 (50%), Gaps = 21/274 (7%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NN 71
+E++E IG G +G + HK + +K + + + E+ +E +++ K N+
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE---EIKEEYNILRKYSNH 62
Query: 72 PYIVKYKDAWVDKGNCVC-----IVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQL 124
P I + A++ K +V C GG + +++K R G EE + L +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCP 183
L + YLH N+V+HRD+K NI LTK+ +++L DFG+ A+L +T ++ +GTP +M P
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 184 ELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAF-RAPDMAGLINKINRSSISPL--P 235
E++A D Y +SD+WSLG E+A +P M L KI R+ L P
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIPRNPPPTLKSP 241
Query: 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
+S I L KN E RP +LL HP +
Sbjct: 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 5e-39
Identities = 73/261 (27%), Positives = 123/261 (47%), Gaps = 22/261 (8%)
Query: 18 IEQIGRGAFGAAFL-VLHKIERKKYV------LKKIRLAKQTEKFKRTALQEMDLISKLN 70
+++G GAFG + L KK V LK+ +Q E+F L+E ++ KL+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEF----LREARIMRKLD 59
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+P +VK ++ + IV Y EGGD+ ++K R L + Q+ ++Y
Sbjct: 60 HPNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEY 117
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT-P-NYMCPELLAD 188
L S +HRDL N + ++ +++ DFGL++ L +D G P +M PE L +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 189 IPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQ 244
+ KSD+WS G ++EI QP P M+ ++ + P P +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLEYLKNGYRLPQPPNCPPELYD 234
Query: 245 IIKSMLRKNPEHRPTASDLLR 265
++ ++PE RPT S+L+
Sbjct: 235 LMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 70/261 (26%), Positives = 124/261 (47%), Gaps = 21/261 (8%)
Query: 18 IEQIGRGAFGA---AFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMDLISKLN 70
+++G GAFG L ++ V LK+ +Q E+F L+E ++ KL+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF----LREARIMRKLD 59
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+P IVK ++ + IV Y GGD+ + ++K R L + Q+ ++Y
Sbjct: 60 HPNIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT-P-NYMCPELLAD 188
L S +HRDL N + ++ +++ DFGL++ L +D G P +M PE L +
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 189 IPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQ 244
+ KSD+WS G ++EI +P P M+ ++ + + P P + +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYLKKGYRLPKPPNCPPELYK 235
Query: 245 IIKSMLRKNPEHRPTASDLLR 265
++ ++PE RPT S+L+
Sbjct: 236 LMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 86/303 (28%), Positives = 130/303 (42%), Gaps = 54/303 (17%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF-KRTALQEMDLISKLNNPY 73
YE+++ IG GA+G + K +K +KKI KR L+E+ L+ L +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI-LREIKLLRHLRHEN 60
Query: 74 IVKYKDAWVDKG----NCVCIVTGYCEGGDMAEIIKKARGACFPEEKL----CKWLT-QL 124
I+ D N V IVT E D+ ++IK + L ++ Q+
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKS-------PQPLTDDHIQYFLYQI 112
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV----VGTPNY 180
L + YLHS V+HRDLK SNI + + D+++ DFGLA+ ++ ++ V T Y
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 181 MCPEL-LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----LP 235
PEL L+ Y DIWS+GC E+ +P F D +N I +P L
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232
Query: 236 IVYSSTMKQIIKS--------------------------MLRKNPEHRPTASDLLRHPHL 269
+ S + +KS ML +P+ R TA + L HP+L
Sbjct: 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
Query: 270 QPY 272
Sbjct: 293 AQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 81/256 (31%), Positives = 146/256 (57%), Gaps = 6/256 (2%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
+E+IG+G+FG + + ++ +K I L + ++ + QE+ ++S+ ++PYI +Y
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYITRY 67
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
+++ KG + I+ Y GG +++K E + L ++L +DYLHS R +
Sbjct: 68 YGSYL-KGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERKI 123
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLA-KLLNTEDLASSVVGTPNYMCPELLADIPYGYKSD 196
HRD+K +N+ L++ D++L DFG+A +L +T+ ++ VGTP +M PE++ Y +K+D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 197 IWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEH 256
IWSLG E+A +P ++ I ++S L YS K+ +++ L K+P
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRF 243
Query: 257 RPTASDLLRHPHLQPY 272
RPTA +LL+H + Y
Sbjct: 244 RPTAKELLKHKFITRY 259
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 83/290 (28%), Positives = 135/290 (46%), Gaps = 47/290 (16%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKR----TALQEMDLISKLN 70
Y+++ +IG G F + K Y +K + K+ FK L+E+ + +L+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM---KK--HFKSLEQVNNLREIQALRRLS 55
Query: 71 -NPYIVKYKDAWVD-KGNCVCIVTGYCEGGDMA--EIIKKARGACFPEEKLCKWLTQLLL 126
+P I++ + D K + +V E DM E+IK R PE+++ ++ QLL
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALV---FELMDMNLYELIKG-RKRPLPEKRVKSYMYQLLK 111
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE-L 185
++D++H N + HRD+K NI L KD+ ++L DFG + + ++ + + T Y PE L
Sbjct: 112 SLDHMHRNGIFHRDIKPENI-LIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL 170
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI---------------NRSS 230
L D YG K DIW++GC FEI + P F + I KI +S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230
Query: 231 -------------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ L S+ ++K +L +P+ R TA LRHP
Sbjct: 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 23/265 (8%)
Query: 16 EVIEQIGRGAFGAAFLVLHKIERKKY-------VLKKIRLAKQTEKFKRTALQEMDLISK 68
E+ +++G GAFG + K + + LK+ ++ E+F L+E ++ K
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMKK 57
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
L++P IV+ +G + IVT Y GGD+ + ++K G + L + Q+ +
Sbjct: 58 LSHPNIVRLL-GVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGM 115
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP---NYMCPEL 185
+YL S +HRDL N +T++ +++ DFGL++ + +D G +M PE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 186 LADIPYGYKSDIWSLGCCMFEI----AAHQPAFRAPDMAGLINKINRSSISPLPIVYSST 241
L D + KSD+WS G ++EI P ++ L+ R P P
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR---LPRPENCPDE 232
Query: 242 MKQIIKSMLRKNPEHRPTASDLLRH 266
+ +++ +PE RPT S+L+
Sbjct: 233 LYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 85/289 (29%), Positives = 153/289 (52%), Gaps = 24/289 (8%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
+ + GD +S L+++ +IG G+ G + K ++ +KK+ L KQ +R L
Sbjct: 10 LVVDPGDPRSYLDNFV---KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELL 63
Query: 61 -QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
E+ ++ +P IV+ +++ G+ + +V + EGG + +I+ R EE++
Sbjct: 64 FNEVVIMRDYQHPNIVEMYSSYL-VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAT 119
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA--SSVVGT 177
+L A+ +LH+ V+HRD+K +I LT D ++L DFG + ++++ S+VGT
Sbjct: 120 VCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV-SKEVPRRKSLVGT 178
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFE-IAAHQPAFRAPDMAGLINKINRSSISPL-- 234
P +M PE+++ +PYG + DIWSLG + E + P F P + + K R ++ P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM--KRIRDNLPPKLK 236
Query: 235 -PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSV 282
S ++ + ML ++P R TA++LL H P+L + PSS+
Sbjct: 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH----PFLAKAGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 6e-37
Identities = 81/255 (31%), Positives = 146/255 (57%), Gaps = 6/255 (2%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E + +E+IG+G+FG F + ++ +K I L + ++ + QE+ ++S+ ++P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSP 62
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
Y+ KY +++ KG + I+ Y GG +++ R F E ++ L ++L +DYLH
Sbjct: 63 YVTKYYGSYL-KGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLH 118
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLA-KLLNTEDLASSVVGTPNYMCPELLADIPY 191
S + +HRD+K +N+ L++ D++L DFG+A +L +T+ ++ VGTP +M PE++ Y
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
K+DIWSLG E+A +P ++ I +++ L +S K+ I + L
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238
Query: 252 KNPEHRPTASDLLRH 266
K+P RPTA +LL+H
Sbjct: 239 KDPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 83/292 (28%), Positives = 139/292 (47%), Gaps = 50/292 (17%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKR----TALQEMDLISKLN 70
Y+VI+Q+G G FG+ +L +K + +KK++ +KF L+E+ + KLN
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-----KKFYSWEECMNLREVKSLRKLN 55
Query: 71 -NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
+P IVK K+ + + + + V Y EG ++ +++K +G F E + + Q+L +
Sbjct: 56 EHPNIVKLKEVFREN-DELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE-LLAD 188
++H + HRDLK N+ ++ +++ DFGLA+ + + + V T Y PE LL
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAF----------------------RAPDMAGLINKI 226
Y DIW+LGC M E+ +P F P+ L +K+
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 227 NRSSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHP 267
P +++ Q+ IK MLR +P+ RPTAS L+HP
Sbjct: 234 GFR----FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-36
Identities = 94/265 (35%), Positives = 147/265 (55%), Gaps = 16/265 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E +E+I ++G GAFG + +K E K+ K E+ + + E+D+++ ++P
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 62
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDM-AEIIKKARGACFPEEKL-CKWLTQLLLAVDY 130
IVK DA+ + N + I+ +C GG + A +++ R P+ ++ CK Q L A++Y
Sbjct: 63 NIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCK---QTLEALNY 118
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELL--- 186
LH N+++HRDLK NI T D DI+L DFG+ AK T S +GTP +M PE++
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 187 --ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL--PIVYSSTM 242
D PY YK+D+WSLG + E+A +P + ++ KI +S L P +SS
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHP 267
K +K L KN + R T + LL+HP
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHP 263
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 5e-36
Identities = 73/263 (27%), Positives = 135/263 (51%), Gaps = 17/263 (6%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT----EKFKRTALQEMDLISKLNNPYI 74
+Q+G GAF + + +K++ + T E+ +E+ L+++LN+P+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
++ A + + + + GG ++ ++ K GA F E + + QLL + YLH N
Sbjct: 66 IRMLGATCEDSH-FNLFVEWMAGGSVSHLLSKY-GA-FKEAVIINYTEQLLRGLSYLHEN 122
Query: 135 RVLHRDLKCSNIFL-TKDNDIRLGDFGLAKLLNTE-----DLASSVVGTPNYMCPELLAD 188
+++HRD+K +N+ + + +R+ DFG A L + + ++GT +M PE+L
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA---GLINKINRSSISP-LPIVYSSTMKQ 244
YG D+WS+GC + E+A +P + A + LI KI ++ +P +P S ++
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRD 242
Query: 245 IIKSMLRKNPEHRPTASDLLRHP 267
+ L PE RP + +LL+HP
Sbjct: 243 VTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
++YE + +I G +G + K + LKK+++ K+ E F T+L+E++++ KL +P
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 73 YIVKYKDAWVDKG-NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
IV K+ V + + +V Y E D+ +++ + E C + QLL V +L
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC-LMLQLLSGVAHL 122
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL--NTEDLASSVVGTPNYMCPELLADI 189
H N +LHRDLK SN+ L +++ DFGLA+ + VV T Y PELL
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGA 181
Query: 190 P-YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI-------NRSS---ISPLPIVY 238
Y D+WS+GC E+ +P F +NKI S LP
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 239 SSTMKQ---------------------IIKSMLRKNPEHRPTASDLLRHP 267
T + ++ +L +P R +A D L+HP
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 91/302 (30%), Positives = 143/302 (47%), Gaps = 43/302 (14%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
K ++ +++I QIG G +G + K + LKK+RL + E F TA++E+ ++ +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 69 LNNPYIVKYKDAWVDKGNCV---------CIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
LN+ IV K+ DK + + +V Y + M + ++ F E+ +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFSEDHIKS 120
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--LASSVVGT 177
++ QLL ++Y H LHRD+KCSNI L I+L DFGLA+L N+E+ ++ V T
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 178 PNYMCPELL-ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP- 235
Y PELL + YG D+WS GC + E+ +P F+A + I+R SP P
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240
Query: 236 -------IVYSSTMKQ---------------------IIKSMLRKNPEHRPTASDLLRHP 267
+ Y +TMK ++ ML +P R TA + L P
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300
Query: 268 HL 269
L
Sbjct: 301 WL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 76/263 (28%), Positives = 134/263 (50%), Gaps = 15/263 (5%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-KQTEKFKRTALQEMDLISKLNNPY 73
+ + +IG G+FGA + + +KK+ + KQ+ + + ++E+ + +L +P
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEG--GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
++YK ++ + +V YC G D+ E+ KK E ++ L + YL
Sbjct: 77 TIEYKGCYLREHTA-WLVMEYCLGSASDILEVHKKP----LQEVEIAAICHGALQGLAYL 131
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
HS+ +HRD+K NI LT+ ++L DFG A L++ A+S VGTP +M PE++ +
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDE 188
Query: 192 GY---KSDIWSLGCCMFEIAAHQPA-FRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247
G K D+WSLG E+A +P F M+ L + S + +S + +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD 248
Query: 248 SMLRKNPEHRPTASDLLRHPHLQ 270
S L+K P+ RP++ +LL+H +
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 19 EQIGRGAFGAAFL-VLHKIERKK-----YVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+++G GAFG + L + K LK+ ++ + F L+E ++ KL +P
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF----LKEARVMKKLGHP 56
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR-------GACFPEEKLCKWLTQLL 125
+V+ ++ + +V Y EGGD+ + ++K+R + + L + Q+
Sbjct: 57 NVVRLLGVCTEEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP---NYMC 182
++YL S + +HRDL N + +D +++ DFGL++ + +D G +M
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 183 PELLADIPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDM--AGLINKINRSSISPLPIVY 238
PE L D + KSD+WS G ++EI P P + ++ + + P P
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLSNEEVLEYLRKGYRLPKPEYC 232
Query: 239 SSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+ +++ S + +PE RPT S+L+
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 78/255 (30%), Positives = 145/255 (56%), Gaps = 6/255 (2%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E + +E+IG+G+FG F + +K +K I L + ++ + QE+ ++S+ ++P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSP 62
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
Y+ KY +++ K + I+ Y GG ++++ E ++ L ++L +DYLH
Sbjct: 63 YVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH 118
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLA-KLLNTEDLASSVVGTPNYMCPELLADIPY 191
S + +HRD+K +N+ L++ +++L DFG+A +L +T+ ++ VGTP +M PE++ Y
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251
K+DIWSLG E+A +P ++ I +++ L YS +K+ +++ L
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238
Query: 252 KNPEHRPTASDLLRH 266
K P RPTA +LL+H
Sbjct: 239 KEPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 39/287 (13%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFK---RTALQEMDLISKLNN 71
YE +++G G + + K + +KKI+L ++ E TAL+E+ L+ +L +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P I+ D + K N + +V + E D+ ++IK P + ++ L ++YL
Sbjct: 62 PNIIGLLDVFGHKSN-INLVFEFMET-DLEKVIKDKSIVLTPADIKS-YMLMTLRGLEYL 118
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT--EDLASSVVGTPNYMCPELL--A 187
HSN +LHRDLK +N+ + D ++L DFGLA+ + + VV T Y PELL A
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGA 177
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQP-------------AFRA---------PDMAGLINK 225
YG D+WS+GC E+ P F A P + L +
Sbjct: 178 RH-YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236
Query: 226 INRSSISPLPIVY-----SSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ P P+ S +++ +L NP R TA L HP
Sbjct: 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 85/293 (29%), Positives = 137/293 (46%), Gaps = 41/293 (13%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
YEV+ +G GA+G +K + +KK + ++ E K+TAL+E+ ++ +L +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE-KLCKWLTQLLLAVDYL 131
IV K+A+ KG + +V Y E + E+++ + G P+ + W QLL A+ Y
Sbjct: 61 NIVNLKEAFRRKGR-LYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW--QLLQAIAYC 116
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL--NTEDLASSVVGTPNYMCPELL-AD 188
HS+ ++HRD+K NI +++ ++L DFG A+ L + V T Y PELL D
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAF----------------------------RAPDMA 220
YG D+W++GC M E+ +P F P A
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 221 GLINKINRSSISPL----PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
G+ S L P SS +K+ LR +P+ R T +LL+HP+
Sbjct: 237 GVA-FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 84/318 (26%), Positives = 146/318 (45%), Gaps = 51/318 (16%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKI--RLAKQTEKFKRTALQEMDLISKLNN 71
++ I+ +G+G G FLV K K + LK + + + K KR L E ++++ L++
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR-VLTEQEILATLDH 60
Query: 72 PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
P++ Y A +C+V YC GG++ ++++ G C EE + ++LLA++Y
Sbjct: 61 PFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE---------------------- 168
LH +++RDLK NI L + I L DF L+K + E
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 169 DLAS--------SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIA-AHQPAFRAPDM 219
+ S S VGT Y+ PE+++ +G D W+LG ++E+ P F+ +
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP-FKGSNR 237
Query: 220 -AGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHR----PTASDLLRHPHLQPY-- 272
N + + P SS+ + +I+ +L K+P R A+++ +HP +
Sbjct: 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297
Query: 273 -LLRCQNPSSVYLPIKPT 289
L+R P PI P
Sbjct: 298 ALIRHTTP-----PIIPR 310
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 7e-33
Identities = 99/295 (33%), Positives = 160/295 (54%), Gaps = 41/295 (13%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
M + D +S+L +YEVI++IG G FG FLV HK ++ + K I E+ K +
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNC-VCIVTGYCEGGDMAEIIKKARGACFP------ 113
E++++ +L + IV+Y D +++K N + I+ +C+ GD++ I+K C+
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK----CYKMFGKIE 116
Query: 114 EEKLCKWLTQLLLAVDYLHS-------NRVLHRDLKCSNIFLT-----------KDNDI- 154
E + QLL A+ Y H+ RVLHRDLK NIFL+ + N++
Sbjct: 117 EHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 155 -----RLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGY--KSDIWSLGCCMFEI 207
++GDFGL+K + E +A S VGTP Y PELL Y KSD+W+LGC ++E+
Sbjct: 177 GRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 208 AAHQPAF-RAPDMAGLINKINRSSISPLPIV-YSSTMKQIIKSMLRKNPEHRPTA 260
+ + F +A + + LI+++ R LPI S + +IK++L + + RP+A
Sbjct: 237 CSGKTPFHKANNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSA 289
|
Length = 1021 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 28/308 (9%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDA 80
+GR AAF+ + K+ V+ K + E+ A E+ ++ ++ IVK+ D
Sbjct: 75 VGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDD 133
Query: 81 WVDKGNCVCIVTGYCEGGDMAEIIKKARGACFP--EEKLCKWLTQLLLAVDYLHSNRVLH 138
+ + I+ Y GGD+ + IK+ P E ++ Q++LA+D +HS +++H
Sbjct: 134 FKSDDKLLLIME-YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMH 192
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTE---DLASSVVGTPNYMCPELLADIPYGYKS 195
RDLK +NIFL I+LGDFG +K + D+ASS GTP Y+ PEL Y K+
Sbjct: 193 RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKA 252
Query: 196 DIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255
D+WSLG ++E+ F+ P ++ ++ P P SS MK ++ +L KNP
Sbjct: 253 DMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPA 312
Query: 256 HRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNSRKD-----K 310
RPT LL H Y+ N+ ++ R S + + R++ +
Sbjct: 313 LRPTTQQLL-HTEFLKYV---------------ANLFQDIVRHSETISPHDREEILRQLQ 356
Query: 311 GEREAAAP 318
E A P
Sbjct: 357 ESGERAPP 364
|
Length = 478 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 2e-32
Identities = 82/268 (30%), Positives = 141/268 (52%), Gaps = 12/268 (4%)
Query: 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDL 65
GD K K Y E+IG+GA G + + ++ +K++ L +Q +K + E+ +
Sbjct: 15 GDPKKK---YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK--ELIINEILV 69
Query: 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ + NP IV Y D+++ G+ + +V Y GG + +++ + C E ++ + L
Sbjct: 70 MRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECL 125
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPE 184
A+D+LHSN+V+HRD+K NI L D ++L DFG A++ + S++VGTP +M PE
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAF--RAPDMAGLINKINRSSISPLPIVYSSTM 242
++ YG K DIWSLG E+ +P + P A + N + P S+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF 245
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
+ + L + + R +A +LL+HP L+
Sbjct: 246 RDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 2e-32
Identities = 85/286 (29%), Positives = 145/286 (50%), Gaps = 24/286 (8%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
M + GD +S LE+Y +IG G+ G + K ++ +K + L KQ +
Sbjct: 12 MVVDQGDPRSLLENYI---KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR--ELLF 66
Query: 61 QEMDLISKLNNPYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
E+ ++ + +V+ YK V G + ++ + +GG + +I+ + R EE++
Sbjct: 67 NEVVIMRDYQHQNVVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQTR---LNEEQIAT 121
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTP 178
+L A+ YLHS V+HRD+K +I LT D ++L DFG A++ S+VGTP
Sbjct: 122 VCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP 181
Query: 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV- 237
+M PE+++ PYG + DIWSLG + E+ +P + + + + R SP P +
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPPKLK 238
Query: 238 ----YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNP 279
S ++ ++ ML + P+ R TA +LL H P+LL+ P
Sbjct: 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH----PFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 84/284 (29%), Positives = 145/284 (51%), Gaps = 17/284 (5%)
Query: 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDL 65
GD K K Y E+IG+GA G + + ++ +K++ L +Q +K + E+ +
Sbjct: 15 GDPKKK---YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEILV 69
Query: 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ + +P IV Y D+++ G+ + +V Y GG + +++ + C E ++ + L
Sbjct: 70 MRENKHPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECL 125
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPE 184
A+++LHSN+V+HRD+K NI L D ++L DFG A++ + S++VGTP +M PE
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAF--RAPDMAGLINKINRSSISPLPIVYSSTM 242
++ YG K DIWSLG E+ +P + P A + N + P S+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 245
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPI 286
+ + L + E R +A +LL+HP L+ P S P+
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHP-----FLKIAKPLSSLTPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 6e-32
Identities = 83/268 (30%), Positives = 141/268 (52%), Gaps = 12/268 (4%)
Query: 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDL 65
GD K K YE +IG+GA G F + ++ +K+I L KQ +K + E+ +
Sbjct: 15 GDPKKKYTRYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK--ELIINEILV 69
Query: 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ +L NP IV + D+++ G+ + +V Y GG + +++ + C E ++ + L
Sbjct: 70 MKELKNPNIVNFLDSFL-VGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECL 125
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPE 184
A+++LH+N+V+HRD+K N+ L D ++L DFG A++ + S++VGTP +M PE
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAF--RAPDMAGLINKINRSSISPLPIVYSSTM 242
++ YG K DIWSLG E+ +P + P A + N + P S
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF 245
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
+ + L + E R +A +LL+HP L+
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 7e-32
Identities = 69/260 (26%), Positives = 127/260 (48%), Gaps = 18/260 (6%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL--QEMDLISKLNNPYIV 75
++ I +GAFG+ +L + + +K ++ + K + T + + ++ + +PY+
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR 135
K ++ + + +V Y GGD A +IK G PE+ +++ +++L V+ LH
Sbjct: 61 KLYYSF-QSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 136 VLHRDLKCSNIFLTKDNDIRLGDFGLAK--LLNTEDLASSVVGTPNYMCPELLADIPYGY 193
++HRD+K N+ + + ++L DFGL++ L N + VGTP+Y+ PE + +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDDK 172
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY---SSTMKQIIKSML 250
SD WSLGC +FE P F A + + I I+ V S +I +L
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232
Query: 251 RKNPEHRPTAS---DLLRHP 267
+P R A+ ++ HP
Sbjct: 233 CMDPAKRLGANGYQEIKSHP 252
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 8e-32
Identities = 87/298 (29%), Positives = 159/298 (53%), Gaps = 21/298 (7%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
M + GD ++ L+++ +IG G+ G + K K +KK+ L KQ +
Sbjct: 11 MVVDPGDPRTYLDNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR--ELLF 65
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
E+ ++ + +V+ ++++ G+ + +V + EGG + +I+ R EE++
Sbjct: 66 NEVVIMRDYQHENVVEMYNSYL-VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAV 121
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPN 179
+L A+ LH+ V+HRD+K +I LT D ++L DFG ++ E S+VGTP
Sbjct: 122 CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPA-FRAPDMAGLINKINRSSISP-LPIV 237
+M PEL++ +PYG + DIWSLG + E+ +P F P + + K+ R ++ P L +
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDNLPPKLKNL 239
Query: 238 Y--SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMK 293
+ S ++K + +L ++P R TA++LL+H P+L + PS + +P+ N M+
Sbjct: 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH----PFLAKAGPPSCI-VPLMRQNRMR 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 86/296 (29%), Positives = 133/296 (44%), Gaps = 54/296 (18%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y+ +E+IG G +G + K+ + LKKIRL + E TA++E+ L+ +LN+P I
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLC-----KWLTQLLLAVD 129
V+ D V N + +V + D+ +KK + P L +L QLL +
Sbjct: 61 VRLLDV-VHSENKLYLVFEFL---DLD--LKKYMDSS-PLTGLDPPLIKSYLYQLLQGIA 113
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN------TEDLASSVVGTPNYMCP 183
Y HS+RVLHRDLK N+ + ++ ++L DFGLA+ T + V T Y P
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE-----VVTLWYRAP 168
Query: 184 E-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS----------SIS 232
E LL Y DIWS+GC E+ +P F + +I R+ ++
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228
Query: 233 PLPIVYSSTMKQ-------------------IIKSMLRKNPEHRPTASDLLRHPHL 269
LP Y T + ++ ML +P R +A L+HP+
Sbjct: 229 SLP-DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 77/257 (29%), Positives = 124/257 (48%), Gaps = 16/257 (6%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
+G+G+FG L K + Y +K ++ + Q + + T ++ L +P++ +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 79 DAWVDKGNCVCIVTGYCEGGD-MAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
+ K + V Y GGD M I + R F E + + +++L + +LH ++
Sbjct: 63 SCFQTKDR-LFFVMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHERGII 118
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLAK--LLNTEDLASSVVGTPNYMCPELLADIPYGYKS 195
+RDLK N+ L + I++ DFG+ K +L S+ GTP+Y+ PE+L+ PYG
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTSTFCGTPDYIAPEILSYQPYGPAV 177
Query: 196 DIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255
D W+LG ++E+ A Q F D L I + P S K I+KS L KNPE
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR-YPRWLSKEAKSILKSFLTKNPE 236
Query: 256 HR----PTA-SDLLRHP 267
R PT D+ HP
Sbjct: 237 KRLGCLPTGEQDIKGHP 253
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 83/259 (32%), Positives = 137/259 (52%), Gaps = 12/259 (4%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKR--TALQ-EMDLISKLNNPYIVKY 77
+G+GAFG +L ++ K+++ ++ + + +AL+ E+ L+ L + IV+Y
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 78 KDAWVDKGN-CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136
D+ + I Y GG + + +K A GA E K+ Q+L + YLHSN +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLK-AYGA-LTESVTRKYTRQILEGMSYLHSNMI 127
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS----SVVGTPNYMCPELLADIPYG 192
+HRD+K +NI +++LGDFG +K L T ++ SV GTP +M PE+++ YG
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-LPIVYSSTMKQIIKSMLR 251
K+D+WSLGC + E+ +P + + I KI +P LP S + + +
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFV 247
Query: 252 KNPEHRPTASDLLRHPHLQ 270
+ HRP+A +LLRHP Q
Sbjct: 248 E-ARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 86/286 (30%), Positives = 139/286 (48%), Gaps = 37/286 (12%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ---EMDLISKL 69
ED+E I+ I GA+GA +LV HK R+++ +KKI KQ + Q E D+++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN--KQNLILRNQIQQVFVERDILTFA 58
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
NP++V ++ K + +C+V Y EGGD A ++K GA P + + + +LA++
Sbjct: 59 ENPFVVSMFCSFETKRH-LCMVMEYVEGGDCATLLKNI-GA-LPVDMARMYFAETVLALE 115
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK--LLNT--------------EDLASS 173
YLH+ ++HRDLK N+ +T I+L DFGL+K L++ E L
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 174 VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI-- 231
V GTP Y+ PE++ YG D W++G ++E F L ++ I
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235
Query: 232 ----SPLPIVYSSTMKQIIKSMLRKNPEHR---PTASDLLRHPHLQ 270
LP + + +I +LR+NP R A ++ +H
Sbjct: 236 PEGDEALP----ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 75/258 (29%), Positives = 128/258 (49%), Gaps = 14/258 (5%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKI---RLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
+G+G FG K K Y KK+ RL K+ K ++ AL E ++ K+++ +IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR--KGEQMALNEKKILEKVSSRFIVSL 58
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
A+ K + +C+V GGD+ I FPE + + Q++ +++LH R++
Sbjct: 59 AYAFETKDD-LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDI 197
+RDLK N+ L ++R+ D GLA L GTP YM PE+L Y + D
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDW 177
Query: 198 WSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSSTMKQIIKSMLRKNP 254
++LGC ++E+ A + FR ++ R ++ P +S K + +++L+K+P
Sbjct: 178 FALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237
Query: 255 EHR-----PTASDLLRHP 267
E R +A ++ HP
Sbjct: 238 EKRLGCRGGSADEVREHP 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 85/288 (29%), Positives = 147/288 (51%), Gaps = 21/288 (7%)
Query: 4 ENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEM 63
GD + L+ + +IG G+ G + K K+ +KK+ L KQ + E+
Sbjct: 16 SPGDPREYLDSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR--ELLFNEV 70
Query: 64 DLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ 123
++ ++ +V ++++ G+ + +V + EGG + +I+ R EE++
Sbjct: 71 VIMRDYHHENVVDMYNSYL-VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLS 126
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPNYMC 182
+L A+ YLH+ V+HRD+K +I LT D I+L DFG ++ E S+VGTP +M
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186
Query: 183 PELLADIPYGYKSDIWSLGCCMFE-IAAHQPAFRAPDMAGLINKINRSSISP-LPIVY-- 238
PE+++ +PYG + DIWSLG + E I P F P + + + R ++ P + +
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM--RRIRDNLPPRVKDSHKV 244
Query: 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPI 286
SS ++ + ML + P R TA +LL+HP L+ P S +P+
Sbjct: 245 SSVLRGFLDLMLVREPSQRATAQELLQHP-----FLKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 81/308 (26%), Positives = 132/308 (42%), Gaps = 53/308 (17%)
Query: 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL 69
SKL DYE++ ++G G FG + + LKKI + + + F TAL+E+ ++ KL
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 70 NNPYIVKYKDAWVDKG-------NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
+P +V D V++ V +VT Y + D++ +++ + C ++
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKC-YML 122
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-------------LNTED 169
QLL ++YLH N +LHRD+K +NI + +++ DFGLA+ T
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 170 LASSVVGTPNYMCPELLA-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAP----------D 218
+ VV T Y PELL + Y DIW +GC E+ +P +
Sbjct: 183 YTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241
Query: 219 MAGLINKINRSSISPLPIV--------YSSTMKQIIKSMLRK-----------NPEHRPT 259
+ G + LP Y T+++ + + +P R T
Sbjct: 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301
Query: 260 ASDLLRHP 267
ASD L HP
Sbjct: 302 ASDALEHP 309
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 81/301 (26%), Positives = 135/301 (44%), Gaps = 49/301 (16%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIER--KKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNN 71
YE+ IGRG +G + K + K+Y +KK + K Q ++A +E+ L+ +L +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 72 PYIVKYKDAWVDKGN-CVCIVTGYCEGGDMAEIIK---KARGACFPEEKLCKWLTQLLLA 127
+V + +++ + V ++ Y E D+ +IIK +A+ P + L Q+L
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDND----IRLGDFGLAKLLNT--EDLASS--VVGTPN 179
V YLHSN VLHRDLK +NI + + +++GD GLA+L N + LA VV T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 180 YMCPELLADIPYGYKS-----DIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL 234
Y PELL G + DIW++GC E+ +P F+
Sbjct: 181 YRAPELL----LGARHYTKAIDIWAIGCIFAELLTLEPIFKG---------REAKIKKSN 227
Query: 235 PIVYSSTMKQIIKSM----------LRKNPEHRPTASDLLR----HPHLQPYLLRCQNPS 280
P +++I + + ++K PE+ D L ++ + + P
Sbjct: 228 PF-QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD 286
Query: 281 S 281
S
Sbjct: 287 S 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 71/234 (30%), Positives = 115/234 (49%), Gaps = 17/234 (7%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
YE + +IG+G FG F HK ++ LKK+ + + E F TAL+E+ ++ L + +
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV 73
Query: 75 VKYKDAWVDKGN-------CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
V + K +V +CE D+A ++ F ++ K + LL
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNG 131
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK--LLNTED---LASSVVGTPNYMC 182
+ Y+H N++LHRD+K +NI +TKD ++L DFGLA+ L+ ++ V T Y
Sbjct: 132 LYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191
Query: 183 PE-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR--SSISP 233
PE LL + YG D+W GC M E+ P + + I++ SI+P
Sbjct: 192 PELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 97/323 (30%), Positives = 159/323 (49%), Gaps = 26/323 (8%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTA----LQE 62
D + K EDYEV++ IGRGAFG LV HK RK Y +K L + E KR+ +E
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK---LLSKFEMIKRSDSAFFWEE 93
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
D+++ N+P++V+ A+ D + +V Y GGD+ ++ PE+ +
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDD-RYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTA 149
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA--SSVVGTPNY 180
+++LA+D +HS +HRD+K N+ L K ++L DFG +N E + + VGTP+Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209
Query: 181 MCPELL----ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI--NRSSIS-P 233
+ PE+L D YG + D WS+G ++E+ F A + G +KI +++S++ P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269
Query: 234 LPIVYSSTMKQIIKSML--RKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNI 291
S K +I + L R+ R ++ RH + + P+ P
Sbjct: 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP--- 326
Query: 292 MKEKTRKSPSSKHNSRKDKGERE 314
+ S+ + +DKGE E
Sbjct: 327 -DLSSDIDTSNFDDIEEDKGEEE 348
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 69/244 (28%), Positives = 118/244 (48%), Gaps = 17/244 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKK------IRLAKQTEKFKRTALQEMDLI 66
+D E I+ +G G FG LV +I Y LK IRL KQ + E ++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL-KQEQHVH----NEKRVL 55
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
++++P+I++ D+ ++ Y GG++ ++ + F + ++++
Sbjct: 56 KEVSHPFIIRLFWTEHDQRFLYMLME-YVPGGELFSYLRNSGR--FSNSTGLFYASEIVC 112
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
A++YLHS +++RDLK NI L K+ I+L DFG AK L D ++ GTP Y+ PE++
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVI 170
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
+ D W+LG ++E+ P F + G+ KI + P K +I
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE-FPRHLDLYAKDLI 229
Query: 247 KSML 250
K +L
Sbjct: 230 KKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 78/258 (30%), Positives = 125/258 (48%), Gaps = 15/258 (5%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKI--RLAKQTEKFKRTALQEMDLISKL--NNPYIVK 76
IG+G FG + V K R+ Y +K + + ++ T + L+ L +P+IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 77 YKDAWVDKGNCVCIVTGYCEGGDMA-EIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR 135
K ++ + + +VT Y GG++ + K+ R F E++ ++ +L+LA+++LH
Sbjct: 61 LKFSFQTDSD-LYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYD 116
Query: 136 VLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPE-LLADIPYGY 193
+++RDLK NI L I L DFGL+K L ++ GT Y+ PE LL + Y
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
D WSLG +FE+ F A D + I + V S +Q +K +L +N
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRN 236
Query: 254 PEHRPTASD----LLRHP 267
P+HR A L HP
Sbjct: 237 PQHRLGAHRDAVELKEHP 254
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 5e-30
Identities = 76/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-KQTEKFKRTALQEMDLISKLNNPYIVK 76
+ +IG G+FGA + + + +KK+ + KQT + + ++E+ + +L +P ++
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 77 YKDAWVDKGNCVCIVTGYCEGG--DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
YK ++ K + +V YC G D+ E+ KK E ++ L + YLHS+
Sbjct: 86 YKGCYL-KEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSH 140
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI---PY 191
++HRD+K NI LT+ ++L DFG A + A+S VGTP +M PE++ + Y
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQY 197
Query: 192 GYKSDIWSLGCCMFEIAAHQPA-FRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
K D+WSLG E+A +P F M+ L + S + ++ + + + L
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL 257
Query: 251 RKNPEHRPTASDLLRH 266
+K P+ RP +++LLRH
Sbjct: 258 QKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 80/274 (29%), Positives = 136/274 (49%), Gaps = 20/274 (7%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
+ ED E I +G G G+ V H I + KK+ ++ L+E+ ++ +
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKH-IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+PYIV + A++++ N +C+ + + G + I KK G P E L K ++ + Y
Sbjct: 62 SPYIVSFYGAFLNENN-ICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTY 118
Query: 131 LHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLA-KLLNTEDLASSVVGTPNYMCPELLAD 188
L++ +R++HRD+K SNI + I+L DFG++ +L+N+ +A + VGT YM PE +
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQG 176
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAP--------DMAGLINKINRSSISPLPIVYSS 240
Y KSD+WSLG + E+A + F D G+++ + + P P + SS
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236
Query: 241 TMKQIIKSM----LRKNPEHRPTASDLLRHPHLQ 270
+ ++ L K+P RPT L P
Sbjct: 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 79/265 (29%), Positives = 141/265 (53%), Gaps = 21/265 (7%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRL---AKQTEKFKRTAL----QEMDLISKLNNPY 73
IG G+FG+ +L ++ + +K++ L + ++ KR+ L +E+ L+ +L +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
IV+Y + +D + + I Y GG +A ++ GA F E + ++ Q+L ++YLH+
Sbjct: 68 IVQYLGSSLDA-DHLNIFLEYVPGGSVAALLNN-YGA-FEETLVRNFVRQILKGLNYLHN 124
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS-------SVVGTPNYMCPELL 186
++HRD+K +NI + I++ DFG++K L L++ S+ G+ +M PE++
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL--INKINRSSISPLPIVYSSTMKQ 244
Y K+DIWSLGC + E+ + F PD L I KI ++ +P SS
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHPF--PDCTQLQAIFKIGENASPEIPSNISSEAID 242
Query: 245 IIKSMLRKNPEHRPTASDLLRHPHL 269
++ + RPTA++LL+HP L
Sbjct: 243 FLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 85/273 (31%), Positives = 135/273 (49%), Gaps = 24/273 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKR--TAL--QEMDLISK 68
+D+E+++ IGRGAFG +V K + Y +K + + E KR TA +E D++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMK---ILNKWEMLKRAETACFREERDVLVN 57
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
+ +I A+ D+ N ++ Y GGD+ ++ K PE+ +L +++LA+
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYV-GGDLLTLLSKF-EDRLPEDMARFYLAEMVLAI 115
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG-LAKLLNTEDLASSV-VGTPNYMCPELL 186
D +H +HRD+K N+ L K+ IRL DFG +LL + S+V VGTP+Y+ PE+L
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 187 ADIP-----YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI----NRSSISPLPIV 237
+ YG + D WSLG CM+E+ + F A + KI P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD 235
Query: 238 YSSTMKQIIKSMLRKNPEHR---PTASDLLRHP 267
S K +I+ ++ +PE R D HP
Sbjct: 236 VSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHP 267
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 9e-30
Identities = 80/268 (29%), Positives = 140/268 (52%), Gaps = 12/268 (4%)
Query: 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDL 65
GD K K Y E+IG+GA G + + ++ ++++ L +Q +K + E+ +
Sbjct: 16 GDPKKK---YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILV 70
Query: 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ + NP IV Y D+++ G+ + +V Y GG + +++ + C E ++ + L
Sbjct: 71 MRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECL 126
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPE 184
A+++LHSN+V+HRD+K NI L D ++L DFG A++ + S++VGTP +M PE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAF--RAPDMAGLINKINRSSISPLPIVYSSTM 242
++ YG K DIWSLG E+ +P + P A + N + P S+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
+ + L + E R +A +LL+H L+
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 9e-30
Identities = 81/256 (31%), Positives = 131/256 (51%), Gaps = 12/256 (4%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRL---AKQTEKFKRTALQEMDLISKLNNPYIVKY 77
+GRGAFG +L ++ +K++ +++T K E+ L+ L + IV+Y
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 78 KDAWVD-KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136
D + + I Y GG + + +K A GA E ++ Q+L V YLHSN +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLK-AYGA-LTENVTRRYTRQILQGVSYLHSNMI 127
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA----SSVVGTPNYMCPELLADIPYG 192
+HRD+K +NI +++LGDFG +K + T ++ SV GTP +M PE+++ YG
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYG 187
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-LPIVYSSTMKQIIKSMLR 251
K+D+WS+ C + E+ +P + + I KI P LP S + +K +
Sbjct: 188 RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV 247
Query: 252 KNPEHRPTASDLLRHP 267
+ + RPTA LLRHP
Sbjct: 248 EE-KRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 83/269 (30%), Positives = 137/269 (50%), Gaps = 18/269 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN- 71
+ +E+IE IG+G +G F VL+K K +K + E +++ L++
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK---ILDPIHDIDEEIEAEYNILKALSDH 74
Query: 72 PYIVKYKDAWVDK----GNCVCIVTGYCEGGDMAEIIKK--ARGACFPEEKLCKWLTQLL 125
P +VK+ + K G+ + +V C GG + +++K RG E + L + L
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPE 184
+ + +LH N+ +HRD+K +NI LT + ++L DFG+ A+L +T ++ VGTP +M PE
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194
Query: 185 LLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL--PIV 237
++A D Y + D+WSLG E+ P + KI R+ L P +
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPEL 254
Query: 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+S+ I+ L K+ E RPT SDLL+H
Sbjct: 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 82/300 (27%), Positives = 138/300 (46%), Gaps = 51/300 (17%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHK----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
+D+E + ++G G G VLH+ I +K + +I+ A + + ++E+ ++ +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQ-----IIRELKVLHE 55
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
N+PYIV + A+ G + I + +GG + +++KKA PE L K +L +
Sbjct: 56 CNSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGR--IPENILGKISIAVLRGL 112
Query: 129 DYLHSNR-VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA 187
YL ++HRD+K SNI + +I+L DFG++ L + +A+S VGT +YM PE L
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQ 171
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR------------------- 228
Y +SDIWSLG + E+A + PD L R
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 229 SSISPLPI------------------VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
S P+ I +S + + L+KNP+ R +L +HP ++
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 84/279 (30%), Positives = 142/279 (50%), Gaps = 22/279 (7%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL----QE 62
+ K ED++VI+ IGRGAFG LV HK ++ Y +K L+K E KR+ +E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMK--LLSK-FEMIKRSDSAFFWEE 93
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
D+++ N+ +IV+ A+ D + +V Y GGD+ ++ PE+ +
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDD-KYLYMVMEYMPGGDLVNLMSNYD---IPEKWARFYTA 149
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--ASSVVGTPNY 180
+++LA+D +HS +HRD+K N+ L K ++L DFG ++ + + VGTP+Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 181 MCPELL----ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI--NRSSIS-P 233
+ PE+L D YG + D WS+G ++E+ F A + G +KI +++S++ P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP 269
Query: 234 LPIVYSSTMKQIIKSMLRKNPEH--RPTASDLLRHPHLQ 270
I S K +I + L R ++ HP +
Sbjct: 270 DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 77/276 (27%), Positives = 139/276 (50%), Gaps = 33/276 (11%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+D + E +G G G + H + R+ +K I L T + ++ + E++++ K ++P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPL-DITVELQKQIMSELEILYKCDSP 59
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
YI+ + A+ + N + I T + +GG + ++ +K PE L + ++ + YL
Sbjct: 60 YIIGFYGAFFVE-NRISICTEFMDGGSL-DVYRK-----IPEHVLGRIAVAVVKGLTYLW 112
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLA-KLLNTEDLASSVVGTPNYMCPELLADIPY 191
S ++LHRD+K SN+ + ++L DFG++ +L+N+ +A + VGT YM PE ++ Y
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQY 170
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV-------------- 237
G SD+WSLG E+A + F P + N+ S+ PL ++
Sbjct: 171 GIHSDVWSLGISFMELALGR--FPYPQIQK-----NQGSLMPLQLLQCIVDEDPPVLPVG 223
Query: 238 -YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
+S I +RK P+ RP +L+ HP + Y
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 88/293 (30%), Positives = 149/293 (50%), Gaps = 22/293 (7%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTA----LQEMDLI 66
K EDY+V++ IGRGAFG LV HK +K Y +K L + E KR+ +E D++
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMK---LLSKFEMIKRSDSAFFWEERDIM 97
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
+ N+P++V+ A+ D + +V Y GGD+ ++ PE+ + +++L
Sbjct: 98 AFANSPWVVQLFCAFQDDKY-LYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVL 153
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA--SSVVGTPNYMCPE 184
A+D +HS ++HRD+K N+ L K ++L DFG ++ + + VGTP+Y+ PE
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPE 213
Query: 185 LL----ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI--NRSSIS-PLPIV 237
+L D YG + D WS+G +FE+ F A + G +KI +++S++ P +
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273
Query: 238 YSSTMKQIIKSML--RKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288
S K +I + L R+ R ++ +HP + N P+ P
Sbjct: 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVP 326
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 73/252 (28%), Positives = 124/252 (49%), Gaps = 9/252 (3%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRT-ALQEMDLISKLNNPYIVKYKD 79
IG+G+FG V + ++ Y LK IR A + + T L E +++++N P+IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHR 139
++ + +V + GG++ ++ R F + + +LL A++ LH V++R
Sbjct: 61 SFQSPEK-LYLVLAFINGGELFHHLQ--REGRFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 140 DLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIW 198
DLK NI L I L DFGL KL + +D ++ GTP Y+ PELL Y D W
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 199 SLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHR- 257
+LG ++E+ P F ++ + KI + + P + K ++ +L ++P R
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR-FPDGFDRDAKDLLIGLLSRDPTRRL 236
Query: 258 --PTASDLLRHP 267
A ++ HP
Sbjct: 237 GYNGAQEIKNHP 248
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-29
Identities = 81/255 (31%), Positives = 135/255 (52%), Gaps = 12/255 (4%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKR--TALQ-EMDLISKLNNPYIVKY 77
+G+GAFG +L ++ +K+++ ++ + + AL+ E+ L+ L + IV+Y
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 78 KDAWVD-KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136
D + I + GG + + +K + GA E K+ Q+L V YLHSN +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGA-LTENVTRKYTRQILEGVSYLHSNMI 127
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS----SVVGTPNYMCPELLADIPYG 192
+HRD+K +NI +++LGDFG +K L T L+ SV GTP +M PE+++ YG
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYG 187
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-LPIVYSSTMKQIIKSMLR 251
K+DIWS+GC + E+ +P + + I KI +P LP S + +K +
Sbjct: 188 RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV 247
Query: 252 KNPEHRPTASDLLRH 266
+ + RP+A +LLRH
Sbjct: 248 E-AKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 24/284 (8%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKI---RLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
+G+G FG + K Y KK+ R+ K+ K + AL E ++ K+N+ ++V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVSL 65
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
A+ K + +C+V GGD+ I F EE+ + ++ ++ LH R++
Sbjct: 66 AYAYETK-DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDI 197
+RDLK NI L IR+ D GLA + + VGT YM PE++ + Y + D
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDW 184
Query: 198 WSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL----PIVYSSTM----KQIIKSM 249
W LGC ++E+ + FR K+ R + YS + I + +
Sbjct: 185 WGLGCLIYEMIEGKSPFRQRK-----EKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239
Query: 250 LRKNPEHR-----PTASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288
L K+P R A ++ HP + + + P P
Sbjct: 240 LTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 80/267 (29%), Positives = 129/267 (48%), Gaps = 21/267 (7%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
L + E + +IG GA G + V+H+ + Y LK I + +R +E++++ +N+
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVNH 131
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDM--AEIIKKARGACFPEEKLCKWLTQLLLAVD 129
P +VK D + D + ++ + +GG + I E+ L Q+L +
Sbjct: 132 PNVVKCHDMF-DHNGEIQVLLEFMDGGSLEGTHIAD--------EQFLADVARQILSGIA 182
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTPNYMCPEL--- 185
YLH ++HRD+K SN+ + ++++ DFG++++L T D +S VGT YM PE
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242
Query: 186 -LADIPY-GYKSDIWSLGCCMFEIAAHQPAF---RAPDMAGLINKINRSSISPLPIVYSS 240
L Y GY DIWSLG + E + F R D A L+ I S P S
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ I L++ P R +A LL+HP
Sbjct: 303 EFRHFISCCLQREPAKRWSAMQLLQHP 329
|
Length = 353 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 81/300 (27%), Positives = 138/300 (46%), Gaps = 42/300 (14%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
++E + +IG G +G + + LKK+R+ + + ++L+E+ L+ L +P
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 74 IVKYKDAWVDKG-NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IV+ K+ V K + + +V YCE D+A ++ F E ++ + QLL + YLH
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH 125
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN-----YMCPELL- 186
N ++HRDLK SN+ LT +++ DFGLA+ A + TP Y PELL
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPM--TPKVVTLWYRAPELLL 181
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI------NRSSISP----LPI 236
Y D+W++GC + E+ AH+P ++ I SI P LP+
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241
Query: 237 VYSSTMKQ-------------------IIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQ 277
V T+ + ++ +L +P+ R TA + L + + L C+
Sbjct: 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 77/269 (28%), Positives = 133/269 (49%), Gaps = 16/269 (5%)
Query: 16 EVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIV 75
EV++++G+G +G+ + VLH+ +K+IRL KF + E+D++ K +PYIV
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF-NQIIMELDILHKAVSPYIV 62
Query: 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGAC-FPEEKLCKWLTQLLLAVDYL-HS 133
+ A+ +G V + Y + G + ++ PE+ L + ++ + +L
Sbjct: 63 DFYGAFFIEG-AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL------A 187
+ ++HRD+K +N+ + + ++L DFG++ L LA + +G +YM PE +
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 188 DIPYGYKSDIWSLGCCMFEIA----AHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243
+ Y +SD+WSLG + E+A + P A A L + I LP YS +
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL-SAIVDGDPPTLPSGYSDDAQ 239
Query: 244 QIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
+ L K P RPT + LL HP L Y
Sbjct: 240 DFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 18/273 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NN 71
+ +E+IE IG+G +G + V +K K L +++ E +++ L N+
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNK---KDGSLAAVKILDPISDVDEEIEAEYNILQSLPNH 78
Query: 72 PYIVKYKDAWVDKGNCV----CIVTGYCEGGDMAEIIKK--ARGACFPEEKLCKWLTQLL 125
P +VK+ + V +V C GG + E++K G E + L L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPE 184
L + +LH+NR++HRD+K +NI LT + ++L DFG+ A+L +T ++ VGTP +M PE
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 185 LLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL--PIV 237
++A D Y + D+WSLG E+ P + KI R+ L P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEK 258
Query: 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
+ + I L K+ E RP+ + LL HP ++
Sbjct: 259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 76/244 (31%), Positives = 115/244 (47%), Gaps = 47/244 (19%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTA--LQEMDLISKLN 70
+D+E I+ IGRGAFG LV K Y +KK+R ++ EK ++ A E D++++ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK-EQVAHVRAERDILAEAD 59
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGD-MAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
NP++VK ++ D+ I+ Y GGD M ++KK F EE+ ++ + +LA+D
Sbjct: 60 NPWVVKLYYSFQDENYLYLIME-YLPGGDMMTLLMKKD---TFTEEETRFYIAETILAID 115
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL------------------------ 165
+H +HRD+K N+ L I+L DFGL L
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 166 ---------------NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH 210
N LA S VGTP+Y+ PE+ Y + D WSLG M+E+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
Query: 211 QPAF 214
P F
Sbjct: 236 YPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 76/264 (28%), Positives = 134/264 (50%), Gaps = 23/264 (8%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-KQTEKFKRTALQEMDLISKLNNPYIVK 76
+ +IG G+FGA + + +KK+ + KQ+ + + ++E+ + KL +P ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 77 YKDAWVDKGNCVCIVTGYCEGG--DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
Y+ ++ + + +V YC G D+ E+ KK E ++ L + YLHS+
Sbjct: 80 YRGCYL-REHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHSH 134
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI---PY 191
++HRD+K NI L++ ++LGDFG A ++ A+ VGTP +M PE++ + Y
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQY 191
Query: 192 GYKSDIWSLGCCMFEIAAHQPA-FRAPDMAGLINKINRSSISPLPIV----YSSTMKQII 246
K D+WSLG E+A +P F M+ L + S P + +S + +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----PALQSGHWSEYFRNFV 247
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQ 270
S L+K P+ RPT+ LL+H +
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 80/270 (29%), Positives = 133/270 (49%), Gaps = 27/270 (10%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-----QTEKFKRT--AL-QEMDLISKLN 70
E IG+G +G +L L+ + +K++ L + K AL E++ + L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT-QLLLAVD 129
+ IV+Y + + I Y GG + ++ F EE+L ++ T Q+L +
Sbjct: 67 HLNIVQYL-GFETTEEYLSIFLEYVPGGSIGSCLRTY--GRF-EEQLVRFFTEQVLEGLA 122
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-----ASSVVGTPNYMCPE 184
YLHS +LHRDLK N+ + D ++ DFG++K ++D+ S+ G+ +M PE
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 185 LLADIPYGY--KSDIWSLGCCMFEI-AAHQPAFRAPDMAGLINKINRSSISPLPIVYSST 241
++ GY K DIWSLGC + E+ A +P +A + N+ S P+P S
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240
Query: 242 MKQIIKSMLRK----NPEHRPTASDLLRHP 267
+ + L NP++RPTA +LL+HP
Sbjct: 241 LSPVALDFLNACFTINPDNRPTARELLQHP 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFK--RTALQEMDLISKLN 70
D++++ Q+G+G +G FL K + LK R+ K K R L E D+++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALK--RMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK-----KARGACFPEEKLCKWLTQLL 125
+ ++VK A+ D + + Y GGD ++ A F ++ ++
Sbjct: 60 SEWLVKLLYAFQDDEY-LYLAMEYVPGGDFRTLLNNLGVLSEDHARF-------YMAEMF 111
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPEL 185
AVD LH +HRDLK N + I+L DFGL+K A+SVVG+P+YM PE+
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEV 169
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAF 214
L Y + D WSLGC ++E P F
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 83/260 (31%), Positives = 140/260 (53%), Gaps = 21/260 (8%)
Query: 21 IGRGAFGAAFLVLHKIERKK----YVLKKIRLAKQTEKFK---RTALQEMDLISKLNNPY 73
+G+G+FG FLV KI Y +K ++ K T K + RT + E D+++++N+P+
Sbjct: 4 LGQGSFGKVFLV-RKITGPDAGQLYAMKVLK--KATLKVRDRVRTKM-ERDILAEVNHPF 59
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
IVK A+ +G I+ + GGD+ + K F EE + +L +L LA+D+LHS
Sbjct: 60 IVKLHYAFQTEGKLYLILD-FLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS 116
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAK-LLNTEDLASSVVGTPNYMCPELLADIPYG 192
+++RDLK NI L ++ I+L DFGL+K ++ E A S GT YM PE++ +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252
+D WS G MFE+ F+ D + I ++ + +P S + +++++ ++
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-MPQFLSPEAQSLLRALFKR 235
Query: 253 NPEHRPTAS-----DLLRHP 267
NP +R A ++ RHP
Sbjct: 236 NPANRLGAGPDGVEEIKRHP 255
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 80/290 (27%), Positives = 140/290 (48%), Gaps = 44/290 (15%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
+EV+ +G GA+G HK ++ +KK + +++ E+ K T L+E+ ++ L I
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V+ K+A+ +G + +V Y E +M E++++ PE K+ ++ QL+ A+ + H N
Sbjct: 63 VELKEAFRRRGK-LYLVFEYVEK-NMLELLEEMPNGVPPE-KVRSYIYQLIKAIHWCHKN 119
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA--SSVVGTPNYMCPELLADIPYG 192
++HRD+K N+ ++ ++ ++L DFG A+ L+ A + V T Y PELL PYG
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAP---DMAGLINKINRSSISPLPI------------- 236
D+WS+GC + E++ QP F D I K+ + PLP
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKV----LGPLPAEQMKLFYSNPRFH 235
Query: 237 -------------------VYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ S + ++K++L+ NP R L HP
Sbjct: 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 82/280 (29%), Positives = 146/280 (52%), Gaps = 30/280 (10%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN- 71
ED + + +IGRGAFG +LHK +K+IR + EK ++ L ++D++ + ++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMRSSDC 62
Query: 72 PYIVKYKDAWVDKGNC-VCIVTGYCEGGDMA-----EIIKKARGACFPEEKLCKWLTQLL 125
PYIVK+ A +G+C +C+ E D++ + + + + PEE L K +
Sbjct: 63 PYIVKFYGALFREGDCWICM-----ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117
Query: 126 LAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLA-KLLNTEDLASSV-VGTPNYMC 182
A++YL +++HRD+K SNI L ++ +I+L DFG++ +L+++ +A + G YM
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--IAKTRDAGCRPYMA 175
Query: 183 PELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI--- 236
PE + Y +SD+WSLG ++E+A + F P + +++ + PI
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK--FPYPKWNSVFDQLTQVVKGDPPILSN 233
Query: 237 ----VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
+S + I L K+ RP +LL HP ++ Y
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 76/271 (28%), Positives = 137/271 (50%), Gaps = 22/271 (8%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY- 73
+E++E +G G +G + H K L I++ TE + E++++ K ++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRN 74
Query: 74 IVKYKDAWVDKG-----NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
I Y A++ K + + +V +C G + +++K +G E+ + ++L +
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLA 187
+LH+++V+HRD+K N+ LT++ +++L DFG+ A+L T ++ +GTP +M PE++A
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 188 -----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV----Y 238
D Y Y+SDIWSLG E+A P + I R +P P + +
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPKLKSKKW 251
Query: 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
S I+ L KN RP+ LL+HP +
Sbjct: 252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 78/271 (28%), Positives = 138/271 (50%), Gaps = 22/271 (8%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY- 73
+E++E +G G +G + H K L I++ T + QE++++ K ++
Sbjct: 8 FELVELVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 64
Query: 74 IVKYKDAWVDKG-----NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
I Y A++ K + + +V +C G + ++IK +G EE + ++L +
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLA 187
+LH ++V+HRD+K N+ LT++ +++L DFG+ A+L T ++ +GTP +M PE++A
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 188 -----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV----Y 238
D Y +KSD+WSLG E+A P + I R +P P + +
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPAPRLKSKKW 241
Query: 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
S + I+S L KN RPT L++HP +
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 5e-28
Identities = 79/278 (28%), Positives = 144/278 (51%), Gaps = 12/278 (4%)
Query: 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLIS 67
+K + + Y + +G GA G + + + +K + + +E K A E+ +
Sbjct: 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLL 86
Query: 68 KLNNPYIVK-YKD-AWVDKGN-----CVCIVTGYCEGGDMAEIIK-KAR-GACFPEEKLC 118
+ IVK ++D A D N + +V Y GD+ + IK +A+ F E +
Sbjct: 87 NCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN---TEDLASSVV 175
Q+LLAV ++HS ++HRD+K +NI L + ++LGDFG +K+ ++D+ +
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP 235
GTP Y+ PE+ PY K+D++SLG ++E+ + F +M +++K PLP
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266
Query: 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273
S M++I+ ++L +P+ RP++S LL P + ++
Sbjct: 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304
|
Length = 496 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 81/290 (27%), Positives = 133/290 (45%), Gaps = 39/290 (13%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E YE + +IG G++G F ++ + +KK ++ K+ AL+E+ ++ +L +P
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+V + + K + +V YC+ + E+ K RG PE + K + Q L AV++ H
Sbjct: 61 NLVNLIEVFRRKRK-LHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCH 117
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPELL-ADIP 190
+ +HRD+K NI +TK I+L DFG A++L + V T Y PELL D
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAP-----DMAGLINK-----INR------------ 228
YG D+W++GC E+ QP + P D LI K I R
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLW--PGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 229 -------SSISPLPIVYSSTMKQIIKSM---LRKNPEHRPTASDLLRHPH 268
+ PL + + + + L+ +P R + +LL HP+
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 73/268 (27%), Positives = 134/268 (50%), Gaps = 14/268 (5%)
Query: 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRT--ALQEMDL 65
S KL D+E+ E +G G+FG + HK + Y +K ++ ++ K K+ QE +
Sbjct: 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK-KREILKMKQVQHVAQEKSI 71
Query: 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ +L++P+IV ++ D+ N V + + GG++ ++KA FP + + +L+
Sbjct: 72 LMELSHPFIVNMMCSFQDE-NRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELV 128
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPEL 185
LA +YLHS +++RDLK N+ L +++ DFG AK D ++ GTP Y+ PE+
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFTLCGTPEYLAPEV 186
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245
+ +G D W++G ++E A P F + KI + P + + +
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK-FPNWFDGRARDL 245
Query: 246 IKSMLRKNPEHR-----PTASDLLRHPH 268
+K +L+ + R +D+ HP+
Sbjct: 246 VKGLLQTDHTKRLGTLKGGVADVKNHPY 273
|
Length = 329 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 9e-28
Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 35/290 (12%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKLN- 70
+ YE + +IG GA+G F ++V LK++R+ E + ++E+ ++ L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 71 --NPYIVKYKD----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
+P +V+ D + D+ + +V + + D+ + K P E + + QL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE 184
L +D+LHS+RV+HRDLK NI +T I+L DFGLA++ + + +SVV T Y PE
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI------------------ 226
+L Y D+WS+GC E+ +P FR + KI
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239
Query: 227 NRSSISPLPIV----YSSTMKQIIKSMLRK----NPEHRPTASDLLRHPH 268
R + + + + ++ K +L K NP R +A L HP+
Sbjct: 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 75/264 (28%), Positives = 120/264 (45%), Gaps = 20/264 (7%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKD 79
+G+G FG + K Y K++ + + K + AL E ++ K+N+ ++V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHR 139
A+ K + +C+V GGD+ I F EE+ + ++L ++ LH ++R
Sbjct: 68 AYETK-DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126
Query: 140 DLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWS 199
DLK NI L IR+ D GLA + + VGT YM PE+L + Y D W
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWG 186
Query: 200 LGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI----VYSSTM----KQIIKSMLR 251
LGC ++E+ Q FR K+ R + + VYS+ K I K +L
Sbjct: 187 LGCLIYEMIEGQSPFRGRK-----EKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241
Query: 252 KNPEHR-----PTASDLLRHPHLQ 270
K+P+ R A ++ RHP +
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 89/325 (27%), Positives = 148/325 (45%), Gaps = 27/325 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR----LAKQTEKFKRTALQEMDLISK 68
+D++V +GRG FG +V K Y +K ++ LA++T F +E D++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFE---EERDILSI 57
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
N+P+I + + A+ DK N + +V Y GGD+ ++ + F E+ +L +L+LA+
Sbjct: 58 SNSPWIPQLQYAFQDKDN-LYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAI 115
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--LASSVVGTPNYMCPELL 186
+H +HRD+K N+ + + I+L DFG A L + VGTP+Y+ PE+L
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 187 ADI------PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI--NRSSIS-PLPIV 237
+ YG + D WSLG +E+ + F A N I + + P
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235
Query: 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTR 297
SS +I+S+L + R L HP + N + P PT K+
Sbjct: 236 VSSDFLDLIQSLL-CGQKERLGYEGLCCHPFFSK--IDWNNIRNSLPPFVPT----LKSD 288
Query: 298 KSPSSKHNSRKDKGEREAAAPNQLE 322
S+ K+ R ++ QL+
Sbjct: 289 DDTSNFDEPEKNSTRRSQSSTTQLK 313
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 11/284 (3%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRT-ALQEMDLISKLNNPYIVKYKD 79
+G+G FG LV K K Y +K ++ K + L E ++ +P++ K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHR 139
++ K +C V Y GG++ +R F E++ + +++ A+DYLHS ++++R
Sbjct: 63 SFQTKDR-LCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 140 DLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPELLADIPYGYKSDIW 198
DLK N+ L KD I++ DFGL K T+ + GTP Y+ PE+L D YG D W
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 199 SLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHR- 257
LG M+E+ + F D L I I P S+ K ++ +L K+P R
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK-FPRTLSADAKSLLSGLLIKDPNKRL 238
Query: 258 ----PTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTR 297
A +++RH + + P KP + TR
Sbjct: 239 GGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 31/265 (11%)
Query: 21 IGRGAFGAAFLVLHKIERKKY---VLKK--IRLAKQTEKF---KRTALQEMDLISKLNNP 72
+GRG FG L +K + Y LKK I + E KR + +P
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFE----TANSERHP 62
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
++V + + + VC V Y GGD+ I F E + + ++L + YLH
Sbjct: 63 FLVNLFACFQTE-DHVCFVMEYAAGGDLMMHIHTDV---FSEPRAVFYAACVVLGLQYLH 118
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-----ASSVVGTPNYMCPELLA 187
N++++RDLK N+ L + +++ DFGL K E + S+ GTP ++ PE+L
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247
+ Y D W LG ++E+ + F D + + I + P S I++
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMR 233
Query: 248 SMLRKNPEHR-----PTASDLLRHP 267
+LR+NPE R A D+ + P
Sbjct: 234 RLLRRNPERRLGSGEKDAEDVKKQP 258
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 74/247 (29%), Positives = 126/247 (51%), Gaps = 14/247 (5%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKI---RLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
+G+G FG + K Y KK+ RL K+ K A+ E +++K+++ +IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNR 135
A+ K + +C+V GGD+ I FPE + C + Q++ +++LH R
Sbjct: 59 AYAFQTKTD-LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 136 VLHRDLKCSNIFLTKDNDIRLGDFGLA-KLLNTEDLASSVVGTPNYMCPELLADIPYGYK 194
+++RDLK N+ L D ++R+ D GLA +L + + GTP +M PELL Y +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS 177
Query: 195 SDIWSLGCCMFEIAAHQPAFRAP----DMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
D ++LG ++E+ A + FRA + L +I S++ P +S K +++L
Sbjct: 178 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT-YPDKFSPASKSFCEALL 236
Query: 251 RKNPEHR 257
K+PE R
Sbjct: 237 AKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 34/288 (11%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL---NN 71
YE + +IG GA+G + LK +R+ + + ++E+ L+ +L ++
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 72 PYIVKYKD----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
P IV+ D + D+ V +V + + D+ + K P E + + Q L
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA 187
+D+LH+N ++HRDLK NI +T ++L DFGLA++ + + + VV T Y PE+L
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLL 180
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI--------------------- 226
Y D+WS+GC E+ +P F A + KI
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG 240
Query: 227 NRSSISPLPIV-----YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
S P P+ + Q++ ML NP R +A L+HP
Sbjct: 241 AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 42/297 (14%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y+ IE IG GA+G + KK +KKI A + L+E+ ++ + I
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 75 VKYKDAWVDKGNC---VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
+ +D G V +V E D+ II EE + +L QLL + Y+
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYI 123
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-----ASSVVGTPNYMCPELL 186
HS V+HRDLK SN+ + +D ++R+GDFG+A+ L++ + V T Y PELL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 187 ADIP-YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG------------------------ 221
+P Y D+WS+GC E+ + F +
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 222 ---LINKINRSSISPLPIVYSSTMKQ---IIKSMLRKNPEHRPTASDLLRHPHLQPY 272
I + R P ++ + ++ ML+ +PE R T L+HP L Y
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 3e-27
Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-KQTEKFKRTALQEMDLISKLNNPYIVK 76
+ +IG G+FGA + + +KK+ + KQ+ + + ++E+ + ++ +P ++
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 77 YKDAWVDKGNCVCIVTGYCEGG--DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
YK ++ + + +V YC G D+ E+ KK E ++ L + YLHS+
Sbjct: 90 YKGCYL-REHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSH 144
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI---PY 191
++HRD+K NI LT+ ++L DFG A + + A+S VGTP +M PE++ + Y
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQY 201
Query: 192 GYKSDIWSLGCCMFEIAAHQPA-FRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
K D+WSLG E+A +P F M+ L + S + +S + + S L
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 261
Query: 251 RKNPEHRPTASDLLRH 266
+K P+ RPT+ +LL+H
Sbjct: 262 QKIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 85/289 (29%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
++ +E+IG G +G + +K+ + LKKIRL +TE TA++E+ L+ +LN+P I
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE---KLCK-WLTQLLLAVDY 130
VK D + N + +V + + + +KK A L K +L QLL + +
Sbjct: 62 VKLLDV-IHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT--EDLASSVVGTPNYMCPE-LLA 187
HS+RVLHRDLK N+ + + I+L DFGLA+ VV T Y PE LL
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLG 174
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAF----------------------------RAPDM 219
Y DIWSLGC E+ + F PD
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234
Query: 220 AGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPH 268
K R S + + ++ ML +P R +A L HP
Sbjct: 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 27/277 (9%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKY-------VLKKIRLAK--QTEKFKRTALQEMD 64
++E++ +G GA+G FLV K+ VLKK + + +T + RT Q ++
Sbjct: 1 NFELLRVLGTGAYGKVFLV-RKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDM-AEIIKKARGACFPEEKLCKWLTQ 123
+ + P++V A+ + ++ Y GG++ + ++ F E ++ ++ +
Sbjct: 60 AVRR--CPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREH---FTESEVRVYIAE 113
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL--NTEDLASSVVGTPNYM 181
++LA+D+LH +++RD+K NI L + + L DFGL+K E+ A S GT YM
Sbjct: 114 IVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 182 CPELLADIPYGYKS--DIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR---SSISPLPI 236
PE++ G+ D WSLG FE+ F ++I+R S P P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK 233
Query: 237 VYSSTMKQIIKSMLRKNPEHR---PTASDLLRHPHLQ 270
S+ + I+ +L K+P+ R A ++ HP Q
Sbjct: 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 21/277 (7%)
Query: 2 ETENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIER------KKYVLKKIRLAKQTEKF 55
+ +K K ED+ I +G G+FG L +K E K++ KI KQ +
Sbjct: 19 KEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH- 77
Query: 56 KRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE 115
E +++ +N+P+ V ++ D+ + + +V + GG+ ++ R FP +
Sbjct: 78 ---VFSERKILNYINHPFCVNLYGSFKDE-SYLYLVLEFVIGGEFFTFLR--RNKRFPND 131
Query: 116 KLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVV 175
C + Q++L +YL S +++RDLK N+ L KD I++ DFG AK+++T ++
Sbjct: 132 VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLC 189
Query: 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP 235
GTP Y+ PE+L ++ +G +D W+LG ++EI P F A + + KI I P
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY-FP 248
Query: 236 IVYSSTMKQIIKSMLRKNPEHR-----PTASDLLRHP 267
+ K ++K +L + R A ++ HP
Sbjct: 249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285
|
Length = 340 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 69/240 (28%), Positives = 118/240 (49%), Gaps = 7/240 (2%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
+G+G+FG L K + Y +K ++ + Q + T ++ L +P++
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
+ K + V Y GGD+ I+++R F E + + ++ LA+ +LH + V++
Sbjct: 63 CCFQTKDR-LFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKSDI 197
RDLK NI L + +L DFG+ K + ++ GTP+Y+ PE+L ++ YG D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 198 WSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHR 257
W+LG M+E+ A QP F A + L I + P+ S I+K+ + KNP R
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-YPVWLSKEAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 81/287 (28%), Positives = 131/287 (45%), Gaps = 40/287 (13%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
++ +E++G G + + ++ + LK+I L + E TA++E+ L+ +L + I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENI 60
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT-QLLLAVDYLHS 133
V+ D + N + +V Y + D+ + + + K T QLL + + H
Sbjct: 61 VRLHDV-IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL----LNTEDLASSVVGTPNYMCPE-LLAD 188
NRVLHRDLK N+ + K +++L DFGLA+ +NT S+ V T Y P+ LL
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT---FSNEVVTLWYRAPDVLLGS 175
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR----------SSISPLP--- 235
Y DIWS+GC M E+ +P F + + KI R IS LP
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235
Query: 236 ----IVYSSTMKQIIKS-----------MLRKNPEHRPTASDLLRHP 267
++Q+ +L+ NPE R +A D L+HP
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 73/242 (30%), Positives = 119/242 (49%), Gaps = 12/242 (4%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIR----LAKQTEKFKRTALQEMDLISKLNNPYIVK 76
+G+G FG LV K + Y +K +R +AK ++ T + E ++ +P++
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHT-VTESRVLQNTRHPFLTA 59
Query: 77 YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136
K A+ +C V Y GG++ +R F EE+ + +++ A++YLHS V
Sbjct: 60 LKYAFQTHDR-LCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKS 195
++RD+K N+ L KD I++ DFGL K ++ + GTP Y+ PE+L D YG
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 196 DIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255
D W LG M+E+ + F D L I I P S K ++ +L+K+P+
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-FPRTLSPEAKSLLAGLLKKDPK 235
Query: 256 HR 257
R
Sbjct: 236 QR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 31/294 (10%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLK--KIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
+G+G FG LV K K Y +K K + ++ T L E ++ +P++ K
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT-LTESRVLQNTRHPFLTALK 61
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
++ + +C V Y GG++ + + R F E++ + +++ A+ YLHS V++
Sbjct: 62 YSFQTH-DRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-----SSVVGTPNYMCPELLADIPYGY 193
RDLK N+ L KD I++ DFGL K E ++ + GTP Y+ PE+L D YG
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
D W LG M+E+ + F D L I I P S K ++ +L+K+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-FPRTLSPEAKSLLAGLLKKD 233
Query: 254 PEHR-----PTASDLLRHPHLQPYLLRCQNPSSVYL-----PIKPTNIMKEKTR 297
P+ R A +++ H N V P KP + TR
Sbjct: 234 PKQRLGGGPEDAKEIMEHR-----FFASINWQDVVQKKLEPPFKPQVTSETDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 70/260 (26%), Positives = 110/260 (42%), Gaps = 54/260 (20%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL----QEMDLISKLN 70
+ I+ IG GAFG LV Y +K +R + + R E D++++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR---KADVLMRNQAAHVKAERDILAEAD 59
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
N ++VK ++ DK + + V Y GGDM ++ R F E+ ++ +L A++
Sbjct: 60 NEWVVKLYYSFQDK-DNLYFVMDYIPGGDMMSLL--IRLGIFEEDLARFYIAELTCAIES 116
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL----------------------------- 161
+H +HRD+K NI + +D I+L DFGL
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 162 ---------------AKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFE 206
K + LA S+VGTPNY+ PE+L Y D WS+G ++E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 207 IAAHQPAFRAPDMAGLINKI 226
+ QP F A A K+
Sbjct: 237 MLVGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 82/288 (28%), Positives = 140/288 (48%), Gaps = 40/288 (13%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
YE +E+IG G +G F ++ + LK++RL E +AL+E+ L+ +L + I
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGAC--FPEEKLCK-WLTQLLLAVDYL 131
V+ D + + +V YC+ + +KK +C + ++ K ++ QLL + +
Sbjct: 62 VRLYDV-LHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPNYMCPE-LLADI 189
HS+ VLHRDLK N+ + K+ +++L DFGLA+ S+ V T Y P+ L
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 190 PYGYKSDIWSLGCCMFEIA-AHQPAFRAPDMAGLINKINR----------SSISPLP--- 235
Y D+WS GC E+A A +P F D+ + +I R +S LP
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 236 -------------IV--YSSTMKQIIKSMLRKNPEHRPTASDLLRHPH 268
+V +ST + +++++L NP R +A + L+HP+
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 77/295 (26%), Positives = 137/295 (46%), Gaps = 44/295 (14%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y+ + +G GA+G +K +KK+ Q+ + +E+ L+ +++ +
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 75 VKYKDAW-----VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
+ D + ++ V +VT G D+ I+K + ++ + + Q+L +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK---LSDDHIQFLVYQILRGLK 132
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE-LLAD 188
Y+HS ++HRDLK SNI + +D ++++ DFGLA+ T+D + V T Y PE +L
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 190
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFR----------------APDMAGLINKIN----R 228
+ Y DIWS+GC M E+ + F PD L+ KI+ R
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD-EELLQKISSESAR 249
Query: 229 SSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
+ I LP + K++ ++ ML +P+ R TA++ L HP+L Y
Sbjct: 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-26
Identities = 84/273 (30%), Positives = 136/273 (49%), Gaps = 24/273 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL----QEMDLISK 68
ED+E+++ IGRGAFG +V K K + +K + + E KR +E D++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMK---ILNKWEMLKRAETACFREERDVLVN 57
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
+N +I A+ D+ N + +V Y GGD+ ++ K PE+ +L ++++A+
Sbjct: 58 GDNQWITTLHYAFQDENN-LYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAI 115
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG-LAKLLNTEDLASSV-VGTPNYMCPELL 186
D +H +HRD+K NI + + IRL DFG KL+ + SSV VGTP+Y+ PE+L
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 187 ADIP-----YGYKSDIWSLGCCMFEIAAHQPAFRAPDM----AGLINKINRSSISPLPIV 237
+ YG + D WSLG CM+E+ + F A + ++N R
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235
Query: 238 YSSTMKQIIKSMLRKNPEHRPTAS---DLLRHP 267
S K +I+ ++ EHR + D +HP
Sbjct: 236 VSEDAKDLIRRLICSR-EHRLGQNGIEDFKQHP 267
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 80/264 (30%), Positives = 133/264 (50%), Gaps = 15/264 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
ED+E+I++IG G +G + + + +K I+L + E F QE+ ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL-EPGEDFA-VVQQEIIMMKDCKHS 66
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IV Y +++ + + I +C GG + +I E ++ + L + YLH
Sbjct: 67 NIVAYFGSYLRRDK-LWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLH 123
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLA-DIP 190
S +HRD+K +NI LT + ++L DFG+ A++ T S +GTP +M PE+ A +
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 191 YGYKS--DIWSLGCCMFEIAAHQPA-FRAPDMAGLINKINRSSISPL----PIVYSSTMK 243
GY DIW++G E+A QP F M L + +S+ P + +S++
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTKSNFQPPKLKDKMKWSNSFH 242
Query: 244 QIIKSMLRKNPEHRPTASDLLRHP 267
+K L KNP+ RPTA LL+HP
Sbjct: 243 HFVKMALTKNPKKRPTAEKLLQHP 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 80/267 (29%), Positives = 131/267 (49%), Gaps = 15/267 (5%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
++ DYE+I+++G G +G + + + KI + + F QE+ ++ +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKA-RNLHTGELAAVKIIKLEPGDDFSLIQ-QEIFMVKE 62
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
+ IV Y +++ + + I YC GG + +I E ++ + L +
Sbjct: 63 CKHCNIVAYFGSYLSREK-LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGL 119
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLA 187
YLHS +HRD+K +NI LT + D++L DFG+ AK+ T S +GTP +M PE+ A
Sbjct: 120 AYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA 179
Query: 188 ---DIPYGYKSDIWSLGCCMFEIAAHQPA-FRAPDMAGLINKINRSSISPLPI----VYS 239
+ Y DIW++G E+A QP F M L +++S+ P + +S
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSKSNFQPPKLKDKTKWS 238
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRH 266
ST +K L KNP+ RPTA LL H
Sbjct: 239 STFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 86/296 (29%), Positives = 135/296 (45%), Gaps = 45/296 (15%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
++ YE +E+IG G +G + ++ + LKKIRL ++ E TA++E+ L+ ++ +
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPE----EKLCK-WLTQLLL 126
IV+ +D V + +V Y D+ +KK + P+ +L K +L Q+L
Sbjct: 61 GNIVRLQDV-VHSEKRLYLVFEYL---DLD--LKKHMDSS-PDFAKNPRLIKTYLYQILR 113
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTK-DNDIRLGDFGLAKLLN--TEDLASSVVGTPNYMCP 183
+ Y HS+RVLHRDLK N+ + + N ++L DFGLA+ VV T Y P
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAP 172
Query: 184 E-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR----------SSIS 232
E LL Y DIWS+GC E+ +P F + KI R ++
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 233 PLPIVYSSTMK------------------QIIKSMLRKNPEHRPTASDLLRHPHLQ 270
LP S+ K ++ MLR +P R TA L H + +
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 74/258 (28%), Positives = 127/258 (49%), Gaps = 15/258 (5%)
Query: 21 IGRGAFGAAFLVLHKIER---KKYVLKKIRLAKQTEKFKRTA--LQEMDLISKLNNPYIV 75
+G+G +G F V K + +K ++ A K TA E +++ + +P+IV
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR 135
A+ G I+ Y GG++ + R F E+ C +L+++ LA+++LH
Sbjct: 64 DLIYAFQTGGKLYLILE-YLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 136 VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPNYMCPELLADIPYGYK 194
+++RDLK NI L ++L DFGL K E + + GT YM PE+L +G
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKA 180
Query: 195 SDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNP 254
D WSLG M+++ P F A + I+KI + ++ LP + + ++K +L++NP
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN-LPPYLTPEARDLLKKLLKRNP 239
Query: 255 EHR-----PTASDLLRHP 267
R A+++ HP
Sbjct: 240 SSRLGAGPGDAAEVQSHP 257
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 71/225 (31%), Positives = 116/225 (51%), Gaps = 16/225 (7%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL----QEMDLISK 68
+D+E+I+ IGRGAFG +V K + Y +K + + E KR +E +++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMK---ILNKWEMLKRAETACFREERNVLVN 57
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
+ +I A+ D+ N + +V Y GGD+ ++ K PE+ ++ +++LA+
Sbjct: 58 GDCQWITTLHYAFQDE-NYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAI 115
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG-LAKLLNTEDLASSV-VGTPNYMCPELL 186
+H +HRD+K N+ L + IRL DFG K+ + SSV VGTP+Y+ PE+L
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 187 ADI-----PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI 226
+ YG + D WSLG CM+E+ + F A + KI
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 73/243 (30%), Positives = 120/243 (49%), Gaps = 13/243 (5%)
Query: 21 IGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIV-- 75
IG+G+FG L HK + K Y VL+K + K+ E+ K + L+ + +P++V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-KHIMAERNVLLKNVKHPFLVGL 61
Query: 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR 135
Y DK + V Y GG++ +++ R FPE + + ++ A+ YLHS
Sbjct: 62 HYSFQTADK---LYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN 116
Query: 136 VLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYK 194
+++RDLK NI L + L DFGL K + S+ GTP Y+ PE+L PY
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 195 SDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNP 254
D W LG ++E+ P F + D A + + I + L S + + +++ +L+K+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR-LKPNISVSARHLLEGLLQKDR 235
Query: 255 EHR 257
R
Sbjct: 236 TKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 86/324 (26%), Positives = 146/324 (45%), Gaps = 60/324 (18%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA--KQTEKFKRTALQEMDLISKL 69
L YE+++++G+GA+G + + + ++ LKKI A T+ +RT +E+ + +L
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA-QRT-FREIMFLQEL 63
Query: 70 NN-PYIVKYKDAW-VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT-QLLL 126
+ P IVK + + + +V Y E D+ +I+ E+ +++ QLL
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLK 118
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV------VGTPNY 180
A+ Y+HS V+HRDLK SNI L D ++L DFGLA+ L+ + V T Y
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 181 MCPE-LLADIPYGYKSDIWSLGCCMFEIAAHQPAF------------------------- 214
PE LL Y D+WS+GC + E+ +P F
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238
Query: 215 --RAPDMAGLINKINRSSISPLPIVYSSTMKQ---IIKSMLRKNPEHRPTASDLLRHPHL 269
++P A +++ + PL + ++K +L NP R TA + L HP++
Sbjct: 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298
Query: 270 QPYLLRCQNPSS-------VYLPI 286
+ NPS + +P+
Sbjct: 299 AQF----HNPSDEPVLPYPITIPL 318
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 21/277 (7%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
+ L D E + +IG G G + + K +K++R E+ KR L ++D++ K
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRI-LMDLDVVLK 69
Query: 69 LNN-PYIVKYKDAWVDKGNC-VCI-VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
++ PYIVK ++ + +C+ + C + + K PE+ L K ++
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMSTC-----LDKLLKRIQGPIPEDILGKMTVAIV 124
Query: 126 LAVDYLHSNR-VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS-VVGTPNYMCP 183
A+ YL V+HRD+K SNI L +++L DFG++ L + A + G YM P
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL-VDSKAKTRSAGCAAYMAP 183
Query: 184 ELLADIP-----YGYKSDIWSLGCCMFEIAAHQPAFRAPDMA-GLINKINRSSISPLPI- 236
E + D P Y ++D+WSLG + E+A Q ++ ++ KI + LP
Sbjct: 184 ERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242
Query: 237 -VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
+S + L K+ RP +LL+HP ++ Y
Sbjct: 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 67/256 (26%), Positives = 116/256 (45%), Gaps = 10/256 (3%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLK--KIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
+G+G+FG L K + + +K K + + + + T ++ L +P++
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 79 DAWVDKGNCVCIVTGYCEGGD-MAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
+ K + + V Y GGD M I R F E + + +++ + +LH ++
Sbjct: 63 CTFQTKEH-LFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKGII 118
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKSD 196
+RDLK N+ L KD I++ DFG+ K +N E AS+ GTP+Y+ PE+L Y D
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVD 178
Query: 197 IWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEH 256
WS G ++E+ Q F D L + I + P S K + + ++P
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFDSI-LNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 257 R-PTASDLLRHPHLQP 271
R D+ +HP +
Sbjct: 238 RLGVDGDIRQHPFFRG 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 74/267 (27%), Positives = 127/267 (47%), Gaps = 26/267 (9%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
IGRG++ LV K R+ Y +K I+ L E ++ + N+P++V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
+ + + V + GGD+ +++ R PEE + ++ LA+++LH +++
Sbjct: 63 SCFQTESR-LFFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERGIIY 119
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKSDI 197
RDLK N+ L + I+L D+G+ K + D S+ GTPNY+ PE+L YG+ D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 198 WSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL-----------PIVYSSTMKQII 246
W+LG MFE+ A + F D+ G+ + ++++ L P S ++
Sbjct: 180 WALGVLMFEMMAGRSPF---DIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236
Query: 247 KSMLRKNPE-----HRPTA-SDLLRHP 267
K L K+P+ H T D+ HP
Sbjct: 237 KGFLNKDPKERLGCHPQTGFRDIKSHP 263
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 75/236 (31%), Positives = 120/236 (50%), Gaps = 16/236 (6%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
K +D+E I ++G G G V HK K I L + + ++E+ ++ + N
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP-AIRNQIIRELQVLHECN 61
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+PYIV + A+ G + I + +GG + +++K+A+ PEE L K +L + Y
Sbjct: 62 SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAY 118
Query: 131 L-HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI 189
L ++++HRD+K SNI + +I+L DFG++ L + +A+S VGT +YM PE L
Sbjct: 119 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGT 177
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS----------SISPLP 235
Y +SDIWS+G + E+A + PD L R SISP P
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 75/270 (27%), Positives = 129/270 (47%), Gaps = 19/270 (7%)
Query: 14 DYEVIEQ-----IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
+YE E +G+G +G + + + +K+I ++ ++ + +E+ L S
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSY 61
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT-QLLLA 127
L + IV+Y + + I GG ++ +++ G E+ + T Q+L
Sbjct: 62 LKHRNIVQYLGS-DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 128 VDYLHSNRVLHRDLKCSNIFL-TKDNDIRLGDFGLAK-LLNTEDLASSVVGTPNYMCPEL 185
+ YLH N+++HRD+K N+ + T +++ DFG +K L + GT YM PE+
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEV 180
Query: 186 LADIPYGY--KSDIWSLGCCMFEIAAHQPAF---RAPDMAGLINKINRSSISP-LPIVYS 239
+ P GY +DIWSLGC + E+A +P F P A + K+ I P +P S
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMFKIHPEIPESLS 238
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
+ K I +P+ R +A DLL+ P L
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 86/329 (26%), Positives = 143/329 (43%), Gaps = 30/329 (9%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRT-ALQEMDLISKLNNPYI--VKY 77
+G+G FG LV K + Y +K ++ K + L E ++ +P++ +KY
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR-V 136
D+ +C V Y GG++ +R F E++ + +++ A+DYLHS + V
Sbjct: 63 SFQTHDR---LCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS--SVVGTPNYMCPELLADIPYGYK 194
++RDLK N+ L KD I++ DFGL K +D A+ + GTP Y+ PE+L D YG
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 195 SDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNP 254
D W LG M+E+ + F D L I I P S K ++ +L+K+P
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-FPRTLSPEAKSLLSGLLKKDP 235
Query: 255 EHR-----PTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRK----------- 298
+ R A ++++H + + + P KP + TR
Sbjct: 236 KQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMIT 295
Query: 299 -SPSSKHNSRKDKGEREAAAPNQLENVRS 326
+P + +S + Q S
Sbjct: 296 ITPPDQDDSMETVDNERRPHFPQFSYSAS 324
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 80/287 (27%), Positives = 131/287 (45%), Gaps = 33/287 (11%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
DY IE+IG G +G + +K + +KKIRL + E TA++E+ L+ +L +P
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK-WLTQLLLAVDYLH 132
IV +D + + + + ++ + D+ + + + + +L K +L Q+L + + H
Sbjct: 61 IVCLQDVLMQE-SRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPNYMCPE-LLADIP 190
S RVLHRDLK N+ + I+L DFGLA+ + + V T Y PE LL
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----LPIV-----YSST 241
Y DIWS+G E+A +P F + +I R +P P V Y +T
Sbjct: 179 YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238
Query: 242 MKQ-------------------IIKSMLRKNPEHRPTASDLLRHPHL 269
+ +++ ML +P R +A L HP+
Sbjct: 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-25
Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 20/282 (7%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKD 79
+G+G FG + K Y KK+ + + K + AL E ++ K+N+ ++V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHR 139
A+ K + +C+V GGD+ I A F E + + ++ ++ LH R+++R
Sbjct: 68 AYETK-DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126
Query: 140 DLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWS 199
DLK NI L IR+ D GLA + VGT YM PE++ + Y + D W+
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 186
Query: 200 LGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL----PIVYSSTM----KQIIKSMLR 251
LGC ++E+ A Q F+ KI R + L YS + + K +L
Sbjct: 187 LGCLLYEMIAGQSPFQQRK-----KKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 252 KNPEHR-----PTASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288
K+P+ R A ++ HP + + + P KP
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 82/294 (27%), Positives = 134/294 (45%), Gaps = 27/294 (9%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
IGRG++ LV K + Y +K ++ L E ++ N+P++V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
+ + ++ Y GGD+ +++ R PEE + ++ LA++YLH +++
Sbjct: 63 SCFQTESRLFFVIE-YVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIY 119
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKSDI 197
RDLK N+ L + I+L D+G+ K L D S+ GTPNY+ PE+L YG+ D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 198 WSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL-----------PIVYSSTMKQII 246
W+LG MFE+ A + F D+ G + ++++ L P S ++
Sbjct: 180 WALGVLMFEMMAGRSPF---DIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236
Query: 247 KSMLRKNPEHR----PTA--SDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKE 294
KS L K+P+ R P +D+ HP + V P KP NI E
Sbjct: 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKP-NISGE 289
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 83/300 (27%), Positives = 131/300 (43%), Gaps = 46/300 (15%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR-LAKQTEKFKRTALQEMDLISKLNN 71
Y+ + IG GA+G HK K +KKI QT F + L+E+ ++ + +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT--FCQRTLREIKILRRFKH 62
Query: 72 PYIVKYKDAW----VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
I+ D + N V IV E D+ ++IK + + +L Q+L
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH---LSNDHIQYFLYQILRG 118
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV----VGTPNYMCP 183
+ Y+HS VLHRDLK SN+ L + D+++ DFGLA++ + E + V T Y P
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 184 E-LLADIPYGYKSDIWSLGCCMFEIAAHQPAF-------------------RAPDMAGLI 223
E +L Y DIWS+GC + E+ +++P F D+ +I
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238
Query: 224 NKINRSSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
+ R+ I LP ++ + ML NP R T + L HP+L+ Y
Sbjct: 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 73/247 (29%), Positives = 117/247 (47%), Gaps = 14/247 (5%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
IGRG++ LV K + Y +K ++ L E ++ +NP++V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
+ + +V Y GGD+ +++ R PEE + ++ +A+++LH +++
Sbjct: 63 SCFQTTSR-LFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGIIY 119
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKSDI 197
RDLK N+ L D I+L D+G+ K L D S+ GTPNY+ PE+L YG+ D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 198 WSLGCCMFEIAAHQPAFRA----PDMAG---LINKINRSSISPLPIVYSSTMKQIIKSML 250
W+LG MFE+ A + F PDM L I I +P S ++K L
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR-IPRFLSVKASHVLKGFL 238
Query: 251 RKNPEHR 257
K+P+ R
Sbjct: 239 NKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 69/213 (32%), Positives = 117/213 (54%), Gaps = 14/213 (6%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHK----IERKKYVLKKIRLAKQTEKFKRTALQEMDLI 66
K +D+E I ++G G G F V HK I +K + +I+ A + ++E+ ++
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA-----IRNQIIRELQVL 57
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
+ N+PYIV + A+ G + I + +GG + +++KKA PE+ L K ++
Sbjct: 58 HECNSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIK 114
Query: 127 AVDYL-HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPEL 185
+ YL ++++HRD+K SNI + +I+L DFG++ L + +A+S VGT +YM PE
Sbjct: 115 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 173
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD 218
L Y +SDIWS+G + E+A + PD
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 71/249 (28%), Positives = 121/249 (48%), Gaps = 15/249 (6%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLK----KIRLAKQTEKFKRTALQEMDLISKLNNPYIV- 75
IG+G+FG L K++ K Y +K KI L ++ +K + L+ + +P++V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQK--HIMAERNVLLKNVKHPFLVG 60
Query: 76 -KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
Y +K + V + GG++ +++ R FPE + + ++ A+ YLHS
Sbjct: 61 LHYSFQTTEK---LYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSI 115
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGY 193
+++RDLK NI L + L DFGL K + D ++ GTP Y+ PE++ PY
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
D W LG ++E+ P F D+A + + I + P S T I++ +L K+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGA-SLTAWSILEELLEKD 234
Query: 254 PEHRPTASD 262
+ R A +
Sbjct: 235 RQRRLGAKE 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 84/314 (26%), Positives = 139/314 (44%), Gaps = 67/314 (21%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ----EMDLISK 68
ED+ ++ IG+GAFG LV K K Y +K + ++E FK+ L E D++++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL---KSEMFKKDQLAHVKAERDVLAE 57
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGD-MAEIIKKARGACFPEEKLCKWLTQLLLA 127
++P++V ++ D + ++ + GGD M +IK F E+ ++ + +LA
Sbjct: 58 SDSPWVVSLYYSFQD-AQYLYLIMEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLA 113
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA-------------KLL--------- 165
++ +H +HRD+K NI + + I+L DFGL+ KLL
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 166 --------------------------NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWS 199
N +A S VGTP+Y+ PE+ YG + D WS
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233
Query: 200 LGCCMFEIAAHQPAFRAPDMAGLINKIN--RSSIS-PLPIVYSSTMKQIIKSMLRKNPEH 256
LG MFE P F + + KI R ++ P I S + +I+ ++ N E+
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAEN 292
Query: 257 ---RPTASDLLRHP 267
R A ++ HP
Sbjct: 293 RLGRGGAHEIKSHP 306
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 81/294 (27%), Positives = 130/294 (44%), Gaps = 41/294 (13%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y I+ IGRGA+G + +K +KKI A + L+E+ L+ L++ +
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 75 VKYKD----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW-LTQLLLAVD 129
+ KD + N V IV + D+ +II+ ++ + C++ L QLL +
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTL---SDDHCQYFLYQLLRGLK 122
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTPNYMCPELLAD 188
Y+HS VLHRDLK SN+ L + D+++ DFGLA+ + D + V T Y PELL +
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 189 IP-YGYKSDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSISPLPIVYSSTMK 243
Y D+WS+GC E+ +P F D + + + S L + + +
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242
Query: 244 QIIKS--------------------------MLRKNPEHRPTASDLLRHPHLQP 271
+ I+S ML +P R T + L HP+L
Sbjct: 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 75/294 (25%), Positives = 133/294 (45%), Gaps = 49/294 (16%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF-KRTALQEMDLISKLNN 71
E YE + +G G++G HK E + V K L + +K K+ A++E+ ++ +L +
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH 59
Query: 72 PYIV------KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+V + K +V + + + ++ K G E ++ K+L Q+L
Sbjct: 60 ENLVNLIEVFRRKKRLY-------LVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQIL 110
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVVGTPNYMCPE 184
+++ HS+ ++HRD+K NI +++ ++L DFG A+ L ++ + V T Y PE
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170
Query: 185 LL-ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR--SSISP-------- 233
LL D YG DIW++GC + E+ +P F + I + ++ P
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230
Query: 234 --------LPIV------------YSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
LP V S + + K LR +P+ RP++S LL H
Sbjct: 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 70/244 (28%), Positives = 116/244 (47%), Gaps = 10/244 (4%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKI---RLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
+G+G FG V K K Y KK+ RL K++ + + AL E +++ K+N+P+IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE--KMALLEKEILEKVNSPFIVNL 58
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
A+ K + +C+V GGD+ I E++ + Q+ + +LHS ++
Sbjct: 59 AYAFESKTH-LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDI 197
+RD+K N+ L + RL D GLA L + GT YM PE+L + PY Y D
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDW 177
Query: 198 WSLGCCMFEIAAHQPAFR----APDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
+++GC ++E+ A + F+ L + + ++ K I + L K
Sbjct: 178 FAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKK 237
Query: 254 PEHR 257
PE R
Sbjct: 238 PEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 70/256 (27%), Positives = 117/256 (45%), Gaps = 10/256 (3%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKD 79
+G+G FG + K Y KK+ + + K + AL E ++ K+N+ ++V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHR 139
A+ K + +C+V GGD+ I F E++ + +L ++ L R+++R
Sbjct: 68 AYETK-DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 140 DLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWS 199
DLK NI L IR+ D GLA + + VGT YM PE++ + Y + D W
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWG 186
Query: 200 LGCCMFEIAAHQPAFRAPDMAGLINKINR---SSISPLPIVYSSTMKQIIKSMLRKNPEH 256
LGC ++E+ Q FR +++R +S K I + +L KNP+
Sbjct: 187 LGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKE 246
Query: 257 R-----PTASDLLRHP 267
R A+ + +HP
Sbjct: 247 RLGCRGNGAAGVKQHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 74/248 (29%), Positives = 124/248 (50%), Gaps = 13/248 (5%)
Query: 21 IGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIV-- 75
IG+G+FG L HK E K Y VL+K + K+ E+ K + L+ + +P++V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEE-KHIMSERNVLLKNVKHPFLVGL 61
Query: 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR 135
+ DK + V Y GG++ +++ R CF E + + ++ A+ YLHS
Sbjct: 62 HFSFQTADK---LYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN 116
Query: 136 VLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYK 194
+++RDLK NI L I L DFGL K + S+ GTP Y+ PE+L PY
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 195 SDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNP 254
D W LG ++E+ P F + + A + + I + P + +++ + +++ +L+K+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI-TNSARHLLEGLLQKDR 235
Query: 255 EHRPTASD 262
R A D
Sbjct: 236 TKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 7e-23
Identities = 69/241 (28%), Positives = 118/241 (48%), Gaps = 9/241 (3%)
Query: 21 IGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
IG+G+FG L K + Y VL+K + K+ E+ A + + L+ L +P++V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
++ + V Y GG++ +++ R CF E + + ++ A+ YLHS ++
Sbjct: 62 HYSF-QTAEKLYFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKSD 196
+RDLK NI L + L DFGL K + E+ S+ GTP Y+ PE+L PY D
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVD 178
Query: 197 IWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEH 256
W LG ++E+ P F + D++ + + I + LP + ++ +L K+
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ-LPGGKTVAACDLLVGLLHKDQRR 237
Query: 257 R 257
R
Sbjct: 238 R 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 8e-23
Identities = 83/287 (28%), Positives = 144/287 (50%), Gaps = 19/287 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN- 71
+D EVIE++GRGA+G + H +K+IR +++ KR L ++D+ + +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRL-LMDLDISMRSVDC 59
Query: 72 PYIVKYKDAWVDKGNC-VCI-VTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLA 127
PY V + A +G+ +C+ V + + KK +G PE+ L K ++ A
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTS----LDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 128 VDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV-VGTPNYMCPEL 185
++YLHS V+HRD+K SN+ + ++ ++L DFG++ L + +A ++ G YM PE
Sbjct: 116 LEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAPER 174
Query: 186 L--ADIPYGY--KSDIWSLGCCMFEIAAHQ-PAFRAPDMAGLINKINRSSISPLPI-VYS 239
+ GY KSD+WSLG M E+A + P + ++ LP +S
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPI 286
+ + L+KN + RP +LL+HP + +L + + +S I
Sbjct: 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVSLI 281
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 81/297 (27%), Positives = 147/297 (49%), Gaps = 29/297 (9%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIER----KKYVLKKIRLAKQTEKFK-----RTALQEMD 64
++E+++ +G GA+G FLV K+ K Y +K ++ A +K K RT Q ++
Sbjct: 1 NFELLKVLGTGAYGKVFLV-RKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDM-AEIIKKARGACFPEEKLCKWLTQ 123
I + +P++V A+ + ++ Y GG++ + ++ R F E+++ + +
Sbjct: 60 HIRQ--SPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRER---FKEQEVQIYSGE 113
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--ASSVVGTPNYM 181
++LA+++LH +++RD+K NI L + + L DFGL+K + +++ A S GT YM
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 182 CPELLADIPYGYKS--DIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR---SSISPLPI 236
P+++ G+ D WS+G M+E+ F +I+R S P P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 233
Query: 237 VYSSTMKQIIKSMLRKNPEHR----PT-ASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288
S+ K II+ +L K+P+ R P+ A ++ +HP Q V P KP
Sbjct: 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 87/303 (28%), Positives = 134/303 (44%), Gaps = 60/303 (19%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDA 80
+G G+ G F + K+ +KKI L + K AL+E+ +I +L++ IVK +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVL-TDPQSVKH-ALREIKIIRRLDHDNIVKVYEV 70
Query: 81 WVDKG-------------NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
G N V IV Y E D+A ++++ EE ++ QLL
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGP---LSEEHARLFMYQLLRG 126
Query: 128 VDYLHSNRVLHRDLKCSNIFL-TKDNDIRLGDFGLAKLLNTE-----DLASSVVGTPNYM 181
+ Y+HS VLHRDLK +N+F+ T+D +++GDFGLA++++ L+ +V T Y
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYR 185
Query: 182 CPELLADIPYGYKS--DIWSLGCCMFEIAAHQPAF-------------------RAPDMA 220
P LL P Y D+W+ GC E+ +P F R D
Sbjct: 186 SPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRN 244
Query: 221 GLINKI-----------NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
L+N I R LP V + ++ +L NP R TA + L HP++
Sbjct: 245 ELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL-DFLEQILTFNPMDRLTAEEALMHPYM 303
Query: 270 QPY 272
Y
Sbjct: 304 SCY 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-22
Identities = 70/239 (29%), Positives = 107/239 (44%), Gaps = 40/239 (16%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISKLNN 71
+D+E ++ IGRGAFG LV K Y +K +R A EK + ++ E D++ + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
++VK ++ DK N I+ + GGDM ++ K EE ++ + +LA+D +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIME-FLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAI 117
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-------------------------- 165
H +HRD+K N+ L ++L DFGL L
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 166 ----------NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAF 214
N LA S VGTP+Y+ PE+ Y D WSLG M+E+ P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 8e-22
Identities = 71/239 (29%), Positives = 109/239 (45%), Gaps = 40/239 (16%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISKLNN 71
ED+E ++ IGRGAFG LV K Y +K +R A EK + ++ E D++ + ++
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
++VK ++ DK N I+ + GGDM ++ K EE+ ++ + +LA+D +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIME-FLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSI 117
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-------------------------- 165
H +HRD+K N+ L ++L DFGL L
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 166 ----------NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAF 214
N LA S VGTP+Y+ PE+ Y D WSLG M+E+ P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 72/269 (26%), Positives = 124/269 (46%), Gaps = 18/269 (6%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLK--KIRLAKQTEKFKRTALQEMDLISKLNN 71
D+ + +G+G+FG L K + Y +K K + Q + + T +++ L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 72 PYIVKYKDAW--VDKGNCVCIVTGYCEGGD-MAEIIKKARGACFPEEKLCKWLTQLLLAV 128
P++ + + +D+ + V Y GGD M I + + F E + ++ + +
Sbjct: 61 PFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGL 114
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLA 187
+LHS +++RDLK N+ L + I++ DFG+ K + + GTP+Y+ PE++A
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247
PYG D W+ G ++E+ A QP F D L I ++S P S I K
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-YPKSLSKEAVSICK 233
Query: 248 SMLRKNPEHR----PTAS-DLLRHPHLQP 271
+L K+P R PT D+ H +
Sbjct: 234 GLLTKHPAKRLGCGPTGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-21
Identities = 72/291 (24%), Positives = 132/291 (45%), Gaps = 33/291 (11%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E Y ++Q+G GA+G+ + K +K +KK+ Q+E F + A +E+ L+ + +
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
++ D + + Y M ++K G E+K+ + Q+L + Y+H
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH 134
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD-IPY 191
S ++HRDLK N+ + +D ++++ DFGLA+ + E + V T Y PE++ + + Y
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHY 192
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPD-------------------MAGLINKINRSSIS 232
DIWS+GC M E+ + F+ D + L +K +S I
Sbjct: 193 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK 252
Query: 233 PLPIVYSSTMKQ-----------IIKSMLRKNPEHRPTASDLLRHPHLQPY 272
LP +++ ML + + R TA++ L HP+ +
Sbjct: 253 SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 69/265 (26%), Positives = 125/265 (47%), Gaps = 25/265 (9%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLNNPYIVK-- 76
+G+G+FG L K + Y +K ++ + Q + + T ++ L N+P++ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 77 YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136
D+ + V + GGD+ I+K+R F E + + ++ A+ +LH +
Sbjct: 63 CCFQTPDR---LFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKGI 117
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKS 195
++RDLK N+ L + +L DFG+ K + S+ GTP+Y+ PE+L ++ YG
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 196 DIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ----IIKSMLR 251
D W++G ++E+ F A + L I +VY + + Q I+K+ +
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-----VVYPTWLSQDAVDILKAFMT 232
Query: 252 KNPEHRPTASDL------LRHPHLQ 270
KNP R + L LRHP +
Sbjct: 233 KNPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 65/249 (26%), Positives = 122/249 (48%), Gaps = 11/249 (4%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLNN 71
D+ + +G+G+FG L K + Y +K ++ + Q + + T +++ L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 72 PYIVKYKDAW--VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
P++ + + VD+ + V Y GGD+ I++ F E + + ++ + +
Sbjct: 61 PFLTQLHSCFQTVDR---LYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLF 115
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS-SVVGTPNYMCPELLAD 188
+LH +++RDLK N+ L + I++ DFG+ K + + + + GTP+Y+ PE++A
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248
PYG D W+ G ++E+ A QP F D L I ++S P S I K
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-YPKSLSKEAVSICKG 234
Query: 249 MLRKNPEHR 257
++ K+P R
Sbjct: 235 LMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 4e-21
Identities = 70/296 (23%), Positives = 142/296 (47%), Gaps = 42/296 (14%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ Y ++Q+G GA+G L + K +KK+ Q+E F + A +E+ L+ + +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 73 YIVKYKDAW-----VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
++ D + +D+ + +V + G D+ +++K + E+++ + Q+L
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSEDRIQFLVYQMLKG 130
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA 187
+ Y+H+ ++HRDLK N+ + +D ++++ DFGLA+ ++E + V T Y PE++
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVIL 188
Query: 188 D-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP------------- 233
+ + Y DIWS+GC M E+ +P F+ D + +I + + +P
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248
Query: 234 ------LPIVYSSTMK-----------QIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
LP + +++ ML + E R TA++ L HP+ + +
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 8/275 (2%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLNNPYIVK 76
+ +G+G+FG FL K + + +K ++ + + + T +++ L +P++
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 77 YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136
+ K N + V Y GGD+ I+ P + +++ + +LHS +
Sbjct: 61 LYCTFQTKEN-LFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGI 117
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKS 195
++RDLK NI L D I++ DFG+ K + + + GTP+Y+ PE+L Y
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177
Query: 196 DIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255
D WS G ++E+ Q F D L I R P + K I+ + + PE
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-RMDNPCYPRWLTREAKDILVKLFVREPE 236
Query: 256 HR-PTASDLLRHPHLQPYLLRCQNPSSVYLPIKPT 289
R D+ +HP + + P KP
Sbjct: 237 RRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-20
Identities = 75/274 (27%), Positives = 131/274 (47%), Gaps = 17/274 (6%)
Query: 4 ENGDSK-SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQE 62
E GDS + L+ Y+ ++ IG GA G + + +KK+ Q + + A +E
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNC-----VCIVTGYCEGGDMAEIIKKARGACFPEEKL 117
+ L+ +N+ I+ + + + + V +V + ++ ++I+ E++
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME----LDHERM 121
Query: 118 CKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT 177
L Q+L + +LHS ++HRDLK SNI + D +++ DFGLA+ T + + V T
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV 237
Y PE++ + Y DIWS+GC M E+ H+ F D NK+ +P P
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP-- 239
Query: 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271
MK+ ++ +R E+RP + L P L P
Sbjct: 240 --EFMKK-LQPTVRNYVENRPKYAG-LTFPKLFP 269
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 79/315 (25%), Positives = 147/315 (46%), Gaps = 34/315 (10%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKI----ERKKY---VLKKIRLAK--QTEKFKRTALQEMD 64
++E+++ +G GA+G FLV K+ K Y VL+K L + +T + RT ++
Sbjct: 1 NFELLKVLGTGAYGKVFLV-RKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
+ + +P++V A+ + + ++ Y GG+M + + F E+++ + ++
Sbjct: 60 HVRQ--SPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEI 114
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK--LLNTEDLASSVVGTPNYMC 182
+LA+++LH +++RD+K NI L + + L DFGL+K L ++ S GT YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 183 PELL-ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVY 238
PE++ +G D WSLG +FE+ F ++++R + P P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI 234
Query: 239 SSTMKQIIKSMLRKNPEHR-----PTASDLLRHPHLQPYLLRCQNPSSVYLPIKPT---- 289
+ ++ +LRK+P+ R AS++ HP + V P +P+
Sbjct: 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNE 294
Query: 290 ----NIMKEKTRKSP 300
N +E T P
Sbjct: 295 LDVGNFAEEFTNLEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 79/296 (26%), Positives = 140/296 (47%), Gaps = 42/296 (14%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E Y+ + +G GA+G+ R+K +KK+ Q+ R +E+ L+ + +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 73 YIVKYKDAW-----VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
++ D + ++ N V +VT G D+ I+K + +E + + QLL
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQK---LSDEHVQFLIYQLLRG 130
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA 187
+ Y+HS ++HRDLK SN+ + +D ++R+ DFGLA+ +D + V T Y PE++
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVATRWYRAPEIML 188
Query: 188 D-IPYGYKSDIWSLGCCMFEIAAHQPAF----------RAPDMAG-----LINKIN---- 227
+ + Y DIWS+GC M E+ + F R ++ G ++ KI+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248
Query: 228 RSSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
R I LP + +K+I ++ ML + + R +AS+ L HP+ Y
Sbjct: 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 26/272 (9%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKK---YVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
I+Q+G G FG L + V K E+ + +E++++ L++ I
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 75 VKYKD-AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
VKYK G + ++ Y G + + +++ R ++L + +Q+ +DYL S
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS 127
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN-----YMCPELLAD 188
R +HRDL NI + ++ +++ DFGLAK+L ED V P + PE L
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLP-EDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAP-----DMAG----------LINKINRSSISP 233
+ SD+WS G ++E+ + ++P M G L+ + P
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP 246
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
P + ++K P+ RP+ +DL+
Sbjct: 247 RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 74/295 (25%), Positives = 133/295 (45%), Gaps = 42/295 (14%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
KLE Y+ ++++G G++ + K+ + LK+IRL + E TA++E L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAIREASLLKDLK 61
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE-KLCKWLTQLLLAVD 129
+ IV D + + +V Y + D+ + + G +L +L QLL +
Sbjct: 62 HANIVTLHDI-IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL--FLFQLLRGLA 117
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL--AKLLNTEDLASSVVGTPNYMCPE-LL 186
Y H RVLHRDLK N+ +++ +++L DFGL AK + ++ ++ VV T Y P+ LL
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLL 176
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAF----RAPDMAGLINKI-------NRSSISPLP 235
Y D+W +GC +E+A +P F D I ++ +S P
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236
Query: 236 ---------------------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
+ +++ L+ P+ R +A++ ++HP+
Sbjct: 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 63/270 (23%), Positives = 112/270 (41%), Gaps = 44/270 (16%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKY----------VLKKIRLAKQTEKFKRTALQEMDLISK 68
+++G G+FG V+ + E LK +L+ + F L+E ++
Sbjct: 1 KKLGDGSFG----VVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDF----LKEAAIMHS 52
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
L++ +++ + + +VT G + + ++K F LC + Q+ +
Sbjct: 53 LDHENLIRLYGVVLTHP--LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGM 110
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK-LLNTEDLASSVVGTPN------YM 181
YL S R +HRDL NI L D+ +++GDFGL + L ED V + +
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED---HYVMEEHLKVPFAWC 167
Query: 182 CPELLADIPYGYKSDIWSLGCCMFEIAAH--QP--AFRAPDMAGLINK----INRSSISP 233
PE L + + SD+W G ++E+ + +P + I+K + R P
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACP 227
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDL 263
I Y ++ NP RPT + L
Sbjct: 228 QDI-Y-----NVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 41/295 (13%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-N 71
+ YE +E+IG G +G + K K LKK RL E TAL+E+ L+ L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 72 PYIVKYKDA-WVDKGN---CVCIVTGYCEGGDMAEIIKKARGAC---FPEEKLCKWLTQL 124
YIV+ D V++ N + +V Y + D+ + + P + + ++ QL
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLAKLLNT--EDLASSVVGTPNYM 181
L V + H + V+HRDLK N+ + K +++ D GL + + + +V T Y
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYR 178
Query: 182 CPE-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240
PE LL Y DIWS+GC E++ QP F + I + +P V+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 241 TMK---------------------------QIIKSMLRKNPEHRPTASDLLRHPH 268
K +++ MLR +P R +A L HP+
Sbjct: 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 74/296 (25%), Positives = 120/296 (40%), Gaps = 54/296 (18%)
Query: 21 IGRGAFGAAF--LVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISK-LNNPYIVK 76
IG+ L HK +KKI L + E K LQ+ + S+ L +P I+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKL--LQQEIITSRQLQHPNILP 63
Query: 77 YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136
Y +++ + +V+ G +++K PE + L +L A+DY+HS
Sbjct: 64 YVTSFIVDSE-LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLA--------KLLNTEDLASSVVGTPNYMCPELLAD 188
+HR +K S+I L+ D + L + + D S V ++ PE+L
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 189 IPYGY--KSDIWSLG--CCMFEIA-AHQPAFRAPDMAGLINKIN--------RSSI---- 231
GY KSDI+S+G C E+A H P P L+ K+ +S+
Sbjct: 183 NLQGYNEKSDIYSVGITAC--ELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240
Query: 232 ----------------SPLPIVYSSTMK----QIIKSMLRKNPEHRPTASDLLRHP 267
+ Y+ T Q ++ L+++PE RP+AS LL H
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-20
Identities = 71/255 (27%), Positives = 110/255 (43%), Gaps = 60/255 (23%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR-----LAKQTEKFKRTALQEMDLISKL 69
+ I+ +G GAFG L + Y +K +R L Q K E D++++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVK----AERDILAEA 58
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
+N ++V+ ++ DK N + V Y GGDM ++ R FPE+ ++ +L AV+
Sbjct: 59 DNEWVVRLYYSFQDKDN-LYFVMDYIPGGDMMSLL--IRMGIFPEDLARFYIAELTCAVE 115
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL---------AKLLNTED----------- 169
+H +HRD+K NI + +D I+L DFGL +K + D
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 170 ----------------------------LASSVVGTPNYMCPELLADIPYGYKSDIWSLG 201
LA S+VGTPNY+ PE+L Y D WS+G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 202 CCMFEIAAHQPAFRA 216
++E+ QP F A
Sbjct: 236 VILYEMLVGQPPFLA 250
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 71/314 (22%), Positives = 134/314 (42%), Gaps = 65/314 (20%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKR------------TALQEMDLISK 68
+G G +G + K +KK+++ + + + T L+E+ ++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEII-KKARGACFPEEKLCKWLTQLLLA 127
+ + I+ D +V+ + +V D+ +++ +K R E ++ L Q+L
Sbjct: 77 IKHENIMGLVDVYVEGD-FINLVMDIMAS-DLKKVVDRKIR---LTESQVKCILLQILNG 131
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA-------------KLLN---TEDLA 171
++ LH +HRDL +NIF+ ++ DFGLA K E++
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 172 SSVVGTPNYMCPELL--ADIPYGYKSDIWSLGCCMFEIAAHQPAF----------RAPDM 219
S VV T Y PELL A+ Y + D+WS+GC E+ +P F R ++
Sbjct: 192 SKVV-TLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249
Query: 220 AGLINKINRSSISPLPIV--YSSTMKQ---------------IIKSMLRKNPEHRPTASD 262
G N+ N LP+ ++ + +++S+L+ NP R +A +
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309
Query: 263 LLRHPHLQPYLLRC 276
L+H + + L C
Sbjct: 310 ALKHEYFKSDPLPC 323
|
Length = 335 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-20
Identities = 67/254 (26%), Positives = 121/254 (47%), Gaps = 21/254 (8%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLNN 71
D+ + +G+G+FG L K + Y +K ++ + Q + + T +++ L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 72 PYIVKYKDAW--VDKGNCVCIVTGYCEGGD-MAEIIKKARGACFPEEKLCKWLTQLLLAV 128
P++ + + +D+ + V Y GGD M +I + R F E + ++ + +
Sbjct: 61 PFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGL 114
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVV-----GTPNYMCP 183
+LHS +++RDLK N+ L + I++ DFG+ K E++ V GTP+Y+ P
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIAP 170
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243
E++A PYG D W+ G ++E+ A Q F D L I +++ P S
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-YPKSMSKEAV 229
Query: 244 QIIKSMLRKNPEHR 257
I K ++ K+P R
Sbjct: 230 AICKGLMTKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 9e-20
Identities = 71/249 (28%), Positives = 108/249 (43%), Gaps = 52/249 (20%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISKLNNPYIVK 76
I+ +G GAFG L Y +K +R + + ++ E D++++ +N ++VK
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 77 YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136
++ DK N + V Y GGDM ++ R FPE ++ +L LA++ +H
Sbjct: 66 LYYSFQDKDN-LYFVMDYIPGGDMMSLL--IRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLA---------------------------------- 162
+HRD+K NI + D I+L DFGL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 163 -----KLLNTED---------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIA 208
+L E LA S+VGTPNY+ PE+L Y D WS+G +FE+
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 209 AHQPAFRAP 217
QP F AP
Sbjct: 243 VGQPPFLAP 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 70/261 (26%), Positives = 115/261 (44%), Gaps = 18/261 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFL-VLHKIERKKY-----VLKKIRLAKQTEKFKRTALQEMDLI 66
ED + IG G FG + V E +K K EKF LQE ++
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKF----LQEAYIM 61
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
+ ++P+IVK + N V IV G++ ++ + + L + QL
Sbjct: 62 RQFDHPHIVKLIGVITE--NPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLST 118
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-ASSVVGTP-NYMCPE 184
A+ YL S R +HRD+ N+ ++ + ++LGDFGL++ L E +S P +M PE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242
+ + SD+W G CM+EI +P F+ +I +I P+P T+
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKP-FQGVKNNDVIGRIENGERLPMPPNCPPTL 237
Query: 243 KQIIKSMLRKNPEHRPTASDL 263
++ +P RP ++L
Sbjct: 238 YSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 39/290 (13%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y ++ +G GAFG ++ + +KKI T + +E+ L+ L + I
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI 71
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW-LTQLLLAVDYLHS 133
+ D ++ + VT G D+ ++ E++ ++ L Q+L + Y+HS
Sbjct: 72 ISLSDIFISPLEDIYFVTEL-LGTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHS 126
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE-LLADIPYG 192
V+HRDLK SNI + ++ D+++ DFGLA++ + + + V T Y PE +L Y
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYD 184
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAG---------------LINKINRSS----ISP 233
+ DIWS GC E+ +P F D +IN I + +
Sbjct: 185 VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244
Query: 234 LP----IVYSSTMKQ-------IIKSMLRKNPEHRPTASDLLRHPHLQPY 272
LP + +S K +++ ML +P+ R +A++ L HP+L PY
Sbjct: 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 62/241 (25%), Positives = 116/241 (48%), Gaps = 9/241 (3%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
+G+G+FG L K + + + +K ++ + + + T +++ L NP++
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 79 DAWVDKGNCVCIVTGYCEGGD-MAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
+ K + + V + GGD M I K R F + + +++ + +LHS ++
Sbjct: 63 CTFQTKEH-LFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKGII 118
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKSD 196
+RDLK N+ L +D I++ DFG+ K + ++ AS+ GTP+Y+ PE+L + Y + D
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVD 178
Query: 197 IWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEH 256
WS G ++E+ Q F D L I R P + K I++ + ++P
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDEDELFESI-RVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 257 R 257
R
Sbjct: 238 R 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 72/261 (27%), Positives = 124/261 (47%), Gaps = 16/261 (6%)
Query: 4 ENGDSK-SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQE 62
E GDS + L+ Y+ ++ IG GA G I + +KK+ Q + + A +E
Sbjct: 14 EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE 73
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNC-----VCIVTGYCEGGDMAEIIKKARGACFPEEKL 117
+ L+ +N+ I+ + + + + V IV + ++ ++I+ E++
Sbjct: 74 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME----LDHERM 128
Query: 118 CKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT 177
L Q+L + +LHS ++HRDLK SNI + D +++ DFGLA+ T + + V T
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV 237
Y PE++ + Y DIWS+GC M E+ F D NK+ +P P
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP-- 246
Query: 238 YSSTMKQIIKSMLRKNPEHRP 258
MK+ ++ +R E+RP
Sbjct: 247 --EFMKK-LQPTVRTYVENRP 264
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 8/207 (3%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
KLE Y ++++G G + F K+ LK+IRL + E TA++E+ L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIREVSLLKNLK 61
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+ IV D + C+ +V Y + D+ + + G + ++ QLL + Y
Sbjct: 62 HANIVTLHDI-IHTERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSY 118
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL--AKLLNTEDLASSVVGTPNYMCPE-LLA 187
H ++LHRDLK N+ + + +++L DFGL AK + T+ ++ VV T Y P+ LL
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAF 214
Y D+W +GC ++E+A +P F
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 69/248 (27%), Positives = 126/248 (50%), Gaps = 19/248 (7%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLK-----KIRLAKQTEKFKRTALQEMDLISKLNNPYIV 75
IGRG FG + K Y +K +I++ KQ E + L+S + P+IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIV 60
Query: 76 --KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
Y DK +C + GGD+ + ++ F E+++ + T+++L ++++H+
Sbjct: 61 CMTYAFHTPDK---LCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD-IPYG 192
V++RDLK +NI L + +R+ D GLA + + +S VGT YM PE+L Y
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYD 174
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSSTMKQIIKSM 249
+D +SLGC +F++ FR ++I+R +++ LP +S +K +++ +
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGL 233
Query: 250 LRKNPEHR 257
L+++ R
Sbjct: 234 LQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 63/253 (24%), Positives = 116/253 (45%), Gaps = 15/253 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E ++++++G G FG ++ + K I+ KQ L E +L+ +L +P
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV----AIKSLKQGSMSPEAFLAEANLMKQLQHP 61
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+V+ A V + + I+T Y E G + + +K G KL Q+ + ++
Sbjct: 62 RLVRLY-AVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTP-NYMCPELLADIP 190
+HRDL+ +NI +++ ++ DFGLA+L+ + E A P + PE +
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179
Query: 191 YGYKSDIWSLGCCMFEIAAH----QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
+ KSD+WS G + EI + P P+ +I + R P P + +++
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNLERGYRMPRPDNCPEELYELM 236
Query: 247 KSMLRKNPEHRPT 259
+ ++ PE RPT
Sbjct: 237 RLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 8/207 (3%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
K+E Y +E++G G + F K+ LK+IRL + E TA++E+ L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIREVSLLKDLK 62
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+ IV D V + +V Y + D+ + + G + +L Q+L + Y
Sbjct: 63 HANIVTLHDI-VHTDKSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAY 119
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL--AKLLNTEDLASSVVGTPNYMCPE-LLA 187
H +VLHRDLK N+ + + +++L DFGL AK + T+ ++ VV T Y P+ LL
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAF 214
Y + D+W +GC FE+A+ +P F
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 46/213 (21%)
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV 174
E++ L Q+L + +LHS ++HRDLK SNI + D +++ DFGLA+ T + +
Sbjct: 118 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 177
Query: 175 VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI-------- 226
V T Y PE++ + Y DIWS+GC M E+ F D NKI
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237
Query: 227 ----------------NRSSISPLPI------------------VYSSTMKQIIKSMLRK 252
NR + + +S + ++ ML
Sbjct: 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297
Query: 253 NPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLP 285
+PE R + D L+HP++ + +PS V P
Sbjct: 298 DPEKRISVDDALQHPYINVWY----DPSEVEAP 326
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 48/281 (17%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKY-----------VLKKIR--LAKQTEKFKRTALQEMD 64
I+Q+G+G FG+ +E +Y +KK++ A+ F+R E++
Sbjct: 9 IQQLGKGNFGS-------VELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER----EIE 57
Query: 65 LISKLNNPYIVKYKDAWVDKG-NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ 123
++ L + IVKYK G + +V Y G + + ++K R KL + +Q
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD-HRKLLLYASQ 116
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN---- 179
+ ++YL S R +HRDL NI + +N +++GDFGL K+L +D V P
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYKVREPGESPI 175
Query: 180 -YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-----DMAG-----------L 222
+ PE L + + SD+WS G ++E+ + +P M G L
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235
Query: 223 INKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDL 263
I + + P P + + I+K +P RP+ S+L
Sbjct: 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-18
Identities = 78/302 (25%), Positives = 130/302 (43%), Gaps = 53/302 (17%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKL 69
++ Y++I IG+G G +L + ++ LKKIR L+ + K+ L+E + + L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-ENPLLKKRFLREAKIAADL 59
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ------ 123
+P IV D G+ V Y EG + ++K +E L K L +
Sbjct: 60 IHPGIVPVYSICSD-GDPVYYTMPYIEGYTLKSLLKSVW----QKESLSKELAEKTSVGA 114
Query: 124 -------LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE--DLASS- 173
+ ++Y+HS VLHRDLK NI L ++ + D+G A E DL
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 174 ----------------VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP 217
+VGTP+YM PE L +P +DI++LG ++++ +R
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234
Query: 218 DMAGLINK---INRSSISP---LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR---HPH 268
+ + ++ ++P +P S QI L +P R ++ L+ PH
Sbjct: 235 KGRKISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAERYSSVQELKQDLEPH 290
Query: 269 LQ 270
LQ
Sbjct: 291 LQ 292
|
Length = 932 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-18
Identities = 79/283 (27%), Positives = 119/283 (42%), Gaps = 43/283 (15%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
+ ++E GA G AF + + V+K A Q + E ++ +N+P I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIK----AGQ----RGGTATEAHILRAINHPSI 145
Query: 75 VKYKDAWV-DKGNCVCI----VTGYCEGGDMAEIIKKARGACFPEEKLCKWLT---QLLL 126
++ K + +K C+ + YC I +C L +L
Sbjct: 146 IQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNI------------AICDILAIERSVLR 193
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA--KLLNTEDLASSVVGTPNYMCPE 184
A+ YLH NR++HRD+K NIF+ D+ LGDFG A + + GT PE
Sbjct: 194 AIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPE 253
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINK-------INRSSISP--L 234
LLA PYG DIWS G +FE+A H F + G + I RS P
Sbjct: 254 LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313
Query: 235 PIVYSSTMKQIIKSMLRKN---PEHRPTASDLLRHPHLQPYLL 274
PI + + +I + +K+ P RP ++L P YL+
Sbjct: 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLI 356
|
Length = 391 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
K + YE +E++G G++ + K+ K LK IRL ++ E TA++E L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL-QEEEGTPFTAIREASLLKGLK 61
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE-KLCKWLTQLLLAVD 129
+ IV D + + +V Y D+ + + K G PE KL +L QLL +
Sbjct: 62 HANIVLLHDI-IHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL--FLFQLLRGLS 117
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPE-LLA 187
Y+H +LHRDLK N+ ++ +++L DFGLA+ + S+ V T Y P+ LL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR 228
Y D+W +GC E+ AF P M + +++ R
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAF--PGMKDIQDQLER 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 70/297 (23%), Positives = 126/297 (42%), Gaps = 45/297 (15%)
Query: 15 YEVIEQIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NN 71
YE+I+++G+GA+G + E + +KKI + + AL+E+ L+ +
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 72 PYIVKYKD---AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
I D + N + + E D+ +II+ G + ++ Q+L +
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRS--GQPLTDAHFQSFIYQILCGL 118
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-----TEDLASSVVGTPNYMCP 183
Y+HS VLHRDLK N+ + D ++++ DFGLA+ + + V T Y P
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 184 E-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI---------------- 226
E +L+ Y D+WS+GC + E+ +P F+ D +N+I
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 227 -------NRSSISPLPIVYSSTMK-------QIIKSMLRKNPEHRPTASDLLRHPHL 269
RS + + S +++ +L +P R + + L HP+L
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 8/207 (3%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
KLE Y ++++G G + + K+ LK+IRL + E TA++E+ L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLK 62
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+ IV D + + +V Y + D+ + + G + +L QLL ++Y
Sbjct: 63 HANIVTLHDI-IHTEKSLTLVFEYLDK-DLKQYLDDC-GNSINMHNVKLFLFQLLRGLNY 119
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL--AKLLNTEDLASSVVGTPNYMCPE-LLA 187
H +VLHRDLK N+ + + +++L DFGL AK + T+ ++ VV T Y P+ LL
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLG 178
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAF 214
Y + D+W +GC +E++ +P F
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 21 IGRGAFGAAF------LVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
+G GAFG + ++ + +K +R ++ K L+E L+S N+P I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEF-LKEAHLMSNFNHPNI 61
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL-LAVD---- 129
VK + I+ EGGD+ ++ AR F L L +LL + +D
Sbjct: 62 VKLLGVCLLN-EPQYIIMELMEGGDLLSYLRDARVERFGPPLLT--LKELLDICLDVAKG 118
Query: 130 --YLHSNRVLHRDLKCSNIFLT-KDND----IRLGDFGLAKLLNTEDLASSVVGTP---- 178
YL +HRDL N ++ K D +++GDFGLA+ + D G
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-YRKEGEGLLPV 177
Query: 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQP 212
+M PE L D + +SD+WS G M+EI QP
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 69/251 (27%), Positives = 127/251 (50%), Gaps = 25/251 (9%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLK-----KIRLAKQTEKFKRTALQE---MDLISKLNNP 72
IGRG FG + K Y +K +I++ KQ E AL E + L+S + P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETL---ALNERIMLSLVSTGDCP 57
Query: 73 YIV--KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+IV Y DK + + GGD+ + ++ F E ++ + +++L +++
Sbjct: 58 FIVCMSYAFHTPDK---LSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEH 112
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD-I 189
+H+ V++RDLK +NI L + +R+ D GLA + + +S VGT YM PE+L +
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 171
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSSTMKQII 246
Y +D +SLGC +F++ FR ++I+R +++ LP +S ++ ++
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLL 230
Query: 247 KSMLRKNPEHR 257
+ +L+++ R
Sbjct: 231 EGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 71/296 (23%), Positives = 135/296 (45%), Gaps = 42/296 (14%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E Y+ + +G GA+G+ + +KK+ Q+ + +E+ L+ + +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 73 YIVKYKDAW-----VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
++ D + +++ N V +VT + G D+ I+K + ++ + + Q+L
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQK---LTDDHVQFLIYQILRG 132
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA 187
+ Y+HS ++HRDLK SN+ + +D ++++ DFGLA+ +T+D + V T Y PE++
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIML 190
Query: 188 D-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM---------------AGLINKIN---- 227
+ + Y DIWS+GC M E+ + F D A L+ KI+
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250
Query: 228 RSSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
R+ I L + + ++ ML + + R TA+ L H + Y
Sbjct: 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 79/303 (26%), Positives = 129/303 (42%), Gaps = 47/303 (15%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
D E IG GAFG + V + K+ LKK+ Q + +E+ ++ +
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 74 IVKYKD----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
++ D +D + +VT + D+ +II + K+ +L Q+L +
Sbjct: 61 VLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKV--FLYQILRGLK 117
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV-----VGTPNYMCPE 184
YLHS +LHRD+K N+ + + +++ DFGLA++ E+ S V T Y PE
Sbjct: 118 YLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPDESKHMTQEVVTQYYRAPE 174
Query: 185 LLADIP-YGYKSDIWSLGCCMFEIAAHQPAFRA----------------PDMA------- 220
+L Y DIWS+GC E+ + F+A P +
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234
Query: 221 GLINKINRSSISP--LPIVY------SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
G I R P LP++Y + ++ ML +P+ R +A+D L HP+L
Sbjct: 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294
Query: 273 LLR 275
LR
Sbjct: 295 RLR 297
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-17
Identities = 75/296 (25%), Positives = 122/296 (41%), Gaps = 54/296 (18%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y VI+ + G+ G F+ + VLK + K T L E L+ +N+P +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQ--------KGTTLIEAMLLQNVNHPSV 119
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
++ KD V G C+V + D+ + K ++ L Q+L + YLH+
Sbjct: 120 IRMKDTLV-SGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALII-EKQILEGLRYLHAQ 176
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYK 194
R++HRD+K NIF+ + + +GD G A+ + GT PE+LA Y K
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK 236
Query: 195 SDIWSLGCCMFEIAAH-QPAFRAPDMAG----------LINKINRSSISP--LP------ 235
+DIWS G +FE+ A+ F P L+ I+ + P P
Sbjct: 237 ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296
Query: 236 -----IVYSSTMKQ-------------------IIKSMLRKNPEHRPTASDLLRHP 267
I Y+S +Q ++ ML + RP+A ++L +P
Sbjct: 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYP 352
|
Length = 357 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 66/253 (26%), Positives = 130/253 (51%), Gaps = 13/253 (5%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISKLNNPYIVK 76
+++IG G FG +L + +E++K +K IR A E F +E ++ KL++P +V+
Sbjct: 9 VQEIGSGQFGLVWLG-YWLEKRKVAIKTIREGAMSEEDFI----EEAQVMMKLSHPKLVQ 63
Query: 77 YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136
++ +C+V + E G +++ ++ RG F +E L + + YL S+ V
Sbjct: 64 LYGVCTERSP-ICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSNV 121
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP---NYMCPELLADIPYGY 193
+HRDL N + ++ +++ DFG+ + + +D +S GT + PE+ + Y
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 194 KSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252
KSD+WS G M+E+ + + + + ++ IN P + S ++ ++++ ++
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKE 240
Query: 253 NPEHRPTASDLLR 265
PE RP+ S LL
Sbjct: 241 RPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 68/261 (26%), Positives = 121/261 (46%), Gaps = 29/261 (11%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKYV------LKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+++G G FG+ ++ ++ K V LK+ +A ++F L+E ++++L++P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEF----LREASVMAQLDHP 56
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IV+ V KG + +V G + + +KK R P L + Q+ + + YL
Sbjct: 57 CIVRLIG--VCKGEPLMLVMELAPLGPLLKYLKKRRE--IPVSDLKELAHQVAMGMAYLE 112
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTP-NYMCPELLAD 188
S +HRDL N+ L + ++ DFG+++ L A++ P + PE
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC--- 169
Query: 189 IPYG---YKSDIWSLGCCMFEIAAH-QPAFRAPDMAG--LINKINRSSISPLPIVYSSTM 242
I YG KSD+WS G ++E ++ + +M G +I + P P +
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYG--EMKGAEVIAMLESGERLPRPEECPQEI 227
Query: 243 KQIIKSMLRKNPEHRPTASDL 263
I+ S + PE RPT S+L
Sbjct: 228 YSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 65/243 (26%), Positives = 106/243 (43%), Gaps = 47/243 (19%)
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGN-CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
+E++++ L + IVKYK ++G + ++ Y G + + + P+ KL
Sbjct: 55 KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--------PKHKLN- 105
Query: 120 WLTQLLL-------AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT----- 167
L QLLL + YLHS +HRDL N+ L D +++GDFGLAK +
Sbjct: 106 -LAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164
Query: 168 ---EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-----DM 219
ED S V + E L + + Y SD+WS G ++E+ H + ++P +M
Sbjct: 165 RVREDGDSPVF----WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM 220
Query: 220 AG----------LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
G LI + R P P + ++K+ + RPT L+ P L
Sbjct: 221 IGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI--PIL 278
Query: 270 QPY 272
+
Sbjct: 279 KEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 66/271 (24%), Positives = 129/271 (47%), Gaps = 31/271 (11%)
Query: 12 LEDYEVIEQIG--RGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEM--DLIS 67
L++ E+++++ G FG ++ HK +K +V K I+ + F A++ M L+
Sbjct: 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKA----KNF--NAIEPMVHQLMK 66
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
+NP +K + V ++ Y + GD+ +++KK E ++ K + QL+ A
Sbjct: 67 --DNPNFIKLYYS-VTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEA 121
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDND-IRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
++ LH + ++H D+K N+ + D I L D+GL K++ T S GT +Y PE +
Sbjct: 122 LNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKI 178
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRA-------PDMAGLINKINRSSISPLPIVYS 239
Y D W++G +E+ + F+ + + K + + + V S
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES---LLKRQQKKLPFIKNV-S 234
Query: 240 STMKQIIKSMLRKNPEHR-PTASDLLRHPHL 269
++SML+ N +R +++++HP L
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 8/250 (3%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISKLNN 71
E++ + ++G G FG + L K + I++ K + K+ Q E+ + +L +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRV----AIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
+++ A G V I+T E G + ++ G P L Q+ + YL
Sbjct: 62 KHLISLF-AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP-NYMCPELLADIP 190
+HRDL NI + +D ++ DFGLA+L+ + SS P + PE +
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 191 YGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249
+ KSD+WS G ++E+ + Q + + + ++I P P + +I+
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240
Query: 250 LRKNPEHRPT 259
PE RP+
Sbjct: 241 WAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 61/252 (24%), Positives = 115/252 (45%), Gaps = 2/252 (0%)
Query: 6 GDSK-SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMD 64
DS + L+ Y+ ++ IG GA G + +KK+ Q + + A +E+
Sbjct: 13 ADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV 72
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
L+ +N+ I+ + + + + Y M + + E++ L Q+
Sbjct: 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE 184
L + +LHS ++HRDLK SNI + D +++ DFGLA+ T + + V T Y PE
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244
++ + Y DIWS+GC M E+ F+ D NK+ +P + + ++
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP-SAEFMNRLQP 251
Query: 245 IIKSMLRKNPEH 256
+++ + P++
Sbjct: 252 TVRNYVENRPQY 263
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 59/274 (21%), Positives = 117/274 (42%), Gaps = 29/274 (10%)
Query: 13 EDYEVIEQIGRGAFGAAFL-VLHKI---ERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
E +I ++G+G+FG + + + E + V K + + + L E ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK----KARGACFPE----EKLCKW 120
N ++V+ V G +V GD+ ++ +A +K +
Sbjct: 66 FNCHHVVRLLGV-VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGT 177
++ + YL + + +HRDL N + +D +++GDFG+ + + D +
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAGLINK-----INRSS 230
+M PE L D + KSD+WS G ++E+A A QP GL N+ +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP------YQGLSNEEVLKFVIDGG 238
Query: 231 ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
LP + ++++ + NP+ RPT +++
Sbjct: 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 61/252 (24%), Positives = 121/252 (48%), Gaps = 11/252 (4%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
++++G G FG V+H + + + I++ ++ + ++E ++ KL++P +V+
Sbjct: 9 LKELGSGQFG----VVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137
K + IVT Y G + +++ +G E L + + A++YL SN +
Sbjct: 65 YGV-CTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 138 HRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP---NYMCPELLADIPYGYK 194
HRDL N + +DN +++ DFGLA+ + +D +S GT + PE+ + K
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 195 SDIWSLGCCMFEI-AAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKN 253
SD+WS G M+E+ + + + + ++ ++ P + + + I+ S +
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEK 241
Query: 254 PEHRPTASDLLR 265
PE RP LL
Sbjct: 242 PEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 8/203 (3%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y +E++G G++ + + +I + LK I + K E TA++E L+ L + I
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTAIREASLLKGLKHANI 65
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V D + + V Y D+A+ + + G P ++ QLL + Y+H
Sbjct: 66 VLLHDI-IHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ 122
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLA--KLLNTEDLASSVVGTPNYMCPE-LLADIPY 191
+LHRDLK N+ ++ +++L DFGLA K + ++ +S VV T Y P+ LL Y
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDY 181
Query: 192 GYKSDIWSLGCCMFEIAAHQPAF 214
DIW GC E+ QPAF
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 60/256 (23%), Positives = 121/256 (47%), Gaps = 13/256 (5%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
+++ ++++ IG+G FG L ++ K +K I+ + F L E ++++L
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF----LAEASVMTQLR 57
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+ +V+ V++ + IVT Y G + + ++ + + L K+ + A++Y
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTPNYMCPELLADI 189
L +N +HRDL N+ +++DN ++ DFGL K + T+D V + PE L +
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREK 174
Query: 190 PYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247
+ KSD+WS G ++EI + P R P + ++ ++ + P + ++K
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233
Query: 248 SMLRKNPEHRPTASDL 263
+ RP+ L
Sbjct: 234 QCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 78/297 (26%), Positives = 130/297 (43%), Gaps = 45/297 (15%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y++ E IG+G++G + +K +KKI + L+E+ L+ L +P I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 75 VKYKDAWVDKG----NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
V+ K + + +V E D+ ++IK A PE +L QLL A+ Y
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEHHQF-FLYQLLRALKY 118
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV-----VGTPNYMCPEL 185
+H+ V HRDLK NI D +++ DFGLA+ + D +++ V T Y PEL
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 186 LADIPYGYKS--DIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV------ 237
Y DIWS+GC E+ +P F ++ ++ I +P P
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237
Query: 238 -----YSSTMKQ-------------------IIKSMLRKNPEHRPTASDLLRHPHLQ 270
Y S+M++ +++ +L +P+ RPTA + L P+ +
Sbjct: 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 20 QIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
++GRG +G + K + K+Y LK+I + +A +E+ L+ +L +P ++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIAL 63
Query: 78 KDAWVDKGN-CVCIVTGYCEGGDMAEIIKKARGA-------CFPEEKLCKWLTQLLLAVD 129
+ ++ + V ++ Y E D+ IIK R + P + L Q+L +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 130 YLHSNRVLHRDLKCSNIFLTKDND----IRLGDFGLAKLLNT--EDLA--SSVVGTPNYM 181
YLH+N VLHRDLK +NI + + +++ D G A+L N+ + LA VV T Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 182 CPELLADIPYGYKS-DIWSLGCCMFEIAAHQPAF 214
PELL + K+ DIW++GC E+ +P F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 75/277 (27%), Positives = 120/277 (43%), Gaps = 43/277 (15%)
Query: 15 YEVIEQIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
Y ++ + G+ G F+ +RKK ++K + K + E+D++ +++
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR-------EIDILKTISHR 146
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
I+ A+ K + VC+V + D+ + R P E+ +LL A+ YLH
Sbjct: 147 AIINLIHAYRWK-STVCMVMPKYKC-DLFTYVD--RSGPLPLEQAITIQRRLLEALAYLH 202
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV---VGTPNYMCPELLADI 189
++HRD+K NIFL + + LGDFG A L+ GT PELLA
Sbjct: 203 GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD 262
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249
PY K+DIWS G +FE++ L K +SS SS ++ II+ M
Sbjct: 263 PYCAKTDIWSAGLVLFEMSVKN--------VTLFGKQVKSS--------SSQLRSIIRCM 306
Query: 250 LRKNPE-----------HRPTASDLLRHPHLQPYLLR 275
E H + +LR P+ P ++R
Sbjct: 307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIR 343
|
Length = 392 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 35/268 (13%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
++ ++ IG+G FG L ++ +K +K + K + L E +++ L +
Sbjct: 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCL---KDDSTAAQAFLAEASVMTTLRH 59
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD-- 129
P +V+ + GN + IVT Y G + + ++ +RG QL A+D
Sbjct: 60 PNLVQLLGVVLQ-GNPLYIVTEYMAKGSLVDYLR-SRGRAVITLA-----QQLGFALDVC 112
Query: 130 ----YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP-NYMCPE 184
YL +HRDL N+ +++D ++ DFGLAK P + PE
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPE 169
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAH--QPAFRAP--DMAGLINKINRSSISP---LPIV 237
L + + KSD+WS G ++EI + P R P D+ + K R +P P V
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME-APEGCPPEV 228
Query: 238 YSSTMKQIIKSMLRKNPEHRPTASDLLR 265
Y +++K +P RPT L
Sbjct: 229 Y-----KVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 20 QIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
++GRG +G + K + + Y LK+I + +A +E+ L+ +L +P ++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISL 63
Query: 78 KDAWVDKGN-CVCIVTGYCEGGDMAEIIKKARGA-------CFPEEKLCKWLTQLLLAVD 129
+ ++ + V ++ Y E D+ IIK R + P + L Q+L +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 130 YLHSNRVLHRDLKCSNIFLTKDND----IRLGDFGLAKLLNT--EDLA--SSVVGTPNYM 181
YLH+N VLHRDLK +NI + + +++ D G A+L N+ + LA VV T Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 182 CPELLADIPYGYKS-DIWSLGCCMFEIAAHQPAF 214
PELL + K+ DIW++GC E+ +P F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-15
Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 40 KYVLKKIRLAKQTEKFKRTALQ-EMDLISKLNNPYIVKYKDAWVDKGNC----VCIVTGY 94
+ +K +R E+ +R + E L ++L +P IV A +D G + V Y
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIV----ALLDSGEAPPGLLFAVFEY 60
Query: 95 CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDI 154
G + E++ A GA E + + Q+L A+ H+ ++HRDLK NI +++
Sbjct: 61 VPGRTLREVLA-ADGALPAGETG-RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 155 R---LGDFGLAKLL-NTED-------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCC 203
+ DFG+ LL D + V+GTP Y PE L P SD+++ G
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 204 MFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMK-----QIIKSMLRKNPEHR 257
E Q + +A ++ + +SP+ + + Q+++ L K+P R
Sbjct: 179 FLECLTGQRVVQGASVAEILYQ----QLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 66/273 (24%), Positives = 123/273 (45%), Gaps = 38/273 (13%)
Query: 18 IEQIGRGAFGAAFLV-LHKIERKKYVLKKIRLAKQTEKFKRTALQ-----EMDLISKLNN 71
I +GRG FG FL IE + + + L K +K K LQ E+D+ KL++
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEG--GETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67
Query: 72 PYIVKYKDAWVDKGNCV-----CIVTGYCEGGDMAEIIKKARGACFPEEK---------- 116
+V+ G C ++ Y + GD+ + ++ + +
Sbjct: 68 KNVVRLL------GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 117 LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK-LLNTEDLASSVV 175
LC TQ+ L +D+L + R +HRDL N ++ ++++ L+K + N+E
Sbjct: 122 LC---TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 176 GTP-NYMCPELLADIPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAGLINKINRSSIS 232
P ++ PE + + + KSD+WS G M+E+ P + D ++N++ +
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-VLNRLQAGKLE 237
Query: 233 -PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
P+P S + +++ NP+ RP+ S+L+
Sbjct: 238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 11 KLEDYEVIEQIGRGAFGAAFL----VLHKIERKKYV----LKKIRLAKQTEKFKRTALQE 62
+ + + ++G GAFG FL L K+ V LK+ + F+R E
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER----E 58
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE----------IIKKARGACF 112
+L++ + IVK+ + G+ +V Y E GD+ + +K
Sbjct: 59 AELLTNFQHENIVKFYGVCTE-GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 113 P--EEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169
+L + Q+ + YL S +HRDL N + D +++GDFG+++ + T D
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 170 --LASSVVGTPNYMCPELLADIPYG---YKSDIWSLGCCMFEIAAH--QPAF 214
+ + +M PE I Y +SD+WS G ++EI + QP +
Sbjct: 178 YRVGGHTMLPIRWMPPE---SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 66/259 (25%), Positives = 123/259 (47%), Gaps = 25/259 (9%)
Query: 18 IEQIGRGAFGAAFLVLHKIERK---KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
++++G G FG V+H + + K +K I +E+ ++E ++ KL++P +
Sbjct: 9 MKELGSGQFG----VVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61
Query: 75 VKYKDAWVDKGNC-----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
V+ G C + IVT + E G + +++ +G ++ L + ++
Sbjct: 62 VQLY------GVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGME 114
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK-LLNTEDLASSVVGTPNYMC-PELLA 187
YL N +HRDL N ++ +++ DFG+ + +L+ E +SS P PE+
Sbjct: 115 YLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN 174
Query: 188 DIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
Y KSD+WS G M+E+ + F ++ I+R P + S T+ +++
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVM 234
Query: 247 KSMLRKNPEHRPTASDLLR 265
S + PE RPT ++LLR
Sbjct: 235 YSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 48/173 (27%), Positives = 89/173 (51%), Gaps = 10/173 (5%)
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
M + L++ YIV+ + G + +VT G + + +++ R + P+ +L W
Sbjct: 60 MLAMGSLDHAYIVRLLG--ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQ-RLLNWCV 116
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--LASSVVGTP-N 179
Q+ + YL +R++HR+L NI L D+ +++ DFG+A LL +D S TP
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAH--QP--AFRAPDMAGLINKINR 228
+M E + Y ++SD+WS G ++E+ ++ +P R ++ L+ K R
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 68/263 (25%), Positives = 122/263 (46%), Gaps = 15/263 (5%)
Query: 14 DYEVIEQ-IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKLN 70
Y IE+ IG G FG K+ KK + I+ K ++K + L E ++ + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+P I++ + V K V I+T Y E G + + +++ G F +L L + + Y
Sbjct: 64 HPNIIRL-EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKY 121
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVG--TP-NYMCPELLA 187
L +HRDL NI + + ++ DFGL++ L + + G P + PE +A
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 188 DIPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAG--LINKINRSSISPLPIVYSSTMK 243
+ SD+WS G M+E+ ++ +P + DM+ +I + P P+ S +
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYW---DMSNQDVIKAVEDGYRLPPPMDCPSALY 238
Query: 244 QIIKSMLRKNPEHRPTASDLLRH 266
Q++ +K+ RPT S ++
Sbjct: 239 QLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 50/198 (25%), Positives = 97/198 (48%), Gaps = 9/198 (4%)
Query: 16 EVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E I+ +G GAFG + + E +K V K+ + + K + L E +++ +++P
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHP 69
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
++V+ + + V ++T G + + ++ + + L W Q+ + YL
Sbjct: 70 HVVRL--LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY-LLNWCVQIAKGMSYLE 126
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVG--TP-NYMCPELLADI 189
R++HRDL N+ + +++ DFGLAKLL+ ++ G P +M E +
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186
Query: 190 PYGYKSDIWSLGCCMFEI 207
Y +KSD+WS G ++E+
Sbjct: 187 IYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 113/505 (22%), Positives = 190/505 (37%), Gaps = 46/505 (9%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISKLN 70
+E++ +++ I RGAFG +L K K Y +K ++ A K +Q E D ++
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 71 NPYIVK--YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
+P+IV Y + N V +V Y GGD+ ++ F EE K+++++ LA+
Sbjct: 63 SPFIVHLYYS---LQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALAL 117
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCP-ELL 186
DYLH + ++HRDLK N+ ++ + I+L DFGL+K+ LN E ++ TP+ P
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDY 177
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
+ P S I SLG Q + + G + +S L I S +
Sbjct: 178 SRTPGQVLSLISSLGFNTPVGEKDQGSVNSGQNNGTSSVRTGTSHPLLMINKESLPMSL- 236
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSS--KH 304
+ + E ++ L L P LL+ + P T+ S SS
Sbjct: 237 -KLSKSCLETSESSPSLPVR-SLTPNLLKSRKR-----PEASTSSTHSCMTNSLSSCESE 289
Query: 305 NSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKVDPTSY 364
+ E A+ SV + + + +++K
Sbjct: 290 CCSSNLKLLEQASSPSQSPRWSVDEGNII-----------------SEGEKSEKGSVKRS 332
Query: 365 TMEVSSSINDSKERSTQTETSDCSRDKQA--HFNGSTGSDLTSEITA-NSQNEIQEPADA 421
V S +E +T+ + + NG+ + LT EI + N P
Sbjct: 333 FELVEKS--PCQELLQSKKTNAEYKRGCSITETNGNQSTGLTMEIQSLNLSKHKSRPKFL 390
Query: 422 HVQPAEEIDVETVKSKDQNPFSDRVIEEADIEGESAVPLDCGKMTPSSAGCNGNNESPDD 481
A K K + ++ E D +GE + S +
Sbjct: 391 ----AGNEKRTGPKKKSNPVVAKNLMCELDDDGEKDGKYSNSSTSCGDDREIVLKLSLNS 446
Query: 482 KSSSSAIYEPEVAPGSCSPKINSDN 506
SS + + VA S + IN N
Sbjct: 447 DSSFPEMSKNAVAFRSYNSPINVSN 471
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 39/99 (39%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN---TEDLASSVVGTPN 179
QLL A+DY+H ++HRD+K N+ + DI LGDFG A + + GT +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPA-FRAP 217
PE+LA PY DIWS G +FE A H + F A
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSAS 366
|
Length = 461 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 62/259 (23%), Positives = 124/259 (47%), Gaps = 17/259 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+D ++++G G FG +V + R +Y + I++ K+ + ++E ++ KL++
Sbjct: 4 KDLTFLKELGTGQFG---VVKYGKWRGQYDVA-IKMIKEGSMSEDEFIEEAKVMMKLSHE 59
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE--KLCKWLTQLLLAVDY 130
+V+ K + IVT Y G + +++ P + ++CK + + + Y
Sbjct: 60 KLVQLYGV-CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCE---GMAY 115
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP---NYMCPELLA 187
L S + +HRDL N + +++ DFGL++ + ++ SS VG+ + PE+L
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLL 174
Query: 188 DIPYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245
+ KSD+W+ G M+E+ + P R + + + K+++ P + S + I
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRLYRPHLASEKVYAI 233
Query: 246 IKSMLRKNPEHRPTASDLL 264
+ S + E RPT LL
Sbjct: 234 MYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 70/274 (25%), Positives = 124/274 (45%), Gaps = 36/274 (13%)
Query: 21 IGRGAFG----AAFLVLHKIERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKL-NNPY 73
+G G FG A L + K + K+ V +++ K TEK + EM+++ + +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARG---------ACFPEEKL------- 117
I+ A G IV Y G++ E ++ R A P+E++
Sbjct: 83 IINLLGACTQDGPLYVIVE-YASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 118 CKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVG- 176
C + Q+ ++YL S + +HRDL N+ +T++N +++ DFGLA+ +N D
Sbjct: 142 CTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 177 --TPNYMCPELLADIPYGYKSDIWSLGCCMFEI----AAHQPAFRAPDMAGLINKINRSS 230
+M PE L D Y ++SD+WS G M+EI + P ++ L+ + +R
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 259
Query: 231 ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
P ++ + +++ P HRPT L+
Sbjct: 260 ---KPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 29/229 (12%)
Query: 61 QEMDLISKLNNPYIVKYKDAWV-DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
+E++++ L + IVKYK D GN + ++ + G + E + + + +++L K
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL-K 113
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT--------EDLA 171
+ Q+ +DYL S + +HRDL N+ + ++ +++GDFGL K + T +DL
Sbjct: 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173
Query: 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-----DMAG----- 221
S V + PE L + SD+WS G ++E+ + + +P M G
Sbjct: 174 SPVF----WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ 229
Query: 222 -----LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
L+ + P P + Q+++ P R T +L+
Sbjct: 230 MTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 51/199 (25%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
E IG G FGA + +K +K I+ + F L+E +++KL++ +V+
Sbjct: 12 EIIGEGEFGAVLQ--GEYTGQKVAVKNIKCDVTAQAF----LEETAVMTKLHHKNLVRLL 65
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
+ G + IV G++ ++ A +L ++ + ++YL S +++H
Sbjct: 66 GVILHNG--LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIW 198
RDL NI +++D ++ DFGLA+ + + + +S + + PE L + KSD+W
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVW 181
Query: 199 SLGCCMFEIAAHQPAFRAP 217
S G ++E+ ++ RAP
Sbjct: 182 SYGVLLWEVFSYG---RAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 70/258 (27%), Positives = 122/258 (47%), Gaps = 17/258 (6%)
Query: 19 EQIGRGAFGAAFLVLHKIERKK--YVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVK 76
E IG G FG K+ K+ +V K + TEK +R L E ++ + ++P I+
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 77 YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136
+ V K V I+T + E G + +++ G F +L L + + YL
Sbjct: 70 LEGV-VTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYLSEMNY 127
Query: 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKLL--NTED--LASSVVGT-P-NYMCPELLADIP 190
+HRDL NI + + ++ DFGL++ L +T D SS+ G P + PE +A
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 191 YGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQII 246
+ SD+WS G M+E+ ++ +P + DM+ +IN I + P P+ + + Q++
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERPYW---DMSNQDVINAIEQDYRLPPPMDCPTALHQLM 244
Query: 247 KSMLRKNPEHRPTASDLL 264
+K+ RP ++
Sbjct: 245 LDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 67/256 (26%), Positives = 117/256 (45%), Gaps = 17/256 (6%)
Query: 21 IGRGAFGAAF-LVLHKIERKKYVLK-KIRLAKQTEKF-KRTAL-QEMDLISKL-NNPYIV 75
+G GAFG + + + V+K +++ K T +R AL E+ ++S L N+ IV
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR 135
A G + ++T YC GD+ +++ R + E L + Q+ + +L S
Sbjct: 103 NLLGA-CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161
Query: 136 VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN------YMCPELLADI 189
+HRDL N+ LT +++ DFGLA+ + + S+ V N +M PE + +
Sbjct: 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWMAPESIFNC 218
Query: 190 PYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247
Y ++SD+WS G ++EI + P P + I P + + I+K
Sbjct: 219 VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK 278
Query: 248 SMLRKNPEHRPTASDL 263
+ +P RPT +
Sbjct: 279 TCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 67/250 (26%), Positives = 114/250 (45%), Gaps = 19/250 (7%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAK--QTEKFKRTALQEMDLISKLNNPYIVKYK 78
IG G FG K+ K+ + I+ K TEK +R L E ++ + ++P I+ +
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
V K V IVT Y E G + ++K G F +L L + + YL +H
Sbjct: 72 GV-VTKSKPVMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSDMGYVH 129
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN------YMCPELLADIPYG 192
RDL NI + + ++ DFGL+++L ED + T + PE +A +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 193 YKSDIWSLGCCMFEIAAH--QPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQIIKS 248
SD+WS G M+E+ ++ +P + +M+ +I I P P+ + + Q++
Sbjct: 188 SASDVWSYGIVMWEVMSYGERPYW---EMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLD 244
Query: 249 MLRKNPEHRP 258
+K+ RP
Sbjct: 245 CWQKDRNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 69/285 (24%), Positives = 124/285 (43%), Gaps = 35/285 (12%)
Query: 12 LEDYEVIEQIGRGAFGAAFL--VLHKIERKKYV------LKKIRLAKQTEKFKRTALQEM 63
L +E++G GAFG + + ER LK+ K ++F+ QE
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR----QEA 59
Query: 64 DLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKA----RGACFPEEKLC 118
+L+S L +P IV K C++ Y GD+ E +++ + GA +E +
Sbjct: 60 ELMSDLQHPNIVCLLGV-CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 119 KWL---------TQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169
L Q+ ++YL S+ +HRDL N + + +++ DFGL++ + + D
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
Query: 170 ---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAGLIN 224
+ S + +M PE + + +SDIWS G ++EI ++ QP + + +I
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-VIE 237
Query: 225 KINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
I + P P + + ++ + P RP D+ H L
Sbjct: 238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI--HTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 36/283 (12%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLV----LHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLI 66
+ + + +G GAFG L V K+ TEK + EM+++
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 67 SKL-NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR---------GACFPEEK 116
+ + I+ +G +V Y G++ + ++ R PEE
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVE-YAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 117 L-CKWLTQLLLAV----DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171
L K L V ++L S + +HRDL N+ +T+D+ +++ DFGLA+ ++ D
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 172 SSVVGTPN------YMCPELLADIPYGYKSDIWSLGCCMFEI----AAHQPAFRAPDMAG 221
T N +M PE L D Y ++SD+WS G ++EI + P ++
Sbjct: 189 RK---TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245
Query: 222 LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
L+ + R P + + +++ + P RPT L+
Sbjct: 246 LLKEGYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 70/276 (25%), Positives = 117/276 (42%), Gaps = 40/276 (14%)
Query: 21 IGRGAFGAAFLV------LHKIERKKYVLKKIRLAKQTEKFKRTALQEMDL---ISKLNN 71
+G G FG + K R V K+ + TEK + EM++ I K N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARG---------ACFPEEKL----- 117
I+ A G IV Y G++ E ++ R PEE+L
Sbjct: 86 --IINLLGACTQDGPLYVIVE-YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 118 --CKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVV 175
C + Q+ ++YL S + +HRDL N+ +T+DN +++ DFGLA+ ++ D
Sbjct: 143 VSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 176 G---TPNYMCPELLADIPYGYKSDIWSLGCCMFEI----AAHQPAFRAPDMAGLINKINR 228
+M PE L D Y ++SD+WS G ++EI + P ++ L+ + +R
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 260
Query: 229 SSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
P ++ + +++ P RPT L+
Sbjct: 261 MD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 57/251 (22%), Positives = 118/251 (47%), Gaps = 10/251 (3%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNN 71
E ++++++G G FG ++ + K +K ++ + + F L+E +L+ L +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAF----LEEANLMKTLQH 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
+V+ A V K + I+T Y G + + +K G KL + Q+ + Y+
Sbjct: 61 DKLVRLY-AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTP-NYMCPELLADI 189
+HRDL+ +N+ +++ ++ DFGLA+++ + E A P + PE +
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 179
Query: 190 PYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248
+ KSD+WS G ++EI + + + + +++ + R P + I+K+
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKT 239
Query: 249 MLRKNPEHRPT 259
++ E RPT
Sbjct: 240 CWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 66/256 (25%), Positives = 118/256 (46%), Gaps = 19/256 (7%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKLNNPYIVKYK 78
IG G FG F + K+ +K V I+ K TEK ++ L E ++ + ++ I++ +
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
V K I+T Y E G + + ++ G F +L L + + YL +H
Sbjct: 73 GV-VTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN------YMCPELLADIPYG 192
RDL NI + + + ++ DFGL+++L ED T + PE +A +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 193 YKSDIWSLGCCMFEIAAH--QPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQIIKS 248
SD+WS G M+E+ + +P + DM+ ++ IN P P+ S + Q++
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYW---DMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQ 245
Query: 249 MLRKNPEHRPTASDLL 264
+++ RP D++
Sbjct: 246 CWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 39/229 (17%)
Query: 12 LEDYEVIEQIGRGAFGAAFLV-----LHKIERKKYVLK--------KIRLAKQTEKFKRT 58
L + VI+ + GAFG F+ + E ++ V + +AK+ + R
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 59 ALQ---EMDLISKLNNPYIVKYKDAWVDKGNCVCI-------VTGYCEGGDM----AEII 104
A+Q E+ + +LN+ I+K ++ + N I + + ++
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 105 KKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164
K+ R + QLL AV+Y+H +++HRD+K NIFL D I LGDFG A
Sbjct: 267 KQTR----------AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 165 LNTEDLASSV--VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQ 211
E A VGT PE+LA Y +DIWS G + ++ +H
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 60 LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
LQE ++ KL + +V+ ++ + IVT Y G + + +K G +L
Sbjct: 49 LQEAQVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 106
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTP 178
Q+ + Y+ +HRDL+ +NI + ++ ++ DFGLA+L+ + E A P
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166
Query: 179 -NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINK-----INRSSIS 232
+ PE + KSD+WS G + E+ R P G++N+ + R
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG---RVP-YPGMVNREVLDQVERGYRM 222
Query: 233 PLPIVYSSTMKQIIKSMLRKNPEHRPT 259
P P ++ ++ RK PE RPT
Sbjct: 223 PCPPECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 54/251 (21%), Positives = 108/251 (43%), Gaps = 21/251 (8%)
Query: 20 QIGRGAFGAAFLVLHKIER--KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
++G G FG ++K+++ K +K ++ K L+E +++ +L+NPYIV+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 78 -----KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
++W+ +V E G + + ++K + E+ + + + Q+ + + YL
Sbjct: 62 IGICEAESWM-------LVMELAELGPLNKFLQKNKHV--TEKNITELVHQVSMGMKYLE 112
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP----NYMCPELLAD 188
+HRDL N+ L + ++ DFGL+K L ++ + PE +
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 189 IPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247
+ KSD+WS G M+E ++ Q ++ + I P M ++K
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMK 232
Query: 248 SMLRKNPEHRP 258
+ RP
Sbjct: 233 LCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 62/272 (22%), Positives = 121/272 (44%), Gaps = 25/272 (9%)
Query: 20 QIGRGAFGAAFLV--LHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISKLNNPYIVK 76
++G GAFG FL + + + +L ++ K+ + R Q E +L++ L + +IV+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 77 YKDAWVDKGNCVCIVTGYCEGGDM----------AEIIKKARGACFPEEKLCKWL---TQ 123
+ + G + +V Y GD+ A+I+ + L + L +Q
Sbjct: 72 FYGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNY 180
+ + YL S +HRDL N + + +++GDFG+++ + + D + + +
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAGLINKINRSSISPLPIVY 238
M PE + + +SDIWS G ++EI + QP ++ + I I + P
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-IECITQGRELERPRTC 249
Query: 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
+ I++ ++ P+ R D+ H LQ
Sbjct: 250 PPEVYAIMQGCWQREPQQRMVIKDI--HSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 46/184 (25%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT 149
I+T + G++ + +++ L TQ+ A++YL +HRDL N +
Sbjct: 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138
Query: 150 KDNDIRLGDFGLAKLLNTEDLASSVVGTP---NYMCPELLADIPYGYKSDIWSLGCCMFE 206
+++ +++ DFGL++L+ T D ++ G + PE LA + KSD+W+ G ++E
Sbjct: 139 ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 197
Query: 207 IAAH----QPAFRAPDMAGLINK---INRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPT 259
IA + P + L+ K + R P P VY +++++ + NP RP+
Sbjct: 198 IATYGMSPYPGIDLSQVYELLEKGYRMERPEGCP-PKVY-----ELMRACWQWNPSDRPS 251
Query: 260 ASDL 263
+++
Sbjct: 252 FAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 75/284 (26%), Positives = 122/284 (42%), Gaps = 51/284 (17%)
Query: 19 EQIGRGAFGAAFL-VLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
++IG G FG L H+ K V+ K A T + LQE+ +LN+P +++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 78 KDAWVDKGNCV-----CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD--- 129
G C+ +V +C GD+ ++ RG ++ + +A +
Sbjct: 61 L------GQCIESIPYLLVLEFCPLGDLKNYLRSNRGM---VAQMAQKDVLQRMACEVAS 111
Query: 130 ---YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCP 183
+LH +H DL N LT D +++GD+GLA ED ++ P
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171
Query: 184 ELL---------ADIPYGYKSDIWSLGCCMFEI--AAHQPAFRAPDMAGL--INKINRSS 230
EL+ D KS+IWSLG M+E+ AA QP PD++ + ++ R
Sbjct: 172 ELVEIRGQDLLPKDQT--KKSNIWSLGVTMWELFTAADQP---YPDLSDEQVLKQVVREQ 226
Query: 231 ISPLP-----IVYSSTMKQIIKSMLRKNPEHRPTASD---LLRH 266
LP + YS ++++ +PE RPTA + LL +
Sbjct: 227 DIKLPKPQLDLKYSDRWYEVMQ-FCWLDPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 64/276 (23%), Positives = 121/276 (43%), Gaps = 40/276 (14%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKK----YVLKKIRLAKQTEKFKRTALQEMDLI 66
K +++ I+ +G GAFG + L E +K +K++R A + K + L E ++
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVM 63
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPE-----------E 115
+ ++NP+ VC + G C + I + C + +
Sbjct: 64 ASVDNPH--------------VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ 109
Query: 116 KLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVV 175
L W Q+ ++YL R++HRDL N+ + +++ DFGLAKLL ++
Sbjct: 110 YLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 176 G--TP-NYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQP--AFRAPDMAGLINKINR 228
G P +M E + Y ++SD+WS G ++E+ +P A +++ ++ K R
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 229
Query: 229 SSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
P P + + + I+ + + RP +L+
Sbjct: 230 ---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIV-KYKD 79
+G G FG + K K + +A + K T DL+S++ ++ K+K+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 80 AWVDKGNC-----VCIVTGYCEGGDMAEIIKKAR--------GAC-FPEEKL-CKWLT-- 122
G C + ++ Y G++ E ++ R C PEE+L K L
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 123 --QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVG---T 177
Q+ ++YL S + +HRDL N+ +T+DN +++ DFGLA+ ++ D
Sbjct: 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEI----AAHQPAFRAPDMAGLINKINRSSISP 233
+M PE L D Y ++SD+WS G ++EI + P ++ L+ + +R
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMD--- 256
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
P + + I++ P RPT L+
Sbjct: 257 KPANCTHELYMIMRECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 64/253 (25%), Positives = 111/253 (43%), Gaps = 19/253 (7%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
E+IGRG FG F + + +K R + K LQE ++ + ++P IV+
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRLI 59
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
K + IV +GGD ++ G ++L + + ++YL S +H
Sbjct: 60 GVCTQK-QPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVG----TP-NYMCPELLADIPYGY 193
RDL N +T+ N +++ DFG+++ ED + G P + PE L Y
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-----PLPIVYSSTMKQIIKS 248
+SD+WS G ++E + A A L N+ R +I P P + + ++++
Sbjct: 176 ESDVWSFGILLWEAF----SLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMER 231
Query: 249 MLRKNPEHRPTAS 261
+P RP+ S
Sbjct: 232 CWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 11/103 (10%)
Query: 111 CFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170
F + C + Q+ ++YL S R +HRDL N+ +T+DN +++ DFGLA+ ++ D
Sbjct: 132 SFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189
Query: 171 ASSVVGTPN------YMCPELLADIPYGYKSDIWSLGCCMFEI 207
T N +M PE L D Y ++SD+WS G M+EI
Sbjct: 190 YKK---TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 8/192 (4%)
Query: 20 QIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKR-TALQEMDLISKLNNPYIVKYK 78
++G G FG ++K+ +K+ + L + EK R ++E +++ +L+NPYIV+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
V + + +V GG + + + + + + + Q+ + + YL +H
Sbjct: 61 -IGVCEAEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTP-NYMCPELLADIPYGYK 194
RDL N+ L + ++ DFGL+K L +D A S P + PE + + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 195 SDIWSLGCCMFE 206
SD+WS G M+E
Sbjct: 179 SDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 53/189 (28%), Positives = 88/189 (46%), Gaps = 18/189 (9%)
Query: 90 IVTGYCEGGDMAEIIKKAR-GAC---FPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSN 145
++ + + GD+ + +R G C P + L K++T + ++YL S +HRDL N
Sbjct: 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARN 142
Query: 146 IFLTKDNDIRLGDFGLAKLLNTEDL--ASSVVGTP-NYMCPELLADIPYGYKSDIWSLGC 202
L ++ ++ + DFGL+K + D + P ++ E LAD Y KSD+WS G
Sbjct: 143 CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGV 202
Query: 203 CMFEIAAH----QPAFRAPDMAGLINKINRSSISP--LPIVYSSTMKQIIKSMLRKNPEH 256
M+EIA P ++ + + NR P L +YS ++ S NP+
Sbjct: 203 TMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYS-----LMSSCWLLNPKD 257
Query: 257 RPTASDLLR 265
RP+ L
Sbjct: 258 RPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/253 (23%), Positives = 111/253 (43%), Gaps = 15/253 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E ++ +++G G FG ++ + K+ ++ K L E +++ L +
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+VK A V K + I+T + G + + +K G+ P KL + Q+ + ++
Sbjct: 62 KLVKL-HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTP-NYMCPELLADIP 190
+HRDL+ +NI ++ ++ DFGLA+++ + E A P + PE +
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 191 YGYKSDIWSLGCCMFEIAAH----QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
+ KSD+WS G + EI + P P+ +I + R P P + I+
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALERGYRMPRPENCPEELYNIM 236
Query: 247 KSMLRKNPEHRPT 259
+ PE RPT
Sbjct: 237 MRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 69/286 (24%), Positives = 130/286 (45%), Gaps = 42/286 (14%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLV----LHKIERKKYV----LKKIRLAKQTEKFKRTALQE 62
K D + ++G GAFG FL L + K V LK LA + + F+R E
Sbjct: 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-FQR----E 57
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK---------------KA 107
+L++ L + +IVK+ D G+ + +V Y + GD+ + ++ +A
Sbjct: 58 AELLTNLQHEHIVKFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 108 RGACFPEEKLCKWL---TQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164
+G E L + L +Q+ + YL S +HRDL N + + +++GDFG+++
Sbjct: 117 KG----ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 172
Query: 165 LNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDM 219
+ + D + + +M PE + + +SD+WS G ++EI + QP F+ +
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN- 231
Query: 220 AGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
+I I + + P V + I+ ++ P+ R ++ +
Sbjct: 232 TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 63/257 (24%), Positives = 116/257 (45%), Gaps = 22/257 (8%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
E+IG+G FG + + K + V K R + KR LQE +++ + ++P IVK
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAV-KTCR-STLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
V K + IV GG + ++K + +KL + ++YL S +H
Sbjct: 59 GVCVQK-QPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-----LASSVVGTP-NYMCPELLADIPYG 192
RDL N + ++N +++ DFG+++ E+ ++ + P + PE L Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-----PLPIVYSSTMKQIIK 247
+SD+WS G ++E + G+ N+ R I P P + + +++
Sbjct: 174 SESDVWSYGILLWETF----SLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLML 229
Query: 248 SMLRKNPEHRPTASDLL 264
+PE+RP+ S++
Sbjct: 230 QCWAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 60 LQEMDLISKLNNPYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLC 118
L E ++ KL +P +++ Y A + IVT + G + E ++ G +L
Sbjct: 49 LAEAQIMKKLRHPKLIQLY--AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI 106
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP 178
Q+ + YL + +HRDL N+ + ++N ++ DFGLA+++ ED+ + G
Sbjct: 107 DMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK-EDIYEAREGAK 165
Query: 179 ---NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG--LINKINRSSISP 233
+ PE + KSD+WS G + EI + P M ++ ++++ P
Sbjct: 166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG-RMPYPGMTNAEVLQQVDQGYRMP 224
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPT 259
P + I+ +++P+ RPT
Sbjct: 225 CPPGCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 60/258 (23%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 21 IGRGAFGAAF--LVLHKIERKKY-VLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77
+G GAFG + + + E K V K+ + K + L E +++ + +PY+ +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 78 KDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
G C V +VT G + + +++ + + L W Q+ + YL
Sbjct: 75 L------GICLTSTVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMSYLEE 127
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP---NYMCPELLADIP 190
R++HRDL N+ + N +++ DFGLA+LL+ ++ G +M E +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 191 YGYKSDIWSLGCCMFEI----AAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
+ ++SD+WS G ++E+ A A ++ L+ K R P P + + + I+
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER---LPQPPICTIDVYMIM 244
Query: 247 KSMLRKNPEHRPTASDLL 264
+ E RP +L+
Sbjct: 245 VKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 28/255 (10%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK---FKRTA-LQEMDLISKLNNPY 73
++G G FG + ++A +T K A LQE ++ KL +
Sbjct: 11 ERKLGAGQFGEVW--------MGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDK 62
Query: 74 IVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+V+ Y A + + IVT Y G + + +K G +L Q+ + YL
Sbjct: 63 LVQLY--AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTP-NYMCPELLADIP 190
S +HRDL NI + ++ ++ DFGLA+L+ + E A P + PE
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA---AN 177
Query: 191 YG---YKSDIWSLGCCMFEIAAH-QPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQ 244
YG KSD+WS G + EI + + + P M ++ ++ R P P +
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPY--PGMTNREVLEQVERGYRMPRPPNCPEELYD 235
Query: 245 IIKSMLRKNPEHRPT 259
++ K+PE RPT
Sbjct: 236 LMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 59/247 (23%), Positives = 108/247 (43%), Gaps = 17/247 (6%)
Query: 20 QIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKD 79
++G+G FG ++ K I+ K LQE ++ KL + +V
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKV----AIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHR 139
++ + IVT + G + + +K+ G +L Q+ + Y+ +HR
Sbjct: 69 VVSEEP--IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 140 DLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTP-NYMCPELLADIPYGYKSDI 197
DL+ +NI + + ++ DFGLA+L+ + E A P + PE + KSD+
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 198 WSLGCCMFEIAAHQPAFRAPDMAGLINK-----INRSSISPLPIVYSSTMKQIIKSMLRK 252
WS G + E+ R P G++N+ + R P P ++ +++K +K
Sbjct: 187 WSFGILLTELVTKG---RVP-YPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKK 242
Query: 253 NPEHRPT 259
+P+ RPT
Sbjct: 243 DPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 112 FPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170
P + L K++ + L ++YL + +HRDL N L +D + + DFGL+K + + D
Sbjct: 110 LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY 169
Query: 171 -ASSVVGTP-NYMCPELLADIPYGYKSDIWSLGCCMFEIA 208
+ P ++ E LAD Y KSD+W+ G M+EIA
Sbjct: 170 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 52/215 (24%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 20 QIGRGAFGAAFLV-LHKI--ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVK 76
++G GAFG FL + + E+ K ++ L ++ ++ +E +L++ L + +IVK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 77 YKDAWVDKGNCVCIVTGYCEGGDMAEIIKK--------ARG---ACFPEEKLCKWLTQLL 125
+ V+ G+ + +V Y + GD+ + ++ A G A + ++ Q+
Sbjct: 72 FYGVCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMC 182
+ YL S +HRDL N + ++ +++GDFG+++ + + D + + +M
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190
Query: 183 PELLADIPYGYKSDIWSLGCCMFEIAAH--QPAFR 215
PE + + +SD+WSLG ++EI + QP ++
Sbjct: 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 62/281 (22%), Positives = 119/281 (42%), Gaps = 37/281 (13%)
Query: 19 EQIGRGAFGAAFLV----LHKIERKKYVLK-----------KIRLAKQTEKFKRTALQEM 63
E++G G FG L + K K + L K+ + + L+E+
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 64 DLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEK------- 116
++S+L +P I++ + + +C++T Y E GD+ + + + E+
Sbjct: 71 KIMSRLKDPNIIRLLAVCITS-DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 117 --LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LA 171
L TQ+ + YL S +HRDL N + K+ I++ DFG+++ L + D +
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEI---AAHQPAFRAPDMAGLINK--- 225
V +M E + + SD+W+ G ++EI QP + D + N
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEF 249
Query: 226 ---INRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDL 263
R P P + ++ +++ S R+N + RP+ ++
Sbjct: 250 FRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL--NTEDLAS 172
E L + Q+ +++L S + +HRDL NI L+++N +++ DFGLA+ + + + +
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 232
Query: 173 SVVGTP-NYMCPELLADIPYGYKSDIWSLGCCMFEI----AAHQPAFRAPDMAGLINKIN 227
P +M PE + D Y +SD+WS G ++EI A+ P + + ++
Sbjct: 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLK 290
Query: 228 RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+ P + + I+ NPE RPT S+L+
Sbjct: 291 EGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 63/273 (23%), Positives = 119/273 (43%), Gaps = 33/273 (12%)
Query: 18 IEQIGRGAFGAAF---LVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMDLISKLN 70
+E++G AFG + L L ++ + V LK I +Q +F+ QE L+++L+
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ----QEASLMAELH 65
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE--IIKKARG--ACFPEEK---------- 116
+P IV V + VC++ Y GD+ E I++ C +E
Sbjct: 66 HPNIVCLLGV-VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 117 -LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LAS 172
Q+ ++YL S+ +H+DL NI + + +++ D GL++ + + D +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAGLINKINRSS 230
+ +M PE + + SDIWS G ++EI + QP + + +I + +
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-VIEMVRKRQ 243
Query: 231 ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDL 263
+ P M ++ ++ P RP D+
Sbjct: 244 LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 61/252 (24%), Positives = 111/252 (44%), Gaps = 13/252 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNN 71
E ++I+++G G FG ++ K +K ++ + E F L+E ++ KL +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESF----LEEAQIMKKLRH 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
+V+ V + IVT Y G + + +K G L Q+ + Y+
Sbjct: 61 DKLVQLYA--VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTP-NYMCPELLADI 189
+HRDL+ +NI + ++ DFGLA+L+ + E A P + PE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQIIK 247
+ KSD+WS G + E+ + P M ++ ++ R P P ++ +++
Sbjct: 179 RFTIKSDVWSFGILLTELVT-KGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237
Query: 248 SMLRKNPEHRPT 259
+K+PE RPT
Sbjct: 238 QCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 37/180 (20%)
Query: 113 PEEKLCK-WLT---------QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162
+E L K LT Q+ +++L S + +HRDL NI L+++N +++ DFGLA
Sbjct: 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA 226
Query: 163 KLLNTEDLASSVVGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEI--- 207
+ + P+Y M PE + D Y +SD+WS G ++EI
Sbjct: 227 R---------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277
Query: 208 -AAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
A+ P + + ++ + P + M Q + P RPT S+L+ H
Sbjct: 278 GASPYPGVKIDEE--FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 61/251 (24%), Positives = 104/251 (41%), Gaps = 26/251 (10%)
Query: 24 GAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD 83
G LV+ ++ ++LK +R + + + + T I P +V V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLT-------IIPHCVPNMVCLHKYIVS 56
Query: 84 KGNCVCIVTGYCEGGDM-AEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLK 142
+ + V +V + EGG + + I K PEE + +W ++++A+D LH ++ RDL
Sbjct: 57 E-DSVFLVLQHAEGGKLWSHISKFLN---IPEECVKRWAAEMVVALDALHREGIVCRDLN 112
Query: 143 CSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGC 202
+NI L I+L F + ED Y PE+ D WSLG
Sbjct: 113 PNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGA 170
Query: 203 CMFEIAAHQPAFRA-PDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTA- 260
+FE+ + P +G IN + +P S + +++ +L+ NP R A
Sbjct: 171 ILFELLTGKTLVECHP--SG----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224
Query: 261 ----SDLLRHP 267
D+ HP
Sbjct: 225 VAGVEDIKSHP 235
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 27/215 (12%)
Query: 19 EQIGRGAFG----------AAFLVLHKIE---RKKYVLKKIRLAKQTEKFKRTALQEMDL 65
E++G G FG A FL E + V K+ A T+ + L+E+ +
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70
Query: 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDM------AEIIKKARGA----CFPEE 115
+S+L NP I++ V + +C++T Y E GD+ EI A
Sbjct: 71 MSRLKNPNIIRLLGVCV-SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 116 KLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LAS 172
L Q+ + YL S +HRDL N + I++ DFG+++ L + D +
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEI 207
V +M E + + SD+W+ G ++E+
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 33/236 (13%)
Query: 57 RTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR--GACF-- 112
R L E +L+ ++N+P+++K A G + IV Y + G + ++++R G +
Sbjct: 48 RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE-YAKYGSLRSFLRESRKVGPSYLG 106
Query: 113 ------------PEEK------LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDI 154
P+E+ L + Q+ + YL +++HRDL N+ + + +
Sbjct: 107 SDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKM 166
Query: 155 RLGDFGLAKLLNTED--LASSVVGTP-NYMCPELLADIPYGYKSDIWSLGCCMFEI---- 207
++ DFGL++ + ED + S P +M E L D Y +SD+WS G ++EI
Sbjct: 167 KISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226
Query: 208 AAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDL 263
P + L+ R P S M ++ + ++ P+ RPT +D+
Sbjct: 227 GNPYPGIAPERLFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 53/264 (20%), Positives = 116/264 (43%), Gaps = 19/264 (7%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTA--LQEMDLISK 68
E + ++G+G+FG + + K ++ + I+ + + L E ++ +
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARG--------ACFPEEKLCKW 120
N ++V+ V +G ++ GD+ ++ R A +K+ +
Sbjct: 66 FNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGT 177
++ + YL++N+ +HRDL N + +D +++GDFG+ + + D +
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAGLINKINRSSISPLP 235
+M PE L D + SD+WS G ++EIA A QP ++ ++ + + P
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGMSNEQVLRFVMEGGLLDKP 243
Query: 236 IVYSSTMKQIIKSMLRKNPEHRPT 259
+ ++++ + NP+ RP+
Sbjct: 244 DNCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 11/153 (7%)
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV 174
E L + Q+ + +L S +HRDL NI LT ++ DFGLA+ + + S+
Sbjct: 214 EDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND---SNY 270
Query: 175 VGTPN------YMCPELLADIPYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAGLINKI 226
V N +M PE + + Y ++SD+WS G ++EI + P P + I
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330
Query: 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPT 259
P S M I+KS +P RPT
Sbjct: 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPT 363
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 68/266 (25%), Positives = 104/266 (39%), Gaps = 57/266 (21%)
Query: 58 TALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEK 116
T LQ +SKL N+P IV Y+ ++ N + +VT + G ++I E
Sbjct: 44 TFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSFMAYGSAKDLICTHFMDGMSELA 102
Query: 117 LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRL-GDFGLAKLLNTEDLASSVV 175
+ L +L A+DY+H +HR +K S+I ++ D + L G ++N V
Sbjct: 103 IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162
Query: 176 GTPNY-------MCPELLADIPYGY--KSDIWSLGCCMFEIA-AHQPAFRAPDMAGLINK 225
P Y + PE+L GY KSDI+S+G E+A H P P L+ K
Sbjct: 163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222
Query: 226 IN--------------------------------------------RSSISPLPIVYSST 241
+N SS P +S
Sbjct: 223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282
Query: 242 MKQIIKSMLRKNPEHRPTASDLLRHP 267
++ L++NP+ RP+AS LL H
Sbjct: 283 FHHFVEQCLQRNPDARPSASTLLNHS 308
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 61/280 (21%), Positives = 111/280 (39%), Gaps = 37/280 (13%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMD------LI 66
+ ++ +G GAFG + L++ V ++++A +T + E D ++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAV--ELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL- 125
SK N+ IV+ ++ I+ GGD+ +++ R PE + LL
Sbjct: 64 SKFNHQNIVRLIGVSFER-LPRFILLELMAGGDLKSFLRENRPR--PERPSSLTMKDLLF 120
Query: 126 LAVD------YLHSNRVLHRDLKCSNIFLT---KDNDIRLGDFGLAKLLNTEDL---ASS 173
A D YL N +HRD+ N LT ++ DFG+A+ +
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 174 VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-------HQPAFRAPDMAGLINKI 226
+ +M PE D + K+D+WS G ++EI + + + ++
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240
Query: 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+ P P VY +I+ + PE RP + +L
Sbjct: 241 DPPKGCPGP-VY-----RIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 43/196 (21%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVLK-KIRLAKQTEKFKRTA--LQEMDLISKLNNPYI 74
++ +G GAFG + + E + + I++ +T K + E +++ +++P++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V+ + + +VT G + + + + + + L W Q+ + YL
Sbjct: 72 VRLLGVCLSP--TIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEER 128
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP---NYMCPELLADIPY 191
R++HRDL N+ + N +++ DFGLA+LL ++ + G +M E + +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 192 GYKSDIWSLGCCMFEI 207
++SD+WS G ++E+
Sbjct: 189 THQSDVWSYGVTIWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 37/284 (13%)
Query: 14 DYEVIEQIGRGAFGAAF----LVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL 69
+ E + IG+GAFG F L E V K+ + + + +E L+++
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK---------------KARGACFPE 114
++P IVK G +C++ Y GD+ E ++ AR
Sbjct: 66 DHPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 115 EKLCKWLTQLLLAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168
L QL +A YL + +HRDL N + ++ +++ DFGL++ + +
Sbjct: 125 LPLSC-TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 169 DL--ASSVVGTP-NYMCPELLADIPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAG-- 221
D AS P +M PE + Y +SD+W+ G ++EI ++ QP + MA
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY---GMAHEE 240
Query: 222 LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
+I + ++ P + +++ K P RP+ + + R
Sbjct: 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 60/219 (27%)
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRL-GDFGLAKLLNTEDLASSVVGTPNY--- 180
L ++YLH N +HR++K S+I ++ D + L G L L+ A V P +
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 181 ----MCPELLADIPYGY--KSDIWSLGCCMFEIAAHQPAFRAPDM--------------- 219
+ PELL YGY KSDI+S+G E+A + F+ DM
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ--DMLRTQMLLQKLKGPPY 228
Query: 220 -------------------AGLINKINRSSI--------------SPLPIVYSSTMKQII 246
+G+ + I S + +P +S + ++
Sbjct: 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV 288
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLP 285
+ L+++PE RP+AS LL H + + Q LP
Sbjct: 289 ELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGSILSLLP 327
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 59/254 (23%), Positives = 109/254 (42%), Gaps = 15/254 (5%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
E +G+G FG F ++ K V K ++ K L E ++ + ++P IVK
Sbjct: 1 ELLGKGNFGEVFK--GTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
+ + IV GGD ++K + ++L K+ + YL S +H
Sbjct: 59 GVCTQR-QPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS-VVGTP-NYMCPELLADIPYGYKSD 196
RDL N + ++N +++ DFG+++ + +SS + P + PE L Y +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 197 IWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-----PLPIVYSSTMKQIIKSMLR 251
+WS G ++E + G+ N+ R + P + ++++
Sbjct: 177 VWSYGILLWETF----SLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD 232
Query: 252 KNPEHRPTASDLLR 265
PE+RP S+L +
Sbjct: 233 YKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 27/166 (16%)
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV 174
E L + Q+ +++L S + +HRDL NI L+++N +++ DFGLA+ +
Sbjct: 174 EDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---------DI 224
Query: 175 VGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEI----AAHQPAFRAPD 218
P+Y M PE + D Y +SD+WS G ++EI A+ P + +
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284
Query: 219 MAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
++ + P + + +I+ + + +P+ RPT S L+
Sbjct: 285 --EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 64/282 (22%), Positives = 119/282 (42%), Gaps = 46/282 (16%)
Query: 19 EQIGRGAFGAAFL--VLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY-IV 75
++IG G FG L V + V+K++R++ + ++M + + PY +
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-------SVQEQMKFLEEAQ-PYRSL 52
Query: 76 KYKDAWVDKGNCV-----CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD- 129
++ + G C +V +C GD+ ++ R A E T +A +
Sbjct: 53 QHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKA---ELMTPDPTTLQRMACEI 109
Query: 130 -----YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--LASSVVGTP-NYM 181
+LH N +H DL N LT D +++GD+GL+ ED + + P ++
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI 169
Query: 182 CPELLADI-------PYGYKSDIWSLGCCMFEI--AAHQPAFRAPDMAGLINKINRSSIS 232
PEL+ ++ +S++WSLG ++E+ QP D L + +
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK 229
Query: 233 -PLP---IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
P P + S ++++ + PE RP+A ++ HL
Sbjct: 230 LPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV----HLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 113 PEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-- 170
P + L +++ + ++YL S +HRDL N L ++ + + DFGL+K + + D
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR 170
Query: 171 ASSVVGTP-NYMCPELLADIPYGYKSDIWSLGCCMFEIA 208
P ++ E LAD Y SD+W+ G M+EI
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 59/260 (22%), Positives = 110/260 (42%), Gaps = 19/260 (7%)
Query: 19 EQIGRGAFGAAF----LVLHKIERKKYV--LKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
IG+G FG + + + V L +I ++ E+F L+E ++ ++P
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQF----LKEGIIMKDFSHP 56
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEK-LCKWLTQLLLAVDYL 131
++ + +V Y + GD+ I+ P K L + Q+ ++YL
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN--PTVKDLIGFGLQVAKGMEYL 114
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS----SVVGTP-NYMCPELL 186
S + +HRDL N L + +++ DFGLA+ + ++ S + P +M E L
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245
+ KSD+WS G ++E+ P + D + + + P + ++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234
Query: 246 IKSMLRKNPEHRPTASDLLR 265
+ S PE RPT S+L+
Sbjct: 235 MLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 55/283 (19%)
Query: 19 EQIGRGAFGAAFL--VLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVK 76
++IG G FG L + + V+K+++ A + K + LQ+ D L +P I++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELK-ANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 77 YKDAWVDKGNCV-----CIVTGYCEGGDM-------------AEIIKKARGACFPEEKLC 118
G CV +V YCE GD+ ++++ R AC
Sbjct: 60 CL------GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC------- 106
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS---VV 175
++ V ++H + LH DL N FLT D +++GD+G+ ED +
Sbjct: 107 ----EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC 162
Query: 176 GTPNYMCPELLADIPYGY-------KSDIWSLGCCMFEI--AAHQPAFRAPDMAGLINKI 226
++ PEL+ + G S++W+LG ++E+ A QP D L + I
Sbjct: 163 VPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI 222
Query: 227 NRSSIS----PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
+ L + YS ++++ +PE R TA ++ R
Sbjct: 223 KDQQVKLFKPQLELPYSERWYEVLQ-FCWLSPEKRATAEEVHR 264
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 19 EQIGRGAFGAAFLV-------LHKIE--------RKKYVLKKIRLAKQTEKFKRTALQEM 63
E++G G FG L L ++ R V KI + + L+E+
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 64 DLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEII-------KKARGA------ 110
++S+L +P I++ VD+ + +C++T Y E GD+ + + K+ G
Sbjct: 71 KILSRLKDPNIIRLLGVCVDE-DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 111 -CFPE---EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166
C P L Q+ + YL S +HRDL N + ++ I++ DFG+++ L
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 167 TED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEI 207
D + V +M E + + SD+W+ G ++EI
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 16/221 (7%)
Query: 4 ENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEM 63
+N ++S + Y++ IG G+FG + + +K +KK+ Q ++K +E+
Sbjct: 57 DNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL---QDPQYKN---REL 110
Query: 64 DLISKLNNPYIVKYKDAWV-------DKGNCVCIVTGYCEGGDMAEIIKKARG-ACFPEE 115
++ LN+ I+ KD + +K + +V + + AR P
Sbjct: 111 LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF 170
Query: 116 KLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT-KDNDIRLGDFGLAKLLNTEDLASSV 174
+ + QL A+ Y+HS + HRDLK N+ + + ++L DFG AK L + S
Sbjct: 171 LVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY 230
Query: 175 VGTPNYMCPEL-LADIPYGYKSDIWSLGCCMFEIAAHQPAF 214
+ + Y PEL L Y D+WSLGC + E+ P F
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 51/216 (23%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKL- 69
ED + + IG G FG + K + K + I++ K+ +E R E++++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLK-MNAAIKMLKEFASENDHRDFAGELEVLCKLG 60
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEE 115
++P I+ A ++G + I Y G++ + ++K+R + +
Sbjct: 61 HHPNIINLLGACENRGY-LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 116 KLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVV 175
+L ++ + + + YL + +HRDL N+ + ++ ++ DFGL++ E +
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTM 177
Query: 176 G--TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA 209
G +M E L Y KSD+WS G ++EI +
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 43/180 (23%), Positives = 82/180 (45%), Gaps = 26/180 (14%)
Query: 53 EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEII-------- 104
E+FK A+ + S+L +P IV V K + ++ YC D+ E +
Sbjct: 53 EEFKHEAM----MRSRLQHPNIVCLLGV-VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSD 107
Query: 105 -------KKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLG 157
K + P + + +TQ+ +++L S+ V+H+DL N+ + ++++
Sbjct: 108 VGSTDDDKTVKSTLEPADFV-HIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKIS 166
Query: 158 DFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH--QP 212
D GL + + D L + + +M PE + + SDIWS G ++E+ ++ QP
Sbjct: 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELL 186
YL++ + +HRDL N + D +++GDFG+ + + D + +M PE L
Sbjct: 134 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193
Query: 187 ADIPYGYKSDIWSLGCCMFEIA--AHQP 212
D + SD+WS G ++EI A QP
Sbjct: 194 KDGVFTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 47/208 (22%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKL-NNPYIVKY 77
IG G FG K + + + I+ K+ ++ R E++++ KL ++P I+
Sbjct: 3 IGEGNFGQVLKARIKKDGLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQ 123
A +G + + Y G++ + ++K+R + ++L +
Sbjct: 62 LGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVG--TPNYM 181
+ +DYL + +HRDL NI + ++ ++ DFGL++ E +G +M
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWM 178
Query: 182 CPELLADIPYGYKSDIWSLGCCMFEIAA 209
E L Y SD+WS G ++EI +
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK-LLNTEDLASS 173
+ L ++ +Q+ +D+L S +HRD+ N+ LT ++ DFGLA+ ++N D
Sbjct: 212 DDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN--DSNYV 269
Query: 174 VVGTP----NYMCPELLADIPYGYKSDIWSLGCCMFEI 207
V G +M PE + D Y +SD+WS G ++EI
Sbjct: 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 51/219 (23%), Positives = 101/219 (46%), Gaps = 37/219 (16%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP-- 72
++++ +G G FG V+ +RK+ +++ + K+ R A E+ + K+
Sbjct: 131 FKILSLLGEGTFGK---VVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187
Query: 73 ----YIVKYKDAWVDKGNCVCIVT---GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
++K + + ++ +CIV G C + + I K G F L + + Q
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKYGPC----LLDWIMK-HGP-FSHRHLAQIIFQTG 241
Query: 126 LAVDYLHSN-RVLHRDLKCSNIFL-TKDNDI---------------RLGDFGLAKLLNTE 168
+A+DY H+ ++H DLK NI + T D + R+ D G +
Sbjct: 242 VALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG--GCCDER 299
Query: 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEI 207
+++V T +Y PE++ + + Y +D+WS+GC ++E+
Sbjct: 300 HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 4/98 (4%)
Query: 174 VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP 233
++GTP+Y+ PELL P+G D W+LG C+FE P F + I I P
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-P 598
Query: 234 LPI---VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPH 268
P S + I+ +L +P R +L +HP
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 117 LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK-LLNTEDLAS--S 173
L + Q+ +++L S +HRDL N+ L + +++ DFGLA+ +++ + S S
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 174 VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEI 207
+M PE + D Y SD+WS G ++EI
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 55/251 (21%), Positives = 107/251 (42%), Gaps = 13/251 (5%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRL--AKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
+G G FG K+ K+ + I A ++K +R L E + + ++ IV+ +
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138
+ +GN + IVT Y G + ++K G +L L L + YL +H
Sbjct: 73 GV-ITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMGYVH 130
Query: 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN--YMCPELLADIPYGYKSD 196
+ L + + D ++ F + +E + +++ G + PE + + SD
Sbjct: 131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASD 190
Query: 197 IWSLGCCMFEIAAH--QPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQIIKSMLRK 252
+WS G M+E+ ++ +P + DM+G +I + P P + + Q++ +K
Sbjct: 191 VWSFGIVMWEVMSYGERPYW---DMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQK 247
Query: 253 NPEHRPTASDL 263
RP S +
Sbjct: 248 ERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 59/277 (21%), Positives = 115/277 (41%), Gaps = 36/277 (12%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ--------EMDL 65
D + + IG G FG VL +K +R+ ++ K A + E+++
Sbjct: 8 DIKFQDVIGEGNFGQ---VLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 66 ISKLN-NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR--------------GA 110
+ KL +P I+ A +G + + Y G++ + ++K+R +
Sbjct: 61 LCKLGHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 111 CFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170
++L + + +DYL + +HRDL NI + ++ ++ DFGL++ E
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVY 177
Query: 171 ASSVVG--TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKIN 227
+G +M E L Y SD+WS G ++EI + + A L K+
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237
Query: 228 RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
+ P+ + +++ R+ P RP+ + +L
Sbjct: 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 47/217 (21%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 62 EMDLISKLNNPYIVKYKDAWVDKGNCVC---IVTGYCEGGDMAEIIKKARGACFPEEKLC 118
E+ + ++++ I+K +D + + ++ YC G + E++ K EK
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK--------EKDL 119
Query: 119 KWLTQLLLAVD--------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170
+ T+L +A+D Y ++N+ +++L + +T++ +++ GL K+L++
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176
Query: 171 ASSVVGTPNYMCPELLADI--PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR 228
V Y ++L DI Y K DI+SLG ++EI + F + + I
Sbjct: 177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN 236
Query: 229 SSIS-PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
+ S LP+ +K I+++ + RP ++L
Sbjct: 237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 7/174 (4%)
Query: 96 EGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIR 155
E +I ++ + + L + Q+ +++L S +HRDL N+ + + ++
Sbjct: 222 ERTRRDTLINESPALSYMD--LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVK 279
Query: 156 LGDFGLAK--LLNTEDLASSVVGTP-NYMCPELLADIPYGYKSDIWSLGCCMFEI--AAH 210
+ DFGLA+ + ++ ++ P +M PE + + Y SD+WS G ++EI
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339
Query: 211 QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
P P N I R P S + +I++ + E RP S L+
Sbjct: 340 TPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 31/165 (18%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ------TEKFK--RTALQEMDLISKL--- 69
I RGA A + L K V+K R+ K+ E+ + RT E ++S+
Sbjct: 4 IKRGA--EAEIYLGDFLGIKAVIK-WRIPKRYRHPELDERIRRERTRR-EARIMSRARKA 59
Query: 70 --NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
N P + +VD N + IV Y EG + ++I + + ++
Sbjct: 60 GVNVPAVY-----FVDPENFI-IVMEYIEGEPLKDLINS------NGMEELELSREIGRL 107
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLA 171
V LHS ++H DL SN+ L+ I L DFGLA+ ED A
Sbjct: 108 VGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSKDLEDRA 151
|
Length = 211 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 23/90 (25%), Positives = 43/90 (47%), Gaps = 3/90 (3%)
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTP 178
Q+ + YLH V+H+D+ N + ++ +++ D L++ L D L +
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIA 208
+M E L + Y SD+WS G ++E+
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 5e-05
Identities = 47/165 (28%), Positives = 69/165 (41%), Gaps = 34/165 (20%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAK--QTEKF------KRTALQEMDLISKL--- 69
I +GA A + L K V+K R+ K + + +RT E L+S+
Sbjct: 2 IAKGA--EAIIYLGDFLGLKAVIK-ERVPKSYRHPELDERIRRERTRN-EARLLSRARKA 57
Query: 70 --NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
N P + D D IV Y EG + ++I EE + L ++
Sbjct: 58 GVNTPVVY---DVDPDNKT---IVMEYIEGKPLKDVI---------EEGNDELLREIGRL 102
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLA 171
V LH ++H DL SNI + D+ + L DFGL K + ED A
Sbjct: 103 VGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDEIEDKA 146
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 43/226 (19%), Positives = 82/226 (36%), Gaps = 28/226 (12%)
Query: 53 EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC----IVTGYCEGGDMAEIIKKAR 108
F TA L+S+L++ ++VK G CV +V Y + G + + + +
Sbjct: 46 LAFFETA----SLMSQLSHKHLVKLY------GVCVRDENIMVEEYVKFGPLDVFLHREK 95
Query: 109 GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-------DIRLGDFGL 161
QL A+ YL +++H ++ NI + + I+L D G+
Sbjct: 96 N-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154
Query: 162 AK-LLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPA-FRAPDM 219
+L+ E+ + A + +D WS G + EI ++
Sbjct: 155 PITVLSREERVERIPWIAPECIRNGQASLTIA--ADKWSFGTTLLEICSNGEEPLSTLSS 212
Query: 220 AGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
+ LP+ + + +I +P RP+ +LR
Sbjct: 213 SEKERFYQDQHR--LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 53/298 (17%)
Query: 16 EVIEQIGRGAFGA-----AFLVLHKIERKKY-----------VLKKIRLAKQTEKFKRTA 59
+E++G G FG A + E+ +K +R ++ +
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLR-PDASDNAREDF 66
Query: 60 LQEMDLISKLNNPYIVKYKDAWVDKGNCV-----CIVTGYCEGGDMAEIIKKARGA---- 110
L+E+ ++S+L++P I + G C C++ Y E GD+ + ++K
Sbjct: 67 LKEVKILSRLSDPNIARLL------GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 111 -----CFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165
L TQ+ + YL S +HRDL N + K+ I++ DFG+++ L
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 166 NTEDLASSVVGTP----NYMCPELLADIPYGYKSDIWSLGCCMFEI---AAHQPAFRAPD 218
+ D V G +M E + + KSD+W+ G ++EI QP D
Sbjct: 181 YSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239
Query: 219 ------MAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
R P P + +++ R++ E RPT ++ H LQ
Sbjct: 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 34/165 (20%)
Query: 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAK--------QTEKFKRTALQEMDLISKL--- 69
I +GA A + L V+K R+ K + + +RT E +++K
Sbjct: 4 IKQGA--EAIIYLTDFLGLPAVVK-ERIPKRYRHPELDEKLRRERTRR-EARILAKAREA 59
Query: 70 --NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
P + VD N + IV Y EG + + +++AR L + + +L
Sbjct: 60 GVPVPIVYD-----VDPDNGL-IVMEYIEGELLKDALEEARP------DLLREVGRL--- 104
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLA 171
V LH ++H DL SNI L+ I DFGL + + ED A
Sbjct: 105 VGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVEDKA 148
|
Length = 204 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 31/116 (26%), Positives = 47/116 (40%), Gaps = 13/116 (11%)
Query: 98 GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLG 157
+A+I++ RG EE++ Q L A+ LH NI LT D L
Sbjct: 1 VSLADILE-VRGRPLNEEEIWAVCLQCLGALRELHRQAKSG------NILLTWD--GLLK 51
Query: 158 DFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPA 213
G E P +M PE++ Y K+DI+SLG ++E ++
Sbjct: 52 LDGSVAFKTPEQS----RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|233044 TIGR00600, rad2, DNA excision repair protein (rad2) | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 42/207 (20%), Positives = 69/207 (33%), Gaps = 17/207 (8%)
Query: 255 EHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKH---NSRKDKG 311
E P A L PS + + + + E+T K SS+ + R+DK
Sbjct: 482 EAVPKAVQSLLLG-ATNDS---PIPSEFTILDRKSELSIERTVKPVSSEFGLPSQREDKL 537
Query: 312 EREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKKVDPTSYTMEVSSS 371
L+ + + Q PL+ K S + D +P M SS
Sbjct: 538 AIPTEGTQNLQGISDHPEQFEFQNELSPLETKNNESNLSSDAETEGSPNP---EMPSWSS 594
Query: 372 INDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDV 431
+ E ET++ S K+ TG T+ + I P E ++
Sbjct: 595 VTVPSEALDNYETTNPSNAKEVRNFAETGIQTTNVGESADLLLISNP-----MEVEPMES 649
Query: 432 ETVKSKDQNPFS--DRVIEEADIEGES 456
E +S+ F D V +++ S
Sbjct: 650 EKEESESDGSFIEVDSVSSTLELQVPS 676
|
All proteins in this family for which functions are known are flap endonucleases that generate the 3' incision next to DNA damage as part of nucleotide excision repair. This family is related to many other flap endonuclease families including the fen1 family. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 1034 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 644 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.44 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.44 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.33 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.13 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.9 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.87 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.82 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.69 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.66 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.58 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.56 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.45 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.45 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.18 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.15 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.1 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.0 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.94 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.79 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.74 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 96.72 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 96.54 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.5 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.36 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.06 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.03 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.95 | |
| PLN02236 | 344 | choline kinase | 95.74 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.46 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.41 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.37 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.56 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.48 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.28 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.72 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.44 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.39 | |
| PTZ00183 | 158 | centrin; Provisional | 92.96 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.94 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.87 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-55 Score=460.19 Aligned_cols=261 Identities=33% Similarity=0.515 Sum_probs=230.6
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH-----HHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK-----FKRTALQEMDLISKLNNPYIVKYKDAWV 82 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~-----~~~~~~rEi~iL~~L~HPNIVkl~~~~~ 82 (644)
.+...+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+...... -.....+|++||++|+|||||+++++|.
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 34677889999999999999999999999999999999987654321 1234578999999999999999999875
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC---CCeEEecc
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD---NDIRLGDF 159 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~---g~vKL~DF 159 (644)
. ..++||||||++||+|.+.+-.. +.+.+..-+.+++||+.||.|||++||+||||||+|||++.+ ..+||+||
T Consensus 247 ~-~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 247 V-PDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred c-CCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence 5 56789999999999999999764 458888999999999999999999999999999999999876 67999999
Q ss_pred CcccccccccccccccCCCCCCChhhhcCCCC---CcccchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHhccCCCCCC
Q 006460 160 GLAKLLNTEDLASSVVGTPNYMCPELLADIPY---GYKSDIWSLGCCMFEIAAHQPAFRAPDMAG-LINKINRSSISPLP 235 (644)
Q Consensus 160 Gls~~~~~~~~~~~~~GT~~Y~APEvl~~~~y---s~ksDIWSLGvILyeLltG~~PF~~~~~~e-l~~~i~~~~~~~~p 235 (644)
|+|+..+...++.++||||.|.|||++.+.++ ..++||||||||||-+++|.+||....... +.+.|.++.+...|
T Consensus 324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 99999998899999999999999999987663 458899999999999999999998776555 77788877665544
Q ss_pred ---ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 236 ---IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 236 ---~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..++++..+||++||..||+.|||++++|+||||+.
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 557999999999999999999999999999999974
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=449.38 Aligned_cols=261 Identities=32% Similarity=0.608 Sum_probs=241.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
....++.+.++.||+|..|+||+|.|+.|++.+|+|.+. ....+...+++.+|+++|++++|||||.+|++|+..+..+
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 345568899999999999999999999999999999994 4455677899999999999999999999999999866569
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+||+|.++++.. +.++|..+..++.+|++||.|||+ ++||||||||+|||++..|.|||||||.+..+..
T Consensus 154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999999874 469999999999999999999996 8999999999999999999999999999998766
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhccCCCCCCcc-ccHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-----DMAGLINKINRSSISPLPIV-YSST 241 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~-----~~~el~~~i~~~~~~~~p~~-~s~~ 241 (644)
. ...+++||..|||||.+.+..|+.++||||||+.++||++|+.||... +..+++..|.....+.+|.. +|++
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~e 310 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPE 310 (364)
T ss_pred h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHH
Confidence 5 778999999999999999999999999999999999999999999774 67889999999888889997 9999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+++||..||++||.+|||+.|+++|||++.+.
T Consensus 311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 99999999999999999999999999998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-54 Score=446.26 Aligned_cols=279 Identities=31% Similarity=0.560 Sum_probs=254.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH-HHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK-FKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~-~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
....++|++++.||+|+||.||+|+.+.+++.||+|++++....+. ..+....|..||.+++||.||+++..|++. ..
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~-~k 99 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE-EK 99 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC-Ce
Confidence 3568999999999999999999999999999999999988764443 567788999999999999999999999885 56
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc-cc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LN 166 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~-~~ 166 (644)
+|+|+||+.||.|...|++ .+.|+|..++.|+..|+.||.|||++|||||||||+||||+.+|+++|+||||++. ..
T Consensus 100 LylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999999986 44699999999999999999999999999999999999999999999999999995 45
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
.+....++|||+.|||||++.+.+|+..+|+||||+++|+|++|.+||.+.+.....++|.+......|..++.++++|+
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 55667889999999999999999999999999999999999999999999999999999999988888888999999999
Q ss_pred HHHhccCCCCCC----CHHHHhhCCCCchhhhhcCCCCCcccCCCccc
Q 006460 247 KSMLRKNPEHRP----TASDLLRHPHLQPYLLRCQNPSSVYLPIKPTN 290 (644)
Q Consensus 247 ~~~L~~dP~~Rp----Ta~eiL~hp~f~~~~~~~~~~~~~~~p~~p~~ 290 (644)
+++|.+||.+|. ++.+|-+||||..+.|+.........|+.|..
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~ 305 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNV 305 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCC
Confidence 999999999995 68999999999999888766666666666654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=459.16 Aligned_cols=254 Identities=31% Similarity=0.597 Sum_probs=236.6
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.+|+..+.||+|||+.||.+.+..+|..||+|++.+.. ......+.+.+||+|.++|+|||||+++++|.+ .+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-s~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-SNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-CCceEEE
Confidence 56999999999999999999999999999999997753 344557788999999999999999999998877 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~ 170 (644)
.|+|..++|..++++ ...++|.+++.|++||+.||.|||+++|||||||..|+||+.+.+|||+|||||..+... ..
T Consensus 97 LELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 97 LELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 999999999999985 456999999999999999999999999999999999999999999999999999988744 67
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHh
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L 250 (644)
..+.||||.|+|||++...+++..+||||+||+||-||.|+|||+..+..+.+.+|....+. .|..++.++++||.+||
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~-~P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS-MPSHLSAEAKDLIRKLL 253 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc-cccccCHHHHHHHHHHh
Confidence 88999999999999999999999999999999999999999999999999999999887765 78899999999999999
Q ss_pred ccCCCCCCCHHHHhhCCCCc
Q 006460 251 RKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~hp~f~ 270 (644)
..||.+|||+++||.|+||.
T Consensus 254 ~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 254 RPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred cCCcccCCCHHHHhcCHhhh
Confidence 99999999999999999993
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=433.43 Aligned_cols=264 Identities=31% Similarity=0.616 Sum_probs=243.0
Q ss_pred CCCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 5 NGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 5 ~~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
.|.++..+++|.+.++||.|+||+||+|+++.++..||||.+.+.....+..+.+..|++||+.|+|||||++++++..
T Consensus 2 ~~~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~- 80 (429)
T KOG0595|consen 2 AGGSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED- 80 (429)
T ss_pred CCCcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-
Confidence 3556778899999999999999999999999999999999999887777778889999999999999999999997655
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC------CCeEEec
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD------NDIRLGD 158 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~------g~vKL~D 158 (644)
++++|||||||+||+|.+||++.+ .++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 678999999999999999998743 59999999999999999999999999999999999999865 3589999
Q ss_pred cCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC--CCCCCc
Q 006460 159 FGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS--ISPLPI 236 (644)
Q Consensus 159 FGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~--~~~~p~ 236 (644)
||+|+.+.+.....+.||+|.|||||++....|+.|+|+||+|+|+|+|++|++||...+..+++..+.+.. .+..+.
T Consensus 159 FGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 159 FGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred cchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 999999999889999999999999999999999999999999999999999999999999999999887653 345566
Q ss_pred cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..+..+.+++...|..+|..|.++.+-+.|+++..
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 67888889999999999999999999999998853
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-52 Score=420.03 Aligned_cols=261 Identities=27% Similarity=0.513 Sum_probs=230.9
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
|+.|+.+.++|+|+||+||+|+++.||+.||||++.-...++...+..+||+++|++|.|||+|.++++|..+ +.+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-rklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-RKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-ceeEEE
Confidence 5789999999999999999999999999999999988888888899999999999999999999999998764 569999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-cccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~ 170 (644)
+|||+. ++.+.+...+. .++++.+..|++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+. +++.
T Consensus 80 FE~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eeecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 999976 45455555443 48999999999999999999999999999999999999999999999999999887 7778
Q ss_pred cccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC---------------
Q 006460 171 ASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL--------------- 234 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~--------------- 234 (644)
++..+.|.||+|||++.+ ..|+..+|||++||++.||++|.|.|.+.+..+++..|......-+
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 888999999999998877 7899999999999999999999999999998888777644211110
Q ss_pred -----C----------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhh
Q 006460 235 -----P----------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 235 -----p----------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~ 275 (644)
| ..++.-+.+|+++||..||.+|++.+++|.||||..+..+
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence 1 1135678899999999999999999999999999887655
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=409.66 Aligned_cols=273 Identities=27% Similarity=0.514 Sum_probs=249.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
..+++|++++.||.|+||.|.+++++.+|..||+|++.+... .-+..+...+|.++|+.+.||.++++++.|.+ .+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~l 119 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNL 119 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CCeE
Confidence 678999999999999999999999999999999999987643 33455678899999999999999999999988 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
||||||++||.|..++++. ++|++..++.|+.||+.||+|||+++|++|||||+|||||++|.+||+|||.|......
T Consensus 120 ymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999999874 45999999999999999999999999999999999999999999999999999986653
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
..+.||||.|+|||++...+|+.++|+|+|||++|||+.|.+||...+...+.++|..+... +|..++.++++||++
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK-FPSYFSSDAKDLLKK 274 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc-CCcccCHHHHHHHHH
Confidence 78899999999999999999999999999999999999999999999999999999988765 799999999999999
Q ss_pred HhccCCCCC-----CCHHHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 249 MLRKNPEHR-----PTASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 249 ~L~~dP~~R-----pTa~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
+|+.|-.+| ....+|..||||....|.......+..|..|
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 999999999 4678999999999877776555566666666
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-50 Score=432.88 Aligned_cols=258 Identities=30% Similarity=0.592 Sum_probs=235.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc---HHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT---EKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKG 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~ 85 (644)
...+.|++.+.||+|+||.|++|++..++..||+|++.+.... ....+.+.||+.+++.+. ||||+++++++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 5678999999999999999999999999999999988765211 234566778999999998 99999999998764
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-CCeEEeccCcccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLAKL 164 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-g~vKL~DFGls~~ 164 (644)
..+|||||||.||+|.+++.. .+++.|.+++.+++||++|+.|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 559999999999999999987 4569999999999999999999999999999999999999999 9999999999998
Q ss_pred c-ccccccccccCCCCCCChhhhcCCC-C-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccc-cH
Q 006460 165 L-NTEDLASSVVGTPNYMCPELLADIP-Y-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY-SS 240 (644)
Q Consensus 165 ~-~~~~~~~~~~GT~~Y~APEvl~~~~-y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~-s~ 240 (644)
. .......+.|||+.|+|||++.+.. | +.++||||+||+||.|++|..||...+...+...|....+. +|..+ |.
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~-~p~~~~S~ 249 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK-IPSYLLSP 249 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc-CCCCcCCH
Confidence 8 5667889999999999999999988 8 58999999999999999999999999999999988776654 77778 99
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
++++|+.+||..||.+|+|+.+|+.||||+.
T Consensus 250 ~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 250 EARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-52 Score=416.27 Aligned_cols=250 Identities=38% Similarity=0.736 Sum_probs=231.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeee-EEEeCCceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKD-AWVDKGNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~-~~~d~~~~~~ 89 (644)
.+.+|+|.++||+|+||.||+|.+..+|..+|.|.+.....+.+....+..|+.+|++|+|||||++++ .|.+....++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 457899999999999999999999999999999999988888888889999999999999999999999 4444445589
Q ss_pred EEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CC--CccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 90 IVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHS--NR--VLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs--~g--IIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
||||||.+|+|..+|+..+ +..++|..+|.++.|++.||..||+ .. |+||||||.||+|+.+|.+||+||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999998553 5579999999999999999999999 45 9999999999999999999999999999
Q ss_pred cccccc-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC-ccccHH
Q 006460 164 LLNTED-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP-IVYSST 241 (644)
Q Consensus 164 ~~~~~~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p-~~~s~~ 241 (644)
.+.... +..+.+|||+||+||++.+.+|+.++||||+||++|||+.-.+||.+.+..++.++|.++..+++| ..+|.+
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTD 256 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence 886653 456789999999999999999999999999999999999999999999999999999999999999 789999
Q ss_pred HHHHHHHHhccCCCCCCCH
Q 006460 242 MKQIIKSMLRKNPEHRPTA 260 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa 260 (644)
+..||..|+..||++||+.
T Consensus 257 l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHccCCcccCCCc
Confidence 9999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=432.62 Aligned_cols=263 Identities=33% Similarity=0.565 Sum_probs=237.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
+....+|.+.+.||+|+|++|++|+++.+++.||||++.+.- ..+...+.+.+|-..|.+| +||.||+++..|+|..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~- 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE- 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-
Confidence 456789999999999999999999999999999999997653 2233345677888999999 8999999999999854
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+|+||+++|+|.++|++. +.|.+.-++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||-+..+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 599999999999999999875 469999999999999999999999999999999999999999999999999999775
Q ss_pred cccc--------------cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC
Q 006460 167 TEDL--------------ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS 232 (644)
Q Consensus 167 ~~~~--------------~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~ 232 (644)
.... ..+++||..|.+||+|.+...++.+|||+||||||+|+.|.|||.+.+..-++++|....+.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 3311 24589999999999999999999999999999999999999999999999999999888765
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhh
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~ 275 (644)
+|..+++.+++||+++|..||..|+|+.+|.+||||....|.
T Consensus 306 -fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 306 -FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred -CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 788899999999999999999999999999999999877655
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-51 Score=433.79 Aligned_cols=261 Identities=29% Similarity=0.464 Sum_probs=232.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~ 87 (644)
.+.+++|.++++||.|+||.||+|..+.++..||||+++..-...+. -.-+||++.|++|+ |||||++.+++.+..++
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 46789999999999999999999999999999999999766444322 23478999999999 99999999999998879
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+ ..+|+++++.. +..|++..++.|++||++||+|+|++|++|||+||+|||+.....+||+|||+||.+..
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999 56999999975 67899999999999999999999999999999999999999888999999999999988
Q ss_pred ccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-------------
Q 006460 168 EDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP------------- 233 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~------------- 233 (644)
...++.++.|.||+|||++... -|+.++|||++|||++|+.+-+|.|.|.+..+++.+|......|
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 8889999999999999987654 58999999999999999999999999999888888874321111
Q ss_pred ----------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 234 ----------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 234 ----------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+-..++.++.++|.+||.+||.+|||+.++|+||||+..
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 112267899999999999999999999999999999853
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-50 Score=432.10 Aligned_cols=268 Identities=63% Similarity=1.114 Sum_probs=257.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.+++|.+++++|+|+||.+++++++..+..||+|.+......+...+...+|+.+++++.|||||.+++.|.+.+.+++|
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 47899999999999999999999999999999999999988888888999999999999999999999999998777999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
||+||+||+|.+.|+..++..|+|+.++.|+.||+.|+.|||+++|+|||||+.||++++++.|||.|||+|+.+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999999998876
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
...+.+|||+||+||++.+.+|+.|+|||||||++|||++-+++|.+.++..+..+|.+....++|..++.+++.+|+.|
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence 78889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCHHHHhhCCCCchhhhhcCC
Q 006460 250 LRKNPEHRPTASDLLRHPHLQPYLLRCQN 278 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~hp~f~~~~~~~~~ 278 (644)
|..+|..||++.++|.+|.++.+...+..
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~~~~~~~~~ 270 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLLRYLVESQE 270 (426)
T ss_pred hhcCCccCCCHHHHhhChhhhhHHHhhhc
Confidence 99999999999999999999988865544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-50 Score=438.93 Aligned_cols=261 Identities=26% Similarity=0.532 Sum_probs=243.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecc-cccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-KQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
..-++-|++.+.||.|+-|.|-+|+|..||+..|||++.+. ...+.....+.+|+-||+.|.||||+++|++|.. ..+
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~ 86 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQH 86 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-Cce
Confidence 45678999999999999999999999999999999999876 4444455678899999999999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+|.||++||.|++++..+ +++++.++.++++||+.|+.|||..+|+||||||+|+||+..+++||+|||+|..-.+
T Consensus 87 lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999999999874 4699999999999999999999999999999999999999999999999999999888
Q ss_pred ccccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
+.+..+.||+|.|.|||++.|.+| +.++||||+|||||.||+|+.||++.+...++.++.++.+. +|..++.++++||
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~-MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE-MPSNISSEAQDLL 243 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc-CCCcCCHHHHHHH
Confidence 889999999999999999999999 78999999999999999999999999999999999988775 8899999999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.+||..||.+|+|.++|++|||+.++.
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999998765
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=426.10 Aligned_cols=266 Identities=29% Similarity=0.526 Sum_probs=233.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
+..+++|++++.||+|+||.||+|+.+.||..||+|++++..... ...+.+..|-.||....+|+||++|..|++ ..+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~ 215 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEY 215 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCe
Confidence 557899999999999999999999999999999999998875322 235667789999999999999999999988 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+||||||++||++..+|.+. ..|++..++.|+.+++.|++.||+.|+|||||||+|+|||..|++||+||||+..+..
T Consensus 216 LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred eEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999999874 4699999999999999999999999999999999999999999999999999964311
Q ss_pred ----------------------c--------------------------cccccccCCCCCCChhhhcCCCCCcccchhh
Q 006460 168 ----------------------E--------------------------DLASSVVGTPNYMCPELLADIPYGYKSDIWS 199 (644)
Q Consensus 168 ----------------------~--------------------------~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWS 199 (644)
. .+....+|||.|||||++.+.+|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 0123468999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhccC---CCCCCccccHHHHHHHHHHhccCCCCCCC---HHHHhhCCCCchhh
Q 006460 200 LGCCMFEIAAHQPAFRAPDMAGLINKINRSS---ISPLPIVYSSTMKQIIKSMLRKNPEHRPT---ASDLLRHPHLQPYL 273 (644)
Q Consensus 200 LGvILyeLltG~~PF~~~~~~el~~~i~~~~---~~~~p~~~s~~l~dLI~~~L~~dP~~RpT---a~eiL~hp~f~~~~ 273 (644)
|||||||||.|.|||.+.++.+..++|.... ..|-...++.+++|||.+||+ ||.+|.. ++||..||||....
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 9999999999999999999999999886543 223334578999999999998 9999975 89999999999887
Q ss_pred hhcCC
Q 006460 274 LRCQN 278 (644)
Q Consensus 274 ~~~~~ 278 (644)
|....
T Consensus 453 W~~l~ 457 (550)
T KOG0605|consen 453 WDHLR 457 (550)
T ss_pred cchhh
Confidence 76543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=425.28 Aligned_cols=261 Identities=30% Similarity=0.543 Sum_probs=233.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-Cce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~ 87 (644)
....+.|+.+++||+|+||.||+|++..+|+.||+|+++.....+.+.....|||.||++|+|||||++.+...+. ...
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 3566789999999999999999999999999999999999988888889999999999999999999999998886 568
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|||+||++. +|.-++.. .+..|++.++..||.||+.||+|||.+||+|||||..||||+.+|.+||+|||||+++..
T Consensus 193 iYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999999955 88888864 456799999999999999999999999999999999999999999999999999998755
Q ss_pred cc--ccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC---------CC
Q 006460 168 ED--LASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP---------LP 235 (644)
Q Consensus 168 ~~--~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~---------~p 235 (644)
.. .++..+-|+||+|||++.|. .|+.++|+||.||||.||+.|+|+|++.+..+++..|.+..-.| +|
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 43 57788999999999988875 59999999999999999999999999999999999886543222 11
Q ss_pred -------------------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 236 -------------------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 236 -------------------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..++....+|+..||..||.+|.|+.++|+++||..
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 124778889999999999999999999999999953
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=421.44 Aligned_cols=257 Identities=35% Similarity=0.622 Sum_probs=238.5
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
|++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+....++..+.+.+|++|++.|+|||||.+++.| +...++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-Et~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-ETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-cccceEEEE
Confidence 5799999999999999999999999999999999999988888889999999999999999999999975 557889999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-c
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-L 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~ 170 (644)
+|||.| +|..++.. .+.++|+.++.+++|++.||.|||+++|+|||+||.|||+...|.+|+||||+++.+..+. .
T Consensus 80 te~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 999977 99999986 4469999999999999999999999999999999999999999999999999999887654 3
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHh
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L 250 (644)
.+...|||.|||||++.+.+|+..+|+||||||+|||..|+|||-......+.+.|...... +|...+..+..|++.+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK-PPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-CcccccHHHHHHHHHHh
Confidence 45668999999999999999999999999999999999999999999999999998876654 56688999999999999
Q ss_pred ccCCCCCCCHHHHhhCCCCchhh
Q 006460 251 RKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.+||.+|+|+.+++.|||.+...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999987654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=428.81 Aligned_cols=277 Identities=26% Similarity=0.493 Sum_probs=247.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~ 86 (644)
+..+++|+++++||+|+||.|+++..+.+++.||||++++... .....+..+.|.+|+.... ||.+++++..|+. ..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-~~ 442 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-KE 442 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-CC
Confidence 4568999999999999999999999999999999999988753 3334677888999998875 9999999998876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc-
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL- 165 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~- 165 (644)
++|+||||+.||+|..+.+ ...|++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++..
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 7999999999999555443 345999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
..+....++||||.|||||++.+..|+.++|+|||||+|||||.|.+||.+.+.++++..|..... .+|..+|.++.++
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSKEAIAI 598 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCcccHHHHHH
Confidence 356678999999999999999999999999999999999999999999999999999999986654 4899999999999
Q ss_pred HHHHhccCCCCCCCH-----HHHhhCCCCchhhhhcCCCCCcccCCCccc
Q 006460 246 IKSMLRKNPEHRPTA-----SDLLRHPHLQPYLLRCQNPSSVYLPIKPTN 290 (644)
Q Consensus 246 I~~~L~~dP~~RpTa-----~eiL~hp~f~~~~~~~~~~~~~~~p~~p~~ 290 (644)
++++|+++|++|..+ .+|..||||..+.|.......+..|+.|..
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i 648 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTI 648 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCccc
Confidence 999999999999764 789999999998887766666666666654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=407.25 Aligned_cols=257 Identities=33% Similarity=0.618 Sum_probs=223.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc-eEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN-CVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~-~~~L 90 (644)
..+|...+.||+|+||.||++.++.+|..+|+|.+....... .+.+.+|+++|++|+|||||++++....... .++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 567999999999999999999999999999999998763322 5678999999999999999999997444444 7999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-CCCeEEeccCccccccc--
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-DNDIRLGDFGLAKLLNT-- 167 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-~g~vKL~DFGls~~~~~-- 167 (644)
+|||+.||+|.++++..++ .|+|..++.+.+||+.||.|||++|||||||||+|||++. ++.+||+|||++.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998765 7999999999999999999999999999999999999999 69999999999987663
Q ss_pred --ccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHh-ccCCCCCCccccHHH
Q 006460 168 --EDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRA-PDMAGLINKIN-RSSISPLPIVYSSTM 242 (644)
Q Consensus 168 --~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~-~~~~el~~~i~-~~~~~~~p~~~s~~l 242 (644)
........||+.|||||++.+. ...+++|||||||++.||+||++||.. ......+-.+. ....+.+|..+|.++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1234468999999999999852 234599999999999999999999987 44444444443 444668899999999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
++||.+|+.++|.+|||+.++|+|||++.
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 99999999999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=387.26 Aligned_cols=257 Identities=30% Similarity=0.549 Sum_probs=227.8
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
..+|...++||+|.||.||+|++..+|+.||||+++..+..+......+||+++|+.++||||+.++++|-.. ..+.||
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-~~l~lV 79 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-SNLSLV 79 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-CceEEE
Confidence 3689999999999999999999999999999999999887777778899999999999999999999998764 559999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
+||+ ..+|..+|+.. ...++...+..|+.+++.||.|||++.|+||||||+|+|++.+|.+||+|||+++.+.....
T Consensus 80 fEfm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 80 FEFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9999 56999999864 45789999999999999999999999999999999999999999999999999998876543
Q ss_pred cccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCc-------------
Q 006460 171 ASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI------------- 236 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~------------- 236 (644)
....+-|.||+|||++.| ..|+..+||||.|||+.||+-|.|.|.+.+..+++..|.+....|.+.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 334588999999998766 469999999999999999999999999999888888876543322221
Q ss_pred --------------cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 237 --------------VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 237 --------------~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..+.++.+|+.+||.+||.+|+|+.|+|+|+||..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 13577899999999999999999999999999974
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=395.14 Aligned_cols=257 Identities=26% Similarity=0.478 Sum_probs=227.4
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+|++++||||+++++++.+ +..+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEE
Confidence 589999999999999999999999999999999976432 22345668889999999999999999998766 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--T 155 (291)
T ss_pred EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--c
Confidence 9999999999999763 45899999999999999999999999999999999999999999999999999875432 3
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhc
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~ 251 (644)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..... .+|..++..+++||++||.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-EFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-CCCccCCHHHHHHHHHHcC
Confidence 456799999999999998999999999999999999999999999888888877766543 4677789999999999999
Q ss_pred cCCCCCCC-----HHHHhhCCCCchhhhh
Q 006460 252 KNPEHRPT-----ASDLLRHPHLQPYLLR 275 (644)
Q Consensus 252 ~dP~~RpT-----a~eiL~hp~f~~~~~~ 275 (644)
.||.+||+ ++++++||||....+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 99999995 9999999999865443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=391.67 Aligned_cols=264 Identities=26% Similarity=0.459 Sum_probs=224.4
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+++|++++||||++++++|.+ +..+|+||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEE
Confidence 489999999999999999999999999999998765322 2233467889999999999999999998766 56799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~ 172 (644)
||+.+|+|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence 99999999988876555568999999999999999999999999999999999999999999999999998765444445
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH---HHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL---INKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el---~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
...||+.|+|||++.+..|+.++|||||||++|+|++|++||........ ............+..++..+.+|+++|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999987654322 222222333446667899999999999
Q ss_pred hccCCCCCCC-----HHHHhhCCCCchhhhhcCC
Q 006460 250 LRKNPEHRPT-----ASDLLRHPHLQPYLLRCQN 278 (644)
Q Consensus 250 L~~dP~~RpT-----a~eiL~hp~f~~~~~~~~~ 278 (644)
|..||.+||+ ++++++||||....++...
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 273 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE 273 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHH
Confidence 9999999997 8999999999876555433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=401.15 Aligned_cols=262 Identities=27% Similarity=0.488 Sum_probs=231.7
Q ss_pred CCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 6 ~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
..+...+++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+|++++||||++++++|.+
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 89 (329)
T PTZ00263 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD- 89 (329)
T ss_pred ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-
Confidence 4455678999999999999999999999999999999999976532 22334678899999999999999999998876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
+..+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 56799999999999999999763 4589999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
.... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+.... ..+|..++..+++
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ 244 (329)
T PTZ00263 168 VPDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARD 244 (329)
T ss_pred cCCC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHH
Confidence 6442 335689999999999999999999999999999999999999999888887777776654 3467778999999
Q ss_pred HHHHHhccCCCCCCC-----HHHHhhCCCCchhh
Q 006460 245 IIKSMLRKNPEHRPT-----ASDLLRHPHLQPYL 273 (644)
Q Consensus 245 LI~~~L~~dP~~RpT-----a~eiL~hp~f~~~~ 273 (644)
||.+||..||.+||+ +.+++.||||....
T Consensus 245 li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 245 LVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 999999999999997 79999999997643
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=392.57 Aligned_cols=261 Identities=30% Similarity=0.493 Sum_probs=236.7
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
+--+-++|.+.+.||+|.|+.||++.+..+|+.+|+|++...+......+.+.+|++|-+.|+|||||++++.+.+ ..+
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~~ 84 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESF 84 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-cce
Confidence 3345689999999999999999999999999999999998887776677889999999999999999999998655 678
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC---CCeEEeccCcccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD---NDIRLGDFGLAKL 164 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~---g~vKL~DFGls~~ 164 (644)
.|||+|++.|++|..-|... ..++|..+..+++|||.+|.|||.+||||||+||+|+|+-.. ..+||+|||++..
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999999998777653 458999999999999999999999999999999999999643 3599999999999
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---CCCccccHH
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSST 241 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---~~p~~~s~~ 241 (644)
++.+.....+.|||.|||||++...+|+..+|||+.|+|||.|+.|.+||.+.+...+++.|..+... +....++++
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 88767777899999999999999999999999999999999999999999999999999999988653 244567999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+++|+++||..||.+|+|+.|+|+|||+..
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 999999999999999999999999999964
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=396.41 Aligned_cols=253 Identities=28% Similarity=0.508 Sum_probs=221.6
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEG 97 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~G 97 (644)
+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+|++++||||++++++|.. +..+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence 469999999999999999999999999976532 22334567889999999999999999998766 5679999999999
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-cccccccccC
Q 006460 98 GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVG 176 (644)
Q Consensus 98 gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~~~~~~G 176 (644)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+|
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 80 GELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 999999875 3468999999999999999999999999999999999999999999999999987532 2233455789
Q ss_pred CCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCC
Q 006460 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEH 256 (644)
Q Consensus 177 T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~ 256 (644)
|+.|+|||++.+..|+.++|||||||++|+|++|..||...+.......+.... ..+|..++.++.+||.+||..||.+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999999999999999999999999999999999888877777766554 3467788999999999999999999
Q ss_pred CC-----CHHHHhhCCCCchhhhh
Q 006460 257 RP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 257 Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
|| ++.++++||||....+.
T Consensus 237 R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 237 RLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred cCCCCCCCHHHHHcCCCcCCCCHH
Confidence 99 89999999999875444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=396.06 Aligned_cols=262 Identities=32% Similarity=0.472 Sum_probs=227.0
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe----CCce
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD----KGNC 87 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d----~~~~ 87 (644)
-..|..++.||.|+||.|+.|.++.+|+.||+|++.......-..++..||+++|+.++|+|||.+++++.. .-+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 346666899999999999999999999999999998776677778899999999999999999999999875 2357
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+|+|++ +.+|..+++. +..+++..+..+++|||+||+|+|+.||+||||||.|+|++.+..+||+|||+|+....
T Consensus 101 vYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999999 7799999986 33499999999999999999999999999999999999999999999999999998753
Q ss_pred ---ccccccccCCCCCCChhhhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC------------
Q 006460 168 ---EDLASSVVGTPNYMCPELLA-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI------------ 231 (644)
Q Consensus 168 ---~~~~~~~~GT~~Y~APEvl~-~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~------------ 231 (644)
...++..+.|.||+|||++. ...|+.++||||+||||.||++|++.|.|.+...+++.|.....
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 45667789999999999764 56799999999999999999999999999886666555432111
Q ss_pred ----------CCCC--------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhhc
Q 006460 232 ----------SPLP--------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRC 276 (644)
Q Consensus 232 ----------~~~p--------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~~ 276 (644)
+..| ...++.+.+|+.+||.+||.+|+|++|+|.||||.++....
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 1111 23578899999999999999999999999999998876443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=400.50 Aligned_cols=256 Identities=30% Similarity=0.553 Sum_probs=236.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
..-.+|++.+.||+|+||.|-+|+....|+.||||.|++.+. .+...-.+.||++||..|+||||+++|++|.. ...+
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKI 128 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKI 128 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceE
Confidence 344689999999999999999999999999999999988754 34456678999999999999999999999866 4569
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
+|||||..+|.|++|+...+ .++|.+++.+++||++|+.|||+++++|||||.+||||+.++++||+||||+..+...
T Consensus 129 vivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999999998754 5999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
.+..++||+|.|.+||++++.+| ++.+|.||||++||.|+.|.+||++.+...+.++|.++.+..-+ -+.++..||+
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~--~PSdA~gLIR 284 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE--TPSDASGLIR 284 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC--CCchHHHHHH
Confidence 99999999999999999999999 78999999999999999999999999999999999988765322 3678889999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCc
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
.||..||++|.|+.+|..|-|++
T Consensus 285 wmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHhcCcccchhHHHHhhhheee
Confidence 99999999999999999999985
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=396.44 Aligned_cols=262 Identities=28% Similarity=0.521 Sum_probs=229.1
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCC-eEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIER-KKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg-~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
.+..+++|++.+.||+|+||.||+|.++.++ ..||+|.+..... .......+.+|+++++.++|||||++++++.+ +
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~ 103 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-E 103 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-C
Confidence 3456789999999999999999999987665 7899999875432 23345678899999999999999999999876 5
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 6799999999999999999763 45899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+..... .+|..++..+.++
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~l 258 (340)
T PTZ00426 182 DTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKHL 258 (340)
T ss_pred CCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHH
Confidence 432 3457899999999999998899999999999999999999999999888777777766543 4677789999999
Q ss_pred HHHHhccCCCCCC-----CHHHHhhCCCCchhhhh
Q 006460 246 IKSMLRKNPEHRP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 246 I~~~L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
|++||..||.+|+ +++++++||||....+.
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 9999999999995 89999999999865443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=388.22 Aligned_cols=259 Identities=29% Similarity=0.501 Sum_probs=229.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~~~ 89 (644)
.+++|+.+.+|++|+||.||+|+++.|++.||+|+++.....+.+--..+|||.+|.+++|||||.+.++..-. -+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 45899999999999999999999999999999999999887777777889999999999999999999987643 25699
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
||||||+ .+|..++...+ .+|...+++.++.|+|.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 154 ~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999995 49999998764 57999999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC----------CCCC--
Q 006460 169 DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI----------SPLP-- 235 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~----------~~~p-- 235 (644)
..++..+-|.||+|||++.+. .|+.++|+||+|||+.||+.++|.|.+.+..+++.+|.+... ..+|
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 346778899999999988775 599999999999999999999999999999888888754211 1111
Q ss_pred ------------------cc-ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 236 ------------------IV-YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 236 ------------------~~-~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.. +++...+|+..+|.+||.+|.|+.+.|+|.||..
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 01 3578889999999999999999999999999975
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=381.38 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=215.2
Q ss_pred CCeEEEEEeccCCCeEEEEEEEec-CCeEEEEEEEecccccHHHHHHHHHHHHHHHhc---CCCCcceeeeEEEe----C
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKI-ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL---NNPYIVKYKDAWVD----K 84 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~-tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HPNIVkl~~~~~d----~ 84 (644)
++|++.+.||+|+||.||+|.+.. ++..||+|.++...........+.+|+.+++.+ .||||++++++|.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 589999999999999999999865 468899999876544333344556777777765 69999999998752 3
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999995 6999999876556689999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-----------
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----------- 233 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----------- 233 (644)
...........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+..+......+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 665544556789999999999988899999999999999999999999999887766666654321110
Q ss_pred ---------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 234 ---------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 234 ---------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
....++..+.+|+.+||+.||++|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012357788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=409.78 Aligned_cols=257 Identities=29% Similarity=0.562 Sum_probs=233.7
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
.+.....|....+||+|+.|.||.|....+++.||+|.+....+.. ++.+++|+.+|+..+|+|||++++.|... ..
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~-de 344 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVG-DE 344 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhccc-ce
Confidence 3456678999999999999999999999999999999998876554 46789999999999999999999998875 66
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||++||+|.+++... .++|.++..|++.++.||+|||.+||||||||.+|||++.+|.+||+|||++..+..
T Consensus 345 LWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999999999764 399999999999999999999999999999999999999999999999999998766
Q ss_pred cc-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--CCccccHHHHH
Q 006460 168 ED-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSSTMKQ 244 (644)
Q Consensus 168 ~~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~p~~~s~~l~d 244 (644)
.. ...+.+|||+|||||++....|++++||||||+++.||+-|.|||-..++...++.|.....+. .+..+|..+++
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 54 4667899999999999999999999999999999999999999999888877777776655443 45678999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
|+.+||+.||.+|+++.+||+||||+
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhh
Confidence 99999999999999999999999995
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=380.29 Aligned_cols=254 Identities=28% Similarity=0.507 Sum_probs=214.3
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++.+.||+|+||.||+|.++.+++.||+|++..........+.+.+|+.+++.++||||++++++|.. +..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence 47999999999999999999999999999999998765555556778899999999999999999998765 56799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--c
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--L 170 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~--~ 170 (644)
||+.++.|..+... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 99988777655432 3468999999999999999999999999999999999999999999999999998764322 2
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC--------------------
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS-------------------- 230 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~-------------------- 230 (644)
.....|++.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 334578999999999998889999999999999999999999998776544333322110
Q ss_pred -CC----------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 231 -IS----------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 231 -~~----------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.+ .....++..+.+||++||++||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 0012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=381.25 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=214.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
++++|++.++||.|+||.||+|.++.++..||+|+++..... .....+.+|++++++++||||+++++++.. ..++|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEE
Confidence 578999999999999999999999999999999998754322 223456789999999999999999998766 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-c
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-D 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~ 169 (644)
||||+.| +|.+++... +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 v~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 81 VFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 9999965 899988754 345899999999999999999999999999999999999999999999999999764332 2
Q ss_pred ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC----------------
Q 006460 170 LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---------------- 232 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---------------- 232 (644)
......+++.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3345678999999998865 56899999999999999999999999888766655444221100
Q ss_pred -----C--------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 233 -----P--------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 233 -----~--------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
. ....++.++.+||++||++||.+|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0 012357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=393.31 Aligned_cols=259 Identities=28% Similarity=0.461 Sum_probs=220.2
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++++.||+|+||.||+|.++.+++.||+|+++..... ......+.+|+.++..++||||++++++|.+ ...+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEE
Confidence 5899999999999999999999999999999999765322 2334567889999999999999999998876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-- 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-- 169 (644)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 80 MEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999999763 469999999999999999999999999999999999999999999999999987543210
Q ss_pred ----------------------------------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 006460 170 ----------------------------------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFR 215 (644)
Q Consensus 170 ----------------------------------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~ 215 (644)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 1134589999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHhccC-CCCCC--ccccHHHHHHHHHHhccCCC---CCCCHHHHhhCCCCchhhhh
Q 006460 216 APDMAGLINKINRSS-ISPLP--IVYSSTMKQIIKSMLRKNPE---HRPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 216 ~~~~~el~~~i~~~~-~~~~p--~~~s~~l~dLI~~~L~~dP~---~RpTa~eiL~hp~f~~~~~~ 275 (644)
+....+....+.... ...+| ..++.++++||.+|+. +|. .||++++|++||||+...+.
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 988888777776432 11222 2368999999999875 444 45899999999999876544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=399.93 Aligned_cols=258 Identities=34% Similarity=0.566 Sum_probs=232.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCce
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~ 87 (644)
..-..|++.+.||+|.||.||+|.++.+|+.+|+|++.+..... .....+.+|++||++|. |||||.++++|.+ ...
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~~~ 110 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-PDS 110 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-CCe
Confidence 44568999999999999999999999999999999998765432 23567889999999998 9999999999876 557
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC----CCeEEeccCccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD----NDIRLGDFGLAK 163 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~----g~vKL~DFGls~ 163 (644)
+|+|||+|.||.|.+.|... .++|..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999999875 39999999999999999999999999999999999999743 479999999999
Q ss_pred ccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC---CCCCccccH
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---SPLPIVYSS 240 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~---~~~p~~~s~ 240 (644)
...........+||+.|+|||++...+|+..+||||+|+++|.|++|.+||.+.+..+....|..+.+ .+....++.
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 98876678889999999999999999999999999999999999999999999998888888887754 233445699
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+++||++||..||.+|+|+.++|+|||++.
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence 9999999999999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=389.75 Aligned_cols=261 Identities=30% Similarity=0.486 Sum_probs=228.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++...||.|..++||+|+++.++..||||++...+.+.. ...+.+|++.|+.++|||||+++..|.. ++.+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeE
Confidence 346799999999999999999999999999999999999887666 6789999999999999999999999887 67799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||.|+.+|++.++++..-...|.|..+..|++++|.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+....
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999999997766669999999999999999999999999999999999999999999999999997654322
Q ss_pred ----c-cccccCCCCCCChhhhc--CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-CC----C--
Q 006460 170 ----L-ASSVVGTPNYMCPELLA--DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-PL----P-- 235 (644)
Q Consensus 170 ----~-~~~~~GT~~Y~APEvl~--~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~-~~----p-- 235 (644)
. ..+++|||+|||||++. ..+|+.|+||||||++..||++|..||....+.+.+-.-.+...+ +. +
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d 260 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD 260 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence 1 26789999999999964 357999999999999999999999999988776654444333322 11 1
Q ss_pred --ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 236 --IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 236 --~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
..++..++.+|..||++||.+|||++++|+|+||+..
T Consensus 261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 2367889999999999999999999999999999754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=386.19 Aligned_cols=248 Identities=29% Similarity=0.518 Sum_probs=218.1
Q ss_pred eccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCC
Q 006460 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGD 99 (644)
Q Consensus 21 LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~Ggs 99 (644)
||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|++++||||++++++|.. ...+|+||||+.||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence 7999999999999999999999999975432 23345677889999999999999999998765 567999999999999
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-ccccccccCCC
Q 006460 100 MAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVVGTP 178 (644)
Q Consensus 100 L~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-~~~~~~~~GT~ 178 (644)
|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+
T Consensus 80 L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 80 LFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99999763 4589999999999999999999999999999999999999999999999999975322 22344568999
Q ss_pred CCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCC
Q 006460 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRP 258 (644)
Q Consensus 179 ~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rp 258 (644)
.|+|||++.+..|+.++|||||||++|+|++|.+||......+....+..... .+|..++..+.+||.+||..||.+||
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~ 236 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL-RFPDGFDRDAKDLLIGLLSRDPTRRL 236 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence 99999999999999999999999999999999999998888887777765543 46777899999999999999999997
Q ss_pred ---CHHHHhhCCCCchh
Q 006460 259 ---TASDLLRHPHLQPY 272 (644)
Q Consensus 259 ---Ta~eiL~hp~f~~~ 272 (644)
++.++|.||||...
T Consensus 237 ~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 237 GYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCCHHHHHcCCCcCCC
Confidence 58999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=387.04 Aligned_cols=256 Identities=27% Similarity=0.500 Sum_probs=223.0
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+|+.++||||+++++++.. +..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEE
Confidence 5799999999999999999999999999999999765322 2334668889999999999999999998766 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 80 ~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--cc
Confidence 9999999999999753 4589999999999999999999999999999999999999999999999999986543 34
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC---CCCC----ccccHHHHH
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---SPLP----IVYSSTMKQ 244 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~---~~~p----~~~s~~l~d 244 (644)
...+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+....+..... .+.. ..++.++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 567899999999999998999999999999999999999999999888777666543211 1111 145899999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
||.+||..+|.+||++.++++||||....
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 99999999999999999999999998643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=385.31 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=211.3
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----ceEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----NCVC 89 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----~~~~ 89 (644)
+|++.++||+|+||.||+|.++.++..||+|++............+.+|+++|++++||||+++++++.... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999998754333333456889999999999999999999876432 3589
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999999 57899988753 358999999999999999999999999999999999999999999999999998643221
Q ss_pred ----ccccccCCCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhc---------------
Q 006460 170 ----LASSVVGTPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR--------------- 228 (644)
Q Consensus 170 ----~~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~--------------- 228 (644)
......||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2234679999999999876 5789999999999999999999999987664433222111
Q ss_pred ------------cCCCC---CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 229 ------------SSISP---LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 229 ------------~~~~~---~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
....+ ....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00000 012357788999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=391.70 Aligned_cols=258 Identities=32% Similarity=0.542 Sum_probs=221.2
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|+.++||||++++++|.+ +..+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence 589999999999999999999999999999999976532 22345667889999999999999999998876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-- 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-- 169 (644)
||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 80 MEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred ECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999999763 459999999999999999999999999999999999999999999999999987542211
Q ss_pred -------------------------------------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCC
Q 006460 170 -------------------------------------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQP 212 (644)
Q Consensus 170 -------------------------------------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~ 212 (644)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 1123579999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhccCC-CCCC--ccccHHHHHHHHHHhccCCCCCCC---HHHHhhCCCCchhhh
Q 006460 213 AFRAPDMAGLINKINRSSI-SPLP--IVYSSTMKQIIKSMLRKNPEHRPT---ASDLLRHPHLQPYLL 274 (644)
Q Consensus 213 PF~~~~~~el~~~i~~~~~-~~~p--~~~s~~l~dLI~~~L~~dP~~RpT---a~eiL~hp~f~~~~~ 274 (644)
||...+..+....+..... ...| ..+++++.+||.+||. +|.+|++ +.+++.||||....+
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9998887777666654321 1222 3468999999999996 9999998 999999999986544
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=389.95 Aligned_cols=258 Identities=34% Similarity=0.582 Sum_probs=223.9
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+|..++||||++++++|.+ +..+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence 58999999999999999999999999999999997654322 345668889999999999999999998876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-- 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-- 169 (644)
|||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 80 MEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999999864 469999999999999999999999999999999999999999999999999998654432
Q ss_pred ----------------------------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHH
Q 006460 170 ----------------------------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG 221 (644)
Q Consensus 170 ----------------------------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~e 221 (644)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2345679999999999999999999999999999999999999999888777
Q ss_pred HHHHHhc--cC-CCCCCccccHHHHHHHHHHhccCCCCCCC-HHHHhhCCCCchhhh
Q 006460 222 LINKINR--SS-ISPLPIVYSSTMKQIIKSMLRKNPEHRPT-ASDLLRHPHLQPYLL 274 (644)
Q Consensus 222 l~~~i~~--~~-~~~~p~~~s~~l~dLI~~~L~~dP~~RpT-a~eiL~hp~f~~~~~ 274 (644)
....+.. .. ..+....+++++.+||.+||. +|.+||+ +.++++||||+...+
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 7666654 11 112223369999999999997 9999999 999999999986543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=397.36 Aligned_cols=261 Identities=29% Similarity=0.554 Sum_probs=223.7
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH------------HHHHHHHHHHHHHhcCCCCcc
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK------------FKRTALQEMDLISKLNNPYIV 75 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~------------~~~~~~rEi~iL~~L~HPNIV 75 (644)
.+..+++|++++.||+|.||.|-+|++..+++.||||++.+...... -.+...+|+.||++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 44568999999999999999999999999999999999976532211 124778999999999999999
Q ss_pred eeeeEEEe-CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCe
Q 006460 76 KYKDAWVD-KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDI 154 (644)
Q Consensus 76 kl~~~~~d-~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~v 154 (644)
+++++.-+ ....+|||+|||+.|.+...-. ....+++.+++.|++.++.||+|||.+|||||||||.|+||+.+|++
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 99998654 3468999999999888755321 22238999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccc------cccccccccCCCCCCChhhhcCC---CC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 006460 155 RLGDFGLAKLLN------TEDLASSVVGTPNYMCPELLADI---PY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLIN 224 (644)
Q Consensus 155 KL~DFGls~~~~------~~~~~~~~~GT~~Y~APEvl~~~---~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~ 224 (644)
||+|||.+.... ........+|||.|+|||.+.+. .| +.+.||||+||+||.|+.|+.||-+....++..
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 999999998762 22344557999999999988762 23 789999999999999999999999999999999
Q ss_pred HHhccCCCCCCc--cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 225 KINRSSISPLPI--VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 225 ~i~~~~~~~~p~--~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+|....+. +|. .+..++++||.+||.+||++|++..+|..|||...
T Consensus 330 KIvn~pL~-fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 330 KIVNDPLE-FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHhcCccc-CCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 99877553 333 36899999999999999999999999999999964
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=387.38 Aligned_cols=253 Identities=28% Similarity=0.522 Sum_probs=220.5
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEG 97 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~G 97 (644)
+.||+|+||.||+|.++.++..||+|++..... .......+.+|+++++.++||||++++++|.. ...+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence 469999999999999999999999999976532 22344567889999999999999999998876 5679999999999
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-ccccccccC
Q 006460 98 GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVVG 176 (644)
Q Consensus 98 gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-~~~~~~~~G 176 (644)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........|
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 80 GELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 9999988753 4689999999999999999999999999999999999999999999999999875322 223345679
Q ss_pred CCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCC
Q 006460 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEH 256 (644)
Q Consensus 177 T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~ 256 (644)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... .+|..+++++.+||.+||..||.+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999988999999999999999999999999998888777777665443 467788999999999999999999
Q ss_pred CC-----CHHHHhhCCCCchhhhh
Q 006460 257 RP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 257 Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
|+ ++.++++||||....+.
T Consensus 237 R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 237 RLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCCCHH
Confidence 98 89999999999875544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=387.99 Aligned_cols=253 Identities=28% Similarity=0.525 Sum_probs=220.3
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEG 97 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~G 97 (644)
+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+++|+.++||||+++++++.. ...+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence 469999999999999999999999999976532 23345678889999999999999999998765 5679999999999
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-ccccccccC
Q 006460 98 GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVVG 176 (644)
Q Consensus 98 gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-~~~~~~~~G 176 (644)
|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+|
T Consensus 80 g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 80 GELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 9999988753 4589999999999999999999999999999999999999999999999999875322 223345689
Q ss_pred CCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCC
Q 006460 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEH 256 (644)
Q Consensus 177 T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~ 256 (644)
|+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+.... ..+|..++.++.+||.+||..||.+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHHH
Confidence 999999999998899999999999999999999999999888777777665443 3467788999999999999999999
Q ss_pred CC-----CHHHHhhCCCCchhhhh
Q 006460 257 RP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 257 Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
|+ ++.++++||||....+.
T Consensus 237 R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 237 RLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred cCCCCCCCHHHHhcCCCcCCCCHH
Confidence 97 89999999999765443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=385.10 Aligned_cols=255 Identities=26% Similarity=0.522 Sum_probs=220.5
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHH---HhcCCCCcceeeeEEEeCCceEEE
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLI---SKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL---~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
|++++.||+|+||.||+|.+..+++.||+|+++.... .....+.+.+|++++ +.++||||++++++|.. +..+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEE
Confidence 7899999999999999999999999999999976532 222345566676665 46689999999998766 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-ccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TED 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~ 169 (644)
||||+.|++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ...
T Consensus 80 v~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 80 VMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 9999999999988753 358999999999999999999999999999999999999999999999999987532 223
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
.....+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ..|..++..+.+||.+|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~ 235 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRL 235 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHH
Confidence 34557899999999999998999999999999999999999999999888888777765543 36777899999999999
Q ss_pred hccCCCCCC-----CHHHHhhCCCCchhhh
Q 006460 250 LRKNPEHRP-----TASDLLRHPHLQPYLL 274 (644)
Q Consensus 250 L~~dP~~Rp-----Ta~eiL~hp~f~~~~~ 274 (644)
|..||.+|| ++.++++||||....+
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 999999999 7999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=376.68 Aligned_cols=262 Identities=25% Similarity=0.461 Sum_probs=223.5
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
.|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.. +..+|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEE
Confidence 589999999999999999999999999999999764322 2234567889999999999999999998765 46799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~ 172 (644)
||+.|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence 99999999998876545569999999999999999999999999999999999999999999999999998765444445
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH---hccCCCCCCccccHHHHHHHHHH
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI---NRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i---~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
..+|++.|+|||++.+..++.++||||+||++|+|++|..||.+.........+ ........+..++..+.+||.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 568999999999999888999999999999999999999999876654332222 12233345666899999999999
Q ss_pred hccCCCCCC-----CHHHHhhCCCCchhhhhc
Q 006460 250 LRKNPEHRP-----TASDLLRHPHLQPYLLRC 276 (644)
Q Consensus 250 L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~~ 276 (644)
|..||.+|| ++.++++||||....++.
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 999999999 899999999998654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=371.24 Aligned_cols=259 Identities=24% Similarity=0.458 Sum_probs=238.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
-.+++|++.+.||+|-||.||+|+.+.++-.||+|++.+... ......++.||+.|-..|.||||+++|++|.+. ..+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-~ri 97 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-KRI 97 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-cee
Confidence 357899999999999999999999999999999999977642 233457889999999999999999999999885 559
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+++||...|+|...|...+...+++...+.|++|++.||.|||.++||||||||+|+|++..+.+||+|||.+..-. .
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-S 176 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-C
Confidence 999999999999999997667779999999999999999999999999999999999999999999999999998755 3
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
....+.|||..|.+||+..+..++..+|+|++|+++||++.|.+||......+.+++|.+.... +|..++.++.|+|.+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-FPSTISGGAADLISR 255 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-CCcccChhHHHHHHH
Confidence 4567899999999999999999999999999999999999999999999999999999877654 678899999999999
Q ss_pred HhccCCCCCCCHHHHhhCCCCch
Q 006460 249 MLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
||.++|.+|.+..|++.|||+..
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999964
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=391.87 Aligned_cols=259 Identities=29% Similarity=0.466 Sum_probs=217.8
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
..|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+|+.++|||||+++++|.+ ...+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEE
Confidence 469999999999999999999999999999999976542 23345678899999999999999999999876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc---
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE--- 168 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~--- 168 (644)
||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 80 MDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999999763 45899999999999999999999999999999999999999999999999997533100
Q ss_pred ---------------------------------------------cccccccCCCCCCChhhhcCCCCCcccchhhHHHH
Q 006460 169 ---------------------------------------------DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCC 203 (644)
Q Consensus 169 ---------------------------------------------~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvI 203 (644)
......+||+.|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 01134579999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhcc-CCCCCC--ccccHHHHHHHHHHhcc--CCCCCCCHHHHhhCCCCchhhh
Q 006460 204 MFEIAAHQPAFRAPDMAGLINKINRS-SISPLP--IVYSSTMKQIIKSMLRK--NPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 204 LyeLltG~~PF~~~~~~el~~~i~~~-~~~~~p--~~~s~~l~dLI~~~L~~--dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
+|+|++|.+||......+....+... .....| ..++.++.+||.+||.. +|..|+++.+++.||||....+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 99999999999887776655555432 112222 35789999999997654 4455999999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=390.56 Aligned_cols=257 Identities=28% Similarity=0.516 Sum_probs=218.0
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|+++++||+|+||.||+|.++.+++.||+|++..... .......+.+|++++++++|||||+++++|.+ ..++|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEE
Confidence 589999999999999999999999999999999876432 23345678889999999999999999998876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-- 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-- 169 (644)
|||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 80 MEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999999753 468999999999999999999999999999999999999999999999999986321100
Q ss_pred ----------------------------------------------ccccccCCCCCCChhhhcCCCCCcccchhhHHHH
Q 006460 170 ----------------------------------------------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCC 203 (644)
Q Consensus 170 ----------------------------------------------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvI 203 (644)
.....+||+.|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhccC-CCCCC--ccccHHHHHHHHHHhccCCCCC---CCHHHHhhCCCCchhh
Q 006460 204 MFEIAAHQPAFRAPDMAGLINKINRSS-ISPLP--IVYSSTMKQIIKSMLRKNPEHR---PTASDLLRHPHLQPYL 273 (644)
Q Consensus 204 LyeLltG~~PF~~~~~~el~~~i~~~~-~~~~p--~~~s~~l~dLI~~~L~~dP~~R---pTa~eiL~hp~f~~~~ 273 (644)
+|+|++|.+||......+.+..+.... ...+| ..++.++.+||.+||. +|.+| +|+.+++.||||....
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 999999999999888777766665421 12223 2478999999999997 67765 5999999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=382.82 Aligned_cols=257 Identities=25% Similarity=0.480 Sum_probs=222.7
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCC-CcceeeeEEEeCCceEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNP-YIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HP-NIVkl~~~~~d~~~~~~LV 91 (644)
+|++++.||+|+||.||+|.++.+++.||+|++..... .....+.+.+|++++..+.|+ +|++++++|.. ...+|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence 69999999999999999999999999999999976532 223346678899999999765 57788887665 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-cccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~ 170 (644)
|||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ....
T Consensus 80 ~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 80 MEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 9999999999998753 458999999999999999999999999999999999999999999999999987532 2223
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHh
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L 250 (644)
....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+....+.... ..+|..++.++.+|+.+||
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l 236 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLL 236 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHh
Confidence 445689999999999999899999999999999999999999999988888888876554 3467788999999999999
Q ss_pred ccCCCCCCCH-----HHHhhCCCCchhhh
Q 006460 251 RKNPEHRPTA-----SDLLRHPHLQPYLL 274 (644)
Q Consensus 251 ~~dP~~RpTa-----~eiL~hp~f~~~~~ 274 (644)
..||.+|++. .++++||||....+
T Consensus 237 ~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 237 TKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999999986 89999999976543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=384.74 Aligned_cols=260 Identities=29% Similarity=0.484 Sum_probs=227.0
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC-cceeeeEEEeCCc----
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY-IVKYKDAWVDKGN---- 86 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPN-IVkl~~~~~d~~~---- 86 (644)
+..|..+++||+|+||.||+|+.+.+|+.||+|+++.....+......+||+.+|+.|+|+| ||++++++.....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 66788899999999999999999999999999999987665555667899999999999999 9999999887553
Q ss_pred -eEEEEEeccCCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 87 -CVCIVTGYCEGGDMAEIIKKARG--ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 87 -~~~LVmEy~~GgsL~~~L~~~~~--~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
.+++||||+ ..+|..++..... ..++...++.+++||+.||.|||++||+||||||+||||+.+|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 799999999 5699999987653 357889999999999999999999999999999999999999999999999999
Q ss_pred ccc-cccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC----CC--
Q 006460 164 LLN-TEDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----LP-- 235 (644)
Q Consensus 164 ~~~-~~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----~p-- 235 (644)
.+. +...+.+.++|.||+|||++.+. .|+..+||||+|||++||+++++.|.+....+++..|.+....| +|
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 776 44557888999999999998887 69999999999999999999999999999888877775432111 11
Q ss_pred ----------------cc-------ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 236 ----------------IV-------YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 236 ----------------~~-------~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.. .+....+++.+||+++|.+|.|+..+|.||||+..
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 00 12478899999999999999999999999999764
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=390.85 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=218.1
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.+|+++++||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+|++++|||||+++++|.+ +..+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEE
Confidence 369999999999999999999999999999999976432 23345678889999999999999999999876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc---
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE--- 168 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~--- 168 (644)
||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 80 MDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999999999763 45899999999999999999999999999999999999999999999999997532100
Q ss_pred ---------------------------------------------cccccccCCCCCCChhhhcCCCCCcccchhhHHHH
Q 006460 169 ---------------------------------------------DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCC 203 (644)
Q Consensus 169 ---------------------------------------------~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvI 203 (644)
......+||+.|+|||++.+..|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 01123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhccC-CC--CCCccccHHHHHHHHHHhccCCCCCCC---HHHHhhCCCCchhh
Q 006460 204 MFEIAAHQPAFRAPDMAGLINKINRSS-IS--PLPIVYSSTMKQIIKSMLRKNPEHRPT---ASDLLRHPHLQPYL 273 (644)
Q Consensus 204 LyeLltG~~PF~~~~~~el~~~i~~~~-~~--~~p~~~s~~l~dLI~~~L~~dP~~RpT---a~eiL~hp~f~~~~ 273 (644)
+|+|++|.+||...+..+....+.... .. +....+++++.++|.+|+ .+|.+|++ +.++++||||+...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 999999999999887766665554321 11 223457899999999986 59999997 99999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=385.47 Aligned_cols=253 Identities=28% Similarity=0.530 Sum_probs=219.6
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEG 97 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~G 97 (644)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||++++++|.. ...+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence 469999999999999999999999999976532 22334567889999999999999999998766 5679999999999
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCcccccc-ccccccccc
Q 006460 98 GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVV 175 (644)
Q Consensus 98 gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~~~~~~ 175 (644)
|+|..++... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.... .........
T Consensus 80 ~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 80 GELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 9999988753 458999999999999999999997 799999999999999999999999999987532 223344567
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.......+..... .+|..+++++.+||.+||..||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHhhcCHH
Confidence 99999999999998999999999999999999999999998888777777655443 46778899999999999999999
Q ss_pred CCC-----CHHHHhhCCCCchhhhh
Q 006460 256 HRP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 256 ~Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
+|+ ++.++++||||....+.
T Consensus 237 ~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 237 QRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred HhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 997 99999999999865443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=390.62 Aligned_cols=262 Identities=29% Similarity=0.508 Sum_probs=223.6
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
.....++|++.+.||+|+||.||+|.++.++..||+|++...... ......+.+|+.+++.++||||++++++|.+ +.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~ 116 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DK 116 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CC
Confidence 344678999999999999999999999999999999999754322 2233457789999999999999999998765 66
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 799999999999999998653 48999999999999999999999999999999999999999999999999998764
Q ss_pred ccc--ccccccCCCCCCChhhhcCC----CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC-CCCCCc--c
Q 006460 167 TED--LASSVVGTPNYMCPELLADI----PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS-ISPLPI--V 237 (644)
Q Consensus 167 ~~~--~~~~~~GT~~Y~APEvl~~~----~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~-~~~~p~--~ 237 (644)
... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+.... ...+|. .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence 332 22456899999999998653 37899999999999999999999999988877777775432 122333 5
Q ss_pred ccHHHHHHHHHHhccCCCC--CCCHHHHhhCCCCchhh
Q 006460 238 YSSTMKQIIKSMLRKNPEH--RPTASDLLRHPHLQPYL 273 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~--RpTa~eiL~hp~f~~~~ 273 (644)
++.++.+||++||..+|.+ |+|+.++++||||+...
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 7999999999999999988 99999999999997643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=376.29 Aligned_cols=263 Identities=26% Similarity=0.474 Sum_probs=237.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc------ccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK------QTEKFKRTALQEMDLISKL-NNPYIVKYKDAWV 82 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~------~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~ 82 (644)
..++.|.-.+.||.|..++|-++.++.+|..+|+|++.... ......+...+|+.||+++ +||||+++.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 56788999999999999999999999999999999996542 2334556778899999998 7999999999875
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
. +..+++|+|.|..|.|++++... ..++|.+.+.||+|++.|+.|||.++||||||||+|||++++.++||+|||++
T Consensus 94 s-~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 S-DAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred C-cchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence 4 67899999999999999999864 46999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccCCCCCCChhhhc------CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---C
Q 006460 163 KLLNTEDLASSVVGTPNYMCPELLA------DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---P 233 (644)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APEvl~------~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---~ 233 (644)
+.+.++......||||+|+|||.+. ..+|+..+|+|++|+|||-|+.|.+||......-+++.|..+.+. +
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 9999998899999999999999884 346899999999999999999999999998888888888877654 3
Q ss_pred CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhh
Q 006460 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 234 ~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~ 275 (644)
.+..++...++||.+||+.||.+|+|+.|+|.||||+++...
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 445678999999999999999999999999999999988754
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=390.77 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=217.9
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+++|+.++||||++++++|.+ +..+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEE
Confidence 479999999999999999999999999999999875432 22234567889999999999999999998876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc---
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE--- 168 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~--- 168 (644)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 80 ~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 80 MDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999999763 45899999999999999999999999999999999999999999999999997532100
Q ss_pred -----------------------------------------cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHH
Q 006460 169 -----------------------------------------DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEI 207 (644)
Q Consensus 169 -----------------------------------------~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeL 207 (644)
......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 011235799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhccC---CCCCCccccHHHHHHHHHHhccCCCCCC---CHHHHhhCCCCchhh
Q 006460 208 AAHQPAFRAPDMAGLINKINRSS---ISPLPIVYSSTMKQIIKSMLRKNPEHRP---TASDLLRHPHLQPYL 273 (644)
Q Consensus 208 ltG~~PF~~~~~~el~~~i~~~~---~~~~p~~~s~~l~dLI~~~L~~dP~~Rp---Ta~eiL~hp~f~~~~ 273 (644)
++|++||.+....+....+.... ..+....++.++.+||.+|+ .+|.+|+ |+.++++||||+...
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99999999888776666554321 11223357899999999977 5999999 999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=376.93 Aligned_cols=258 Identities=27% Similarity=0.443 Sum_probs=210.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+.++|++.++||+|+||.||+|.++.+++.||+|++....... ....+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 80 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTL 80 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEE
Confidence 4589999999999999999999999999999999997553222 23456789999999999999999998876 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-c
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-D 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~ 169 (644)
||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 81 v~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 81 VFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 99999 56888887653 345899999999999999999999999999999999999999999999999998754322 2
Q ss_pred ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhccCCCC--------------
Q 006460 170 LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINRSSISP-------------- 233 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i~~~~~~~-------------- 233 (644)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.. ....+..+......+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 3345678999999999865 458899999999999999999999997643 223332221100000
Q ss_pred --------CC---------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 234 --------LP---------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 234 --------~p---------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+ ..++..+.+|+.+||+.||.+|||+.++|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 1135678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=385.81 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=216.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG---- 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~---- 85 (644)
..+++|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+++.++||||++++++|....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 5679999999999999999999999999999999999766544555667889999999999999999999886533
Q ss_pred -ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 86 -NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 86 -~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
..+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 357999999965 66666542 388999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC--------------
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS-------------- 230 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~-------------- 230 (644)
...........||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 655444556789999999999999999999999999999999999999998776443322211100
Q ss_pred -------CC--------------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 231 -------IS--------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 231 -------~~--------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+ ......+..+++||.+||..||.+|||+.|+|+||||..+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 00 0111246789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=383.34 Aligned_cols=252 Identities=25% Similarity=0.484 Sum_probs=219.1
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.++.+++.||+|++..... .......+.+|..++..+ +||||+++++++.. ...+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence 469999999999999999999999999976432 223345677888888876 69999999998766 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-ccccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~~~~~~ 175 (644)
||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .........
T Consensus 80 ~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 80 GGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 99999988764 458999999999999999999999999999999999999999999999999987532 223345568
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..++...+..... ..|..++.++.+||.+||+.||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~ 236 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMTKNPT 236 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHH
Confidence 99999999999998999999999999999999999999999988888887765543 45667899999999999999999
Q ss_pred CCCCH------HHHhhCCCCchhhh
Q 006460 256 HRPTA------SDLLRHPHLQPYLL 274 (644)
Q Consensus 256 ~RpTa------~eiL~hp~f~~~~~ 274 (644)
+||++ .++++||||....+
T Consensus 237 ~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 237 MRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred HCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 99998 99999999986544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=382.16 Aligned_cols=253 Identities=26% Similarity=0.490 Sum_probs=220.0
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.++.+++.||+|++..... .......+..|.+++..+ +||||++++++|.. ...+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence 369999999999999999999999999976532 223445677899999866 79999999998876 457999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-ccccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~~~~~~ 175 (644)
|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+
T Consensus 80 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 80 GGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 99999998753 458999999999999999999999999999999999999999999999999987532 223344567
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|++||...+..+....+..... ..|..++.++.+||.+||..||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp~ 236 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNPN 236 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCHH
Confidence 99999999999998999999999999999999999999999998888888776543 35667899999999999999999
Q ss_pred CCC-------CHHHHhhCCCCchhhhh
Q 006460 256 HRP-------TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 256 ~Rp-------Ta~eiL~hp~f~~~~~~ 275 (644)
+|| ++.++++||||....+.
T Consensus 237 ~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 237 KRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred HcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 999 99999999999765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=371.99 Aligned_cols=255 Identities=29% Similarity=0.485 Sum_probs=212.7
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc---CCCCcceeeeEEEeC----Cc
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL---NNPYIVKYKDAWVDK----GN 86 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HPNIVkl~~~~~d~----~~ 86 (644)
+|++.+.||+|+||.||+|.++.+++.||+|.++...........+.+|+.+++.+ +||||++++++|... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999876433222233455677776655 799999999987642 34
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+++||||+. ++|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 6899999996 589998876555568999999999999999999999999999999999999999999999999998766
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC----------------
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS---------------- 230 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~---------------- 230 (644)
.........||+.|+|||++.+..++.++|||||||++|+|++|.+||......+.+..+....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 5444556678999999999998899999999999999999999999998877665554443210
Q ss_pred --CC--------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 231 --IS--------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 231 --~~--------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.. .....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0112357789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=390.22 Aligned_cols=255 Identities=24% Similarity=0.452 Sum_probs=224.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+.+..+.+.||.|+||.||+|.+..+. .||+|++..........+.|.+|+.+|.+|+|||||++++++.+....++
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 44566677788999999999999887543 29999998876665557889999999999999999999999877543689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccccCCCCcEEEcCCC-CeEEeccCccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR-VLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNT 167 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g-IIHRDLKPeNILL~~~g-~vKL~DFGls~~~~~ 167 (644)
|||||+.+|+|..++.......++...+..|+.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999999998754567999999999999999999999999 99999999999999997 999999999998665
Q ss_pred c-cccccccCCCCCCChhhhc--CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHh-ccCCCCCCccccHHHH
Q 006460 168 E-DLASSVVGTPNYMCPELLA--DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKIN-RSSISPLPIVYSSTMK 243 (644)
Q Consensus 168 ~-~~~~~~~GT~~Y~APEvl~--~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~-~~~~~~~p~~~s~~l~ 243 (644)
. ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||.+.........+. ....+.+|..+++.+.
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 4 3344478999999999999 6689999999999999999999999999988766666664 5666777888999999
Q ss_pred HHHHHHhccCCCCCCCHHHHhh
Q 006460 244 QIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.|+.+||..||.+||++.+|+.
T Consensus 277 ~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999975
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=380.43 Aligned_cols=258 Identities=24% Similarity=0.463 Sum_probs=223.5
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+|++.+.||+|+||.||+|.+..++..||+|++..... .......+..|..++..+ .||+|+++++++.. ...+|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence 69999999999999999999999999999999976532 222345567788888877 58899999988765 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-ccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-~~~ 170 (644)
|||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 ~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 80 MEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 9999999999998753 3589999999999999999999999999999999999999999999999999975432 223
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHh
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L 250 (644)
....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...+...+..... .+|..++.++.+|+.+||
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~l 236 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLM 236 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCcCCHHHHHHHHHHc
Confidence 4457899999999999999999999999999999999999999999988888888776543 467788999999999999
Q ss_pred ccCCCCCCC-----HHHHhhCCCCchhhhh
Q 006460 251 RKNPEHRPT-----ASDLLRHPHLQPYLLR 275 (644)
Q Consensus 251 ~~dP~~RpT-----a~eiL~hp~f~~~~~~ 275 (644)
+.+|.+|++ ..++++||||....+.
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 237 TKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred ccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999999998 4899999999765444
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=382.19 Aligned_cols=252 Identities=28% Similarity=0.498 Sum_probs=213.4
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.++.+++.||+|+++..... ......+.+|..+++.+ +||||++++++|.+ ...+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence 4699999999999999999999999999865332 23455678899999988 79999999998766 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc-cccccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~-~~~~~~~~~~ 175 (644)
||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... .........+
T Consensus 80 ~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 80 GGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 99999988753 46999999999999999999999999999999999999999999999999998752 2333445678
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHhccCCCCCCccccHHHHHHH
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD--------MAG-LINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~--------~~e-l~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|+.||.... ... ..+.+. .....+|..++..+.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKASSVL 236 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-cCCCCCCCCCCHHHHHHH
Confidence 9999999999999999999999999999999999999996321 112 233333 333457778899999999
Q ss_pred HHHhccCCCCCCC------HHHHhhCCCCchhhh
Q 006460 247 KSMLRKNPEHRPT------ASDLLRHPHLQPYLL 274 (644)
Q Consensus 247 ~~~L~~dP~~RpT------a~eiL~hp~f~~~~~ 274 (644)
.+||..||.+|+| ++++++||||....+
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999999987 799999999975433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=385.06 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=218.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG---- 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~---- 85 (644)
..+++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||++++++|....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4679999999999999999999999999999999999765544555667889999999999999999999875432
Q ss_pred -ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 86 -NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 86 -~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
..+|+||||+. ++|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 45899999995 577777753 378999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-----------
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----------- 233 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----------- 233 (644)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 665545566789999999999999999999999999999999999999998877655544432211100
Q ss_pred ------------------------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 234 ------------------------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 234 ------------------------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.....+..+++||.+||..||.+|||+.++|+||||+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 011134678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=359.71 Aligned_cols=256 Identities=41% Similarity=0.878 Sum_probs=229.6
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.+.||+|++|.||+|.++.+++.||+|.+..........+.+.+|++++++++|||++++++.+...+..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 59999999999999999999999999999999977655555567788999999999999999999987655667899999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~~ 172 (644)
|+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+... ....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 999999999998755566899999999999999999999999999999999999999999999999999865432 2334
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
...+++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....+..+..++..+.+|+.+||..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSK 240 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhcc
Confidence 56789999999999998899999999999999999999999998887777777766666667778899999999999999
Q ss_pred CCCCCCCHHHHhhCCCC
Q 006460 253 NPEHRPTASDLLRHPHL 269 (644)
Q Consensus 253 dP~~RpTa~eiL~hp~f 269 (644)
+|.+|||+.++++||||
T Consensus 241 ~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 241 RPEKRPSVKSILRQPYI 257 (257)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=389.15 Aligned_cols=259 Identities=30% Similarity=0.534 Sum_probs=220.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
...++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++||||++++++|.+ +..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEE
Confidence 456799999999999999999999999999999999975432 22234567789999999999999999998766 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+|||||.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999999999653 4899999999999999999999999999999999999999999999999999876433
Q ss_pred cc--cccccCCCCCCChhhhcCCC----CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-CCCC--cccc
Q 006460 169 DL--ASSVVGTPNYMCPELLADIP----YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI-SPLP--IVYS 239 (644)
Q Consensus 169 ~~--~~~~~GT~~Y~APEvl~~~~----ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~-~~~p--~~~s 239 (644)
.. ..+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+..... ..+| ..++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 22 24568999999999987643 78999999999999999999999999888777777765322 2233 3468
Q ss_pred HHHHHHHHHHhccCCCC--CCCHHHHhhCCCCchh
Q 006460 240 STMKQIIKSMLRKNPEH--RPTASDLLRHPHLQPY 272 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~--RpTa~eiL~hp~f~~~ 272 (644)
..+++++.+||..+|.+ |+|+.++++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999865544 8999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=378.36 Aligned_cols=256 Identities=30% Similarity=0.508 Sum_probs=219.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++++.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++|++++||||+++++++.. +..+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEE
Confidence 3579999999999999999999999999999999997653 34456778999999999999999999999877 457999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
||||+.|++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..... .
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-S 157 (331)
T ss_pred EeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-c
Confidence 99999999999999764 3589999999999999999999986 699999999999999999999999999986543 2
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhc---------------------
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR--------------------- 228 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~--------------------- 228 (644)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 34556799999999999998999999999999999999999999987665544332211
Q ss_pred -------------------------cCCCCC-CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 229 -------------------------SSISPL-PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 229 -------------------------~~~~~~-p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
...+.. ...++.++.+||.+||.+||++|||+.+||+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 111111 1246889999999999999999999999999999974
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=379.52 Aligned_cols=256 Identities=27% Similarity=0.495 Sum_probs=214.9
Q ss_pred CeEEEEEeccCCCeEEEEEEEe---cCCeEEEEEEEecccc--cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCce
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~ 87 (644)
+|++++.||+|+||.||+|.+. .+++.||+|++..... .....+.+.+|+.+|+.+ +||||++++++|.. +..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence 5999999999999999999874 4789999999976432 223345678899999999 59999999998765 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999998753 4589999999999999999999999999999999999999999999999999986533
Q ss_pred cc--ccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhccCCCCCCccccH
Q 006460 168 ED--LASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSISPLPIVYSS 240 (644)
Q Consensus 168 ~~--~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~----~~el~~~i~~~~~~~~p~~~s~ 240 (644)
.. .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ...+...+.. ...+++..++.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIGP 236 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCH
Confidence 22 23356799999999999765 47899999999999999999999996432 2333333333 33456777899
Q ss_pred HHHHHHHHHhccCCCCCC-----CHHHHhhCCCCchhh
Q 006460 241 TMKQIIKSMLRKNPEHRP-----TASDLLRHPHLQPYL 273 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~Rp-----Ta~eiL~hp~f~~~~ 273 (644)
.+.+||.+||..||.+|| +++++++||||+...
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999999999 889999999997643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=384.15 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=218.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG---- 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~---- 85 (644)
..+++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||++++++|....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 5689999999999999999999999999999999999776555555677889999999999999999999886432
Q ss_pred -ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 86 -NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 86 -~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
..+|+||||+.+ +|...+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999965 67776643 388999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-------------
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI------------- 231 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~------------- 231 (644)
...........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 6655455667899999999999999999999999999999999999999988765443332211000
Q ss_pred ----------------------------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 232 ----------------------------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 232 ----------------------------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
...+...+..+++||.+||..||.+|||+.++|+||||+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 001122356789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=383.34 Aligned_cols=265 Identities=26% Similarity=0.479 Sum_probs=234.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
--+++|++++.||.|.-|.||+|..+.++..+|+|++.+.... .+...++..|-.||+.++||.++.+|.+|.. +.+.
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~ 152 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-DKYS 152 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-ccee
Confidence 4567899999999999999999999999999999999876433 3445677889999999999999999998754 7899
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT- 167 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~- 167 (644)
|+|||||.||+|..++++..+..|++..++.|+..++.||+|||..|||+|||||+||||.++|++.|.||.|+.....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999853210
Q ss_pred --------------------------------c-c-----------------------ccccccCCCCCCChhhhcCCCC
Q 006460 168 --------------------------------E-D-----------------------LASSVVGTPNYMCPELLADIPY 191 (644)
Q Consensus 168 --------------------------------~-~-----------------------~~~~~~GT~~Y~APEvl~~~~y 191 (644)
. . ....++||-.|+|||++.+.+.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 1134689999999999999999
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-CCCccccHHHHHHHHHHhccCCCCCCC----HHHHhhC
Q 006460 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-PLPIVYSSTMKQIIKSMLRKNPEHRPT----ASDLLRH 266 (644)
Q Consensus 192 s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~-~~p~~~s~~l~dLI~~~L~~dP~~RpT----a~eiL~h 266 (644)
+.++|||+|||++|||+.|..||.+.+..+.+..|...... +-...++..++|||+++|.+||.+|.. +.||-+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 99999999999999999999999999999888888755432 112256899999999999999999998 9999999
Q ss_pred CCCchhhhh
Q 006460 267 PHLQPYLLR 275 (644)
Q Consensus 267 p~f~~~~~~ 275 (644)
|||++..|.
T Consensus 393 pFF~gVnWa 401 (459)
T KOG0610|consen 393 PFFEGVNWA 401 (459)
T ss_pred ccccCCChh
Confidence 999987765
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=381.55 Aligned_cols=252 Identities=29% Similarity=0.502 Sum_probs=220.3
Q ss_pred EEeccCCCeEEEEEEEe---cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEecc
Q 006460 19 EQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYC 95 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~ 95 (644)
+.||+|+||.||++.+. .+++.||+|++............+.+|+++|++++||||++++++|.. +..+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCC
Confidence 67999999999999874 578999999998655444445567889999999999999999998876 56799999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cccccc
Q 006460 96 EGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSV 174 (644)
Q Consensus 96 ~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~~~~ 174 (644)
.|++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 99999999865 345899999999999999999999999999999999999999999999999999865433 234456
Q ss_pred cCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCC
Q 006460 175 VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNP 254 (644)
Q Consensus 175 ~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP 254 (644)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .+|..++..+.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhcCH
Confidence 899999999999998899999999999999999999999999888887777765543 4677789999999999999999
Q ss_pred CCCCC-----HHHHhhCCCCchhhh
Q 006460 255 EHRPT-----ASDLLRHPHLQPYLL 274 (644)
Q Consensus 255 ~~RpT-----a~eiL~hp~f~~~~~ 274 (644)
.+||+ +.+++.||||....+
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 99999 788999999986543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=385.78 Aligned_cols=259 Identities=28% Similarity=0.480 Sum_probs=220.7
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++++.||+|+||.||+|.++.+++.||+|+++.... .......+.+|+.++..++||||+++++.|.+ ...+|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 579999999999999999999999999999999976432 23345677889999999999999999998766 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-- 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-- 169 (644)
||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 80 MEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999999763 458999999999999999999999999999999999999999999999999987542110
Q ss_pred ----------------------------------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCC
Q 006460 170 ----------------------------------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFR 215 (644)
Q Consensus 170 ----------------------------------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~ 215 (644)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 1124579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHhccC-CCCCC--ccccHHHHHHHHHHhccCCCCCC---CHHHHhhCCCCchhhhh
Q 006460 216 APDMAGLINKINRSS-ISPLP--IVYSSTMKQIIKSMLRKNPEHRP---TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 216 ~~~~~el~~~i~~~~-~~~~p--~~~s~~l~dLI~~~L~~dP~~Rp---Ta~eiL~hp~f~~~~~~ 275 (644)
..........+.... ...+| ..++.++++||.+|+ .+|.+|+ ++.+++.||||+...|.
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence 888877777665422 11222 236899999999987 5999998 58999999999876544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=379.61 Aligned_cols=252 Identities=27% Similarity=0.499 Sum_probs=215.6
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHH-HHHhcCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMD-LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~-iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.++.+++.||+|++...... ......+++|.. +++.++||||++++++|.. ...+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence 4699999999999999999999999999765321 222344555554 5678999999999998866 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-ccccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~~~~~~ 175 (644)
||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+
T Consensus 80 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 9999999876 3468999999999999999999999999999999999999999999999999987532 223344568
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+....+...... .+..++..+.+||.+||+.||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR-LKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHHhhcCHH
Confidence 999999999999999999999999999999999999999998888887777665443 4556799999999999999999
Q ss_pred CCCCH----HHHhhCCCCchhhh
Q 006460 256 HRPTA----SDLLRHPHLQPYLL 274 (644)
Q Consensus 256 ~RpTa----~eiL~hp~f~~~~~ 274 (644)
+||++ .++++||||....+
T Consensus 237 ~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 237 KRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred hCCCCCCCHHHHHcCCCcCCCCH
Confidence 99987 69999999976544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=378.94 Aligned_cols=252 Identities=27% Similarity=0.525 Sum_probs=218.3
Q ss_pred EEEeccCCCeEEEEEEEe---cCCeEEEEEEEecccc--cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 18 IEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~--~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++.||+|+||.||+|.+. .+++.||+|++..... .......+.+|+.+|+.++||||++++++|.. +..+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEE
Confidence 368999999999999874 4688999999976432 22334567789999999999999999998876 56799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-cccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLA 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-~~~~ 171 (644)
||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 80 EYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred eCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 999999999999763 4588999999999999999999999999999999999999999999999999875322 2233
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhc
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~ 251 (644)
....||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......+..... .+|..++..+.+||.+||.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-NLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHcc
Confidence 456799999999999998899999999999999999999999999888877777766543 4677789999999999999
Q ss_pred cCCCCCC-----CHHHHhhCCCCchhh
Q 006460 252 KNPEHRP-----TASDLLRHPHLQPYL 273 (644)
Q Consensus 252 ~dP~~Rp-----Ta~eiL~hp~f~~~~ 273 (644)
.+|.+|| ++.+++.||||....
T Consensus 237 ~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred cCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999 899999999997543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=378.79 Aligned_cols=259 Identities=28% Similarity=0.475 Sum_probs=221.9
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.+.||+|+||.||+|.++.+++.||+|+++.... .......+.+|+.+++.++||||+++++++.+ ...+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEE
Confidence 579999999999999999999999999999999986543 23345667889999999999999999998766 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
|||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 80 MEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred ECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999999999865 24699999999999999999999999999999999999999999999999999987644322
Q ss_pred -cccccCCCCCCChhhhc------CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC-CCCCC--ccccH
Q 006460 171 -ASSVVGTPNYMCPELLA------DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS-ISPLP--IVYSS 240 (644)
Q Consensus 171 -~~~~~GT~~Y~APEvl~------~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~-~~~~p--~~~s~ 240 (644)
.....||+.|+|||++. ...|+.++|||||||++|+|++|..||........+..+.... ...+| ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 23357999999999986 4567899999999999999999999999888777666664432 11222 35789
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
.+.+||.+||. +|.+|||+.+++.||||....+
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 99999999997 9999999999999999986543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=395.10 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=212.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC------
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK------ 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~------ 84 (644)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+|+.++|||||+++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 4468999999999999999999999999999999886432 1234699999999999999999987532
Q ss_pred -CceEEEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-CeEEeccC
Q 006460 85 -GNCVCIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFG 160 (644)
Q Consensus 85 -~~~~~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-~vKL~DFG 160 (644)
..++++||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 235789999995 5787777542 345689999999999999999999999999999999999999665 69999999
Q ss_pred cccccccccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC---------
Q 006460 161 LAKLLNTEDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS--------- 230 (644)
Q Consensus 161 ls~~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~--------- 230 (644)
+++.+..........||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+....+.+..+....
T Consensus 217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 99876555545567899999999988664 68999999999999999999999999877655544443210
Q ss_pred ----------CC---------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 231 ----------IS---------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 231 ----------~~---------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
++ .+|...+.++.+||.+||.+||.+|||+.++|.||||..+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00 12334678999999999999999999999999999997654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=400.35 Aligned_cols=265 Identities=28% Similarity=0.518 Sum_probs=236.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC---
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG--- 85 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~--- 85 (644)
...-++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+|..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34568999999999999999999999999999999999877666666677889999999999999999988775432
Q ss_pred ----ceEEEEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEecc
Q 006460 86 ----NCVCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDF 159 (644)
Q Consensus 86 ----~~~~LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DF 159 (644)
..+++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 14789999999999999987532 346899999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc---cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCc
Q 006460 160 GLAKLLNTE---DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI 236 (644)
Q Consensus 160 Gls~~~~~~---~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~ 236 (644)
|+++.+... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+....+++..+......++|.
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 267 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 999865432 23456789999999999999899999999999999999999999999999888888888777778888
Q ss_pred cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.+++++.+|+.+||..||.+||++.++++|||++.+.
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 8999999999999999999999999999999987654
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=378.27 Aligned_cols=253 Identities=23% Similarity=0.467 Sum_probs=217.1
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.++.++..||+|.++..... ......+..|..++..+ +||||++++++|.+ ..++|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence 4699999999999999999999999999765321 12344567788888754 89999999998876 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-cccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-~~~~~~~~ 175 (644)
|++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+
T Consensus 80 ~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 80 GGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 99999998763 4589999999999999999999999999999999999999999999999999875321 22345578
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.......+... ...+|..++.++.+||.+||..||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~ 236 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFERDPT 236 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999988888777776544 3456777899999999999999999
Q ss_pred CCCCH-HHHhhCCCCchhhhh
Q 006460 256 HRPTA-SDLLRHPHLQPYLLR 275 (644)
Q Consensus 256 ~RpTa-~eiL~hp~f~~~~~~ 275 (644)
+||++ +++++||||....+.
T Consensus 237 ~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 237 RRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred HcCCChHHHHcCCCcCCCCHH
Confidence 99997 589999999865443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=369.73 Aligned_cols=260 Identities=26% Similarity=0.472 Sum_probs=220.5
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.++++++|+||+++++.+.+ +..+|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEE
Confidence 488999999999999999999999999999998764322 2334567789999999999999999998876 46799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~ 172 (644)
||+.|++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 99999999999876555569999999999999999999999999999999999999999999999999997655444444
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA---GLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~---el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
...|++.|+|||++.+..++.++|||||||++|+|++|.+||...... +....+........+..++.++.+|+.+|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 568999999999999989999999999999999999999999865421 22222222222335567889999999999
Q ss_pred hccCCCCCCC-----HHHHhhCCCCchhhh
Q 006460 250 LRKNPEHRPT-----ASDLLRHPHLQPYLL 274 (644)
Q Consensus 250 L~~dP~~RpT-----a~eiL~hp~f~~~~~ 274 (644)
|+.||.+||| +.++++||||....+
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 9999999999 999999999976433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=379.67 Aligned_cols=253 Identities=28% Similarity=0.498 Sum_probs=212.9
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.++.++ +||||+++++++.. ...+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence 469999999999999999999999999986532 223445677899988876 79999999998876 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-ccccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~~~~~~ 175 (644)
|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+
T Consensus 80 ~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 80 GGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 99999988753 459999999999999999999999999999999999999999999999999987532 223345578
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHhccCCCCCCccccHHHHHHH
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD--------MAG-LINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~--------~~e-l~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
||+.|+|||++.+..++.++|||||||++|+|++|..||.... ... +...+. .....+|..++..+.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKAASVL 236 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCCCCCCHHHHHHH
Confidence 9999999999999999999999999999999999999995211 112 233333 333457788899999999
Q ss_pred HHHhccCCCCCCC------HHHHhhCCCCchhhhh
Q 006460 247 KSMLRKNPEHRPT------ASDLLRHPHLQPYLLR 275 (644)
Q Consensus 247 ~~~L~~dP~~RpT------a~eiL~hp~f~~~~~~ 275 (644)
++||..||.+||| +.++++||||....+.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 9999999999998 5899999999865443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=374.96 Aligned_cols=252 Identities=27% Similarity=0.510 Sum_probs=219.0
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.++.++..||+|+++.... .......+.+|..+++.+ +||||+++++++.. ...+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 469999999999999999999999999986532 223345677899999888 69999999998766 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-ccccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~~~~~~ 175 (644)
|++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+
T Consensus 80 ~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 80 GGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 99999988763 359999999999999999999999999999999999999999999999999987532 222334567
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... ..|..++..+.+||.+||..||.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dP~ 236 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFLTKNPE 236 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHccCCHH
Confidence 99999999999999999999999999999999999999998888877777765543 46677899999999999999999
Q ss_pred CCCCH-----HHHhhCCCCchhhh
Q 006460 256 HRPTA-----SDLLRHPHLQPYLL 274 (644)
Q Consensus 256 ~RpTa-----~eiL~hp~f~~~~~ 274 (644)
+|||+ .+++.||||....+
T Consensus 237 ~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 237 KRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred HcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999 99999999976443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=368.08 Aligned_cols=254 Identities=29% Similarity=0.505 Sum_probs=212.8
Q ss_pred eccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCC
Q 006460 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGD 99 (644)
Q Consensus 21 LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~Ggs 99 (644)
||+|+||.||+|.++.+++.||+|.+....... .....+..|+++|+.++||||++++++|.. ...+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence 799999999999999999999999987653222 233567789999999999999999998765 567999999999999
Q ss_pred HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-ccccccC
Q 006460 100 MAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVG 176 (644)
Q Consensus 100 L~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~~~~~G 176 (644)
|..++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+.... ......|
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 99887542 23468999999999999999999999999999999999999999999999999997654432 2334679
Q ss_pred CCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH----HHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA----GLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 177 T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~----el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+... ....+..++..+.+|+.+||..
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHHHHhcC
Confidence 99999999999999999999999999999999999999765432 222222222 2345567899999999999999
Q ss_pred CCCCCC-----CHHHHhhCCCCchhhhhc
Q 006460 253 NPEHRP-----TASDLLRHPHLQPYLLRC 276 (644)
Q Consensus 253 dP~~Rp-----Ta~eiL~hp~f~~~~~~~ 276 (644)
||.+|| +++++++||||+...+..
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred CHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 999999 889999999998755443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=355.16 Aligned_cols=255 Identities=37% Similarity=0.754 Sum_probs=230.7
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|.+.+.||+|+||.||+|.+..++..|++|.+............+.+|+++++.++||||+++++++.. ...+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEE
Confidence 5899999999999999999999999999999998765556667788999999999999999999998876 467999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-ccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~~ 172 (644)
|+.|++|.+++....+..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+.... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 9999999999987655679999999999999999999999999999999999999999999999999988654432 233
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.....++.+..++..+.+++.+||+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence 45789999999999988899999999999999999999999998888777787777777777778899999999999999
Q ss_pred CCCCCCCHHHHhhCCCC
Q 006460 253 NPEHRPTASDLLRHPHL 269 (644)
Q Consensus 253 dP~~RpTa~eiL~hp~f 269 (644)
+|++||++.++++|||+
T Consensus 240 ~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 240 DYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CcccCcCHHHHhhCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=389.27 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=241.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.-+-|.+.+.||+|.|++|-+|+|.-+|.+||||++.+.+.+......+++|++.|+.++|||||++|++ .+....+||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-iDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-IDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-hcccceEEE
Confidence 4467899999999999999999999999999999999998888778889999999999999999999998 466677999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc-CCCCeEEeccCccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT-KDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~-~~g~vKL~DFGls~~~~~~~ 169 (644)
|+|+-+||+|++||-+.. ..+.|+.+++|+.||+.|+.|||+..+|||||||+||.+- +-|-|||.|||++-.+.++.
T Consensus 95 iLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999998754 4599999999999999999999999999999999998664 66899999999999999999
Q ss_pred ccccccCCCCCCChhhhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYG-YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys-~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
...+.||++.|-|||++.+..|+ +++||||||||||.|+||++||+..+..+.+-.|....+. .|..++.++++||..
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt-vPshvS~eCrdLI~s 252 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT-VPSHVSKECRDLIQS 252 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc-CchhhhHHHHHHHHH
Confidence 99999999999999999999995 6899999999999999999999999999999999888765 789999999999999
Q ss_pred HhccCCCCCCCHHHHhhCCCCchhh
Q 006460 249 MLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
||..||++|.+.++|..++|+++.-
T Consensus 253 MLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHhcCchhhccHHHHhccccccCCC
Confidence 9999999999999999999998643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=395.32 Aligned_cols=257 Identities=32% Similarity=0.591 Sum_probs=232.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.-..|..+.+||+|.||.||+|.+..+++.||+|++........ .+.+.+|+.+|.++++|||.++|+.|.. +..+++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~-g~~Lwi 88 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWI 88 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheee-cccHHH
Confidence 34578889999999999999999999999999999988754433 5678889999999999999999999887 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
+||||.||++.++++. +..+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++..+....
T Consensus 89 iMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999999975 4456899999999999999999999999999999999999999999999999998875543
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
...+++|||.|||||++.+..|+.++||||||++.|||++|.||+....++..+..|.+...+.+...+++.+++||..|
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 34789999999999999999999999999999999999999999998888777777777777777778999999999999
Q ss_pred hccCCCCCCCHHHHhhCCCCch
Q 006460 250 LRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
|.+||+.||+|.++|+|+|++.
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHh
Confidence 9999999999999999999974
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=368.00 Aligned_cols=253 Identities=27% Similarity=0.467 Sum_probs=212.1
Q ss_pred eccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCC
Q 006460 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGD 99 (644)
Q Consensus 21 LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~Ggs 99 (644)
||+|+||.||+|.++.+|+.||+|.+....... .....+..|+.++++++||||++++++|.. +..+|+||||+.|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence 799999999999999999999999996543221 223455679999999999999999998765 567999999999999
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccccccCCCC
Q 006460 100 MAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN 179 (644)
Q Consensus 100 L~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~ 179 (644)
|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.............|++.
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 99988765555689999999999999999999999999999999999999999999999999987655444445679999
Q ss_pred CCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM----AGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 180 Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~----~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
|+|||++.+..++.++|||||||++|+|++|.+||..... ......+...........++.++.+||.+||.+||.
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 9999999988899999999999999999999999976432 233333333332222346799999999999999999
Q ss_pred CCCCH----HHHhhCCCCchhhh
Q 006460 256 HRPTA----SDLLRHPHLQPYLL 274 (644)
Q Consensus 256 ~RpTa----~eiL~hp~f~~~~~ 274 (644)
+||++ .+++.||||+...+
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred hCCCCccchhhhhcChhhcCCCH
Confidence 99999 67889999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=376.05 Aligned_cols=252 Identities=24% Similarity=0.462 Sum_probs=216.2
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.+..+++.||+|+++..... ......+..|..++..+ +||||+++++++.. +..+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 4699999999999999999999999999765321 22344556677777654 89999999998765 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-cccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-~~~~~~~~ 175 (644)
||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus 80 gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 80 GGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 99999998763 3589999999999999999999999999999999999999999999999999975432 23344568
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..++...+... .+.+|..++.++.+||.+||..+|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P~ 236 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFERDPT 236 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999989999999999999999999999999998888777776543 4456778899999999999999999
Q ss_pred CCCCH-HHHhhCCCCchhhh
Q 006460 256 HRPTA-SDLLRHPHLQPYLL 274 (644)
Q Consensus 256 ~RpTa-~eiL~hp~f~~~~~ 274 (644)
+||++ .++++||||....+
T Consensus 237 ~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 237 KRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred HcCCChHHHHcCcccCCCCH
Confidence 99986 58899999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=384.10 Aligned_cols=260 Identities=31% Similarity=0.518 Sum_probs=220.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
....++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++||||++++++|.+ +.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~ 117 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRY 117 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCE
Confidence 4456899999999999999999999999999999999975432 22334567889999999999999999998866 577
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 99999999999999998753 489999999999999999999999999999999999999999999999999987643
Q ss_pred ccc--cccccCCCCCCChhhhcCCC----CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-CCC--Cccc
Q 006460 168 EDL--ASSVVGTPNYMCPELLADIP----YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI-SPL--PIVY 238 (644)
Q Consensus 168 ~~~--~~~~~GT~~Y~APEvl~~~~----ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~-~~~--p~~~ 238 (644)
... ....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||...+.......+..... ..+ +..+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 274 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCC
Confidence 322 23568999999999987543 78999999999999999999999999888877777764321 122 3357
Q ss_pred cHHHHHHHHHHhccCCCC--CCCHHHHhhCCCCchh
Q 006460 239 SSTMKQIIKSMLRKNPEH--RPTASDLLRHPHLQPY 272 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~--RpTa~eiL~hp~f~~~ 272 (644)
+..+++||.+||..++.+ |+++.++++||||+..
T Consensus 275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999999844443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=373.64 Aligned_cols=259 Identities=24% Similarity=0.474 Sum_probs=222.7
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~~LV 91 (644)
+|++.+.||+|+||.||+|.++.+++.||+|++..... .....+.+..|+.+++.+. ||+|+++++++.. ...+|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence 58899999999999999999999999999999976532 2223456778999998886 5677788887765 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~ 170 (644)
|||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 80 MEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 9999999999998753 45999999999999999999999999999999999999999999999999998764322 22
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHh
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L 250 (644)
.....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+..... ..|..++.++.+|+.+||
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l 236 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-SYPKSLSKEAVSICKGLM 236 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHc
Confidence 3456799999999999998999999999999999999999999999888888777766544 467778999999999999
Q ss_pred ccCCCCCCC-----HHHHhhCCCCchhhhhc
Q 006460 251 RKNPEHRPT-----ASDLLRHPHLQPYLLRC 276 (644)
Q Consensus 251 ~~dP~~RpT-----a~eiL~hp~f~~~~~~~ 276 (644)
.++|.+|++ ..++++||||....+..
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~ 267 (323)
T cd05615 237 TKHPSKRLGCGPEGERDIREHAFFRRIDWDK 267 (323)
T ss_pred ccCHhhCCCCCCCCHHHHhcCcccCCCCHHH
Confidence 999999997 57999999998765543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=381.12 Aligned_cols=255 Identities=29% Similarity=0.517 Sum_probs=214.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+++|+++++||+|+||.||+|.+..+++.||+|++.... .......+.+|+++|+.++||||++++++|.. +..+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEE
Confidence 35789999999999999999999999999999999986543 34456778899999999999999999998765 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
+||||+.+++|... ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 149 lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 149 VLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999999998653 23567888999999999999999999999999999999999999999999999875432
Q ss_pred cccccccCCCCCCChhhhcC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHhccCCCCCCccccH
Q 006460 169 DLASSVVGTPNYMCPELLAD-----IPYGYKSDIWSLGCCMFEIAAHQPAFRAPD---MAGLINKINRSSISPLPIVYSS 240 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~-----~~ys~ksDIWSLGvILyeLltG~~PF~~~~---~~el~~~i~~~~~~~~p~~~s~ 240 (644)
.......||..|+|||++.. ..++.++|||||||++|+|++|+.||.... ...+...+........+..++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 22345689999999998743 234579999999999999999999997433 2333334444444556677899
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
++.+||.+||..||.+|||+.++|+||||...
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 99999999999999999999999999999754
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=374.82 Aligned_cols=253 Identities=24% Similarity=0.455 Sum_probs=217.1
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHh-cCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISK-LNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~-L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.+..+++.||+|+++.... .......+..|..+++. ++||||+++++++.+ ...+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence 469999999999999999999999999976532 12223456678888876 489999999998876 457999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-cccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-~~~~~~~~ 175 (644)
||+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 80 ~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 80 GGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 99999999763 3589999999999999999999999999999999999999999999999999875322 22334567
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..++...+.... ...|..++.++.+||.+||..||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~ 236 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREPE 236 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCHh
Confidence 9999999999999899999999999999999999999999988888777776543 346667899999999999999999
Q ss_pred CCCCHH-HHhhCCCCchhhhh
Q 006460 256 HRPTAS-DLLRHPHLQPYLLR 275 (644)
Q Consensus 256 ~RpTa~-eiL~hp~f~~~~~~ 275 (644)
+||++. ++++||||....+.
T Consensus 237 ~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 237 RRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred hcCCChHHHHcCcccCCCCHH
Confidence 999996 89999999875443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=393.94 Aligned_cols=258 Identities=22% Similarity=0.449 Sum_probs=209.7
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC------CCCcceeeeEEEeCC
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN------NPYIVKYKDAWVDKG 85 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~------HPNIVkl~~~~~d~~ 85 (644)
.++|+++++||+|+||.||+|.+..+++.||||+++... ...+.+..|+++++.+. |+++++++++|....
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 478999999999999999999999999999999996432 22344556777777664 456899999887766
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCC------------
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDN------------ 152 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g------------ 152 (644)
..+|+||+++ |++|.+++.+. ..+++..++.|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 7899999999 88999988753 469999999999999999999998 5999999999999998765
Q ss_pred ----CeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhc
Q 006460 153 ----DIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR 228 (644)
Q Consensus 153 ----~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~ 228 (644)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+..
T Consensus 282 ~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 499999998865322 34567899999999999999999999999999999999999999988776554443322
Q ss_pred cCCC-------------------------C--CC--------------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCC
Q 006460 229 SSIS-------------------------P--LP--------------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267 (644)
Q Consensus 229 ~~~~-------------------------~--~p--------------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp 267 (644)
.... + .+ ...+..+.+||.+||++||.+|||+.|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 1100 0 00 01135678999999999999999999999999
Q ss_pred CCchhhhhcC
Q 006460 268 HLQPYLLRCQ 277 (644)
Q Consensus 268 ~f~~~~~~~~ 277 (644)
||..+...+.
T Consensus 440 ~~~~~~~~~~ 449 (467)
T PTZ00284 440 YVLKYYPECR 449 (467)
T ss_pred cccccCCccc
Confidence 9987665543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=375.23 Aligned_cols=253 Identities=27% Similarity=0.492 Sum_probs=214.2
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.++.++ +||||++++++|.. ...+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence 4799999999999999999999999999865332 23456678899999888 69999999998766 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc-cccccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~-~~~~~~~~~~ 175 (644)
|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... .........+
T Consensus 80 ~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 80 GGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 99999988753 35999999999999999999999999999999999999999999999999998753 2233345678
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC------ChH-HHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP------DMA-GLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~------~~~-el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|.+||... ... .....+. ......|..++..+.++|.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-hCCCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999532 122 2333333 33345777889999999999
Q ss_pred HhccCCCCCCC------HHHHhhCCCCchhhhh
Q 006460 249 MLRKNPEHRPT------ASDLLRHPHLQPYLLR 275 (644)
Q Consensus 249 ~L~~dP~~RpT------a~eiL~hp~f~~~~~~ 275 (644)
||..||.+|++ +.+++.||||....+.
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 99999999998 5799999999876544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=372.94 Aligned_cols=252 Identities=27% Similarity=0.497 Sum_probs=214.8
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHH-HHHhcCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMD-LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~-iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|.. +++.++||||++++++|.+ ...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 469999999999999999999999999976532 2223344555554 6788999999999998765 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc-cccccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~-~~~~~~~~~~ 175 (644)
|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. .........+
T Consensus 80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 80 GGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 9999988875 345899999999999999999999999999999999999999999999999998753 2223345568
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+...+...+.... ..+|...+..+.++|.+||+.+|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~ 236 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHKDQR 236 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHh
Confidence 9999999999998899999999999999999999999999988887777776554 346667899999999999999999
Q ss_pred CCCCH----HHHhhCCCCchhhh
Q 006460 256 HRPTA----SDLLRHPHLQPYLL 274 (644)
Q Consensus 256 ~RpTa----~eiL~hp~f~~~~~ 274 (644)
+||++ .++++||||....+
T Consensus 237 ~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 237 RRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred hcCCCCCCHHHHhCCCCcCCCCH
Confidence 99875 59999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=374.22 Aligned_cols=278 Identities=27% Similarity=0.533 Sum_probs=246.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
+..+++|..++.||+|+||.|.+|+.+.+++.||+|++++... .......-+.|-++|+.+.||.+..+...|+.. ..
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-dr 242 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-DR 242 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-ce
Confidence 3568999999999999999999999999999999999987642 223345567899999999999999998887764 56
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc-cc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LN 166 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~-~~ 166 (644)
+|+||||.+||.|+-.|.+. ..|+|...+.|...|++||.|||+++||+||||.+|+|++++|++||+|||+++. +.
T Consensus 243 lCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999999999764 4699999999999999999999999999999999999999999999999999985 45
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
.+....++||||.|+|||++.+..|+.++|+|.+|++||||+||+.||...+...++..|....+. +|..++++++.|+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k-FPr~ls~eAktLL 399 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK-FPRTLSPEAKTLL 399 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc-CCccCCHHHHHHH
Confidence 556788999999999999999999999999999999999999999999999998888888766654 7999999999999
Q ss_pred HHHhccCCCCCCC-----HHHHhhCCCCchhhhhcCCCCCcccCCCccc
Q 006460 247 KSMLRKNPEHRPT-----ASDLLRHPHLQPYLLRCQNPSSVYLPIKPTN 290 (644)
Q Consensus 247 ~~~L~~dP~~RpT-----a~eiL~hp~f~~~~~~~~~~~~~~~p~~p~~ 290 (644)
..+|.+||.+|.. +.+|.+|+||....|...-...+..|++|.-
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 9999999999954 7899999999888776655555666666644
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.99 Aligned_cols=253 Identities=27% Similarity=0.506 Sum_probs=214.7
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHH-HHHHhcCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEM-DLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi-~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.+..+++.||+|++...... ......+.+|. .+++.++||||++++++|.. ...+|+||||+.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence 4699999999999999999999999999764321 12223444444 45678899999999998766 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-ccccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~~~~~~ 175 (644)
|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+
T Consensus 80 ~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 80 GGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 99999999763 458899999999999999999999999999999999999999999999999997532 223345578
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+....+...... .+..++..+.++|.+||+.+|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~l~~~p~ 236 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ-LKPNITNSARHLLEGLLQKDRT 236 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC-CCCCCCHHHHHHHHHHcccCHH
Confidence 999999999999999999999999999999999999999998888877777655443 4556899999999999999999
Q ss_pred CCCCHH----HHhhCCCCchhhhh
Q 006460 256 HRPTAS----DLLRHPHLQPYLLR 275 (644)
Q Consensus 256 ~RpTa~----eiL~hp~f~~~~~~ 275 (644)
+|+++. ++++|+||.++.+.
T Consensus 237 ~R~~~~~~~~~i~~~~~~~~~~~~ 260 (325)
T cd05602 237 KRLGAKDDFMEIKNHIFFSPINWD 260 (325)
T ss_pred HCCCCCCCHHHHhcCcccCCCCHH
Confidence 999865 89999999876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=373.59 Aligned_cols=254 Identities=21% Similarity=0.394 Sum_probs=212.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~ 84 (644)
..++|++.++||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+|+++ +|||||+++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4579999999999999999999853 345789999987543 233456789999999999 899999999998776
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc--------------------------------------------------------
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR-------------------------------------------------------- 108 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~-------------------------------------------------------- 108 (644)
+..+|+||||++||+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 667999999999999999997532
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc---ccccccCCCCCC
Q 006460 109 ----GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYM 181 (644)
Q Consensus 109 ----~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~ 181 (644)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 1247788999999999999999999999999999999999999999999999998653321 122345678899
Q ss_pred ChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChH-HHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCC
Q 006460 182 CPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMA-GLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPT 259 (644)
Q Consensus 182 APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~-el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpT 259 (644)
|||++.+..|+.++|||||||++|+|++ |.+||.+.... .+...+........|..++..+.+|+.+||..||.+|||
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 323 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT 323 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999999899999999999999999997 99999875543 344445555555567778999999999999999999999
Q ss_pred HHHHhh
Q 006460 260 ASDLLR 265 (644)
Q Consensus 260 a~eiL~ 265 (644)
+.++++
T Consensus 324 ~~el~~ 329 (338)
T cd05102 324 FSALVE 329 (338)
T ss_pred HHHHHH
Confidence 999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=375.20 Aligned_cols=253 Identities=27% Similarity=0.497 Sum_probs=215.2
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHH-HHHhcCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMD-LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~-iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.++.+++.||+|++..... .......+.+|.. +++.++||||++++++|.. +..+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence 469999999999999999999999999976532 2223345555654 5677999999999998766 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-ccccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~~~~~~ 175 (644)
|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+
T Consensus 80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 9999998875 3468999999999999999999999999999999999999999999999999987532 223345568
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+....+...... .+...+..+.++|.+||..+|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~ll~~~p~ 236 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLV-LRPGASLTAWSILEELLEKDRQ 236 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCcc-CCCCCCHHHHHHHHHHhccCHH
Confidence 999999999999999999999999999999999999999998888887777665433 3445789999999999999999
Q ss_pred CCCCH----HHHhhCCCCchhhhh
Q 006460 256 HRPTA----SDLLRHPHLQPYLLR 275 (644)
Q Consensus 256 ~RpTa----~eiL~hp~f~~~~~~ 275 (644)
+||++ .+++.||||....+.
T Consensus 237 ~R~~~~~~~~~i~~h~~f~~~~~~ 260 (325)
T cd05604 237 RRLGAKEDFLEIQEHPFFESLSWT 260 (325)
T ss_pred hcCCCCCCHHHHhcCCCcCCCCHH
Confidence 99876 699999999865443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=372.06 Aligned_cols=261 Identities=29% Similarity=0.493 Sum_probs=218.5
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++||||++++++|.+ +..+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEE
Confidence 589999999999999999999999999999999975322 22334567889999999999999999998766 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
|||+.|++|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999999753 34689999999999999999999999999999999999999999999999999876543322
Q ss_pred -cccccCCCCCCChhhhcC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC----CCCCCccccH
Q 006460 171 -ASSVVGTPNYMCPELLAD-----IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS----ISPLPIVYSS 240 (644)
Q Consensus 171 -~~~~~GT~~Y~APEvl~~-----~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~----~~~~p~~~s~ 240 (644)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.... .++....++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 223569999999999863 457889999999999999999999999888777766664322 2222334789
Q ss_pred HHHHHHHHHhccCCCC--CCCHHHHhhCCCCchhhhh
Q 006460 241 TMKQIIKSMLRKNPEH--RPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~--RpTa~eiL~hp~f~~~~~~ 275 (644)
.+++||++||..++.+ |+++.++++||||....+.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~ 275 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence 9999999999765444 7899999999999765443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=378.02 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=215.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC---
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG--- 85 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~--- 85 (644)
....++|++++.||.|+||.||+|.+..++..||+|++............+.+|+++|++++||||++++++|....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34568999999999999999999999999999999999765444344566789999999999999999999875422
Q ss_pred --ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 86 --NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 86 --~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
..+|++++++ |++|..+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccce
Confidence 4579999998 8899988753 359999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-----------
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI----------- 231 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~----------- 231 (644)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.....
T Consensus 167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 7543 2345689999999999876 5689999999999999999999999987765544443321100
Q ss_pred -----------CCC--------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 232 -----------SPL--------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 232 -----------~~~--------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+.. ....++.+.+||.+||..||.+|||+.++|.||||..+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 000 11245678899999999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=361.62 Aligned_cols=260 Identities=27% Similarity=0.482 Sum_probs=221.8
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+++|+.++|+||++++++|.. +...|+||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEE
Confidence 488999999999999999999999999999998765332 2234557889999999999999999998766 56799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~ 172 (644)
||+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 99999999998876555579999999999999999999999999999999999999999999999999997655444445
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhc---cCCCCCCccccHHHHHHHHHH
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR---SSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~---~~~~~~p~~~s~~l~dLI~~~ 249 (644)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+.. ......+..++..+.+|+.+|
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 56899999999999888899999999999999999999999987665433333321 222334566789999999999
Q ss_pred hccCCCCCCC-----HHHHhhCCCCchhhh
Q 006460 250 LRKNPEHRPT-----ASDLLRHPHLQPYLL 274 (644)
Q Consensus 250 L~~dP~~RpT-----a~eiL~hp~f~~~~~ 274 (644)
|..||.+||+ +.+++.|+||..+.+
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 9999999999 899999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=376.34 Aligned_cols=250 Identities=30% Similarity=0.504 Sum_probs=212.6
Q ss_pred eccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhc---CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKL---NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 21 LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L---~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
||+|+||.||+|.++.+++.||+|++..... .........+|..++..+ .||||++++++|.. ...+|+||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence 7999999999999999999999999975432 122234456677777765 69999999998766 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-cccccccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVV 175 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-~~~~~~~~ 175 (644)
||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+
T Consensus 80 ~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 80 GGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999999875 34689999999999999999999999999999999999999999999999999875422 23345678
Q ss_pred CCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCC
Q 006460 176 GTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNP 254 (644)
Q Consensus 176 GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP 254 (644)
||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...........++.++.+||++||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence 99999999998754 58999999999999999999999999988888877776655443334579999999999999999
Q ss_pred CCCC----CHHHHhhCCCCchhh
Q 006460 255 EHRP----TASDLLRHPHLQPYL 273 (644)
Q Consensus 255 ~~Rp----Ta~eiL~hp~f~~~~ 273 (644)
.+|| ++.++++||||....
T Consensus 238 ~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 238 QHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HHCCCCCCCHHHHhcCccccCCC
Confidence 9998 799999999997544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=358.10 Aligned_cols=252 Identities=34% Similarity=0.637 Sum_probs=215.4
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEec
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGY 94 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy 94 (644)
|++++.||+|+||.||+|.+..+++.||+|++..............+|+.+++++.||||+++++++.. ....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence 899999999999999999999999999999999887666655566779999999999999999999877 5678899999
Q ss_pred cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc-cccccccc
Q 006460 95 CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASS 173 (644)
Q Consensus 95 ~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~-~~~~~~~~ 173 (644)
+.+++|.+++... ..+++..++.++.||+.||.+||++||+||||||+||+++.++.++|+|||.+... ........
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999843 35899999999999999999999999999999999999999999999999999753 23344556
Q ss_pred ccCCCCCCChhhhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHH---HHHHHhccCCC---CCCccccHHHHHHH
Q 006460 174 VVGTPNYMCPELLA-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG---LINKINRSSIS---PLPIVYSSTMKQII 246 (644)
Q Consensus 174 ~~GT~~Y~APEvl~-~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~e---l~~~i~~~~~~---~~p~~~s~~l~dLI 246 (644)
..+++.|+|||++. +..++.++||||||+++|+|++|..||....... ........... ......+..+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 78999999999998 7788999999999999999999999999873332 22222211110 01111248999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCC
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.+||..||.+|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=391.10 Aligned_cols=258 Identities=32% Similarity=0.522 Sum_probs=227.9
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecC-CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIE-RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~t-g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||+++++|.. +..+||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEE
Confidence 44599999999999999999998888 7889999775433 2334567789999999999999999999876 467999
Q ss_pred EEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 91 VTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
||||++||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999999988643 2446899999999999999999999999999999999999999999999999999875432
Q ss_pred c---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 169 D---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 169 ~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
. .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+++..+......+.|..++.++.+|
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 302 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKAL 302 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHH
Confidence 2 2445679999999999999899999999999999999999999999988888888887777777888899999999
Q ss_pred HHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 246 IKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
|.+||..+|.+||++.+++.|+|++..
T Consensus 303 i~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 999999999999999999999998643
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.43 Aligned_cols=255 Identities=36% Similarity=0.690 Sum_probs=229.4
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.+.||+|+||.||+|.+..++..+|+|.+............+.+|+++|+.++||||+++++.+.. +..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence 6999999999999999999999999999999998765555556788999999999999999999998765 567999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-CeEEeccCcccccccccccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-~vKL~DFGls~~~~~~~~~~ 172 (644)
|++|++|.+++....+..+++..+..++.|++.||.|||++||+||||+|+||+++.++ .+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999999999876556689999999999999999999999999999999999998654 58999999998776544445
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
...|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......+.+..++..+.+++.+||..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence 56789999999999988889999999999999999999999998888777777777766777888899999999999999
Q ss_pred CCCCCCCHHHHhhCCCC
Q 006460 253 NPEHRPTASDLLRHPHL 269 (644)
Q Consensus 253 dP~~RpTa~eiL~hp~f 269 (644)
+|.+|||+.+++.||||
T Consensus 240 ~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 240 DPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ChhhCCCHHHHhhCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=366.14 Aligned_cols=260 Identities=25% Similarity=0.443 Sum_probs=215.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
.++++|++.++||+|+||.||+|.++.++..||+|.++..... .....+.+|+.++++++||||+++++++.. +...|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 80 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLT 80 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEE
Confidence 3578999999999999999999999999999999998765322 223456789999999999999999998876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
+||||+.+ +|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 99999964 888888654 345899999999999999999999999999999999999999999999999999764332
Q ss_pred cccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC----------------
Q 006460 169 DLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---------------- 231 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~---------------- 231 (644)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22344578999999998865 4589999999999999999999999988776554443322100
Q ss_pred -----CC--------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 232 -----SP--------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 232 -----~~--------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+. ....++.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00 1123578899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=390.98 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=219.0
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-C-----CCcceeeeEEEeCCce
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-N-----PYIVKYKDAWVDKGNC 87 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-H-----PNIVkl~~~~~d~~~~ 87 (644)
+|.|++.||+|+||.|.+|++..|++.||||+++... .+..+...|++||..|+ | -|+|+++++|.. .++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-ccc
Confidence 8999999999999999999999999999999997653 46677788999999996 3 489999999887 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC--CeEEeccCccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN--DIRLGDFGLAKLL 165 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g--~vKL~DFGls~~~ 165 (644)
.|||+|.+ +-+|+++|+..+-.+|+...++.++.|||.||.+||+.||||+|||||||||..-+ .|||+|||.|+..
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 77999999998888899999999999999999999999999999999999998543 6999999999986
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC------------
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP------------ 233 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~------------ 233 (644)
... ..+.+.+..|+|||++.|.+|+.+.||||||||++||.+|.|.|.+.+..+++..|......|
T Consensus 342 ~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~ 419 (586)
T KOG0667|consen 342 SQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH 419 (586)
T ss_pred CCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence 542 338899999999999999999999999999999999999999999999888777762210000
Q ss_pred ---------------------------------------CC-----------ccccHHHHHHHHHHhccCCCCCCCHHHH
Q 006460 234 ---------------------------------------LP-----------IVYSSTMKQIIKSMLRKNPEHRPTASDL 263 (644)
Q Consensus 234 ---------------------------------------~p-----------~~~s~~l~dLI~~~L~~dP~~RpTa~ei 263 (644)
.| ..-...+.+||++||.+||.+|+|+.++
T Consensus 420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa 499 (586)
T KOG0667|consen 420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA 499 (586)
T ss_pred eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence 01 0012467899999999999999999999
Q ss_pred hhCCCCch
Q 006460 264 LRHPHLQP 271 (644)
Q Consensus 264 L~hp~f~~ 271 (644)
|+||||..
T Consensus 500 l~Hpfl~~ 507 (586)
T KOG0667|consen 500 LNHPFLTG 507 (586)
T ss_pred hcCccccc
Confidence 99999974
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=381.21 Aligned_cols=249 Identities=29% Similarity=0.435 Sum_probs=204.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
...+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++|+|||||+++++|.. +...|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY-NKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEE
Confidence 34689999999999999999999999999999996532 346789999999999999999998876 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc--
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-- 168 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-- 168 (644)
|||++ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 161 v~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 161 ILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 99999 57898888753 35899999999999999999999999999999999999999999999999999753221
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhc-------------
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-------MAGLINKINR------------- 228 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-------~~el~~~i~~------------- 228 (644)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.... ....+..+..
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 22345689999999999999899999999999999999999998764321 1111111110
Q ss_pred -------------c-CCCC--CC-----ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 229 -------------S-SISP--LP-----IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 229 -------------~-~~~~--~p-----~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
. ...+ .+ ..++.++.+||.+||++||.+|||+.++|+||||+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0 0000 00 124668999999999999999999999999999975
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=349.77 Aligned_cols=255 Identities=40% Similarity=0.717 Sum_probs=230.8
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++++.||.|+||.||.+.+..++..+++|.+............+.+|++++++++||||+++++++.+ ...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEE
Confidence 6999999999999999999999999999999998766555666778899999999999999999999877 567999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-ccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~~ 172 (644)
|+.|++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 9999999999987555678999999999999999999999999999999999999999999999999998654433 334
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
...|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+......+.+..++.++.+|+.+||..
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence 56789999999999888899999999999999999999999999888888888877777777777899999999999999
Q ss_pred CCCCCCCHHHHhhCCCC
Q 006460 253 NPEHRPTASDLLRHPHL 269 (644)
Q Consensus 253 dP~~RpTa~eiL~hp~f 269 (644)
+|.+||++.++|+|||+
T Consensus 240 ~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 240 DPEKRPTADEVLDQPLL 256 (256)
T ss_pred CcccCCCHHHHhhCcCC
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=370.99 Aligned_cols=256 Identities=30% Similarity=0.521 Sum_probs=216.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++.++||.|+||.||+|.+..++..+|+|++.... .......+.+|+++|++++||||++++++|.+ +..+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEE
Confidence 3579999999999999999999999999999999987653 33445678899999999999999999999877 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
||||+.|++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+.. .
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-S 157 (333)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-h
Confidence 99999999999999763 3589999999999999999999985 799999999999999999999999999976533 2
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH-----------------------
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI----------------------- 226 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i----------------------- 226 (644)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||.......+...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 334567999999999999888999999999999999999999999765543332211
Q ss_pred ---------------------hccCCCCCC-ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 227 ---------------------NRSSISPLP-IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 227 ---------------------~~~~~~~~p-~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.....+..+ ..++.++++||.+||++||.+|||+.+++.||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 111111111 135788999999999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=349.45 Aligned_cols=256 Identities=45% Similarity=0.765 Sum_probs=230.5
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe-CCceEEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD-KGNCVCIVT 92 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d-~~~~~~LVm 92 (644)
+|++.+.||.|+||.||+|.+..++..||+|.+............+.+|+++++.++||||+++++++.. .+..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 6999999999999999999999999999999997765556666788899999999999999999998765 345789999
Q ss_pred eccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 93 GYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLH-----SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLH-----s~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
||+.+++|.+++.... ...+++..++.++.||+.||.||| +.+|+||||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999997642 356899999999999999999999 899999999999999999999999999999876
Q ss_pred ccccc-cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 166 NTEDL-ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 166 ~~~~~-~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
..... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||.......+...+.......++..++..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNE 240 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 55433 44567899999999998888999999999999999999999999988877888888877777788889999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
++.+||..+|.+|||+.+|++|||+
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=377.43 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=214.5
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----ceEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----NCVC 89 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----~~~~ 89 (644)
+|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+|+.++||||+++++++.... ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999999999999999998655434444567889999999999999999999987643 2689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
+||||+. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9999995 688888764 346899999999999999999999999999999999999999999999999999865332
Q ss_pred -cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc-----------------
Q 006460 169 -DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS----------------- 229 (644)
Q Consensus 169 -~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~----------------- 229 (644)
.......+++.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 223345789999999998774 4799999999999999999999999887766555444221
Q ss_pred ------CC-C-------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 230 ------SI-S-------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 230 ------~~-~-------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.. . ......+.++.+||.+||..||.+|||+.++|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00 0 1223357889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=369.64 Aligned_cols=261 Identities=29% Similarity=0.487 Sum_probs=219.2
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.++||+|+||.||++.++.+++.||+|++..... .......+.+|+.++..++||||+++++++.+ ...+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEE
Confidence 589999999999999999999999999999999865332 22234457789999999999999999998766 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
|||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999999764 34589999999999999999999999999999999999999999999999999876533221
Q ss_pred -cccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC----CCCCCccccH
Q 006460 171 -ASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS----ISPLPIVYSS 240 (644)
Q Consensus 171 -~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~----~~~~p~~~s~ 240 (644)
....+||+.|+|||++. ...|+.++|||||||++|+|++|++||...+..+....+.... .+..+..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 23457999999999986 3458899999999999999999999999988877777775442 2222345799
Q ss_pred HHHHHHHHHhccCCCC--CCCHHHHhhCCCCchhhhh
Q 006460 241 TMKQIIKSMLRKNPEH--RPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~--RpTa~eiL~hp~f~~~~~~ 275 (644)
++.+||++||..++.+ |+++.++++||||....+.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 9999999999765544 6899999999999865443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=358.62 Aligned_cols=258 Identities=30% Similarity=0.548 Sum_probs=226.9
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+++|++++||||+++++++.+ +..+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEE
Confidence 579999999999999999999999999999999876432 22345678899999999999999999998876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||+|.|||++.++.+||+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--C
Confidence 9999999999999764 46899999999999999999999999999999999999999999999999999876543 3
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhc
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~ 251 (644)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.... .++|..++..++++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK-VRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-ccCCccCCHHHHHHHHHHcc
Confidence 45678999999999988888999999999999999999999998888666666665433 45677789999999999999
Q ss_pred cCCCCCC-----CHHHHhhCCCCchhhhhc
Q 006460 252 KNPEHRP-----TASDLLRHPHLQPYLLRC 276 (644)
Q Consensus 252 ~dP~~Rp-----Ta~eiL~hp~f~~~~~~~ 276 (644)
.+|.+|+ +++++++||||....+..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 264 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence 9999999 999999999997655443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=349.39 Aligned_cols=255 Identities=39% Similarity=0.796 Sum_probs=229.1
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.+.||+|+||.||++.+..+++.||+|.+............+.+|+.++++++||||+++++++.. ....|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence 6999999999999999999999999999999997665445556678999999999999999999998765 567999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-ccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~~ 172 (644)
|+.+++|.+++.......+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++....... ...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 9999999999986555568999999999999999999999999999999999999999999999999998654432 123
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||......+....+.....++.+..++.++.++|.+||..
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence 45688999999999888899999999999999999999999998888888888877777778888999999999999999
Q ss_pred CCCCCCCHHHHhhCCCC
Q 006460 253 NPEHRPTASDLLRHPHL 269 (644)
Q Consensus 253 dP~~RpTa~eiL~hp~f 269 (644)
+|.+||++.+++.||||
T Consensus 240 ~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 240 NPRDRPSVNSILEKNFI 256 (256)
T ss_pred ChhhCcCHHHHhhCcCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=350.31 Aligned_cols=254 Identities=30% Similarity=0.537 Sum_probs=219.3
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH---HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE---KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~---~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
++|++.+.||+|+||.||.|.+..+++.||+|.+....... .....+.+|++++++++||||+++++++.. +..+|
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEE
Confidence 57999999999999999999999999999999987553222 234568889999999999999999998876 45799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+|+||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999999764 358999999999999999999999999999999999999999999999999987653321
Q ss_pred c----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhc-cCCCCCCccccHHHHH
Q 006460 170 L----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR-SSISPLPIVYSSTMKQ 244 (644)
Q Consensus 170 ~----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~-~~~~~~p~~~s~~l~d 244 (644)
. .....|+..|+|||++.+..++.++||||||+++|+|++|++||...........+.. .....++..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 1 1345688899999999998899999999999999999999999987665554444433 3445567788999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
||.+||..+|.+|||+.++++||||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.82 Aligned_cols=261 Identities=28% Similarity=0.486 Sum_probs=219.2
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.++..++||||+++++++.+ .+++|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 589999999999999999999999999999999975422 22334557789999999999999999998765 5779999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
|||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999999864 34689999999999999999999999999999999999999999999999999986544322
Q ss_pred -cccccCCCCCCChhhhcC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC-CCCCC---ccccH
Q 006460 171 -ASSVVGTPNYMCPELLAD-----IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS-ISPLP---IVYSS 240 (644)
Q Consensus 171 -~~~~~GT~~Y~APEvl~~-----~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~-~~~~p---~~~s~ 240 (644)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.... ..++| ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 223579999999999875 457899999999999999999999999888777777665432 12223 34689
Q ss_pred HHHHHHHHHhccCCCC--CCCHHHHhhCCCCchhhhh
Q 006460 241 TMKQIIKSMLRKNPEH--RPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~--RpTa~eiL~hp~f~~~~~~ 275 (644)
++.+||.+||...+.+ |++++++++||||+...+.
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999876654 4799999999999865443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=407.55 Aligned_cols=271 Identities=35% Similarity=0.589 Sum_probs=229.8
Q ss_pred CCCCCCCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 006460 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDA 80 (644)
Q Consensus 1 m~~~~~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~ 80 (644)
|++.-.+-...+++|+++++||+|+||.||+|.++.++..||+|++............+.+|+.+|+.|.|||||+++++
T Consensus 1 Mp~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred CCccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 66667777788999999999999999999999999999999999998766666667788999999999999999999999
Q ss_pred EEeC-CceEEEEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCccccCCCCcEEEcC
Q 006460 81 WVDK-GNCVCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSN-------RVLHRDLKCSNIFLTK 150 (644)
Q Consensus 81 ~~d~-~~~~~LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~-------gIIHRDLKPeNILL~~ 150 (644)
|... ...+||||||+.+++|.++|.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 8754 457899999999999999997532 34699999999999999999999994 4999999999999964
Q ss_pred C-----------------CCeEEeccCcccccccccccccccCCCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCC
Q 006460 151 D-----------------NDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQ 211 (644)
Q Consensus 151 ~-----------------g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~ 211 (644)
. +.+||+|||++..+.........+||+.|+|||++.+ ..|+.++||||||||||+|++|.
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 2 3489999999987655555556789999999999864 45889999999999999999999
Q ss_pred CCCCCCCh-HHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 212 PAFRAPDM-AGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 212 ~PF~~~~~-~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+||..... ..++..+......+ ...++.++.+||..||..+|.+||++.++|.||||...
T Consensus 241 ~PF~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 241 TPFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCCcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 99976543 34444444333222 23468999999999999999999999999999999754
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=360.67 Aligned_cols=262 Identities=27% Similarity=0.531 Sum_probs=225.3
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+++|+.++||||+++++++.. +...|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence 47999999999999999999999999999999998764432 345678899999999999999999998766 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-- 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-- 169 (644)
|||+.|++|.+++....+..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 999999999999986555679999999999999999999999999999999999999999999999999987543211
Q ss_pred ----------------------------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHH
Q 006460 170 ----------------------------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG 221 (644)
Q Consensus 170 ----------------------------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~e 221 (644)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1123468899999999998889999999999999999999999999888776
Q ss_pred HHHHHhccCCC-CCCccccHHHHHHHHHHhccCCCCCCC----HHHHhhCCCCchhhhh
Q 006460 222 LINKINRSSIS-PLPIVYSSTMKQIIKSMLRKNPEHRPT----ASDLLRHPHLQPYLLR 275 (644)
Q Consensus 222 l~~~i~~~~~~-~~p~~~s~~l~dLI~~~L~~dP~~RpT----a~eiL~hp~f~~~~~~ 275 (644)
.+..+...... +....++..+.+||.+||..+|.+||| ++++|.||||+...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~ 298 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA 298 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence 66665543322 122236899999999999999999999 9999999999875543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=359.71 Aligned_cols=260 Identities=25% Similarity=0.443 Sum_probs=216.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
.++++|++.++||.|+||.||+|.++.++..||+|.+....... ....+.+|+.+++.++||||+++++++.. ...+|
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~ 80 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLT 80 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEE
Confidence 36789999999999999999999999999999999987553222 23456789999999999999999999876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
+||||+. ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 9999996 5898888754 346899999999999999999999999999999999999999999999999999764332
Q ss_pred cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC----------------
Q 006460 169 DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---------------- 231 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~---------------- 231 (644)
.......+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+....+.....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 223345678999999988654 578999999999999999999999988776655444322110
Q ss_pred -----CC--------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 232 -----SP--------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 232 -----~~--------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+. ....+++.+.+||.+||+.||.+|||+.++|+||||+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 1124678899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=369.08 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=218.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-c---e
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG-N---C 87 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~-~---~ 87 (644)
.=.|.-.+.+|.|+||.||.|....+++.+|||+.-.... .--+|++||+.+.|||||++..+|.... . +
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 3468889999999999999999999999999999865532 1235999999999999999999887532 2 5
Q ss_pred EEEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-CCeEEeccCcccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLAKL 164 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-g~vKL~DFGls~~ 164 (644)
..+||||+ ..+|..+++.. .+..++.-.++-|++||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 97 lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 66899999 67999999853 24568899999999999999999999999999999999999976 8899999999999
Q ss_pred cccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-----------
Q 006460 165 LNTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----------- 232 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~----------- 232 (644)
+..+..-.+...|.+|+|||++.+ ..|+.+.||||.|||+.||+-|++.|.+.+..+++..|.+....
T Consensus 176 L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 176 LVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred eccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 888777788899999999998766 46999999999999999999999999998877766665321100
Q ss_pred -------------C----CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 233 -------------P----LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 233 -------------~----~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+ +....++++.+|+.++|.++|.+|.++.++|.||||....
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 0 2234588999999999999999999999999999998654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=355.00 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=211.3
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.+.||.|+||.||+|.+..++..||+|+++...........+.+|+.++++++||||+++++++.+ +..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEe
Confidence 6999999999999999999999999999999997654444445667889999999999999999999876 567999999
Q ss_pred ccCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-ccc
Q 006460 94 YCEGGDMAEIIKKAR-GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLA 171 (644)
Q Consensus 94 y~~GgsL~~~L~~~~-~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~ 171 (644)
|+. ++|.+++.... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 996 58988887543 256899999999999999999999999999999999999999999999999999765432 223
Q ss_pred ccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc---------------------
Q 006460 172 SSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS--------------------- 229 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~--------------------- 229 (644)
....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 345678999999988654 5789999999999999999999999876543332221110
Q ss_pred -------CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 230 -------SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 230 -------~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
........++.++.+||.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0001123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=388.56 Aligned_cols=255 Identities=35% Similarity=0.617 Sum_probs=227.2
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
+.|.|++.||.|+||.||+|.++.++...|.|+|... .+...+.++-|+.||..|+||+||++++.|+-. +.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~e-nkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-NKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-CceEEEE
Confidence 5688999999999999999999999988899988654 344567889999999999999999999998874 4599999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-ccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLA 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~~~~~ 171 (644)
|||.||-...++... +..+++..+..+++|++.||+|||+++|||||||..|||++-+|.++|+|||++.... .....
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 999999999998865 4579999999999999999999999999999999999999999999999999987543 22345
Q ss_pred ccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--CCccccHHHHH
Q 006460 172 SSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSSTMKQ 244 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~p~~~s~~l~d 244 (644)
.++.|||+|||||+.. +.+|++++||||||++|.+|.-+.||....+++.++-+|.....+. .|..|+..+.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 6789999999999764 5689999999999999999999999999988888888887765544 36779999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
|+++||.+||..||++++||+|||++.
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCccccc
Confidence 999999999999999999999999983
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=351.43 Aligned_cols=254 Identities=29% Similarity=0.493 Sum_probs=213.1
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++.+.||+|+||.||+|.++.+++.||+|++..........+.+.+|+.+++++.||||++++++|.. +..+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEE
Confidence 57999999999999999999999999999999987654333345567889999999999999999998876 56799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-cc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LA 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~ 171 (644)
||++++.|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred eccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 99999888887654 3358999999999999999999999999999999999999999999999999998765433 23
Q ss_pred ccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-------------------
Q 006460 172 SSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI------------------- 231 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~------------------- 231 (644)
....++..|+|||++.+ ..++.++||||||+++|+|++|.+||.+....+....+.....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34568899999998876 4578999999999999999999999987765544433321100
Q ss_pred -CCC----------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 232 -SPL----------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 232 -~~~----------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.+. ...++..+.+|+.+||..+|++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 12357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=364.34 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=210.0
Q ss_pred EEEEeccC--CCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEec
Q 006460 17 VIEQIGRG--AFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGY 94 (644)
Q Consensus 17 i~~~LG~G--~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy 94 (644)
++++||+| +||.||++.++.+|+.||+|++..........+.+.+|+.+++.++|||||+++++|.. +...|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEec
Confidence 56789999 78899999999999999999998765555666778889999999999999999999877 4679999999
Q ss_pred cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc------
Q 006460 95 CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE------ 168 (644)
Q Consensus 95 ~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~------ 168 (644)
+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 99999999997654456899999999999999999999999999999999999999999999999875433211
Q ss_pred --cccccccCCCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC------------
Q 006460 169 --DLASSVVGTPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS------------ 232 (644)
Q Consensus 169 --~~~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~------------ 232 (644)
.......++..|+|||++.+ ..|+.++|||||||++|+|++|.+||.................+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 11123456778999999876 46899999999999999999999999765543332222111100
Q ss_pred ---------------------------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 233 ---------------------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 233 ---------------------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+....+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 1122356789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=351.88 Aligned_cols=254 Identities=31% Similarity=0.597 Sum_probs=223.9
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++.+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+++++.++||||+++++++.+ +..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEE
Confidence 579999999999999999999999999999999876542 2334567889999999999999999998876 47799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-ccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLA 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~ 171 (644)
||+.+++|.+++... .+++..++.++.||+.||.|||+++++||||+|+||+++.++.++|+|||++..+... ...
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 999999999998753 6899999999999999999999999999999999999999999999999999876543 223
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCcc-ccHHHHHHHHHHh
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV-YSSTMKQIIKSML 250 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~-~s~~l~dLI~~~L 250 (644)
....+++.|+|||++.+..++.++|||||||++|+|++|.+||...........+.....+..+.. ++..+.+++.+||
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 456788999999999988899999999999999999999999988776666666665555555555 7899999999999
Q ss_pred ccCCCCCCCHHHHhhCCCCch
Q 006460 251 RKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..+|++|||++++++||||+.
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred hCChhhCcCHHHHhhChhhcC
Confidence 999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=360.62 Aligned_cols=247 Identities=27% Similarity=0.463 Sum_probs=195.5
Q ss_pred EEEeccCCCeEEEEEEEec--CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CceEEEEEec
Q 006460 18 IEQIGRGAFGAAFLVLHKI--ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNCVCIVTGY 94 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~--tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~~~LVmEy 94 (644)
.++||+|+||.||+|.++. +++.||+|.+...... ..+.+|+++|++++||||++++++|... +..+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 4689999999999999764 6789999998654332 3467899999999999999999988653 4678999999
Q ss_pred cCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE----cCCCCeEEeccCccc
Q 006460 95 CEGGDMAEIIKKAR-------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL----TKDNDIRLGDFGLAK 163 (644)
Q Consensus 95 ~~GgsL~~~L~~~~-------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL----~~~g~vKL~DFGls~ 163 (644)
+ +++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 9 568988876432 2258999999999999999999999999999999999999 455789999999998
Q ss_pred cccccc----ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHhcc
Q 006460 164 LLNTED----LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM---------AGLINKINRS 229 (644)
Q Consensus 164 ~~~~~~----~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~---------~el~~~i~~~ 229 (644)
.+.... ......||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||..... ...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 754321 2345688999999999876 4589999999999999999999999965331 1111111110
Q ss_pred CC-------------C------------------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 230 SI-------------S------------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 230 ~~-------------~------------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.. + ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0 0001124578899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=351.07 Aligned_cols=253 Identities=30% Similarity=0.550 Sum_probs=216.4
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.+.||.|+||.||+|.+..++..||+|++............+.+|+.++++++||||+++++++.. +..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEec
Confidence 6999999999999999999999999999999998766545556778999999999999999999998876 667999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--cc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--LA 171 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~--~~ 171 (644)
|+ |++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99 999999987643 569999999999999999999999999999999999999999999999999998765432 23
Q ss_pred ccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-----------------
Q 006460 172 SSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----------------- 233 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----------------- 233 (644)
....|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+......+..+......+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 456789999999988654 46899999999999999999999998776555444433211100
Q ss_pred ------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 234 ------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 234 ------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.....+..+.+||.+||..+|.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 112346889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.48 Aligned_cols=251 Identities=41% Similarity=0.795 Sum_probs=224.3
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.+.||.|+||.||++.+..++..||+|.++.... ....+.+.+|+.+++.++||||++++++|.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEe
Confidence 69999999999999999999999999999999876543 2345677889999999999999999998866 567999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-ccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~~ 172 (644)
|+++++|.+++....+..+++..++.++.||+.||.|||++||+|+||||.||+++.++.++|+|||++....... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 9999999999876556678999999999999999999999999999999999999999999999999998654322 234
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
...|++.|+|||++.+..++.++|+||||+++|+|++|.+||...+.......+......+.+..++..+.+||.+||..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence 46789999999999988899999999999999999999999998888888888877777778888999999999999999
Q ss_pred CCCCCCCHHHHhhC
Q 006460 253 NPEHRPTASDLLRH 266 (644)
Q Consensus 253 dP~~RpTa~eiL~h 266 (644)
||.+|||+.+++.-
T Consensus 239 ~P~~Rp~~~~il~~ 252 (255)
T cd08219 239 NPRSRPSATTILSR 252 (255)
T ss_pred CcccCCCHHHHhhc
Confidence 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=349.47 Aligned_cols=256 Identities=28% Similarity=0.541 Sum_probs=216.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC-----
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK----- 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~----- 84 (644)
.-+.|++.+.||.|+||.||+|.+..+++.||+|.+...... ...+.+|+.+++++ +||||++++++|...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 346799999999999999999999999999999998765332 34577899999998 699999999998753
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...+|+||||+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 24689999999999999999875556789999999999999999999999999999999999999999999999999976
Q ss_pred cccc-cccccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-CCCCcc
Q 006460 165 LNTE-DLASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI-SPLPIV 237 (644)
Q Consensus 165 ~~~~-~~~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~-~~~p~~ 237 (644)
.... .......|++.|+|||++. +..|+.++|||||||++|+|++|.+||...........+..... ...+..
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 5332 2234567899999999986 34588999999999999999999999976665544444433322 223345
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
++..+.+|+.+||..+|.+|||+.+++.||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=344.95 Aligned_cols=255 Identities=31% Similarity=0.569 Sum_probs=219.4
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++.+.||.|+||.||+|.+..++..+++|++....... ....+.+|+.+|+.++||||+++++.+.. +..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEE
Confidence 58999999999999999999999999999999987654433 45678899999999999999999998876 56799999
Q ss_pred eccCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--
Q 006460 93 GYCEGGDMAEIIKKARG-ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-- 169 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~-~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-- 169 (644)
||+.|++|.+++..... ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999976432 468999999999999999999999999999999999999999999999999998664432
Q ss_pred ---ccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC-----ccccH
Q 006460 170 ---LASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP-----IVYSS 240 (644)
Q Consensus 170 ---~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p-----~~~s~ 240 (644)
......|+..|+|||++... .++.++|+|||||++|+|++|+.||...........+........+ ..++.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12345789999999998776 7899999999999999999999999877666555554444322222 25678
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.+.+|+.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=339.97 Aligned_cols=255 Identities=45% Similarity=0.876 Sum_probs=231.6
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.+.||.|+||.||+|.+..++..|++|.+............+.+|+++++.++|||++++++.+... ...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence 69999999999999999999999999999999987665556667789999999999999999999998764 67999999
Q ss_pred ccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-c
Q 006460 94 YCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-L 170 (644)
Q Consensus 94 y~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~ 170 (644)
|++|++|.+++.... ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999999998653 4679999999999999999999999999999999999999999999999999998765433 3
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHh
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L 250 (644)
.....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+......+++..++..+.+++.+||
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 34467899999999998888999999999999999999999999988888888888777778888889999999999999
Q ss_pred ccCCCCCCCHHHHhhCCCC
Q 006460 251 RKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~hp~f 269 (644)
..+|.+|||+.++|.||||
T Consensus 240 ~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 240 QKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=346.07 Aligned_cols=253 Identities=28% Similarity=0.532 Sum_probs=220.0
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-------HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-------EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-------~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
+|.+.+.||.|+||.||+|.+..++..||+|.+...... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-AD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Confidence 588899999999999999999999999999988654321 2234678899999999999999999998776 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
+.++||||+.+++|.+++... ..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 789999999999999999764 458999999999999999999999999999999999999999999999999998664
Q ss_pred ccc-------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCcccc
Q 006460 167 TED-------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS 239 (644)
Q Consensus 167 ~~~-------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s 239 (644)
... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.....+..+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS 237 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccC
Confidence 221 1123468899999999988889999999999999999999999998776655555555555666777889
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
..+.++|.+||+.+|.+||++.++++||||
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=347.96 Aligned_cols=252 Identities=29% Similarity=0.554 Sum_probs=222.2
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
+|++.+.||.|+||.||+|.+..++..||+|.+....... ...+.+.+|++++++++||||+++++.+.. +..+|+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence 6999999999999999999999999999999997654322 456788999999999999999999998765 66799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~ 172 (644)
||+.|++|..++... ..+++..+..++.||+.||.|||++|++|+||+|.||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 80 DLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred eCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 999999999999764 468999999999999999999999999999999999999999999999999998765544445
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM---AGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~---~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
...|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ..+.... .......|..++..+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ-ETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh-ccccccCcccCcHHHHHHHHHH
Confidence 57789999999999888899999999999999999999999987763 3333333 3245567778899999999999
Q ss_pred hccCCCCCCCH--HHHhhCCCC
Q 006460 250 LRKNPEHRPTA--SDLLRHPHL 269 (644)
Q Consensus 250 L~~dP~~RpTa--~eiL~hp~f 269 (644)
|..||.+||++ .++++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=350.54 Aligned_cols=254 Identities=22% Similarity=0.381 Sum_probs=222.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCC-----eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIER-----KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
.+++|++.+.||+|+||.||+|.+...+ ..+|+|.+.... .......+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-E 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-C
Confidence 4678999999999999999999987665 789999886543 33445678899999999999999999998766 4
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARG--------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~--------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~ 151 (644)
...|++|||+.+++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 568999999999999999976421 457889999999999999999999999999999999999999
Q ss_pred CCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 006460 152 NDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKIN 227 (644)
Q Consensus 152 g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~ 227 (644)
+.++|+|||++....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999998653322 2334567889999999988889999999999999999998 999999988888888888
Q ss_pred ccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 228 RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 228 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.....+.+..++.++.+|+.+||..||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777777888899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.59 Aligned_cols=255 Identities=35% Similarity=0.736 Sum_probs=225.1
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|.+.+.||+|+||.||+|.++.++..+|+|.+..........+.+.+|+.+++.++||||+++++.+.. +..+|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence 5899999999999999999999999999999997754444445677899999999999999999998765 567999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC-eEEeccCccccccccc-cc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND-IRLGDFGLAKLLNTED-LA 171 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~-vKL~DFGls~~~~~~~-~~ 171 (644)
|+.+++|.+++....+..+++..+..++.||+.||.|||+++|+|+||||.||+++.++. +||+|||.+....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999998765556899999999999999999999999999999999999998864 6999999998764432 22
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhc
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~ 251 (644)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+......+.+..++..+.++|.+||.
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence 34568999999999988889999999999999999999999999888777777766666666677789999999999999
Q ss_pred cCCCCCCCHHHHhhCCCC
Q 006460 252 KNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 252 ~dP~~RpTa~eiL~hp~f 269 (644)
.+|.+|||+.+++.||||
T Consensus 240 ~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 240 VSPRDRPSITSILKRPFL 257 (257)
T ss_pred cChhhCcCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=352.59 Aligned_cols=253 Identities=29% Similarity=0.493 Sum_probs=209.2
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.+.||.|+||.||+|.++.+|..||+|.+............+.+|+.++++++||||+++++++.+ ...+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEe
Confidence 5999999999999999999999999999999997654444444567789999999999999999999876 457999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~~ 172 (644)
|+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+... ....
T Consensus 80 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 80 YCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 996 5888887653 346899999999999999999999999999999999999999999999999999865432 2234
Q ss_pred cccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCC-CCCChHHHHHHHhccC-------------------C
Q 006460 173 SVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAF-RAPDMAGLINKINRSS-------------------I 231 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF-~~~~~~el~~~i~~~~-------------------~ 231 (644)
...+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+..+.... .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 45778999999988764 4789999999999999999988774 5555444444332110 0
Q ss_pred C---------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 232 S---------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 232 ~---------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
. .....++.++.+||.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 1112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=348.79 Aligned_cols=256 Identities=33% Similarity=0.593 Sum_probs=221.6
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++.+.||.|+||.||+|.++.+++.+|+|.+...... .....+.+|+++++.+.||||+++++++.. ...+|+|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEE
Confidence 4789999999999999999999999999999998765433 445678899999999999999999998876 46799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
||+.|++|.+++.... ..+++..+..++.||+.||.|||+ .|++||||||+||+++.++.++|+|||.+....... .
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~ 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-A 156 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-h
Confidence 9999999999998643 568999999999999999999999 999999999999999999999999999987654322 2
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhccCCCCCCcc-ccHHHHHH
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-----DMAGLINKINRSSISPLPIV-YSSTMKQI 245 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~-----~~~el~~~i~~~~~~~~p~~-~s~~l~dL 245 (644)
....++..|+|||.+.+..++.++||||||+++|+|++|..||... ........+........+.. ++.++.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 2377899999999999989999999999999999999999999654 23344555544444445544 88999999
Q ss_pred HHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 246 IKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
|.+||..+|.+|||+.+++.||||+.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=372.57 Aligned_cols=278 Identities=26% Similarity=0.453 Sum_probs=242.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+.|+..+.||+||||.||.|+.+.||+.||+|.+.+.... .+.....++|-+||++++.|.||.+-..|.. ...+|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-kd~LC 261 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-KDALC 261 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-CCceE
Confidence 346788889999999999999999999999999988655332 2234567889999999999999999887755 56699
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||..++||+|.-.|.+..+..|++..++.|+.+|+.||.+||+.+||+|||||+|||||+.|+++|+|+|||..+..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999999999988777789999999999999999999999999999999999999999999999999999998888
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH----HHHHHHhccCCCCCCccccHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA----GLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~----el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
.....+||.+|||||++.+..|+.+.|+|||||++|+|+.|+.||...... ++-+++. .....++..+|+++++|
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-EDPEEYSDKFSEEAKSL 420 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-cchhhcccccCHHHHHH
Confidence 888889999999999999999999999999999999999999999765433 3333333 33345778899999999
Q ss_pred HHHHhccCCCCCCC-----HHHHhhCCCCchhhhhcCCCCCcccCCCccc
Q 006460 246 IKSMLRKNPEHRPT-----ASDLLRHPHLQPYLLRCQNPSSVYLPIKPTN 290 (644)
Q Consensus 246 I~~~L~~dP~~RpT-----a~eiL~hp~f~~~~~~~~~~~~~~~p~~p~~ 290 (644)
.+.+|++||.+|.. ++++.+||||+...|+.........|+.|..
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp 470 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP 470 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence 99999999999965 6799999999999888877777777776644
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.93 Aligned_cols=250 Identities=28% Similarity=0.521 Sum_probs=212.0
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+++|++++||||++++++|.. ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEE
Confidence 47999999999999999999999999999999987643 23345678899999999999999999999877 56789999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~ 172 (644)
||+++++|..+. .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+... ...
T Consensus 79 e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~ 151 (279)
T cd06619 79 EFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAK 151 (279)
T ss_pred ecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-ccc
Confidence 999999996542 3789999999999999999999999999999999999999999999999999865442 344
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhccCCCCC-CccccHHHHH
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-------MAGLINKINRSSISPL-PIVYSSTMKQ 244 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-------~~el~~~i~~~~~~~~-p~~~s~~l~d 244 (644)
..+|++.|+|||++.+..++.++|||||||++|+|++|..||.... .......+........ ...++.++.+
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 5689999999999998889999999999999999999999996432 1122233322222222 2347889999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
|+.+||..+|.+||++.++++||||..
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCccccc
Confidence 999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.62 Aligned_cols=254 Identities=31% Similarity=0.550 Sum_probs=215.6
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|++++++++||||++++++|.+ +..+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEe
Confidence 47999999999999999999999999999999986542 34456678899999999999999999999877 56799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
||++|++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||.|||++.++.+||+|||++...... ..
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cc
Confidence 999999999999764 458999999999999999999997 59999999999999999999999999998765432 34
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc----------------------
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS---------------------- 229 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~---------------------- 229 (644)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 5568899999999998888999999999999999999999999765544333222111
Q ss_pred --------------CCCCCC-ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 230 --------------SISPLP-IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 230 --------------~~~~~p-~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..+..| ..++.++.+|+.+||..+|++|||+.++++||||..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 011111 136788999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=380.87 Aligned_cols=260 Identities=25% Similarity=0.489 Sum_probs=240.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.++.|.+.+.||+|.|+.|.+|++..++..||||++.+...+......+.+|+++|+.|+|||||+++.+... ...+|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeEE
Confidence 5689999999999999999999999999999999999887777666679999999999999999999998654 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+.||.+++++.+. +.+.+..++.++.|++++++|||+++|||||||.+||||+.+.++||+|||++..+.....
T Consensus 133 V~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence 99999999999999874 3578899999999999999999999999999999999999999999999999999998888
Q ss_pred cccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
..++||++.|.|||++.+..| ++.+|+||||+++|-|++|..||.+....++..+...+.+. +|..++.++.++|+++
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r-Ip~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR-IPFYMSCDCEDLLRKF 289 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec-ccceeechhHHHHHHh
Confidence 999999999999999999988 78999999999999999999999999988888887777654 7888999999999999
Q ss_pred hccCCCCCCCHHHHhhCCCCchhhh
Q 006460 250 LRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
|..+|.+|++.++++.|.|+.....
T Consensus 290 lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred hccCccccCCHHHhhhhcccchhhh
Confidence 9999999999999999999975443
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.04 Aligned_cols=253 Identities=33% Similarity=0.617 Sum_probs=220.3
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc---cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ---TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~---~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+|+..+.||+|+||.||+|.+..++..|++|.+..... .....+.+.+|+.+++.++||||+++++++.. +..+|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEE
Confidence 58889999999999999999998999999999876442 23445678899999999999999999998765 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
|+||++|++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 80 FLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 99999999999999764 3588999999999999999999999999999999999999999999999999987655444
Q ss_pred cccccCCCCCCChhhhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhc-cCCCCCCccccHHHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIP-YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR-SSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~-ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~-~~~~~~p~~~s~~l~dLI~~ 248 (644)
.....|++.|++||.+.... ++.++|+|||||++|+|++|.+||...........+.. ...+..+..++..+.+|+.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 45677899999999987766 89999999999999999999999987665555444444 44455667789999999999
Q ss_pred HhccCCCCCCCHHHHhhCCCC
Q 006460 249 MLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~hp~f 269 (644)
||..+|.+||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=349.92 Aligned_cols=257 Identities=34% Similarity=0.598 Sum_probs=221.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.++|++++.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.++++++||||+++++++.. +..+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEE
Confidence 468999999999999999999999999999999987543 3334678889999999999999999999876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-c
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-L 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~ 170 (644)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 81 IEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 9999999999998764 3469999999999999999999999999999999999999999999999999987643322 2
Q ss_pred cccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--CCccccHHHH
Q 006460 171 ASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSSTMK 243 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~p~~~s~~l~ 243 (644)
.....+++.|+|||++. ...++.++|||||||++|+|++|.+||...........+.....+. .+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 33457899999999875 3457889999999999999999999999887777666665543322 3456889999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+||.+||..+|.+||++.++++||||...
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=361.83 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=216.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG---- 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~---- 85 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.++++++||||++++++|....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4578999999999999999999999999999999998755444444566788999999999999999999886432
Q ss_pred -ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 86 -NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 86 -~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
..+|+||||+. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 35799999995 588887754 288999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-----------
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----------- 233 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----------- 233 (644)
...........+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+......+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 655444455678999999999999999999999999999999999999998776544333321110000
Q ss_pred -------------------------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 234 -------------------------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 234 -------------------------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.+...+..+.+||.+||..||.+|||+.++|.||||....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 0113466789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.88 Aligned_cols=257 Identities=26% Similarity=0.515 Sum_probs=216.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe-----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD----- 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d----- 83 (644)
...+.|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....+.+|+.+++++ +||||++++++|..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 45579999999999999999999999999999999986543 2235577899999998 79999999999864
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
....+|++|||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 24678999999999999999987666678999999999999999999999999999999999999999999999999987
Q ss_pred ccccc-cccccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-CCCCc
Q 006460 164 LLNTE-DLASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI-SPLPI 236 (644)
Q Consensus 164 ~~~~~-~~~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~-~~~p~ 236 (644)
..... .......|++.|+|||++. +..++.++|||||||++|+|++|.+||...........+..... ...+.
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 65322 2234567899999999875 34688899999999999999999999976665444443333322 22334
Q ss_pred cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.++..+.+||.+||..||.+|||+.+||+||||
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=344.28 Aligned_cols=255 Identities=31% Similarity=0.543 Sum_probs=216.3
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc---cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CceE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ---TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNCV 88 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~---~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~~ 88 (644)
.+|++.+.||+|+||.||+|.+..++..|++|++..... .......+.+|+.++++++||||+++++++... +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 379999999999999999999999999999999875432 223456788999999999999999999987653 4678
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
+++|||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999999753 35899999999999999999999999999999999999999999999999998765321
Q ss_pred ----cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc-CCCCCCccccHHHH
Q 006460 169 ----DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-SISPLPIVYSSTMK 243 (644)
Q Consensus 169 ----~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~-~~~~~p~~~s~~l~ 243 (644)
.......++..|+|||++.+..++.++|||||||++|+|++|.+||...........+... ..+.+|..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence 1122356889999999999888999999999999999999999999877655544444332 23445667788999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
+|+ +||..+|.+||++.++++||||+
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=346.37 Aligned_cols=257 Identities=29% Similarity=0.518 Sum_probs=210.7
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHH-HHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDL-ISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~i-L~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.+.||+|+||.||+|.++.+|+.||+|.+........ ...+..|+.+ ++.++||||+++++++.. +..+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEE
Confidence 589999999999999999999999999999999976543333 2345556665 566789999999998876 5569999
Q ss_pred EeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 92 TGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|||++ ++|.+++... ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99995 6888888653 234689999999999999999999998 9999999999999999999999999999876543
Q ss_pred cccccccCCCCCCChhhhcC----CCCCcccchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHhccCCCCCC-ccccHHH
Q 006460 169 DLASSVVGTPNYMCPELLAD----IPYGYKSDIWSLGCCMFEIAAHQPAFRAP-DMAGLINKINRSSISPLP-IVYSSTM 242 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~----~~ys~ksDIWSLGvILyeLltG~~PF~~~-~~~el~~~i~~~~~~~~p-~~~s~~l 242 (644)
.......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||... ...+.+..+........+ ..++.++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence 33344678999999998865 45789999999999999999999999643 222333333333333333 3578999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+||.+||..+|.+||++.+++.||||...
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.50 Aligned_cols=251 Identities=19% Similarity=0.306 Sum_probs=217.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEe---cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
..+|++.+.||+|+||.||+|+++ ..+..||+|.++.... ......+.+|+.++++++||||+++++++.. +...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCc
Confidence 468999999999999999999876 3457899999876532 3445678899999999999999999998776 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.++++|||.+......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999999764 346899999999999999999999999999999999999999999999999987754332
Q ss_pred cccc--cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 169 DLAS--SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 169 ~~~~--~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
.... ...++..|+|||++.+..++.++|||||||++|+|++ |.+||......+....+......+.|..++..+.++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 2222 2345678999999999899999999999999999775 999999988888888887776667788899999999
Q ss_pred HHHHhccCCCCCCCHHHHhh
Q 006460 246 IKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~ 265 (644)
+.+||..+|.+||++.+|++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=343.19 Aligned_cols=252 Identities=33% Similarity=0.600 Sum_probs=215.9
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc----cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ----TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~----~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
+|++.+.||.|+||.||+|.. .++..+|+|.+..... .......+.+|+.+|++++||||+++++++.+ ...+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEE
Confidence 689999999999999999976 4788999999875432 12334568899999999999999999999876 57799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc--
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-- 167 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-- 167 (644)
+||||+.|++|.+++.+. ..+++..++.++.||+.||.|||+.||+|+||+|.||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 79 IFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999999763 3589999999999999999999999999999999999999999999999999876421
Q ss_pred -----ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhc--cCCCCCCccccH
Q 006460 168 -----EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR--SSISPLPIVYSS 240 (644)
Q Consensus 168 -----~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~--~~~~~~p~~~s~ 240 (644)
........|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ...+..+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 1123345789999999999988899999999999999999999999987665544443332 234556777899
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
++.+||.+||..+|.+||++.+++.||||
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=350.27 Aligned_cols=257 Identities=29% Similarity=0.558 Sum_probs=220.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
+....+|++.+.||+|+||.||+|.+..++..|++|.+....... ...+.+|+.+++.+.||||+++++.|.. +...
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~ 92 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV-GDEL 92 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEE
Confidence 456689999999999999999999999999999999987654332 3567889999999999999999998876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999999999999864 24789999999999999999999999999999999999999999999999998865433
Q ss_pred c-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC--CCCccccHHHHHH
Q 006460 169 D-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--PLPIVYSSTMKQI 245 (644)
Q Consensus 169 ~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~--~~p~~~s~~l~dL 245 (644)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|++||...........+.....+ +.+..++..+.+|
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 2 233457899999999998888999999999999999999999999877765444333332222 2355678899999
Q ss_pred HHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 246 IKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+.+||..+|.+|||+.++++||||..
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhc
Confidence 99999999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=347.58 Aligned_cols=253 Identities=28% Similarity=0.510 Sum_probs=214.3
Q ss_pred eccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCC
Q 006460 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGD 99 (644)
Q Consensus 21 LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~Ggs 99 (644)
||+|+||.||+|.+..+++.||+|.+...... ......+.+|+++|+.++||||++++++|.. ...+|+||||++|++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence 69999999999999999999999998754322 2234556789999999999999999998765 567999999999999
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccccccCCCC
Q 006460 100 MAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN 179 (644)
Q Consensus 100 L~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~ 179 (644)
|.+++.......+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.............++..
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 99999875555699999999999999999999999999999999999999999999999999987654434445678889
Q ss_pred CCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM----AGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 180 Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~----~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
|+|||++.+..++.++|||||||++|+|++|+.||..... ..+...+ .......+..++..+.++|.+||..+|.
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-ccccccCCccCCHHHHHHHHHHccCChh
Confidence 9999999888899999999999999999999999977653 2222222 2233345667899999999999999999
Q ss_pred CCC-----CHHHHhhCCCCchhhhh
Q 006460 256 HRP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 256 ~Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
+|| ++.+++.||||....++
T Consensus 239 ~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 239 KRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred HccCCCcccHHHHHhChhhhcCChh
Confidence 999 89999999999765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=340.86 Aligned_cols=252 Identities=31% Similarity=0.623 Sum_probs=218.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
-++|++.+.||.|+||.||+|.+..++..|++|.+..... ...+.+|++++++++||||+++++++.+ ...+|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEE
Confidence 3689999999999999999999999999999999875532 5678899999999999999999999876 4679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-c
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-L 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~ 170 (644)
+||+.+++|.+++... +..+++..++.++.||+.||.|||+.||+||||+|.||+++.++.++|+|||++....... .
T Consensus 77 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 77 MEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred EecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999999999999753 3568999999999999999999999999999999999999999999999999998765433 2
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC--CCCccccHHHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--PLPIVYSSTMKQIIKS 248 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~--~~p~~~s~~l~dLI~~ 248 (644)
.....++..|+|||++.+..++.++||||||+++|+|++|++||...........+...... ..+..++..+.+||.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 33456889999999999989999999999999999999999999876655544443322221 2344578899999999
Q ss_pred HhccCCCCCCCHHHHhhCCCC
Q 006460 249 MLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~hp~f 269 (644)
||..+|.+|||+.++|.||||
T Consensus 236 ~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 236 CLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=349.61 Aligned_cols=258 Identities=33% Similarity=0.579 Sum_probs=219.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.-+.|+++++||.|+||.||+|.+..++..+++|.+.... ....+.+.+|+++++.++||||+++++++.. +..+|+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEE
Confidence 4478999999999999999999999999999999987542 3445678889999999999999999998876 457999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-c
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-D 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~ 169 (644)
||||+.|++|..++.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 87 MIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999999999998886543 45899999999999999999999999999999999999999999999999998754322 2
Q ss_pred ccccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC--CCCccccHHH
Q 006460 170 LASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--PLPIVYSSTM 242 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~--~~p~~~s~~l 242 (644)
......+++.|+|||++. ...++.++|||||||++|+|++|.+||...........+.....+ ..+..++.++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence 234457889999999884 345788999999999999999999999877766555555443322 2345678899
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+||.+||..+|++||++.++++||||...
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 246 RDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=341.38 Aligned_cols=257 Identities=31% Similarity=0.571 Sum_probs=216.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK---- 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~---- 84 (644)
...++|++.+.||.|+||.||+|.++.+++.+++|++..... ....+.+|+.+++++ .||||++++++|...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 356899999999999999999999999999999999876543 235678899999999 799999999998753
Q ss_pred -CceEEEEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 85 -GNCVCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 85 -~~~~~LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
+..+|+||||+.+++|.+++.... +..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 346899999999999999987644 45789999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-cccccccCCCCCCChhhhcC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC-
Q 006460 162 AKLLNTE-DLASSVVGTPNYMCPELLAD-----IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL- 234 (644)
Q Consensus 162 s~~~~~~-~~~~~~~GT~~Y~APEvl~~-----~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~- 234 (644)
+...... .......|++.|+|||++.. ..++.++|||||||+||+|++|.+||...........+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence 8764332 22344678999999998753 3468899999999999999999999987665555555544433222
Q ss_pred -CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 235 -PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 235 -p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
+..++..+.+||.+||..||.+|||+.+++.|||+
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 23368899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=339.74 Aligned_cols=253 Identities=32% Similarity=0.541 Sum_probs=217.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.++|++.+.||.|+||.||+|.+..++..+++|.+...... ....+.+|+.++++++||||+++++++.. +..+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEE
Confidence 47899999999999999999999999999999999765432 35678899999999999999999998876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-c
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-L 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~ 170 (644)
|||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 9999999999998764 2468999999999999999999999999999999999999999999999999998654322 2
Q ss_pred cccccCCCCCCChhhhcCC---CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC----CCccccHHHH
Q 006460 171 ASSVVGTPNYMCPELLADI---PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----LPIVYSSTMK 243 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~---~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----~p~~~s~~l~ 243 (644)
.....++..|+|||++.+. .++.++|+|||||++|+|++|.+||...........+......+ .+..++.++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3456789999999998776 78999999999999999999999998877655544444332211 2334678899
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCC
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPH 268 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~ 268 (644)
+|+.+||..+|..|||+.+++.|+|
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=346.09 Aligned_cols=258 Identities=29% Similarity=0.526 Sum_probs=216.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCC---
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKG--- 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~--- 85 (644)
...++|.+.+.||+|+||.||+|.+..+++.+|+|.+..... ....+.+|+.+++++ +|||+++++++|...+
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 457889999999999999999999999999999999865432 234567799999998 8999999999987533
Q ss_pred -ceEEEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 86 -NCVCIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 86 -~~~~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
..+|+||||+.|++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 4689999999999999988642 3456899999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-ccccccCCCCCCChhhhcCC-----CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--C
Q 006460 163 KLLNTED-LASSVVGTPNYMCPELLADI-----PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--L 234 (644)
Q Consensus 163 ~~~~~~~-~~~~~~GT~~Y~APEvl~~~-----~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~ 234 (644)
....... ......|+..|+|||++... .++.++|||||||++|+|++|++||...........+....... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH 255 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc
Confidence 8654332 22345788999999987543 36899999999999999999999998776655555554443222 2
Q ss_pred CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 235 p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
+..++..+.+||.+||..+|.+||++.+++.||||+
T Consensus 256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 445678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=340.18 Aligned_cols=256 Identities=33% Similarity=0.637 Sum_probs=226.7
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++.+.||.|++|.||+|.+..+++.|++|++...... .....+.+|++++.+++||||+++++++.. ...+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEE
Confidence 4799999999999999999999999999999998766443 446778999999999999999999998876 46799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
||+.+++|.+++... ..+++..++.++.||+.||.|||+ +|++||||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999999999864 468999999999999999999999 99999999999999999999999999999876543332
Q ss_pred -ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHhccCCCCCCcc-ccHHHHHHH
Q 006460 172 -SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP---DMAGLINKINRSSISPLPIV-YSSTMKQII 246 (644)
Q Consensus 172 -~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~---~~~el~~~i~~~~~~~~p~~-~s~~l~dLI 246 (644)
....++..|+|||.+.+..++.++|+||||+++|+|++|.+||... ...+....+........+.. ++..+.++|
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 2557889999999998888999999999999999999999999776 55566666666666666666 899999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+||..+|.+|||+.++++||||+.+
T Consensus 237 ~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 237 SACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.32 Aligned_cols=260 Identities=28% Similarity=0.485 Sum_probs=216.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-ceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG-NCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~-~~~ 88 (644)
..+++|++.+.||.|+||.||+|.++.++..||+|.++...........+.+|+.++++++||||+++++++.... ..+
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3578999999999999999999999999999999999765433333345677999999999999999999987543 568
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999995 58988887543 46899999999999999999999999999999999999999999999999999876543
Q ss_pred c-ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC--------------
Q 006460 169 D-LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-------------- 232 (644)
Q Consensus 169 ~-~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~-------------- 232 (644)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 2 2233456888999998865 45799999999999999999999999988877666555431100
Q ss_pred -------CC--------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 233 -------PL--------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 233 -------~~--------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.. ....++.+.+||.+||..||.+|||+.+++.||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00 0124788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=349.01 Aligned_cols=257 Identities=28% Similarity=0.546 Sum_probs=218.6
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEE
Confidence 47999999999999999999999999999999987543 33334678899999999999999999998776 56799999
Q ss_pred eccCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 93 GYCEGGDMAEIIKKAR-GACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~-~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||++|++|..++.... ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++..+... .
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-L 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-c
Confidence 9999999999887531 2368999999999999999999997 59999999999999999999999999999765432 3
Q ss_pred cccccCCCCCCChhhhcCC------CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH---HHHhccCCCCCCccccHH
Q 006460 171 ASSVVGTPNYMCPELLADI------PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLI---NKINRSSISPLPIVYSST 241 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~------~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~---~~i~~~~~~~~p~~~s~~ 241 (644)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..||......... ..+........+..++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 4456788999999988543 3588999999999999999999999765544433 334444555667778999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+.+||.+||..+|.+||++.+++.||||...
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=364.56 Aligned_cols=248 Identities=28% Similarity=0.466 Sum_probs=201.4
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
.+|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+|++++|||||++++++.. +...|+||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEE
Confidence 4699999999999999999999999999999975432 23458999999999999999999877 46689999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~ 172 (644)
||+ .++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 137 e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 137 PHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred Ecc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 999 56888888653 4468999999999999999999999999999999999999999999999999998644433445
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhC-CCCCCCCChH----------HHHHHHhccCC--CCCC----
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMA----------GLINKINRSSI--SPLP---- 235 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG-~~PF~~~~~~----------el~~~i~~~~~--~~~p---- 235 (644)
...||+.|+|||++.+..|+.++|||||||++|+|+++ .++|...... .+...+..... ..++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 56799999999999998999999999999999999985 4444432211 11111110000 0001
Q ss_pred --------------------------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 236 --------------------------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 236 --------------------------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 134667788999999999999999999999999974
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=353.67 Aligned_cols=257 Identities=30% Similarity=0.471 Sum_probs=222.6
Q ss_pred CCCCCCeEEEE-EeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe---
Q 006460 9 KSKLEDYEVIE-QIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD--- 83 (644)
Q Consensus 9 ~~~~~~Y~i~~-~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d--- 83 (644)
....++|.+.. +||-|-.|.|..|.++.|++++|+|++... ....||+++--.. .|||||.++++|..
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 35778898864 699999999999999999999999988643 3456788876555 69999999999853
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC---CCeEEeccC
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD---NDIRLGDFG 160 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~---g~vKL~DFG 160 (644)
...++.||||.++||.|+..|+..+...|+|.++..|++||..|+.|||+.+|.||||||+|+|+... ..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 34689999999999999999998888889999999999999999999999999999999999999854 469999999
Q ss_pred cccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhccCCCC---
Q 006460 161 LAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSISP--- 233 (644)
Q Consensus 161 ls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~----~~el~~~i~~~~~~~--- 233 (644)
+++.-.......+.|.||+|.|||++....|+..+|+||+||+||.||||.|||.... ..+...+|..+.+..
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 9998766667888999999999999999999999999999999999999999996433 235566666665432
Q ss_pred CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 234 ~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
-+..+|+..+++|+.+|..+|.+|.|+.+++.|||+..+
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 223468999999999999999999999999999999754
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=342.36 Aligned_cols=250 Identities=28% Similarity=0.551 Sum_probs=218.2
Q ss_pred eccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCC
Q 006460 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGD 99 (644)
Q Consensus 21 LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~Ggs 99 (644)
||.|+||.||+|.+..++..||+|.+...... ....+.+.+|+++++.++||||+++++++.+ +..+|+||||+.|++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence 79999999999999999999999999765432 3345778999999999999999999998765 567999999999999
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccccccCCCC
Q 006460 100 MAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN 179 (644)
Q Consensus 100 L~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~ 179 (644)
|.+++.+. ..+++..+..++.||+.||.|||++|++|+||+|.||+++.++.++|+|||++.............+++.
T Consensus 80 L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 80 LWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred HHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 99999764 3489999999999999999999999999999999999999999999999999987655433445678999
Q ss_pred CCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHhc-cCCCCCCccccHHHHHHHHHHhccCCCC
Q 006460 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD--MAGLINKINR-SSISPLPIVYSSTMKQIIKSMLRKNPEH 256 (644)
Q Consensus 180 Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~--~~el~~~i~~-~~~~~~p~~~s~~l~dLI~~~L~~dP~~ 256 (644)
|++||++.+..++.++|+||||+++|+|++|..||.... .......+.. ......|...+..+.+||.+||..+|.+
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 237 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence 999999988889999999999999999999999998776 5566666553 3344566667899999999999999999
Q ss_pred CCC-----HHHHhhCCCCchhh
Q 006460 257 RPT-----ASDLLRHPHLQPYL 273 (644)
Q Consensus 257 RpT-----a~eiL~hp~f~~~~ 273 (644)
||+ +.++++||||+.+.
T Consensus 238 R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 238 RLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred CcCCcccCHHHHhcChhhhCCC
Confidence 999 99999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.72 Aligned_cols=254 Identities=31% Similarity=0.506 Sum_probs=212.5
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++++.||.|+||.||+|.+..++..||+|.+............+.+|++++++++||||+++++++.+ +..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEee
Confidence 5999999999999999999999999999999987654444444678889999999999999999998765 567999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~~ 172 (644)
|+. ++|..++.......+++..++.++.||+.||.|||++|++||||+|+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 995 68999887665667899999999999999999999999999999999999999999999999998765432 2233
Q ss_pred cccCCCCCCChhhhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--------------------
Q 006460 173 SVVGTPNYMCPELLADIP-YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI-------------------- 231 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~-ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~-------------------- 231 (644)
...+++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 456788999999887644 58899999999999999999999987765443333221100
Q ss_pred --------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 232 --------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 232 --------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
......++.++.+||.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=339.81 Aligned_cols=255 Identities=30% Similarity=0.526 Sum_probs=216.7
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc---ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CceE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK---QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNCV 88 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~~ 88 (644)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+++++++.||||+++++++.+. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 58999999999999999999999999999999886432 2233456788999999999999999999987654 3578
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||.||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999998753 34889999999999999999999999999999999999999999999999999865321
Q ss_pred ----cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc-CCCCCCccccHHHH
Q 006460 169 ----DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-SISPLPIVYSSTMK 243 (644)
Q Consensus 169 ----~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~-~~~~~p~~~s~~l~ 243 (644)
.......|+..|+|||++.+..++.++|||||||++|+|++|.+||...........+... ..+..|..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 1123456899999999998888999999999999999999999999876655444444433 23445667788999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
++|.+|| .+|.+||+++++++|||+.
T Consensus 240 ~~i~~~l-~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 240 DFLKRIF-VEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHh-cChhhCCCHHHHhcCcccC
Confidence 9999999 5999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=345.99 Aligned_cols=254 Identities=33% Similarity=0.556 Sum_probs=216.7
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
-|++.+.||.|+||.||+|.+..++..+++|.+.... ......+.+|+++++.++||||++++++|.. ....|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEE
Confidence 3788999999999999999999999999999986543 3345678889999999999999999999877 467999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~~ 172 (644)
|+.+++|..++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 83 FCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 99999999987653 346899999999999999999999999999999999999999999999999998764322 2234
Q ss_pred cccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--CCCCccccHHHHHH
Q 006460 173 SVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--SPLPIVYSSTMKQI 245 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--~~~p~~~s~~l~dL 245 (644)
...+++.|+|||++. +..++.++|||||||++|+|++|.+||...+..+....+..... ...+..++.++.+|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 467899999999884 44578899999999999999999999988776666555544332 23455688999999
Q ss_pred HHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 246 IKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
|.+||..+|.+|||+.++++||||..
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEec
Confidence 99999999999999999999999963
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=337.02 Aligned_cols=254 Identities=37% Similarity=0.775 Sum_probs=229.2
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.++||.|+||.||+|.+..++..+++|.+............+.+|++++++++||||+++++++.+ +..+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEeh
Confidence 6999999999999999999999999999999998765555556778899999999999999999998876 477999999
Q ss_pred ccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 94 YCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 94 y~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|+++++|..++.... ...+++..++.++.||+.||.|||++|++||||+|.||+++.++.+||+|||++...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~ 158 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA 158 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence 999999999987532 346899999999999999999999999999999999999999999999999999876554 44
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhc
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~ 251 (644)
....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...+...+......+.+..++.++.+++.+||.
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence 45678999999999999889999999999999999999999999998888888887777777888899999999999999
Q ss_pred cCCCCCCCHHHHhhCCCC
Q 006460 252 KNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 252 ~dP~~RpTa~eiL~hp~f 269 (644)
.+|.+|||+.++++||++
T Consensus 239 ~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 239 VKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=344.26 Aligned_cols=259 Identities=31% Similarity=0.564 Sum_probs=215.5
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe---
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD--- 83 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d--- 83 (644)
.....++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.+ +||||++++++|..
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 34577899999999999999999999999999999998764322 234567899999999 69999999998753
Q ss_pred -CCceEEEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccC
Q 006460 84 -KGNCVCIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG 160 (644)
Q Consensus 84 -~~~~~~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFG 160 (644)
.+..+|+||||++|++|.+++... ....+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 345799999999999999988642 23468999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc-ccccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--C
Q 006460 161 LAKLLNTED-LASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--S 232 (644)
Q Consensus 161 ls~~~~~~~-~~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--~ 232 (644)
++..+.... ......|++.|+|||++. +..|+.++|||||||++|+|++|.+||...........+..... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 988654332 233457899999999875 34578999999999999999999999987665444433332221 1
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
..+..++..+.+||.+||..+|++|||+.++++|+||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2345578899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.48 Aligned_cols=255 Identities=29% Similarity=0.521 Sum_probs=212.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
+...++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~ 81 (267)
T cd06645 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKL 81 (267)
T ss_pred cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEE
Confidence 3455789999999999999999999999999999999876532 223457789999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999999999998753 36899999999999999999999999999999999999999999999999998765322
Q ss_pred -cccccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--C--CccccH
Q 006460 169 -DLASSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--L--PIVYSS 240 (644)
Q Consensus 169 -~~~~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~--p~~~s~ 240 (644)
.......|++.|+|||++. ...++.++|||||||++|+|++|.+||..................+ . ...++.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN 239 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence 1223457899999999874 4458899999999999999999999986655433333322222211 1 124678
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCC
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPH 268 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~ 268 (644)
.+.+||.+||..+|++|||+.+++.|||
T Consensus 240 ~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 240 SFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=350.88 Aligned_cols=257 Identities=30% Similarity=0.564 Sum_probs=219.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
+...++|++.+.||+|+||.||+|.+..++..||+|.+...... ..+.+.+|+.+++.++||||++++++|.. +..+
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV-GDEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 34558999999999999999999999999999999998764433 24567889999999999999999998876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999999999864 24889999999999999999999999999999999999999999999999998765433
Q ss_pred c-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--CCCCccccHHHHHH
Q 006460 169 D-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--SPLPIVYSSTMKQI 245 (644)
Q Consensus 169 ~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--~~~p~~~s~~l~dL 245 (644)
. ......+++.|+|||.+.+..++.++|+|||||++|+|++|.+||...+.......+..... ...+..++..+.+|
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence 2 22345789999999999988899999999999999999999999987665433332222221 22455678899999
Q ss_pred HHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 246 IKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+.+||..+|.+||++.++++||||+.
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCchhcc
Confidence 99999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=342.57 Aligned_cols=253 Identities=29% Similarity=0.477 Sum_probs=210.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.++++++||||+++++++.. ...+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEE
Confidence 456899999999999999999999999999999998754322 23457789999999999999999999876 467999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..+....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999999998753 458999999999999999999999999999999999999999999999999998654322
Q ss_pred ccccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC----CCCccccHHH
Q 006460 170 LASSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTM 242 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~----~~p~~~s~~l 242 (644)
......|++.|+|||.+. ...++.++|||||||++|+|++|.+||...........+...... ..+..++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 234467899999999874 345788999999999999999999999655443332222222111 1123468899
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPH 268 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~ 268 (644)
.+||++||..+|.+|||++++|+|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=345.68 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=215.4
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++.+.||.|+||.||+|.+..+++.||+|.++...........+.+|++++++++||||+++++++.. +...|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEE
Confidence 47999999999999999999999999999999987655555556788999999999999999999999876 56799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--c
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--L 170 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~--~ 170 (644)
||+.++.|..++.. ...+++..++.++.||+.||.|||++||+||||+|+||+++.++.+||+|||++....... .
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 80 EYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 99988777665543 3458999999999999999999999999999999999999999999999999998765443 3
Q ss_pred cccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC-------------------
Q 006460 171 ASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS------------------- 230 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~------------------- 230 (644)
.....++..|+|||++.+. .++.++||||||+++|+|++|.+||.+....+....+....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 4456789999999999887 78999999999999999999999998766554433322100
Q ss_pred --C----------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 231 --I----------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 231 --~----------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
. ...+..++.++.+||++||..+|++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01223358889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=371.05 Aligned_cols=246 Identities=25% Similarity=0.444 Sum_probs=219.0
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
+.+++++.||+|.||.||+|.+..+ ..||+|.++..... ...|.+|+++|++|+|+|||++++++...+ .+||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVt 280 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVT 280 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEE
Confidence 3456678999999999999988644 38999998775433 346779999999999999999999987644 599999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~ 172 (644)
||+..|+|.++|+...+..+.......++.||++|++||+++++|||||...||||+.++.+||+||||++....+. +.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~ 359 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YT 359 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc-ee
Confidence 99999999999998667789999999999999999999999999999999999999999999999999999654432 22
Q ss_pred ccc---CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 173 SVV---GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 173 ~~~---GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
... -..-|+|||.+....++.++|||||||+||||.| |+.||.+.+..++++.+.++.+.+-|..+|.++.+++..
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~ 439 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS 439 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Confidence 222 2456999999999999999999999999999998 999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCHHHHh
Q 006460 249 MLRKNPEHRPTASDLL 264 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL 264 (644)
||..+|++|||++.+.
T Consensus 440 CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 440 CWHEDPEDRPTFETLR 455 (468)
T ss_pred HhhCCcccCCCHHHHH
Confidence 9999999999999775
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=341.45 Aligned_cols=254 Identities=26% Similarity=0.551 Sum_probs=215.2
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc----cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ----TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~----~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
+|+..+.||+|+||.||+|.+..++..||+|.+..... .....+.+.+|++++++++||||+++++++.+ ...++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEE
Confidence 58899999999999999999999999999999875431 22345788999999999999999999999876 45799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-CeEEeccCcccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTE 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-~vKL~DFGls~~~~~~ 168 (644)
+||||+.|++|.+++... ..+++..++.++.||+.||.|||++|++||||+|.||+++.++ .+||+|||++..+...
T Consensus 80 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999999999763 3589999999999999999999999999999999999998776 5999999999776432
Q ss_pred c-----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH---h-ccCCCCCCcccc
Q 006460 169 D-----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI---N-RSSISPLPIVYS 239 (644)
Q Consensus 169 ~-----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i---~-~~~~~~~p~~~s 239 (644)
. ......|+..|+|||++.+..++.++|||||||++|+|++|.+||...........+ . .......+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 122356888999999998888999999999999999999999999755432222222 1 223345666788
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
.++.+++.+||..+|.+|||+.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=376.41 Aligned_cols=250 Identities=28% Similarity=0.544 Sum_probs=221.8
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecc-cccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-KQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
|.-++.||.|+||.||.|++..+.+.||||++... +.....+..++.|++.|++|.|||+|.+.++|.. +...|+|||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHHH
Confidence 55577899999999999999999999999999875 4555567889999999999999999999998876 566999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS 173 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~ 173 (644)
|| -|+-.+++...+ .++-|-++..|+.+.|.||.|||+++.||||||..|||++..|.|||+|||.+....+ .++
T Consensus 107 YC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---Ans 181 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANS 181 (948)
T ss_pred HH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhc
Confidence 99 568888887654 4688999999999999999999999999999999999999999999999999987654 568
Q ss_pred ccCCCCCCChhhhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC-ccccHHHHHHHHHH
Q 006460 174 VVGTPNYMCPELLAD---IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP-IVYSSTMKQIIKSM 249 (644)
Q Consensus 174 ~~GT~~Y~APEvl~~---~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p-~~~s~~l~dLI~~~ 249 (644)
++|||+|||||++.. ..|+-++||||||+++.||.-.+||+...+.+..+..|-...-+.++ ..||..++.|+..|
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 261 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHH
Confidence 999999999998864 46999999999999999999999998888877777777766555554 34899999999999
Q ss_pred hccCCCCCCCHHHHhhCCCCc
Q 006460 250 LRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~hp~f~ 270 (644)
|++-|..|||.+++|+|+|+.
T Consensus 262 LqKipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 262 LQKIPQERPTSEELLKHRFVL 282 (948)
T ss_pred HhhCcccCCcHHHHhhcchhc
Confidence 999999999999999999984
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=347.95 Aligned_cols=256 Identities=30% Similarity=0.573 Sum_probs=221.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
....+|++.+.||.|+||.||+|.+..+++.|++|.+...... ....+.+|+.+++.++||||+++++++.. +..+|
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 92 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLV-GDELF 92 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEE
Confidence 3457899999999999999999999999999999998764332 24567889999999999999999998876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+|+||+.|++|..++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 93 VVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999999999988642 48999999999999999999999999999999999999999999999999988654432
Q ss_pred c-cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--CCCCccccHHHHHHH
Q 006460 170 L-ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--SPLPIVYSSTMKQII 246 (644)
Q Consensus 170 ~-~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--~~~p~~~s~~l~dLI 246 (644)
. .....+++.|+|||.+.+..++.++|||||||++|+|++|.+||...+.......+..... ...+..++..+.+||
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 2 3345789999999999888899999999999999999999999988776655544433322 224556789999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCch
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+||..+|.+|||+.+++.||||+.
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHhhcChhhCCCHHHHhhChHhhh
Confidence 9999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=346.39 Aligned_cols=259 Identities=30% Similarity=0.503 Sum_probs=211.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC---
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG--- 85 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~--- 85 (644)
...+++|++.++||+|+||.||+|.+..+++.||+|.+............+.+|++++++++||||+++++++...+
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 45678999999999999999999999999999999998765444444455678999999999999999999876532
Q ss_pred ----ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 86 ----NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 86 ----~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
...|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 88 NRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred cCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 35799999995 5888888653 34689999999999999999999999999999999999999999999999999
Q ss_pred cccccccc-----ccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---
Q 006460 162 AKLLNTED-----LASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--- 232 (644)
Q Consensus 162 s~~~~~~~-----~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~--- 232 (644)
+..+.... ......++..|+|||++.+. .++.++||||||+++|+|++|.+||.+.........+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 98654322 12345678899999988664 4788999999999999999999999887765443333221100
Q ss_pred ---------------CC-------------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 233 ---------------PL-------------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 233 ---------------~~-------------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.. +...+..+.+||.+||..||.+|||++++|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00 11235678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=345.57 Aligned_cols=255 Identities=31% Similarity=0.591 Sum_probs=222.9
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
..|+.++.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++++.||||+++++++.+ +..+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEE
Confidence 468889999999999999999999999999999875533 2335678899999999999999999998876 56899999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-c
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-A 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~-~ 171 (644)
||+.|++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 99999999999864 3589999999999999999999999999999999999999999999999999976544332 2
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhc
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~ 251 (644)
....++..|+|||++.+..++.++|+|||||++|+|++|.+||...........+.....+..+..++..+.+|+.+||.
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 33568889999999988889999999999999999999999998877766666665555555666788999999999999
Q ss_pred cCCCCCCCHHHHhhCCCCchh
Q 006460 252 KNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 252 ~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+|.+||++.+++.||||...
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred cCcccCcCHHHHHhChHhhhc
Confidence 999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=365.09 Aligned_cols=249 Identities=29% Similarity=0.466 Sum_probs=203.6
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEe--cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+|++++.||+|+||.||+|... .++..||+|.+.... ...+|+++|++|+|||||+++++|.. ...+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRW-KSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEee-CCEEE
Confidence 357999999999999999999764 356789999886432 24579999999999999999998876 46799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+|||++ +++|..++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+....
T Consensus 163 lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 163 MVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999 5688888853 4569999999999999999999999999999999999999999999999999997654322
Q ss_pred ---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHhc----c----------
Q 006460 170 ---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA---GLINKINR----S---------- 229 (644)
Q Consensus 170 ---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~---el~~~i~~----~---------- 229 (644)
......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... ..+..+.. .
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 123467999999999999999999999999999999999999999764321 11111110 0
Q ss_pred ------------CCCC--CC-----ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 230 ------------SISP--LP-----IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 230 ------------~~~~--~p-----~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..++ .+ ..++.++.+||.+||..||++|||+.++|.||||..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 0000 11 134678899999999999999999999999999974
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=335.68 Aligned_cols=253 Identities=32% Similarity=0.587 Sum_probs=217.0
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.+.||+|+||.||+|.+..++..|++|.+..........+.+.+|+.+++.++||||+++++++.. ...+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEe
Confidence 6999999999999999999999999999999998776555567889999999999999999999998665 567999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc---
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--- 170 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~--- 170 (644)
|+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999999763 3588999999999999999999999999999999999999999999999999987643322
Q ss_pred --cccccCCCCCCChhhhcCCC---CCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhccCCCCCCcc--ccHHH
Q 006460 171 --ASSVVGTPNYMCPELLADIP---YGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINRSSISPLPIV--YSSTM 242 (644)
Q Consensus 171 --~~~~~GT~~Y~APEvl~~~~---ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i~~~~~~~~p~~--~s~~l 242 (644)
.....+++.|+|||++.+.. ++.++||||||+++|+|++|..||.... .......+.......+|.. ++..+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 12356788999999998766 8999999999999999999999997653 3333333333333444444 38899
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.+||.+||+.+|.+|||+.+++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=347.91 Aligned_cols=257 Identities=30% Similarity=0.519 Sum_probs=216.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-ceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG-NCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~-~~~~ 89 (644)
.+++|++.+.||.|+||.||+|.+..+++.+++|.++...........+.+|+.++++++||||+++++++.... ..+|
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 357899999999999999999999999999999999876554445556788999999999999999999887642 6799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999996 59999887643 36899999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccCCCCCCChhhhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC----------------
Q 006460 169 DLASSVVGTPNYMCPELLADIP-YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---------------- 231 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~-ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~---------------- 231 (644)
.......+++.|+|||.+.+.. ++.++||||||+++|+|++|.+||..........++.....
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 2334456789999999887644 68999999999999999999999988776555444322110
Q ss_pred --------------CCCCcc-ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 232 --------------SPLPIV-YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 232 --------------~~~p~~-~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
..++.. +++.+.+||++||..+|++|||+.++|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 57889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=347.56 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=214.9
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc---HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT---EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+|++.+.||.|+||.||+|.+..+++.||+|.++..... ......+.+|+.++++++||||+++++++.+ ....|+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence 589999999999999999999999999999999766443 3345667789999999999999999999877 678999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-c
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-D 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~ 169 (644)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++...... .
T Consensus 80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99999 999999997533 36899999999999999999999999999999999999999999999999999876543 2
Q ss_pred ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC----------------
Q 006460 170 LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---------------- 232 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---------------- 232 (644)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||......+.+..+......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2334567889999998854 45789999999999999999999999877765554444321100
Q ss_pred ------C-----CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 233 ------P-----LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 233 ------~-----~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
. .....+..+.+||.+||..+|.+|||+.++|.||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 0 11234678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=346.64 Aligned_cols=248 Identities=17% Similarity=0.265 Sum_probs=211.6
Q ss_pred CCeEEE--EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEe--C-Cc
Q 006460 13 EDYEVI--EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVD--K-GN 86 (644)
Q Consensus 13 ~~Y~i~--~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d--~-~~ 86 (644)
++++.. ..||+|++|.||+|.. +|+.||+|.++..... ....+.+.+|+.+|++++|||||++++++.+ . ..
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 344444 6799999999999987 6889999999765433 3345778899999999999999999999876 2 35
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
.+++||||+.||+|.+++... ..+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 689999999999999999763 4588999999999999999999985 9999999999999999999999999999865
Q ss_pred ccccccccccCCCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc-CCCCCCccccHHH
Q 006460 166 NTEDLASSVVGTPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-SISPLPIVYSSTM 242 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~-~~~~~p~~~s~~l 242 (644)
... .....|++.|+|||++.+ ..|+.++|||||||++|+|++|..||...+..++...+... ...+.|..++..+
T Consensus 174 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 251 (283)
T PHA02988 174 SSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEI 251 (283)
T ss_pred ccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHH
Confidence 432 234678999999999976 67999999999999999999999999988887777776433 3445566789999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+|+.+||+.||.+|||+.+++..
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999999999999999999863
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.11 Aligned_cols=253 Identities=19% Similarity=0.356 Sum_probs=220.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
....+|.+.+.||+|+||.||+|.++.++..||+|.+..... ....+.+|+++++.++||||+++++++.. +..++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch---HHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcE
Confidence 345679999999999999999999999999999999865422 24568889999999999999999998766 55689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||+.+++|.+++.......+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999987655568999999999999999999999999999999999999999999999999998765432
Q ss_pred cc--ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 170 LA--SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 170 ~~--~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
.. ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+........+..++..+.+++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 21 12234567999999998899999999999999999998 9999998888888787776656667778899999999
Q ss_pred HHHhccCCCCCCCHHHHhhC
Q 006460 247 KSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~h 266 (644)
.+||..+|.+|||+.++++.
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHccCCcccCCCHHHHHHH
Confidence 99999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.09 Aligned_cols=255 Identities=27% Similarity=0.482 Sum_probs=207.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
++++|++.+.||.|+||.||+|.++.+++.||+|.+....... ....+.+|+.++++++||||+++++++.+ +.+.|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEE
Confidence 5789999999999999999999999999999999987643221 12346789999999999999999998765 568999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-c
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-D 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~ 169 (644)
||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .
T Consensus 81 v~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 999996 49999887643 36899999999999999999999999999999999999999999999999998754322 1
Q ss_pred ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhccCCC---------------
Q 006460 170 LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINRSSIS--------------- 232 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i~~~~~~--------------- 232 (644)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.... ..+....+......
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 2233457889999998865 458999999999999999999999997655 33332222110000
Q ss_pred ---------C-----CCcccc--HHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 233 ---------P-----LPIVYS--STMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 233 ---------~-----~p~~~s--~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
+ ....++ ..+.+++.+||..+|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 001223 788899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.79 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=217.6
Q ss_pred eEEEEEeccCCCeEEEEEEEecC---CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----c
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIE---RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG-----N 86 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~-----~ 86 (644)
|++.+.||+|+||.||.|....+ +..||+|++............+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987754 478999999876555555677899999999999999999999876533 2
Q ss_pred eEEEEEeccCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKAR----GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~----~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
..++||||+.+++|..++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 4799999999999999986542 235899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc---ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccc
Q 006460 163 KLLNTEDLA---SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVY 238 (644)
Q Consensus 163 ~~~~~~~~~---~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~ 238 (644)
+........ ....++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+....+....+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC 240 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCC
Confidence 865433221 12335678999999988889999999999999999998 99999988888888888777777778889
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+..+.+++.+||..||.+|||+.+++++
T Consensus 241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 241 LDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=348.69 Aligned_cols=247 Identities=28% Similarity=0.486 Sum_probs=194.0
Q ss_pred EEEeccCCCeEEEEEEEec--CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe-CCceEEEEEec
Q 006460 18 IEQIGRGAFGAAFLVLHKI--ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD-KGNCVCIVTGY 94 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~--tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d-~~~~~~LVmEy 94 (644)
..+||+|+||.||+|.++. ++..||+|.+...... ..+.+|+++|++++||||+++++++.. .+..+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3689999999999999764 5688999988654332 346789999999999999999998864 34678999999
Q ss_pred cCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE----cCCCCeEEeccCccc
Q 006460 95 CEGGDMAEIIKKAR-------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL----TKDNDIRLGDFGLAK 163 (644)
Q Consensus 95 ~~GgsL~~~L~~~~-------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL----~~~g~vKL~DFGls~ 163 (644)
+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 58888875321 2358899999999999999999999999999999999999 456789999999998
Q ss_pred cccccc----ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChH---------HHHHHHhcc
Q 006460 164 LLNTED----LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA---------GLINKINRS 229 (644)
Q Consensus 164 ~~~~~~----~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~---------el~~~i~~~ 229 (644)
.+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ..+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 764322 2234578999999999876 45899999999999999999999999754321 111110000
Q ss_pred -C------------------------------------CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 230 -S------------------------------------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 230 -~------------------------------------~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
. ........+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000011235678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.11 Aligned_cols=253 Identities=21% Similarity=0.359 Sum_probs=207.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEec----------------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKI----------------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~----------------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNI 74 (644)
..++|++.++||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+++|++++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 45799999999999999999998643 34579999987643 23445678999999999999999
Q ss_pred ceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 006460 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR-----------------GACFPEEKLCKWLTQLLLAVDYLHSNRVL 137 (644)
Q Consensus 75 Vkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~-----------------~~~l~e~~i~~i~~QIL~gL~yLHs~gII 137 (644)
+++++++.+. ...|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+
T Consensus 82 v~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 82 IRLLGVCVDE-DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eEEEEEEecC-CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999998764 56899999999999999986532 12367788999999999999999999999
Q ss_pred cccCCCCcEEEcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh--CCC
Q 006460 138 HRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA--HQP 212 (644)
Q Consensus 138 HRDLKPeNILL~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt--G~~ 212 (644)
||||||+|||++.++.+||+|||+++.+.... ......++..|+|||++.+..++.++|||||||++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999998654332 1233456788999999988889999999999999999986 667
Q ss_pred CCCCCChHHHHHHHhc-------cCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 213 AFRAPDMAGLINKINR-------SSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 213 PF~~~~~~el~~~i~~-------~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
||......+....+.. ......+..++..+.+|+.+||..+|.+|||+.+|..
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 8887666555444321 1112234567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.17 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=210.3
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCc----e
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGN----C 87 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~----~ 87 (644)
++|++.+.||.|+||.||+|.+..+++.||+|.+............+.+|+.+++++. ||||+++++++..... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5799999999999999999999999999999998765443334456788999999995 6999999998875332 4
Q ss_pred EEEEEeccCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-CCCeEEeccCccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKAR---GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-DNDIRLGDFGLAK 163 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~---~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-~g~vKL~DFGls~ 163 (644)
.|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999975 8988886543 235899999999999999999999999999999999999998 8899999999988
Q ss_pred ccccc-cccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC----------
Q 006460 164 LLNTE-DLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---------- 231 (644)
Q Consensus 164 ~~~~~-~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~---------- 231 (644)
.+... .......+++.|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+.......+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 65332 22334467889999998865 4579999999999999999999999987765544433321100
Q ss_pred ---------CC--------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 232 ---------SP--------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 232 ---------~~--------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
.. ....++..+.+||.+||..||.+||++.++|.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 0123678899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=330.37 Aligned_cols=254 Identities=35% Similarity=0.623 Sum_probs=223.1
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-ceEEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG-NCVCIVT 92 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~-~~~~LVm 92 (644)
+|++.+.||+|++|.||+|.+..++..+++|++..........+.+.+|+.++++++||||+++++.+.... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 589999999999999999999999999999999876654556678899999999999999999999887641 6799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc--
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-- 170 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~-- 170 (644)
||+.+++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999999998643 689999999999999999999999999999999999999999999999999987665443
Q ss_pred -cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhc-cCCCCCCccccHHHHHHHH
Q 006460 171 -ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINR-SSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 171 -~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i~~-~~~~~~p~~~s~~l~dLI~ 247 (644)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+.. ......+..++..+.+||.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 455678999999999988889999999999999999999999998766 3333333332 3445567778999999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCC
Q 006460 248 SMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f 269 (644)
+||..+|.+||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.75 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=213.9
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+++|++.+.||.|++|.||+|.++.+++.||+|.+............+.+|++++++++||||+++++++.+ +..+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEE
Confidence 578999999999999999999999999999999987654444445678889999999999999999999876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-CCCeEEeccCcccccccc-c
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-DNDIRLGDFGLAKLLNTE-D 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-~g~vKL~DFGls~~~~~~-~ 169 (644)
|||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++...... .
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 99995 58888887655545788999999999999999999999999999999999985 457999999999765332 2
Q ss_pred ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-----------------
Q 006460 170 LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI----------------- 231 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~----------------- 231 (644)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 2344567899999998866 4578999999999999999999999987765544443321100
Q ss_pred ---CC--------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 232 ---SP--------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 232 ---~~--------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.. ....++..+.+++.+||..+|.+||++.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 112457889999999999999999999999999999753
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.31 Aligned_cols=257 Identities=35% Similarity=0.594 Sum_probs=216.7
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~~~LV 91 (644)
++|++.+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|++++++++||||++++++|.+. ...+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 5799999999999999999999999999999998765332 4457789999999999999999999988653 3478999
Q ss_pred EeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 92 TGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
|||++|++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~- 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS- 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc-
Confidence 9999999999987642 3456899999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhccCCCCCC------ccc
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-----DMAGLINKINRSSISPLP------IVY 238 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~-----~~~el~~~i~~~~~~~~p------~~~ 238 (644)
......++..|+|||.+.+..++.++|||||||++|+|++|..||... ...+....+.......++ ..+
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd06621 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238 (287)
T ss_pred ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence 223456788999999999889999999999999999999999999765 233444444432222221 235
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
++.+.+||.+||..+|.+|||+.+++.||||+.
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 678999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=330.76 Aligned_cols=253 Identities=36% Similarity=0.627 Sum_probs=226.0
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+++++++.|||++++++++.+ +..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEe
Confidence 6899999999999999999999999999999998776555567789999999999999999999998766 577999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-cc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-AS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~-~~ 172 (644)
|+++++|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ ..
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 99999999999764 4689999999999999999999999999999999999999999999999999987654332 23
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
...++..|+|||.+.+..++.++||||||+++|+|++|.+||...........+........+..++..+.+++.+||..
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQK 237 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhC
Confidence 45788999999999888889999999999999999999999987776666666655666667788899999999999999
Q ss_pred CCCCCCCHHHHhhCCCC
Q 006460 253 NPEHRPTASDLLRHPHL 269 (644)
Q Consensus 253 dP~~RpTa~eiL~hp~f 269 (644)
+|++|||+.+++.||||
T Consensus 238 ~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 238 DPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ChhhCcCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=342.68 Aligned_cols=253 Identities=21% Similarity=0.385 Sum_probs=219.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEec-----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKI-----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+++|+.+.||||+++++++.. +
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTE-G 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEec-C
Confidence 45789999999999999999998753 367899999875433 3345788999999999999999999999876 4
Q ss_pred ceEEEEEeccCCCCHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKAR------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND 153 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~ 153 (644)
...|+||||+.|++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 67999999999999999997542 234788999999999999999999999999999999999999999
Q ss_pred eEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcc
Q 006460 154 IRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRS 229 (644)
Q Consensus 154 vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~ 229 (644)
+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999997653322 1233456788999999999899999999999999999998 99999888888888888777
Q ss_pred CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 230 SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 230 ~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.....+..++..+.+|+.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 766677788999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=345.12 Aligned_cols=254 Identities=26% Similarity=0.482 Sum_probs=212.4
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++.++||+|+||.||+|.++.+++.||+|.+..........+.+.+|+++++.++||||++++++|.. +...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence 57999999999999999999999999999999987654444445678889999999999999999999865 56799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-ccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLA 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~ 171 (644)
||+.++.|..+... ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..+... ...
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred ecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99999999887654 234899999999999999999999999999999999999999999999999998865432 223
Q ss_pred ccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc---------------------
Q 006460 172 SSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS--------------------- 229 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~--------------------- 229 (644)
....++..|+|||++.+ ..++.++||||||+++|+|++|.+||......+....+...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 44568899999998875 34788999999999999999999999876654433332210
Q ss_pred CCC---------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 230 SIS---------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 230 ~~~---------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
..+ .....++..+.+|+.+||..+|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 0122457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=397.95 Aligned_cols=264 Identities=31% Similarity=0.500 Sum_probs=230.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
+-.-++|.|++.||+|+||.|.+|+++.+++.||+|++.+-... ......|..|-.+|..-+.+.||+++..|++ .++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD-~~~ 149 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD-ERY 149 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-ccc
Confidence 34568999999999999999999999999999999999763221 1123457778899998899999999999988 578
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.||+|..++.+.. ++||..++.|+..|+.||..||+.|+|||||||+||||+..|++||+|||.+-.+..
T Consensus 150 LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 999999999999999998754 699999999999999999999999999999999999999999999999999887765
Q ss_pred ccc--cccccCCCCCCChhhhc----C-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC-CCCCC--cc
Q 006460 168 EDL--ASSVVGTPNYMCPELLA----D-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS-ISPLP--IV 237 (644)
Q Consensus 168 ~~~--~~~~~GT~~Y~APEvl~----~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~-~~~~p--~~ 237 (644)
.+. ....+|||.|++||++. + ..|+..+|+||+||++|||+.|..||......+.+.+|.... .-.+| ..
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~ 307 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETD 307 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccc
Confidence 443 34578999999999985 2 468999999999999999999999999999999999987652 12244 45
Q ss_pred ccHHHHHHHHHHhccCCCCCCC---HHHHhhCCCCchhhhhc
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPT---ASDLLRHPHLQPYLLRC 276 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpT---a~eiL~hp~f~~~~~~~ 276 (644)
+|.++++||.++| .+|..|.. ++++..||||.+..|..
T Consensus 308 VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 308 VSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred cCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhh
Confidence 8999999999999 68899998 99999999999888754
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=344.97 Aligned_cols=256 Identities=29% Similarity=0.533 Sum_probs=217.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+++++.++||||+++++++... ..+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEE
Confidence 3578999999999999999999999999999999986543 344567889999999999999999999998774 67999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
||||+++++|..++... +.+++..++.++.||+.||.|||+ +||+||||+|+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999999998763 458999999999999999999997 59999999999999999999999999998754332
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH-----------HHHHHHhccCCCCCCcc-
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA-----------GLINKINRSSISPLPIV- 237 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~-----------el~~~i~~~~~~~~p~~- 237 (644)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... +....+.......++..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 234567899999999998888999999999999999999999999865431 23333333333333333
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
++..+.+|+.+||..||.+|||+.++++||||..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 7889999999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.23 Aligned_cols=256 Identities=31% Similarity=0.604 Sum_probs=221.1
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
+.|++.+.||.|+||.||+|.+..++..||+|.+...... .....+.+|+.++++++||||++++++|.. +..+|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEE
Confidence 3577788899999999999999999999999998755332 345678899999999999999999998876 56799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-c
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-A 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~-~ 171 (644)
||+.+++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 99999999998864 3589999999999999999999999999999999999999999999999999986544322 2
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhc
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~ 251 (644)
....|+..|+|||++.+..++.++|+|||||++|+|++|.+||...........+.......++..++..+.+||.+||.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 33568899999999998889999999999999999999999998766665555555555455566678899999999999
Q ss_pred cCCCCCCCHHHHhhCCCCchhh
Q 006460 252 KNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 252 ~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.+|.+|||+.+++.||||..+.
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHHh
Confidence 9999999999999999997654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=335.95 Aligned_cols=247 Identities=21% Similarity=0.407 Sum_probs=216.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.+.+|++.+.||+|+||.||+|... +..+|+|.++.... .+.+.+|+.++++++|||++++++++...+..+|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCch----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 4679999999999999999999764 77899998865432 35678899999999999999999987766677999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-- 155 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 155 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--
Confidence 999999999999998755556899999999999999999999999999999999999999999999999998764332
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
.....++..|+|||++.+..++.++|||||||++|+|++ |++||...........+........+..++..+.+|+.+|
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 233455678999999988889999999999999999997 9999998888888877776655666778899999999999
Q ss_pred hccCCCCCCCHHHHhh
Q 006460 250 LRKNPEHRPTASDLLR 265 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~ 265 (644)
|..+|.+|||+.++++
T Consensus 236 l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 236 WHLDAATRPSFLQLRE 251 (256)
T ss_pred hcCChhhCcCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.21 Aligned_cols=256 Identities=21% Similarity=0.375 Sum_probs=215.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeE--EEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCC
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKK--YVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKG 85 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~--vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~ 85 (644)
...+++|++.+.||+|+||.||+|.++.++.. +++|.+... ........+.+|+.++.++ +||||+++++++.. +
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-R 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-C
Confidence 34678999999999999999999999887765 466665432 2334456788899999999 89999999998766 5
Q ss_pred ceEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~ 151 (644)
..+|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 67999999999999999997542 1357899999999999999999999999999999999999999
Q ss_pred CCeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccC
Q 006460 152 NDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSS 230 (644)
Q Consensus 152 g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~ 230 (644)
+.+||+|||++.............++..|+|||++.+..++.++|||||||++|+|++ |.+||......+....+....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9999999999874322211222334667999999988889999999999999999998 999998888777777766554
Q ss_pred CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 231 ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 231 ~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
....+..++..+.+|+.+||..+|++||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 455666788999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=338.97 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=207.2
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeC-CceEEEEE
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDK-GNCVCIVT 92 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~-~~~~~LVm 92 (644)
|++.++||+|+||.||+|.+..++..||+|.++........ ....+|+.+++++. ||||+++++++.+. ...+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 78999999999999999999999999999998764332222 23457889999885 99999999998764 15789999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~ 172 (644)
||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||+|.||+++. +.+||+|||++..........
T Consensus 80 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 80 ELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred ecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 9996 58888876533 46899999999999999999999999999999999999999 999999999998765544445
Q ss_pred cccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-----------------C--
Q 006460 173 SVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI-----------------S-- 232 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~-----------------~-- 232 (644)
...+++.|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+....+..... .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 5678999999997654 4568999999999999999999999988776554444321100 0
Q ss_pred ---------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 233 ---------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 233 ---------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.....++..+.+||.+||.++|.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0112457899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=332.54 Aligned_cols=246 Identities=25% Similarity=0.453 Sum_probs=219.0
Q ss_pred EEeccCCCeEEEEEEEecC---CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEecc
Q 006460 19 EQIGRGAFGAAFLVLHKIE---RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYC 95 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~ 95 (644)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+++++.++||||+++++++.. +..+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEec
Confidence 4699999999999999876 8999999997765443 45778899999999999999999998876 66799999999
Q ss_pred CCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 96 EGGDMAEIIKKAR-------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 96 ~GgsL~~~L~~~~-------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||+|.||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999998642 356899999999999999999999999999999999999999999999999999876543
Q ss_pred c---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 169 D---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 169 ~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
. ......+++.|+|||.+....++.++|||||||++|+|++ |..||.......+...+........+..++.++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE 238 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence 2 2344567889999999988889999999999999999998 69999999888888888877667778888999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~h 266 (644)
++.+||..+|.+|||+.+++++
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=327.66 Aligned_cols=251 Identities=35% Similarity=0.675 Sum_probs=218.7
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|.+.+.||.|++|.||+|.+..++..+++|++..... .....+.+|+.+++++.||||+++++++.. +...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEe
Confidence 58999999999999999999999999999999976543 345678899999999999999999998776 467999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS 173 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~ 173 (644)
|+.|++|.+++.... ..+++..++.++.|++.||.|||++|++||||+|.||+++.++.++|+|||.+...........
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 999999999987642 4689999999999999999999999999999999999999999999999999987665433455
Q ss_pred ccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCcc--ccHHHHHHHHHHhc
Q 006460 174 VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV--YSSTMKQIIKSMLR 251 (644)
Q Consensus 174 ~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~--~s~~l~dLI~~~L~ 251 (644)
..++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+........+.. ++..+.+||.+||.
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 6789999999999888899999999999999999999999988765555444444433333333 48899999999999
Q ss_pred cCCCCCCCHHHHhhCCC
Q 006460 252 KNPEHRPTASDLLRHPH 268 (644)
Q Consensus 252 ~dP~~RpTa~eiL~hp~ 268 (644)
.||.+|||+.+++.|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.48 Aligned_cols=253 Identities=21% Similarity=0.374 Sum_probs=214.0
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCe--EEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERK--KYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~--~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~ 88 (644)
+++|++.+.||+|+||.||+|..+.++. .+++|.++... .....+.+.+|+.+++++ +||||+++++++.. ...+
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~ 78 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYL 78 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcc
Confidence 5799999999999999999999887765 46888776322 233456788999999999 79999999998766 4569
Q ss_pred EEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCe
Q 006460 89 CIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDI 154 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~v 154 (644)
|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999999999999997532 1248899999999999999999999999999999999999999999
Q ss_pred EEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCC
Q 006460 155 RLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISP 233 (644)
Q Consensus 155 KL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~ 233 (644)
||+|||++..............+..|+|||++.+..++.++|||||||++|+|++ |.+||...........+.......
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 9999999875332211122233557999999988889999999999999999997 999999888888888777665566
Q ss_pred CCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 234 ~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+..++..+.+|+.+||..+|.+|||++++++.
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 677789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=335.23 Aligned_cols=254 Identities=34% Similarity=0.679 Sum_probs=216.3
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~ 79 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNI 79 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEE
Confidence 478999999999999999999999999999999886533 334455678899999999999999999999876 457899
Q ss_pred EEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 91 VTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
||||+.+++|.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999999988643 2345899999999999999999999999999999999999999999999999998876443
Q ss_pred cc-cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHhccCCCCCC-ccccHHHHH
Q 006460 169 DL-ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD--MAGLINKINRSSISPLP-IVYSSTMKQ 244 (644)
Q Consensus 169 ~~-~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~--~~el~~~i~~~~~~~~p-~~~s~~l~d 244 (644)
.. .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+.....++.+ ..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 21 234578899999999988889999999999999999999999986543 34555555555544443 357889999
Q ss_pred HHHHHhccCCCCCCCHHHHhhC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~h 266 (644)
|+.+||..+|.+||++.++++.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.47 Aligned_cols=259 Identities=18% Similarity=0.361 Sum_probs=218.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEec-----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKI-----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
..++|++.++||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSK-G 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-C
Confidence 35789999999999999999997653 355899998764432 2334567889999999999999999998766 4
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEe
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARG--------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLG 157 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~--------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~ 157 (644)
...|+||||+.+|+|.+++..... ..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 568999999999999999975321 234567889999999999999999999999999999999999999999
Q ss_pred ccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCC
Q 006460 158 DFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISP 233 (644)
Q Consensus 158 DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~ 233 (644)
|||+++....... .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+....+....+.......
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999986543221 122345678999999988889999999999999999998 799999888888888777776666
Q ss_pred CCccccHHHHHHHHHHhccCCCCCCCHHHHhh------CCCCch
Q 006460 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR------HPHLQP 271 (644)
Q Consensus 234 ~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~------hp~f~~ 271 (644)
.+..++..+.+|+.+||..+|++|||+.++++ ||||.+
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 77778899999999999999999999999986 788764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.94 Aligned_cols=254 Identities=20% Similarity=0.352 Sum_probs=218.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEe----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHK----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
.+.+|++.+.||+|+||.||+|.+. ..+..+++|.+..... ......+.+|+.+++.++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CC
Confidence 4688999999999999999999864 3457899999875433 3344678889999999999999999998766 55
Q ss_pred eEEEEEeccCCCCHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC
Q 006460 87 CVCIVTGYCEGGDMAEIIKKAR---------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~---------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~ 151 (644)
..|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 6999999999999999986322 1247889999999999999999999999999999999999999
Q ss_pred CCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 006460 152 NDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKIN 227 (644)
Q Consensus 152 g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~ 227 (644)
+.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.........+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999998654322 2233456678999999988889999999999999999998 999998888777888887
Q ss_pred ccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 228 RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 228 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.....+.+..++..+.+++.+||+.+|.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 777777788889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=343.59 Aligned_cols=257 Identities=30% Similarity=0.533 Sum_probs=218.8
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.+.||+|+||.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+.. +..+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence 479999999999999999999999999999999876532 22334677889999999999999999998765 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc---
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE--- 168 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~--- 168 (644)
|||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||.||+++.++.++|+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 80 MEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999999764 35899999999999999999999999999999999999999999999999998642110
Q ss_pred -------------cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--CC
Q 006460 169 -------------DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--SP 233 (644)
Q Consensus 169 -------------~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--~~ 233 (644)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+....+..... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 011234678899999999888899999999999999999999999998887777777655432 22
Q ss_pred CCccccHHHHHHHHHHhccCCCCCCC---HHHHhhCCCCchh
Q 006460 234 LPIVYSSTMKQIIKSMLRKNPEHRPT---ASDLLRHPHLQPY 272 (644)
Q Consensus 234 ~p~~~s~~l~dLI~~~L~~dP~~RpT---a~eiL~hp~f~~~ 272 (644)
.+..++.++.+||.+||..+|.+||+ +.++|+||||...
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 22357899999999999999999998 7899999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.64 Aligned_cols=252 Identities=22% Similarity=0.382 Sum_probs=214.6
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCe--EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----Cce
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERK--KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-----GNC 87 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~--~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-----~~~ 87 (644)
|.+.+.||+|+||.||+|.+..++. .+|+|.++...........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999887765 689999877654555567888999999999999999999987532 135
Q ss_pred EEEEEeccCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKAR----GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~----~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
.++||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 789999999999999885422 2348899999999999999999999999999999999999999999999999998
Q ss_pred ccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCcccc
Q 006460 164 LLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYS 239 (644)
Q Consensus 164 ~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s 239 (644)
.+..... .....+++.|++||.+.+..++.++|||||||++|+|++ |.+||...........+......+.+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL 240 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 7643321 122345678999999998889999999999999999998 899999888878777777766656677788
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+.++|.+||..+|.+|||+.+++++
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 241 DGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.70 Aligned_cols=254 Identities=20% Similarity=0.368 Sum_probs=219.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCC-----eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIER-----KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...++|++.+.||+|+||.||+|.++..+ ..||+|.+..... ......+.+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVST- 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-
Confidence 35679999999999999999999887544 8899999865432 2334567889999999999999999998776
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEE
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR--------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRL 156 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~--------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL 156 (644)
+...|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 467999999999999999997532 123678899999999999999999999999999999999999999999
Q ss_pred eccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCC
Q 006460 157 GDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSIS 232 (644)
Q Consensus 157 ~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~ 232 (644)
+|||+++.+..... .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 99999986543321 234456789999999988889999999999999999998 99999988888888888766666
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
..|..++..+.+|+.+||..+|.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 778888999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.44 Aligned_cols=250 Identities=20% Similarity=0.394 Sum_probs=216.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|+++++||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEE
Confidence 4679999999999999999999864 556799998765332 24578889999999999999999998765 566899
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+.+++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999999876566789999999999999999999999999999999999999999999999999987643221
Q ss_pred --cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 171 --ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 171 --~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......+.+..++.++.+|+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 122345678999999988889999999999999999998 99999988887777777766555556678999999999
Q ss_pred HHhccCCCCCCCHHHHhh
Q 006460 248 SMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~ 265 (644)
+||..+|++|||++++++
T Consensus 239 ~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 239 TCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.24 Aligned_cols=253 Identities=20% Similarity=0.372 Sum_probs=215.0
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEec-----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKI-----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
-++|++.+.||+|+||.||+|.++. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+ +.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC
Confidence 4689999999999999999998753 356799998864332 2334568899999999999999999998765 55
Q ss_pred eEEEEEeccCCCCHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEec
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARG--------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGD 158 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~--------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~D 158 (644)
..++||||+.+++|.+++..... ..++...+..++.||+.||.|||++|++||||||+|||++.++.++|+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 69999999999999999975321 2356788999999999999999999999999999999999999999999
Q ss_pred cCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCC
Q 006460 159 FGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPL 234 (644)
Q Consensus 159 FGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~ 234 (644)
||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.........+........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK 242 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 999876543221 122355778999999998889999999999999999998 7999998888887777777666677
Q ss_pred CccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 235 p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 243 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=348.54 Aligned_cols=252 Identities=22% Similarity=0.414 Sum_probs=215.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeE----EEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKK----YVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~----vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
...+|++.+.||+|+||.||+|.+..++.. ||+|.+... ......+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--
Confidence 356899999999999999999998766654 899988643 2344556788999999999999999999988653
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
..++|++|+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 4779999999999999998643 458899999999999999999999999999999999999999999999999998765
Q ss_pred ccccc---ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 167 TEDLA---SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 167 ~~~~~---~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
..... ....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+....++...+......+.+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 43221 12234668999999999899999999999999999997 999999888777766666666666677789999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+++.+||..+|.+|||+.+++.+
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=334.35 Aligned_cols=248 Identities=23% Similarity=0.410 Sum_probs=214.0
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.++|++.+.||+|+||.||+|.++. +..+|+|.+...... ...+.+|+.+|++++||||+++++++.. ...+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEE
Confidence 4689999999999999999998754 567999987654332 3467889999999999999999998765 5569999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||+.||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999999987543 35899999999999999999999999999999999999999999999999999865332221
Q ss_pred --ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 172 --SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 172 --~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
....++..|+|||++.+..++.++||||||+++|+|++ |++||...+..+....+........|...+..+.+|+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 12235568999999988889999999999999999999 999999988888888887776666677788999999999
Q ss_pred HhccCCCCCCCHHHHhh
Q 006460 249 MLRKNPEHRPTASDLLR 265 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~ 265 (644)
||..+|.+||++.++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=369.43 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=203.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
...|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++|+|||||++++++.. +...|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEE
Confidence 3479999999999999999999999999999996432 235679999999999999999998876 4568999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-- 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-- 169 (644)
|+++ .++|..++... ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 239 ~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 239 LPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9999 56888888653 3469999999999999999999999999999999999999999999999999998653321
Q ss_pred -ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCC-CCC-------ChHHHHHHHhccCC--CCCC---
Q 006460 170 -LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAF-RAP-------DMAGLINKINRSSI--SPLP--- 235 (644)
Q Consensus 170 -~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF-~~~-------~~~el~~~i~~~~~--~~~p--- 235 (644)
......||+.|+|||++.+..|+.++|||||||+||||++|..|+ ... ....+.+.+..... ..++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 223457999999999999999999999999999999999887554 221 12223333322111 0000
Q ss_pred ----------------------------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 236 ----------------------------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 236 ----------------------------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..++..+.+||.+||.+||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 123568899999999999999999999999999963
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=351.42 Aligned_cols=257 Identities=31% Similarity=0.494 Sum_probs=210.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----ce
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----NC 87 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----~~ 87 (644)
-++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4789999999999999999999999999999999864322 234566788999999999999999999865432 35
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
.|+|+||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 899999995 588887753 3599999999999999999999999999999999999999999999999999976543
Q ss_pred cc----ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-----------
Q 006460 168 ED----LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI----------- 231 (644)
Q Consensus 168 ~~----~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~----------- 231 (644)
.. ......|++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 22 1233578999999998654 5689999999999999999999999987664433322211000
Q ss_pred --------------C--C---CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 232 --------------S--P---LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 232 --------------~--~---~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
. + ....++..+.+||.+||..+|.+|||+.++++||||..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 0 0123577899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=333.81 Aligned_cols=244 Identities=23% Similarity=0.397 Sum_probs=209.1
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGG 98 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~Gg 98 (644)
+.||+|+||.||+|.++.+++.||+|.+.... .......+.+|+++++.++||||+++++++.. ...+|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCC
Confidence 36899999999999999999999999886443 34456778999999999999999999998876 45799999999999
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc---ccc
Q 006460 99 DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS---SVV 175 (644)
Q Consensus 99 sL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~---~~~ 175 (644)
+|.+++... +..+++..++.++.||+.||.|||++||+||||||.|||++.++.+||+|||++.......... ...
T Consensus 79 ~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 79 DFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 999999753 3468999999999999999999999999999999999999999999999999987654321111 112
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNP 254 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP 254 (644)
++..|+|||.+.+..++.++|||||||++|+|++ |.+||...........+......+.+..++..+.+|+.+||..+|
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 2456999999988889999999999999999997 999998777766666666655556777789999999999999999
Q ss_pred CCCCCHHHHhh
Q 006460 255 EHRPTASDLLR 265 (644)
Q Consensus 255 ~~RpTa~eiL~ 265 (644)
.+|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=332.57 Aligned_cols=253 Identities=33% Similarity=0.691 Sum_probs=217.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+++|++.+.||+|+||.||+|.+..+++.||+|.++.... .......+.+|++++++++|+||+++++++.. +...++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~l 79 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNI 79 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEE
Confidence 4789999999999999999999999999999999875432 23346678899999999999999999999876 567999
Q ss_pred EEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 91 VTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
||||+.|++|..++... ....+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999999998753 2345899999999999999999999999999999999999999999999999998765432
Q ss_pred c-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHhccCCCCCCc-cccHHHHH
Q 006460 169 D-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD--MAGLINKINRSSISPLPI-VYSSTMKQ 244 (644)
Q Consensus 169 ~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~--~~el~~~i~~~~~~~~p~-~~s~~l~d 244 (644)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|..||.... .......+......+.|. .++..+.+
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 2 2334578999999999988889999999999999999999999996543 334555555555566665 68889999
Q ss_pred HHHHHhccCCCCCCCHHHHhh
Q 006460 245 IIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~ 265 (644)
+|.+||..+|.+|||+.+|++
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=334.91 Aligned_cols=242 Identities=22% Similarity=0.380 Sum_probs=211.4
Q ss_pred EeccCCCeEEEEEEE--ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCC
Q 006460 20 QIGRGAFGAAFLVLH--KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEG 97 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~--k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~G 97 (644)
+||+|+||.||+|.+ ..++..+|+|++..........+.+.+|+.+++.+.||||+++++++. +...++||||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence 689999999999965 456789999998766655666778899999999999999999999764 3457899999999
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc----ccc
Q 006460 98 GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL----ASS 173 (644)
Q Consensus 98 gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~----~~~ 173 (644)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++........ ...
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999999753 3589999999999999999999999999999999999999999999999999987643321 122
Q ss_pred ccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 174 VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 174 ~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
..+++.|+|||.+....++.++|||||||++|+|++ |.+||......++...+......+.|..++.++.+||.+||+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 334578999999988889999999999999999997 9999998888888888887777778888999999999999999
Q ss_pred CCCCCCCHHHHhh
Q 006460 253 NPEHRPTASDLLR 265 (644)
Q Consensus 253 dP~~RpTa~eiL~ 265 (644)
||..||++++|..
T Consensus 238 ~p~~Rp~~~~i~~ 250 (257)
T cd05116 238 GVDERPGFAVVEL 250 (257)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.18 Aligned_cols=257 Identities=30% Similarity=0.534 Sum_probs=210.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----- 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----- 85 (644)
.+++|++.++||.|+||.||+|.++.++..+|+|.+............+.+|+++++.++||||+++++++.+..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 479999999999999999999999999999999998765433333445678999999999999999999876533
Q ss_pred --ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 86 --NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 86 --~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
..+|+||+|+. ++|...+... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 35799999995 4777766542 3469999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc------------cccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC
Q 006460 164 LLNTEDL------------ASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS 230 (644)
Q Consensus 164 ~~~~~~~------------~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~ 230 (644)
....... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 6533211 123467889999998765 357899999999999999999999998877665544433211
Q ss_pred CCC----------------------CC-------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 231 ISP----------------------LP-------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 231 ~~~----------------------~p-------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
..+ .+ ..++..+.+||.+||..+|.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 00 1234678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=339.46 Aligned_cols=254 Identities=30% Similarity=0.588 Sum_probs=222.0
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
-|++.+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.++++++||||++++++|.+ +..+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEE
Confidence 47889999999999999999999999999998865433 2345678899999999999999999998876 567999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-cc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-AS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~-~~ 172 (644)
|+.+++|..++.. ..+++..+..++.|++.||.|||++|++|+||+|.||+++.++.++|+|||++..+..... ..
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 9999999999864 3589999999999999999999999999999999999999999999999999876544321 23
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
...++..|+|||.+.+..++.++|+|||||++|+|++|.+||...........+.....+.++..++.++.+++.+||..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 45688999999999888889999999999999999999999988777666666665555556677899999999999999
Q ss_pred CCCCCCCHHHHhhCCCCchh
Q 006460 253 NPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 253 dP~~RpTa~eiL~hp~f~~~ 272 (644)
+|.+||++.++++||||...
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=340.37 Aligned_cols=253 Identities=21% Similarity=0.389 Sum_probs=218.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
.+..+|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ......+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVE- 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 45678999999999999999999863 345678999886542 3345678899999999999999999998876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR-----------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND 153 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~-----------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~ 153 (644)
...+|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 567999999999999999997532 124899999999999999999999999999999999999999999
Q ss_pred eEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcc
Q 006460 154 IRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRS 229 (644)
Q Consensus 154 vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~ 229 (644)
+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||......+....+...
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999986543221 223445778999999998889999999999999999998 99999988888888888877
Q ss_pred CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 230 SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 230 ~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.....+..++.++.+|+.+||..||.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 766777788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=336.36 Aligned_cols=254 Identities=32% Similarity=0.509 Sum_probs=213.3
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc---CCCCcceeeeEEEeCCc----e
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL---NNPYIVKYKDAWVDKGN----C 87 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HPNIVkl~~~~~d~~~----~ 87 (644)
|++.+.||.|+||.||+|.++.++..||+|.++...........+.+|+.+++++ .||||+++++++..... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999999999999999976544444445566788877766 59999999999876432 4
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
++++|||+. ++|.+++.......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 899999996 5899988765555699999999999999999999999999999999999999999999999999987655
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---------------
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--------------- 232 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~--------------- 232 (644)
........+++.|+|||++.+..++.++|||||||++|+|++|.+||......+....+......
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 44444556889999999999888999999999999999999999999988776665555321100
Q ss_pred ---C--------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 233 ---P--------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 233 ---~--------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
. ....++..+.+||.+||..||.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 001245778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=339.72 Aligned_cols=257 Identities=20% Similarity=0.366 Sum_probs=220.5
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCC-----eEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEE
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIER-----KKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAW 81 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~ 81 (644)
.....++|++.+.||+|+||.||++.+.... ..+|+|.+..... ......+.+|+.+++++ +||||+++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4456689999999999999999999887543 7899999875533 33346688999999999 799999999988
Q ss_pred EeCCceEEEEEeccCCCCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEE
Q 006460 82 VDKGNCVCIVTGYCEGGDMAEIIKKA--------------RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIF 147 (644)
Q Consensus 82 ~d~~~~~~LVmEy~~GgsL~~~L~~~--------------~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNIL 147 (644)
.. +..+|+||||+.+++|..++... ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 86 ~~-~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 86 TQ-EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred cC-CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 66 45699999999999999999752 2346889999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 006460 148 LTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLI 223 (644)
Q Consensus 148 L~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~ 223 (644)
++.++.+||+|||+++.+..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 99999999999999987654321 122335678999999988889999999999999999997 99999988888888
Q ss_pred HHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 224 NKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 224 ~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+........+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8877776666777889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.59 Aligned_cols=258 Identities=30% Similarity=0.465 Sum_probs=212.8
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----ce
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----NC 87 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----~~ 87 (644)
..+|++.+.||+|+||.||+|.+..++..||+|.+............+.+|+.+++.++||||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 36899999999999999999999999999999998754333333456778999999999999999999876432 35
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+|+||+ +++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCC-CCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 89999999 5789988875 34699999999999999999999999999999999999999999999999999987544
Q ss_pred c-cccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc----------------
Q 006460 168 E-DLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS---------------- 229 (644)
Q Consensus 168 ~-~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~---------------- 229 (644)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3 33445678999999998765 46899999999999999999999999876543322222110
Q ss_pred --------C------CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 230 --------S------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 230 --------~------~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
. .......++.++.+||.+||+.+|.+|||+.++++||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 001123468889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=359.09 Aligned_cols=254 Identities=22% Similarity=0.367 Sum_probs=209.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCC-----eEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIER-----KKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d 83 (644)
...++|++.+.||+|+||.||+|.+...+ ..||+|++...... .....+.+|+++|+.+ +|||||+++++|..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 44568999999999999999999876544 47999999765433 3356788999999999 89999999998876
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhc-------------------------------------------------------
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKAR------------------------------------------------------- 108 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~------------------------------------------------------- 108 (644)
. ..+|+|||||.+|+|.+++....
T Consensus 114 ~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 114 G-GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred C-CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 4 56999999999999999986532
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc---cc
Q 006460 109 -------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL---AS 172 (644)
Q Consensus 109 -------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~---~~ 172 (644)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 12478889999999999999999999999999999999999999999999999986543221 12
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH-HHHhccCCCCCCccccHHHHHHHHHHh
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLI-NKINRSSISPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~-~~i~~~~~~~~p~~~s~~l~dLI~~~L 250 (644)
...+++.|+|||++.+..|+.++|||||||++|+|++ |.+||......... ..+........+..++.++.+++.+||
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 2345667999999988899999999999999999997 99999776544333 333333334455667899999999999
Q ss_pred ccCCCCCCCHHHHhh
Q 006460 251 RKNPEHRPTASDLLR 265 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~ 265 (644)
+.||.+|||+.++++
T Consensus 353 ~~dp~~RPs~~~l~~ 367 (374)
T cd05106 353 NLEPTERPTFSQISQ 367 (374)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=339.19 Aligned_cols=253 Identities=30% Similarity=0.501 Sum_probs=211.7
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEec
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGY 94 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy 94 (644)
|++.+.||.|++|.||+|.++.+|..||+|++............+.+|+.+++.++|||++++++++.+ +...|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEec
Confidence 788999999999999999999999999999997665444445667889999999999999999999876 5679999999
Q ss_pred cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-ccccc
Q 006460 95 CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASS 173 (644)
Q Consensus 95 ~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~~~ 173 (644)
+ +++|.+++.......+++..+..++.||+.||.|||+++++||||+|.||+++.++.++|+|||++...... .....
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 9 568999987655446899999999999999999999999999999999999999999999999999765332 22234
Q ss_pred ccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC----------------------
Q 006460 174 VVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS---------------------- 230 (644)
Q Consensus 174 ~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~---------------------- 230 (644)
..+++.|+|||++.+. .++.++||||||+++|+|++|.+||...+.......+.+..
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 4678899999987664 57899999999999999999999998776544333322110
Q ss_pred ------CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 231 ------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 231 ------~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.......++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=370.50 Aligned_cols=279 Identities=25% Similarity=0.445 Sum_probs=251.1
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecc-cccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-KQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
....+.+.+++..||-|+||.|=++..+.....+|+|++++. ....+..+.+..|-+||..+..|.||++|..|.+ +.
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~k 493 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SK 493 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-ch
Confidence 345788999999999999999999988877777999998765 3344456778899999999999999999999877 67
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
++||+||-|-||.|+.+++. .+.|.+..++.|+..+++|++|||++|||+|||||+|.+++.+|.+||.|||+++.+.
T Consensus 494 yvYmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 89999999999999999986 4569999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc-CCCCCCccccHHHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-SISPLPIVYSSTMKQI 245 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~-~~~~~p~~~s~~l~dL 245 (644)
.+....++||||.|.|||++.+.+.+.++|.||||+++|||++|.|||++.+++..++.|.++ ....+|..++..+.+|
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 999999999999999999999999999999999999999999999999999999998888776 3456888999999999
Q ss_pred HHHHhccCCCCCCC-----HHHHhhCCCCchhhhhcCCCCCcccCCCcc
Q 006460 246 IKSMLRKNPEHRPT-----ASDLLRHPHLQPYLLRCQNPSSVYLPIKPT 289 (644)
Q Consensus 246 I~~~L~~dP~~RpT-----a~eiL~hp~f~~~~~~~~~~~~~~~p~~p~ 289 (644)
|+++...+|.+|.. +.+|-+|.||..+.|..........|+.|.
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~ 700 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPS 700 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCcccc
Confidence 99999999999976 789999999999988766655555565543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=333.79 Aligned_cols=252 Identities=21% Similarity=0.380 Sum_probs=217.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecC---CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIE---RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
.++|++.+.||+|+||.||+|.++.+ ...||+|.++... .......+.+|+.++++++||||+++++.+.. +..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCce
Confidence 36899999999999999999998754 4579999886543 33445678899999999999999999998765 5669
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||.|||++.++.++|+|||++..+...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999997643 36899999999999999999999999999999999999999999999999999876421
Q ss_pred -cccc--cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 169 -DLAS--SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 169 -~~~~--~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
.... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+......+.+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1111 2334678999999998889999999999999999997 99999888877777777766555667788999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~h 266 (644)
|+.+||..+|.+||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=343.92 Aligned_cols=255 Identities=32% Similarity=0.516 Sum_probs=205.7
Q ss_pred CeEEEEEeccCCCeEEEEEEEec--CCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CceEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKI--ERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNCVC 89 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~--tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~~~ 89 (644)
+|++.++||+|+||.||+|.+.. ++..||+|.+.... ........+.+|+.++++++||||+++++++.+. +..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 89999999997743 1222345678899999999999999999998774 26799
Q ss_pred EEEeccCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC----CCCeEEeccCcc
Q 006460 90 IVTGYCEGGDMAEIIKKAR---GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK----DNDIRLGDFGLA 162 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~---~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~----~g~vKL~DFGls 162 (644)
+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 57877776432 236899999999999999999999999999999999999999 899999999999
Q ss_pred cccccccc----cccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHH---------HHHHHh-
Q 006460 163 KLLNTEDL----ASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG---------LINKIN- 227 (644)
Q Consensus 163 ~~~~~~~~----~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~e---------l~~~i~- 227 (644)
..+..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+..... .+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87543221 234567899999998866 457999999999999999999999997654321 000000
Q ss_pred ------------------------ccCCCCCC-----------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 228 ------------------------RSSISPLP-----------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 228 ------------------------~~~~~~~p-----------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.......+ ...+..+.+++.+||..||.+|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00001111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=337.78 Aligned_cols=254 Identities=20% Similarity=0.341 Sum_probs=216.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEec-----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKI-----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFER- 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-
Confidence 34789999999999999999999987 778999998864432 33345688899999999999999999988764
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC---CeEEe
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARG-----ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN---DIRLG 157 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~-----~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g---~vKL~ 157 (644)
...|+||||+.|++|.+++..... ..+++..+..++.||+.||.|||+++++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 458899999999999999986532 2588999999999999999999999999999999999998765 59999
Q ss_pred ccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCC
Q 006460 158 DFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISP 233 (644)
Q Consensus 158 DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~ 233 (644)
|||+++.+..... ......+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999987633221 112233567999999988889999999999999999996 999999888888777777666666
Q ss_pred CCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 234 ~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.|..++..+.+|+.+||..+|++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 778889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=356.34 Aligned_cols=252 Identities=29% Similarity=0.560 Sum_probs=221.0
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
-|.++++||+|+||.||+|.|+.+|..+|||.+..... .+.++.|+.||++|..|++|++|+.|+.. ..+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD----LQEIIKEISIMQQC~S~yVVKYYGSYFK~-sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD----LQEIIKEISIMQQCKSKYVVKYYGSYFKH-SDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch----HHHHHHHHHHHHHcCCchhhhhhhhhccC-CceEeehh
Confidence 46788999999999999999999999999999877543 56678899999999999999999998874 45999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~~ 172 (644)
||..|+..++++. ++.+++|.++..+++.-|.||.|||...-||||||..|||++.+|..||+|||++..+... ...+
T Consensus 109 YCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 109 YCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred hcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 9999999999985 4567999999999999999999999999999999999999999999999999999765432 2356
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC--CCCccccHHHHHHHHHHh
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--PLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~--~~p~~~s~~l~dLI~~~L 250 (644)
+..|||.|||||++...+|+.++||||||++..||.-|+|||..--+...+-.|.....+ ..|..||.++.+|+++||
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 789999999999999999999999999999999999999999876554444344333222 235678999999999999
Q ss_pred ccCCCCCCCHHHHhhCCCCch
Q 006460 251 RKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.++|++|.|+-++++|||++.
T Consensus 268 iK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred cCCHHHHHHHHHHhhhhhhcC
Confidence 999999999999999999963
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.99 Aligned_cols=251 Identities=26% Similarity=0.457 Sum_probs=203.0
Q ss_pred EeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHH---HHhcCCCCcceeeeEEEeCCceEEEEEecc
Q 006460 20 QIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDL---ISKLNNPYIVKYKDAWVDKGNCVCIVTGYC 95 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~i---L~~L~HPNIVkl~~~~~d~~~~~~LVmEy~ 95 (644)
.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|..+ +....||||+.+++++.. ++.+|+||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence 4899999999999999999999999987643221 112233444433 344579999999998766 45799999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccccccc
Q 006460 96 EGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVV 175 (644)
Q Consensus 96 ~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~ 175 (644)
.|++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 80 ~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~ 156 (279)
T cd05633 80 NGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV 156 (279)
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcC
Confidence 999999998753 35999999999999999999999999999999999999999999999999998765432 223457
Q ss_pred CCCCCCChhhhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 176 GTPNYMCPELLA-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM--AGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 176 GT~~Y~APEvl~-~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~--~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
|++.|+|||.+. +..++.++||||+||++|+|++|..||..... ..............++..++.++.+||.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 999999999886 45689999999999999999999999975432 222222222333446677899999999999999
Q ss_pred CCCCCC-----CHHHHhhCCCCchhhh
Q 006460 253 NPEHRP-----TASDLLRHPHLQPYLL 274 (644)
Q Consensus 253 dP~~Rp-----Ta~eiL~hp~f~~~~~ 274 (644)
||.+|| |+.++++||||+.+.+
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 999999 6999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=353.19 Aligned_cols=254 Identities=22% Similarity=0.407 Sum_probs=212.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEec-----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCC
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKI-----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKG 85 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~ 85 (644)
-++|++.+.||.|+||.||+|.+.. +++.||+|+++.... ......+.+|+.+++++ +||||++++++|...+
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4589999999999999999997543 457899999875432 33346678899999999 7999999999988777
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcC--------------------------------------------------------
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARG-------------------------------------------------------- 109 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~-------------------------------------------------------- 109 (644)
..++++|||+.+++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 789999999999999999865321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc---cccccCCCCCCCh
Q 006460 110 ---ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCP 183 (644)
Q Consensus 110 ---~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~AP 183 (644)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..... .....++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2578999999999999999999999999999999999999999999999999987533221 2234557789999
Q ss_pred hhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHH-HHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHH
Q 006460 184 ELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAG-LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTAS 261 (644)
Q Consensus 184 Evl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~e-l~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~ 261 (644)
|++.+..++.++|||||||++|+|++ |.+||.+....+ +...+........+..++.++.+++.+||+.+|.+||++.
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999999999999999997 999998754433 3344444444455667889999999999999999999999
Q ss_pred HHhhC
Q 006460 262 DLLRH 266 (644)
Q Consensus 262 eiL~h 266 (644)
++++|
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.71 Aligned_cols=254 Identities=19% Similarity=0.349 Sum_probs=219.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecC-----CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIE-----RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~t-----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
.+.+|++.++||+|+||.||+|.+..+ +..||+|.+.... .......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~- 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE- 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-
Confidence 456799999999999999999987654 5789999987543 234456788999999999999999999987664
Q ss_pred ceEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~ 151 (644)
...++++||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||.|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 56899999999999999985321 2347889999999999999999999999999999999999999
Q ss_pred CCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 006460 152 NDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKIN 227 (644)
Q Consensus 152 g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~ 227 (644)
+.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999988654322 1234456789999999988889999999999999999998 899999988888888888
Q ss_pred ccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 228 RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 228 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.....+.+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 888777888899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=357.13 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=209.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEE-----ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLH-----KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~-----k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~ 84 (644)
..++|++.+.||+|+||.||+|.+ ..++..||+|+++.... ....+.+.+|+++|+.+ +|||||+++++|..
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~- 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTV- 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc-
Confidence 445899999999999999999975 34567899999865433 23356788999999999 89999999998876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc--------------------------------------------------------
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR-------------------------------------------------------- 108 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~-------------------------------------------------------- 108 (644)
+...|+|||||+||+|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 456899999999999999997532
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 109 -----------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 109 -----------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478889999999999999999999999999999999999999999999999986543221
Q ss_pred --cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChH-HHHHHHhccCCCCCCccccHHHHHHH
Q 006460 171 --ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMA-GLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 171 --~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~-el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
.....++..|+|||++.+..++.++|||||||++|+|++ |.+||...... .....+........|...+.++.+|+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 122345667999999999899999999999999999997 89999775533 44444444444445666789999999
Q ss_pred HHHhccCCCCCCCHHHHhhC
Q 006460 247 KSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~h 266 (644)
.+||..||.+|||+.++++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=331.14 Aligned_cols=254 Identities=30% Similarity=0.537 Sum_probs=217.3
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc---ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CceE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK---QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNCV 88 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~~ 88 (644)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.++++++||||+++++++.+. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999886432 2233456788999999999999999999987654 3568
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
++||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 8999999999999998753 34889999999999999999999999999999999999999999999999999865321
Q ss_pred ----cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc-CCCCCCccccHHHH
Q 006460 169 ----DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-SISPLPIVYSSTMK 243 (644)
Q Consensus 169 ----~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~-~~~~~p~~~s~~l~ 243 (644)
.......++..|+|||++.+..++.++|+|||||++|+|++|.+||...........+... ..+.+|..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 239 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence 1123456899999999998888999999999999999999999999877655555444433 33456788899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
++|.+||. +|..||++.+++.|||.
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999998 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=334.10 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=213.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++.++||+|+||.||+|.+..++ .||+|++...... ...+.+|+++++.++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC--CCCcEE
Confidence 4578999999999999999999887664 6999998764432 245788999999999999999998764 345899
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+.+++|.+++....+..+++..+..++.||+.||.|||++||+||||||.||+++.++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999999999865555689999999999999999999999999999999999999999999999999986644322
Q ss_pred c--ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 171 A--SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 171 ~--~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
. ....++..|+|||++.+..++.++|||||||++|+|++ |.+||......+....+......+.+..++..+.+|+.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 237 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 1 22345678999999988889999999999999999999 89999888777777777655545556678999999999
Q ss_pred HHhccCCCCCCCHHHHhh
Q 006460 248 SMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~ 265 (644)
+||+.+|.+||++.+++.
T Consensus 238 ~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 238 QCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=337.19 Aligned_cols=253 Identities=32% Similarity=0.575 Sum_probs=215.8
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCceEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN---NPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HPNIVkl~~~~~d~~~~~~L 90 (644)
.|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.+. |||++++++++.. +..+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEE
Confidence 58899999999999999999999999999999876433 233456788999999986 9999999998876 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
||||+.|++|.+++.. ..+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+....
T Consensus 80 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999999999864 258999999999999999999999999999999999999999999999999998764432
Q ss_pred ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCcc-ccHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV-YSSTMKQIIK 247 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~-~s~~l~dLI~ 247 (644)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+.....+.++.. ++.++.+|+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 2334578999999998864 4578999999999999999999999988776655544444333334433 7889999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCch
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||..||.+||++.+++.||||+.
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhc
Confidence 999999999999999999999964
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=336.78 Aligned_cols=253 Identities=28% Similarity=0.471 Sum_probs=210.3
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|++.++||.|++|.||+|.+..++..||+|.++..... .....+.+|+.++++++||||+++++++.+. ...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTE-NKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-CcEEEEEe
Confidence 699999999999999999999999999999999765332 2234567899999999999999999998774 56899999
Q ss_pred ccCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-ccc
Q 006460 94 YCEGGDMAEIIKKAR-GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLA 171 (644)
Q Consensus 94 y~~GgsL~~~L~~~~-~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~ 171 (644)
|+.+ +|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9975 8888886543 245899999999999999999999999999999999999999999999999999765332 123
Q ss_pred ccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-----------------C
Q 006460 172 SSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-----------------P 233 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~-----------------~ 233 (644)
....+++.|++||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+...... .
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 345678999999988653 5789999999999999999999999887766554443221100 0
Q ss_pred -----------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 234 -----------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 234 -----------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
....++..+.++|.+||+.||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112347788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=333.46 Aligned_cols=249 Identities=20% Similarity=0.356 Sum_probs=213.6
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+...... ...+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEE
Confidence 4689999999999999999997654 456999988754332 3467889999999999999999998765 4568999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||.||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999997643 36899999999999999999999999999999999999999999999999998865433211
Q ss_pred --ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 172 --SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 172 --~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......+.+...+..+.+++.+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 12235567999999988889999999999999999998 999998888777777777666666677789999999999
Q ss_pred HhccCCCCCCCHHHHhhC
Q 006460 249 MLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~h 266 (644)
||..+|.+|||+.+|+.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=332.04 Aligned_cols=249 Identities=22% Similarity=0.429 Sum_probs=216.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|+++++||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++||||+++++++. ...+|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEE
Confidence 4578999999999999999999865 5678999998765433 346788999999999999999999764 346899
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+.+++|.+++....+..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999999999876666789999999999999999999999999999999999999999999999999986553221
Q ss_pred --cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 171 --ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 171 --~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
.....++..|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+......+.+..++.++.+|+.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR 237 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 122345678999999988889999999999999999998 99999988887777777766666677778999999999
Q ss_pred HHhccCCCCCCCHHHHhh
Q 006460 248 SMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~ 265 (644)
+||..+|++|||+++++.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 238 LCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHccCChhhCCCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=332.76 Aligned_cols=249 Identities=22% Similarity=0.408 Sum_probs=214.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++.++||+|+||.||+|.+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcEE
Confidence 4578999999999999999999765 5567999998765443 245788999999999999999999764 345889
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999999865555689999999999999999999999999999999999999999999999999986543221
Q ss_pred --cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 171 --ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 171 --~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
.....++..|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+......+.+...+..+.+|+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 122345567999999988889999999999999999999 99999988887888887766666677788999999999
Q ss_pred HHhccCCCCCCCHHHHhh
Q 006460 248 SMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~ 265 (644)
+||..+|.+|||+.++..
T Consensus 238 ~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 238 QCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=333.98 Aligned_cols=253 Identities=34% Similarity=0.668 Sum_probs=214.9
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+++|++.+.||.|+||.||+|.+..++..+|+|.+..... .......+.+|+++++.++||||++++++|.+ +..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~ 79 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNI 79 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEE
Confidence 4789999999999999999999999999999998865432 23345678899999999999999999999877 457999
Q ss_pred EEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 91 VTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
+|||+.|++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999999998743 2346899999999999999999999999999999999999999999999999998865433
Q ss_pred c-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHhccCCCCCC-ccccHHHHH
Q 006460 169 D-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM--AGLINKINRSSISPLP-IVYSSTMKQ 244 (644)
Q Consensus 169 ~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~--~el~~~i~~~~~~~~p-~~~s~~l~d 244 (644)
. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+... ......+.....++.+ ..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 2 23345789999999999888899999999999999999999999976543 3444455444444333 357889999
Q ss_pred HHHHHhccCCCCCCCHHHHhh
Q 006460 245 IIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~ 265 (644)
|+.+||..+|.+|||+.+|++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=341.77 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=211.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~~L 90 (644)
.++|...+.||+|+||.||++.+..++..||+|.+...... .....+.+|+.++.++. ||||+++++++.. +...++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEE
Confidence 35788889999999999999999999999999998765433 33567888999999996 9999999998876 456889
Q ss_pred EEeccCCCCHHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 91 VTGYCEGGDMAEIIK---KARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 91 VmEy~~GgsL~~~L~---~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
+|||+. ++|.++.. ......+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++..+.
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999984 56655443 22345699999999999999999999975 99999999999999999999999999998655
Q ss_pred cccccccccCCCCCCChhhhcCC---CCCcccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhccCCCCC----Cccc
Q 006460 167 TEDLASSVVGTPNYMCPELLADI---PYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-AGLINKINRSSISPL----PIVY 238 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~---~ys~ksDIWSLGvILyeLltG~~PF~~~~~-~el~~~i~~~~~~~~----p~~~ 238 (644)
.........|++.|+|||++.+. .++.++|||||||++|+|++|++||..... .+....+.....+.. +..+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence 44444456789999999998775 689999999999999999999999976542 222222222222222 2347
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+.++.+||.+||..+|.+|||+.+++.||||+.+.
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 88999999999999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=334.66 Aligned_cols=253 Identities=32% Similarity=0.567 Sum_probs=220.8
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~~L 90 (644)
++|.+.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.+++++. ||||+++++++.. +..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence 589999999999999999999999999999999876432 2334567888999999998 9999999998765 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
||||+.+++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 80 VLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999999864 369999999999999999999999999999999999999999999999999998654322
Q ss_pred --------------------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc
Q 006460 170 --------------------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS 229 (644)
Q Consensus 170 --------------------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~ 229 (644)
......++..|+|||++.+..++.++|+||||+++|+|++|..||...........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 123356789999999998888999999999999999999999999988766666665533
Q ss_pred CCCCCCccccHHHHHHHHHHhccCCCCCCCH----HHHhhCCCC
Q 006460 230 SISPLPIVYSSTMKQIIKSMLRKNPEHRPTA----SDLLRHPHL 269 (644)
Q Consensus 230 ~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa----~eiL~hp~f 269 (644)
...++..+++.+.+||.+||..+|.+|||+ .++++||||
T Consensus 238 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 -EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred -CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 334677789999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.80 Aligned_cols=251 Identities=20% Similarity=0.397 Sum_probs=215.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCe----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK----KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
...+|+++++||.|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT--S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--C
Confidence 45789999999999999999999887776 48999886543 33445678899999999999999999998764 3
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
..+++++|+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 478999999999999998753 3458999999999999999999999999999999999999999999999999998764
Q ss_pred ccccc---ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 167 TEDLA---SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 167 ~~~~~---~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
..... ....+++.|+|||.+.+..++.++|||||||++|||++ |.+||...........+......+.+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 32221 12234678999999988889999999999999999998 999998887777777776666666677789999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.+++.+||..||.+||++.+++.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.92 Aligned_cols=255 Identities=29% Similarity=0.530 Sum_probs=217.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..+.|.....||.|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+.. +...|+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~l 96 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWV 96 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEE
Confidence 3456677788999999999999999999999999986543 2335668899999999999999999998776 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-c
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-D 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~ 169 (644)
||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 97 v~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 97 VMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999999999998854 34899999999999999999999999999999999999999999999999998764322 2
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--CCccccHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSSTMKQIIK 247 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~p~~~s~~l~dLI~ 247 (644)
......|++.|+|||++.+..++.++||||||+++|+|++|..||...+....+..+....... ....++..+.+|+.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 2334678999999999988889999999999999999999999998877766655554332222 22346889999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCch
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||..+|.+|||+.++++||||..
T Consensus 254 ~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 254 LMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHccCChhHCcCHHHHhhChhhhc
Confidence 999999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.33 Aligned_cols=251 Identities=25% Similarity=0.459 Sum_probs=205.2
Q ss_pred EeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHH---HHHHHhcCCCCcceeeeEEEeCCceEEEEEecc
Q 006460 20 QIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQE---MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYC 95 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rE---i~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~ 95 (644)
.||+|+||.||+|.+..+++.||+|.+....... .....+..| +++++...||||+.+++++.. ...+|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence 3899999999999999999999999987643221 111222333 445555689999999998766 46799999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccccccc
Q 006460 96 EGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVV 175 (644)
Q Consensus 96 ~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~ 175 (644)
.|++|..++.. ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..+... ......
T Consensus 80 ~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~ 156 (278)
T cd05606 80 NGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV 156 (278)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcC
Confidence 99999998875 346999999999999999999999999999999999999999999999999998765432 234567
Q ss_pred CCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHhccCCCCCCccccHHHHHHHHHHhc
Q 006460 176 GTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPD---MAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251 (644)
Q Consensus 176 GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~---~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~ 251 (644)
|+..|+|||++.+ ..++.++||||+||++|+|++|..||.... .......+ ......+|..++..+.+++.+||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHHHhh
Confidence 9999999999874 468999999999999999999999997663 23332222 233345667789999999999999
Q ss_pred cCCCCCC-----CHHHHhhCCCCchhhhh
Q 006460 252 KNPEHRP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 252 ~dP~~Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
.+|.+|| ++.++++||||....+.
T Consensus 236 ~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred cCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 9999999 99999999999875543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.97 Aligned_cols=249 Identities=21% Similarity=0.388 Sum_probs=214.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++.+.||+|+||.||+|.+.. +..||+|.++..... .+.+.+|++++++++||||+++++++.. .+..|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEec-CCCeee
Confidence 34689999999999999999998754 568999998765432 3457889999999999999999998765 566899
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+.|++|.+++....+..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999999999865545689999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccC---CCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 171 ASSVVG---TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 171 ~~~~~G---T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
....| +..|+|||++.+..++.++||||||+++|+|++ |++||.+.........+......+.+..++..+.+++
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 159 -EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred -cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 22222 457999999988889999999999999999999 9999998887777777766655556677899999999
Q ss_pred HHHhccCCCCCCCHHHHhh
Q 006460 247 KSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~ 265 (644)
.+||..+|.+||++.+++.
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=349.46 Aligned_cols=257 Identities=30% Similarity=0.503 Sum_probs=212.7
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe---CCceEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD---KGNCVC 89 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d---~~~~~~ 89 (644)
++|++.+.||.|+||.||+|.++.++..||+|++............+.+|+.+|++++||||++++++|.. ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 78999999999999999999999999999999987654333445677889999999999999999998753 235789
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||+. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 9999994 689888864 3459999999999999999999999999999999999999999999999999997653321
Q ss_pred -----ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc--------------
Q 006460 170 -----LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-------------- 229 (644)
Q Consensus 170 -----~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~-------------- 229 (644)
......|+..|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 1234578999999998865 45899999999999999999999999876644332221110
Q ss_pred -----------CCCCC-----CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 230 -----------SISPL-----PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 230 -----------~~~~~-----p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
..... ....+..+.+||++||+.+|.+|||+.+++.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00111 13358899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=330.79 Aligned_cols=248 Identities=30% Similarity=0.556 Sum_probs=215.1
Q ss_pred eccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCC
Q 006460 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGD 99 (644)
Q Consensus 21 LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~Ggs 99 (644)
||.|+||.||+|.+..+++.+++|.+..... .......+.+|++++++++||||+++++.+.. +..+|+||||+.|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence 6999999999999999999999999876532 23455678899999999999999999998765 677999999999999
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc---------c
Q 006460 100 MAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---------L 170 (644)
Q Consensus 100 L~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~---------~ 170 (644)
|.+++.... .+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....... .
T Consensus 80 L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 80 LASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999998643 58999999999999999999999999999999999999999999999999987643321 2
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccc--cHHHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY--SSTMKQIIKS 248 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~--s~~l~dLI~~ 248 (644)
.....++..|++||.+.+..++.++||||||+++|+|++|..||......+....+..... ..+... +..+.+|+.+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 236 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISK 236 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHH
Confidence 2345688899999999888899999999999999999999999998888887777765433 234444 8999999999
Q ss_pred HhccCCCCCCCH---HHHhhCCCCchh
Q 006460 249 MLRKNPEHRPTA---SDLLRHPHLQPY 272 (644)
Q Consensus 249 ~L~~dP~~RpTa---~eiL~hp~f~~~ 272 (644)
||+.+|.+|||+ .++|+||||...
T Consensus 237 ~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 237 LLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HhcCCHhhcCCCccHHHHhcCccccCC
Confidence 999999999999 999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=334.54 Aligned_cols=250 Identities=22% Similarity=0.387 Sum_probs=218.6
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
-.+|++.++||.|+||.||+|.+.. +..+++|.+..... .....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEEE
Confidence 4679999999999999999999988 88999999875432 234567889999999999999999998766 5569999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
|||+.+++|.+++....+..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999999876566789999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||......+.+..+......+.+..++..+.+++.+|
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 240 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHH
Confidence 123345678999999988889999999999999999998 8999988887777777776666667788899999999999
Q ss_pred hccCCCCCCCHHHHhh
Q 006460 250 LRKNPEHRPTASDLLR 265 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~ 265 (644)
|..+|.+|||+.++++
T Consensus 241 l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 241 WAAEPEDRPSFKALRE 256 (261)
T ss_pred cCCCchhCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.37 Aligned_cols=253 Identities=28% Similarity=0.530 Sum_probs=210.9
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc--------cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ--------TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~--------~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
+|.+.+.||.|+||.||+|.+..+++.+|+|.++.... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-E 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-C
Confidence 58999999999999999999999999999998864321 11234567889999999999999999998765 5
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+++||||+.|++|.+++... ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 6799999999999999999764 46899999999999999999999999999999999999999999999999998764
Q ss_pred ccc---cccccccCCCCCCChhhhcCCC--CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc-CCCCCC----
Q 006460 166 NTE---DLASSVVGTPNYMCPELLADIP--YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-SISPLP---- 235 (644)
Q Consensus 166 ~~~---~~~~~~~GT~~Y~APEvl~~~~--ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~-~~~~~p---- 235 (644)
... .......|+..|+|||++.... ++.++|+||||+++|+|++|..||...........+... .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 321 1123456889999999987654 789999999999999999999999765554433333222 122222
Q ss_pred ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 236 ~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
..++..+.+||.+||..+|.+|||+.++|+||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2458899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.15 Aligned_cols=277 Identities=26% Similarity=0.478 Sum_probs=241.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~ 86 (644)
+.+..+|.++..||+|+||.|.+|..+.+.+.||||++++...- ....+--+.|-++|.... -|.+++++.+|+.- .
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-D 423 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-D 423 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-h
Confidence 56788999999999999999999999999999999999876322 222344456777777654 67888888877664 4
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc-
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL- 165 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~- 165 (644)
.+|+||||++||+|.-.|++.+ .|.|..+..|+..|+-||-+||++|||+||||.+||||+.+|++||+|||++..-
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred heeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 5999999999999999998754 5999999999999999999999999999999999999999999999999999863
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
-......++||||.|+|||++...+|+.++|+||+|++||||+.|++||.+.+..++++.|...... +|..+|.++.++
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-yPKslSkEAv~i 580 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-YPKSLSKEAVAI 580 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc-CcccccHHHHHH
Confidence 3334567899999999999999999999999999999999999999999999999999999877665 799999999999
Q ss_pred HHHHhccCCCCCCCH-----HHHhhCCCCchhhhhcCCCCCcccCCCcc
Q 006460 246 IKSMLRKNPEHRPTA-----SDLLRHPHLQPYLLRCQNPSSVYLPIKPT 289 (644)
Q Consensus 246 I~~~L~~dP~~RpTa-----~eiL~hp~f~~~~~~~~~~~~~~~p~~p~ 289 (644)
.+..|.+.|.+|... .+|-.||||..+-|.......+..|++|.
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk 629 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPK 629 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCc
Confidence 999999999999654 68999999998877766666666666664
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.38 Aligned_cols=257 Identities=32% Similarity=0.481 Sum_probs=218.9
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----ceEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----NCVC 89 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----~~~~ 89 (644)
+|++.+.||.|+||.||+|.+..++..||+|++..........+.+.+|+.+++.++||||+++++++.... ..+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999999999999999765443445677889999999999999999999987654 4789
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||+|+. ++|.+++.. +..+++..++.++.||+.||.|||++||+||||||.|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999996 589888865 3369999999999999999999999999999999999999999999999999998765442
Q ss_pred ----ccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-----------
Q 006460 170 ----LASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----------- 233 (644)
Q Consensus 170 ----~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----------- 233 (644)
......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||......+.+..+......+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 23445789999999999887 78999999999999999999999998887766555543321110
Q ss_pred -------------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 234 -------------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 234 -------------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
....++..+.+||.+||..+|.+|||+.+++.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1123578899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.25 Aligned_cols=256 Identities=22% Similarity=0.382 Sum_probs=217.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecC-------CeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIE-------RKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDA 80 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~t-------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~ 80 (644)
....++|.+.+.||+|+||.||+|.+... ...+|+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 34568999999999999999999987542 3469999987543 233356788899999999 79999999998
Q ss_pred EEeCCceEEEEEeccCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcE
Q 006460 81 WVDKGNCVCIVTGYCEGGDMAEIIKKARG--------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNI 146 (644)
Q Consensus 81 ~~d~~~~~~LVmEy~~GgsL~~~L~~~~~--------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNI 146 (644)
+.. ...+|+||||+.+++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 93 ~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 93 CTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred Eec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 876 4568999999999999999976421 2478899999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHH
Q 006460 147 FLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGL 222 (644)
Q Consensus 147 LL~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el 222 (644)
|++.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||......++
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 999999999999999976543221 112234578999999988889999999999999999998 8999998888888
Q ss_pred HHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 223 INKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 223 ~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
...+........+..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 88877776666777889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=331.56 Aligned_cols=249 Identities=23% Similarity=0.403 Sum_probs=213.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
..+|++.+.||+|+||.||+|.++ ++..+|+|.+...... ...+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEE
Confidence 357999999999999999999876 4668999988654332 2457789999999999999999998765 4678999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999999997643 36899999999999999999999999999999999999999999999999999865432211
Q ss_pred c--cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 172 S--SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 172 ~--~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
. ...++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+......+.+..++..+.+|+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1 1223457999999998899999999999999999998 899998888887777777666666777889999999999
Q ss_pred HhccCCCCCCCHHHHhhC
Q 006460 249 MLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~h 266 (644)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=347.93 Aligned_cols=261 Identities=26% Similarity=0.461 Sum_probs=217.5
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG- 85 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~- 85 (644)
..-...++|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||++++++|....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3345678999999999999999999999999999999998765444555667889999999999999999999886533
Q ss_pred ----ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 86 ----NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 86 ----~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
..+|+||+|+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 2468999999 8899988863 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC---------
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--------- 231 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--------- 231 (644)
+...... .....+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+.....
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 9865432 234577899999998876 4588999999999999999999999987765443333221110
Q ss_pred ---------------------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 232 ---------------------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 232 ---------------------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
......++..+.++|.+||..||.+|||+.+++.||||+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 011234677899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.84 Aligned_cols=247 Identities=22% Similarity=0.388 Sum_probs=217.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++.+.||.|+||.||+|... ++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+ ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEE
Confidence 3578999999999999999999764 78999999975543 45678899999999999999999998876 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+.+++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999999999999987554568999999999999999999999999999999999999999999999999998764322
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
....++..|+|||.+....++.++||||||+++|+|++ |..||.......+...+........+..++..+.+||.+|
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence 23345667999999988889999999999999999997 9999998888887777776655566777899999999999
Q ss_pred hccCCCCCCCHHHHhh
Q 006460 250 LRKNPEHRPTASDLLR 265 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~ 265 (644)
|..+|.+|||+.+++.
T Consensus 236 l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 236 WELDPAKRPTFKQLRE 251 (256)
T ss_pred hccChhhCcCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.76 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=214.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK----- 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~----- 84 (644)
...++|.+.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 355899999999999999999999999999999999976544444456788899999999999999999987542
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...+|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 23578899988 8899988764 2489999999999999999999999999999999999999999999999999886
Q ss_pred cccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC------------
Q 006460 165 LNTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI------------ 231 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~------------ 231 (644)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+.....
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 433 2344678999999998866 5688999999999999999999999977665443333221100
Q ss_pred ------------------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 232 ------------------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 232 ------------------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
.......+..+.+||.+||..||.+||++.+++.||||+.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0011235788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.31 Aligned_cols=256 Identities=22% Similarity=0.362 Sum_probs=207.5
Q ss_pred EEeccC--CCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRG--AFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G--~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
..||.| +||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||++++++|.. +...|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence 456666 99999999999999999999998765555556788999999999999999999999876 566899999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc------
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL------ 170 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~------ 170 (644)
+++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999999876555689999999999999999999999999999999999999999999999986543221110
Q ss_pred --cccccCCCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc-CC--------------
Q 006460 171 --ASSVVGTPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-SI-------------- 231 (644)
Q Consensus 171 --~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~-~~-------------- 231 (644)
.....++..|+|||++.+ ..|+.++|||||||++|+|++|.+||...........+... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 111234567999999876 34789999999999999999999999876543332222111 00
Q ss_pred -------------------------------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhh
Q 006460 232 -------------------------------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 232 -------------------------------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~ 275 (644)
.+.+..++..+.+||++||..||.+|||+.++|+||||......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 11122356789999999999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=335.21 Aligned_cols=252 Identities=31% Similarity=0.523 Sum_probs=214.5
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEec
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGY 94 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy 94 (644)
|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+++|++++||||+++++++.. +..+|+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEec
Confidence 788999999999999999999999999999987765554556778899999999999999999998776 4679999999
Q ss_pred cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-cccc
Q 006460 95 CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASS 173 (644)
Q Consensus 95 ~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~~~ 173 (644)
+.+ +|..++.... ..+++..++.++.||+.||.|||++||+|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 80 MDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred cCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 965 8888887643 468999999999999999999999999999999999999999999999999998765543 3344
Q ss_pred ccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-------------------
Q 006460 174 VVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP------------------- 233 (644)
Q Consensus 174 ~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~------------------- 233 (644)
..++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+..+.+..+......+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5688899999998776 78999999999999999999999998877665554443221110
Q ss_pred ----------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 234 ----------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 234 ----------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
....++.++.+||.+||..||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.58 Aligned_cols=254 Identities=25% Similarity=0.474 Sum_probs=209.7
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.+.......||+|+||.||+|.+..++..|++|.+..... ...+.+.+|+.+++.++||||+++++++.. +..+|+|
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEEEEE
Confidence 3445556789999999999999999999999998865432 234678899999999999999999998766 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-CCCeEEeccCcccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACF--PEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-DNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l--~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-~g~vKL~DFGls~~~~~~ 168 (644)
+||+.+++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||||.||+++. ++.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 84 MEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999997642 234 78889999999999999999999999999999999986 678999999998765432
Q ss_pred c-ccccccCCCCCCChhhhcCCC--CCcccchhhHHHHHHHHHhCCCCCCCCChHH--HHHHHhccCCCCCCccccHHHH
Q 006460 169 D-LASSVVGTPNYMCPELLADIP--YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 169 ~-~~~~~~GT~~Y~APEvl~~~~--ys~ksDIWSLGvILyeLltG~~PF~~~~~~e--l~~~i~~~~~~~~p~~~s~~l~ 243 (644)
. ......|++.|+|||++.+.. ++.++||||||+++|+|++|.+||....... ..........+.+|..++.++.
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK 242 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHH
Confidence 2 233456889999999986543 7899999999999999999999997644322 1111122334456777899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
+|+.+||..+|.+|||+.+++.||||
T Consensus 243 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 243 NFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.93 Aligned_cols=248 Identities=25% Similarity=0.499 Sum_probs=208.2
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHH-HhcCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLI-SKLNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL-~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||.|+||.||+|.+..+++.||+|.+...... ......+..|..++ ..++||||+++++++.. +..+|+||||+.
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence 5799999999999999999999999998764322 22233444555544 44589999999998865 567999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccccccC
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVG 176 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~G 176 (644)
|++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|.||+++.++.++|+|||++..... .....|
T Consensus 81 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 81 GGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCC
Confidence 99999999764 3589999999999999999999999999999999999999999999999999876433 234578
Q ss_pred CCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---CCCccccHHHHHHHHHHhccC
Q 006460 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSSTMKQIIKSMLRKN 253 (644)
Q Consensus 177 T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---~~p~~~s~~l~dLI~~~L~~d 253 (644)
++.|+|||.+.+..++.++||||||+++|+|++|.+||...+.......+...... ..+..++..+.+++.+||..+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 89999999998888999999999999999999999999988877776666544322 233357899999999999999
Q ss_pred CCCCC---CHHHHhhCCCCchh
Q 006460 254 PEHRP---TASDLLRHPHLQPY 272 (644)
Q Consensus 254 P~~Rp---Ta~eiL~hp~f~~~ 272 (644)
|++|| ++.++|.||||...
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcC
Confidence 99999 55899999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.09 Aligned_cols=253 Identities=21% Similarity=0.365 Sum_probs=215.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
.+..+|++.++||+|+||.||+|... .++..+++|.+... .......+.+|+++++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE- 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-
Confidence 46789999999999999999999753 34678899987643 23445678999999999999999999998776
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARG-------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~-------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~ 151 (644)
...+|+||||+.+++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 4568999999999999999976421 247899999999999999999999999999999999999999
Q ss_pred CCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 006460 152 NDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKIN 227 (644)
Q Consensus 152 g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~ 227 (644)
+.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||......+....+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 9999999999976543221 223345778999999998899999999999999999998 999998877777777776
Q ss_pred ccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 228 RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 228 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.......+..++..+.+|+.+||+.||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 66555667788999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=335.35 Aligned_cols=248 Identities=28% Similarity=0.509 Sum_probs=210.6
Q ss_pred EEEEEeccCCCeEEEEEEEe----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 16 EVIEQIGRGAFGAAFLVLHK----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 16 ~i~~~LG~G~fG~Vyla~~k----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++.+.||.|.||.||+|.+. ..+..|+||.+... ........+.+|++++++++||||+++++++... ..+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-EPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-SSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccc-cccccc
Confidence 57899999999999999988 45678999999553 3444467889999999999999999999998854 448999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-- 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-- 169 (644)
+|||.+|+|.+++.......+++..+..|+.||+.||.|||+++|+|++|++.|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999998645679999999999999999999999999999999999999999999999999998763221
Q ss_pred -ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 170 -LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 170 -~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
......+...|+|||.+.+..++.++||||||+++|||++ |..||......++...+......+.+..++..+.++|.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ 239 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence 2233456778999999988889999999999999999999 78999999888888888777777778889999999999
Q ss_pred HHhccCCCCCCCHHHHhh
Q 006460 248 SMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~ 265 (644)
+||..+|.+|||+.+|++
T Consensus 240 ~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 240 QCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHT-SSGGGS--HHHHHH
T ss_pred HHcCCChhhCcCHHHHHh
Confidence 999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.20 Aligned_cols=253 Identities=32% Similarity=0.550 Sum_probs=212.9
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CceEEEEEe
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNCVCIVTG 93 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~~~LVmE 93 (644)
|++.++||.|+||.||+|.+..+++.+|+|++............+.+|+.+++.++|||++++++++... ....|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7899999999999999999999999999999987653444556788999999999999999999998765 267999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--cc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--LA 171 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~--~~ 171 (644)
|+. ++|..++... ...+++..++.++.||+.||.|||++|++|+||+|.||+++.++.++|+|||++....... ..
T Consensus 81 ~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 81 YMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred ccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 996 5898888653 2468999999999999999999999999999999999999999999999999998765432 23
Q ss_pred ccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-----------------
Q 006460 172 SSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----------------- 233 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----------------- 233 (644)
....++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...........+......+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 34567889999997765 457899999999999999999999998877665555443211100
Q ss_pred -------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 234 -------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 234 -------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
....++..+.+++.+||..+|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=338.99 Aligned_cols=258 Identities=33% Similarity=0.554 Sum_probs=213.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG---- 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~---- 85 (644)
..+++|++.+.||+|+||.||+|.++.+++.||+|.++...........+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4578999999999999999999999999999999999765443334456778999999999999999999876533
Q ss_pred -----ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccC
Q 006460 86 -----NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG 160 (644)
Q Consensus 86 -----~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFG 160 (644)
..+|+|+||+.+ +|..++... ...+++..++.++.||+.||.|||+.||+||||||.||+++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 378999999965 777777643 3468999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc--ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC----
Q 006460 161 LAKLLNTED--LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP---- 233 (644)
Q Consensus 161 ls~~~~~~~--~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~---- 233 (644)
++..+.... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||......+.+..+......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 998654332 2233456788999998865 357899999999999999999999998776655544443321100
Q ss_pred -------------------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 234 -------------------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 234 -------------------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
....++..+.+|+.+||..+|.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 112357899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.51 Aligned_cols=252 Identities=29% Similarity=0.550 Sum_probs=216.4
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+|...+.||.|++|.||++.+..++..+++|.+..... ...+.+.+|+.+++.++||||+++++++.. +...|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEe
Confidence 56667899999999999999999999999998865432 234567899999999999999999998766 567999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-ccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~~ 172 (644)
|+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|.||+++.++.++|+|||++....... ...
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9999999999876 358999999999999999999999999999999999999999999999999887543321 223
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC--CccccHHHHHHHHHHh
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL--PIVYSSTMKQIIKSML 250 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~--p~~~s~~l~dLI~~~L 250 (644)
...|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+........ +..++..+.+|+.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 45689999999999888899999999999999999999999988777666666654432222 2337889999999999
Q ss_pred ccCCCCCCCHHHHhhCCCCch
Q 006460 251 RKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..+|.+|||+.++++||||..
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred ccChhhCcCHHHHccCccccc
Confidence 999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=337.56 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=206.5
Q ss_pred CCCCCCCCCeEEEEEe--ccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHh-cCCCCcceeeeEEE
Q 006460 6 GDSKSKLEDYEVIEQI--GRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK-LNNPYIVKYKDAWV 82 (644)
Q Consensus 6 ~~~~~~~~~Y~i~~~L--G~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~-L~HPNIVkl~~~~~ 82 (644)
.+.....++|.+.+.+ |.|+||.||++.++.++..+|+|.+........ |+..... .+||||+++++.|.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEe
Confidence 3344456788888877 999999999999999999999999876432211 2222221 27999999999987
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-CeEEeccCc
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGL 161 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-~vKL~DFGl 161 (644)
. ...+|+||||++|++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+
T Consensus 80 ~-~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 80 T-LKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred c-CCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 7 45799999999999999999764 3699999999999999999999999999999999999999998 999999999
Q ss_pred ccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH----HHHHhccCCCCCCcc
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL----INKINRSSISPLPIV 237 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el----~~~i~~~~~~~~p~~ 237 (644)
+...... ....++..|+|||++.+..++.++|||||||++|+|++|..||........ +.... ....+.+..
T Consensus 157 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (267)
T PHA03390 157 CKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKN 232 (267)
T ss_pred ceecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccc
Confidence 8765432 345789999999999988999999999999999999999999975543221 11111 222345557
Q ss_pred ccHHHHHHHHHHhccCCCCCCC-HHHHhhCCCCc
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPT-ASDLLRHPHLQ 270 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpT-a~eiL~hp~f~ 270 (644)
++..+.+||.+||+.+|.+||+ ++++|+||||+
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 8999999999999999999996 69999999995
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=328.89 Aligned_cols=242 Identities=23% Similarity=0.393 Sum_probs=209.2
Q ss_pred EEeccCCCeEEEEEEEecCC---eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEecc
Q 006460 19 EQIGRGAFGAAFLVLHKIER---KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYC 95 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~ 95 (644)
++||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+++++.+.|||||++++++. +..+++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeC
Confidence 47999999999999876665 78999998766543 44567889999999999999999999764 44689999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc----
Q 006460 96 EGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA---- 171 (644)
Q Consensus 96 ~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~---- 171 (644)
.+++|.+++.... .+++..+..++.||+.||.|||.+|++||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999998643 6899999999999999999999999999999999999999999999999999866433211
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHh
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L 250 (644)
....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..++...+......+.+..++..+.+||.+||
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 235 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW 235 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence 11223467999999988889999999999999999997 99999988887777777776666677788999999999999
Q ss_pred ccCCCCCCCHHHHhh
Q 006460 251 RKNPEHRPTASDLLR 265 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~ 265 (644)
..+|.+||++.+++.
T Consensus 236 ~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 236 KYRPEDRPTFSELES 250 (257)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.42 Aligned_cols=253 Identities=21% Similarity=0.377 Sum_probs=217.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEec-----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKI-----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
.+..+|.+.+.||+|+||.||+|.+.. ++..+++|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGD- 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-
Confidence 456789999999999999999998643 45668888875433 2334568899999999999999999998765
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK 150 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~ 150 (644)
....++||||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||.|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 567999999999999999997532 134789999999999999999999999999999999999999
Q ss_pred CCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 006460 151 DNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKI 226 (644)
Q Consensus 151 ~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i 226 (644)
++.++|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||......+....+
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999997654322 1233456788999999998899999999999999999998 99999888887787777
Q ss_pred hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 227 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
........+..++..+.+|+.+||..+|.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 777666677778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=331.90 Aligned_cols=254 Identities=19% Similarity=0.330 Sum_probs=218.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEec----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKI----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
.-++|++.+.||+|+||.||+|.+.. ++..+++|++... ........+.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 35789999999999999999999886 3578899987643 334446778899999999999999999998877667
Q ss_pred eEEEEEeccCCCCHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccC
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARG------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG 160 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFG 160 (644)
..+++++|+.+++|.+++..... ..+++..++.++.||+.||.|||++|++||||||.||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 78999999999999999976432 458999999999999999999999999999999999999999999999999
Q ss_pred cccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCc
Q 006460 161 LAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPI 236 (644)
Q Consensus 161 ls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~ 236 (644)
+++.+..... .....++..|+|||++.+..++.++|||||||++|+|++ |++||......++...+........+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI 242 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCC
Confidence 9986543221 123445678999999988889999999999999999998 999998888777777766665545566
Q ss_pred cccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.++..+.+++.+||..+|++|||+.+++.
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 67899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=329.09 Aligned_cols=248 Identities=21% Similarity=0.379 Sum_probs=212.6
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.++|++.++||+|+||.||+|.+..++ .+|+|.+...... .+.+.+|+++++.+.|||++++++++. ....|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEE
Confidence 468999999999999999999876654 6999987654332 356788999999999999999998764 3458899
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
|||+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999999999865555688999999999999999999999999999999999999999999999999986543221
Q ss_pred -cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 171 -ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 171 -~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
.....++..|+|||.+.+..++.++||||||+++|+|++ |.+||.+....+....+......+.+..++..+.+|+.+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 122345678999999988889999999999999999999 999999888777777776665556677789999999999
Q ss_pred HhccCCCCCCCHHHHhh
Q 006460 249 MLRKNPEHRPTASDLLR 265 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~ 265 (644)
||..+|.+||+++++++
T Consensus 239 ~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 239 CWKKDPDERPTFEYIQS 255 (260)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=340.85 Aligned_cols=259 Identities=24% Similarity=0.419 Sum_probs=220.2
Q ss_pred CCCCCCeEEE-EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 9 KSKLEDYEVI-EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~-~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
..+.+-|++. +.||+|+||.|--|....++..||||++.+. ..+...++.||+.++.++ +|+||++++++|.+ +.
T Consensus 73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-d~ 149 (463)
T KOG0607|consen 73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED-DT 149 (463)
T ss_pred chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-cc
Confidence 3445556664 4699999999999999999999999999876 456678899999999999 59999999998776 55
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC---CeEEeccCccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN---DIRLGDFGLAK 163 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g---~vKL~DFGls~ 163 (644)
.+|||||.+.||.|...|.+.. .|+|.++.++++.|+.||.|||.+||.||||||+|||-...+ .+|||||.|..
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 6999999999999999998754 599999999999999999999999999999999999998655 48999999987
Q ss_pred cccccc--------ccccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCC------------
Q 006460 164 LLNTED--------LASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD------------ 218 (644)
Q Consensus 164 ~~~~~~--------~~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~------------ 218 (644)
.+.... ...+.+|+..|||||+.. ...|+.++|.||||+|+|.||+|++||.+.-
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 543221 234578899999999763 3458999999999999999999999997642
Q ss_pred ---hHHHHHHHhccCCCCCCc----cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 219 ---MAGLINKINRSSISPLPI----VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 219 ---~~el~~~i~~~~~~~~p~----~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
...++..|..+.+. +|. .+|.+.+++++.+|..++.+|.++.++++|||++...
T Consensus 308 r~CQ~~LFesIQEGkYe-FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYE-FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHHHHHhccCCc-CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 34677778877665 343 3799999999999999999999999999999998654
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.58 Aligned_cols=258 Identities=27% Similarity=0.493 Sum_probs=214.2
Q ss_pred CeEEEEEeccCCCeEEEEEEEe---cCCeEEEEEEEecccc--cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCce
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~ 87 (644)
+|++.+.||.|+||.||+|.+. .+|..||+|.+..... .....+.+.+|+++|+++ +||||++++++|.. +..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence 5899999999999999999875 4789999999875432 122346678899999999 59999999988765 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++||||+|.|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 80 LHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999999763 4589999999999999999999999999999999999999999999999999987544
Q ss_pred cc--ccccccCCCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhccCCCCCCcccc
Q 006460 168 ED--LASSVVGTPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSISPLPIVYS 239 (644)
Q Consensus 168 ~~--~~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~~PF~~~~----~~el~~~i~~~~~~~~p~~~s 239 (644)
.. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.... ...+...+.. ...+.+..++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMS 236 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCC
Confidence 32 2234678999999998865 346889999999999999999999996433 2233333322 3345677789
Q ss_pred HHHHHHHHHHhccCCCCCC-----CHHHHhhCCCCchhhhh
Q 006460 240 STMKQIIKSMLRKNPEHRP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
..+.+|+.+||..+|.+|| ++.+++.||||+...+.
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 277 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD 277 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence 9999999999999999997 89999999999876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.52 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=204.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
...+|++.+.||+|+||.||+|.++.++..||+|.+...... .....+.+|+.+++.++||||+++++++.. +...|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEE
Confidence 357899999999999999999999999999999998654321 223356789999999999999999998765 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-c
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-D 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~ 169 (644)
||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..... .
T Consensus 81 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 81 VFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 999995 6787776543 345788899999999999999999999999999999999999999999999998764322 2
Q ss_pred ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHhcc-C----------------
Q 006460 170 LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA-GLINKINRS-S---------------- 230 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~-el~~~i~~~-~---------------- 230 (644)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...... +.+..+... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2344567999999998875 45788999999999999999999999765431 222211100 0
Q ss_pred ----CCC-CC---------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 231 ----ISP-LP---------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 231 ----~~~-~p---------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
... .+ ...+..+.+|+.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 00 0125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.82 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=213.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCe----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK----KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
..++|++.+.||.|+||.||+|.+..++. .+++|.+.... .......+..|+.+++++.||||+++++++. +.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CC
Confidence 45799999999999999999999987776 47777764332 2333456778899999999999999999864 34
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
..++++||+.+|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 578999999999999999764 3468999999999999999999999999999999999999999999999999998654
Q ss_pred ccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 167 TED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 167 ~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
... ......++..|+|||++.+..|+.++|||||||++|+|++ |..||.+.........+......+.+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 322 1223456778999999988889999999999999999998 999999888777767676666666677788899
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+++.+||..+|.+|||+.++++.
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=337.49 Aligned_cols=256 Identities=27% Similarity=0.521 Sum_probs=216.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
...+.|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||++++++|.+ +...
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~ 90 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTA 90 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeE
Confidence 34467999999999999999999999999999999986543 233445678899999999999999999999877 4568
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+. |+|.+++... ...+++..+..++.||+.||.|||+.||+||||+|.||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 91 WLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99999996 5777777643 345899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC-CccccHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL-PIVYSSTMKQ 244 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~-p~~~s~~l~d 244 (644)
....+++.|+|||++. ...++.++||||||+++|+|++|.+||...+.......+.....+.. +..++..+.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 3467889999999874 35688999999999999999999999988776666555544333332 3457889999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
||.+||..+|.+||++.+++.||||..
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 999999999999999999999999963
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=325.26 Aligned_cols=249 Identities=25% Similarity=0.427 Sum_probs=218.2
Q ss_pred eEEEEEeccCCCeEEEEEEEecCC----eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIER----KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+++.+.||.|+||.||+|.+...+ ..+|+|.+...... .....+.+|+.+++.++||||+++++++.+. ..+|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEE
Confidence 467889999999999999998876 89999999665432 2456788899999999999999999988764 67999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
+|||+.+++|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999865433389999999999999999999999999999999999999999999999999987655432
Q ss_pred ccc--ccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 171 ASS--VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 171 ~~~--~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
... ..+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+........+..++..+.+++.
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML 238 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 222 336789999999988889999999999999999998 89999988888888888877777777788999999999
Q ss_pred HHhccCCCCCCCHHHHhh
Q 006460 248 SMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~ 265 (644)
+||..+|.+|||+.++++
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 239 QCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHCcCChhhCcCHHHHHh
Confidence 999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.86 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=204.3
Q ss_pred CCCe-EEEEEeccCCCeEEEEEEE----ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-C
Q 006460 12 LEDY-EVIEQIGRGAFGAAFLVLH----KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-G 85 (644)
Q Consensus 12 ~~~Y-~i~~~LG~G~fG~Vyla~~----k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~ 85 (644)
.++| ++++.||+|+||.||++.. ..++..||+|.+..... ......+.+|+++|++++||||+++++++... .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3567 9999999999999988753 35678899999875432 23456778899999999999999999987653 4
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 5689999999999999999753 4899999999999999999999999999999999999999999999999999876
Q ss_pred ccccc----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH---------------HHHHHH
Q 006460 166 NTEDL----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA---------------GLINKI 226 (644)
Q Consensus 166 ~~~~~----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~---------------el~~~i 226 (644)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 43221 12234566799999998888999999999999999999999998643211 111112
Q ss_pred hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 227 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
......+.+..++..+.+|+.+||..+|.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222233446667899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=319.39 Aligned_cols=257 Identities=29% Similarity=0.535 Sum_probs=224.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+++|..+++||+|+||+||+|+++.+++.||+|.++.....+......+||+.+|+.|.|.|||+++++... ++.+-+|
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlv 79 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLV 79 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEe
Confidence 457888999999999999999999999999999999988888888889999999999999999999998654 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~ 170 (644)
+||| ..+|..+.... ++.+..+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+||+|||+++.++-. ..
T Consensus 80 fe~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 80 FEFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HHHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9999 66899998865 456899999999999999999999999999999999999999999999999999987654 24
Q ss_pred cccccCCCCCCChhhhcCCC-CCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCC---------------
Q 006460 171 ASSVVGTPNYMCPELLADIP-YGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISP--------------- 233 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~-ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~--------------- 233 (644)
+...+-|.||++|.++.+.. |+.+.|+||.|||+.|+.. |+|.|.+.+..+++.+|.+....+
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 56678899999999887754 8999999999999999985 889999999999888875432111
Q ss_pred -CCc------------cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 234 -LPI------------VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 234 -~p~------------~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+|. .++..-+++++++|..+|.+|++++.+|+||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 111 12345679999999999999999999999999964
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=334.09 Aligned_cols=257 Identities=35% Similarity=0.619 Sum_probs=222.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...+.|++.+.||.|+||.||+|.+..++..|++|.+..... ....+.+|+.+++.++||||+++++++.. ....|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV-GDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEE
Confidence 356779999999999999999999999999999999976543 35667889999999999999999999877 46799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+|+||+.|++|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|.||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999999998753 368999999999999999999999999999999999999999999999999987543321
Q ss_pred -ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC--ccccHHHHHHH
Q 006460 170 -LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP--IVYSSTMKQII 246 (644)
Q Consensus 170 -~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p--~~~s~~l~dLI 246 (644)
......+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+........+ ..++..+.+||
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 223456888999999998888999999999999999999999999887766655555444333322 33789999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCch
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+||+.+|.+|||+.+++.||||..
T Consensus 251 ~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHhccChhhCcCHHHHhhChHhhc
Confidence 9999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=329.86 Aligned_cols=251 Identities=23% Similarity=0.392 Sum_probs=214.3
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCe---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERK---KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
.++|++.+.||+|+||.||+|.++.++. .+|+|.++.... ....+.+.+|+.++++++||||+++++++.. +..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCcc
Confidence 4689999999999999999999875543 789998865432 3345678899999999999999999998765 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||++|++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999997643 45899999999999999999999999999999999999999999999999999875432
Q ss_pred cc--c--ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHH
Q 006460 169 DL--A--SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 169 ~~--~--~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~ 243 (644)
.. . ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....+......+.+..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 21 1 11233567999999998889999999999999999886 9999988887777777776655556667899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhh
Q 006460 244 QIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+++.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.27 Aligned_cols=255 Identities=29% Similarity=0.567 Sum_probs=216.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++.+.||+|+||.||++.+..++..|++|.+...... ..+.+.+|+.++++++||||++++++|.. +..+|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~l 93 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLV-GDELWV 93 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEE
Confidence 358999999999999999999999999999999998654322 24667889999999999999999999876 456999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
|+||+.+++|.+++... .+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 94 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999999998753 47899999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--CCccccHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSSTMKQIIK 247 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~p~~~s~~l~dLI~ 247 (644)
......|++.|++||.+.+..++.++|+|||||++|+|++|.+||...........+.....+. .+..++..+.+||.
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 2334578899999999988889999999999999999999999998776554433333222222 23446788999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCch
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||..+|.+||++.+++.||||+.
T Consensus 251 ~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred HHccCChhhCcCHHHHhcCHHHhc
Confidence 999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=340.49 Aligned_cols=255 Identities=27% Similarity=0.511 Sum_probs=217.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
...-|.....||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||++++++|.. +..+|+
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~i 95 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWV 95 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEE
Confidence 345566677899999999999999999999999998654332 24567889999999999999999998876 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+....
T Consensus 96 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 96 LMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 9999999999998764 348999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC--CCCccccHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--PLPIVYSSTMKQIIK 247 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~--~~p~~~s~~l~dLI~ 247 (644)
......|++.|+|||++.+..++.++|||||||++|+|++|++||......+....+...... ..+..++..+.++|.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence 233467899999999999888999999999999999999999999887776666665443221 123356889999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCch
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||+.+|.+||++.++++||||..
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhhcc
Confidence 999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.84 Aligned_cols=258 Identities=26% Similarity=0.462 Sum_probs=216.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG---- 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~---- 85 (644)
..-++|++.+.||.|+||.||+|.+..++..||+|++............+.+|+.+++++.||||+++++++...+
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3567899999999999999999999999999999998765433444566788999999999999999999776533
Q ss_pred -ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 86 -NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 86 -~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
..+|+|+||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 2489999999 7799998874 3589999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-----------
Q 006460 165 LNTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----------- 232 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~----------- 232 (644)
.... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+......+..+......
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 5432 345678899999998865 46789999999999999999999999877765554443321110
Q ss_pred -------------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 233 -------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 233 -------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.....++..+.+||.+||..+|.+|||+.+|+.||||+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 01123588999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=359.24 Aligned_cols=256 Identities=30% Similarity=0.499 Sum_probs=208.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~ 89 (644)
+=..|+++++||+||.+.||+|..- ....||+|++.....++....-+.+|+.+|.+| +|.+||++|+|- -.+.++|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-v~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-VTDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-ccCceEE
Confidence 3358999999999999999999754 445788888777777788888999999999999 599999999974 4578999
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
|||||- ..+|..+|++... .++.-.++.|..|||.+++++|.+||||.||||.|+|+- .|.+||+|||+|..+....
T Consensus 437 mvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 999997 5699999987543 345458999999999999999999999999999999885 7899999999999876643
Q ss_pred ---ccccccCCCCCCChhhhcCCC-----------CCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcc-CCCC
Q 006460 170 ---LASSVVGTPNYMCPELLADIP-----------YGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINRS-SISP 233 (644)
Q Consensus 170 ---~~~~~~GT~~Y~APEvl~~~~-----------ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i~~~-~~~~ 233 (644)
...+.+||+.||+||.+.... .+.++||||||||||+|+.|++||.... ...-+..|... ...+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 245679999999999886433 4689999999999999999999997433 22222222222 1112
Q ss_pred CCcccc-HHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 234 LPIVYS-STMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 234 ~p~~~s-~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+|..-+ .++.++++.||..||++|||+.++|+|||+++
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 333322 34999999999999999999999999999975
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=326.30 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=216.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++.+.||.|+||.||+|.+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++.. ....++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEE
Confidence 4579999999999999999999875 4578999998765433 3467889999999999999999998765 466899
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+.+++|.+++....+..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999999999875555789999999999999999999999999999999999999999999999999987643221
Q ss_pred --cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 171 --ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 171 --~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+......+.+...+..+.+++.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML 238 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 112334568999999998889999999999999999998 99999988888888887766666667778999999999
Q ss_pred HHhccCCCCCCCHHHHhh
Q 006460 248 SMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~ 265 (644)
+||..+|.+||++.+++.
T Consensus 239 ~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 239 QCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHcccCcccCCCHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.60 Aligned_cols=254 Identities=39% Similarity=0.762 Sum_probs=217.4
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc---ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK---QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+|.+.+.||+|+||.||+|.+..++..+++|+++... ........+.+|+.++++++||||+++++++.+. ...++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-DAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-CceEE
Confidence 6999999999999999999998887777777664322 2222334567799999999999999999988764 56899
Q ss_pred EEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 91 VTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
||||+.+++|.+++... ....+++..++.++.||+.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999988652 3456899999999999999999999999999999999999974 67999999998765332
Q ss_pred -cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 169 -DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 169 -~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+..+..++.++.++|.
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 2334567899999999998888999999999999999999999999887777777777666666677788999999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCC
Q 006460 248 SMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f 269 (644)
+||..+|.+||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=333.82 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=212.7
Q ss_pred CeEEEEEeccCCCeEEEEEEEecC-----CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIE-----RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~t-----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
+|++.+.||+|+||.||+|.+... ...+++|.+..... ......+.+|+.+++.++||||+++++.+.. ....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCc
Confidence 589999999999999999987642 35688888765433 3334678899999999999999999998766 4568
Q ss_pred EEEEeccCCCCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcE
Q 006460 89 CIVTGYCEGGDMAEIIKKAR----------------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNI 146 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~----------------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNI 146 (644)
|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999999987532 12478899999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHH
Q 006460 147 FLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGL 222 (644)
Q Consensus 147 LL~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el 222 (644)
|++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |.+||.+.....+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999986533221 122345678999999988889999999999999999998 9999998888888
Q ss_pred HHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 223 INKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 223 ~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
...+......+.+..++.++.+|+.+||..+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7777766556667788999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=344.71 Aligned_cols=255 Identities=31% Similarity=0.470 Sum_probs=208.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC------
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG------ 85 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~------ 85 (644)
-++|++.+.||.|+||.||+|.++.++..||+|++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 4799999999999999999999999999999999876543 23466788999999999999999998766532
Q ss_pred -------ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-CCCeEEe
Q 006460 86 -------NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-DNDIRLG 157 (644)
Q Consensus 86 -------~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-~g~vKL~ 157 (644)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 589888753 35899999999999999999999999999999999999985 4578999
Q ss_pred ccCccccccccc----ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC--
Q 006460 158 DFGLAKLLNTED----LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS-- 230 (644)
Q Consensus 158 DFGls~~~~~~~----~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~-- 230 (644)
|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+....+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999997653321 1223467889999997654 567899999999999999999999998766544433322110
Q ss_pred ----------------------CC-----CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 231 ----------------------IS-----PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 231 ----------------------~~-----~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.. .....++.++.+||.+||..||.+|||+.++|.||||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 0112467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=336.20 Aligned_cols=257 Identities=23% Similarity=0.387 Sum_probs=219.0
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEec-------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeee
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKI-------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKD 79 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~ 79 (644)
.....++|.+.+.||+|+||.||+|.+.. .+..+|+|.+.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 34567899999999999999999997632 34579999886543 233456788999999999 8999999999
Q ss_pred EEEeCCceEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 006460 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSN 145 (644)
Q Consensus 80 ~~~d~~~~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeN 145 (644)
++.. ...+|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|
T Consensus 89 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 89 ACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 8876 456899999999999999997642 1347788899999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHH
Q 006460 146 IFLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAG 221 (644)
Q Consensus 146 ILL~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~e 221 (644)
||++.++.+||+|||+++.+..... .....+++.|+|||++.+..|+.++||||||+++|+|++ |..||.+.+..+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 9999999999999999987643221 223445678999999988889999999999999999998 899999988888
Q ss_pred HHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 222 LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 222 l~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+...+........+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 888887776666677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=337.43 Aligned_cols=255 Identities=22% Similarity=0.366 Sum_probs=215.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEec-------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKI-------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAW 81 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~ 81 (644)
...++|.+.++||+|+||.||+|.+.. ....+|+|.++.... ......+.+|+++++++ +||||+++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 345789999999999999999998642 345789998875433 33356688899999999 699999999988
Q ss_pred EeCCceEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEE
Q 006460 82 VDKGNCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIF 147 (644)
Q Consensus 82 ~d~~~~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNIL 147 (644)
.. ...+|+||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~-~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 88 TQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred cc-CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 76 456899999999999999997642 134788999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 006460 148 LTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLI 223 (644)
Q Consensus 148 L~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~ 223 (644)
++.++.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||......++.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986543221 122234567999999988889999999999999999998 89999988888888
Q ss_pred HHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 224 NKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 224 ~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+........+..++.++.+|+.+||..+|.+|||+.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8877766556677789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.86 Aligned_cols=264 Identities=27% Similarity=0.478 Sum_probs=215.7
Q ss_pred CCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 006460 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK 84 (644)
Q Consensus 6 ~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~ 84 (644)
......+++|++.+.||+|+||.||+|.+..++..||+|.+........ ...+.+|+.++.++ +||||+++++++.+
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~- 85 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVKCYGYFIT- 85 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-HHHHHHHHHHHHhccCCCchHhhheeeec-
Confidence 3456788999999999999999999999999999999999976543332 34566677766666 59999999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
+..+|+||||+ +++|..++.... ..+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 86 DSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 56799999999 558888876543 468999999999999999999997 599999999999999999999999999998
Q ss_pred ccccccccccccCCCCCCChhhhcCCC----CCcccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhccCCCCCC--c
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLADIP----YGYKSDIWSLGCCMFEIAAHQPAFRAPDM-AGLINKINRSSISPLP--I 236 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~~~----ys~ksDIWSLGvILyeLltG~~PF~~~~~-~el~~~i~~~~~~~~p--~ 236 (644)
.+..........+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+.+..+........+ .
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06618 164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE 243 (296)
T ss_pred hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence 665433334456888999999987553 78999999999999999999999976332 2334444333322222 3
Q ss_pred cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.++.++.+|+.+||..||.+||++.+++.||||+.+.
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 4788999999999999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.59 Aligned_cols=256 Identities=27% Similarity=0.488 Sum_probs=211.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----- 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----- 85 (644)
..++|.+.+.||+|+||.||+|.+..++..||+|++......+.....+.+|+++++.+.||||++++++|....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 357999999999999999999999999999999998765444444566889999999999999999999876432
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+|+||+. .+|..++ +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred ceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 34799999995 4776654 235899999999999999999999999999999999999999999999999998764
Q ss_pred ccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC--------------
Q 006460 166 NTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS-------------- 230 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~-------------- 230 (644)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 168 DA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 33 2234577899999998866 468999999999999999999999998877554443332210
Q ss_pred --------CCC--------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 231 --------ISP--------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 231 --------~~~--------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.+. .....+..+.+||.+||+.||.+||++.+++.||||+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 0123567899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=325.41 Aligned_cols=244 Identities=21% Similarity=0.401 Sum_probs=209.3
Q ss_pred EEeccCCCeEEEEEEEec-CC--eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEecc
Q 006460 19 EQIGRGAFGAAFLVLHKI-ER--KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYC 95 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~-tg--~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~ 95 (644)
+.||+|++|.||+|.+.. .+ ..||+|.+...... ...+.+.+|++++++++||||+++++++.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEec
Confidence 368999999999999866 33 36899999776544 556788999999999999999999999876 6799999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc----cc
Q 006460 96 EGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED----LA 171 (644)
Q Consensus 96 ~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~----~~ 171 (644)
++++|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..+.... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999999987543568999999999999999999999999999999999999999999999999998764421 12
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhc-cCCCCCCccccHHHHHHHHHH
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINR-SSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~-~~~~~~p~~~s~~l~dLI~~~ 249 (644)
....++..|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+.. ....+.+..++..+.+++.+|
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence 23457788999999998899999999999999999998 9999988777776666653 333345566789999999999
Q ss_pred hccCCCCCCCHHHHhh
Q 006460 250 LRKNPEHRPTASDLLR 265 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~ 265 (644)
|..+|.+|||+.++++
T Consensus 238 l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 238 WAHNPADRPTFAALRE 253 (257)
T ss_pred CCCCcccCCCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=331.98 Aligned_cols=253 Identities=22% Similarity=0.380 Sum_probs=211.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCC----------------eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIER----------------KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg----------------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNI 74 (644)
..++|++++.||+|+||.||+|.+...+ ..||+|.+..... ......+.+|++++++++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCE
Confidence 4579999999999999999999877544 5689998875533 2445678899999999999999
Q ss_pred ceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 006460 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARG---------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSN 145 (644)
Q Consensus 75 Vkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~---------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeN 145 (644)
++++++|.. +..+++||||+.+++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 82 ~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 82 ARLLGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999998876 4679999999999999999976431 258999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh--CCCCCCCCChH
Q 006460 146 IFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMA 220 (644)
Q Consensus 146 ILL~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt--G~~PF~~~~~~ 220 (644)
|+++.++.++|+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999998654332 2234456788999999988889999999999999999997 78899877666
Q ss_pred HHHHHHhcc-------CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 221 GLINKINRS-------SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 221 el~~~i~~~-------~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
..+..+... ...+.+..++.++.+|+.+||..+|.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 655554322 112334557889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=327.46 Aligned_cols=251 Identities=23% Similarity=0.408 Sum_probs=214.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCe---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERK---KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
.++|++.+.||+|+||.||+|.++.++. .||+|.+.... .......+.+|+.+++.++||||+++++++.. +..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCce
Confidence 5689999999999999999999987765 59999886542 34456778999999999999999999998765 5668
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
++||||+.+++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999999764 346899999999999999999999999999999999999999999999999998765432
Q ss_pred cccc----ccc--CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 169 DLAS----SVV--GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 169 ~~~~----~~~--GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
.... ... .+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+......+.+..++..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 2111 111 2357999999998899999999999999999886 99999888877777777655555566678899
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhh
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+.+++.+||..+|.+||++.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=326.47 Aligned_cols=243 Identities=21% Similarity=0.385 Sum_probs=207.9
Q ss_pred EeccCCCeEEEEEEEe--cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCC
Q 006460 20 QIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEG 97 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~k--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~G 97 (644)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.++++++||||+++++++. ...+++||||+.+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCC
Confidence 4899999999999776 345679999886543 3445667899999999999999999999864 3468999999999
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc----ccc
Q 006460 98 GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL----ASS 173 (644)
Q Consensus 98 gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~----~~~ 173 (644)
++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+..... ...
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999998753 34689999999999999999999999999999999999999999999999999976543221 111
Q ss_pred ccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc
Q 006460 174 VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK 252 (644)
Q Consensus 174 ~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~ 252 (644)
..+++.|+|||++....++.++|||||||++|+|++ |.+||......+....+........+..++.++.+++.+||..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 233578999999988889999999999999999996 9999998888888888877776777888899999999999999
Q ss_pred CCCCCCCHHHHhhC
Q 006460 253 NPEHRPTASDLLRH 266 (644)
Q Consensus 253 dP~~RpTa~eiL~h 266 (644)
+|++||++.++++.
T Consensus 238 ~~~~Rp~~~~i~~~ 251 (257)
T cd05115 238 KWEDRPNFAKVEER 251 (257)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=331.87 Aligned_cols=253 Identities=20% Similarity=0.354 Sum_probs=216.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEec-----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKI-----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
..++|++.+.||.|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++++++||||+++++++.. +
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV-G 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-C
Confidence 35789999999999999999998753 67899999886543 33445678899999999999999999998766 4
Q ss_pred ceEEEEEeccCCCCHHHHHHHhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKAR--------------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSN 145 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~--------------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeN 145 (644)
..+|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||++|++||||||.|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 56899999999999999997532 1247888999999999999999999999999999999
Q ss_pred EEEcCCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHH
Q 006460 146 IFLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAG 221 (644)
Q Consensus 146 ILL~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~e 221 (644)
||++.++.++|+|||++..+..... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876533221 122344667999999988899999999999999999997 888998888888
Q ss_pred HHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 222 LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 222 l~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
....+......+.+..++..+.+|+.+||+.+|.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 88887777666667778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.34 Aligned_cols=261 Identities=30% Similarity=0.486 Sum_probs=214.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC-Cc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK-GN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~-~~ 86 (644)
....++|++.+.||+|+||.||+|.+..++..+|+|++............+.+|+.+++++ +||||++++++|... +.
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 4567899999999999999999999999999999998865433333345677899999999 999999999987653 45
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 7899999996 5999888653 58899999999999999999999999999999999999999999999999998654
Q ss_pred ccc------ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC---------
Q 006460 167 TED------LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS--------- 230 (644)
Q Consensus 167 ~~~------~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~--------- 230 (644)
... ......|++.|+|||++.+ ..++.++||||||+++|+|++|++||.+.........+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 322 2234578999999998755 457899999999999999999999998766544433321110
Q ss_pred ------------------C---CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 231 ------------------I---SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 231 ------------------~---~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
. ......++.++.+||.+||+.+|.+|||+.++++|||++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0 011122688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.21 Aligned_cols=255 Identities=22% Similarity=0.419 Sum_probs=211.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~ 84 (644)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++.... ......+.+|+.+|.++ +|||||++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4578999999999999999999853 4678999999975433 23356788999999999 689999999988777
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcC-------------------------------------------------------
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARG------------------------------------------------------- 109 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~------------------------------------------------------- 109 (644)
+..+++|||||.+|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 7789999999999999999875321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc---cccccC
Q 006460 110 ----------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL---ASSVVG 176 (644)
Q Consensus 110 ----------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~---~~~~~G 176 (644)
..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++........ .....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 2367788899999999999999999999999999999999999999999999986532211 122345
Q ss_pred CCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChH-HHHHHHhccCCCCCCccccHHHHHHHHHHhccCC
Q 006460 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMA-GLINKINRSSISPLPIVYSSTMKQIIKSMLRKNP 254 (644)
Q Consensus 177 T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~-el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP 254 (644)
++.|+|||++.+..++.++||||||+++|+|++ |..||...... .....+......+.|..+++.+.+++.+||..+|
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p 323 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 323 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 677999999988889999999999999999996 99999765433 3444444444555666678899999999999999
Q ss_pred CCCCCHHHHhhC
Q 006460 255 EHRPTASDLLRH 266 (644)
Q Consensus 255 ~~RpTa~eiL~h 266 (644)
.+|||+.+|++|
T Consensus 324 ~~Rps~~eil~~ 335 (343)
T cd05103 324 SQRPTFSELVEH 335 (343)
T ss_pred hhCcCHHHHHHH
Confidence 999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=329.01 Aligned_cols=251 Identities=22% Similarity=0.403 Sum_probs=216.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCe----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK----KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
...+|++.+.||+|+||.||+|.++.++. .+|+|.+..... ......+.+|+.++++++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS--S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 45789999999999999999999877664 589998765533 3445678899999999999999999998875 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
..++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 6899999999999999997643 358999999999999999999999999999999999999999999999999998764
Q ss_pred cccccc---cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 167 TEDLAS---SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 167 ~~~~~~---~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
...... ...++..|+|||.+....++.++|+|||||++|+|++ |.+||......++...+......+.|..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 332211 1223567999999988889999999999999999998 999999988888888887766666777788999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.+++.+||..+|..|||+.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.16 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=201.7
Q ss_pred CCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCCHHHHH
Q 006460 25 AFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEII 104 (644)
Q Consensus 25 ~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L 104 (644)
++|.||++.+..+++.||+|++............+.+|+.+++.++||||++++++|.+ ....|++|||+.+++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccCCCCHHHHH
Confidence 45667777777899999999998764455566789999999999999999999998876 46689999999999999999
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--------ccccccC
Q 006460 105 KKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--------LASSVVG 176 (644)
Q Consensus 105 ~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~--------~~~~~~G 176 (644)
.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+..+.... ......+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 87655568999999999999999999999999999999999999999999999999987543211 1234567
Q ss_pred CCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH-HHHhccC-----------------------
Q 006460 177 TPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLI-NKINRSS----------------------- 230 (644)
Q Consensus 177 T~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~-~~i~~~~----------------------- 230 (644)
+..|+|||++.+ ..|+.++|||||||++|+|++|..||......... ..+....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 788999999876 45889999999999999999999999865543322 2221100
Q ss_pred ---------CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 231 ---------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 231 ---------~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
....+..++.++.+|+.+||..||.+|||+.++|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 001112245688999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=330.39 Aligned_cols=252 Identities=31% Similarity=0.498 Sum_probs=212.8
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEec
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGY 94 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy 94 (644)
|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.++++++||||+++++++.+ ...+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-ERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-CCceEEEecC
Confidence 788899999999999999999999999999998765444455677889999999999999999998876 4679999999
Q ss_pred cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-cccc
Q 006460 95 CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASS 173 (644)
Q Consensus 95 ~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~~~ 173 (644)
+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 96 59999998653 458999999999999999999999999999999999999999999999999998754432 2334
Q ss_pred ccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--------------------C
Q 006460 174 VVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--------------------S 232 (644)
Q Consensus 174 ~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--------------------~ 232 (644)
..++..|+|||.+.+. .++.++|||||||++|+|++|.+||......+.+..+..... +
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 5667889999998766 789999999999999999999999988776555444322100 0
Q ss_pred C--------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 233 P--------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 233 ~--------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
. ....++..+.++|.+||..+|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=340.62 Aligned_cols=256 Identities=25% Similarity=0.464 Sum_probs=209.0
Q ss_pred CeEEEEEeccCCCeEEEEEEEecC--CeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe---CCce
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIE--RKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD---KGNC 87 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~t--g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d---~~~~ 87 (644)
+|++.+.||+|+||.||+|.+..+ +..||+|.+..........+.+.+|+.+++++ +||||+++++++.. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 599999999999999999999988 89999999875433333456788899999999 59999999987542 2346
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|++++|+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELM-EADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecc-cCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 88999999 4689998864 34689999999999999999999999999999999999999999999999999986543
Q ss_pred cc-----ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC-----------
Q 006460 168 ED-----LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS----------- 230 (644)
Q Consensus 168 ~~-----~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~----------- 230 (644)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+....
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 1234578999999998765 568999999999999999999999998766444333221110
Q ss_pred -------------------CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 231 -------------------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 231 -------------------~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+.......+..+.+|+.+||..+|.+|||+.+++.|||+..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 001112357889999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=351.23 Aligned_cols=256 Identities=29% Similarity=0.561 Sum_probs=218.5
Q ss_pred CCCCeEE-EEEeccCCCeEEEEEEEecCCeEEEEEEEeccc--ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-c
Q 006460 11 KLEDYEV-IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK--QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG-N 86 (644)
Q Consensus 11 ~~~~Y~i-~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~-~ 86 (644)
.-++|.. ...||+|+|-+||+|.+..+|..||--.++..+ ..+...++|..|+.+|+.|+|||||++|++|.+.. .
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 3455544 457999999999999999999998765554433 34455688999999999999999999999999754 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccccCCCCcEEEcCC-CCeEEeccCccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN--RVLHRDLKCSNIFLTKD-NDIRLGDFGLAK 163 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~--gIIHRDLKPeNILL~~~-g~vKL~DFGls~ 163 (644)
++.+|+|++.+|+|..|+++.+. +....++.|++|||.||.|||++ .|||||||.+||+|+.+ |.|||+|+|||.
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence 78899999999999999998654 77789999999999999999999 79999999999999865 889999999999
Q ss_pred ccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHhccCCCC-CCccccHH
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRA-PDMAGLINKINRSSISP-LPIVYSST 241 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~-~~~~el~~~i~~~~~~~-~p~~~s~~ 241 (644)
..... .....+|||.|||||++. ..|+..+||||||++|.||+|+..||.. .....+++++..+..+. +...-.++
T Consensus 195 l~r~s-~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 195 LLRKS-HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred Hhhcc-ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 87664 345589999999999997 6899999999999999999999999964 56677777777665432 23344789
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+++||.+||.. ...|+|+.+||.||||..
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 99999999998 999999999999999974
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=325.31 Aligned_cols=251 Identities=21% Similarity=0.382 Sum_probs=214.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCe---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERK---KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
.++|...+.||+|+||.||+|.++.++. .+++|.+..... ......+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCCc
Confidence 4589999999999999999999887654 689998865432 3345678899999999999999999998766 4568
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 82 MIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999999764 346899999999999999999999999999999999999999999999999999765432
Q ss_pred cc--cc--cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHH
Q 006460 169 DL--AS--SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 169 ~~--~~--~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~ 243 (644)
.. .. ....++.|+|||++.+..++.++|||||||++|+|++ |..||......++...+......+.+..++..+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11 11 1223457999999988889999999999999999997 9999988888888888876665566667899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhh
Q 006460 244 QIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+|+.+||..+|..||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=325.11 Aligned_cols=244 Identities=22% Similarity=0.383 Sum_probs=212.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+++|++.+.||+|+||.||++. .+++.||+|.++.... ...+.+|+.++++++||||+++++++.. ...|+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVT----AQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcch----HHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEE
Confidence 5789999999999999999986 4678899999865432 3567889999999999999999998765 347899
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||+.+++|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~ 154 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--V 154 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--C
Confidence 99999999999998765556899999999999999999999999999999999999999999999999998764321 2
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHh
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L 250 (644)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |.+||......+....+........+..++..+.+|+.+||
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHc
Confidence 23345678999999988889999999999999999997 99999988888877777766555566778999999999999
Q ss_pred ccCCCCCCCHHHHhh
Q 006460 251 RKNPEHRPTASDLLR 265 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~ 265 (644)
..+|.+||++.+++.
T Consensus 235 ~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 235 ETEPKKRPSFHKLRE 249 (254)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=357.40 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=222.5
Q ss_pred eEE--EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 15 YEV--IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 15 Y~i--~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
|+| -+.||+|.||+||-|.|+.+|+.||||+|.+.....+....+.+|+.||+++.||.||.+.-.|.. ...+++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEe
Confidence 444 368999999999999999999999999999887777777889999999999999999999887755 45699999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC---CCeEEeccCccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD---NDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~---g~vKL~DFGls~~~~~~~ 169 (644)
|.+. |++.++|.....+++++..-..++.|||.||.|||-+||+|+||||+|||+... .++||||||+++.++...
T Consensus 643 EKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 643 EKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 9994 566666655567789999999999999999999999999999999999999754 369999999999999998
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---CCCccccHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSSTMKQII 246 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---~~p~~~s~~l~dLI 246 (644)
+..+.+|||.|+|||++..++|....|+||.|+|+|--+.|..||.... ++-.+|....+. .-+..++.++.+||
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHH
Confidence 9999999999999999999999999999999999999999999996533 344455444332 22345789999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
..+|+..-.+|.|+++.|.|||++.|.
T Consensus 800 n~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHhcchHhhccchhhhcch
Confidence 999999999999999999999998763
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=326.22 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=215.0
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecC---CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIE---RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
-++|.+.+.||+|+||.||+|.+... ...+++|.+..... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCc
Confidence 46799999999999999999987654 45789998865432 3445678999999999999999999998764 457
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 89999999999999997643 35899999999999999999999999999999999999999999999999999865443
Q ss_pred cccc--cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 169 DLAS--SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 169 ~~~~--~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
.... ...+++.|+|||.+....++.++|||||||++|+|++ |..||......+....+......+.+..++..+.+|
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 3221 2234567999999988889999999999999999986 999999888777777777766667778889999999
Q ss_pred HHHHhccCCCCCCCHHHHhhC
Q 006460 246 IKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~h 266 (644)
+.+||..+|.+|||+.+++..
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=360.13 Aligned_cols=244 Identities=28% Similarity=0.566 Sum_probs=214.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..|+...-++.||.|+.|.||+|+.+ ++.||||+++.-+ ..+|+-|++|+||||+.+.++|.. ..+||
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtq-sPcyC 188 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQ-SPCYC 188 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecC-CceeE
Confidence 34455556789999999999999764 6799999775322 347899999999999999999865 68999
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
||||||..|-|..+|+. +..+....+..|..+|+.|++|||.+.|||||||.-||||+.+..|||+|||-++......
T Consensus 189 IiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS 266 (904)
T ss_pred EeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence 99999999999999986 4568899999999999999999999999999999999999999999999999999887766
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc-CCCCCCccccHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-SISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~-~~~~~p~~~s~~l~dLI~~ 248 (644)
....++||..|||||++...+.+.|+|||||||||||||||..||..-+...++.-+... .--+.|..+++.++-||+.
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHH
Confidence 677899999999999999999999999999999999999999999877766555444322 2346788999999999999
Q ss_pred HhccCCCCCCCHHHHhhCC
Q 006460 249 MLRKNPEHRPTASDLLRHP 267 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~hp 267 (644)
||.-.|..||++.+||.|-
T Consensus 347 cw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 347 CWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHhcCCCCCccHHHHHHHH
Confidence 9999999999999999983
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.26 Aligned_cols=250 Identities=21% Similarity=0.394 Sum_probs=214.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.++||+|+||.||+|.+. .+..+|+|.+.... .....+.+|++++++++|+||+++++++.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeE
Confidence 34689999999999999999999754 45679999886542 234578889999999999999999998765 5689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
++|||+.+++|.+++....+..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999987555668899999999999999999999999999999999999999999999999997654322
Q ss_pred c--cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 170 L--ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 170 ~--~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
. .....++..|+|||++.+..++.++|+|||||++|+|++ |.+||...+.......+......+.+..++..+.+++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence 1 122345677999999988889999999999999999998 9999998888777777776655566677899999999
Q ss_pred HHHhccCCCCCCCHHHHhh
Q 006460 247 KSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~ 265 (644)
.+||..+|.+||++.+++.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 237 MRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.82 Aligned_cols=249 Identities=23% Similarity=0.465 Sum_probs=213.5
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+...... ...+.+|++++++++||||+++++++.. ...+|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEE
Confidence 468999999999999999999875 4678999988755433 2357789999999999999999998766 4568999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
|||+.+++|.+++.... ..++++.++.++.|++.||.|||++|++||||||.||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999987543 4588999999999999999999999999999999999999999999999999876543221
Q ss_pred -cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 171 -ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 171 -~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
.....++..|+|||++.+..++.++||||||+++|+|++ |.+||...........+........+...+..+.+|+.+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 112335578999999988889999999999999999998 999999888888888777665555567789999999999
Q ss_pred HhccCCCCCCCHHHHhhC
Q 006460 249 MLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~h 266 (644)
||..+|.+|||+.+++++
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=321.70 Aligned_cols=245 Identities=34% Similarity=0.604 Sum_probs=215.9
Q ss_pred eccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCC
Q 006460 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGD 99 (644)
Q Consensus 21 LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~Ggs 99 (644)
||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++||||+++++++.. +..+|+||||+.+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence 79999999999999999999999998765432 2245678889999999999999999998765 677999999999999
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cccccccCCC
Q 006460 100 MAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTP 178 (644)
Q Consensus 100 L~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~~~~~GT~ 178 (644)
|.+++... ..+++..+..++.||+.||.|||+++++|+||+|.||+++.++.++|+|||++...... .......++.
T Consensus 80 L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 80 LFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99999764 35899999999999999999999999999999999999999999999999999875443 2344567889
Q ss_pred CCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCC
Q 006460 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRP 258 (644)
Q Consensus 179 ~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~Rp 258 (644)
.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.. ...+++...+..+.+|+++||..||++||
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~ 236 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRL 236 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence 99999999888889999999999999999999999988887666666665 33457777899999999999999999999
Q ss_pred CH---HHHhhCCCC
Q 006460 259 TA---SDLLRHPHL 269 (644)
Q Consensus 259 Ta---~eiL~hp~f 269 (644)
++ .+++.||||
T Consensus 237 ~~~~~~~l~~~~~f 250 (250)
T cd05123 237 GSGGAEEIKAHPFF 250 (250)
T ss_pred CcccHHHHHhCCCC
Confidence 99 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=328.08 Aligned_cols=244 Identities=21% Similarity=0.386 Sum_probs=204.6
Q ss_pred EeccCCCeEEEEEEEecCCe--EEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 20 QIGRGAFGAAFLVLHKIERK--KYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~k~tg~--~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
.||+|+||.||+|.++.++. .+++|.+.... .......+.+|+.+++++ +||||+++++++.. ...+|+||||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCC
Confidence 58999999999999988875 45777775332 233456788899999999 79999999998866 456899999999
Q ss_pred CCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 97 GGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 97 GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
+++|.+++.... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997532 124789999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 163 KLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
..............+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+........+..++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE 239 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHH
Confidence 64322111122234567999999988889999999999999999996 99999888877777777665555566678899
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhh
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+.+|+.+||..+|.+|||+.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 240 VYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHcccChhhCCCHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.40 Aligned_cols=246 Identities=21% Similarity=0.339 Sum_probs=205.8
Q ss_pred EEeccCCCeEEEEEEEec---CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEecc
Q 006460 19 EQIGRGAFGAAFLVLHKI---ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYC 95 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~---tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~ 95 (644)
+.||+|+||.||+|.+.. .+..+|+|.+.... .......+.+|+.+++.++||||+++++++...+...|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999998754 34679999875432 23345678889999999999999999998776566789999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-----c
Q 006460 96 EGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-----L 170 (644)
Q Consensus 96 ~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-----~ 170 (644)
.+++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 80 KHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999997543 346778888999999999999999999999999999999999999999999997653321 1
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
.....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+........+..++..+.+++.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence 123345778999999988889999999999999999999 5778887777777777766655556667789999999999
Q ss_pred hccCCCCCCCHHHHhhC
Q 006460 250 LRKNPEHRPTASDLLRH 266 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~h 266 (644)
|..+|.+||++.+++..
T Consensus 239 l~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 239 WHPKPEMRPTFSELVSR 255 (262)
T ss_pred cCCChhhCCCHHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=330.49 Aligned_cols=251 Identities=22% Similarity=0.414 Sum_probs=207.3
Q ss_pred CeEEEEEeccCCCeEEEEEEE----ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CceE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLH----KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNCV 88 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~----k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~~ 88 (644)
-|++++.||+|+||.||+|.. +.++..||+|.++.... ......+.+|+++++.+.||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 478999999999999999974 45688999999865432 34456789999999999999999999988765 3678
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
++||||++|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.+...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 9999999999999999754 335899999999999999999999999999999999999999999999999999876443
Q ss_pred c----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC---------------ChHHHHHHHhcc
Q 006460 169 D----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP---------------DMAGLINKINRS 229 (644)
Q Consensus 169 ~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~---------------~~~el~~~i~~~ 229 (644)
. ......++..|+|||++.+..++.++|||||||++|+|+++..|+... ........+...
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 2 123455677899999998888999999999999999999987664221 111222333334
Q ss_pred CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 230 SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 230 ~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
...+.+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 4445566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=339.38 Aligned_cols=257 Identities=27% Similarity=0.481 Sum_probs=212.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..-++|++.+.||.|+||.||+|.+..++..||+|++..........+.+.+|+.+++.++||||++++++|...+..+|
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 34578999999999999999999999999999999886543333345667889999999999999999999877667799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||+ +++|..+++. ..+++..+..++.||+.||.|||++||+||||+|.|||++.++.++|+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred EEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 999999 6789888763 34888999999999999999999999999999999999999999999999999865332
Q ss_pred ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhc--------------------
Q 006460 170 LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR-------------------- 228 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~-------------------- 228 (644)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+..
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 244577889999998765 5689999999999999999999999977654322111110
Q ss_pred ----c-CCCCC-----CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 229 ----S-SISPL-----PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 229 ----~-~~~~~-----p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
. ...+. ...++..+.++|.+||+.+|.+|||+.+++.||||..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0 00111 12467899999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.62 Aligned_cols=254 Identities=22% Similarity=0.396 Sum_probs=211.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d 83 (644)
...++|.+.+.||+|+||.||+|.+. .++..+|+|.++.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 44568999999999999999999763 3456899998875533 33456788999999999 79999999998876
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
...+|+||||+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 111 -~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 111 -GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 4569999999999999999986554458999999999999999999999999999999999999999999999999998
Q ss_pred cccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH-hccCCCCCCccc
Q 006460 164 LLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKI-NRSSISPLPIVY 238 (644)
Q Consensus 164 ~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i-~~~~~~~~p~~~ 238 (644)
.+.... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||........+... ........+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence 654322 1223456788999999988889999999999999999998 99999876655444333 333333455567
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+..+.+|+.+||..+|++|||+.+++.
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=350.13 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=210.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecC-----CeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIE-----RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~t-----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d 83 (644)
..-++|++.++||+|+||.||+|.+... +..||+|++..... ....+.+.+|+++|+++. |||||+++++|.+
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 4567889999999999999999987543 35799999865432 334567899999999996 9999999999876
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhc-------------------------------------------------------
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKAR------------------------------------------------------- 108 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~------------------------------------------------------- 108 (644)
...+|||||||++|+|.+++....
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 113 -SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred -CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 456999999999999999986532
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc
Q 006460 109 ---------------------------------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT 149 (644)
Q Consensus 109 ---------------------------------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~ 149 (644)
...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 12478888999999999999999999999999999999999
Q ss_pred CCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChH-HHHH
Q 006460 150 KDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMA-GLIN 224 (644)
Q Consensus 150 ~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~-el~~ 224 (644)
.++.+||+|||+++.+..... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .+..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 999999999999986533221 223456788999999998889999999999999999997 99999765433 3344
Q ss_pred HHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 225 KINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 225 ~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.+......+.+..++..+.+|+.+||..+|++|||+.++.+
T Consensus 352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 44444445566778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=363.38 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=195.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCe-EEEEEEE---------------ecccccHHHHHHHHHHHHHHHhcCCCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK-KYVLKKI---------------RLAKQTEKFKRTALQEMDLISKLNNPYI 74 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~-~vAiK~i---------------~~~~~~~~~~~~~~rEi~iL~~L~HPNI 74 (644)
.+++|+++++||+|+||.||+|..+.... .++.|.+ +...........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 46789999999999999999997654332 2222211 0111222345567899999999999999
Q ss_pred ceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC
Q 006460 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR---GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 75 Vkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~---~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~ 151 (644)
|++++++.. ....|+|++++ +++|..++.... ........++.|+.||+.||.|||++|||||||||+|||++.+
T Consensus 226 v~l~~~~~~-~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRS-EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEE-CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999876 45689999999 567777765321 1223466788999999999999999999999999999999999
Q ss_pred CCeEEeccCccccccccc--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCC-CCCCCC--h-HHHHHH
Q 006460 152 NDIRLGDFGLAKLLNTED--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQP-AFRAPD--M-AGLINK 225 (644)
Q Consensus 152 g~vKL~DFGls~~~~~~~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~-PF~~~~--~-~el~~~ 225 (644)
+.+||+|||++..+.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.. ||.... . ..+...
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999998765432 2234679999999999999999999999999999999999875 443221 1 222221
Q ss_pred HhccC---------------------CCCCC---------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 226 INRSS---------------------ISPLP---------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 226 i~~~~---------------------~~~~p---------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+.... ....+ ..++..+.++|.+||.+||.+|||+.|+|.||||..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 11100 00000 124567888999999999999999999999999964
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=339.63 Aligned_cols=261 Identities=25% Similarity=0.427 Sum_probs=212.9
Q ss_pred CCCCCCCeEEE-EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH------------HHHHHHHHHHHHHhcCCCCc
Q 006460 8 SKSKLEDYEVI-EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK------------FKRTALQEMDLISKLNNPYI 74 (644)
Q Consensus 8 ~~~~~~~Y~i~-~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~------------~~~~~~rEi~iL~~L~HPNI 74 (644)
+.+..++|..+ +.||.|+||.||+|.+..+++.||+|++........ ....+.+|+++++.++||||
T Consensus 3 ~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred ccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 34566888754 679999999999999999999999999865432210 11257789999999999999
Q ss_pred ceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCe
Q 006460 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDI 154 (644)
Q Consensus 75 Vkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~v 154 (644)
++++++|.. +...|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+
T Consensus 83 v~~~~~~~~-~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 83 MGLVDVYVE-GDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeeEEEec-CCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 999998876 567999999996 689998875 3458999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccccc---------------cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 006460 155 RLGDFGLAKLLNTE---------------DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPD 218 (644)
Q Consensus 155 KL~DFGls~~~~~~---------------~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~ 218 (644)
+|+|||++...... .......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999865411 112234578899999988764 46899999999999999999999998887
Q ss_pred hHHHHHHHhccCCCC---------------------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 219 MAGLINKINRSSISP---------------------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 219 ~~el~~~i~~~~~~~---------------------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..+.+..+......+ .....+..+.+||.+||..+|.+|||++++|.||||+.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 666555443211000 01234778999999999999999999999999999975
Q ss_pred h
Q 006460 272 Y 272 (644)
Q Consensus 272 ~ 272 (644)
.
T Consensus 319 ~ 319 (335)
T PTZ00024 319 D 319 (335)
T ss_pred C
Confidence 4
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=329.23 Aligned_cols=252 Identities=31% Similarity=0.519 Sum_probs=210.7
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceEEEEEe
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
|++.+.||+|+||.||+|....+++.|++|.+........ .....+|+..++++. ||||+++++++.+ +...|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEe
Confidence 7899999999999999999999999999999865433221 234567999999998 9999999999877 567999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS 173 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~ 173 (644)
|+ +++|.+++....+..+++..+..++.||+.+|.|||++|++|+||+|.||+++.++.++|+|||++...........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 99 88999998875545689999999999999999999999999999999999999999999999999987665444555
Q ss_pred ccCCCCCCChhhhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC--------------------
Q 006460 174 VVGTPNYMCPELLA-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-------------------- 232 (644)
Q Consensus 174 ~~GT~~Y~APEvl~-~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~-------------------- 232 (644)
..++..|+|||++. ...++.++|+||||+++|+|++|.+||......+....+......
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 67899999999875 445789999999999999999999999877655544433211000
Q ss_pred ---------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 233 ---------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 233 ---------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
......+..+.+||.+||..+|.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0011225789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.31 Aligned_cols=260 Identities=31% Similarity=0.528 Sum_probs=212.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCe----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK----KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
.+..|+++++||+|+||.||+|..+.++. .||+|+++-.+....+-....||+.+++.|+|||||.+..+|...+.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 45689999999999999999997665543 68999998776555556678899999999999999999999998788
Q ss_pred eEEEEEeccCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC----CCeEEecc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKAR---GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD----NDIRLGDF 159 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~---~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~----g~vKL~DF 159 (644)
+++|++||.+. +|+.+|+-.+ ...++...++.|++||+.|+.|||++=|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999965 8999987432 3468999999999999999999999999999999999999988 89999999
Q ss_pred Cccccccccc----ccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCh---------HHHHHH
Q 006460 160 GLAKLLNTED----LASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDM---------AGLINK 225 (644)
Q Consensus 160 Gls~~~~~~~----~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~---------~el~~~ 225 (644)
|+++.+...- .....+-|.||+|||++.+. .|+.+.|||++|||+.||++-.|.|.+... .+++.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999875431 23346779999999988764 599999999999999999999999976432 123333
Q ss_pred HhccCCCC----------CC--------------------------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 226 INRSSISP----------LP--------------------------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 226 i~~~~~~~----------~p--------------------------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
|......| +| ..-++...+|+.+||++||.+|+|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 32211000 01 0114457899999999999999999999999999
Q ss_pred ch
Q 006460 270 QP 271 (644)
Q Consensus 270 ~~ 271 (644)
..
T Consensus 341 ~~ 342 (438)
T KOG0666|consen 341 TE 342 (438)
T ss_pred cc
Confidence 63
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.90 Aligned_cols=254 Identities=22% Similarity=0.374 Sum_probs=215.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecC-------CeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIE-------RKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWV 82 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~t-------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~ 82 (644)
.-.+|++.+.||+|+||.||+|.+... +..||+|.+... ........+.+|+++++++ +||||+++++++.
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 345799999999999999999987542 236899987643 2334456788999999999 7999999999887
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL 148 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL 148 (644)
. +..+|++|||+.+++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 89 Q-DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred c-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 6 456899999999999999997632 1246778899999999999999999999999999999999
Q ss_pred cCCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 006460 149 TKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLIN 224 (644)
Q Consensus 149 ~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~ 224 (644)
+.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999986543221 122334567999999998899999999999999999998 899999988888888
Q ss_pred HHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 225 KINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 225 ~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+......+.+..++..+.+|+.+||..+|.+|||+.+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 887776666777889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=361.70 Aligned_cols=251 Identities=27% Similarity=0.492 Sum_probs=215.7
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCC
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEG 97 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~G 97 (644)
.-+||+|+||+||.|++..+....|||-+.... ..+.+-+..|+.+-++|.|.|||+++|.+-+ +.++-|.||-++|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPG 656 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCC
Confidence 347999999999999999999999999886543 3345678889999999999999999998655 5689999999999
Q ss_pred CCHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-CCCeEEeccCcccccc-ccccccc
Q 006460 98 GDMAEIIKKARGACF--PEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-DNDIRLGDFGLAKLLN-TEDLASS 173 (644)
Q Consensus 98 gsL~~~L~~~~~~~l--~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-~g~vKL~DFGls~~~~-~~~~~~~ 173 (644)
|+|.++++..-+ ++ .|..+-.|.+|||+||+|||++.|||||||-+||||+. .|.+||.|||-++.+. -.....+
T Consensus 657 GSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 999999987543 46 78899999999999999999999999999999999984 5889999999998653 3345778
Q ss_pred ccCCCCCCChhhhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 174 VVGTPNYMCPELLADI--PYGYKSDIWSLGCCMFEIAAHQPAFRAPD--MAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 174 ~~GT~~Y~APEvl~~~--~ys~ksDIWSLGvILyeLltG~~PF~~~~--~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
+.||..|||||++... +|+.++|||||||++.||+||+|||-... ...+++--....-+++|..++.+++.||.+|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999754 58999999999999999999999996433 2223332233445778999999999999999
Q ss_pred hccCCCCCCCHHHHhhCCCCchh
Q 006460 250 LRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
...+|..||++.++|..||++.-
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999864
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=373.05 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=208.6
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+++|++.++||+|+||.||+|.+..+++.||+|+++... ......+++.+|++++++++|||||++++++.+ +...|+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyL 79 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYY 79 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEE
Confidence 589999999999999999999999999999999997543 234456788999999999999999999998776 567999
Q ss_pred EEeccCCCCHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 91 VTGYCEGGDMAEIIKKAR---------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~---------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
||||++|++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999999987421 12355677889999999999999999999999999999999999999999999
Q ss_pred ccccccc-------------------cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 006460 162 AKLLNTE-------------------DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL 222 (644)
Q Consensus 162 s~~~~~~-------------------~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el 222 (644)
+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9865211 011235799999999999999999999999999999999999999987654443
Q ss_pred HHHHhccCCCC--CCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 223 INKINRSSISP--LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 223 ~~~i~~~~~~~--~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
........... ....++..+.+++.+||..||.+|++..+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32211111111 123578899999999999999999887665543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=368.58 Aligned_cols=247 Identities=28% Similarity=0.518 Sum_probs=208.4
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeee-EEEeC-----Cc
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKD-AWVDK-----GN 86 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~-~~~d~-----~~ 86 (644)
+++|.+.|-+|||+.||+|.+...+..||+|++... ++...+.+.+||.+|++|. |||||.|++ ..... .-
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 678899999999999999999999899999998765 5666788999999999995 999999999 43321 13
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR--VLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g--IIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
.++|+||||.||.|-+++.......|+|.++.+|++|+++|+.+||..+ |||||||-|||||+.+|+.||||||.++.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 5789999999999999998776677999999999999999999999996 99999999999999999999999999975
Q ss_pred ccccc-c---------cccccCCCCCCChhhh---cCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC
Q 006460 165 LNTED-L---------ASSVVGTPNYMCPELL---ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI 231 (644)
Q Consensus 165 ~~~~~-~---------~~~~~GT~~Y~APEvl---~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~ 231 (644)
....- . --...-|+.|+|||++ .+.+.+.|+|||+|||+||.|+....||....... |..+.+
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Ilng~Y 271 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILNGNY 271 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEeccc
Confidence 32111 0 0123568999999976 57788999999999999999999999998775432 333333
Q ss_pred C-CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 232 S-PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 232 ~-~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
. |....++..+++||+.||+.||.+||++.|++.+
T Consensus 272 ~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 272 SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 2 2224689999999999999999999999998864
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=320.27 Aligned_cols=243 Identities=23% Similarity=0.392 Sum_probs=208.4
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGG 98 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~Gg 98 (644)
++||.|+||.||+|.+.. ++.|++|.+...... .....+.+|++++++++||||+++++++.+ ....|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCC
Confidence 469999999999999888 999999998765443 445678899999999999999999998776 45689999999999
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc---cccc
Q 006460 99 DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA---SSVV 175 (644)
Q Consensus 99 sL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~---~~~~ 175 (644)
+|.+++... ...+++..+..++.|++.||.|||++|++||||+|+|||++.++.++|+|||++......... ....
T Consensus 78 ~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 78 SLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999999764 335889999999999999999999999999999999999999999999999999865422111 1223
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNP 254 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP 254 (644)
++..|+|||++.+..++.++|||||||++|+|++ |..||...........+......+.+..++..+.+|+.+||..+|
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 4567999999988889999999999999999998 899998887777666666554455667789999999999999999
Q ss_pred CCCCCHHHHhh
Q 006460 255 EHRPTASDLLR 265 (644)
Q Consensus 255 ~~RpTa~eiL~ 265 (644)
.+|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.70 Aligned_cols=253 Identities=27% Similarity=0.536 Sum_probs=213.6
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+-|...++||+|+||.||+|.+..++..|++|++..... .......+.+|+.+++.++|||++++++++.+ ....|+|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 99 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLV 99 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEE
Confidence 347778899999999999999999999999999875432 33344678889999999999999999999877 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++..... .
T Consensus 100 ~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~ 174 (313)
T cd06633 100 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---A 174 (313)
T ss_pred EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---C
Confidence 99995 5788877653 34689999999999999999999999999999999999999999999999999865322 3
Q ss_pred ccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC-CccccHHHHHHHH
Q 006460 172 SSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL-PIVYSSTMKQIIK 247 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~-p~~~s~~l~dLI~ 247 (644)
....|+..|+|||++. ...++.++|||||||++|+|++|.+||...+.......+.....+.. ...++..+.+|+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 4567899999999874 35578899999999999999999999988776665555544433322 3356788999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCch
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||+.+|.+||++.+++.||||..
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 255 YCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred HHccCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999963
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=332.83 Aligned_cols=248 Identities=29% Similarity=0.523 Sum_probs=212.1
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCC
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEG 97 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~G 97 (644)
..+||+|+||.||++.+..++..||+|++.... ......+.+|+.+++.++||||++++++|.. +...|+||||+.+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCC
Confidence 367999999999999999999999999886543 2345678899999999999999999998876 5679999999999
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-ccccccC
Q 006460 98 GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVG 176 (644)
Q Consensus 98 gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~~~~~G 176 (644)
++|.+++.. ..+++..++.++.||+.||.|||++|++||||+|.||+++.++.++|+|||++....... ......|
T Consensus 102 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 102 GALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 999998753 348999999999999999999999999999999999999999999999999987654321 2234568
Q ss_pred CCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--CCccccHHHHHHHHHHhccCC
Q 006460 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSSTMKQIIKSMLRKNP 254 (644)
Q Consensus 177 T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~p~~~s~~l~dLI~~~L~~dP 254 (644)
++.|+|||.+.+..++.++|+||+|+++|+|++|.+||.+.........+....... ....++..+.+++.+||..+|
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 899999999988888999999999999999999999998877666555554332222 223468899999999999999
Q ss_pred CCCCCHHHHhhCCCCch
Q 006460 255 EHRPTASDLLRHPHLQP 271 (644)
Q Consensus 255 ~~RpTa~eiL~hp~f~~ 271 (644)
.+||++.+++.||||..
T Consensus 259 ~~R~~~~~ll~~~~~~~ 275 (292)
T cd06657 259 AQRATAAELLKHPFLAK 275 (292)
T ss_pred ccCcCHHHHhcChHHhc
Confidence 99999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.12 Aligned_cols=258 Identities=27% Similarity=0.490 Sum_probs=213.0
Q ss_pred CeEEEEEeccCCCeEEEEEEEe---cCCeEEEEEEEeccccc--HHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCce
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQT--EKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~~--~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~ 87 (644)
+|++.+.||+|+||.||+|.+. .++..||+|.++..... ......+.+|++++.++ +||||+++++.+.. +..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence 5899999999999999999864 45788999998754322 23345678899999999 69999999998765 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||+++.+..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999999998753 4589999999999999999999999999999999999999999999999999876543
Q ss_pred ccc--cccccCCCCCCChhhhcCCC--CCcccchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhccCCCCCCcccc
Q 006460 168 EDL--ASSVVGTPNYMCPELLADIP--YGYKSDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSISPLPIVYS 239 (644)
Q Consensus 168 ~~~--~~~~~GT~~Y~APEvl~~~~--ys~ksDIWSLGvILyeLltG~~PF~~~~----~~el~~~i~~~~~~~~p~~~s 239 (644)
... .....|++.|+|||.+.+.. ++.++||||||+++|+|++|..||.... ..++...+.. ...+.+..++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKTMS 236 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCCCcccC
Confidence 321 22356899999999987654 6889999999999999999999996432 2233333333 3345677789
Q ss_pred HHHHHHHHHHhccCCCCCCC---HHHHhhCCCCchhhhh
Q 006460 240 STMKQIIKSMLRKNPEHRPT---ASDLLRHPHLQPYLLR 275 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpT---a~eiL~hp~f~~~~~~ 275 (644)
..+.+||.+||+.+|++||| +.++|+||||+...+.
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 99999999999999999998 5678999999876553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=318.07 Aligned_cols=244 Identities=21% Similarity=0.371 Sum_probs=207.7
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGG 98 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~Gg 98 (644)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+++++.++||||+++++++.. ....++||||+.++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCC
Confidence 36899999999999854 67899999886543 34445578899999999999999999998876 45689999999999
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc--ccccC
Q 006460 99 DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA--SSVVG 176 (644)
Q Consensus 99 sL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~--~~~~G 176 (644)
+|.+++... ...+++..+..++.||+.+|.|||++|++||||||+||+++.++.+||+|||++......... ....+
T Consensus 78 ~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 999998754 345889999999999999999999999999999999999999999999999998764332211 12344
Q ss_pred CCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 177 T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
++.|+|||++.+..++.++||||||+++|+|++ |..||...........+........+..++..+.+|+.+||..+|+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 567999999988889999999999999999998 9999988887777777766655556677899999999999999999
Q ss_pred CCCCHHHHhhC
Q 006460 256 HRPTASDLLRH 266 (644)
Q Consensus 256 ~RpTa~eiL~h 266 (644)
+||++.++++.
T Consensus 237 ~Rp~~~~l~~~ 247 (250)
T cd05085 237 NRPKFSELQKE 247 (250)
T ss_pred cCCCHHHHHHH
Confidence 99999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=331.80 Aligned_cols=252 Identities=27% Similarity=0.529 Sum_probs=214.5
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
..|...+.||+|+||.||+|.+..++..+|+|.+.... ........+.+|++++++++|||++++++++.+ +...|+|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEE
Confidence 45889999999999999999999999999999987542 233445678899999999999999999998876 5568999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||+|.||+++.++.++|+|||++..... .
T Consensus 104 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~ 178 (317)
T cd06635 104 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---A 178 (317)
T ss_pred EeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---c
Confidence 99996 4787777643 34689999999999999999999999999999999999999999999999999875433 2
Q ss_pred ccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-CCccccHHHHHHHH
Q 006460 172 SSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-LPIVYSSTMKQIIK 247 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~-~p~~~s~~l~dLI~ 247 (644)
....|++.|+|||++. ...++.++|||||||++|+|++|.+||...........+....... .+..++..+.+|+.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 3467899999999874 3468899999999999999999999998777666666655444332 33457889999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCc
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
+||..+|.+||++.++++|+|+.
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhh
Confidence 99999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.69 Aligned_cols=251 Identities=25% Similarity=0.445 Sum_probs=204.1
Q ss_pred CCeEEEEEeccCCCeEEEEEEE----ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-Cce
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLH----KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNC 87 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~----k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~ 87 (644)
++|++.+.||+|+||.||+|.. ..++..||+|.+.... ....+.+.+|+++|+.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5899999999999999999974 4578899999986543 33456788999999999999999999987643 356
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 89999999999999999754 33589999999999999999999999999999999999999999999999999987543
Q ss_pred ccc----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH----------------HHHHHHh
Q 006460 168 EDL----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA----------------GLINKIN 227 (644)
Q Consensus 168 ~~~----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~----------------el~~~i~ 227 (644)
... .....++..|+|||++.+..++.++|||||||++|+|++|..|+...... .+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 221 11223345699999998888999999999999999999987765433211 1112222
Q ss_pred ccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 228 RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 228 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.....+.+..++..+.+|+.+||..+|.+|||+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 333334556678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.89 Aligned_cols=252 Identities=22% Similarity=0.419 Sum_probs=206.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEec----------------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcc
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKI----------------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIV 75 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~----------------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIV 75 (644)
.++|++.++||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4689999999999999999986543 34568999886543 334456788999999999999999
Q ss_pred eeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcE
Q 006460 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARG---------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNI 146 (644)
Q Consensus 76 kl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~---------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNI 146 (644)
++++++.. +..+|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 83 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 83 RLLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99998876 4568999999999999999976421 2367788999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh--CCCCCCCCChHH
Q 006460 147 FLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAG 221 (644)
Q Consensus 147 LL~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt--G~~PF~~~~~~e 221 (644)
|++.++.++|+|||++..+..... .....+++.|++||+..+..++.++|||||||++|+|++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543221 222344678999998888889999999999999999998 778997766555
Q ss_pred HHHHHh-------ccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 222 LINKIN-------RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 222 l~~~i~-------~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
...... .....+.+..++..+.+|+.+||..||.+||++.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 443321 11223345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.98 Aligned_cols=254 Identities=29% Similarity=0.520 Sum_probs=212.8
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-----C---CCcceeeeEEEe-
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-----N---PYIVKYKDAWVD- 83 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----H---PNIVkl~~~~~d- 83 (644)
++|.++++||||.|++||+|++..+.+.||+|+.+ ..+.+.+..+.||++|+++. | .+||+++++|.-
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK---SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK---SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe---hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 79999999999999999999999999999999886 44678899999999999982 3 479999999975
Q ss_pred --CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEE------------
Q 006460 84 --KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFL------------ 148 (644)
Q Consensus 84 --~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL------------ 148 (644)
++.++|||+|++ |.+|..+|++.....+|...++.|++|||.||.|||.. ||||.||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 457999999999 99999999998888999999999999999999999987 99999999999999
Q ss_pred --------------------------------------------------------------------------------
Q 006460 149 -------------------------------------------------------------------------------- 148 (644)
Q Consensus 149 -------------------------------------------------------------------------------- 148 (644)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred ----------------------cC----------------------------------------------------CCCe
Q 006460 149 ----------------------TK----------------------------------------------------DNDI 154 (644)
Q Consensus 149 ----------------------~~----------------------------------------------------~g~v 154 (644)
.+ +-+|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 00 0137
Q ss_pred EEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-------------hHH
Q 006460 155 RLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-------------MAG 221 (644)
Q Consensus 155 KL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-------------~~e 221 (644)
||+|||.|++... .++..+.|..|+|||++.+.+|+..+||||++|++|||+||...|.... +.+
T Consensus 394 KIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E 471 (590)
T KOG1290|consen 394 KIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME 471 (590)
T ss_pred EEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence 9999999998543 4567789999999999999999999999999999999999999985322 112
Q ss_pred HHHHH------------------------hccCCCCCC----------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCC
Q 006460 222 LINKI------------------------NRSSISPLP----------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267 (644)
Q Consensus 222 l~~~i------------------------~~~~~~~~p----------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp 267 (644)
++..+ .+..++++. ..-..++.+||.-||+++|++||||.++|+||
T Consensus 472 LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP 551 (590)
T KOG1290|consen 472 LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP 551 (590)
T ss_pred HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence 22221 111111111 11245788999999999999999999999999
Q ss_pred CCchh
Q 006460 268 HLQPY 272 (644)
Q Consensus 268 ~f~~~ 272 (644)
|+++.
T Consensus 552 wLn~~ 556 (590)
T KOG1290|consen 552 WLNPV 556 (590)
T ss_pred cccCC
Confidence 99754
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.28 Aligned_cols=252 Identities=34% Similarity=0.650 Sum_probs=216.0
Q ss_pred CeEEEEEeccCCCeEEEEEEEec-CCeEEEEEEEeccc--------ccHHHHHHHHHHHHHHHh-cCCCCcceeeeEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKI-ERKKYVLKKIRLAK--------QTEKFKRTALQEMDLISK-LNNPYIVKYKDAWVD 83 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~-tg~~vAiK~i~~~~--------~~~~~~~~~~rEi~iL~~-L~HPNIVkl~~~~~d 83 (644)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58899999999999999999988 68899999886432 223345667889998875 799999999998876
Q ss_pred CCceEEEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccC
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFG 160 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFG 160 (644)
+...|+||||+.|++|.+++... ....+++..++.++.|++.||.|||. .|++||||+|.|||++.++.++|+|||
T Consensus 81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence 56799999999999999988542 34568999999999999999999996 789999999999999999999999999
Q ss_pred cccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCc-ccc
Q 006460 161 LAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI-VYS 239 (644)
Q Consensus 161 ls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~-~~s 239 (644)
++.............|+..|+|||.+.+..++.++||||||+++|+|++|.+||...........+......+.+. .++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred ceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 9987655444456678999999999998889999999999999999999999998888777777766655554444 678
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+.+||.+||..||++||++.++..+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.68 Aligned_cols=253 Identities=21% Similarity=0.359 Sum_probs=207.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecC--------------CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcce
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIE--------------RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVK 76 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~t--------------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVk 76 (644)
...+|++.+.||+|+||.||+|.+..+ ...||+|.++... .......+.+|++++++++||||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 346999999999999999999987543 2358999987543 3344567889999999999999999
Q ss_pred eeeEEEeCCceEEEEEeccCCCCHHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcE
Q 006460 77 YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARG----------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNI 146 (644)
Q Consensus 77 l~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~----------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNI 146 (644)
+++++.. ....|+||||+.+++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 82 LLGVCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 9998865 5679999999999999999865321 1367889999999999999999999999999999999
Q ss_pred EEcCCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh--CCCCCCCCChHH
Q 006460 147 FLTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAG 221 (644)
Q Consensus 147 LL~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt--G~~PF~~~~~~e 221 (644)
|++.++.+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976543221 223345678999999988889999999999999999987 678998776665
Q ss_pred HHHHHhc-------cCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 222 LINKINR-------SSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 222 l~~~i~~-------~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
....+.. ......+..++..+.+|+.+||..+|.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5544321 1122345567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=321.85 Aligned_cols=252 Identities=20% Similarity=0.356 Sum_probs=212.4
Q ss_pred eEEEEEeccCCCeEEEEEEEec---CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----c
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKI---ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG-----N 86 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~---tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~-----~ 86 (644)
|++.+.||+|+||.||+|.... ++..+|+|.+..........+.+.+|+++++.++||||+++++++.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 7788999999999999998654 5789999999776555555677889999999999999999999876432 2
Q ss_pred eEEEEEeccCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKAR----GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~----~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
..+++++|+.+|+|..++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999999999998875432 124789999999999999999999999999999999999999999999999999
Q ss_pred cccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccc
Q 006460 163 KLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVY 238 (644)
Q Consensus 163 ~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~ 238 (644)
+....... .....+++.|++||.+.+..++.++|||||||++|+|++ |.+||...+..+....+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 86543221 223345678999999988889999999999999999998 99999888877777777665554555667
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+..+.+++.+||..+|..|||+.+++..
T Consensus 241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=329.98 Aligned_cols=254 Identities=26% Similarity=0.515 Sum_probs=214.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
...|...+.||+|+||.||+|.++.++..+|+|.+.... ........+.+|+++++.++|||++++++++.. ....|+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeEE
Confidence 345888999999999999999999999999999987532 233345678889999999999999999998876 467899
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+. ++|.+++... ...+++..++.++.||+.||.|||++|++||||+|.|||++.++.++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 999995 6888877643 34589999999999999999999999999999999999999999999999999876543
Q ss_pred cccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-CCccccHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-LPIVYSSTMKQII 246 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~-~p~~~s~~l~dLI 246 (644)
.....+++.|+|||++. ...++.++|||||||++|+|++|..||...........+.....+. .+..++..+.+||
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 23457889999999874 3457889999999999999999999998766555555554444333 2446788999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCch
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+||..+|.+||++.+++.|||+..
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCccccc
Confidence 9999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=328.81 Aligned_cols=252 Identities=19% Similarity=0.363 Sum_probs=213.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCe----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK----KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
..++|++.+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~ 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLS--P 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--C
Confidence 45789999999999999999999987776 46888876443 23334568899999999999999999998765 3
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
..+++++|+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 467999999999999998754 3358999999999999999999999999999999999999999999999999998654
Q ss_pred cccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 167 TEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 167 ~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
.... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+......+.+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 3221 122345678999999998889999999999999999997 999998877776666666655555666788999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+++.+||..+|.+||++.+++..
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=321.78 Aligned_cols=245 Identities=24% Similarity=0.403 Sum_probs=206.8
Q ss_pred EEeccCCCeEEEEEEEecCC------eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 19 EQIGRGAFGAAFLVLHKIER------KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
+.||+|+||.||+|.++... ..+|+|.+..... ......+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEE
Confidence 36899999999999886544 7899998865432 2335678889999999999999999998876 45689999
Q ss_pred eccCCCCHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-----CeEEeccCcc
Q 006460 93 GYCEGGDMAEIIKKAR-----GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-----DIRLGDFGLA 162 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~-----~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-----~vKL~DFGls 162 (644)
||+.|++|.+++.... ...+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999997542 23478899999999999999999999999999999999999877 8999999999
Q ss_pred cccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccc
Q 006460 163 KLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVY 238 (644)
Q Consensus 163 ~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~ 238 (644)
........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+........+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence 76543221 123355788999999998889999999999999999998 99999887777777776665555667778
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+..+.+||.+||..+|.+||++.++++
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=363.03 Aligned_cols=150 Identities=32% Similarity=0.592 Sum_probs=135.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
.+++|+++++||+|+||.||+|.+..+++.||+|+++... ........+.+|+.+++.++||||+++++++.. ...+|
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~ 80 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVY 80 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEE
Confidence 3689999999999999999999999999999999997643 334455778899999999999999999988765 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
|||||+.|++|.+++... ..+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999763 358999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=320.69 Aligned_cols=253 Identities=21% Similarity=0.412 Sum_probs=212.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecC-----CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIE-----RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~t-----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
.++|++++.||.|+||.||+|+.+.+ .+.+++|.+.... .......+.+|+++|++++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CC
Confidence 36899999999999999999997643 4678999876543 23356678899999999999999999998765 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEecc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARG-------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDF 159 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~-------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DF 159 (644)
..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 78999999999999999976441 15899999999999999999999999999999999999999999999999
Q ss_pred Cccccccccc--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCC-CCCC
Q 006460 160 GLAKLLNTED--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSI-SPLP 235 (644)
Q Consensus 160 Gls~~~~~~~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~-~~~p 235 (644)
|++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+..... .+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 9987543221 1233456778999999988888999999999999999998 8899987776666666654332 3345
Q ss_pred ccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 236 ~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..++..+.+++.+||..+|.+|||+.+++..
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 5688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=385.19 Aligned_cols=257 Identities=29% Similarity=0.489 Sum_probs=227.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..-+|+...+||.|.||.||-|.+..+|.-.|+|-++...........+.+|+++|..|+|||+|++|++=.. ...++|
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHHHHH
Confidence 3447788889999999999999999999999999998876655556677889999999999999999998655 455899
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
.||||+||+|.+++.. ++..+|...+.|..|++.|+.|||++|||||||||+||+|+.+|-+|++|||.|..+...-
T Consensus 1312 FMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 9999999999999975 4457888889999999999999999999999999999999999999999999998765431
Q ss_pred ----ccccccCCCCCCChhhhcCC---CCCcccchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHhccCCCCCCccccHH
Q 006460 170 ----LASSVVGTPNYMCPELLADI---PYGYKSDIWSLGCCMFEIAAHQPAFRAP-DMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 170 ----~~~~~~GT~~Y~APEvl~~~---~ys~ksDIWSLGvILyeLltG~~PF~~~-~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
-.....||+.|||||++.+. +...+.||||||||+.||+||+.||... ....++..+..+..+++|..++.+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 23457899999999999764 4578999999999999999999999654 466788889999999999999999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
.++||.+||..||++|.++.|||+|.|-+
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 99999999999999999999999998764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=324.07 Aligned_cols=259 Identities=26% Similarity=0.472 Sum_probs=220.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~ 88 (644)
..+++.+++..||.|+.|.||+++++.+|...|||.++.....++ .+++++.+.++.+. +.|+||+.+++|... ..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-~kRILmDldvv~~s~dcpyIV~c~GyFi~n-~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGYFITN-TDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-HHHHHHhhhHHhhccCCCeeeeeeeEEeeC-chH
Confidence 456778888999999999999999999999999999988766555 46677777777665 489999999999874 458
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|.||.+ +..+..++++. .+++||.-+-.+...++.||.||-. +||||||+||.|||++..|++||||||++-.+-.
T Consensus 167 ~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 8999998 55777777764 4569999999999999999999975 5999999999999999999999999999988777
Q ss_pred ccccccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhccCCCCCCc--cccHH
Q 006460 168 EDLASSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINRSSISPLPI--VYSST 241 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i~~~~~~~~p~--~~s~~ 241 (644)
....+...|.+.|||||.+. ...|+.++||||||+.|+||+||..||.+.+ ..+.+.++.....+.+|. .+|+.
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~ 324 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPD 324 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHH
Confidence 67777788999999999885 3468999999999999999999999998854 345566665544343443 37999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+.+|+..||++|+.+||-+.++|+|||+..|
T Consensus 325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 9999999999999999999999999998754
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.23 Aligned_cols=244 Identities=25% Similarity=0.415 Sum_probs=195.2
Q ss_pred EEeccCCCeEEEEEEEec--CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKI--ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~--tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.+++.++||||+++++.+.. ...+|+||||+.
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCC
Confidence 368999999999996543 34578888775433 34445678899999999999999999998876 456999999999
Q ss_pred CCCHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc---
Q 006460 97 GGDMAEIIKKARG---ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--- 170 (644)
Q Consensus 97 GgsL~~~L~~~~~---~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~--- 170 (644)
+|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999999976432 2346788899999999999999999999999999999999999999999999875433221
Q ss_pred cccccCCCCCCChhhhcC-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCC-----CCCCcc
Q 006460 171 ASSVVGTPNYMCPELLAD-------IPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSI-----SPLPIV 237 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~-------~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~-----~~~p~~ 237 (644)
.....+++.|+|||++.. ..++.++|||||||++|+|++ |.+||......+.+..+..... +..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 122345678999998743 356889999999999999998 8889987766655555433322 223446
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
++..+.+++..|| .||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7889999999999 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=316.45 Aligned_cols=236 Identities=19% Similarity=0.317 Sum_probs=195.0
Q ss_pred EEeccCCCeEEEEEEEecCC----------eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 19 EQIGRGAFGAAFLVLHKIER----------KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg----------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+|++++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR--DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec--CCc
Confidence 46899999999999998777 35777776544321 5678899999999999999999998876 457
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-------CeEEeccCc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-------DIRLGDFGL 161 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-------~vKL~DFGl 161 (644)
++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 89999999999999998643 2689999999999999999999999999999999999999887 799999999
Q ss_pred ccccccccccccccCCCCCCChhhhcCC--CCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccc
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLADI--PYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVY 238 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~~~--~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~ 238 (644)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||................. .+...
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~ 229 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--LPMPD 229 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC--CCCCC
Confidence 986543 2235577789999999876 78999999999999999998 6888877654444333332222 22333
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
...+.+|+.+||..+|.+|||+.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 488999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=343.03 Aligned_cols=255 Identities=23% Similarity=0.373 Sum_probs=211.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d 83 (644)
...++|.+.++||+|+||.||+|.+. .++..||+|++...... .....+.+|+++|.++. |||||+++++|..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 45578999999999999999999864 34578999999765333 33456889999999997 9999999999876
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcC------------------------------------------------------
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARG------------------------------------------------------ 109 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~------------------------------------------------------ 109 (644)
. ..+|+|||||.+|+|.+++.....
T Consensus 113 ~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 113 G-GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred C-CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 4 569999999999999999975321
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEE
Q 006460 110 ------------------------------------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIF 147 (644)
Q Consensus 110 ------------------------------------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNIL 147 (644)
..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 23677788999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHH-
Q 006460 148 LTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGL- 222 (644)
Q Consensus 148 L~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el- 222 (644)
++.++.+||+|||+++.+.... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999998653221 1223467888999999988889999999999999999998 8999977655444
Q ss_pred HHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 223 INKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 223 ~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
...+......+.|..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 34444444455667789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.48 Aligned_cols=252 Identities=23% Similarity=0.438 Sum_probs=208.6
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEec----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-Cc
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKI----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GN 86 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~ 86 (644)
-.+|++.+.||+|+||.||+|.+.. ++..+|+|.+...... .....+.+|+++++.+.||||+++++++... +.
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 3578999999999999999998653 4789999999765443 4456789999999999999999999987652 35
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
..++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||.||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 6899999999999999997643 358999999999999999999999999999999999999999999999999998765
Q ss_pred cccc----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh---------------HHHHHHHh
Q 006460 167 TEDL----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM---------------AGLINKIN 227 (644)
Q Consensus 167 ~~~~----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~---------------~el~~~i~ 227 (644)
.... .....++..|++||.+.+..++.++|||||||++|+|++|..||..... ......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 3221 1123445679999999888899999999999999999999999865332 12223333
Q ss_pred ccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 228 RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 228 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.....+.+..++.++.+|+.+||..+|.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 33334445667889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=346.72 Aligned_cols=253 Identities=23% Similarity=0.443 Sum_probs=219.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCe---E-EEEEEEecc-cccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK---K-YVLKKIRLA-KQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~---~-vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
..++-.+.++||+|+||.||+|..+..+. . ||+|..+.. .........+++|+++|++++|||||++||+....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~- 233 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE- 233 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-
Confidence 34566677999999999999998876532 3 899988753 35556678899999999999999999999998874
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
.-+|||||+|.||+|.++|++.++ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++.-
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 459999999999999999998654 5899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccc-cCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH-hccCCCCCCccccHHH
Q 006460 166 NTEDLASSV-VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKI-NRSSISPLPIVYSSTM 242 (644)
Q Consensus 166 ~~~~~~~~~-~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i-~~~~~~~~p~~~s~~l 242 (644)
......... .-...|+|||.+....|+.++|||||||++||+.+ |..||.+....++..+| ......+.|...+.++
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence 433322222 24568999999999899999999999999999987 88899999999999999 5566777888889999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
..++.+||..+|++|||+.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999875
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=320.74 Aligned_cols=239 Identities=19% Similarity=0.342 Sum_probs=196.5
Q ss_pred EEeccCCCeEEEEEEEecCCe-------EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 19 EQIGRGAFGAAFLVLHKIERK-------KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~-------~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+.||.|+||.||+|.++..+. .+++|.+.... ....+.+.+|+.+++.++|||||++++++.. +...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEE
Confidence 368999999999999876544 38888775432 3345678889999999999999999999876 4568999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC--------eEEeccCccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND--------IRLGDFGLAK 163 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~--------vKL~DFGls~ 163 (644)
|||+.+|+|..++... +..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999999754 336899999999999999999999999999999999999987764 6999999987
Q ss_pred ccccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG-~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
..... ....+++.|+|||++.+ ..++.++|||||||++|+|++| .+||.............. ...+|...+.+
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 231 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--RHQLPAPKWTE 231 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--cccCCCCCcHH
Confidence 65432 33568889999999976 4579999999999999999998 577776665544433322 23456666789
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+.+|+.+||+.+|++|||++++++.
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=330.54 Aligned_cols=259 Identities=30% Similarity=0.519 Sum_probs=220.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC------
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK------ 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~------ 84 (644)
..+.|+.+.+||+|.||.||+|+++.++++||+|++......+.+-...++|+++|..|.|+|++.++++|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 45678889999999999999999999999999999888777777778899999999999999999999987532
Q ss_pred -CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 85 -GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 85 -~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
...+|+||.+|+ .+|.-++.. ....|+..++..++.+++.||.|+|+..|+|||+||+|+||+.+|.+||+|||+++
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 135899999995 488888864 34569999999999999999999999999999999999999999999999999998
Q ss_pred ccccc-----cccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC-------
Q 006460 164 LLNTE-----DLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS------- 230 (644)
Q Consensus 164 ~~~~~-----~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~------- 230 (644)
.+... ..++..+-|.+|++||.+.+ ..|+++.|||..||||.+|++|.+.|++......+..|....
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 76433 23556778999999997765 569999999999999999999999999998877766653221
Q ss_pred --------------CCCCCcc-------------ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 231 --------------ISPLPIV-------------YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 231 --------------~~~~p~~-------------~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..|+|.. -.+++.+|+.++|..||.+|++++++|+|.||.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 1112211 1357889999999999999999999999999963
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.88 Aligned_cols=244 Identities=22% Similarity=0.369 Sum_probs=194.8
Q ss_pred EEeccCCCeEEEEEEEe--cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.||+|+||.||+|... .++..+|+|.++..... .....+.+|+.++++++||||+++++++.+ ...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCC
Confidence 36899999999999764 35678999988765432 334568889999999999999999998766 456899999999
Q ss_pred CCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc---
Q 006460 97 GGDMAEIIKKAR---GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--- 170 (644)
Q Consensus 97 GgsL~~~L~~~~---~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~--- 170 (644)
+|+|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999997543 22456778889999999999999999999999999999999999999999999976433221
Q ss_pred cccccCCCCCCChhhhcCC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCC-----CCCCcc
Q 006460 171 ASSVVGTPNYMCPELLADI-------PYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSI-----SPLPIV 237 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~-------~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~-----~~~p~~ 237 (644)
.....+++.|+|||++.+. .++.++|||||||++|+|++ |.+||......+.......... +.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 1234578889999988642 35789999999999999996 9999987665554443322211 122234
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.+..+.+++.+|+ .+|.+|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999999 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=348.76 Aligned_cols=250 Identities=24% Similarity=0.456 Sum_probs=217.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++..+...||+|.||+||+|.+.. .||||++..........+.|.+|+..|++-+|-||+=+.|++... . +.
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-~-~A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-P-LA 463 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-c-ee
Confidence 455678889999999999999998864 799999999888888889999999999999999999999988653 3 48
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc---c
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL---N 166 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~---~ 166 (644)
||+.+|+|.+|+.+|.... ..|.-...+.|++||++|+.|||.++|||||||..||+|..++.|||+||||+..- .
T Consensus 464 IiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 9999999999999998643 46888999999999999999999999999999999999999999999999999742 2
Q ss_pred cccccccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC----CCcccc
Q 006460 167 TEDLASSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----LPIVYS 239 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----~p~~~s 239 (644)
.........|...|||||++. ..+|++.+||||||||+|||++|..||.....+.++-.+.++...+ ....++
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence 223345566788899999885 4579999999999999999999999999777777777777774433 224468
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+++++|+..||.+++++||++.+||.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 89999999999999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=315.06 Aligned_cols=229 Identities=25% Similarity=0.375 Sum_probs=192.6
Q ss_pred CCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCCHHHH
Q 006460 24 GAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEI 103 (644)
Q Consensus 24 G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~ 103 (644)
|.||.||+|+++.+++.||+|.++.... ..+|...+....||||+++++++.. ...+|+||||+.|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976431 2234455556679999999998876 5679999999999999999
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccccccCCCCCCCh
Q 006460 104 IKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCP 183 (644)
Q Consensus 104 L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~AP 183 (644)
+.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+...... .....++..|+||
T Consensus 76 l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aP 151 (237)
T cd05576 76 ISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAP 151 (237)
T ss_pred HHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCC
Confidence 87643 4899999999999999999999999999999999999999999999999988665432 2345667889999
Q ss_pred hhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCH---
Q 006460 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTA--- 260 (644)
Q Consensus 184 Evl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa--- 260 (644)
|.+.+..++.++|+||+||++|+|++|..||...... +........|..++..+.+||.+||..||.+||++
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 9998888999999999999999999999987643321 11111223566789999999999999999999985
Q ss_pred --HHHhhCCCC
Q 006460 261 --SDLLRHPHL 269 (644)
Q Consensus 261 --~eiL~hp~f 269 (644)
+++++||||
T Consensus 227 ~~~~~~~h~~~ 237 (237)
T cd05576 227 GVEDIKSHPFF 237 (237)
T ss_pred chHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.01 Aligned_cols=239 Identities=18% Similarity=0.295 Sum_probs=192.9
Q ss_pred EEeccCCCeEEEEEEEecC------------CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 19 EQIGRGAFGAAFLVLHKIE------------RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~t------------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
+.||+|+||.||+|..... ...+++|.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRD-V 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3689999999999975422 3358888775532 33455788899999999999999999998764 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC-------eEEecc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND-------IRLGDF 159 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~-------vKL~DF 159 (644)
..++||||+.+++|..++... ...+++..++.++.||+.||.|||++||+||||||.|||++.++. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 688999999999999988753 346899999999999999999999999999999999999987664 899999
Q ss_pred CcccccccccccccccCCCCCCChhhhc-CCCCCcccchhhHHHHHHHHH-hCCCCCCCCChHHHHHHHhccCCCCCCcc
Q 006460 160 GLAKLLNTEDLASSVVGTPNYMCPELLA-DIPYGYKSDIWSLGCCMFEIA-AHQPAFRAPDMAGLINKINRSSISPLPIV 237 (644)
Q Consensus 160 Gls~~~~~~~~~~~~~GT~~Y~APEvl~-~~~ys~ksDIWSLGvILyeLl-tG~~PF~~~~~~el~~~i~~~~~~~~p~~ 237 (644)
|++..... .....++..|+|||++. +..++.++|||||||++|+|+ +|.+||......+...... ... .....
T Consensus 157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~-~~~~~ 231 (262)
T cd05077 157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-GQC-MLVTP 231 (262)
T ss_pred CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh-cCc-cCCCC
Confidence 99875432 23356788999999886 466899999999999999998 5899988766554433222 221 12233
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+.++.+||.+||..||.+||++.+|+++
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 46789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=319.61 Aligned_cols=249 Identities=19% Similarity=0.259 Sum_probs=193.9
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecC---CeEEEEEEEecccccHHH---------HHHHHHHHHHHHhcCCCCcceeee
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIE---RKKYVLKKIRLAKQTEKF---------KRTALQEMDLISKLNNPYIVKYKD 79 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~t---g~~vAiK~i~~~~~~~~~---------~~~~~rEi~iL~~L~HPNIVkl~~ 79 (644)
-++|++.+.||+|+||.||+|.+..+ +..+|+|+.......... ......++..++.+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999998887 677788765433221100 112233445566779999999998
Q ss_pred EEEeCC---ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEE
Q 006460 80 AWVDKG---NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRL 156 (644)
Q Consensus 80 ~~~d~~---~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL 156 (644)
++.... .+.+++++++ +.++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 765433 2457888988 55787777653 23678899999999999999999999999999999999999999999
Q ss_pred eccCccccccccc--------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh-H-------
Q 006460 157 GDFGLAKLLNTED--------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-A------- 220 (644)
Q Consensus 157 ~DFGls~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~-~------- 220 (644)
+|||+++.+.... ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+... .
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 9999998653211 12335799999999999999999999999999999999999999987632 2
Q ss_pred -HHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 221 -GLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 221 -el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+....+..... .+..+++.+.++++.||..+|++||++.++++
T Consensus 248 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 CDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 12233332221 23346889999999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=356.92 Aligned_cols=253 Identities=22% Similarity=0.410 Sum_probs=224.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecC-----CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIE-----RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~t-----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
....+-++.+.||+|+||.||+|....- ...||||.++... ..+...+|.||+.+|..|+|||||+++|+|.+
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~- 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCRE- 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-
Confidence 4566778899999999999999976533 3568999886554 44467889999999999999999999999987
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc--------CC----CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR--------GA----CFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN 152 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~--------~~----~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g 152 (644)
++-+|||+||+..|+|.++|+... +. .++..+...|+.||+.|+.||-++.+|||||...|+||..+.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 566999999999999999998542 12 288899999999999999999999999999999999999999
Q ss_pred CeEEeccCccccccccccccc---ccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhc
Q 006460 153 DIRLGDFGLAKLLNTEDLASS---VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINR 228 (644)
Q Consensus 153 ~vKL~DFGls~~~~~~~~~~~---~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~ 228 (644)
.|||+|||+++.+...+.+.. ..-...|||||.+...+|+.++||||+||+|||+.+ |+.||.+....+.++.|..
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 999999999998766554432 234567999999999999999999999999999996 9999999999999999999
Q ss_pred cCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHh
Q 006460 229 SSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264 (644)
Q Consensus 229 ~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL 264 (644)
+..-+.|..+|.++..|+..||+.+|.+||++.+|-
T Consensus 721 g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 721 GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999999999999999999999999999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.35 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=214.8
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCC
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKG 85 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~ 85 (644)
.+..+.++|.+...+|.|+|+.|-.+.+..+++.+++|++...... ..+|+.++... +||||++++++|.+ +
T Consensus 316 ~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~-~ 388 (612)
T KOG0603|consen 316 VTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYED-G 388 (612)
T ss_pred ccCCcchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecC-C
Confidence 3456789999999999999999999999999999999999876222 22366555544 79999999999866 6
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE-cCCCCeEEeccCcccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL-TKDNDIRLGDFGLAKL 164 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL-~~~g~vKL~DFGls~~ 164 (644)
...|+|||++.|+.|.+.+...+ ....++..|+++|+.++.|||++|||||||||+|||+ +..++++|+|||.++.
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 77999999999999988887543 2337888899999999999999999999999999999 5889999999999988
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHhccCCCCCCccccHHHH
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA-GLINKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~-el~~~i~~~~~~~~p~~~s~~l~ 243 (644)
.... ..+.+-|..|.|||++...+|+.++||||||++||+||+|+.||...... ++..++....+ ...+|..++
T Consensus 466 ~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~---s~~vS~~AK 540 (612)
T KOG0603|consen 466 LERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF---SECVSDEAK 540 (612)
T ss_pred Cchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc---ccccCHHHH
Confidence 6654 55678899999999999999999999999999999999999999876655 66666655543 377899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
+||++||+.||.+|+++.+++.||||
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999999
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=317.91 Aligned_cols=238 Identities=19% Similarity=0.297 Sum_probs=192.6
Q ss_pred EeccCCCeEEEEEEEecC------------------------CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcc
Q 006460 20 QIGRGAFGAAFLVLHKIE------------------------RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIV 75 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~k~t------------------------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIV 75 (644)
.||+|+||.||+|....+ ...+++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999975432 2357888875432 23346688899999999999999
Q ss_pred eeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC---
Q 006460 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN--- 152 (644)
Q Consensus 76 kl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g--- 152 (644)
++++++.+ +...|+||||+++++|..++... ...+++..+..++.||+.||.|||++||+||||||.|||++..+
T Consensus 80 ~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVR-GSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEe-CCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999876 45689999999999999998753 34689999999999999999999999999999999999998654
Q ss_pred ----CeEEeccCcccccccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHH-hCCCCCCCCChHHHHHHH
Q 006460 153 ----DIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIA-AHQPAFRAPDMAGLINKI 226 (644)
Q Consensus 153 ----~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLl-tG~~PF~~~~~~el~~~i 226 (644)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|.+||......+.....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 3899999998653221 23467888999998865 56899999999999999985 799999877665544433
Q ss_pred hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 227 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.... ..+...+..+.+||.+||..+|.+|||+.++|++
T Consensus 235 ~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred Hhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 3222 2344456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.52 Aligned_cols=285 Identities=26% Similarity=0.490 Sum_probs=235.0
Q ss_pred CCCCCCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhc-CCCCcceeee
Q 006460 2 ETENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKL-NNPYIVKYKD 79 (644)
Q Consensus 2 ~~~~~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L-~HPNIVkl~~ 79 (644)
+..--...--+++|.+++.||+|+|+.|.+++++.|.+.||+|++++.-.++ +...-...|-.+..+- +||.+|-++.
T Consensus 239 ~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 239 DGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred cccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence 3333344456789999999999999999999999999999999998764332 2233344455555554 7999999999
Q ss_pred EEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEecc
Q 006460 80 AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDF 159 (644)
Q Consensus 80 ~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DF 159 (644)
+|+.+ ..+++|.||++||+|.-.+++.+ .+||+.++.|...|..||+|||++|||+||||..|||++..|++||.|+
T Consensus 319 cfqte-srlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 319 CFQTE-SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred hhccc-ceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeeccc
Confidence 87764 55999999999999998888644 5999999999999999999999999999999999999999999999999
Q ss_pred Ccccc-cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-------ChHHHHHHHhccCC
Q 006460 160 GLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-------DMAGLINKINRSSI 231 (644)
Q Consensus 160 Gls~~-~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~-------~~~el~~~i~~~~~ 231 (644)
|+.+. +.+++...++||||.|+|||++.+..|++++|+|+||++|+||+.|+.||..- +.++.+-.+.-...
T Consensus 396 gmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred chhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 99985 56778889999999999999999999999999999999999999999999532 23344434433344
Q ss_pred CCCCccccHHHHHHHHHHhccCCCCCC------CHHHHhhCCCCchhhhhcCCCCCcccCCCcc
Q 006460 232 SPLPIVYSSTMKQIIKSMLRKNPEHRP------TASDLLRHPHLQPYLLRCQNPSSVYLPIKPT 289 (644)
Q Consensus 232 ~~~p~~~s~~l~dLI~~~L~~dP~~Rp------Ta~eiL~hp~f~~~~~~~~~~~~~~~p~~p~ 289 (644)
..+|..+|-.+..+++..|.+||.+|. .+.++..|+||...-|..........|..|.
T Consensus 476 iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~ 539 (593)
T KOG0695|consen 476 IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQ 539 (593)
T ss_pred ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCc
Confidence 457888899999999999999999994 4789999999987777655555555555443
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.96 Aligned_cols=260 Identities=26% Similarity=0.390 Sum_probs=210.4
Q ss_pred CCCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe-
Q 006460 5 NGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD- 83 (644)
Q Consensus 5 ~~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d- 83 (644)
++.....=++|+|.+.||+|||+-||+|.+..+++.||+|++.-.. .+..+..++|++.-++++|||+++++++...
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 3445566689999999999999999999999999999999997655 3446778999999999999999999998653
Q ss_pred ---CCceEEEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCcEEEcCCCCeEE
Q 006460 84 ---KGNCVCIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNR--VLHRDLKCSNIFLTKDNDIRL 156 (644)
Q Consensus 84 ---~~~~~~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~g--IIHRDLKPeNILL~~~g~vKL 156 (644)
.....||+++|+..|+|.+.+... ++..++|.++.+|+.+|++||++||+.. +.||||||.|||+++.+.++|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 235699999999999999998754 3557999999999999999999999998 999999999999999999999
Q ss_pred eccCcccccccc-----c-----ccccccCCCCCCChhhhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCCChH--H
Q 006460 157 GDFGLAKLLNTE-----D-----LASSVVGTPNYMCPELLAD---IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA--G 221 (644)
Q Consensus 157 ~DFGls~~~~~~-----~-----~~~~~~GT~~Y~APEvl~~---~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~--e 221 (644)
.|||.++...-. + -......|..|+|||++.- ...+.++|||||||+||.|+.|..||...-.. .
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 999999764211 0 1123467889999999864 34689999999999999999999999531110 0
Q ss_pred HHHHHhccCC-CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 222 LINKINRSSI-SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 222 l~~~i~~~~~-~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+.-.+..... .|-...+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0000111111 12223489999999999999999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=366.60 Aligned_cols=254 Identities=33% Similarity=0.626 Sum_probs=207.8
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-------
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK------- 84 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~------- 84 (644)
+.+|+.+..||+||||.||+|+++-+|+.||||+|.... .......+.+|+++|.+|+|||||+|+..|.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 468889999999999999999999999999999998876 566678899999999999999999999887411
Q ss_pred -----------------------------------------------C--------------------------------
Q 006460 85 -----------------------------------------------G-------------------------------- 85 (644)
Q Consensus 85 -----------------------------------------------~-------------------------------- 85 (644)
.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 006460 86 --------------------------------NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133 (644)
Q Consensus 86 --------------------------------~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs 133 (644)
.++||-||||+..+|.+++.+..... ....+|+++++|++||.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 24689999999988888887643211 468899999999999999999
Q ss_pred CCCccccCCCCcEEEcCCCCeEEeccCcccccc-------------------cccccccccCCCCCCChhhhcCCC---C
Q 006460 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-------------------TEDLASSVVGTPNYMCPELLADIP---Y 191 (644)
Q Consensus 134 ~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-------------------~~~~~~~~~GT~~Y~APEvl~~~~---y 191 (644)
+|||||||||.||+++.++.|||+|||++.... .....+..+||..|+|||++.+.. |
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999998721 001345678999999999997755 9
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHhccCCCCC---CccccHHHHHHHHHHhccCCCCCCCHHHHhhCC
Q 006460 192 GYKSDIWSLGCCMFEIAAHQPAFRAP-DMAGLINKINRSSISPL---PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267 (644)
Q Consensus 192 s~ksDIWSLGvILyeLltG~~PF~~~-~~~el~~~i~~~~~~~~---p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp 267 (644)
+.|+|+|||||||+||+. ||... .....+..+..+.++.. ...--+.-..+|++||..||.+||||.|+|++.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 999999999999999984 46432 23344555554444332 122234456899999999999999999999999
Q ss_pred CCc
Q 006460 268 HLQ 270 (644)
Q Consensus 268 ~f~ 270 (644)
||.
T Consensus 873 llp 875 (1351)
T KOG1035|consen 873 LLP 875 (1351)
T ss_pred CCC
Confidence 885
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.95 Aligned_cols=243 Identities=23% Similarity=0.386 Sum_probs=193.6
Q ss_pred EeccCCCeEEEEEEEecC--CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCC
Q 006460 20 QIGRGAFGAAFLVLHKIE--RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEG 97 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~k~t--g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~G 97 (644)
.||+|+||.||+|..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+ ...+|+||||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCC
Confidence 699999999999975443 24566776654332 3345778999999999999999999998876 4568999999999
Q ss_pred CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc---ccc
Q 006460 98 GDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LAS 172 (644)
Q Consensus 98 gsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~---~~~ 172 (644)
|+|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++....... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 99999997642 2346777888999999999999999999999999999999999999999999986432211 123
Q ss_pred cccCCCCCCChhhhcC-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccC-----CCCCCcccc
Q 006460 173 SVVGTPNYMCPELLAD-------IPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSS-----ISPLPIVYS 239 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~-------~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~-----~~~~p~~~s 239 (644)
..++++.|+|||++.. ..++.++|||||||++|+|++ |.+||......+.+..+.... .+.++..++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 4578899999998743 245789999999999999996 678998777666555543332 123444578
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
..+.+++..|| .+|++||++.++++
T Consensus 240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 240 ERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 89999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.91 Aligned_cols=257 Identities=29% Similarity=0.457 Sum_probs=215.4
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
-|..++.||-|+||.|++|....|...||+|.+++.+.-. ........|-.||..-+++.||++|..|++++ ++|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-nLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-ceEEEE
Confidence 5788999999999999999999999999999998764322 22344566889999999999999999999854 599999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc------
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN------ 166 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~------ 166 (644)
+|+.||+|..+|-+. +.|+|+.++.|+..+.+|+++.|+.|+|||||||+|||||.+|++||.||||+.-+.
T Consensus 709 dYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred eccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999999999998764 469999999999999999999999999999999999999999999999999996431
Q ss_pred ---cc----------------------------------cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh
Q 006460 167 ---TE----------------------------------DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA 209 (644)
Q Consensus 167 ---~~----------------------------------~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt 209 (644)
.+ ......+||+.|+|||++...+|+..+|+||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 00 01234689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcc---CCCCCCccccHHHHHHHHHHhccCCCCCCC---HHHHhhCCCCchhhh
Q 006460 210 HQPAFRAPDMAGLINKINRS---SISPLPIVYSSTMKQIIKSMLRKNPEHRPT---ASDLLRHPHLQPYLL 274 (644)
Q Consensus 210 G~~PF~~~~~~el~~~i~~~---~~~~~p~~~s~~l~dLI~~~L~~dP~~RpT---a~eiL~hp~f~~~~~ 274 (644)
|++||-...+.+...++... .-.+....++.++.++|.++. .+++.|.. ++++..||||+.+-+
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccch
Confidence 99999877766554444322 112334568999999999876 68888864 678999999987654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=329.99 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=200.9
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.++|.-...||+|+||.||+|.-... ..||||++....... .+.|.+|+.+|.+++|||+|+++|||.+.+...+||
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 45777788999999999999987654 899999887654432 345999999999999999999999998755358999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCCCCcEEEcCCCCeEEeccCccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN---RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT- 167 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~---gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~- 167 (644)
+||+..|+|.++|.......++|....+|+.+++.||.|||.. .||||||||.|||||.+..+||+|||+++....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 9999999999999754332789999999999999999999986 399999999999999999999999999976654
Q ss_pred ccccccc-cCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---hHHHHH----HHhccC-----CCCC
Q 006460 168 EDLASSV-VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD---MAGLIN----KINRSS-----ISPL 234 (644)
Q Consensus 168 ~~~~~~~-~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~---~~el~~----~i~~~~-----~~~~ 234 (644)
.....+. .||.+|++||++.....+.++||||||++|.||++|+.+..... ...+.. .+.... .+.+
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 3333333 89999999999988889999999999999999999998876432 111111 111111 1111
Q ss_pred C-cccc-----HHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 235 P-IVYS-----STMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 235 p-~~~s-----~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
. ..++ ..+..+..+|++.+|..||++.++++
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1 2222 23567888999999999999999764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=329.43 Aligned_cols=254 Identities=26% Similarity=0.481 Sum_probs=211.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--C----CcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN--P----YIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--P----NIVkl~~~~~d~ 84 (644)
...+|.+++.||+|+||.|..+++..++..||+|+++.- .++.+..+-|+++|++|.+ | -+|++.++ ++-
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-Fdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-FDY 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-hhc
Confidence 367999999999999999999999999999999998643 4567778889999999942 3 25666664 465
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC--------------
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-------------- 150 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-------------- 150 (644)
.++.|||+|.+ |.+++++++.+...+||...++.+.+||+.++.|||+.+++|.||||+|||+..
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 67899999999 889999999888888999999999999999999999999999999999999842
Q ss_pred ------CCCeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHH---
Q 006460 151 ------DNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG--- 221 (644)
Q Consensus 151 ------~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~e--- 221 (644)
+..|+|+|||.++.... ...+.+.|..|+|||++.+.+++.++||||+||||+||.+|...|+..+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred eeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 23489999999987544 3477899999999999999999999999999999999999999998877554
Q ss_pred HHHHHhccC-----------------CCCCCcc-------------------------ccHHHHHHHHHHhccCCCCCCC
Q 006460 222 LINKINRSS-----------------ISPLPIV-------------------------YSSTMKQIIKSMLRKNPEHRPT 259 (644)
Q Consensus 222 l~~~i~~~~-----------------~~~~p~~-------------------------~s~~l~dLI~~~L~~dP~~RpT 259 (644)
++++|.... .-.++.. ...++.|||++||.+||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 333332100 0000100 1235789999999999999999
Q ss_pred HHHHhhCCCCch
Q 006460 260 ASDLLRHPHLQP 271 (644)
Q Consensus 260 a~eiL~hp~f~~ 271 (644)
+.|+|.||||..
T Consensus 400 l~EAL~HpFF~~ 411 (415)
T KOG0671|consen 400 LREALSHPFFAR 411 (415)
T ss_pred HHHHhcCHHhhc
Confidence 999999999963
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=343.60 Aligned_cols=263 Identities=29% Similarity=0.557 Sum_probs=229.9
Q ss_pred CCCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 006460 5 NGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD 83 (644)
Q Consensus 5 ~~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d 83 (644)
-..+...-+-|+|...||.|.+|.||+++++.+++..|+|++......+ +.+.-|..||+.+ .|||++.+|++|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445567788999999999999999999999999999999997765443 3345588999877 69999999999874
Q ss_pred C----CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEecc
Q 006460 84 K----GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDF 159 (644)
Q Consensus 84 ~----~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DF 159 (644)
. +..+|||||||.||+..++++...+..+.|+.+.+|++.++.||.+||++.+||||||-.|||++.++.|||+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 3 468999999999999999999888889999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc-cccccccCCCCCCChhhhcCC-----CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC
Q 006460 160 GLAKLLNTE-DLASSVVGTPNYMCPELLADI-----PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP 233 (644)
Q Consensus 160 Gls~~~~~~-~~~~~~~GT~~Y~APEvl~~~-----~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~ 233 (644)
|++..+... ....+.+|||.|||||++... .|+..+|+||||++-.||.-|.||+-..-+...+-.|.+.+.+.
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 999876443 346788999999999998643 47889999999999999999999998777666666665554443
Q ss_pred C--CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 234 L--PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 234 ~--p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
+ |..|++++.+||..||.+|-.+||+..++|+|||+.
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 3 567899999999999999999999999999999996
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=307.83 Aligned_cols=255 Identities=27% Similarity=0.498 Sum_probs=214.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeC-CceE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDK-GNCV 88 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~-~~~~ 88 (644)
..++|++.+++|+|-|+.||.|.+..++++++||+++.-+ .+.+.||++||+.|. |||||+++++..+. +...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 5689999999999999999999999999999999997654 567889999999995 99999999998764 3567
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-CCeEEeccCccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLAKLLNT 167 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-g~vKL~DFGls~~~~~ 167 (644)
.+|+||+++.+...+... ++.-.++.++++||.||.|||+.||+|||+||.|++|+.. ..++|+|+|+|.++.+
T Consensus 111 aLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 899999999888776643 7888999999999999999999999999999999999965 5699999999999988
Q ss_pred ccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCC-CCCChHHHHHHHhc-----------------
Q 006460 168 EDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAF-RAPDMAGLINKINR----------------- 228 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF-~~~~~~el~~~i~~----------------- 228 (644)
+.-++-.+.+.+|--||++.+. .|+++.|+|||||+|..|+..+.|| .+.+..+++-+|.+
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 8878888999999999988764 5899999999999999999988776 44443333222210
Q ss_pred -----------cCCCC--------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhh
Q 006460 229 -----------SSISP--------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 229 -----------~~~~~--------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~ 275 (644)
....+ .....++++.||+.++|.+|..+|+|+.|++.||||.+....
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 00000 011246899999999999999999999999999999876543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=352.79 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=220.8
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCe-----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERK-----KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~-----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
...-.+.+.||+|+||.||.|....... .||+|.+.... .......|++|..+|++++|||||+++|++.+ ..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CC
Confidence 4567889999999999999998775533 38888886543 34557889999999999999999999999998 45
Q ss_pred eEEEEEeccCCCCHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKAR-----GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~-----~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
..+|++||+.||+|..+|++.+ ...++-.++..++.||+.|++||+++++|||||...|+||+....+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 5889999999999999999762 34578899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccc---cCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCcc
Q 006460 162 AKLLNTEDLASSV---VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIV 237 (644)
Q Consensus 162 s~~~~~~~~~~~~---~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~ 237 (644)
|+.+...+.+... .-...|||||.+.+..++.|+|||||||+|||+++ |..||...+..+++.....+.+-+.|..
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 9965444333221 22357999999999999999999999999999998 9999999999999997777778888999
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
++..+.++|..||+.+|++||++..|++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=293.87 Aligned_cols=241 Identities=37% Similarity=0.667 Sum_probs=209.9
Q ss_pred CCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCCHHHHH
Q 006460 25 AFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEII 104 (644)
Q Consensus 25 ~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L 104 (644)
+||.||+|.+..++..+|+|++........ .+.+.+|++.+++++|+||+++++.+.. ....++++||+.+++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999976544322 5678899999999999999999998776 46799999999999999999
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccccccCCCCCCChh
Q 006460 105 KKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE 184 (644)
Q Consensus 105 ~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APE 184 (644)
.... .++...++.++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||.+.............++..|++||
T Consensus 79 ~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 79 KKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred Hhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 7643 38899999999999999999999999999999999999999999999999998876654556678899999999
Q ss_pred hhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHhccCCCCCCcc--ccHHHHHHHHHHhccCCCCCCCHH
Q 006460 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRA-PDMAGLINKINRSSISPLPIV--YSSTMKQIIKSMLRKNPEHRPTAS 261 (644)
Q Consensus 185 vl~~~~ys~ksDIWSLGvILyeLltG~~PF~~-~~~~el~~~i~~~~~~~~p~~--~s~~l~dLI~~~L~~dP~~RpTa~ 261 (644)
.+.+..++.++||||||+++|+|++|..||.. .........+........+.. ++.++.+++.+||..+|.+||++.
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 236 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE 236 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence 99888889999999999999999999999987 555556665555444433332 789999999999999999999999
Q ss_pred HHhhCCCC
Q 006460 262 DLLRHPHL 269 (644)
Q Consensus 262 eiL~hp~f 269 (644)
++++||||
T Consensus 237 ~~~~~~~~ 244 (244)
T smart00220 237 EALQHPFF 244 (244)
T ss_pred HHhhCCCC
Confidence 99999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.56 Aligned_cols=270 Identities=27% Similarity=0.463 Sum_probs=223.7
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-----cHHHHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-----TEKFKRTALQEMDLISKLNNPYIVKYKDAWV 82 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-----~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~ 82 (644)
-+..-++|-++..||+|||+.||+|++....+.||+|+-...+. .+.+.+...||.+|-+.|+||.||++|++|.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 34566789999999999999999999999999999998765532 2345677899999999999999999999998
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccccCCCCcEEEcC---CCCeEEe
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN--RVLHRDLKCSNIFLTK---DNDIRLG 157 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~--gIIHRDLKPeNILL~~---~g~vKL~ 157 (644)
-....+|-|+|||+|.+|.-||+..+ .++|.+++.|+.||+.||.||.+. .|||-||||.||||-. -|.+||.
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 76778999999999999999998754 589999999999999999999987 7999999999999963 3679999
Q ss_pred ccCccccccccc--------ccccccCCCCCCChhhhc-C---CCCCcccchhhHHHHHHHHHhCCCCCCCCChH-HHHH
Q 006460 158 DFGLAKLLNTED--------LASSVVGTPNYMCPELLA-D---IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA-GLIN 224 (644)
Q Consensus 158 DFGls~~~~~~~--------~~~~~~GT~~Y~APEvl~-~---~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~-el~~ 224 (644)
||||+..+.... +.....||.||++||.+. + ...+.++||||+|||+|.++.|+.||...... ++++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 999999875432 345578999999999764 2 23588999999999999999999999765432 3332
Q ss_pred H--Hhc---cCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhhcCCCC
Q 006460 225 K--INR---SSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPS 280 (644)
Q Consensus 225 ~--i~~---~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~~~~~~ 280 (644)
. |.. ..+++ ...++.++++||++||++--+.|..+.++..||||.+...+.....
T Consensus 696 eNTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~g 755 (775)
T KOG1151|consen 696 ENTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTG 755 (775)
T ss_pred hhchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccC
Confidence 2 221 12333 3457999999999999999999999999999999988665544433
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.57 Aligned_cols=247 Identities=30% Similarity=0.474 Sum_probs=199.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----C
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-----G 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-----~ 85 (644)
.-.-|..-+.||+|+||.||+++++.+|+.||||.++.... ..-.++..+|+++|++|+|||||++.++=.+. .
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 33567788899999999999999999999999999876432 22356678899999999999999999863221 2
Q ss_pred ceEEEEEeccCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC--CCC--eEEeccC
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKAR-GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK--DND--IRLGDFG 160 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~-~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~--~g~--vKL~DFG 160 (644)
...++|||||.||+|..++.+.. ..+++|.++..++..+..||.|||++||+||||||.||++-. +|+ .||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 34679999999999999997532 235999999999999999999999999999999999998863 343 7999999
Q ss_pred cccccccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChH----HHHHHHhcc------
Q 006460 161 LAKLLNTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA----GLINKINRS------ 229 (644)
Q Consensus 161 ls~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~----el~~~i~~~------ 229 (644)
+|+.+..+....+.+||+.|++||++.. ..|+..+|.|||||++|+++||..||...... ++...+...
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9999998888999999999999999984 78999999999999999999999999543322 222222111
Q ss_pred --------------CCCCCCccccH----HHHHHHHHHhccCCCCCC
Q 006460 230 --------------SISPLPIVYSS----TMKQIIKSMLRKNPEHRP 258 (644)
Q Consensus 230 --------------~~~~~p~~~s~----~l~dLI~~~L~~dP~~Rp 258 (644)
..-|.|..++. .+-.++..+|..+|.+|.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11122333333 355788889999999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=326.97 Aligned_cols=244 Identities=23% Similarity=0.432 Sum_probs=217.0
Q ss_pred EEEeccCCCeEEEEEEEecC----CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 18 IEQIGRGAFGAAFLVLHKIE----RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~t----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
.++||.|.||.||.|..... .-.||||..+.....+ ..+.|++|.-+|++++|||||+++|++.+ .-.|||||
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~~e--~P~WivmE 470 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWIVME 470 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeeeec--cceeEEEe
Confidence 45799999999999976543 3458999887654333 37889999999999999999999999875 45899999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS 173 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~ 173 (644)
++..|.|..|++..+ ..++...+..|++||..+|.|||+.++|||||...|||+.....|||+|||+++.+.....+..
T Consensus 471 L~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka 549 (974)
T KOG4257|consen 471 LAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA 549 (974)
T ss_pred cccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc
Confidence 999999999999754 4689999999999999999999999999999999999999999999999999999887766655
Q ss_pred ccCC--CCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHh
Q 006460 174 VVGT--PNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 174 ~~GT--~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L 250 (644)
..|. .-|||||-++-..++.++|||-|||+|||++. |..||.+-...+.+..|..+...|.|..+|+.+..|+.+||
T Consensus 550 S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcW 629 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCW 629 (974)
T ss_pred cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHh
Confidence 5553 45999999998899999999999999999874 99999998888889999999999999999999999999999
Q ss_pred ccCCCCCCCHHHHhh
Q 006460 251 RKNPEHRPTASDLLR 265 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~ 265 (644)
.++|.+||.+.+|..
T Consensus 630 ayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 630 AYEPSKRPRFTEIKA 644 (974)
T ss_pred ccCcccCCcHHHHHH
Confidence 999999999988753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=335.37 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=180.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecC----CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEE--
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIE----RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWV-- 82 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~t----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~-- 82 (644)
....++|++.+.||+|+||.||+|.+..+ +..||+|++......+. ...+ .++...+.+++.++..|.
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHHH--HHHhhchhhHHHHHHhhhcc
Confidence 45678999999999999999999999999 99999998764332211 1111 112222333333322221
Q ss_pred ---eCCceEEEEEeccCCCCHHHHHHHhcCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 006460 83 ---DKGNCVCIVTGYCEGGDMAEIIKKARGA------------------CFPEEKLCKWLTQLLLAVDYLHSNRVLHRDL 141 (644)
Q Consensus 83 ---d~~~~~~LVmEy~~GgsL~~~L~~~~~~------------------~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDL 141 (644)
..+..+++|+||+.+++|.+++...... ...+..+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2346799999999999999998753210 1123456789999999999999999999999
Q ss_pred CCCcEEEcC-CCCeEEeccCcccccccc--cccccccCCCCCCChhhhcCC----------------------CCCcccc
Q 006460 142 KCSNIFLTK-DNDIRLGDFGLAKLLNTE--DLASSVVGTPNYMCPELLADI----------------------PYGYKSD 196 (644)
Q Consensus 142 KPeNILL~~-~g~vKL~DFGls~~~~~~--~~~~~~~GT~~Y~APEvl~~~----------------------~ys~ksD 196 (644)
||+|||++. ++.+||+|||+++.+... ......++++.|+|||++... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 578999999999865332 234567899999999976432 2345679
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC----------CCC----------CccccHHHHHHHHHHhccCCCC
Q 006460 197 IWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI----------SPL----------PIVYSSTMKQIIKSMLRKNPEH 256 (644)
Q Consensus 197 IWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~----------~~~----------p~~~s~~l~dLI~~~L~~dP~~ 256 (644)
||||||+||||+++..++... ...+...+..... ... .........+||.+||++||.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999976664321 1111111111110 000 0111234568999999999999
Q ss_pred CCCHHHHhhCCCCch
Q 006460 257 RPTASDLLRHPHLQP 271 (644)
Q Consensus 257 RpTa~eiL~hp~f~~ 271 (644)
|||+.++|+||||+.
T Consensus 441 R~ta~e~L~Hpff~~ 455 (566)
T PLN03225 441 RISAKAALAHPYFDR 455 (566)
T ss_pred CCCHHHHhCCcCcCC
Confidence 999999999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.62 Aligned_cols=261 Identities=30% Similarity=0.479 Sum_probs=214.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~ 89 (644)
..++.+-+..||.|+||+|++-.|+.+|+..|||+|+.... ++..++++.|.....+- +.||||++|+..+.++. .|
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-cW 139 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-CW 139 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-ee
Confidence 34455667789999999999999999999999999987655 45567788887766554 68999999999888665 89
Q ss_pred EEEeccCCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 90 IVTGYCEGGDMAEIIKK---ARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~---~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
|.||++ ..+|..+.+. .....++|.-+-.|....+.||.||-.. .|||||+||+||||+..|.+||||||++..+
T Consensus 140 iCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 140 ICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999999 5577666543 2355799999999999999999999765 9999999999999999999999999999876
Q ss_pred ccccccccccCCCCCCChhhhc--CCCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhccCCCCCC-----cc
Q 006460 166 NTEDLASSVVGTPNYMCPELLA--DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINRSSISPLP-----IV 237 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~--~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i~~~~~~~~p-----~~ 237 (644)
...-..+...|...|||||.+. +.+|+.++||||||++|||++||..||+..+ ..+++..+..+..+.+- ..
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence 6554456678999999999885 4469999999999999999999999997644 34455555544433221 23
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
++..+..||.-||.+|-..||.+.+++.+||..-|..
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 7889999999999999999999999999999876543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.21 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=225.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCC---eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIER---KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
+-.++.++.++||+|.||+|+.|.++..+ ..||||.++...... ....|++|+.+|.+|.|||+|++|++..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~--q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD--Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc--c
Confidence 34456777889999999999999887653 458999998776554 57889999999999999999999999875 4
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
-+.||||++.+|+|.+.|.+.....|....++.|+.||+.||.||..+++|||||...|+||-....|||+||||.+.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 57899999999999999998777789999999999999999999999999999999999999998899999999999887
Q ss_pred ccccccccc----CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 167 TEDLASSVV----GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 167 ~~~~~~~~~----GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
.++-+..+. -...|+|||.+....++.++|||++||++|||++ |..||.+.....+++.|..+..-+-|..++++
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csed 343 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSED 343 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHH
Confidence 665443332 2346999999999999999999999999999997 89999999999999999988888889999999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHh
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLL 264 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL 264 (644)
+.++++.||..+|..|||+..|.
T Consensus 344 IY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 344 IYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred HHHHHHHhccCCccccccHHHHH
Confidence 99999999999999999999885
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=305.14 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=219.1
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG- 85 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~- 85 (644)
.+-+.-.+|.-++.+|.|.- .|..|.+..++++||+|++........-.++..||+.++..+.|+||++++.+|....
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 44456678999999999998 8899999999999999998776554445678899999999999999999999987532
Q ss_pred ----ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 86 ----NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 86 ----~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
..+|+||||+ ..+|...+.. .+.-..+..+++|++.|++|||+.||+||||||+||++..++.+||.|||+
T Consensus 90 l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 90 LEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchh
Confidence 4689999999 5689988873 377889999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--------
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-------- 233 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~-------- 233 (644)
++.-...-..+..+.|.+|.|||++.+..|...+||||+||++.||++|...|.+.+..++..++......+
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 998766545677899999999999999999999999999999999999999999887665555542211111
Q ss_pred ----------------------CC-----------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 234 ----------------------LP-----------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 234 ----------------------~p-----------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
+| ..-+..+++++.+||..||++|.+++++|+|||++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00 01134688999999999999999999999999998
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=315.59 Aligned_cols=247 Identities=19% Similarity=0.385 Sum_probs=221.5
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
+..+..+||.|.||.||.|.++.-.-.||||.++-.. -..+.|+.|..+|+.+.|||+|+++++|..+ .-+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~E-pPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-PPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccC-CCeEEEEe
Confidence 3455679999999999999999999999999885432 2357789999999999999999999999764 45999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS 173 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~ 173 (644)
|+..|+|.+||+.+....++.-.+.+++.||.+|++||..+++|||||...|.|+..+..||++||||++.+... .++.
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYTA 422 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYTA 422 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC-ceec
Confidence 999999999999988777888888999999999999999999999999999999999999999999999987653 3333
Q ss_pred ccC---CCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 174 VVG---TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 174 ~~G---T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
..| ..-|.|||-+....++.|+|||+|||+|||+.| |-.||.+-+....+..+..+....-|..|++.+.+|+..|
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraC 502 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRAC 502 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHH
Confidence 333 456999999988899999999999999999997 8899999999999999999999999999999999999999
Q ss_pred hccCCCCCCCHHHHhh
Q 006460 250 LRKNPEHRPTASDLLR 265 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~ 265 (644)
|+++|..||++++|-+
T Consensus 503 W~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 503 WNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred hcCCcccCccHHHHHH
Confidence 9999999999998743
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=317.05 Aligned_cols=264 Identities=19% Similarity=0.269 Sum_probs=191.2
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEe----------------cCCeEEEEEEEecccccH--HH----------HHHH
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHK----------------IERKKYVLKKIRLAKQTE--KF----------KRTA 59 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k----------------~tg~~vAiK~i~~~~~~~--~~----------~~~~ 59 (644)
.+...++|++.++||+|+||.||+|... ..++.||||.+....... .+ .+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3456789999999999999999999752 234679999986543211 11 1223
Q ss_pred HHHHHHHHhcCCCCc-----ceeeeEEEeC-------CceEEEEEeccCCCCHHHHHHHhcC------------------
Q 006460 60 LQEMDLISKLNNPYI-----VKYKDAWVDK-------GNCVCIVTGYCEGGDMAEIIKKARG------------------ 109 (644)
Q Consensus 60 ~rEi~iL~~L~HPNI-----Vkl~~~~~d~-------~~~~~LVmEy~~GgsL~~~L~~~~~------------------ 109 (644)
..|+.++.++.|.++ ++++++|... ....|+||||+.+++|.+++....+
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 457777777766554 6777766431 2458999999999999999864211
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccccc--ccCCCCCCCh
Q 006460 110 ----ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS--VVGTPNYMCP 183 (644)
Q Consensus 110 ----~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~--~~GT~~Y~AP 183 (644)
..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........... ..+++.|+||
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1235677889999999999999999999999999999999999999999999976544322222 2348899999
Q ss_pred hhhcCCC--------------------C--CcccchhhHHHHHHHHHhCCC-CCCCCChH-----------HHHHHHhcc
Q 006460 184 ELLADIP--------------------Y--GYKSDIWSLGCCMFEIAAHQP-AFRAPDMA-----------GLINKINRS 229 (644)
Q Consensus 184 Evl~~~~--------------------y--s~ksDIWSLGvILyeLltG~~-PF~~~~~~-----------el~~~i~~~ 229 (644)
|++.... | ..+.||||+||++|+|++|.. ||...... .....+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875322 2 235799999999999999875 76532111 011111111
Q ss_pred CC-CCCCccccHHHHHHHHHHhccCC---CCCCCHHHHhhCCCCch
Q 006460 230 SI-SPLPIVYSSTMKQIIKSMLRKNP---EHRPTASDLLRHPHLQP 271 (644)
Q Consensus 230 ~~-~~~p~~~s~~l~dLI~~~L~~dP---~~RpTa~eiL~hp~f~~ 271 (644)
.. .+.....+...++|+.+||..+| .+|+|+.|+|+||||.+
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 11 11233468899999999999876 68999999999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=326.08 Aligned_cols=251 Identities=23% Similarity=0.423 Sum_probs=225.1
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCC---eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIER---KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..-+|.+.||.|.||.||.|+.+..| ..||||.++.. -.++..+.|+.|+.||-+.+||||+++.++.. +.+-+.
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-ks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-KSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-cCceeE
Confidence 45678899999999999999998877 45899998655 45667889999999999999999999999865 467799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
||+||+++|+|..+|+...+ .|+..++.-+++.|+.|++||-+.|+|||||...|||++.+-.+|++||||++.+..+.
T Consensus 707 IiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999999998765 49999999999999999999999999999999999999999999999999999875433
Q ss_pred --ccccccC--CCCCCChhhhcCCCCCcccchhhHHHHHHHHH-hCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 170 --LASSVVG--TPNYMCPELLADIPYGYKSDIWSLGCCMFEIA-AHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 170 --~~~~~~G--T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLl-tG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
.+++.-| ...|.|||.+...+++.++||||+|++|||.+ .|..||...+..+.++.|..+..-|-|..+|..+.+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q 865 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ 865 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence 2233333 35799999999999999999999999999976 599999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~h 266 (644)
|+..||++|-..||.+.||+.+
T Consensus 866 LMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 866 LMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.45 Aligned_cols=254 Identities=21% Similarity=0.354 Sum_probs=213.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..-+...+.++||+|-||.|.+|.-.. +..||+|+++.... ......|.+|+++|.+|+|||||.++++|.. +..++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQ-DDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeec-CCchH
Confidence 344567789999999999999997543 68999999976544 3446889999999999999999999999987 45699
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+|+||++.|+|.+++.+..-..+.......|+.||++||.||.+.++|||||.+.|+|++.++++||+|||+++.+...+
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999999987643334556677799999999999999999999999999999999999999999999776655
Q ss_pred ccc---cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHH--hCCCCCCCCChHHHHHHHhcc-------CCCCCCcc
Q 006460 170 LAS---SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAGLINKINRS-------SISPLPIV 237 (644)
Q Consensus 170 ~~~---~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLl--tG~~PF~~~~~~el~~~i~~~-------~~~~~p~~ 237 (644)
.+. ..+-...|||||.+...+++.++|+|+||++|||++ |...||.....++..+....- .....|..
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 432 345578899999888889999999999999999974 688999877766665554321 23345777
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
++..+.+++-+||..+-.+||+++++-.|
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 89999999999999999999999998653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=307.48 Aligned_cols=252 Identities=25% Similarity=0.462 Sum_probs=209.8
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC------CCCcceeeeEEEeCCc
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN------NPYIVKYKDAWVDKGN 86 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~------HPNIVkl~~~~~d~~~ 86 (644)
.+|.+....|+|-|+.|..|.+...|..||||+|+... -..+.-++|++||++|+ .-|+++++-+|.. .+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-kn 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-KN 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh-cc
Confidence 48999999999999999999999999999999998653 34566678999999995 3588999998876 57
Q ss_pred eEEEEEeccCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-CCeEEeccCcccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKAR-GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLAKL 164 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~-~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-g~vKL~DFGls~~ 164 (644)
++|||||-+ ..+|.++|++.+ +..|....++.|+.|++-||..|-..||+|.||||.|||++.. ..+||||||.|..
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 899999999 789999999764 3457788999999999999999999999999999999999965 4689999999988
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhc--cCCC----------
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR--SSIS---------- 232 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~--~~~~---------- 232 (644)
...+. .+.+.-+..|.|||++.|.+|++..|+||.||+||||.||+..|.+.....++..... +.++
T Consensus 587 ~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~ 665 (752)
T KOG0670|consen 587 ASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK 665 (752)
T ss_pred ccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence 77654 4455667789999999999999999999999999999999999988764443332110 0000
Q ss_pred ------C--------------------------------------CCcc---ccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 233 ------P--------------------------------------LPIV---YSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 233 ------~--------------------------------------~p~~---~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
. +|.. .-..+.+|+.+||..||.+|.|+.++|.
T Consensus 666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 0000 1135789999999999999999999999
Q ss_pred CCCCc
Q 006460 266 HPHLQ 270 (644)
Q Consensus 266 hp~f~ 270 (644)
||||+
T Consensus 746 HpFi~ 750 (752)
T KOG0670|consen 746 HPFIT 750 (752)
T ss_pred CCccc
Confidence 99996
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=294.12 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=212.1
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----ceEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----NCVC 89 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----~~~~ 89 (644)
+.+--+.||-|+||.||-+.+..+|+.||+|++..-...-...+++.+|+++|...+|.|++..+++.+... ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 445567899999999999999999999999998765544455688999999999999999999999865433 2468
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+|+|++ ..+|..+|.. ...++.+.+.-+++||++||+|||+.||.||||||.|+|++.+..+||||||+++.....+
T Consensus 134 V~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 899998 5688888865 3468999999999999999999999999999999999999999999999999999765433
Q ss_pred --ccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC----------------
Q 006460 170 --LASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS---------------- 230 (644)
Q Consensus 170 --~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~---------------- 230 (644)
.++..+-|-+|+|||++.+. .|+.++||||.|||+.||+..+..|+..++.+.++.|....
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 34556778999999998775 59999999999999999999999999888776666653211
Q ss_pred --------C-CCCCcc--------ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 231 --------I-SPLPIV--------YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 231 --------~-~~~p~~--------~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
. +.++.. -..+..+++..+|.+||++|++..+.+.|+++....
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 1 111111 124677899999999999999999999999986543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=330.93 Aligned_cols=238 Identities=21% Similarity=0.293 Sum_probs=188.6
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
..|...+.||+|+||.||+|.++.++..||+|++...... ..+|++++++++|||||+++++|.+. ...|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~-~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE-KGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC-CCCEEEE
Confidence 4566778999999999999999999999999988654321 12468899999999999999998764 5689999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH---SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLH---s~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
||++||+|.++++. +++..+..++.||+.||.||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 99999999999963 788999999999999999999 6699999999999999988887765 666544322
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhc---------cCC---C
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-----MAGLINKINR---------SSI---S 232 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-----~~el~~~i~~---------~~~---~ 232 (644)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..+..+.... ... .
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 223478999999999999899999999999999999999999985321 1111111100 000 0
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+.+.....++.+++.+||..+|.+|||+.++++.
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 1111223457789999999999999999999875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=310.57 Aligned_cols=251 Identities=27% Similarity=0.453 Sum_probs=215.8
Q ss_pred CCeEEEEEeccCCCeEEEEEEEec-------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeC
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKI-------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDK 84 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~ 84 (644)
++..+.+.||+|.||.|++|.-.. ....||+|..+..... ...+.+..|+.+|+.+. |||||.+++++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 344667799999999999986442 1457899988766554 56788999999999995 9999999999877
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc------C--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR------G--------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK 150 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~------~--------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~ 150 (644)
+..+++|+|||..|+|..+++..+ . ..++...+..+++||+.|++||++.++|||||-..|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 567999999999999999998765 0 13888999999999999999999999999999999999999
Q ss_pred CCCeEEeccCccccccccccccc--ccC--CCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCC-hHHHHH
Q 006460 151 DNDIRLGDFGLAKLLNTEDLASS--VVG--TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPD-MAGLIN 224 (644)
Q Consensus 151 ~g~vKL~DFGls~~~~~~~~~~~--~~G--T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~-~~el~~ 224 (644)
+..+||+|||+++.......+.. ..| ...|||||.+....|+.++||||+|++|||+.+ |..||.+-. ..++.+
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 99999999999996555443321 222 334999999999999999999999999999997 889998755 677788
Q ss_pred HHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 225 KINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 225 ~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.+..+.....|..++.++.+|++.||..+|++||++.++..
T Consensus 534 ~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 88999998999999999999999999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-33 Score=308.69 Aligned_cols=257 Identities=28% Similarity=0.530 Sum_probs=217.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..-++|.++.++|.|+||.||+++++.+++..|+|+++...... ..-+.+|+-+++.++|||||.|++.|... ...+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~-dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRR-DKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhh-cCcE
Confidence 45689999999999999999999999999999999998765332 34566799999999999999999998764 4599
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
+.||||.||+|.++..- .+.++|.++.++++..+.||+|||+.|-+|||||-.|||++..|.+||+|||.+..+...
T Consensus 89 icMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999999998753 567999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccCCCCCCChhhh---cCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC----CCccccHH
Q 006460 169 DLASSVVGTPNYMCPELL---ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----LPIVYSST 241 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl---~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----~p~~~s~~ 241 (644)
.....+.|||+|||||+. ....|...+|||++|+.-.|+.--++|....-++..+..+....+.+ -+..+++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 224568999999999975 35679999999999999999988887754444444444444443332 23458999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+.+|++.+|.++|++|||++.+|.|||+..
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 999999999999999999999999999854
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=263.70 Aligned_cols=222 Identities=28% Similarity=0.496 Sum_probs=186.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~L 90 (644)
-++...+..||+|++|.|-+.+|..+|...|+|.++..... +..++.++|+.+..+. .+|++|.+|+.++..+. ++|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-vwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-VWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-EEE
Confidence 34555677899999999999999999999999999876554 4456778899887765 69999999999888665 999
Q ss_pred EEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 91 VTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
.||.+ ..+|..+.++. .++.+||..+-+|+..++.||.|||++ .+||||+||.||||+.+|++|+||||++-.+..
T Consensus 123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99999 55787766532 467899999999999999999999998 999999999999999999999999999987655
Q ss_pred ccccccccCCCCCCChhhhc----CCCCCcccchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHhccCCCCCCc
Q 006460 168 EDLASSVVGTPNYMCPELLA----DIPYGYKSDIWSLGCCMFEIAAHQPAFRA-PDMAGLINKINRSSISPLPI 236 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~----~~~ys~ksDIWSLGvILyeLltG~~PF~~-~~~~el~~~i~~~~~~~~p~ 236 (644)
.-..+...|.-.|||||.+. ...|+.++||||||+++.||++++.||.. .++.++++.+.....+.+|.
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 43333367888999999874 34799999999999999999999999964 45667778777776665554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=247.79 Aligned_cols=212 Identities=40% Similarity=0.775 Sum_probs=187.2
Q ss_pred eccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCCH
Q 006460 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDM 100 (644)
Q Consensus 21 LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL 100 (644)
||.|++|.||+|....+++.+++|++....... ....+.+|++.++.+.|++|+++++++... ...+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcH
Confidence 699999999999998889999999997665432 346788999999999999999999987764 679999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-CCCeEEeccCccccccccc-ccccccCCC
Q 006460 101 AEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-DNDIRLGDFGLAKLLNTED-LASSVVGTP 178 (644)
Q Consensus 101 ~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-~g~vKL~DFGls~~~~~~~-~~~~~~GT~ 178 (644)
.+++.... ..++...++.++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+....... ......+..
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 99998642 35899999999999999999999999999999999999998 8999999999998754432 134466888
Q ss_pred CCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCC
Q 006460 179 NYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHR 257 (644)
Q Consensus 179 ~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~R 257 (644)
.|++||.+... .++.+.|+|+||+++|+| ..+.+++.+||..+|.+|
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccC
Confidence 99999999877 788999999999999999 678899999999999999
Q ss_pred CCHHHHhhCC
Q 006460 258 PTASDLLRHP 267 (644)
Q Consensus 258 pTa~eiL~hp 267 (644)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=303.50 Aligned_cols=243 Identities=26% Similarity=0.404 Sum_probs=189.5
Q ss_pred EEeccCCCe-EEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFG-AAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG-~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.+|.|+-| .||+|.. .++.||||++-. .....+.||+++|+.- .|||||++++.=. ..+..||..|.|
T Consensus 515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~-d~qF~YIalELC- 585 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQ-DRQFLYIALELC- 585 (903)
T ss_pred HHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeecc-CCceEEEEehHh-
Confidence 357899887 6789865 577999997743 3355678899999987 5999999997633 367899999999
Q ss_pred CCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC---CC--CeEEeccCccccccccc
Q 006460 97 GGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK---DN--DIRLGDFGLAKLLNTED 169 (644)
Q Consensus 97 GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~---~g--~vKL~DFGls~~~~~~~ 169 (644)
..+|.+++... ..........+.++.|++.||.+||+.+||||||||.||||+. ++ .++|+|||+++.+..+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 66999999863 1111122456788999999999999999999999999999986 34 58999999999876543
Q ss_pred ----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHhccCCC--CCCccccHHH
Q 006460 170 ----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSIS--PLPIVYSSTM 242 (644)
Q Consensus 170 ----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG-~~PF~~~~~~el~~~i~~~~~~--~~p~~~s~~l 242 (644)
...+..||.+|+|||++....-+.++||||||||+|+.++| ..||...-..+ ..|..+... .+......++
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchHHH
Confidence 24567899999999999988888899999999999998875 89997543321 222222211 1111112289
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+||.+||.++|..||++.++|.||+|...
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 999999999999999999999999999753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=290.05 Aligned_cols=202 Identities=27% Similarity=0.460 Sum_probs=177.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH-HH-----HHHHHHHHHHHhcC---CCCcceeeeE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK-FK-----RTALQEMDLISKLN---NPYIVKYKDA 80 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~-~~-----~~~~rEi~iL~~L~---HPNIVkl~~~ 80 (644)
.++.+|..++.||.|+||.|++|.|+.+...|++|.|.+.+.-.. +. -.+-.|++||..|+ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 567899999999999999999999999999999999987653221 11 13456999999997 9999999998
Q ss_pred EEeCCceEEEEEec-cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEecc
Q 006460 81 WVDKGNCVCIVTGY-CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDF 159 (644)
Q Consensus 81 ~~d~~~~~~LVmEy-~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DF 159 (644)
|.+ +.++||+||- -+|-+|+++|..++ .++|.++..|++||+.|+++||+.||||||||-+||.++.+|-+||+||
T Consensus 638 FEd-dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 638 FED-DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eec-CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 766 6679999986 56789999998744 5999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 006460 160 GLAKLLNTEDLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFR 215 (644)
Q Consensus 160 Gls~~~~~~~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~ 215 (644)
|.+..... ..+..++||..|.|||++.|.+| +..-|||+||++||-++...-||.
T Consensus 715 gsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987665 45678999999999999999998 788999999999999998888874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=248.58 Aligned_cols=216 Identities=35% Similarity=0.571 Sum_probs=185.3
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEec
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGY 94 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy 94 (644)
|.+.+.||.|++|.||+|.+..++..+++|.+...... .....+.+|++.++++.|+|++++++++.. ....++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEec
Confidence 67899999999999999999988999999999765433 245678889999999999999999998765 4678999999
Q ss_pred cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--ccc
Q 006460 95 CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--LAS 172 (644)
Q Consensus 95 ~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~--~~~ 172 (644)
+.+++|.+++..... .+++..++.++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999999986432 17899999999999999999999999999999999999999999999999998765542 345
Q ss_pred cccCCCCCCChhhh-cCCCCCcccchhhHHHHHHHHHhCCCCCCC--CChHHHHHHHhccCCCC
Q 006460 173 SVVGTPNYMCPELL-ADIPYGYKSDIWSLGCCMFEIAAHQPAFRA--PDMAGLINKINRSSISP 233 (644)
Q Consensus 173 ~~~GT~~Y~APEvl-~~~~ys~ksDIWSLGvILyeLltG~~PF~~--~~~~el~~~i~~~~~~~ 233 (644)
...++..|++||.+ ....++.++|+|+||+++|+|++|++||.. .....+.+.+..+...+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL 221 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence 56788899999998 666788899999999999999999999977 44446666666655433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=291.63 Aligned_cols=247 Identities=21% Similarity=0.364 Sum_probs=214.6
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCe----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERK----KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.+..++||.|+||.||+|.+...|+ +||+|++.... ..+....+++|+-+|.+|+|||++++++++... .+-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHH
Confidence 3456789999999999998876664 57888875543 333356788999999999999999999998753 3789
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
|++|+++|.|.++++..+ ..+-......|.+||++||.|||.++++||||-..|||+..-.++|+.|||+++.+.....
T Consensus 775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999999754 4688889999999999999999999999999999999999999999999999998766543
Q ss_pred cc-cccC--CCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 171 AS-SVVG--TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 171 ~~-~~~G--T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
.. ...| .+-|||=|.+....|+.++||||+||++||++| |..|+.+....++-..+..+.+-+.|..++-++.-++
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 22 2222 345899999999999999999999999999997 9999999999999999988888888999999999999
Q ss_pred HHHhccCCCCCCCHHHHhh
Q 006460 247 KSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~ 265 (644)
.+||-.|+..||++.++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=276.62 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=202.2
Q ss_pred CCCCCCCCCCeEEEEEeccCCCeEEEEEEEec---CCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeE
Q 006460 5 NGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKI---ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDA 80 (644)
Q Consensus 5 ~~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~---tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~ 80 (644)
.++-......|+++.+||.|+|++||++.+.. .++.||+|.+...... .++.+|+++|..+ .+.||+++.++
T Consensus 28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhh
Confidence 34455677889999999999999999998887 7889999999776543 4578899999998 58999999997
Q ss_pred EEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-CCeEEecc
Q 006460 81 WVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDF 159 (644)
Q Consensus 81 ~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-g~vKL~DF 159 (644)
+.. +..+++|+||++.....+++.. ++..+++.|++.++.||.++|.+|||||||||.|+|.+.. +.-.|+||
T Consensus 104 ~rn-nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 104 FRN-NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred hcc-CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEec
Confidence 655 5669999999999999888764 6789999999999999999999999999999999999854 67899999
Q ss_pred Ccccccccc----------------------------------c-----------ccccccCCCCCCChhhhcCC-CCCc
Q 006460 160 GLAKLLNTE----------------------------------D-----------LASSVVGTPNYMCPELLADI-PYGY 193 (644)
Q Consensus 160 Gls~~~~~~----------------------------------~-----------~~~~~~GT~~Y~APEvl~~~-~ys~ 193 (644)
|++...... . ......||++|+|||++..- ..+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 999721000 0 01135799999999988764 4588
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHH----------------hc---------------------c------
Q 006460 194 KSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKI----------------NR---------------------S------ 229 (644)
Q Consensus 194 ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i----------------~~---------------------~------ 229 (644)
++||||.|+|+.-++++..||-... ..+.+..| .+ .
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999999999999983221 10000000 00 0
Q ss_pred -------CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 230 -------SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 230 -------~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
........++..+.+|+.+||..||.+|+|++++|.||||..
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 000011124557899999999999999999999999999974
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=270.78 Aligned_cols=241 Identities=24% Similarity=0.418 Sum_probs=189.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHh--cCCCCcceeeeEEEeCCc---
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK--LNNPYIVKYKDAWVDKGN--- 86 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~--L~HPNIVkl~~~~~d~~~--- 86 (644)
+...++.+.||+|.||.||+|... ++.||||++.... +..+..|-.|.+. +.|+||++++++- ..+.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~e-kr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAE-KRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchh-ccCCccc
Confidence 556778889999999999999754 5899999986542 4567778787775 4799999999863 3333
Q ss_pred -eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCccccCCCCcEEEcCCCCeEE
Q 006460 87 -CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN---------RVLHRDLKCSNIFLTKDNDIRL 156 (644)
Q Consensus 87 -~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~---------gIIHRDLKPeNILL~~~g~vKL 156 (644)
.++||++|.+.|+|.+||+.+ .+++....+++..|++||.|||+- .|+|||||..||||..|+.+.|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 799999999999999999864 489999999999999999999953 5999999999999999999999
Q ss_pred eccCccccccccc---ccccccCCCCCCChhhhcCCC-CC-----cccchhhHHHHHHHHHhCC------------CCCC
Q 006460 157 GDFGLAKLLNTED---LASSVVGTPNYMCPELLADIP-YG-----YKSDIWSLGCCMFEIAAHQ------------PAFR 215 (644)
Q Consensus 157 ~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~-ys-----~ksDIWSLGvILyeLltG~------------~PF~ 215 (644)
+|||+|..+.... .....+||..|||||++.+.- +. .+.||||+|.|||||++.- +||.
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 9999998876442 233479999999999997632 22 4789999999999998753 2332
Q ss_pred -----CCChHHHHHHHhcc-CCCCCCccc-----cHHHHHHHHHHhccCCCCCCCHHHH
Q 006460 216 -----APDMAGLINKINRS-SISPLPIVY-----SSTMKQIIKSMLRKNPEHRPTASDL 263 (644)
Q Consensus 216 -----~~~~~el~~~i~~~-~~~~~p~~~-----s~~l~dLI~~~L~~dP~~RpTa~ei 263 (644)
.+...++...+.+. .++.+|..+ ..-+++.+..||..||+-|.|+.=+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 22333444444333 344445433 4568899999999999999998533
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=263.68 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=193.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHh--cCCCCcceeeeEEEeCC-
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK--LNNPYIVKYKDAWVDKG- 85 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~--L~HPNIVkl~~~~~d~~- 85 (644)
++.-.+-.+++.||+|.||.||+|.++ |+.||||++.-.+. +...||.+|.+. |+|+||+.+++.-....
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE-----RSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch-----hhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 456678999999999999999999886 77999999976542 445667777765 59999999998743221
Q ss_pred --ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccccCCCCcEEEcCCCCeE
Q 006460 86 --NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN--------RVLHRDLKCSNIFLTKDNDIR 155 (644)
Q Consensus 86 --~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~--------gIIHRDLKPeNILL~~~g~vK 155 (644)
..+|||++|.+.|+|+++|.+. .++.+...+++..+++||.+||.. .|.|||||..|||+.++|.+.
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 4789999999999999999863 488999999999999999999943 499999999999999999999
Q ss_pred EeccCccccccccc-----ccccccCCCCCCChhhhcCCC----C--CcccchhhHHHHHHHHHhC----------CCCC
Q 006460 156 LGDFGLAKLLNTED-----LASSVVGTPNYMCPELLADIP----Y--GYKSDIWSLGCCMFEIAAH----------QPAF 214 (644)
Q Consensus 156 L~DFGls~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~----y--s~ksDIWSLGvILyeLltG----------~~PF 214 (644)
|+|+|||-...... ..+..+||-.|||||++...- + -..+||||||.|+||++.. .+||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999997654331 245689999999999996532 1 1468999999999998753 4777
Q ss_pred CC-----CChHHHHHHHh-ccCCCCCCcccc-----HHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 215 RA-----PDMAGLINKIN-RSSISPLPIVYS-----STMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 215 ~~-----~~~~el~~~i~-~~~~~~~p~~~s-----~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.. ++.+++.+-+. +...+..|..+. ..+..+++.||..||.-|.|+-.|.+
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 42 33444444333 233444555543 24668999999999999999877653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=302.26 Aligned_cols=200 Identities=13% Similarity=0.197 Sum_probs=151.1
Q ss_pred cCC-CCcceeeeEEEe------CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 006460 69 LNN-PYIVKYKDAWVD------KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDL 141 (644)
Q Consensus 69 L~H-PNIVkl~~~~~d------~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDL 141 (644)
+.| +||++++++|.. ....++++|||+ +++|.++|... ...+++.++..|++||+.||.|||++||+||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 455 588888887621 124678889988 77999999743 346999999999999999999999999999999
Q ss_pred CCCcEEEcC-------------------CCCeEEeccCcccccccc-----------------cccccccCCCCCCChhh
Q 006460 142 KCSNIFLTK-------------------DNDIRLGDFGLAKLLNTE-----------------DLASSVVGTPNYMCPEL 185 (644)
Q Consensus 142 KPeNILL~~-------------------~g~vKL~DFGls~~~~~~-----------------~~~~~~~GT~~Y~APEv 185 (644)
||+||||+. ++.+||+|||+++..... ......+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 445667777776542110 00112468999999999
Q ss_pred hcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 186 l~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+.+..|+.++|||||||+||||++|.+||.... ..+..+.....++..........+++.+||..+|.+||++.++|+
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 999999999999999999999999999876432 222222222222221122455678999999999999999999999
Q ss_pred CCCCchh
Q 006460 266 HPHLQPY 272 (644)
Q Consensus 266 hp~f~~~ 272 (644)
||||...
T Consensus 265 h~~~~~~ 271 (793)
T PLN00181 265 SEFINEP 271 (793)
T ss_pred chhhhhh
Confidence 9999753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=253.10 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=200.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~ 88 (644)
...+.|.|.+.||+|.||.+.+|.|+.++..+|+|.+...-.. .+.|.+|..---.| .|.||+.-|++-+.....+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 4567899999999999999999999999999999998765432 46788887654455 4899999999877778889
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC--CCCeEEeccCcccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK--DNDIRLGDFGLAKLLN 166 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~--~g~vKL~DFGls~~~~ 166 (644)
++++||++.|+|.+-+.. .++-|.....++.|+++||.|+|++++||||||.+||||-. ..++||||||+.+..+
T Consensus 98 vF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999999987764 34889999999999999999999999999999999999963 3479999999998644
Q ss_pred cccccccccCCCCCCChhhhcCC---C--CCcccchhhHHHHHHHHHhCCCCCCCCChH-----HHHHHHhccCCCCCC-
Q 006460 167 TEDLASSVVGTPNYMCPELLADI---P--YGYKSDIWSLGCCMFEIAAHQPAFRAPDMA-----GLINKINRSSISPLP- 235 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~---~--ys~ksDIWSLGvILyeLltG~~PF~~~~~~-----el~~~i~~~~~~~~p- 235 (644)
. .....-.+..|.+||++... . ..+.+|+|.||+|+|.+++|.+||+..... +..+. .....+..|
T Consensus 175 ~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-~~rk~~~~P~ 251 (378)
T KOG1345|consen 175 T--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-LKRKNPALPK 251 (378)
T ss_pred c--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-hcccCccCch
Confidence 3 22233456679999976432 2 367899999999999999999999743322 22222 222222333
Q ss_pred --ccccHHHHHHHHHHhccCCCCC---CCHHHHhhCCCCchh
Q 006460 236 --IVYSSTMKQIIKSMLRKNPEHR---PTASDLLRHPHLQPY 272 (644)
Q Consensus 236 --~~~s~~l~dLI~~~L~~dP~~R---pTa~eiL~hp~f~~~ 272 (644)
..+++.+..+.++-|..+|+.| -++.......|....
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 4478999999999999999999 566666666676543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-26 Score=229.75 Aligned_cols=252 Identities=34% Similarity=0.579 Sum_probs=208.6
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH-HHHHHHHHHHHHHhcCCC-CcceeeeEEEeCCceEEEEE
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK-FKRTALQEMDLISKLNNP-YIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~-~~~~~~rEi~iL~~L~HP-NIVkl~~~~~d~~~~~~LVm 92 (644)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++++.. ....++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEE
Confidence 889999999999999999988 7899999977655443 577889999999999988 79999999854 44589999
Q ss_pred eccCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-CeEEeccCccccccccc-
Q 006460 93 GYCEGGDMAEIIKKARG-ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~-~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-~vKL~DFGls~~~~~~~- 169 (644)
+|+.+++|.+++..... ..+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++..+....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977765321 2589999999999999999999999999999999999999888 69999999998654432
Q ss_pred ------ccccccCCCCCCChhhhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHhccCCC----
Q 006460 170 ------LASSVVGTPNYMCPELLAD---IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM----AGLINKINRSSIS---- 232 (644)
Q Consensus 170 ------~~~~~~GT~~Y~APEvl~~---~~ys~ksDIWSLGvILyeLltG~~PF~~~~~----~el~~~i~~~~~~---- 232 (644)
......||..|++||.+.+ ..+....|+||+|++++++++|..||..... ......+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 3467889999999999987 5789999999999999999999999887763 4455554444332
Q ss_pred CCCccc----cHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 233 PLPIVY----SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 233 ~~p~~~----s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
...... ...+.+++.+++..+|..|.+......+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 111111 15789999999999999999999988885543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=248.71 Aligned_cols=252 Identities=18% Similarity=0.289 Sum_probs=216.0
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCC-----eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIER-----KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
.+++....+-+|+||.||.|.++... +.+.+|.++.. ..+-....+++|--+|..+.|||+..+.++..+....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 45777788999999999999776543 23455555332 3344456788899899999999999999999987888
Q ss_pred EEEEEeccCCCCHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARG------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
.++++.+..-|+|..++..+++ ..++..++..++.|+..|+.|||++||||.||...|.+|++.-++||+|=.+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 8999999999999999985432 2466778889999999999999999999999999999999999999999999
Q ss_pred ccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCcc
Q 006460 162 AKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIV 237 (644)
Q Consensus 162 s~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~ 237 (644)
++-+.+.+. .........||+||.+.+..|+.++|+||||++||||++ |+.|+-.-++.++...+..+.+-..|.+
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~N 522 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFN 522 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCC
Confidence 997665543 223344567999999999999999999999999999997 9999999999999999999998889999
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+|+++..++.-||...|++||+++|+..
T Consensus 523 CPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=228.60 Aligned_cols=160 Identities=23% Similarity=0.324 Sum_probs=130.8
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccccccCC
Q 006460 98 GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT 177 (644)
Q Consensus 98 gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT 177 (644)
|+|.+++... +..+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 6899999754 446999999999999999999999999 999999999999999 9999875442 23789
Q ss_pred CCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhccCCCC------CCccccH--HHHHHHHH
Q 006460 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-AGLINKINRSSISP------LPIVYSS--TMKQIIKS 248 (644)
Q Consensus 178 ~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~-~el~~~i~~~~~~~------~p~~~s~--~l~dLI~~ 248 (644)
+.|||||++.+..|+.++|||||||++|+|++|.+||..... ...+..+....... .+..++. .+.+||.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 999999999999999999999999999999999999976543 22233332221111 1223344 69999999
Q ss_pred HhccCCCCCCCHHHHhhCCCCc
Q 006460 249 MLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
||..+|.+||++.+++.|+|+.
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=238.63 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=199.0
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCC-eEEEEEEEecccccHHHHHHHHHHHHHHHhcC----CCCcceeeeEEEeCCceE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIER-KKYVLKKIRLAKQTEKFKRTALQEMDLISKLN----NPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg-~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~----HPNIVkl~~~~~d~~~~~ 88 (644)
+|++.++||+|+||.||+|.+..++ ..+|+|.......... ..+..|+.+|..+. .+++..+++.....+.+-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999998875 6788888765432211 14556888888886 268899998874446788
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-----CCeEEeccCccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-----NDIRLGDFGLAK 163 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-----g~vKL~DFGls~ 163 (644)
||||+.+ |.+|.++........|+...+..++.|++.+|++||+.|++||||||.|+++... ..+.|+|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999 9999999877666789999999999999999999999999999999999999865 359999999999
Q ss_pred --cccccc--------c-cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH---hcc
Q 006460 164 --LLNTED--------L-ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI---NRS 229 (644)
Q Consensus 164 --~~~~~~--------~-~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i---~~~ 229 (644)
.+.... . ...+.||..|+++....+...+.+.|+||++.++.+|+.|..||...........+ ...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 321111 1 23456999999999999999999999999999999999999999766533222222 222
Q ss_pred CCCC-CCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 230 SISP-LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 230 ~~~~-~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.... .....+.++..+...+-..+...+|.+..+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2111 334456788888888888999999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-27 Score=267.35 Aligned_cols=258 Identities=23% Similarity=0.371 Sum_probs=205.7
Q ss_pred CCCCe-EEEEEeccCCCeEEEEEEEecCCeEEEEEEEe----cccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 11 KLEDY-EVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR----LAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 11 ~~~~Y-~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~----~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
.++.| .....+|.|++|.|+.+........++.|.++ .......+...+..|+.+-..+.|||++..+..+++..
T Consensus 315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 34556 55778999999999998888777777777655 22333334444777888888999999998888777654
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
... -+||||++ +|+.++... ..+...++..++.||+.|++|||..||.||||||+|++++.+|.+||+|||.+..+
T Consensus 395 ~~~-~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 395 GIL-QSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred cch-hhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence 433 34999999 999999763 35888999999999999999999999999999999999999999999999999875
Q ss_pred ccc-----cccccccCCCCCCChhhhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCChHHHH-HHHhc-------cCC
Q 006460 166 NTE-----DLASSVVGTPNYMCPELLADIPYG-YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLI-NKINR-------SSI 231 (644)
Q Consensus 166 ~~~-----~~~~~~~GT~~Y~APEvl~~~~ys-~ksDIWSLGvILyeLltG~~PF~~~~~~el~-~~i~~-------~~~ 231 (644)
... ......+|+..|+|||++.+..|+ ...||||.|++++.|++|+.||......+.. ..... ...
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 433 234567899999999999999995 5799999999999999999999765544332 11111 111
Q ss_pred CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 232 SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 232 ~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
..+...++...+.+|.+||+.+|.+|.|+++|++.+||+..
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 22334468889999999999999999999999999999753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=236.49 Aligned_cols=167 Identities=16% Similarity=0.160 Sum_probs=132.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEec-CCeEEEEEEEecccc---cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKI-ERKKYVLKKIRLAKQ---TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~-tg~~vAiK~i~~~~~---~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
+...++|.+.+.||+|+||.||+|.++. ++..+|||++..... .......+.+|+++|++|+|+|||..+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3567889999999999999999999886 677789998753311 233456789999999999999999643222
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccC-CCCcEEEcCCCCeEEeccCccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDL-KCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDL-KPeNILL~~~g~vKL~DFGls~ 163 (644)
+ ..|+||||+.|++|.. +. . .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+++
T Consensus 91 ~-~~~LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 G-KDGLVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred C-CcEEEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 2 4799999999999963 21 1 11 1467899999999999999999999 9999999999999999999998
Q ss_pred cccccc---------ccccccCCCCCCChhhhcC
Q 006460 164 LLNTED---------LASSVVGTPNYMCPELLAD 188 (644)
Q Consensus 164 ~~~~~~---------~~~~~~GT~~Y~APEvl~~ 188 (644)
.+.... -..+..+++.|+|||.+.-
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 654322 1245678899999998854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-26 Score=252.55 Aligned_cols=258 Identities=26% Similarity=0.453 Sum_probs=212.3
Q ss_pred EeccCCCeEEEEEEE---ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceEEEEEecc
Q 006460 20 QIGRGAFGAAFLVLH---KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCVCIVTGYC 95 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~---k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~~LVmEy~ 95 (644)
.+|.|+||.|++++- ...+.-||+|+.++.............|..++..++ ||.+|+++..|+. +...|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence 379999999998753 344677999988765433332334556788888886 9999999988776 45599999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccccccc
Q 006460 96 EGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVV 175 (644)
Q Consensus 96 ~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~ 175 (644)
.||.|...+.. ...+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-..... |
T Consensus 80 rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---c 154 (612)
T KOG0603|consen 80 RGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---C 154 (612)
T ss_pred ccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---c
Confidence 99999988765 445888999999999999999999999999999999999999999999999999976554333 9
Q ss_pred CCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCC
Q 006460 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255 (644)
Q Consensus 176 GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~ 255 (644)
||..|||||++. +....+|+||+|+++|+|++|..||.+ +....|..... ..|..++..+++++..++..+|.
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~-~~p~~l~~~a~~~~~~l~~r~p~ 227 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL-EMPRELSAEARSLFRQLFKRNPE 227 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc-CCchhhhHHHHHHHHHHHhhCHH
Confidence 999999999998 567899999999999999999999998 56666665443 47888999999999999999999
Q ss_pred CCCC-----HHHHhhCCCCchhhhhcCCCCCcccCCCccc
Q 006460 256 HRPT-----ASDLLRHPHLQPYLLRCQNPSSVYLPIKPTN 290 (644)
Q Consensus 256 ~RpT-----a~eiL~hp~f~~~~~~~~~~~~~~~p~~p~~ 290 (644)
.|.. +.++++|++|+.+.|..........|++|..
T Consensus 228 nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~ 267 (612)
T KOG0603|consen 228 NRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGS 267 (612)
T ss_pred HHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcc
Confidence 9965 4799999999988877544444455555433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=209.02 Aligned_cols=247 Identities=19% Similarity=0.255 Sum_probs=197.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN-PYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H-PNIVkl~~~~~d~~~~~ 88 (644)
...+.|+++++||.|+||.+|+|.+..+|..||||.-+..... ..+..|.++.+.|.+ ..|..+..+ ..+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y-~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHY-GTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhh-ccccccc
Confidence 5678999999999999999999999999999999987665433 235568888888865 455555544 4456788
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC---CCeEEeccCccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD---NDIRLGDFGLAKLL 165 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~---g~vKL~DFGls~~~ 165 (644)
.+||+++ |.+|.+++.-+ ...|+-..+.-.+-|++.-++|+|.+++|||||||+|+|+.-. ..+.|+|||+|+.+
T Consensus 87 vlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9999999 99999998754 4468889999999999999999999999999999999999743 46899999999876
Q ss_pred ccc--------cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHH---HHHHHhccCC---
Q 006460 166 NTE--------DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG---LINKINRSSI--- 231 (644)
Q Consensus 166 ~~~--------~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~e---l~~~i~~~~~--- 231 (644)
... .......||..|.+--...+...+...|+-|+|.+|.++.-|..||++..... -.++|.....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 432 22345689999999888888888999999999999999999999999865432 2333333322
Q ss_pred -CCCCccccHHHHHHHHHHhccCCCCCCCHHHH
Q 006460 232 -SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDL 263 (644)
Q Consensus 232 -~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~ei 263 (644)
..+...+|.++.-.+..|-..--++-|...-+
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 23445678999999999988877777886544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=216.73 Aligned_cols=243 Identities=19% Similarity=0.263 Sum_probs=198.3
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
.|++.++||+|+||+.++|.+..++++||||.-......++ +..|.+..+.| ..+.|...|. |-..+.+-.|||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQ----LrdEYr~YKlL~g~~GIP~vYY-FGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQ----LRDEYRTYKLLGGTEGIPQVYY-FGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcch----HHHHHHHHHHHcCCCCCCceee-eccccchhhhhh
Confidence 79999999999999999999999999999998766554443 34466666666 4688887775 445577788999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-----CeEEeccCccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-----DIRLGDFGLAKLLNT 167 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-----~vKL~DFGls~~~~~ 167 (644)
|++ |.+|.+++.-+ +..|+...+..++.|++.-++|+|++.+|+|||||+|+||..-+ .+.|+|||+++.+..
T Consensus 104 dLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999 99999999865 56799999999999999999999999999999999999998544 489999999998754
Q ss_pred cc--------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHhccCCC----
Q 006460 168 ED--------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA---GLINKINRSSIS---- 232 (644)
Q Consensus 168 ~~--------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~---el~~~i~~~~~~---- 232 (644)
.. -.....||..||+--...+...+...|+-|||.++++.|-|..||++.... +-.++|......
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 32 245678999999999999999999999999999999999999999876533 344555443322
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHH
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDL 263 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~ei 263 (644)
.+...+|.++..-+.-.-..+-.+-|..+-+
T Consensus 262 ~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 262 VLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred HHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 2334578888888887777777788887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-23 Score=237.53 Aligned_cols=222 Identities=31% Similarity=0.550 Sum_probs=174.6
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
=.+|..++.|..|+||.||+++|+.+.+.+|+| +.+.. .++|. ||....+|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-------lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-------LILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-------hhhhc--cccccCCccee----------------
Confidence 368999999999999999999999999999994 43322 11111 23333444443
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc---
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE--- 168 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~--- 168 (644)
|+-..+++.. +.++... +.+++|||+.||+|||+||+|.||+.-|++|+.|||++......
T Consensus 136 ------gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ------GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ------chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 3444445432 2355443 78999999999999999999999999999999999999753211
Q ss_pred ------------c-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--CC
Q 006460 169 ------------D-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--SP 233 (644)
Q Consensus 169 ------------~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--~~ 233 (644)
. .....||||.|+|||++...+|+..+|||+||+|+|+.+-|..||.+..+++++..+..... +.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 0 12346999999999999999999999999999999999999999999999999888765432 22
Q ss_pred CCccccHHHHHHHHHHhccCCCCC---CCHHHHhhCCCCchhhhh
Q 006460 234 LPIVYSSTMKQIIKSMLRKNPEHR---PTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 234 ~p~~~s~~l~dLI~~~L~~dP~~R---pTa~eiL~hp~f~~~~~~ 275 (644)
-..-++.++++++.++|+.+|..| ..+.++.+|+||+..-|.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 234468899999999999999999 567789999999876665
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-22 Score=201.36 Aligned_cols=173 Identities=15% Similarity=0.232 Sum_probs=136.0
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHH------HHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRT------ALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~------~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
-++|++.+.||.|+||.||++.. ++..+|+|.++..... +..... +.+|++.+.+|.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 46899999999999999999654 4678999999755322 233333 57899999999999999999987653
Q ss_pred C-------ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEe
Q 006460 85 G-------NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLG 157 (644)
Q Consensus 85 ~-------~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~ 157 (644)
. ...+|||||++|.+|.++.. +++. .+.+|+.+|..||+.|++|||++|.||+++.+| ++|+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 2 34789999999999988732 3332 456999999999999999999999999999988 9999
Q ss_pred ccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHH
Q 006460 158 DFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIA 208 (644)
Q Consensus 158 DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLl 208 (644)
|||........... ..++....|..++|+|+||+++..+.
T Consensus 177 Dfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 99988654322111 11444556788999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=196.21 Aligned_cols=142 Identities=17% Similarity=0.144 Sum_probs=111.5
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH------------------------HHHHHHHHHHHHHhcCCCC
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK------------------------FKRTALQEMDLISKLNNPY 73 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~------------------------~~~~~~rEi~iL~~L~HPN 73 (644)
.+.||+|+||.||+|.+. +|+.||+|+++....... ......+|+++|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 899999999976532110 0123345999999998887
Q ss_pred cceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccccCCCCcEEEcCCC
Q 006460 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL-HSNRVLHRDLKCSNIFLTKDN 152 (644)
Q Consensus 74 IVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yL-Hs~gIIHRDLKPeNILL~~~g 152 (644)
+.....+... . .+|||||+.|++|...+.. ...+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++
T Consensus 81 v~~p~~~~~~--~-~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 81 IPCPEPILLK--S-HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCcEEEec--C-CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 7544433222 2 3799999998877655432 34689999999999999999999 799999999999999998 57
Q ss_pred CeEEeccCcccccc
Q 006460 153 DIRLGDFGLAKLLN 166 (644)
Q Consensus 153 ~vKL~DFGls~~~~ 166 (644)
.++|+|||++....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=199.85 Aligned_cols=236 Identities=20% Similarity=0.280 Sum_probs=151.7
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCC----------CCcceeeeEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNN----------PYIVKYKDAWV 82 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~H----------PNIVkl~~~~~ 82 (644)
.+...+.||.|+++.||.|.+..|++.+|+|+........ ...+.+.+|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5677889999999999999999999999999986654222 234555555543333221 12222222221
Q ss_pred --------eCC---c-----eEEEEEeccCCCCHHHHHHH---hcCCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 006460 83 --------DKG---N-----CVCIVTGYCEGGDMAEIIKK---ARGAC--FPEEKLCKWLTQLLLAVDYLHSNRVLHRDL 141 (644)
Q Consensus 83 --------d~~---~-----~~~LVmEy~~GgsL~~~L~~---~~~~~--l~e~~i~~i~~QIL~gL~yLHs~gIIHRDL 141 (644)
..+ . ..+++|+-+ .++|.+++.. ..... +.......+..|++..+.+||.+|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 1 136788887 5688887653 22111 112222345589999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCcccccccccccccccCCCCCCChhhhcC--------CCCCcccchhhHHHHHHHHHhCCCC
Q 006460 142 KCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD--------IPYGYKSDIWSLGCCMFEIAAHQPA 213 (644)
Q Consensus 142 KPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~--------~~ys~ksDIWSLGvILyeLltG~~P 213 (644)
+|+|++++.+|.++|+||+.....+... .....+..|.+||.... ..++.+.|.|+||+++|.|+||..|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 9999999999999999999887655432 22455678999997744 2478999999999999999999999
Q ss_pred CCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCC
Q 006460 214 FRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHR 257 (644)
Q Consensus 214 F~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~R 257 (644)
|........... .+.... .+|+.++.||..+|+.||.+|
T Consensus 250 f~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 986543221111 222233 678999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.2e-21 Score=186.61 Aligned_cols=144 Identities=15% Similarity=0.109 Sum_probs=114.1
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc------------------------HHHHHHHHHHHHHHHhcCCC
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT------------------------EKFKRTALQEMDLISKLNNP 72 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~------------------------~~~~~~~~rEi~iL~~L~HP 72 (644)
+.+.||+|+||.||+|.+. +|+.||+|+++..... ......+.+|.+.+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999999865211 00122345799999999999
Q ss_pred CcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCC
Q 006460 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 73 NIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~ 151 (644)
++.....++.. . .||||||+.|+++...... ...+++..+..++.|++.+|.+||. +||+||||||+|||++ +
T Consensus 80 ~i~~p~~~~~~-~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 80 GVPVPEPILLK-K--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCCceEEEec-C--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C
Confidence 88655544433 2 4799999988865443222 2357889999999999999999999 9999999999999998 8
Q ss_pred CCeEEeccCccccccc
Q 006460 152 NDIRLGDFGLAKLLNT 167 (644)
Q Consensus 152 g~vKL~DFGls~~~~~ 167 (644)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-22 Score=231.53 Aligned_cols=245 Identities=21% Similarity=0.303 Sum_probs=179.6
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc---HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT---EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+|...+.||++.|=.|.+|++... .|++|++-+.... ..+. +.++|++ ...+++||++++.-+ ....+..||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~-qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFK-QRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHH-HHHHHHH-HHhhcCCcccchHHH-HHhhHHHHH
Confidence 788999999999999999987644 4999988655421 2233 3344555 555689999999875 555778899
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc--ccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL--NTE 168 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~--~~~ 168 (644)
|-+|+ ..+|++.+... ..+...+.++|+.||+.||+.+|+.||+|||||.+||||+.-+-+-|+||..-+.. ..+
T Consensus 99 vRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 99 VRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 99999 56999988753 35778899999999999999999999999999999999999999999999876542 111
Q ss_pred ---c---ccccccCCCCCCChhhhcCC----------C-CCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccC
Q 006460 169 ---D---LASSVVGTPNYMCPELLADI----------P-YGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSS 230 (644)
Q Consensus 169 ---~---~~~~~~GT~~Y~APEvl~~~----------~-ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~ 230 (644)
+ ++.+...-..|+|||.+... . .+++.||||+||+++||++ |.|||.-.........-....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 1 11222333469999987542 1 4789999999999999987 799995322111100000000
Q ss_pred CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 231 ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 231 ~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..-+...-+..++++|..|++.||.+|.++++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000011124478899999999999999999999986
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-21 Score=200.97 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=185.4
Q ss_pred CCCCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCe-----------------------------------EEEEEEEec
Q 006460 4 ENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERK-----------------------------------KYVLKKIRL 48 (644)
Q Consensus 4 ~~~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~-----------------------------------~vAiK~i~~ 48 (644)
++-+++..+++|+|...||+|.-+.||.|.....|. +.|||.+-.
T Consensus 148 ~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN 227 (598)
T KOG4158|consen 148 NRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFN 227 (598)
T ss_pred chhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcc
Confidence 345778899999999999999999999886654221 145665432
Q ss_pred c---cccHHHHHHHHHHH------HHH--------Hh--------cCCCCcceeeeEEEeC-------------------
Q 006460 49 A---KQTEKFKRTALQEM------DLI--------SK--------LNNPYIVKYKDAWVDK------------------- 84 (644)
Q Consensus 49 ~---~~~~~~~~~~~rEi------~iL--------~~--------L~HPNIVkl~~~~~d~------------------- 84 (644)
- .......+...+|+ ..+ +. -.|||||++..+|.+.
T Consensus 228 ~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~ 307 (598)
T KOG4158|consen 228 FEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARW 307 (598)
T ss_pred cccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCccccccee
Confidence 2 12222333333321 111 11 1599999999988642
Q ss_pred -------CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc--CCC--C
Q 006460 85 -------GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT--KDN--D 153 (644)
Q Consensus 85 -------~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~--~~g--~ 153 (644)
+..+|+||-.+ ..+|..++... ..+....+-++.|+|+|+.|||++||.|||+|.+||||. +|+ .
T Consensus 308 ~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~ 383 (598)
T KOG4158|consen 308 YPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQ 383 (598)
T ss_pred cccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcE
Confidence 24689999988 56999999753 367788888999999999999999999999999999996 333 4
Q ss_pred eEEeccCcccccccc-------cccccccCCCCCCChhhhcCCCC------CcccchhhHHHHHHHHHhCCCCCCCCChH
Q 006460 154 IRLGDFGLAKLLNTE-------DLASSVVGTPNYMCPELLADIPY------GYKSDIWSLGCCMFEIAAHQPAFRAPDMA 220 (644)
Q Consensus 154 vKL~DFGls~~~~~~-------~~~~~~~GT~~Y~APEvl~~~~y------s~ksDIWSLGvILyeLltG~~PF~~~~~~ 220 (644)
++|+|||++---..- ...-..-|.-..||||+....+= -.++|.|+.|.+-||+++..-||......
T Consensus 384 LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem 463 (598)
T KOG4158|consen 384 LVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM 463 (598)
T ss_pred EEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh
Confidence 899999987532211 11122456778899999875431 24899999999999999999999775433
Q ss_pred HH-HHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHH
Q 006460 221 GL-INKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTAS 261 (644)
Q Consensus 221 el-~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~ 261 (644)
-+ ...-....++.+|..+++.+++++..+|+.||.+|++..
T Consensus 464 ~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 464 LLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 22 112344567889999999999999999999999999854
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=184.00 Aligned_cols=186 Identities=18% Similarity=0.159 Sum_probs=141.2
Q ss_pred EEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH--HHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceEEEEE
Q 006460 16 EVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK--FKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 16 ~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~--~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~~LVm 92 (644)
-+...||+|+||+||++.. .+.+++.+.+........ ....+.+|+++|++|. |++|++++++ ...|++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEE
Confidence 3567899999999997755 677888777655433211 2235789999999995 5889999885 2368999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccC-CCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDL-KCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDL-KPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
+|+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999998754321 1 1357889999999999999999999 79999999999999999999986543221
Q ss_pred -------------cccccCCCCCCChhhhcCC-CCC-cccchhhHHHHHHHHHhCCCCCCCC
Q 006460 171 -------------ASSVVGTPNYMCPELLADI-PYG-YKSDIWSLGCCMFEIAAHQPAFRAP 217 (644)
Q Consensus 171 -------------~~~~~GT~~Y~APEvl~~~-~ys-~ksDIWSLGvILyeLltG~~PF~~~ 217 (644)
.....+++.|+.|+...-. ..+ ...++++.|+-+|.++|+..|+.+.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0112368889999854332 223 5778999999999999999887543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=181.50 Aligned_cols=136 Identities=17% Similarity=0.200 Sum_probs=107.6
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-----CCCCcceeeeEEEeCC--ce-E
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-----NNPYIVKYKDAWVDKG--NC-V 88 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-----~HPNIVkl~~~~~d~~--~~-~ 88 (644)
-.+.||+|+||.||. |..++.. +||++...... ..+.+.+|+++++.+ .||||+++++++.... .. +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 357899999999995 7767665 69988764322 246789999999999 5799999999987653 23 3
Q ss_pred EEEEec--cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCCccccCCCCcEEEcCC----CCeEEeccCc
Q 006460 89 CIVTGY--CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV-DYLHSNRVLHRDLKCSNIFLTKD----NDIRLGDFGL 161 (644)
Q Consensus 89 ~LVmEy--~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL-~yLHs~gIIHRDLKPeNILL~~~----g~vKL~DFGl 161 (644)
.+|||| +.+++|.+++++. .+++. ..++.|++.++ .|||+++|+||||||+|||++.. +.++|+||+-
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 378999 5579999999752 36666 35688888888 99999999999999999999843 3799999544
Q ss_pred c
Q 006460 162 A 162 (644)
Q Consensus 162 s 162 (644)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-20 Score=188.25 Aligned_cols=248 Identities=16% Similarity=0.268 Sum_probs=203.5
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
++..+++..++.+|.+...|..|+|++..+ .+++|++..........+.|-.|.-.|+-..||||+.+++.|... ..
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-pn 261 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-PN 261 (448)
T ss_pred cCcchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-CC
Confidence 445677778888999999999999998744 788898888777777777888898888888999999999998775 45
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCc-cccCCCCcEEEcCCCCeEE--eccCccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVL-HRDLKCSNIFLTKDNDIRL--GDFGLAK 163 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gII-HRDLKPeNILL~~~g~vKL--~DFGls~ 163 (644)
+.++..|++.|+|+.++....+......++.+++..|++|+.|||+. .++ ---|....++|+.+-..+| +|--++.
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence 88999999999999999877666678889999999999999999998 444 3458888999998876554 3422221
Q ss_pred ccccccccccccCCCCCCChhhhcCCCC---CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHh-ccCCCCCCcccc
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLADIPY---GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKIN-RSSISPLPIVYS 239 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y---s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~-~~~~~~~p~~~s 239 (644)
. .......|.||+||.+...+- -.++|+|||++++|||.|...||..-.+.+.--+|. .+....+|..++
T Consensus 342 q------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis 415 (448)
T KOG0195|consen 342 Q------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS 415 (448)
T ss_pred e------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc
Confidence 1 122345788999999987664 358999999999999999999999888777655553 455667899999
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHh
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLL 264 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL 264 (644)
..+..|++-|+..||.+||.++.|.
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999999998775
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=209.52 Aligned_cols=232 Identities=21% Similarity=0.344 Sum_probs=172.9
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCceEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN---NPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HPNIVkl~~~~~d~~~~~~ 89 (644)
+.|.|.+.||+|+||.||+|.+.. |+.||+|+-+.....+-+.- .+++.+|+ -+.|+.+..++.- .+..+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~-----~q~~~RLk~~~~~~~~~~~~a~~~-~~~S~ 770 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC-----LQVMERLKPQMLPSIMHISSAHVF-QNASV 770 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh-----HHHHHhhchhhhcchHHHHHHHcc-CCcce
Confidence 479999999999999999999887 99999998877654433221 13333333 2344544444433 23467
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-------CCCeEEeccCcc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-------DNDIRLGDFGLA 162 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-------~g~vKL~DFGls 162 (644)
||+||.+.|+|.+++. ....+++..++.++.|||..++.||..+|||+||||+|+||.. .-.++|+|||.+
T Consensus 771 lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 9999999999999997 4556999999999999999999999999999999999999963 235999999999
Q ss_pred ccc---ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC----CC
Q 006460 163 KLL---NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----LP 235 (644)
Q Consensus 163 ~~~---~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----~p 235 (644)
.-+ .....+...++|-.+-++|+..|.++++.+|.|.|+.++|-||.|+.. + ...+..+. ++
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------q-~~~g~~~~~~~~~~ 917 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------E-VKNGSSWMVKTNFP 917 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------H-hcCCcceeccccch
Confidence 643 333356678899999999999999999999999999999999998632 2 11221111 33
Q ss_pred ccccHHH-HHHHHHHhccCCCCCCCHHHHh
Q 006460 236 IVYSSTM-KQIIKSMLRKNPEHRPTASDLL 264 (644)
Q Consensus 236 ~~~s~~l-~dLI~~~L~~dP~~RpTa~eiL 264 (644)
..+..++ .+|+..+|..|-..=|...+|.
T Consensus 918 Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 918 RYWKRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred hhhhHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 3344444 4788889983333335555543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.4e-20 Score=199.37 Aligned_cols=177 Identities=28% Similarity=0.492 Sum_probs=140.1
Q ss_pred eEEEEEeccCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKA-RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~-~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
++||.|++|.-.+|.+||... .....+......++.|+..|++| +|.+|||+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 689999999999999999743 23345677889999999999999 99999999999999999999999999999865
Q ss_pred cccc-------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHhccCCCCCCcc
Q 006460 166 NTED-------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-DMAGLINKINRSSISPLPIV 237 (644)
Q Consensus 166 ~~~~-------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~-~~~el~~~i~~~~~~~~p~~ 237 (644)
.... ..+...||.+||+||++.+..|+.++||||||+|||||+. +|... .....+..+..+.+++....
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~~ 483 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFLQ 483 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHhh
Confidence 4433 4566789999999999999999999999999999999996 22211 12223334444544432222
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
--+.-..|+.+||...|.+||++.+.-.|+|+
T Consensus 484 d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 484 DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 23344589999999999999988777777765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.8e-19 Score=178.75 Aligned_cols=146 Identities=17% Similarity=0.127 Sum_probs=114.5
Q ss_pred CeEEEEEeccCCCeEEEEEE-EecCCeEEEEEEEeccccc----------------------HHHHHHHHHHHHHHHhcC
Q 006460 14 DYEVIEQIGRGAFGAAFLVL-HKIERKKYVLKKIRLAKQT----------------------EKFKRTALQEMDLISKLN 70 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~-~k~tg~~vAiK~i~~~~~~----------------------~~~~~~~~rEi~iL~~L~ 70 (644)
-|.+.+.||.|+||.||+|. +..+|+.||+|+++..... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999999 7788999999999754311 011234568999999997
Q ss_pred CCC--cceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccccCCCCcEE
Q 006460 71 NPY--IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR-VLHRDLKCSNIF 147 (644)
Q Consensus 71 HPN--IVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g-IIHRDLKPeNIL 147 (644)
+.. +.++++ . .. .|+||||+.|.+|..+... ...+.+..+..++.||+.+|.+||.+| |+||||||+||+
T Consensus 109 ~~~i~~p~~~~---~-~~-~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIA---W-RR-NVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeE---e-cC-ceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 532 333333 2 22 4799999999888765432 234666778899999999999999999 999999999999
Q ss_pred EcCCCCeEEeccCccccccc
Q 006460 148 LTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 148 L~~~g~vKL~DFGls~~~~~ 167 (644)
++ ++.++|+|||.+.....
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 99 88999999999875433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=170.00 Aligned_cols=136 Identities=26% Similarity=0.281 Sum_probs=112.6
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc------HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT------EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~------~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
+.||+|++|.||+|.+ .+..+++|+....... ......+.+|+.++..+.|++|+....++... ...++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-ENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-CCCEEEE
Confidence 5799999999999987 6778999986543211 11234678899999999999988777666554 4578999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
||++|++|.+++... .. ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999998642 12 7888999999999999999999999999999999 78899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=161.75 Aligned_cols=132 Identities=27% Similarity=0.310 Sum_probs=105.2
Q ss_pred EeccCCCeEEEEEEEecCCeEEEEEEEecccc-c-----HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 20 QIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-T-----EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~-----~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
.||+|+||.||+|.+ .+..+++|....... . .....++.+|+++++.+.|+++....-++... ...++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-DNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-CCCEEEEE
Confidence 389999999999984 567899998654321 1 11235678899999999988765544444443 34689999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
|++|++|.+++.... . .++.||+.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~------~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN------D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH------H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999875421 1 7899999999999999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-19 Score=207.24 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=208.3
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecC-CeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIE-RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~t-g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~~ 89 (644)
...|++.+.||+|+|+.|-++..... ...+|.|.+............+..|..+-+.+. |+|++.+++.+.. .+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-PRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-Ccccc
Confidence 67899999999999999999877544 456777777665544445566667888888887 9999999998655 56789
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCCCCcEEEcCCC-CeEEeccCccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH-SNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNT 167 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLH-s~gIIHRDLKPeNILL~~~g-~vKL~DFGls~~~~~ 167 (644)
++++|..|+++...+........+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999999884222225777888999999999999999 99999999999999999999 999999999987655
Q ss_pred -c---cccccccC-CCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHH--HHHHhccC--CCCCCcc
Q 006460 168 -E---DLASSVVG-TPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL--INKINRSS--ISPLPIV 237 (644)
Q Consensus 168 -~---~~~~~~~G-T~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el--~~~i~~~~--~~~~p~~ 237 (644)
. ......+| ++.|+|||.+.+..| ....|+||+|+++.-+++|..|+........ ...+.... .......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 2 23445678 999999999988544 7899999999999999999999876543321 11111111 1223455
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
++....+++.++|..+|..|.+..++-.+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 6888999999999999999999999999999976
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=163.91 Aligned_cols=139 Identities=22% Similarity=0.225 Sum_probs=109.8
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH--------------------HHHHHHHHHHHHHHhcCCCC-
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE--------------------KFKRTALQEMDLISKLNNPY- 73 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~--------------------~~~~~~~rEi~iL~~L~HPN- 73 (644)
|.+.+.||.|+||.||+|.+. +|+.+|+|+++...... .....+.+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999875 79999999986543110 11123677999999998774
Q ss_pred -cceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC
Q 006460 74 -IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN 152 (644)
Q Consensus 74 -IVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g 152 (644)
++..++. ...++||||+.|++|..+... .....++.+|+.++.++|..||+||||||.||+++.++
T Consensus 96 ~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW-----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec-----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 4444431 235899999999998765421 34567889999999999999999999999999999999
Q ss_pred CeEEeccCccccccc
Q 006460 153 DIRLGDFGLAKLLNT 167 (644)
Q Consensus 153 ~vKL~DFGls~~~~~ 167 (644)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=181.55 Aligned_cols=140 Identities=22% Similarity=0.176 Sum_probs=110.5
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-c-----cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-Q-----TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~-----~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
...|...+.||+|+||.||+|.+... .+++|+..... . ......++.+|+++++.+.|++++..+.++...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~- 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP- 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-
Confidence 34556688999999999999976543 44444432211 1 112235688999999999999998877766653
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
...++||||++|++|.+++. ....++.||+.+|.|||++||+||||||+|||+ .++.++|+|||+++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 44789999999999999885 245789999999999999999999999999999 5789999999998753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=176.07 Aligned_cols=198 Identities=23% Similarity=0.384 Sum_probs=158.0
Q ss_pred HHhcCCCCcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-ccccCCCC
Q 006460 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV-LHRDLKCS 144 (644)
Q Consensus 66 L~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gI-IHRDLKPe 144 (644)
|+.+.|.|+.++++.+.+. ...++|.+||..|+|.+.+.. ....++.-....+++.|+.||.|||+-.| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4568999999999999885 669999999999999999986 34567888888999999999999999877 99999999
Q ss_pred cEEEcCCCCeEEeccCcccccccc---cccccccCCCCCCChhhhcCCC-------CCcccchhhHHHHHHHHHhCCCCC
Q 006460 145 NIFLTKDNDIRLGDFGLAKLLNTE---DLASSVVGTPNYMCPELLADIP-------YGYKSDIWSLGCCMFEIAAHQPAF 214 (644)
Q Consensus 145 NILL~~~g~vKL~DFGls~~~~~~---~~~~~~~GT~~Y~APEvl~~~~-------ys~ksDIWSLGvILyeLltG~~PF 214 (644)
|.+++....+||.|||+....... .......-...|.|||++.... .+.+.||||+|+++||+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765321 1112223345699999987632 367899999999999999999999
Q ss_pred CCC----ChHHHHHHHhc-cCCCCCCc-----cccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 215 RAP----DMAGLINKINR-SSISPLPI-----VYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 215 ~~~----~~~el~~~i~~-~~~~~~p~-----~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
... +..+++..+.. .....-|. ...+++..++..||..+|..||++.++-.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 652 23456666665 22222222 23457899999999999999999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.3e-16 Score=152.22 Aligned_cols=138 Identities=22% Similarity=0.262 Sum_probs=100.1
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHH----------------------HHHHHHHHHhcCCCC--
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRT----------------------ALQEMDLISKLNNPY-- 73 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~----------------------~~rEi~iL~~L~HPN-- 73 (644)
.+.||+|+||.||+|.+. +++.||+|+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999886 8899999998764322111111 135666676665433
Q ss_pred cceeeeEEEeCCceEEEEEeccCCCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCC
Q 006460 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 74 IVkl~~~~~d~~~~~~LVmEy~~GgsL~~-~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~ 151 (644)
+.+.+++ ...++||||+.|+.+.. .+.... .. ..+..++.+++.++.++|. +||+||||||+||+++ +
T Consensus 81 ~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 81 VPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCceEec-----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 4444432 12589999999854322 121111 11 6778899999999999999 9999999999999999 8
Q ss_pred CCeEEeccCcccccc
Q 006460 152 NDIRLGDFGLAKLLN 166 (644)
Q Consensus 152 g~vKL~DFGls~~~~ 166 (644)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=156.13 Aligned_cols=137 Identities=24% Similarity=0.331 Sum_probs=105.5
Q ss_pred EEec-cCCCeEEEEEEEecCCeEEEEEEEecccc-----------cHHHHHHHHHHHHHHHhcCCCCc--ceeeeEEEeC
Q 006460 19 EQIG-RGAFGAAFLVLHKIERKKYVLKKIRLAKQ-----------TEKFKRTALQEMDLISKLNNPYI--VKYKDAWVDK 84 (644)
Q Consensus 19 ~~LG-~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-----------~~~~~~~~~rEi~iL~~L~HPNI--Vkl~~~~~d~ 84 (644)
..|| .||.|+||.+... +..+|+|.+..... ......++.+|+.++.+|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3577 7888888888664 77899998864321 11223567889999999988774 6677664433
Q ss_pred CceE---EEEEeccCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccC
Q 006460 85 GNCV---CIVTGYCEG-GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG 160 (644)
Q Consensus 85 ~~~~---~LVmEy~~G-gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFG 160 (644)
.... ++||||++| .+|.+++.. ..+++.. +.||+.+|.+||++||+||||||.|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 3323 599999997 699988864 2356543 5789999999999999999999999999998999999999
Q ss_pred cccc
Q 006460 161 LAKL 164 (644)
Q Consensus 161 ls~~ 164 (644)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-15 Score=135.52 Aligned_cols=132 Identities=20% Similarity=0.220 Sum_probs=109.3
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--CCcceeeeEEEeCCceEEEEEec
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN--PYIVKYKDAWVDKGNCVCIVTGY 94 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--PNIVkl~~~~~d~~~~~~LVmEy 94 (644)
+++.||.|.++.||++.... ..+++|....... ...+.+|+.+++.+.| +++++++.++.. ....+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEe
Confidence 46789999999999998754 6899998865543 3467789999999976 588888876544 4679999999
Q ss_pred cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 95 CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN---RVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 95 ~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~---gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
+.|+.+..+ +......++.+++.+|.+||.. +++|+||+|.||+++..+.++++|||+++.
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988877654 3456667889999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-15 Score=169.18 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=197.5
Q ss_pred CCeEEEEEecc--CCCeEEEEEEE--ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCce
Q 006460 13 EDYEVIEQIGR--GAFGAAFLVLH--KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 13 ~~Y~i~~~LG~--G~fG~Vyla~~--k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~ 87 (644)
+.+.+...+|. |.+|.||.+.. ..++..+|+|.-+..........+-++|+.-.+++ .|+|.|+.+..|.. +..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCc
Confidence 46778889999 99999999988 88999999998655544444344446677777777 49999998888765 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCCccccCCCCcEEEcCC-CCeEEeccCcc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL----AVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLA 162 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~----gL~yLHs~gIIHRDLKPeNILL~~~-g~vKL~DFGls 162 (644)
.|+-+|+| |.+|..+... ....+++..++.++.+... ||..+|..+++|-|+||.||++..+ ..++++|||+.
T Consensus 193 lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred ceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 89999999 6788887764 3445899999999999999 9999999999999999999999999 88999999999
Q ss_pred ccccccccccc------ccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHhccCCCCC
Q 006460 163 KLLNTEDLASS------VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP--DMAGLINKINRSSISPL 234 (644)
Q Consensus 163 ~~~~~~~~~~~------~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~--~~~el~~~i~~~~~~~~ 234 (644)
..+....+... ..|...|++||++.+ -++...|+|+||.++.+..+|..++... .....+..+. ....+
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~e~ 347 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--IPLEF 347 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--Cchhh
Confidence 98877653322 256778999999876 5789999999999999998887665543 2111111110 00112
Q ss_pred CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 235 p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
....+.++...+..|+..+|..|++++.++.|+++.
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 223466777799999999999999999999999986
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.9e-15 Score=175.16 Aligned_cols=266 Identities=23% Similarity=0.352 Sum_probs=206.4
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH-HHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK-FKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~-~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
+++-.+.+.+++-+-+|.++.++.+.-..++...++|.......-.. ..+.+.++-.++-...+|-++...--+.. ..
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~-rs 877 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC-RS 877 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC-CC
Confidence 56788999999999999999999998888887777765543321110 11222233333333345666655443323 34
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
-.+||++|+.|++|...+.... ..+++-++.++..+..+++|||...+.|||++|.|+|+..+++.++.|||......
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 5889999999999999987643 57788888899999999999999999999999999999999999999998443211
Q ss_pred c----------------c----------------cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCC
Q 006460 167 T----------------E----------------DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAF 214 (644)
Q Consensus 167 ~----------------~----------------~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF 214 (644)
. . .......||+.|.+||.+.+......+|+|+.|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0123457899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhccCC--CCCCccccHHHHHHHHHHhccCCCCCCCHH---HHhhCCCCchhhhhc
Q 006460 215 RAPDMAGLINKINRSSI--SPLPIVYSSTMKQIIKSMLRKNPEHRPTAS---DLLRHPHLQPYLLRC 276 (644)
Q Consensus 215 ~~~~~~el~~~i~~~~~--~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~---eiL~hp~f~~~~~~~ 276 (644)
........++.|..... +..+...+.++++++.++|..+|.+|..+. ++-.||+|+...|..
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 99999988888766543 234456789999999999999999998877 889999998765543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=8e-13 Score=146.73 Aligned_cols=144 Identities=18% Similarity=0.230 Sum_probs=102.0
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccccH--------------------------------HHHH------HHH
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE--------------------------------KFKR------TAL 60 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~--------------------------------~~~~------~~~ 60 (644)
+.||.|++|.||+|..+ +|+.||||+.+...... .+.. .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999865 78999999986542110 0111 234
Q ss_pred HHHHHHHhc----CCCCcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 006460 61 QEMDLISKL----NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL-AVDYLHSNR 135 (644)
Q Consensus 61 rEi~iL~~L----~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~-gL~yLHs~g 135 (644)
+|++.+.++ .|.+-|.+-.+|.+.....+|||||++|++|.++...... .+. ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 556555555 2333444444554434457899999999999988754221 122 2345556655 478899999
Q ss_pred CccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 136 VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 136 IIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
++|+|++|.||+++.++.++|+|||++..+..
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.8e-13 Score=151.15 Aligned_cols=151 Identities=19% Similarity=0.300 Sum_probs=105.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc--------------------------------HHHHH
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT--------------------------------EKFKR 57 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~--------------------------------~~~~~ 57 (644)
..+..|.. +.||.|++|+||+|+.+.+|+.||||++++.... .++.+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34667787 7899999999999999988999999999754210 12222
Q ss_pred HH------HHHHHHHHhc----CCCCcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCC----CCCHHHHHHHHHH
Q 006460 58 TA------LQEMDLISKL----NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGA----CFPEEKLCKWLTQ 123 (644)
Q Consensus 58 ~~------~rEi~iL~~L----~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~----~l~e~~i~~i~~Q 123 (644)
.+ .+|+..+.++ .+.+.|.+-.+|.+-....+|||||+.|+.|.++..-...+ .+.+..+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 23 3344444444 24445555555555445578999999999998753211111 2444445555555
Q ss_pred HHHHHHHHHHCCCccccCCCCcEEEcCCC----CeEEeccCcccccccc
Q 006460 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDN----DIRLGDFGLAKLLNTE 168 (644)
Q Consensus 124 IL~gL~yLHs~gIIHRDLKPeNILL~~~g----~vKL~DFGls~~~~~~ 168 (644)
|+ ..|++|+|+||.||+++.+| .++++|||++..+...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 54 59999999999999999888 8999999999876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.4e-13 Score=151.04 Aligned_cols=254 Identities=25% Similarity=0.317 Sum_probs=191.7
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEe-cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCC
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHK-IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKG 85 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k-~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~ 85 (644)
......+|..+..||.|.|+.|+.+... .++..|++|..............-+.|+-+...+ .|.+++.++..|....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3457789999999999999999998755 6678899998766544433334446677777766 5999999999988754
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-CCeEEeccCcccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLAKL 164 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-g~vKL~DFGls~~ 164 (644)
+ .|+-.|||+|+++...+.- ...+.+...+++..|++.++.++|+..++|+|+||.||++..+ +..++.|||+...
T Consensus 340 ~-~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 Q-GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred c-ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 4 6699999999998877643 2347889999999999999999999999999999999999986 7789999999865
Q ss_pred cccccccccccCCCCCC--ChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 165 LNTEDLASSVVGTPNYM--CPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~--APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
+.... ....+.-+++ +|.......+..+.|++|||.-+++.++|.+.-.... ....|..+..+..+ .....+
T Consensus 417 ~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~~-~~~~~~ 490 (524)
T KOG0601|consen 417 LAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPNLP-GLKLQL 490 (524)
T ss_pred cceec--ccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecccccCCC-chHHhh
Confidence 32211 1122233344 5556667778999999999999999999875432211 12233333333333 334888
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
..+.+.++..++..||.+.++..|.-|.
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhh
Confidence 9999999999999999999998886553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.8e-12 Score=143.02 Aligned_cols=184 Identities=18% Similarity=0.303 Sum_probs=140.3
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
-|.+ ...+-++.+.+-.|..+.++.++.++.++.... .....+.+-++-|+.|+||||+++++.+.. +.+.|||+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTE 89 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTE 89 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEee
Confidence 4555 444444444322577888899999999877655 445667788999999999999999998765 557999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-c
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH-SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-A 171 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLH-s~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~-~ 171 (644)
.+. -|..++++ +....+...++||+.||.||| +.+++|++|.-..|+++..|..||++|-++........ .
T Consensus 90 rV~--Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~ 162 (690)
T KOG1243|consen 90 RVR--PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA 162 (690)
T ss_pred ccc--cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc
Confidence 986 57788876 347888899999999999998 56999999999999999999999999988865332221 1
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhC
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH 210 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG 210 (644)
....---.|..|+.+.... ...|.|-|||++++++.|
T Consensus 163 ~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 1122223466777654333 467999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-13 Score=143.90 Aligned_cols=200 Identities=27% Similarity=0.447 Sum_probs=142.2
Q ss_pred HHhcCCCCcceeeeEEEeCC----ceEEEEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC--CCc
Q 006460 66 ISKLNNPYIVKYKDAWVDKG----NCVCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSN--RVL 137 (644)
Q Consensus 66 L~~L~HPNIVkl~~~~~d~~----~~~~LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~--gII 137 (644)
|-.+-|-|||+++.||.+.. ..+.++.||++.|+|..+|++.+ ...+......+|+.||+.||.|||+. .|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 34457999999999987532 35789999999999999998643 34577888899999999999999998 699
Q ss_pred cccCCCCcEEEcCCCCeEEeccCccccccccc-----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCC
Q 006460 138 HRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQP 212 (644)
Q Consensus 138 HRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~ 212 (644)
|+++...-|++..+|-+|+.---.......-. -.....+-++|.+||.=.....+.++|||++|+...+|..|..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 99999999999988888864322111100000 1122346788999997655566789999999999999988764
Q ss_pred C-CCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 213 A-FRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 213 P-F~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
- -........-..+....+. + -...-++++.+||.-.|..||++..++.||.+
T Consensus 281 q~tnseS~~~~ee~ia~~i~~-l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIANVIIG-L---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred ccCCCcceeehhhhhhhheee-c---cCccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 3 2222211111111111100 0 01123478999999999999999999999875
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.8e-12 Score=120.59 Aligned_cols=128 Identities=21% Similarity=0.211 Sum_probs=95.7
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcce-eeeEEEeCCceEEEEEeccC
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVK-YKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVk-l~~~~~d~~~~~~LVmEy~~ 96 (644)
++.|+.|.++.||++... +..|++|........ ...+.+|+.+++.+.+.++++ ++.+ ... ..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~-~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYF--DPE-TGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEE--eCC-CCeEEEEecC
Confidence 467899999999999864 778999987554311 123467899999886655544 4432 222 2479999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----ccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV-----LHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gI-----IHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
|.++... . . ....++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~-~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE-D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc-c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 0 1 113456799999999999985 9999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.3e-11 Score=120.02 Aligned_cols=141 Identities=13% Similarity=0.109 Sum_probs=101.7
Q ss_pred EEEeccCCCeEEEEEEEec------CCeEEEEEEEecccc-----------cHH---------HHH----HHHHHHHHHH
Q 006460 18 IEQIGRGAFGAAFLVLHKI------ERKKYVLKKIRLAKQ-----------TEK---------FKR----TALQEMDLIS 67 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~------tg~~vAiK~i~~~~~-----------~~~---------~~~----~~~rEi~iL~ 67 (644)
...||.|--+.||.|.... .+..+|+|+++.... ... ..+ ...+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997553 357999999854211 000 011 2347999999
Q ss_pred hcC--CCCcceeeeEEEeCCceEEEEEeccCCCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccccCCC
Q 006460 68 KLN--NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAVDYL-HSNRVLHRDLKC 143 (644)
Q Consensus 68 ~L~--HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~-~L~~~~~~~l~e~~i~~i~~QIL~gL~yL-Hs~gIIHRDLKP 143 (644)
+|. .-++..++++ . .-+|||||+.+..+.. .++. ..+++..+..++.+++.+|..| |+.||||+||++
T Consensus 82 rl~~~Gv~vP~pi~~--~---~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL--K---KHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe--c---CCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 985 3466666653 1 2468999997654432 2222 2356667788899999999999 899999999999
Q ss_pred CcEEEcCCCCeEEeccCccccccc
Q 006460 144 SNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 144 eNILL~~~g~vKL~DFGls~~~~~ 167 (644)
.|||+. ++.+.|+|||.+.....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCCC
Confidence 999997 57899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-09 Score=118.22 Aligned_cols=213 Identities=18% Similarity=0.324 Sum_probs=156.6
Q ss_pred eEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe---CCceEEEEEeccCC-CCHHH
Q 006460 27 GAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD---KGNCVCIVTGYCEG-GDMAE 102 (644)
Q Consensus 27 G~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d---~~~~~~LVmEy~~G-gsL~~ 102 (644)
.+.|+|+...+|..|++|++.-..... ......-+++++++.|+|||++.++|.. .+..+++|++|+++ ++|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 578999999999999999993322110 1112335788999999999999999873 24679999999865 56766
Q ss_pred HHHHh-------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 103 IIKKA-------------RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 103 ~L~~~-------------~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+.-.. .+...+|+.+|.|+.||..||.++|+.|+.-+=|.|.+||++.+.+++|...|....+..+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 54211 12356899999999999999999999999999999999999988888888777766554432
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCC-CCCChHHH-HHHHhccCCCCCCccccHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAF-RAPDMAGL-INKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF-~~~~~~el-~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
+ +.+.. -.+-|.--||.+++-|.||..-- ........ +.. +-..++.+++++|.
T Consensus 448 ------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~--------I~~~yS~D~rn~v~ 503 (655)
T KOG3741|consen 448 ------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR--------ITTTYSTDLRNVVE 503 (655)
T ss_pred ------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------hhhhhhHHHHHHHH
Confidence 1 11211 24678889999999999995431 11111111 222 34457899999999
Q ss_pred HHhccCCCCCCCHHHHhhC
Q 006460 248 SMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~h 266 (644)
.+...+++. -++.+++.+
T Consensus 504 yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 504 YLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHhcCccc-ccHHHHHHH
Confidence 999999887 788888865
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.2e-10 Score=111.28 Aligned_cols=142 Identities=16% Similarity=0.194 Sum_probs=103.7
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--CCcceeeeEEEeCC--ceEEEEEe
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN--PYIVKYKDAWVDKG--NCVCIVTG 93 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--PNIVkl~~~~~d~~--~~~~LVmE 93 (644)
.+.||.|..+.||++.... |..|++|+....... .....+.+|+++++.+.+ .++.+++.+..... ...++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 3678999999999997643 679999987654321 123467789999999865 34566666543321 25689999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS---------------------------------------- 133 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs---------------------------------------- 133 (644)
|++|.+|...+.. ..+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999888765421 236666677777777777777773
Q ss_pred ----------------CCCccccCCCCcEEEcC--CCCeEEeccCcccc
Q 006460 134 ----------------NRVLHRDLKCSNIFLTK--DNDIRLGDFGLAKL 164 (644)
Q Consensus 134 ----------------~gIIHRDLKPeNILL~~--~g~vKL~DFGls~~ 164 (644)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.8e-09 Score=105.62 Aligned_cols=131 Identities=28% Similarity=0.338 Sum_probs=93.5
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEE-----ecccccHH-HHHHHHHHHHHHHhcCCCC--cceeeeEEEeCCceEEE
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKI-----RLAKQTEK-FKRTALQEMDLISKLNNPY--IVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i-----~~~~~~~~-~~~~~~rEi~iL~~L~HPN--IVkl~~~~~d~~~~~~L 90 (644)
..+++|+-+.+|.+.+. |.++++|.= +....+++ -..+..+|+++|.++.--. ...+++ .+..+ ..|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD~~~-~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VDPDN-GLI 76 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--EcCCC-CEE
Confidence 35789999999999653 445555532 22222232 2356788999999885433 333443 44443 569
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
+|||++|..|.+++... ...++..+-.-+.-||..||+|+||.++||++... .+.++||||+..
T Consensus 77 ~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 99999999999888753 13456667777788999999999999999999855 499999999874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-08 Score=105.81 Aligned_cols=135 Identities=17% Similarity=0.088 Sum_probs=94.7
Q ss_pred EEEEEEEecCCeEEEEEEEecccccHHHHH---------HHHHHHHHHHhcCC--CCcceeeeEEEeC----CceEEEEE
Q 006460 28 AAFLVLHKIERKKYVLKKIRLAKQTEKFKR---------TALQEMDLISKLNN--PYIVKYKDAWVDK----GNCVCIVT 92 (644)
Q Consensus 28 ~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~---------~~~rEi~iL~~L~H--PNIVkl~~~~~d~----~~~~~LVm 92 (644)
.|+.+. -.|+.|.+|............. .+.+|.+.+.+|.. -..+..+.+.... ....+|||
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 355543 3577899997744332211111 36788888887732 2223333333221 23478999
Q ss_pred eccCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-------CCCeEEeccCcccc
Q 006460 93 GYCEGG-DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-------DNDIRLGDFGLAKL 164 (644)
Q Consensus 93 Ey~~Gg-sL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-------~g~vKL~DFGls~~ 164 (644)
|+++|. +|.+++........++.....++.+|+..+.-||.+||+|+|+++.|||++. +..+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999876 8999986433334567788899999999999999999999999999999985 35799999998753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.8e-09 Score=102.48 Aligned_cols=145 Identities=23% Similarity=0.277 Sum_probs=106.1
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEE-----EecccccHH-HHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKK-----IRLAKQTEK-FKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~-----i~~~~~~~~-~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.+..|-+|+-+.|+++.+ .|+.++||. ++....+.+ ...+..+|+++|.++.--.|.-..-+|.+..+ -.|
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~-~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG-GQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC-CeE
Confidence 678889999999999866 466777764 333333332 34678899999999853333322223445332 458
Q ss_pred EEeccCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC---eEEeccCcccc
Q 006460 91 VTGYCEG-GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND---IRLGDFGLAKL 164 (644)
Q Consensus 91 VmEy~~G-gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~---vKL~DFGls~~ 164 (644)
+|||++| .++.+++...............+++.|-+.+.-||..+|||+||..+||+|.+++. +.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999977 58888887655444444455789999999999999999999999999999987763 58999999865
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.3e-10 Score=124.84 Aligned_cols=149 Identities=20% Similarity=0.285 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCccccccccc----------ccccccCCCCCCChhhhcCCCC
Q 006460 123 QLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED----------LASSVVGTPNYMCPELLADIPY 191 (644)
Q Consensus 123 QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~----------~~~~~~GT~~Y~APEvl~~~~y 191 (644)
+++.||.|+|.. ++||++|.|++|.++..+..||+.|+.+....... ......-...|.|||++.....
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 344999999987 99999999999999999999999999886543311 1111234567999999998888
Q ss_pred CcccchhhHHHHHHHHH-hCCCCCCCCChHHHHHHH---hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCC
Q 006460 192 GYKSDIWSLGCCMFEIA-AHQPAFRAPDMAGLINKI---NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267 (644)
Q Consensus 192 s~ksDIWSLGvILyeLl-tG~~PF~~~~~~el~~~i---~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp 267 (644)
+.++|+||||+++|.+. .|++.+...........- ...........+++++++=+.++|..++..||++..++..|
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 99999999999999998 677777655433222221 11222234466889999999999999999999999999999
Q ss_pred CCch
Q 006460 268 HLQP 271 (644)
Q Consensus 268 ~f~~ 271 (644)
||+.
T Consensus 267 ff~D 270 (700)
T KOG2137|consen 267 FFSD 270 (700)
T ss_pred ccCC
Confidence 9864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=8.5e-08 Score=103.43 Aligned_cols=236 Identities=15% Similarity=0.230 Sum_probs=158.2
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEE-------eCCceEE
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWV-------DKGNCVC 89 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~-------d~~~~~~ 89 (644)
.+.||+|+-+.+|..-.. ...+.|++......-+.. .+..|... .||-+-. .-+|- +.+..+.
T Consensus 16 gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aq-----k~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQ-----KVAELAATPDAPLLNY-RVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CccccCCccceeeecchh---hchhheeecCCCchHHHH-----HHHHhccCCCCcchhh-hhcccHHHhhCCCccceeE
Confidence 467999999999975322 245678876654322211 22333333 4664332 11121 2233477
Q ss_pred EEEeccCCCC-HHHHHH----HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 90 IVTGYCEGGD-MAEIIK----KARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 90 LVmEy~~Ggs-L~~~L~----~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
++|..+.|.. ...++. +.....+.+..+.++.+.|+.+...||+.|.+-+|+.++|+|+++++.+.|+|-.....
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 8898887752 222221 11233467888999999999999999999999999999999999999999999765555
Q ss_pred cccccccccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhC-CCCCCCCC-------hHH--HHHH----
Q 006460 165 LNTEDLASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPD-------MAG--LINK---- 225 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG-~~PF~~~~-------~~e--l~~~---- 225 (644)
...+..+...+|.+.|.+||.-. +..-+...|.|.||+++|+|+.| ..||.+-. ..+ +...
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 45555677789999999999643 44557899999999999999876 89997532 111 1000
Q ss_pred --HhccCCCCCCc-----cccHHHHHHHHHHhcc--CCCCCCCHHH
Q 006460 226 --INRSSISPLPI-----VYSSTMKQIIKSMLRK--NPEHRPTASD 262 (644)
Q Consensus 226 --i~~~~~~~~p~-----~~s~~l~dLI~~~L~~--dP~~RpTa~e 262 (644)
-....+.+-|. .+++.+..|..+|... ++.-|||++-
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 01112222222 3578899999999974 3678999764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.5e-08 Score=96.36 Aligned_cols=128 Identities=20% Similarity=0.250 Sum_probs=83.2
Q ss_pred EEEEEEEecCCeEEEEEEEecccc------------------------cHHHHHHHHHHHHHHHhcCCC--CcceeeeEE
Q 006460 28 AAFLVLHKIERKKYVLKKIRLAKQ------------------------TEKFKRTALQEMDLISKLNNP--YIVKYKDAW 81 (644)
Q Consensus 28 ~Vyla~~k~tg~~vAiK~i~~~~~------------------------~~~~~~~~~rEi~iL~~L~HP--NIVkl~~~~ 81 (644)
.||.|.. ..+..+|+|+.+.... .........+|++.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 3888876 4677999999854211 111234567899999999755 56666653
Q ss_pred EeCCceEEEEEeccC--CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHCCCccccCCCCcEEEcCCCCeEEec
Q 006460 82 VDKGNCVCIVTGYCE--GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY-LHSNRVLHRDLKCSNIFLTKDNDIRLGD 158 (644)
Q Consensus 82 ~d~~~~~~LVmEy~~--GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~y-LHs~gIIHRDLKPeNILL~~~g~vKL~D 158 (644)
. . -+|||||+. |..+..+... . ++......++.+++..+.. +|+.||+|+||.+.|||++.+ .+.|+|
T Consensus 79 -~-~--~~ivME~I~~~G~~~~~l~~~-~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 -N-R--NVIVMEYIGEDGVPLPRLKDV-D---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp -E-T--TEEEEE--EETTEEGGCHHHC-G---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--
T ss_pred -e-C--CEEEEEecCCCccchhhHHhc-c---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEe
Confidence 2 2 259999998 6555543332 1 2234566778888885555 579999999999999999876 999999
Q ss_pred cCcccccc
Q 006460 159 FGLAKLLN 166 (644)
Q Consensus 159 FGls~~~~ 166 (644)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=94.57 Aligned_cols=106 Identities=19% Similarity=0.231 Sum_probs=81.0
Q ss_pred HHHHHHHHHHHhcCC--CCcceeeeEEEeC---CceEEEEEeccCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 006460 57 RTALQEMDLISKLNN--PYIVKYKDAWVDK---GNCVCIVTGYCEGG-DMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130 (644)
Q Consensus 57 ~~~~rEi~iL~~L~H--PNIVkl~~~~~d~---~~~~~LVmEy~~Gg-sL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~y 130 (644)
.+..+|...+..|.. -.+...+.+.... ....++|+|+++|. +|.+++..... ++......++.++...+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 457778887777732 2233344433321 13468999999884 79999876332 5667788999999999999
Q ss_pred HHHCCCccccCCCCcEEEcCCC---CeEEeccCcccc
Q 006460 131 LHSNRVLHRDLKCSNIFLTKDN---DIRLGDFGLAKL 164 (644)
Q Consensus 131 LHs~gIIHRDLKPeNILL~~~g---~vKL~DFGls~~ 164 (644)
||.+||+|+|++|.|||++.++ .+.|+||+-++.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 799999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1e-07 Score=98.48 Aligned_cols=137 Identities=22% Similarity=0.250 Sum_probs=102.9
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc--------------------HHHHHHHHHHHHHHHhcCCC--
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT--------------------EKFKRTALQEMDLISKLNNP-- 72 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~--------------------~~~~~~~~rEi~iL~~L~HP-- 72 (644)
+.+...||-|--+.||.|.+. .|.++|+|.-+..... ..-...+.+|+++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 346789999999999999876 7889999976443211 11123567899999999655
Q ss_pred CcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC
Q 006460 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN 152 (644)
Q Consensus 73 NIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g 152 (644)
.|.+.+++ + .-++||||++|-.|...- +..+....++..|+.-+.-+-..||||+|+.+-||+++.+|
T Consensus 172 ~VP~P~~~----n-RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 172 KVPKPIAW----N-RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCCcccc----c-cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence 67777763 2 246999999997765432 23455566677777777777799999999999999999999
Q ss_pred CeEEeccCcccc
Q 006460 153 DIRLGDFGLAKL 164 (644)
Q Consensus 153 ~vKL~DFGls~~ 164 (644)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999965443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.4e-09 Score=117.96 Aligned_cols=246 Identities=19% Similarity=0.259 Sum_probs=170.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC-cceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY-IVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPN-IVkl~~~~~d~~~~~ 88 (644)
.+..-|....-+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++.+ +.+.+.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~-~~E~~~ 309 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY-DGEDYL 309 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC-Cccccc
Confidence 34445666677899999999998877665444 5555433 12233788999999999 77777654 346789
Q ss_pred EEEEeccCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 89 CIVTGYCEGG-DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 89 ~LVmEy~~Gg-sL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+++++++.++ +-....... .-.+-+-+...+.+.-+.+|+|||+--=+||| ||+.. ++..++.||+....+..
T Consensus 310 ~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTR 383 (829)
T ss_pred chhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCc
Confidence 9999999887 221111100 01133344555667778899999998779999 77765 47899999999988776
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCcc-----ccHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV-----YSSTM 242 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~-----~s~~l 242 (644)
....++..+++.++|||+.....|....|.|++|.--.+|.-|.+|-..... ....+..+. ..+.. ++...
T Consensus 384 ~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p--~s~~L~~~~aw~~~~ 459 (829)
T KOG0576|consen 384 TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGP--NSPMLTDKSAWSPVF 459 (829)
T ss_pred ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCC--CccccchhhhcCccc
Confidence 6566788999999999999999999999999999877788888877654211 000110010 01111 11222
Q ss_pred H-HHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 243 K-QIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 243 ~-dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
. ++...|+..-|..|++...++-|.+|.....
T Consensus 460 ~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 460 HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred ccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 2 4888899999999999999988877765443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.4e-06 Score=86.11 Aligned_cols=140 Identities=16% Similarity=0.138 Sum_probs=99.5
Q ss_pred ccCCCeEEEEEEEecCCeEEEEEEEeccc-cc---HHHHHHHHHHHHHHHhcCC--CCcceeeeEEEe---C-CceEEEE
Q 006460 22 GRGAFGAAFLVLHKIERKKYVLKKIRLAK-QT---EKFKRTALQEMDLISKLNN--PYIVKYKDAWVD---K-GNCVCIV 91 (644)
Q Consensus 22 G~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~---~~~~~~~~rEi~iL~~L~H--PNIVkl~~~~~d---~-~~~~~LV 91 (644)
|+||.+.|+..... |..|-+|...... .. +.....|.+|+..|++|.. -.+.+.. ++.. . .-..+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 66888889987543 3368888764110 00 1134678889999988842 2244444 2221 1 1246789
Q ss_pred EeccCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC--eEEeccCcccc
Q 006460 92 TGYCEG-GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND--IRLGDFGLAKL 164 (644)
Q Consensus 92 mEy~~G-gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~--vKL~DFGls~~ 164 (644)
+|-+.| .+|.+++....-...++.....++.+|...|.-||..|+.|+|+-+.|||++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997743 68988886543335677878899999999999999999999999999999987777 99999976654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.6e-06 Score=85.20 Aligned_cols=140 Identities=20% Similarity=0.262 Sum_probs=90.5
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHH------HHHHHHHHHhc---CCCCcceeeeEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRT------ALQEMDLISKL---NNPYIVKYKDAW 81 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~------~~rEi~iL~~L---~HPNIVkl~~~~ 81 (644)
-++|++.+.+-.....-|.+. ...|..+++|..+..... +..... ..+++..+.++ +--.++.++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 357888888888776666655 456789999987654321 111111 22334433333 222333322222
Q ss_pred Ee----CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEe
Q 006460 82 VD----KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLG 157 (644)
Q Consensus 82 ~d----~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~ 157 (644)
.. -....+|||||++|..|.++.. +++. +...|..++.-||+.|++|+|..|.|++++. +.++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iI 176 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRII 176 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEE
Confidence 11 1245679999999998877542 3332 4456778899999999999999999999985 559999
Q ss_pred ccCcccc
Q 006460 158 DFGLAKL 164 (644)
Q Consensus 158 DFGls~~ 164 (644)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.6e-08 Score=121.36 Aligned_cols=256 Identities=15% Similarity=0.093 Sum_probs=179.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeE-EEEEE---EecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe-CC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKK-YVLKK---IRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD-KG 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~-vAiK~---i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d-~~ 85 (644)
.++.|++.=-+|-|.++ ++.+...... +-+|+ +......+-.++..+.|...++...|++++..+.-..+ .+
T Consensus 1227 ~~e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred Hhhhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 34556665555555543 2322222111 22333 33334444455666777777788899998877654333 23
Q ss_pred ceEEEEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-C----CccccCCCCcEEEcCCCCeEEec
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSN-R----VLHRDLKCSNIFLTKDNDIRLGD 158 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~-g----IIHRDLKPeNILL~~~g~vKL~D 158 (644)
...|.+++||.+|.+...|-+.- ...+.+.-+.....+.+....-+|+. + .+|++||+.|.+|..+.++++.+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 45689999999999999987532 22333444444444548888888866 2 58999999999999999999999
Q ss_pred cCcccc-cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCcc
Q 006460 159 FGLAKL-LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV 237 (644)
Q Consensus 159 FGls~~-~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~ 237 (644)
+|+.+. -..........+++.|+.|++.....++.++|+|..|+.+|.+..|.++|.......+...+..+.....+..
T Consensus 1384 ~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l 1463 (2724)
T KOG1826|consen 1384 GGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKL 1463 (2724)
T ss_pred cccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccccccccccccc
Confidence 999993 3333456678899999999999999999999999999999999999888764443444444445555556666
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.|.+.......+|-..-..||.-...+.-+.+
T Consensus 1464 ~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1464 KPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred CCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 77777777777777788899999888887665
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.7e-06 Score=100.25 Aligned_cols=201 Identities=20% Similarity=0.278 Sum_probs=145.5
Q ss_pred HHHHHHHHHhcCCCCcceeeeEEEeCCc---eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 006460 59 ALQEMDLISKLNNPYIVKYKDAWVDKGN---CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR 135 (644)
Q Consensus 59 ~~rEi~iL~~L~HPNIVkl~~~~~d~~~---~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g 135 (644)
..-|+..+.++.|+|++.++.+-.+.-. ...+..++|++.++...+... ..++.+.++.+..+++.||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3446777888899999999987654321 223456899999999988763 45888999999999999999999996
Q ss_pred CccccCCCC---cEEEcCCCCeEEe--ccCcccccccccccccccCCCCCCChhhhcCCCCCcc--cchhhHHHHHHHHH
Q 006460 136 VLHRDLKCS---NIFLTKDNDIRLG--DFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYK--SDIWSLGCCMFEIA 208 (644)
Q Consensus 136 IIHRDLKPe---NILL~~~g~vKL~--DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~k--sDIWSLGvILyeLl 208 (644)
..|.-|... +.-.+..+.+.+. ||+.+..+...........+..+.+||......+..+ .|+|.+|..+..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 666555444 3333445556655 8888887766555555666777889998877666544 69999999999998
Q ss_pred hCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 209 AHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 209 tG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.|..+-.... .....++........+++.+|+.-++++|+++.+++.|+|+..
T Consensus 387 ~~~~i~~~~~----------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 387 QGEDISEKSA----------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hcCccccccc----------chhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 8765422111 1111122223337789999999999999999999999999864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.5e-06 Score=95.40 Aligned_cols=146 Identities=17% Similarity=0.237 Sum_probs=97.4
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc--------------------------------HHHHH------HHH
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT--------------------------------EKFKR------TAL 60 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~--------------------------------~~~~~------~~~ 60 (644)
.-|+.++-|+||.|..+. |+.||||+.+..... .++.+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 468899999999998875 999999998654210 11111 233
Q ss_pred HHHHHHHhc----CCCCcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 006460 61 QEMDLISKL----NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136 (644)
Q Consensus 61 rEi~iL~~L----~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gI 136 (644)
+|...+.++ .+..-+++-.+|.+-.+.-+|+|||+.|-.+.++..... ..++...+...+.++ -+..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 455555554 223334444555553445679999999999988853222 235533333322222 1334445899
Q ss_pred ccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 137 IHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
+|.|.+|.||++..+|.+.+.|||+...+.+.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 99999999999999999999999999876553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.6e-05 Score=80.99 Aligned_cols=136 Identities=18% Similarity=0.175 Sum_probs=80.6
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC--cceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY--IVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPN--IVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
..||.|..+.||+. .+..+++|....... ...+.+|.++++.+..-. +.+.+++..+ +...++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD----KETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCC----HHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecC
Confidence 57899999999984 255788898765332 234577999998885333 3455554433 455789999999
Q ss_pred CCC-HH--------------HHHHH----hcCC---CCCHHHH-HHHHHH----------HHH-HHHHHHH----CCCcc
Q 006460 97 GGD-MA--------------EIIKK----ARGA---CFPEEKL-CKWLTQ----------LLL-AVDYLHS----NRVLH 138 (644)
Q Consensus 97 Ggs-L~--------------~~L~~----~~~~---~l~e~~i-~~i~~Q----------IL~-gL~yLHs----~gIIH 138 (644)
|.+ +. ..+.. -... ..+.... ..+..+ +.. ...+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11 11111 1110 1111110 111111 111 1222221 24689
Q ss_pred ccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 139 RDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 139 RDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
+|+.|.||+++.++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999887 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.1e-05 Score=77.74 Aligned_cols=141 Identities=19% Similarity=0.234 Sum_probs=82.3
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC--CcceeeeEEEeC--CceEEEEEe
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP--YIVKYKDAWVDK--GNCVCIVTG 93 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HP--NIVkl~~~~~d~--~~~~~LVmE 93 (644)
++.|+.|..+.||++.... ..+++|..... .....+.+|+.+++.|... .+.+++...... ....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999998765 49999987654 2345566788888887432 345555533221 235789999
Q ss_pred ccCCCCHHH----------------HHHHhcC-----CCCCHHH------HHHH---------------HHHHHH-HHHH
Q 006460 94 YCEGGDMAE----------------IIKKARG-----ACFPEEK------LCKW---------------LTQLLL-AVDY 130 (644)
Q Consensus 94 y~~GgsL~~----------------~L~~~~~-----~~l~e~~------i~~i---------------~~QIL~-gL~y 130 (644)
+++|..+.. .+..... ..+.... .... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999988877 1211111 0111000 0000 111222 3333
Q ss_pred HHH-------CCCccccCCCCcEEEc-CCCCeEEeccCcccc
Q 006460 131 LHS-------NRVLHRDLKCSNIFLT-KDNDIRLGDFGLAKL 164 (644)
Q Consensus 131 LHs-------~gIIHRDLKPeNILL~-~~g~vKL~DFGls~~ 164 (644)
+++ ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 332 3589999999999999 556667999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.4e-05 Score=80.37 Aligned_cols=139 Identities=14% Similarity=0.107 Sum_probs=94.8
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH----------------------HHHHHHHHHHHHHhcC--CCCc
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK----------------------FKRTALQEMDLISKLN--NPYI 74 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~----------------------~~~~~~rEi~iL~~L~--HPNI 74 (644)
..|..|--+.||+|.. ..+..+|+|+++....... ...-...|++-|+++. +=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3666777779999865 5678999999865432111 1112346888888874 4445
Q ss_pred ceeeeEEEeCCceEEEEEeccCCCCHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCC
Q 006460 75 VKYKDAWVDKGNCVCIVTGYCEGGDMA-EIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDN 152 (644)
Q Consensus 75 Vkl~~~~~d~~~~~~LVmEy~~GgsL~-~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g 152 (644)
.+.+.+. . -.|||||+....+- -.|+ ...+...++..+..+++..+.-|-. .|+||+||+.=|||+. ++
T Consensus 133 P~Pi~~~-~----nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFR-N----NVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeec-C----CeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence 5555542 1 35999998432110 0111 1223344688888999999999977 8999999999999999 88
Q ss_pred CeEEeccCccccccc
Q 006460 153 DIRLGDFGLAKLLNT 167 (644)
Q Consensus 153 ~vKL~DFGls~~~~~ 167 (644)
.+.++|||-+....+
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999998875543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=5.9e-05 Score=85.55 Aligned_cols=146 Identities=14% Similarity=0.195 Sum_probs=96.1
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-----------------------------HHHHHH------HHHHH
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-----------------------------EKFKRT------ALQEM 63 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-----------------------------~~~~~~------~~rEi 63 (644)
+.||.-+.|.||+|+-+. |+.||||+-+..-.. ++..+. |.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 468889999999999876 999999997654211 111112 23344
Q ss_pred HHHHhc----CCCC---cceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 006460 64 DLISKL----NNPY---IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRV 136 (644)
Q Consensus 64 ~iL~~L----~HPN---IVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gI 136 (644)
+-..++ .|-+ -|.+-.+|.+-...-+|+||||+|..+.++-.- ....++...+...+.+... ..|=..|+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~--~qIf~~Gf 322 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYL--EQIFKTGF 322 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence 333332 3444 233444555545567899999999888776332 2234666655554444422 33445789
Q ss_pred ccccCCCCcEEEcC----CCCeEEeccCcccccccc
Q 006460 137 LHRDLKCSNIFLTK----DNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 137 IHRDLKPeNILL~~----~g~vKL~DFGls~~~~~~ 168 (644)
+|.|=+|.||++.+ ++.+.+.|||+...+.+.
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 99999999999994 567999999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00012 Score=88.08 Aligned_cols=148 Identities=21% Similarity=0.356 Sum_probs=91.0
Q ss_pred EEEEeccCCCeEEEEEEEecCC--eEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCc--ceeeeEEEeCC--ceEE
Q 006460 17 VIEQIGRGAFGAAFLVLHKIER--KKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYI--VKYKDAWVDKG--NCVC 89 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg--~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNI--Vkl~~~~~d~~--~~~~ 89 (644)
.+..|+.|.++.+|+......+ ..+++|+........ ....+.+|+++|+.|. |+++ .+++.++.+.. ...|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3678899999999998765432 478888765432211 1345778999999995 6664 66666554421 3578
Q ss_pred EEEeccCCCCHHH--------------------HHHHhcCC-----C---------CCHHHHHHHHHH------------
Q 006460 90 IVTGYCEGGDMAE--------------------IIKKARGA-----C---------FPEEKLCKWLTQ------------ 123 (644)
Q Consensus 90 LVmEy~~GgsL~~--------------------~L~~~~~~-----~---------l~e~~i~~i~~Q------------ 123 (644)
+||||++|..+.+ .+..-... . +....+..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999998864321 11111110 0 111233322222
Q ss_pred ---HHHHHHHHHH-----------CCCccccCCCCcEEEcCC-CC-eEEeccCccccc
Q 006460 124 ---LLLAVDYLHS-----------NRVLHRDLKCSNIFLTKD-ND-IRLGDFGLAKLL 165 (644)
Q Consensus 124 ---IL~gL~yLHs-----------~gIIHRDLKPeNILL~~~-g~-vKL~DFGls~~~ 165 (644)
+...+.+|.. ..+||+|++|.|||++.+ +. +-|+||.++..-
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233566643 249999999999999853 33 569999998753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00013 Score=74.23 Aligned_cols=136 Identities=15% Similarity=0.090 Sum_probs=79.8
Q ss_pred eccCCC-eEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceEEEEEeccCCC
Q 006460 21 IGRGAF-GAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCVCIVTGYCEGG 98 (644)
Q Consensus 21 LG~G~f-G~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~~LVmEy~~Gg 98 (644)
|-.|.. ..||++... +..+++|+..... ...+.+|+++++.+. +--+.+++++... +...++||++++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD-DGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec-CCccEEEEEeeCCc
Confidence 444555 789998653 4688888775432 234567888888874 3345566665544 34578999999998
Q ss_pred CHHHHH----------------HHhcCC-----CCCH---HHHHHH---HH----------------HHHHHHHHHH---
Q 006460 99 DMAEII----------------KKARGA-----CFPE---EKLCKW---LT----------------QLLLAVDYLH--- 132 (644)
Q Consensus 99 sL~~~L----------------~~~~~~-----~l~e---~~i~~i---~~----------------QIL~gL~yLH--- 132 (644)
+|.... .+.... .+.. ...... +. .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 776431 111110 1110 000000 00 0111122221
Q ss_pred ----HCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 133 ----SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 133 ----s~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12489999999999999877788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00052 Score=68.89 Aligned_cols=128 Identities=23% Similarity=0.297 Sum_probs=90.9
Q ss_pred CCeEEEEEeccCCC-eEEEEEEEecCCeEEEEEEEec---cc-------cc---------HHHHHHHHHHHHHHHhc---
Q 006460 13 EDYEVIEQIGRGAF-GAAFLVLHKIERKKYVLKKIRL---AK-------QT---------EKFKRTALQEMDLISKL--- 69 (644)
Q Consensus 13 ~~Y~i~~~LG~G~f-G~Vyla~~k~tg~~vAiK~i~~---~~-------~~---------~~~~~~~~rEi~iL~~L--- 69 (644)
.+++.++.||.|.- |.||++.. .|+.||+|..+. .. .. ..+...|..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 99999964 577999999321 10 00 02334567787776666
Q ss_pred CCCCc--ceeeeEEEeCC-----------------ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 006460 70 NNPYI--VKYKDAWVDKG-----------------NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130 (644)
Q Consensus 70 ~HPNI--Vkl~~~~~d~~-----------------~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~y 130 (644)
++.++ |+.+++..-.. ....||.||+.... .+.. .-+.+|++-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHH
Confidence 45566 89988764321 13467888876543 1222 235678888999
Q ss_pred HHHCCCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 131 LHs~gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
+|..||+-+|+++.|.. + -||+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc---C--CEEEecccC
Confidence 99999999999999985 2 388999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00021 Score=70.93 Aligned_cols=98 Identities=21% Similarity=0.173 Sum_probs=77.3
Q ss_pred HHHHHHHhcCC-CCcceeeeEEEeCCceEEEEEeccCCCCHHHH---HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---
Q 006460 61 QEMDLISKLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEI---IKKARGACFPEEKLCKWLTQLLLAVDYLHS--- 133 (644)
Q Consensus 61 rEi~iL~~L~H-PNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~---L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs--- 133 (644)
.|.-+|+.+.+ +++.+++|+| +. ++|.||...+++... +.. ...-++....+|+.+++..+.+|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C---G~--~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC---GR--FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC---CC--EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 47888888875 6999999987 33 568999977665421 111 1125789999999999999999987
Q ss_pred CCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 134 ~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+.-.|++|+|+-++.+|++|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 35677999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0003 Score=71.54 Aligned_cols=74 Identities=15% Similarity=0.106 Sum_probs=44.4
Q ss_pred EEEeccCCCe-EEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC---CcceeeeEEEeCC--ceEEEE
Q 006460 18 IEQIGRGAFG-AAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP---YIVKYKDAWVDKG--NCVCIV 91 (644)
Q Consensus 18 ~~~LG~G~fG-~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HP---NIVkl~~~~~d~~--~~~~LV 91 (644)
+..|+.|+.. .||++. ..+++|..+... ....+.+|+++|+.|... .+.++++.....+ ...+++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 3567777776 599862 367888654322 234677899999887532 2333333221111 235789
Q ss_pred EeccCCCCH
Q 006460 92 TGYCEGGDM 100 (644)
Q Consensus 92 mEy~~GgsL 100 (644)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00042 Score=68.07 Aligned_cols=129 Identities=19% Similarity=0.197 Sum_probs=91.2
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
+.+.||+|++|.||+|.+. |..+|+|+-+.... ...+..|+++|..+..-++-+-+-. +.. .++.|||+.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~-yg~---~~i~me~i~ 95 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYF-YGE---DFIRMEYID 95 (201)
T ss_pred hhhhhhcccccEEEEeecc--CceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEE-ech---hhhhhhhhc
Confidence 4567999999999999875 45899998765543 4567779999999987776554432 232 336699999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCC-CCcEEEcCCCCeEEeccCcccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLK-CSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLK-PeNILL~~~g~vKL~DFGls~~ 164 (644)
|..|..+-... . ++-+..+++.---|-..||-|..|. |..++|-.++.+.|+||.-|..
T Consensus 96 G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98887754321 1 1223455666555677799999995 5555555566999999998874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0011 Score=67.00 Aligned_cols=75 Identities=9% Similarity=0.116 Sum_probs=47.8
Q ss_pred EEEeccCCCeEEEEEEEec-CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCceEEEEEecc
Q 006460 18 IEQIGRGAFGAAFLVLHKI-ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI-VKYKDAWVDKGNCVCIVTGYC 95 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~-tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNI-Vkl~~~~~d~~~~~~LVmEy~ 95 (644)
++.|..|-...+|++.... .+..|++|+...... .. -...+|+.+++.+....+ ++++.. .+ + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~-~d~~~E~~~~~~l~~~gl~P~v~~~-~~-~---~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LI-IDRERELRIHKLLSKHGLAPKLYAT-FQ-N---GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ce-ecHHHHHHHHHHHHhCCCCCeEEEE-eC-C---cEEEEee
Confidence 5678889999999996443 356899997754321 11 123468888888854333 344332 22 2 3799999
Q ss_pred CCCCH
Q 006460 96 EGGDM 100 (644)
Q Consensus 96 ~GgsL 100 (644)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.002 Score=64.61 Aligned_cols=129 Identities=17% Similarity=0.238 Sum_probs=87.9
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEeccc--------------ccHHHHHHHHHHHHHHHhcC------CCCcceee
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK--------------QTEKFKRTALQEMDLISKLN------NPYIVKYK 78 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~--------------~~~~~~~~~~rEi~iL~~L~------HPNIVkl~ 78 (644)
..||.|+.=.||.- .......||++.... ......+...+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899998888863 344567888886655 01111244555665555554 78999999
Q ss_pred eEEEeCCceEEEEEeccCC------CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC
Q 006460 79 DAWVDKGNCVCIVTGYCEG------GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN 152 (644)
Q Consensus 79 ~~~~d~~~~~~LVmEy~~G------gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g 152 (644)
|.. +++....+|+|.+.. .+|.++++.. .+++ .+. ..+-.-..||-+++|+.+||+|.||++....
T Consensus 84 G~v-eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFV-ETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEE-ecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 965 556667888887532 4788888542 3655 333 3444556788999999999999999998543
Q ss_pred ----CeEEec
Q 006460 153 ----DIRLGD 158 (644)
Q Consensus 153 ----~vKL~D 158 (644)
.+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 477887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00043 Score=77.30 Aligned_cols=162 Identities=22% Similarity=0.280 Sum_probs=106.1
Q ss_pred HHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 006460 58 TALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVL 137 (644)
Q Consensus 58 ~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gII 137 (644)
+++--.++++.+.|+|...++++-........+|||++ +.+|.++++... +-.. +++ .
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~-------s~~-----------~ 85 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDE-------SLL-----------A 85 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchh-------hhc-----------c
Confidence 45566789999999999999987655445688999999 789999987532 1111 111 3
Q ss_pred cccCCCCcEEEcCCCCeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 006460 138 HRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP 217 (644)
Q Consensus 138 HRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~ 217 (644)
||-+ +-||+ ..+| .+... ..+ ..++|+||||+|.++.++.-|...+...
T Consensus 86 ~~~~-~~~~~-------~~td-----~~~t~--~~~----------------~~~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 86 HGVL-HLNII-------YITD-----HFLTK--YPS----------------PIGPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred cccc-eehhh-------hccc-----ccccc--CCC----------------CCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 3311 11222 2223 00000 001 1124999999999999999887776655
Q ss_pred ChHHHHHHHhccCCCCCC-----------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 218 DMAGLINKINRSSISPLP-----------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 218 ~~~el~~~i~~~~~~~~p-----------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
...+....+..-...+.. ..++..+.++..+|+-..|..||...++++++-|..-
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 555555555443322211 1246678899999999999999999999999888643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0046 Score=63.57 Aligned_cols=134 Identities=13% Similarity=0.209 Sum_probs=77.3
Q ss_pred eccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcc-eeeeEEEeCCceEEEEEeccCCCC
Q 006460 21 IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIV-KYKDAWVDKGNCVCIVTGYCEGGD 99 (644)
Q Consensus 21 LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIV-kl~~~~~d~~~~~~LVmEy~~Ggs 99 (644)
+..|-.+.+|++. .++..+++|........ ..-...+|.++++.+....++ +++.. .. -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~---~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILV--NE---HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEE--eC---CEEEEEeccCcc
Confidence 5568888999886 45678888875443211 101235688888888643333 33332 22 258999999866
Q ss_pred HHH--------------HHHHhcCC-----CCC-HHHHHHHHHHH---------HHHHHHHHHC--------CCccccCC
Q 006460 100 MAE--------------IIKKARGA-----CFP-EEKLCKWLTQL---------LLAVDYLHSN--------RVLHRDLK 142 (644)
Q Consensus 100 L~~--------------~L~~~~~~-----~l~-e~~i~~i~~QI---------L~gL~yLHs~--------gIIHRDLK 142 (644)
+.. .+.+-... .++ ...+..+..++ ...+..+-.. .++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 531 12221111 111 12222322222 1112222221 47999999
Q ss_pred CCcEEEcCCCCeEEeccCcccc
Q 006460 143 CSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 143 PeNILL~~~g~vKL~DFGls~~ 164 (644)
|.||+++.++ +.|+||..+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999876 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00033 Score=74.56 Aligned_cols=132 Identities=23% Similarity=0.298 Sum_probs=93.1
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc------------------HHHH--HHHHHHHHHHHhcC-CC-
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT------------------EKFK--RTALQEMDLISKLN-NP- 72 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~------------------~~~~--~~~~rEi~iL~~L~-HP- 72 (644)
|.+...||-|--+.||.+-+. .|.++++|.-+..... ..+. -...+|+..|+.|. |-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567889999999999999764 5778888865432211 1111 23467899999884 32
Q ss_pred CcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC
Q 006460 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN 152 (644)
Q Consensus 73 NIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g 152 (644)
-|.+.+++ .+ -++|||++.|..|...-.- ..+..+...+..-+.-|-++|+||+|+.--||++..++
T Consensus 173 pVPkpiD~----~R-H~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 173 PVPKPIDH----NR-HCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCcccc----cc-eeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 23444443 23 5799999999888764321 12233445556666778999999999999999999999
Q ss_pred CeEEeccC
Q 006460 153 DIRLGDFG 160 (644)
Q Consensus 153 ~vKL~DFG 160 (644)
.++++||-
T Consensus 240 ~i~vIDFP 247 (465)
T KOG2268|consen 240 KIVVIDFP 247 (465)
T ss_pred CEEEeech
Confidence 99999994
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.007 Score=64.07 Aligned_cols=144 Identities=19% Similarity=0.248 Sum_probs=80.8
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC--CcceeeeE-----EEeCCc
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP--YIVKYKDA-----WVDKGN 86 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HP--NIVkl~~~-----~~d~~~ 86 (644)
....++.++.|....+|++.. ++..+++|+....... ..+..|++++..|... .+.+++.. +..-+.
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~----~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKA----EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred CceeccccCCccccceEEEEe--CCCcEEEEEecCCCCH----HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 344467788888889998853 3447889987553221 2234566777666321 13333321 111134
Q ss_pred eEEEEEeccCCCCHH-----------HHHHHhc--CCCCCH-------HHHH----------------HHHHHHHHHHHH
Q 006460 87 CVCIVTGYCEGGDMA-----------EIIKKAR--GACFPE-------EKLC----------------KWLTQLLLAVDY 130 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~-----------~~L~~~~--~~~l~e-------~~i~----------------~i~~QIL~gL~y 130 (644)
..+++++|++|..+. ..+.... ...++. ...+ .....+...+.+
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 578999999885431 1111100 001100 0000 001122334555
Q ss_pred HHH-------CCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 131 LHS-------NRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 131 LHs-------~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
+.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 542 589999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.013 Score=62.19 Aligned_cols=31 Identities=29% Similarity=0.284 Sum_probs=26.1
Q ss_pred CCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 134 ~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999998665568999998753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.009 Score=63.39 Aligned_cols=78 Identities=13% Similarity=0.041 Sum_probs=53.0
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC---CCcceeeeEEEeC--CceEEEE
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN---PYIVKYKDAWVDK--GNCVCIV 91 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H---PNIVkl~~~~~d~--~~~~~LV 91 (644)
-.+.||.|..+.||..... +..+++|..+.... ...+.+|...|+.|.. -.+.++++++... ....+||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 18 RVECISEQPYAALWALYDS--QGNPMPLMARSFST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeeecCCccceeEEEEEcC--CCCEEEEEeccccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3567999999999998532 23577777433111 2356778888888843 3577777765432 2457999
Q ss_pred EeccCCCCH
Q 006460 92 TGYCEGGDM 100 (644)
Q Consensus 92 mEy~~GgsL 100 (644)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0079 Score=62.94 Aligned_cols=141 Identities=16% Similarity=0.190 Sum_probs=81.1
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC--CcceeeeE-----EEeCCceEE
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP--YIVKYKDA-----WVDKGNCVC 89 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HP--NIVkl~~~-----~~d~~~~~~ 89 (644)
-++.|..|....+|++.. .+..+++|+.... . ...+..|+++++.|.+. .+.+++.. +..-+...+
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 366788888889999853 3457999987641 1 23455677777777422 24444331 111123468
Q ss_pred EEEeccCCCCHHH-----------HHHHhc--CCCCCH--------HHHH------------HHHHHHHHHHHHHHH---
Q 006460 90 IVTGYCEGGDMAE-----------IIKKAR--GACFPE--------EKLC------------KWLTQLLLAVDYLHS--- 133 (644)
Q Consensus 90 LVmEy~~GgsL~~-----------~L~~~~--~~~l~e--------~~i~------------~i~~QIL~gL~yLHs--- 133 (644)
+|++|++|..+.. .+.+.. ...+.. .-.. .....+...+.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 111100 000000 0000 011112334445443
Q ss_pred ----CCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 134 ----NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 134 ----~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999877678999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0088 Score=66.14 Aligned_cols=79 Identities=15% Similarity=0.076 Sum_probs=53.3
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecc-----cccHHHHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCceEE
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-----KQTEKFKRTALQEMDLISKLN---NPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~-----~~~~~~~~~~~rEi~iL~~L~---HPNIVkl~~~~~d~~~~~~ 89 (644)
.+.||.|.+..||++.....++.++||.-... ........+...|.+.|+.+. ..++.+++.+ +. ...+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~-~~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE-ELAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC-CCCE
Confidence 46799999999999998654468999975321 100112356667888888763 3456667654 43 3467
Q ss_pred EEEeccCCCC
Q 006460 90 IVTGYCEGGD 99 (644)
Q Consensus 90 LVmEy~~Ggs 99 (644)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998743
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.017 Score=60.82 Aligned_cols=76 Identities=13% Similarity=0.173 Sum_probs=48.1
Q ss_pred EEEeccCCCeEEEEEEEec------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCceEEE
Q 006460 18 IEQIGRGAFGAAFLVLHKI------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI-VKYKDAWVDKGNCVCI 90 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNI-Vkl~~~~~d~~~~~~L 90 (644)
++.|..|-...||++.... .++.|++|+....... .....+|+++++.+....+ .+++.++ . + .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~-~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIF-P-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEe-C-C---Cc
Confidence 4567778888999987543 2578999987553211 1234668888888753333 3444433 2 2 26
Q ss_pred EEeccCCCCHH
Q 006460 91 VTGYCEGGDMA 101 (644)
Q Consensus 91 VmEy~~GgsL~ 101 (644)
|++|++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.00023 Score=67.77 Aligned_cols=121 Identities=11% Similarity=0.124 Sum_probs=88.8
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccccccc-----ccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTE-----TSDCSRD 390 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~-----~~~l~~a 390 (644)
+.+..++++..+.++..++. .......+..+++.+.|.|++|.| |+.||+..+.......+ .+.+..|
T Consensus 12 ~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I-~~~eF~~l~~~~~~~~~~~~~~~~el~ea 90 (151)
T KOG0027|consen 12 EAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTI-DFEEFLDLMEKLGEEKTDEEASSEELKEA 90 (151)
T ss_pred HHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeE-cHHHHHHHHHhhhcccccccccHHHHHHH
Confidence 34556666666666655553 233567778999999999999999 99999987754433322 3489999
Q ss_pred cccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhc
Q 006460 391 KQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADI 452 (644)
Q Consensus 391 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (644)
|+.+++ |++++||+++++.+..-.|.... .+|. -+.++..|.| .|+.|++.+|
T Consensus 91 F~~fD~-----d~~G~Is~~el~~~l~~lg~~~~-~~e~-~~mi~~~d~d--~dg~i~f~ef 143 (151)
T KOG0027|consen 91 FRVFDK-----DGDGFISASELKKVLTSLGEKLT-DEEC-KEMIREVDVD--GDGKVNFEEF 143 (151)
T ss_pred HHHHcc-----CCCCcCcHHHHHHHHHHhCCcCC-HHHH-HHHHHhcCCC--CCCeEeHHHH
Confidence 999999 99999999999999777776665 2222 2347788887 8888876554
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.00033 Score=67.55 Aligned_cols=121 Identities=10% Similarity=0.107 Sum_probs=91.8
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccc-ccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERS-TQTETSDCSRDKQAH 394 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s-~~~~~~~l~~af~~~ 394 (644)
+.++.++.+..+.+...++. +...++..+.++++..|. ++|+| ||.+||.++=-++ .-.+++.|+.||+++
T Consensus 24 eaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~-~~~~i-df~~Fl~~ms~~~~~~~~~Eel~~aF~~f 101 (160)
T COG5126 24 EAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA-GNETV-DFPEFLTVMSVKLKRGDKEEELREAFKLF 101 (160)
T ss_pred HHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccC-CCCcc-CHHHHHHHHHHHhccCCcHHHHHHHHHHh
Confidence 44666777677776666653 345677788999999999 99999 9999999985555 555789999999999
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
++ |.+|+|..++|..++--.|... .-||+ .+++...|.+ .||.|++.+|-
T Consensus 102 D~-----d~dG~Is~~eL~~vl~~lge~~-~deev-~~ll~~~d~d--~dG~i~~~eF~ 151 (160)
T COG5126 102 DK-----DHDGYISIGELRRVLKSLGERL-SDEEV-EKLLKEYDED--GDGEIDYEEFK 151 (160)
T ss_pred CC-----CCCceecHHHHHHHHHhhcccC-CHHHH-HHHHHhcCCC--CCceEeHHHHH
Confidence 99 9999999999999975444222 22233 2457777777 88999888875
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.019 Score=62.36 Aligned_cols=143 Identities=19% Similarity=0.187 Sum_probs=95.8
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc----------------------cH-H-HHHHHHHHHHHHHhcCCC
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ----------------------TE-K-FKRTALQEMDLISKLNNP 72 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~----------------------~~-~-~~~~~~rEi~iL~~L~HP 72 (644)
|-.+|.-|--+.||.|.. ..|..+|||+++-... ++ + ..-.+..|++-|++|...
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 456778888899999875 4566799999843211 11 1 112345688888888654
Q ss_pred CcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccccCCCCcEEEcCC
Q 006460 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL-HSNRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 73 NIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yL-Hs~gIIHRDLKPeNILL~~~ 151 (644)
.|.-.--+... + -+|||+|+. .+=+..-+ .+...++...+..+-.|++.-+.-| |..++||.||.-=|+|+. +
T Consensus 227 GIP~PePIlLk--~-hVLVM~FlG-rdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 227 GIPCPEPILLK--N-HVLVMEFLG-RDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCCCceeee--c-ceEeeeecc-CCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence 43322212221 2 369999994 33322111 1233477888998888999988888 556999999999999996 7
Q ss_pred CCeEEeccCcccccc
Q 006460 152 NDIRLGDFGLAKLLN 166 (644)
Q Consensus 152 g~vKL~DFGls~~~~ 166 (644)
|.+.|+|.+-+....
T Consensus 301 G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHD 315 (520)
T ss_pred CEEEEEEccccccCC
Confidence 899999988776543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.013 Score=61.47 Aligned_cols=30 Identities=30% Similarity=0.426 Sum_probs=25.4
Q ss_pred CCccccCCCCcEEEcCCCC-eEEeccCcccc
Q 006460 135 RVLHRDLKCSNIFLTKDND-IRLGDFGLAKL 164 (644)
Q Consensus 135 gIIHRDLKPeNILL~~~g~-vKL~DFGls~~ 164 (644)
.++|+|++|.|||++.++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.086 Score=55.37 Aligned_cols=29 Identities=28% Similarity=0.471 Sum_probs=25.4
Q ss_pred CCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 134 ~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.028 Score=61.07 Aligned_cols=121 Identities=19% Similarity=0.295 Sum_probs=80.4
Q ss_pred CCCCcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEE
Q 006460 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFL 148 (644)
Q Consensus 70 ~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL 148 (644)
.-++..+.+-+-.++..+.|++|++- |+.|.. ++. ...+++..|+.+.+..+.-+..+ .+-|||+...||||
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI 355 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI 355 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecC-Cceeee-eec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee
Confidence 34444444433235567889999987 666543 221 23577888899888888777766 78999999999999
Q ss_pred cCCCCeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHH
Q 006460 149 TKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCC 203 (644)
Q Consensus 149 ~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvI 203 (644)
+ .|+|-|+||-+++.-.... .+.....--|-.+.|.. +..-+||-+--.
T Consensus 356 d-~GnvtLIDfklsRl~~~q~----~isy~rldhp~lF~G~d-d~QFeIYrlMr~ 404 (488)
T COG5072 356 D-EGNVTLIDFKLSRLSYSQG----IISYNRLDHPDLFNGVD-DYQFEIYRLMRR 404 (488)
T ss_pred e-cCceEEEEeeeeecccCCc----eeeccccCchhhhcCcc-ceeeeHHHHHHH
Confidence 9 9999999999998532222 11122233455566544 677777775333
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.04 Score=59.19 Aligned_cols=149 Identities=17% Similarity=0.254 Sum_probs=81.4
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--CCcceeeeEEEeCC-ceEEEE
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN--PYIVKYKDAWVDKG-NCVCIV 91 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--PNIVkl~~~~~d~~-~~~~LV 91 (644)
..++..+-.|.--.+|..... ++++++. .......-.......+|+++++.+.- --+...++++.+.. ...|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 344555533433445555443 7788888 33212222234456678888887743 22233444444433 346899
Q ss_pred EeccCCCCH------------------HHHHHHhcC------------CCCCHHHHHHHHHHH--------------HHH
Q 006460 92 TGYCEGGDM------------------AEIIKKARG------------ACFPEEKLCKWLTQL--------------LLA 127 (644)
Q Consensus 92 mEy~~GgsL------------------~~~L~~~~~------------~~l~e~~i~~i~~QI--------------L~g 127 (644)
|+|++|..+ .++|..-.. ..+...++..+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 999998322 222221110 001111222222222 223
Q ss_pred HHHHHHC--------CCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 128 VDYLHSN--------RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 128 L~yLHs~--------gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
..||+.+ .++|+|+++.||+++..+.+=++||+++..-.
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 4555443 48999999999999998889999999987543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.04 Score=59.75 Aligned_cols=141 Identities=13% Similarity=0.169 Sum_probs=81.2
Q ss_pred EEEEEeccCCCeEEEEEEEec----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcc-eeeeEEEeCCceEEE
Q 006460 16 EVIEQIGRGAFGAAFLVLHKI----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIV-KYKDAWVDKGNCVCI 90 (644)
Q Consensus 16 ~i~~~LG~G~fG~Vyla~~k~----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIV-kl~~~~~d~~~~~~L 90 (644)
.-+..|-.|-.-.+|++.... .++.|++|+..... +.+.. ..+|+.+++.+..-++. ++++.+ . +. .
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~-~-~g---~ 110 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRF-P-NG---R 110 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEE-C-Cc---e
Confidence 344556568888999986532 34689999875532 22222 25688888888543333 444543 2 22 5
Q ss_pred EEeccCCCCHHH--------------HHHHhcCCC-------CCHHHHHHHHHHHH-----------------HHHHHH-
Q 006460 91 VTGYCEGGDMAE--------------IIKKARGAC-------FPEEKLCKWLTQLL-----------------LAVDYL- 131 (644)
Q Consensus 91 VmEy~~GgsL~~--------------~L~~~~~~~-------l~e~~i~~i~~QIL-----------------~gL~yL- 131 (644)
|.+|++|.+|.. .+.+..... .....+..++.++. ..+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 789988866531 111111111 11233334432221 111112
Q ss_pred ---H----HCCCccccCCCCcEEEcC-CCCeEEeccCcccc
Q 006460 132 ---H----SNRVLHRDLKCSNIFLTK-DNDIRLGDFGLAKL 164 (644)
Q Consensus 132 ---H----s~gIIHRDLKPeNILL~~-~g~vKL~DFGls~~ 164 (644)
. ...++|+|+++.|||++. ++.+.|+||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225799999999999986 46799999988753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.23 Score=52.73 Aligned_cols=30 Identities=17% Similarity=0.221 Sum_probs=27.5
Q ss_pred CCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 135 gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
+++|+|+.+.|||++.++.+-++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999998999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.096 Score=57.25 Aligned_cols=76 Identities=13% Similarity=0.107 Sum_probs=48.0
Q ss_pred EeccCCCeEEEEEEEecCCeEEEEEEEecc-----cccHHHHHHHHHHHHHHHhcC--CC-CcceeeeEEEeCCceEEEE
Q 006460 20 QIGRGAFGAAFLVLHKIERKKYVLKKIRLA-----KQTEKFKRTALQEMDLISKLN--NP-YIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~-----~~~~~~~~~~~rEi~iL~~L~--HP-NIVkl~~~~~d~~~~~~LV 91 (644)
.||.|...-||++.....++.++||.-..- ...+....+..-|...|+... -| .+.++|. +++. ...+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e-~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE-MAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc-cceeh
Confidence 579999999999997544468999964321 111222345556778887663 35 4444553 3433 46699
Q ss_pred EeccCCC
Q 006460 92 TGYCEGG 98 (644)
Q Consensus 92 mEy~~Gg 98 (644)
||+++..
T Consensus 79 MEdL~~~ 85 (370)
T TIGR01767 79 MEDLSHH 85 (370)
T ss_pred HhhCccc
Confidence 9998553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.23 Score=53.45 Aligned_cols=139 Identities=14% Similarity=0.223 Sum_probs=78.7
Q ss_pred EEEeccCCCeEEEEEEEecC---CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCceEEEEEe
Q 006460 18 IEQIGRGAFGAAFLVLHKIE---RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI-VKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNI-Vkl~~~~~d~~~~~~LVmE 93 (644)
++.|..|-...+|++..... +..|++++...... .. -.-.+|..+++.+..-++ .++++++ . +. +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~-IdR~~E~~il~~l~~~gl~P~~l~~~-~-~G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YV-IDRERELQAIKYLSAAGFGAKLLGVF-G-NG---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eE-echHHHHHHHHHHHhcCCCCceeEEe-C-Cc---Eeeh
Confidence 44455588889999875432 34788998754321 11 122468888888865444 3445443 3 22 5889
Q ss_pred ccCCCCHHH--------------HHHHhcCCCC-------CHHHHHHHHHHH-------------------------HHH
Q 006460 94 YCEGGDMAE--------------IIKKARGACF-------PEEKLCKWLTQL-------------------------LLA 127 (644)
Q Consensus 94 y~~GgsL~~--------------~L~~~~~~~l-------~e~~i~~i~~QI-------------------------L~g 127 (644)
|++|..|.. .+++.....+ ....+..++.++ +..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 988765421 1222222111 122333333222 111
Q ss_pred HHHHH-HCC----CccccCCCCcEEEcC-CCCeEEeccCcccc
Q 006460 128 VDYLH-SNR----VLHRDLKCSNIFLTK-DNDIRLGDFGLAKL 164 (644)
Q Consensus 128 L~yLH-s~g----IIHRDLKPeNILL~~-~g~vKL~DFGls~~ 164 (644)
+..+. ..+ ++|.|+.+.|||++. ++.++++||..+..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11121 112 689999999999975 46899999998754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.2 Score=55.50 Aligned_cols=77 Identities=17% Similarity=0.204 Sum_probs=50.7
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEe----cccccHHHHHHHHHHHHHHHhcC--CC-CcceeeeEEEeCCceEEE
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIR----LAKQTEKFKRTALQEMDLISKLN--NP-YIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~----~~~~~~~~~~~~~rEi~iL~~L~--HP-NIVkl~~~~~d~~~~~~L 90 (644)
.+.||.|.-.-||++.+...++.++||.-. ......-...+..-|..+|+.+. -| ++.++|. +++. ...+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e-~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV-MNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH-HhhH
Confidence 678899999999999985445679998642 21111223456666888888763 35 4445553 3433 4678
Q ss_pred EEeccCC
Q 006460 91 VTGYCEG 97 (644)
Q Consensus 91 VmEy~~G 97 (644)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999865
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.26 Score=54.80 Aligned_cols=76 Identities=16% Similarity=0.155 Sum_probs=49.6
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc--c---HHHHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCceE
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ--T---EKFKRTALQEMDLISKLN---NPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~--~---~~~~~~~~rEi~iL~~L~---HPNIVkl~~~~~d~~~~~ 88 (644)
..+.||.|....||++.+. +..++||.-..... . .....+...|+..|+.+. ..++.+++.++. ...
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de---d~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR---TMA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC---CCC
Confidence 4778899999999999863 45699997642111 1 112344455677776653 246777776543 336
Q ss_pred EEEEeccCC
Q 006460 89 CIVTGYCEG 97 (644)
Q Consensus 89 ~LVmEy~~G 97 (644)
+++|||+++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 789999977
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.11 Score=53.06 Aligned_cols=103 Identities=19% Similarity=0.222 Sum_probs=68.2
Q ss_pred eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHH
Q 006460 39 KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLC 118 (644)
Q Consensus 39 ~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~ 118 (644)
.+..+|+++.-...-. ..-+..+.+++.++. .|+++.. +.+-.+.++.|+|..... ...
T Consensus 86 G~L~lKKi~slp~~~~-~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~i---------------~~~ 144 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCIN-DALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIKI---------------NFS 144 (308)
T ss_pred chhhhhhccCCCcccc-hhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCccc---------------chh
Confidence 4566676654332211 133567888888775 6787774 345567899999942111 111
Q ss_pred HHHHHHHHHHHHHHHC--CCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 119 KWLTQLLLAVDYLHSN--RVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 119 ~i~~QIL~gL~yLHs~--gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
.++..=+..|.-.|+. +.+|+|-.|+||+-+..|.+||.|-+..
T Consensus 145 N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 145 NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 2222335677778943 7999999999999999999999997653
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.72 E-value=0.24 Score=49.37 Aligned_cols=30 Identities=37% Similarity=0.571 Sum_probs=21.2
Q ss_pred CCccccCCCCcEEE-cCCCCeEEeccCcccc
Q 006460 135 RVLHRDLKCSNIFL-TKDNDIRLGDFGLAKL 164 (644)
Q Consensus 135 gIIHRDLKPeNILL-~~~g~vKL~DFGls~~ 164 (644)
-++|+||.|.|||+ +.++.++|+||-.+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 7889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.33 Score=51.54 Aligned_cols=74 Identities=15% Similarity=0.105 Sum_probs=43.2
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCceEEEEEe
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN---NPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
-.+.||.|....+|+.. .+++.+.+|.-.... ...+..|..-|+.|. .-.+.+.+.+... ....|||||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-~~~~fLlle 92 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEY-DDDAFLLLE 92 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE--SSCCEEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-cCCceEEEE
Confidence 35678889999999986 778899999876322 234555777777773 3446667765544 334589999
Q ss_pred ccCCC
Q 006460 94 YCEGG 98 (644)
Q Consensus 94 y~~Gg 98 (644)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 98776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.39 E-value=2.6 Score=45.19 Aligned_cols=28 Identities=29% Similarity=0.254 Sum_probs=23.8
Q ss_pred CCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 134 ~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3789999999999995 4 57899999775
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=92.96 E-value=0.013 Score=55.07 Aligned_cols=97 Identities=9% Similarity=0.178 Sum_probs=69.8
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccc-cccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ 424 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (644)
....++.++...|.+++|.| ++.||+.+.... .....++.++.+|+.... +.+++++.+++...+...+.+.
T Consensus 51 ~~~~~~~l~~~~d~~~~g~i-~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~-----~~~G~i~~~e~~~~l~~~~~~l- 123 (158)
T PTZ00183 51 KKEEIKQMIADVDKDGSGKI-DFEEFLDIMTKKLGERDPREEILKAFRLFDD-----DKTGKISLKNLKRVAKELGETI- 123 (158)
T ss_pred CHHHHHHHHHHhCCCCCCcE-eHHHHHHHHHHHhcCCCcHHHHHHHHHHhCC-----CCCCcCcHHHHHHHHHHhCCCC-
Confidence 34467888999999999999 999999876442 344556788889988777 8889999999999987655332
Q ss_pred cccccccc-cccccCCCCCchhhhhhhhcc
Q 006460 425 PAEEIDVE-TVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 425 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+..++ ++..-|.+ .++.|++.+|-
T Consensus 124 --~~~~~~~~~~~~d~~--~~g~i~~~ef~ 149 (158)
T PTZ00183 124 --TDEELQEMIDEADRN--GDGEISEEEFY 149 (158)
T ss_pred --CHHHHHHHHHHhCCC--CCCcCcHHHHH
Confidence 222221 35555666 67778777664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.94 E-value=1.2 Score=55.23 Aligned_cols=31 Identities=39% Similarity=0.507 Sum_probs=26.6
Q ss_pred CCCccccCCCCcEEEcCCC--CeE-EeccCcccc
Q 006460 134 NRVLHRDLKCSNIFLTKDN--DIR-LGDFGLAKL 164 (644)
Q Consensus 134 ~gIIHRDLKPeNILL~~~g--~vK-L~DFGls~~ 164 (644)
+++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999775 555 999998864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.87 E-value=0.27 Score=54.21 Aligned_cols=76 Identities=12% Similarity=0.170 Sum_probs=43.5
Q ss_pred EEEEeccCCCeEEEEEEEecC-CeEE-----EEEEEecccccHHHHHHHHHHHHHHHhcCCCCcce-eeeEEEeCCceEE
Q 006460 17 VIEQIGRGAFGAAFLVLHKIE-RKKY-----VLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVK-YKDAWVDKGNCVC 89 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~t-g~~v-----AiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVk-l~~~~~d~~~~~~ 89 (644)
.++.|..|-...+|++..... +..+ .+.... ...... -.-.+|+++++.|...++-+ +++.+ . -+
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g--~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f-~----~g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS--TYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRF-G----DF 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc--CCCceE-eccHHHHHHHHHHHhCCCCCeEEEec-C----CE
Confidence 345565688899999975433 2233 333221 111111 12256899999997655544 44433 2 25
Q ss_pred EEEeccCCCCH
Q 006460 90 IVTGYCEGGDM 100 (644)
Q Consensus 90 LVmEy~~GgsL 100 (644)
+|.||++|-.|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 89999998765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 644 | ||||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-55 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-47 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-46 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-46 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-39 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-36 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-36 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-33 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-33 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-32 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-32 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-32 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-31 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-31 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-31 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-31 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-31 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-30 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-29 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-29 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-29 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-29 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-29 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-29 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-29 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-29 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-29 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-29 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-29 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-28 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-28 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-28 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-28 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-28 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-28 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-28 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-28 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-28 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-28 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-28 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-28 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-28 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-28 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-28 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-27 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-27 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-27 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-27 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-27 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-27 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-27 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-27 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-27 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-27 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-27 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-27 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-27 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-27 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-27 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-27 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-26 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-26 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-26 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-26 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-26 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-26 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-26 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-26 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-26 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-26 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-26 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-26 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-26 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-26 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-26 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-25 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-25 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-25 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-25 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-25 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-25 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-25 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-25 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-25 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-25 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-25 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-25 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-25 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-25 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-25 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-25 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-25 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-25 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-25 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-25 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-25 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-25 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-25 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-25 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-25 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-25 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-25 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-25 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-25 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-25 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-25 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-25 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-25 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-25 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-25 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-25 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-25 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-25 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-25 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-25 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-25 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-25 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-25 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-25 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-25 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-25 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-25 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-25 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-25 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-25 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-25 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-25 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-25 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-25 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-25 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-25 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-25 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-25 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-25 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-25 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-25 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-25 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-25 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-25 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-25 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-25 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-25 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-25 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-25 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-25 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-25 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-25 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-25 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-25 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-25 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-25 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-25 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-25 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-25 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-25 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-25 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-25 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-25 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-25 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-25 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-25 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-25 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-24 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-24 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-24 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-24 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-24 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-24 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-24 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-24 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-24 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-24 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-24 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-24 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-24 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-24 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-24 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-24 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-24 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-24 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-23 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-23 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-23 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-23 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-23 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-23 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-23 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-23 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-23 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-23 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-23 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-23 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-23 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-23 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-23 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-23 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-23 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-23 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-23 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-23 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-23 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-23 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-23 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-23 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-22 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-22 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-22 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-22 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-22 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-22 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-22 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-22 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-22 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-22 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-22 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-22 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-22 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-21 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-21 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-21 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-21 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-21 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-21 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-21 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-21 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-21 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-21 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-21 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-21 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-21 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-21 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-21 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-20 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-20 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-20 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-20 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-20 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-20 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-20 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-20 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-20 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-20 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-20 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-20 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-20 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-20 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-20 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-20 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-20 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-20 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-20 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-20 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-20 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-20 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-20 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-20 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-20 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-20 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-20 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-20 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-20 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-20 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-20 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-20 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-20 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-20 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-20 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-20 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-20 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-20 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-19 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-19 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-19 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-19 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-19 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-19 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-19 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-19 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-19 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-19 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-19 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-19 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-19 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-19 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-19 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-19 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-19 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-19 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-19 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-19 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-19 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-19 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-18 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-18 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-18 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-18 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-18 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-18 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-18 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-18 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-18 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-18 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-18 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-18 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-18 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-18 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-18 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-18 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-18 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-18 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-17 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-17 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-17 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-17 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-17 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-17 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-16 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-15 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-15 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-14 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-14 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-14 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-14 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-13 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 |
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 430 bits (1108), Expect = e-147
Identities = 102/319 (31%), Positives = 187/319 (58%), Gaps = 3/319 (0%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
+ TEN +S +E Y +++IG G+FG A LV + ++YV+K+I +++ + K + +
Sbjct: 13 LGTENLYFQS-MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR 71
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
+E+ +++ + +P IV+Y++++ + + IV YCEGGD+ + I +G F E+++ W
Sbjct: 72 REVAVLANMKHPNIVQYRESFEEN-GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTPN 179
Q+ LA+ ++H ++LHRD+K NIFLTKD ++LGDFG+A++LN T +LA + +GTP
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS 239
Y+ PE+ + PY KSDIW+LGC ++E+ + AF A M L+ KI S P+ + YS
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS 250
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKS 299
++ ++ + ++NP RP+ + +L + + + +P + K ++
Sbjct: 251 YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPI 310
Query: 300 PSSKHNSRKDKGEREAAAP 318
P+ + S ++ A
Sbjct: 311 PAKRPASGQNSISVMPAQK 329
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-137
Identities = 102/274 (37%), Positives = 151/274 (55%), Gaps = 9/274 (3%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
S+ EDYEV+ IG G++G + K + K V K++ TE K+ + E++L+ +
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 69 LNNPYIVKYKDAWVDK-GNCVCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLL 125
L +P IV+Y D +D+ + IV YCEGGD+A +I K EE + + +TQL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 126 LAVDYLHS-----NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTPN 179
LA+ H + VLHRDLK +N+FL +++LGDFGLA++L + A + VGTP
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS 239
YM PE + + Y KSDIWSLGC ++E+ A P F A L KI +P YS
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273
+ +II ML HRP+ ++L +P + +
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 382 bits (982), Expect = e-129
Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 26/275 (9%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
D++ IE IG G FG F H+I+ K YV+K+++ + A +E+ ++KL++
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDH 63
Query: 72 PYIVKYKDAWVD---------------KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEK 116
IV Y W K C+ I +C+ G + + I+K RG +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 117 LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVG 176
+ Q+ VDY+HS ++++RDLK SNIFL +++GDFGL L + + G
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG 183
Query: 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI 236
T YM PE ++ YG + D+++LG + E+ A + + + +
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLH--VCDTAFETSKFFTDLRD---GIISD 238
Query: 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271
++ K +++ +L K PE RP S++LR +
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-129
Identities = 86/275 (31%), Positives = 150/275 (54%), Gaps = 8/275 (2%)
Query: 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLI 66
+ L ++ + ++IGRG F + ++ LKK+++ K + ++E+DL+
Sbjct: 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL 86
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK--KARGACFPEEKLCKWLTQL 124
+LN+P ++KY ++++ N + IV + GD++ +IK K + PE + K+ QL
Sbjct: 87 KQLNHPNVIKYYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTPNYMCP 183
A++++HS RV+HRD+K +N+F+T ++LGD GL + + A S+VGTP YM P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRA--PDMAGLINKINRSSISPLP-IVYSS 240
E + + Y +KSDIWSLGC ++E+AA Q F ++ L KI + PLP YS
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLR 275
++Q++ + +PE RP + +
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-121
Identities = 82/311 (26%), Positives = 146/311 (46%), Gaps = 40/311 (12%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
L D+E I+ +GRG FG F +K++ Y +K+IRL + E + ++E+ ++KL +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEH 62
Query: 72 PYIVKYKDAWVDKGN-----------CVCIVTGYCEGGDMAEIIKKARGACFPEEKLC-K 119
P IV+Y +AW++K + I C ++ + + E +C
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV----- 174
Q+ AV++LHS ++HRDLK SNIF T D+ +++GDFGL ++ ++ +V
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 175 --------VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI 226
VGT YM PE + Y +K DI+SLG +FE+ P + + +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDV 240
Query: 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPI 286
PL +++ ML +P RP A +++ + + + P
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE----------DLDFPG 290
Query: 287 KPTNIMKEKTR 297
K ++++++R
Sbjct: 291 KT--VLRQRSR 299
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-110
Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 9/261 (3%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-N 70
+ ++ + ++G G++G F V K + + Y +K+ + K + L E+ K+
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+P V+ + AW + G + + T C G + + + GA PE ++ +L LLA+ +
Sbjct: 116 HPCCVRLEQAWEEGG-ILYLQTELC-GPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAH 172
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIP 190
LHS ++H D+K +NIFL +LGDFGL L T G P YM PELL
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-S 231
Query: 191 YGYKSDIWSLGCCMFEIAAHQP-AFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249
YG +D++SLG + E+A + L SS ++ ++ M
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP---PEFTAGLSSELRSVLVMM 288
Query: 250 LRKNPEHRPTASDLLRHPHLQ 270
L +P+ R TA LL P L+
Sbjct: 289 LEPDPKLRATAEALLALPVLR 309
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 320 bits (821), Expect = e-105
Identities = 67/283 (23%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-N 70
++ +E+IG G FG+ F + +++ Y +K+ + ++ AL+E+ + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAV 128
+ ++V+Y AW + + + I YC GG +A+ I + + F E +L L Q+ +
Sbjct: 70 HSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDI-------------------RLGDFGLAKLLNTED 169
Y+HS ++H D+K SNIF+++ + ++GD G +++
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS-- 186
Query: 170 LASSVVGTPNYMCPELLA-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR 228
G ++ E+L + + K+DI++L + A +P R D ++I +
Sbjct: 187 -PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQ 242
Query: 229 SSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271
+ +P V S +++K M+ +PE RP+A L++H L
Sbjct: 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 315 bits (808), Expect = e-103
Identities = 83/292 (28%), Positives = 138/292 (47%), Gaps = 37/292 (12%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
D+E I +G+GAFG + ++ + Y +KKIR TE+ T L E+ L++ LN+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNH 61
Query: 72 PYIVKYKDAWVDKGN------------CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
Y+V+Y AW+++ N + I YCE G + ++I ++ +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWR 120
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN------------- 166
Q+L A+ Y+HS ++HRDLK NIF+ + ++++GDFGLAK ++
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 167 --TEDLASSVVGTPNYMCPELLADIP-YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLI 223
+ D +S +GT Y+ E+L Y K D++SLG FE+ P + ++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238
Query: 224 NKINRSSI---SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
K+ SI K+II+ ++ +P RP A LL L
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 1e-87
Identities = 65/295 (22%), Positives = 122/295 (41%), Gaps = 28/295 (9%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ Y I+++G G F LV + Y LK+I +Q ++ A +E D+ N+P
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHP 86
Query: 73 YIVKYKDAWVDK---GNCVCIVTGYCEGGDMAEIIK--KARGACFPEEKLCKWLTQLLLA 127
I++ + + + ++ + + G + I+ K +G E+++ L +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA-----------KLLNTEDLASSVVG 176
++ +H+ HRDLK +NI L + L D G + L +D A +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA-AQRC 205
Query: 177 TPNYMCPELLADIPY---GYKSDIWSLGCCMFEIAAHQPAFRAPDMAG--LINKINRSSI 231
T +Y PEL + + ++D+WSLGC ++ + + + G + +
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 232 SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPI 286
P +SS + Q++ SM+ +P RP LL L+ P I
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE----ALQPPAPGQHTTQI 316
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 1e-84
Identities = 66/329 (20%), Positives = 123/329 (37%), Gaps = 73/329 (22%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIER----------------KKYVLKKIRLAKQ---- 51
L D+E I+ +GRG FG F +K++ ++ V+++++ +
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 52 ------------------------------------TEKFKRTALQEMDLISKLNNPYIV 75
+ ++ + + V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLC-KWLTQLLLAVDYLHSN 134
K + I C ++ + + + E +C Q+ AV++LHS
Sbjct: 125 GQLQPSSPK-VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV-------------VGTPNYM 181
++HRDLK SNIF T D+ +++GDFGL ++ ++ +V VGT YM
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 182 CPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSST 241
PE + Y +K DI+SLG +FE+ + +I + L
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFTQKYPQ 301
Query: 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
+++ ML +P RP A+D++ + +
Sbjct: 302 EHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 9e-75
Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 12/260 (4%)
Query: 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYK 78
+IGRG+F + L + +++ K T+ ++ +E +++ L +P IV++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 79 DAWVD---KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR 135
D+W C+ +VT G + +K+ + + L W Q+L + +LH+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 136 --VLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYG 192
++HRDLKC NIF+T +++GD GLA L A +V+GTP +M PE+ + Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYD 207
Query: 193 YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSSTMKQIIKSML 250
D+++ G CM E+A + + A I + S + P V +K+II+ +
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 251 RKNPEHRPTASDLLRHPHLQ 270
R+N + R + DLL H Q
Sbjct: 268 RQNKDERYSIKDLLNHAFFQ 287
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-72
Identities = 74/326 (22%), Positives = 143/326 (43%), Gaps = 24/326 (7%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-- 70
Y +++QIG G F VL++ +++ Y +K + L + + + E+ ++KL
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+ I++ D + + +V C D+ +KK + + + +L AV
Sbjct: 68 SDKIIRLYDYEITD-QYIYMVM-ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHT 123
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN---TEDLASSVVGTPNYMCPELLA 187
+H + ++H DLK +N L D ++L DFG+A + T + S VGT NYM PE +
Sbjct: 124 IHQHGIVHSDLKPANF-LIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 188 DIP-----------YGYKSDIWSLGCCMFEIAAHQPAF--RAPDMAGLINKINRSSISPL 234
D+ KSD+WSLGC ++ + + F ++ L I+ +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKE 294
P + ++ ++K L+++P+ R + +LL HP++Q + + +
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQL 302
Query: 295 KTRKSPSSKHNSRKDKGEREAAAPNQ 320
SP+S + K E + +
Sbjct: 303 VGLNSPNSILKAAKTLYEHYSGGESH 328
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 9e-72
Identities = 70/280 (25%), Positives = 132/280 (47%), Gaps = 24/280 (8%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
K Y +++QIG G F VL++ +++ Y +K + L + + + E+ ++KL
Sbjct: 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 71 --NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
+ I++ D + + +V C D+ +KK + + + +L AV
Sbjct: 85 QHSDKIIRLYDYEITDQY-IYMVM-ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAV 140
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN---TEDLASSVVGTPNYMCPEL 185
+H + ++H DLK +N L D ++L DFG+A + T + S VGT NYM PE
Sbjct: 141 HTIHQHGIVHSDLKPANF-LIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 186 LADIP-----------YGYKSDIWSLGCCMFEIAAHQPAF--RAPDMAGLINKINRSSIS 232
+ D+ KSD+WSLGC ++ + + F ++ L I+ +
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259
Query: 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
P + ++ ++K L+++P+ R + +LL HP++Q
Sbjct: 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-70
Identities = 75/336 (22%), Positives = 145/336 (43%), Gaps = 24/336 (7%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
K Y +++QIG G F VL++ +++ Y +K + L + + + E+ ++K
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 69 LN--NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
L + I++ D + + +V C D+ +KK + + + +L
Sbjct: 111 LQQHSDKIIRLYDYEITD-QYIYMVM-ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLE 166
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN---TEDLASSVVGTPNYMCP 183
AV +H + ++H DLK +N FL D ++L DFG+A + T + S VG NYM P
Sbjct: 167 AVHTIHQHGIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 184 ELLADIP-----------YGYKSDIWSLGCCMFEIAAHQPAF--RAPDMAGLINKINRSS 230
E + D+ KSD+WSLGC ++ + + F ++ L I+ +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285
Query: 231 ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTN 290
P + ++ ++K L+++P+ R + +LL HP++Q +
Sbjct: 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV 345
Query: 291 IMKEKTRKSPSSKHNSRKDKGEREAAAPNQLENVRS 326
+ + SP+S + K E + + +
Sbjct: 346 LGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSK 381
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 1e-68
Identities = 74/314 (23%), Positives = 122/314 (38%), Gaps = 34/314 (10%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPY 73
V + G F + ++Y LK RL E+ R +QE+ + KL +P
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALK--RLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 74 IVKYKDAWV-------DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
IV++ A ++T C+G + + K + + K Q
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 127 AVDYLHSNR--VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS----------- 173
AV ++H + ++HRDLK N+ L+ I+L DFG A ++ S
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 174 --VVGTPNYMCPELL---ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR 228
TP Y PE++ ++ P G K DIW+LGC ++ + Q F G +I
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIVN 263
Query: 229 SSIS-PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIK 287
S P + +I++ML+ NPE R + ++++ R NP S +
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA-AARNVNPKSPITELL 322
Query: 288 PTNIMKEKTRKSPS 301
N S
Sbjct: 323 EQNGGYGSATLSRG 336
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-66
Identities = 77/276 (27%), Positives = 124/276 (44%), Gaps = 19/276 (6%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
++ + + + ++ ++GRG+FG + K + +KK+RL
Sbjct: 46 LKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV------- 98
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
+E+ + L++P IV A +G V I EGG + ++IK+ C PE++ +
Sbjct: 99 EELVACAGLSSPRIVPLYGAVR-EGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYY 155
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLAKLLNTEDLAS------S 173
L Q L ++YLH+ R+LH D+K N+ L+ D + L DFG A L + L
Sbjct: 156 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 174 VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI--NRSSI 231
+ GT +M PE++ P K DIWS C M + + L KI I
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI 275
Query: 232 SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+P + Q I+ LRK P HR +A +L R
Sbjct: 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKV 311
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 1e-63
Identities = 78/306 (25%), Positives = 138/306 (45%), Gaps = 20/306 (6%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK-----KIRLAKQTEKFKRTALQEM 63
Y +G+G F F + ++ + K + Q EK E+
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EI 92
Query: 64 DLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ 123
+ L + ++V + + D + V +V C + E+ K+ + E + +L Q
Sbjct: 93 SIHRSLAHQHVVGFHGFFEDN-DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQ 149
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPNYMC 182
++L YLH NRV+HRDLK N+FL +D ++++GDFGLA + + + GTPNY+
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 183 PELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242
PE+L+ + ++ D+WS+GC M+ + +P F + +I ++ S +P +
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-IPKHINPVA 268
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSS 302
+I+ ML+ +P RPT ++LL LPI I + S
Sbjct: 269 ASLIQKMLQTDPTARPTINELLNDEFFT------SGYIPARLPITCLTIPPRFSIAPSSL 322
Query: 303 KHNSRK 308
++RK
Sbjct: 323 DPSNRK 328
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 1e-63
Identities = 76/268 (28%), Positives = 134/268 (50%), Gaps = 13/268 (4%)
Query: 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK-----KIRLAKQTEKFKRTAL 60
K+ED++V +G+G+F + + +K + A ++ +
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN--- 60
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
E+ + +L +P I++ + + D V +V C G+M +K R F E + +
Sbjct: 61 -EVKIHCQLKHPSILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKN-RVKPFSENEARHF 117
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPN 179
+ Q++ + YLHS+ +LHRDL SN+ LT++ +I++ DFGLA L ++ GTPN
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS 239
Y+ PE+ +G +SD+WSLGC + + +P F + +NK+ + +P S
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-MPSFLS 236
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHP 267
K +I +LR+NP R + S +L HP
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLDHP 264
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 5e-63
Identities = 71/265 (26%), Positives = 128/265 (48%), Gaps = 14/265 (5%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK-----KIRLAKQTEKFKRTALQEM 63
Y +G+G F F + ++ + K + Q EK E+
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EI 66
Query: 64 DLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ 123
+ L + ++V + + D + V +V C + E+ K+ + E + +L Q
Sbjct: 67 SIHRSLAHQHVVGFHGFFEDN-DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQ 123
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPNYMC 182
++L YLH NRV+HRDLK N+FL +D ++++GDFGLA + + + GTPNY+
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 183 PELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242
PE+L+ + ++ D+WS+GC M+ + +P F + +I ++ S +P +
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-IPKHINPVA 242
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHP 267
+I+ ML+ +P RPT ++LL
Sbjct: 243 ASLIQKMLQTDPTARPTINELLNDE 267
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-61
Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 23/305 (7%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
++ D E + ++G G G + + + +K++R + E+ KR L ++D++ K +
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI-LMDLDVVLKSH 81
Query: 71 N-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
+ PYIV+ ++ V I AE +KK PE L K ++ A+
Sbjct: 82 DCPYIVQCFGTFI-TNTDVFIAMELMGTC--AEKLKKRMQGPIPERILGKMTVAIVKALY 138
Query: 130 YLHSNR-VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE---- 184
YL V+HRD+K SNI L + I+L DFG++ L + G YM PE
Sbjct: 139 YLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP 198
Query: 185 -LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRA--PDMAGLINKINRSSISPLP--IVYS 239
Y ++D+WSLG + E+A Q ++ D ++ K+ + LP + +S
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTKVLQEEPPLLPGHMGFS 257
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMK--EKTR 297
+ +K L K+ RP + LL H ++ Y V + ++M E R
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY-----ETLEVDVASWFKDVMAKTESPR 312
Query: 298 KSPSS 302
PSS
Sbjct: 313 SGPSS 317
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-60
Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 23/282 (8%)
Query: 3 TENGDSKSKLEDYEVIEQ-------IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF 55
TE GD +S L +Y+ +G+G +G + + + +K+I
Sbjct: 5 TEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY-- 62
Query: 56 KRTAL-QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPE 114
L +E+ L L + IV+Y ++ + + I GG ++ +++ G
Sbjct: 63 -SQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 115 EKL-CKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL-TKDNDIRLGDFGLAK-LLNTEDLA 171
E+ + Q+L + YLH N+++HRD+K N+ + T +++ DFG +K L
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180
Query: 172 SSVVGTPNYMCPE--LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLIN---KI 226
+ GT YM PE YG +DIWSLGC + E+A +P F ++ K+
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF--YELGEPQAAMFKV 238
Query: 227 NRSSISP-LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ P +P S+ K I +P+ R A+DLL
Sbjct: 239 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-60
Identities = 80/306 (26%), Positives = 131/306 (42%), Gaps = 49/306 (16%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
K +D+E I ++G G G F V HK K I L + + ++E+ ++ + N
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ-IIRELQVLHECN 89
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+PYIV + A+ + I + +GG + +++KKA PE+ L K ++ + Y
Sbjct: 90 SPYIVGFYGAFY-SDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTY 146
Query: 131 LHSNR-VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI 189
L ++HRD+K SNI + +I+L DFG++ L + +A+S VGT +YM PE L
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGT 205
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG---------------------------- 221
Y +SDIWS+G + E+A + PD
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 222 --------------LINKINRSSISPLP-IVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
L++ I LP V+S + + L KNP R L+ H
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325
Query: 267 PHLQPY 272
++
Sbjct: 326 AFIKRS 331
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-60
Identities = 79/257 (30%), Positives = 143/257 (55%), Gaps = 8/257 (3%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E + +E+IG+G+FG F + +K +K I L + ++ + QE+ ++S+ ++P
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSP 80
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
Y+ KY +++ K + I+ Y GG ++++ E ++ L ++L +DYLH
Sbjct: 81 YVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH 136
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLADIPY 191
S + +HRD+K +N+ L++ +++L DFG+ +L +T+ ++ VGTP +M PE++ Y
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 196
Query: 192 GYKSDIWSLGCCMFEIA-AHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
K+DIWSLG E+A P M L I +++ L YS +K+ +++ L
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACL 255
Query: 251 RKNPEHRPTASDLLRHP 267
K P RPTA +LL+H
Sbjct: 256 NKEPSFRPTAKELLKHK 272
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-60
Identities = 73/272 (26%), Positives = 128/272 (47%), Gaps = 13/272 (4%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
K +D E I ++GRGA+G + H + +K+IR +++ KR L ++D+ +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL-LMDLDISMRTV 63
Query: 71 N-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKK--ARGACFPEEKLCKWLTQLLLA 127
+ P+ V + A + V I + + + K+ +G PE+ L K ++ A
Sbjct: 64 DCPFTVTFYGALF-REGDVWICMELMDTS-LDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 128 VDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE-- 184
+++LHS V+HRD+K SN+ + +++ DFG++ L + G YM PE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 185 --LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA-GLINKINRSSISPLP-IVYSS 240
L Y KSDIWSLG M E+A + + + + ++ LP +S+
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
L+KN + RPT +L++HP +
Sbjct: 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 7e-60
Identities = 70/268 (26%), Positives = 129/268 (48%), Gaps = 14/268 (5%)
Query: 5 NGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK-----KIRLAKQTEKFKRTA 59
+ + LED+E+ +G+G FG +L K + LK ++ A + +R
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR-- 58
Query: 60 LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
E+++ S L +P I++ + D V ++ Y G + ++K F E++
Sbjct: 59 --EVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLS--KFDEQRTAT 113
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN 179
++T+L A+ Y HS RV+HRD+K N+ L ++++ DFG + + + + GT +
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLCGTLD 172
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS 239
Y+ PE++ + K D+WSLG +E +P F A +I+R + P +
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-FPDFVT 231
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ +I +L+ NP RP ++L HP
Sbjct: 232 EGARDLISRLLKHNPSQRPMLREVLEHP 259
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-59
Identities = 58/309 (18%), Positives = 111/309 (35%), Gaps = 50/309 (16%)
Query: 8 SKSKLED-YEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEM 63
S+S + + + +G+GA F HK + V I + + R E
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----EF 58
Query: 64 DLISKLNNPYIVKYKDAWVDKGNC-VCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWL 121
+++ KLN+ IVK + ++ +C G + + + + PE + L
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND----IRLGDFGLAKLLNTEDLASSVVGT 177
++ +++L N ++HR++K NI D +L DFG A+ L ++ S+ GT
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT 178
Query: 178 PNYMCPELLADI--------PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG----LINK 225
Y+ P++ YG D+WS+G + A FR + ++ K
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238
Query: 226 INR--------------------SSISPLPIVYSSTMK----QIIKSMLRKNPEHRPTAS 261
I S P+ S ++ ++ ++L + E
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298
Query: 262 DLLRHPHLQ 270
Sbjct: 299 QFFAETSDI 307
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 5e-59
Identities = 79/264 (29%), Positives = 141/264 (53%), Gaps = 21/264 (7%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E ++V+E++G G++G+ + +HK + +K++ + ++ +E+ ++ + ++P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII----KEISIMQQCDSP 84
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
++VKY ++ K + IV YC G +++II+ R E+++ L L ++YLH
Sbjct: 85 HVVKYYGSYF-KNTDLWIVMEYCGAGSVSDIIR-LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLADIPY 191
R +HRD+K NI L + +L DFG+ +L +T ++V+GTP +M PE++ +I Y
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 192 GYKSDIWSLGCCMFEIAAHQP------AFRAPDMAGLINKINRSSISPL--PIVYSSTMK 243
+DIWSLG E+A +P RA I I + P ++S
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPTNPPPTFRKPELWSDNFT 256
Query: 244 QIIKSMLRKNPEHRPTASDLLRHP 267
+K L K+PE R TA+ LL+HP
Sbjct: 257 DFVKQCLVKSPEQRATATQLLQHP 280
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 7e-59
Identities = 69/277 (24%), Positives = 133/277 (48%), Gaps = 19/277 (6%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
ED + + +IGRGA+G+ ++HK + +K+IR ++ K+ L ++D++ + +
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL-LMDLDVVMRSS 78
Query: 71 N-PYIVKYKDAWVDKGNCVCIVTGYCEGG--DMAEIIKKARGACFPEEKLCKWLTQLLLA 127
+ PYIV++ A + I + + PEE L K + A
Sbjct: 79 DCPYIVQFYGALF-REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 128 VDYLHSNR-VLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLA-SSVVGTPNYMCPE 184
+++L N ++HRD+K SNI L + +I+L DFG+ +L+++ +A + G YM PE
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPE 195
Query: 185 ----LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINRSS----ISPLP 235
+ Y +SD+WSLG ++E+A + + + + + ++ + +
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
+S + + L K+ RP +LL+HP + Y
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-58
Identities = 76/267 (28%), Positives = 137/267 (51%), Gaps = 21/267 (7%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ Y E+IG+GA G + + ++ ++++ L +Q +K + E+ ++ + NP
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNP 77
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IV Y D+++ G+ + +V Y GG + +++ + C E ++ + L A+++LH
Sbjct: 78 NIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH 133
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLADIPY 191
SN+V+HRD+K NI L D ++L DFG A++ + S++VGTP +M PE++ Y
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 192 GYKSDIWSLGCCMFEIA------AHQPAFRAPDMAGLINKINRSSISPL--PIVYSSTMK 243
G K DIWSLG E+ ++ RA + I + L P S+ +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQNPEKLSAIFR 247
Query: 244 QIIKSMLRKNPEHRPTASDLLRHPHLQ 270
+ L + E R +A +LL+H L+
Sbjct: 248 DFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-58
Identities = 90/269 (33%), Positives = 140/269 (52%), Gaps = 24/269 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E +E++ ++G GAFG + +K K I + E + E+++++ ++P
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYIVEIEILATCDHP 76
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
YIVK A+ + I+ +C GG + I+ + E ++ Q+L A+++LH
Sbjct: 77 YIVKLLGAYY-HDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLH 134
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLA---- 187
S R++HRDLK N+ +T + DIRL DFG+ AK L T S +GTP +M PE++
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 188 -DIPYGYKSDIWSLGCCMFEIAAHQP------AFRAPDMAGLINKINRSSISPL--PIVY 238
D PY YK+DIWSLG + E+A +P R + KI +S L P +
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSDPPTLLTPSKW 248
Query: 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
S + +K L KNPE RP+A+ LL HP
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEHP 277
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 1e-57
Identities = 75/263 (28%), Positives = 130/263 (49%), Gaps = 14/263 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E Y ++ +G+G+FG +I +++Y +K I A K T L+E++L+ KL++P
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAVDYL 131
I+K + D + IV GG++ + IIK+ R F E + + Q+ + Y+
Sbjct: 82 NIMKLFEILEDS-SSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYM 137
Query: 132 HSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD 188
H + ++HRDLK NI +K+ D I++ DFGL+ +GT Y+ PE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMKQ 244
Y K D+WS G ++ + + P F + ++ ++ + + S K
Sbjct: 198 -TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI-SDDAKD 255
Query: 245 IIKSMLRKNPEHRPTASDLLRHP 267
+I+ ML +P R TA+ L HP
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHP 278
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 69/259 (26%), Positives = 128/259 (49%), Gaps = 11/259 (4%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ +IG G+ G L K ++ +K + L KQ + E+ ++ +
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHF 102
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+V+ +++ G + ++ + +GG + +I+ + R EE++ +L A+ YLH
Sbjct: 103 NVVEMYKSYL-VGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH 158
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPELLADIPY 191
+ V+HRD+K +I LT D ++L DFG A++ S+VGTP +M PE+++ Y
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 192 GYKSDIWSLGCCMFEIAAHQ-PAFRAPDMAGLINKINRSSISPL--PIVYSSTMKQIIKS 248
+ DIWSLG + E+ + P F + + ++ S L S ++ ++
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFLER 277
Query: 249 MLRKNPEHRPTASDLLRHP 267
ML ++P+ R TA +LL HP
Sbjct: 278 MLVRDPQERATAQELLDHP 296
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 197 bits (501), Expect = 4e-57
Identities = 70/364 (19%), Positives = 127/364 (34%), Gaps = 67/364 (18%)
Query: 13 EDYEVIEQIGRGA--FGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
YE++ IG+G L +K + +++I L + + E+ + N
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+P IV Y+ ++ N + +VT + G ++I E + L +L A+DY
Sbjct: 85 HPNIVPYRATFI-ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFG-LAKLLNT-------EDLASSVVGTPNYMC 182
+H +HR +K S+I ++ D + L +++ D V ++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 183 PELLA--DIPYGYKSDIWSLGCCMFEIA------AHQPAFRA------------------ 216
PE+L Y KSDI+S+G E+A PA +
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263
Query: 217 ---------------------PDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPE 255
+ S P +S ++ L++NP+
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323
Query: 256 HRPTASDLLRHPHLQPYLLRCQNPSSVYL-----PIKPTNIMKEKTRKSPSSKHNSRKDK 310
RP+AS LL H + + + +S L P+ P + + S +
Sbjct: 324 ARPSASTLLNHSFFK----QIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNL 379
Query: 311 GERE 314
E E
Sbjct: 380 EELE 383
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 4e-57
Identities = 79/290 (27%), Positives = 137/290 (47%), Gaps = 15/290 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISKLNN 71
+ Y+ +G+G+FG L KI ++ +K I + +K + +L E+ L+ +L++
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAVDY 130
P I+K + + DK +V GG++ + II + R F E + + Q+L + Y
Sbjct: 86 PNIMKLYEFFEDK-GYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITY 141
Query: 131 LHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA 187
+H N+++HRDLK N+ +K D IR+ DFGL+ +GT Y+ PE+L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMK 243
Y K D+WS G ++ + + P F + ++ K+ + + V S + K
Sbjct: 202 G-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV-SESAK 259
Query: 244 QIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMK 293
+I+ ML P R +A D L H +Q Y + L NI +
Sbjct: 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQ 309
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 5e-57
Identities = 76/274 (27%), Positives = 134/274 (48%), Gaps = 28/274 (10%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NN 71
+E++E +G G +G + H + +K + + E+ QE++++ K ++
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHH 80
Query: 72 PYIVKYKDAWVDKGNCVC-----IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
I Y A++ K +V +C G + ++IK +G EE + ++L
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLASSVVGTPNYMCPEL 185
+ +LH ++V+HRD+K N+ LT++ +++L DFG+ A+L T ++ +GTP +M PE+
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 186 LA-----DIPYGYKSDIWSLGCCMFEIAAHQP------AFRAPDMAGLINKINRSSISPL 234
+A D Y +KSD+WSLG E+A P RA + I R+ L
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIPRNPAPRL 254
Query: 235 -PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+S + I+S L KN RP L++HP
Sbjct: 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 5e-57
Identities = 76/263 (28%), Positives = 131/263 (49%), Gaps = 14/263 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E Y+ ++++G GA+G L K+ + +K IR + L+E+ ++ L++P
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAVDYL 131
I+K D + DK N +V +GG++ + II + + F E + Q+L V YL
Sbjct: 97 NIMKLYDFFEDKRN-YYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYL 152
Query: 132 HSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD 188
H + ++HRDLK N+ +K+ D I++ DFGL+ + + +GT Y+ PE+L
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK 212
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMKQ 244
Y K D+WS+G +F + A P F ++ K+ + + V S K
Sbjct: 213 -KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKD 270
Query: 245 IIKSMLRKNPEHRPTASDLLRHP 267
+IK ML+ + + R +A L HP
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHP 293
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-57
Identities = 81/277 (29%), Positives = 137/277 (49%), Gaps = 21/277 (7%)
Query: 4 ENGDSKSKLED-YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKI---RLAKQTEKFKRTA 59
EN + ++D + ++G GAFG LV + + V+K I R E+ +
Sbjct: 12 ENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA-- 69
Query: 60 LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEII--KKARGACFPEEKL 117
E++++ L++P I+K + + D N + IV CEGG++ E I +ARG E +
Sbjct: 70 --EIEVLKSLDHPNIIKIFEVFEDYHN-MYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 118 CKWLTQLLLAVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSV 174
+ + Q++ A+ Y HS V+H+DLK NI F I++ DFGLA+L +++ +++
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186
Query: 175 VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-- 232
GT YM PE+ +K DIWS G M+ + F + + K +
Sbjct: 187 AGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245
Query: 233 --PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
P+ + ++K ML K+PE RP+A+ +L H
Sbjct: 246 VECRPL--TPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-56
Identities = 59/275 (21%), Positives = 126/275 (45%), Gaps = 18/275 (6%)
Query: 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK-----KIRLAKQTEKFKRTALQE 62
K ++D+++ +G+G FG +L K + LK ++ + +R E
Sbjct: 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR----E 64
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
+++ S L +P I++ + + D+ + ++ + G++ + ++K F E++ ++
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDR-KRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFME 121
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMC 182
+L A+ Y H +V+HRD+K N+ + ++++ DFG + + ++ GT +Y+
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR-RTMCGTLDYLP 180
Query: 183 PELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242
PE++ + K D+W G +E P F +P +I + P S
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-FPPFLSDGS 239
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHP----HLQPYL 273
K +I +LR +P R ++ HP + + L
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-56
Identities = 81/297 (27%), Positives = 137/297 (46%), Gaps = 38/297 (12%)
Query: 1 METENGDSKSKL--EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRT 58
M ++ + +DYE+ E IG GA +++K +K+I L K
Sbjct: 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-E 59
Query: 59 ALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKA------RGACF 112
L+E+ +S+ ++P IV Y ++V + + +V GG + +IIK +
Sbjct: 60 LLKEIQAMSQCHHPNIVSYYTSFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118
Query: 113 PEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL-AKLLNTEDLA 171
E + L ++L ++YLH N +HRD+K NI L +D +++ DFG+ A L D+
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178
Query: 172 S-----SVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIA------AHQPAFRA--- 216
+ VGTP +M PE++ + Y +K+DIWS G E+A P +
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 217 ------PDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
P + + Y + +++I L+K+PE RPTA++LLRH
Sbjct: 239 TLQNDPPSLETGVQDKEMLK------KYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 4e-56
Identities = 80/273 (29%), Positives = 134/273 (49%), Gaps = 21/273 (7%)
Query: 6 GDSKSKLED-YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKI--RLAKQTEKFKRTALQE 62
G +K + Y + IGRG++G + + K R + KKI + ++FK+ E
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ----E 56
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWL 121
++++ L++P I++ + + D + + +V C GG++ E ++ K F E + +
Sbjct: 57 IEIMKSLDHPNIIRLYETFEDNTD-IYLVMELCTGGELFERVVHKRV---FRESDAARIM 112
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTP 178
+L AV Y H V HRDLK N FLT D ++L DFGLA + + VGTP
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172
Query: 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PL 234
Y+ P++L YG + D WS G M+ + P F AP + ++ KI + +
Sbjct: 173 YYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW 231
Query: 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
V S + +I+ +L K+P+ R T+ L H
Sbjct: 232 LNV-SPQAESLIRRLLTKSPKQRITSLQALEHE 263
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-56
Identities = 76/263 (28%), Positives = 124/263 (47%), Gaps = 16/263 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ + +E +G GAF FLV ++ K + LK I+ K + E+ ++ K+ +
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLKKIKHE 66
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAVDYL 131
IV +D + +V GG++ + I+++ + E+ + Q+L AV YL
Sbjct: 67 NIVTLEDIYEST-THYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYL 122
Query: 132 HSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD 188
H N ++HRDLK N+ +LT + + I + DFGL+K+ + S+ GTP Y+ PE+LA
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM-STACGTPGYVAPEVLAQ 181
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMKQ 244
PY D WS+G + + P F + L KI + S + K
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI-SESAKD 240
Query: 245 IIKSMLRKNPEHRPTASDLLRHP 267
I +L K+P R T L HP
Sbjct: 241 FICHLLEKDPNERYTCEKALSHP 263
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-56
Identities = 76/273 (27%), Positives = 133/273 (48%), Gaps = 15/273 (5%)
Query: 4 ENGDSKSKLED-YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQE 62
EN + + Y ++ +G+G+FG +I +++Y +K I A K T L+E
Sbjct: 12 ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWL 121
++L+ KL++P I+K + D + IV GG++ + IIK+ R F E + +
Sbjct: 72 VELLKKLDHPNIMKLFEILEDSSS-FYIVGELYTGGELFDEIIKRKR---FSEHDAARII 127
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTP 178
Q+ + Y+H + ++HRDLK NI +K+ D I++ DFGL+ +GT
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PL 234
Y+ PE+L Y K D+WS G ++ + + P F + ++ ++ +
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246
Query: 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ S K +I+ ML +P R TA+ L HP
Sbjct: 247 RTI-SDDAKDLIRKMLTFHPSLRITATQCLEHP 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-55
Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 13/263 (4%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
++Y+V E++G+GAF +HK ++ K I K + + + +E + KL +P
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAVDYL 131
IV+ D+ ++ +V GG++ E I+ + + E + Q+L ++ Y
Sbjct: 66 NIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 121
Query: 132 HSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD 188
HSN ++HR+LK N+ +K ++L DFGLA +N + GTP Y+ PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMKQ 244
PY DIW+ G ++ + P F D L +I + V + K
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV-TPEAKS 240
Query: 245 IIKSMLRKNPEHRPTASDLLRHP 267
+I SML NP+ R TA L+ P
Sbjct: 241 LIDSMLTVNPKKRITADQALKVP 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-55
Identities = 73/273 (26%), Positives = 132/273 (48%), Gaps = 19/273 (6%)
Query: 5 NGDSKSKLED-YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEM 63
+G ++ L D +EV ++GRGA + K +K Y LK ++ + + E+
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT----EI 99
Query: 64 DLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLT 122
++ +L++P I+K K+ + + +V GG++ + I++K + E +
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTE-ISLVLELVTGGELFDRIVEKGY---YSERDAADAVK 155
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPN 179
Q+L AV YLH N ++HRDLK N+ + T D +++ DFGL+K++ + L +V GTP
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-DMAGLINKINRSSIS----PL 234
Y PE+L YG + D+WS+G + + F + +I
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275
Query: 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
V S K +++ ++ +P+ R T L+HP
Sbjct: 276 DEV-SLNAKDLVRKLIVLDPKKRLTTFQALQHP 307
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 4e-55
Identities = 75/272 (27%), Positives = 134/272 (49%), Gaps = 18/272 (6%)
Query: 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEMD 64
K + ED++ + +G G+F L ++Y +L+K + K+ K +E D
Sbjct: 25 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYV-TRERD 82
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
++S+L++P+ VK + D + Y + G++ + I+K F E + ++
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEI 139
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL---NTEDLASSVVGTPNYM 181
+ A++YLH ++HRDLK NI L +D I++ DFG AK+L + + A+S VGT Y+
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 182 CPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSST 241
PELL + SD+W+LGC ++++ A P FRA + + KI + P +
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-FPEKFFPK 258
Query: 242 MKQIIKSMLRKNPEHRPT------ASDLLRHP 267
+ +++ +L + R L HP
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 5e-55
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-----------QTEKFKRTALQ 61
E Y + ++G GA+G L K + +K I+ ++ EKF
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 62 EMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKW 120
E+ L+ L++P I+K D + DK +VT + EGG++ E II + + F E
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDK-KYFYLVTEFYEGGELFEQIINRHK---FDECDAANI 151
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGT 177
+ Q+L + YLH + ++HRD+K NI K++ I++ DFGL+ + + +GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----P 233
Y+ PE+L Y K D+WS G M+ + P F + +I K+ +
Sbjct: 212 AYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ S K++IK ML + R TA + L
Sbjct: 271 WKNI-SDEAKELIKLMLTYDYNKRCTAEEALNSR 303
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 7e-55
Identities = 57/308 (18%), Positives = 110/308 (35%), Gaps = 49/308 (15%)
Query: 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQE 62
G + + + + +G+GA F HK + V I + + R E
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR----E 57
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNC-VCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKW 120
+++ KLN+ IVK + ++ +C G + + + + PE +
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND----IRLGDFGLAKLLNTEDLASSVVG 176
L ++ +++L N ++HR++K NI D +L DFG A+ L ++ S+ G
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG 177
Query: 177 TPNYMCPELLADI--------PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG----LIN 224
T Y+ P++ YG D+WS+G + A FR + ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 225 KINR--------------------SSISPLPIVYSSTMK----QIIKSMLRKNPEHRPTA 260
KI S P+ S ++ ++ ++L + E
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 261 SDLLRHPH 268
Sbjct: 298 DQFFAETS 305
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-54
Identities = 65/317 (20%), Positives = 128/317 (40%), Gaps = 57/317 (17%)
Query: 6 GDSKSKLED-YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKI---RLAKQTEKFKRTALQ 61
G S +L+ Y + IG+G++G + + R +K + ++ + K
Sbjct: 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77
Query: 62 EMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKK--------------- 106
E+ L+ KL++P I + + + D+ +C+V C GG + + +
Sbjct: 78 EVRLMKKLHHPNIARLYEVYEDE-QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 107 -----------------------ARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKC 143
+ E+ + + Q+ A+ YLH+ + HRD+K
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196
Query: 144 SNIFLTKDND--IRLGDFGLAKLLNTEDLA-----SSVVGTPNYMCPELL--ADIPYGYK 194
N + + I+L DFGL+K + ++ GTP ++ PE+L + YG K
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256
Query: 195 SDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMKQIIKSML 250
D WS G + + F + A I+++ + ++ S + ++ ++L
Sbjct: 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL-SPLARDLLSNLL 315
Query: 251 RKNPEHRPTASDLLRHP 267
+N + R A L+HP
Sbjct: 316 NRNVDERFDAMRALQHP 332
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-54
Identities = 71/297 (23%), Positives = 136/297 (45%), Gaps = 11/297 (3%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ Y+++E++G GAFG + K + +V K I K T E+ ++++L++P
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHP 108
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
++ DA+ DK + ++ + GG++ + I A E ++ ++ Q + ++H
Sbjct: 109 KLINLHDAFEDK-YEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 133 SNRVLHRDLKCSNIFLT--KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIP 190
+ ++H D+K NI K + +++ DFGLA LN +++ T + PE++ P
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMKQII 246
G+ +D+W++G + + + F D + + R V S K I
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV-SPEAKDFI 285
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSK 303
K++L+K P R T D L HP L+ + K +KEK P+ +
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQ 342
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-54
Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 14/271 (5%)
Query: 6 GDSKSKLED-YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMD 64
++ +K D Y+V E++G+GAF +HK ++ K I K + + + +E
Sbjct: 21 MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR 80
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQ 123
+ KL +P IV+ D+ ++ +V GG++ E I+ + + E + Q
Sbjct: 81 ICRKLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQ 136
Query: 124 LLLAVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNY 180
+L ++ Y HSN ++HR+LK N+ +K ++L DFGLA +N + GTP Y
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPI 236
+ PE+L PY DIW+ G ++ + P F D L +I +
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 256
Query: 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
V + K +I SML NP+ R TA L+ P
Sbjct: 257 V-TPEAKSLIDSMLTVNPKKRITADQALKVP 286
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-53
Identities = 72/297 (24%), Positives = 136/297 (45%), Gaps = 35/297 (11%)
Query: 2 ETENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRT 58
+ + +L Y + ++IG+G++G L ++ + Y VL K +L +Q +R
Sbjct: 2 SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 59 AL---------------------QEMDLISKLNNPYIVKYKDAWVD-KGNCVCIVTGYCE 96
QE+ ++ KL++P +VK + D + + +V
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN 121
Query: 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRL 156
G + E+ E++ + L+ ++YLH +++HRD+K SN+ + +D I++
Sbjct: 122 QGPVMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKI 178
Query: 157 GDFGLAKLLNTED-LASSVVGTPNYMCPELLADIPYGY---KSDIWSLGCCMFE-IAAHQ 211
DFG++ D L S+ VGTP +M PE L++ + D+W++G ++ +
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 212 PAFRAPDMAGLINKINRSSIS-PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
P F + L +KI ++ P + +K +I ML KNPE R ++ HP
Sbjct: 239 P-FMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-53
Identities = 87/335 (25%), Positives = 149/335 (44%), Gaps = 32/335 (9%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NN 71
+ YEV E IG G++ +HK ++ +K I +K KR +E++++ + +
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQH 75
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAVDY 130
P I+ KD + D V +VT +GG++ + I+++ F E + L + V+Y
Sbjct: 76 PNIITLKDVYDDG-KYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEY 131
Query: 131 LHSNRVLHRDLKCSNI-FLTKDND---IRLGDFGLAKLLNTED-LASSVVGTPNYMCPEL 185
LH+ V+HRDLK SNI ++ + + IR+ DFG AK L E+ L + T N++ PE+
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM---AGLINKINRSSIS----PLPIVY 238
L Y DIWSLG ++ + F ++ +I S V
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV- 250
Query: 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRK 298
S T K ++ ML +P R TA+ +LRHP + Q P + +
Sbjct: 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH---WDQLPQY---QLNRQDAPHLVKGA 304
Query: 299 SPSSKHNSRKDKGER-EAAAPNQLENVRSVAKNIA 332
++ +++ E + L R + K +
Sbjct: 305 MAATYSALNRNQSPVLEPVGRSTLAQRRGIKKITS 339
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-53
Identities = 66/274 (24%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 4 ENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTAL 60
+ + + +E++ IG+G+FG +V +K Y + K + ++ E R
Sbjct: 6 FDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVF 63
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
+E+ ++ L +P++V ++ D+ + +V GGD+ +++ F EE + +
Sbjct: 64 KELQIMQGLEHPFLVNLWYSFQDEEDM-FMVVDLLLGGDLRYHLQQNV--HFKEETVKLF 120
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNY 180
+ +L++A+DYL + R++HRD+K NI L + + + DF +A +L E +++ GT Y
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPY 180
Query: 181 MCPELLADIP---YGYKSDIWSLGCCMFEIAAHQPAFR---APDMAGLINKINRSSISPL 234
M PE+ + Y + D WSLG +E+ + + + +++ + +
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-TY 239
Query: 235 PIVYSSTMKQIIKSMLRKNPEHR-PTASDLLRHP 267
P +S M ++K +L NP+ R SD+ P
Sbjct: 240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-53
Identities = 73/264 (27%), Positives = 125/264 (47%), Gaps = 14/264 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E+Y++ E++G+GAF + + ++Y I K + + + +E + L +P
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAVDYL 131
IV+ D+ ++G+ ++ GG++ E I+ + + E + Q+L AV +
Sbjct: 71 NIVRLHDSISEEGH-HYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHC 126
Query: 132 HSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPELLA 187
H V+HR+LK N+ +K ++L DFGLA + E A GTP Y+ PE+L
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMK 243
PYG D+W+ G ++ + P F D L +I + V + K
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV-TPEAK 245
Query: 244 QIIKSMLRKNPEHRPTASDLLRHP 267
+I ML NP R TA++ L+HP
Sbjct: 246 DLINKMLTINPSKRITAAEALKHP 269
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 7e-53
Identities = 57/262 (21%), Positives = 114/262 (43%), Gaps = 14/262 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNN 71
E Y + E +GRG FG + +K Y+ K +++ K+ E+ +++ +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARH 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
I+ +++ + ++ + G D+ E I E ++ ++ Q+ A+ +L
Sbjct: 61 RNILHLHESFESMEE-LVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFL 118
Query: 132 HSNRVLHRDLKCSNIFLT--KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI 189
HS+ + H D++ NI + + I++ +FG A+ L D + P Y PE+
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMKQI 245
+D+WSLG ++ + + F A +I I + + + S
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI-SIEAMDF 237
Query: 246 IKSMLRKNPEHRPTASDLLRHP 267
+ +L K + R TAS+ L+HP
Sbjct: 238 VDRLLVKERKSRMTASEALQHP 259
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-52
Identities = 62/288 (21%), Positives = 120/288 (41%), Gaps = 30/288 (10%)
Query: 1 METENGDSKSKLE-----DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF 55
+E ++GD ++ + + + +G GA G + + +K+I +
Sbjct: 7 LEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP-----EC 60
Query: 56 KRTALQEMDLISKLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPE 114
A +E+ L+ + + P +++Y D+ I C + E +++ +
Sbjct: 61 FSFADREVQLLRESDEHPNVIRYFCTEKDR-QFQYIAIELC-AATLQEYVEQ-KDFAHLG 117
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND-----IRLGDFGLAKLLNTED 169
+ L Q + +LHS ++HRDLK NI ++ N + DFGL K L
Sbjct: 118 LEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 170 LA----SSVVGTPNYMCPELLADIP---YGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAG 221
+ S V GT ++ PE+L++ Y DI+S GC + + + F
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237
Query: 222 LINKINRSSISPLPI--VYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ S+ L +++I+ M+ +P+ RP+A +L+HP
Sbjct: 238 ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 184 bits (467), Expect = 2e-52
Identities = 48/278 (17%), Positives = 96/278 (34%), Gaps = 32/278 (11%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLIS 67
+ V +G GAF + ++K+VLK + A E + T Q M+ +
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT--QLMERLK 122
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR---GACFPEEKLCKWLTQL 124
+K+ A + + N +V G + I + P+ + + ++
Sbjct: 123 PSMQHMFMKFYSAHLFQ-NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLT-----------KDNDIRLGDFGLA---KLLNTEDL 170
L ++ +H ++H D+K N L + L D G + KL +
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFE-IAAHQPAFRAPDMAGLINKINRS 229
++ T + C E+L++ P+ Y+ D + + ++ + + + R
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 230 SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ ML H + DLLR
Sbjct: 302 LPHL------DMWNEFFHVMLNIPDCHHLPSLDLLRQK 333
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-52
Identities = 71/268 (26%), Positives = 128/268 (47%), Gaps = 16/268 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTA---LQEMDLISKL 69
+ YE+ E IG+G F +++ +++ +K + +AK T + +E + L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKAR-GACFPEEKLCKWLTQLLLA 127
+P+IV+ + + G + +V + +G D+ I+K+A G + E ++ Q+L A
Sbjct: 84 KHPHIVELLETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 128 VDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLA-SSVVGTPNYMCP 183
+ Y H N ++HRD+K + +K+N ++LG FG+A L L VGTP++M P
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYS 239
E++ PYG D+W G +F + + F L I + + S
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI-S 260
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ K +++ ML +P R T + L HP
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHP 288
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-52
Identities = 65/267 (24%), Positives = 124/267 (46%), Gaps = 16/267 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF----KRTALQEMDLISK 68
+ YE+ E++G G F K K+Y K I+ + + + +E++++ +
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
+ +P I+ D + +K V ++ GG++ + + + E++ ++L Q+L V
Sbjct: 65 IRHPNIITLHDIFENK-TDVVLILELVSGGELFDFLA-EKE-SLTEDEATQFLKQILDGV 121
Query: 129 DYLHSNRVLHRDLKCSNIFLT----KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE 184
YLHS R+ H DLK NI L + I+L DFG+A + + ++ GTP ++ PE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSS 240
++ P G ++D+WS+G + + + F + I+ + S
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT-SE 240
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHP 267
K I+ +L K+P+ R T + L H
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHS 267
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-52
Identities = 63/268 (23%), Positives = 120/268 (44%), Gaps = 18/268 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF----KRTALQEMDLISK 68
+ Y++ E++G G F K +Y K I+ + + +E+ ++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLA 127
+ + ++ D + ++ + V ++ GG++ + + +K EE+ ++ Q+L
Sbjct: 72 VLHHNVITLHDVYENRTD-VVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDG 127
Query: 128 VDYLHSNRVLHRDLKCSNI-FLTKDND---IRLGDFGLAKLLNTEDLASSVVGTPNYMCP 183
V+YLH+ ++ H DLK NI L K+ I+L DFGLA + ++ GTP ++ P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYS 239
E++ P G ++D+WS+G + + + F + I S S
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT-S 246
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHP 267
K I+ +L K R T + LRHP
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHP 274
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-52
Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-------EKFKRTALQEMDL 65
E+YE E +GRG +HK K+Y +K I + ++ + L+E+D+
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 66 ISKLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQ 123
+ K++ P I++ KD + +V + G++ + + +K E++ K +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRA 132
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCP 183
LL + LH ++HRDLK NI L D +I+L DFG + L+ + V GTP+Y+ P
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 184 ELLADI------PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----P 233
E++ YG + D+WS G M+ + A P F ++ I +
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
S T+K ++ L P+ R TA + L HP
Sbjct: 253 WDDY-SDTVKDLVSRFLVVQPQKRYTAEEALAHP 285
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 7e-52
Identities = 71/286 (24%), Positives = 135/286 (47%), Gaps = 32/286 (11%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISKLNN 71
+ + + +IG G+FGA + + +KK+ + + K + E+ + KL +
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P ++Y+ ++ + + +V YC G +++++ + E ++ L + YL
Sbjct: 114 PNTIQYRGCYL-REHTAWLVMEYCLGS-ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYL 170
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA---D 188
HS+ ++HRD+K NI L++ ++LGDFG A ++ A+S VGTP +M PE++ +
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDE 227
Query: 189 IPYGYKSDIWSLGCCMFEIA------AHQPAFRAPDMAGLINKINRSSISPL-PIVYSST 241
Y K D+WSLG E+A + A A + I ++ L +S
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESPALQSGHWSEY 281
Query: 242 MKQIIKSMLRKNPEHRPTASDLLRHP---------HLQPYLLRCQN 278
+ + S L+K P+ RPT+ LL+H + + R ++
Sbjct: 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKD 327
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 189 bits (480), Expect = 8e-52
Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 10/269 (3%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
+E+ E++G G FG +H+ ++ +K+ R + +R E+ ++ KLN+P
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW-CLEIQIMKKLNHPN 73
Query: 74 IVKYKD-----AWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLA 127
+V ++ + + + YCEGGD+ + + + E + L+ + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDND---IRLGDFGLAKLLNTEDLASSVVGTPNYMCPE 184
+ YLH NR++HRDLK NI L ++ D G AK L+ +L + VGT Y+ PE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244
LL Y D WS G FE F + R + +VY
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
Query: 245 IIKSMLRKNPEHRPTASDLLRHPHLQPYL 273
+ S + P H LQ L
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCML 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-51
Identities = 64/272 (23%), Positives = 127/272 (46%), Gaps = 18/272 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF----KRTALQEMDLISK 68
+ Y+ E++G G F K +Y K I+ + + +E+ ++ +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLA 127
+ +P ++ + + +K V ++ GG++ + + +K EE+ ++L Q+L
Sbjct: 71 IQHPNVITLHEVYENK-TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 128 VDYLHSNRVLHRDLKCSNIFLT----KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCP 183
V YLHS ++ H DLK NI L I++ DFGLA ++ + ++ GTP ++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYS 239
E++ P G ++D+WS+G + + + F + ++ + S
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-S 245
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271
+ K I+ +L K+P+ R T D L+HP ++P
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-51
Identities = 90/322 (27%), Positives = 148/322 (45%), Gaps = 27/322 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTA------LQEMDLI 66
++Y + + +G GA G L + KK +K I K R A E++++
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLL 125
KLN+P I+K K+ + + IV EGG++ + ++ R E + Q+L
Sbjct: 70 KKLNHPCIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQML 124
Query: 126 LAVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMC 182
LAV YLH N ++HRDLK N+ +++ D I++ DFG +K+L L ++ GTP Y+
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 183 PELLADI---PYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-AGLINKINRSSISPLPIVY 238
PE+L + Y D WSLG +F + P F L ++I +
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-FIPEV 243
Query: 239 ----SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKE 294
S ++K +L +P+ R T + LRHP LQ ++ + + + T + +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 303
Query: 295 KTRKSPSSKHNSRKDKGEREAA 316
+ S S K R +GE E A
Sbjct: 304 LAQPSTSRK---RPREGEAEGA 322
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-51
Identities = 74/359 (20%), Positives = 153/359 (42%), Gaps = 33/359 (9%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTA----LQEMDLISK 68
+ Y++ E++G G F K +Y K I+ + + +E+ ++ +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLA 127
+ +P I+ D + ++ + V ++ GG++ + + +K EE+ ++ Q+L
Sbjct: 72 VLHPNIITLHDVYENRTD-VVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDG 127
Query: 128 VDYLHSNRVLHRDLKCSNI-FLTKDND---IRLGDFGLAKLLNTEDLASSVVGTPNYMCP 183
V+YLH+ ++ H DLK NI L K+ I+L DFGLA + ++ GTP ++ P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYS 239
E++ P G ++D+WS+G + + + F + I S S
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT-S 246
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKS 299
K I+ +L K R T + LRHP + + + + + + E +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWIT------PVDTQQAMVRRESVVNLENFK-- 298
Query: 300 PSSKHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLDDKPTSSTSTEDNLETKK 358
K R+ R + + + + +++ +++ +D + TE+N+ +K
Sbjct: 299 ---KQYVRR----RWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRK 350
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-51
Identities = 86/353 (24%), Positives = 140/353 (39%), Gaps = 45/353 (12%)
Query: 3 TENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKK--IRLAKQTEKFKR 57
+ + + +D+E+++ IGRGAF +V K + Y ++ K + + F+
Sbjct: 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR- 109
Query: 58 TALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKL 117
+E D++ + +I + A+ D+ + +V Y GGD+ ++ K G P E
Sbjct: 110 ---EERDVLVNGDRRWITQLHFAFQDENY-LYLVMEYYVGGDLLTLLSK-FGERIPAEMA 164
Query: 118 CKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--ASSVV 175
+L ++++A+D +H +HRD+K NI L + IRL DFG L + + V
Sbjct: 165 RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 176 GTPNYMCPELL-------ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI-- 226
GTP+Y+ PE+L YG + D W+LG +E+ Q F A A KI
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284
Query: 227 --NRSSISPLPIVYSSTMKQIIKSMLRKNPEHR---PTASDLLRHP---HLQPYLLRCQN 278
S+ + + I+ +L PE R A D HP L LR
Sbjct: 285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSV 343
Query: 279 PSSVYLPIKPT--------NIMKEKTRKSPS-SKHNSRKDKGEREAAAPNQLE 322
P P P N + + S A L
Sbjct: 344 P-----PFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLP 391
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 6e-51
Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 24/282 (8%)
Query: 4 ENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTA---- 59
++ K+ ++Y + + +G GA G L + KK ++ I K R A
Sbjct: 126 QSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL 185
Query: 60 --LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGD-MAEIIKKARGACFPEEK 116
E++++ KLN+P I+K K+ + + IV EGG+ +++ R E
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKR---LKEAT 240
Query: 117 LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT---KDNDIRLGDFGLAKLLNTEDLASS 173
+ Q+LLAV YLH N ++HRDLK N+ L+ +D I++ DFG +K+L L +
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300
Query: 174 VVGTPNYMCPELLADI---PYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-AGLINKINRS 229
+ GTP Y+ PE+L + Y D WSLG +F + P F L ++I
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 230 SISPLPIVY----SSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ S ++K +L +P+ R T + LRHP
Sbjct: 361 KYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-50
Identities = 69/309 (22%), Positives = 134/309 (43%), Gaps = 17/309 (5%)
Query: 6 GDSKSKLED-YEVI-EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEM 63
S + Y + +++GRG F + K ++Y K ++ ++ + + L E+
Sbjct: 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEI 79
Query: 64 DLISKLN-NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWL 121
++ P ++ + + + + + ++ Y GG++ + + E + + +
Sbjct: 80 AVLELAKSCPRVINLHEVYENT-SEIILILEYAAGGEIFSLCLPELAE-MVSENDVIRLI 137
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNIFL---TKDNDIRLGDFGLAKLLNTEDLASSVVGTP 178
Q+L V YLH N ++H DLK NI L DI++ DFG+++ + ++GTP
Sbjct: 138 KQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PL 234
Y+ PE+L P +D+W++G + + H F D I++ ++
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257
Query: 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKE 294
V S I+S+L KNPE RPTA L H LQ + ++ ++
Sbjct: 258 SSV-SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW---DFENLFHPEETSSSSQTQD 313
Query: 295 KTRKSPSSK 303
+ +S K
Sbjct: 314 HSVRSSEDK 322
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-50
Identities = 64/264 (24%), Positives = 114/264 (43%), Gaps = 15/264 (5%)
Query: 13 EDYEV--IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
Y V E +G G FG K K I+ + K K E+ ++++L+
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK--TRGMKDKEEVKNEISVMNQLD 144
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAVD 129
+ +++ DA+ K N + +V Y +GG++ + II E ++ Q+ +
Sbjct: 145 HANLIQLYDAFESK-NDIVLVMEYVDGGELFDRII--DESYNLTELDTILFMKQICEGIR 201
Query: 130 YLHSNRVLHRDLKCSNIFLT--KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA 187
++H +LH DLK NI I++ DFGLA+ + GTP ++ PE++
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMK 243
+ +D+WS+G + + + F + A +N I + S K
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI-SEEAK 320
Query: 244 QIIKSMLRKNPEHRPTASDLLRHP 267
+ I +L K R +AS+ L+HP
Sbjct: 321 EFISKLLIKEKSWRISASEALKHP 344
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-50
Identities = 70/324 (21%), Positives = 136/324 (41%), Gaps = 22/324 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ Y++ E++G GAFG V + + K + +++K T +E+ +S L +P
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHP 214
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+V DA+ D N + ++ + GG++ E + E++ +++ Q+ + ++H
Sbjct: 215 TLVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH 272
Query: 133 SNRVLHRDLKCSNIFLT--KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIP 190
N +H DLK NI T + N+++L DFGL L+ + GT + PE+ P
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSSTMKQII 246
GY +D+WS+G + + + F + + + + + S K I
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI-SEDGKDFI 391
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNS 306
+ +L +P R T L HP L P +P +++ +
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLTP---GNAPGRDSQIPSSRYTKIRDSIKT-------- 440
Query: 307 RKDKGEREAAAPNQLENVRSVAKN 330
+ D ++ N S+ K+
Sbjct: 441 KYDAWPEPLPPLGRISNYSSLRKH 464
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-50
Identities = 70/273 (25%), Positives = 124/273 (45%), Gaps = 23/273 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK------QTEKFKRTALQEMDLI 66
+ Y+ + IGRG +H+ ++ +K + + Q E+ + +E ++
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 67 SKLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQL 124
++ P+I+ D++ + +V G++ + + +K E++ + L
Sbjct: 154 RQVAGHPHIITLIDSYESSSF-MFLVFDLMRKGELFDYLTEKVA---LSEKETRSIMRSL 209
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE 184
L AV +LH+N ++HRDLK NI L + IRL DFG + L + + GTP Y+ PE
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 185 LL------ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PL 234
+L YG + D+W+ G +F + A P F ++ I
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329
Query: 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
SST+K +I +L+ +PE R TA L+HP
Sbjct: 330 DDR-SSTVKDLISRLLQVDPEARLTAEQALQHP 361
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-50
Identities = 75/270 (27%), Positives = 140/270 (51%), Gaps = 22/270 (8%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKK---IRLAKQTEKFKRTALQE 62
K L+D++++ +G G+FG L+ + + Y VLKK +RL KQ E T E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVE---HT-NDE 56
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
++S + +P+I++ + D + ++ Y EGG++ +++K++ FP +
Sbjct: 57 RLMLSIVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAA 113
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMC 182
++ LA++YLHS +++RDLK NI L K+ I++ DFG AK + D+ ++ GTP+Y+
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIA 171
Query: 183 PELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242
PE+++ PY D WS G ++E+ A F + KI + + P ++ +
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-FPPFFNEDV 230
Query: 243 KQIIKSMLRKNPEHR-----PTASDLLRHP 267
K ++ ++ ++ R D+ HP
Sbjct: 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 9e-50
Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 25/271 (9%)
Query: 13 EDYEVI-EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+DY++ + +G G G H+ +K LK + + A QE+D + +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL------YDSPK-ARQEVDHHWQASG 80
Query: 72 -PYIVKYKDAWVDKGN---CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
P+IV D + + + C+ I+ EGG++ I++ F E + + + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 128 VDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCPE 184
+ +LHS+ + HRD+K N+ + +K+ D ++L DFG AK L + TP Y+ PE
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPE 199
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSIS----PLPI 236
+L Y D+WSLG M+ + P F + G+ +I
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
V S KQ+I+ +L+ +P R T + + HP
Sbjct: 260 V-SEDAKQLIRLLLKTDPTERLTITQFMNHP 289
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-49
Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 37/289 (12%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKLN 70
+E YE I +IG G++G F ++ + + V +KK ++ K+ AL+E+ ++ +L
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+P +V + + K + +V YC+ + + + + PE + Q L AV++
Sbjct: 61 HPNLVNLLEVFRRKRR-LHLVFEYCDH-TVLHELDRYQRG-VPEHLVKSITWQTLQAVNF 117
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPE-LLAD 188
H + +HRD+K NI +TK + I+L DFG A+LL V T Y PE L+ D
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR-------------------- 228
YG D+W++GC E+ + P + + I +
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 229 -------SSISPLPIVY---SSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ PL + + S ++K L +P R T LL HP
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 71/278 (25%), Positives = 132/278 (47%), Gaps = 17/278 (6%)
Query: 2 ETENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKK---Y---VLKKIRLAKQTEKF 55
G K + E +E++ +G+G +G F V + VLKK + + +
Sbjct: 6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65
Query: 56 KRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE 115
T E +++ ++ +P+IV A+ G + ++ Y GG++ +++ F E+
Sbjct: 66 AHT-KAERNILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREG--IFMED 121
Query: 116 KLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSV 174
C +L ++ +A+ +LH +++RDLK NI L ++L DFGL K ++ + +
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181
Query: 175 VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL 234
GT YM PE+L + D WSLG M+++ P F + I+KI + + L
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NL 240
Query: 235 PIVYSSTMKQIIKSMLRKNPEHR----PT-ASDLLRHP 267
P + + ++K +L++N R P A ++ HP
Sbjct: 241 PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 75/271 (27%), Positives = 137/271 (50%), Gaps = 22/271 (8%)
Query: 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKK---IRLAKQTEKFKRTALQ 61
+ ++L+ ++ I+ +G G+FG LV HK Y +L K ++L KQ E L
Sbjct: 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEH----TLN 90
Query: 62 EMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWL 121
E ++ +N P++VK + ++ D N + +V Y GG+M +++ F E +
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYA 147
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYM 181
Q++L +YLHS +++RDLK N+ + + I++ DFG AK + + ++ GTP +
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEAL 205
Query: 182 CPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSST 241
PE++ Y D W+LG ++E+AA P F A + KI + P +SS
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-FPSHFSSD 264
Query: 242 MKQIIKSMLRKNPEHR-----PTASDLLRHP 267
+K +++++L+ + R +D+ H
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 3e-49
Identities = 83/278 (29%), Positives = 142/278 (51%), Gaps = 19/278 (6%)
Query: 2 ETENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKK---Y---VLKKIRLAKQTEKF 55
+ G K+ +E+++ +G+G+FG FLV Y VLKK L +
Sbjct: 13 HVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV- 71
Query: 56 KRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE 115
RT E D++ ++N+P+IVK A+ +G + ++ + GGD+ + K F EE
Sbjct: 72 -RT-KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEV--MFTEE 126
Query: 116 KLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSV 174
+ +L +L LA+D+LHS +++RDLK NI L ++ I+L DFGL+K ++ E A S
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 175 VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL 234
GT YM PE++ + +D WS G MFE+ F+ D + I ++ + +
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-M 245
Query: 235 PIVYSSTMKQIIKSMLRKNPEHR----PT-ASDLLRHP 267
P S + +++ + ++NP +R P ++ RH
Sbjct: 246 PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 3e-49
Identities = 80/301 (26%), Positives = 130/301 (43%), Gaps = 37/301 (12%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTA 59
ME + + YE + +IG GA+G F ++V LK++R+ E +
Sbjct: 1 MEKDGL--CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST 58
Query: 60 LQEMDLISKLNN---PYIVKYKD----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACF 112
++E+ ++ L P +V+ D + D+ + +V + + D+ + K
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 113 PEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172
P E + + QLL +D+LHS+RV+HRDLK NI +T I+L DFGLA++ + + +
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI------ 226
SVV T Y PE+L Y D+WS+GC E+ +P FR + KI
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 227 -------------NRSSISPLPIVYSSTMKQI-------IKSMLRKNPEHRPTASDLLRH 266
++ S + I + L NP R +A L H
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 267 P 267
P
Sbjct: 298 P 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-49
Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 37/291 (12%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLIS 67
+ +E Y+ +E++G G +G + + + V LK+IRL + E TA++E+ L+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAEDEGIPSTAIREISLLK 74
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
+L++P IV D + + +V + E D+ +++ + + + ++ +L QLL
Sbjct: 75 ELHHPNIVSLIDVIHSERC-LTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLLRG 131
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPE-L 185
V + H +R+LHRDLK N+ + D ++L DFGLA+ + + V T Y P+ L
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS----------SISPLP 235
+ Y DIWS+GC E+ +P F + KI + LP
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251
Query: 236 IVYSSTMKQ-------------------IIKSMLRKNPEHRPTASDLLRHP 267
+ T + ++ +ML +P R +A D + HP
Sbjct: 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-49
Identities = 40/300 (13%), Positives = 83/300 (27%), Gaps = 44/300 (14%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQE----------- 62
+++E + G FLV + + LK + + + + L E
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 63 --------------MDLISKLNNPYIVKYKDAWVDKGNC-VCIVTGYCEGGDMAEIIKK- 106
D ++ + P + D ++ D+ +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV-DLELLFSTL 181
Query: 107 ----ARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162
L QL+ L S ++H N+F+ D + LGD
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 163 KLLNTEDLASSVVGTPNYMCPELL--ADIPYGYKSDIWSLGCCMFEIAAHQPAF--RAPD 218
+ T + Y E L + + + + W LG ++ + F P
Sbjct: 242 WKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 219 MAGLINKINRSSISPLPIVY------SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
+ G + + + + +K +I L + R + + P
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-49
Identities = 82/280 (29%), Positives = 133/280 (47%), Gaps = 26/280 (9%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKK--IRLAKQTEKFKRTALQ 61
+ ED+E+++ IGRGAFG +V K K + +L K + +T F+ +
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR----E 123
Query: 62 EMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWL 121
E D++ ++ +I A+ D N + +V Y GGD+ ++ K PEE +L
Sbjct: 124 ERDVLVNGDSKWITTLHYAFQDDNN-LYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYL 181
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--ASSVVGTPN 179
++++A+D +H +HRD+K NI + + IRL DFG L + +S VGTP+
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 180 YMCPELLADIP-----YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI----NRSS 230
Y+ PE+L + YG + D WSLG CM+E+ + F A + KI R
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301
Query: 231 ISPLPIVYSSTMKQIIKSMLRKNPEHR---PTASDLLRHP 267
S K +I+ ++ + EHR D +HP
Sbjct: 302 FPTQVTDVSENAKDLIRRLI-CSREHRLGQNGIEDFKKHP 340
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-49
Identities = 75/330 (22%), Positives = 130/330 (39%), Gaps = 51/330 (15%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLH-------KIERKKYVLK----------KIRLA 49
+ + DY +I + +G F L K K + K KI +
Sbjct: 25 EKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIK 84
Query: 50 KQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKK--- 106
+ + FK E+ +I+ + N Y + + + V I+ Y E + + +
Sbjct: 85 SKYDDFKN----ELQIITDIKNEYCLTCEGIITNYDE-VYIIYEYMENDSILKFDEYFFV 139
Query: 107 ---ARGACFPEEKLCKWLTQLLLAVDYLHSNR-VLHRDLKCSNIFLTKDNDIRLGDFGLA 162
P + + + +L + Y+H+ + + HRD+K SNI + K+ ++L DFG +
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 163 KLLNTEDLASSVVGTPNYMCPELLADIP--YGYKSDIWSLGCCMFEIAAHQPAFRA-PDM 219
+ + + + S GT +M PE ++ G K DIWSLG C++ + + F +
Sbjct: 200 EYMVDKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 220 AGLINKINRSSIS-PLPIVY-----------------SSTMKQIIKSMLRKNPEHRPTAS 261
L N I +I PL + S+ +K LRKNP R T+
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
Query: 262 DLLRHPHLQPYLLRCQNPSSVYLPIKPTNI 291
D L+H L + S L K +
Sbjct: 319 DALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-49
Identities = 63/310 (20%), Positives = 127/310 (40%), Gaps = 35/310 (11%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
+E YE + +G G++G +K + +KK + + K+ A++E+ L+ +L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+ +V + K +V + + + + ++ + + K+L Q++ + +
Sbjct: 83 HENLVNLLEVCKKKKR-WYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGF 139
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPE-LLAD 188
HS+ ++HRD+K NI +++ ++L DFG A+ L V T Y PE L+ D
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD 199
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR----------SSISPLPIVY 238
+ YG D+W++GC + E+ +P F + I + P+
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259
Query: 239 SSTMKQI--------------------IKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQN 278
+ +I K L +P+ RP ++LL H Q +
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERF 319
Query: 279 PSSVYLPIKP 288
+ L ++
Sbjct: 320 SQELQLKVQK 329
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-49
Identities = 71/272 (26%), Positives = 130/272 (47%), Gaps = 24/272 (8%)
Query: 12 LEDYEVIEQ-IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
++DY+V Q +G G G + +K ++K+ LK ++ K +R E++L + +
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARR----EVELHWRAS 112
Query: 71 N-PYIVKYKDAWVDKG---NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
P+IV+ D + + C+ IV +GG++ I+ F E + + + +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 127 AVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCP 183
A+ YLHS + HRD+K N+ + +K + ++L DFG AK + + ++ TP Y+ P
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM----AGLINKINRSSIS----PLP 235
E+L Y D+WSLG M+ + P F + G+ +I
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292
Query: 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
V S +K +I+++L+ P R T ++ + HP
Sbjct: 293 EV-SEEVKMLIRNLLKTEPTQRMTITEFMNHP 323
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 72/321 (22%), Positives = 138/321 (42%), Gaps = 19/321 (5%)
Query: 3 TENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQE 62
D + + +Y +++ IG+G F L H + ++ +K I + + +E
Sbjct: 5 ASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE 64
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWL 121
+ ++ LN+P IVK + + + ++ Y GG++ + ++ R E++
Sbjct: 65 VRIMKILNHPNIVKLFEVIETE-KTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKF 120
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYM 181
Q++ AV Y H R++HRDLK N+ L D +I++ DFG + + G P Y
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 182 CPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240
PEL Y G + D+WSLG ++ + + F ++ L ++ +P S+
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRGKYRIPFYMST 239
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHP-----HLQPYLLRCQNPSSVYLPIKPTNIM--- 292
+ ++K L NP R T +++ H + L P K +IM
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299
Query: 293 ---KEKTRKS-PSSKHNSRKD 309
+E+ ++S K++
Sbjct: 300 GYSQEEIQESLSKMKYDEITA 320
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 32/276 (11%)
Query: 13 EDYEV---IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISK 68
+ Y++ + +G G+F +HK + + +K I K Q E+ +
Sbjct: 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII------SKRMEANTQKEITALKL 61
Query: 69 LNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLL 126
P IVK + + D+ +V GG++ E I KK F E + + +L+
Sbjct: 62 CEGHPNIVKLHEVFHDQ-LHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVS 117
Query: 127 AVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTED-LASSVVGTPNYMC 182
AV ++H V+HRDLK N+ F ++++ I++ DFG A+L ++ + T +Y
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 183 PELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-------MAGLINKINRSSIS--- 232
PELL Y D+WSLG ++ + + Q F++ D ++ KI + S
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 233 -PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
V S K +I+ +L +P R S L +
Sbjct: 238 EAWKNV-SQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-48
Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 14/270 (5%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEMDL 65
+ +G+G FG + K Y L+K R+ K+ + AL E +
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE--AMALNEKQI 237
Query: 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ K+N+ ++V A+ K +C+V GGD+ I A FPE + + ++
Sbjct: 238 LEKVNSRFVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPEL 185
++ LH R+++RDLK NI L IR+ D GLA + VGT YM PE+
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSSTM 242
+ + Y + D W+LGC ++E+ A Q F+ ++ R +S
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416
Query: 243 KQIIKSMLRKNPEHR-----PTASDLLRHP 267
+ + +L K+P R +A ++ HP
Sbjct: 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHP 446
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-48
Identities = 86/278 (30%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-----KQTEKFKRTALQ 61
D + K EDYEV++ IGRGAFG LV HK RK Y +K + + F +
Sbjct: 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF----WE 118
Query: 62 EMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWL 121
E D+++ N+P++V+ A+ D + +V Y GGD+ ++ PE+ +
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRY-LYMVMEYMPGGDLVNLMSNYD---VPEKWARFYT 174
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE--DLASSVVGTPN 179
+++LA+D +HS +HRD+K N+ L K ++L DFG +N E + VGTP+
Sbjct: 175 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 180 YMCPELL----ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--- 232
Y+ PE+L D YG + D WS+G ++E+ F A + G +KI S
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 294
Query: 233 PLPIVYSSTMKQIIKSMLRKNPEHR---PTASDLLRHP 267
P S K +I + L + E R ++ RH
Sbjct: 295 PDDNDISKEAKNLICAFL-TDREVRLGRNGVEEIKRHL 331
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-48
Identities = 77/268 (28%), Positives = 132/268 (49%), Gaps = 15/268 (5%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEMDL 65
K + D++ ++ +G+G FG LV K + Y +L+K + + E T + E +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHT-VTESRV 58
Query: 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ +P++ K A+ +C V Y GG++ + + R F EE+ + +++
Sbjct: 59 LQNTRHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIV 115
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPNYMCPE 184
A++YLHS V++RD+K N+ L KD I++ DFGL K ++ + GTP Y+ PE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244
+L D YG D W LG M+E+ + F D L I I P S K
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKS 234
Query: 245 IIKSMLRKNPEHR----PT-ASDLLRHP 267
++ +L+K+P+ R P+ A +++ H
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHR 262
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (436), Expect = 5e-48
Identities = 35/296 (11%), Positives = 77/296 (26%), Gaps = 50/296 (16%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-----EKFKRTA--------- 59
+G+ A + + + + ++ ++ K
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 60 ------------LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMA----EI 103
+ DL+ +++ + D ++ +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 104 IKKARGACFPEEKLCKWLT-QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162
+ + LT Q++ + LH ++H L+ +I L + + L F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 163 KLLNTEDLASSVVGTPNYMCPELLAD-----------IPYGYKSDIWSLGCCMFEIAAHQ 211
+ + PEL A + D W+LG ++ I
Sbjct: 254 VRDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 212 PAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
G I RS ++ +++ LR E R + P
Sbjct: 311 LPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 361
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-48
Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 13/273 (4%)
Query: 3 TENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTA 59
+ + +K D+ ++ IG+G+FG L HK E Y VL+K + K+ E+ K
Sbjct: 28 GPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE-KHIM 86
Query: 60 LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
+ L+ + +P++V ++ + V Y GG++ +++ R CF E +
Sbjct: 87 SERNVLLKNVKHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRER--CFLEPRARF 143
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTP 178
+ ++ A+ YLHS +++RDLK NI L I L DFGL K + S+ GTP
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTP 203
Query: 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY 238
Y+ PE+L PY D W LG ++E+ P F + + A + + I + L
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ-LKPNI 262
Query: 239 SSTMKQIIKSMLRKNPEHR----PTASDLLRHP 267
+++ + +++ +L+K+ R ++ H
Sbjct: 263 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 38/288 (13%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKLN 70
+E Y +E+IG G +G + + + LKKIRL K+ E T ++E+ ++ +L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY--GETFALKKIRLEKEDEGIPSTTIREISILKELK 58
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+ IVK D K + +V + + D+ +++ G +L QLL + Y
Sbjct: 59 HSNIVKLYDVIHTKKR-LVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAY 115
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPE-LLAD 188
H RVLHRDLK N+ + ++ ++++ DFGLA+ + + T Y P+ L+
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR----------SSISPLPIVY 238
Y DIWS+GC E+ P F A + +I R +++ LP Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP-KY 234
Query: 239 SSTMKQ-------------------IIKSMLRKNPEHRPTASDLLRHP 267
++ ML+ +P R TA L H
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-47
Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 20/281 (7%)
Query: 5 NGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK-----KIRLAKQTEKFKRTA 59
D + K+ Y + + +G G FG + H++ K +K KIR K KR
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-- 60
Query: 60 LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLC 118
E+ + +P+I+K +V Y GG++ + I K R E +
Sbjct: 61 --EIQNLKLFRHPHIIKLYQVISTP-TDFFMVMEYVSGGELFDYICKHGR---VEEMEAR 114
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP 178
+ Q+L AVDY H + V+HRDLK N+ L + ++ DFGL+ +++ + + G+P
Sbjct: 115 RLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP 174
Query: 179 NYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV 237
NY PE+++ Y G + DIWS G ++ + F + L KI +P
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY-IPEY 233
Query: 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRHP----HLQPYLL 274
+ ++ ++ ML+ +P R T D+ H L YL
Sbjct: 234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 72/297 (24%), Positives = 118/297 (39%), Gaps = 41/297 (13%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE---KFKRTALQEMDL 65
YE + +IG GA+G + LK +R+ + ++E+ L
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 66 ISKLNN---PYIVKYKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLC 118
+ +L P +V+ D V +V + + D+ + KA P E +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP 178
+ Q L +D+LH+N ++HRDLK NI +T ++L DFGLA++ + + + VV T
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL 183
Query: 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS--------- 229
Y PE+L Y D+WS+GC E+ +P F A + KI
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243
Query: 230 -SISPLPIVYSSTMKQ------------------IIKSMLRKNPEHRPTASDLLRHP 267
LP + + ++ ML NP R +A L+H
Sbjct: 244 PRDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 87/343 (25%), Positives = 151/343 (44%), Gaps = 38/343 (11%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK---FKRTALQEM 63
D KS+ + YE ++ +G G F + K + +KKI+L ++E RTAL+E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 64 DLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ 123
L+ +L++P I+ DA+ K N + +V + E D+ IIK + ++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSN-ISLVFDFMET-DLEVIIKDNSLV-LTPSHIKAYMLM 120
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMC 182
L ++YLH + +LHRDLK +N+ L ++ ++L DFGLAK + + A + V T Y
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180
Query: 183 PELL--ADIPYGYKSDIWSLGCCMFEIAAHQPAFRA----------------------PD 218
PELL A + YG D+W++GC + E+ P PD
Sbjct: 181 PELLFGARM-YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239
Query: 219 MAGLINKINRSSISPLPI-----VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273
M L + + S +P+ + +I+ + NP R TA+ L+ +
Sbjct: 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299
Query: 274 LRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNSRKDKGEREAA 316
+ P P +KE++ + + K + +
Sbjct: 300 GPT-PGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLP 341
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 3e-47
Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 22/279 (7%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEMDLIS 67
+ED+++++ +G GA+G L ++++ + ++ R E K+ E+ +
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINK 60
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDM-AEIIKKARGACFPEEKLCKWLTQLLL 126
LN+ +VK+ + N + YC GG++ I PE ++ QL+
Sbjct: 61 MLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA 116
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL---NTEDLASSVVGTPNYMCP 183
V YLH + HRD+K N+ L + +++++ DFGLA + N E L + + GT Y+ P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 184 ELLADIPY-GYKSDIWSLGCCMFE-IAAHQPAFRAPDMAGLINKINRSSISPLPIVY-SS 240
ELL + D+WS G + +A P + D + P S
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHP----HLQPYLLR 275
++ +L +NP R T D+ + L+ R
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-46
Identities = 64/262 (24%), Positives = 119/262 (45%), Gaps = 10/262 (3%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKL 69
D + E+IG G+FG V V +K + + L+E+ ++ +L
Sbjct: 35 PWCDLNIKEKIGAGSFGT---VHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEII-KKARGACFPEEKLCKWLTQLLLAV 128
+P IV + V + + IVT Y G + ++ K E + + +
Sbjct: 92 RHPNIVLFM-GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 129 DYLHSNR--VLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTPNYMCPEL 185
+YLH+ ++HR+LK N+ + K +++ DFGL++L +T + S GTP +M PE+
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-LPIVYSSTMKQ 244
L D P KSD++S G ++E+A Q + + A ++ + +P + +
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270
Query: 245 IIKSMLRKNPEHRPTASDLLRH 266
II+ P RP+ + ++
Sbjct: 271 IIEGCWTNEPWKRPSFATIMDL 292
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 70/266 (26%), Positives = 122/266 (45%), Gaps = 24/266 (9%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKL 69
++ EV E +GRGAFG V R K V +K+I + + F E+ +S++
Sbjct: 6 DYKEIEVEEVVGRGAFGV---VCKAKWRAKDVAIKQIESESERKAFIV----ELRQLSRV 58
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGAC-FPEEKLCKWLTQLLLAV 128
N+P IVK A ++ VC+V Y EGG + ++ A + W Q V
Sbjct: 59 NHPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 129 DYLHS---NRVLHRDLKCSNIFLTKDND-IRLGDFGLAKLLNTEDLASSVVGTPNYMCPE 184
YLHS ++HRDLK N+ L +++ DFG A + T ++ G+ +M PE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----PLPIVYSS 240
+ Y K D++S G ++E+ + F ++ G +I + + PL
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKNLPK 231
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRH 266
++ ++ K+P RP+ ++++
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-46
Identities = 73/272 (26%), Positives = 127/272 (46%), Gaps = 21/272 (7%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEMDLISK 68
+ + +GRG FG F K K Y L K RL K+ + A+ E +++K
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY--QGAMVEKKILAK 241
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDM----AEIIKKARGACFPEEKLCKWLTQL 124
+++ +IV A+ K + +C+V GGD+ + + G F E + + Q+
Sbjct: 242 VHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPG--FQEPRAIFYTAQI 298
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK-LLNTEDLASSVVGTPNYMCP 183
+ +++LH +++RDLK N+ L D ++R+ D GLA L + GTP +M P
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSS 240
ELL Y + D ++LG ++E+ A + FRA ++ + + P +S
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418
Query: 241 TMKQIIKSMLRKNPEHR-----PTASDLLRHP 267
K +++L+K+PE R + L HP
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 71/290 (24%), Positives = 140/290 (48%), Gaps = 35/290 (12%)
Query: 3 TENGDSKSKLEDYEVIEQIGRGAFGAAFLVLH------------KIERKKYVLKKIRLAK 50
K +E++E+++ +G GA+G FLV K+ +K +++K + +
Sbjct: 44 LTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE 103
Query: 51 QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGA 110
T + +R L+ + +P++V A+ + + ++ Y GG++ + +
Sbjct: 104 HT-RTERQVLEHIR-----QSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRE-- 154
Query: 111 CFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK--LLNTE 168
F E ++ ++ +++LA+++LH +++RD+K NI L + + L DFGL+K + +
Sbjct: 155 RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214
Query: 169 DLASSVVGTPNYMCPELLADIPYGY-KS-DIWSLGCCMFEIAAHQPAFRAPD----MAGL 222
+ A GT YM P+++ G+ K+ D WSLG M+E+ F A +
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
Query: 223 INKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHR----PT-ASDLLRHP 267
+I +S P P S+ K +I+ +L K+P+ R P A ++ H
Sbjct: 275 SRRILKSEP-PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 76/287 (26%), Positives = 130/287 (45%), Gaps = 34/287 (11%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
++ YE +E+IG G +G F ++ + LK++RL E +AL+E+ L+ +L +
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
IV+ D + +V +C+ D+ + G E + +L QLL + +
Sbjct: 61 KNIVRLHDVLHSDKK-LTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFC 117
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPE-LLADI 189
HS VLHRDLK N+ + ++ +++L +FGLA+ S+ V T Y P+ L
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 190 PYGYKSDIWSLGCCMFE-IAAHQPAFRAPDMAGLINKINRS----------SISPLPIVY 238
Y D+WS GC E A +P F D+ + +I R S++ LP
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 239 SSTMKQ------------------IIKSMLRKNPEHRPTASDLLRHP 267
M +++++L+ NP R +A + L+HP
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 10/271 (3%)
Query: 2 ETENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRT 58
E + K K+ED+ + + +G+G+FG FL K + + LKK + + + T
Sbjct: 6 ERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECT 64
Query: 59 ALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLC 118
+++ L +P++ + K N + V Y GGD+ I+ F +
Sbjct: 65 MVEKRVLSLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCH--KFDLSRAT 121
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGT 177
+ +++L + +LHS +++RDLK NI L KD I++ DFG+ K + + ++ GT
Sbjct: 122 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT 181
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV 237
P+Y+ PE+L Y + D WS G ++E+ Q F D L + I + P
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRW 240
Query: 238 YSSTMKQIIKSMLRKNPEHR-PTASDLLRHP 267
K ++ + + PE R D+ +HP
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-46
Identities = 68/299 (22%), Positives = 136/299 (45%), Gaps = 26/299 (8%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQT---EKFKRTALQEMDLISK 68
Y + + +G G++G VL + +LKK +L + K+ E+ L+ +
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK----EIQLLRR 62
Query: 69 LNNPYIVKYKDAWVDK-GNCVCIVTGYCEGG--DMAEIIKKARGACFPEEKLCKWLTQLL 125
L + +++ D ++ + +V YC G +M + + + R FP + + QL+
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLI 119
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT---EDLASSVVGTPNYMC 182
++YLHS ++H+D+K N+ LT +++ G+A+ L+ +D + G+P +
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 183 PELLADI-PY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240
PE+ + + G+K DIWS G ++ I F ++ L I + S + +P
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA-IPGDCGP 238
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKS 299
+ ++K ML P R + + +H + P+ +PI P+ K++ R
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH----PPAEAPVPIPPSPDTKDRWRSM 293
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-46
Identities = 59/298 (19%), Positives = 116/298 (38%), Gaps = 46/298 (15%)
Query: 9 KSKLED-YEVIEQ-IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLI 66
+ ED Y++ E +G GA ++ I ++Y +K I KQ + +E++++
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEML 64
Query: 67 SKLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQL 124
+ +++ + + ++ + +V GG + I K+ F E + + +
Sbjct: 65 YQCQGHRNVLELIEFFEEE-DRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDV 120
Query: 125 LLAVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSV------- 174
A+D+LH+ + HRDLK NI + +++ DF L + S +
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 175 -VGTPNYMCPELL-----ADIPYGYKSDIWSLG-------C--------CMFEIAAHQPA 213
G+ YM PE++ Y + D+WSLG C + +
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240
Query: 214 FRAPDMAGLINKINRSSIS----PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
L I + S K +I +L ++ + R +A+ +L+HP
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHI-SCAAKDLISKLLVRDAKQRLSAAQVLQHP 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 167 bits (423), Expect = 6e-46
Identities = 32/294 (10%), Positives = 77/294 (26%), Gaps = 43/294 (14%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-----EKFKRTALQE------- 62
+G+ A + + + + ++ ++ K L+
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 63 --------------MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK--- 105
DL+ +++ + D ++ +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 106 --KARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163
+ + Q++ + LH ++H L+ +I L + + L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 164 LLNTEDLAS--SVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRA 216
++ P +L + D W+LG ++ I
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 217 PDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
G I RS + ++ +++ LR E R + P +
Sbjct: 320 DAALGGSEWIFRSCKNI-----PQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-46
Identities = 77/329 (23%), Positives = 140/329 (42%), Gaps = 19/329 (5%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK---KIRLAKQTEKFKR 57
+E + Y + +G GAFG + + K + K+ V+K K ++ +
Sbjct: 12 LEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDP 71
Query: 58 TALQ---EMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDM-AEIIKKARGACFP 113
+ E+ ++S++ + I+K D + ++G ++ + G D+ A I + R
Sbjct: 72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LD 128
Query: 114 EEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS 173
E QL+ AV YL ++HRD+K NI + +D I+L DFG A L L +
Sbjct: 129 EPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 174 VVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS 232
GT Y PE+L PY G + ++WSLG ++ + + F + + ++I
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIH 242
Query: 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL-QPYLLRCQNPSSVYLPIKPTNI 291
P P + S + ++ +L+ PE R T L+ P + QP L V+ KP +
Sbjct: 243 P-PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESG 301
Query: 292 MKEKTRKSPSSKHNSRKDKGEREAAAPNQ 320
+ ++ S + +
Sbjct: 302 VLSAASLEMGNRSLSDVAQAQELCGGEGH 330
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-46
Identities = 76/328 (23%), Positives = 143/328 (43%), Gaps = 41/328 (12%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+E Y ++++G G + + K+ LK+IRL + E TA++E+ L+ L +
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLKH 59
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
IV D + + + +V Y + D+ + + G + +L QLL + Y
Sbjct: 60 ANIVTLHDIIHTEKS-LTLVFEYLDK-DLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYC 116
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN--TEDLASSVVGTPNYMCPE-LLAD 188
H +VLHRDLK N+ + + +++L DFGLA+ + T+ + VV T Y P+ LL
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGS 175
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS----------SISPLPIVY 238
Y + D+W +GC +E+A +P F + ++ I R I
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235
Query: 239 SSTMKQ-------------------IIKSMLRKNPEHRPTASDLLRHP---HLQPYLLRC 276
+ + ++ +L+ +R +A D ++HP L + +
Sbjct: 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKL 295
Query: 277 QNPSSVYLPIKPTNIMKEKTRKSPSSKH 304
+ +S++ +K + KE + +S H
Sbjct: 296 PDTTSIF-ALKEIQLQKEASLRSAHHHH 322
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-45
Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 16/275 (5%)
Query: 3 TENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTA 59
+ + ++E ++ +G+G FG LV K + Y +LKK + + E
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV--AHT 195
Query: 60 LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCK 119
L E ++ +P++ K ++ +C V Y GG++ + + R F E++
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSRER--VFSEDRARF 252
Query: 120 WLTQLLLAVDYLHSNR-VLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGT 177
+ +++ A+DYLHS + V++RDLK N+ L KD I++ DFGL K + + GT
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 312
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV 237
P Y+ PE+L D YG D W LG M+E+ + F D L I I P
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-FPRT 371
Query: 238 YSSTMKQIIKSMLRKNPEHR----PT-ASDLLRHP 267
K ++ +L+K+P+ R A ++++H
Sbjct: 372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 22/279 (7%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQEMDLIS 67
+ED+++++ +G GA+G L ++++ + ++ R E K+ E+ +
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINK 60
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDM-AEIIKKARGACFPEEKLCKWLTQLLL 126
LN+ +VK+ + N + YC GG++ I PE ++ QL+
Sbjct: 61 MLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA 116
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL---NTEDLASSVVGTPNYMCP 183
V YLH + HRD+K N+ L + +++++ DFGLA + N E L + + GT Y+ P
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 184 ELLADIPY-GYKSDIWSLGCCMFE-IAAHQPAFRAPDMAGLINKINRSSISPLPIVY-SS 240
ELL + D+WS G + +A P + D + P S
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHP----HLQPYLLR 275
++ +L +NP R T D+ + L+ R
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-45
Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 26/281 (9%)
Query: 2 ETENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKK--IRLAKQTE--K 54
+ + KL D+ + +G+G+FG L K + Y +LKK + E
Sbjct: 9 DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM 68
Query: 55 FKRTALQEMDLISKLNNPYIVKYKDAW--VDKGNCVCIVTGYCEGGDMAEIIKKARGACF 112
++ L P++ + + +D+ + V Y GGD+ I++ F
Sbjct: 69 VEKRVLALPG-----KPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVG--RF 118
Query: 113 PEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLA 171
E + ++ + + +L S +++RDLK N+ L + I++ DFG+ K +
Sbjct: 119 KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178
Query: 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI 231
+ GTP+Y+ PE++A PYG D W+ G ++E+ A Q F D L I ++
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 238
Query: 232 SPLPIVYSSTMKQIIKSMLRKNPEHR----PT-ASDLLRHP 267
+ P S I K ++ K+P R P D+ H
Sbjct: 239 A-YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-45
Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 27/279 (9%)
Query: 5 NGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKK--IRLAKQTE--KFKR 57
N ++ ++++E I +G+G+FG L K Y VLKK I E ++
Sbjct: 15 NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK 74
Query: 58 TALQEMDLISKLNNPYIVKYKDAW--VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE 115
L N+P++ + + D+ + V + GGD+ I+K+R F E
Sbjct: 75 RILSLAR-----NHPFLTQLFCCFQTPDR---LFFVMEFVNGGDLMFHIQKSR--RFDEA 124
Query: 116 KLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSV 174
+ + +++ A+ +LH +++RDLK N+ L + +L DFG+ K + ++
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184
Query: 175 VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL 234
GTP+Y+ PE+L ++ YG D W++G ++E+ F A + L I +
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-Y 243
Query: 235 PIVYSSTMKQIIKSMLRKNPEHR------PTASDLLRHP 267
P I+KS + KNP R +LRHP
Sbjct: 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-45
Identities = 59/301 (19%), Positives = 120/301 (39%), Gaps = 45/301 (14%)
Query: 4 ENGDSKSKLED-YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQE 62
+ + L++ + +G G+ G + + +K++ + AL E
Sbjct: 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCD-----IALME 58
Query: 63 MDLISKLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKK-----ARGACFPEEK 116
+ L+++ ++ P +++Y + + I C ++ ++++ E
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTD-RFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 117 LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT-------------KDNDIRLGDFGLAK 163
L Q+ V +LHS +++HRDLK NI ++ ++ I + DFGL K
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 164 LLNTEDLA-----SSVVGTPNYMCPELLADI-------PYGYKSDIWSLGCCMFEIAAH- 210
L++ + ++ GT + PELL + DI+S+GC + I +
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 211 QPAFRAPDMAGLINKINRSSISPLPIVY----SSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+ F S+ + ++ + +I M+ +P RPTA +LRH
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 267 P 267
P
Sbjct: 297 P 297
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 9e-45
Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 22/281 (7%)
Query: 2 ETENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRT 58
+ + + D+ V IGRG FG + K Y L K R+ + +
Sbjct: 178 KNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--TL 235
Query: 59 ALQEMDLISKLNN---PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE 115
AL E ++S ++ P+IV A+ + + GGD+ + + F E
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGV--FSEA 292
Query: 116 KLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVV 175
+ + +++L ++++H+ V++RDLK +NI L + +R+ D GLA ++ + V
Sbjct: 293 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASV 351
Query: 176 GTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAP---DMAGLINKINRSSI 231
GT YM PE+L + Y +D +SLGC +F++ FR D + ++
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411
Query: 232 SPLPIVYSSTMKQIIKSMLRKNPEHR-----PTASDLLRHP 267
LP +S ++ +++ +L+++ R A ++ P
Sbjct: 412 E-LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 23/323 (7%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKI-RLAKQTEKFKRTALQEMDLISKL 69
+ Y+ ++ IG G FG A L+ K+ ++ +K I R A E +R E+ L
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSL 73
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKWLTQLLLAV 128
+P IV++K+ + + + I+ Y GG++ E I R F E++ + QLL V
Sbjct: 74 RHPNIVRFKEVILTPTH-LAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGV 129
Query: 129 DYLHSNRVLHRDLKCSNIFL--TKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
Y HS ++ HRDLK N L + +++ DFG +K S VGTP Y+ PE+L
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 189
Query: 187 ADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS-----PLPIVYSS 240
Y G +D+WS G ++ + F P+ K + +S P I S
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSP 300
+I + +P R + ++ H L P+ + + +E +
Sbjct: 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNL-----PADLMNESNTGSQFQEPEQPMQ 304
Query: 301 SSKHNSRKDKGEREAAAPNQLEN 323
S + A N+ +
Sbjct: 305 SLDTIMQIISEATIPAVRNRCLD 327
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 70/303 (23%), Positives = 123/303 (40%), Gaps = 40/303 (13%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
M S + ++ Y I ++G G +G + + + + +K+IRL + E TA+
Sbjct: 22 MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI 81
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
+E+ L+ +L + I++ K + ++ Y E D+ + + K + +
Sbjct: 82 REVSLLKELQHRNIIELKSVIHHNHR-LHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSF 137
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND-----IRLGDFGLAKLLNTEDLA-SSV 174
L QL+ V++ HS R LHRDLK N+ L+ + +++GDFGLA+ +
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 175 VGTPNYMCPE-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI------- 226
+ T Y PE LL Y DIWS+ C E+ P F + KI
Sbjct: 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257
Query: 227 ----------------------NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
++ L + ++ +ML +P R +A + L
Sbjct: 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317
Query: 265 RHP 267
HP
Sbjct: 318 EHP 320
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-44
Identities = 73/354 (20%), Positives = 137/354 (38%), Gaps = 60/354 (16%)
Query: 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL 69
++ YE + +IG+G FG F H+ +K LKK+ + + E F TAL+E+ ++ L
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 70 NNPYIVKYKDAWVDKGNCVC-------IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
+ +V + K + +V +CE D+A ++ F ++ + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQ 131
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN--- 179
LL + Y+H N++LHRD+K +N+ +T+D ++L DFGLA+ + + T
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 180 --YMCPE-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS------- 229
Y PE LL + YG D+W GC M E+ P + + I++
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251
Query: 230 ---SISPLPIVYSSTMKQ---------------------IIKSMLRKNPEHRPTASDLLR 265
++ + + + +I +L +P R + D L
Sbjct: 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311
Query: 266 HPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNSRKDKGEREAAAPN 319
H +P +P ++ +S + +
Sbjct: 312 HDFFW------SDP----MPSDLKGMLSTH----LTSMFEYLAPPRRKHHHHHH 351
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-44
Identities = 70/282 (24%), Positives = 135/282 (47%), Gaps = 17/282 (6%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK-----KIRLAKQTEKFKRTALQ 61
SK + Y + E +G G+FG L H ++K LK ++ + + +R
Sbjct: 3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER---- 58
Query: 62 EMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPEEKLCKW 120
E+ + L +P+I+K D + +V Y GG++ + I++K R E++ ++
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTP-TDIVMVIEYA-GGELFDYIVEKKR---MTEDEGRRF 113
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNY 180
Q++ A++Y H ++++HRDLK N+ L + ++++ DFGL+ ++ + + G+PNY
Sbjct: 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNY 173
Query: 181 MCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS 239
PE++ Y G + D+WS G ++ + + F + L K+N +P S
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV-MPDFLS 232
Query: 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSS 281
+ +I+ M+ +P R T ++ R P L P
Sbjct: 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPME 274
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-44
Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 22/286 (7%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK-----KIRLAKQTEKF 55
E + D + K+ Y + + +G G FG + H++ K +K KIR K
Sbjct: 4 AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI 63
Query: 56 KRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAE-IIKKARGACFPE 114
+R E+ + +P+I+K + + +V Y GG++ + I K R E
Sbjct: 64 RR----EIQNLKLFRHPHIIKLYQVISTP-SDIFMVMEYVSGGELFDYICKNGR---LDE 115
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV 174
++ + Q+L VDY H + V+HRDLK N+ L + ++ DFGL+ +++ + +
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175
Query: 175 VGTPNYMCPELLADIPY-GYKSDIWSLGCCMFE-IAAHQPAFRAPDMAGLINKINRSSIS 232
G+PNY PE+++ Y G + DIWS G ++ + P F + L KI I
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP-FDDDHVPTLFKKI-CDGIF 233
Query: 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP----HLQPYLL 274
P + ++ ++K ML+ +P R T D+ H L YL
Sbjct: 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLF 279
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-44
Identities = 69/297 (23%), Positives = 123/297 (41%), Gaps = 42/297 (14%)
Query: 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL 69
S ++ +E++G G + + L+K LK+++L E TA++E+ L+ +L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIREISLMKEL 60
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK----KARGACFPEEKLCKWLTQLL 125
+ IV+ D + + +V + + D+ + + + + QLL
Sbjct: 61 KHENIVRLYDVIHTENK-LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGTPNYMCPE 184
+ + H N++LHRDLK N+ + K ++LGDFGLA+ SS V T Y P+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 185 -LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS----------SISP 233
L+ Y DIWS GC + E+ +P F + + I S++
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 234 LPIVYSSTMKQ-----------------------IIKSMLRKNPEHRPTASDLLRHP 267
LP + ++ + +L+ NP+ R +A L HP
Sbjct: 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 79/283 (27%), Positives = 128/283 (45%), Gaps = 28/283 (9%)
Query: 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRTALQE 62
L+D++++ IGRG++ LV K + Y V+KK L E ++
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK-ELVNDDEDIDWVQTEK 60
Query: 63 MDLISKLNNPYIVKYKDAW--VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
N+P++V + + + V Y GGD+ +++ R PEE +
Sbjct: 61 HVFEQASNHPFLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQRQR--KLPEEHARFY 115
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVVGTPN 179
++ LA++YLH +++RDLK N+ L + I+L D+G+ K L D S+ GTPN
Sbjct: 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 175
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG---------LINKINRSS 230
Y+ PE+L YG+ D W+LG MFE+ A + F + L I
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235
Query: 231 ISPLPIVYSSTMKQIIKSMLRKNPEHR------PTASDLLRHP 267
I +P S ++KS L K+P+ R +D+ HP
Sbjct: 236 IR-IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-43
Identities = 64/285 (22%), Positives = 126/285 (44%), Gaps = 28/285 (9%)
Query: 2 ETENGDSKSKLEDYEV-------IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK 54
+ S+ +D+E+ ++IG G+FG V +K + + T +
Sbjct: 6 HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQ 62
Query: 55 FKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPE 114
+ E+ ++ K + I+ + + IVT +CEG + + + F
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQL-AIVTQWCEGSSLYHHLHASETK-FEM 119
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS-- 172
+KL Q +DYLH+ ++HRDLK +NIFL +DN +++GDFGLA + +
Sbjct: 120 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 173 -SVVGTPNYMCPELLAD---IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-------AG 221
+ G+ +M PE++ PY ++SD+++ G ++E+ Q + ++
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIEM 237
Query: 222 LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+ +S + MK+++ L+K + RP+ +L
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 58/289 (20%), Positives = 122/289 (42%), Gaps = 30/289 (10%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKL 69
E E+ E IG+G FG ++ V ++ I + + E + +E+ +
Sbjct: 31 PFEQLEIGELIGKGRFG----QVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
+ +V + A + + + I+T C+G + +++ A+ K + +++ +
Sbjct: 87 RHENVVLFMGACMSPPH-LAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMG 144
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL------LNTEDLASSVVGTPNYMCP 183
YLH+ +LH+DLK N+F + + + DFGL + ED G ++ P
Sbjct: 145 YLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 184 ELL---------ADIPYGYKSDIWSLGCCMFEIAAHQPAFR---APDMAGLINKINRSSI 231
E++ +P+ SD+++LG +E+ A + F+ A + + + ++
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263
Query: 232 SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPS 280
S + + + I+ E RPT + L+ L+ R + S
Sbjct: 264 SQIGM--GKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLS 308
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 64/293 (21%), Positives = 122/293 (41%), Gaps = 22/293 (7%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ----E 62
+ + Y+V +G G FG+ + + + +K + + ++ + E
Sbjct: 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 96
Query: 63 MDLISKLNN--PYIVKYKDAWVDKGNCVCIVTGYCEG-GDMAE-IIKKARGACFPEEKLC 118
+ L+ K+++ +++ D W ++ + ++ E D+ + I ++ EE
Sbjct: 97 VVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGA---LQEELAR 152
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFL-TKDNDIRLGDFGLAKLLNTEDLASSVVGT 177
+ Q+L AV + H+ VLHRD+K NI + +++L DFG LL GT
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-DGT 211
Query: 178 PNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI 236
Y PE + Y G + +WSLG ++++ F + +I R +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF-FRQ 264
Query: 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPT 289
SS + +I+ L P RPT ++ HP +Q LL + + P
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 317
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 81/287 (28%), Positives = 131/287 (45%), Gaps = 28/287 (9%)
Query: 2 ETENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY---VLKKIRLAKQTEKFKRT 58
E+ S L+D++++ IGRG++ LV K + Y V+KK L E
Sbjct: 41 ESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK-ELVNDDEDIDWV 99
Query: 59 ALQEMDLISKLNNPYIVKYKDAW--VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEK 116
++ N+P++V + + + V Y GGD+ +++ R PEE
Sbjct: 100 QTEKHVFEQASNHPFLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQRQR--KLPEEH 154
Query: 117 LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDLASSVV 175
+ ++ LA++YLH +++RDLK N+ L + I+L D+G+ K L D S+
Sbjct: 155 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 214
Query: 176 GTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG---------LINKI 226
GTPNY+ PE+L YG+ D W+LG MFE+ A + F + L I
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274
Query: 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHR------PTASDLLRHP 267
I +P S ++KS L K+P+ R +D+ HP
Sbjct: 275 LEKQIR-IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 21/270 (7%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
D E +G+G FG A V H+ + V+K++ + E+ +RT L+E+ ++ L +P
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHP 67
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
++K+ + +T Y +GG + IIK +P + + + + YLH
Sbjct: 68 NVLKFIGVLYKDKR-LNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLH 125
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS---------------SVVGT 177
S ++HRDL N + ++ ++ + DFGLA+L+ E +VVG
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM--AGLINKINRSSISPLP 235
P +M PE++ Y K D++S G + EI A + P
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
+ I +PE RP+ L
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 55/277 (19%), Positives = 113/277 (40%), Gaps = 31/277 (11%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTAL-----QEMD 64
+ E +QIG+G FG + K V +K + L + + +E+
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
++S LN+P IVK + +V + GD+ + + + + +
Sbjct: 76 IMSNLNHPNIVKLYGLMHNP---PRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDI 131
Query: 125 LLAVDYLHSNR--VLHRDLKCSNIFLTKDND-----IRLGDFGLAKLLNTEDLASSVVGT 177
L ++Y+ + ++HRDL+ NIFL ++ ++ DFGL++ S ++G
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGN 189
Query: 178 PNYMCPELLA--DIPYGYKSDIWSLGCCMFEIAAHQPAFR------APDMAGLINKINRS 229
+M PE + + Y K+D +S ++ I + F + + + R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 230 SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+I P ++ +I+ +P+ RP S +++
Sbjct: 250 TI---PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 64/272 (23%), Positives = 119/272 (43%), Gaps = 45/272 (16%)
Query: 12 LEDYEVI-EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
++DY+V + +G G G + +K ++K+ LK + + K +R E++L + +
Sbjct: 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKARR----EVELHWRAS 68
Query: 71 N-PYIVKYKDAWVDKG---NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
P+IV+ D + + C+ IV +GG++ I+ F E + + + +
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 127 AVDYLHSNRVLHRDLKCSNI-FLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCP 183
A+ YLHS + HRD+K N+ + +K + ++L DFG A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------K 168
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA----GLINKINRSSIS----PLP 235
E + Y D+WSLG M+ + P F + G+ +I
Sbjct: 169 ETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
V S +K +I+++L+ P R T ++ + HP
Sbjct: 228 EV-SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-41
Identities = 66/282 (23%), Positives = 118/282 (41%), Gaps = 28/282 (9%)
Query: 2 ETENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ 61
+ + KL D+ + +G+G+FG L K + Y +K ++ K +Q
Sbjct: 330 DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQ 381
Query: 62 EMD----------LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGAC 111
+ D L P++ + + + V Y GGD+ I++
Sbjct: 382 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVG--R 438
Query: 112 FPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-LNTEDL 170
F E + ++ + + +L S +++RDLK N+ L + I++ DFG+ K +
Sbjct: 439 FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498
Query: 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS 230
+ GTP+Y+ PE++A PYG D W+ G ++E+ A Q F D L I +
Sbjct: 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558
Query: 231 ISPLPIVYSSTMKQIIKSMLRKNPEHR-----PTASDLLRHP 267
++ P S I K ++ K+P R D+ H
Sbjct: 559 VA-YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 63/299 (21%), Positives = 118/299 (39%), Gaps = 28/299 (9%)
Query: 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK---KIRLAKQTEKFKRTALQ-E 62
D ++ +Y + +G+G FG F +R + +K + R+ + E
Sbjct: 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 63 MDLISKLNN----PYIVKYKDAWVDKGNCVCIVTGY-CEGGDMAEIIKKARGACFPEEKL 117
+ L+ K+ P +++ D W + +V D+ + I + +G E
Sbjct: 85 VALLWKVGAGGGHPGVIRLLD-WFETQEGFMLVLERPLPAQDLFDYITE-KG-PLGEGPS 141
Query: 118 CKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL-TKDNDIRLGDFGLAKLLNTEDLASSVVG 176
+ Q++ A+ + HS V+HRD+K NI + + +L DFG LL+ E G
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF-DG 200
Query: 177 TPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP 235
T Y PE ++ Y + +WSLG ++++ F +I + + P
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELH-FP 253
Query: 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP----HLQPYLLRC--QNPSSVYLPIKP 288
S +I+ L P RP+ ++L P + L P+ + + P
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLLP 312
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 33/266 (12%), Positives = 98/266 (36%), Gaps = 19/266 (7%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKL 69
+ + ++ G + + + +K +++ + + R +E +
Sbjct: 8 DFKQLNFLTKLNENHSGE---LWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 70 NNPYIVKYKDAWVD-KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
++P ++ A ++T + G + ++ + + + K+ + +
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 129 DYLHS--NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
+LH+ + L ++ + +D R+ + + + P ++ PE L
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEAL 180
Query: 187 ADIPYGY---KSDIWSLGCCMFEIAAHQPAFRAPDMAGL--INKINRSSISP-LPIVYSS 240
P +D+WS ++E+ + F D++ + K+ + P +P S
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPF--ADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRH 266
+ +++K + ++P RP ++
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 65/302 (21%), Positives = 124/302 (41%), Gaps = 53/302 (17%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN- 71
+DY+++ ++GRG + F ++ +K V+K ++ K K+ +E+ ++ L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKI-KREIKILENLRGG 90
Query: 72 PYIVKYKDAWVD--KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
P I+ D D + + D ++ + + + ++ ++L A+D
Sbjct: 91 PNIITLADIVKDPVSRTPALVFE-HVNNTDFKQLYQT-----LTDYDIRFYMYEILKALD 144
Query: 130 YLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD 188
Y HS ++HRD+K N+ + ++ +RL D+GLA+ + + V + + PELL D
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 189 IP-YGYKSDIWSLGCCMFE-IAAHQPAFR----------------APDMAGLINKIN--- 227
Y Y D+WSLGC + I +P F D+ I+K N
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 228 -RSSISPLPIVYSSTMKQIIKS----------------MLRKNPEHRPTASDLLRHPHLQ 270
L ++ + S +LR + + R TA + + HP+
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
Query: 271 PY 272
Sbjct: 325 TV 326
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 62/273 (22%), Positives = 110/273 (40%), Gaps = 27/273 (9%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTA--LQEMDLIS 67
+ + E IG G FG V V +K R + + QE L +
Sbjct: 5 DFAELTLEEIIGIGGFGK---VYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
L +P I+ + K +C+V + GG + ++ R P + L W Q+
Sbjct: 62 MLKHPNIIALRGV-CLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARG 117
Query: 128 VDYLHSNR---VLHRDLKCSNIFLTKDND--------IRLGDFGLAKLLNTEDLASSVVG 176
++YLH ++HRDLK SNI + + + +++ DFGLA+ S G
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSAAG 176
Query: 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL---INKINRSSISP 233
+M PE++ + SD+WS G ++E+ + F + GL P
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF--RGIDGLAVAYGVAMNKLALP 234
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+P ++++ +P RP+ +++L
Sbjct: 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 82/385 (21%), Positives = 148/385 (38%), Gaps = 79/385 (20%)
Query: 7 DSKSKLED-YEVI-EQIGRGAFGAAFLVLHKIER--KKYVLKKIRLAKQTEKFKRTALQE 62
+ ++ED +E ++GRG +G + K + K Y LK+I +A +E
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACRE 68
Query: 63 MDLISKLNNPYIVKYKDAWVDKG-NCVCIVTGYCEGGDMAEIIKKARGAC-------FPE 114
+ L+ +L +P ++ + ++ V ++ Y E D+ IIK R + P
Sbjct: 69 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPR 127
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND----IRLGDFGLAKLLNTE-- 168
+ L Q+L + YLH+N VLHRDLK +NI + + +++ D G A+L N+
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 169 ---DLASSVVGTPNYMCPE-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRA-------- 216
DL VV T Y PE LL Y DIW++GC E+ +P F
Sbjct: 188 PLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246
Query: 217 -----------------------------PDMAGLINKINRSSISPLPIVY--------- 238
P+ + L+ R++ + ++
Sbjct: 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306
Query: 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQN---PSSVYLPIKPTNIMKEK 295
S +++ +L +P R T+ ++ P+ L + + P + + E+
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKRE--FLTEE 364
Query: 296 TRKSPSSKHNSRKDKGEREAAAPNQ 320
K N ++ +G
Sbjct: 365 EPDDKGDKKNQQQQQGNNHTNGTGH 389
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 76/297 (25%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF-KRTALQEMDLISKLNN 71
+ Y +G GA+G+ + K +K +KK+ Q+E F KR +E+ L+ + +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQH 82
Query: 72 PYIVKYKD-----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
++ D + + +V + + D+ +I+ F EEK+ + Q+L
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK----FSEEKIQYLVYQMLK 137
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE-L 185
+ Y+HS V+HRDLK N+ + +D ++++ DFGLA+ + ++ VV T Y PE +
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYVV-TRWYRAPEVI 195
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-------------------MAGLINKI 226
L+ + Y DIWS+GC M E+ + F+ D + L +K
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255
Query: 227 NRSSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
+S I LP Q+ ++ ML + + R TA+ L HP +P+
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 54/309 (17%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
Y ++ +G G G F + K+ +KKI L K L+E+ +I +L++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS-VKHA-LREIKIIRRLDH 67
Query: 72 PYIVKYKD-------------AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLC 118
IVK + + + N V IV Y E D+A ++++ EE
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP---LLEEHAR 123
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTEDLASSV--- 174
++ QLL + Y+HS VLHRDLK +N+F+ ++ +++GDFGLA++++
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 175 -VGTPNYMCPE-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI------ 226
+ T Y P LL+ Y D+W+ GC E+ + F + I
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 227 ------------NRSSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDL 263
I + Q+ ++ +L +P R TA +
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 264 LRHPHLQPY 272
L HP++ Y
Sbjct: 304 LSHPYMSIY 312
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 68/308 (22%), Positives = 128/308 (41%), Gaps = 53/308 (17%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF-KRTALQEMDLISKLN 70
L+ Y+ ++ IG GA G I + +KK+ Q + KR +E+ L+ +N
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 82
Query: 71 NPYIVKYKDAW-----VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ I+ + + +++ V IV + ++ ++I+ E++ L Q+L
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME----LDHERMSYLLYQML 137
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPEL 185
+ +LHS ++HRDLK SNI + D +++ DFGLA+ T + + V T Y PE+
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM---------------AGLINKIN--- 227
+ + Y DIWS+GC M E+ F D + K+
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 228 RSSISPLPIVYSSTMKQI-----------------------IKSMLRKNPEHRPTASDLL 264
R+ + P + +++ + ML + R + + L
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317
Query: 265 RHPHLQPY 272
+HP++ +
Sbjct: 318 QHPYINVW 325
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 46/300 (15%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF-KRTALQEMDLISKLNN 71
Y + IG GA+G + + + +KKI + + + +RT L+E+ ++ + +
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRT-LREIKILLRFRH 84
Query: 72 PYIVKYKD----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
I+ D +++ V IV E D+ +++K + +C +L Q+L
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH---LSNDHICYFLYQILRG 140
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV----VGTPNYMCP 183
+ Y+HS VLHRDLK SN+ L D+++ DFGLA++ + + + V T Y P
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 184 E-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-------------------MAGLI 223
E +L Y DIWS+GC + E+ +++P F + +I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 224 NKINRSSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
N R+ + LP ++ + ML NP R L HP+L+ Y
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 68/306 (22%), Positives = 118/306 (38%), Gaps = 50/306 (16%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF----------KRTALQE 62
Y V I G++GA + E +K++ + KR L+E
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV-LRE 79
Query: 63 MDLISKLNNPYIVKYKDAWV----DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLC 118
+ L++ ++P I+ +D +V + + +VT D+A++I R + +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIV-ISPQHIQ 137
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTP 178
++ +LL + LH V+HRDL NI L +NDI + DF LA+ + + V
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 179 NYMCPE-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD------------------- 218
Y PE ++ + D+WS GC M E+ + FR
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 219 MAGLINKINRSSI-SPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRH 266
+ + R + + L V + + I ML NP+ R + LRH
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 267 PHLQPY 272
P+ +
Sbjct: 318 PYFESL 323
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 69/295 (23%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF-KRTALQEMDLISKLNNPY 73
Y+ + +G GA+G+ + +KK+ Q+ KRT +E+ L+ + +
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHMKHEN 89
Query: 74 IVKYKD-----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
++ D +++ N V +VT D+ I+K + ++ + + Q+L +
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK---LTDDHVQFLIYQILRGL 145
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE-LLA 187
Y+HS ++HRDLK SN+ + +D ++++ DFGLA+ +T D + V T Y PE +L
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLN 203
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-------------------MAGLINKINR 228
+ Y DIWS+GC M E+ + F D + + ++ R
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 229 SSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
+ I L + + ++ ML + + R TA+ L H + Y
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 69/297 (23%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF-KRTALQEMDLISKLNN 71
Y ++ +G GA+GA + K +KK+ Q+E F KR +E+ L+ + +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHMRH 83
Query: 72 PYIVKYKDAW-----VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
++ D + +D +V + D+ +++K + E+++ + Q+L
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK---LGEDRIQFLVYQMLK 139
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE-L 185
+ Y+H+ ++HRDLK N+ + +D ++++ DFGLA+ ++E + V T Y PE +
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVI 197
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFR-------------------APDMAGLINKI 226
L + Y DIWS+GC M E+ + F+ A + L +
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257
Query: 227 NRSSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
++ + LP + I ++ ML + E R TA + L HP+ +
Sbjct: 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-36
Identities = 71/308 (23%), Positives = 129/308 (41%), Gaps = 53/308 (17%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF-KRTALQEMDLISKLN 70
L+ Y+ ++ IG GA G + + +KK+ Q + KR +E+ L+ +N
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 119
Query: 71 NPYIVKYKDA-----WVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ I+ + +++ V +V + ++ ++I+ E++ L Q+L
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME----LDHERMSYLLYQML 174
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPEL 185
+ +LHS ++HRDLK SNI + D +++ DFGLA+ T + + V T Y PE+
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKIN------------------ 227
+ + Y DIWS+GC M E+ H+ F D NK+
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 228 RSSISPLPIVYSSTMKQI-----------------------IKSMLRKNPEHRPTASDLL 264
R+ + P T ++ + ML +P R + D L
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 265 RHPHLQPY 272
+HP++ +
Sbjct: 355 QHPYINVW 362
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 63/262 (24%), Positives = 109/262 (41%), Gaps = 19/262 (7%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-----EKFKRTALQEMDLISKL 69
Y + +GRG G + + + LK + + + +R E +L
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQR----EARTAGRL 91
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
P++V D G + + G D+A ++++ +G P + + Q+ A+D
Sbjct: 92 QEPHVVPIHDFGEIDGQ-LYVDMRLINGVDLAAMLRR-QGPLAPPRAV-AIVRQIGSALD 148
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--ASSVVGTPNYMCPELLA 187
H+ HRD+K NI ++ D+ L DFG+A E L + VGT YM PE +
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 188 DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS---TMKQ 244
+ Y++DI++L C ++E P ++ D ++ +I V
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267
Query: 245 IIKSMLRKNPEHR-PTASDLLR 265
+I + KNPE R T DL
Sbjct: 268 VIARGMAKNPEDRYVTCGDLSA 289
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 72/308 (23%), Positives = 128/308 (41%), Gaps = 52/308 (16%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
D+++ +G GA+G HK + +KKI + RT L+E+ ++ +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 72 PYIVKYKD----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
I+ + + N V I+ + D+ +I ++ + ++ Q L A
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM---LSDDHIQYFIYQTLRA 124
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN-------- 179
V LH + V+HRDLK SN+ + + D+++ DFGLA++++ +S
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 180 ---YMCPE-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRA----------------PDM 219
Y PE +L Y D+WS GC + E+ +P F P
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 220 AGLINKIN----RSSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLL 264
+ I R I LP+ ++ ++++ ++ ML +P R TA + L
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304
Query: 265 RHPHLQPY 272
HP+LQ Y
Sbjct: 305 EHPYLQTY 312
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 63/297 (21%), Positives = 109/297 (36%), Gaps = 51/297 (17%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+ E IG+G FG V R + V KI +++ + R E+ L +
Sbjct: 41 ARTIVLQESIGKGRFGE---VWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRH 95
Query: 72 PYIVKYKDAWVDKGN---CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
I+ + A + +V+ Y E G + + + + E + K +
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGL 152
Query: 129 DYLHSNR--------VLHRDLKCSNIFLTKDNDIRLGDFGLAKLL----NTEDLAS-SVV 175
+LH + HRDLK NI + K+ + D GLA +T D+A V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 176 GTPNYMCPELL------ADIPYGYKSDIWSLGCCMFEIA------AHQPAFRAP------ 217
GT YM PE+L ++DI+++G +EIA ++ P
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 218 ------DMAGLI-NKINRSSISPLPIVYS--STMKQIIKSMLRKNPEHRPTASDLLR 265
+M ++ + R +I M +I++ N R TA + +
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 60/296 (20%), Positives = 123/296 (41%), Gaps = 29/296 (9%)
Query: 15 YEVIEQIGRGAFGAAFLVL-HKIERK---KYVLKKIRLAKQ---TEKFKRTALQEMDLIS 67
Y++++++G G +L + K K + ++ ++F+R S
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFI-PPREKEETLKRFEREVHN----SS 66
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
+L++ IV D ++ +C +V Y EG ++E I+ G + + + Q+L
Sbjct: 67 QLSHQNIVSMID-VDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAI-NFTNQILDG 123
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--ASSVVGTPNYMCPEL 185
+ + H R++HRD+K NI + + +++ DFG+AK L+ L + V+GT Y PE
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 186 LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSST---- 241
+DI+S+G ++E+ +P F + K + S+ +
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 242 MKQIIKSMLRKNPEHRP-TASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKT 296
+ +I K+ +R T ++ L + + + + MK
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMKDD------LSSVLHENRANEDVYELDKMKTIA 293
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 68/323 (21%), Positives = 118/323 (36%), Gaps = 78/323 (24%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP-- 72
Y ++ ++G G F +L + +V KI + + + A E+ L+ ++N+
Sbjct: 21 YILVRKLGWGHFSTVWLAKD-MVNNTHVAMKI--VRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 73 ---------YIVKYKDAWVDKGNC---VCIVTGYCE--GGDMAEIIKKARGACFPEEKLC 118
+I+K D + KG V +V E G ++ +IKK P +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVF---EVLGENLLALIKKYEHRGIPLIYVK 134
Query: 119 KWLTQLLLAVDYLHSN-RVLHRDLKCSNIFL------TKDNDIRLGDFGLAKLLNTEDLA 171
+ QLLL +DY+H ++H D+K N+ + I++ D G A +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--Y 192
Query: 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLIN------- 224
++ + T Y PE+L P+G +DIWS C +FE+ F +
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 225 ------------------------------KINRSSISPLPIVYSSTMKQI--------- 245
I++ PL V + K
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 246 -IKSMLRKNPEHRPTASDLLRHP 267
+ ML+ +P R A L+ HP
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHP 335
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 74/342 (21%), Positives = 133/342 (38%), Gaps = 52/342 (15%)
Query: 5 NGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMD 64
+ S+ +++ ++V G+G FG L K +KK+ + R LQ M
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR--NRE-LQIMQ 71
Query: 65 LISKLNNPYIVKYKDAWVDKGN------CVCIVTGYCEGGDMAEIIKKARGACFP-EEKL 117
++ L++P IV+ + + G + +V Y + + L
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPIL 130
Query: 118 CKWLT-QLLLAVDYLH--SNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTEDLASS 173
K QL+ ++ LH S V HRD+K N+ + + + ++L DFG AK L+ + +
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 174 VVGTPNYMCPEL-LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI------ 226
+ + Y PEL + Y DIWS+GC E+ +P FR + AG +++I
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250
Query: 227 -NRSSIS-----------------PLPIVYSSTMKQI-------IKSMLRKNPEHRPTAS 261
+R + P V+S + + ++L+ PE R
Sbjct: 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 262 DLLRHPHLQPYLLRCQN---PSSVYLPIKPTNIMKEKTRKSP 300
+ L HP+ L P++ LP + +
Sbjct: 311 EALCHPYFDE--LHDPATKLPNNKDLPEDLFRFLPNEIEVMS 350
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-33
Identities = 57/256 (22%), Positives = 108/256 (42%), Gaps = 21/256 (8%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
YEV I G G +L L + + V+ K + + + A+ E ++++ +P I
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 75 VKYKDAWVDKGNCVC----IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
V+ + IV Y G + + P + +L ++L A+ Y
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSY 197
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIP 190
LHS +++ DLK NI LT++ ++L D G +N+ + GTP + PE++ P
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINS---FGYLYGTPGFQAPEIVRTGP 253
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
+DI+++G + + P + GL P+ Y S ++++ +
Sbjct: 254 -TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDS-YGRLLRRAI 305
Query: 251 RKNPEHRP-TASDLLR 265
+P R TA ++
Sbjct: 306 DPDPRQRFTTAEEMSA 321
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 60/297 (20%), Positives = 110/297 (37%), Gaps = 51/297 (17%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+ ++++QIG+G +G V R + V K+ + + R E+ + +
Sbjct: 36 AKQIQMVKQIGKGRYGE---VWMGKWRGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRH 90
Query: 72 PYIVKYKDAWVDKGNCV---CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
I+ + A + ++T Y E G + + +K + + K + +
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGL 147
Query: 129 DYLHSNR--------VLHRDLKCSNIFLTKDNDIRLGDFGLAKLL----NTEDLAS-SVV 175
+LH+ + HRDLK NI + K+ + D GLA N D+ + V
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 176 GTPNYMCPELLA------DIPYGYKSDIWSLGCCMFEIA------AHQPAFRAP------ 217
GT YM PE+L +D++S G ++E+A ++ P
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 218 ------DMAGLI-NKINRSSISPLPIVYS--STMKQIIKSMLRKNPEHRPTASDLLR 265
DM ++ K R S M +++ NP R TA + +
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 75/384 (19%), Positives = 137/384 (35%), Gaps = 50/384 (13%)
Query: 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDL 65
G + + Y + IG G+FG + + +KK+ KR +E+ +
Sbjct: 47 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQI 100
Query: 66 ISKLNNPYIVKYKDAW---VDKGNCVCI--VTGYCEGGDMAEIIKKARGA--CFPEEKLC 118
+ KL++ IV+ + + +K + V + V Y + + + A P +
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK 159
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDI-RLGDFGLAKLLNTEDLASSVVGT 177
++ QL ++ Y+HS + HRD+K N+ L D + +L DFG AK L + S + +
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 178 PNYMCPEL-LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR-------- 228
Y PEL Y D+WS GC + E+ QP F + +I +
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 229 --SSISP------LPIVYSSTMKQI------------IKSMLRKNPEHRPTASDLLRHPH 268
++P P + + ++ +L P R T + H
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 269 LQPYLLR---CQNPSSVYLPIKPTNIMKEKTRKSPSSKHNSRKDKGEREAAAPNQLENVR 325
LR + P+ P N ++ +P +AAA
Sbjct: 340 FDE--LRDPNVKLPNGRDTP-ALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATA 396
Query: 326 SVAKNIAVQLNNLPLDDKPTSSTS 349
+ N + S+++
Sbjct: 397 ASDANTGDRGQTNNAASASASNST 420
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 58/296 (19%), Positives = 114/296 (38%), Gaps = 51/296 (17%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
D ++E +G+G +G V + + V KI ++ + + R E+ L +
Sbjct: 8 RDITLLECVGKGRYGE---VWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHE 62
Query: 73 YIVKYKDA---WVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
I+ + + + ++T Y E G + + ++ + + + +
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLA 119
Query: 130 YLHSNR--------VLHRDLKCSNIFLTKDNDIRLGDFGLAKLL----NTEDLAS-SVVG 176
+LH + HRDLK NI + K+ + D GLA + N D+ + VG
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 177 TPNYMCPELLADIP------YGYKSDIWSLGCCMFEIA------AHQPAFRAP------- 217
T YM PE+L + + DIW+ G ++E+A ++ P
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 218 -----DMAGLI-NKINRSSISPLPIVYS--STMKQIIKSMLRKNPEHRPTASDLLR 265
DM ++ R +I +++ +++K +NP R TA + +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 67/307 (21%), Positives = 117/307 (38%), Gaps = 45/307 (14%)
Query: 3 TENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQE 62
++ + + Y + IG G+FG F E + +KK+ KR +E
Sbjct: 30 SDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV-ESDEVAIKKVLQ------DKRFKNRE 82
Query: 63 MDLISKLNNPYIVKYKDAWVDKG-----NCVCIVTGYCEGGDMAEIIK--KARGACFPEE 115
+ ++ + +P +V K + G + +V Y + + P
Sbjct: 83 LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPML 141
Query: 116 KLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND-IRLGDFGLAKLLNTEDLASSV 174
+ ++ QLL ++ Y+HS + HRD+K N+ L + ++L DFG AK+L + S
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 175 VGTPNYMCPEL-LADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR----- 228
+ + Y PEL Y DIWS GC M E+ QP F + +I +
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 229 -----SSISP------LPIVYSSTMKQIIKS------------MLRKNPEHRPTASDLLR 265
+++P P + ++ + +L P R TA + L
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 266 HPHLQPY 272
HP
Sbjct: 322 HPFFDEL 328
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 75/306 (24%), Positives = 134/306 (43%), Gaps = 34/306 (11%)
Query: 15 YEVIEQIGRGAFGAAFLVL-HKIERK---KYVLKKIRLAKQTE---KFKRTALQEMDLIS 67
YE+ E +G G L + R K VL+ LA+ +F+R A +
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRA-DLARDPSFYLRFRREAQN----AA 67
Query: 68 KLNNPYIVKYKDAWVDKGNCVC---IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
LN+P IV D + IV Y +G + +I+ G P+ + + +
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAI-EVIADA 125
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA----SSVVGTPNY 180
A+++ H N ++HRD+K +NI ++ N +++ DFG+A+ + + ++V+GT Y
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240
+ PE +SD++SLGC ++E+ +P F + + R P +
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245
Query: 241 ---TMKQIIKSMLRKNPEHRP-TASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKT 296
+ ++ L KNPE+R TA+++ L+R N P T+ E+T
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAEMRAD------LVRVHNGEPPEAPKVLTD--AERT 297
Query: 297 RKSPSS 302
S+
Sbjct: 298 SLLSSA 303
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-31
Identities = 73/355 (20%), Positives = 129/355 (36%), Gaps = 99/355 (27%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ YE+ IG G++G K+E++ +KKI + + L+E+ ++++LN+
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 73 YIVKYKD----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT-QLLLA 127
++VK D V+K + + +V + D ++ + E K L LL+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYL---TELHIKTLLYNLLVG 168
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN-------- 179
V Y+HS +LHRDLK +N + +D +++ DFGLA+ ++ + +S +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 180 --------------------YMCPE-LLADIPYGYKSDIWSLGCCMFEI------AAHQP 212
Y PE +L Y D+WS+GC E+
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 213 AFRAP--------------------------------------------DMAGLINKINR 228
A R P D+ L + +
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 229 SSISPLPIVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
I P + + + +K ML NP R T ++ L HP +
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-30
Identities = 73/333 (21%), Positives = 127/333 (38%), Gaps = 77/333 (23%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF-KRTALQEMDLISKLN 70
L YE+++++G+GA+G + + + + +KKI A Q +RT +E+ ++++L+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTELS 66
Query: 71 N-PYIVKYKDAWV-DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
IV + D V +V Y E D+ +I R + QL+ +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI---RANILEPVHKQYVVYQLIKVI 122
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN--------- 179
YLHS +LHRD+K SNI L + +++ DFGL++ ++ +
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 180 -------------YMCPE-LLADIPYGYKSDIWSLGCCMFEIAAHQPAFR---------- 215
Y PE LL Y D+WSLGC + EI +P F
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 216 ---------APDMAGLINKINRSSISPLPIVYSSTMKQI--------------------- 245
D+ + + ++ I L
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 246 ------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
+ +L+ NP R +A+D L+HP + +
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 65/328 (19%), Positives = 124/328 (37%), Gaps = 74/328 (22%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ Y + + +G G+FG V K++ LKK+ R +E+D++ L++
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHV 60
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGG---------------------------------- 98
I+K D + G+ +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 99 --DMAEIIKKARGAC--FPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL-TKDND 153
+ +++K + P + ++ QL AV ++HS + HRD+K N+ + +KDN
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 154 IRLGDFGLAKLLNTEDLASSVVGTPNYMCPEL-LADIPYGYKSDIWSLGCCMFEIAAHQP 212
++L DFG AK L + + + + + Y PEL L Y D+WS+GC E+ +P
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 213 AFRAPDMAGLINKINR----------SSISP------LPIVYSSTMKQI----------- 245
F + +I + ++P P + + ++I
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300
Query: 246 -IKSMLRKNPEHRPTASDLLRHPHLQPY 272
++ +LR P+ R + + HP
Sbjct: 301 LLEQILRYEPDLRINPYEAMAHPFFDHL 328
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 78/348 (22%), Positives = 130/348 (37%), Gaps = 91/348 (26%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKF-KRTALQEMDLISKLN 70
++Y + IGRG++G +L K K +KK+ + KR L+E+ ++++L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI-LREITILNRLK 83
Query: 71 NPYIVKYKD----AWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
+ YI++ D + K + + IV + D+ ++ K EE + L LLL
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKT--PIFLTEEHIKTILYNLLL 140
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPN------- 179
+++H + ++HRDLK +N L +D +++ DFGLA+ +N+E + V
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 180 ----------------YMCPE-LLADIPYGYKSDIWSLGCCMFEI------AAHQPAFRA 216
Y PE +L Y DIWS GC E+ + P R
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
Query: 217 P-----------------------------------------DMAGLINKINRSSISPLP 235
P D+ + I P
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320
Query: 236 IVYSSTMKQI-----------IKSMLRKNPEHRPTASDLLRHPHLQPY 272
+KQ ++SML+ NP R T L HP+L+
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 55/226 (24%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 4 ENGDSKSKLED-----YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRT 58
+ G D YEV++ IG+G+FG + + ++V K+ + ++F R
Sbjct: 83 DQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKA-YDHKVHQHVALKM--VRNEKRFHRQ 139
Query: 59 ALQEMDLISKLN------NPYIVKYKDAWVDKGNCVCIVTGYCE--GGDMAEIIKKARGA 110
A +E+ ++ L ++ + + + + +C+ E ++ E+IKK +
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH-ICMTF---ELLSMNLYELIKKNKFQ 195
Query: 111 CFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT--KDNDIRLGDFGLAKLLNTE 168
F + K+ +L +D LH NR++H DLK NI L + I++ DFG + +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-- 253
Query: 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAF 214
+ + + Y PE++ YG D+WSLGC + E+ P
Sbjct: 254 QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 61/294 (20%), Positives = 125/294 (42%), Gaps = 40/294 (13%)
Query: 13 EDYEVIEQIGRGAFGA---AFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMDL 65
+++ I+ +G GAFG + + K V L++ K ++ L E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYV 70
Query: 66 ISKLNNPYIVK-YKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
++ ++NP++ + G C V ++T G + + +++ + + L W
Sbjct: 71 MASVDNPHVCRLL-------GICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNW 122
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT--P 178
Q+ ++YL R++HRDL N+ + +++ DFGLAKLL E+ G P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 179 -NYMCPELLADIPYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAG--LINKINRSSISP 233
+M E + Y ++SD+WS G ++E+ +P + + + + + P
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP---YDGIPASEISSILEKGERLP 239
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIK 287
P + + + I++ + + RP +L ++P YL I+
Sbjct: 240 QPPICTIDVYMIMRKCWMIDADSRPKFREL--IIEFSKMA---RDPQR-YLVIQ 287
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 55/297 (18%), Positives = 110/297 (37%), Gaps = 53/297 (17%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+++E RG FG + +YV KI + + ++ E+ + + +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPIQDKQSWQN--EYEVYSLPGMKHE 78
Query: 73 YIVKYKDAWVDKGNCV----CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
I+++ A +G V ++T + E G +++ +K +LC + +
Sbjct: 79 NILQFIGA-EKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGL 134
Query: 129 DYLHSN----------RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL---NTEDLASSVV 175
YLH + + HRD+K N+ L + + DFGLA + V
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 176 GTPNYMCPELL-----ADIPYGYKSDIWSLGCCMFEIA-------AHQPAFRAP------ 217
GT YM PE+L + D++++G ++E+A + P
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 218 ------DMAGLI-NKINRSSISP--LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
DM ++ +K R + + + + I+ + E R +A +
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 81/350 (23%), Positives = 134/350 (38%), Gaps = 93/350 (26%)
Query: 4 ENGDSKSKLED-----YEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKR 57
E K + VI ++G G FG L H + KKY +K +R +K+ R
Sbjct: 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVR---NIKKYTR 76
Query: 58 TALQEMDLISKLN-----NPYIVKYKDAWVDKGNCVCIVTGYCE--GGDMAEIIKKARGA 110
+A E D++ K+ N IVKY + +C++ E G + EII +
Sbjct: 77 SAKIEADILKKIQNDDINNNNIVKYHG-KFMYYDHMCLIF---EPLGPSLYEIITRNNYN 132
Query: 111 CFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT--------------------- 149
F E + + ++L A++YL + H DLK NI L
Sbjct: 133 GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192
Query: 150 ----KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMF 205
K I+L DFG A + D S++ T Y PE++ ++ + SD+WS GC +
Sbjct: 193 IYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250
Query: 206 EIAAHQPAFRAPD----------MAGLINK--INRSS-----------ISPLPIVYSSTM 242
E+ FR + + I K + ++ L +++
Sbjct: 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASS 310
Query: 243 KQIIK----------------------SMLRKNPEHRPTASDLLRHPHLQ 270
IK S+L+ +P RP+ ++LL+H L+
Sbjct: 311 INSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 73/357 (20%), Positives = 127/357 (35%), Gaps = 83/357 (23%)
Query: 4 ENGDSKSKLED-----YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRT 58
+ G ++ D YE++ +G G FG L K V KI + K++
Sbjct: 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREA 62
Query: 59 ALQEMDLISKLNNP------YIVKYKDAWVDKGNCVCIVTGYCE--GGDMAEIIKKARGA 110
A E++++ K+ V D + G+ +CI E G + E +K+
Sbjct: 63 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH-MCIAF---ELLGKNTFEFLKENNFQ 118
Query: 111 CFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT-------------------KD 151
+P + QL A+ +LH N++ H DLK NI K+
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178
Query: 152 NDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQ 211
IR+ DFG A + E +++V T +Y PE++ ++ + D+WS+GC +FE
Sbjct: 179 TSIRVADFGSATFDH-EHH-TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
Query: 212 PAFRAPD----------MAGLI----------------NKINRSSISPLPIVYSSTMKQI 245
F+ + + G I + S K +
Sbjct: 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL 296
Query: 246 -----------------IKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLP 285
++ ML +P R T ++ L HP ++ + P
Sbjct: 297 KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 61/320 (19%), Positives = 111/320 (34%), Gaps = 64/320 (20%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
ME + L++ +++E IGRG +GA V ++ V K+ + F
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGA---VYKGSLDERPVAVKVFSFANRQNFINE-- 55
Query: 61 QEMDLISKLNNPYIVKY-----KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEE 115
+ + + + + I ++ + + +V Y G + + +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEY-LLVMEYYPNGSLXKYLSLHT---SDWV 111
Query: 116 KLCKWLTQLLLAVDYLHS---------NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166
C+ + + YLH+ + HRDL N+ + D + DFGL+ L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 167 TEDLA---------SSVVGTPNYMCPELLADI-------PYGYKSDIWSLGCCMFEIA-- 208
L S VGT YM PE+L + D+++LG +EI
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 209 -----------AHQPAFRA--------PDMAGLI-NKINRSSIS---PLPIVYSSTMKQI 245
+Q AF+ DM L+ + R + ++K+
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 246 IKSMLRKNPEHRPTASDLLR 265
I+ ++ E R TA
Sbjct: 292 IEDCWDQDAEARLTAQXAEE 311
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 71/324 (21%), Positives = 126/324 (38%), Gaps = 80/324 (24%)
Query: 15 YEVIEQIGRGAFGAAFLVL-HKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP- 72
YE+++ +G GAFG + HK + +K ++ +++ A E+ ++ LN
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTD 72
Query: 73 -----YIVKYKDAWVDKGNCVCIVTGYCE--GGDMAEIIKKARGACFPEEKLCKWLTQLL 125
V+ + + G+ +CIV E G + IK+ F + + K Q+
Sbjct: 73 PNSTFRCVQMLEWFEHHGH-ICIVF---ELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLT-------------------KDNDIRLGDFGLAKLLN 166
+V++LHSN++ H DLK NI + DI++ DFG A +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-------- 218
E S++V T +Y PE++ + + D+WS+GC + E F D
Sbjct: 189 -EHH-STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246
Query: 219 --MAGLI----------------NKINRSSISPLPIVYSSTMKQI--------------- 245
+ G + ++++ S S K +
Sbjct: 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306
Query: 246 --IKSMLRKNPEHRPTASDLLRHP 267
I+ ML +P R T + L+HP
Sbjct: 307 DLIQKMLEYDPAKRITLREALKHP 330
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 74/361 (20%), Positives = 122/361 (33%), Gaps = 114/361 (31%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN--- 71
Y VI ++G G F +L I+ KK+V K+ K E + TAL E+ L+ + N
Sbjct: 39 YHVIRKLGWGHFSTVWLSWD-IQGKKFVAMKV--VKSAEHYTETALDEIRLLKSVRNSDP 95
Query: 72 -----PYIVKYKDAWVDKGNC---VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ 123
+V+ D + G +C+V G + + I K+ P + K + Q
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 124 LLLAVDYLHS-NRVLHRDLKCSNIFLT--------------------------------- 149
+L +DYLH+ R++H D+K NI L+
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 150 ----------------KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGY 193
+ +++ D G A ++ + + T Y E+L Y
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGSGYNT 272
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPD-------------MAGLI----------------- 223
+DIWS C FE+A F + L+
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 224 -----NKINRSSISPLPIVYSSTMK------------QIIKSMLRKNPEHRPTASDLLRH 266
+ + + + P + K + ML PE R TA++ LRH
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 267 P 267
P
Sbjct: 393 P 393
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 62/321 (19%), Positives = 123/321 (38%), Gaps = 40/321 (12%)
Query: 13 EDYEVIEQIGRGAFGA---AFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMDL 65
+ ++ +G G FG + K V ++ + + M
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV----TDHMLA 68
Query: 66 ISKLNNPYIVK-YKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
I L++ +IV+ G C + +VT Y G + + +++ RGA + L W
Sbjct: 69 IGSLDHAHIVRLL-------GLCPGSSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNW 120
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT--P 178
Q+ + YL + ++HR+L N+ L + +++ DFG+A LL +D P
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 179 -NYMCPELLADIPYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAG--LINKINRSSISP 233
+M E + Y ++SD+WS G ++E+ +P + + + + +
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP---YAGLRLAEVPDLLEKGERLA 237
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMK 293
P + + + ++ + RPT +L ++P YL IK +
Sbjct: 238 QPQICTIDVYMVMVKCWMIDENIRPTFKEL--ANEFTRMA---RDPPR-YLVIKRESGPG 291
Query: 294 EKTRKSPSSKHNSRKDKGERE 314
P N + ++ E E
Sbjct: 292 IAPGPEPHGLTNKKLEEVELE 312
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 60/240 (25%), Positives = 108/240 (45%), Gaps = 26/240 (10%)
Query: 4 ENGDSKSKLED-----YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRT 58
+N D K + YE+ IG+G+FG ++E++ +K I+ + F
Sbjct: 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQ 96
Query: 59 ALQEMDLISKLNNP------YIVKYKDAWVDKGNCVCIVTGYCE--GGDMAEIIKKARGA 110
A E+ L+ +N YIV K ++ + + +C+V E ++ ++++
Sbjct: 97 AQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH-LCLVF---EMLSYNLYDLLRNTNFR 152
Query: 111 CFPEEKLCKWLTQLLLAVDYLHSNR--VLHRDLKCSNIFLT--KDNDIRLGDFGLAKLLN 166
K+ Q+ A+ +L + ++H DLK NI L K + I++ DFG + L
Sbjct: 153 GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212
Query: 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI 226
+ + Y PE+L +PY D+WSLGC + E+ +P F + +NKI
Sbjct: 213 --QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 61/265 (23%), Positives = 112/265 (42%), Gaps = 23/265 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR---LAKQTEKFKRTALQEMDLISKL 69
ED + EQIGRG FG F + + +K R KF LQE ++ +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQY 169
Query: 70 NNPYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
++P IV+ + + IV +GGD ++ GA + L + + +
Sbjct: 170 SHPNIVRLI--GVCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGM 226
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNY----MCPE 184
+YL S +HRDL N +T+ N +++ DFG+++ + + ++ G PE
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPE 285
Query: 185 LLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAGL--INKINRSSISPLPIVYSS 240
L Y +SD+WS G ++E P P+++ + + P P +
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASP---YPNLSNQQTREFVEKGGRLPCPELCPD 342
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLR 265
+ ++++ P RP+ S + +
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 62/326 (19%), Positives = 132/326 (40%), Gaps = 38/326 (11%)
Query: 13 EDYEVIEQIGRGAFG---AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMDL 65
+++ I+ +G GAFG + + K V L++ K ++ L E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYV 70
Query: 66 ISKLNNPYIVKYKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWL 121
++ ++NP++ + G C V ++T G + + +++ + + L W
Sbjct: 71 MASVDNPHVCRLL------GICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWC 123
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT--P- 178
Q+ ++YL R++HRDL N+ + +++ DFGLAKLL E+ G P
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAG--LINKINRSSISPL 234
+M E + Y ++SD+WS G ++E+ +P + + + + + P
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP---YDGIPASEISSILEKGERLPQ 240
Query: 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKE 294
P + + + I+ + + RP +L ++P YL I+ M
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFREL--IIEFSKMA---RDPQR-YLVIQGDERMHL 294
Query: 295 KTRKSPSSKHNSRKDKGEREAAAPNQ 320
+ + ++ + ++
Sbjct: 295 PSPTDSNFYRALMDEEDMDDVVDADE 320
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 64/281 (22%), Positives = 119/281 (42%), Gaps = 30/281 (10%)
Query: 18 IEQIGRGAFGAAFLVLHKIERKKYVL----KKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
++Q+G+G FG+ + + + KK++ TE+ R +E++++ L +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQHDN 103
Query: 74 IVKYKDAWVDKGNC-VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IVKYK G + ++ Y G + + ++K + KL ++ +Q+ ++YL
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLG 162
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVVGT--P-NYMCPELLAD 188
+ R +HRDL NI + +N +++GDFGL K+L ++ P + PE L +
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 189 IPYGYKSDIWSLGCCMFEI-----AAHQPAFRAPDMAG-----------LINKINRSSIS 232
+ SD+WS G ++E+ + P M G LI + +
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 282
Query: 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273
P P + I+ N RP+ DL +
Sbjct: 283 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDL--ALRVDQIR 321
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-26
Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 32/277 (11%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYV------LKKIRLAKQTEKFKRTALQEMDLI 66
E E+ IG G FG ++ + K EKF LQE +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF----LQEALTM 445
Query: 67 SKLNNPYIVKYKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
+ ++P+IVK G V I+ C G++ ++ + + L +
Sbjct: 446 RQFDHPHIVKLI------GVITENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAY 498
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVG-TP-NY 180
QL A+ YL S R +HRD+ N+ ++ ++ ++LGDFGL++ + + G P +
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPI 236
M PE + + SD+W G CM+EI +P + +I +I P+P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNNDVIGRIENGERLPMPP 615
Query: 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273
T+ ++ +P RP ++L L L
Sbjct: 616 NCPPTLYSLMTKCWAYDPSRRPRFTEL--KAQLSTIL 650
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 67/297 (22%), Positives = 117/297 (39%), Gaps = 38/297 (12%)
Query: 13 EDYEVIEQIGRGAFGA---AFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMDL 65
+ I +G G FG + V LK + + QE+D+
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW----KQEIDI 86
Query: 66 ISKLNNPYIVKYKDAWVDKGNC-VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
+ L + +I+KYK D G + +V Y G + + + + +L + Q+
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQI 143
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGT--P-NY 180
+ YLH+ +HRDL N+ L D +++GDFGLAK + + P +
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEI-----AAHQPAFRAPDMAG----------LINK 225
PE L + + Y SD+WS G ++E+ ++ P + ++ G L
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263
Query: 226 INRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL--LRCQNPS 280
+ R P P + + ++K+ RPT +L P L+ + Q PS
Sbjct: 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL--IPILKTVHEKYQGQAPS 318
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 67/282 (23%), Positives = 114/282 (40%), Gaps = 39/282 (13%)
Query: 6 GDSKSKLEDYEV-------IEQIGRGAFGAAFLVLHKIERKKYV------LKKIRLAKQT 52
G S DYE+ IG G FG ++ + K
Sbjct: 1 GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR 60
Query: 53 EKFKRTALQEMDLISKLNNPYIVK-YKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKA 107
EKF LQE + + ++P+IVK G V I+ C G++ ++
Sbjct: 61 EKF----LQEALTMRQFDHPHIVKLI-------GVITENPVWIIMELCTLGELRSFLQVR 109
Query: 108 RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167
+ + L + QL A+ YL S R +HRD+ N+ ++ ++ ++LGDFGL++ +
Sbjct: 110 KYS-LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168
Query: 168 EDLASSVVGT-P-NYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG-- 221
+ G P +M PE + + SD+W G CM+EI +P +
Sbjct: 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQGVKNND 225
Query: 222 LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDL 263
+I +I P+P T+ ++ +P RP ++L
Sbjct: 226 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 267
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 58/278 (20%), Positives = 108/278 (38%), Gaps = 32/278 (11%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKY-------VLKKIRLAKQTEKFKRTALQEMDL 65
+ I +G G FG L + E LK +E+++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL----KKEIEI 76
Query: 66 ISKLNNPYIVKYKDAWVDKGNC-VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
+ L + IVKYK + G + ++ + G + E + K + ++ K+ Q+
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQI 135
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVVGT--P-NY 180
+DYL S + +HRDL N+ + ++ +++GDFGL K + T ++ + P +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEI-----AAHQPAFRA--------PDMAG--LINK 225
PE L + SD+WS G + E+ + P M L+N
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 226 INRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDL 263
+ P P + Q+++ P +R + +L
Sbjct: 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 64/281 (22%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 18 IEQIGRGAFGAAFL-VLHKIERKKYVL---KKIRLAKQTEKFKRTALQEMDLISKLNNPY 73
++Q+G+G FG+ + ++ + KK++ TE+ R +E++++ L +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQHDN 72
Query: 74 IVKYKDAWVDKGNC-VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IVKYK G + ++ Y G + + ++K + KL ++ +Q+ ++YL
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLG 131
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVVGT--P-NYMCPELLAD 188
+ R +HRDL NI + +N +++GDFGL K+L ++ P + PE L +
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 189 IPYGYKSDIWSLGCCMFEI-----AAHQPAFRAPDMAG-----------LINKINRSSIS 232
+ SD+WS G ++E+ + P M G LI + +
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 251
Query: 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273
P P + I+ N RP+ DL +
Sbjct: 252 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDL--ALRVDQIR 290
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 60/289 (20%), Positives = 113/289 (39%), Gaps = 38/289 (13%)
Query: 5 NGDSKSKLEDYEV---------IEQIGRGAFGAAF--LVLHKIERKKYV----LKKIRLA 49
N + ++ + E IGRG FG + +L +K + L +I
Sbjct: 8 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 67
Query: 50 KQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARG 109
+ +F L E ++ ++P ++ + +V Y + GD+ I+
Sbjct: 68 GEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 123
Query: 110 ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169
+ L + Q+ + YL S + +HRDL N L + +++ DFGLA+ + ++
Sbjct: 124 N-PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
Query: 170 LASSVVGTPN-----YMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDM--A 220
S T +M E L + KSD+WS G ++E+ P PD+
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVNTF 239
Query: 221 GLINKINRSSISPLPIVYSSTMKQIIKSMLR---KNPEHRPTASDLLRH 266
+ + + P + ++ ML+ E RP+ S+L+
Sbjct: 240 DITVYLLQGRRLLQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSR 285
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-25
Identities = 49/262 (18%), Positives = 115/262 (43%), Gaps = 17/262 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISKLNN 71
D + ++G G +G + + K +K ++ + E+F L+E ++ ++ +
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKH 275
Query: 72 PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
P +V+ + I+T + G++ + +++ L TQ+ A++Y
Sbjct: 276 PNLVQLL--GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNY--MCPELLAD 188
L +HR+L N + +++ +++ DFGL++L+ + + PE LA
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 189 IPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQ 244
+ KSD+W+ G ++EIA P P + + + + P + +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSP---YPGIDLSQVYELLEKDYRMERPEGCPEKVYE 450
Query: 245 IIKSMLRKNPEHRPTASDLLRH 266
++++ + NP RP+ +++ +
Sbjct: 451 LMRACWQWNPSDRPSFAEIHQA 472
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 67/320 (20%), Positives = 122/320 (38%), Gaps = 45/320 (14%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLK------KIRLAKQTEKFKRTALQEMDLI 66
+ I Q+G+G FG+ L + + Q F +E+ ++
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF----QREIQIL 78
Query: 67 SKLNNPYIVKYKDAWVDKGNC-VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
L++ +IVKY+ G + +V Y G + + +++ R +L + +Q+
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQIC 137
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTP-NYM 181
++YL S R +HRDL NI + + +++ DFGLAKLL + + +P +
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 182 CPELLADIPYGYKSDIWSLGCCMFEI-------------AAHQPAFRAPDMAG--LINKI 226
PE L+D + +SD+WS G ++E+ A L+ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPI 286
P P + + +++K +P+ RP+ S L P L
Sbjct: 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL--GPQLDMLW---SGSRGCETHA 312
Query: 287 KPTNIMKEKTRKSPSSKHNS 306
P KH+S
Sbjct: 313 FTA---------HPEGKHHS 323
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 60/308 (19%), Positives = 118/308 (38%), Gaps = 40/308 (12%)
Query: 5 NGDSKSKLEDYEV---------IEQIGRGAFGAAFLVLHKIERKKYV------LKKIRLA 49
+ ++++D + IG+G FG + + + + + L +I
Sbjct: 4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63
Query: 50 KQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARG 109
+Q E F L+E L+ LN+P ++ + ++ Y GD+ + I+ +
Sbjct: 64 QQVEAF----LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR 119
Query: 110 ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169
+ L + Q+ ++YL + +HRDL N L + +++ DFGLA+ + +
Sbjct: 120 N-PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178
Query: 170 LASSVVGTPN-----YMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG- 221
S + E L + KSD+WS G ++E+ P +
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP---YRHIDPF 235
Query: 222 -LINKINRSSISPLPIVYSSTMKQIIKSMLR---KNPEHRPTASDLLRHPHLQPYLLRCQ 277
L + + + P P ++ Q+ M + +P RPT L ++ +
Sbjct: 236 DLTHFLAQGRRLPQPEYCPDSLYQV---MQQCWEADPAVRPTFRVL--VGEVEQIVSALL 290
Query: 278 NPSSVYLP 285
V LP
Sbjct: 291 GDHYVQLP 298
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 58/259 (22%), Positives = 108/259 (41%), Gaps = 25/259 (9%)
Query: 20 QIGRGAFGAAFL-VLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
++G G FG+ V +++ V LK+ TE+ ++E ++ +L+NPYI
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLDNPYI 72
Query: 75 VK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
V+ V + + +V GG + + + R P + + L Q+ + + YL
Sbjct: 73 VRLIG---VCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEE 128
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGT--P-NYMCPELLADI 189
+HRDL N+ L + ++ DFGL+K L +D ++ P + PE +
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 190 PYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQI 245
+ +SD+WS G M+E + +P M G ++ I + P + +
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP---YKKMKGPEVMAFIEQGKRMECPPECPPELYAL 245
Query: 246 IKSMLRKNPEHRPTASDLL 264
+ E RP +
Sbjct: 246 MSDCWIYKWEDRPDFLTVE 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 66/291 (22%), Positives = 112/291 (38%), Gaps = 43/291 (14%)
Query: 13 EDYEVIEQIGRGAFGAAFL-VLHKIERKKY-----VLKKIRLAKQTEKFKRTALQEMDLI 66
ED + +G G FG + V + +K KK EKF + E ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF----MSEAVIM 67
Query: 67 SKLNNPYIVK-YKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWL 121
L++P+IVK G I+ G++ +++ + + L +
Sbjct: 68 KNLDHPHIVKLI-------GIIEEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYS 119
Query: 122 TQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT-P-N 179
Q+ A+ YL S +HRD+ NI + ++LGDFGL++ + ED + V P
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
Query: 180 YMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAGL--INKINRSSISPLP 235
+M PE + + SD+W CM+EI QP + I + + P P
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP---FFWLENKDVIGVLEKGDRLPKP 236
Query: 236 IVYSSTMKQIIKSMLR---KNPEHRPTASDLLRHPHLQPYLLRCQNPSSVY 283
+ + + M R +P RP ++L L Q +
Sbjct: 237 DLCPPVLYTL---MTRCWDYDPSDRPRFTEL--VCSLSDVY---QMEKDIA 279
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 66/284 (23%), Positives = 115/284 (40%), Gaps = 30/284 (10%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISKLNN 71
E + ++G+G FG ++ + + K ++ E F LQE ++ KL +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAI-KTLKPGTMSPEAF----LQEAQVMKKLRH 238
Query: 72 PYIVKYKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
+V+ + IVT Y G + + +K G +L Q+
Sbjct: 239 EKLVQLY------AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTP-NYMCPEL 185
+ Y+ +HRDL+ +NI + ++ ++ DFGLA+L+ E A P + PE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 186 LADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSST 241
+ KSD+WS G + E+ P P M +++++ R P P +
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVP---YPGMVNREVLDQVERGYRMPCPPECPES 409
Query: 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLP 285
+ ++ RK PE RPT L L+ Y + Y P
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYL--QAFLEDYF---TSTEPQYQP 448
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 66/289 (22%), Positives = 116/289 (40%), Gaps = 36/289 (12%)
Query: 13 EDYEVIEQIGRGAFGAAFL-VLHKIERKKY-----VLKKIRLAKQTEKFKRTALQEMDLI 66
+ + IG G G L ++ LK +Q F L E ++
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIM 104
Query: 67 SKLNNPYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLL 125
+ ++P I++ V +G IVT Y E G + ++ G F +L L +
Sbjct: 105 GQFDHPNIIRLE--GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 126 LAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGT--P-NYM 181
+ YL +HRDL N+ + + ++ DFGL+++L + D A + G P +
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 182 CPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIV 237
PE +A + SD+WS G M+E+ +P +M +I+ + P P+
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP---YWNMTNRDVISSVEEGYRLPAPMG 278
Query: 238 YSSTMKQIIKSMLR---KNPEHRPTASDLLRHPHLQPYLLRCQNPSSVY 283
+ Q+ ML K+ RP S + L + ++P S+
Sbjct: 279 CPHALHQL---MLDCWHKDRAQRPRFSQI--VSVLDALI---RSPESLR 319
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 59/316 (18%), Positives = 118/316 (37%), Gaps = 36/316 (11%)
Query: 1 METENGDSKSKLEDYEV---------IEQIGRGAFGAAF--LVLHKIERKKYV----LKK 45
+ N + ++ + E IGRG FG + +L +K + L +
Sbjct: 68 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 127
Query: 46 IRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIK 105
I + +F L E ++ ++P ++ + +V Y + GD+ I+
Sbjct: 128 ITDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 183
Query: 106 KARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165
+ L + Q+ + +L S + +HRDL N L + +++ DFGLA+ +
Sbjct: 184 NETHN-PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242
Query: 166 NTEDLASSVVGTPN-----YMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPD 218
++ S T +M E L + KSD+WS G ++E+ P + +
Sbjct: 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVN 301
Query: 219 MAGLINKINRSSISPLPIVYSSTMKQIIKSMLR---KNPEHRPTASDLLRHPHLQPYLLR 275
+ + + P + ++ ML+ E RP+ S+L +
Sbjct: 302 TFDITVYLLQGRRLLQPEYCPDPLYEV---MLKCWHPKAEMRPSFSEL--VSRISAIFST 356
Query: 276 CQNPSSVYLPIKPTNI 291
V++ N+
Sbjct: 357 FIGEHYVHVNATYVNV 372
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 65/316 (20%), Positives = 127/316 (40%), Gaps = 44/316 (13%)
Query: 5 NGDSKSKLEDYEV-------IEQIGRGAFGAAF--LVLHKIERKKYV----LKK-IRLAK 50
+ + K KLED + +G+G FG+ + + V LK I +
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS 67
Query: 51 QTEKFKRTALQEMDLISKLNNPYIVK-----YKDAWVDKGNCVCIVTGYCEGGDMAEIIK 105
E+F L+E + + ++P++ K + + ++ + + GD+ +
Sbjct: 68 DIEEF----LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL 123
Query: 106 KAR----GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161
+R P + L +++ + ++YL S +HRDL N L +D + + DFGL
Sbjct: 124 ASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
Query: 162 AKLLNTEDLASSVVGT--P-NYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRA 216
++ + + D + P ++ E LAD Y SD+W+ G M+EI P +
Sbjct: 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-YAG 242
Query: 217 PDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR---KNPEHRPTASDLLRHPHLQPYL 273
+ A + N + + P + + M + +P+ RP+ + L L+ L
Sbjct: 243 IENAEIYNYLIGGNRLKQPPECMEEVYDL---MYQCWSADPKQRPSFTCL--RMELENIL 297
Query: 274 LRCQNPSSVYLPIKPT 289
+ S + P
Sbjct: 298 ---GHLSVLSTSQDPL 310
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 51/262 (19%), Positives = 117/262 (44%), Gaps = 17/262 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISKLNN 71
D + ++G G +G + + K +K ++ + E+F L+E ++ ++ +
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKH 68
Query: 72 PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
P +V+ + I+T + G++ + +++ L TQ+ A++Y
Sbjct: 69 PNLVQLL--GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT-P-NYMCPELLAD 188
L +HRDL N + +++ +++ DFGL++L+ + + P + PE LA
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 189 IPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQ 244
+ KSD+W+ G ++EIA P P + + + + P + +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP---YPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243
Query: 245 IIKSMLRKNPEHRPTASDLLRH 266
++++ + NP RP+ +++ +
Sbjct: 244 LMRACWQWNPSDRPSFAEIHQA 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 65/308 (21%), Positives = 124/308 (40%), Gaps = 38/308 (12%)
Query: 13 EDYEVIEQIGRGAFG---AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMDL 65
+ IG G FG L +++ V LK KQ F L E +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGI 99
Query: 66 ISKLNNPYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
+ + ++ I++ + K + I+T Y E G + + +++ G F +L L +
Sbjct: 100 MGQFSHHNIIRLE--GVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGI 156
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGT--P-NY 180
+ YL + +HRDL NI + + ++ DFGL+++L + + + G P +
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPI 236
PE ++ + SD+WS G M+E+ +P +++ ++ IN P P+
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---YWELSNHEVMKAINDGFRLPTPM 273
Query: 237 VYSSTMKQIIKSMLR---KNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMK 293
S + Q+ M++ + RP +D+ L + + P S + +
Sbjct: 274 DCPSAIYQL---MMQCWQQERARRPKFADI--VSILDKLI---RAPDS-LKTLADFDPRV 324
Query: 294 EKTRKSPS 301
S S
Sbjct: 325 SIRLPSTS 332
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 66/286 (23%), Positives = 116/286 (40%), Gaps = 30/286 (10%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISKLNN 71
E + ++G+G FG ++ + + K ++ E F LQE ++ KL +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAI-KTLKPGTMSPEAF----LQEAQVMKKLRH 321
Query: 72 PYIVKYKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
+V+ + IVT Y G + + +K G +L Q+
Sbjct: 322 EKLVQLY------AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTP-NYMCPEL 185
+ Y+ +HRDL+ +NI + ++ ++ DFGLA+L+ E A P + PE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 186 LADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSST 241
+ KSD+WS G + E+ P P M +++++ R P P +
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVP---YPGMVNREVLDQVERGYRMPCPPECPES 492
Query: 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIK 287
+ ++ RK PE RPT L L+ Y + Y P +
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYL--QAFLEDYF---TSTEPQYQPGE 533
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 34/295 (11%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYV------LKKIRLAKQTEKFKRTALQEMDLI 66
+ + + +G G FG K+ KK + LK KQ F L E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIM 100
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
+ ++P I++ + V K V IVT Y E G + ++K F +L L +
Sbjct: 101 GQFDHPNIIRLE-GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGT--P-NYMC 182
+ YL +HRDL NI + + ++ DFGL ++L + + A + G P +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 183 PELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAGL--INKINRSSISPLPIVY 238
PE +A + SD+WS G ++E+ +P +M+ I ++ P P+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAVDEGYRLPPPMDC 275
Query: 239 SSTMKQIIKSMLR---KNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTN 290
+ + Q+ ML K+ +RP + L + +NP S+ +
Sbjct: 276 PAALYQL---MLDCWQKDRNNRPKFEQI--VSILDKLI---RNPGSLKIITSAAA 322
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 56/295 (18%), Positives = 120/295 (40%), Gaps = 55/295 (18%)
Query: 13 EDYEVIEQIGRGAFG----AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMD 64
E + ++G+G+FG + K E + V + + ++ +F L E
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF----LNEAS 80
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ- 123
++ + N ++V+ V +G ++ GD+ ++ R A + +
Sbjct: 81 VMKEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPA-MANNPVLAPPSLS 138
Query: 124 --LLLAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVV 175
+ +A + YL++N+ +HRDL N + +D +++GDFG+ + + D
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------ 192
Query: 176 GTPNY-------------MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMA 220
Y M PE L D + SD+WS G ++EIA A QP ++
Sbjct: 193 ----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLS 245
Query: 221 G--LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273
++ + + P + ++++ + NP+ RP+ ++ ++ +
Sbjct: 246 NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI--ISSIKEEM 298
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 58/277 (20%), Positives = 116/277 (41%), Gaps = 28/277 (10%)
Query: 20 QIGRGAFGAAFLVLHKIERKKY-----VLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
++G G FG+ ++++ +K+ VLK+ TE+ ++E ++ +L+NPYI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLDNPYI 398
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V+ V + + +V GG + + + R P + + L Q+ + + YL
Sbjct: 399 VRLIG--VCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK 455
Query: 135 RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-SSVVGT--P-NYMCPELLADIP 190
+HR+L N+ L + ++ DFGL+K L +D ++ P + PE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 191 YGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQII 246
+ +SD+WS G M+E + +P M G ++ I + P + ++
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP---YKKMKGPEVMAFIEQGKRMECPPECPPELYALM 572
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVY 283
E RP + ++ + +S
Sbjct: 573 SDCWIYKWEDRPDFLTV--EQRMRACY---YSLASKV 604
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 59/282 (20%), Positives = 111/282 (39%), Gaps = 28/282 (9%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E ++ +++G G FG + K+ ++ K L E +++ L +
Sbjct: 188 ESLKLEKKLGAGQFG----EVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 73 YIVKYKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
+VK + I+T + G + + +K G+ P KL + Q+ +
Sbjct: 244 KLVKLH------AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT-P-NYMCPELL 186
++ +HRDL+ +NI ++ ++ DFGLA+++ + + P + PE +
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 357
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAG--LINKINRSSISPLPIVYSSTM 242
+ KSD+WS G + EI + P P M+ +I + R P P +
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIP---YPGMSNPEVIRALERGYRMPRPENCPEEL 414
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYL 284
I+ + PE RPT + L + S Y
Sbjct: 415 YNIMMRCWKNRPEERPTFEYI--QSVLDDFY---TATESQYE 451
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 59/262 (22%), Positives = 119/262 (45%), Gaps = 23/262 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKLNN 71
++ ++++ IG+G FG V+ R V +K I+ + F L E ++++L +
Sbjct: 21 KELKLLQTIGKGEFGD---VMLGDYRGNKVAVKCIKNDATAQAF----LAEASVMTQLRH 73
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
+V+ V++ + IVT Y G + + ++ + + L K+ + A++YL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT--P-NYMCPELLAD 188
N +HRDL N+ +++DN ++ DFGL K + +S+ P + PE L +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 188
Query: 189 IPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQ 244
+ KSD+WS G ++EI P P + ++ ++ + P + +
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 245
Query: 245 IIKSMLRKNPEHRPTASDLLRH 266
++K+ + RP+ L
Sbjct: 246 VMKNCWHLDAAMRPSFLQLREQ 267
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 59/272 (21%), Positives = 115/272 (42%), Gaps = 33/272 (12%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYV---LKKIRLAKQTEKFKRTA-LQEMDLISK 68
+D ++E++G G+FG K V +K ++ ++ ++E++ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 69 LNNPYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
L++ +++ Y V + +VT G + + ++K +G F L ++ Q+
Sbjct: 78 LDHRNLIRLYG---VVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEG 133
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTP-NYMCP 183
+ YL S R +HRDL N+ L + +++GDFGL + L D + P + P
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAG--LINKINRS-------SIS 232
E L + + SD W G ++E+ +P + G +++KI++
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264
P +Y ++ PE RPT L
Sbjct: 251 P-QDIY-----NVMVQCWAHKPEDRPTFVALR 276
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 65/285 (22%), Positives = 118/285 (41%), Gaps = 32/285 (11%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISKLNN 71
E +++E++G G FG ++ + K V K ++ + + F L E +L+ +L +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAV-KSLKQGSMSPDAF----LAEANLMKQLQH 67
Query: 72 PYIVK-YKDAWVDKGNC----VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
+V+ Y + I+T Y E G + + +K G KL Q+
Sbjct: 68 QRLVRLY-------AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT-P-NYMCPE 184
+ ++ +HRDL+ +NI ++ ++ DFGLA+L+ + + P + PE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 185 LLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSS 240
+ + KSD+WS G + EI P P M +I + R P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPE 237
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLP 285
+ Q+++ ++ PE RPT L L+ + Y P
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRS--VLEDFF---TATEGQYQP 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 8e-23
Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 21/261 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISKLNN 71
E+ +++++G G FG L K + V K I+ + ++F QE + KL++
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAV-KMIKEGSMSEDEF----FQEAQTMMKLSH 62
Query: 72 PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
P +VK Y K + IVT Y G + ++ G +L + + + +
Sbjct: 63 PKLVKFY--GVCSKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAF 119
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT--P-NYMCPELLA 187
L S++ +HRDL N + +D +++ DFG+ + + +D S VGT P + PE+
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 188 DIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMK 243
Y KSD+W+ G M+E+ P ++ K+++ P + S T+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMP---YDLYTNSEVVLKVSQGHRLYRPHLASDTIY 235
Query: 244 QIIKSMLRKNPEHRPTASDLL 264
QI+ S + PE RPT LL
Sbjct: 236 QIMYSCWHELPEKRPTFQQLL 256
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-23
Identities = 71/261 (27%), Positives = 124/261 (47%), Gaps = 21/261 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISKLNN 71
+ +++IG G FG L + K + K IR A E F ++E +++ KL++
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAI-KTIREGAMSEEDF----IEEAEVMMKLSH 62
Query: 72 PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
P +V+ Y + +C+VT + E G +++ ++ RG F E L + + Y
Sbjct: 63 PKLVQLY--GVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAY 119
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT--P-NYMCPELLA 187
L V+HRDL N + ++ I++ DFG+ + + +D +S GT P + PE+ +
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFS 178
Query: 188 DIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMK 243
Y KSD+WS G M+E+ P + + ++ I+ P + S+ +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIP---YENRSNSEVVEDISTGFRLYKPRLASTHVY 235
Query: 244 QIIKSMLRKNPEHRPTASDLL 264
QI+ R+ PE RP S LL
Sbjct: 236 QIMNHCWRERPEDRPAFSRLL 256
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 53/286 (18%), Positives = 105/286 (36%), Gaps = 58/286 (20%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA---------KQTEKFKRTALQEM 63
ED E +G+G F F + + L + + +E F +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF----FEAA 63
Query: 64 DLISKLNNPYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
++SKL++ ++V Y G+ +V + + G + +KK + C +
Sbjct: 64 SMMSKLSHKHLVLNY--GVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAK 120
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDND--------IRLGDFGLAKLLNTEDLASSV 174
QL A+ +L N ++H ++ NI L ++ D I+L D G++ + +D
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175
Query: 175 VGTPNY-------MCPELLAD-IPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAGL-- 222
+ PE + + +D WS G ++EI +P +
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP---LSALDSQRK 227
Query: 223 INKINRSSISPLPI---VYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
+ P P + +I + + P+HRP+ ++R
Sbjct: 228 LQFYEDRHQLPAPKAAELA-----NLINNCMDYEPDHRPSFRAIIR 268
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 55/260 (21%), Positives = 110/260 (42%), Gaps = 19/260 (7%)
Query: 17 VIEQIGRGAFGAAFL-VLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
+++G G FG + K V +K ++ K L E +++ +L+NPYI
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 75 VK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
V+ + + +V E G + + +++ R ++ + + + Q+ + + YL
Sbjct: 81 VRMIG---ICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEE 135
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDLASSVVGT--P-NYMCPELLADI 189
+ +HRDL N+ L + ++ DFGL+K L E+ + P + PE +
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 190 PYGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQI 245
+ KSD+WS G M+E ++ +P M G + + + P M +
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 252
Query: 246 IKSMLRKNPEHRPTASDLLR 265
+ + E+RP + +
Sbjct: 253 MNLCWTYDVENRPGFAAVEL 272
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 62/261 (23%), Positives = 116/261 (44%), Gaps = 21/261 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISKLNN 71
+D ++++G G FG + + + K I+ + ++F ++E ++ L++
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAI-KMIKEGSMSEDEF----IEEAKVMMNLSH 78
Query: 72 PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+V+ Y K + I+T Y G + +++ R F ++L + + A++Y
Sbjct: 79 EKLVQLY--GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEY 135
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT--P-NYMCPELLA 187
L S + LHRDL N + +++ DFGL++ + +D +S VG+ P + PE+L
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLM 194
Query: 188 DIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMK 243
+ KSDIW+ G M+EI P I + P + S +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMP---YERFTNSETAEHIAQGLRLYRPHLASEKVY 251
Query: 244 QIIKSMLRKNPEHRPTASDLL 264
I+ S + + RPT LL
Sbjct: 252 TIMYSCWHEKADERPTFKILL 272
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 64/290 (22%), Positives = 118/290 (40%), Gaps = 34/290 (11%)
Query: 5 NGDSKSKLEDYEV-------IEQIGRGAFGAAF--LVLHKIERKKYV-LKKIRLAKQTEK 54
+ + ++KLED + + +G G FG+ + + V +K ++L +++
Sbjct: 19 SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR 78
Query: 55 FKRTALQEMDLISKLNNPYIVKY----KDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR-- 108
L E + ++P +++ + ++ + + GD+ + +R
Sbjct: 79 EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 109 --GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166
P + L K++ + L ++YL + LHRDL N L D + + DFGL+K +
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198
Query: 167 TEDLASSVVGT--P-NYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG 221
+ D P ++ E LAD Y KSD+W+ G M+EIA P P +
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP---YPGVQN 255
Query: 222 --LINKINRSSISPLPIVYSSTMKQIIKSML---RKNPEHRPTASDLLRH 266
+ + + P + +I M R +P RPT S L
Sbjct: 256 HEMYDYLLHGHRLKQPEDCLDELYEI---MYSCWRTDPLDRPTFSVLRLQ 302
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 66/321 (20%), Positives = 117/321 (36%), Gaps = 64/321 (19%)
Query: 13 EDYEVIEQIGRGAFG----AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMD 64
++ +I +G GAFG + V L ++ + F L E
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEAL 85
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
+ISK N+ IV+ + I+ GGD+ +++ R L + L
Sbjct: 86 IISKFNHQNIVRCI-GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA--MLDL 142
Query: 125 L-LAVD------YLHSNRVLHRDLKCSNIFLTK---DNDIRLGDFGLAKLLNTEDLASSV 174
L +A D YL N +HRD+ N LT ++GDFG+A+ +
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----- 197
Query: 175 VGTPNY-------------MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDM 219
Y M PE + + K+D WS G ++EI + P P
Sbjct: 198 -----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSK 249
Query: 220 AG--LINKINRSSISPLPIVYSSTMKQIIKSMLR---KNPEHRPTASDLLRHPHLQPYLL 274
+ ++ + P + +I M + PE RP + + ++ Y
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAII--LERIE-YCT 303
Query: 275 RCQNPSSVYLPIKPTNIMKEK 295
+ + + LPI+ +++E+
Sbjct: 304 QDPDVINTALPIEYGPLVEEE 324
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 60/260 (23%), Positives = 119/260 (45%), Gaps = 23/260 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKLNN 71
++ ++++ IG+G FG V+ R V +K I+ + F L E ++++L +
Sbjct: 193 KELKLLQTIGKGEFGD---VMLGDYRGNKVAVKCIKNDATAQAF----LAEASVMTQLRH 245
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
+V+ V++ + IVT Y G + + ++ + + L K+ + A++YL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT--P-NYMCPELLAD 188
N +HRDL N+ +++DN ++ DFGL K + +S+ P + PE L +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 360
Query: 189 IPYGYKSDIWSLGCCMFEIAAH--QPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQ 244
+ KSD+WS G ++EI + P P + ++ ++ + P +
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD 417
Query: 245 IIKSMLRKNPEHRPTASDLL 264
++K+ + RPT L
Sbjct: 418 VMKNCWHLDAATRPTFLQLR 437
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 57/292 (19%), Positives = 104/292 (35%), Gaps = 45/292 (15%)
Query: 13 EDYEVIEQIGRGAFG----AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMD 64
+E++G FG E+ + V LK E+F E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF----RHEAM 64
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW---- 120
L ++L +P +V V K + ++ YC GD+ E +
Sbjct: 65 LRARLQHPNVVCLL-GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 121 ---LTQLL-LAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170
+ L YL S+ V+H+DL N+ + ++++ D GL + + D
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 171 ASSVVGTP---NYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LI 223
+ + +M PE + + SDIWS G ++E+ QP + ++
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---YCGYSNQDVV 240
Query: 224 NKINRSSISPLPIVYSSTMKQIIKSML---RKNPEHRPTASDLLRHPHLQPY 272
I + P P + + + M+ + P RP D+ H L+ +
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYAL---MIECWNEFPSRRPRFKDI--HSRLRAW 287
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 59/309 (19%), Positives = 115/309 (37%), Gaps = 57/309 (18%)
Query: 13 EDYEVIEQIGRGAFGAAFL-VLHKIERKKYVL----KKIRLAKQTEKFKRTALQEMDLIS 67
D + ++G GAFG FL H + ++ + K ++ A +E ++ +E +L++
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLT 98
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
L + +IV++ +G + +V Y GD+ ++ L
Sbjct: 99 MLQHQHIVRFFGV-CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 128 VD-------------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV 174
YL +HRDL N + + +++GDFG+++ + + D
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----- 212
Query: 175 VGTPNY-------------MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDM 219
Y M PE + + +SD+WS G ++EI QP +
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP---WYQL 264
Query: 220 AG--LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQ 277
+ I+ I + P + I++ ++ P+ R + D+ L
Sbjct: 265 SNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR------LQALA 318
Query: 278 NPSSVYLPI 286
VYL +
Sbjct: 319 QAPPVYLDV 327
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 29/253 (11%), Positives = 71/253 (28%), Gaps = 38/253 (15%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-KQTEKFKRTALQEMDLISKLNNPY 73
Y ++ G + L ++ L + + + L +S+++ P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
+ + D V +V + GG + E+ + P + + + L A D H
Sbjct: 93 VARVLDV-VHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAI-RAMQSLAAAADAAHR 147
Query: 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGY 193
V S + ++ D D+ L M
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA-------NP 181
Query: 194 KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYS------STMKQIIK 247
+ DI +G ++ + ++ + + R + + +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 248 SMLRKNPEHRPTA 260
++ + R +
Sbjct: 242 RSVQGDGGIRSAS 254
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 66/321 (20%), Positives = 117/321 (36%), Gaps = 64/321 (19%)
Query: 13 EDYEVIEQIGRGAFG----AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMD 64
++ +I +G GAFG + V L ++ + F L E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEAL 126
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
+ISK N+ IV+ + I+ GGD+ +++ R L + L
Sbjct: 127 IISKFNHQNIVRCI-GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA--MLDL 183
Query: 125 L-LAVD------YLHSNRVLHRDLKCSNIFLTK---DNDIRLGDFGLAKLLNTEDLASSV 174
L +A D YL N +HRD+ N LT ++GDFG+A+ +
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----- 238
Query: 175 VGTPNY-------------MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDM 219
Y M PE + + K+D WS G ++EI + P P
Sbjct: 239 -----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSK 290
Query: 220 AG--LINKINRSSISPLPIVYSSTMKQIIKSMLR---KNPEHRPTASDLLRHPHLQPYLL 274
+ ++ + P + +I M + PE RP + + ++ Y
Sbjct: 291 SNQEVLEFVTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAII--LERIE-YCT 344
Query: 275 RCQNPSSVYLPIKPTNIMKEK 295
+ + + LPI+ +++E+
Sbjct: 345 QDPDVINTALPIEYGPLVEEE 365
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 64/301 (21%), Positives = 116/301 (38%), Gaps = 58/301 (19%)
Query: 13 EDYEVIEQIGRGAFG----AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMD 64
+ ++ + +GRGAFG A + K + V LK+ + + E+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----MSELK 82
Query: 65 LISKLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ 123
++ + + +V A G + ++ +C+ G+++ ++ R P + + L +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 124 LLL--------AVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169
L + +L S + +HRDL NI L++ N +++ DFGLA+ + +
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 170 LASSVVGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFR 215
+Y M PE + D Y +SD+WS G ++EI P
Sbjct: 203 ---------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 216 APDMAGLINKINRSSISPLPIVYSSTMKQIIKSML---RKNPEHRPTASDLLRHPHLQPY 272
++ + P + M Q ML P RPT S+L HL
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSEL--VEHLGNL 308
Query: 273 L 273
L
Sbjct: 309 L 309
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 63/305 (20%), Positives = 122/305 (40%), Gaps = 49/305 (16%)
Query: 6 GDSKSKLEDYEV-------IEQIGRGAFGAAFL-VLHKIERKKYVL----KKIRLAKQTE 53
G S + + ++G GAFG FL + + K + K ++ T
Sbjct: 1 GAMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TL 58
Query: 54 KFKRTALQEMDLISKLNNPYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACF 112
++ +E +L++ L + +IVK Y G+ + +V Y + GD+ + ++
Sbjct: 59 AARKDFQREAELLTNLQHEHIVKFY--GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM 116
Query: 113 PEEKLCKW-------LTQLL-LAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGD 158
L+Q+L +A YL S +HRDL N + + +++GD
Sbjct: 117 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGD 176
Query: 159 FGLAKLLNTEDLASSVVGTP---NYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPA 213
FG+++ + + D T +M PE + + +SD+WS G ++EI QP
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP- 235
Query: 214 FRAPDMAG--LINKINRSSISPLPIVYSSTMKQIIKSML---RKNPEHRPTASDLLRHPH 268
++ +I I + + P V + + ML ++ P+ R ++ +
Sbjct: 236 --WFQLSNTEVIECITQGRVLERPRVCPKEVYDV---MLGCWQREPQQRLNIKEI--YKI 288
Query: 269 LQPYL 273
L
Sbjct: 289 LHALG 293
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 66/319 (20%), Positives = 111/319 (34%), Gaps = 70/319 (21%)
Query: 13 EDYEVIEQIGRGAFG------AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQE 62
+ + + +G GAFG A + K + V LK K + E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSE 90
Query: 63 MDLISKLNN-PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR--------GACF 112
M+++ + I+ + + ++ Y G++ E ++ R
Sbjct: 91 MEMMKMIGKHKNIINLL--GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 113 PEEKLCKWLTQLLLAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166
E+ + + YL S + +HRDL N+ +T++N +++ DFGLA+ +N
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 167 TEDLASSVVGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQP 212
D Y M PE L D Y ++SD+WS G M+EI P
Sbjct: 209 NID---------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 213 AFRAPDMAG--LINKINRSSISPLPIVYSSTMKQIIKSML---RKNPEHRPTASDLLRHP 267
P + L + P ++ + + M P RPT L
Sbjct: 260 ---YPGIPVEELFKLLKEGHRMDKPANCTNELYMM---MRDCWHAVPSQRPTFKQL--VE 311
Query: 268 HLQPYLLRCQNPSSVYLPI 286
L L N YL +
Sbjct: 312 DLDRILTLTTNE--EYLDL 328
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 62/306 (20%), Positives = 106/306 (34%), Gaps = 68/306 (22%)
Query: 13 EDYEVIEQIGRGAFG------AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQE 62
+ + + +G G FG A + K + V LK K + E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSE 136
Query: 63 MDLISKLNN-PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR--------GACF 112
M+++ + I+ + + ++ Y G++ E ++ R
Sbjct: 137 MEMMKMIGKHKNIINLL--GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 113 PEEKLCKWLTQLLLAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166
E+ + + YL S + +HRDL N+ +T++N +++ DFGLA+ +N
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 167 TEDLASSVVGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQP 212
D Y M PE L D Y ++SD+WS G M+EI P
Sbjct: 255 NID---------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 213 AFRAPDMAG--LINKINRSSISPLPIVYSSTMKQIIKSML---RKNPEHRPTASDLLRHP 267
P + L + P ++ + + M P RPT L
Sbjct: 306 ---YPGIPVEELFKLLKEGHRMDKPANCTNELYMM---MRDCWHAVPSQRPTFKQL--VE 357
Query: 268 HLQPYL 273
L L
Sbjct: 358 DLDRIL 363
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 67/312 (21%), Positives = 113/312 (36%), Gaps = 61/312 (19%)
Query: 13 EDYEVIEQIGRGAFG----AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMD 64
+ +G GAFG A L K + V LK + E + E+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL----MSELK 78
Query: 65 LISKLNN-PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW-- 120
++S L N IV G ++T YC GD+ +++ R + +
Sbjct: 79 VLSYLGNHMNIVNLL--GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 121 -------LTQLL-LAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166
L LL + +L S +HRDL NI LT ++ DFGLA+ +
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 167 TEDLASSVVGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQP 212
+ NY M PE + + Y ++SD+WS G ++E+ P
Sbjct: 197 NDS---------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 213 AFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
P + I P + M I+K+ +P RPT +++
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL------ 301
Query: 273 LLRCQNPSSVYL 284
+ + + S+ ++
Sbjct: 302 IEKQISESTNHI 313
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 64/300 (21%), Positives = 102/300 (34%), Gaps = 59/300 (19%)
Query: 13 EDYEVIEQIGRGAFG----AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMD 64
+ + + +G GAFG A L K + V LK A + E + E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL----MSELK 101
Query: 65 LISKLNN-PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
++S L IV G V ++T YC GD+ +++ + +
Sbjct: 102 IMSHLGQHENIVNLL--GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 123 QLLL------AVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170
+ +L S +HRD+ N+ LT + ++GDFGLA+ + +
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS- 218
Query: 171 ASSVVGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRA 216
NY M PE + D Y +SD+WS G ++EI P
Sbjct: 219 --------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270
Query: 217 PDMAGLINKINRSSISPLPIVYSSTMKQIIKSML---RKNPEHRPTASDLLRHPHLQPYL 273
+ + P + I M P HRPT + LQ
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSI---MQACWALEPTHRPTFQQICS--FLQEQA 325
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 60/304 (19%), Positives = 114/304 (37%), Gaps = 71/304 (23%)
Query: 13 EDYEVIEQIGRGAFG----AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMD 64
++ + + +G G FG A L V LK+ + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----LSEFN 78
Query: 65 LISKLNNPYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW--- 120
++ ++N+P+++K Y + + ++ Y + G + ++++R
Sbjct: 79 VLKQVNHPHVIKLY--GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 121 ------------LTQLL-LAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161
+ L+ A YL +++HRDL NI + + +++ DFGL
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 162 AKLLNTEDLASSVVGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEIA- 208
++ + ED +Y M E L D Y +SD+WS G ++EI
Sbjct: 197 SRDVYEED---------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 209 -AHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQIIKSML---RKNPEHRPTASD 262
P P + L N + P S M ++ ML ++ P+ RP +D
Sbjct: 248 LGGNP---YPGIPPERLFNLLKTGHRMERPDNCSEEMYRL---MLQCWKQEPDKRPVFAD 301
Query: 263 LLRH 266
+ +
Sbjct: 302 ISKD 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 65/320 (20%), Positives = 110/320 (34%), Gaps = 62/320 (19%)
Query: 13 EDYEVIEQIGRGAFG------AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQE 62
+ + + +G GAFG A L K R V LK K + E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL----ISE 124
Query: 63 MDLISKLNN-PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
M+++ + I+ + + ++ Y G++ E ++ R
Sbjct: 125 MEMMKMIGKHKNIINLL--GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 121 -------LTQLL-LAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166
L+ A YL S + +HRDL N+ +T+DN +++ DFGLA+ ++
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 167 TEDLASSVVGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEIA--AHQP 212
D Y M PE L D Y ++SD+WS G ++EI P
Sbjct: 243 HID---------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 213 AFRAPDMAG--LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
P + L + P ++ + +++ P RPT L L
Sbjct: 294 ---YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL--VEDLD 348
Query: 271 PYLLRCQNPSSVYLPIKPTN 290
+ N Y +
Sbjct: 349 RIVALTSNQEMGYYHHHHHH 368
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 68/323 (21%), Positives = 113/323 (34%), Gaps = 75/323 (23%)
Query: 13 EDYEVIEQIGRGAFG----AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMD 64
+ E + IG GAFG A L E V LK+ A F +E
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----QREAA 102
Query: 65 LISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW---- 120
L+++ +NP IVK G +C++ Y GD+ E ++
Sbjct: 103 LMAEFDNPNIVKLLGV-CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 121 -----------LTQLL-LAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162
+ L +A YL + +HRDL N + ++ +++ DFGL+
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 163 KLLNTEDLASSVVGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEIA-- 208
+ + + D Y M PE + Y +SD+W+ G ++EI
Sbjct: 222 RNIYSAD---------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 209 AHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTMKQIIKSMLR---KNPEHRPTASDL 263
QP MA +I + +I P + ++ M K P RP+ +
Sbjct: 273 GLQP---YYGMAHEEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSI 326
Query: 264 LRHPHLQPYLLRCQNPSSVYLPI 286
R L R + + +
Sbjct: 327 HRI------LQRMCERAEGTVGV 343
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 67/309 (21%), Positives = 108/309 (34%), Gaps = 68/309 (22%)
Query: 13 EDYEVIEQIGRGAFG----AAFLVLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMD 64
E+ E + +G GAFG A + K V LK+ + + E + E+
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL----MSELK 100
Query: 65 LISKLNN-PYIVK-YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR------------GA 110
++++L + IV + ++ YC GD+ ++ R
Sbjct: 101 MMTQLGSHENIVNLL--GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 111 CFPEEKLCKWLTQLLL---AVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161
EE+ LT L A +L +HRDL N+ +T +++ DFGL
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 162 AKLLNTEDLASSVVGTPNY------------MCPELLADIPYGYKSDIWSLGCCMFEIA- 208
A+ + ++ NY M PE L + Y KSD+WS G ++EI
Sbjct: 219 ARDIMSDS---------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 209 -AHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML---RKNPEHRPTASDLL 264
P P A I P + + I M + RP+ +L
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYII---MQSCWAFDSRKRPSFPNL- 325
Query: 265 RHPHLQPYL 273
L L
Sbjct: 326 -TSFLGCQL 333
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 60/284 (21%), Positives = 107/284 (37%), Gaps = 44/284 (15%)
Query: 13 EDYEVIEQIGRGAFGAAFL-VLHKIERKKYV----LKKIRLAKQTEKFKRTALQEMDLIS 67
D + + IG G FG + K + +K+ F E++++
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF----AGELEVLC 80
Query: 68 KLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKAR-----GACFPEEKLCKWL 121
KL + P I+ + + + Y G++ + ++K+R A L
Sbjct: 81 KLGHHPNIINLL-GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 122 T--QLL-LAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172
+ QLL A D YL + +HRDL NI + ++ ++ DFGL++ +++
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV 196
Query: 173 SVVGT--P-NYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPAFRAPDMAG--LINK 225
P +M E L Y SD+WS G ++EI P M L K
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---YCGMTCAELYEK 253
Query: 226 INRSSISPLPIVYSSTMKQIIKSML---RKNPEHRPTASDLLRH 266
+ + P+ + + M R+ P RP+ + +L
Sbjct: 254 LPQGYRLEKPLNCDDEVYDL---MRQCWREKPYERPSFAQILVS 294
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 20/102 (19%)
Query: 120 WLTQLLLAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---L 170
W + +A +LH N +HRD+K +NI L + ++ DFGLA+ +
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 171 ASSVVGTPNYMCPELLADIPY--GY---KSDIWSLGCCMFEI 207
S +VGT YM PE G KSDI+S G + EI
Sbjct: 192 TSRIVGTTAYMAPE------ALRGEITPKSDIYSFGVVLLEI 227
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 44/170 (25%)
Query: 62 EMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYC-EGGDMA---EIIKKA------RGAC 111
E++ +S +P++V + G+C E +M + ++ G+
Sbjct: 85 EIETLSFCRHPHLVS--------------LIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 112 FPEEKLCKWLTQLLLAVD------YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165
P + W +L + + YLH+ ++HRD+K NI L ++ ++ DFG++K
Sbjct: 131 LPTMSM-SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 166 NTED---LASSVVGTPNYMCPE-----LLADIPYGYKSDIWSLGCCMFEI 207
D L++ V GT Y+ PE L + KSD++S G +FE+
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTE-----KSDVYSFGVVLFEV 234
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 5/173 (2%)
Query: 99 DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGD 158
+ E + E L + Q+ +++L S + +HRDL NI L++ N +++ D
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 159 FGLAKLLNTED--LASSVVGTP-NYMCPELLADIPYGYKSDIWSLGCCMFEIA--AHQPA 213
FGLA+ + + + P +M PE + D Y +SD+WS G ++EI P
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
Query: 214 FRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
++ + P + M Q + P RPT S+L+ H
Sbjct: 297 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 39/218 (17%), Positives = 77/218 (35%), Gaps = 27/218 (12%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKI--------ERKKYVLK----KIRLAKQTEKFKRTA--- 59
+++ R G + +++K+ LK RL + F+R A
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 60 -LQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLC 118
+ + + I V + +V G + + + E +
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVL 162
Query: 119 KWLTQLLLAVDYLHSNRVLHRDLKCSNIFL--TKDNDIRLGDFGLAK--------LLNTE 168
+ +LL A+++LH N +H ++ NIF+ + + L +G A + E
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFE 206
S G ++ +L +SD+ SLG CM +
Sbjct: 223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 29/89 (32%), Positives = 52/89 (58%), Gaps = 17/89 (19%)
Query: 130 YLH--SN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED--LASSVVGTPNYMCPE 184
YLH + +++HRD+K +NI L ++ + +GDFGLAKL++ +D + ++V GT ++ PE
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 205
Query: 185 LLADIPYG------YKSDIWSLGCCMFEI 207
Y K+D++ G + E+
Sbjct: 206 ------YLSTGKSSEKTDVFGYGVMLLEL 228
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 42/202 (20%), Positives = 74/202 (36%), Gaps = 25/202 (12%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ---EMDLISKLNN 71
Y + +IG G+FG +L ++ A + E K Q E + +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEV-------AIKLECVKTKHPQLHIESKIYKMMQG 63
Query: 72 -PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
I + + V ++ G + ++ F + + Q++ ++Y
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVME--LLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEY 120
Query: 131 LHSNRVLHRDLKCSNIFL---TKDNDIRLGDFGLAKL---LNTE-----DLASSVVGTPN 179
+HS +HRD+K N + K N + + DFGLAK T ++ GT
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 180 YMCPELLADIPYGYKSDIWSLG 201
Y I + D+ SLG
Sbjct: 181 YASINTHLGIEQSRRDDLESLG 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 42/222 (18%), Positives = 83/222 (37%), Gaps = 38/222 (17%)
Query: 15 YEVIEQIGRGAFGAAFLVLH------------KIERKKY--------VLKKIRLAKQTEK 54
+ + ++IG G FG +L K+E ++ + R+AK+
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQ--RVAKKDCI 96
Query: 55 FKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPE 114
K +++D L P + +V G D+ +I + F +
Sbjct: 97 KKWIERKQLDY---LGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKK 150
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL--TKDNDIRLGDFGLAKLLNT----- 167
+ + ++L ++Y+H N +H D+K +N+ L + + L D+GL+
Sbjct: 151 STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 168 ---EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFE 206
E+ GT + + + +SD+ LG CM
Sbjct: 211 QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 43/218 (19%), Positives = 76/218 (34%), Gaps = 31/218 (14%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ-EMDLISKLNNPY 73
++V IG+G FG +L + + V + E L E+ + P
Sbjct: 37 WKVGLPIGQGGFGCIYLA--DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 74 -IVKYKDAWVDKGNCVCIVTGYCE----------------GGDMAEIIKKARGACFPEEK 116
I K+ K V G G D+ +I + F +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NAKRFSRKT 153
Query: 117 LCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL--TKDNDIRLGDFGLAKL---LNT---- 167
+ + ++L ++Y+H + +H D+K SN+ L + + L D+GLA
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213
Query: 168 -EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCM 204
D GT + + + + D+ LG CM
Sbjct: 214 AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM 251
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-11
Identities = 45/310 (14%), Positives = 82/310 (26%), Gaps = 74/310 (23%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT------EKFKRTALQEMDLI 66
E + E+IG G FG F + +K I + +K L E+ +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 67 SKLNN---------PYIVKYKDAWVDKGNC-----------------------------V 88
+L+ + +G+ +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 89 CIVTGYCEGG-DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNI 146
IV + GG D+ ++ K L QL ++ ++ R HRDL N+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSS----LATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 147 FLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFE 206
L K + +L K + + I Y +
Sbjct: 194 LLKKTSLKKLHYTLNGKSST--------IPSCGLQVSI----IDYTLSRLERDGIVVFCD 241
Query: 207 IAAHQPAFRAPD--------MAGLINKINRSSISPLPIVY--SSTMKQIIKSMLRKNPEH 256
++ + F + N P V +++K M K +
Sbjct: 242 VSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCN 301
Query: 257 RPTASDLLRH 266
P + R
Sbjct: 302 TPAMKQIKRK 311
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 42/202 (20%), Positives = 76/202 (37%), Gaps = 25/202 (12%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ---EMDLISKLNN 71
+ + +IG G+FG +L + ++ A + E K Q E + L
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEV-------AIKLENVKTKHPQLLYESKIYRILQG 61
Query: 72 -PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
I + V+ V ++ G + ++ + + Q++ V++
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMD--LLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEF 118
Query: 131 LHSNRVLHRDLKCSNIFL---TKDNDIRLGDFGLAKL---LNTE-----DLASSVVGTPN 179
+HS LHRD+K N + + N + + DFGLAK +T ++ GT
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 180 YMCPELLADIPYGYKSDIWSLG 201
Y I + D+ SLG
Sbjct: 179 YASVNTHLGIEQSRRDDLESLG 200
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 42/205 (20%), Positives = 75/205 (36%), Gaps = 29/205 (14%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQ---EMDLISKLNN 71
Y+V +IG G+FG F + + ++ A + E + A Q E L
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQV-------AIKFEPRRSDAPQLRDEYRTYKLLAG 64
Query: 72 -PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
I + + V ++ G + +++ F + + Q+L V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVID--LLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQS 121
Query: 131 LHSNRVLHRDLKCSNIFL------TKDNDIRLGDFGLAKL---LNTE-----DLASSVVG 176
+H +++RD+K N FL N I + DFG+ K T+ ++ G
Sbjct: 122 IHEKSLVYRDIKPDN-FLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 177 TPNYMCPELLADIPYGYKSDIWSLG 201
T YM + D+ +LG
Sbjct: 181 TARYMSINTHLGREQSRRDDLEALG 205
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 38/201 (18%), Positives = 70/201 (34%), Gaps = 21/201 (10%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN-PY 73
+ V ++IG G FG L + + +K L + E +L +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSR-APQLHLEYRFYKQLGSGDG 66
Query: 74 IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS 133
I + ++ G + ++ F + + QL+ ++Y+HS
Sbjct: 67 IPQVYYFGPCGKYNAMVLE--LLGPSLEDLFDL-CDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 134 NRVLHRDLKCSNIFL-----TKDNDIRLGDFGLAKL---LNTE-----DLASSVVGTPNY 180
+++RD+K N + I + DF LAK T+ S+ GT Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 181 MCPELLADIPYGYKSDIWSLG 201
M + D+ +LG
Sbjct: 184 MSINTHLGKEQSRRDDLEALG 204
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 5e-09
Identities = 56/458 (12%), Positives = 105/458 (22%), Gaps = 176/458 (38%)
Query: 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTAL 60
++TE Y IEQ R + + R + LK L R AL
Sbjct: 98 IKTEQRQPSMMTRMY--IEQRDRLYNDNQVFAKYNVSRLQPYLK---L--------RQAL 144
Query: 61 QEMDLISKLNNPYIVKY---------------KDA-----------WVDKGNCVC----- 89
E+ ++ W++ NC
Sbjct: 145 LELR-----PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 90 ---------IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL---------LLAVDYL 131
I + D + IK + L +L LL + +
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIK------LRIHSIQAELRRLLKSKPYENCLLVLLNV 253
Query: 132 HSNRVLHR-DLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIP 190
+ + + +L C + T+ + T+ L+++ L
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQV------------TDFLSAATT------THISLDHHS 295
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
D + P + +P + II +
Sbjct: 296 MTLTPD-EVKS--LLLKYLDCRPQDLPREV--------LTTNPRRL-------SIIAESI 337
Query: 251 RKNPEHRPTASDLLRHP--------------HLQPYLLRCQN-------PSSVYLPIK-- 287
R D +H L+P R + P S ++P
Sbjct: 338 RDGLAT----WDNWKHVNCDKLTTIIESSLNVLEPAEYR-KMFDRLSVFPPSAHIPTILL 392
Query: 288 -----------PTNIMKEKTRKSPSSKHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLN 336
++ + + S K K + +
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQP-----------------------KESTISIP 429
Query: 337 NLPLDDKPTSSTSTEDNLETKKVDPTSYTMEVSSSIND 374
++ L+ K L VD Y + + +D
Sbjct: 430 SIYLELKVKLENEYA--LHRSIVD--HYNIPKTFDSDD 463
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 644 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.52 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.0 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.78 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.69 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.37 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.3 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 97.22 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 97.2 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 97.19 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 97.08 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 97.04 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.02 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 96.98 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 96.97 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 96.94 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 96.94 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.86 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.74 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.71 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 96.66 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 96.6 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 96.59 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.59 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.52 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 96.44 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 96.44 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 96.4 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 96.39 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 96.32 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 96.29 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 96.25 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.24 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 96.24 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 96.24 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 96.23 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 96.13 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 96.07 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 96.03 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 96.01 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 95.88 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 95.85 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 95.8 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 95.8 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 95.79 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 95.76 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.75 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 95.74 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 95.69 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 95.64 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 95.62 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 95.61 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 95.59 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 95.57 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 95.52 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 95.51 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 95.47 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 95.47 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 95.46 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 95.44 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 95.39 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 95.29 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 95.25 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 95.25 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 95.19 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 95.16 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 95.09 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 95.08 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 95.08 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.07 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 95.07 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 94.96 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 94.88 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 94.88 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 94.82 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 94.79 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 94.78 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 94.74 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 94.72 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 94.7 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 94.66 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 94.6 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 94.58 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 94.58 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 94.54 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 94.36 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 94.36 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 94.3 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 94.25 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 94.18 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 94.1 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 94.05 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 93.88 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 93.85 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 93.79 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 93.75 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 93.52 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 93.45 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 93.24 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 93.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.0 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 92.89 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 92.78 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 92.5 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 92.48 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 92.43 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 92.21 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.09 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 91.85 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 91.18 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 88.35 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 87.99 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 87.94 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 87.58 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 87.04 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 86.47 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 85.21 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 83.88 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 83.84 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 81.67 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 81.5 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 81.5 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 80.77 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.7 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 80.66 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 80.48 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 80.07 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-62 Score=523.76 Aligned_cols=263 Identities=35% Similarity=0.769 Sum_probs=238.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+++|+++++||+|+||.||+|+++.+|+.||||++..........+.+.+|+++|++|+|||||+++++|.+ +..+|
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~y 99 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLY 99 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEE
Confidence 35789999999999999999999999999999999998877667777889999999999999999999999877 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
||||||+||+|.++|...++..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999999998776677899999999999999999999999999999999999999999999999999987543
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
....+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++..+.....++.+..+|.++++||.+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 23456789999999999999999999999999999999999999999999999999999888888888999999999999
Q ss_pred HhccCCCCCCCHHHHhhCCCCchhh
Q 006460 249 MLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
||++||.+|||+.|+|+||||+...
T Consensus 260 ~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HccCChhHCcCHHHHhcCHHhhcCC
Confidence 9999999999999999999997543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-61 Score=505.35 Aligned_cols=262 Identities=28% Similarity=0.512 Sum_probs=235.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
...++|++++.||+|+||.||+|+++.+++.||||++.+.... ....+.+.+|+++|++|+|||||+++++|.+ +..+
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~ 107 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKL 107 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEE
Confidence 4567899999999999999999999999999999999765322 2235678999999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|||||||+||+|.+++++. +.++|..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 108 yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999999999874 35999999999999999999999999999999999999999999999999999976432
Q ss_pred ---cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 169 ---DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 169 ---~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..|..... .+|..+++++++|
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dl 264 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDL 264 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHH
Confidence 245678999999999999999999999999999999999999999999999999999887765 4678899999999
Q ss_pred HHHHhccCCCCCCCHHH------HhhCCCCchhhhh
Q 006460 246 IKSMLRKNPEHRPTASD------LLRHPHLQPYLLR 275 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~e------iL~hp~f~~~~~~ 275 (644)
|.+||++||.+|||++| |++||||+.+.|.
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 99999999999999887 6899999876544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-60 Score=490.85 Aligned_cols=258 Identities=24% Similarity=0.509 Sum_probs=214.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
+..+++|++++.||+|+||.||+|.++.+|+.||+|++.+.... ......+.+|+++|++|+|||||+++++|.+ ...
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~ 87 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDE 87 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCE
Confidence 45689999999999999999999999999999999999765432 2345678999999999999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+||||||| +|+|.+++.+. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 99999999 78999999763 4699999999999999999999999999999999999999999999999999998776
Q ss_pred ccccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
.....+.+||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+...+++.+..... ++|..+|+++++||
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 243 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-TLPKFLSPGAAGLI 243 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHH
Confidence 666778899999999999998886 5899999999999999999999999999888888876654 47788999999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCch
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+||++||.+|||++|+|+||||+.
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=501.93 Aligned_cols=254 Identities=28% Similarity=0.512 Sum_probs=229.9
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.+.|+++++||+|+||.||+|.++.+|+.||||++....... .+.+.+|+++|++|+|||||+++++|.+ +..+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence 467999999999999999999999999999999997654332 3567899999999999999999999887 4679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~ 170 (644)
||||+||+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.+... ..
T Consensus 150 mEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999999999975 24999999999999999999999999999999999999999999999999999876543 44
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--CCccccHHHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSSTMKQIIKS 248 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~p~~~s~~l~dLI~~ 248 (644)
..+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+.+..+....... .+..+|+++++||.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 667899999999999999999999999999999999999999999999998888887654333 345689999999999
Q ss_pred HhccCCCCCCCHHHHhhCCCCch
Q 006460 249 MLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
||++||.+|||+.|+|+||||+.
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HcCCChhHCcCHHHHhcCHhhcC
Confidence 99999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-60 Score=501.61 Aligned_cols=266 Identities=29% Similarity=0.501 Sum_probs=228.6
Q ss_pred CCCCCCCCCeEEEEEeccCCCeEEEEEEEe---cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 006460 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWV 82 (644)
Q Consensus 6 ~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~ 82 (644)
+..+...++|++++.||+|+||.||+|++. .+++.||+|+++...........+.+|+++|++|+|||||+++++|.
T Consensus 17 ~~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 17 GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp TCCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE
T ss_pred ccccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 344455578999999999999999999985 46789999999765432222345778999999999999999999988
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
+ +..+|||||||+||+|.+++.+.. .+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|
T Consensus 97 ~-~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 97 T-EGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp E-TTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred E-CCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 7 567999999999999999998743 5999999999999999999999999999999999999999999999999999
Q ss_pred ccccc-ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 163 KLLNT-EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 163 ~~~~~-~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
+.... .....+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++..+..... ++|..+|++
T Consensus 174 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~ 252 (304)
T 3ubd_A 174 KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPE 252 (304)
T ss_dssp EC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHH
T ss_pred eeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHH
Confidence 86533 3445678999999999999999999999999999999999999999999999999998887654 467889999
Q ss_pred HHHHHHHHhccCCCCCCC-----HHHHhhCCCCchhhhh
Q 006460 242 MKQIIKSMLRKNPEHRPT-----ASDLLRHPHLQPYLLR 275 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpT-----a~eiL~hp~f~~~~~~ 275 (644)
+++||.+||++||.+||| ++|+++||||+.+.|.
T Consensus 253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp HHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 999999999999999998 5899999999876554
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=482.66 Aligned_cols=255 Identities=27% Similarity=0.562 Sum_probs=223.7
Q ss_pred CCe-EEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC---CceE
Q 006460 13 EDY-EVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK---GNCV 88 (644)
Q Consensus 13 ~~Y-~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~---~~~~ 88 (644)
++| ++.++||+|+||.||+|.++.++..||+|++..........+.+.+|+++|++|+|||||+++++|.+. ..++
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 455 788899999999999999999999999999988776666678899999999999999999999998652 4578
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCcEEEcC-CCCeEEeccCccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR--VLHRDLKCSNIFLTK-DNDIRLGDFGLAKLL 165 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g--IIHRDLKPeNILL~~-~g~vKL~DFGls~~~ 165 (644)
|||||||+||+|.+++.+. ..+++..++.|+.||+.||.|||++| ||||||||+||||+. +|.+||+|||+|+..
T Consensus 105 ~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999999999864 35999999999999999999999998 999999999999984 789999999999864
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhccCCC-CCCccccHHHH
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINRSSIS-PLPIVYSSTMK 243 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i~~~~~~-~~p~~~s~~l~ 243 (644)
.. ....+.+||+.|||||++.+ .|+.++|||||||+||+|++|++||.+.. ...+...+.....+ .++..++++++
T Consensus 183 ~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (290)
T 3fpq_A 183 RA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260 (290)
T ss_dssp CT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred CC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHH
Confidence 43 45567899999999999876 69999999999999999999999997654 45555666554332 34566789999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||.+||.+||.+|||+.++|+||||+.
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=504.46 Aligned_cols=255 Identities=28% Similarity=0.510 Sum_probs=230.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..+.|+++++||+|+||.||+|.++.+|+.||||++....... .+.+.+|+.+|++|+|||||+++++|.+ +..+||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~i 225 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWV 225 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEE
Confidence 3467999999999999999999999999999999997654322 3568899999999999999999999887 467999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-c
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-D 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~ 169 (644)
|||||+||+|.++++.. .+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.+... .
T Consensus 226 VmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999999999752 4999999999999999999999999999999999999999999999999999876543 3
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC--CCCccccHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--PLPIVYSSTMKQIIK 247 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~--~~p~~~s~~l~dLI~ 247 (644)
...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|...... ..+..+|+++++||.
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 456789999999999999999999999999999999999999999999999888888765433 234568999999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCch
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||.+||.+|||+.|+|+||||+.
T Consensus 383 ~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 383 RLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHcCCChhHCcCHHHHhcCHHhcC
Confidence 999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-58 Score=486.58 Aligned_cols=253 Identities=31% Similarity=0.484 Sum_probs=221.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..++.|++.++||+|+||.||+|+++.+|+.||||+++.... ..+|+.+|++|+|||||+++++|.+ +..+|
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVRE-GPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEE-TTEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEE-CCEEE
Confidence 456789999999999999999999999999999999986543 2469999999999999999999877 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-CeEEeccCcccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTE 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-~vKL~DFGls~~~~~~ 168 (644)
||||||+||+|.++|++. +.+++..++.|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+.+...
T Consensus 127 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999999999864 3599999999999999999999999999999999999999988 6999999999876543
Q ss_pred cc------cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--CCCCccccH
Q 006460 169 DL------ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--SPLPIVYSS 240 (644)
Q Consensus 169 ~~------~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--~~~p~~~s~ 240 (644)
.. ....+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.....++..+..... ..+|..+++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 284 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP 284 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCH
Confidence 22 2346899999999999999999999999999999999999999998877777777765543 235678899
Q ss_pred HHHHHHHHHhccCCCCCCCHHHH-------------hhCCCCchh
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDL-------------LRHPHLQPY 272 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~ei-------------L~hp~f~~~ 272 (644)
.+.+||.+||++||.+|||+.|+ |+|||+..+
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 99999999999999999999998 467888643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=483.93 Aligned_cols=258 Identities=29% Similarity=0.478 Sum_probs=225.1
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----Cce
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-----GNC 87 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-----~~~ 87 (644)
++|++++.||+|+||.||+|+++.+|+.||||+++.........+.+++|+++|++|+|||||++++++... ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999987766666678899999999999999999999987542 357
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|||||||+ |+|.+++.. ...+++..++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+++.+..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 999999995 679999865 45699999999999999999999999999999999999999999999999999987533
Q ss_pred c-----cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC-------
Q 006460 168 E-----DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL------- 234 (644)
Q Consensus 168 ~-----~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~------- 234 (644)
. ....+.+||++|||||++.+. .|+.++||||+|||+|+|++|++||.+.+..+++..|......+.
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2 345678999999999998875 469999999999999999999999999998888877754321111
Q ss_pred -----------------------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 235 -----------------------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 235 -----------------------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
...+++++.+||.+||++||.+|||+.|+|+||||+.+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 123588999999999999999999999999999998653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=503.93 Aligned_cols=423 Identities=23% Similarity=0.352 Sum_probs=324.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|+++++||+|+||.||+|.++.++..||+|++............+.+|+.+|+.++|||||+++++|.+ ...+|+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence 3457999999999999999999999999999999998765433335678899999999999999999999876 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC---CCeEEeccCccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD---NDIRLGDFGLAKLLNT 167 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~---g~vKL~DFGls~~~~~ 167 (644)
|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++..+..
T Consensus 114 v~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999999998764 359999999999999999999999999999999999999764 4599999999998776
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC---ccccHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP---IVYSSTMKQ 244 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p---~~~s~~l~d 244 (644)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+....+++..+......... ..++..+.+
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred CccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 666677899999999999864 6999999999999999999999999999999998888776554322 357999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCchhhhhcCCCCCcccCCCccccccccccCCCCCccCCCCCc------chhhhcCc
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNSRKDK------GEREAAAP 318 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~~~~~~~~~~p~~p~~~~k~k~~~~~~~~~~~~k~~------~~~e~~~~ 318 (644)
||.+||..||.+|||+.++|+||||+......... ...|..... .... ++........+... -..+....
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~--~~~~~~~~~-~~~~-~~~~~~~~l~qa~l~~ia~~~~~~~~~~ 346 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESG--IELPSLANA-IENM-RKFQNSQKLAQAALLYMASKLTSQEETK 346 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC-----CCCCSSH-HHHH-HTTTTCCHHHHHHHHHHHHHSCCHHHHH
T ss_pred HHHHHCCCChhhCccHHHHhcCcccccCccccccc--ccccccHHH-HHHH-HHHHHhHHHHHHHHHHHHHhcccHHHHH
Confidence 99999999999999999999999998764432111 111111111 1100 00000000000000 00001111
Q ss_pred chhhhhhhHhhhccccccCcCCCCC--------------CCCCchhhccccccccCCCCccccccchhhhcccccccccc
Q 006460 319 NQLENVRSVAKNIAVQLNNLPLDDK--------------PTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTET 384 (644)
Q Consensus 319 ~~le~~~~~~~n~~~q~~~~~~~~~--------------~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~ 384 (644)
...+.++.++.+.++.++..++... ......++.+|...|.|++|+| +|.||+.+...+....++
T Consensus 347 ~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I-~~~EF~~~~~~~~~~~~~ 425 (494)
T 3lij_A 347 ELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYI-DYSEFVTVAMDRKSLLSK 425 (494)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSE-EHHHHHHHHSCHHHHTCH
T ss_pred HHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcC-cHHHHHHHHHhhhccccH
Confidence 2234467778888888777766211 2235667889999999999999 999999999888888888
Q ss_pred cccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 385 SDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 385 ~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+.+..+|+..++ |.+++++.+|+.+........-..+++ ++..-|.| .|+.|++.||.
T Consensus 426 ~~~~~~F~~~D~-----d~~G~Is~~El~~~l~~~~~~~~~~~~----~~~~~D~d--~dG~I~~~EF~ 483 (494)
T 3lij_A 426 DKLESAFQKFDQ-----DGNGKISVDELASVFGLDHLESKTWKE----MISGIDSN--NDGDVDFEEFC 483 (494)
T ss_dssp HHHHHHHHHHCT-----TCSSEECHHHHHHHC-CCSCCCHHHHH----HHHTTCSS--SSSSEEHHHHH
T ss_pred HHHHHHHHHHCC-----CCCCcCCHHHHHHHHHhcCCCHHHHHH----HHHHhCCC--CCCcCCHHHHH
Confidence 999999999998 999999999999997543333333333 37778888 89999998886
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=505.03 Aligned_cols=426 Identities=23% Similarity=0.366 Sum_probs=317.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|+++++||+|+||.||+|.++.+++.||+|++............+.+|+++|++++|||||++++++.+ ...+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEE
Confidence 45679999999999999999999999999999999997654333335678899999999999999999999876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc---CCCCeEEeccCcccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT---KDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~---~~g~vKL~DFGls~~~~ 166 (644)
+|||||.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 98 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999999987643 599999999999999999999999999999999999995 45679999999998876
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC---CCccccHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP---LPIVYSSTMK 243 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~---~p~~~s~~l~ 243 (644)
........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+....+++..+....... .+..++.+++
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 6656667889999999999976 59999999999999999999999999999998888887765432 2245799999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCchhhhhcCCCCCcccCCCcc--ccccccccCCCCCccC--CCCCcchhhhcCcc
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPT--NIMKEKTRKSPSSKHN--SRKDKGEREAAAPN 319 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~~~~~~~~~~p~~p~--~~~k~k~~~~~~~~~~--~~k~~~~~e~~~~~ 319 (644)
+||.+||..||.+|||+.++|+||||+.+..... .....|.... ..++............ .....-..+.....
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~ 332 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETP--TISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQ 332 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCC--CGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHhcCHhhccCcccCc--cccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHH
Confidence 9999999999999999999999999976432110 0000000000 0000000000000000 00000000011112
Q ss_pred hhhhhhhHhhhccccccCcCCC-----------CC---------CCCCchhhccccccccCCCCccccccchhhhccccc
Q 006460 320 QLENVRSVAKNIAVQLNNLPLD-----------DK---------PTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERS 379 (644)
Q Consensus 320 ~le~~~~~~~n~~~q~~~~~~~-----------~~---------~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s 379 (644)
..+.++.++.+.++.++..++. .. ......++.+|...|.|++|.| |+.||+.+...+.
T Consensus 333 l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I-~~~Ef~~~~~~~~ 411 (486)
T 3mwu_A 333 LTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSI-EYSEFIASAIDRT 411 (486)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSB-CHHHHHHHHSCTT
T ss_pred HHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcC-cHHHHHHHHHhhh
Confidence 2345677888888888776661 11 1225567889999999999999 9999999999988
Q ss_pred ccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 380 TQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 380 ~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
...+++.+..+|+..++ |.+++++.+|+.+.....+... ..+++ ++...|.| .|+.|++.||.
T Consensus 412 ~~~~~~~~~~~F~~~D~-----d~dG~Is~~El~~~l~~~g~~~~~~~~~~----~~~~~D~d--~dG~I~~~EF~ 476 (486)
T 3mwu_A 412 ILLSRERMERAFKMFDK-----DGSGKISTKELFKLFSQADSSIQMEELES----IIEQVDNN--KDGEVDFNEFV 476 (486)
T ss_dssp TTCCHHHHHHHHHHHCS-----SCSSSBCSSCC------------------------CCCCSS--CSSSBCHHHHH
T ss_pred ccchHHHHHHHHHHhCC-----CCCCcCCHHHHHHHHHHcCCCCCHHHHHH----HHHHhCCC--CCCcEeHHHHH
Confidence 88889999999999988 9999999999999987666332 23333 37777888 89999998885
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=468.18 Aligned_cols=257 Identities=30% Similarity=0.532 Sum_probs=208.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc-----
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN----- 86 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~----- 86 (644)
+++|++++.||+|+||.||+|+++.+++.||||+++... .+...+.+.+|+++|++|+|||||+++++|.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 568999999999999999999999999999999997654 34456788999999999999999999999876432
Q ss_pred ------eEEEEEeccCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEecc
Q 006460 87 ------CVCIVTGYCEGGDMAEIIKKARG-ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDF 159 (644)
Q Consensus 87 ------~~~LVmEy~~GgsL~~~L~~~~~-~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DF 159 (644)
++|||||||+||+|.+++..... ...++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999975322 12456678999999999999999999999999999999999999999999
Q ss_pred Cccccccccc-------------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHH
Q 006460 160 GLAKLLNTED-------------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINK 225 (644)
Q Consensus 160 Gls~~~~~~~-------------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~ 225 (644)
|+|+.+.... ...+.+||+.|||||++.+..|+.++|||||||+||||++ ||.... ....+..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 9998764432 1234689999999999999999999999999999999996 776432 2233444
Q ss_pred HhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 226 INRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 226 i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+.....++.+...++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 240 ~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 44455444445567788999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-57 Score=502.29 Aligned_cols=424 Identities=23% Similarity=0.337 Sum_probs=328.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-----------HHHHHHHHHHHHHHhcCCCCcceee
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-----------KFKRTALQEMDLISKLNNPYIVKYK 78 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-----------~~~~~~~rEi~iL~~L~HPNIVkl~ 78 (644)
...++|+++++||+|+||.||+|.++.++..||+|++....... ...+.+.+|+.+|++++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45689999999999999999999999999999999997654221 2356788999999999999999999
Q ss_pred eEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC---CeE
Q 006460 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN---DIR 155 (644)
Q Consensus 79 ~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g---~vK 155 (644)
++|.+ +..+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 113 ~~~~~-~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFED-KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEEC-SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEc-CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 99876 56799999999999999999764 3599999999999999999999999999999999999999776 699
Q ss_pred EeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC
Q 006460 156 LGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP 235 (644)
Q Consensus 156 L~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p 235 (644)
|+|||++..+.........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+....+++..+.........
T Consensus 190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred EEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 999999998776656677889999999999875 6999999999999999999999999999999999888877544221
Q ss_pred ---ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhhcCCCCCcccCCCccccccccccCCCCCccCCCC----
Q 006460 236 ---IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNSRK---- 308 (644)
Q Consensus 236 ---~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~~~~~~~~~~p~~p~~~~k~k~~~~~~~~~~~~k---- 308 (644)
..++.++.+||.+||..||.+|||+.++|+||||+.+...... ...+. ....+....+-....+.....
T Consensus 269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~kl~~a~l~~i 344 (504)
T 3q5i_A 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK---SDQKT-LCGALSNMRKFEGSQKLAQAAILFI 344 (504)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCG---GGHHH-HHHHHHHHHHCCCCSHHHHHHHHHH
T ss_pred cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccc---cchhh-HHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 4579999999999999999999999999999999764321100 00000 000000000000000000000
Q ss_pred -CcchhhhcCcchhhhhhhHhhhccccccCcCCC--------------CCCCCCchhhccccccccCCCCccccccchhh
Q 006460 309 -DKGEREAAAPNQLENVRSVAKNIAVQLNNLPLD--------------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSIN 373 (644)
Q Consensus 309 -~~~~~e~~~~~~le~~~~~~~n~~~q~~~~~~~--------------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~ 373 (644)
..--.+.......+.++.++.+.++.++..++. ....+...++.++...|.|++|.| ++.||+.
T Consensus 345 ~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I-~~~EF~~ 423 (504)
T 3q5i_A 345 GSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYI-EYSEFIS 423 (504)
T ss_dssp HHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSE-EHHHHHH
T ss_pred hccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcE-eHHHHHH
Confidence 000000111122345677888888888777652 123455678999999999999999 9999999
Q ss_pred hcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 374 DSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 374 a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+...+....+++.++.+|+..++ |.+++++.+|+.+.....+..-..+++. +..-|.| .|+.|++.||-
T Consensus 424 ~~~~~~~~~~~~~~~~~F~~~D~-----d~dG~Is~~El~~~l~~~~~~~~~~~~~----~~~~D~d--~dG~I~~~EF~ 492 (504)
T 3q5i_A 424 VCMDKQILFSEERLRRAFNLFDT-----DKSGKITKEELANLFGLTSISEKTWNDV----LGEADQN--KDNMIDFDEFV 492 (504)
T ss_dssp HHSCHHHHTCHHHHHHHHHHHCT-----TCCSEECHHHHHHHTTCSCCCHHHHHHH----HHTTCSS--CSSSEEHHHHH
T ss_pred HHHhhhcccCHHHHHHHHHHhcC-----CCCCcCcHHHHHHHHhhCCCCHHHHHHH----HHHhCCC--CCCcEeHHHHH
Confidence 99888777888999999999988 9999999999999976544444444444 7888888 89999998885
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=503.60 Aligned_cols=425 Identities=23% Similarity=0.362 Sum_probs=328.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
...++|++.+.||+|+||.||+|.++.+++.||+|++...... ......+.+|+.+|++++|||||+++++|.+ ...+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 101 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYF 101 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEE
Confidence 3456899999999999999999999999999999999765322 2235678899999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE---cCCCCeEEeccCccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL---TKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL---~~~g~vKL~DFGls~~~ 165 (644)
|+|||||.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+
T Consensus 102 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999999875 3469999999999999999999999999999999999999 46788999999999887
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC---CCccccHHH
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP---LPIVYSSTM 242 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~---~p~~~s~~l 242 (644)
.........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+....... .+..+++.+
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 66655666789999999999977 69999999999999999999999999999999888887765432 224579999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCchhhhhcCCCCCcccCCCcccc--ccccccCCCCCccC--CCCCcchhhhcCc
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNI--MKEKTRKSPSSKHN--SRKDKGEREAAAP 318 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~~~~~~~~~~p~~p~~~--~k~k~~~~~~~~~~--~~k~~~~~e~~~~ 318 (644)
++||.+||..||.+|||+.++|+||||+.+...... ...|...... ++.........+.. .....-..+....
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~ 335 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS---VDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETK 335 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC--------CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhccccccccc---ccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHH
Confidence 999999999999999999999999999875432111 1111110000 00000000000000 0000000011111
Q ss_pred chhhhhhhHhhhccccccCcCC----C-------CCCC------CCchhhccccccccCCCCccccccchhhhccccccc
Q 006460 319 NQLENVRSVAKNIAVQLNNLPL----D-------DKPT------SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQ 381 (644)
Q Consensus 319 ~~le~~~~~~~n~~~q~~~~~~----~-------~~~~------ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~ 381 (644)
...+.+..++.+.++.++..++ . ..++ ....++.+|...|.|++|+| |+.||+.+...+...
T Consensus 336 ~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i-~~~Ef~~~~~~~~~~ 414 (484)
T 3nyv_A 336 ELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYI-EYSEFVTVAMDRKTL 414 (484)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEE-EHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeE-eHHHHHHHHHhcccc
Confidence 2234567788888888877766 1 1111 14567889999999999999 999999999888777
Q ss_pred ccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 382 TETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 382 ~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+++.+..+|+..++ |.+++++.+|+.......+.....+++ ++..-|.| .|+.|++.||.
T Consensus 415 ~~~~~~~~~F~~~D~-----d~dG~I~~~El~~~l~~~~~~~~~~~~----~~~~~D~d--~dG~i~~~Ef~ 475 (484)
T 3nyv_A 415 LSRERLERAFRMFDS-----DNSGKISSTELATIFGVSDVDSETWKS----VLSEVDKN--NDGEVDFDEFQ 475 (484)
T ss_dssp HHHHHHHHHHHHHCT-----TCCSEEEHHHHHHHHHHTTCCHHHHHH----HHHHHCTT--CCSEEEHHHHH
T ss_pred CcHHHHHHHHHHHCC-----CCCCcCCHHHHHHHHHhcCCCHHHHHH----HHHHhcCC--CCCcCCHHHHH
Confidence 888999999999998 999999999999987543333333333 37778888 89999998885
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=456.03 Aligned_cols=259 Identities=21% Similarity=0.383 Sum_probs=227.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...++|.+.++||+|+||.||+|.+. .++..||||+++.. .....+.|.+|+++|++|+|||||+++++|.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~- 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE- 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-
Confidence 45679999999999999999999875 35789999999754 34456789999999999999999999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR-----------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND 153 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~-----------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~ 153 (644)
+..+|||||||+||+|.++|.... ...+++..+..|+.||+.||.|||+++||||||||+||||+.++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 456999999999999999997632 346999999999999999999999999999999999999999999
Q ss_pred eEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcc
Q 006460 154 IRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRS 229 (644)
Q Consensus 154 vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~ 229 (644)
+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||+| |++||.+.+..+++..+..+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999987644332 234579999999999999999999999999999999998 99999999999999999988
Q ss_pred CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 230 SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 230 ~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
...+.|..+|+++.+|+.+||+.||.+|||+.+|+ +|++.+.
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~ 288 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLA 288 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHH
Confidence 88888999999999999999999999999999995 5676543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=455.88 Aligned_cols=254 Identities=21% Similarity=0.365 Sum_probs=219.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...++|.+.++||+|+||.||+|.++ .++..||||+++.. .....+.|.+|+++|++|+|||||+++++|.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~- 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE- 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence 34578999999999999999999875 46889999999754 34456789999999999999999999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR-------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~-------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~ 151 (644)
+..+|||||||+||+|.+++.... ...+++.++..|+.||+.||.|||+++||||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 456999999999999999997532 2468999999999999999999999999999999999999999
Q ss_pred CCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 006460 152 NDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKIN 227 (644)
Q Consensus 152 g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~ 227 (644)
+.+||+|||+++.+.... .....+||+.|||||++.+..|+.++|||||||+||||+| |++||.+.+..+++..+.
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999998764432 2345689999999999999999999999999999999998 999999999999999998
Q ss_pred ccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 228 RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 228 ~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+...+.|..+++++.+|+.+||+.||.+|||+.+|+.+
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 888788899999999999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=492.85 Aligned_cols=275 Identities=24% Similarity=0.425 Sum_probs=232.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc----cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ----TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~----~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...+++|++++.||+|+||.||+|+++.+|+.||||++.+... .........+++.+++.++|||||+++++|.+
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~- 263 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 263 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-
Confidence 3467999999999999999999999999999999999976432 22222333445677778899999999999877
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...+|||||||+||+|..+|.+. +.|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 56799999999999999999874 3599999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccCCCCCCChhhhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHhccCCCCCCccccH
Q 006460 165 LNTEDLASSVVGTPNYMCPELLA-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAP---DMAGLINKINRSSISPLPIVYSS 240 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~-~~~ys~ksDIWSLGvILyeLltG~~PF~~~---~~~el~~~i~~~~~~~~p~~~s~ 240 (644)
+... ...+.+||+.|||||++. +..|+.++|||||||+||+|++|.+||.+. +...+...+.... ..+|..+|+
T Consensus 342 ~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~-~~~p~~~S~ 419 (689)
T 3v5w_A 342 FSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDSFSP 419 (689)
T ss_dssp CSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-CCCCTTSCH
T ss_pred cCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-CCCCccCCH
Confidence 7553 456789999999999996 467999999999999999999999999764 3445555554443 357788999
Q ss_pred HHHHHHHHHhccCCCCCCC-----HHHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 241 TMKQIIKSMLRKNPEHRPT-----ASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpT-----a~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
++++||.+||++||.+|++ +++|++||||+.+.|..........|+.|
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P 472 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 472 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccC
Confidence 9999999999999999998 79999999999887765433334445444
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-54 Score=459.99 Aligned_cols=251 Identities=21% Similarity=0.336 Sum_probs=207.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEe---cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
.-++|++.++||+|+||.||+|+++ .+++.||+|++..... ..++.+|+++|+.+ +|||||+++++|.+ ..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRK-ND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEE-CC
Confidence 4478999999999999999999986 3578999999866543 34577899999998 69999999999877 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-CCeEEeccCccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLAKLL 165 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-g~vKL~DFGls~~~ 165 (644)
++|||||||+||+|.+++. .+++.+++.|++||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 7999999999999999884 38999999999999999999999999999999999999877 79999999999754
Q ss_pred ccc-----------------------------cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 006460 166 NTE-----------------------------DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFR 215 (644)
Q Consensus 166 ~~~-----------------------------~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~ 215 (644)
... ....+.+||++|||||++.+. .|+.++||||+|||+|+|++|++||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 322 123456899999999999875 48999999999999999999999985
Q ss_pred C-CChHHHHHHHhcc-----------------------------------------------------CCCCCCccccHH
Q 006460 216 A-PDMAGLINKINRS-----------------------------------------------------SISPLPIVYSST 241 (644)
Q Consensus 216 ~-~~~~el~~~i~~~-----------------------------------------------------~~~~~p~~~s~~ 241 (644)
. .+..+.+..|... ........+|++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 4 4444443333210 000112346889
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+++||++||++||.+|||++|+|+||||+.
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=452.32 Aligned_cols=255 Identities=18% Similarity=0.359 Sum_probs=225.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
..++++++.++||+|+||.||+|.+. .+++.||||+++.... ....+.|.+|+.+|++|+|||||+++++|.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTK- 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-
Confidence 45678999999999999999999864 4678999999975432 2345678999999999999999999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK 150 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~ 150 (644)
+..+|||||||++|+|.++|.... ...+++..+..|+.||+.||.|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 456899999999999999997532 235899999999999999999999999999999999999999
Q ss_pred CCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 006460 151 DNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKI 226 (644)
Q Consensus 151 ~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i 226 (644)
++.+||+|||+++.+...+ .....+||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+..++...+
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999998764432 3455789999999999999999999999999999999998 89999999999999999
Q ss_pred hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 227 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+...+.|..++..+.+|+.+||..||.+|||+.+|+++
T Consensus 261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9888888999999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-54 Score=486.14 Aligned_cols=258 Identities=26% Similarity=0.456 Sum_probs=233.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.+++|++++.||+|+||.||+|.++.+|+.||+|++..... ...+.+.+|+++|+.|+|||||+++++|.+ ...+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch--hhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEE
Confidence 46899999999999999999999999999999999976543 335678899999999999999999999876 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC--CCeEEeccCcccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD--NDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~--g~vKL~DFGls~~~~~~ 168 (644)
|||||+||+|.++|... ...|++..++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 232 v~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999999998643 3469999999999999999999999999999999999999854 88999999999988777
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC---CCccccHHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP---LPIVYSSTMKQI 245 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~---~p~~~s~~l~dL 245 (644)
......+||+.|||||++.+..|+.++|||||||+||+|++|.+||.+.+..+++..|....... .+..+|.++++|
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 77778899999999999999999999999999999999999999999999999999887765432 234589999999
Q ss_pred HHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 246 IKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
|.+||++||.+|||+.|+|+||||++.
T Consensus 391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=448.11 Aligned_cols=251 Identities=23% Similarity=0.413 Sum_probs=211.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.++||+|+||.||+|.++ ..||||+++.........+.|.+|+++|++|+|||||++++++.+ ..+|
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~ 107 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLA 107 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEE
Confidence 45679999999999999999999764 369999998776666777889999999999999999999998643 3489
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
||||||+||+|.++|... ...+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 108 iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999999999753 456999999999999999999999999999999999999999999999999999875432
Q ss_pred --cccccccCCCCCCChhhhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHhccCC----CCCCccc
Q 006460 169 --DLASSVVGTPNYMCPELLAD---IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL-INKINRSSI----SPLPIVY 238 (644)
Q Consensus 169 --~~~~~~~GT~~Y~APEvl~~---~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el-~~~i~~~~~----~~~p~~~ 238 (644)
......+||+.|||||++.+ ..|+.++|||||||+||||+||++||.+.+.... ...+..... ...+..+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 23456789999999999864 3589999999999999999999999987665444 444443322 2345678
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+.++.+|+.+||+.||.+|||+.+|+++
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=452.15 Aligned_cols=256 Identities=21% Similarity=0.389 Sum_probs=224.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCC-----eEEEEEEEecccccHHHHHHHHHHHHHHHhcCC-CCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIER-----KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN-PYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H-PNIVkl~~~~~d 83 (644)
...++|++.++||+|+||.||+|.+..++ +.||+|++..... ....+.+.+|+++|+++.| ||||+++++|.+
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 34579999999999999999999987653 6799999976543 3445779999999999965 899999999887
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT 149 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~ 149 (644)
.+..+|||||||+||+|.++|+... ...+++..+..|+.||+.||.|||+++||||||||+|||++
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 6677999999999999999998643 23589999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCC-hHHHHH
Q 006460 150 KDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPD-MAGLIN 224 (644)
Q Consensus 150 ~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~-~~el~~ 224 (644)
.++.+||+|||+|+.+.... .....+||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.. ...+..
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998764432 2345689999999999999999999999999999999998 999998865 455667
Q ss_pred HHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 225 KINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 225 ~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+..+...+.|..+++++.+||.+||+.||.+|||+.+|++|
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 777777778899999999999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=431.88 Aligned_cols=261 Identities=23% Similarity=0.480 Sum_probs=238.5
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
....+++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+++|+.++||||+++++++.. ...
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~ 88 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKT 88 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCE
Confidence 3456899999999999999999999999999999999998876666667889999999999999999999998765 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999999999764 3599999999999999999999999999999999999999999999999999988766
Q ss_pred ccccccccCCCCCCChhhhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYG-YKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys-~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
.......+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+...+...+..... ..|..++.++.+||
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 245 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLL 245 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHH
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHH
Confidence 6666778999999999999988875 899999999999999999999999999988888877654 46778899999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+||..||.+|||+.++++||||+..
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 99999999999999999999999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=429.26 Aligned_cols=275 Identities=27% Similarity=0.513 Sum_probs=237.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
..+++|++++.||+|+||.||+|.++.+++.||+|+++.... .......+.+|+++|+.++||||++++++|.. ...+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 80 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEE
Confidence 357899999999999999999999999999999999976432 11224567889999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc-c
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-T 167 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~-~ 167 (644)
|+||||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... .
T Consensus 81 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999999999864 359999999999999999999999999999999999999999999999999998643 3
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...+...+..... .+|..++.++.+||.
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 237 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLA 237 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Confidence 3345678899999999999999999999999999999999999999999988888888776544 467789999999999
Q ss_pred HHhccCCCCCC-----CHHHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 248 SMLRKNPEHRP-----TASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 248 ~~L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
+||..||.+|| ++.++++||||....|..........|..|
T Consensus 238 ~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p 283 (337)
T 1o6l_A 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCC
Confidence 99999999999 999999999998766554333333334443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=434.31 Aligned_cols=276 Identities=25% Similarity=0.482 Sum_probs=232.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
+..+++|++++.||+|+||.||+|.++.+++.||+|+++.... .......+.+|.++|+.+ +|||||+++++|.+ ..
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~ 97 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PD 97 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SS
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CC
Confidence 3567899999999999999999999999999999999976532 222346678899999988 79999999999876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+|||||.||+|..++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 7999999999999999998753 59999999999999999999999999999999999999999999999999998643
Q ss_pred -cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 167 -TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 167 -~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
......+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+..... .+|..++..+.+|
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~l 254 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGI 254 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHH
Confidence 22345667899999999999998999999999999999999999999999999999888877654 3677789999999
Q ss_pred HHHHhccCCCCCCCH------HHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 246 IKSMLRKNPEHRPTA------SDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 246 I~~~L~~dP~~RpTa------~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
|++||.+||.+||++ .++++||||+...|..........|..|
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p 303 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRP 303 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccC
Confidence 999999999999998 8999999998876654333333334433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=419.48 Aligned_cols=262 Identities=25% Similarity=0.536 Sum_probs=233.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
..+++|++++.||+|+||.||+|.++.+++.||+|++....... ...+.+.+|+.+|+.++|||||+++++|.+ ...+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~ 81 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQI 81 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEE
Confidence 45789999999999999999999999999999999997653211 224567789999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 9999999999999999863 4599999999999999999999999999999999999999999999999999987543
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
...+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+.......+..... .+|..++.++.+||.+
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSR 236 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998888888876654 4677889999999999
Q ss_pred HhccCCCCCC-----CHHHHhhCCCCchhhhhcC
Q 006460 249 MLRKNPEHRP-----TASDLLRHPHLQPYLLRCQ 277 (644)
Q Consensus 249 ~L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~~~ 277 (644)
||..||.+|| +++++++||||+...|...
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~ 270 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence 9999999999 9999999999987665543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=427.46 Aligned_cols=280 Identities=24% Similarity=0.445 Sum_probs=236.7
Q ss_pred CCCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceeeeEEE
Q 006460 5 NGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKL-NNPYIVKYKDAWV 82 (644)
Q Consensus 5 ~~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~ 82 (644)
....+..+++|++++.||+|+||.||+|.++.+++.||+|++...... ......+.+|.++|..+ .||||++++++|.
T Consensus 12 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp -------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred CCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 344456789999999999999999999999999999999999765321 12245678899999988 7999999999887
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
+ ...+|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 92 ~-~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 92 T-MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp C-SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred c-CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 6 567999999999999999998643 5999999999999999999999999999999999999999999999999999
Q ss_pred cccc-cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 163 KLLN-TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 163 ~~~~-~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
+... ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+..... .+|..++.+
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~ 247 (353)
T 2i0e_A 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKE 247 (353)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHH
T ss_pred cccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHH
Confidence 8643 23345678999999999999999999999999999999999999999999999888888876654 467789999
Q ss_pred HHHHHHHHhccCCCCCCC-----HHHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 242 MKQIIKSMLRKNPEHRPT-----ASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpT-----a~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
+.+||.+||..||.+||+ +.+|++||||+...|..........|+.|
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p 299 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP 299 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCC
Confidence 999999999999999994 69999999998766654333333334433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=433.44 Aligned_cols=276 Identities=28% Similarity=0.519 Sum_probs=232.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
...+++|++++.||+|+||.||+|+++.+++.||+|++++.... ......+.+|..+|+++ +|||||+++++|.+ ..
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~ 126 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ES 126 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SS
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CC
Confidence 35678999999999999999999999999999999999876432 22345677899999887 89999999998876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc-c
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL-L 165 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~-~ 165 (644)
.+|+|||||.||+|..++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++. .
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 7999999999999999998643 599999999999999999999999999999999999999999999999999986 3
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHhccCCCCCCc
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD---------MAGLINKINRSSISPLPI 236 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~---------~~el~~~i~~~~~~~~p~ 236 (644)
.......+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.... ...+...+... ...+|.
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~ 283 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPR 283 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-CCCCCT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-ccCCCC
Confidence 34445677899999999999999999999999999999999999999996432 23344444443 345788
Q ss_pred cccHHHHHHHHHHhccCCCCCCCH------HHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTA------SDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa------~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
.++.++.+||++||++||.+||++ .+|++||||+...|..........|+.|
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p 341 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP 341 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcC
Confidence 899999999999999999999984 8999999998876654333333444444
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=420.73 Aligned_cols=264 Identities=28% Similarity=0.510 Sum_probs=229.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
...+++|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+|+++ +|||||+++++|.+ ..
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~ 83 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ES 83 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SS
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CC
Confidence 4568899999999999999999999999999999999987643 344566788999999988 89999999999876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc-
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL- 165 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~- 165 (644)
.+|+||||+.||+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 7999999999999999998643 5999999999999999999999999999999999999999999999999999863
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCC---------CChHHHHHHHhccCCCCCCc
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRA---------PDMAGLINKINRSSISPLPI 236 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~---------~~~~el~~~i~~~~~~~~p~ 236 (644)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.. .....+...+.... ..+|.
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~~p~ 240 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIPR 240 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-CCCCT
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-CCCCC
Confidence 233445677999999999999999999999999999999999999999975 23334445554443 45778
Q ss_pred cccHHHHHHHHHHhccCCCCCCCH------HHHhhCCCCchhhhhc
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTA------SDLLRHPHLQPYLLRC 276 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa------~eiL~hp~f~~~~~~~ 276 (644)
.++..+.+||.+||..||.+||++ .++++||||+.+.|..
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~ 286 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 286 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence 899999999999999999999995 8999999998766543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=424.85 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=231.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH----HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE----KFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
...++|++.+.||+|+||.||+|.++.+|+.||+|++....... ...+.+.+|+.+|+++.|||||+++++|.+ .
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~ 87 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-R 87 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-S
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-C
Confidence 45578999999999999999999999999999999997654321 124568899999999999999999999866 5
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC----CeEEeccCc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN----DIRLGDFGL 161 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g----~vKL~DFGl 161 (644)
..+|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred CEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 679999999999999999965 44699999999999999999999999999999999999998777 799999999
Q ss_pred ccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC---Cccc
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL---PIVY 238 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~---p~~~ 238 (644)
+..+.........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+........ +..+
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred ceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence 9987665556778899999999999999999999999999999999999999999999888888876654322 2457
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+..+++||.+||..||.+|||+.++|+||||+..
T Consensus 246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 8999999999999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=425.32 Aligned_cols=276 Identities=25% Similarity=0.468 Sum_probs=234.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
+..+++|++.+.||+|+||.||+|.++.+++.||+|+++..... ......+.+|..+|+.+ +||||++++++|.+ ..
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~ 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KE 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CC
Confidence 45789999999999999999999999999999999999765321 11235577899999887 89999999999876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 7999999999999999998643 59999999999999999999999999999999999999999999999999998643
Q ss_pred c-ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 167 T-EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 167 ~-~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
. .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+.... ..+|..++.++.+|
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDL 248 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHHH
Confidence 2 234567899999999999999999999999999999999999999999999888888887654 34677899999999
Q ss_pred HHHHhccCCCCCCCHH-HHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 246 IKSMLRKNPEHRPTAS-DLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~-eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
|.+||..||.+||++. ++++||||+...|..........|..|
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p 292 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRP 292 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC----
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCCcCC
Confidence 9999999999999998 999999998876554333333334333
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=422.04 Aligned_cols=261 Identities=27% Similarity=0.504 Sum_probs=234.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
...+++|++++.||+|+||.||+|.++.+++.||+|++....... ...+.+.+|+++|+.++||||++++++|.+ ...
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 115 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSN 115 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCE
Confidence 356899999999999999999999999999999999997653211 234578889999999999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999999998643 599999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
. ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+..... .+|..++.++.+||.
T Consensus 194 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLR 270 (350)
T ss_dssp C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHH
T ss_pred C--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Confidence 3 3567899999999999999999999999999999999999999999998888888877654 467789999999999
Q ss_pred HHhccCCCCCCC-----HHHHhhCCCCchhhhh
Q 006460 248 SMLRKNPEHRPT-----ASDLLRHPHLQPYLLR 275 (644)
Q Consensus 248 ~~L~~dP~~RpT-----a~eiL~hp~f~~~~~~ 275 (644)
+||..||.+||+ +.+|++||||....|.
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 999999999998 9999999999876554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=408.88 Aligned_cols=257 Identities=29% Similarity=0.556 Sum_probs=227.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
....++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.++++++|||||+++++|.. +..+
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 92 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV-GDEL 92 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEE
Confidence 345689999999999999999999999999999999997654332 3567889999999999999999999877 4569
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999999999763 4899999999999999999999999999999999999999999999999999876543
Q ss_pred c-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--CCCCccccHHHHHH
Q 006460 169 D-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--SPLPIVYSSTMKQI 245 (644)
Q Consensus 169 ~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--~~~p~~~s~~l~dL 245 (644)
. .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...........+..... ...+..++..+.+|
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 2 34557899999999999999999999999999999999999999998887776666554432 33466789999999
Q ss_pred HHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 246 IKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
|.+||..||.+|||+.++|+||||+.
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHccCChhHCcCHHHHhhChhhcc
Confidence 99999999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=421.08 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=231.5
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.++|++.+.||+|+||.||+|.++.++..||+|++..........+.+.+|+++|++|+|||||+++++|.+ ...+|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence 358999999999999999999999999999999998776666666789999999999999999999998876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC---CeEEeccCcccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN---DIRLGDFGLAKLLNTE 168 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g---~vKL~DFGls~~~~~~ 168 (644)
||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp ECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 999999999999864 34699999999999999999999999999999999999998654 5999999999887665
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC---CccccHHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL---PIVYSSTMKQI 245 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~---p~~~s~~l~dL 245 (644)
......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...+...+........ ...++.++.+|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 556678999999999999998999999999999999999999999999998888888876654322 24579999999
Q ss_pred HHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 246 IKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
|.+||..||.+|||+.++|+||||+..
T Consensus 265 i~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=414.55 Aligned_cols=258 Identities=22% Similarity=0.367 Sum_probs=230.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.++.+++.||+|++..... ....+.+|+.+|+.++||||++++++|.+ ...+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFES-MEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc---cHHHHHHHHHHHHhCCCCCCCeEeEEEec-CCEEE
Confidence 457899999999999999999999999999999999975432 24567899999999999999999999877 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC--CCCeEEeccCccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK--DNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~--~g~vKL~DFGls~~~~~ 167 (644)
+|||||+|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+..
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999999999643 346999999999999999999999999999999999999997 78999999999998766
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC---ccccHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP---IVYSSTMKQ 244 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p---~~~s~~l~d 244 (644)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+....+....+........+ ..++.++.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 65566678999999999999888999999999999999999999999999988888888776554322 357999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
||.+||..||.+|||+.++|+||||+..
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=426.09 Aligned_cols=278 Identities=24% Similarity=0.511 Sum_probs=236.7
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
.....+++|++++.||+|+||.||+|.++.+++.||+|++...... ....+.+.+|+++|+.++|||||+++++|.+ .
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~ 87 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-E 87 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-S
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-C
Confidence 3445789999999999999999999999999999999999765321 1234678899999999999999999999876 4
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+.||+|..++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 579999999999999999975 446999999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccCCCCCCChhhhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHhccCCCCCCcccc
Q 006460 166 NTEDLASSVVGTPNYMCPELLAD---IPYGYKSDIWSLGCCMFEIAAHQPAFRAP---DMAGLINKINRSSISPLPIVYS 239 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~---~~ys~ksDIWSLGvILyeLltG~~PF~~~---~~~el~~~i~~~~~~~~p~~~s 239 (644)
.........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||... ........+... ....|..++
T Consensus 166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~p~~~s 244 (384)
T 4fr4_A 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPSAWS 244 (384)
T ss_dssp CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-CCCCCTTSC
T ss_pred cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-ccCCCCcCC
Confidence 66666778899999999999864 45899999999999999999999999743 344444444433 445778899
Q ss_pred HHHHHHHHHHhccCCCCCCC-HHHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 240 STMKQIIKSMLRKNPEHRPT-ASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpT-a~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
..+.+||.+||..||.+||+ ++++++||||+...|..........|+.|
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p 294 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIP 294 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCCC
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCCC
Confidence 99999999999999999998 89999999998876654433334444444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=433.93 Aligned_cols=258 Identities=27% Similarity=0.457 Sum_probs=218.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----- 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----- 85 (644)
..++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+++|+.++|||||+++++|....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 468999999999999999999999999999999999877666666788999999999999999999999986543
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+||||||+.+ +|...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred CeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 468999999965 5666663 24899999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC----------
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP---------- 235 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p---------- 235 (644)
.........+||++|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+......+.+
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 7666667789999999999999999999999999999999999999999999877776666442211110
Q ss_pred --------------------c-----------cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 236 --------------------I-----------VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 236 --------------------~-----------~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
. ..+.++.+||.+||.+||.+|||+.|+|+||||+.+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0 0156799999999999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=420.08 Aligned_cols=264 Identities=23% Similarity=0.370 Sum_probs=224.0
Q ss_pred CCCCCeEEEEEeccC--CCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 10 SKLEDYEVIEQIGRG--AFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G--~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
...++|+++++||+| +||.||+|.++.+++.||+|++..........+.+.+|+++|+.++|||||+++++|.+ +..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-CCE
Confidence 467899999999999 99999999999999999999998877667777889999999999999999999999887 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+|||||.|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999876556799999999999999999999999999999999999999999999999999865422
Q ss_pred c--------cccccccCCCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC-------
Q 006460 168 E--------DLASSVVGTPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS------- 230 (644)
Q Consensus 168 ~--------~~~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~------- 230 (644)
. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.........+....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 1 12334588999999999987 579999999999999999999999998765444433322111
Q ss_pred --------------------------------------CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 231 --------------------------------------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 231 --------------------------------------~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
..+.+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 112345578899999999999999999999999999999865
Q ss_pred hh
Q 006460 273 LL 274 (644)
Q Consensus 273 ~~ 274 (644)
..
T Consensus 341 ~~ 342 (389)
T 3gni_B 341 KR 342 (389)
T ss_dssp --
T ss_pred hh
Confidence 43
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=403.68 Aligned_cols=258 Identities=28% Similarity=0.503 Sum_probs=220.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+++|+++++||+|+||.||+|.++.+++.||+|++............+.+|+.+|++++||||+++++++.+ +..+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEE
Confidence 579999999999999999999999999999999998776655566788899999999999999999999877 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~ 170 (644)
|||+.| +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 999965 666666543 456999999999999999999999999999999999999999999999999999876432 33
Q ss_pred cccccCCCCCCChhhhcCCC-CCcccchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHhccCCC----------------
Q 006460 171 ASSVVGTPNYMCPELLADIP-YGYKSDIWSLGCCMFEIAAHQPA-FRAPDMAGLINKINRSSIS---------------- 232 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~-ys~ksDIWSLGvILyeLltG~~P-F~~~~~~el~~~i~~~~~~---------------- 232 (644)
.....||+.|+|||++.+.. |+.++|||||||++|+|++|..| |.+.+..+.+..+......
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 45678999999999997765 89999999999999999976655 6777776666665432110
Q ss_pred ------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 233 ------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 233 ------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.....++..+.+||.+||+.||.+|||+.++|+||||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1122468899999999999999999999999999999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=422.06 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=214.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCC-ce
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKG-NC 87 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~-~~ 87 (644)
..+++|++++.||+|+||.||+|.++.+++.||+|++............+.+|+.+|+.+. |||||+++++|...+ ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3568999999999999999999999999999999999776556666778899999999997 999999999987543 47
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+|||||. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 999999996 5899998752 589999999999999999999999999999999999999999999999999986532
Q ss_pred ----------------------ccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 006460 168 ----------------------EDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLIN 224 (644)
Q Consensus 168 ----------------------~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~ 224 (644)
.......+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 122345689999999999876 678999999999999999999999999988877766
Q ss_pred HHhccCCCCC----------------------------------------------CccccHHHHHHHHHHhccCCCCCC
Q 006460 225 KINRSSISPL----------------------------------------------PIVYSSTMKQIIKSMLRKNPEHRP 258 (644)
Q Consensus 225 ~i~~~~~~~~----------------------------------------------p~~~s~~l~dLI~~~L~~dP~~Rp 258 (644)
.+......+. +..+++++.+||.+||..||.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 6643211110 115688999999999999999999
Q ss_pred CHHHHhhCCCCchhh
Q 006460 259 TASDLLRHPHLQPYL 273 (644)
Q Consensus 259 Ta~eiL~hp~f~~~~ 273 (644)
|+.++|+||||+.+.
T Consensus 322 t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 322 SANDALKHPFVSIFH 336 (388)
T ss_dssp CHHHHTTSTTTTTTC
T ss_pred CHHHHhCCHHHHHhc
Confidence 999999999998654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=411.16 Aligned_cols=265 Identities=26% Similarity=0.486 Sum_probs=222.0
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEe---cCCeEEEEEEEecccc--cHHHHHHHHHHHHHHHhcCCCCcceeeeEE
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKLNNPYIVKYKDAW 81 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~--~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~ 81 (644)
......++|++.+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|+.+|+.++||||++++++|
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 34566789999999999999999999986 6899999999976532 222345678899999999999999999998
Q ss_pred EeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 82 VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 82 ~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
.. +..+|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 91 ~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 91 QT-GGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EC-SSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred Ec-CCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 76 566999999999999999998643 589999999999999999999999999999999999999999999999999
Q ss_pred cccccc-ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccH
Q 006460 162 AKLLNT-EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240 (644)
Q Consensus 162 s~~~~~-~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~ 240 (644)
++.... .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+..... .+|..++.
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~ 246 (327)
T 3a62_A 168 CKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQ 246 (327)
T ss_dssp C----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCTTSCH
T ss_pred ccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCH
Confidence 986432 2334567899999999999998999999999999999999999999999998888888776544 46778899
Q ss_pred HHHHHHHHHhccCCCCCC-----CHHHHhhCCCCchhhhh
Q 006460 241 TMKQIIKSMLRKNPEHRP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
.+.+||.+||..||.+|| ++.++++||||+...+.
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 999999999999999999 89999999999876544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=428.88 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=230.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.++.+++.||+|++..........+.+.+|+++|+.++|||||+++++|.+ +..+|
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEE
Confidence 34578999999999999999999999999999999998876666667788999999999999999999998866 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc---CCCCeEEeccCcccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT---KDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~---~~g~vKL~DFGls~~~~ 166 (644)
+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 87 lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999999863 4699999999999999999999999999999999999998 45789999999998765
Q ss_pred ccc-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC---CCccccHHH
Q 006460 167 TED-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP---LPIVYSSTM 242 (644)
Q Consensus 167 ~~~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~---~p~~~s~~l 242 (644)
... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+....... ....+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 432 3456789999999999999899999999999999999999999999999988888887765432 224679999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+||.+||..||.+|||+.++|+||||+..
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=431.53 Aligned_cols=276 Identities=30% Similarity=0.499 Sum_probs=233.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
+...++|++++.||+|+||.||+|.++.+++.||+|++....... .....+.+|+.+|+.++|||||+++++|.+ +..
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~ 143 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRY 143 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCE
Confidence 456789999999999999999999999999999999997632211 112346789999999999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|||||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999999999752 489999999999999999999999999999999999999999999999999987654
Q ss_pred cc--ccccccCCCCCCChhhhcCCC----CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC---CCCCCccc
Q 006460 168 ED--LASSVVGTPNYMCPELLADIP----YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS---ISPLPIVY 238 (644)
Q Consensus 168 ~~--~~~~~~GT~~Y~APEvl~~~~----ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~---~~~~p~~~ 238 (644)
.. ...+.+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+....+.... ..+.+..+
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccc
Confidence 43 244678999999999998765 8899999999999999999999999999888888876532 22333468
Q ss_pred cHHHHHHHHHHhccCCCC--CCCHHHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 239 SSTMKQIIKSMLRKNPEH--RPTASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~--RpTa~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
+.++++||.+||..+|.+ ||++++|++||||+...|..........|+.|
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p 352 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP 352 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCC
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCC
Confidence 999999999999999988 99999999999998765543333333334443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=430.79 Aligned_cols=275 Identities=27% Similarity=0.526 Sum_probs=228.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
..+++|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+++|+.++||||++++++|.. ...+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~ 223 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRL 223 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-TTEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-CCEE
Confidence 456899999999999999999999999999999999976532 22334567889999999999999999999877 4569
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCcccccc-
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN- 166 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~- 166 (644)
|+||||++||+|..++.... .+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999999997643 59999999999999999999998 999999999999999999999999999998643
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...+...+..... .+|..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHH
Confidence 33345668899999999999999999999999999999999999999999998888888776554 46778899999999
Q ss_pred HHHhccCCCCCC-----CHHHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 247 KSMLRKNPEHRP-----TASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 247 ~~~L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
.+||..||.+|| |+.++++||||+...+..........|..|
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p 427 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKP 427 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccC
Confidence 999999999999 999999999998876554333333334444
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=415.37 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=196.9
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC---ceEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG---NCVC 89 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~---~~~~ 89 (644)
.+|.+.++||+|+||.||+|.+ +|+.||||++...... .....+|+..+.+++|||||++++++.+.+ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 5799999999999999999987 5889999999755322 122345677777899999999999988644 3689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN--------RVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~--------gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
||||||+||+|.++++.. .+++..+..++.|++.||.|||++ +||||||||+||||+.++.+||+|||+
T Consensus 78 lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999999753 489999999999999999999987 999999999999999999999999999
Q ss_pred cccccccc-----ccccccCCCCCCChhhhcCC------CCCcccchhhHHHHHHHHHhCCCCCCCC-------------
Q 006460 162 AKLLNTED-----LASSVVGTPNYMCPELLADI------PYGYKSDIWSLGCCMFEIAAHQPAFRAP------------- 217 (644)
Q Consensus 162 s~~~~~~~-----~~~~~~GT~~Y~APEvl~~~------~ys~ksDIWSLGvILyeLltG~~PF~~~------------- 217 (644)
++...... .....+||+.|||||++.+. .|+.++|||||||+||||+||.+||...
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98764432 12346899999999999764 3678999999999999999998766321
Q ss_pred --ChHHHHHHHhccC-CCCCCcc-----ccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 218 --DMAGLINKINRSS-ISPLPIV-----YSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 218 --~~~el~~~i~~~~-~~~~p~~-----~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
....+...+.... .+.+|.. .+..+.+|+.+||..||.+|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2234444443333 3344443 24578999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=405.27 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=218.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc---HHHHHHHHHHHHHHHhc---CCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT---EKFKRTALQEMDLISKL---NNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~---~~~~~~~~rEi~iL~~L---~HPNIVkl~~~~~d~ 84 (644)
..++|+++++||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+ .||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 458999999999999999999999999999999999754321 11123455677776665 599999999998764
Q ss_pred Cc----eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccC
Q 006460 85 GN----CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG 160 (644)
Q Consensus 85 ~~----~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFG 160 (644)
.. .+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 43 6899999995 699999987655569999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-------
Q 006460 161 LAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP------- 233 (644)
Q Consensus 161 ls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~------- 233 (644)
+++...........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+......+..+......+
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 9988766666677889999999999999999999999999999999999999999988887776664321100
Q ss_pred -------------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 234 -------------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 234 -------------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
....++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 11246789999999999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=394.19 Aligned_cols=259 Identities=29% Similarity=0.465 Sum_probs=232.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.++.++..||+|++..........+.+.+|++++++++||||+++++++.. +...|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEE
Confidence 45689999999999999999999999999999999998877666667788999999999999999999998865 56789
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC---eEEeccCcccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND---IRLGDFGLAKLLN 166 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~---vKL~DFGls~~~~ 166 (644)
+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999999998764 35999999999999999999999999999999999999987665 9999999998876
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC---CCccccHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP---LPIVYSSTMK 243 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~---~p~~~s~~l~ 243 (644)
.........||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+....... ....+++.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 6665667889999999999999999999999999999999999999999998888888776654332 2246799999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||.+||..||.+|||+.++|+||||+.
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred HHHHHHcccChhhCCCHHHHhcCccccC
Confidence 9999999999999999999999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=421.26 Aligned_cols=276 Identities=26% Similarity=0.487 Sum_probs=230.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHH-HHhcCCCCcceeeeEEEeCCc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDL-ISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~i-L~~L~HPNIVkl~~~~~d~~~ 86 (644)
+...++|++++.||+|+||.||+|+++.+++.||+|++...... ......+.+|..+ ++.++|||||+++++|.+ ..
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~ 112 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-AD 112 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SS
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CC
Confidence 45678999999999999999999999999999999999876432 2234556677776 567899999999999876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc-
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL- 165 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~- 165 (644)
.+|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 7999999999999999998643 5899999999999999999999999999999999999999999999999999863
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+..... .++..++..+.+|
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l 269 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHL 269 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-CCCSSSCHHHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHH
Confidence 333445678999999999999999999999999999999999999999999998888888876654 3567789999999
Q ss_pred HHHHhccCCCCCCCH----HHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 246 IKSMLRKNPEHRPTA----SDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 246 I~~~L~~dP~~RpTa----~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
|.+||+.||.+||++ .++++||||+...|..........|+.|
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p 316 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNP 316 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCC
Confidence 999999999999986 6999999998776654333333334444
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=407.16 Aligned_cols=259 Identities=28% Similarity=0.503 Sum_probs=215.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+++|+++++||+|+||.||+|.+. +++.||+|++............+.+|+++|++++|||||++++++.+ +..+|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEE
Confidence 57899999999999999999999985 58999999997765555556778899999999999999999998765 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
+||||+.| +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99999965 888888753 446999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--------------
Q 006460 169 DLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-------------- 233 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~-------------- 233 (644)
.......||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+....+.+..+......+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 23455689999999999876 568999999999999999999999998877665555543211111
Q ss_pred ---------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 234 ---------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 234 ---------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
....+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 112357899999999999999999999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=409.09 Aligned_cols=258 Identities=24% Similarity=0.448 Sum_probs=228.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH----HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE----KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
..++|++.+.||+|+||.||+|.++.++..||+|++....... ...+.+.+|+.+|++++||||++++++|.+ ..
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 87 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KT 87 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CC
Confidence 4468999999999999999999999999999999997653221 124568899999999999999999999876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC----CeEEeccCcc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN----DIRLGDFGLA 162 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g----~vKL~DFGls 162 (644)
.+|+||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 79999999999999999964 34699999999999999999999999999999999999999877 7999999999
Q ss_pred cccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC---Ccccc
Q 006460 163 KLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL---PIVYS 239 (644)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~---p~~~s 239 (644)
............+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+....+.+..+........ +..++
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 887655556677899999999999998999999999999999999999999999888888777765543322 23578
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 99999999999999999999999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=420.73 Aligned_cols=259 Identities=25% Similarity=0.513 Sum_probs=226.9
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
++..+++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~ 82 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PT 82 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SS
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CC
Confidence 4567899999999999999999999999999999999997543221 123568899999999999999999999876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 799999999 789999987643 59999999999999999999999999999999999999999999999999999877
Q ss_pred cccccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
........+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.....+...+... ....|..+++.+.+|
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSL 238 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHH
T ss_pred CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHH
Confidence 7666778899999999999988776 78999999999999999999999876655444443332 334677789999999
Q ss_pred HHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 246 IKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
|.+||..||.+|||+.++++||||+.
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HHHHcCCChhHCcCHHHHHhChhhcc
Confidence 99999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=401.76 Aligned_cols=259 Identities=29% Similarity=0.478 Sum_probs=217.8
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+++|+++++||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++||||++++++|.. ...+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEE
Confidence 689999999999999999999999999999999998776666667888999999999999999999999876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~ 170 (644)
|||+.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999999999998764 345999999999999999999999999999999999999999999999999999876532 33
Q ss_pred cccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-----------------
Q 006460 171 ASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----------------- 232 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~----------------- 232 (644)
.....||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+....+....+......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 456789999999999876 56899999999999999999999999988877665554321100
Q ss_pred ---CCC----------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 233 ---PLP----------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 233 ---~~p----------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+.+ ..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 000 24688899999999999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=399.44 Aligned_cols=256 Identities=27% Similarity=0.467 Sum_probs=214.7
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+++|++++.||+|+||.||+|.+ .+++.||+|++............+.+|++++++++||||+++++++.. ...+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCeEEEE
Confidence 57999999999999999999998 678999999997665444344667899999999999999999999876 4569999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~ 170 (644)
|||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp EECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 999965 999988753 346999999999999999999999999999999999999999999999999999865432 23
Q ss_pred cccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-----------------
Q 006460 171 ASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----------------- 232 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~----------------- 232 (644)
.....||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+....+.+..+......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 3456899999999998764 5899999999999999999999999988877666555321000
Q ss_pred -----------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 233 -----------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 233 -----------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.....++.++.+||.+||..||.+|||+.++|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012346899999999999999999999999999999964
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=411.78 Aligned_cols=259 Identities=27% Similarity=0.491 Sum_probs=222.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc---HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT---EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
-++|++.+.||+|+||.||+|.++.+++.||+|++...... ....+.+.+|+.+|+.++|||||+++++|.+ ...+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~ 101 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DGML 101 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEE
Confidence 46899999999999999999999999999999999754311 1124568899999999999999999999877 5679
Q ss_pred EEEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC---eEEeccCccc
Q 006460 89 CIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND---IRLGDFGLAK 163 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~---vKL~DFGls~ 163 (644)
|+|||||+|++|.+++.... +..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999999998886542 345899999999999999999999999999999999999987654 9999999998
Q ss_pred ccccccc-cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC---cccc
Q 006460 164 LLNTEDL-ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP---IVYS 239 (644)
Q Consensus 164 ~~~~~~~-~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p---~~~s 239 (644)
....... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.. ..+...+........+ ..++
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s 260 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSC
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCC
Confidence 7655432 456789999999999999999999999999999999999999998754 4555555555443322 3578
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 999999999999999999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=400.76 Aligned_cols=258 Identities=27% Similarity=0.503 Sum_probs=219.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH------------------------HHHHHHHHHHHH
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE------------------------KFKRTALQEMDL 65 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~------------------------~~~~~~~rEi~i 65 (644)
..+++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45789999999999999999999999999999999997653211 123568899999
Q ss_pred HHhcCCCCcceeeeEEEeC-CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 006460 66 ISKLNNPYIVKYKDAWVDK-GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCS 144 (644)
Q Consensus 66 L~~L~HPNIVkl~~~~~d~-~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPe 144 (644)
|++++||||+++++++.+. ...+|+||||+++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 9999999999999998763 568999999999999988653 346999999999999999999999999999999999
Q ss_pred cEEEcCCCCeEEeccCccccccccc-ccccccCCCCCCChhhhcCCC---CCcccchhhHHHHHHHHHhCCCCCCCCChH
Q 006460 145 NIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPNYMCPELLADIP---YGYKSDIWSLGCCMFEIAAHQPAFRAPDMA 220 (644)
Q Consensus 145 NILL~~~g~vKL~DFGls~~~~~~~-~~~~~~GT~~Y~APEvl~~~~---ys~ksDIWSLGvILyeLltG~~PF~~~~~~ 220 (644)
|||++.++.+||+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9999999999999999998765432 345578999999999997765 378899999999999999999999998887
Q ss_pred HHHHHHhccCCC-CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 221 GLINKINRSSIS-PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 221 el~~~i~~~~~~-~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
.....+...... +.+..++..+.+||.+||..||.+|||+.++|+||||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 777776654332 23356899999999999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=425.17 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=204.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----c
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----N 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----~ 86 (644)
..++|++++.||+|+||.||+|.++.+++.||||++..........+.+.+|+++|++++|||||+++++|.... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 447899999999999999999999999999999999776556666788999999999999999999999986432 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||+ +++|..++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999998 6799999874 4469999999999999999999999999999999999999999999999999998754
Q ss_pred cc----------------------------cccccccCCCCCCChhhh-cCCCCCcccchhhHHHHHHHHHh--------
Q 006460 167 TE----------------------------DLASSVVGTPNYMCPELL-ADIPYGYKSDIWSLGCCMFEIAA-------- 209 (644)
Q Consensus 167 ~~----------------------------~~~~~~~GT~~Y~APEvl-~~~~ys~ksDIWSLGvILyeLlt-------- 209 (644)
.. ......+||++|+|||++ .+..|+.++||||||||||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 22 123456889999999976 56679999999999999999998
Q ss_pred ---CCCCCCCCCh--------------------HHHHHHHhccC------------------------------CCCCCc
Q 006460 210 ---HQPAFRAPDM--------------------AGLINKINRSS------------------------------ISPLPI 236 (644)
Q Consensus 210 ---G~~PF~~~~~--------------------~el~~~i~~~~------------------------------~~~~p~ 236 (644)
|.++|.+.+. ...+..+.... ......
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7788866542 11222211100 000112
Q ss_pred cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhhc
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRC 276 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~~ 276 (644)
.++.++.+||.+||.+||.+|||++++|+||||+.+.+..
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 3588999999999999999999999999999998765443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=406.59 Aligned_cols=259 Identities=23% Similarity=0.443 Sum_probs=218.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
.++++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++|||||++++++.+ +...|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~ 81 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQY 81 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEE
Confidence 4689999999999999999999999999999999999765432 234567889999999999999999998766 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
+|||||.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999998864 345999999999999999999999999999999999999999999999999999865322
Q ss_pred --cccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChH--HHHHHHhccCCCCCCccccHHHH
Q 006460 169 --DLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMA--GLINKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 169 --~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~--el~~~i~~~~~~~~p~~~s~~l~ 243 (644)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||...... ............+....++..+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 23456789999999999988775 78999999999999999999999876543 22222222233333456899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+||.+||..||.+|||+.++++||||+..
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 99999999999999999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=406.95 Aligned_cols=261 Identities=26% Similarity=0.454 Sum_probs=211.3
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
....+++|+++++||+|+||.||+|.+..+++.||+|++............+.+|+++|++++|||||++++++.+ +..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-NHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-TTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-CCE
Confidence 3467889999999999999999999999999999999998776555556778899999999999999999999877 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc-----CCCCeEEeccCcc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT-----KDNDIRLGDFGLA 162 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~-----~~g~vKL~DFGls 162 (644)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999999996 5999999764 3599999999999999999999999999999999999995 4455999999999
Q ss_pred cccccc-cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC------
Q 006460 163 KLLNTE-DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL------ 234 (644)
Q Consensus 163 ~~~~~~-~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~------ 234 (644)
+.+... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+....+.+..+......+.
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 876432 234556789999999999874 489999999999999999999999999887776666543211100
Q ss_pred -----------------------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 235 -----------------------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 235 -----------------------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+..++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 11267899999999999999999999999999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=404.60 Aligned_cols=262 Identities=26% Similarity=0.433 Sum_probs=207.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
+..++|++++.||+|+||.||+|.++.+++.||+|++...... .....+.+|+++|++++|||||++++++.. +..+|
T Consensus 2 s~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~ 79 (317)
T 2pmi_A 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLT 79 (317)
T ss_dssp -----------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEE
T ss_pred CcccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEE
Confidence 3468999999999999999999999999999999999765321 223567889999999999999999998766 56799
Q ss_pred EEEeccCCCCHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARG----ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~----~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
+||||+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9999997 599999876531 35899999999999999999999999999999999999999999999999999876
Q ss_pred ccc-cccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-----------
Q 006460 166 NTE-DLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----------- 232 (644)
Q Consensus 166 ~~~-~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~----------- 232 (644)
... .......||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+....+.+..+......
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 432 23455689999999999876 46899999999999999999999999998887776665431100
Q ss_pred ----------------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 233 ----------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 233 ----------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
..+..++.++.+||.+||..||.+|||+.++|+||||+.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 011246889999999999999999999999999999987553
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=392.14 Aligned_cols=259 Identities=27% Similarity=0.501 Sum_probs=226.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
...+++|++.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.++++++||||++++++|.+ ...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATR 83 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCE
Confidence 346899999999999999999999999999999999997643222 234668899999999999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999999998653 589999999999999999999999999999999999999999999999999876544
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+..... ..|..++..+.+||.
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 S-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLIS 239 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHH
T ss_pred c-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-CCCCcCCHHHHHHHH
Confidence 3 34556899999999999999999999999999999999999999999998888887766544 467778999999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCchh
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+||..||.+|||+.++++||||+..
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHhccChhhCCCHHHHhhCccccCC
Confidence 9999999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=403.71 Aligned_cols=258 Identities=29% Similarity=0.521 Sum_probs=215.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc----
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN---- 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~---- 86 (644)
.+++|++++.||+|+||.||+|.++.+++.||+|++..... ....+.+.+|+++|++++|||||+++++|.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 45789999999999999999999999999999999976542 3345778999999999999999999999866432
Q ss_pred ----------------------------------------------------eEEEEEeccCCCCHHHHHHHhcC-CCCC
Q 006460 87 ----------------------------------------------------CVCIVTGYCEGGDMAEIIKKARG-ACFP 113 (644)
Q Consensus 87 ----------------------------------------------------~~~LVmEy~~GgsL~~~L~~~~~-~~l~ 113 (644)
++|+|||||+|++|.+++..... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 48999999999999999986432 2346
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-------------ccccccCCCCC
Q 006460 114 EEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-------------LASSVVGTPNY 180 (644)
Q Consensus 114 e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-------------~~~~~~GT~~Y 180 (644)
+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....+||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 66789999999999999999999999999999999999999999999998765431 23446799999
Q ss_pred CChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCH
Q 006460 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTA 260 (644)
Q Consensus 181 ~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa 260 (644)
+|||++.+..|+.++|||||||++|+|++|..|+.. .......+.....+..+...++.+.+||.+||..||.+|||+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 999999999999999999999999999998776532 223334444444443445567889999999999999999999
Q ss_pred HHHhhCCCCch
Q 006460 261 SDLLRHPHLQP 271 (644)
Q Consensus 261 ~eiL~hp~f~~ 271 (644)
.++|+||||+.
T Consensus 321 ~~~l~~~~f~~ 331 (332)
T 3qd2_B 321 TDIIENAIFEN 331 (332)
T ss_dssp HHHHHSTTCCC
T ss_pred HHHhhchhhhc
Confidence 99999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=388.55 Aligned_cols=258 Identities=28% Similarity=0.495 Sum_probs=229.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.+..++..+|+|++....... .+.+.+|++++++++||||++++++|.+ +..+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEE
Confidence 34578999999999999999999999999999999997654322 4568889999999999999999999876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE---cCCCCeEEeccCcccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL---TKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL---~~~g~vKL~DFGls~~~~ 166 (644)
+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999999998764 358999999999999999999999999999999999999 778899999999998877
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCc---cccHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI---VYSSTMK 243 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~---~~s~~l~ 243 (644)
.........||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+.......... .+++.+.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 66666778899999999998764 8999999999999999999999999999888888887765543222 5799999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+||.+||..||.+|||+.++|+||||+...
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=424.91 Aligned_cols=266 Identities=28% Similarity=0.474 Sum_probs=228.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
+...++|+++++||+|+||.||+|.++.+++.||+|++....... .....+.+|+.+|..++|||||+++++|.+ ...
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~ 148 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-DNN 148 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCE
Confidence 345689999999999999999999999999999999997643211 112337789999999999999999998876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|||||||.||+|.+++... ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999999753 34699999999999999999999999999999999999999999999999999986644
Q ss_pred ccc--cccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc----CCCCCCc
Q 006460 168 EDL--ASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS----SISPLPI 236 (644)
Q Consensus 168 ~~~--~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~----~~~~~p~ 236 (644)
... ....+||+.|+|||++. ...|+.++|||||||++|+|++|++||.+.+..+....+... .++..+.
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 332 34478999999999987 456899999999999999999999999999988888777542 3333334
Q ss_pred cccHHHHHHHHHHhccCCCC--CCCHHHHhhCCCCchhhhhc
Q 006460 237 VYSSTMKQIIKSMLRKNPEH--RPTASDLLRHPHLQPYLLRC 276 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~--RpTa~eiL~hp~f~~~~~~~ 276 (644)
.+++++++||++||+.+|++ |++++++++||||+...|..
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 58999999999999998888 99999999999998776553
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=419.66 Aligned_cols=265 Identities=29% Similarity=0.443 Sum_probs=227.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
...++|++++.||+|+||.||+|+++.+++.||+|++.+.... ......+.+|+.+|..++|||||+++++|.+ ...+
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-ENYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEE
Confidence 4568999999999999999999999999999999999764321 1123457789999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
||||||+.||+|.+++.+. +..+++..++.|+.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 9999999999999999864 346999999999999999999999999999999999999999999999999999876543
Q ss_pred cc--cccccCCCCCCChhhhc-------CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc----CCCCCC
Q 006460 169 DL--ASSVVGTPNYMCPELLA-------DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS----SISPLP 235 (644)
Q Consensus 169 ~~--~~~~~GT~~Y~APEvl~-------~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~----~~~~~p 235 (644)
.. ....+||+.|+|||++. ...|+.++|||||||++|+|++|++||.+.+..+....+... ..+..+
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 32 34568999999999987 356899999999999999999999999999988887777542 233344
Q ss_pred ccccHHHHHHHHHHhccCCCCC---CCHHHHhhCCCCchhhhhcC
Q 006460 236 IVYSSTMKQIIKSMLRKNPEHR---PTASDLLRHPHLQPYLLRCQ 277 (644)
Q Consensus 236 ~~~s~~l~dLI~~~L~~dP~~R---pTa~eiL~hp~f~~~~~~~~ 277 (644)
..++.++++||++||. +|.+| |+++++++||||+.+.|...
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 6789999999999998 99998 59999999999988766543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=407.50 Aligned_cols=256 Identities=27% Similarity=0.465 Sum_probs=208.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++++.||+|+||.||+|.++.+++.||+|++...... ...+.+|+.+++.++|||||+++++|.. ...+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILT-PTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEE
Confidence 4568999999999999999999999999999999999765432 2456789999999999999999999876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC--eEEeccCccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND--IRLGDFGLAKLLNT 167 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~--vKL~DFGls~~~~~ 167 (644)
+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 93 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999999997643 5999999999999999999999999999999999999987765 99999999986554
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhccCC-CCCCccccHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYK-SDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSI-SPLPIVYSST 241 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~k-sDIWSLGvILyeLltG~~PF~~~~----~~el~~~i~~~~~-~~~p~~~s~~ 241 (644)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+.. ....+..+..... .+....++..
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 250 (361)
T 3uc3_A 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence 445566789999999999988888655 899999999999999999998644 3344444443332 2233457999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+.+||.+||..||.+|||+.++++||||..
T Consensus 251 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 251 CCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 999999999999999999999999999964
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=391.53 Aligned_cols=261 Identities=28% Similarity=0.484 Sum_probs=219.4
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
.++..++|++.++||+|+||.||+|.++.++..+|+|++....... ..+.+.+|+++|++++||||++++++|.+ ...
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 94 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHN 94 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch-hHHHHHHHHHHHHhCCCchHHhHHHheec-CCe
Confidence 3456689999999999999999999999999999999997654321 24668889999999999999999999866 567
Q ss_pred EEEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc---CCCCeEEeccCcc
Q 006460 88 VCIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT---KDNDIRLGDFGLA 162 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~---~~g~vKL~DFGls 162 (644)
+|+||||+.|++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999999998653 345699999999999999999999999999999999999994 5578999999999
Q ss_pred cccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--CCccccH
Q 006460 163 KLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSS 240 (644)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~p~~~s~ 240 (644)
..+..........||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+....... ....+++
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP 253 (285)
T ss_dssp CC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred eecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH
Confidence 8776655566778999999999986 478999999999999999999999999988887777665443222 2234789
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 9999999999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=416.96 Aligned_cols=262 Identities=29% Similarity=0.463 Sum_probs=214.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----c
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----N 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----~ 86 (644)
.-++|++.+.||+|+||.||+|.++.+++.||||++..........+.+.+|+++|++++|||||++++++.... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 467999999999999999999999999999999999876556666788999999999999999999999987643 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 6999999995 699999975 4469999999999999999999999999999999999999999999999999998764
Q ss_pred ccc-----------------------ccccccCCCCCCChhhh-cCCCCCcccchhhHHHHHHHHHh-----------CC
Q 006460 167 TED-----------------------LASSVVGTPNYMCPELL-ADIPYGYKSDIWSLGCCMFEIAA-----------HQ 211 (644)
Q Consensus 167 ~~~-----------------------~~~~~~GT~~Y~APEvl-~~~~ys~ksDIWSLGvILyeLlt-----------G~ 211 (644)
... .....+||++|+|||++ .+..|+.++|||||||++|+|++ |.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 321 23667899999999986 56679999999999999999998 55
Q ss_pred CCCCCCCh-----------------HHHHHHHh------------------------ccCC-CCC-----CccccHHHHH
Q 006460 212 PAFRAPDM-----------------AGLINKIN------------------------RSSI-SPL-----PIVYSSTMKQ 244 (644)
Q Consensus 212 ~PF~~~~~-----------------~el~~~i~------------------------~~~~-~~~-----p~~~s~~l~d 244 (644)
++|.+.+. ...+..+. .... .+. ...+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 55555431 11111111 1110 000 1347899999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCchhhhh
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~ 275 (644)
||.+||..||.+|||+.++|+||||+.+.+.
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 9999999999999999999999999876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=399.06 Aligned_cols=260 Identities=24% Similarity=0.425 Sum_probs=229.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH----HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE----KFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
...++|++.+.||+|+||.||+|.++.+++.||+|++....... .....+.+|+.+|+++.||||++++++|.+ .
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 87 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-R 87 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-S
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 34578999999999999999999999999999999997653221 124568899999999999999999998866 5
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC----CeEEeccCc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN----DIRLGDFGL 161 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g----~vKL~DFGl 161 (644)
..+|+||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 679999999999999999975 34689999999999999999999999999999999999999887 799999999
Q ss_pred ccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC---Cccc
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL---PIVY 238 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~---p~~~ 238 (644)
+.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+........ +..+
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (321)
T 2a2a_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245 (321)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence 9887665555667899999999999999999999999999999999999999999988888887776544322 2457
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+..+.+||.+||..||.+|||+.++++||||+..
T Consensus 246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 8999999999999999999999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=427.26 Aligned_cols=262 Identities=25% Similarity=0.466 Sum_probs=234.7
Q ss_pred CCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 6 ~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
..-...+++|.+.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+++|+.++||||+++++++..
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~- 87 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST- 87 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence 334467899999999999999999999999999999999997653221 234578899999999999999999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...+|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 5679999999999999999964 44699999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHH
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~ 243 (644)
........+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.......+...+..... ..|..++.++.
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~ 244 (476)
T 2y94_A 166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVI 244 (476)
T ss_dssp CCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHHH
T ss_pred ccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHHH
Confidence 776666677899999999999988776 7899999999999999999999999988888888876654 46777899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||.+||..||.+|||+.++++||||+.
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 9999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=409.86 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=219.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----- 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----- 85 (644)
..++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+++|+.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 457899999999999999999999999999999999776666667788999999999999999999999987542
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 3579999999 8899999975 35899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-------------
Q 006460 166 NTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI------------- 231 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~------------- 231 (644)
.. .....+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..+.....
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 43 2456789999999999877 6799999999999999999999999999887766665533111
Q ss_pred -----------------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 232 -----------------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 232 -----------------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
......+++.+.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 112234688999999999999999999999999999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=442.50 Aligned_cols=276 Identities=24% Similarity=0.452 Sum_probs=239.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
+..+++|++++.||+|+||.||+|.++.+++.||||+++.... .....+.+.+|..+|..+ +||||++++++|.+ ..
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~ 415 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MD 415 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SS
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CC
Confidence 3568899999999999999999999999999999999976432 112345678899999987 79999999998765 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+||||||++||+|..++.... .+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 7999999999999999998753 59999999999999999999999999999999999999999999999999998632
Q ss_pred -cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 167 -TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 167 -~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
......+.+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+++..|..... .+|..++.++.+|
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 572 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAI 572 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-CCCTTSCHHHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHH
Confidence 33345678999999999999999999999999999999999999999999999999999887654 4678899999999
Q ss_pred HHHHhccCCCCCCCH-----HHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 246 IKSMLRKNPEHRPTA-----SDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 246 I~~~L~~dP~~RpTa-----~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
|++||.+||.+||++ ++|++||||+.+.|..........|+.|
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p 620 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP 620 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCC
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCC
Confidence 999999999999997 9999999999876665444444444444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=404.33 Aligned_cols=258 Identities=26% Similarity=0.455 Sum_probs=212.6
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+++|++++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+++|++++||||+++++++.. +..+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEE
Confidence 57999999999999999999999999999999999754322 122245679999999999999999999876 5669999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~ 170 (644)
|||+. ++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 99996 5999998764 446999999999999999999999999999999999999999999999999999865432 23
Q ss_pred cccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC---------------
Q 006460 171 ASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL--------------- 234 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~--------------- 234 (644)
.....||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....+......+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 445688999999999876 5689999999999999999999999999988877766644211111
Q ss_pred --------------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 235 --------------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 235 --------------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+..++.++.+||.+||..||.+|||+.++|+||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 123578899999999999999999999999999998654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=436.27 Aligned_cols=277 Identities=25% Similarity=0.461 Sum_probs=236.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
...++|++.+.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+++|+.++|||||+++++|.+ ...+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDAL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEE
Confidence 45688999999999999999999999999999999997653211 224567889999999999999999998876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||++||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999999998655556999999999999999999999999999999999999999999999999999887665
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhccCCCCCCccccHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~----~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.... ...+...+... ...++..++.++.+
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~p~~~s~~~~d 418 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYSERFSPQARS 418 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCCCCTTSCHHHHH
T ss_pred ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cccCCccCCHHHHH
Confidence 55566799999999999999899999999999999999999999998753 34444544433 34467789999999
Q ss_pred HHHHHhccCCCCCC-----CHHHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 245 IIKSMLRKNPEHRP-----TASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 245 LI~~~L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
||.+||..||.+|| ++.++++||||+...|..........|+.|
T Consensus 419 LI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p 467 (576)
T 2acx_A 419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKP 467 (576)
T ss_dssp HHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCC
Confidence 99999999999999 899999999998766554333333334433
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=386.51 Aligned_cols=255 Identities=26% Similarity=0.482 Sum_probs=220.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~ 88 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.++..+ +||||+++++++.+ ...+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeE
Confidence 456799999999999999999999999999999999987655444567788999999999 89999999999877 5679
Q ss_pred EEEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC---------------
Q 006460 89 CIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD--------------- 151 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~--------------- 151 (644)
|+||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999999998643 2568999999999999999999999999999999999999844
Q ss_pred ----CCeEEeccCcccccccccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 006460 152 ----NDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI 226 (644)
Q Consensus 152 ----g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i 226 (644)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.... ....+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~ 240 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI 240 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred cCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence 47999999999876543 335699999999999765 56789999999999999999998876543 34555
Q ss_pred hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 227 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.....+..+..++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 666677788889999999999999999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=408.46 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=212.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----- 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----- 85 (644)
..++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||++++++|...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 468999999999999999999999999999999999876555666778899999999999999999999987643
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred cceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 37899999996 478888752 4899999999999999999999999999999999999999999999999999877
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC----------
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP---------- 235 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p---------- 235 (644)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+......+.+
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 6554556678999999999999999999999999999999999999999998887776666543222111
Q ss_pred -------------------------------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 236 -------------------------------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 236 -------------------------------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
...+..+.+||.+||..||.+|||+.++|+||||+.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0125689999999999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=387.88 Aligned_cols=262 Identities=39% Similarity=0.688 Sum_probs=234.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe-CCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD-KGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d-~~~~~ 88 (644)
...++|++.+.||+|+||.||+|.++.+++.||+|++..........+.+.+|++++++++||||+++++++.+ .+..+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 46789999999999999999999999999999999998776666667889999999999999999999998765 35679
Q ss_pred EEEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccccCCCCcEEEcCCCCeEEeccCc
Q 006460 89 CIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSNR-----VLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~g-----IIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
|+||||++|++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997643 345899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccc-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccH
Q 006460 162 AKLLNTED-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240 (644)
Q Consensus 162 s~~~~~~~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~ 240 (644)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||.......+...+.......++..++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCH
Confidence 98754432 23346799999999999998999999999999999999999999999998888888888887788888999
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
++.+||.+||..||.+|||+.++++|+|+..
T Consensus 243 ~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 9999999999999999999999999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=412.55 Aligned_cols=259 Identities=24% Similarity=0.461 Sum_probs=229.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
+...++|++++.||+|+||.||+|.++.+++.||+|++..... .....+.+|+.+|+.++|||||+++++|.+ ...+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEE
Confidence 3567899999999999999999999999999999999976532 234578899999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC--CCCeEEeccCcccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK--DNDIRLGDFGLAKLLN 166 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~--~g~vKL~DFGls~~~~ 166 (644)
|+||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++...
T Consensus 124 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999999998643 346999999999999999999999999999999999999974 4679999999999876
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---CCCccccHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSSTMK 243 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---~~p~~~s~~l~ 243 (644)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+...... ..+..++.++.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 655556678999999999999999999999999999999999999999999888888877665432 23346799999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||.+||..||.+|||+.++|+||||+.
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 9999999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=400.93 Aligned_cols=253 Identities=28% Similarity=0.514 Sum_probs=219.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-----CCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-----NPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----HPNIVkl~~~~~d~ 84 (644)
..-++|+++++||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+. |||||+++++|..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~- 107 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY- 107 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-
Confidence 3457999999999999999999999999999999999643 234556778999999996 9999999999877
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC--------------
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-------------- 150 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-------------- 150 (644)
...+|+||||+ |++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 46799999999 999999998876667999999999999999999999999999999999999975
Q ss_pred -----------CCCeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh
Q 006460 151 -----------DNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM 219 (644)
Q Consensus 151 -----------~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~ 219 (644)
++.+||+|||++..... ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||.....
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 78899999999986443 34567899999999999999999999999999999999999999998887
Q ss_pred HHHHHHHhccCCCCCC----------------------------------------------ccccHHHHHHHHHHhccC
Q 006460 220 AGLINKINRSSISPLP----------------------------------------------IVYSSTMKQIIKSMLRKN 253 (644)
Q Consensus 220 ~el~~~i~~~~~~~~p----------------------------------------------~~~s~~l~dLI~~~L~~d 253 (644)
.+.+..+...... .| ...++.+.+||.+||+.|
T Consensus 265 ~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 265 MEHLAMMESIIQP-IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHTCC-CCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCC-CCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 7766655432211 11 112377889999999999
Q ss_pred CCCCCCHHHHhhCCCCc
Q 006460 254 PEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 254 P~~RpTa~eiL~hp~f~ 270 (644)
|.+|||+.++|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999995
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=403.64 Aligned_cols=262 Identities=28% Similarity=0.482 Sum_probs=221.4
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC---
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK--- 84 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~--- 84 (644)
....+++|++++.||+|+||.||+|.++.+++.||+|++............+.+|+++|+.++||||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp TSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred ccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 33578999999999999999999999999999999999976654444455678899999999999999999998764
Q ss_pred ----CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccC
Q 006460 85 ----GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG 160 (644)
Q Consensus 85 ----~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFG 160 (644)
...+|+||||+.| +|...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999965 787777643 3469999999999999999999999999999999999999999999999999
Q ss_pred cccccccc-----cccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC
Q 006460 161 LAKLLNTE-----DLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL 234 (644)
Q Consensus 161 ls~~~~~~-----~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~ 234 (644)
+++.+... .......||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99865421 23455688999999999876 4589999999999999999999999999888777766654321111
Q ss_pred Ccc-------------------------------ccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 235 PIV-------------------------------YSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 235 p~~-------------------------------~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+.. .++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 110 2677999999999999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=386.42 Aligned_cols=262 Identities=25% Similarity=0.450 Sum_probs=221.1
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
......++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 83 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-P 83 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-S
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-C
Confidence 4456789999999999999999999999999999999999764321 1234578899999999999999999998866 5
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred CeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 67999999999999999998643 5899999999999999999999999999999999999999999999999999887
Q ss_pred ccccccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
..........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.... ...|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVAT 240 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHH
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHH
Confidence 66555566789999999999988766 689999999999999999999999988888777776554 3467778999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
||.+||..||.+|||+.++++||||+..
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccC
Confidence 9999999999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=386.38 Aligned_cols=264 Identities=29% Similarity=0.506 Sum_probs=229.8
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-------ccHHHHHHHHHHHHHHHhcC-CCCcceee
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-------QTEKFKRTALQEMDLISKLN-NPYIVKYK 78 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-------~~~~~~~~~~rEi~iL~~L~-HPNIVkl~ 78 (644)
......++|++.+.||+|+||.||+|.++.+++.||+|++.... ......+.+.+|+++|+++. ||||++++
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp ----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 34567899999999999999999999999999999999997653 11234567889999999995 99999999
Q ss_pred eEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEec
Q 006460 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGD 158 (644)
Q Consensus 79 ~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~D 158 (644)
+++.. ...+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 91 DTYET-NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EEEEC-SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeecc-CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence 98865 56799999999999999999864 3589999999999999999999999999999999999999999999999
Q ss_pred cCcccccccccccccccCCCCCCChhhhc------CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC
Q 006460 159 FGLAKLLNTEDLASSVVGTPNYMCPELLA------DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS 232 (644)
Q Consensus 159 FGls~~~~~~~~~~~~~GT~~Y~APEvl~------~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~ 232 (644)
||++.............||+.|+|||++. ...++.++||||||+++|+|++|..||...........+......
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 99998876655566778999999999885 456889999999999999999999999998888777777665433
Q ss_pred C---CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 233 P---LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 233 ~---~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
. ....++..+.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 2 2246799999999999999999999999999999998654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=429.94 Aligned_cols=278 Identities=27% Similarity=0.455 Sum_probs=235.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
....++|++.+.||+|+||.||+|+++.+|+.||+|++....... .....+.+|+++|++++|||||+++++|.. ...
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~ 259 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTD 259 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCE
Confidence 356789999999999999999999999999999999997653221 224567889999999999999999998876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
+|+||||++||+|..++.... ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999999997643 346999999999999999999999999999999999999999999999999999876
Q ss_pred ccccc-cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHhccCCCCCCccccH
Q 006460 166 NTEDL-ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP----DMAGLINKINRSSISPLPIVYSS 240 (644)
Q Consensus 166 ~~~~~-~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~----~~~el~~~i~~~~~~~~p~~~s~ 240 (644)
..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+. ....+...+.... ..+|..++.
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-~~~p~~~s~ 418 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-VTYPDKFSP 418 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-CCCCTTSCH
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-cCCCcccCH
Confidence 54432 34569999999999999999999999999999999999999999875 3455666655443 346778999
Q ss_pred HHHHHHHHHhccCCCCCCC-----HHHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 241 TMKQIIKSMLRKNPEHRPT-----ASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpT-----a~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
.+.+||.+||.+||.+||+ +++|++||||+...|..........|+.|
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P 471 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVP 471 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCC
Confidence 9999999999999999996 58999999999876654333333344444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=392.60 Aligned_cols=264 Identities=22% Similarity=0.410 Sum_probs=216.8
Q ss_pred CCCCCCCCCCCCeEEE-EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeE
Q 006460 3 TENGDSKSKLEDYEVI-EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDA 80 (644)
Q Consensus 3 ~~~~~~~~~~~~Y~i~-~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~ 80 (644)
+.+.-+..+.++|++. +.||+|+||.||+|.+..+++.||+|++...... ....+.+|+++|+++ +||||++++++
T Consensus 2 ~~~~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~ 79 (316)
T 2ac3_A 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEF 79 (316)
T ss_dssp CSCSSCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCccCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3455566777899996 7899999999999999999999999999765322 245688999999985 79999999999
Q ss_pred EEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC---eEEe
Q 006460 81 WVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND---IRLG 157 (644)
Q Consensus 81 ~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~---vKL~ 157 (644)
+.+ ...+|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 80 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 80 FEE-EDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp EEE-TTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred Eee-CCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEE
Confidence 877 567999999999999999998643 5899999999999999999999999999999999999998776 9999
Q ss_pred ccCccccccccc--------ccccccCCCCCCChhhhcC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCC------
Q 006460 158 DFGLAKLLNTED--------LASSVVGTPNYMCPELLAD-----IPYGYKSDIWSLGCCMFEIAAHQPAFRAPD------ 218 (644)
Q Consensus 158 DFGls~~~~~~~--------~~~~~~GT~~Y~APEvl~~-----~~ys~ksDIWSLGvILyeLltG~~PF~~~~------ 218 (644)
|||++....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+..
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 999997653211 2234579999999999875 458899999999999999999999997754
Q ss_pred ---------hHHHHHHHhccCCCCCC----ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 219 ---------MAGLINKINRSSISPLP----IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 219 ---------~~el~~~i~~~~~~~~p----~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
...+...+...... +| ..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 237 DRGEACPACQNMLFESIQEGKYE-FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp ----CCHHHHHHHHHHHHHCCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred cccccchhHHHHHHHHHhccCcc-cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 23345555544432 33 3478999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=387.42 Aligned_cols=263 Identities=26% Similarity=0.411 Sum_probs=207.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
....++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.++..+++.++||||+++++++.+ +..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCCE
Confidence 356789999999999999999999999999999999997765544445555666666888899999999999876 4569
Q ss_pred EEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
|+||||+. ++|.+++... .+..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 5888887642 345799999999999999999999998 9999999999999999999999999999877
Q ss_pred ccccccccccCCCCCCChhhh----cCCCCCcccchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHhccC-CCCCCcccc
Q 006460 166 NTEDLASSVVGTPNYMCPELL----ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-DMAGLINKINRSS-ISPLPIVYS 239 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl----~~~~ys~ksDIWSLGvILyeLltG~~PF~~~-~~~el~~~i~~~~-~~~~p~~~s 239 (644)
..........||+.|+|||++ .+..++.++|||||||++|+|++|..||... ............. ....+..++
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 665555566899999999996 5567899999999999999999999999863 3333344433333 333345689
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
..+.+||.+||..||.+|||+.++++||||+...
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 9999999999999999999999999999997643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=387.01 Aligned_cols=259 Identities=22% Similarity=0.459 Sum_probs=229.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
...+++|++.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.++++++||||+++++++.+ ...
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 88 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKR 88 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCE
Confidence 456799999999999999999999999999999999997643221 124568899999999999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999999998653 589999999999999999999999999999999999999999999999999976544
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+..... .+|..++..+.+||.
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 244 (284)
T 2vgo_A 167 L-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDLIS 244 (284)
T ss_dssp S-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHH
T ss_pred c-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-CCCCcCCHHHHHHHH
Confidence 2 24457899999999999998999999999999999999999999999888887777765543 467778999999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCchh
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+||..||.+|||+.++++||||+..
T Consensus 245 ~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 245 KLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 9999999999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=402.96 Aligned_cols=254 Identities=27% Similarity=0.485 Sum_probs=205.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+++|++++||||++++++|.. ...+|+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEE
Confidence 45679999999999999999999999999999999976432 3557789999999999999999999876 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC---CCCeEEeccCccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK---DNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~---~g~vKL~DFGls~~~~~ 167 (644)
||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 126 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 126 VLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999999999865 345899999999999999999999999999999999999975 78999999999987766
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHhccCCC---CCCccccHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG-LINKINRSSIS---PLPIVYSSTMK 243 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~e-l~~~i~~~~~~---~~p~~~s~~l~ 243 (644)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||....... ....+...... +....++.++.
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 555667789999999999999899999999999999999999999997765544 55555544332 23356899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||.+||..||.+|||+.++|+||||+.
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=402.36 Aligned_cols=263 Identities=25% Similarity=0.452 Sum_probs=224.1
Q ss_pred CCCCeEEE-EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceE
Q 006460 11 KLEDYEVI-EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 11 ~~~~Y~i~-~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~ 88 (644)
+-++|.+. +.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.+ .||||++++++|.+ ...+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-TSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe-CCeE
Confidence 33568888 899999999999999999999999999987654433456788999999999 56999999999866 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC---CCCeEEeccCccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK---DNDIRLGDFGLAKLL 165 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~---~g~vKL~DFGls~~~ 165 (644)
|+||||+.|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 99999999999999986544567999999999999999999999999999999999999997 789999999999987
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---CCCccccHHH
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSSTM 242 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---~~p~~~s~~l 242 (644)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||......+....+...... +.+..++..+
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence 6655556678999999999999999999999999999999999999999998888777776654332 2334689999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
.+||.+||..||.+|||+.++|+||||+...+
T Consensus 265 ~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred HHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 99999999999999999999999999986543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=387.39 Aligned_cols=260 Identities=29% Similarity=0.556 Sum_probs=201.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE-KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
+..+++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|++++++++||||+++++++.+ ...
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 85 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNY 85 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCe
Confidence 456789999999999999999999999999999999997543221 224678899999999999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999999999753 35699999999999999999999999999999999999999999999999999987643
Q ss_pred c-cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 168 E-DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 168 ~-~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
. .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+.... ...|..++.++.+||
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li 243 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSFLSIEAKDLI 243 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC-CCCCTTSCHHHHHHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc-cCCccccCHHHHHHH
Confidence 2 22345679999999999998889999999999999999999999998877655555544333 245677899999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCch
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+||..||.+|||+.++++||||..
T Consensus 244 ~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred HHHcccCHhhCCCHHHHhcCccccC
Confidence 9999999999999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=411.95 Aligned_cols=256 Identities=27% Similarity=0.491 Sum_probs=209.0
Q ss_pred CCCCCCeEEE-EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHh-cCCCCcceeeeEEEe---
Q 006460 9 KSKLEDYEVI-EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK-LNNPYIVKYKDAWVD--- 83 (644)
Q Consensus 9 ~~~~~~Y~i~-~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~-L~HPNIVkl~~~~~d--- 83 (644)
...+++|.+. +.||+|+||.||+|.++.+++.||+|++... ..+.+|+.++.+ ++||||++++++|..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 3567899998 6899999999999999999999999999643 245678888754 589999999998764
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC---CCCeEEeccC
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK---DNDIRLGDFG 160 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~---~g~vKL~DFG 160 (644)
...++|||||||.||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 2467999999999999999998654456999999999999999999999999999999999999997 7889999999
Q ss_pred cccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH----HHHHHHhccCCC---C
Q 006460 161 LAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA----GLINKINRSSIS---P 233 (644)
Q Consensus 161 ls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~----el~~~i~~~~~~---~ 233 (644)
+++...........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.... .....+...... +
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 998776555566789999999999999999999999999999999999999999765432 133334333322 1
Q ss_pred CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 234 ~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
....++.++.+||.+||..||.+|||+.++|+||||..
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 22468999999999999999999999999999999964
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=383.05 Aligned_cols=255 Identities=27% Similarity=0.551 Sum_probs=221.4
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC---CceEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK---GNCVC 89 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~---~~~~~ 89 (644)
..|++.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+|++++||||++++++|... ...+|
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 458999999999999999999999999999999988776666678899999999999999999999988652 46789
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCcEEEc-CCCCeEEeccCcccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR--VLHRDLKCSNIFLT-KDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g--IIHRDLKPeNILL~-~~g~vKL~DFGls~~~~ 166 (644)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999999864 35899999999999999999999999 99999999999998 78899999999997654
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhccCC-CCCCccccHHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-AGLINKINRSSI-SPLPIVYSSTMKQ 244 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~-~el~~~i~~~~~-~~~p~~~s~~l~d 244 (644)
. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ......+..... ...+..+++++.+
T Consensus 184 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 261 (290)
T 1t4h_A 184 A-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred c-cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHH
Confidence 4 33455689999999998875 589999999999999999999999987544 444444443322 2244567889999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
||.+||..||.+|||+.++|+||||+.
T Consensus 262 li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 262 IIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHccCChhhCCCHHHHhhCccccc
Confidence 999999999999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=394.73 Aligned_cols=252 Identities=29% Similarity=0.518 Sum_probs=211.3
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.++||+|+||.||+|.+..+++.||+|++..............+|+..+.++ .|||||+++++|.+ +..+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEEEE
Confidence 679999999999999999999999999999999876655555555666677666665 89999999999876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||+ +++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 136 ~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp EECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred Eecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 9999 77999998765 456999999999999999999999999999999999999999999999999999887665556
Q ss_pred ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-CCCCccccHHHHHHHHHHh
Q 006460 172 SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI-SPLPIVYSSTMKQIIKSML 250 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~-~~~p~~~s~~l~dLI~~~L 250 (644)
....||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... ...+..... ..++..++..+.+||.+||
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L 289 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMML 289 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHS
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHc
Confidence 66789999999999887 799999999999999999999776654322 233333222 1234567899999999999
Q ss_pred ccCCCCCCCHHHHhhCCCCch
Q 006460 251 RKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..||.+|||+.++|+||||+.
T Consensus 290 ~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 290 EPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CSSTTTSCCHHHHHTSGGGSC
T ss_pred CCChhhCcCHHHHHhCccccC
Confidence 999999999999999999963
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=403.47 Aligned_cols=255 Identities=31% Similarity=0.522 Sum_probs=219.7
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
.....++|++.+.||+|+||.||+|.++.+++.||+|++...... ..+|+++|.++ +|||||+++++|.+ +.
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~-~~ 89 (342)
T 2qr7_A 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD-GK 89 (342)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC-SS
T ss_pred ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc-CC
Confidence 334567899999999999999999999999999999999765432 34588888887 79999999999866 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-C---CeEEeccCcc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-N---DIRLGDFGLA 162 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-g---~vKL~DFGls 162 (644)
.+|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+... + .+||+|||++
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 79999999999999999975 3469999999999999999999999999999999999998543 2 4999999999
Q ss_pred cccccc-cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCC---CChHHHHHHHhccCCCC---CC
Q 006460 163 KLLNTE-DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRA---PDMAGLINKINRSSISP---LP 235 (644)
Q Consensus 163 ~~~~~~-~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~---~~~~el~~~i~~~~~~~---~p 235 (644)
...... ....+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.. ....+++..+....... .+
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 876433 345567899999999999888899999999999999999999999986 45667777776665432 23
Q ss_pred ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 236 ~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..++.++.+||.+||..||.+|||+.++++||||..
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 568999999999999999999999999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=384.96 Aligned_cols=260 Identities=25% Similarity=0.457 Sum_probs=223.8
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH----HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE----KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCeE
Confidence 57999999999999999999999999999999997653221 124568899999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC----CeEEeccCcccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN----DIRLGDFGLAKL 164 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g----~vKL~DFGls~~ 164 (644)
|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999764 3589999999999999999999999999999999999999877 799999999987
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC---CccccHH
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL---PIVYSST 241 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~---p~~~s~~ 241 (644)
...........||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+........ +..++..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 7655555667899999999999988999999999999999999999999999888887777765543322 2457889
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhh
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~ 275 (644)
+.+||.+||..||.+|||+.++|+||||+....+
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 9999999999999999999999999999876544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=398.91 Aligned_cols=259 Identities=23% Similarity=0.401 Sum_probs=219.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|++++++++||||+++++++.+ ...+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEE
Confidence 57899999999999999999999999999999999998777666677788999999999999999999999876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
+||||+.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 101 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999999988887654 345999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC----------------
Q 006460 169 DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---------------- 231 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~---------------- 231 (644)
.......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+.....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 334567899999999998775 689999999999999999999999998887665554432110
Q ss_pred -----CC---------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 232 -----SP---------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 232 -----~~---------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+. ....++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 00 01246889999999999999999999999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=393.20 Aligned_cols=252 Identities=26% Similarity=0.496 Sum_probs=223.3
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEe
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
.|...+.||+|+||.||+|.++.+|+.||+|++...... ..+.+.+|+.+|++++||||++++++|.. +..+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLV-GEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEe
Confidence 488899999999999999999999999999999765432 24567889999999999999999999877 457999999
Q ss_pred ccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-ccc
Q 006460 94 YCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LAS 172 (644)
Q Consensus 94 y~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~~~ 172 (644)
|+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 123 ~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred cCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 9999999998863 359999999999999999999999999999999999999999999999999998764432 345
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--CCccccHHHHHHHHHHh
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSSTMKQIIKSML 250 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~p~~~s~~l~dLI~~~L 250 (644)
...||+.|+|||++.+..|+.++|||||||++|+|++|.+||...........+.....+. .+..++..+.+||.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 5789999999999999899999999999999999999999999988888877776654433 23457899999999999
Q ss_pred ccCCCCCCCHHHHhhCCCCch
Q 006460 251 RKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 251 ~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..||.+|||+.++++||||..
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGG
T ss_pred cCChhhCcCHHHHhcChhhcc
Confidence 999999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=391.53 Aligned_cols=262 Identities=29% Similarity=0.463 Sum_probs=222.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc---CCCCcceeeeEEEe--
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL---NNPYIVKYKDAWVD-- 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HPNIVkl~~~~~d-- 83 (644)
...++|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.+ .||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34589999999999999999999995 6789999999976543322223455677777666 89999999999862
Q ss_pred --CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 84 --KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 84 --~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
....+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 3567999999996 6999999876656699999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC----------
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---------- 231 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~---------- 231 (644)
+.............||+.|+|||++.+..++.++|||||||++|+|++|.+||.+......+..+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 9887655556677899999999999998999999999999999999999999999887776666543110
Q ss_pred ----------------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 232 ----------------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 232 ----------------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
..++..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 01234578999999999999999999999999999999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=400.21 Aligned_cols=262 Identities=24% Similarity=0.445 Sum_probs=219.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc---cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ---TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~---~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
.-++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+++|++++|||||+++++|.+ ...
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-EQY 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-CCe
Confidence 34689999999999999999999999999999999976532 23345678999999999999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhc--------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 006460 88 VCIVTGYCEGGDMAEIIKKAR--------------------------------------GACFPEEKLCKWLTQLLLAVD 129 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~--------------------------------------~~~l~e~~i~~i~~QIL~gL~ 129 (644)
+|+|||||.||+|.+++.... ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 999999999999999884110 112467889999999999999
Q ss_pred HHHHCCCccccCCCCcEEEcCCC--CeEEeccCccccccccc-----ccccccCCCCCCChhhhcC--CCCCcccchhhH
Q 006460 130 YLHSNRVLHRDLKCSNIFLTKDN--DIRLGDFGLAKLLNTED-----LASSVVGTPNYMCPELLAD--IPYGYKSDIWSL 200 (644)
Q Consensus 130 yLHs~gIIHRDLKPeNILL~~~g--~vKL~DFGls~~~~~~~-----~~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSL 200 (644)
|||++||+||||||+|||++.++ .+||+|||++..+.... ......||+.|+|||++.+ ..|+.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 89999999998653321 2345689999999999875 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC---ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 201 GCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP---IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 201 GvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p---~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
||++|+|++|..||.+....+....+......... ..++..+.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999998888877777655443222 24789999999999999999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=404.51 Aligned_cols=258 Identities=25% Similarity=0.455 Sum_probs=218.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK----- 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~----- 84 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+|+++|+.++|||||+++++|...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 356799999999999999999999999999999999865432 223699999999999999999998543
Q ss_pred --------------------------------CceEEEEEeccCCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHH
Q 006460 85 --------------------------------GNCVCIVTGYCEGGDMAEIIKK--ARGACFPEEKLCKWLTQLLLAVDY 130 (644)
Q Consensus 85 --------------------------------~~~~~LVmEy~~GgsL~~~L~~--~~~~~l~e~~i~~i~~QIL~gL~y 130 (644)
..++++||||+. ++|.+.+.. ..+..+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 235899999996 588888764 235679999999999999999999
Q ss_pred HHHCCCccccCCCCcEEEc-CCCCeEEeccCcccccccccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHH
Q 006460 131 LHSNRVLHRDLKCSNIFLT-KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIA 208 (644)
Q Consensus 131 LHs~gIIHRDLKPeNILL~-~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLl 208 (644)
||++||+||||||+|||++ .++.+||+|||+++.+..........||+.|+|||++.+. .|+.++|||||||++|+|+
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 9999999999999999998 6789999999999987666666678899999999998775 4899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhccCCCC----------------------------CCccccHHHHHHHHHHhccCCCCCCCH
Q 006460 209 AHQPAFRAPDMAGLINKINRSSISP----------------------------LPIVYSSTMKQIIKSMLRKNPEHRPTA 260 (644)
Q Consensus 209 tG~~PF~~~~~~el~~~i~~~~~~~----------------------------~p~~~s~~l~dLI~~~L~~dP~~RpTa 260 (644)
+|.+||.+....+.+..+......+ ++..++.++.+||.+||..||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 9999999988777666654311100 344578899999999999999999999
Q ss_pred HHHhhCCCCchhhh
Q 006460 261 SDLLRHPHLQPYLL 274 (644)
Q Consensus 261 ~eiL~hp~f~~~~~ 274 (644)
.++|+||||+....
T Consensus 317 ~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 317 YEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHTSGGGHHHHH
T ss_pred HHHhcCHHHHHHHh
Confidence 99999999987653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=398.11 Aligned_cols=258 Identities=28% Similarity=0.496 Sum_probs=219.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----c
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----N 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----~ 86 (644)
.-++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+++|++++||||+++++++.... .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3469999999999999999999999999999999997543 3445677899999999999999999999986543 4
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 6899999996 5999998752 49999999999999999999999999999999999999999999999999998765
Q ss_pred ccc----ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--------
Q 006460 167 TED----LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-------- 233 (644)
Q Consensus 167 ~~~----~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~-------- 233 (644)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+....+.+..+......+
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 432 2345689999999998654 458999999999999999999999999887666655543211110
Q ss_pred ----------------------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 234 ----------------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 234 ----------------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
....++.++.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 1134688999999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=405.38 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=220.8
Q ss_pred CeEE--EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 14 DYEV--IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 14 ~Y~i--~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.|.+ .+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+++|++++|||||+++++|.+ ...+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEE
Confidence 4555 6789999999999999999999999999976542 335678899999999999999999998876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE--cCCCCeEEeccCccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL--TKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL--~~~g~vKL~DFGls~~~~~~~ 169 (644)
|||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 165 ~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999999999998754 3458999999999999999999999999999999999999 456789999999999877666
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC---CccccHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL---PIVYSSTMKQII 246 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~---p~~~s~~l~dLI 246 (644)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+..+........ ...++.++.+||
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 66677899999999999988899999999999999999999999999998888888776554322 245799999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.+||..||.+|||+.++|+||||+...
T Consensus 324 ~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 999999999999999999999997654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=387.30 Aligned_cols=260 Identities=23% Similarity=0.451 Sum_probs=224.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc--HHHHHHHHHHHHHHHhcCCCCcceeeeEEEe-CCce
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT--EKFKRTALQEMDLISKLNNPYIVKYKDAWVD-KGNC 87 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~--~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d-~~~~ 87 (644)
.+++|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|++++++++||||+++++++.. ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 568999999999999999999999999999999999765322 1235678899999999999999999999864 3457
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999776 88888776666799999999999999999999999999999999999999999999999999987543
Q ss_pred c---cccccccCCCCCCChhhhcCCCC--CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 168 E---DLASSVVGTPNYMCPELLADIPY--GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 168 ~---~~~~~~~GT~~Y~APEvl~~~~y--s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
. .......||+.|+|||++.+... +.++|||||||++|+|++|..||.+.........+..... ..+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~l 240 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-AIPGDCGPPL 240 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CCCSSSCHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-CCCCccCHHH
Confidence 2 22345679999999999976543 7899999999999999999999999988888888776644 4677889999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+||.+||..||.+|||+.++++||||+..
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=395.51 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=212.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--CCcceeeeEEEeCCceE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN--PYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--PNIVkl~~~~~d~~~~~ 88 (644)
.-++|++++.||+|+||.||+|.+ .+++.||+|++............+.+|+.+|+++.| |||+++++++.. +..+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEE
Confidence 346799999999999999999988 468899999998776666667889999999999976 999999998776 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|||||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+...
T Consensus 85 ~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999995 488999999863 4699999999999999999999999999999999999997 688999999999876443
Q ss_pred c---ccccccCCCCCCChhhhcC-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHH-HhccCCC
Q 006460 169 D---LASSVVGTPNYMCPELLAD-----------IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-AGLINK-INRSSIS 232 (644)
Q Consensus 169 ~---~~~~~~GT~~Y~APEvl~~-----------~~ys~ksDIWSLGvILyeLltG~~PF~~~~~-~el~~~-i~~~~~~ 232 (644)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||..... ...+.. +......
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 2 2345689999999999865 6789999999999999999999999986432 223333 3333445
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
.+|...+..+.+||.+||..||.+|||+.++|+||||+
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 56777889999999999999999999999999999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=385.90 Aligned_cols=256 Identities=29% Similarity=0.503 Sum_probs=224.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.++++++||||++++++|.+ ...+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 82 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYY 82 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEE
Confidence 3457899999999999999999999999999999999765322 23567889999999999999999998866 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE---cCCCCeEEeccCcccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL---TKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL---~~~g~vKL~DFGls~~~~ 166 (644)
+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999999997643 58999999999999999999999999999999999999 678899999999997654
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---CCCccccHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSSTMK 243 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---~~p~~~s~~l~ 243 (644)
. .......||+.|+|||++.+..|+.++|||||||++|+|++|.+||.......+...+...... +.+..++..+.
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 161 N-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp C-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred C-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 3 2344567999999999999989999999999999999999999999998888888887765432 33456899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||.+||..||.+|||+.++|+||||+.
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=382.43 Aligned_cols=258 Identities=26% Similarity=0.523 Sum_probs=229.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFV 90 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEE
Confidence 45679999999999999999999999999999999997654 234456778899999999999999999998866 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999999998764 35899999999999999999999999999999999999999999999999999876432
Q ss_pred -cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 169 -DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 169 -~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.... ...|..++..+.+||.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQ 247 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHH
Confidence 23445679999999999999889999999999999999999999999988887777766554 3467788999999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCch
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||..||.+|||+.++++||||..
T Consensus 248 ~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 248 KMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHcccChhhCcCHHHHhhChheec
Confidence 999999999999999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=396.67 Aligned_cols=256 Identities=27% Similarity=0.494 Sum_probs=226.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc------cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ------TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK 84 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~------~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~ 84 (644)
.++|++.+.||+|+||.||+|.++.+|+.||||+++.... .....+.+.+|+.+++++ +||||++++++|..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES- 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence 3679999999999999999999999999999999976531 133456788999999999 79999999998866
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
....|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 56799999999999999999864 3599999999999999999999999999999999999999999999999999988
Q ss_pred cccccccccccCCCCCCChhhhcC------CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC---
Q 006460 165 LNTEDLASSVVGTPNYMCPELLAD------IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP--- 235 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~------~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p--- 235 (644)
+.........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||...........+.........
T Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 766656667899999999999863 35889999999999999999999999998888777777665543221
Q ss_pred ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 236 ~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
..++..+.+||.+||..||.+|||+.++|+||||+
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 35788999999999999999999999999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=391.84 Aligned_cols=253 Identities=25% Similarity=0.472 Sum_probs=214.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeC-CceE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDK-GNCV 88 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~-~~~~ 88 (644)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+++|+++. ||||+++++++.+. ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 4578999999999999999999999999999999997543 356788999999997 99999999998763 4678
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-CeEEeccCccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNT 167 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-~vKL~DFGls~~~~~ 167 (644)
++||||+.+++|..++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 109 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999998743 89999999999999999999999999999999999999777 899999999988766
Q ss_pred ccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHH-------------hccCC-
Q 006460 168 EDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAP-DMAGLINKI-------------NRSSI- 231 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~-~~~el~~~i-------------~~~~~- 231 (644)
........||+.|+|||++.+ ..|+.++|||||||++|+|++|..||... ...+.+..+ .....
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 666677889999999999877 66899999999999999999999998433 222222211 11111
Q ss_pred ----------------------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 232 ----------------------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 232 ----------------------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
...+..++.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 111233789999999999999999999999999999998643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=397.54 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=200.0
Q ss_pred CCCCeEEE---EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVI---EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~---~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~ 86 (644)
++++|.+. +.||+|+||.||+|.++.+++.||+|++.... ...+.+|+.+++.+. |||||+++++|.+ +.
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHD-QL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CC
Confidence 35678886 78999999999999999999999999997542 345678999999997 9999999999876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC---CeEEeccCccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN---DIRLGDFGLAK 163 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g---~vKL~DFGls~ 163 (644)
.+|+||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 79999999999999999986 34699999999999999999999999999999999999998766 79999999998
Q ss_pred ccccc-cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhccCCCCCC
Q 006460 164 LLNTE-DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-------MAGLINKINRSSISPLP 235 (644)
Q Consensus 164 ~~~~~-~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-------~~el~~~i~~~~~~~~p 235 (644)
..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.... ..++...+........+
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence 65433 23456789999999999999999999999999999999999999997643 34566666665543322
Q ss_pred ---ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 236 ---IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 236 ---~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..++.++.+||.+||..||.+|||+.++++||||+.
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 347999999999999999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=404.23 Aligned_cols=257 Identities=25% Similarity=0.423 Sum_probs=204.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----C
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-----G 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-----~ 85 (644)
..++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+++|+.++||||++++++|... .
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 34799999999999999999999999999999999977655556677889999999999999999999998653 2
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 7899998865 35999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC------------
Q 006460 166 NTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS------------ 232 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~------------ 232 (644)
.. .....+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..+......
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 183 AD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 43 2455789999999999877 67899999999999999999999999998877666655432110
Q ss_pred ----------CC--------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 233 ----------PL--------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 233 ----------~~--------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.. ....++.+.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 00 123578899999999999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=394.74 Aligned_cols=260 Identities=31% Similarity=0.502 Sum_probs=222.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+++|++++||||++++++|.. +..+|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEIS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCEEE
Confidence 45679999999999999999999999999999999997653 34556788999999999999999999999877 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
+||||++|++|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 108 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp EEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 9999999999999998753 589999999999999999999996 999999999999999999999999999976543
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH------------------------
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLIN------------------------ 224 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~------------------------ 224 (644)
.......||+.|+|||++.+..|+.++|||||||++|+|++|..||...+......
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 23455789999999999999999999999999999999999999998766544322
Q ss_pred ------------------HHhccCCCCCC-ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 225 ------------------KINRSSISPLP-IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 225 ------------------~i~~~~~~~~p-~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
.+........+ ..++.++.+||.+||..||.+|||+.++|+||||+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 22222222222 347889999999999999999999999999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=405.95 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=217.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc------CCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL------NNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L------~HPNIVkl~~~~~d~ 84 (644)
...+|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+++++.+ +||||++++++|..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~- 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF- 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-
Confidence 346799999999999999999999999999999999754 23455677788888877 57899999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC--eEEeccCcc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND--IRLGDFGLA 162 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~--vKL~DFGls 162 (644)
...+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 171 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 46799999999 469999998766667999999999999999999999999999999999999999887 999999999
Q ss_pred cccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC---------
Q 006460 163 KLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--------- 233 (644)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--------- 233 (644)
+.... ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 250 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 250 CYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp EETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred eecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 76543 3456789999999999999999999999999999999999999999988777665553221000
Q ss_pred -------------------------------------------------CCccccHHHHHHHHHHhccCCCCCCCHHHHh
Q 006460 234 -------------------------------------------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLL 264 (644)
Q Consensus 234 -------------------------------------------------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL 264 (644)
++...++.+.+||.+||+.||.+|||+.|+|
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 0112367899999999999999999999999
Q ss_pred hCCCCchhh
Q 006460 265 RHPHLQPYL 273 (644)
Q Consensus 265 ~hp~f~~~~ 273 (644)
+||||+...
T Consensus 408 ~Hpw~~~~~ 416 (429)
T 3kvw_A 408 RHPWLRRRL 416 (429)
T ss_dssp TSTTTC---
T ss_pred CChhhccCC
Confidence 999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=391.39 Aligned_cols=258 Identities=26% Similarity=0.524 Sum_probs=229.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||++++++|.+ ...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeE
Confidence 34578999999999999999999999999999999997653 234456778899999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 117 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999999998764 35899999999999999999999999999999999999999999999999999876432
Q ss_pred -cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 169 -DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 169 -~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..... .++..++..+.+||.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 273 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQ 273 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-CCCccCCHHHHHHHH
Confidence 234556899999999999998999999999999999999999999999888777777665543 467788999999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCch
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+||..||.+|||+.++|+||||..
T Consensus 274 ~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 274 KMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHccCChhHCcCHHHHhcCccccC
Confidence 999999999999999999999964
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=391.14 Aligned_cols=262 Identities=23% Similarity=0.386 Sum_probs=220.6
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG- 85 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~- 85 (644)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|++++++++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 3456789999999999999999999999999999999997653 33455678899999999999999999999987543
Q ss_pred --ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 86 --NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 86 --~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
..+|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 24699999999999999998643 59999999999999999999999999999999999999999999999999998
Q ss_pred cccccc----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC---Cc
Q 006460 164 LLNTED----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL---PI 236 (644)
Q Consensus 164 ~~~~~~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~---p~ 236 (644)
.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......+. +.
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 654332 23346799999999999999999999999999999999999999999888777666655443321 23
Q ss_pred cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.++.++.+||.+||..||.+||++.++|.|+|++.
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 47899999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=387.00 Aligned_cols=262 Identities=27% Similarity=0.531 Sum_probs=220.5
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC-
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK- 84 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~- 84 (644)
......++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+|+.+++++ +||||++++++|...
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3445678999999999999999999999999999999999765432 34677899999999 799999999998764
Q ss_pred ----CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccC
Q 006460 85 ----GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG 160 (644)
Q Consensus 85 ----~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFG 160 (644)
...+|+||||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 4679999999999999999987655679999999999999999999999999999999999999999999999999
Q ss_pred cccccccc-cccccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-
Q 006460 161 LAKLLNTE-DLASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP- 233 (644)
Q Consensus 161 ls~~~~~~-~~~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~- 233 (644)
++...... .......||+.|+|||++. +..++.++|||||||++|+|++|.+||...........+.....+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC
Confidence 99875432 2234567999999999987 5568999999999999999999999999888777666665544332
Q ss_pred CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 234 ~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+..++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 255 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 34568999999999999999999999999999999964
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=396.82 Aligned_cols=261 Identities=28% Similarity=0.473 Sum_probs=212.7
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH---HHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE---KFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~---~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
.+...++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+++++.++||||++++++|.+
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH- 83 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-
Confidence 4567899999999999999999999999999999999997643221 223567899999999999999999999866
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...+|+||||+.+ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 4568999999975 898888653 34689999999999999999999999999999999999999999999999999987
Q ss_pred cccc-cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC----C----
Q 006460 165 LNTE-DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----L---- 234 (644)
Q Consensus 165 ~~~~-~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----~---- 234 (644)
+... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+....+.+..+......+ +
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 6433 334567899999999998654 58999999999999999999999999988877766664321110 0
Q ss_pred -------------------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 235 -------------------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 235 -------------------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
...++.++.+||.+||..||.+|||+.++|+||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 1345789999999999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=399.99 Aligned_cols=251 Identities=27% Similarity=0.441 Sum_probs=218.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH------HHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE------KFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~------~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
..++|++.+.||+|+||.||+|.++.+++.||+|++....... .....+.+|+.+|++++||||++++++|.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4568999999999999999999999999999999997654211 123356779999999999999999998866
Q ss_pred CceEEEEEeccCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 85 GNCVCIVTGYCEGG-DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 85 ~~~~~LVmEy~~Gg-sL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
...+|+||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 56799999998666 99999975 3469999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
...........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... . .......|..++.++
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~-~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------T-VEAAIHPPYLVSKEL 251 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G-TTTCCCCSSCCCHHH
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------H-HhhccCCCcccCHHH
Confidence 8776666677889999999999988877 8899999999999999999999975321 1 122233566689999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+||.+||..||.+|||+.++++||||+.
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 99999999999999999999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=384.13 Aligned_cols=256 Identities=30% Similarity=0.568 Sum_probs=230.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.-+.|++++.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+ ...+|+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-THHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-HHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEE
Confidence 3467999999999999999999999999999999997654322 34678899999999999999999999877 467999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
||||+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 98 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 9999999999999863 459999999999999999999999999999999999999999999999999998765433
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+........+..++..+.+||.+|
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHH
Confidence 23456799999999999998999999999999999999999999999888888777777777777888999999999999
Q ss_pred hccCCCCCCCHHHHhhCCCCch
Q 006460 250 LRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
|..||.+|||+.++++||||..
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHH
T ss_pred cCCChhhCcCHHHHhhChhhhc
Confidence 9999999999999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=398.98 Aligned_cols=264 Identities=26% Similarity=0.467 Sum_probs=220.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe---cCCeEEEEEEEecccc--cHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d 83 (644)
..+++|++.+.||+|+||.||+|.+. .+++.||+|+++.... .......+.+|+++|+++ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 45689999999999999999999985 4789999999865431 111234566799999999 69999999998876
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
...+|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 131 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 -ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred -CceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 567999999999999999998643 59999999999999999999999999999999999999999999999999998
Q ss_pred ccccc--cccccccCCCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhccCCCCCC
Q 006460 164 LLNTE--DLASSVVGTPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSISPLP 235 (644)
Q Consensus 164 ~~~~~--~~~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~~PF~~~~----~~el~~~i~~~~~~~~p 235 (644)
.+... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ...+...+.. ...+.+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~ 286 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYP 286 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCCCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-cCCCCC
Confidence 65432 22345689999999999985 347899999999999999999999997532 3344444433 345577
Q ss_pred ccccHHHHHHHHHHhccCCCCCC-----CHHHHhhCCCCchhhhhcC
Q 006460 236 IVYSSTMKQIIKSMLRKNPEHRP-----TASDLLRHPHLQPYLLRCQ 277 (644)
Q Consensus 236 ~~~s~~l~dLI~~~L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~~~ 277 (644)
..++..+.+||.+||..||.+|| |+.++++||||+...+...
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l 333 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 333 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHh
Confidence 78899999999999999999999 9999999999987655433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=390.35 Aligned_cols=257 Identities=20% Similarity=0.344 Sum_probs=216.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-ceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG-NCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~-~~~ 88 (644)
..-++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+++|++++||||+++++++.... ..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34578999999999999999999999999999999997643222 2456788999999999999999999987643 378
Q ss_pred EEEEeccCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE----cCCCCeEEeccCccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARG-ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL----TKDNDIRLGDFGLAK 163 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~-~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL----~~~g~vKL~DFGls~ 163 (644)
|+||||+.|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999986432 348999999999999999999999999999999999999 777789999999999
Q ss_pred ccccccccccccCCCCCCChhhhc--------CCCCCcccchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhccCC
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLA--------DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSI 231 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~--------~~~ys~ksDIWSLGvILyeLltG~~PF~~~~----~~el~~~i~~~~~ 231 (644)
............||+.|+|||++. +..|+.++|||||||++|+|++|.+||.... ..+.+..+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 876666666778999999999986 5678999999999999999999999996432 2344444433221
Q ss_pred C------------------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCC
Q 006460 232 S------------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267 (644)
Q Consensus 232 ~------------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp 267 (644)
. .++..++..+.+||.+||+.||.+|||++|+|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 1 12234567899999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=387.66 Aligned_cols=263 Identities=20% Similarity=0.352 Sum_probs=208.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCe---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERK---KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
....++|++.+.||+|+||.||+|.+..++. .||+|++..........+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3456789999999999999999999888775 8999999776544445678899999999999999999999987643
Q ss_pred c-----eEEEEEeccCCCCHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEE
Q 006460 86 N-----CVCIVTGYCEGGDMAEIIKKARG----ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRL 156 (644)
Q Consensus 86 ~-----~~~LVmEy~~GgsL~~~L~~~~~----~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL 156 (644)
. ..|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 3 23899999999999999976432 25899999999999999999999999999999999999999999999
Q ss_pred eccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCC
Q 006460 157 GDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSIS 232 (644)
Q Consensus 157 ~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~ 232 (644)
+|||+++....... .....+++.|+|||++.+..|+.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 258 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL 258 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence 99999987644332 223456788999999999999999999999999999999 99999999988888888877777
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCC-------HHHHhhCCCCch
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPT-------ASDLLRHPHLQP 271 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpT-------a~eiL~hp~f~~ 271 (644)
..+..++..+.+||.+||..||.+||| +++++.|||+..
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 259 KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 788889999999999999999999999 677788999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=378.81 Aligned_cols=258 Identities=23% Similarity=0.443 Sum_probs=219.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.+++|++.+.||+|+||.||+|.++.+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+ +...|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEE
Confidence 467899999999999999999999999999999999765432 235678899999999999999999999876 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc--
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-- 168 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-- 168 (644)
||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+...
T Consensus 83 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 83 FLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 9999999999998864 345899999999999999999999999999999999999999999999999999865332
Q ss_pred -cccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHhc-cCCCCCCccccHHHHH
Q 006460 169 -DLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMA-GLINKINR-SSISPLPIVYSSTMKQ 244 (644)
Q Consensus 169 -~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~-el~~~i~~-~~~~~~p~~~s~~l~d 244 (644)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+.. ....+.+..++..+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence 23456789999999999987765 78999999999999999999999876543 22222222 2222334568999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
||.+||..||.+|||+.++++||||+..
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 9999999999999999999999999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=401.50 Aligned_cols=253 Identities=26% Similarity=0.464 Sum_probs=213.7
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC--CCCcceeeeEEEeCCceEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN--NPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~--HPNIVkl~~~~~d~~~~~~L 90 (644)
.+|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|++|. |||||++++++.. ...+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-CCEEEE
Confidence 459999999999999999999865 889999999877666667788999999999996 5999999998776 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus 134 v~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 999 5588999999864 3689999999999999999999999999999999999995 6899999999998765432
Q ss_pred --ccccccCCCCCCChhhhcC-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhc-cCCCCC
Q 006460 170 --LASSVVGTPNYMCPELLAD-----------IPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINR-SSISPL 234 (644)
Q Consensus 170 --~~~~~~GT~~Y~APEvl~~-----------~~ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i~~-~~~~~~ 234 (644)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.... ....+..+.. .....+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 2346789999999999865 368999999999999999999999998653 3333444433 333456
Q ss_pred CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 235 p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
|...+..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 6777899999999999999999999999999999963
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=381.64 Aligned_cols=258 Identities=32% Similarity=0.585 Sum_probs=219.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++++.||+|+||.||+|.+..++..||+|++..... .....+.+|+++++.++||||+++++++.. ...+|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEE
Confidence 355799999999999999999999999999999999865432 224678889999999999999999999876 45699
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
+||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999998764 345999999999999999999999999999999999999999999999999998643221
Q ss_pred cccccccCCCCCCChhhh-----cCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC--CCccccHH
Q 006460 169 DLASSVVGTPNYMCPELL-----ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP--LPIVYSST 241 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl-----~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~--~p~~~s~~ 241 (644)
.......||+.|+|||++ .+..++.++|||||||++|+|++|.+||...+.......+....... .+..++..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence 223456799999999988 36678999999999999999999999999988877776666554332 35678999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
+.+||.+||..||.+|||+.++++||||+.
T Consensus 252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred HHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 999999999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=394.32 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=217.0
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc-----
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN----- 86 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~----- 86 (644)
-++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||++++++|...+.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 479999999999999999999999999999999998776667777889999999999999999999999876443
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||+. ++|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 2499999996 68877763 349999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-------------
Q 006460 167 TEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS------------- 232 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~------------- 232 (644)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 196 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 196 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred c--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3 2455789999999999877 67899999999999999999999999998877666655331110
Q ss_pred -----------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 233 -----------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 233 -----------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
..+..++..+.+||.+||+.||.+|||+.++|+||||+.+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 01234689999999999999999999999999999998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=381.64 Aligned_cols=260 Identities=30% Similarity=0.551 Sum_probs=227.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|++++++++||||+++++++.+ ...+|
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEE
Confidence 45679999999999999999999999999999999997665443445678899999999999999999998876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC---CCeEEeccCcccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD---NDIRLGDFGLAKLLN 166 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~---g~vKL~DFGls~~~~ 166 (644)
+||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999999987643 58999999999999999999999999999999999999754 469999999998766
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-CC--ccccHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-LP--IVYSSTMK 243 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~-~p--~~~s~~l~ 243 (644)
.........||+.|+|||++.+ .++.++||||||+++|+|++|.+||.+.........+....... .+ ..++.++.
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred CCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 5554556678999999999876 48999999999999999999999999998888888877665432 22 45799999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+||.+||..||.+|||+.++|+||||+.+.
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999999997643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=405.01 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=214.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----C
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-----G 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-----~ 85 (644)
...+|++.+.||+|+||.||+|.++.+++.||||++..... ...+|+++|+.|+|||||+++++|... .
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 34479999999999999999999999999999999865432 234699999999999999999998642 2
Q ss_pred ceEEEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-CCeEEeccCcc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLA 162 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-g~vKL~DFGls 162 (644)
.++++||||+.+ +|..++... ....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 357899999965 777766532 34579999999999999999999999999999999999999965 56899999999
Q ss_pred cccccccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc------------
Q 006460 163 KLLNTEDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS------------ 229 (644)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~------------ 229 (644)
+.+.........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 977655555667899999999998764 7999999999999999999999999988866655554321
Q ss_pred -------CCCC---------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 230 -------SISP---------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 230 -------~~~~---------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.++. ++..++.++.+||.+||.+||.+|||+.++|+||||+.+.
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0000 1234688999999999999999999999999999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=409.01 Aligned_cols=259 Identities=30% Similarity=0.494 Sum_probs=209.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc------HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT------EKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~------~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
..++|++.+.||+|+||.||+|.++.+++.||+|++...... ......+.+|+++|++++|||||+++++|..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 357899999999999999999999999999999999765321 1223357889999999999999999998643
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC---CeEEeccCc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN---DIRLGDFGL 161 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g---~vKL~DFGl 161 (644)
..+|+||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred -CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 458999999999999998864 45699999999999999999999999999999999999997554 599999999
Q ss_pred ccccccccccccccCCCCCCChhhhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHhccCCCCCC--
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLAD---IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA-GLINKINRSSISPLP-- 235 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~~---~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~-el~~~i~~~~~~~~p-- 235 (644)
++...........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||...... .+...+........+
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 998776666677899999999999853 56889999999999999999999999765432 334444444443333
Q ss_pred -ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 236 -IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 236 -~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 35789999999999999999999999999999997543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=391.68 Aligned_cols=252 Identities=27% Similarity=0.524 Sum_probs=221.2
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+.|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+++|++++|||||+++++|.. +...|+|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEEE
Confidence 459999999999999999999999999999999976533 33445778999999999999999999999877 4679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA 171 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~ 171 (644)
|||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 133 ~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~ 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---A 207 (348)
T ss_dssp EECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---B
T ss_pred EecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---C
Confidence 99996 6888888654 35699999999999999999999999999999999999999999999999999987644 2
Q ss_pred ccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-CCccccHHHHHHHH
Q 006460 172 SSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP-LPIVYSSTMKQIIK 247 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~-~p~~~s~~l~dLI~ 247 (644)
...+||+.|+|||++. +..|+.++|||||||++|+|++|.+||........+..+.....+. .+..++..+.+||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 287 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 4568999999999985 4678999999999999999999999999888777766665554333 34568999999999
Q ss_pred HHhccCCCCCCCHHHHhhCCCCc
Q 006460 248 SMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 248 ~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
+||..||.+|||+.++++||||.
T Consensus 288 ~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 288 SCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHH
T ss_pred HHcccChhhCcCHHHHhhChhhh
Confidence 99999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=395.49 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=212.3
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC--------CCCcceeeeEEEe
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN--------NPYIVKYKDAWVD 83 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~--------HPNIVkl~~~~~d 83 (644)
.++|++.++||+|+||.||+|.+..+++.||+|++... ....+.+.+|+++|+.+. ||||++++++|..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999999999999999999754 344567889999999985 7889999999873
Q ss_pred ---CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCC-------
Q 006460 84 ---KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDN------- 152 (644)
Q Consensus 84 ---~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g------- 152 (644)
.+..+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 356899999999 67777777765556799999999999999999999999 999999999999999775
Q ss_pred ------------------------------------------CeEEeccCcccccccccccccccCCCCCCChhhhcCCC
Q 006460 153 ------------------------------------------DIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIP 190 (644)
Q Consensus 153 ------------------------------------------~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ 190 (644)
.+||+|||+++..... ....+||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence 7999999999876542 45578999999999999999
Q ss_pred CCcccchhhHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcc--C--------------------------------
Q 006460 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDM------AGLINKINRS--S-------------------------------- 230 (644)
Q Consensus 191 ys~ksDIWSLGvILyeLltG~~PF~~~~~------~el~~~i~~~--~-------------------------------- 230 (644)
|+.++|||||||++|+|++|.+||..... ...+..+... .
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 99999999999999999999999976541 2222222110 0
Q ss_pred -------CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 231 -------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 231 -------~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
....+...+..+.+||.+||..||.+|||+.++|+||||+
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0012334467889999999999999999999999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=381.05 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=214.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
.-++|++++.||+|+||.||+|.+..++..||+|++.... ......+.+.+|+.++++++||||+++++++.+ +..+|
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~ 87 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYY 87 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEE
Confidence 4578999999999999999999999999999999986543 344556789999999999999999999998765 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 88 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999999998643 59999999999999999999999999999999999999999999999999998765432
Q ss_pred --ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC----CCccccHHHH
Q 006460 170 --LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----LPIVYSSTMK 243 (644)
Q Consensus 170 --~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----~p~~~s~~l~ 243 (644)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+...............+. .+..++..+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 2334679999999999999999999999999999999999999999988777665555444433 2455789999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCC
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPH 268 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~ 268 (644)
++|.+||..||.+||+..+.+.+.|
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHHhcCCHhHccccHHHHHHHH
Confidence 9999999999999995554444433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=384.05 Aligned_cols=254 Identities=24% Similarity=0.424 Sum_probs=215.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
....++|++.+.||+|+||.||+|.+ ++..||+|++..........+.+.+|+++|++++||||+++++++.. ...+
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-PPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCce
Confidence 35678999999999999999999976 68899999998776666667789999999999999999999998866 4568
Q ss_pred EEEEeccCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKAR-GACFPEEKLCKWLTQLLLAVDYLHSNR--VLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~-~~~l~e~~i~~i~~QIL~gL~yLHs~g--IIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
|+||||+.|++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999997532 123899999999999999999999999 999999999999999999999999999865
Q ss_pred cccc-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHh-ccCCCCCCccccHHHH
Q 006460 166 NTED-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKIN-RSSISPLPIVYSSTMK 243 (644)
Q Consensus 166 ~~~~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~-~~~~~~~p~~~s~~l~ 243 (644)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+. .......|..++..+.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 4332 2345689999999999999999999999999999999999999999988887777664 3445567888999999
Q ss_pred HHHHHHhccCCCCCCCHHHHhh
Q 006460 244 QIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+||.+||..||.+|||+.++++
T Consensus 270 ~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 270 AIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999997
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=387.49 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=217.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC----C
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK----G 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~----~ 85 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+++|++++||||+++++++... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 45689999999999999999999999999999999996543 344566788999999999999999999987643 2
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 67899999996 699999875 35999999999999999999999999999999999999999999999999999875
Q ss_pred cccc-----------ccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--
Q 006460 166 NTED-----------LASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI-- 231 (644)
Q Consensus 166 ~~~~-----------~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~-- 231 (644)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 4321 1234578999999998764 6789999999999999999999999998886655544322100
Q ss_pred ---------------------C--------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 232 ---------------------S--------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 232 ---------------------~--------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
. ..+..++.++.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0 01135788999999999999999999999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=394.35 Aligned_cols=255 Identities=23% Similarity=0.386 Sum_probs=225.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEec-------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKI-------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAW 81 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~ 81 (644)
...++|++.+.||+|+||.||+|.+.. ++..||+|+++... .....+.+.+|+.+|+.+ +|||||+++++|
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345799999999999999999999863 45679999997653 345567899999999999 899999999988
Q ss_pred EeCCceEEEEEeccCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEE
Q 006460 82 VDKGNCVCIVTGYCEGGDMAEIIKKARG--------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIF 147 (644)
Q Consensus 82 ~d~~~~~~LVmEy~~GgsL~~~L~~~~~--------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNIL 147 (644)
.+ ...+|+||||+.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 157 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 157 TQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp CS-SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred cc-CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 66 4568999999999999999986531 35889999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 006460 148 LTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLI 223 (644)
Q Consensus 148 L~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~ 223 (644)
++.++.+||+|||+++.+.... ......+|+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+....++.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999998654432 2234567889999999999999999999999999999999 99999999988888
Q ss_pred HHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 224 NKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 224 ~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+........|..++..+.+||.+||..||.+|||+.+++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8888887777888899999999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=389.12 Aligned_cols=259 Identities=31% Similarity=0.508 Sum_probs=215.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc------HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT------EKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~------~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+++|++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 346899999999999999999999999999999999764321 1223457889999999999999999998765
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC---eEEeccCc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND---IRLGDFGL 161 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~---vKL~DFGl 161 (644)
+. +|+||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred Cc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 33 8999999999999998864 446999999999999999999999999999999999999987664 99999999
Q ss_pred ccccccccccccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHhccCCCCCC--
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA-GLINKINRSSISPLP-- 235 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~-el~~~i~~~~~~~~p-- 235 (644)
+.............||+.|+|||++. ...|+.++|||||||++|+|++|.+||...... .+...+........+
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 98776554455678999999999874 457899999999999999999999999765432 333444444333222
Q ss_pred -ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 236 -IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 236 -~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 45789999999999999999999999999999997543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=373.03 Aligned_cols=253 Identities=24% Similarity=0.433 Sum_probs=225.0
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
.....++|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|++++++++||||+++++++.+ ...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE-QAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS-SSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEec-CCc
Confidence 3455689999999999999999999986 57789999998765443 457889999999999999999998866 456
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999999999753 34689999999999999999999999999999999999999999999999999986544
Q ss_pred cc--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 168 ED--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 168 ~~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||......+....+........+..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 238 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence 32 2334567788999999998899999999999999999999 99999999999999888887777778889999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~h 266 (644)
|+.+||..||.+|||+.++++|
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=378.56 Aligned_cols=262 Identities=24% Similarity=0.406 Sum_probs=215.9
Q ss_pred CCCCCCCCCCCCCCeEEEEEeccCCCeEEEEEEEecC---CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCccee
Q 006460 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIE---RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKY 77 (644)
Q Consensus 1 m~~~~~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl 77 (644)
|.++..+.....++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.++++++||||+++
T Consensus 3 ~~~s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~ 81 (281)
T 1mp8_A 3 MGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKL 81 (281)
T ss_dssp ------CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccccccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceE
Confidence 5566677778889999999999999999999998764 4579999886543 34456788999999999999999999
Q ss_pred eeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEe
Q 006460 78 KDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLG 157 (644)
Q Consensus 78 ~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~ 157 (644)
++++. +..+|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 82 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (281)
T 1mp8_A 82 IGVIT--ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 158 (281)
T ss_dssp EEEEC--SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEEc--cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEEC
Confidence 99874 34588999999999999999864 3468999999999999999999999999999999999999999999999
Q ss_pred ccCcccccccccc--cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCC
Q 006460 158 DFGLAKLLNTEDL--ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPL 234 (644)
Q Consensus 158 DFGls~~~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~ 234 (644)
|||+++....... .....+|+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+....+....+......+.
T Consensus 159 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~ 238 (281)
T 1mp8_A 159 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 238 (281)
T ss_dssp C-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred ccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC
Confidence 9999987654332 233456788999999998899999999999999999996 9999999888888888887777778
Q ss_pred CccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 235 p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+..++..+.+||.+||..||.+|||+.+++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88899999999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=380.09 Aligned_cols=256 Identities=29% Similarity=0.584 Sum_probs=218.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++++++||||+++++++.. ...+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEE
Confidence 456789999999999999999999999999999999976543 2457789999999999999999999877 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 101 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999999999753 4569999999999999999999999999999999999999999999999999998754432
Q ss_pred -ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC--CCCccccHHHHHHH
Q 006460 170 -LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--PLPIVYSSTMKQII 246 (644)
Q Consensus 170 -~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~--~~p~~~s~~l~dLI 246 (644)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ..+..++..+.+||
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence 234567999999999999989999999999999999999999999988776665555444322 23566899999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCch
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+||..||.+|||+.++++||||+.
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred HHHccCChhhCcCHHHHHhCHHHhc
Confidence 9999999999999999999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=382.98 Aligned_cols=261 Identities=30% Similarity=0.542 Sum_probs=199.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.++++++||||+++++++... ..+|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-DELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-SCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-CCcE
Confidence 456899999999999999999999999999999999865432 23356688999999999999999999998764 5699
Q ss_pred EEEeccCCCCHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 90 IVTGYCEGGDMAEIIKKA------RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~------~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
+||||+.|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999999999752 23458999999999999999999999999999999999999999999999999997
Q ss_pred ccccc------cccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC----
Q 006460 164 LLNTE------DLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---- 232 (644)
Q Consensus 164 ~~~~~------~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---- 232 (644)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 65432 12345679999999999875 56899999999999999999999999887765554444333222
Q ss_pred -----CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 233 -----PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 233 -----~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.....++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1234578999999999999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=380.75 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=217.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEE-ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC------CcceeeeEEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLH-KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP------YIVKYKDAWV 82 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~-k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HP------NIVkl~~~~~ 82 (644)
...++|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+++++.+.|+ +|++++++|.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3457999999999999999999998 568899999999653 33456788899999988665 4999999887
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC------------
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK------------ 150 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~------------ 150 (644)
. ...+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~-~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 88 H-HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp E-TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred c-CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 6 56799999999 899999998766567999999999999999999999999999999999999987
Q ss_pred -------CCCeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 006460 151 -------DNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLI 223 (644)
Q Consensus 151 -------~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~ 223 (644)
++.+||+|||++..... ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 66899999999987543 245678999999999999999999999999999999999999999988876655
Q ss_pred HHHhccCCC-------------------------------------------CCCccccHHHHHHHHHHhccCCCCCCCH
Q 006460 224 NKINRSSIS-------------------------------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTA 260 (644)
Q Consensus 224 ~~i~~~~~~-------------------------------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa 260 (644)
..+...... ..+...+..+.+||.+||..||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 544321110 0112246789999999999999999999
Q ss_pred HHHhhCCCCchh
Q 006460 261 SDLLRHPHLQPY 272 (644)
Q Consensus 261 ~eiL~hp~f~~~ 272 (644)
.++|+||||+..
T Consensus 324 ~ell~hp~f~~~ 335 (339)
T 1z57_A 324 REALKHPFFDLL 335 (339)
T ss_dssp HHHTTSGGGGGG
T ss_pred HHHhcCHHHHHH
Confidence 999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=388.65 Aligned_cols=255 Identities=27% Similarity=0.484 Sum_probs=217.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc-----
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN----- 86 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~----- 86 (644)
.++|.+.+.||+|+||.||+|.++.+|+.||+|++..........+.+.+|+.+|+.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 479999999999999999999999999999999998766666677889999999999999999999999876432
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 3599999996 58877663 349999999999999999999999999999999999999999999999999998754
Q ss_pred cccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc----------------
Q 006460 167 TEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS---------------- 229 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~---------------- 229 (644)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 178 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 178 AE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred CC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 32 345689999999999877 67899999999999999999999999988876655554321
Q ss_pred --------------CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 230 --------------SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 230 --------------~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.....+..++..+.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 11223346789999999999999999999999999999997643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=391.23 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=208.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG---- 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~---- 85 (644)
..+++|++.+.||+|+||.||+|.++.+++.||+|++...... .....++++.++.++||||++++++|...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 4678999999999999999999999999999999998654321 234567888889999999999999987532
Q ss_pred --ceEEEEEeccCCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccccCCCCcEEEcC-CCCeEEec
Q 006460 86 --NCVCIVTGYCEGGDMAEIIKK--ARGACFPEEKLCKWLTQLLLAVDYLH--SNRVLHRDLKCSNIFLTK-DNDIRLGD 158 (644)
Q Consensus 86 --~~~~LVmEy~~GgsL~~~L~~--~~~~~l~e~~i~~i~~QIL~gL~yLH--s~gIIHRDLKPeNILL~~-~g~vKL~D 158 (644)
.++|+||||+.+ +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 248899999976 55555443 23456899999999999999999999 999999999999999996 89999999
Q ss_pred cCcccccccccccccccCCCCCCChhhhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC------
Q 006460 159 FGLAKLLNTEDLASSVVGTPNYMCPELLADIP-YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI------ 231 (644)
Q Consensus 159 FGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~-ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~------ 231 (644)
||+++.+..........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+....+..+.+...
T Consensus 176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 99999877666666778999999999986654 89999999999999999999999999887776666543211
Q ss_pred -------------------------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 232 -------------------------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 232 -------------------------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
...+..++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 112223578999999999999999999999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=399.93 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=212.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----- 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----- 85 (644)
.-.+|++.+.||+|+||.||+|.+..++. +|+|++..... ...+|+++|+.++|||||+++++|...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 44689999999999999999999887766 88888755432 1236999999999999999999986533
Q ss_pred ceEEEEEeccCCCCHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc-CCCCeEEeccCccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKK-ARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT-KDNDIRLGDFGLAK 163 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~-~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~-~~g~vKL~DFGls~ 163 (644)
.++|+||||+.++.+..+... .....+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 348899999976544333321 2245799999999999999999999999999999999999999 78999999999998
Q ss_pred ccccccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC------------
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS------------ 230 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~------------ 230 (644)
.+..........||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 87665556678899999999998765 58999999999999999999999999988776665553311
Q ss_pred -------CC---------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 231 -------IS---------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 231 -------~~---------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
++ .++..++.++.+||.+||.+||.+|||+.++|+||||+....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00 012347889999999999999999999999999999986543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=391.59 Aligned_cols=256 Identities=22% Similarity=0.414 Sum_probs=221.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEE-----EecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVL-----HKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~-----~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d 83 (644)
...++|++.+.||+|+||.||+|. +..+++.||+|++.... .....+.+.+|+++|+++ +|||||+++++|.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 456899999999999999999999 44567899999997653 334457789999999999 78999999999888
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcC------------------------------------------------------
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARG------------------------------------------------------ 109 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~------------------------------------------------------ 109 (644)
.+..+|+|||||.||+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 77779999999999999999976432
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc---ccccccC
Q 006460 110 ----------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVG 176 (644)
Q Consensus 110 ----------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~---~~~~~~G 176 (644)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ......|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 128999999999999999999999999999999999999999999999999998653322 2344678
Q ss_pred CCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCh-HHHHHHHhccCCCCCCccccHHHHHHHHHHhccCC
Q 006460 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDM-AGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNP 254 (644)
Q Consensus 177 T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~-~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP 254 (644)
|+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+... ......+........+..+++++.+||.+||..||
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 337 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 337 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 899999999999999999999999999999998 9999987663 44555566666667788899999999999999999
Q ss_pred CCCCCHHHHhhC
Q 006460 255 EHRPTASDLLRH 266 (644)
Q Consensus 255 ~~RpTa~eiL~h 266 (644)
.+|||+.++++|
T Consensus 338 ~~Rps~~ell~~ 349 (359)
T 3vhe_A 338 SQRPTFSELVEH 349 (359)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCCCHHHHHHH
Confidence 999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=384.91 Aligned_cols=255 Identities=21% Similarity=0.347 Sum_probs=225.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEec-----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKI-----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...++|++.+.||+|+||.||+|.+.. +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV- 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-
Confidence 456899999999999999999999984 45899999997653 34456788999999999999999999998866
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR----------------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLK 142 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~----------------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLK 142 (644)
+..+|+||||+.|++|.+++.... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 556899999999999999998642 1468999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 006460 143 CSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPD 218 (644)
Q Consensus 143 PeNILL~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~ 218 (644)
|+|||++.++.+||+|||+++...... ......+|+.|+|||++.+..|+.++|||||||++|+|++ |..||.+..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999998654332 2334578899999999998899999999999999999998 999999999
Q ss_pred hHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 219 MAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 219 ~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+....+........|..++..+.+||.+||..||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999888888888777888999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=389.19 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=210.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc---------ccHHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK---------QTEKFKRTALQEMDLISKLNNPYIVKYKDA 80 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~---------~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~ 80 (644)
...++|++.+.||+|+||.||+|.+.. +..||+|++.... ......+.+.+|+++|++++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 456899999999999999999999865 8999999986532 223445788999999999999999999999
Q ss_pred EEeC----CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEE
Q 006460 81 WVDK----GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRL 156 (644)
Q Consensus 81 ~~d~----~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL 156 (644)
|... ...+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 8643 347899999996 6888888743 446999999999999999999999999999999999999999999999
Q ss_pred eccCcccccccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC----
Q 006460 157 GDFGLAKLLNTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---- 231 (644)
Q Consensus 157 ~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~---- 231 (644)
+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+.....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999987655555566789999999999877 6789999999999999999999999999887776665532111
Q ss_pred -------------------CC--------CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 232 -------------------SP--------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 232 -------------------~~--------~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.. .+..+++.+.+||.+||..||.+|||+.++|+||||+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 11 122457889999999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=395.47 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=225.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEE-----EecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVL-----HKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~-----~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...++|++++.||+|+||.||+|. +..++..||+|++.... .......+.+|+.+|++++|||||++++++.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~- 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ- 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 346789999999999999999999 55678899999996543 34445678899999999999999999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC---CeEE
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARG-----ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN---DIRL 156 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~-----~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g---~vKL 156 (644)
....|+|||||.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 4558999999999999999987542 3589999999999999999999999999999999999999655 4999
Q ss_pred eccCcccccccc---cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCC
Q 006460 157 GDFGLAKLLNTE---DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSIS 232 (644)
Q Consensus 157 ~DFGls~~~~~~---~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~ 232 (644)
+|||+++.+... .......||+.|+|||++.+..|+.++|||||||++|+|++ |.+||......++...+......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999865322 22344678999999999999899999999999999999998 99999999999999999888777
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
..+..++..+.+||.+||..||.+|||+.+|+++.++
T Consensus 306 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 306 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 7888899999999999999999999999999998665
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=380.22 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=212.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe------
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD------ 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d------ 83 (644)
..-++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 34579999999999999999999999999999999987543 3446778899999999999999999998742
Q ss_pred -------CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc-CCCCeE
Q 006460 84 -------KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT-KDNDIR 155 (644)
Q Consensus 84 -------~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~-~~g~vK 155 (644)
....+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 2367899999996 599998853 4589999999999999999999999999999999999997 567899
Q ss_pred EeccCcccccccc----cccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC
Q 006460 156 LGDFGLAKLLNTE----DLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS 230 (644)
Q Consensus 156 L~DFGls~~~~~~----~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~ 230 (644)
|+|||+++..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999876432 22345678999999998865 678999999999999999999999999888776665554321
Q ss_pred CC-----------------------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 231 IS-----------------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 231 ~~-----------------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.. ..+..++.++.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 10 01234789999999999999999999999999999997543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=385.48 Aligned_cols=254 Identities=21% Similarity=0.381 Sum_probs=222.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCe---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERK---KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
...++|++.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+|++++||||++++++|.+ +.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 123 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GR 123 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CC
Confidence 456799999999999999999999986654 59999997543 34456788999999999999999999998865 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred ccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 789999999999999999753 3469999999999999999999999999999999999999999999999999998764
Q ss_pred ccc----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 167 TED----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 167 ~~~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
... ......+|+.|+|||++.+..|+.++|||||||++|+|++ |..||......+....+......+.+..++..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence 432 1223456778999999998899999999999999999998 99999999999999998888777888899999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+.+||.+||..||.+|||+.++++.
T Consensus 283 l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=369.69 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=224.6
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
+.....++|++.+.||+|+||.||+|.++ ++..||+|++....... ..+.+|++++++++||||+++++++.+ ..
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 76 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSK-EY 76 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ceEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEcc-CC
Confidence 44567789999999999999999999765 57789999997665443 457889999999999999999998765 55
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred ceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 6999999999999999998653 358999999999999999999999999999999999999999999999999998764
Q ss_pred cccc--cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHH
Q 006460 167 TEDL--ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 167 ~~~~--~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~ 243 (644)
.... .....+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...........+........|..+++.+.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIY 235 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHH
Confidence 4322 233456778999999998889999999999999999998 9999999998888888888877777888899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhC
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+||.+||..||.+|||+.+++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=405.61 Aligned_cols=252 Identities=14% Similarity=0.126 Sum_probs=205.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHH---HHHHhcCCCCcceee-------e
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEM---DLISKLNNPYIVKYK-------D 79 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi---~iL~~L~HPNIVkl~-------~ 79 (644)
..++|++.+.||+|+||.||+|.++.+++.||||++.... ......+.+.+|+ ++|++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3578999999999999999999999999999999997542 2233456788999 555566899999998 6
Q ss_pred EEEeCCc----------------eEEEEEeccCCCCHHHHHHHhcCCCCCH-------HHHHHHHHHHHHHHHHHHHCCC
Q 006460 80 AWVDKGN----------------CVCIVTGYCEGGDMAEIIKKARGACFPE-------EKLCKWLTQLLLAVDYLHSNRV 136 (644)
Q Consensus 80 ~~~d~~~----------------~~~LVmEy~~GgsL~~~L~~~~~~~l~e-------~~i~~i~~QIL~gL~yLHs~gI 136 (644)
++.+.+. ..||||||+ +|+|.+++..... +++ ..++.|+.||+.||.|||++||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS--HSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH--TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc--cccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 6554322 388999999 6899999986532 444 7888899999999999999999
Q ss_pred ccccCCCCcEEEcCCCCeEEeccCcccccccccccccccCCCCCCChhhhcCC-----------CCCcccchhhHHHHHH
Q 006460 137 LHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI-----------PYGYKSDIWSLGCCMF 205 (644)
Q Consensus 137 IHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~-----------~ys~ksDIWSLGvILy 205 (644)
+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .|+.++|||||||++|
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 9999999999999999999999999986433 3456678 999999999887 7999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 206 EIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 206 eLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+|++|.+||.+.........+.. .+..++.++.+||.+||..||.+|||+.++++||||+...
T Consensus 305 elltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHSSCCC------CCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHCCCCCcccccccchhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 99999999977654433332221 2356789999999999999999999999999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=378.17 Aligned_cols=263 Identities=25% Similarity=0.448 Sum_probs=206.5
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
....+++|++++.||+|+||.||+|.++.+++.||+|++..........+.+.++..+++.++||||+++++++.+ ...
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~ 98 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTD 98 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCc
Confidence 3457889999999999999999999999999999999998765555545555666677888999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
+|+||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 99999999 66776666543 45699999999999999999999995 99999999999999999999999999998766
Q ss_pred cccccccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHhccCCCCCC--ccc
Q 006460 167 TEDLASSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRA-PDMAGLINKINRSSISPLP--IVY 238 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~-~~~~el~~~i~~~~~~~~p--~~~ 238 (644)
.........||+.|+|||++. ...++.++|||||||++|+|++|..||.. ......+..+........+ ..+
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence 555555678999999999984 45689999999999999999999999987 3455556666555444343 357
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+..+.+||.+||..||.+|||+.++++||||+.+.
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 99999999999999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=378.81 Aligned_cols=256 Identities=21% Similarity=0.361 Sum_probs=225.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD 83 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d 83 (644)
....++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+++|++++||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 455689999999999999999999984 445899999997543 34456778999999999999999999998866
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARG----------------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDL 141 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~----------------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDL 141 (644)
...+|+||||+.|++|.+++..... ..+++..++.++.||+.||.|||++||+||||
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred -CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 4568999999999999999986432 23899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 006460 142 KCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAP 217 (644)
Q Consensus 142 KPeNILL~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~ 217 (644)
||+|||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998664332 2234567888999999998889999999999999999999 99999998
Q ss_pred ChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 218 DMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 218 ~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
....+...+........+..++..+.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8888888888777777888899999999999999999999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=370.95 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=222.5
Q ss_pred CCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 6 ~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
+......++|++++.||+|+||.||+|.+. ++..||+|++....... +.+.+|++++++++||||+++++++.+ .
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 91 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK-Q 91 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEec-C
Confidence 344466789999999999999999999776 67789999998765443 457889999999999999999998765 5
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 56999999999999999997533 35999999999999999999999999999999999999999999999999999876
Q ss_pred cccc--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 166 NTED--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 166 ~~~~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
.... ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...........+........+..++..+
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHH
Confidence 4432 2233456788999999998899999999999999999998 999999999988888888887777788889999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+||.+||..||.+|||+.++++|
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=372.02 Aligned_cols=254 Identities=32% Similarity=0.581 Sum_probs=208.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC------
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK------ 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~------ 84 (644)
..++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++++++||||++++++|.+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 346899999999999999999999999999999999643 33457788999999999999999999988653
Q ss_pred ------CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEec
Q 006460 85 ------GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGD 158 (644)
Q Consensus 85 ------~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~D 158 (644)
...+|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 35789999999999999999863 44588999999999999999999999999999999999999999999999
Q ss_pred cCcccccccc---------------cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCC-CChHH
Q 006460 159 FGLAKLLNTE---------------DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRA-PDMAG 221 (644)
Q Consensus 159 FGls~~~~~~---------------~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~-~~~~e 221 (644)
||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++ ||.. .....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9999865421 223456799999999999865 68999999999999999998 4542 23334
Q ss_pred HHHHHhccCC---CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 222 LINKINRSSI---SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 222 l~~~i~~~~~---~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
....+..... ..++...+..+.+||.+||..||.+|||+.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 4444443322 2244556788999999999999999999999999999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=381.09 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=215.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCC-eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC------cceeeeEEEe
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIER-KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY------IVKYKDAWVD 83 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg-~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPN------IVkl~~~~~d 83 (644)
..++|++.+.||+|+||.||+|.+..++ ..||+|+++.. ......+.+|+.+++.+.|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 4579999999999999999999998877 78999999653 234567788999999997665 8999988766
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE---------------
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL--------------- 148 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL--------------- 148 (644)
...+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 94 -~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 94 -HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred -CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 56799999999 7788888877655679999999999999999999999999999999999999
Q ss_pred ----cCCCCeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 006460 149 ----TKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLIN 224 (644)
Q Consensus 149 ----~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~ 224 (644)
+.++.+||+|||++..... ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||......+.+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5678999999999986443 2456789999999999999999999999999999999999999999887766554
Q ss_pred HHhccCCC-------------------------------------------CCCccccHHHHHHHHHHhccCCCCCCCHH
Q 006460 225 KINRSSIS-------------------------------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTAS 261 (644)
Q Consensus 225 ~i~~~~~~-------------------------------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~ 261 (644)
.+...... ......+..+.+||.+||..||.+|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 44322110 00112256889999999999999999999
Q ss_pred HHhhCCCCchhh
Q 006460 262 DLLRHPHLQPYL 273 (644)
Q Consensus 262 eiL~hp~f~~~~ 273 (644)
++|+||||+...
T Consensus 330 e~l~hp~f~~~~ 341 (355)
T 2eu9_A 330 EALLHPFFAGLT 341 (355)
T ss_dssp HHTTSGGGGGCC
T ss_pred HHhcChhhcCCC
Confidence 999999998654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=396.78 Aligned_cols=260 Identities=14% Similarity=0.150 Sum_probs=198.8
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhc--CCCCcceee-------eEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKL--NNPYIVKYK-------DAW 81 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L--~HPNIVkl~-------~~~ 81 (644)
..+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3469999999999999999999999999999999988654 334456677785444444 699988755 444
Q ss_pred EeCC----------------ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHCCCccc
Q 006460 82 VDKG----------------NCVCIVTGYCEGGDMAEIIKKARGACFPEEKL------CKWLTQLLLAVDYLHSNRVLHR 139 (644)
Q Consensus 82 ~d~~----------------~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i------~~i~~QIL~gL~yLHs~gIIHR 139 (644)
...+ ..+||||||+. ++|.+++..... .+++..+ ..++.||+.||.|||++||+||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 4322 34899999997 899999987532 3455555 6777999999999999999999
Q ss_pred cCCCCcEEEcCCCCeEEeccCcccccccccccccccCCCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 006460 140 DLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQPAFRAP 217 (644)
Q Consensus 140 DLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~~PF~~~ 217 (644)
||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||...
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999999876442 224567799999999987 67999999999999999999999999876
Q ss_pred ChHHH--HHH---H---hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhhh
Q 006460 218 DMAGL--INK---I---NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLR 275 (644)
Q Consensus 218 ~~~el--~~~---i---~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~~ 275 (644)
..... ... . ......+.+..++..+.+||.+||..||.+|||+.++|+||||+...+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence 42210 000 0 0011112234679999999999999999999999999999999876543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=378.33 Aligned_cols=255 Identities=20% Similarity=0.366 Sum_probs=224.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...++|++.+.||+|+||.||+|.++ .++..||+|++.... .......+.+|++++++++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ- 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc-
Confidence 44578999999999999999999887 467889999997543 33345678899999999999999999998765
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEE
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARG--------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRL 156 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~--------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL 156 (644)
+..+|+||||+.|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 5568999999999999999976431 35789999999999999999999999999999999999999999999
Q ss_pred eccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCC
Q 006460 157 GDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSIS 232 (644)
Q Consensus 157 ~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~ 232 (644)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.........+......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC
Confidence 9999998654432 2234467889999999998899999999999999999999 89999999988888888888777
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+..++..+.+||.+||..||.+|||+.+++++
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7888899999999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=389.85 Aligned_cols=258 Identities=27% Similarity=0.458 Sum_probs=222.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHH---------------HHHHHHHHHHHHHhcCCCCc
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK---------------FKRTALQEMDLISKLNNPYI 74 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~---------------~~~~~~rEi~iL~~L~HPNI 74 (644)
..+++|++.+.||+|+||.||+|.+ +++.||+|++........ ....+.+|+.++++++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 4568999999999999999999998 899999999975432210 11678889999999999999
Q ss_pred ceeeeEEEeCCceEEEEEeccCCCCHHHH------HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEE
Q 006460 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEI------IKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIF 147 (644)
Q Consensus 75 Vkl~~~~~d~~~~~~LVmEy~~GgsL~~~------L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNIL 147 (644)
+++++++.+ ...+|+||||++|++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 106 ~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 106 LTCEGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCCSEEEES-SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred ceEEEEEee-CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 999999876 5679999999999999998 654335679999999999999999999999 99999999999999
Q ss_pred EcCCCCeEEeccCcccccccccccccccCCCCCCChhhhcCC-CCCc-ccchhhHHHHHHHHHhCCCCCCCCCh-HHHHH
Q 006460 148 LTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI-PYGY-KSDIWSLGCCMFEIAAHQPAFRAPDM-AGLIN 224 (644)
Q Consensus 148 L~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~-~ys~-ksDIWSLGvILyeLltG~~PF~~~~~-~el~~ 224 (644)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|.+||..... .++..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred EcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999999999999999876543 34567899999999999887 6666 99999999999999999999988776 67777
Q ss_pred HHhccCCCCCC-------------------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 225 KINRSSISPLP-------------------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 225 ~i~~~~~~~~p-------------------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+..... ..| ..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 264 ~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 264 NIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 7665533 233 5689999999999999999999999999999999753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=367.14 Aligned_cols=253 Identities=13% Similarity=0.264 Sum_probs=221.8
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-Cc
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GN 86 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~ 86 (644)
....+++|++.+.||+|+||.||+|.+. +..||+|++..........+.+.+|+.++++++||||+++++++.+. ..
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 4567899999999999999999999985 88999999988766666677899999999999999999999998764 26
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR--VLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g--IIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
.+++||||++|++|.+++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 7899999999999999998655446999999999999999999999999 99999999999999999999999988765
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCc---ccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHh-ccCCCCCCccccH
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGY---KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKIN-RSSISPLPIVYSS 240 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~---ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~-~~~~~~~p~~~s~ 240 (644)
.. .....||+.|+|||++.+..++. ++|||||||++|+|++|..||...........+. .......+..++.
T Consensus 163 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 163 FQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp TS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred ec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 32 23467899999999998765544 8999999999999999999999888777655554 3445567788999
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+.+||.+||..||.+|||+.++++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=389.68 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=214.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CC-----CcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NP-----YIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HP-----NIVkl~~~~~d~ 84 (644)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+++++.+. |+ +|++++++|..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-
Confidence 468999999999999999999999999999999999753 234566778899988885 44 49999998877
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccccCCCCcEEEc--CCCCeEEeccC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH--SNRVLHRDLKCSNIFLT--KDNDIRLGDFG 160 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLH--s~gIIHRDLKPeNILL~--~~g~vKL~DFG 160 (644)
...+|+||||+. ++|.+++.......+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 467999999995 59999998765566999999999999999999999 57999999999999995 46789999999
Q ss_pred cccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC------
Q 006460 161 LAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL------ 234 (644)
Q Consensus 161 ls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~------ 234 (644)
+++.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 207 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (382)
T 2vx3_A 207 SSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284 (382)
T ss_dssp TCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred Cceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9987643 34567899999999999999999999999999999999999999999887777666543211000
Q ss_pred -----------Cc----------------------------------------------cccHHHHHHHHHHhccCCCCC
Q 006460 235 -----------PI----------------------------------------------VYSSTMKQIIKSMLRKNPEHR 257 (644)
Q Consensus 235 -----------p~----------------------------------------------~~s~~l~dLI~~~L~~dP~~R 257 (644)
+. ..+..+.+||.+||+.||.+|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 00 001478999999999999999
Q ss_pred CCHHHHhhCCCCch
Q 006460 258 PTASDLLRHPHLQP 271 (644)
Q Consensus 258 pTa~eiL~hp~f~~ 271 (644)
||+.++|+||||+.
T Consensus 365 pta~e~L~hp~f~~ 378 (382)
T 2vx3_A 365 IQPYYALQHSFFKK 378 (382)
T ss_dssp CCHHHHTTSGGGCC
T ss_pred CCHHHHhcCccccc
Confidence 99999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=386.80 Aligned_cols=255 Identities=23% Similarity=0.387 Sum_probs=226.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCC-------eEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIER-------KKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAW 81 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg-------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~ 81 (644)
...++|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+++++++ +|||||+++++|
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 34579999999999999999999986543 579999997653 344567889999999999 899999999988
Q ss_pred EeCCceEEEEEeccCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEE
Q 006460 82 VDKGNCVCIVTGYCEGGDMAEIIKKARG--------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIF 147 (644)
Q Consensus 82 ~d~~~~~~LVmEy~~GgsL~~~L~~~~~--------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNIL 147 (644)
.. ...+|+||||+.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 145 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 145 TQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp CS-SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred cc-CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 66 4568999999999999999987542 35899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 006460 148 LTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLI 223 (644)
Q Consensus 148 L~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~ 223 (644)
++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998765432 2334567889999999999999999999999999999999 99999999999999
Q ss_pred HHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 224 NKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 224 ~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+........+..++.++.+||.+||..||.+|||+.+++++
T Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9888887777888899999999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=372.12 Aligned_cols=255 Identities=18% Similarity=0.349 Sum_probs=228.1
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
.....++|++.+.||+|+||.||+|.++.++..||+|++..... ..+.+.+|++++++++||||+++++++.+ ...
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCC
Confidence 34567899999999999999999999999999999999975433 24668899999999999999999998765 556
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||+.|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999876666799999999999999999999999999999999999999999999999999987654
Q ss_pred cc--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 168 ED--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 168 ~~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...+.......+........+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence 32 2233457889999999998899999999999999999999 99999998888888888877777788889999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~h 266 (644)
||.+||..||.+|||+.++++.
T Consensus 244 li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 244 LMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCChhhCcCHHHHHHH
Confidence 9999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=375.20 Aligned_cols=254 Identities=23% Similarity=0.435 Sum_probs=213.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEE----EecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVL----HKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK- 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~----~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~- 84 (644)
..-++|++++.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+++|++++||||+++++++...
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 356899999999999999999998 56789999999987543 34456789999999999999999999988653
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 245899999999999999998643 3589999999999999999999999999999999999999999999999999987
Q ss_pred ccccc----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH----------------HHHH
Q 006460 165 LNTED----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA----------------GLIN 224 (644)
Q Consensus 165 ~~~~~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~----------------el~~ 224 (644)
..... ......+++.|+|||++.+..|+.++|||||||++|+|++|..||...... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 64432 223345777899999999999999999999999999999999998653321 2334
Q ss_pred HHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 225 KINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 225 ~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+......+.+..++.++.+||.+||..||.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 445555666788899999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=379.28 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=213.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+++|++++||||+++++++.+ +..+|+
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeEE
Confidence 468999999999999999999999999999999988543 34456788999999999999999999999877 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999864 44699999999999999999999999999999999999999999999999999987643321
Q ss_pred ---------------cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHH-----HHHHHhccC
Q 006460 171 ---------------ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG-----LINKINRSS 230 (644)
Q Consensus 171 ---------------~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~e-----l~~~i~~~~ 230 (644)
....+||+.|+|||++.+..|+.++|||||||++|+|++|..||....... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--
Confidence 125689999999999999999999999999999999999999986532110 0011111
Q ss_pred CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 231 ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 231 ~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
...+..++..+.+||.+||..||.+|||+.++++ |++.+
T Consensus 242 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 242 -RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp -HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred -ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 1235667889999999999999999999999986 45443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=380.42 Aligned_cols=255 Identities=21% Similarity=0.380 Sum_probs=221.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEE--EEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY--VLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~v--AiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
..+++|++.+.||+|+||.||+|.++.++..+ |+|.+.... .....+.+.+|+++|+++ +||||+++++++.+ ..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee-CC
Confidence 46689999999999999999999999999866 999886533 233456788999999999 89999999999876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC
Q 006460 87 CVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN 152 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g 152 (644)
.+|+||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 7999999999999999997532 24689999999999999999999999999999999999999999
Q ss_pred CeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCC
Q 006460 153 DIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSI 231 (644)
Q Consensus 153 ~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~ 231 (644)
.+||+|||+++............+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....+.....
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence 999999999986544333445677899999999998889999999999999999998 9999999999888888887766
Q ss_pred CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 232 SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 232 ~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
...+..++..+.+||.+||..||.+|||+.+++++
T Consensus 260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 67788899999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=383.44 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=212.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-----------CCCcceeee
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-----------NPYIVKYKD 79 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HPNIVkl~~ 79 (644)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+++++++. ||||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 4579999999999999999999999999999999997542 33466788999998886 899999999
Q ss_pred EEEeCC---ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcC-----
Q 006460 80 AWVDKG---NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTK----- 150 (644)
Q Consensus 80 ~~~d~~---~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~----- 150 (644)
++...+ ..+++||||+ |++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 987532 3789999999 99999999886666799999999999999999999998 9999999999999953
Q ss_pred -CCCeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh------HHHH
Q 006460 151 -DNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM------AGLI 223 (644)
Q Consensus 151 -~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~------~el~ 223 (644)
.+.+||+|||++..... ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||..... ...+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 34799999999987654 24556899999999999999999999999999999999999999986542 1222
Q ss_pred HHHhcc-----------------------------------------CCCCCCccccHHHHHHHHHHhccCCCCCCCHHH
Q 006460 224 NKINRS-----------------------------------------SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASD 262 (644)
Q Consensus 224 ~~i~~~-----------------------------------------~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~e 262 (644)
..+... ....++..++.++.+||.+||..||.+|||+.+
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 221110 011234456788999999999999999999999
Q ss_pred HhhCCCCchhh
Q 006460 263 LLRHPHLQPYL 273 (644)
Q Consensus 263 iL~hp~f~~~~ 273 (644)
+|+||||+...
T Consensus 331 ll~hp~f~~~~ 341 (373)
T 1q8y_A 331 LVNHPWLKDTL 341 (373)
T ss_dssp HHTCGGGTTCT
T ss_pred HhhChhhhccc
Confidence 99999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=395.46 Aligned_cols=256 Identities=28% Similarity=0.467 Sum_probs=194.6
Q ss_pred CCCeEE-EEEeccCCCeEEEEEEEe--cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe-CCce
Q 006460 12 LEDYEV-IEQIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD-KGNC 87 (644)
Q Consensus 12 ~~~Y~i-~~~LG~G~fG~Vyla~~k--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d-~~~~ 87 (644)
-+.|++ .++||+|+||.||+|.++ .+++.||+|++...... ..+.+|+.+|++|+|||||+++++|.. .+..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 345777 457999999999999976 56889999999765443 346789999999999999999999875 4568
Q ss_pred EEEEEeccCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE----cCCCCeEE
Q 006460 88 VCIVTGYCEGGDMAEIIKKAR-------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL----TKDNDIRL 156 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~-------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL----~~~g~vKL 156 (644)
+|+||||+. ++|.+++.... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 58888886432 1248999999999999999999999999999999999999 67789999
Q ss_pred eccCcccccccc----cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChH---------HH
Q 006460 157 GDFGLAKLLNTE----DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA---------GL 222 (644)
Q Consensus 157 ~DFGls~~~~~~----~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~---------el 222 (644)
+|||+++.+... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.... +.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999876432 233457899999999999874 5899999999999999999999999765532 33
Q ss_pred HHHHhccCCCCC-------------------------------------CccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 223 INKINRSSISPL-------------------------------------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 223 ~~~i~~~~~~~~-------------------------------------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+..+......+. ....+..+.+||.+||..||.+|||+.++|+
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 333321110000 0012678899999999999999999999999
Q ss_pred CCCCchh
Q 006460 266 HPHLQPY 272 (644)
Q Consensus 266 hp~f~~~ 272 (644)
||||...
T Consensus 334 hp~f~~~ 340 (405)
T 3rgf_A 334 DPYFLED 340 (405)
T ss_dssp SGGGTSS
T ss_pred ChhhccC
Confidence 9999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=372.47 Aligned_cols=259 Identities=24% Similarity=0.453 Sum_probs=215.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+++|.....||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||++++++|.+ ...++
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-CCcEE
Confidence 344555556699999999999999999999999999976532 335678899999999999999999999876 45799
Q ss_pred EEEeccCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-CCCeEEeccCccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKAR-GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-DNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~-~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-~g~vKL~DFGls~~~~~ 167 (644)
+||||+.|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999999998653 235679999999999999999999999999999999999997 89999999999987543
Q ss_pred cc-ccccccCCCCCCChhhhcCCC--CCcccchhhHHHHHHHHHhCCCCCCCCChHH--HHHHHhccCCCCCCccccHHH
Q 006460 168 ED-LASSVVGTPNYMCPELLADIP--YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAG--LINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 168 ~~-~~~~~~GT~~Y~APEvl~~~~--ys~ksDIWSLGvILyeLltG~~PF~~~~~~e--l~~~i~~~~~~~~p~~~s~~l 242 (644)
.. ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||....... ..........+.++..++.++
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence 22 234568999999999987643 8899999999999999999999997543322 222223344456778899999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
.+||.+||..||.+|||+.++|+||||+.
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 99999999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=373.51 Aligned_cols=257 Identities=22% Similarity=0.343 Sum_probs=216.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEec---CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKI---ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~---tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
...++|++.+.||+|+||.||+|.+.. ++..||+|++..........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 445799999999999999999998876 45689999998776666667789999999999999999999999876442
Q ss_pred ----eEEEEEeccCCCCHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEec
Q 006460 87 ----CVCIVTGYCEGGDMAEIIKKA----RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGD 158 (644)
Q Consensus 87 ----~~~LVmEy~~GgsL~~~L~~~----~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~D 158 (644)
..|+||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 469999999999999999643 235699999999999999999999999999999999999999999999999
Q ss_pred cCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCC
Q 006460 159 FGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPL 234 (644)
Q Consensus 159 FGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~ 234 (644)
||++....... ......+++.|+|||++.+..|+.++|||||||++|+|++ |.+||...........+........
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 270 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC
Confidence 99998764432 2233567889999999999999999999999999999999 9999999888888888887777778
Q ss_pred CccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 235 p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+..++..+.+||.+||..||.+|||+.+++++
T Consensus 271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88899999999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=362.33 Aligned_cols=251 Identities=24% Similarity=0.450 Sum_probs=223.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|++++++++||||+++++++.+ ...+|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCeE
Confidence 45679999999999999999999986 67899999998765443 467889999999999999999998876 45689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999999999864 3468999999999999999999999999999999999999999999999999998754322
Q ss_pred --ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 170 --LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 170 --~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
......+++.|+|||++.+..++.++||||||+++|+|++ |.+||......+....+........+..++..+.+|+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 238 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 238 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHH
Confidence 2234567888999999998899999999999999999999 9999999998888888887766677888899999999
Q ss_pred HHHhccCCCCCCCHHHHhhC
Q 006460 247 KSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~h 266 (644)
.+||..||.+|||+.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 239 NHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=389.94 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=224.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.++.++..||+|+++... .......+.+|+++|++++|||||++++++.. ...+|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-SSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-CCCcE
Confidence 34579999999999999999999999999999999987543 34445678899999999999999999999866 45689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||++||+|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 189 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999999999864 3458999999999999999999999999999999999999999999999999998654322
Q ss_pred cc---ccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 170 LA---SSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 170 ~~---~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
.. ....+++.|+|||++.+..|+.++|||||||++|||++ |.+||.+....+....+......+.|..++..+.+|
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11 12235678999999998889999999999999999998 999999999888888888877778888899999999
Q ss_pred HHHHhccCCCCCCCHHHHhhC
Q 006460 246 IKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~h 266 (644)
|.+||..||.+|||+.++++.
T Consensus 348 i~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHHH
Confidence 999999999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.20 Aligned_cols=252 Identities=23% Similarity=0.414 Sum_probs=214.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEE----EEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKY----VLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~v----AiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
..++|++.+.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.++++++|||||+++++|...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence 4578999999999999999999998887654 777665432 223456788999999999999999999998763
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
..++|++|+.+|+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred CeEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 378999999999999999864 3569999999999999999999999999999999999999999999999999998764
Q ss_pred cccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 167 TEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 167 ~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
.... .....+|+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+.....+...+......+.+..++..+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 4322 223456889999999999999999999999999999999 999999988888888888777777888899999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+|+.+||..||.+|||+.+++++
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=394.58 Aligned_cols=248 Identities=22% Similarity=0.405 Sum_probs=221.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.+. +..||||+++.... .+.+.+|+++|++++|||||++++++......+|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTT----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchH----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 45689999999999999999999875 77999999976542 3567889999999999999999999887666799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
|||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 9999999999999998765556899999999999999999999999999999999999999999999999999864332
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
.....+++.|+|||++.+..|+.++|||||||++|+|++ |..||......+....+..+...+.|..++..+.+||.+
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 233467899999999999999999999999999999998 999999888888888888777777888999999999999
Q ss_pred HhccCCCCCCCHHHHhh
Q 006460 249 MLRKNPEHRPTASDLLR 265 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~ 265 (644)
||..||.+|||+.++++
T Consensus 422 cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 422 CWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCChhHCcCHHHHHH
Confidence 99999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=369.29 Aligned_cols=253 Identities=20% Similarity=0.348 Sum_probs=219.6
Q ss_pred CCCCCCeEEEE-EeccCCCeEEEEEEE--ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 9 KSKLEDYEVIE-QIGRGAFGAAFLVLH--KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 9 ~~~~~~Y~i~~-~LG~G~fG~Vyla~~--k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
....++|++.+ .||+|+||.||+|.+ ..+++.||+|++..........+.+.+|+++++.++||||+++++++ . .
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~-~ 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E-A 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E-S
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C-C
Confidence 34567899999 999999999999955 55678999999987655455567899999999999999999999987 3 3
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 5588999999999999999863 45999999999999999999999999999999999999999999999999999876
Q ss_pred ccccc----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccH
Q 006460 166 NTEDL----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSS 240 (644)
Q Consensus 166 ~~~~~----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~ 240 (644)
..... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+........+..++.
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 247 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 44321 223456788999999998889999999999999999999 9999999998888888888777778888999
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.+.+||.+||..||.+|||+.++++
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.02 Aligned_cols=247 Identities=30% Similarity=0.590 Sum_probs=216.0
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe--------
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD-------- 83 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d-------- 83 (644)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|++++++++||||++++++|..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 468999999999999999999999999999999997653 245679999999999999999998753
Q ss_pred -------CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEE
Q 006460 84 -------KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRL 156 (644)
Q Consensus 84 -------~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL 156 (644)
....+|+||||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 1356899999999999999998766667999999999999999999999999999999999999999999999
Q ss_pred eccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCc
Q 006460 157 GDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI 236 (644)
Q Consensus 157 ~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~ 236 (644)
+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.. .......+... ..+.
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~---~~~~ 238 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDG---IISD 238 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTT---CCCT
T ss_pred CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhcc---cccc
Confidence 999999887665555667899999999999999999999999999999999999988743 22333333332 3456
Q ss_pred cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
.++..+.+||.+||..||.+|||+.++++|+|.
T Consensus 239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 789999999999999999999999999998664
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=379.07 Aligned_cols=263 Identities=26% Similarity=0.443 Sum_probs=195.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHH-HHHhcCCCCcceeeeEEEeCCce
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMD-LISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~-iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
....++|++++.||+|+||.||+|.++.+++.||+|++....... ....+.+|+. +++.++||||+++++++.. ...
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFR-EGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-SSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-CCc
Confidence 356789999999999999999999999999999999997654333 3345555665 6777899999999999876 467
Q ss_pred EEEEEeccCCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKA---RGACFPEEKLCKWLTQLLLAVDYLHSN-RVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~---~~~~l~e~~i~~i~~QIL~gL~yLHs~-gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
+|+||||+.| +|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999965 888887642 245789999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccCCCCCCChhhh----cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhccCCCCCC---
Q 006460 164 LLNTEDLASSVVGTPNYMCPELL----ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-AGLINKINRSSISPLP--- 235 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl----~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~-~el~~~i~~~~~~~~p--- 235 (644)
............||+.|+|||++ .+..++.++|||||||++|+|++|..||..... .+.+..+.......++
T Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3aln_A 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254 (327)
T ss_dssp C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence 76554444556899999999998 456789999999999999999999999986432 2222222222222222
Q ss_pred -ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 236 -IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 236 -~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
..++..+.+||.+||..||.+|||+.++++||||.....
T Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 357899999999999999999999999999999976543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=368.11 Aligned_cols=248 Identities=21% Similarity=0.397 Sum_probs=213.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+++|++.+.||+|+||.||+|.+ ++..||+|++.... ..+.+.+|++++++++||||+++++++.+....+|
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 5678999999999999999999977 48899999997543 24567889999999999999999998877666789
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 9999999999999998654444899999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
.....+++.|+|||++.+..++.++||||||+++|+|++ |.+||......+....+........+..+++.+.+||.+
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 249 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 249 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence 234568899999999998899999999999999999998 999999988888888887776677788899999999999
Q ss_pred HhccCCCCCCCHHHHhh
Q 006460 249 MLRKNPEHRPTASDLLR 265 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~ 265 (644)
||..||.+|||+.++++
T Consensus 250 ~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 250 CWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HhcCChhhCCCHHHHHH
Confidence 99999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=382.29 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=187.7
Q ss_pred CCCCCeEEEE-EeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe---CC
Q 006460 10 SKLEDYEVIE-QIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD---KG 85 (644)
Q Consensus 10 ~~~~~Y~i~~-~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d---~~ 85 (644)
...++|++.+ .||+|+||.||+|.++.+++.||+|++.... ...+ +....++.+.||||++++++|.. .+
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQ---EVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 4568999976 5999999999999999999999999996542 1111 22334566799999999999865 24
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC---CCeEEeccCcc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD---NDIRLGDFGLA 162 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~---g~vKL~DFGls 162 (644)
.++|+|||||.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 568999999999999999987655579999999999999999999999999999999999999864 45999999999
Q ss_pred cccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH----HHHhccC---CCCCC
Q 006460 163 KLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLI----NKINRSS---ISPLP 235 (644)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~----~~i~~~~---~~~~p 235 (644)
..... .......||+.|+|||++.+..|+.++|||||||++|+|++|.+||......... ..+.... ..+..
T Consensus 179 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 179 KETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp EEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred eeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 87654 3345678899999999998888999999999999999999999999776544331 1221111 12223
Q ss_pred ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 236 ~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 4679999999999999999999999999999999753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=362.47 Aligned_cols=250 Identities=24% Similarity=0.501 Sum_probs=205.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc--HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT--EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~--~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
..+++|++.+.||+|+||.||+|.+. +..||+|++...... ....+.+.+|+++++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 80 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPN 80 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCc
Confidence 46789999999999999999999874 889999998765322 2234678899999999999999999998866 556
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCCCCcEEEcC--------CCCeEE
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR---VLHRDLKCSNIFLTK--------DNDIRL 156 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g---IIHRDLKPeNILL~~--------~g~vKL 156 (644)
+|+||||+.|++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 899999999999999885 346999999999999999999999999 899999999999986 678999
Q ss_pred eccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc-CCCCCC
Q 006460 157 GDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS-SISPLP 235 (644)
Q Consensus 157 ~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~-~~~~~p 235 (644)
+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........+... ...+.+
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 9999998765432 34568999999999999989999999999999999999999999988877766665544 344567
Q ss_pred ccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 236 ~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..++..+.+||.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 7889999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=373.45 Aligned_cols=256 Identities=22% Similarity=0.408 Sum_probs=220.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d 83 (644)
...++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+++|+++ +||||+++++++..
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 45579999999999999999999864 467899999997653 334456789999999999 79999999999887
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARG--------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT 149 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~--------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~ 149 (644)
.+..+|+||||+.|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 66779999999999999999976432 1288999999999999999999999999999999999999
Q ss_pred CCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCh-HHHHH
Q 006460 150 KDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDM-AGLIN 224 (644)
Q Consensus 150 ~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~-~el~~ 224 (644)
.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+... .....
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 99999999999998654332 1234567889999999999999999999999999999998 9999987663 44555
Q ss_pred HHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 225 KINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 225 ~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+........+..++..+.++|.+||..||.+|||+.++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555666666778889999999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=367.53 Aligned_cols=254 Identities=19% Similarity=0.296 Sum_probs=219.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecC---CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIE---RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
...+|++.+.||+|+||.||+|.+..+ ...+|+|.+.... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 345799999999999999999987644 3468999886543 344467789999999999999999999998776778
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
.|+||||+.|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 8999999999999999975 345689999999999999999999999999999999999999999999999999987644
Q ss_pred cc-----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 168 ED-----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 168 ~~-----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
.. ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||......+....+........+..++..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 32 1234567889999999999999999999999999999999 78888888877777777777777778889999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+.+|+.+||..||.+|||+.++++.
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=367.59 Aligned_cols=255 Identities=20% Similarity=0.357 Sum_probs=223.6
Q ss_pred CCCCCCeEEEE-EeccCCCeEEEEEEEe--cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 9 KSKLEDYEVIE-QIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 9 ~~~~~~Y~i~~-~LG~G~fG~Vyla~~k--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
....++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|++++++++||||+++++++. .
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--A 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--S
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec--C
Confidence 34567899988 9999999999999864 467889999997653 3445677899999999999999999999883 3
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+.|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 458999999999999999864 3456999999999999999999999999999999999999999999999999999876
Q ss_pred ccccc----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccH
Q 006460 166 NTEDL----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSS 240 (644)
Q Consensus 166 ~~~~~----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~ 240 (644)
..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+........+..++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 240 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCH
Confidence 43321 233456889999999998889999999999999999998 9999999888888888888777778889999
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCC
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHP 267 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp 267 (644)
.+.+||.+||..||.+|||+.+++++.
T Consensus 241 ~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 241 ELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 999999999999999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=376.76 Aligned_cols=246 Identities=18% Similarity=0.227 Sum_probs=209.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~L 90 (644)
-++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|++++++| +||||+++++++.. +...|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEE
Confidence 37899999999999999999999999999999998765432 3467899999999 99999999998877 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC-----eEEeccCccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND-----IRLGDFGLAKLL 165 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~-----vKL~DFGls~~~ 165 (644)
||||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.+
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999 99999999864 456999999999999999999999999999999999999998887 999999999875
Q ss_pred ccccc--------cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHhccCCCC-
Q 006460 166 NTEDL--------ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP---DMAGLINKINRSSISP- 233 (644)
Q Consensus 166 ~~~~~--------~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~---~~~el~~~i~~~~~~~- 233 (644)
..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+. ...+.+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 43321 24678999999999999999999999999999999999999999874 3444444443322111
Q ss_pred ---CCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 234 ---LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 234 ---~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
....++ ++.+|+.+||..||.+||++.+|++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 112345 9999999999999999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=363.92 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=220.2
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCe---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERK---KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.|++.++||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.++++++||||+++++++.+.+...++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 56778999999999999999876654 79999987543 334467789999999999999999999998876666699
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 101 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 9999999999999975 34568999999999999999999999999999999999999999999999999998654322
Q ss_pred ----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 170 ----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 170 ----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+......+.+..++..+.+
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 259 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHH
Confidence 2344567889999999999999999999999999999999 67778888888888888877777788889999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~h 266 (644)
||.+||..||.+|||+.++++.
T Consensus 260 li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 260 VMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999964
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=381.07 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=217.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeE----EEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKK----YVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~----vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
...++|++++.||+|+||.||+|.+..++.. ||+|.+...... .....+.+|+.++++++||||+++++++. +
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVRLLGLCP--G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC-SCBCSCCHHHHHHHTCCCTTBCCEEEEEC--B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence 3467999999999999999999999988876 677766433211 12245677999999999999999999874 3
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
...++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 4589999999999999999753 346899999999999999999999999999999999999999999999999999876
Q ss_pred cccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 166 NTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 166 ~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
.... ......||+.|+|||++.+..|+.++|||||||++|+|++ |..||.+....+....+........+..++.+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence 4432 2344568889999999998899999999999999999999 99999998888888888877777778888999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+.+||.+||..||.+|||+.+++++
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=369.42 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=218.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEE-----ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLH-----KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~-----k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d 83 (644)
...++|++.+.||+|+||.||+|.+ ..++..||+|++..... ....+.+.+|+++|+++ +||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 4567999999999999999999986 34678999999976543 33457789999999999 89999999999876
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEE
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARG----------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIF 147 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~----------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNIL 147 (644)
+...|+||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 99 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 99 -GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 4568999999999999999986542 24899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCcccccccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHH-H
Q 006460 148 LTKDNDIRLGDFGLAKLLNTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAG-L 222 (644)
Q Consensus 148 L~~~g~vKL~DFGls~~~~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~e-l 222 (644)
++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+..... .
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999987654322 234567889999999998899999999999999999998 999998776443 3
Q ss_pred HHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 223 INKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 223 ~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
...+........+..++..+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 34444444455667789999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=374.39 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=222.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-------cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-------IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAW 81 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-------~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~ 81 (644)
...++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+++++++ +||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34589999999999999999999986 457789999997553 344567789999999999 899999999988
Q ss_pred EeCCceEEEEEeccCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEE
Q 006460 82 VDKGNCVCIVTGYCEGGDMAEIIKKARG--------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIF 147 (644)
Q Consensus 82 ~d~~~~~~LVmEy~~GgsL~~~L~~~~~--------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNIL 147 (644)
.. ...+|+||||+.|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 111 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 111 TQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp CS-SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cc-CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 66 5568999999999999999986431 24899999999999999999999999999999999999
Q ss_pred EcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 006460 148 LTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLI 223 (644)
Q Consensus 148 L~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~ 223 (644)
++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999998765432 2334567889999999988889999999999999999999 99999999998888
Q ss_pred HHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 224 NKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 224 ~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+........+..++..+.+||.+||..||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8888877777888899999999999999999999999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=364.76 Aligned_cols=256 Identities=33% Similarity=0.660 Sum_probs=209.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
..+++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++++++||||+++++++.. ...+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcE
Confidence 46789999999999999999999999999999999997643 334556778999999999999999999999887 4579
Q ss_pred EEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
++||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999999753 34568999999999999999999999999999999999999999999999999998754
Q ss_pred ccc-ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHhccCCCCCC-ccccHHH
Q 006460 167 TED-LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP--DMAGLINKINRSSISPLP-IVYSSTM 242 (644)
Q Consensus 167 ~~~-~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~--~~~el~~~i~~~~~~~~p-~~~s~~l 242 (644)
... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+. ........+......+.+ ..++.++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 432 234567999999999999989999999999999999999999999764 344555666655554443 5689999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+||.+||..||.+|||+.+++++
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=376.54 Aligned_cols=255 Identities=21% Similarity=0.339 Sum_probs=214.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d 83 (644)
...++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+|+++ +||||+++++++..
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34579999999999999999999984 356789999997543 233456788999999999 89999999998876
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARG---------------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLK 142 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~---------------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLK 142 (644)
...+|+||||++||+|.+++..... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 121 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 121 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred -CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 4568999999999999999976432 237899999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 006460 143 CSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPD 218 (644)
Q Consensus 143 PeNILL~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~ 218 (644)
|+|||++.++.+||+|||++....... ......||+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999998764432 2234567889999999998899999999999999999998 999998776
Q ss_pred hHH-HHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 219 MAG-LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 219 ~~e-l~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
... ....+......+.+..++..+.+||.+||..||.+|||+.++++|
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 444 344444455556677889999999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.49 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=220.0
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecC---CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIE---RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
.....++|++.+.||+|+||.||+|.+... +..||+|++.... .....+.+.+|++++++++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 345678999999999999999999987653 3569999987653 33446778999999999999999999998754
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...|+||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred -CCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 3468999999999999999864 34689999999999999999999999999999999999999999999999999987
Q ss_pred cccccc--cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 165 LNTEDL--ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 165 ~~~~~~--~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+......+.+..+++.
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence 654322 234567889999999998899999999999999999998 99999888777777777777777778889999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+.+||.+||..||.+|||+.+++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=375.27 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=220.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEE-----EecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVL-----HKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~-----~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...++|++.+.||+|+||.||+|. +..++..||+|++.... .......+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ- 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-
Confidence 456899999999999999999998 56778899999996443 34445678899999999999999999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC---CCeEE
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARG-----ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD---NDIRL 156 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~-----~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~---g~vKL 156 (644)
...+|+||||+.|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 4558999999999999999987532 348999999999999999999999999999999999999944 46999
Q ss_pred eccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCC
Q 006460 157 GDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSIS 232 (644)
Q Consensus 157 ~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~ 232 (644)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||......+....+......
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 9999997543322 2334578999999999998899999999999999999998 99999999988888888887777
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
..+..++..+.+||.+||..||.+|||+.+++++.|+
T Consensus 265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 7788899999999999999999999999999999775
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=370.15 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=211.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC--CCCcceeeeEEEeCCce
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN--NPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~--HPNIVkl~~~~~d~~~~ 87 (644)
..-++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+++++++. ||||+++++++.. ...
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~ 102 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQY 102 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-SSE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-CCE
Confidence 34568999999999999999999885 5889999999877666666788999999999997 5999999998776 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+..
T Consensus 103 ~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 103 IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred EEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence 9999995 588999999863 4689999999999999999999999999999999999996 58999999999987644
Q ss_pred cc---ccccccCCCCCCChhhhcC-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHh-ccCC
Q 006460 168 ED---LASSVVGTPNYMCPELLAD-----------IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-AGLINKIN-RSSI 231 (644)
Q Consensus 168 ~~---~~~~~~GT~~Y~APEvl~~-----------~~ys~ksDIWSLGvILyeLltG~~PF~~~~~-~el~~~i~-~~~~ 231 (644)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+. ....
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 258 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence 32 2235679999999999875 4688999999999999999999999976532 23333333 3334
Q ss_pred CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 232 SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 232 ~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
...+...+..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 4566777999999999999999999999999999999964
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=368.36 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=207.4
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
..+..+++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.. +
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~ 106 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-D 106 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-T
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-C
Confidence 345688999999999999999999999999999999999976533 34456788999999999999999999999877 5
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 6799999999999999999864 35899999999999999999999999999999999999999999999999999875
Q ss_pred cccc--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--CCCCccccHH
Q 006460 166 NTED--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--SPLPIVYSST 241 (644)
Q Consensus 166 ~~~~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--~~~p~~~s~~ 241 (644)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......+...+..... ...+..++..
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence 4432 23356799999999999998999999999999999999999999998776655554443322 1245568899
Q ss_pred HHHHHHHHhccCCCCCC-CHHHHhh
Q 006460 242 MKQIIKSMLRKNPEHRP-TASDLLR 265 (644)
Q Consensus 242 l~dLI~~~L~~dP~~Rp-Ta~eiL~ 265 (644)
+.+||.+||..||.+|| |++++++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999 8888875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=369.02 Aligned_cols=253 Identities=22% Similarity=0.414 Sum_probs=213.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEE----EecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVL----HKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG- 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~----~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~- 85 (644)
...+|++++.||+|+||.||+|. +..+++.||+|++..... ......+.+|+++|++++||||+++++++...+
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 34579999999999999999998 567899999999975532 223467889999999999999999999987643
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 56899999999999999997643 45999999999999999999999999999999999999999999999999999876
Q ss_pred cccc----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC---------------ChHHHHHHH
Q 006460 166 NTED----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP---------------DMAGLINKI 226 (644)
Q Consensus 166 ~~~~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~---------------~~~el~~~i 226 (644)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..|+... ........+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 5432 234567888899999999989999999999999999999999876422 123344555
Q ss_pred hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 227 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
......+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 556666778889999999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=364.47 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=211.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH--HHH---HHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE--KFK---RTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~--~~~---~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... ... +.+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34579999999999999999999999999999999986543221 111 6788999999999999999999987543
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCcEEEcCCCC-----eEEe
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR--VLHRDLKCSNIFLTKDND-----IRLG 157 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g--IIHRDLKPeNILL~~~g~-----vKL~ 157 (644)
. ++||||+.|++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+
T Consensus 96 -~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 -P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 2 6999999999999988753 446999999999999999999999999 999999999999988776 9999
Q ss_pred ccCcccccccccccccccCCCCCCChhhhc--CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH--HHHHh-ccCCC
Q 006460 158 DFGLAKLLNTEDLASSVVGTPNYMCPELLA--DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL--INKIN-RSSIS 232 (644)
Q Consensus 158 DFGls~~~~~~~~~~~~~GT~~Y~APEvl~--~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el--~~~i~-~~~~~ 232 (644)
|||+++.... ......||+.|+|||++. ...|+.++|||||||++|+|++|..||........ ...+. .....
T Consensus 172 Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 172 DFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 9999986443 345578999999999984 45578999999999999999999999986553322 33333 34445
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
..+..+++.+.+||.+||..||.+|||+.++++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 677889999999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=361.92 Aligned_cols=249 Identities=17% Similarity=0.203 Sum_probs=211.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~ 89 (644)
.-++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+++++.+ +|||++++++++.. +...|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeE
Confidence 457899999999999999999999999999999998755432 3467799999999 79999999998765 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC-----eEEeccCcccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND-----IRLGDFGLAKL 164 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~-----vKL~DFGls~~ 164 (644)
+||||+ |++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 83 lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999999 99999999864 346999999999999999999999999999999999999987776 99999999987
Q ss_pred ccccc--------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHhcc----
Q 006460 165 LNTED--------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP---DMAGLINKINRS---- 229 (644)
Q Consensus 165 ~~~~~--------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~---~~~el~~~i~~~---- 229 (644)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ........+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 64432 234567999999999999999999999999999999999999999874 333444433322
Q ss_pred CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 230 SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 230 ~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
........++..+.+|+.+||..||.+|||+.+|++.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2222334678999999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=390.81 Aligned_cols=251 Identities=21% Similarity=0.396 Sum_probs=222.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
....++|++.+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+++|++++|||||++++++. ...+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT--KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe--CCcc
Confidence 345678999999999999999999885 4678999999765433 467889999999999999999999875 4458
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999999998554446899999999999999999999999999999999999999999999999999876443
Q ss_pred c--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 169 D--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 169 ~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
. ......+++.|+|||++....|+.++|||||||+||+|++ |.+||.+....++...+......+.|..++..+.+|
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2 1233456788999999998899999999999999999999 999999999989888888887777888899999999
Q ss_pred HHHHhccCCCCCCCHHHHhh
Q 006460 246 IKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~ 265 (644)
|.+||..||.+|||+.+|+.
T Consensus 418 i~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 418 MMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHH
Confidence 99999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.05 Aligned_cols=252 Identities=22% Similarity=0.404 Sum_probs=220.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
....++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+++|++++||||+++++++.. ...
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPI 82 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC--CCc
Confidence 345689999999999999999999865 5678999999765433 3567889999999999999999998753 458
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.|++|.+++....+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 89999999999999997544335899999999999999999999999999999999999999999999999999876543
Q ss_pred c--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 169 D--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 169 ~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
. ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....+........+..++..+.+|
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 242 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence 2 2234567889999999988889999999999999999999 999999998888888888776667778899999999
Q ss_pred HHHHhccCCCCCCCHHHHhhC
Q 006460 246 IKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~h 266 (644)
+.+||..||.+|||+.++++.
T Consensus 243 i~~~l~~~p~~Rps~~~l~~~ 263 (279)
T 1qpc_A 243 MRLCWKERPEDRPTFDYLRSV 263 (279)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccChhhCCCHHHHHHH
Confidence 999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=369.68 Aligned_cols=254 Identities=21% Similarity=0.357 Sum_probs=216.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCC----eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIER----KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
...++|++.+.||+|+||.||+|.++.++ ..||+|++.... .......+.+|++++++++||||+++++++.. .
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-Y 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-C
Confidence 45578999999999999999999987654 459999997543 34445678999999999999999999998765 5
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 6699999999999999999764 356999999999999999999999999999999999999999999999999999876
Q ss_pred ccccc----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccH
Q 006460 166 NTEDL----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSS 240 (644)
Q Consensus 166 ~~~~~----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~ 240 (644)
..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......++...+......+.+..++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 43321 122356788999999999999999999999999999998 9999999998888888887777777888999
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+.+||.+||..||.+||++.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=372.59 Aligned_cols=253 Identities=24% Similarity=0.439 Sum_probs=218.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEE----EecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe-CC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVL----HKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD-KG 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~----~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d-~~ 85 (644)
..++|++++.||+|+||.||+|. +..++..||+|++.... ....+.+.+|+++|++++||||+++++++.. ..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 44699999999999999999998 46789999999997653 3445678999999999999999999998874 35
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred ceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 67999999999999999998643 35899999999999999999999999999999999999999999999999999876
Q ss_pred cccc----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh---------------HHHHHHH
Q 006460 166 NTED----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM---------------AGLINKI 226 (644)
Q Consensus 166 ~~~~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~---------------~el~~~i 226 (644)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 4332 23445688889999999998899999999999999999999999864332 2344455
Q ss_pred hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 227 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
......+.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5566667788899999999999999999999999999865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.30 Aligned_cols=253 Identities=23% Similarity=0.415 Sum_probs=214.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEE----EEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKY----VLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~v----AiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
...++|++++.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.+|++++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence 35689999999999999999999999888765 666664332 222346788999999999999999999998763
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..++|++|+.+|+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -CceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 378999999999999999864 346999999999999999999999999999999999999999999999999999876
Q ss_pred ccccc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 166 NTEDL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 166 ~~~~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
..... .....+|+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+.....+...+......+.+..++.+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 44322 233456788999999999999999999999999999999 99999999988888888888777788889999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+.+||.+||..||.+|||+.++++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=396.43 Aligned_cols=252 Identities=18% Similarity=0.359 Sum_probs=225.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.++||+|+||.||+|.++.++..||+|++...... .+.+.+|+++|++++|||||+++++|.. ...+|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~ 292 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFY 292 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEec-CCcEE
Confidence 3557899999999999999999999999999999999765433 4568899999999999999999999866 45689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
|||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999999987666679999999999999999999999999999999999999999999999999998764332
Q ss_pred --ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 170 --LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 170 --~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
......+++.|+|||++.+..|+.++|||||||+||+|++ |.+||.+.+..++...+......+.|..++..+.+||
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 452 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 452 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1233456778999999998899999999999999999998 9999999888888888877777778888999999999
Q ss_pred HHHhccCCCCCCCHHHHhh
Q 006460 247 KSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~ 265 (644)
.+||..||.+|||+.+|++
T Consensus 453 ~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 453 RACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCcChhHCcCHHHHHH
Confidence 9999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=364.06 Aligned_cols=248 Identities=21% Similarity=0.373 Sum_probs=211.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCC-------eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIER-------KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWV 82 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg-------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~ 82 (644)
...++|++.+.||+|+||.||+|.+..++ ..||+|++..... ...+.+.+|++++++++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 45689999999999999999999999887 5799999865432 23467889999999999999999999987
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC--------e
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND--------I 154 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~--------v 154 (644)
+ +...|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 83 ~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 83 C-GDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp C-TTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred e-CCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 6 456889999999999999998643 34899999999999999999999999999999999999998887 9
Q ss_pred EEeccCcccccccccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCC
Q 006460 155 RLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSIS 232 (644)
Q Consensus 155 KL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~ 232 (644)
||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.............. ..
T Consensus 161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~~ 235 (289)
T 4fvq_A 161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--RH 235 (289)
T ss_dssp EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TC
T ss_pred eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--cC
Confidence 99999999765432 23568899999999987 678999999999999999999 5667766666555544433 23
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+..++.++.+||.+||..||.+|||+.+++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4556678899999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=383.82 Aligned_cols=253 Identities=22% Similarity=0.391 Sum_probs=210.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEe---cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
..++|++.+.||+|+||.||+|.++ .++..||+|+++... .....+.+.+|+.+|++++|||||++++++.+ +..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCc
Confidence 4568999999999999999999987 457789999997653 34456789999999999999999999998866 556
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|+||||++|++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred eEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 89999999999999999753 44699999999999999999999999999999999999999999999999999987644
Q ss_pred ccc----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 168 EDL----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 168 ~~~----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
... .....+++.|+|||++.+..|+.++|||||||++|+|++ |..||......++...+......+.+..++..+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 279 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 321 122345778999999999999999999999999999997 999999999888888887776666777889999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+||.+||..||.+||++.++++.
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHHH
Confidence 999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=360.05 Aligned_cols=250 Identities=18% Similarity=0.246 Sum_probs=211.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.-++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.+.|++++..+.++...+...|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 457999999999999999999999999999999998765433 3467899999999999988888877777788999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc---CCCCeEEeccCccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT---KDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~---~~g~vKL~DFGls~~~~~ 167 (644)
||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999 99999999754 34699999999999999999999999999999999999994 788999999999987654
Q ss_pred ccc--------cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHhc----cCCC
Q 006460 168 EDL--------ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM---AGLINKINR----SSIS 232 (644)
Q Consensus 168 ~~~--------~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~---~el~~~i~~----~~~~ 232 (644)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+..+.. ....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 322 2456899999999999999999999999999999999999999986432 122222221 1112
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+..++..+.+||.+||..||.+|||+.++++.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 2335678999999999999999999999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=374.19 Aligned_cols=251 Identities=20% Similarity=0.308 Sum_probs=205.3
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC--
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG-- 85 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~-- 85 (644)
.....++|++.+.||+|+||.||+|.+. ++.||+|++..... ......+|+.+|++++|||||++++++....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch---HHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 3356689999999999999999999875 78999999975432 2344566999999999999999999988643
Q ss_pred -ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCccccCCCCcEEEcCCCCe
Q 006460 86 -NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN----------RVLHRDLKCSNIFLTKDNDI 154 (644)
Q Consensus 86 -~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~----------gIIHRDLKPeNILL~~~g~v 154 (644)
..+|+|||||.+|+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred CceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 3589999999999999999763 489999999999999999999999 99999999999999999999
Q ss_pred EEeccCccccccccc---ccccccCCCCCCChhhhcCC-----CCCcccchhhHHHHHHHHHhCCCCCCCCC--------
Q 006460 155 RLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADI-----PYGYKSDIWSLGCCMFEIAAHQPAFRAPD-------- 218 (644)
Q Consensus 155 KL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~-----~ys~ksDIWSLGvILyeLltG~~PF~~~~-------- 218 (644)
||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+..
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 999999998764432 23346899999999999863 45678999999999999999999997532
Q ss_pred --------hHHHHHHHhccCCCC-CCcc-----ccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 219 --------MAGLINKINRSSISP-LPIV-----YSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 219 --------~~el~~~i~~~~~~~-~p~~-----~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.......+......+ .+.. .+.++.+||.+||..||.+|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 223333333332222 2221 24569999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=377.49 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=215.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH----HHHHHHHHHHHHHHhcC--CCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE----KFKRTALQEMDLISKLN--NPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~--HPNIVkl~~~~~d 83 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++++. ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 45678999999999999999999999999999999997653221 11234567999999996 5999999998876
Q ss_pred CCceEEEEEeccCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc-CCCCeEEeccCc
Q 006460 84 KGNCVCIVTGYCEG-GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT-KDNDIRLGDFGL 161 (644)
Q Consensus 84 ~~~~~~LVmEy~~G-gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~-~~g~vKL~DFGl 161 (644)
...+++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 120 -~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 -PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp -SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred -CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 5679999999976 8999999864 3589999999999999999999999999999999999999 678999999999
Q ss_pred ccccccccccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccH
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~ 240 (644)
+...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .+... ....+..++.
T Consensus 197 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-~~~~~~~~~~ 268 (320)
T 3a99_A 197 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFFRQRVSS 268 (320)
T ss_dssp CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCCCSSCCCH
T ss_pred ccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-cccccccCCH
Confidence 9876543 3456789999999999887665 788999999999999999999997532 12222 2335677899
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
++.+||.+||..||.+|||+.++++||||+...
T Consensus 269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 999999999999999999999999999997543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=361.04 Aligned_cols=250 Identities=19% Similarity=0.252 Sum_probs=206.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..-++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.+.|++++..+..+...+...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 3457999999999999999999999999999999987654332 346779999999999998888888877778899
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE---cCCCCeEEeccCcccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL---TKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL---~~~g~vKL~DFGls~~~~ 166 (644)
+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999999 99999999854 3469999999999999999999999999999999999999 788999999999998765
Q ss_pred ccc--------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHhc----cCC
Q 006460 167 TED--------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA---GLINKINR----SSI 231 (644)
Q Consensus 167 ~~~--------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~---el~~~i~~----~~~ 231 (644)
... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.... .....+.. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 432 223568999999999999999999999999999999999999999764321 22222211 111
Q ss_pred CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 232 SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 232 ~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
......++..+.+||.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1223557899999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=369.57 Aligned_cols=255 Identities=22% Similarity=0.386 Sum_probs=217.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCe-----EEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERK-----KYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD 83 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~-----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d 83 (644)
...++|++.+.||+|+||.||+|.+..++. .||+|++..... ....+.+.+|+++|+++ +||||+++++++..
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 456799999999999999999999987664 799999976543 33457789999999999 89999999998866
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKAR------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD 151 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~ 151 (644)
+..+|+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred -CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 456899999999999999998643 3458999999999999999999999999999999999999999
Q ss_pred CCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH-HHH
Q 006460 152 NDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLI-NKI 226 (644)
Q Consensus 152 g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~-~~i 226 (644)
+.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+....... ..+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 999999999998654332 2234567889999999998899999999999999999998 99999876644433 333
Q ss_pred hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 227 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
........+..++..+.+||.+||..||.+|||+.+++++
T Consensus 281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 4444455677789999999999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=367.37 Aligned_cols=254 Identities=22% Similarity=0.333 Sum_probs=209.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe---CCce
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD---KGNC 87 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d---~~~~ 87 (644)
.-++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 3468999999999999999999999999999999986542 3445678899999999999999999999873 2357
Q ss_pred EEEEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
+|+||||+.+++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 89999999999999999864 2456999999999999999999999999999999999999999999999999998764
Q ss_pred cccc----------ccccccCCCCCCChhhhcCCC---CCcccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHhccC
Q 006460 166 NTED----------LASSVVGTPNYMCPELLADIP---YGYKSDIWSLGCCMFEIAAHQPAFRAPD--MAGLINKINRSS 230 (644)
Q Consensus 166 ~~~~----------~~~~~~GT~~Y~APEvl~~~~---ys~ksDIWSLGvILyeLltG~~PF~~~~--~~el~~~i~~~~ 230 (644)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... .......+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 3211 112356799999999987654 6899999999999999999999995311 011222233333
Q ss_pred CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 231 ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 231 ~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 334456789999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=361.86 Aligned_cols=251 Identities=26% Similarity=0.472 Sum_probs=202.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..-++|++.++||+|+||.||+|.+. ..+|+|++..........+.+.+|+++|++++||||+++++++ . ...++
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~-~~~~~ 95 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T-APQLA 95 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C-SSSCE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c-CCccE
Confidence 45679999999999999999999754 3599999987776667778899999999999999999999964 3 44589
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc--
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-- 167 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-- 167 (644)
+||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999999998643 34699999999999999999999999999999999999999999999999999986543
Q ss_pred -ccccccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHhccCCCC----CCccc
Q 006460 168 -EDLASSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA-GLINKINRSSISP----LPIVY 238 (644)
Q Consensus 168 -~~~~~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~-el~~~i~~~~~~~----~p~~~ 238 (644)
........||+.|+|||++. +..++.++|||||||++|+|++|..||...... .+...+......+ .+..+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence 12334567999999999986 567899999999999999999999999875544 4444444443322 33467
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+..+.+||.+||..||.+|||+.++++.
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 8999999999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=384.95 Aligned_cols=256 Identities=20% Similarity=0.344 Sum_probs=214.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-ceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG-NCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~-~~~ 88 (644)
..-++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+++|++++|||||++++++.... ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34578999999999999999999999999999999997643222 2456778999999999999999999987643 378
Q ss_pred EEEEeccCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE----cCCCCeEEeccCccc
Q 006460 89 CIVTGYCEGGDMAEIIKKAR-GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL----TKDNDIRLGDFGLAK 163 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~-~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL----~~~g~vKL~DFGls~ 163 (644)
|+|||||.||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999997543 2349999999999999999999999999999999999999 677789999999999
Q ss_pred ccccccccccccCCCCCCChhhhcC--------CCCCcccchhhHHHHHHHHHhCCCCCCC----CChHHHHHHHhccCC
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLAD--------IPYGYKSDIWSLGCCMFEIAAHQPAFRA----PDMAGLINKINRSSI 231 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~--------~~ys~ksDIWSLGvILyeLltG~~PF~~----~~~~el~~~i~~~~~ 231 (644)
............||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.. ....+.+..+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 8776666667889999999999865 4678899999999999999999999964 223444555443321
Q ss_pred C------------------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 232 S------------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 232 ~------------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
. .++..++..+.+||.+||..||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1 1123456788999999999999999999999765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=370.06 Aligned_cols=262 Identities=24% Similarity=0.424 Sum_probs=218.8
Q ss_pred CCCCCCCCCe-EEEEEeccCCCeEEEEEEE----ecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 006460 6 GDSKSKLEDY-EVIEQIGRGAFGAAFLVLH----KIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDA 80 (644)
Q Consensus 6 ~~~~~~~~~Y-~i~~~LG~G~fG~Vyla~~----k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~ 80 (644)
++....-++| +++++||+|+||.||+|.. ..+++.||+|++.... .....+.+.+|+++|++++||||++++++
T Consensus 23 g~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (318)
T 3lxp_A 23 GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGC 101 (318)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEE
Confidence 4555566677 9999999999999988754 4578999999997653 34456778999999999999999999999
Q ss_pred EEeC-CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEecc
Q 006460 81 WVDK-GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDF 159 (644)
Q Consensus 81 ~~d~-~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DF 159 (644)
+.+. ...+|+||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 102 CEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCc
Confidence 8875 46799999999999999999643 3899999999999999999999999999999999999999999999999
Q ss_pred Cccccccccc----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH---------------
Q 006460 160 GLAKLLNTED----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA--------------- 220 (644)
Q Consensus 160 Gls~~~~~~~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~--------------- 220 (644)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 9998765432 234456888899999999988999999999999999999999999754321
Q ss_pred HHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 221 GLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 221 el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.+...+......+.+..++..+.+||.+||..||.+|||+.++++ +|+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l~ 309 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVH 309 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHH
Confidence 233444555566678889999999999999999999999999995 354443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=368.85 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=207.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH----HHHHHHHHHHHHHHhc----CCCCcceeeeEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE----KFKRTALQEMDLISKL----NNPYIVKYKDAW 81 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L----~HPNIVkl~~~~ 81 (644)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 45678999999999999999999999999999999997654322 1223456799999998 899999999987
Q ss_pred EeCCceEEEEEec-cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc-CCCCeEEecc
Q 006460 82 VDKGNCVCIVTGY-CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT-KDNDIRLGDF 159 (644)
Q Consensus 82 ~d~~~~~~LVmEy-~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~-~~g~vKL~DF 159 (644)
.. ...+++|||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 108 ~~-~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 108 ET-QEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ec-CCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 66 4568899999 78999999998643 589999999999999999999999999999999999999 7899999999
Q ss_pred CcccccccccccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccc
Q 006460 160 GLAKLLNTEDLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY 238 (644)
Q Consensus 160 Gls~~~~~~~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~ 238 (644)
|++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... . +.. ....++..+
T Consensus 185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~-~~~~~~~~~ 256 (312)
T 2iwi_A 185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILE-AELHFPAHV 256 (312)
T ss_dssp SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHH-TCCCCCTTS
T ss_pred chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhh-hccCCcccC
Confidence 999876553 3456789999999999887666 459999999999999999999997532 1 111 223456778
Q ss_pred cHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 239 SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 239 s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+..+.+||.+||..||.+|||+.++++||||+..
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 9999999999999999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=360.39 Aligned_cols=248 Identities=21% Similarity=0.377 Sum_probs=200.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHh--cCCCCcceeeeEEEeC--
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK--LNNPYIVKYKDAWVDK-- 84 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~--L~HPNIVkl~~~~~d~-- 84 (644)
+...++|++.+.||+|+||.||+|.+ +++.||+|++.... ...+.+|.+++.. ++||||+++++++...
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 45678999999999999999999987 68999999986543 2344557777766 7999999999987652
Q ss_pred -CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCccccCCCCcEEEcCCCCeE
Q 006460 85 -GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH--------SNRVLHRDLKCSNIFLTKDNDIR 155 (644)
Q Consensus 85 -~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLH--------s~gIIHRDLKPeNILL~~~g~vK 155 (644)
...+|+||||+.+|+|.++++. ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+|
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred CCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 3568999999999999999953 45999999999999999999999 99999999999999999999999
Q ss_pred EeccCcccccccccc-----cccccCCCCCCChhhhcCC------CCCcccchhhHHHHHHHHHhC----------CCCC
Q 006460 156 LGDFGLAKLLNTEDL-----ASSVVGTPNYMCPELLADI------PYGYKSDIWSLGCCMFEIAAH----------QPAF 214 (644)
Q Consensus 156 L~DFGls~~~~~~~~-----~~~~~GT~~Y~APEvl~~~------~ys~ksDIWSLGvILyeLltG----------~~PF 214 (644)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++| .+||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 999999976543221 2345899999999999876 455799999999999999999 8888
Q ss_pred CCCC-----hHHHHHHHhcc-CCCCCCc-----cccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 215 RAPD-----MAGLINKINRS-SISPLPI-----VYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 215 ~~~~-----~~el~~~i~~~-~~~~~p~-----~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.... .......+... ..+..+. .++..+.+||.+||..||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 5432 22233322222 2222332 256789999999999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=386.49 Aligned_cols=250 Identities=22% Similarity=0.384 Sum_probs=216.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.++||+|+||.||+|.+.. +..||+|+++..... .+.+.+|+++|++++|||||++++++.+ ..+|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceE
Confidence 455789999999999999999999875 467999999765433 3568899999999999999999998754 4589
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||+.+|+|.+++....+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999999986555569999999999999999999999999999999999999999999999999998764332
Q ss_pred c--cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 170 L--ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 170 ~--~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
. .....+++.|+|||++.+..|+.++|||||||++|+|++ |.+||.+....+....+......+.|..++..+.+||
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 414 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 414 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1 223456788999999998899999999999999999999 9999999998888888888877778889999999999
Q ss_pred HHHhccCCCCCCCHHHHhh
Q 006460 247 KSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~ 265 (644)
.+||..||.+|||+.++++
T Consensus 415 ~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 415 CQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCcCHHHHHH
Confidence 9999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=380.03 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=209.7
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCC---eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIER---KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..|++.+.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+.+|++++|||||++++++...+...|
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC-SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 35889999999999999999886543 4689998865433 3345778999999999999999999998876666789
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 168 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999999753 4468999999999999999999999999999999999999999999999999998654322
Q ss_pred c-----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHH
Q 006460 170 L-----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 170 ~-----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~ 243 (644)
. .....+|+.|+|||++.+..|+.++|||||||++|+|++ |.+||......+....+........|..++..+.
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1 233467788999999999999999999999999999999 7899988777777777777766677888999999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhC
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+||.+||..||.+|||+.+++++
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=374.43 Aligned_cols=251 Identities=18% Similarity=0.261 Sum_probs=201.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEec---CCeEEEEEEEecccccHH---------HHHHHHHHHHHHHhcCCCCcceeee
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKI---ERKKYVLKKIRLAKQTEK---------FKRTALQEMDLISKLNNPYIVKYKD 79 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~---tg~~vAiK~i~~~~~~~~---------~~~~~~rEi~iL~~L~HPNIVkl~~ 79 (644)
-++|++.+.||+|+||.||+|.+.. ++..+|+|++........ ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 788999999976532110 1124678899999999999999999
Q ss_pred EEEeC---CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC--Ce
Q 006460 80 AWVDK---GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN--DI 154 (644)
Q Consensus 80 ~~~d~---~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g--~v 154 (644)
++... ...+|+||||+ |++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 98763 56899999999 999999997543 699999999999999999999999999999999999999887 99
Q ss_pred EEeccCccccccccc--------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCC--CChHHHHH
Q 006460 155 RLGDFGLAKLLNTED--------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRA--PDMAGLIN 224 (644)
Q Consensus 155 KL~DFGls~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~--~~~~el~~ 224 (644)
||+|||+++.+.... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.. ........
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999998764322 12456899999999999999999999999999999999999999965 22222221
Q ss_pred HHhccCCCCCCc---------cccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 225 KINRSSISPLPI---------VYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 225 ~i~~~~~~~~p~---------~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
. ........+. .++.++.+||.+||..||.+|||+.++++.
T Consensus 273 ~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 A-KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp H-HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred H-HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1 1111111222 678899999999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=375.79 Aligned_cols=253 Identities=17% Similarity=0.238 Sum_probs=202.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecC-----CeEEEEEEEecccccHHH---------HHHHHHHHHHHHhcCCCCcce
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIE-----RKKYVLKKIRLAKQTEKF---------KRTALQEMDLISKLNNPYIVK 76 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~t-----g~~vAiK~i~~~~~~~~~---------~~~~~rEi~iL~~L~HPNIVk 76 (644)
..++|++.+.||+|+||.||+|.+..+ ++.||+|++......... ...+.+|+..++.+.||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999998775 588999998765321110 123445667778889999999
Q ss_pred eeeEEEeC---CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc--CC
Q 006460 77 YKDAWVDK---GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT--KD 151 (644)
Q Consensus 77 l~~~~~d~---~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~--~~ 151 (644)
+++++... ..++||||||+ |++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++ .+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 99998763 25689999999 99999999864 45699999999999999999999999999999999999999 88
Q ss_pred CCeEEeccCcccccccccc--------cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHH
Q 006460 152 NDIRLGDFGLAKLLNTEDL--------ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGL 222 (644)
Q Consensus 152 g~vKL~DFGls~~~~~~~~--------~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el 222 (644)
+.+||+|||+++.+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.. ....
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 9999999999987644322 234569999999999999999999999999999999999999998532 2221
Q ss_pred HHHHhcc---CCC------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 223 INKINRS---SIS------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 223 ~~~i~~~---~~~------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
....... ... ..+..++.++.+|+..||..+|.+||++.+|++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111100 000 012456899999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=372.21 Aligned_cols=247 Identities=17% Similarity=0.251 Sum_probs=206.8
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecC--------CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcce-------
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIE--------RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVK------- 76 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~t--------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVk------- 76 (644)
-++|++.+.||+|+||.||+|.+..+ ++.||+|++... ..+.+|+++++++.|||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 37999999999999999999999884 889999999754 35678999999999999988
Q ss_pred --------eeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE
Q 006460 77 --------YKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL 148 (644)
Q Consensus 77 --------l~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL 148 (644)
+++++...+..+|+||||+ |++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6777766678899999999 9999999987544679999999999999999999999999999999999999
Q ss_pred cCCC--CeEEeccCccccccccc--------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 006460 149 TKDN--DIRLGDFGLAKLLNTED--------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD 218 (644)
Q Consensus 149 ~~~g--~vKL~DFGls~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~ 218 (644)
+.++ .+||+|||+++.+.... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9988 89999999998764332 1234589999999999999999999999999999999999999998753
Q ss_pred --hHHHHHHHh--ccCCCCCC------ccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 219 --MAGLINKIN--RSSISPLP------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 219 --~~el~~~i~--~~~~~~~p------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
...+..... ......++ ..++..+.+||.+||..||.+|||+.++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 333322222 11111111 2468999999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=363.75 Aligned_cols=248 Identities=26% Similarity=0.456 Sum_probs=191.2
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEE-------eC
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWV-------DK 84 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~-------d~ 84 (644)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++++. ||||+++++++. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 48999999999999999999999999999999985542 344567889999999996 999999999985 33
Q ss_pred CceEEEEEeccCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCcEEEcCCCCeEEeccCc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKA-RGACFPEEKLCKWLTQLLLAVDYLHSNR--VLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~-~~~~l~e~~i~~i~~QIL~gL~yLHs~g--IIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
...+++||||+. |+|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 456899999995 7999988753 3456999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccc-------------cccccCCCCCCChhhh---cCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 006460 162 AKLLNTEDL-------------ASSVVGTPNYMCPELL---ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINK 225 (644)
Q Consensus 162 s~~~~~~~~-------------~~~~~GT~~Y~APEvl---~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~ 225 (644)
+........ .....||+.|+|||++ .+..++.++|||||||++|+|++|..||...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 987654321 1245699999999998 566789999999999999999999999987654433322
Q ss_pred HhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 226 INRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 226 i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
....+.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 265 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 265 ---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22233445567889999999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=362.43 Aligned_cols=246 Identities=26% Similarity=0.497 Sum_probs=205.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.+. ++.||+|++.... ..+.+.+|+++|++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES----ERKAFIVELRQLSRVNHPNIVKLYGACLN---PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcE
Confidence 45689999999999999999999874 7899999986432 34678899999999999999999998653 378
Q ss_pred EEEeccCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCCCCcEEEcCCCC-eEEeccCcccc
Q 006460 90 IVTGYCEGGDMAEIIKKARG-ACFPEEKLCKWLTQLLLAVDYLHS---NRVLHRDLKCSNIFLTKDND-IRLGDFGLAKL 164 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~-~~l~e~~i~~i~~QIL~gL~yLHs---~gIIHRDLKPeNILL~~~g~-vKL~DFGls~~ 164 (644)
+||||++|++|.+++..... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999975322 247899999999999999999999 89999999999999998887 79999999986
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHhccCCCCCCccccHHH
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD--MAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~--~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+......+.+..++..+
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence 5432 344579999999999999999999999999999999999999997543 334455555666667778899999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhC
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+||.+||..||.+|||+.+++++
T Consensus 234 ~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 234 ESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=357.86 Aligned_cols=254 Identities=20% Similarity=0.360 Sum_probs=208.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecC-C--eEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIE-R--KKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~t-g--~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
...++|++.+.||+|+||.||+|.+... + ..||+|++..... .....+.+.+|++++++++||||+++++++...
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 93 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-
Confidence 3457899999999999999999987543 3 3689998876532 223457789999999999999999999988653
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
. .++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred C-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 3 789999999999999998653 45899999999999999999999999999999999999999999999999999876
Q ss_pred cccc----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcc-CCCCCCcccc
Q 006460 166 NTED----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRS-SISPLPIVYS 239 (644)
Q Consensus 166 ~~~~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~-~~~~~p~~~s 239 (644)
.... ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||......+....+... ...+.+..++
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 4432 2234567888999999998889999999999999999999 99999999888888777654 3345567789
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+.+||.+||..||.+|||+.+++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999974
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=371.31 Aligned_cols=254 Identities=21% Similarity=0.290 Sum_probs=209.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
....++|++.+.||+|+||.||+|.+ .+++.||+|++...... ..+.+.+|+++|+.++||||+++++++.. ...+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 110 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQ--GIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEM 110 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSS--HHHHHHHHHHGGGSCCCTTBCCEEEECCC-TTCC
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCeE
Confidence 34668999999999999999999996 46889999988765432 35678899999999999999999998765 5668
Q ss_pred EEEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
|+||||+.|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999999886432 2358999999999999999999999999999999999999999999999999998643
Q ss_pred cc---cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH---H----HHHhccC------
Q 006460 167 TE---DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL---I----NKINRSS------ 230 (644)
Q Consensus 167 ~~---~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el---~----~~i~~~~------ 230 (644)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. . .......
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 22 223445689999999999888999999999999999999999999976442211 1 1111111
Q ss_pred ---CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 231 ---ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 231 ---~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
....+..++..+.+|+.+||..||.+|||+.+++++
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112334457789999999999999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=389.89 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=222.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.++||+|+||.||+|.+.. +..||||+++..... .+.+.+|+++|++|+|||||++++++.+ ..+|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee--ccce
Confidence 456789999999999999999999875 467999999765433 3568899999999999999999998754 4589
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
|||||+.+|+|.+++....+..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999999986545569999999999999999999999999999999999999999999999999998765322
Q ss_pred --ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 170 --LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 170 --~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
......++..|+|||++.+..|+.++|||||||+||+|++ |..||.+....+++..+......+.+..++..+.+||
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 497 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 497 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1233456788999999998899999999999999999999 9999999998888888888777778888999999999
Q ss_pred HHHhccCCCCCCCHHHHhhC
Q 006460 247 KSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~h 266 (644)
.+||..||.+|||+.+|++.
T Consensus 498 ~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 498 CQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999863
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=356.83 Aligned_cols=236 Identities=26% Similarity=0.476 Sum_probs=195.4
Q ss_pred CCCCCCeEEE-EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHH-HhcCCCCcceeeeEEEe---
Q 006460 9 KSKLEDYEVI-EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLI-SKLNNPYIVKYKDAWVD--- 83 (644)
Q Consensus 9 ~~~~~~Y~i~-~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL-~~L~HPNIVkl~~~~~d--- 83 (644)
...+++|.+. +.||+|+||.||+|.++.+++.||+|++... ..+.+|+.++ +.++||||++++++|..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 4578999998 7799999999999999999999999999643 2456788888 55689999999998865
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC---CCCeEEeccC
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK---DNDIRLGDFG 160 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~---~g~vKL~DFG 160 (644)
....+|+||||+.|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 2467999999999999999998865567999999999999999999999999999999999999998 7889999999
Q ss_pred cccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhcc---CCCCCC--
Q 006460 161 LAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRS---SISPLP-- 235 (644)
Q Consensus 161 ls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~---~~~~~p-- 235 (644)
++.... +..|+.++|||||||++|+|++|.+||...........+... .....+
T Consensus 166 ~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 166 FAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp TCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred cccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence 986532 235788999999999999999999999876544332222111 111122
Q ss_pred --ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 236 --IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 236 --~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
..++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 4578999999999999999999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=394.56 Aligned_cols=249 Identities=20% Similarity=0.353 Sum_probs=216.2
Q ss_pred CeEEE-EEeccCCCeEEEEEEEe--cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 14 DYEVI-EQIGRGAFGAAFLVLHK--IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 14 ~Y~i~-~~LG~G~fG~Vyla~~k--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.+.+. ++||+|+||.||+|.+. .+++.||||+++.........+.+.+|+++|++++|||||++++++.. ..+++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEE
Confidence 34443 48999999999999654 567899999998765555556789999999999999999999998753 34889
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~- 169 (644)
||||+.||+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus 447 v~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred EEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 9999999999999975 3469999999999999999999999999999999999999999999999999998764432
Q ss_pred ---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 170 ---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 170 ---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
......+|+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+....++...+........|..++.++.+|
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 604 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 604 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1233456788999999999999999999999999999998 999999999999999998888888889999999999
Q ss_pred HHHHhccCCCCCCCHHHHhhC
Q 006460 246 IKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~h 266 (644)
|.+||..||.+|||+.+|++.
T Consensus 605 i~~cl~~dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 605 MNLCWTYDVENRPGFAAVELR 625 (635)
T ss_dssp HHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=361.50 Aligned_cols=253 Identities=24% Similarity=0.432 Sum_probs=213.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEE----EecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVL----HKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG 85 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~----~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~ 85 (644)
...++|++++.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+++|++++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 345679999999999999999998 46689999999997643 234567899999999999999999999886543
Q ss_pred -ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 86 -NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 86 -~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
..+++||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4689999999999999999864 34589999999999999999999999999999999999999999999999999987
Q ss_pred cccccc----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh----------------HHHHH
Q 006460 165 LNTEDL----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM----------------AGLIN 224 (644)
Q Consensus 165 ~~~~~~----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~----------------~el~~ 224 (644)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||..... ..+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 654321 2345677889999999988899999999999999999999999864311 12233
Q ss_pred HHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 225 KINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 225 ~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.+......+.+..++.++.+||.+||..||.+|||+.++++
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 34444455677789999999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.13 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=194.4
Q ss_pred CCCCCCCCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 006460 1 METENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDA 80 (644)
Q Consensus 1 m~~~~~~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~ 80 (644)
|+..-......+++|++.+.||+|+||.||+|.+ +++.||+|++....... .....|+..+..+.||||+++++.
T Consensus 1 m~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~e~~~~~~~~~~h~~i~~~~~~ 75 (336)
T 3g2f_A 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVG 75 (336)
T ss_dssp --------CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred CCCcccCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh---HHHHHHHHHHHhccCcchhhheec
Confidence 6666667778899999999999999999999965 68999999997553221 112234444556899999999976
Q ss_pred EEe----CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCccccCCCCcEE
Q 006460 81 WVD----KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN---------RVLHRDLKCSNIF 147 (644)
Q Consensus 81 ~~d----~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~---------gIIHRDLKPeNIL 147 (644)
+.. ....+|+|||||+||+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nil 152 (336)
T 3g2f_A 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152 (336)
T ss_dssp EEEECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEE
T ss_pred ccccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEE
Confidence 542 234689999999999999999753 368999999999999999999999 9999999999999
Q ss_pred EcCCCCeEEeccCccccccccc---------ccccccCCCCCCChhhhcC-------CCCCcccchhhHHHHHHHHHhCC
Q 006460 148 LTKDNDIRLGDFGLAKLLNTED---------LASSVVGTPNYMCPELLAD-------IPYGYKSDIWSLGCCMFEIAAHQ 211 (644)
Q Consensus 148 L~~~g~vKL~DFGls~~~~~~~---------~~~~~~GT~~Y~APEvl~~-------~~ys~ksDIWSLGvILyeLltG~ 211 (644)
++.++.+||+|||+++.+.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 9999999999999998754321 2235679999999999977 35678999999999999999996
Q ss_pred CCCC-CCC-----------------hHHHHHHHhc-cCCCCCCcc------ccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 212 PAFR-APD-----------------MAGLINKINR-SSISPLPIV------YSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 212 ~PF~-~~~-----------------~~el~~~i~~-~~~~~~p~~------~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.||. +.. .......+.. ...+.+|.. ++..+.+||.+||..||.+|||+.++++
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 6552 221 1111111211 122233332 4568999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=391.17 Aligned_cols=251 Identities=20% Similarity=0.372 Sum_probs=215.9
Q ss_pred CCCCeEEEE-EeccCCCeEEEEEEEec--CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 11 KLEDYEVIE-QIGRGAFGAAFLVLHKI--ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 11 ~~~~Y~i~~-~LG~G~fG~Vyla~~k~--tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
..++|.+.+ .||+|+||.||+|.++. ++..||||+++.... ....+.+.+|+++|++++|||||++++++.. ..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~ 409 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EA 409 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SS
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CC
Confidence 345677777 89999999999998874 456799999976532 2235678899999999999999999999865 35
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|||||||.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 89999999999999999643 45699999999999999999999999999999999999999999999999999987643
Q ss_pred ccc----cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 168 EDL----ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 168 ~~~----~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
... .....+++.|+|||++.+..|+.++|||||||+||||++ |..||.+....++...+......+.|..++.++
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 568 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 321 122345689999999998899999999999999999998 999999999889999998888778888999999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.+||.+||..||.+|||+.++++
T Consensus 569 ~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 569 YALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.05 Aligned_cols=246 Identities=21% Similarity=0.358 Sum_probs=198.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc--CCCCcceeeeEEEeCC---
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL--NNPYIVKYKDAWVDKG--- 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L--~HPNIVkl~~~~~d~~--- 85 (644)
..++|++.+.||+|+||.||+|.+. ++.||+|++..... ....+|..++..+ +||||+++++++....
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3468999999999999999999875 89999999865432 2334455555554 8999999999988753
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccccCCCCcEEEcCCCCeEEe
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN--------RVLHRDLKCSNIFLTKDNDIRLG 157 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~--------gIIHRDLKPeNILL~~~g~vKL~ 157 (644)
..+|+||||+.||+|.++++.. .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 5799999999999999999753 489999999999999999999999 99999999999999999999999
Q ss_pred ccCcccccccccc-----cccccCCCCCCChhhhcCCCCCcc------cchhhHHHHHHHHHhC----------CCCCCC
Q 006460 158 DFGLAKLLNTEDL-----ASSVVGTPNYMCPELLADIPYGYK------SDIWSLGCCMFEIAAH----------QPAFRA 216 (644)
Q Consensus 158 DFGls~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~ys~k------sDIWSLGvILyeLltG----------~~PF~~ 216 (644)
|||++..+..... .....||+.|+|||++.+..++.. +|||||||++|+|++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999976543321 235689999999999988776655 9999999999999999 677754
Q ss_pred CC-----hHHHHHHHhccC-CCCCCc-----cccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 217 PD-----MAGLINKINRSS-ISPLPI-----VYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 217 ~~-----~~el~~~i~~~~-~~~~p~-----~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.. .......+.... ....+. .++..+.+||.+||..||.+|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 21 223333332222 223333 456789999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=376.20 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=193.5
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+.|.+.+.||+|+||.||.+ ...+|+.||||++.... ...+.+|+++|+++ +|||||++++++.+ +..+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEE
Confidence 45666788999999999875 56689999999987543 24567899999886 89999999998765 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-------------CC
Q 006460 92 TGYCEGGDMAEIIKKARGAC-----FPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-------------ND 153 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~-----l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-------------g~ 153 (644)
||||. |+|.+++....... .++..++.++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 69999997532211 1233467899999999999999999999999999999754 37
Q ss_pred eEEeccCccccccccc-----ccccccCCCCCCChhhhcC-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCChH
Q 006460 154 IRLGDFGLAKLLNTED-----LASSVVGTPNYMCPELLAD-------IPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMA 220 (644)
Q Consensus 154 vKL~DFGls~~~~~~~-----~~~~~~GT~~Y~APEvl~~-------~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~ 220 (644)
+||+|||++..+.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998765432 1234689999999999975 568999999999999999998 99999765544
Q ss_pred HHHHHHhccC--CCCC----CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 221 GLINKINRSS--ISPL----PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 221 el~~~i~~~~--~~~~----p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.. .+.... .... +..++.++.+||.+||..||.+|||+.++++||||.+.
T Consensus 247 ~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 247 ES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred HH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 32 222221 1111 22356889999999999999999999999999999653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=366.05 Aligned_cols=244 Identities=18% Similarity=0.271 Sum_probs=197.8
Q ss_pred CCCeEEEEEeccCCCeEEEEE-----EEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC---CCCcceeeeEEEe
Q 006460 12 LEDYEVIEQIGRGAFGAAFLV-----LHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN---NPYIVKYKDAWVD 83 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla-----~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HPNIVkl~~~~~d 83 (644)
-++|++.+.||+|+||.||+| .+..+++.||+|++.... ...+.+|+++++.+. |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 467999999999999999999 477889999999997653 234667888888886 9999999999876
Q ss_pred CCceEEEEEeccCCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC----------
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKA---RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK---------- 150 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~---~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~---------- 150 (644)
....|||||||+||+|.+++... ....+++..++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 139 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 139 -QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp -SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred -CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 45689999999999999999864 2456999999999999999999999999999999999999998
Q ss_pred -CCCeEEeccCcccccc---cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 006460 151 -DNDIRLGDFGLAKLLN---TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI 226 (644)
Q Consensus 151 -~g~vKL~DFGls~~~~---~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i 226 (644)
++.+||+|||+++.+. ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ .
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~ 294 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---K 294 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---E
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---e
Confidence 8999999999997543 33345667899999999999999999999999999999999999999964322100 0
Q ss_pred hccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 227 NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 227 ~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
........ ..++.+.+|+.+||..+|.+|++..+.+.+
T Consensus 295 ~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 295 PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 00111111 246788999999999999999665554443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=377.00 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=198.9
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~LV 91 (644)
.+|.+.+.||+|+||.||. ....+++.||||++...... .+.+|+++|+.+ +|||||++++++.+ ...+|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEE
Confidence 3599999999999999763 45678899999999654322 245799999999 79999999998876 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC---C--CCeEEeccCcccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK---D--NDIRLGDFGLAKLLN 166 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~---~--g~vKL~DFGls~~~~ 166 (644)
||||. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. + ..+||+|||+++...
T Consensus 97 ~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 99995 69999997543 34566677899999999999999999999999999999953 2 357899999998765
Q ss_pred cc----cccccccCCCCCCChhhhc---CCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCC--CCc
Q 006460 167 TE----DLASSVVGTPNYMCPELLA---DIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISP--LPI 236 (644)
Q Consensus 167 ~~----~~~~~~~GT~~Y~APEvl~---~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~--~p~ 236 (644)
.. ......+||+.|+|||++. ...++.++|||||||++|+|++ |.+||...........+....... .+.
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccc
Confidence 43 2234568999999999997 4567889999999999999999 999997665554433333222221 123
Q ss_pred cccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 237 VYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 237 ~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
..+..+.+||.+||..||.+|||+.++++||||+...+
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 34667899999999999999999999999999976543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=369.12 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=205.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.+.||+|+||.||+|.+ .+++.||+|++....... ....+.+|+++++.+.||||+++++++.. ....+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC-SSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEec-CCceE
Confidence 3467999999999999999999975 468899999987653221 12357889999999999999999999876 45688
Q ss_pred EEEeccCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 90 IVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLLAVDYLHSN---RVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~--~~~l~e~~i~~i~~QIL~gL~yLHs~---gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
+||||+.|++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 9999999999999997543 23489999999999999999999999 999999999999999999999999999987
Q ss_pred cccc--cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHh---cc-----
Q 006460 165 LNTE--DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP-----DMAGLINKIN---RS----- 229 (644)
Q Consensus 165 ~~~~--~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~-----~~~el~~~i~---~~----- 229 (644)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||... ........+. ..
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred cCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence 6432 2234456999999999998888999999999999999999999999521 1111111111 00
Q ss_pred -----CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCC
Q 006460 230 -----SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267 (644)
Q Consensus 230 -----~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp 267 (644)
.....+...+..+.+|+.+||..||.+|||+.++++|.
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 01122333467899999999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=355.90 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=204.9
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccc--ccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK--QTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
|...+.||+|+||.||+|.+ ++..||+|++.... ......+.+.+|++++++++||||+++++++.+ ...+|+||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-GDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-CCceEEEE
Confidence 44558999999999999976 67899999987542 233456778999999999999999999998866 45689999
Q ss_pred eccCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc--
Q 006460 93 GYCEGGDMAEIIKKAR-GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-- 169 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~-~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-- 169 (644)
||+.|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 9999999999997543 3468999999999999999999999999999999999999999999999999998654321
Q ss_pred -ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH----HHHHHHh----------ccCCCCC
Q 006460 170 -LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA----GLINKIN----------RSSISPL 234 (644)
Q Consensus 170 -~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~----el~~~i~----------~~~~~~~ 234 (644)
......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...... .+...+. .......
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 2344679999999999876 5899999999999999999999999765432 2222221 1222334
Q ss_pred CccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 235 p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+..++..+.+|+.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 55567889999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=379.97 Aligned_cols=250 Identities=19% Similarity=0.269 Sum_probs=208.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.++||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.|.|++++..+.+|.......|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 3458999999999999999999999999999999998765432 246779999999988666655555555677899
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE---cCCCCeEEeccCcccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL---TKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL---~~~g~vKL~DFGls~~~~ 166 (644)
|||||+ |++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+.
T Consensus 80 lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999999 99999999864 3469999999999999999999999999999999999999 578999999999998765
Q ss_pred cccc--------cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcc----CC
Q 006460 167 TEDL--------ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDM---AGLINKINRS----SI 231 (644)
Q Consensus 167 ~~~~--------~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~---~el~~~i~~~----~~ 231 (644)
.... .....||+.|+|||++.+..|+.++|||||||+||+|++|..||.+... ...+..+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 4321 2367899999999999999999999999999999999999999987442 3333333222 22
Q ss_pred CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 232 SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 232 ~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
..++..++.++.+||.+||..+|.+||++.+|++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2233567899999999999999999999998865
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=361.00 Aligned_cols=254 Identities=21% Similarity=0.383 Sum_probs=211.8
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 7 DSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 7 ~~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
......++|++.+.||+|+||.||+|.+.. .+|+|++..........+.+.+|+.++++++||||+++++++... .
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-P 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-S
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-C
Confidence 344677999999999999999999998754 599999876543333345567899999999999999999998764 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+++||||+.|++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 699999999999999999753 34689999999999999999999999999999999999998 7899999999987543
Q ss_pred cc------cccccccCCCCCCChhhhcC---------CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC
Q 006460 167 TE------DLASSVVGTPNYMCPELLAD---------IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI 231 (644)
Q Consensus 167 ~~------~~~~~~~GT~~Y~APEvl~~---------~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~ 231 (644)
.. .......||+.|+|||++.+ ..|+.++|||||||++|+|++|..||...........+.....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 21 22344568999999999864 4578999999999999999999999999988888877776655
Q ss_pred CCCC-ccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 232 SPLP-IVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 232 ~~~p-~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+..+ ..++..+.+||.+||..||.+|||+.++++.
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 4433 3578899999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.03 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=203.3
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHh--cCCCCcceeeeEEEeCC---ce
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK--LNNPYIVKYKDAWVDKG---NC 87 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~--L~HPNIVkl~~~~~d~~---~~ 87 (644)
++|++.+.||+|+||.||+|.+ +++.||+|++.... ...+.+|+++++. ++||||+++++++.... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 6899999999999999999987 58999999996543 3456778999887 78999999999987654 27
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCccccCCCCcEEEcCCCCeEEecc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH--------SNRVLHRDLKCSNIFLTKDNDIRLGDF 159 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLH--------s~gIIHRDLKPeNILL~~~g~vKL~DF 159 (644)
+|+||||+.+|+|.+++... .+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 99999999999999999753 4899999999999999999999 899999999999999999999999999
Q ss_pred Cccccccccc-----ccccccCCCCCCChhhhcCCC------CCcccchhhHHHHHHHHHhC----------CCCCCCC-
Q 006460 160 GLAKLLNTED-----LASSVVGTPNYMCPELLADIP------YGYKSDIWSLGCCMFEIAAH----------QPAFRAP- 217 (644)
Q Consensus 160 Gls~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~------ys~ksDIWSLGvILyeLltG----------~~PF~~~- 217 (644)
|++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998764432 234568999999999997752 34789999999999999999 7888654
Q ss_pred ----ChHHHHHHHhccC-CCCCCc-----cccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 218 ----DMAGLINKINRSS-ISPLPI-----VYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 218 ----~~~el~~~i~~~~-~~~~p~-----~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
....+...+.... .+..+. .++..+.+||.+||..||.+|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2344444443332 233333 245689999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=385.30 Aligned_cols=253 Identities=24% Similarity=0.415 Sum_probs=220.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecC---CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIE---RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
...++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+|++++|||||++++++.+ .
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE--N 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--C
Confidence 3457899999999999999999998754 4679999886543 34456788999999999999999999998743 4
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 589999999999999999864 3468999999999999999999999999999999999999999999999999998765
Q ss_pred cccc--cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHH
Q 006460 167 TEDL--ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 167 ~~~~--~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~ 243 (644)
.... .....+|+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+....+....+......+.|..++..+.
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 622 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 622 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence 4332 223456789999999998899999999999999999997 9999999999999888888877788889999999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhC
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+||.+||..||.+|||+.++++.
T Consensus 623 ~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 623 SLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=371.76 Aligned_cols=254 Identities=13% Similarity=0.102 Sum_probs=200.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCC-CCccee---------ee
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNN-PYIVKY---------KD 79 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~H-PNIVkl---------~~ 79 (644)
...+|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.+.| +|+... .+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34569999999999999999999999999999999874432 22335678889999999977 322111 11
Q ss_pred E------------EEeC----CceEEEEEeccCCCCHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 006460 80 A------------WVDK----GNCVCIVTGYCEGGDMAEIIKKA-----RGACFPEEKLCKWLTQLLLAVDYLHSNRVLH 138 (644)
Q Consensus 80 ~------------~~d~----~~~~~LVmEy~~GgsL~~~L~~~-----~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIH 138 (644)
. +... ...++++|+++ +++|.+++... ....+++..++.++.||+.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1 1110 12467888877 78999998632 2334778899999999999999999999999
Q ss_pred ccCCCCcEEEcCCCCeEEeccCcccccccccccccccCCCCCCChhhh----------cCCCCCcccchhhHHHHHHHHH
Q 006460 139 RDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL----------ADIPYGYKSDIWSLGCCMFEIA 208 (644)
Q Consensus 139 RDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl----------~~~~ys~ksDIWSLGvILyeLl 208 (644)
|||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..|+.++|||||||++|+|+
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999875543 456788 999999999 5556889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 209 AHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 209 tG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
+|+.||...........+.. ....++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 312 tg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HCCCCCCCcchhhhHHHHHh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 99999987665433333222 1235689999999999999999999999999999998654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=395.46 Aligned_cols=264 Identities=26% Similarity=0.401 Sum_probs=214.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEe-----
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVD----- 83 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d----- 83 (644)
...+++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+.+|+++|++++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 34679999999999999999999999999999999998764 344556778999999999999999999998643
Q ss_pred CCceEEEEEeccCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCC---eEEecc
Q 006460 84 KGNCVCIVTGYCEGGDMAEIIKKAR-GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDND---IRLGDF 159 (644)
Q Consensus 84 ~~~~~~LVmEy~~GgsL~~~L~~~~-~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~---vKL~DF 159 (644)
.+...|+|||||.||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 2456899999999999999998633 235899999999999999999999999999999999999997765 999999
Q ss_pred CcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH---------H----
Q 006460 160 GLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINK---------I---- 226 (644)
Q Consensus 160 Gls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~---------i---- 226 (644)
|++.............||+.|+|||++.+..|+.++|||||||++|+|++|..||........... +
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 999987766666778999999999999999999999999999999999999999976533221100 0
Q ss_pred -hcc-----CC----CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 227 -NRS-----SI----SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 227 -~~~-----~~----~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
... .. ..++..++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 000 00 112334678999999999999999999999999999997643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.37 Aligned_cols=244 Identities=22% Similarity=0.258 Sum_probs=194.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc------cHHHHHHHHHHHHHHHhcC---------CCCcce
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ------TEKFKRTALQEMDLISKLN---------NPYIVK 76 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~------~~~~~~~~~rEi~iL~~L~---------HPNIVk 76 (644)
.++|++.+.||+|+||.||+|.+ +++.||+|++..... .....+.+.+|+.+|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999988 789999999986532 1222356788999988885 777777
Q ss_pred eeeEEEe-----------------------------CCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Q 006460 77 YKDAWVD-----------------------------KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127 (644)
Q Consensus 77 l~~~~~d-----------------------------~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~g 127 (644)
+++++.. ....+|||||||.+|+|.+.+.. ..+++..++.|+.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 7766532 15679999999999976665532 458999999999999999
Q ss_pred HHHHH-HCCCccccCCCCcEEEcCCC--------------------CeEEeccCcccccccccccccccCCCCCCChhhh
Q 006460 128 VDYLH-SNRVLHRDLKCSNIFLTKDN--------------------DIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186 (644)
Q Consensus 128 L~yLH-s~gIIHRDLKPeNILL~~~g--------------------~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl 186 (644)
|.||| ++||+||||||+||||+.++ .+||+|||+++..... ..+||+.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence 99999 99999999999999999887 8999999999876542 45899999999999
Q ss_pred cCCCCCcccchhhHHHH-HHHHHhCCCCCCCCCh-HHHHHHHhcc-CCC-----CCCccccHHHHHHHHHHhccCCCCCC
Q 006460 187 ADIPYGYKSDIWSLGCC-MFEIAAHQPAFRAPDM-AGLINKINRS-SIS-----PLPIVYSSTMKQIIKSMLRKNPEHRP 258 (644)
Q Consensus 187 ~~~~ys~ksDIWSLGvI-LyeLltG~~PF~~~~~-~el~~~i~~~-~~~-----~~p~~~s~~l~dLI~~~L~~dP~~Rp 258 (644)
.+.. +.++||||||++ .++++.|..||..... ......+... ... +.+..+++++.+||.+||++|
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 8766 899999998777 7788999999854221 1122232211 111 112347889999999999976
Q ss_pred CHHHHh-hCCCCc
Q 006460 259 TASDLL-RHPHLQ 270 (644)
Q Consensus 259 Ta~eiL-~hp~f~ 270 (644)
|+.++| +||||+
T Consensus 324 sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHCGGGC
T ss_pred CHHHHHhcCCCcC
Confidence 999999 999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=333.80 Aligned_cols=223 Identities=13% Similarity=0.119 Sum_probs=186.2
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
-++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l 108 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-RAGGLV 108 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-CCcEEE
Confidence 3789999999999999999999999999999999987643 34556788999999999999999999999877 467999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL 170 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~ 170 (644)
||||++|++|.++++. + ....++..|+.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~--~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT--S--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT--C--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEEecCCCCHHHHHhc--C--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999999999853 2 4566788999999999999999999999999999999999999998543
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH---HHhccCCC---CCCccccHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLIN---KINRSSIS---PLPIVYSSTMKQ 244 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~---~i~~~~~~---~~p~~~s~~l~d 244 (644)
|++ .++.++|||||||++|+|++|+.||.+.+....+. ........ ..+..++..+.+
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 333 37899999999999999999999998765432110 00011111 122457899999
Q ss_pred HHHHHhccCCCCCCCHHHHhhC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~h 266 (644)
||.+||..||.+| |+.++++.
T Consensus 239 li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999 99999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=379.14 Aligned_cols=242 Identities=21% Similarity=0.339 Sum_probs=201.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEec-CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc----
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKI-ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN---- 86 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~-tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~---- 86 (644)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... .......+.+|+++|++++|||||+++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3899999999999999999999986 78999999986543 34456678899999999999999999999876443
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
..||||||+.|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+|||++.+ .+||+|||+++...
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred eeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 27999999999999987743 59999999999999999999999999999999999999875 89999999998765
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
.. ...+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+..... ..........+..+.+||
T Consensus 233 ~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li 301 (681)
T 2pzi_A 233 SF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------LPEDDPVLKTYDSYGRLL 301 (681)
T ss_dssp CC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-------CCTTCHHHHHCHHHHHHH
T ss_pred cC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-------ccccccccccCHHHHHHH
Confidence 43 556899999999998764 5899999999999999999999987532110 000001112467899999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCc
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
.+||..||.+||+..+.+.|+|+.
T Consensus 302 ~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 302 RRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhhccCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-33 Score=315.79 Aligned_cols=229 Identities=14% Similarity=0.097 Sum_probs=154.7
Q ss_pred EeccCCCeEEEEEEEecCCeEEEEEEEeccc--------ccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCceEEE
Q 006460 20 QIGRGAFGAAFLVLHKIERKKYVLKKIRLAK--------QTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 20 ~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~--------~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~~~~L 90 (644)
.++.|++|.+..++....|+.|++|++.+.. ..+...+.+.+|+++|+++ .|+||+++++++.+ +..+||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWL 319 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEE
Confidence 4567788888888888889999999997642 1233456799999999999 69999999998766 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-c
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-D 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~ 169 (644)
|||||+|++|.++|.. ++.+++. .|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++..... .
T Consensus 320 VMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 9999999999999975 4457764 47899999999999999999999999999999999999999999876443 3
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
...+.+||+.|||||++.+ .+..++|+||+|+++|+|.++..+| ...+.... +.. ..+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~~----~~~--~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQEP----VER--WNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH--------HHHHHTSC----GGG--CSHHHHHHHH
T ss_pred cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh--------HHHhhcCC----CCC--CcHHHHHHHH
Confidence 4556789999999999977 4678899999999999887664432 11111111 111 1234566666
Q ss_pred hccCCCCCCCHHHHhhCCCC
Q 006460 250 LRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~hp~f 269 (644)
+..+|..|+.......++|.
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHH
T ss_pred hCCCCCCCCChhhhccchhH
Confidence 77777777665555555544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-28 Score=270.51 Aligned_cols=184 Identities=21% Similarity=0.196 Sum_probs=144.6
Q ss_pred EEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc------cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 16 EVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ------TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 16 ~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~------~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...+.||+|+||.||+| ...+..+++|+...... .....+++.+|+++|++++||||+++..++...+ ..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD-NKR 415 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT-TTE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC-ccE
Confidence 34568999999999999 55678999998754321 1123456899999999999999996555555533 469
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
|||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++......
T Consensus 416 lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999998864 5689999999999999999999999999999998 99999999999875532
Q ss_pred --------ccccccCCCCCCChhhhcC--CCCCcccchhhHHHHHHHHHhCCCCC
Q 006460 170 --------LASSVVGTPNYMCPELLAD--IPYGYKSDIWSLGCCMFEIAAHQPAF 214 (644)
Q Consensus 170 --------~~~~~~GT~~Y~APEvl~~--~~ys~ksDIWSLGvILyeLltG~~PF 214 (644)
.....+||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1246789999999999987 56888999999998888887776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-25 Score=227.12 Aligned_cols=155 Identities=18% Similarity=0.201 Sum_probs=122.3
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH----------------HHHHHHHHHHHHHHhcCCCCcceeeeE
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE----------------KFKRTALQEMDLISKLNNPYIVKYKDA 80 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~----------------~~~~~~~rEi~iL~~L~HPNIVkl~~~ 80 (644)
+.+.||+|+||.||+|.+ .+|+.||+|+++...... .....+.+|+.+|++++ | ++++++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 349999999999999999 889999999996543211 13467889999999999 5 666665
Q ss_pred EEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccC
Q 006460 81 WVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFG 160 (644)
Q Consensus 81 ~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFG 160 (644)
+.. +..|+||||++|++|.+ +. . .....++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 170 ~~~--~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 170 YAW--EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp EEE--ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred Eec--cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 433 34689999999999987 31 1 23557999999999999999999999999999999 9999999999
Q ss_pred cccccccccccccccCCCCCCChhhhcC----------CCCCcccchhh
Q 006460 161 LAKLLNTEDLASSVVGTPNYMCPELLAD----------IPYGYKSDIWS 199 (644)
Q Consensus 161 ls~~~~~~~~~~~~~GT~~Y~APEvl~~----------~~ys~ksDIWS 199 (644)
+++. +..|+|||++.+ ..|+..+|+|.
T Consensus 238 ~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 238 QSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9863 345789998854 33455556654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=8.8e-21 Score=193.30 Aligned_cols=139 Identities=16% Similarity=0.150 Sum_probs=110.0
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeE--EEEEEEeccccc----------------------HHHHHHHHHHHHHHHhcC
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKK--YVLKKIRLAKQT----------------------EKFKRTALQEMDLISKLN 70 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~--vAiK~i~~~~~~----------------------~~~~~~~~rEi~iL~~L~ 70 (644)
|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ......+.+|+++|+.|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999888999 999997654211 112246788999999998
Q ss_pred CCCc--ceeeeEEEeCCceEEEEEeccCC-C----CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCC
Q 006460 71 NPYI--VKYKDAWVDKGNCVCIVTGYCEG-G----DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH-SNRVLHRDLK 142 (644)
Q Consensus 71 HPNI--Vkl~~~~~d~~~~~~LVmEy~~G-g----sL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLH-s~gIIHRDLK 142 (644)
|+++ +.+++ . ...||||||+.+ | .|.++... +++..+..++.||+.||.||| ++||+|||||
T Consensus 129 ~~~i~~p~~~~--~---~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYT--Y---MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEE--E---ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred hCCCCCCeEEE--c---CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 8864 33333 2 236899999932 3 77766432 335678899999999999999 9999999999
Q ss_pred CCcEEEcCCCCeEEeccCccccc
Q 006460 143 CSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 143 PeNILL~~~g~vKL~DFGls~~~ 165 (644)
|+|||++. .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999997 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=5.2e-17 Score=175.73 Aligned_cols=138 Identities=18% Similarity=0.201 Sum_probs=101.0
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc----------------HH----HHHHHHHHHHHHHhcCCCCc
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT----------------EK----FKRTALQEMDLISKLNNPYI 74 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~----------------~~----~~~~~~rEi~iL~~L~HPNI 74 (644)
|++.++||.|+||.||+|.+. +|+.||||+++..... .. ..-...+|...|.+|.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999874 6899999998643110 00 11123467888888855444
Q ss_pred ceeeeEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC--
Q 006460 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-- 152 (644)
Q Consensus 75 Vkl~~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-- 152 (644)
.-..-+... . .+|||||+.|+.|..+. .......++.||+.+|.|||++|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~~-~--~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQS-R--HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCCCEEEEE-T--TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCeeeecc-C--ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 222211122 2 36999999998886532 1234567889999999999999999999999999999876
Q ss_pred --------CeEEeccCcccc
Q 006460 153 --------DIRLGDFGLAKL 164 (644)
Q Consensus 153 --------~vKL~DFGls~~ 164 (644)
.+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 388999986653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-11 Score=125.04 Aligned_cols=143 Identities=17% Similarity=0.131 Sum_probs=110.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~ 88 (644)
..++.|++...+|.|+++.||++.. .+..+++|+........ ...+.+|+++|+.|. +..+.++++++.. ....
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~ 85 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWS 85 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCce
Confidence 3467899999999999999999964 36799999986532111 234778999999884 6778888887765 4668
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS----------------------------------- 133 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs----------------------------------- 133 (644)
|+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999999987521 122334678899999999998
Q ss_pred ------------------------CCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 134 ------------------------NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 134 ------------------------~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998655567999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=8.7e-11 Score=116.77 Aligned_cols=139 Identities=17% Similarity=0.094 Sum_probs=99.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC--cceeeeEEEeCCc
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY--IVKYKDAWVDKGN 86 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPN--IVkl~~~~~d~~~ 86 (644)
...+.+|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+|+.+.+.+ +.+++.++.. +.
T Consensus 16 ~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~ 88 (264)
T 1nd4_A 16 VERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE-AG 88 (264)
T ss_dssp TTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SS
T ss_pred HHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccC-CC
Confidence 45567888866655677799999953 567789999876531 134667999998885444 4557776554 45
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR------------------------------- 135 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g------------------------------- 135 (644)
..|+||||++|.+|. .. . .. ...++.++...|..||+..
T Consensus 89 ~~~~v~e~i~G~~l~--~~---~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SS---H--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp CEEEEEECCSSEETT--TS---C--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCEEEEEecCCcccC--cC---c--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 589999999998874 11 1 11 1245667777777777643
Q ss_pred ---------------------------CccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 136 ---------------------------VLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 136 ---------------------------IIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998765567999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=7.3e-10 Score=117.08 Aligned_cols=143 Identities=13% Similarity=0.202 Sum_probs=105.5
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEe--cccccHHHHHHHHHHHHHHHhcC--CCCcceeeeEEEeCC--ceE
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKLN--NPYIVKYKDAWVDKG--NCV 88 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~--~~~~~~~~~~~~~rEi~iL~~L~--HPNIVkl~~~~~d~~--~~~ 88 (644)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+++|+.|. +..+.+++.++.+.. ...
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 445788999999999998753 4689999776 33211 12346778999999996 456788887765431 347
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS----------------------------------- 133 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs----------------------------------- 133 (644)
|+||||++|..+.+.. -..+++.....++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 8999999998774311 1236788888999999999999997
Q ss_pred -----------------------CCCccccCCCCcEEEcCCCC--eEEeccCcccc
Q 006460 134 -----------------------NRVLHRDLKCSNIFLTKDND--IRLGDFGLAKL 164 (644)
Q Consensus 134 -----------------------~gIIHRDLKPeNILL~~~g~--vKL~DFGls~~ 164 (644)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997764 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.95 E-value=8.7e-10 Score=113.95 Aligned_cols=182 Identities=14% Similarity=0.209 Sum_probs=121.3
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCC--cceeeeEEEeCC--ceEEEEE
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPY--IVKYKDAWVDKG--NCVCIVT 92 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPN--IVkl~~~~~d~~--~~~~LVm 92 (644)
++.++.|....||++. ..+++|+.... .....+.+|+++|+.+. +.. +.+++......+ ...|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3458999999999874 47899986533 33466888999999883 332 233333221211 2358899
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS--------------------------------------- 133 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs--------------------------------------- 133 (644)
++++|..|...... .++.++...++.|+...|..||+
T Consensus 96 ~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99999888754332 36778888889999999999986
Q ss_pred -------------------CCCccccCCCCcEEEcC--CCCeEEeccCcccccccccccccccCCCCC---CChhhhcC-
Q 006460 134 -------------------NRVLHRDLKCSNIFLTK--DNDIRLGDFGLAKLLNTEDLASSVVGTPNY---MCPELLAD- 188 (644)
Q Consensus 134 -------------------~gIIHRDLKPeNILL~~--~g~vKL~DFGls~~~~~~~~~~~~~GT~~Y---~APEvl~~- 188 (644)
..++|+|++|.||+++. .+.+.|+||+.+....... .......+ ..|+....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHH
Confidence 13699999999999998 4557899999987532210 00011111 23332211
Q ss_pred -CCC------------CcccchhhHHHHHHHHHhCCCCCC
Q 006460 189 -IPY------------GYKSDIWSLGCCMFEIAAHQPAFR 215 (644)
Q Consensus 189 -~~y------------s~ksDIWSLGvILyeLltG~~PF~ 215 (644)
..| ..-.+.|++|.++|.+.+|.++|-
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 011 122589999999999999987763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.1e-06 Score=91.36 Aligned_cols=135 Identities=19% Similarity=0.202 Sum_probs=94.0
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCC---CcceeeeEEEeCCceEEEEEec
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP---YIVKYKDAWVDKGNCVCIVTGY 94 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HP---NIVkl~~~~~d~~~~~~LVmEy 94 (644)
+..++.|....||++ +..+++|+... ......+.+|+++|+.|.+. .+.+.+.+........|+||+|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456788999999998 56889998532 23356788899999999652 2455555544344567899999
Q ss_pred cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------
Q 006460 95 CEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN---------------------------------------- 134 (644)
Q Consensus 95 ~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~---------------------------------------- 134 (644)
++|..|....-. .++......++.++...|..||+.
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 999888763211 134455555555555555555532
Q ss_pred --------------------CCccccCCCCcEEEcC---CCCe-EEeccCccccc
Q 006460 135 --------------------RVLHRDLKCSNIFLTK---DNDI-RLGDFGLAKLL 165 (644)
Q Consensus 135 --------------------gIIHRDLKPeNILL~~---~g~v-KL~DFGls~~~ 165 (644)
.++|+|++|.|||++. ++.+ .|+||+.+..-
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3589999999999997 4554 89999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=7.6e-06 Score=82.14 Aligned_cols=139 Identities=17% Similarity=0.129 Sum_probs=96.4
Q ss_pred CCeEEEEEeccCCCe-EEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceEEE
Q 006460 13 EDYEVIEQIGRGAFG-AAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG-~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~~L 90 (644)
..|+... +..|..| .||+......+..+++|+-.... ...+.+|..+|+.|. +--+.+++.++.+. ...|+
T Consensus 25 ~g~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~-----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~l 97 (272)
T 4gkh_A 25 YGYRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKGSV-----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWL 97 (272)
T ss_dssp TTCEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEETHH-----HHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEE
T ss_pred cCCeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCCCC-----HhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEE
Confidence 3455443 3445554 69998887788899999875432 345677999998884 32356677766664 56899
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN------------------------------------ 134 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~------------------------------------ 134 (644)
|||+++|.++.+..... ......+..++...|..||..
T Consensus 98 vme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER 171 (272)
T ss_dssp EEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred EEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence 99999999887765431 122334555666666666621
Q ss_pred ----------------------CCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 135 ----------------------RVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 135 ----------------------gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999776667999998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=4.4e-05 Score=78.66 Aligned_cols=30 Identities=20% Similarity=0.328 Sum_probs=27.2
Q ss_pred CCCccccCCCCcEEEcCCCCeEEeccCccc
Q 006460 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAK 163 (644)
Q Consensus 134 ~gIIHRDLKPeNILL~~~g~vKL~DFGls~ 163 (644)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999878889999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1.6e-05 Score=84.91 Aligned_cols=79 Identities=15% Similarity=0.126 Sum_probs=49.4
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc--cH---HHHHHHHHHHHHHHhcCC--CCcc-eeeeEEEeCCceE
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ--TE---KFKRTALQEMDLISKLNN--PYIV-KYKDAWVDKGNCV 88 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~--~~---~~~~~~~rEi~iL~~L~H--PNIV-kl~~~~~d~~~~~ 88 (644)
-.+.||.|.++.||++....+++.+++|....... .+ ....++.+|.++|+.+.. |.++ +++. + +.+. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~-~-d~~~-~ 110 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-S-DTEM-A 110 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-E-ETTT-T
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE-E-cCCc-c
Confidence 46789999999999997766678999998653211 00 012345678888887742 4444 4443 2 4333 5
Q ss_pred EEEEeccCCC
Q 006460 89 CIVTGYCEGG 98 (644)
Q Consensus 89 ~LVmEy~~Gg 98 (644)
++||||+.|.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999773
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=3.5e-05 Score=80.72 Aligned_cols=85 Identities=11% Similarity=0.050 Sum_probs=53.1
Q ss_pred EEEEEe-ccCCCeEEEEEEEe--c----CCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcC-C--CCcceeeeEEEeC
Q 006460 16 EVIEQI-GRGAFGAAFLVLHK--I----ERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLN-N--PYIVKYKDAWVDK 84 (644)
Q Consensus 16 ~i~~~L-G~G~fG~Vyla~~k--~----tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~-H--PNIVkl~~~~~d~ 84 (644)
...+.| +.|....+|++... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88999999988653 1 256899997654320 0000124566888888773 2 3466677654432
Q ss_pred C--ceEEEEEeccCCCCH
Q 006460 85 G--NCVCIVTGYCEGGDM 100 (644)
Q Consensus 85 ~--~~~~LVmEy~~GgsL 100 (644)
. ...|+||||++|..|
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 1 246799999988654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00038 Score=69.34 Aligned_cols=136 Identities=16% Similarity=0.108 Sum_probs=94.0
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCcccccccccccccccC
Q 006460 98 GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVG 176 (644)
Q Consensus 98 gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~~~~G 176 (644)
.+|.++|+.. +.+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|+|..+|.|.+.+ +.+. ..
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 3899999865 5689999999999999999887722 2223444567999999999998764 2111 11
Q ss_pred CCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhcc----
Q 006460 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLRK---- 252 (644)
Q Consensus 177 T~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~---- 252 (644)
...+.|||... ...+.+.=|||||+++|.-+--..| ...+..+|+.|..||..|..-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~~~d~ 160 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANTVEAD 160 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTCCC--
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhccccc
Confidence 22456888763 3446788899999999998853222 234667899999999999866
Q ss_pred ---------------------CCCCCCCHHHHhh
Q 006460 253 ---------------------NPEHRPTASDLLR 265 (644)
Q Consensus 253 ---------------------dP~~RpTa~eiL~ 265 (644)
.+..|+++++|++
T Consensus 161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp ------------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccccccccCcCCHHHHHH
Confidence 2457788888875
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=97.68 E-value=1.1e-06 Score=85.18 Aligned_cols=121 Identities=9% Similarity=0.041 Sum_probs=85.8
Q ss_pred hhhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccc
Q 006460 321 LENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAH 394 (644)
Q Consensus 321 le~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~ 394 (644)
.+.++.++.+..+.++..++. ....+...++.++...|.|++|.| +|.||+.+.+.......++.++.+|+..
T Consensus 60 ~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~~g~I-~~~EF~~~~~~~~~~~~~~~l~~~F~~~ 138 (197)
T 3pm8_A 60 RNIFIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDIDSNASGQI-HYTDFLAATIDKQTYLKKEVCLIPFKFF 138 (197)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHHC----CHHHHHHHHC-------CE-EHHHHHHTTCCHHHHCSHHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeE-cHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 344566777777776666553 223566778999999999999999 9999999999998888999999999999
Q ss_pred cCCccCCCCchhhhhhhhhhhcccc--c--cCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPA--D--AHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. |.+++++.+|+.+.+... + +.-..+++ ++...|.+ .|+.|++.||.
T Consensus 139 D~-----d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~----l~~~~D~d--~dG~Is~~EF~ 190 (197)
T 3pm8_A 139 DI-----DGNGKISVEELKRIFGRDDIENPLIDKAIDS----LLQEVDLN--GDGEIDFHEFM 190 (197)
T ss_dssp CT-----TCSSEECHHHHHHHHC----CCHHHHHHHHH----HHHHHCTT--CSSSEEHHHHH
T ss_pred CC-----CCCCCCCHHHHHHHHHhcccCCCCCHHHHHH----HHHHHcCC--CCCcCcHHHHH
Confidence 88 999999999999998765 2 22223333 37778888 89999998885
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00062 Score=73.38 Aligned_cols=33 Identities=18% Similarity=0.318 Sum_probs=28.3
Q ss_pred HHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 132 Hs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
+...++|+|++|.|||++.++ ++|+||+.+..-
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 345799999999999998776 999999988753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0019 Score=67.42 Aligned_cols=76 Identities=11% Similarity=0.019 Sum_probs=56.8
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC---CCCcceeeeEEEeCCceEEEEEe
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN---NPYIVKYKDAWVDKGNCVCIVTG 93 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HPNIVkl~~~~~d~~~~~~LVmE 93 (644)
-.+.|+.|....+|++.. .+..+++|+..... ...+.+|+..|+.|. ...+.+++.+... ....|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEE
Confidence 467789999999999864 46789999876432 345677888888873 3567777776544 456899999
Q ss_pred ccCCCCH
Q 006460 94 YCEGGDM 100 (644)
Q Consensus 94 y~~GgsL 100 (644)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=97.22 E-value=2e-05 Score=75.10 Aligned_cols=120 Identities=11% Similarity=0.098 Sum_probs=88.9
Q ss_pred hhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccc-ccccccccccccccc
Q 006460 323 NVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERST-QTETSDCSRDKQAHF 395 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~-~~~~~~l~~af~~~~ 395 (644)
.+..++++..+.++..++. .-..+...++.++...|.|++|.| +|.||+........ ..+++.|..||+.++
T Consensus 16 ~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d~d~~~~i-~~~ef~~~~~~~~~~~~~~~~l~~aF~~fD 94 (176)
T 2lhi_A 16 AFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQI-EFSEFLALMSRQLKSNDSEQELLEAFKVFD 94 (176)
T ss_dssp HHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTCSSCSSSB-CTTHHHHHHTSSCCSSHHHHHHHHHHHHHC
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhCcCCCccc-hHHHHHHHHHHhcccCCcHHHHHHHHHHhC
Confidence 4566677777777766653 223456677899999999999999 99999987755433 335678999999999
Q ss_pred CCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 396 NGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+ |.+++++.+++.+++...+..... +|++ ++++..| | .|+.|+|.||-
T Consensus 95 ~-----d~~G~I~~~el~~~l~~~g~~~~~-~ei~-~l~~~~d-d--~dG~I~~~EF~ 142 (176)
T 2lhi_A 95 K-----NGDGLISAAELKHVLTSIGEKLTD-AEVD-DMLREVS-D--GSGEINIQQFA 142 (176)
T ss_dssp S-----SCSSSBCHHHHHHHHHTTTCCCCH-HHHH-HHHHHHH-T--TSSCBCTTHHH
T ss_pred C-----CCCCcCcHHHHHHHHHHcCcccch-HHHH-HHHHhhc-C--CCCeEeHHHHH
Confidence 8 999999999999997666544322 1111 2366666 7 79999999997
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.20 E-value=2.9e-05 Score=74.36 Aligned_cols=118 Identities=10% Similarity=0.101 Sum_probs=89.6
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCC
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNG 397 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~ 397 (644)
+..++.+..+.++..++. ........++.++...|.|++|.| +|.||+...........++.+..+|+..+.
T Consensus 16 F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D~d~dG~I-~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~- 93 (188)
T 1s6i_A 16 FKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTI-DYGEFIAATVHLNKLEREENLVSAFSYFDK- 93 (188)
T ss_dssp HHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEE-CHHHHHHHHTTSSSSCCCCSTHHHHHHTTT-
T ss_pred HHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeE-eHHHHHHHHHHHhccCHHHHHHHHHHHHCC-
Confidence 444555555555444431 112344667899999999999999 999999988776666677889999999988
Q ss_pred ccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 398 STGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.+++++.+++.+.+...++....+++. +..-|.+ .|+.|++.||.
T Consensus 94 ----d~dG~Is~~El~~~l~~~g~~~~~~~~~----~~~~D~d--~dG~Is~~EF~ 139 (188)
T 1s6i_A 94 ----DGSGYITLDEIQQACKDFGLDDIHIDDM----IKEIDQD--NDGQIDYGEFA 139 (188)
T ss_dssp ----TCSSEEEHHHHHHTTTTTTCCTTHHHHH----HHHHCSS--SSSEEETTHHH
T ss_pred ----CCCCcCcHHHHHHHHHHcCCCHHHHHHH----HHHHCCC--CCCcEeHHHHH
Confidence 8999999999999987777544444443 7777888 89999999987
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=97.19 E-value=2.7e-05 Score=76.92 Aligned_cols=120 Identities=12% Similarity=0.012 Sum_probs=93.2
Q ss_pred hhhhhHhhhccccccCcCCCC-------CCCCCchhhcccccc---------ccCCCCccccccchhhhccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLDD-------KPTSSTSTEDNLETK---------KVDPTSYTMEVSSSINDSKERSTQTETS 385 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~~-------~~~ss~~~ed~~~~~---------d~D~nG~i~d~~efi~a~~d~s~~~~~~ 385 (644)
+.+..++.+..+.++..++.. -......+..++... |.|++|.| +|.||+...+....+..++
T Consensus 55 ~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I-~~~EF~~~~~~~~~~~~~~ 133 (226)
T 2lvv_A 55 ELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNKVKGVGEE-DLVEFLEFRLMLCYIYDIF 133 (226)
T ss_dssp HHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHHHSCCCCC-SCBCHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCCCCCCCcC-CHHHHHHHHHHHHhccCHH
Confidence 456677788777777666631 123344566777777 99999999 9999999876666777778
Q ss_pred ccccccccccCCccCCCCchhhhhhhhhhhcccc---ccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 386 DCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA---DAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 386 ~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+..+|+..+. |.+++++.+|+.+++... +.....+++. +..-|.+ .|+.|++.||-
T Consensus 134 ~l~~~F~~~D~-----d~dG~Is~~El~~~l~~~~~~g~~~~e~~~~----~~~~D~d--~dG~Is~~EF~ 193 (226)
T 2lvv_A 134 ELTVMFDTMDK-----DGSLLLELQEFKEALPKLKEWGVDITDATTV----FNEIDTN--GSGVVTFDEFS 193 (226)
T ss_dssp HHHHHHHHHSC-----SSCCEECHHHHHHHHHHHHHHTCCCCSCHHH----HHHHCCS--CSSCEEHHHHH
T ss_pred HHHHHHHHHcC-----CCCCeEcHHHHHHHHHHHhhcCCCHHHHHHH----HHHhCCC--CCCcEeHHHHH
Confidence 99999999988 999999999999997665 6665555554 8888888 89999998886
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=97.08 E-value=2.6e-05 Score=84.63 Aligned_cols=122 Identities=11% Similarity=0.118 Sum_probs=90.4
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc-cccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQAH 394 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~~ 394 (644)
+.|+.++.+..+.++..++. .-..+..+++.++...|.|++|.| ||.||+.....+ ....+++.|+.||+..
T Consensus 306 EaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~DgDG~I-dFeEFl~lms~~lk~~d~eeeLreAFk~f 384 (440)
T 3u0k_A 306 EAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTI-DFPEFLIMMARKMKDTDSEEEIREAFRVF 384 (440)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCSSSE-EHHHHHHHHHTC------CHHHHHHHHHH
T ss_pred HHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcC-cHHHHHHHHHHHhcCCChHHHHHHHHHHH
Confidence 44667788888888777763 223456678999999999999999 999999887554 3345678899999999
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
++ |.+++++.+++.+++...+..+.. +|+ -+++...|.| .|+.|++.||-
T Consensus 385 Dk-----DgdG~IS~eELr~vL~~lGe~LSd-eEI-deLfke~D~D--gDGkIsyeEFv 434 (440)
T 3u0k_A 385 DK-----DGNGYISAAELRHVMTNLGEKLTD-EEV-DEMIREADID--GDGQVNYEEFV 434 (440)
T ss_dssp CT-----TCSSEECHHHHHHHHHHHTCCCCH-HHH-HHHHHHHCTT--CSSSEEHHHHH
T ss_pred CC-----CCcCcCCHHHHHHHHHHhCCCCCH-HHH-HHHHHHhCCC--CCCcEeHHHHH
Confidence 88 999999999999997766643321 111 1247778888 89999998885
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=97.04 E-value=6.1e-05 Score=72.16 Aligned_cols=122 Identities=12% Similarity=0.089 Sum_probs=87.5
Q ss_pred hhhhhHhhhccccccCcCCC-----CCCCCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccC
Q 006460 322 ENVRSVAKNIAVQLNNLPLD-----DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFN 396 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~-----~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~ 396 (644)
..+..++.+..+.++..++. .....+..++.++...|.|++|.| +|.||+.....+.. .+++.+..+|+..+.
T Consensus 56 ~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~l~~~~D~d~~g~i-~~~EF~~~~~~~~~-~~~~~l~~~F~~~D~ 133 (191)
T 3k21_A 56 STFLVLDEDGKGYITKEQLKKGLEKDGLKLPYNFDLLLDQIDSDGSGKI-DYTEFIAAALDRKQ-LSKKLIYCAFRVFDV 133 (191)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHTTCCCCTTHHHHHHHHCTTCSSSE-EHHHHHHHHSCGGG-CCHHHHHHHHHHHST
T ss_pred HHHHHHCCCCCCCCcHHHHHHHHHHcCCCcHHHHHHHHHHhCCCCCCeE-eHHHHHHHHHhhhh-ccHHHHHHHHHHhCC
Confidence 34555666666666655552 111122778899999999999999 99999999877664 667889999999988
Q ss_pred CccCCCCchhhhhhhhhhhccccc--cCccc--ccccccccccccCCCCCchhhhhhhhcc
Q 006460 397 GSTGSDLTSEITANSQNEIQEPAD--AHVQP--AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.+++++.+|+.+.....+ ..+.. .+++ -.++...|.| .|+.|++.||.
T Consensus 134 -----d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~-~~~~~~~D~d--~dG~Is~~EF~ 186 (191)
T 3k21_A 134 -----DNDGEITTAELAHILYNGNKKGNITQRDVNRV-KRMIRDVDKN--NDGKIDFHEFS 186 (191)
T ss_dssp -----TCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHH-HHHHHHHCSS--SSSSBCHHHHH
T ss_pred -----CCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHH-HHHHHHhcCC--CCCeECHHHHH
Confidence 8999999999999975422 22111 0111 1247777888 89999998885
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.002 Score=65.87 Aligned_cols=134 Identities=15% Similarity=0.185 Sum_probs=74.2
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCceEEEEEecc-
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI-VKYKDAWVDKGNCVCIVTGYC- 95 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNI-Vkl~~~~~d~~~~~~LVmEy~- 95 (644)
++.|+.|....+|++ ..+++|+..... ... ....+|+.+++.+....+ .+++.+ +.+. -++|++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~--~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~-~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT--EEY-INRANEAVAAREAAKAGVSPEVLHV--DPAT-GVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC------C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTT-CCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc--cce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCC-CEEEEeecC
Confidence 788999999999999 578999876431 111 112357777776642222 345443 3222 46899999
Q ss_pred CCCCHHH---------------HHHHhcCC--CCC-----HHHHHHHHHH--------------HHHHHHHH----HH--
Q 006460 96 EGGDMAE---------------IIKKARGA--CFP-----EEKLCKWLTQ--------------LLLAVDYL----HS-- 133 (644)
Q Consensus 96 ~GgsL~~---------------~L~~~~~~--~l~-----e~~i~~i~~Q--------------IL~gL~yL----Hs-- 133 (644)
+|.+|.. .+.+.... .++ ...+..+..+ +...+..| ..
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6654421 11111111 111 1122222111 11111111 11
Q ss_pred --CCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 134 --NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 134 --~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 14799999999999 5577899999998864
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=96.98 E-value=2.5e-05 Score=70.96 Aligned_cols=119 Identities=8% Similarity=0.099 Sum_probs=85.7
Q ss_pred hhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccc-cccccccccccccccc
Q 006460 323 NVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERS-TQTETSDCSRDKQAHF 395 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s-~~~~~~~l~~af~~~~ 395 (644)
.+..++.+..+.++..++. ..+.+...++.++...|.|++|.| +|.||+.....+. ...+.+.+..||+.++
T Consensus 11 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i-~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D 89 (143)
T 2obh_A 11 AFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKM-NFGDFLTVMTQKMSEKDTKEEILKAFKLFD 89 (143)
T ss_dssp HHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEE-EHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCee-eHHHHHHHHHHHhccccHHHHHHHHHHHhC
Confidence 3455666666666665552 223455677889999999999999 9999998764321 1223567889999998
Q ss_pred CCccCCCCchhhhhhhhhhhccccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 396 NGSTGSDLTSEITANSQNEIQEPADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+ |.+++++.+++..++...|... ..+++ ++..-|.+ .|+.|++.||-
T Consensus 90 ~-----d~~G~I~~~el~~~l~~~g~~~~~~~~~~----~~~~~D~d--~dG~I~~~eF~ 138 (143)
T 2obh_A 90 D-----DETGKISFKNLKRVAKELGENLTDEELQE----MIDEADRD--GDGEVSEQEFL 138 (143)
T ss_dssp T-----TCSSSBCHHHHHHHHHHTTCCCCHHHHHH----HHHHHCTT--SSSSBCHHHHH
T ss_pred C-----CCCCcCcHHHHHHHHHHhCCCCCHHHHHH----HHHHhCCC--CCCcEeHHHHH
Confidence 8 8999999999999976655432 22333 36677878 89999988875
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.97 E-value=5.7e-05 Score=69.51 Aligned_cols=96 Identities=15% Similarity=0.107 Sum_probs=74.6
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQP 425 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (644)
....++.++...|.|++|.| ++.||+............+.+..+|+..+. |.+++++.+++...+...++....
T Consensus 61 ~~~~~~~~~~~~d~~~~g~i-~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~i~~~e~~~~l~~~~~~~~~ 134 (166)
T 2aao_A 61 KESEILDLMQAADVDNSGTI-DYKEFIAATLHLNKIEREDHLFAAFTYFDK-----DGSGYITPDELQQACEEFGVEDVR 134 (166)
T ss_dssp CHHHHHHHHHHHCTTCCSSB-CHHHHHHHHTTCHHHHTTHHHHHHHHHHCT-----TCSSSBCHHHHHHHTCC-------
T ss_pred CHHHHHHHHHHhCCCCCCeE-cHHHHHHHHHHHhhcccHHHHHHHHHHhCC-----CCCCcCcHHHHHHHHHHcCCCHHH
Confidence 34567889999999999999 999999998776666677889999998888 889999999999998877765444
Q ss_pred ccccccccccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+++. +..-|.+ .|+.|++.||.
T Consensus 135 ~~~~----~~~~d~~--~dg~i~~~eF~ 156 (166)
T 2aao_A 135 IEEL----MRDVDQD--NDGRIDYNEFV 156 (166)
T ss_dssp -CCH----HHHHCTT--CSSSBCHHHHH
T ss_pred HHHH----HHHhCCC--CCCcEeHHHHH
Confidence 4444 6777777 78999988886
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=96.94 E-value=6.3e-05 Score=67.82 Aligned_cols=118 Identities=11% Similarity=0.090 Sum_probs=83.3
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhcccccc-ccCCCCccccccchhhhcccc------cccccccccccc
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETK-KVDPTSYTMEVSSSINDSKER------STQTETSDCSRD 390 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~-d~D~nG~i~d~~efi~a~~d~------s~~~~~~~l~~a 390 (644)
+..++.+..+.++..++. ....+...++.++... |.|++|.| +|.||+...... ......+.+..+
T Consensus 10 F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D~~~~g~i-~~~eF~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (148)
T 1m45_A 10 FTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSL-TLDQITGLIEVNEKELDATTKAKTEDFVKA 88 (148)
T ss_dssp HHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEE-EHHHHHHHHHHTHHHHHGGGCCCTHHHHHH
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhCCCCCCeE-cHHHHHHHHHHHHhhccccccccHHHHHHH
Confidence 444555555555554441 1223456678899999 99999999 999999988776 444567889999
Q ss_pred cccccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 391 KQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 391 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|+..++ |.+++++.+++...+...|.... .+++ ++..-|.+ .|+.|++.||-
T Consensus 89 F~~~D~-----d~~G~I~~~el~~~l~~~g~~~~~~~~~~----~~~~~d~d--~dg~i~~~eF~ 142 (148)
T 1m45_A 89 FQVFDK-----ESTGKVSVGDLRYMLTGLGEKLTDAEVDE----LLKGVEVD--SNGEIDYKKFI 142 (148)
T ss_dssp HHTTCS-----SSSSEEEHHHHHHHHHHSTTCCCHHHHHH----HHTTCCCC--TTSEEEHHHHH
T ss_pred HHHhCC-----CCCCcCCHHHHHHHHHHcCCCCCHHHHHH----HHHHhCCC--CCCeEeHHHHH
Confidence 999888 88999999999999876664432 1222 36666777 88999988875
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=96.94 E-value=3.7e-05 Score=70.40 Aligned_cols=122 Identities=11% Similarity=0.081 Sum_probs=92.8
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc-cccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQAH 394 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~~ 394 (644)
+.++.++++..+.++..++. ........+..++...|.+++|.| ++.||+.....+ ....+++.++.||+..
T Consensus 14 ~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i-~~~ef~~~~~~~~~~~~~~~~l~~aF~~~ 92 (148)
T 2lmt_A 14 DAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQL-NFTEFCGIMAKQMRETDTEEEMREAFKIF 92 (148)
T ss_dssp HHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHHTTSTTEE-EHHHHHHHHHHTTTTTTTHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcccCCCCcc-cHHHHHHHHHHHhcccCcHHHHHHHHHHH
Confidence 44677888888888887773 233455667888999999999999 999999866443 3344667899999999
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. |.+++++.+++..++...|..... +|+ -.+++.-|.| .|+.|++.||-
T Consensus 93 D~-----d~~G~I~~~El~~~l~~~g~~~~~-~e~-~~l~~~~D~d--~dG~I~~~EF~ 142 (148)
T 2lmt_A 93 DR-----DGDGFISPAELRFVMINLGEKVTD-EEI-DEMIREADFD--GDGMINYEEFV 142 (148)
T ss_dssp HS-----SCSSEECHHHHHHHHHHHTCCCCH-HHH-HHHHHHHCCS--CCSSEEHHHHH
T ss_pred CC-----CCcCcCcHHHHHHHHHHcCccccH-HHH-HHHHHHhCCC--CCCeEeHHHHH
Confidence 98 999999999999997666644422 111 1247888888 89999998885
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0042 Score=63.08 Aligned_cols=78 Identities=8% Similarity=0.010 Sum_probs=52.3
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--C-CcceeeeEEEeCCceEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN--P-YIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--P-NIVkl~~~~~d~~~~~~L 90 (644)
...-+..+|.|..+.||++.. .+|+.|++|+....... ....+.+|++.|+.|.- + -+.+++.+ . . -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~-~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW--D-D--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E-T--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec--c-C--ceE
Confidence 345678899999999999974 56889999976543211 12346679999988842 2 23444432 2 2 368
Q ss_pred EEeccCCCC
Q 006460 91 VTGYCEGGD 99 (644)
Q Consensus 91 VmEy~~Ggs 99 (644)
||||+.++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0024 Score=66.10 Aligned_cols=31 Identities=29% Similarity=0.433 Sum_probs=27.1
Q ss_pred CCCccccCCCCcEEEcCC----CCeEEeccCcccc
Q 006460 134 NRVLHRDLKCSNIFLTKD----NDIRLGDFGLAKL 164 (644)
Q Consensus 134 ~gIIHRDLKPeNILL~~~----g~vKL~DFGls~~ 164 (644)
..++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 468999999999999874 6799999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0046 Score=63.43 Aligned_cols=144 Identities=19% Similarity=0.204 Sum_probs=77.0
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-----CCCcceee-e-EEEeCCce
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-----NPYIVKYK-D-AWVDKGNC 87 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----HPNIVkl~-~-~~~d~~~~ 87 (644)
..-++.|+.|....+|++... +..+++|+...... ...+..|+.+++.|. -|.++... + .+..-...
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred ceEeeccCCCcccceEEEEeC--CccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 344677888988999998643 33789998875311 123445777776663 23333211 0 00111245
Q ss_pred EEEEEeccCCCCHH-----------HH---HHHhc-CCC------CCHHHHHHH---------------HHHHHHHHHHH
Q 006460 88 VCIVTGYCEGGDMA-----------EI---IKKAR-GAC------FPEEKLCKW---------------LTQLLLAVDYL 131 (644)
Q Consensus 88 ~~LVmEy~~GgsL~-----------~~---L~~~~-~~~------l~e~~i~~i---------------~~QIL~gL~yL 131 (644)
.++||+|++|..+. .. +.... ... ......... -..+...+.++
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 78999999886431 11 11110 100 010100000 01133445555
Q ss_pred HH-------CCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 132 HS-------NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 132 Hs-------~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
+. .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 52 3689999999999998765568999997753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.01 Score=64.42 Aligned_cols=74 Identities=19% Similarity=0.188 Sum_probs=48.8
Q ss_pred EEEEeccCCCeEEEEEEEec-------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCceE
Q 006460 17 VIEQIGRGAFGAAFLVLHKI-------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI-VKYKDAWVDKGNCV 88 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNI-Vkl~~~~~d~~~~~ 88 (644)
-++.|+.|....||++.... .+..+++|+.... .. ...+.+|+.+++.|...++ .++++.+ . +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~-~-~--- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIF-S-G--- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE-T-T---
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe-C-C---
Confidence 45678889999999997653 2578999988432 11 1234578888888853333 5566543 2 2
Q ss_pred EEEEeccCCCC
Q 006460 89 CIVTGYCEGGD 99 (644)
Q Consensus 89 ~LVmEy~~Ggs 99 (644)
.+|++|++|..
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28999998733
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0028 Score=68.07 Aligned_cols=139 Identities=15% Similarity=0.158 Sum_probs=81.6
Q ss_pred EEEeccCCCeEEEEEEEec-------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceEE
Q 006460 18 IEQIGRGAFGAAFLVLHKI-------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~~ 89 (644)
++.|..|-...+|++.... .+..|++++....... ...+.+|.++++.|. +.-..++++++ .+.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~g--- 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG---VDSLVLESVMFAILAERSLGPQLYGVF--PEG--- 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC---HHHHHHHHHHHHHHHHTTSSCCEEEEE--TTE---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch---HHHHHHHHHHHHHHHhcCCCCeEEEEc--CCc---
Confidence 4567778888999997642 3578999986332111 234558999988874 22234555543 232
Q ss_pred EEEeccCCCCHH--------------HHHHHhcCCC------C--CHHHHHHHHHHHHH-------------------HH
Q 006460 90 IVTGYCEGGDMA--------------EIIKKARGAC------F--PEEKLCKWLTQLLL-------------------AV 128 (644)
Q Consensus 90 LVmEy~~GgsL~--------------~~L~~~~~~~------l--~e~~i~~i~~QIL~-------------------gL 128 (644)
+||||++|..|. ..|.+..... . ....+.+|+.++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999885442 2222222111 1 23556666655422 23
Q ss_pred HHHH----HC----CCccccCCCCcEEEcCC----CCeEEeccCcccc
Q 006460 129 DYLH----SN----RVLHRDLKCSNIFLTKD----NDIRLGDFGLAKL 164 (644)
Q Consensus 129 ~yLH----s~----gIIHRDLKPeNILL~~~----g~vKL~DFGls~~ 164 (644)
..|. .. .++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 22 58999999999999876 6899999998764
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=96.66 E-value=5.3e-05 Score=68.79 Aligned_cols=118 Identities=10% Similarity=0.112 Sum_probs=83.5
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc-cccccccccccccccccC
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQAHFN 396 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~~~~ 396 (644)
+..++.+..+.++..++. ....+...++.++...|.|++|.| +|.||+...... ....+.+.+..+|+..++
T Consensus 16 F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i-~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~ 94 (148)
T 1exr_A 16 FALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI-DFPEFLSLMARKMKEQDSEEELIEAFKVFDR 94 (148)
T ss_dssp HHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSE-EHHHHHHHHHHHHHHHHHHHHHHHHHHHHST
T ss_pred HHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcC-cHHHHHHHHHhcccCCCcHHHHHHHHHHhCC
Confidence 455566655555554442 122345567889999999999999 999999877543 223455778899999888
Q ss_pred CccCCCCchhhhhhhhhhhccccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 397 GSTGSDLTSEITANSQNEIQEPADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.+++++.+++..++...+... ..+++ ++..-|.+ .|+.|++.||-
T Consensus 95 -----d~~G~I~~~el~~~l~~~g~~~~~~~~~~----~~~~~d~d--~dg~i~~~eF~ 142 (148)
T 1exr_A 95 -----DGNGLISAAELRHVMTNLGEKLTDDEVDE----MIREADID--GDGHINYEEFV 142 (148)
T ss_dssp -----TCSSCBCHHHHHHHHHHTTCCCCHHHHHH----HHHHHCSS--SSSSBCHHHHH
T ss_pred -----CCCCcCCHHHHHHHHHHhCCCCCHHHHHH----HHHHhCCC--CCCcEeHHHHH
Confidence 8899999999999976666432 22222 36666777 88999988875
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.00016 Score=68.03 Aligned_cols=94 Identities=13% Similarity=0.150 Sum_probs=76.3
Q ss_pred chhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccccc
Q 006460 348 TSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAE 427 (644)
Q Consensus 348 ~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (644)
..++.++...|.|++|.| +|.||+..........+++.+..+|+..+. |.+++++.+++.+.+.........++
T Consensus 87 ~~~~~~~~~~D~d~~g~i-~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~I~~~E~~~~l~~~~~~~~~~~ 160 (191)
T 3khe_A 87 AEVDHILQSVDFDRNGYI-EYSEFVTVCMDKQLLLSRERLLAAFQQFDS-----DGSGKITNEELGRLFGVTEVDDETWH 160 (191)
T ss_dssp HHHHHHHHHTCTTCSSSE-EHHHHHHHHSCHHHHCCHHHHHHHHHHHCT-----TCSSEECHHHHHHHTTSSCCCHHHHH
T ss_pred HHHHHHHHHhCCCCCCcC-CHHHHHHHHHHhcccchHHHHHHHHHHHCC-----CCcCcCCHHHHHHHHccCCCCHHHHH
Confidence 456788899999999999 999999999888888888999999999888 88999999999999873333333333
Q ss_pred ccccccccccCCCCCchhhhhhhhcc
Q 006460 428 EIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. +..-|.+ .|+.|++.||.
T Consensus 161 ~~----~~~~D~~--~dg~i~~~eF~ 180 (191)
T 3khe_A 161 QV----LQECDKN--NDGEVDFEEFV 180 (191)
T ss_dssp HH----HHHHCTT--CSSSEEHHHHH
T ss_pred HH----HHHhCCC--CCCCCCHHHHH
Confidence 33 6777777 88999888875
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.00021 Score=64.81 Aligned_cols=92 Identities=13% Similarity=0.072 Sum_probs=50.3
Q ss_pred hhccccccccCCCCccccccchhhhccccc-ccccccccccccccccCCccCCCCchhhhhhhhhhhcccccc-Cc--cc
Q 006460 350 TEDNLETKKVDPTSYTMEVSSSINDSKERS-TQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADA-HV--QP 425 (644)
Q Consensus 350 ~ed~~~~~d~D~nG~i~d~~efi~a~~d~s-~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~ 425 (644)
...++...|.|++|.| +|.||+.....+. .....+.++.+|+.+++ |.+++++.+++..++...+. .+ ..
T Consensus 5 ~~~l~~~~D~d~~G~I-~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~-----d~~G~I~~~el~~~l~~~g~~~~~~~e 78 (135)
T 3h4s_E 5 EKSMLLETTSTTKMET-KYEDMLPVMAEKMDVEEFVSELCKGFSLLAD-----PERHLITAESLRRNSGILGIEGMSKED 78 (135)
T ss_dssp --------------CC-CC-----------CHHHHHHHHHHHHHHHSB-----TTTTBBCHHHHHHHGGGGTCCCCCHHH
T ss_pred HHHHHHHHcCCCCCcE-eHHHHHHHHHHHccccchHHHHHHHHHHHCC-----CCCCcCCHHHHHHHHHHhCCCCCCHHH
Confidence 3578899999999999 9999998875432 22245778999999988 88999999999999877663 22 22
Q ss_pred ccccccccccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+++ ++..-|.+ .|+.|++.||-
T Consensus 79 ~~~----~~~~~D~d--~dG~I~~~EF~ 100 (135)
T 3h4s_E 79 AQG----MVREGDLD--GDGALNQTEFC 100 (135)
T ss_dssp HHH----HHHHHCSS--CSSSBCHHHHH
T ss_pred HHH----HHHHhCCC--CCCCCcHHHHH
Confidence 333 36777777 88888887774
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.014 Score=59.98 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=76.1
Q ss_pred EEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--CCcceeeeE----EEeCCceEEEEE
Q 006460 19 EQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN--PYIVKYKDA----WVDKGNCVCIVT 92 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--PNIVkl~~~----~~d~~~~~~LVm 92 (644)
..|+ |....||++.. .+|+.+++|+........ ..+..|+.+++.|.. -.+++++.. +...+...++||
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4566 88889998753 346689999987442222 344557777776631 123333332 011134568899
Q ss_pred eccCCCCHH-----H------HH---HHh-cC------CCCCHHHH----------------------HHHHHHHHHHHH
Q 006460 93 GYCEGGDMA-----E------II---KKA-RG------ACFPEEKL----------------------CKWLTQLLLAVD 129 (644)
Q Consensus 93 Ey~~GgsL~-----~------~L---~~~-~~------~~l~e~~i----------------------~~i~~QIL~gL~ 129 (644)
+|++|..+. . .+ ... .. ..+..... ...+..++..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999874321 1 11 111 00 01111111 111122222222
Q ss_pred HH----HHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 130 YL----HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 130 yL----Hs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
-+ ....++|+|++|.|||++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22 123589999999999998 4 899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.016 Score=63.58 Aligned_cols=76 Identities=14% Similarity=0.157 Sum_probs=47.8
Q ss_pred EEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeCCceEEEEEecc
Q 006460 17 VIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI-VKYKDAWVDKGNCVCIVTGYC 95 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNI-Vkl~~~~~d~~~~~~LVmEy~ 95 (644)
-++.|+.|-...+|++.....+..|++|+...... ... ...+|+.+|+.|...++ .++++++ . +. +||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~i-dR~~E~~vl~~L~~~gl~P~ll~~~-~-~G---~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EII-NREREKKISCILYNKNIAKKIYVFF-T-NG---RIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCS-CHHHHHHHHHHHTTSSSBCCEEEEE-T-TE---EEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhc-CHHHHHHHHHHHHhcCCCCCEEEEe-C-Ce---EEEEee
Confidence 35678889999999998754457899998754311 111 11468899998865555 4566544 2 22 599999
Q ss_pred CCCCH
Q 006460 96 EGGDM 100 (644)
Q Consensus 96 ~GgsL 100 (644)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87433
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=96.44 E-value=0.00027 Score=64.26 Aligned_cols=118 Identities=6% Similarity=-0.035 Sum_probs=84.7
Q ss_pred hhhhHhh--hccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccc--cccccccccccc
Q 006460 323 NVRSVAK--NIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERST--QTETSDCSRDKQ 392 (644)
Q Consensus 323 ~~~~~~~--n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~--~~~~~~l~~af~ 392 (644)
.+..++. +..+.++..++. ....+...++.+ ...|.|++|.| +|.||+........ ......+..+|+
T Consensus 14 ~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D~~~~g~i-~~~eF~~~~~~~~~~~~~~~~~l~~~F~ 91 (156)
T 1wdc_C 14 VFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSL-PFEEFLPAYEGLMDCEQGTFADYMEAFK 91 (156)
T ss_dssp HHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEE-CHHHHHHHHHHHTTSCCCCHHHHHHHHH
T ss_pred HHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhCCCCCCee-eHHHHHHHHHHHhhccCChHHHHHHHHH
Confidence 3555666 666666655552 122344566777 88899999999 99999988766543 445678899999
Q ss_pred cccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccc--cCCCCCchhhhhhhhcc
Q 006460 393 AHFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKS--KDQNPFSDRVIEEADIE 453 (644)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 453 (644)
..+. |.+++++.+++...+...|.... .+++ ++.. .|.+ .|+.|++.||-
T Consensus 92 ~~D~-----d~~G~I~~~el~~~l~~~g~~~~~~~~~~----~~~~~~~D~d--~dg~i~~~eF~ 145 (156)
T 1wdc_C 92 TFDR-----EGQGFISGAELRHVLTALGERLSDEDVDE----IIKLTDLQED--LEGNVKYEDFV 145 (156)
T ss_dssp TTCS-----SSSSEEEHHHHHHHHHHSSSCCCHHHHHH----HHHHHTCCCC--TTSEEEHHHHH
T ss_pred HhCC-----CCCCcCcHHHHHHHHHHcCCCCCHHHHHH----HHHHhCCCCC--CCCcEeHHHHH
Confidence 9888 88999999999999876664322 2222 3566 6777 89999998886
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=96.44 E-value=0.00022 Score=64.38 Aligned_cols=119 Identities=7% Similarity=0.035 Sum_probs=84.3
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccC--CCCccccccchhhhccccccc---ccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVD--PTSYTMEVSSSINDSKERSTQ---TETSDCSRD 390 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D--~nG~i~d~~efi~a~~d~s~~---~~~~~l~~a 390 (644)
..+..++.+..+.++..++. ....+...++.++...|.| ++|.| +|.||+......... .....+..+
T Consensus 14 ~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~~~g~i-~~~eF~~~~~~~~~~~~~~~~~~l~~~ 92 (151)
T 1w7j_B 14 EAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRV-DFETFLPMLQAVAKNRGQGTYEDYLEG 92 (151)
T ss_dssp HHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEE-EHHHHHHHHHHHCC--------CCHHH
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCcCCCCcC-cHHHHHHHHHHHhccCCCCcHHHHHHH
Confidence 34556666677666666552 1233456788999999999 99999 999999887654322 245678889
Q ss_pred cccccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 391 KQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 391 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|+..+. |.+++++.+++...+...|..+. .+++ ++...| + .|+.|++.||-
T Consensus 93 F~~~D~-----d~~G~I~~~el~~~l~~~g~~~~~~~~~~----~~~~~d-~--~dg~i~~~eF~ 145 (151)
T 1w7j_B 93 FRVFDK-----EGNGKVMGAELRHVLTTLGEKMTEEEVET----VLAGHE-D--SNGCINYEAFL 145 (151)
T ss_dssp HHTTCT-----TSSSEEEHHHHHHHHHHSSSCCCHHHHHH----HHTTCC-C--TTSEEEHHHHH
T ss_pred HHHhCC-----CCCCcCcHHHHHHHHHHcCCCCCHHHHHH----HHHhcc-C--CCCeEeHHHHH
Confidence 998888 88999999999999877664332 2222 366677 7 89999998885
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.00011 Score=65.64 Aligned_cols=117 Identities=5% Similarity=-0.039 Sum_probs=83.3
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccc-ccccccccccccccccccC
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKE-RSTQTETSDCSRDKQAHFN 396 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d-~s~~~~~~~l~~af~~~~~ 396 (644)
++.++.+..+.++..++. ..+.+...++.++...|.|++|.| +|.||+..... .......+.+..+|+..+.
T Consensus 12 F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i-~~~eF~~~~~~~~~~~~~~~~~~~~F~~~D~ 90 (142)
T 2bl0_C 12 FELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKI-QFPEFLSMMGRRMKQTTSEDILRQAFRTFDP 90 (142)
T ss_dssp HHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSEE-EHHHHHHHHHHHHTTCCCHHHHHHHHHHTCC
T ss_pred HHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCee-eHHHHHHHHHHHhcCCChHHHHHHHHHHHCC
Confidence 444555555544444432 123345567899999999999999 99999998865 2333466788899999888
Q ss_pred CccCCCCchhhhhhhhhhhccccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 397 GSTGSDLTSEITANSQNEIQEPADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.+++++.+++...+...+..+ ..+++ ++..-| + .|+.|++.||-
T Consensus 91 -----d~~G~i~~~el~~~l~~~g~~~~~~~~~~----~~~~~d-~--~dg~i~~~eF~ 137 (142)
T 2bl0_C 91 -----EGTGYIPKAALQDALLNLGDRLKPHEFAE----FLGITE-T--EKGQIRYDNFI 137 (142)
T ss_dssp -----SSCSCEEHHHHHHHHHHSSSCCCHHHHHH----HHHHHC-C--SSSEECSHHHH
T ss_pred -----CCCCcCcHHHHHHHHHHcCCCCCHHHHHH----HHHHhC-C--CCCcEeHHHHH
Confidence 8899999999999987666432 12222 366677 7 88999988886
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=96.39 E-value=0.00017 Score=65.82 Aligned_cols=120 Identities=9% Similarity=0.073 Sum_probs=84.5
Q ss_pred hhhhhHhhhc-cccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccc----ccccccccccc
Q 006460 322 ENVRSVAKNI-AVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERS----TQTETSDCSRD 390 (644)
Q Consensus 322 e~~~~~~~n~-~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s----~~~~~~~l~~a 390 (644)
..+..++.+. .+.++..++. ....+...++.++...|.|++|.| +|.||+....... .....+.+..+
T Consensus 22 ~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i-~~~eF~~~~~~~~~~~~~~~~~~~~~~~ 100 (161)
T 1dtl_A 22 AAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTV-DFDEFLVMMVRSMKDDSKGKSEEELSDL 100 (161)
T ss_dssp HHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSB-CHHHHHHHHHHHHC-----CHHHHHHHH
T ss_pred HHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeE-cHHHHHHHHHHHhcccccchHHHHHHHH
Confidence 3355566666 6666555442 223355677889999999999999 9999998876543 23456678889
Q ss_pred cccccCCccCCCCchhhhhhhhhhhccccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 391 KQAHFNGSTGSDLTSEITANSQNEIQEPADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 391 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|+..+. |.+++++.+++...+...+..+ ..+++ ++..-|.+ .|+.|++.||.
T Consensus 101 F~~~D~-----d~~G~i~~~El~~~l~~~g~~~~~~~~~~----~~~~~D~d--~dg~i~~~eF~ 154 (161)
T 1dtl_A 101 FRMFDK-----NADGYIDLEELKIMLQATGETITEDDIEE----LMKDGDKN--NDGRIDYDEFL 154 (161)
T ss_dssp HHHHCT-----TCSSEEEHHHHGGGGTTC--CCCHHHHHH----HHHHHCTT--SSSEEEHHHHH
T ss_pred HHHhCC-----CCCCcCcHHHHHHHHHHhCCCCCHHHHHH----HHHHhCCC--CCCcEeHHHHH
Confidence 999888 8899999999999987666332 22222 36666777 88999888875
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=96.32 E-value=0.00012 Score=66.62 Aligned_cols=96 Identities=6% Similarity=0.010 Sum_probs=74.8
Q ss_pred CCchhhccccccccCCCCccccccchhhhccccccc-----ccccccccccccccCCccCCCCchhhhhhhhhhhccccc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQ-----TETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPAD 420 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~-----~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (644)
+...++.++...|.|++|.| +|.||+......... .....+..+|+..+. |.+++++.+++...+...+
T Consensus 48 ~~~~~~~l~~~~D~~~~g~i-~~~eF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~I~~~el~~~l~~~g 121 (158)
T 2jnf_A 48 TKSTIRQLIDEFDPFGNGDI-DFDSFKIIGARFLGEEVNPEQMQQELREAFRLYDK-----EGNGYISTDVMREILAELD 121 (158)
T ss_dssp SHHHHHHHHHHHCTTCCSEE-CHHHHHHHHHHHCCCCCCTTTTSSTHHHHHHHHCS-----SSSSSEEHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhCCCCCCcC-cHHHHHHHHHHHhccccchhhHHHHHHHHHHHhCC-----CCCCeEcHHHHHHHHHHhC
Confidence 45567889999999999999 999999988544322 456788999999988 8999999999999987666
Q ss_pred cCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 421 AHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 421 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..+ ..+++ ++..-|.+ .|+.|++.||.
T Consensus 122 ~~~~~~~~~~----~~~~~D~d--~dg~i~~~eF~ 150 (158)
T 2jnf_A 122 ETLSSEDLDA----MIDEIDAD--GSGTVDFEEFM 150 (158)
T ss_dssp TTCCHHHHHH----HHHHHCSS--CCSEECSHHHH
T ss_pred CcCCHHHHHH----HHHHhCCC--CCCcEeHHHHH
Confidence 432 22222 46777777 89999998886
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=96.29 E-value=0.00049 Score=64.34 Aligned_cols=114 Identities=9% Similarity=-0.000 Sum_probs=76.4
Q ss_pred hccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc---cccccccccccccccccCCccC
Q 006460 330 NIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER---STQTETSDCSRDKQAHFNGSTG 400 (644)
Q Consensus 330 n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~---s~~~~~~~l~~af~~~~~~~~~ 400 (644)
+..+.++..++. .-..+..+++.++. .|.+++|.| +|.||+...... ....+.+.+..||+.+++
T Consensus 23 d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~-~d~~~~g~i-~f~eFl~~~~~~~~~~~~~~~~~l~~aF~~fD~---- 96 (159)
T 3i5g_C 23 GRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGG-TKKMGEKAY-KLEEILPIYEEMSSKDTGTAADEFMEAFKTFDR---- 96 (159)
T ss_dssp TSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTC-CSSTTSCEE-CHHHHHHHHHHHTTCCTTCCHHHHHHHHHHHCT----
T ss_pred CCCCeECHHHHHHHHHHcCCCCCHHHHHHHHc-ccccCCCcc-cHHHHHHHHHHhhcccccchHHHHHHHHHHHhc----
Confidence 455566555552 11223445555544 577889999 999999865432 234456779999999999
Q ss_pred CCCchhhhhhhhhhhccccccCccccccccc-ccccccCCCCCchhhhhhhhcc
Q 006460 401 SDLTSEITANSQNEIQEPADAHVQPAEEIDV-ETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.+|+|+.+++.+++...|.... +..+ .+++..|-+.-.||.|+|.||-
T Consensus 97 -d~~G~I~~~el~~~l~~~g~~ls---~~e~~~l~~~~D~~~d~dG~I~~~EF~ 146 (159)
T 3i5g_C 97 -EGQGLISSAEIRNVLKMLGERIT---EDQCNDIFTFCDIREDIDGNIKYEDLM 146 (159)
T ss_dssp -TSSSEECHHHHHHHHHHSSSCCC---HHHHHHHHHHTTCCCCSSCCEEHHHHH
T ss_pred -CCCCcCcHHHHHHHHHHhCCCCC---HHHHHHHHHHhCcCCCCCCeEeHHHHH
Confidence 99999999999999877665432 2222 2355555322278999999985
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.00025 Score=68.24 Aligned_cols=121 Identities=7% Similarity=0.017 Sum_probs=87.4
Q ss_pred hhhhhhHhhhccccccCcCCCCC--------CCCCchhhccc-------cccccCCCCccccccchhhhccc--------
Q 006460 321 LENVRSVAKNIAVQLNNLPLDDK--------PTSSTSTEDNL-------ETKKVDPTSYTMEVSSSINDSKE-------- 377 (644)
Q Consensus 321 le~~~~~~~n~~~q~~~~~~~~~--------~~ss~~~ed~~-------~~~d~D~nG~i~d~~efi~a~~d-------- 377 (644)
...+..++.+..+.++..++... ......++.++ ...|.|++|.| ++.||+.....
T Consensus 39 ~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i-~~~EF~~~~~~~~~~~~~~ 117 (208)
T 2hpk_A 39 YKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGL-LREDWVEANRVFAEAERER 117 (208)
T ss_dssp HHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBE-EGGGHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeE-cHHHHHHHHHHHhhhhhhh
Confidence 34566777777777776666421 33455677787 99999999999 99999998641
Q ss_pred ---ccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 378 ---RSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 378 ---~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
...-..++.++.+|+..+. |.+++++.+|+...+...|+....+++. +..-|.| .|+.|++.||.
T Consensus 118 ~~~~~~~~~~~~~~~~F~~~D~-----d~~G~Is~~El~~~l~~~g~~~~~~~~~----~~~~D~d--~dG~I~~~EF~ 185 (208)
T 2hpk_A 118 ERRGEPSLIALLSNSYYDVLDD-----DGDGTVDVDELKTMMKAFDVPQEAAYTF----FEKADTD--KSGKLERTELV 185 (208)
T ss_dssp HHTTCCCHHHHHHHHHHHHHCT-----TCSSSBCHHHHHHHHHHTTSCTTHHHHH----HHHHCTT--CCSSBCHHHHH
T ss_pred hccCChHHHHHHHHHHHHHhCC-----CCCCcCCHHHHHHHHHHhCcCHHHHHHH----HHHhCCC--CCCcCcHHHHH
Confidence 1111112237889999888 9999999999999987777444444443 7777888 89999998886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.24 E-value=0.026 Score=58.99 Aligned_cols=31 Identities=19% Similarity=0.380 Sum_probs=27.6
Q ss_pred CCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 134 ~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888899999988765
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=96.24 E-value=0.00087 Score=57.52 Aligned_cols=92 Identities=11% Similarity=0.051 Sum_probs=67.8
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc---ccC
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA---DAH 422 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 422 (644)
+..+++.++...| ++|.| +|.||+....- .....+.++.+|+..+. |.+++++.+++....... +..
T Consensus 7 ~~~e~~~l~~~~d--~~g~i-~~~eF~~~~~~--~~~~~~~l~~~F~~~D~-----d~~G~I~~~el~~~l~~~~~~g~~ 76 (108)
T 2kyc_A 7 SPSDIAAALRDCQ--APDSF-SPKKFFQISGM--SKKSSSQLKEIFRILDN-----DQSGFIEEDELKYFLQRFESGARV 76 (108)
T ss_dssp CHHHHHHHHTTSC--STTTC-CHHHHHHHHTC--TTCCSSSHHHHCSSSCS-----CCSSCCCGGGTTTSHHHHSSSCCC
T ss_pred CHHHHHHHHHHcC--CCCcC-CHHHHHHHHhh--CcccHHHHHHHHHHhCC-----CCCCeEcHHHHHHHHHHHhhccCC
Confidence 4456777888776 89999 99999988632 23456788999999888 889999999999997655 322
Q ss_pred --cccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 --VQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
...+++ +++.-|.+ .|+.|++.||-
T Consensus 77 ~~~~~~~~----~~~~~D~d--~dg~i~~~eF~ 103 (108)
T 2kyc_A 77 LTASETKT----FLAAADHD--GDGKIGAEEFQ 103 (108)
T ss_dssp CCTTTTHH----HHTTTCCS--SSSCCCSSHHH
T ss_pred CCHHHHHH----HHHHhCCC--CCCcCCHHHHH
Confidence 222332 36677777 78889887774
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=96.24 E-value=0.00019 Score=67.74 Aligned_cols=118 Identities=7% Similarity=-0.047 Sum_probs=80.4
Q ss_pred hhhhHhhhccccccCcCCCC----CCCCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCc
Q 006460 323 NVRSVAKNIAVQLNNLPLDD----KPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGS 398 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~~----~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~ 398 (644)
.++.++.+..+.++..++.. -......++.++...|.|++|.| +|.||+........ .+++.+..+|+..+.
T Consensus 44 ~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~D~d~~g~i-~~~Ef~~~~~~~~~-~~~~~~~~~F~~~D~-- 119 (180)
T 3mse_B 44 LFYKLDTNHNGSLSHREIYTVLASVGIKKWDINRILQALDINDRGNI-TYTEFMAGCYRWKN-IESTFLKAAFNKIDK-- 119 (180)
T ss_dssp HHHHHCTTCSSSEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCCSEE-CHHHHHHHHSCCTT-C--CHHHHHHHHHCT--
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHcCCCHHHHHHHHHHhCCCCCCcC-cHHHHHHHHHhccc-CCHHHHHHHHHHHCC--
Confidence 34555666665555544420 01123667899999999999999 99999988766443 345788999999888
Q ss_pred cCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCch--------hhhhhhhcc
Q 006460 399 TGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSD--------RVIEEADIE 453 (644)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 453 (644)
|.+++++.+++.+.+.-..+....+++ ++..-|.+ .| +.|++.||.
T Consensus 120 ---d~~G~I~~~El~~~l~~~~~~~~~~~~----~~~~~d~~--~d~~~~~~~~G~i~~~eF~ 173 (180)
T 3mse_B 120 ---DEDGYISKSDIVSLVHDKVLDNNDIDN----FFLSVHSI--KKGIPREHIINKISFQEFK 173 (180)
T ss_dssp ---TCSSCBCHHHHHHHTTTSSCCHHHHHH----HHHHHHTC-----------CCCBCHHHHH
T ss_pred ---CCCCCCCHHHHHHHHcCCCCCHHHHHH----HHHHhhhc--cCcccccccCCeeeHHHHH
Confidence 899999999999998733333233333 36666766 55 788888875
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.00028 Score=63.79 Aligned_cols=119 Identities=9% Similarity=0.055 Sum_probs=83.8
Q ss_pred hhhhHhhhccccccCcCCCC--CCCCCchhhccccccccCCCCccccccchhhhccccccc-ccccccccccccccCCcc
Q 006460 323 NVRSVAKNIAVQLNNLPLDD--KPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQ-TETSDCSRDKQAHFNGST 399 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~~--~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~-~~~~~l~~af~~~~~~~~ 399 (644)
.++.++.+..+.++..++.. .......++.++...|.|++|.| +|.||+......... ...+.+..+|+..+.
T Consensus 11 ~F~~~D~d~~G~i~~~el~~l~~~~~~~~~~~~~~~~D~~~~g~i-~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~--- 86 (155)
T 3ll8_B 11 RFKKLDLDNSGSLSVEEFMSLPELQQNPLVQRVIDIFDTDGNGEV-DFKEFIEGVSQFSVKGDKEQKLRFAFRIYDM--- 86 (155)
T ss_dssp HHHHHCTTCSSSBCHHHHTTSGGGTTCTTHHHHHHHHCTTCSSSB-CHHHHHHHHGGGCSSCCHHHHHHHHHHHHCT---
T ss_pred HHHHhCcCCCCeEcHHHHHHhhccccchHHHHHHHHHCCCCCCcC-cHHHHHHHHHHHcccCCHHHHHHHHHHHhCC---
Confidence 35556666666666555521 11223367889999999999999 999999988654322 455788899999888
Q ss_pred CCCCchhhhhhhhhhhccc-cccCc--ccccccccccccc----cCCCCCchhhhhhhhcc
Q 006460 400 GSDLTSEITANSQNEIQEP-ADAHV--QPAEEIDVETVKS----KDQNPFSDRVIEEADIE 453 (644)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 453 (644)
|.++.++.+++...+.. .+... ..+++. +.. -|.+ .|+.|++.||.
T Consensus 87 --d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~----~~~~~~~~D~~--~dg~i~~~eF~ 139 (155)
T 3ll8_B 87 --DKDGYISNGELFQVLKMMVGNNLKDTQLQQI----VDKTIINADKD--GDGRISFEEFC 139 (155)
T ss_dssp --TCSSCBCHHHHHHHHHHHHGGGSCHHHHHHH----HHHHHHHHCTT--SSSSBCHHHHH
T ss_pred --CCCCcCcHHHHHHHHHHHhccCCCHHHHHHH----HHHHHHHhCCC--CCCcCcHHHHH
Confidence 88999999999999765 34322 222222 444 6777 88999988886
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=96.13 E-value=0.00021 Score=64.19 Aligned_cols=120 Identities=12% Similarity=0.084 Sum_probs=84.9
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccccc-----cccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQT-----ETSDCSRD 390 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~-----~~~~l~~a 390 (644)
..++.++.+..+.++..++. ........+..++...|.|++|.| +|.||+.......... ..+.+..+
T Consensus 15 ~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i-~~~eF~~~~~~~~~~~~~~~~~~~~~~~~ 93 (153)
T 3ox6_A 15 EAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHV-DFDDFVELMGPKLLAETADMIGVKELRDA 93 (153)
T ss_dssp HHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSTTCC-CHHHHHHHHHHHHTTCCHHHHCHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCccC-cHHHHHHHHHHHhhccccccccHHHHHHH
Confidence 34556666666666555442 223455667889999999999999 9999998875432222 24678889
Q ss_pred cccccCCccCCCCchhhhhhhhhhhccc-cccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 391 KQAHFNGSTGSDLTSEITANSQNEIQEP-ADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 391 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|+..++ |.+++++.+++.+.+.. .+..+ ..+++ ++..-|.+ .|+.|++.||-
T Consensus 94 F~~~D~-----d~~G~i~~~el~~~l~~~~~~~~~~~~~~~----~~~~~d~~--~dg~i~~~eF~ 148 (153)
T 3ox6_A 94 FREFDT-----NGDGEISTSELREAMRALLGHQVGHRDIEE----IIRDVDLN--GDGRVDFEEFV 148 (153)
T ss_dssp HHHHCT-----TCSSSBCHHHHHHHHHHHHSSCCCHHHHHH----HHHHHCSS--SSSSBCHHHHH
T ss_pred HHHhCC-----CCCCcCcHHHHHHHHHHHhcCCCCHHHHHH----HHHHhCCC--CCCeEeHHHHH
Confidence 999888 88999999999999765 55333 22333 36667777 88999888875
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=96.07 E-value=0.00053 Score=58.97 Aligned_cols=96 Identities=9% Similarity=0.047 Sum_probs=68.9
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQP 425 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (644)
+..+++.++...| ++|+| +|.||+..... .....+.++.+|+..++ |.+++++.+++...+...+..-..
T Consensus 8 ~~~ei~~~~~~~D--~~g~i-~~~eF~~~~~~--~~~~~~~l~~~F~~~D~-----d~~G~i~~~el~~~l~~~~~~~~~ 77 (109)
T 3fs7_A 8 SAKDIESALSSCQ--AADSF-NYKSFFSTVGL--SSKTPDQIKKVFGILDQ-----DKSGFIEEEELQLFLKNFSSSARV 77 (109)
T ss_dssp CHHHHHHHHHHTC--STTCC-CHHHHHHHHTC--TTCCHHHHHHHHHHHST-----TCSSSBCHHHHHTTGGGTCTTSCC
T ss_pred CHHHHHHHHHhcC--CCCcC-cHHHHHHHHhc--CCCcHHHHHHHHHHHCC-----CCCCeEeHHHHHHHHHHHhccccc
Confidence 3456677888777 89999 99999988754 23456789999999988 889999999999998766210111
Q ss_pred cccccc-ccccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDV-ETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+.+..+ .++..-|.+ .|+.|++.||.
T Consensus 78 ~~~~~~~~~~~~~D~~--~dg~i~~~EF~ 104 (109)
T 3fs7_A 78 LTSAETKAFLAAGDTD--GDGKIGVEEFQ 104 (109)
T ss_dssp CCHHHHHHHHHHHCTT--CSSSBCHHHHH
T ss_pred CCHHHHHHHHHHhCCC--CCCcCcHHHHH
Confidence 111111 236667777 88999888774
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.00044 Score=61.89 Aligned_cols=116 Identities=7% Similarity=0.081 Sum_probs=79.9
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhcccccc---ccCCCCccccccchhhhccccc---cccccccccccc
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETK---KVDPTSYTMEVSSSINDSKERS---TQTETSDCSRDK 391 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~---d~D~nG~i~d~~efi~a~~d~s---~~~~~~~l~~af 391 (644)
+..++.+..+.++..++. ....+...+..++... |.|+ |.| +|.||+....... .......+..+|
T Consensus 14 F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d~~~-g~i-~~~eF~~~~~~~~~~~~~~~~~~~~~~F 91 (149)
T 2mys_C 14 FLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNA-AAI-TFEEFLPMLQAAANNKDQGTFEDFVEGL 91 (149)
T ss_pred HHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhccccC-CcC-cHHHHHHHHHHHhccCCcchHHHHHHHH
Confidence 344455555544444331 1123455677888888 9999 999 9999998886642 234557788899
Q ss_pred ccccCCccCCCCchhhhhhhhhhhccccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 392 QAHFNGSTGSDLTSEITANSQNEIQEPADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+..++ |.+++++.+++...+...+... ..+++ ++.. |.+ .|+.|++.||.
T Consensus 92 ~~~D~-----d~~G~i~~~el~~~l~~~g~~~~~~~~~~----~~~~-d~~--~dg~i~~~eF~ 143 (149)
T 2mys_C 92 RVFDK-----EGNGTVMGAELRHVLATLGEKMTEEEVEE----LMKG-QED--SNGCINYEAFV 143 (149)
T ss_pred HHhCC-----CCCceEcHHHHHHHHHHhCCCCCHHHHHH----HHhh-CCC--CCCcEeHHHHH
Confidence 98888 8899999999999987666432 22222 3555 666 89999998885
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=96.01 E-value=0.00026 Score=64.42 Aligned_cols=120 Identities=13% Similarity=0.080 Sum_probs=86.2
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc-cccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQAH 394 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~~ 394 (644)
..+..++.+..+.++..++. ..+.....++.++...|.|++|.| +|.||+...... ......+.+..+|+..
T Consensus 27 ~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i-~~~eF~~~~~~~~~~~~~~~~~~~~F~~~ 105 (161)
T 3fwb_A 27 EAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSEGRHLM-KYDDFYIVMGEKILKRDPLDEIKRAFQLF 105 (161)
T ss_dssp HHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSCE-EHHHHHHHHHHHHHTCCHHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCCCeE-eHHHHHHHHHHHHhcCCcHHHHHHHHHHH
Confidence 34555666666666555542 223455677889999999999999 999999888653 2233467788899998
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. |.+++++.+++.+.++..+..+ ..+++ ++..-|.+ .|+.|++.||-
T Consensus 106 D~-----d~~G~i~~~el~~~l~~~~~~~~~~~~~~----~~~~~d~~--~~g~i~~~eF~ 155 (161)
T 3fwb_A 106 DD-----DHTGKISIKNLRRVAKELGETLTDEELRA----MIEEFDLD--GDGEINENEFI 155 (161)
T ss_dssp CT-----TCSSEECHHHHHHHHHHTTCCCCHHHHHH----HHHTTCSS--SSSSEEHHHHH
T ss_pred cC-----CCCCeEeHHHHHHHHHHhCCCCCHHHHHH----HHHHhCCC--CCCcCcHHHHH
Confidence 88 8899999999999987666432 22222 36667777 78899888874
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.00052 Score=65.27 Aligned_cols=124 Identities=7% Similarity=0.015 Sum_probs=86.2
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccccccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHF 395 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~ 395 (644)
..++.++.+..+.++..++. ........++.++...|.|++|.| +|.||+...........++.+..+|+..+
T Consensus 41 ~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~d~dg~i-~~~ef~~~~~~~~~~~~~~~~~~~F~~~D 119 (204)
T 3e3r_A 41 RFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTL-DLEEFLRALRPPMSQAREAVIAAAFAKLD 119 (204)
T ss_dssp HHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSB-CHHHHHHHTSCCCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCcC-cHHHHHHHHHhhcCchHHHHHHHHHHHhC
Confidence 34556666666666555542 123345677899999999999999 99999999876655556678899999888
Q ss_pred CCccCCCCchhhhhhhhhhhccccccC-----cccccccccccccccCC-CCCchhhhhhhhcc
Q 006460 396 NGSTGSDLTSEITANSQNEIQEPADAH-----VQPAEEIDVETVKSKDQ-NPFSDRVIEEADIE 453 (644)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 453 (644)
. |.+++++.+++.+.....+.. ....++.=-.++..-|. + .|+.|++.||.
T Consensus 120 ~-----d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d--~dg~Is~~EF~ 176 (204)
T 3e3r_A 120 R-----SGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSE--KDGQVTLAEFQ 176 (204)
T ss_dssp T-----TCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSS--CCSCEEHHHHH
T ss_pred c-----CCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccC--CCCcCcHHHHH
Confidence 8 889999999999997633210 01111111123566676 7 78899888875
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.00081 Score=64.26 Aligned_cols=92 Identities=10% Similarity=0.054 Sum_probs=71.8
Q ss_pred hhccccccccCCCCccccccchhhhccccc-----------------ccccccccccccccccCCccCCCCchhhhhhhh
Q 006460 350 TEDNLETKKVDPTSYTMEVSSSINDSKERS-----------------TQTETSDCSRDKQAHFNGSTGSDLTSEITANSQ 412 (644)
Q Consensus 350 ~ed~~~~~d~D~nG~i~d~~efi~a~~d~s-----------------~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~ 412 (644)
++.++...|.|++|.| +|.||+....... .....+.++.+|+..+. |.+++++.+++
T Consensus 63 ~~~l~~~~D~d~dg~i-~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~-----d~dG~Is~~El 136 (202)
T 2bec_A 63 GDRIIESFFPDGSQRV-DFPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDL-----DRDGKISRHEM 136 (202)
T ss_dssp HHHHHHTTSCSSCCCC-CHHHHHHHHGGGSCCCHHHHC-----CCCCTTSHHHHHHHHHHHHCT-----TCSSEECHHHH
T ss_pred HHHHHHHhCCCCCCcC-cHHHHHHHHHHhcccchhcccccccccccccccHHHHHHHHHHHhCC-----CCCCeEcHHHH
Confidence 7889999999999999 9999999886654 23445678889999988 89999999999
Q ss_pred hhhcccc-ccCcc--cccccccccccc----cCCCCCchhhhhhhhcc
Q 006460 413 NEIQEPA-DAHVQ--PAEEIDVETVKS----KDQNPFSDRVIEEADIE 453 (644)
Q Consensus 413 ~~~~~~~-~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 453 (644)
...+... |..+. .+++ ++.. -|.+ .|+.|++.||-
T Consensus 137 ~~~l~~~~g~~~~~~~~~~----~~~~~~~~~D~d--~dG~Is~~EF~ 178 (202)
T 2bec_A 137 LQVLRLMVGVQVTEEQLEN----IADRTVQEADED--GDGAVSFVEFT 178 (202)
T ss_dssp HHHHHHSCCSCCCHHHHHH----HHHHHHHHHCSS--CSSSEEHHHHH
T ss_pred HHHHHHhcCCCCCHHHHHH----HHHHHHHHcCCC--CCCcCcHHHHH
Confidence 9997655 53321 2222 2444 6777 89999999987
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=95.80 E-value=0.00053 Score=66.10 Aligned_cols=122 Identities=8% Similarity=0.035 Sum_probs=86.8
Q ss_pred hhhhhHhhhccccccCcCCCCC--CCCCchhhccccccccCCCCccccccchhhhccccccc----------------cc
Q 006460 322 ENVRSVAKNIAVQLNNLPLDDK--PTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQ----------------TE 383 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~~~--~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~----------------~~ 383 (644)
..+..++.+..+.++..++..- .......+.++...|.|++|.| +|.||+......... ..
T Consensus 33 ~~F~~~D~d~dG~Is~~El~~~~~lg~~~~~~~l~~~~d~~~~g~i-~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (208)
T 2ct9_A 33 SRFTSLDKGENGTLSREDFQRIPELAINPLGDRIINAFFSEGEDQV-NFRGFMRTLAHFRPIEDNEKSKDVNGPEPLNSR 111 (208)
T ss_dssp HHHHHHCTTCSSEECTGGGGGCHHHHTSTTHHHHHHTTSCTTCSCE-EHHHHHHHHHTTSCCC-----------CCTTSH
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHHcCCCCcHHHHHHHHcCCCCCcC-cHHHHHHHHHhhccccchhhhcccccccccccH
Confidence 3456677777777777766431 1111234678888999999999 999999887654432 15
Q ss_pred ccccccccccccCCccCCCCchhhhhhhhhhhcccc-ccCcccccccccc-----cccccCCCCCchhhhhhhhccc
Q 006460 384 TSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA-DAHVQPAEEIDVE-----TVKSKDQNPFSDRVIEEADIEG 454 (644)
Q Consensus 384 ~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 454 (644)
.+.++.+|+..+. |.+++++.+++...+... |..+ .+..++ ++..-|.+ .|+.|++.||-.
T Consensus 112 ~~~l~~~F~~~D~-----d~dG~Is~~El~~~l~~~~g~~~---s~~~~~~l~~~~~~~~D~d--~dG~Is~~EF~~ 178 (208)
T 2ct9_A 112 SNKLHFAFRLYDL-----DKDDKISRDELLQVLRMMVGVNI---SDEQLGSIADRTIQEADQD--GDSAISFTEFVK 178 (208)
T ss_dssp HHHHHHHHHHHCT-----TCSSEECHHHHHHHHHHHSCTTC---CHHHHHHHHHHHHHHHCSS--SSSSEEHHHHHH
T ss_pred HHHHHHHHHHHCC-----CCCCEEcHHHHHHHHHHHhCCCC---CHHHHHHHHHHHHHHhCCC--CCCcCcHHHHHH
Confidence 5788899999988 999999999999997653 5332 222222 26667777 899999999873
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=95.79 E-value=0.00089 Score=57.43 Aligned_cols=92 Identities=8% Similarity=0.038 Sum_probs=68.2
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc---ccC
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA---DAH 422 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 422 (644)
+..+++.++...| ++|.| +|.||+....- .....+.++.+|+..++ |.+++++.+++....... +..
T Consensus 7 ~~~e~~~l~~~~d--~~g~i-~~~eF~~~~~~--~~~~~~~l~~~F~~~D~-----d~~G~I~~~el~~~l~~~~~~g~~ 76 (108)
T 2pvb_A 7 KDADVAAALAACS--AADSF-KHKEFFAKVGL--ASKSLDDVKKAFYVIDQ-----DKSGFIEEDELKLFLQNFSPSARA 76 (108)
T ss_dssp CHHHHHHHHHHTC--STTCC-CHHHHHHHHTG--GGSCHHHHHHHHHHHCT-----TCSSSBCHHHHHTGGGGTCTTSCC
T ss_pred CHHHHHHHHHHhC--CCCcC-cHHHHHHHHhC--ChhHHHHHHHHHHHHCC-----CCCCcCCHHHHHHHHHHHhccCCC
Confidence 4456677887776 89999 99999988632 23456789999999988 889999999999998766 322
Q ss_pred c--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 V--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
. ..+++ +++.-|.+ .|+.|++.||-
T Consensus 77 ~~~~~~~~----~~~~~D~~--~dg~i~~~eF~ 103 (108)
T 2pvb_A 77 LTDAETKA----FLADGDKD--GDGMIGVDEFA 103 (108)
T ss_dssp CCHHHHHH----HHHHHCTT--CSSSBCHHHHH
T ss_pred CCHHHHHH----HHHHhCCC--CCCcEeHHHHH
Confidence 2 22222 36667777 88899888874
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=95.76 E-value=0.00059 Score=60.83 Aligned_cols=116 Identities=9% Similarity=0.016 Sum_probs=81.6
Q ss_pred hhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc--cccccccccccccccc
Q 006460 323 NVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER--STQTETSDCSRDKQAH 394 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~--s~~~~~~~l~~af~~~ 394 (644)
.++.++.+..+.++..++. ....+...+..++.. |++|.| +|.||+...... ........+..+|+..
T Consensus 10 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~---~~~g~i-~~~eF~~~~~~~~~~~~~~~~~l~~~F~~~ 85 (145)
T 2bl0_B 10 CFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ---LNAKEF-DLATFKTVYRKPIKTPTEQSKEMLDAFRAL 85 (145)
T ss_dssp HHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH---HTSSEE-CHHHHHHHHTSCCCCGGGGHHHHHHHHHHH
T ss_pred HHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh---cCCCeE-cHHHHHHHHHHHhhcCcccHHHHHHHHHHh
Confidence 3555666666666555552 122344556666665 889999 999999988665 3445667889999988
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. |.+++++.+++...+...+... ..+++ ++..-|.+ .|+.|++.||-
T Consensus 86 D~-----d~~G~i~~~e~~~~l~~~g~~~~~~~~~~----~~~~~d~~--~dg~i~~~eF~ 135 (145)
T 2bl0_B 86 DK-----EGNGTIQEAELRQLLLNLGDALTSSEVEE----LMKEVSVS--GDGAINYESFV 135 (145)
T ss_dssp CS-----SSSSEEEHHHHHHHHHHSSSCCCHHHHHH----HHTTCCCC--TTSEEEHHHHH
T ss_pred CC-----CCCCeEcHHHHHHHHHHcCCCCCHHHHHH----HHHHcCCC--CCCcEeHHHHH
Confidence 88 8899999999999987666432 22222 36666777 78999988885
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.75 E-value=0.016 Score=60.96 Aligned_cols=75 Identities=13% Similarity=0.177 Sum_probs=43.6
Q ss_pred EEEEeccCCCeEEEEEEEec--------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC-cceeeeEEEeCCce
Q 006460 17 VIEQIGRGAFGAAFLVLHKI--------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY-IVKYKDAWVDKGNC 87 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~--------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPN-IVkl~~~~~d~~~~ 87 (644)
-+..|+.|....+|++.... .+..+++|+...... .. ....+|..+++.|...+ +.++++.+ .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--EL-YNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GT-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ce-ecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 45678888889999997653 136888988754321 11 11245777877774333 34565432 22
Q ss_pred EEEEEeccCCCC
Q 006460 88 VCIVTGYCEGGD 99 (644)
Q Consensus 88 ~~LVmEy~~Ggs 99 (644)
++||+|++|..
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 58999998853
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0004 Score=64.13 Aligned_cols=90 Identities=9% Similarity=-0.031 Sum_probs=69.5
Q ss_pred ccccccccCCCCccccccchhhhccccccccc--------ccccccccccccCCccCCCCchhhhhhhhhhhccccccCc
Q 006460 352 DNLETKKVDPTSYTMEVSSSINDSKERSTQTE--------TSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHV 423 (644)
Q Consensus 352 d~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~--------~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (644)
.++...|.|++|.| ++.||+........... +..++.+|+..+. |.+++++.+++...+...+...
T Consensus 62 ~lf~~~D~d~dg~i-~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~I~~~e~~~~l~~~g~~~ 135 (176)
T 1nya_A 62 YLAKEAGVGSDGSL-TEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDK-----NADGQINADEFAAWLTALGMSK 135 (176)
T ss_dssp HHHHHHTSCTTCCB-CHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCS-----SCCSEEEHHHHHHHHHHTTCCH
T ss_pred HHHHHhCCCCCCeE-cHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcC-----CCCCCCCHHHHHHHHHHhCCCH
Confidence 78889999999999 99999988765433222 3558889998888 8899999999999987666333
Q ss_pred ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 424 QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..+++ ++..-|.+ .|+.|++.||.
T Consensus 136 ~~~~~----~~~~~D~d--~dg~i~~~ef~ 159 (176)
T 1nya_A 136 AEAAE----AFNQVDTN--GNGELSLDELL 159 (176)
T ss_dssp HHHHH----HHHHHCTT--CSSEEEHHHHH
T ss_pred HHHHH----HHHHhCCC--CCCCCcHHHHH
Confidence 33333 36677877 89999998887
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=95.69 E-value=0.00033 Score=64.47 Aligned_cols=120 Identities=10% Similarity=0.124 Sum_probs=87.3
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccc-cccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERST-QTETSDCSRDKQAH 394 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~-~~~~~~l~~af~~~ 394 (644)
..++.++.+..+.++..++. ....+...++.++...|.|++|.| +|.||+........ ....+.+..+|+..
T Consensus 32 ~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i-~~~eF~~~~~~~~~~~~~~~~~~~~F~~~ 110 (169)
T 3qrx_A 32 EAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTI-DFEEFLTMMTAKMGERDSREEILKAFRLF 110 (169)
T ss_dssp HHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCSSSSSSE-EHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCCcC-CHHHHHHHHHHHhcccCcHHHHHHHHHHh
Confidence 44566777777766666552 223456678899999999999999 99999988754321 22356788899988
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. |.+++++.+++.+.+...+.... .+++ ++..-|.+ .|+.|++.||-
T Consensus 111 D~-----d~~G~i~~~el~~~l~~~g~~~~~~~~~~----~~~~~D~~--~dg~i~~~eF~ 160 (169)
T 3qrx_A 111 DD-----DNSGTITIKDLRRVAKELGENLTEEELQE----MIAEADRN--DDNEIDEDEFI 160 (169)
T ss_dssp CT-----TCSSSBCHHHHHHHHHHTTCCCCHHHHHH----HHHHHCCS--SSSCBCHHHHH
T ss_pred CC-----CCCCcCCHHHHHHHHHHcCCCCCHHHHHH----HHHHhCCC--CCCCEeHHHHH
Confidence 88 88999999999999876663322 2222 36667777 88999988875
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=95.64 E-value=0.00044 Score=62.93 Aligned_cols=118 Identities=12% Similarity=0.113 Sum_probs=82.2
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccccc-c---ccccccccccc
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQ-T---ETSDCSRDKQA 393 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~-~---~~~~l~~af~~ 393 (644)
+..++.+..+.++..++. ....+...+..++...|.|++|.| +|.||+......... . ..+.+..+|+.
T Consensus 26 F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i-~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~ 104 (162)
T 1top_A 26 FDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI-DFEEFLVMMVRQMKEDAKGKSEEELANCFRI 104 (162)
T ss_dssp HHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEE-EHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCcE-eHHHHHHHHHHHhccccccccHHHHHHHHHH
Confidence 344555555555544441 123345677889999999999999 999999887543211 1 45678889999
Q ss_pred ccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 394 HFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+. |.+++++.+++.......+..+. .+++ ++..-|.+ .|+.|++.||.
T Consensus 105 ~D~-----d~~G~I~~~e~~~~l~~~g~~~~~~~~~~----~~~~~d~~--~dg~i~~~eF~ 155 (162)
T 1top_A 105 FDK-----NADGFIDIEELGEILRATGEHVTEEDIED----LMKDSDKN--NDGRIDFDEFL 155 (162)
T ss_dssp HCT-----TCSSCBCHHHHHHHHHTTTCCCCHHHHHH----HHHHHCTT--CSSSBCHHHHH
T ss_pred hCC-----CCCCcCcHHHHHHHHHHhCCCCCHHHHHH----HHHHhCCC--CCCcCcHHHHH
Confidence 888 88999999999999876663322 2222 36666777 88999888875
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=95.62 E-value=0.00099 Score=57.15 Aligned_cols=92 Identities=11% Similarity=0.089 Sum_probs=67.5
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccc---cC
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPAD---AH 422 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 422 (644)
+..+++.++...| ++|.| +|.||+....- .....+.++.+|+..+. |.+++++.+++.......+ ..
T Consensus 7 t~~e~~~~~~~~d--~~g~i-~~~eF~~~~~~--~~~~~~~l~~~F~~~D~-----d~~G~I~~~el~~~l~~~~~~g~~ 76 (108)
T 1rro_A 7 SAEDIAAALQECQ--DPDTF-EPQKFFQTSGL--SKMSASQVKDIFRFIDN-----DQSGYLDGDELKYFLQKFQSDARE 76 (108)
T ss_dssp CHHHHHHHHHHTC--STTCC-CHHHHHHHHSG--GGSCHHHHHHHHHHHCT-----TCSSEECTHHHHTGGGGTCTTSCC
T ss_pred CHHHHHHHHHHcc--CCCCc-CHHHHHHHHhc--CcccHHHHHHHHHHhCC-----CCCCcCCHHHHHHHHHHHhhccCC
Confidence 4456677777776 89999 99999987632 23456788999999988 8899999999999987653 22
Q ss_pred c--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 V--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
. ..+++ +++.-|.+ .|+.|++.||.
T Consensus 77 ~~~~~~~~----~~~~~D~~--~dg~i~~~eF~ 103 (108)
T 1rro_A 77 LTESETKS----LMDAADND--GDGKIGADEFQ 103 (108)
T ss_dssp CCHHHHHH----HHHHHCCS--SSSSEEHHHHH
T ss_pred CCHHHHHH----HHHHhCCC--CCCcCcHHHHH
Confidence 1 22222 36666777 88899888875
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=95.61 E-value=0.00031 Score=61.42 Aligned_cols=94 Identities=10% Similarity=-0.024 Sum_probs=71.8
Q ss_pred CCchhhccccccccCCCCccccccchhhhcc---cccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccC
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSK---ERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAH 422 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~---d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (644)
....++.++...|.|++|.| ++.||+.... ....-.+...+..+|+..+. |.++.++.+++.......+..
T Consensus 34 ~~~~~~~~~~~~D~~~~g~i-~~~ef~~~~~~~~~~~~~~~~~~~~~~f~~~D~-----d~~G~i~~~e~~~~l~~~~~~ 107 (134)
T 1jfj_A 34 NEQLLQLIFKSIDADGNGEI-DQNEFAKFYGSIQGQDLSDDKIGLKVLYKLMDV-----DGDGKLTKEEVTSFFKKHGIE 107 (134)
T ss_dssp HHHHHHHHHHHHCSSCCSEE-EHHHHHHHTTCSSCCSSHHHHHHHHHHHHHHCC-----SSSSEEEHHHHHHHHTTTTCH
T ss_pred CHHHHHHHHHHHcCCCCCeE-cHHHHHHHHHHhcccccCCCHHHHHHHHHHHCC-----CCCCccCHHHHHHHHHHhCHH
Confidence 34567889999999999999 9999998875 33333345568889988877 889999999999998766544
Q ss_pred cccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 VQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
. +.+. +..-|.+ .|+.|++.||-
T Consensus 108 ~--~~~~----~~~~D~~--~dg~i~~~ef~ 130 (134)
T 1jfj_A 108 K--VAEQ----VMKADAN--GDGYITLEEFL 130 (134)
T ss_dssp H--HHHH----HHHHHCS--SSSEEEHHHHH
T ss_pred H--HHHH----HHHhCCC--CCCcEeHHHHH
Confidence 3 3333 6667777 78888887774
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=95.59 E-value=0.00039 Score=64.75 Aligned_cols=119 Identities=8% Similarity=0.110 Sum_probs=82.9
Q ss_pred hhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccc-cccccccccccccccc
Q 006460 323 NVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERS-TQTETSDCSRDKQAHF 395 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s-~~~~~~~l~~af~~~~ 395 (644)
.+..++.+..+.++..++. ........++.++...|.|++|.| +|.||+....... .....+.+..+|+..+
T Consensus 16 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i-~~~EF~~~~~~~~~~~~~~~~~~~~F~~~D 94 (179)
T 2f2o_A 16 AFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI-DFPEFLTMMARKMKDTDSEEEIREAFRVFD 94 (179)
T ss_dssp HHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSB-CHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCC-cHHHHHHHHHHHccCcccHHHHHHHHHHhC
Confidence 3455566655555544442 123345567889999999999999 9999998875431 2234567888999888
Q ss_pred CCccCCCCchhhhhhhhhhhccccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 396 NGSTGSDLTSEITANSQNEIQEPADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
. |.+++++.+++...+...+... ..+++ ++..-|.+ .|+.|++.||.
T Consensus 95 ~-----d~~G~I~~~E~~~~l~~~g~~~~~~~~~~----~~~~~D~~--~dg~i~~~eF~ 143 (179)
T 2f2o_A 95 K-----DGNGYISAAELRHVMTNLGEKLTDEEVDE----MIREADID--GDGQVNYEEFV 143 (179)
T ss_dssp T-----TCSSEECHHHHHHHHHHC--CCCHHHHHH----HHHHHCTT--CSSSEEHHHHH
T ss_pred C-----CCCCcCcHHHHHHHHHHhCCCCCHHHHHH----HHHHcCCC--CCCcCcHHHHH
Confidence 7 8899999999999976665332 22222 36666777 88999998886
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=95.57 E-value=0.0012 Score=60.62 Aligned_cols=96 Identities=9% Similarity=0.018 Sum_probs=42.2
Q ss_pred hhccccccccCCCCccccccchhhhcccc-----cccccccccccccccccCCccCCCCchhhhhhhhhhhcccccc---
Q 006460 350 TEDNLETKKVDPTSYTMEVSSSINDSKER-----STQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADA--- 421 (644)
Q Consensus 350 ~ed~~~~~d~D~nG~i~d~~efi~a~~d~-----s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 421 (644)
....|...|.|++|+| ++.||+.+.... +....++.++.+|+.++. |.+++++.+|+.......+.
T Consensus 29 ~~~~f~~~D~d~dG~I-~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~-----d~dG~I~~~El~~~l~~~~~~~~ 102 (143)
T 3a4u_B 29 SFSQPGSMGLDKNTVH-DQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDY-----DGNNLLDGLELSTAITHVHKEEG 102 (143)
T ss_dssp -----------------------------------CCCHHHHHHHHHHHTCT-----TCSSCEEHHHHHHTCC-------
T ss_pred CHHHHHHhCCCCCCcC-cHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCC-----CCCCccCHHHHHHHHHHHHhhhc
Confidence 3578899999999999 999999876443 123445678889999888 88999999999999765431
Q ss_pred -------CcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 422 -------HVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 422 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
....+++.=-.+.+.-|.| .|+.|++.||-
T Consensus 103 ~~~g~~~s~~e~~~~~~~~f~~~D~d--~dG~Is~~EF~ 139 (143)
T 3a4u_B 103 SEQAPLMSEDELINIIDGVLRDDDKN--NDGYIDYAEFA 139 (143)
T ss_dssp ------CCHHHHHHHHHHHHHHHCTT--CSSEECHHHHH
T ss_pred cccCCCCCHHHHHHHHHHHHHHcCCC--CCCcEeHHHHH
Confidence 1111111100112566777 88999888875
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=95.52 E-value=0.00083 Score=63.98 Aligned_cols=114 Identities=11% Similarity=0.025 Sum_probs=84.3
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccccccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHF 395 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~ 395 (644)
..++.++.+..+.++..++. ..+.....++.++...|.|++|.| +|.||+..... ...++.+|+..+
T Consensus 31 ~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I-~~~EF~~~~~~------~~~~~~~F~~~D 103 (191)
T 1y1x_A 31 EWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEI-TFDEFKDLHHF------ILSMREGFRKRD 103 (191)
T ss_dssp HHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSB-CHHHHHHHHHH------HHHHHHHHHHHC
T ss_pred HHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeE-cHHHHHHHHHH------HHHHHHHHHHhC
Confidence 34566777776666655542 123455677889999999999999 99999988643 257788999988
Q ss_pred CCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 396 NGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
. |.+++++.+++...+...+.... .++ .++..-|.+ .|+.|++.||.
T Consensus 104 ~-----d~~G~i~~~e~~~~l~~~g~~~~~~~~~----~~~~~~D~d--~dg~i~~~eF~ 152 (191)
T 1y1x_A 104 S-----SGDGRLDSNEVRAALLSSGYQVSEQTFQ----ALMRKFDRQ--RRGSLGFDDYV 152 (191)
T ss_dssp T-----TSSSCBCHHHHHHHHHTTSCCCCHHHHH----HHHHHHCTT--CSSSBCHHHHH
T ss_pred C-----CCCCeEcHHHHHHHHHHhCCCCCHHHHH----HHHHHhCCC--CCCeEeHHHHH
Confidence 8 88999999999999876664322 222 246677777 88999988885
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=95.51 E-value=0.00051 Score=67.15 Aligned_cols=120 Identities=9% Similarity=-0.024 Sum_probs=81.4
Q ss_pred hhhhhHhhhccccccCcCCCC-------CCCCCchhhcccccc---------ccCCCCccccccchhhhccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLDD-------KPTSSTSTEDNLETK---------KVDPTSYTMEVSSSINDSKERSTQTETS 385 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~~-------~~~ss~~~ed~~~~~---------d~D~nG~i~d~~efi~a~~d~s~~~~~~ 385 (644)
..+..++.+..+.++..++.. .......++.++... ++|++|.| +|.||+..........+++
T Consensus 52 ~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I-~~~EF~~~~~~~~~~~~~~ 130 (219)
T 3cs1_A 52 ELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSE-DFVEFLEFRLMLCYIYDFF 130 (219)
T ss_dssp HHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHHHHHHHHHHTSCCC-SSBCHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHhhhhccCCCCcC-CHHHHHHHHHHHhccchHH
Confidence 345556666666665554421 111223333333322 45899999 9999998865555556678
Q ss_pred ccccccccccCCccCCCCchhhhhhhhhhhcccccc---CcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 386 DCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADA---HVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 386 ~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+..+|+..+. |.+++++.+++...+...+. ....+++ ++..-|.+ .|+.|++.||-
T Consensus 131 ~l~~~F~~~D~-----d~~G~Is~~El~~~l~~~g~~~~~~~e~~~----l~~~~D~d--~dG~I~~~EF~ 190 (219)
T 3cs1_A 131 ELTVMFDEIDA-----SGNMLVDEEEFKRAVPKLEAWGAKVEDPAA----LFKELDKN--GTGSVTFDEFA 190 (219)
T ss_dssp HHHHHHHTTCS-----SSSSEEEHHHHHHHHHHHHHHTCCCSCHHH----HHHHHCTT--SSSEEEHHHHH
T ss_pred HHHHHHHHHCC-----CCCCcCcHHHHHHHHHHhcccCCCHHHHHH----HHHHhCCC--CCCcEeHHHHH
Confidence 89999999988 99999999999999765543 2233333 37777888 89999988886
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=95.47 E-value=0.0015 Score=60.21 Aligned_cols=89 Identities=12% Similarity=0.018 Sum_probs=69.1
Q ss_pred hccccccccCCCCccccccchhhhcccccc-----cccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccc
Q 006460 351 EDNLETKKVDPTSYTMEVSSSINDSKERST-----QTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQP 425 (644)
Q Consensus 351 ed~~~~~d~D~nG~i~d~~efi~a~~d~s~-----~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (644)
+.++...| ++|.| ++.||+........ ......++.+|+..+. |.+++++.+++...+...++....
T Consensus 58 ~~l~~~~D--~~g~i-~~~EF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~i~~~e~~~~l~~~g~~~~~ 129 (174)
T 1q80_A 58 DNFLTAVA--GGKGI-DETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDT-----NEDNNISRDEYGIFFGMLGLDKTM 129 (174)
T ss_dssp HHTGGGTT--TTSCE-EHHHHHHHHHHHTTSTTCHHHHHTHHHHHHHHHCT-----TSSSSBCHHHHHHHHHHHTCCGGG
T ss_pred HHHHHhcC--CCCeE-cHHHHHHHHHHHcCcccHHHHHHHHHHHHHHHhCC-----CCCCcccHHHHHHHHHHcCCCHHH
Confidence 35677777 89999 99999988765443 2234778889999888 999999999999998766655444
Q ss_pred ccccccccccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+++. +..-|.+ .|+.|++.||.
T Consensus 130 ~~~~----~~~~D~d--~dg~i~~~ef~ 151 (174)
T 1q80_A 130 APAS----FDAIDTN--NDGLLSLEEFV 151 (174)
T ss_dssp HHHH----HHHHCTT--CSSSBCHHHHH
T ss_pred HHHH----HHHhCCC--CCceEeHHHHH
Confidence 4444 7777888 89999998886
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=95.47 E-value=0.00064 Score=64.07 Aligned_cols=120 Identities=5% Similarity=-0.060 Sum_probs=85.7
Q ss_pred hhhhhH-hhhccccccCcCCC----------CCCCCCchhhccc-----------cccccCCCCccccccchhhhccccc
Q 006460 322 ENVRSV-AKNIAVQLNNLPLD----------DKPTSSTSTEDNL-----------ETKKVDPTSYTMEVSSSINDSKERS 379 (644)
Q Consensus 322 e~~~~~-~~n~~~q~~~~~~~----------~~~~ss~~~ed~~-----------~~~d~D~nG~i~d~~efi~a~~d~s 379 (644)
..++.+ +.+..+.++..++. ........++.++ ...|.|++|.| ++.||+.......
T Consensus 16 ~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i-~~~Ef~~~~~~~~ 94 (191)
T 2ccm_A 16 RVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQV-TKEEWLKMWAECV 94 (191)
T ss_dssp HHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCE-EHHHHHHHHHHHH
T ss_pred HhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeE-CHHHHHHHHHHHh
Confidence 345566 77777777666552 1233455667777 89999999999 9999998764421
Q ss_pred ---------ccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhh
Q 006460 380 ---------TQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEA 450 (644)
Q Consensus 380 ---------~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (644)
.-..+..+..+|+..+. |.++.++.+|+...+...++....+++ +...-|.| .|+.|++.
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~dG~I~~~E~~~~l~~~g~~~~~~~~----~~~~~D~d--~dG~i~~~ 163 (191)
T 2ccm_A 95 KSVEKGESLPEWLTKYMNFMFDVNDT-----SGDNIIDKHEYSTVYMSYGIPKSDCDA----AFDTLSDG--GKTMVTRE 163 (191)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHCT-----TCSSBCCHHHHHHHHHTTTCCHHHHHH----HHHHHTTT--TTSCCBHH
T ss_pred ccccchhhchHHHHHHHHHHHHHhCC-----CCCCcCcHHHHHHHHHHhCCCHHHHHH----HHHHhCCC--CCCCcCHH
Confidence 12234567889988888 899999999999998666643333433 37777888 89999988
Q ss_pred hcc
Q 006460 451 DIE 453 (644)
Q Consensus 451 ~~~ 453 (644)
||.
T Consensus 164 Ef~ 166 (191)
T 2ccm_A 164 IFA 166 (191)
T ss_dssp HHH
T ss_pred HHH
Confidence 886
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=95.46 E-value=0.00061 Score=66.94 Aligned_cols=114 Identities=5% Similarity=-0.175 Sum_probs=81.3
Q ss_pred hhhhHhhhccccccCcCCCC------CCCCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccC
Q 006460 323 NVRSVAKNIAVQLNNLPLDD------KPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFN 396 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~~------~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~ 396 (644)
.++.++.+..+.++..++.. ...+...++.++...|.|++|.| +|.||+...... ..+..+|+..++
T Consensus 56 ~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I-~~~EF~~~~~~~------~~l~~~F~~~D~ 128 (220)
T 3sjs_A 56 WFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGHI-SFYEFMAMYKFM------ELAYNLFVMNAR 128 (220)
T ss_dssp HHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCTTCSSCB-CHHHHHHHHHHH------HHHHHHHHHHCC
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcC-CHHHHHHHHHHH------HHHHHHHHHHCC
Confidence 35566666666665555521 12345567889999999999999 999999987552 668889999888
Q ss_pred CccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 397 GSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.+++++.+|+.+.+...|..... +++ -.+++.-| + .|+.|++.||-
T Consensus 129 -----d~~G~I~~~El~~~l~~~g~~~~~-~~~-~~l~~~~d-d--~dg~I~~~eF~ 175 (220)
T 3sjs_A 129 -----ARSGTLEPHEILPALQQLGFYINQ-RTS-LLLHRLFA-R--GMAFCDLNCWI 175 (220)
T ss_dssp -----SSTTEECHHHHHHHHHHHTCCCCH-HHH-HHHHHHHC-----CCSEEHHHHH
T ss_pred -----CCCCCCcHHHHHHHHHHhCCCCCH-HHH-HHHHHHhc-C--CCCcCcHHHHH
Confidence 899999999999998766644322 111 12466777 7 78999888875
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=95.44 E-value=0.00093 Score=57.34 Aligned_cols=91 Identities=8% Similarity=0.059 Sum_probs=67.1
Q ss_pred CchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc---ccCc
Q 006460 347 STSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA---DAHV 423 (644)
Q Consensus 347 s~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 423 (644)
..+++.++...| ++|.| +|.||+....- .....+.++.+|+..+. |.+++++.+++....... +...
T Consensus 8 ~~e~~~~~~~~d--~~g~i-~~~eF~~~~~~--~~~~~~~l~~~F~~~D~-----d~~G~I~~~el~~~l~~~~~~g~~~ 77 (109)
T 1rwy_A 8 AEDIKKAIGAFT--AADSF-DHKKFFQMVGL--KKKSADDVKKVFHILDK-----DKSGFIEEDELGSILKGFSSDARDL 77 (109)
T ss_dssp HHHHHHHHHTTC--STTCC-CHHHHHHHHTG--GGSCHHHHHHHHHHHST-----TCSSEECHHHHHTHHHHHCTTCCCC
T ss_pred HHHHHHHHHHcC--CCCcE-eHHHHHHHHhc--CcchHHHHHHHHHHHCC-----CCCCeEcHHHHHHHHHHHhccCCCC
Confidence 345677777766 89999 99999988632 23456788999999888 889999999999997665 3222
Q ss_pred --ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 424 --QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 424 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..+++ +++..|.+ .|+.|++.||.
T Consensus 78 ~~~~~~~----~~~~~D~~--~dg~i~~~eF~ 103 (109)
T 1rwy_A 78 SAKETKT----LMAAGDKD--GDGKIGVEEFS 103 (109)
T ss_dssp CHHHHHH----HHHHHCTT--CSSSEEHHHHH
T ss_pred CHHHHHH----HHHHHCCC--CCCcCCHHHHH
Confidence 22222 36667777 88899888875
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=95.39 E-value=0.0013 Score=64.80 Aligned_cols=93 Identities=14% Similarity=-0.003 Sum_probs=71.5
Q ss_pred hhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccc--------
Q 006460 349 STEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPAD-------- 420 (644)
Q Consensus 349 ~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 420 (644)
.++.+|...|.|++|+| ++.||+.+......-.+++.++.+|+..+. |.+++++.+|+.+.....+
T Consensus 103 ~~~~lf~~~D~d~~G~I-~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~-----d~dG~Is~~E~~~~l~~~~~~~~~~~~ 176 (229)
T 3dd4_A 103 YAHFLFNAFDTDHNGAV-SFEDFIKGLSILLRGTVQEKLNWAFNLYDI-----NKDGYITKEEMLDIMKAIYDMMGKCTY 176 (229)
T ss_dssp HHHHHHHTTCSSCCSSC-CHHHHHHHHHHHHHSCHHHHHHHHHHHHCT-----TCSSCCBHHHHHHHHHHHHHHCC----
T ss_pred HHHHHHHHcCCCCCCeE-eHHHHHHHHHHHcCCChHHHHHHHHHHhCC-----CCCCeECHHHHHHHHHHHHHHhccccC
Confidence 35678889999999999 999999988665555667889999999888 8999999999999875431
Q ss_pred ------cCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 421 ------AHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 421 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.....+++ +...-|.| .|+.|++.||.
T Consensus 177 ~~~~~~~~~~~~~~----~f~~~D~d--~dG~Is~~EF~ 209 (229)
T 3dd4_A 177 PVLKEDAPRQHVET----FFQKMDKN--KDGVVTIDEFI 209 (229)
T ss_dssp -------CCTHHHH----HHHHHCSS--CSSBCCHHHHH
T ss_pred CCcchhhHHHHHHH----HHHHhcCC--CCCcEeHHHHH
Confidence 11122222 36667777 88999888886
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=95.29 E-value=0.00045 Score=61.67 Aligned_cols=117 Identities=10% Similarity=0.074 Sum_probs=81.7
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccc-ccccccccccccccccC
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERS-TQTETSDCSRDKQAHFN 396 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s-~~~~~~~l~~af~~~~~ 396 (644)
++.++.+..+.++..++. ..+.....++.++...|.|++|.| +|.||+....... ....++.+..+|+..+.
T Consensus 17 F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i-~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~ 95 (147)
T 4ds7_A 17 FALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNHAI-EFSEFLALMSRQLKCNDSEQELLEAFKVFDK 95 (147)
T ss_dssp HHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSEE-EHHHHHHHHHHHHHTHHHHHHHHHHHHHHCT
T ss_pred HHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcC-cHHHHHHHHHHhccCCCcHHHHHHHHHHhCC
Confidence 444555555544444431 123455667889999999999999 9999998875432 22455788889998887
Q ss_pred CccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 397 GSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.++.++.+++.+.+...+.... .+++ ++..-| + .|+.|++.||-
T Consensus 96 -----d~~G~i~~~e~~~~l~~~~~~~~~~~~~~----~~~~~d-~--~dg~i~~~eF~ 142 (147)
T 4ds7_A 96 -----NGDGLISAAELKHVLTSIGEKLTDAEVDE----MLREVS-D--GSGEINIKQFA 142 (147)
T ss_dssp -----TCSSEECHHHHHHHHHHTTCCCCHHHHHH----HHHHHS-S--SCSSEEHHHHH
T ss_pred -----CCCCeECHHHHHHHHHHcCCCCCHHHHHH----HHHHhc-C--CCCcCcHHHHH
Confidence 88999999999999876663332 2222 366667 6 78899888875
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=95.25 E-value=0.0011 Score=57.00 Aligned_cols=92 Identities=10% Similarity=0.052 Sum_probs=68.3
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc---ccC
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA---DAH 422 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 422 (644)
+..+++.++...| ++|.| +|.||+....- +....+.++.+|+..++ |.+++++.+++....... +..
T Consensus 8 ~~~e~~~~~~~~d--~~g~i-~~~eF~~~~~~--~~~~~~~l~~~F~~~D~-----d~~G~I~~~el~~~l~~~~~~g~~ 77 (109)
T 1bu3_A 8 ADADVAAALKACE--AADSF-NYKAFFAKVGL--TAKSADDIKKAFFVIDQ-----DKSGFIEEDELKLFLQVFSAGARA 77 (109)
T ss_dssp CHHHHHHHHHHTC--STTCC-CHHHHHHHHTG--GGSCHHHHHHHHHHHCT-----TCSSSEEHHHHHTHHHHHSTTCCC
T ss_pred CHHHHHHHHHHhC--CCCcC-cHHHHHHHHHc--ChhhHHHHHHHHHHHCC-----CCCCcCcHHHHHHHHHHHcccCCC
Confidence 4456777888776 89999 99999987643 23456788999999888 889999999999997665 322
Q ss_pred c--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 V--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
. ..+++ +++..|.+ .|+.|++.||.
T Consensus 78 ~~~~~~~~----~~~~~D~~--~dg~i~~~eF~ 104 (109)
T 1bu3_A 78 LTDAETKA----FLKAGDSD--GDGAIGVDEWA 104 (109)
T ss_dssp CCHHHHHH----HHHHHCTT--CSSEECHHHHH
T ss_pred CCHHHHHH----HHHHhCCC--CCCcEeHHHHH
Confidence 2 22222 36667777 88899888875
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=95.25 E-value=0.0017 Score=55.70 Aligned_cols=91 Identities=12% Similarity=0.084 Sum_probs=66.9
Q ss_pred CchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc---ccCc
Q 006460 347 STSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA---DAHV 423 (644)
Q Consensus 347 s~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 423 (644)
..+++.++...| ++|.| +|.||+....- .....+.++.+|+.+++ |.+++++.+++....... +...
T Consensus 9 ~~e~~~~~~~~d--~~g~i-~~~ef~~~~~~--~~~~~~~l~~~F~~~D~-----d~~G~I~~~el~~~l~~~~~~g~~~ 78 (110)
T 1pva_A 9 ADDIKKALDAVK--AEGSF-NHKKFFALVGL--KAMSANDVKKVFKAIDA-----DASGFIEEEELKFVLKSFAADGRDL 78 (110)
T ss_dssp HHHHHHHHHHTC--STTCC-CHHHHHHHHTC--TTSCHHHHHHHHHHHCT-----TCSSSBCHHHHHTGGGGTCTTCCCC
T ss_pred HHHHHHHHHhcC--CCCcC-cHHHHHHHHcc--CcchHHHHHHHHHHhCC-----CCCCcCcHHHHHHHHHHHhhcCCCC
Confidence 445677777766 89999 99999988632 23456788999999988 889999999999998766 3222
Q ss_pred --ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 424 --QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 424 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..+++ ++..-|.+ .|+.|++.||-
T Consensus 79 ~~~~~~~----~~~~~d~~--~dg~i~~~eF~ 104 (110)
T 1pva_A 79 TDAETKA----FLKAADKD--GDGKIGIDEFE 104 (110)
T ss_dssp CHHHHHH----HHHHHCTT--CSSSBCHHHHH
T ss_pred CHHHHHH----HHHHhCCC--CCCeEcHHHHH
Confidence 12222 36666777 78889888775
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.19 E-value=0.00097 Score=63.80 Aligned_cols=102 Identities=13% Similarity=0.023 Sum_probs=75.2
Q ss_pred CCCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc----
Q 006460 344 PTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA---- 419 (644)
Q Consensus 344 ~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 419 (644)
+.....++.+|...|.|++|.| ++.||+.+......-.+++.+..+|+..+. |.+++++.+++.......
T Consensus 55 ~~~~~~~~~~f~~~D~d~~G~i-~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~I~~~E~~~~l~~~~~~~ 128 (204)
T 1jba_A 55 EEATQYVEAMFRAFDTNGDNTI-DFLEYVAALNLVLRGTLEHKLKWTFKIYDK-----DRNGCIDRQELLDIVESIYKLK 128 (204)
T ss_dssp STTHHHHHHHHHHHCCSSSSEE-CHHHHHHHHHHHSSCCCTHHHHHHHHHHCS-----SCSSCBCHHHHHHHHHHHHHHH
T ss_pred CCcHHHHHHHHHHHcCCCCCeE-eHHHHHHHHHHHccCCHHHHHHHHHHHhCC-----CCCCcCcHHHHHHHHHHHHHHh
Confidence 3455567889999999999999 999999988765555677889999998888 889999999999886543
Q ss_pred ccC---c--------ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 420 DAH---V--------QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 420 ~~~---~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.. . ...++.=-.+...-|.+ .|+.|++.||.
T Consensus 129 g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d--~dG~Is~~Ef~ 171 (204)
T 1jba_A 129 KACSVEVEAEQQGKLLTPEEVVDRIFLLVDEN--GDGQLSLNEFV 171 (204)
T ss_dssp HHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCS--CCSCBCHHHHH
T ss_pred CCCCccccccccCchhhHHHHHHHHHHHhCCC--CCCeEcHHHHH
Confidence 210 0 01111111236667777 89999988886
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=95.16 E-value=0.0015 Score=58.26 Aligned_cols=92 Identities=5% Similarity=0.021 Sum_probs=67.4
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccc-cccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ 424 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (644)
+...++.++.. ++|.| +|.||+...... .....++.+..+|+..+. |.+++++.+++..++...+....
T Consensus 41 ~~~~~~~~~~~----~~g~i-~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~-----d~~G~I~~~El~~~l~~~g~~~~ 110 (143)
T 3j04_B 41 TDEYLEGMMSE----APGPI-NFTMFLTMFGEKLNGTDPEDVIRNAFACFDE-----EASGFIHEDHLRELLTTMGDRFT 110 (143)
T ss_dssp CHHHHHTTTTT----SSSCC-CHHHHHHHHHHTTTSSCCHHHHHHHHTTSCS-----SSCCCCCTTTHHHHHHTSSSCCC
T ss_pred CHHHHHHHHHh----CCCCc-CHHHHHHHHHHHhccCCcHHHHHHHHHHHCC-----CCCCeEcHHHHHHHHHHcCCCCC
Confidence 33445555554 88999 999999988643 334456788999999888 89999999999999876664332
Q ss_pred --cccccccccccccCCCCCchhhhhhhhcc
Q 006460 425 --PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 425 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+++ ++..-|.+ .|+.|++.||-
T Consensus 111 ~~~~~~----~~~~~D~d--~dg~i~~~eF~ 135 (143)
T 3j04_B 111 DEEVDE----MYREAPID--KKGNFNYVEFT 135 (143)
T ss_dssp HHHHHH----HHHHTTCC--SSSCCCSTHHH
T ss_pred HHHHHH----HHHHcCCC--CCCcCcHHHHH
Confidence 2222 36667777 88999888875
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=95.09 E-value=0.0021 Score=59.63 Aligned_cols=115 Identities=8% Similarity=0.036 Sum_probs=78.9
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccccc-ccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQ-TETSDCSRDKQAH 394 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~-~~~~~l~~af~~~ 394 (644)
+.++.++++..+.++..++. ....+ +..+...+.+.+|.| ||.+|+......... .+++.|+.||+.+
T Consensus 20 ~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~----~~~~~~~~~~~~~~i-~f~ef~~~~~~~~~~~~~~~~l~~aF~~f 94 (153)
T 3i5g_B 20 EAFTMIDQDRDGFIGMEDLKDMFSSLGRVPP----DDELNAMLKECPGQL-NFTAFLTLFGEKVSGTDPEDALRNAFSMF 94 (153)
T ss_dssp HHHHHHCCSTTSCCCHHHHHHHHHHTTSCCC----HHHHHHHHHTSSSCC-CSHHHHHTTTTTTTTCCCHHHHHHHHHTT
T ss_pred HHHHHHCCCCCCeEcHHHHHHHHHHcCCCcc----HHHHHHHHHhccCCc-cHHHHHHHHHhhhcccccHHHHHHHHhcc
Confidence 33556667777766666552 11112 233455566778889 999999988665433 3567899999999
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
++ |++|+|+.+++..++...|..+. .+++ +++..|. .|+.|+|.||-
T Consensus 95 D~-----d~~G~I~~~el~~~l~~~g~~ls~~ei~~----~~~~~D~---~dG~I~y~EF~ 143 (153)
T 3i5g_B 95 DE-----DGQGFIPEDYLKDLLENMGDNFSKEEIKN----VWKDAPL---KNKQFNYNKMV 143 (153)
T ss_dssp CS-----SCSSCCCHHHHHHHHHSSSSCCCHHHHHH----HHTTCCE---ETTEECHHHHH
T ss_pred cc-----CCCCeEeHHHHHHHHHHcCCcCCHHHHHH----HHHHhCC---CcCEEcHHHHH
Confidence 99 99999999999999876664332 2222 3555552 48999999885
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=95.08 E-value=0.0023 Score=61.21 Aligned_cols=116 Identities=3% Similarity=0.002 Sum_probs=81.8
Q ss_pred hhhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc-ccccccccccccccc
Q 006460 321 LENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQA 393 (644)
Q Consensus 321 le~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~ 393 (644)
...+..++.+..+.++..++. ....+...+..++... +|.| +|.||+.....+ ......+.+..+|+.
T Consensus 60 ~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~----~g~i-~~~eF~~~~~~~~~~~~~~~~l~~~F~~ 134 (196)
T 3dtp_E 60 KEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA----PGPI-NFTMFLTIFGDRIAGTDEEDVIVNAFNL 134 (196)
T ss_dssp HHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS----SSCC-BHHHHHHHHHHCCCSSCCHHHHHHHHHT
T ss_pred HHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc----cCCC-cHHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 345666777777777666552 1223444455565554 8999 999999987543 233456788999999
Q ss_pred ccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 394 HFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
++. |.+++++.+++..++ ..|..+. .+++ ++..-|.+ .|+.|++.||-
T Consensus 135 ~D~-----d~~G~Is~~El~~~l-~~g~~~~~~~~~~----l~~~~D~d--~dG~I~~~EF~ 184 (196)
T 3dtp_E 135 FDE-----GDGKCKEETLKRSLT-TWGEKFSQDEVDQ----ALSEAPID--GNGLIDIKKFA 184 (196)
T ss_dssp TCS-----SSSCCBHHHHHHHHH-HSSSCCCHHHHHH----HHHSSCEE--TTEECHHHHHH
T ss_pred HCC-----CCCCcCcHHHHHHHH-HcCCCCCHHHHHH----HHHHcCCC--CCCEEeHHHHH
Confidence 988 999999999999999 7764332 2222 46777777 89999998886
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.08 E-value=0.002 Score=59.67 Aligned_cols=90 Identities=1% Similarity=-0.130 Sum_probs=69.8
Q ss_pred ccccccccCCCCccccccchhhhccccccc---------ccccccccccccccCCccCCCCchhhhhhhhhhhccccccC
Q 006460 352 DNLETKKVDPTSYTMEVSSSINDSKERSTQ---------TETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAH 422 (644)
Q Consensus 352 d~~~~~d~D~nG~i~d~~efi~a~~d~s~~---------~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (644)
.++...|.|++|.| ++.||+......... ..+..++.+|+..+. |.+++++.+|+...+...++.
T Consensus 64 ~~f~~~D~d~dG~I-~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~dG~Is~~E~~~~l~~~g~~ 137 (185)
T 2sas_A 64 DLKGRADINKDDVV-SWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDV-----SGDGIVDLEEFQNYCKNFQLQ 137 (185)
T ss_dssp HHHHHHCTTCSSCE-EHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCT-----TSSSCCCHHHHHHHTTSSCCC
T ss_pred HHHHhcCCCCCCeE-cHHHHHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcC-----CCCCeEcHHHHHHHHHHhCCC
Confidence 44889999999999 999999877543221 133677889988888 889999999999998777755
Q ss_pred cccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 VQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
...+++. +..-|.+ .|+.|++.||.
T Consensus 138 ~~~~~~~----~~~~D~d--~dG~i~~~ef~ 162 (185)
T 2sas_A 138 CADVPAV----YNVITDG--GKVTFDLNRYK 162 (185)
T ss_dssp CSSHHHH----HHHHHTT--TTSCCSHHHHH
T ss_pred HHHHHHH----HHHhcCC--CCCcCcHHHHH
Confidence 4444444 7777888 89999988886
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=95.07 E-value=0.00031 Score=73.65 Aligned_cols=193 Identities=9% Similarity=0.041 Sum_probs=110.0
Q ss_pred ccHHHHHHHHHHh---ccCCCCCCCHHHHhhC------CCCchhhhhcCCC-------------CCcccCC-Cc--ccc-
Q 006460 238 YSSTMKQIIKSML---RKNPEHRPTASDLLRH------PHLQPYLLRCQNP-------------SSVYLPI-KP--TNI- 291 (644)
Q Consensus 238 ~s~~l~dLI~~~L---~~dP~~RpTa~eiL~h------p~f~~~~~~~~~~-------------~~~~~p~-~p--~~~- 291 (644)
.+.++.+|.++++ ..+|+.|.+.++.+.| +|+..+..+.+++ .....+. .. ...
T Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~vl 96 (323)
T 1ij5_A 17 VHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLL 96 (323)
T ss_dssp HHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHHHH
Confidence 4678889999998 8999999999998888 8887664332111 0000000 00 000
Q ss_pred --cc-ccccCCCCCccCCCCCcchhhhcCcchhhhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCC
Q 006460 292 --MK-EKTRKSPSSKHNSRKDKGEREAAAPNQLENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPT 362 (644)
Q Consensus 292 --~k-~k~~~~~~~~~~~~k~~~~~e~~~~~~le~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~n 362 (644)
++ .........+ ...... +.........+..++.+..+.++..++. ........++.++...|.|++
T Consensus 97 ~~l~~~f~~~~~lkk--~~~~Ls--~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D~d~~ 172 (323)
T 1ij5_A 97 KDLEDDASGYNRLRP--SKPMLS--EEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTK 172 (323)
T ss_dssp HHC---------------CCCCC--HHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHCCS
T ss_pred HHHHHHHHHhhhHHH--HHHhCC--HHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCC
Confidence 00 0000000000 000000 0111112333455566666665555442 123346678899999999999
Q ss_pred CccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCC
Q 006460 363 SYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQN 440 (644)
Q Consensus 363 G~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 440 (644)
|+| +|.+|+... .....+..+|...+. |++++++.+++...+ .+..+. .+.+. ++...|.+
T Consensus 173 G~I-~f~ef~~l~------~~~~~l~~~F~~~D~-----d~dG~Is~~El~~~l--~g~~~~~~ei~~~---l~~~~D~d 235 (323)
T 1ij5_A 173 GRM-SYITLVAVA------NDLAALVADFRKIDT-----NSNGTLSRKEFREHF--VRLGFDKKSVQDA---LFRYADED 235 (323)
T ss_dssp STH-HHHHHTTSH------HHHHTSCCCHHHHCT-----TCCSEECHHHHHHHH--HHTTCCCHHHHHH---HHHHHCTT
T ss_pred CcC-cHHHHHhhh------hHHHHHHHHHHHHCC-----CCCCcCcHHHHHHHH--cCCCCCHHHHHHH---HHHHhcCC
Confidence 999 999998754 345678889998887 889999999999988 443321 12220 36667777
Q ss_pred CCchhhhhhhhcc
Q 006460 441 PFSDRVIEEADIE 453 (644)
Q Consensus 441 ~~~~~~~~~~~~~ 453 (644)
.|+.|++.+|-
T Consensus 236 --~dG~Is~~EF~ 246 (323)
T 1ij5_A 236 --ESDDVGFSEYV 246 (323)
T ss_dssp --CSSCEEHHHHH
T ss_pred --CCCEEeHHHHH
Confidence 88999988886
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=94.96 E-value=0.0023 Score=62.43 Aligned_cols=96 Identities=7% Similarity=0.015 Sum_probs=71.2
Q ss_pred hhccccccccCCCCc-cccccchhhhcccccccc-cccccccccccccCCccCCCCchhhhhhhhhhhccccccCc--cc
Q 006460 350 TEDNLETKKVDPTSY-TMEVSSSINDSKERSTQT-ETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHV--QP 425 (644)
Q Consensus 350 ~ed~~~~~d~D~nG~-i~d~~efi~a~~d~s~~~-~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 425 (644)
.+.++...|.|++|. | +|.||+.+........ .++.++.+|+..+. |.+++++.+++.+.+...+... ..
T Consensus 93 ~~~lf~~~D~d~dG~~I-~f~EF~~~~~~~~~~~~~~~~l~~~F~~~D~-----d~dG~Is~~El~~~l~~~~~~~~~~~ 166 (214)
T 2l4h_A 93 KERICRVFSTSPAKDSL-SFEDFLDLLSVFSDTATPDIKSHYAFRIFDF-----DDDGTLNREDLSRLVNCLTGEGEDTR 166 (214)
T ss_dssp HHHHHHHHCCSSSCCSE-EHHHHHHHHHHTSSCSCHHHHHHHHHHHHCT-----TCSSCBCHHHHHHHHHHHHHSSSCTT
T ss_pred HHHHHHHhCcCCCCCEe-cHHHHHHHHHHHcCCCCHHHHHHHHHHHhCC-----CCCCcCCHHHHHHHHHHHhccccCCC
Confidence 356888899999999 9 9999998876543322 35689999999988 9999999999999976554210 12
Q ss_pred ccccccc-----cccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVE-----TVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+.+..++ ++...|.+ .|+.|++.||.
T Consensus 167 ~s~~e~~~~~~~~~~~~D~d--~dG~Is~~EF~ 197 (214)
T 2l4h_A 167 LSASEMKQLIDNILEESDID--RDGTINLSEFQ 197 (214)
T ss_dssp CSCTHHHHHHHHHHHHHCCS--CCSSBCSHHHH
T ss_pred CCHHHHHHHHHHHHHHhCCC--CCCcCCHHHHH
Confidence 2222232 57777888 89999998886
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=94.88 E-value=0.00081 Score=63.33 Aligned_cols=120 Identities=12% Similarity=0.029 Sum_probs=78.0
Q ss_pred hhhhhHhhhccccccCcCCC-----C-----CCCC-Cc-----hhhccccccccCCCCccccccchhhhccccccc----
Q 006460 322 ENVRSVAKNIAVQLNNLPLD-----D-----KPTS-ST-----STEDNLETKKVDPTSYTMEVSSSINDSKERSTQ---- 381 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~-----~-----~~~s-s~-----~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~---- 381 (644)
..++.++.+..+.++..++. . .... .. .++.++...|.|++|.| ++.||+.........
T Consensus 24 ~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i-~~~EF~~~~~~~~~~~~~~ 102 (195)
T 1qv0_A 24 HMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEI-AFPQFLDGWKQLATSELKK 102 (195)
T ss_dssp HHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCB-CHHHHHHHHHHHHHHHHHH
T ss_pred HHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCCCCCceE-cHHHHHHHHHHHHhhhhhc
Confidence 44566777777666665553 1 1111 11 46778999999999999 999999876432211
Q ss_pred ---ccccccc----cccccccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhc
Q 006460 382 ---TETSDCS----RDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADI 452 (644)
Q Consensus 382 ---~~~~~l~----~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (644)
...+.++ .+|+..+. |.+++++.+++...+...|..+. .+++ ++..-|.+ .|+.|++.||
T Consensus 103 ~~~~~~~~~~~~~~~~F~~~D~-----d~~G~I~~~El~~~l~~~g~~~~~~~~~~----~~~~~D~d--~dg~i~~~eF 171 (195)
T 1qv0_A 103 WARNEPTLIREWGDAVFDIFDK-----DGSGTITLDEWKAYGKISGISPSQEDCEA----TFRHCDLD--NAGDLDVDEM 171 (195)
T ss_dssp HHTTCCCHHHHHHHHHHHHTC---------CEECHHHHHHHHHHHSSCCCHHHHHH----HHHHSCCC--TTSCEEHHHH
T ss_pred ccccHHHHHHHHHHHHHHHhcC-----CCCCcCcHHHHHHHHHHhCCCCCHHHHHH----HHHHhCCC--CCCcCCHHHH
Confidence 1112343 79998888 99999999999999876664322 2222 36677777 8999999888
Q ss_pred c
Q 006460 453 E 453 (644)
Q Consensus 453 ~ 453 (644)
-
T Consensus 172 ~ 172 (195)
T 1qv0_A 172 T 172 (195)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=94.88 E-value=0.0025 Score=61.00 Aligned_cols=100 Identities=10% Similarity=0.003 Sum_probs=75.1
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc----c-
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA----D- 420 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~- 420 (644)
....+..+|...|.|++|+| ++.||+.+......-.+++.++.+|+..+. |.+++++.+++....... |
T Consensus 69 ~~~~~~~~f~~~D~d~~G~i-~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~-----d~~G~I~~~E~~~~l~~~~~~~g~ 142 (207)
T 2d8n_A 69 PKAYAQHVFRSFDSNLDGTL-DFKEYVIALHMTTAGKTNQKLEWAFSLYDV-----DGNGTISKNEVLEIVMAIFKMITP 142 (207)
T ss_dssp CHHHHHHHHHHHCTTCCSEE-EHHHHHHHHHHHSCSSSSTTHHHHHHHHCT-----TCSSEECHHHHHHHHHHHHHHSCH
T ss_pred cHHHHHHHHHHhcCCCCCeE-eHHHHHHHHHHHcCCCHHHHHHHHHHHhcC-----CCCCeEcHHHHHHHHHHHHHHhcc
Confidence 34567889999999999999 999999988766555678889999998888 889999999999886543 3
Q ss_pred ---cCccc----ccccccccccccCCCCCchhhhhhhhcc
Q 006460 421 ---AHVQP----AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 421 ---~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..+.. .++.=-.++..-|.+ .|+.|++.||.
T Consensus 143 ~~~~~l~~~~~~~~~~~~~~f~~~D~d--~dG~I~~~Ef~ 180 (207)
T 2d8n_A 143 EDVKLLPDDENTPEKRAEKIWKYFGKN--DDDKLTEKEFI 180 (207)
T ss_dssp HHHHTSCTTTSSHHHHHHHHHHHTTCC--TTCCEEHHHHH
T ss_pred ccCCCcccccccHHHHHHHHHHHcCCC--CCCcCcHHHHH
Confidence 22211 011111246777877 88999988886
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=94.82 E-value=0.0016 Score=60.19 Aligned_cols=111 Identities=9% Similarity=-0.029 Sum_probs=77.0
Q ss_pred hhhhHhhhccccccCcCCC-------C----CCCCCchhhccccccccCCCCccccccchhhhccccccccccccccccc
Q 006460 323 NVRSVAKNIAVQLNNLPLD-------D----KPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDK 391 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~-------~----~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af 391 (644)
.+..++.+..+.++..++. . .+.+...++.++...|.|++|.| +|.||+...... +.++.+|
T Consensus 6 ~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i-~~~eF~~~~~~~------~~~~~~F 78 (167)
T 1gjy_A 6 GYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTM-GFNEFKELWAVL------NGWRQHF 78 (167)
T ss_dssp HHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCB-CHHHHHHHHHHH------HHHHHHH
T ss_pred HHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcC-CHHHHHHHHHHH------HHHHHHH
Confidence 3445555555555444441 1 13455677899999999999999 999999977542 5788899
Q ss_pred ccccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 392 QAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+..+. |.+++++.+++.......+.... .+++. +..- + .|+.|++.||.
T Consensus 79 ~~~D~-----d~~G~i~~~el~~~l~~~g~~~~~~~~~~~----~~~~--d--~dg~i~~~eF~ 129 (167)
T 1gjy_A 79 ISFDS-----DRSGTVDPQELQKALTTMGFRLNPQTVNSI----AKRY--S--TSGKITFDDYI 129 (167)
T ss_dssp HHHCT-----TCCSEECHHHHHHHHHTTTCCCCHHHHHHH----HHHT--C--BTTBEEHHHHH
T ss_pred HHhCC-----CCCCcCCHHHHHHHHHHcCCCCCHHHHHHH----HHHh--C--cCCcCcHHHHH
Confidence 98888 88999999999999876654321 22222 3333 4 67888888775
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=94.79 E-value=0.0017 Score=59.76 Aligned_cols=89 Identities=10% Similarity=-0.068 Sum_probs=66.8
Q ss_pred CCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcc
Q 006460 345 TSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ 424 (644)
Q Consensus 345 ~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (644)
.+...++.++...|.|++|.| +|.||+...... ..++.+|+..+. |.+++++.+++.......+....
T Consensus 37 ~~~~~~~~l~~~~D~~~~g~i-~~~eF~~~~~~~------~~~~~~F~~~D~-----d~~G~i~~~el~~~l~~~g~~~~ 104 (165)
T 1k94_A 37 FSLETCRIMIAMLDRDHTGKM-GFNAFKELWAAL------NAWKENFMTVDQ-----DGSGTVEHHELRQAIGLMGYRLS 104 (165)
T ss_dssp CCHHHHHHHHHHHCTTCSSCB-CHHHHHHHHHHH------HHHHHHHHHHCT-----TCCSBCCHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHHhCCCCCCcC-CHHHHHHHHHHH------HHHHHHHHHhCC-----CCCceECHHHHHHHHHHhCCCCC
Confidence 355677899999999999999 999999876442 578889998888 88999999999999876664321
Q ss_pred --cccccccccccccCCCCCchhhhhhhhcc
Q 006460 425 --PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 425 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+++. +... + .|+.|++.||.
T Consensus 105 ~~~~~~~----~~~~--d--~dg~i~~~eF~ 127 (165)
T 1k94_A 105 PQTLTTI----VKRY--S--KNGRIFFDDYV 127 (165)
T ss_dssp HHHHHHH----HHHH--C--BTTBCBHHHHH
T ss_pred HHHHHHH----HHHh--C--CCCeEcHHHHH
Confidence 22222 2222 4 67888888775
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=94.78 E-value=0.0017 Score=55.79 Aligned_cols=92 Identities=7% Similarity=0.019 Sum_probs=67.6
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc---ccC
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA---DAH 422 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 422 (644)
+..+++.++...|. +|.| +|.||+..... .....+.++.+|+..++ |.+++++.+++...+... +..
T Consensus 7 s~~ei~~~~~~~d~--~g~i-~~~eF~~~~~~--~~~~~~~l~~~F~~~D~-----d~~G~i~~~el~~~l~~~~~~g~~ 76 (109)
T 5pal_A 7 KADDINKAISAFKD--PGTF-DYKRFFHLVGL--KGKTDAQVKEVFEILDK-----DQSGFIEEEELKGVLKGFSAHGRD 76 (109)
T ss_dssp CHHHHHHHHHHTCS--TTCC-CHHHHHHHHTC--TTCCHHHHHHHHHHHCT-----TCSSEECHHHHHTHHHHHCTTCCC
T ss_pred CHHHHHHHHHHhCC--CCcC-cHHHHHHHHhh--ccCcHHHHHHHHHHHCC-----CCCCcCcHHHHHHHHHHHHHcCCC
Confidence 34556777777665 9999 99999998743 24456789999999988 889999999999997655 332
Q ss_pred cc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 VQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. .+++ ++..-|.+ .|+.|++.||-
T Consensus 77 ~~~~~~~~----~~~~~D~~--~dg~i~~~eF~ 103 (109)
T 5pal_A 77 LNDTETKA----LLAAGDSD--HDGKIGADEFA 103 (109)
T ss_dssp CCHHHHHH----HHHHHCTT--CSSSEEHHHHH
T ss_pred CCHHHHHH----HHHHhCCC--CCCcCcHHHHH
Confidence 21 1222 35666777 88899887774
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=94.74 E-value=0.0024 Score=62.52 Aligned_cols=124 Identities=9% Similarity=0.004 Sum_probs=82.5
Q ss_pred hhhhhHhhh--ccccccCcCCC----CC-CCCCchhhccccccccCCCCccccccchhhhccccc-cccccccccccccc
Q 006460 322 ENVRSVAKN--IAVQLNNLPLD----DK-PTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERS-TQTETSDCSRDKQA 393 (644)
Q Consensus 322 e~~~~~~~n--~~~q~~~~~~~----~~-~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s-~~~~~~~l~~af~~ 393 (644)
..+..++.+ ..+.++..++. .. ......++.+|...|.|++|.| ++.||+....... ....++.++.+|+.
T Consensus 52 ~~F~~~D~d~~~~G~I~~~El~~~l~~~~~~~~~~~~~~f~~~D~d~dG~I-~~~Ef~~~~~~~~~~~~~~~~l~~~F~~ 130 (226)
T 2zfd_A 52 ELFKKISSAVIDDGLINKEEFQLALFKTNKKESLFADRVFDLFDTKHNGIL-GFEEFARALSVFHPNAPIDDKIHFSFQL 130 (226)
T ss_dssp HHHHHHHTSSSCSSSBCHHHHHHHHHSCSSCCCHHHHHHHHHHCSSCSSSB-CHHHHHHHHHHTSTTSCHHHHHHHHHHH
T ss_pred HHHHHhCcccCCCCeEcHHHHHHHHhccCcccHHHHHHHHHHHcCCCCCcC-cHHHHHHHHHHHccCCCHHHHHHHHHHH
Confidence 345666666 66666555442 11 2233345679999999999999 9999998876543 22346678999999
Q ss_pred ccCCccCCCCchhhhhhhhhhhcc----ccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 394 HFNGSTGSDLTSEITANSQNEIQE----PADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+. |.+++++.+++..... ..|... ..+++.=-.+....|.+ .|+.|++.||.
T Consensus 131 ~D~-----d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d--~dG~I~~~EF~ 189 (226)
T 2zfd_A 131 YDL-----KQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTK--HDGKIDKEEWR 189 (226)
T ss_dssp HCT-----TSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSS--CSSEECHHHHH
T ss_pred hCC-----CCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCC--CCCcCcHHHHH
Confidence 888 9999999999998863 223221 11111100112367777 89999998886
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=94.72 E-value=0.0016 Score=60.83 Aligned_cols=101 Identities=10% Similarity=-0.020 Sum_probs=74.3
Q ss_pred CCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc----c
Q 006460 345 TSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA----D 420 (644)
Q Consensus 345 ~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 420 (644)
.....++.+|...|.|++|+| ++.||+.+......-.+++.++.+|+..+. |.+++++.+++....... |
T Consensus 53 ~~~~~~~~~f~~~D~d~~g~i-~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~-----d~~G~i~~~e~~~~~~~~~~~~g 126 (183)
T 1s6c_A 53 DASTYAHYLFNAFDTTQTGSV-KFEDFVTALSILLRGTVHEKLRWTFNLYDI-----NKDGYINKEEMMDIVKAIYDMMG 126 (183)
T ss_dssp CCHHHHHHHHHHHCTTCSSCE-EHHHHHHHHHHHHHCCHHHHHHHHHHHHCT-----TCSSCEEHHHHHHHHHHHHHHTC
T ss_pred ChHHHHHHHHHHhCCCCCCcE-eHHHHHHHHHHHcCCCHHHHHHHHHHHhCC-----CCCCeEcHHHHHHHHHHHHHHhc
Confidence 345567889999999999999 999999988665555567788999998888 889999999999986544 4
Q ss_pred cCccc-c-----cccccccccccCCCCCchhhhhhhhcc
Q 006460 421 AHVQP-A-----EEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 421 ~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..... + ++.=-+++..-|.+ .|+.|++.||.
T Consensus 127 ~~~~~~~~~~~~~~~~~~~f~~~D~d--~dG~i~~~Ef~ 163 (183)
T 1s6c_A 127 KYTYPVLKEDTPRQHVDVFFQKMDKN--KDGIVTLDEFL 163 (183)
T ss_dssp -----------CHHHHHHHHHHHCTT--CSSEECHHHHH
T ss_pred cccCcCccHHHHHHHHHHHHHHhCCC--CCCcEeHHHHH
Confidence 22111 1 11112346677777 88999988886
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=94.70 E-value=0.0018 Score=58.97 Aligned_cols=90 Identities=10% Similarity=0.014 Sum_probs=66.3
Q ss_pred ccccccccCCCCccccccchhhhcccccccc-------cccccccccccccCCccCCCCchhhhhhhhhhhccccccCcc
Q 006460 352 DNLETKKVDPTSYTMEVSSSINDSKERSTQT-------ETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ 424 (644)
Q Consensus 352 d~~~~~d~D~nG~i~d~~efi~a~~d~s~~~-------~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (644)
.++...|.|++|.| ++.||+........-. ....+..+|+..+. |.+++++.+++...+...+....
T Consensus 59 ~~f~~~D~d~~g~i-~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~i~~~E~~~~l~~~~~~~~ 132 (166)
T 3akb_A 59 GLAGIADRDGDQRI-TREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADT-----DGDGAVTVADTARALTAFGVPED 132 (166)
T ss_dssp HHHHHHCTTSSSCE-EHHHHHHTHHHHHHHSHHHHHHHHHHHHHHHHHHHCS-----SSSSCCBHHHHHHHHHHTTCCHH
T ss_pred HHHHHhCCCCCCcC-cHHHHHHHHHHHhccCccchHHHHHHHHHHHHHHhCC-----CCCCcCCHHHHHHHHHHhCCCHH
Confidence 45788999999999 9999998765432111 02348889988888 88999999999999766663333
Q ss_pred cccccccccccccCCCCCchhhhhhhhcc
Q 006460 425 PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+++. +..-|.+ .|+.|++.||.
T Consensus 133 ~~~~~----~~~~D~d--~dg~i~~~ef~ 155 (166)
T 3akb_A 133 LARQA----AAALDTD--GDGKVGETEIV 155 (166)
T ss_dssp HHHHH----HHHHCTT--CSSBCCHHHHH
T ss_pred HHHHH----HHHhCCC--CCCcCcHHHHH
Confidence 33333 6667777 88999888875
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=94.66 E-value=0.0019 Score=60.77 Aligned_cols=100 Identities=15% Similarity=0.049 Sum_probs=73.3
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccc----ccc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEP----ADA 421 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 421 (644)
....++.+|...|.|++|+| ++.||+.+......-.+++.+..+|+..+. |.+++++.+++...... .|.
T Consensus 61 ~~~~~~~~f~~~D~d~~G~i-~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~-----d~~G~i~~~e~~~~~~~~~~~~g~ 134 (190)
T 2l2e_A 61 PSAFAEYVFNVFDADKNGYI-DFKEFICALSVTSRGELNDKLIWAFQLYDL-----DNNGLISYDEMLRIVDAIYKMVGS 134 (190)
T ss_dssp HHHHHHHHHHHHCSSSTTCE-EHHHHHHHHTTSSCSCSHHHHHHHHHHHCT-----TSCSCBCHHHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHhcCCCCCeE-eHHHHHHHHHHHcCCCHHHHHHHHHhHccC-----CCCCcCcHHHHHHHHHHHHHHhcc
Confidence 34567889999999999999 999999988766666677888899988877 88999999999988644 221
Q ss_pred Cc------ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 422 HV------QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 422 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+ ...++.=-.+...-|.+ .|+.|++.||.
T Consensus 135 ~~~~~~~~~~~~~~~~~~f~~~D~d--~dG~I~~~Ef~ 170 (190)
T 2l2e_A 135 MVKLPEDEDTPEKRVNKIFNMMDKN--KDGQLTLEEFC 170 (190)
T ss_dssp HSCCCSSCCCTHHHHHHHHHHHTCC--SSCCBCHHHHH
T ss_pred ccCcccccccHHHHHHHHHHHhCCC--CCCcCcHHHHH
Confidence 10 00111111236667777 88999888876
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=94.60 E-value=0.0023 Score=61.20 Aligned_cols=123 Identities=7% Similarity=0.006 Sum_probs=80.2
Q ss_pred hhhhHhhh--ccccccCcCCC-----CCCCCCchhhccccccccCCCCccccccchhhhcccccc-cccccccccccccc
Q 006460 323 NVRSVAKN--IAVQLNNLPLD-----DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERST-QTETSDCSRDKQAH 394 (644)
Q Consensus 323 ~~~~~~~n--~~~q~~~~~~~-----~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~-~~~~~~l~~af~~~ 394 (644)
.+..++.+ ..+.++..++. ........++.+|...|.|++|.| ++.||+........ -..++.+..+|+..
T Consensus 42 ~F~~~D~d~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~f~~~D~d~~g~i-~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~ 120 (207)
T 2ehb_A 42 LFKKLSSSIIDDGLIHKEEFQLALFRNRNRRNLFADRIFDVFDVKRNGVI-EFGEFVRSLGVFHPSAPVHEKVKFAFKLY 120 (207)
T ss_dssp HHHHHTTSSSCSSCEEHHHHHHHHHSCTTCCCHHHHHHHHHHCTTCSSEE-CHHHHHHHHGGGSTTSCHHHHHHHHHHHH
T ss_pred HHHHhccccCCCCccCHHHHHHHHhccccccHHHHHHHHHHhcCCCCCeE-eHHHHHHHHHHHccCCCHHHHHHHHHHHh
Confidence 34555555 55555444442 112233345779999999999999 99999998865432 23466788999988
Q ss_pred cCCccCCCCchhhhhhhhhhhccc----cccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEP----ADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. |.+++++.+++...... .+... ..+++.=-.+...-|.+ .|+.|++.||.
T Consensus 121 D~-----d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d--~dG~I~~~Ef~ 178 (207)
T 2ehb_A 121 DL-----RQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRK--NDGKIDIDEWK 178 (207)
T ss_dssp CT-----TCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTT--CSSEECHHHHH
T ss_pred CC-----CCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCC--CCCcCcHHHHH
Confidence 88 89999999999988641 22221 11111100112466777 89999998886
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=94.58 E-value=0.0016 Score=60.47 Aligned_cols=114 Identities=11% Similarity=0.038 Sum_probs=81.5
Q ss_pred hhhhhHhhhccccccCcCCC------C-CCCCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------D-KPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAH 394 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~-~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~ 394 (644)
+.++.++.+..+.++..++. . .+.+...++.++...|.|++|.| ++.||+..... ...++.+|+..
T Consensus 11 ~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i-~~~ef~~~~~~------~~~~~~~F~~~ 83 (172)
T 2znd_A 11 NVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGV-NFSEFTGVWKY------ITDWQNVFRTY 83 (172)
T ss_dssp HHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEE-CHHHHHHHHHH------HHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcC-CHHHHHHHHHH------HHHHHHHHHHH
Confidence 33555666666665554442 1 23455667889999999999999 99999987643 25688899988
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. |.+++++.+++.......+.... .+++ +++.-|.+ .|+.|++.||.
T Consensus 84 D~-----d~~G~i~~~el~~~l~~~g~~~~~~~~~~----~~~~~d~~--~dg~i~~~eF~ 133 (172)
T 2znd_A 84 DR-----DNSGMIDKNELKQALSGFGYRLSDQFHDI----LIRKFDRQ--GRGQIAFDDFI 133 (172)
T ss_dssp CT-----TCSSEECHHHHHHHHHHTTCCCCHHHHHH----HHHHHCTT--CSSSEEHHHHH
T ss_pred CC-----CCCCccCHHHHHHHHHHcCCCCCHHHHHH----HHHHhCCC--CCCcCcHHHHH
Confidence 88 88999999999999766653321 2222 36666777 78899888875
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=94.58 E-value=0.0028 Score=59.36 Aligned_cols=96 Identities=7% Similarity=0.015 Sum_probs=71.8
Q ss_pred hhccccccccCCCCc-cccccchhhhcccccccc-cccccccccccccCCccCCCCchhhhhhhhhhhccccccCc--cc
Q 006460 350 TEDNLETKKVDPTSY-TMEVSSSINDSKERSTQT-ETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHV--QP 425 (644)
Q Consensus 350 ~ed~~~~~d~D~nG~-i~d~~efi~a~~d~s~~~-~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 425 (644)
.+.++...|.|++|. | +|.||+.......... .++.++.+|+..+. |.+++++.+++...+...+... ..
T Consensus 62 ~~~l~~~~D~d~~G~~I-~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~-----d~~G~I~~~El~~~l~~~~~~~~~~~ 135 (183)
T 1dgu_A 62 KERICRVFSTSPAKDSL-SFEDFLDLLSVFSDTATPDIKSHYAFRIFDF-----DDDGTLNREDLSRLVNCLTGEGEDTR 135 (183)
T ss_dssp HHHHHHHHSCSSSSCCC-CHHHHHHHHHHHSTTCCHHHHHHHHHHHHCT-----TCSSEEEHHHHHHHHHHHHSSSCCCH
T ss_pred HHHHHHHhCCCCCCCEe-cHHHHHHHHHHhcCCCCHHHHHHHHHHHhCC-----CCCCcCCHHHHHHHHHHHhcccccCC
Confidence 457888899999999 9 9999998876543322 24588999999988 8999999999999876554310 12
Q ss_pred ccccccc-----cccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVE-----TVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+.+..++ ++...|.+ .|+.|++.||.
T Consensus 136 ~~~~~~~~~~~~~~~~~D~d--~dG~I~~~EF~ 166 (183)
T 1dgu_A 136 LSASEMKQLIDNILEESDID--RDGTINLSEFQ 166 (183)
T ss_dssp HHHHHHHHHHHHHHHHHCTT--SSSEEEHHHHH
T ss_pred CCHHHHHHHHHHHHHHhCCC--CCCeEcHHHHH
Confidence 3333333 57777888 89999998886
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.54 E-value=0.0028 Score=61.24 Aligned_cols=97 Identities=11% Similarity=0.026 Sum_probs=72.6
Q ss_pred chhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccccc-----C
Q 006460 348 TSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADA-----H 422 (644)
Q Consensus 348 ~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 422 (644)
..++.+|...|.|++|+| ++.||+.+......-.+++.++.+|+..+. |.+++++.+++.......+. .
T Consensus 57 ~~~~~~f~~~D~d~dG~I-~~~Ef~~~~~~~~~~~~~~~l~~~F~~~D~-----d~~G~I~~~E~~~~l~~~~~~~~~~~ 130 (211)
T 2ggz_A 57 KHIDQVYNTFDTNKDGFV-DFLEFIAAVNLIMQEKMEQKLKWYFKLYDA-----DGNGSIDKNELLDMFMAVQALNGQQT 130 (211)
T ss_dssp HHHHHHHHHHCTTCSSEE-EHHHHHHHHHHHSCSSHHHHHHHHHHHHCT-----TCSSSBCHHHHHHHHHHHTTSSCCCS
T ss_pred HHHHHHHHHHcCCCCCeE-eHHHHHHHHHHhccCchHHHHHHHHHHhcC-----CCCCcCcHHHHHHHHHHHHhhcCCcc
Confidence 347889999999999999 999999988654444566788999998888 88999999999988654431 1
Q ss_pred cccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 VQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.. .++.=-.+...-|.+ .|+.|++.||.
T Consensus 131 ~~-~~~~~~~~f~~~D~d--~dG~I~~~Ef~ 158 (211)
T 2ggz_A 131 LS-PEEFINLVFHKIDIN--NDGELTLEEFI 158 (211)
T ss_dssp CT-HHHHHHHHHHHHCTT--CSSSBCHHHHH
T ss_pred cc-HHHHHHHHHHHhCCC--CCCCCcHHHHH
Confidence 11 111111235677877 89999998887
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=94.36 E-value=0.0026 Score=58.40 Aligned_cols=116 Identities=7% Similarity=0.019 Sum_probs=79.8
Q ss_pred hhhhhHhhhccccccCcCCC------CC-CCCCchhhccccccccCCCCccccccchhhhcccc-ccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DK-PTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQA 393 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~-~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~ 393 (644)
..+..++.+..+.++..++. .. ..+...++.++.. .+|.| +|.||+...... ......+.+..+|+.
T Consensus 29 ~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~----~dg~i-~~~eF~~~~~~~~~~~~~~~~l~~~F~~ 103 (166)
T 2mys_B 29 EAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKE----ASGPI-NFTVFLTMFGEKLKGADPEDVIMGAFKV 103 (166)
T ss_pred HHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHH----CCCCc-CHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 44566777777766665553 11 2233445555553 37999 999999887643 233456788999999
Q ss_pred ccCCccCCCCchhhhhhhhhhhccccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 394 HFNGSTGSDLTSEITANSQNEIQEPADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+. |.+++++.+++...+...+... ..+++ ++..-|.+ .|+.|++.||.
T Consensus 104 ~D~-----d~~G~I~~~el~~~l~~~g~~~~~~~~~~----~~~~~D~d--~dg~I~~~eF~ 154 (166)
T 2mys_B 104 LDP-----DGKGSIKKSFLEELLTTGGGRFTPEEIKN----MWAAFPPD--VAGNVDYKNIC 154 (166)
T ss_pred hCC-----CCCcceeHHHHHHHHHHcCCCCCHHHHHH----HHHhcCCC--CCCeEeHHHHH
Confidence 888 9999999999999987666432 22222 36666777 89999998886
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=94.36 E-value=0.003 Score=59.40 Aligned_cols=100 Identities=13% Similarity=0.026 Sum_probs=72.7
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc----cc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA----DA 421 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 421 (644)
....++.+|...|.|++|+| ++.||+.+......-.+++.+..+|+..+. |.++.++.+++....... +.
T Consensus 61 ~~~~~~~~f~~~D~d~~g~i-~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~-----d~~G~I~~~E~~~~~~~~~~~~g~ 134 (193)
T 1bjf_A 61 ASKFAEHVFRTFDANGDGTI-DFREFIIALSVTSRGKLEQKLKWAFSMYDL-----DGNGYISKAEMLEIVQAIYKMVSS 134 (193)
T ss_dssp CHHHHHHHHHHHCSSCSSEE-EHHHHHHHHHHHTSSCHHHHHHHHHHHHCT-----TCSSCEEHHHHHHHHHHHHTTCCC
T ss_pred hHHHHHHHHHHhCCCCCCcC-cHHHHHHHHHHHcCCCHHHHHHHHHhhcCC-----CCCCeECHHHHHHHHHHHHHHhcc
Confidence 34457889999999999999 999999988665555667788899988877 889999999999876432 21
Q ss_pred --Cccc----ccccccccccccCCCCCchhhhhhhhcc
Q 006460 422 --HVQP----AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 422 --~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.... .++.=-.+...-|.+ .|+.|++.||.
T Consensus 135 ~~~~~~~~~~~~~~~~~~f~~~D~d--~dG~I~~~Ef~ 170 (193)
T 1bjf_A 135 VMKMPEDESTPEKRTEKIFRQMDTN--RDGKLSLEEFI 170 (193)
T ss_dssp TTTSCGGGSSHHHHHHHHHHHSCTT--CSSEECHHHHH
T ss_pred ccCCCcccccHHHHHHHHHHHhCCC--CCCeEeHHHHH
Confidence 1110 001111246667777 89999888886
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=94.30 E-value=0.0028 Score=62.31 Aligned_cols=100 Identities=10% Similarity=-0.020 Sum_probs=74.7
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc----cc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA----DA 421 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 421 (644)
....++.+|...|.|++|+| ++.||+.+......-.+++.++.+|+..+. |.+++++.+++....... |.
T Consensus 87 ~~~~~~~~f~~~D~d~~G~I-~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~-----d~dG~Is~~E~~~~l~~~~~~~g~ 160 (224)
T 1s1e_A 87 ASTYAHYLFNAFDTTQTGSV-KFEDFVTALSILLRGTVHEKLRWTFNLYDI-----NKDGYINKEEMMDIVKAIYDMMGK 160 (224)
T ss_dssp CHHHHHHHHHHHCTTCSSCB-CHHHHHHHHHHHHHCCHHHHHHHHHHHHCT-----TCCSEECHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHhcCCCCCcE-eHHHHHHHHHHHccCCHHHHHHHHHHHHcC-----CCCCeECHHHHHHHHHHHHHHhcc
Confidence 44567889999999999999 999999988665555567789999998888 889999999999986543 42
Q ss_pred Cccc-c-----cccccccccccCCCCCchhhhhhhhcc
Q 006460 422 HVQP-A-----EEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 422 ~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.... + ++.=-++++.-|.| .|+.|++.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~f~~~D~d--~dG~Is~~EF~ 196 (224)
T 1s1e_A 161 YTYPVLKEDTPRQHVDVFFQKMDKN--KDGIVTLDEFL 196 (224)
T ss_dssp CCCGGGCSSSHHHHHHHHHHHHCTT--CSSCEEHHHHH
T ss_pred cCCCCCCHhHHHHHHHHHHHHhCCC--CCCcEeHHHHH
Confidence 2111 1 11111246677877 89999888886
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=94.25 E-value=0.0034 Score=58.66 Aligned_cols=93 Identities=15% Similarity=0.081 Sum_probs=68.1
Q ss_pred hhhccccccccCCCCccccccchhhhccccccc-------ccccccc----cccccccCCccCCCCchhhhhhhhhhhcc
Q 006460 349 STEDNLETKKVDPTSYTMEVSSSINDSKERSTQ-------TETSDCS----RDKQAHFNGSTGSDLTSEITANSQNEIQE 417 (644)
Q Consensus 349 ~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~-------~~~~~l~----~af~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (644)
.++.++...|.|++|.| ++.||+......... ...+.++ .+|+..+. |.+++++.+++...+.
T Consensus 63 ~~~~l~~~~D~d~~g~i-~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~Is~~El~~~l~ 136 (191)
T 1uhk_A 63 AVEAFFGGAGMKYGVET-DWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDK-----DQNGAITLDEWKAYTK 136 (191)
T ss_dssp HHHHHHHHTTCCTTCEE-EHHHHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCT-----TCSSEECHHHHHHHHH
T ss_pred HHHHHHHHhCcCCCCcC-cHHHHHHHHHHHhcchhhhhhhhhHHHHHHHHHHHHHHhcC-----CCCCcCcHHHHHHHHH
Confidence 46778899999999999 999999876443211 1122343 79988888 8999999999999987
Q ss_pred ccccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 418 PADAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 418 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..+... ..+++ ++..-|.+ .|+.|++.||-
T Consensus 137 ~~g~~~~~~~~~~----~~~~~D~d--~dG~i~~~eF~ 168 (191)
T 1uhk_A 137 AAGIIQSSEDCEE----TFRVCDID--ESGQLDVDEMT 168 (191)
T ss_dssp HHTSCCSHHHHHH----HHHHSCCC--TTSCEEHHHHH
T ss_pred HhCCCCCHHHHHH----HHHHhCCC--CCCcCcHHHHH
Confidence 666432 12222 36777877 89999998886
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=94.18 E-value=0.0026 Score=69.76 Aligned_cols=121 Identities=9% Similarity=0.111 Sum_probs=87.1
Q ss_pred hhhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc-ccccccccccccccc
Q 006460 321 LENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQA 393 (644)
Q Consensus 321 le~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~ 393 (644)
...++.++.+..+.++..++. ....+...++.++...|.|++|.| ++.||+...... .....++.++.+|+.
T Consensus 315 ~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~DgdG~I-sfeEFl~ll~~~~~~~~~~e~l~~aFk~ 393 (450)
T 3sg6_A 315 KEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI-DFPEFLTMMARKMKDTDSEEEIREAFRV 393 (450)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTSSSSE-EHHHHHHHHHC------CHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcc-cHHHHHHHHHhhccccchhhHHHHHHHH
Confidence 344566777777777666652 223455667889999999999999 999999887543 223355678899999
Q ss_pred ccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 394 HFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.++ |.+++++.+|+.++++..+..+. .+++ ++..-|.+ .|+.|++.||-
T Consensus 394 fD~-----D~dG~Is~eELr~~L~~lG~~ls~eei~~----Lf~~~D~D--~DG~IsfdEFv 444 (450)
T 3sg6_A 394 FDK-----DGNGYISAAELRHVMTNLGEKLTDEEVDE----MIREADID--GDGQVNYEEFV 444 (450)
T ss_dssp HCT-----TCSSEECHHHHHHHHHHHTCCCCHHHHHH----HHHHHCTT--SSSSEEHHHHH
T ss_pred hCC-----CCCCeEeHHHHHHHHHHhCCCCCHHHHHH----HHHHhCCC--CCCcEeHHHHH
Confidence 988 89999999999999877664332 2222 36666777 88999888875
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=94.10 E-value=0.0034 Score=55.73 Aligned_cols=90 Identities=9% Similarity=0.055 Sum_probs=62.9
Q ss_pred CchhhccccccccCCCCccccccchhhhcccccccc---cccccccccccccCCccCCCCchhhhhhhhhhhccccccCc
Q 006460 347 STSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQT---ETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHV 423 (644)
Q Consensus 347 s~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~---~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (644)
...+..++. |++|.| +|.||+.......... ..+.+..+|+..+. |.+++++.+++...+...|..+
T Consensus 40 ~~~~~~~~~----~~~g~i-~~~eF~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~i~~~el~~~l~~~g~~~ 109 (140)
T 1ggw_A 40 LAEITEIES----TLPAEV-DMEQFLQVLNRPNGFDMPGDPEEFVKGFQVFDK-----DATGMIGVGELRYVLTSLGEKL 109 (140)
T ss_dssp HHHHHHHHT----TSCSSE-EHHHHHHHHCTTSSSSSSCCHHHHHHHHHTTCS-----SCSSCCCHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHh----CCCCcC-cHHHHHHHHHHHhcccCcccHHHHHHHHHHhCC-----CCCCcEeHHHHHHHHHHcCCCC
Confidence 344555555 889999 9999998886654322 23788899998888 8899999999999987666432
Q ss_pred c--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 424 Q--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 424 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
. .+++ ++..-|. .|+.|++.||-
T Consensus 110 ~~~~~~~----~~~~~d~---~dg~i~~~eF~ 134 (140)
T 1ggw_A 110 SNEEMDE----LLKGVPV---KDGMVNYHDFV 134 (140)
T ss_dssp CHHHHHH----HHHHTTC---SSCCSTTTHHH
T ss_pred CHHHHHH----HHHhccC---CCCcEeHHHHH
Confidence 1 1222 2444443 67888887774
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=94.05 E-value=0.0034 Score=59.85 Aligned_cols=110 Identities=9% Similarity=-0.024 Sum_probs=78.5
Q ss_pred hhhHhhhccccccCcCCC-------C----CCCCCchhhccccccccCCCCccccccchhhhcccccccccccccccccc
Q 006460 324 VRSVAKNIAVQLNNLPLD-------D----KPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQ 392 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~-------~----~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~ 392 (644)
+..++.+..+.++..++. . .+.+...++.++...|.|++|.| +|.||+...... ..++.+|+
T Consensus 38 F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i-~~~eF~~~~~~~------~~~~~~F~ 110 (198)
T 1juo_A 38 YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTM-GFNEFKELWAVL------NGWRQHFI 110 (198)
T ss_dssp HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCE-EHHHHHHHHHHH------HHHHHHHH
T ss_pred HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeE-CHHHHHHHHHHH------HHHHHHHH
Confidence 666777776666655552 1 13355667889999999999999 999999877542 57788999
Q ss_pred cccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 393 AHFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..+. |.++.++.+++.......+.... .+++. +..- + .|+.|++.||.
T Consensus 111 ~~D~-----d~~G~I~~~el~~~l~~~g~~~~~~~~~~l----~~~~--d--~dg~i~~~eF~ 160 (198)
T 1juo_A 111 SFDT-----DRSGTVDPQELQKALTTMGFRLSPQAVNSI----AKRY--S--TNGKITFDDYI 160 (198)
T ss_dssp TTCT-----TCCSEECHHHHHHHHHHTTCCCCHHHHHHH----HHHT--C--SSSSEEHHHHH
T ss_pred HhCC-----CCCCcCCHHHHHHHHHHhCCCCCHHHHHHH----HHHh--C--CCCeEcHHHHH
Confidence 8888 88999999999999876664321 22222 2222 4 67888888775
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=93.88 E-value=0.0049 Score=57.73 Aligned_cols=100 Identities=15% Similarity=0.027 Sum_probs=72.5
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccc----ccc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEP----ADA 421 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 421 (644)
....++.+|...|.|++|+| ++.||+.+......-.+++.+..+|+..+. |.+++++.+++...... .|.
T Consensus 61 ~~~~~~~~f~~~D~d~~G~i-~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~-----d~~G~i~~~ef~~~~~~~~~~~g~ 134 (190)
T 1fpw_A 61 PEDFANHLFTVFDKDNNGFI-HFEEFITVLSTTSRGTLEEKLSWAFELYDL-----NHDGYITFDEMLTIVASVYKMMGS 134 (190)
T ss_dssp CSHHHHHHHHTCCSSCSSEE-CHHHHHHHHHHHSCCCSTHHHHHHHHHHCS-----SCSSEEEHHHHHHHHHHHHTTSCS
T ss_pred cHHHHHHHHHHHCCCCCCcE-eHHHHHHHHHHHccCCcHHHHHHHHHHhcC-----CCCCcCcHHHHHHHHHHHHHHhcc
Confidence 34567889999999999999 999999887665555677888899988887 88999999999988644 232
Q ss_pred Cc------ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 422 HV------QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 422 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. ...++.=-.+.+.-|.+ .|+.|++.||.
T Consensus 135 ~~~~~~~~~~~~~~~~~~f~~~D~d--~dG~I~~~Ef~ 170 (190)
T 1fpw_A 135 MVTLNEDEATPEMRVKKIFKLMDKN--EDGYITLDEFR 170 (190)
T ss_dssp TTSSSCCCCCHHHHHHHHHHHHTTT--CSSEEEHHHHH
T ss_pred ccCcccccchHHHHHHHHHHHhCCC--CCCcCcHHHHH
Confidence 10 01111111235666777 88999888876
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=93.85 E-value=0.0068 Score=60.59 Aligned_cols=100 Identities=13% Similarity=-0.001 Sum_probs=74.2
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc----cc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA----DA 421 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 421 (644)
....++.+|...|.|++|+| ++.||+.+......-.+++.++.+|+..+. |.+++++.+++....... |.
T Consensus 127 ~~~~~~~~f~~~D~d~dG~I-~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~-----d~dG~I~~~Ef~~~l~~~~~~~g~ 200 (256)
T 2jul_A 127 ATTYAHFLFNAFDADGNGAI-HFEDFVVGLSILLRGTVHEKLKWAFNLYDI-----NKDGCITKEEMLAIMKSIYDMMGR 200 (256)
T ss_dssp CHHHHHHHHHHSSCSCCSEE-CSHHHHHHHHHHHSCCHHHHHHHHHHHTCC-----SSSSCBCHHHHHHHHHHHHHHCCC
T ss_pred cHHHHHHHHHHhccCCCCcC-cHHHHHHHHHHHhccChHHHHHHHHHHhCC-----CCCCcCcHHHHHHHHHHHHHHhCC
Confidence 34567889999999999999 999999988665555677889999998887 889999999999986543 32
Q ss_pred Cccc------ccccccccccccCCCCCchhhhhhhhcc
Q 006460 422 HVQP------AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 422 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+... .++.=-.+...-|.| .|+.|++.||.
T Consensus 201 ~~~~~~~~~~~~~~~~~~f~~~D~d--~dG~Is~~Ef~ 236 (256)
T 2jul_A 201 HTYPILREDAPLEHVERFFQKMDRN--QDGVVTIDEFL 236 (256)
T ss_dssp CCSCCSCCCCHHHHHHHHHHHSCCS--TTCSBCHHHHH
T ss_pred CCCcccchhhHHHHHHHHHHHHCCC--CCCcEeHHHHH
Confidence 2110 111112346677777 88999888875
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=93.79 E-value=0.0048 Score=58.58 Aligned_cols=98 Identities=14% Similarity=0.027 Sum_probs=72.5
Q ss_pred chhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccccc-----C
Q 006460 348 TSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADA-----H 422 (644)
Q Consensus 348 ~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 422 (644)
..++.+|...|.|++|+| ++.||+.+......-.+++.++.+|+..+. |.+++++.+++.......+. .
T Consensus 52 ~~~~~~f~~~D~d~~G~I-~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~I~~~Ef~~~~~~~~~~~~~~~ 125 (198)
T 2r2i_A 52 KYVEQMFETFDFNKDGYI-DFMEYVAALSLVLKGKVDQKLRWYFKLYDV-----DGNGCIDRGELLNIIKAIRAINRCNE 125 (198)
T ss_dssp HHHHHHHHHHCTTCSSCE-EHHHHHHHHHHHSSCCHHHHHHHHHHHHCT-----TCSSCEEHHHHHHHHHHTTGGGGSSS
T ss_pred HHHHHHHHHHCCCCCCeE-cHHHHHHHHHHHccCchHHHHHHHHHHhcC-----CCCCcCcHHHHHHHHHHHHhhcCCCc
Confidence 347889999999999999 999999988665555567788899998887 88999999999998654331 0
Q ss_pred cccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 VQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
....++.=-.+.+.-|.+ .|+.|++.||.
T Consensus 126 ~~~~~~~~~~~f~~~D~d--~dG~I~~~Ef~ 154 (198)
T 2r2i_A 126 AMTAEEFTNMVFDKIDIN--GDGELSLEEFM 154 (198)
T ss_dssp CCCHHHHHHHHHHHHCTT--CSSEECHHHHH
T ss_pred hhhHHHHHHHHHHHhCCC--CCCcCcHHHHH
Confidence 011111111235677778 89999988886
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=93.75 E-value=0.0085 Score=53.65 Aligned_cols=87 Identities=13% Similarity=0.134 Sum_probs=40.8
Q ss_pred CchhhccccccccCCCCccccccchhhh----cccccc--cccccccccccccccCCccCCCCchhhhhhhhhhhccccc
Q 006460 347 STSTEDNLETKKVDPTSYTMEVSSSIND----SKERST--QTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPAD 420 (644)
Q Consensus 347 s~~~ed~~~~~d~D~nG~i~d~~efi~a----~~d~s~--~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (644)
..+++.++... +|.| ||.||+.+ .+.+.. ....+.++.||+.++ ++++.+++..+.+..|
T Consensus 11 ~~ei~~~~~~~----~g~i-~f~EF~~~~~~~~~~~~~~~~~~~~~l~~aF~~fD---------G~I~~~El~~~l~~lG 76 (123)
T 2kld_A 11 YSEVKSDLAQQ----KAEM-ELSDLIRKGYHKALVKLKLKKNTVDDISESLRQGG---------GKLNFDELRQDLKGKG 76 (123)
T ss_dssp ---------------------------------------------CCSCSSTTTT---------TCEEHHHHHHHTTTCC
T ss_pred HHHHHHHHHHc----CCCc-cHHHHHhHhHHHHHHHhhcChhHHHHHHHHHHHhC---------CCCCHHHHHHHHHHhC
Confidence 34455666544 7899 99999983 222221 223467888998775 8899999999987777
Q ss_pred cCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 421 AHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..-..++ ++++..|.| .|+.|++.||-
T Consensus 77 ~t~~ei~----~~~~~~D~d--~dG~I~~~EF~ 103 (123)
T 2kld_A 77 HTDAEIE----AIFTKYDQD--GDQELTEHEHQ 103 (123)
T ss_dssp SSHHHHH----HHHHHHSSS--SCCEECSHHHH
T ss_pred CCHHHHH----HHHHHHcCC--CCCcCcHHHHH
Confidence 5222233 347778888 89999999986
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=93.52 E-value=0.0055 Score=60.31 Aligned_cols=93 Identities=9% Similarity=-0.001 Sum_probs=66.3
Q ss_pred cccccccCCCCccccccchhhhcccc--------cccccccccccccccccCCccCCCCchhhhhhhhhhhccccccC-c
Q 006460 353 NLETKKVDPTSYTMEVSSSINDSKER--------STQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAH-V 423 (644)
Q Consensus 353 ~~~~~d~D~nG~i~d~~efi~a~~d~--------s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 423 (644)
++...|.|++|.| +|.||+...... ......+.+..+|+..++ |.+++++.+++.......+.. -
T Consensus 152 ~~~~~d~~~dg~i-~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~is~~El~~~l~~~~~~~~ 225 (263)
T 2f33_A 152 MLKLFDSNNDGKL-ELTEMARLLPVQENFLLKFQGIKMCGKEFNKAFELYDQ-----DGNGYIDENELDALLKDLCEKNK 225 (263)
T ss_dssp HHHHTCSSSSSCB-CHHHHHHHSCTTTCSHHHHHHTCCCHHHHHHHHHHHCC-----SSSSCEEHHHHHHHHHHHHHHCT
T ss_pred HHHhcCCCCCCeE-cHHHHHHHHHHHHHHHHHhcCcchHHHHHHHHHHHhCC-----CCCCcccHHHHHHHHHHHHHhcC
Confidence 8899999999999 999998876541 233456788899999888 899999999999987554430 0
Q ss_pred ccccccccc-cccc-cCCCCCchhhhhhhhcc
Q 006460 424 QPAEEIDVE-TVKS-KDQNPFSDRVIEEADIE 453 (644)
Q Consensus 424 ~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~ 453 (644)
..+.+..+. ++.. .|.+ .|+.|++.||.
T Consensus 226 ~~~~~~e~~~~~~~~~D~d--~dG~i~~~EF~ 255 (263)
T 2f33_A 226 QELDINNISTYKKNIMALS--DGGKLYRTDLA 255 (263)
T ss_dssp TTCCTTTHHHHHHHHHTTS--BTTEECGGGTH
T ss_pred CCCCHHHHHHHHHHhhccC--CCCeEcHHHHH
Confidence 012222222 2332 3666 89999998886
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=93.24 E-value=0.0039 Score=58.42 Aligned_cols=98 Identities=15% Similarity=0.025 Sum_probs=70.7
Q ss_pred chhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccc----cccCc
Q 006460 348 TSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEP----ADAHV 423 (644)
Q Consensus 348 ~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 423 (644)
..++.+|...|.|++|.| ++.||+.+......-.+++.+..+|+..+. |.+++++.+++...... .|.+.
T Consensus 63 ~~~~~~f~~~D~d~~g~i-~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~-----d~~G~i~~~e~~~~l~~~~~~~g~~~ 136 (190)
T 1g8i_A 63 KFATFVFNVFDENKDGRI-EFSEFIQALSVTSRGTLDEKLRWAFKLYDL-----DNDGYITRNEMLDIVDAIYQMVGNTV 136 (190)
T ss_dssp HHHHHHHHHHCTTCSSEE-EHHHHHHHHHHHHHCCHHHHHHHHHHHHCT-----TCSSEEEHHHHHHHHHHHHHHC----
T ss_pred HHHHHHHHHHhcCCCCeE-eHHHHHHHHHHhcCCCHHHHHHHHHHhhcC-----CCCCeECHHHHHHHHHHHHHHhCCcc
Confidence 457889999999999999 999999887665555667788899988887 88999999999988654 23211
Q ss_pred ------ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 424 ------QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 424 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
...++.=-.+...-|.+ .|+.|++.||.
T Consensus 137 ~~~~~~~~~~~~~~~~f~~~D~d--~dG~i~~~ef~ 170 (190)
T 1g8i_A 137 ELPEEENTPEKRVDRIFAMMDKN--ADGKLTLQEFQ 170 (190)
T ss_dssp -CCGGGSSHHHHHHHHHHHHCSS--CSSEEEHHHHH
T ss_pred CCccccccHHHHHHHHHHHhcCC--CCCcEeHHHHH
Confidence 01111111235666777 88889888875
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=93.17 E-value=0.011 Score=61.79 Aligned_cols=90 Identities=8% Similarity=-0.009 Sum_probs=70.9
Q ss_pred CCchhhc-cccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhc-cccccCc
Q 006460 346 SSTSTED-NLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQ-EPADAHV 423 (644)
Q Consensus 346 ss~~~ed-~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 423 (644)
+...++. ++...|.|++|.| +|.||+....... .+..+|+.++. |.+++++.+++...+ ...|..+
T Consensus 220 ~~~ei~~~l~~~~D~d~dG~I-s~~EF~~~l~~~~------~l~~~F~~~D~-----d~dG~Is~~El~~~l~~~~g~~l 287 (323)
T 1ij5_A 220 DKKSVQDALFRYADEDESDDV-GFSEYVHLGLCLL------VLRILYAFADF-----DKSGQLSKEEVQKVLEDAHIPES 287 (323)
T ss_dssp CCHHHHHHHHHHHCTTCSSCE-EHHHHHHHHHHHH------HHHHHHHHTCS-----SSCSSEEHHHHHHHHHHTTCCGG
T ss_pred CHHHHHHHHHHHhcCCCCCEE-eHHHHHHHHHHHH------HHHHHHHHhCC-----CCCCCccHHHHHHHHHHHcCCCC
Confidence 4556788 9999999999999 9999998876543 67889999888 899999999999998 7666432
Q ss_pred --ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 424 --QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 424 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..+.+ ++...|.+ .|+.|++.||-
T Consensus 288 s~~e~~~----l~~~~D~d--~dG~Is~~EF~ 313 (323)
T 1ij5_A 288 ARKKFEH----QFSVVDVD--DSKSLSYQEFV 313 (323)
T ss_dssp GCSTHHH----HHHHHTTT--TCSEECHHHHH
T ss_pred CHHHHHH----HHHHHCCC--CCCcEeHHHHH
Confidence 22222 36666777 88999988875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.00 E-value=0.32 Score=52.76 Aligned_cols=75 Identities=17% Similarity=0.148 Sum_probs=46.9
Q ss_pred EEEEeccCCCeEEEEEEEecC-------CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCC-cceeeeEEEeCCceE
Q 006460 17 VIEQIGRGAFGAAFLVLHKIE-------RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPY-IVKYKDAWVDKGNCV 88 (644)
Q Consensus 17 i~~~LG~G~fG~Vyla~~k~t-------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPN-IVkl~~~~~d~~~~~ 88 (644)
-++.|..|-...+|++..... +..|++++..... ... -...+|.++++.|..-+ ..++++. ..+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~-idR~~E~~~l~~L~~~gi~P~l~~~--~~~--- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKF-YDSKVELDVFRYLSNINIAPNIIAD--FPE--- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CC-CCHHHHHHHHHHHHHTTSSCCEEEE--ETT---
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chh-cCHHHHHHHHHHHHhcCCCCCEEEE--cCC---
Confidence 456677788899999986521 5789999864432 111 11246888888774222 3445542 222
Q ss_pred EEEEeccCCCC
Q 006460 89 CIVTGYCEGGD 99 (644)
Q Consensus 89 ~LVmEy~~Ggs 99 (644)
++||+|++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 58999999865
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.89 E-value=0.0072 Score=57.31 Aligned_cols=88 Identities=6% Similarity=-0.102 Sum_probs=65.0
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc----cc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA----DA 421 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 421 (644)
+...++.++...|.|++|.| ||.||+...... ..++.+|+.+ - |.+++++.+++..+.+.. |.
T Consensus 44 ~~~~~~~l~~~~D~d~~G~I-~f~EF~~~~~~~------~~l~~aF~~f-----D-d~~G~I~~~El~~~l~~l~~~~G~ 110 (174)
T 2i7a_A 44 SLDECRSLVALMELKVNGRL-DQEEFARLWKRL------VHYQHVFQKV-----Q-TSPGVLLSSDLWKAIENTDFLRGI 110 (174)
T ss_dssp CHHHHHHHHHHHCSSCSSEE-CHHHHHHHHHHH------HHHHHHHHHH-----C-SBTTBEEGGGHHHHHHTCGGGTTC
T ss_pred CHHHHHHHHHHHCCCCCCcC-CHHHHHHHHHHH------HHHHHHHHHh-----c-CCCCcCCHHHHHHHHHHhHhccCC
Confidence 35677889999999999999 999999876432 4577788655 3 567899999999997666 54
Q ss_pred Cc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 422 HV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 422 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+ ..+++ ++...| + .|+.|++.||-
T Consensus 111 ~~~~~~~~~----l~~~~d-d--~dG~I~~~EF~ 137 (174)
T 2i7a_A 111 FISRELLHL----VTLRYS-D--SVGRVSFPSLV 137 (174)
T ss_dssp CCCHHHHHH----HHHHHS-C--TTSEECHHHHH
T ss_pred CCCHHHHHH----HHHHHc-C--CCCeEcHHHHH
Confidence 32 22222 356666 6 78999888875
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=92.78 E-value=0.0071 Score=69.07 Aligned_cols=118 Identities=11% Similarity=0.036 Sum_probs=46.0
Q ss_pred hhhhhHhhhccccccCcCCCC------CCCCCchhhccccccccCCCCccccccchhhhccccccccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLDD------KPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHF 395 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~~------~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~ 395 (644)
+.++.++.+.++.++..++.. ...+...++.+|...|.|++|.| ||.||+..... +..++.++.+|+.++
T Consensus 15 ~~F~~fD~d~dG~Is~~El~~~l~~lg~~~s~~el~~lf~~~D~d~~G~I-~f~EF~~~~~~---l~~~~el~~aF~~fD 90 (624)
T 1djx_A 15 SCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQTDSL-EDEEIETFYKM---LTQRAEIDRAFEEAA 90 (624)
T ss_dssp ------------------------------------------------------CTTHHHHH---HTCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeE-eHHHHHHHHHH---hccHHHHHHHHHHhc
Confidence 345667777777777766642 12345678899999999999999 99999988754 345678999999887
Q ss_pred CCccCCCCchhhhhhhhhhhcccc-cc---CcccccccccccccccCCCC--Cchhhhhhhhcc
Q 006460 396 NGSTGSDLTSEITANSQNEIQEPA-DA---HVQPAEEIDVETVKSKDQNP--FSDRVIEEADIE 453 (644)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 453 (644)
+ + +++++.+++.+..... +. ....+++ ++...|.+. ..|+.|++.+|.
T Consensus 91 ~-----~-~G~Is~~EL~~fL~~~qge~~ls~ee~~~----ii~~~d~d~~~~~dG~Is~deF~ 144 (624)
T 1djx_A 91 G-----S-AETLSVERLVTFLQHQQREEEAGPALALS----LIERYEPSETAKAQRQMTKDGFL 144 (624)
T ss_dssp T-----T-SSSEEHHHHHHHHHHTSCCSSCSHHHHHH----HHHHHCCCHHHHHTTEECHHHHH
T ss_pred C-----C-CCeecHHHHHHHHHHHhCCCCCCHHHHHH----HHHHhCCChhhccCCCCCHHHHH
Confidence 5 4 6899999998886422 22 2222222 355555541 146778887775
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=92.50 E-value=0.0061 Score=55.24 Aligned_cols=115 Identities=5% Similarity=0.026 Sum_probs=75.0
Q ss_pred hhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc-ccccccccccccccccc
Q 006460 323 NVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQAHF 395 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~~~ 395 (644)
.+..++.+..+.++..++. ....+...++.++. +++|.| +|.||+...... ......+.+..+|+..+
T Consensus 23 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~----~~~g~i-~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D 97 (156)
T 1wdc_B 23 AFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPL-NFTMFLSIFSDKLSGTDSEETIRNAFAMFD 97 (156)
T ss_dssp HHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCC-CHHHHHHHHHHHTCSCCCHHHHHHHHHTTC
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHH----hCCCcC-cHHHHHHHHHHHhcCCChHHHHHHHHHHHC
Confidence 3455666666655554442 11223334455553 578999 999999887643 33345678899999988
Q ss_pred CCccCCCCchhhhhhhhhhhccccccCccccccccc-ccccccCCCCCchhhhhhhhcc
Q 006460 396 NGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDV-ETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+ |.+++++.+++...+...|.... +..+ .+++.-|.+ |+.|++.||.
T Consensus 98 ~-----d~~G~I~~~el~~~l~~~g~~~~---~~~~~~~~~~~d~~---dg~i~~~eF~ 145 (156)
T 1wdc_B 98 E-----QETKKLNIEYIKDLLENMGDNFN---KDEMRMTFKEAPVE---GGKFDYVKFT 145 (156)
T ss_dssp T-----TCCSCEEHHHHHHHHHHSSSCCC---HHHHHHHHHHCCEE---TTEECHHHHH
T ss_pred c-----CCCCccCHHHHHHHHHHhCCCCC---HHHHHHHHHhcCCC---CCEEeHHHHH
Confidence 8 88999999999999766664321 1111 235555555 8899988886
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=92.48 E-value=0.017 Score=56.80 Aligned_cols=100 Identities=10% Similarity=0.031 Sum_probs=73.5
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccc---------cccccccccccccccccCCccCCCCchhhhhhhhhhhc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKER---------STQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQ 416 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~---------s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (644)
....++.++...|.|++|.| +|.||+...... ....+.+.++.+|+..++ |.+++++.+++....
T Consensus 56 ~~~~~~~l~~~~D~~~~g~i-~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~-----d~~G~i~~~el~~~l 129 (263)
T 2f33_A 56 LSPEMKTFVDQYGQRDDGKI-GIVELAHVLPTEENFLLLFRCQQLKSCEEFMKTWRKYDT-----DHSGFIETEELKNFL 129 (263)
T ss_dssp CCHHHHHHHHHHTTGGGCCB-CHHHHHHHTTSCTTHHHHHGGGTSSCHHHHHHHHTTSST-----TTCSSBCHHHHHHHH
T ss_pred hHHHHHHHHHHhCCCCCCcC-cHHHHHHHHhhhhhHHHHHHHhhccHHHHHHHHHHHHCC-----CCCCCcCHHHHHHHH
Confidence 34566788999999999999 999999887543 445567788899988887 889999999999987
Q ss_pred ccc----ccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 417 EPA----DAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 417 ~~~----~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
... +.... .+++.--.+++..|.+ .|+.|++.||.
T Consensus 130 ~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~--~dg~i~~~ef~ 170 (263)
T 2f33_A 130 KDLLEKANKTVDDTKLAEYTDLMLKLFDSN--NDGKLELTEMA 170 (263)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHHHHTCSS--SSSCBCHHHHH
T ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHhcCCC--CCCeEcHHHHH
Confidence 544 33322 1111000146777777 88999998886
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=92.43 E-value=0.018 Score=47.01 Aligned_cols=82 Identities=10% Similarity=0.061 Sum_probs=56.8
Q ss_pred CCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCC
Q 006460 360 DPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQ 439 (644)
Q Consensus 360 D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (644)
|++|.| ||.|++.+..=.. .....++.+|+..++ |.+++++.+++..+.+..+..+.. +++ -.+++.-|.
T Consensus 1 ~~~G~i-~~~e~~~~~~l~~--~~~~~~~~~F~~~D~-----d~~G~i~~~el~~~l~~~~~~~~~-~~~-~~l~~~~d~ 70 (87)
T 1s6j_A 1 HSSGHI-DDDDKHMAERLSE--EEIGGLKELFKMIDT-----DNSGTITFDELKDGLKRVGSELME-SEI-KDLMDAADI 70 (87)
T ss_dssp CCSSSS-SSHHHHSSSSSCS--SSTTTTTTHHHHHCT-----TCSSCEEHHHHHHHHHTTTSSCCH-HHH-HHHHHHHCT
T ss_pred CCCCcc-CccHHHHHHHCCH--HHHHHHHHHHHHHCC-----CCCCcCcHHHHHHHHHHhCCCCCH-HHH-HHHHHHhCC
Confidence 578999 9999766532111 123468889998887 889999999999998776654321 111 124677777
Q ss_pred CCCchhhhhhhhcc
Q 006460 440 NPFSDRVIEEADIE 453 (644)
Q Consensus 440 ~~~~~~~~~~~~~~ 453 (644)
+ .|+.|++.||-
T Consensus 71 ~--~~g~i~~~eF~ 82 (87)
T 1s6j_A 71 D--KSGTIDYGEFI 82 (87)
T ss_dssp T--CSSEECHHHHT
T ss_pred C--CCCcCcHHHHH
Confidence 7 78999988875
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=92.21 E-value=0.014 Score=68.81 Aligned_cols=116 Identities=4% Similarity=-0.046 Sum_probs=81.1
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccc-ccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERS-TQTETSDCSRDKQAH 394 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s-~~~~~~~l~~af~~~ 394 (644)
..|+.++.+.++.++..++. ....+...++.++...|.|++|+| ||.||+....... ...+.+.+..+|+.+
T Consensus 729 ~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I-~~~EF~~~~~~~~~~~~~~~~l~~aF~~~ 807 (863)
T 1sjj_A 729 ASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDPNRMGVV-TFQAFIDFMSRETADTDTADQVMASFKIL 807 (863)
T ss_dssp HHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCTTSCSEE-ETTHHHHTHHHHSTTCSSSHHHHHHHHGG
T ss_pred HHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcC-cHHHHHHHHHHHhcCCCCHHHHHHHHHHH
Confidence 34556677777777777663 223456778999999999999999 9999998875432 234557888999887
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCC--CC-chhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQN--PF-SDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~ 453 (644)
. |++|+++.+++..... ...+++ ++..-|.+ +- .|+.|++.||-
T Consensus 808 -~-----d~~G~Is~~El~~~l~-----~~~~~~----l~~~~d~~~~~~~~dg~I~~~eF~ 854 (863)
T 1sjj_A 808 -A-----GDKNYITVDELRRELP-----PDQAEY----CIARMAPYNGRDAVPGALDYMSFS 854 (863)
T ss_dssp -G-----TSSSEEEHHHHHHHSC-----HHHHHH----HHHHSEECCSSCCCTTEEESHHHH
T ss_pred -h-----CCCCcCcHHHHHHHCC-----HHHHHH----HHHHcchhcCCCCCCCceeHHHHH
Confidence 6 7889999999999873 111222 23433332 11 47899998886
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.09 E-value=0.31 Score=52.03 Aligned_cols=29 Identities=28% Similarity=0.405 Sum_probs=24.5
Q ss_pred CccccCCCCcEEEc------CCCCeEEeccCcccc
Q 006460 136 VLHRDLKCSNIFLT------KDNDIRLGDFGLAKL 164 (644)
Q Consensus 136 IIHRDLKPeNILL~------~~g~vKL~DFGls~~ 164 (644)
++|+|+.+.|||+. .++.+.++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 57999999999993 456799999998864
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=91.85 E-value=0.014 Score=53.96 Aligned_cols=91 Identities=8% Similarity=-0.032 Sum_probs=67.3
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQP 425 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (644)
+...++.++...|.|++|.| +|.||+..... ...++.+|+..+. |.+++++.+++....+..+.....
T Consensus 45 ~~~~~~~l~~~~D~~~~g~i-~~~eF~~~~~~------~~~~~~~F~~~D~-----d~~G~i~~~el~~~l~~~g~~~~~ 112 (173)
T 1alv_A 45 GIDTCRSMVAVMDSDTTGKL-GFEEFKYLWNN------IKKWQAIYKQFDV-----DRSGTIGSSELPGAFEAAGFHLNE 112 (173)
T ss_dssp CHHHHHHHHHHHCTTCSSSB-CHHHHHHHHHH------HHHHHHHHHHHCT-----TCCSSBCTTTHHHHHHHHTCCCCH
T ss_pred CHHHHHHHHHHHcCCCCCcc-CHHHHHHHHHH------HHHHHHHHHHHCC-----CCCCCCCHHHHHHHHHHcCCCCCH
Confidence 45567889999999999999 99999987753 2568889998888 889999999999998766643321
Q ss_pred ccccccccccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+++ -.++..-| + .|+.|++.||-
T Consensus 113 -~~~-~~~~~~~d-d--~dg~i~~~eF~ 135 (173)
T 1alv_A 113 -HLY-SMIIRRYS-D--EGGNMDFDNFI 135 (173)
T ss_dssp -HHH-HHHHHHHT-C--SSSCBCHHHHH
T ss_pred -HHH-HHHHHHhc-C--CCCcCcHHHHH
Confidence 111 11244445 5 68888888874
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=91.18 E-value=0.011 Score=58.51 Aligned_cols=95 Identities=9% Similarity=0.038 Sum_probs=70.2
Q ss_pred hccccccccCCCCccccccchhhhcccc------------cccccccccccccccccCCccCCCCchhhhhhhhhhhccc
Q 006460 351 EDNLETKKVDPTSYTMEVSSSINDSKER------------STQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEP 418 (644)
Q Consensus 351 ed~~~~~d~D~nG~i~d~~efi~a~~d~------------s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (644)
+.++...|.|++|.| +|.||+...... ....+.+.+..+|+..++ |.+++++.+|+.+....
T Consensus 151 ~~~~~~~D~~~dg~i-~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~Is~~E~~~~l~~ 224 (272)
T 2be4_A 151 DAMMKIFDKNKDGRL-DLNDLARILALQENFLLQFKMDASSQVERKRDFEKIFAHYDV-----SRTGALEGPEVDGFVKD 224 (272)
T ss_dssp HHHHHHHCSSCSSEE-EHHHHGGGSCCSSCSSTTSCCCHHHHHHHHHHHHHHHHHHCT-----TCCSEEETHHHHHHHHH
T ss_pred HHHHHHhccCCCCcC-cHHHHHHHHhhhHHHHhhhhhhhccccccHHHHHHHHHHhCC-----CCCCeecHHHHHHHHHH
Confidence 348899999999999 999999887542 122455678889999888 89999999999988755
Q ss_pred cccCc-ccccccccc-----cccccCCCCCchhhhhhhhcc
Q 006460 419 ADAHV-QPAEEIDVE-----TVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 419 ~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+... ..+.+..++ ++..-|.+ .|+.|++.||.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~l~~~~D~d--~dG~is~~EF~ 263 (272)
T 2be4_A 225 MMELVRPSISGGDLDKFRECLLTHCDMN--KDGKIQKSELA 263 (272)
T ss_dssp HHHHHSSSCCHHHHHHHHHHHHHHHCCS--TTCEEEHHHHH
T ss_pred HHHHcCCCCCHHHHHHHHHHHHHHhCCC--CCCcCcHHHHH
Confidence 44310 012222232 57778888 89999998886
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=88.35 E-value=0.019 Score=51.29 Aligned_cols=115 Identities=8% Similarity=-0.050 Sum_probs=75.5
Q ss_pred hhhhhHhhhc-cccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc-ccccccccccccccc
Q 006460 322 ENVRSVAKNI-AVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQA 393 (644)
Q Consensus 322 e~~~~~~~n~-~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~ 393 (644)
..+..++.+. .+.++..++. ....+...++.++...|.| | +|.||+...... ......+.+..+|+.
T Consensus 18 ~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~----i-~~~eF~~~~~~~~~~~~~~~~l~~~F~~ 92 (146)
T 2qac_A 18 DVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGDN----L-TYEQYLEYLSICVHDKDNVEELIKMFAH 92 (146)
T ss_dssp HHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSE----E-CHHHHHHHHHHTCCTTCCHHHHHHHHHT
T ss_pred HHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC----C-CHHHHHHHHHHHhcCcchHHHHHHHHHH
Confidence 3455666666 6666555442 1223445677788777766 6 999999887542 223456778899999
Q ss_pred ccCCccCCCCchhhhhhhhhhhccccccCccccccccccc-ccccCCCCCchhhhhhhhcc
Q 006460 394 HFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVET-VKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 453 (644)
.++ |.+++++.+++...+...|... .+..++- +... + .|+.|++.||-
T Consensus 93 ~D~-----d~~G~I~~~el~~~l~~~g~~~---~~~~~~~~~~~~--d--~dg~i~~~eF~ 141 (146)
T 2qac_A 93 FDN-----NCTGYLTKSQMKNILTTWGDAL---TDQEAIDALNAF--S--SEDNIDYKLFC 141 (146)
T ss_dssp TCT-----TCSSEEEHHHHHHHHHHSSSCC---CHHHHHHHHHHH--C--SSSEEEHHHHH
T ss_pred hCC-----CCCCCCCHHHHHHHHHHhCCCC---CHHHHHHHHHHc--C--CCCcCcHHHHH
Confidence 888 8899999999999987666432 2211211 2322 4 67888887774
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=87.99 E-value=0.03 Score=55.26 Aligned_cols=93 Identities=12% Similarity=0.090 Sum_probs=67.1
Q ss_pred cccccccCCCCccccccchhhhccc-----------ccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc--
Q 006460 353 NLETKKVDPTSYTMEVSSSINDSKE-----------RSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA-- 419 (644)
Q Consensus 353 ~~~~~d~D~nG~i~d~~efi~a~~d-----------~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 419 (644)
++...|.|++|.| +|.||+...+. .....+...++.+|+..+. |.+++++.+++.......
T Consensus 62 ~f~~~D~d~~g~i-~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~-----d~~G~i~~~e~~~~l~~~~~ 135 (272)
T 2be4_A 62 FMSAYDATFDGRL-QIEELANMILPQEENFLLIFRREAPLDNSVEFMKIWRKYDA-----DSSGYISAAELKNFLKDLFL 135 (272)
T ss_dssp HSCHHHHTCCSEE-EHHHHHHHHSCHHHHHHHHHHHHSCCCCHHHHHHHHHHHCT-----TCCSEEEGGGHHHHHHHHHH
T ss_pred HHHHhcCCCCCcE-eHHHHHHHHhhhhHHHHHHHhhccCcccHHHHHHHHHHhCC-----CCCCccCHHHHHHHHHHHHH
Confidence 5688999999999 99999998442 2224566788899998887 889999999999987544
Q ss_pred --ccCccc--ccccccccccccCCCCCchhhhhhhhcc
Q 006460 420 --DAHVQP--AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 420 --~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+..... +++.=-.++..-|.+ .|+.|++.||.
T Consensus 136 ~~g~~~~~~~~~~~~~~~~~~~D~~--~dg~i~~~ef~ 171 (272)
T 2be4_A 136 QHKKKIPPNKLDEYTDAMMKIFDKN--KDGRLDLNDLA 171 (272)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHCSS--CSSEEEHHHHG
T ss_pred hcCCCCCHHHHHHHHHHHHHHhccC--CCCcCcHHHHH
Confidence 333221 111001256777777 89999998886
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=87.94 E-value=0.068 Score=63.36 Aligned_cols=113 Identities=10% Similarity=-0.071 Sum_probs=78.2
Q ss_pred hhhhHhhhccccccCcCCCCC--------------CCCCchhhccccccccCCCCccccccchhhhcccccccccccccc
Q 006460 323 NVRSVAKNIAVQLNNLPLDDK--------------PTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCS 388 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~~~--------------~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~ 388 (644)
.+..++ +..+.++..++... .-+....+.++...|.|++|.| +|.||+...... ..++
T Consensus 539 ~F~~~D-~~dG~Is~~El~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I-~~~EF~~~~~~~------~~l~ 610 (900)
T 1qxp_A 539 LFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKL-GLVEFNILWNRI------RNYL 610 (900)
T ss_dssp --CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCC-CSSSHHHHHHHH------HHHH
T ss_pred HHHHHc-CCCCcCCHHHHHHHHHHhhcccccccCCCCCHHHHHHHHHHhCCCCCCcC-CHHHHHHHHHHH------HHHH
Confidence 345566 67777777776432 2234566888999999999999 999999887543 6788
Q ss_pred cccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 389 RDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 389 ~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+|+.++. |.+++++.+|+..+.+..+..+..- ++ -.++..-| + .|+.|++.||.
T Consensus 611 ~~F~~~D~-----d~~G~Is~~El~~~l~~~g~~l~~~-~~-~~l~~~~d-d--~dg~I~~~eF~ 665 (900)
T 1qxp_A 611 TIFRKFDL-----DKSGSMSAYEMRMAIEAAGFKLPCQ-LH-QVIVARFA-D--DELIIDFDNFV 665 (900)
T ss_dssp HHHGGGCT-----TCCSCCBHHHHHHHHHHTTEECCHH-HH-HHHHHHTS-C--SSSBCCHHHHH
T ss_pred HHHHhhCC-----CCCCeECHHHHHHHHHHhCCCCCHH-HH-HHHHHHhC-C--CCCeEcHHHHH
Confidence 99999988 8999999999999987666433211 11 11355555 5 68888888874
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=87.58 E-value=0.023 Score=53.81 Aligned_cols=97 Identities=13% Similarity=0.009 Sum_probs=65.6
Q ss_pred chhhccccccc---cCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcc-ccccC-
Q 006460 348 TSTEDNLETKK---VDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQE-PADAH- 422 (644)
Q Consensus 348 ~~~ed~~~~~d---~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~- 422 (644)
..++.++...| -+++|.| ++.||+...........++.|+.+|+.++. |.+++++.+|+.++.+ ..+..
T Consensus 59 ~~~~~i~~~~d~~~~~~~~~i-~~~ef~~~~~~~~~~~~~~~l~~~F~~~D~-----d~dG~Is~~El~~~l~~~~g~~~ 132 (179)
T 3a8r_A 59 EFAVQMFDSLARKRGIVKQVL-TKDELKDFYEQLTDQGFDNRLRTFFDMVDK-----NADGRLTAEEVKEIIALSASANK 132 (179)
T ss_dssp HHHHHHHHHHHHHHTCCSSEE-CHHHHHHHHHHHHCCCHHHHHHHHHHHHCT-----TCSSCBCHHHHHHHHHHHHHTTH
T ss_pred HHHHHHHHHHHHhccCCCCCc-CHHHHHHHHHHHcCCCHHHHHHHHHHHHCC-----CCCCcCCHHHHHHHHHHHhcccc
Confidence 34556666555 4667888 888887654332222345789999999988 9999999999999986 44432
Q ss_pred cc-----cccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 VQ-----PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. .-+++ -.++...|.| .|+.|++.||.
T Consensus 133 ~~~~~~~~~~~~-~~~~~~~D~d--~dG~I~~~EF~ 165 (179)
T 3a8r_A 133 LSKIKERADEYT-ALIMEELDPT--NLGYIEMEDLE 165 (179)
T ss_dssp HHHHHHHHHHHH-HHHHHHHSTT--CCSEECHHHHH
T ss_pred ccccccchHHHH-HHHHHHhCCC--CCCcCcHHHHH
Confidence 10 11111 1246777888 89999998886
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=87.04 E-value=0.047 Score=63.25 Aligned_cols=112 Identities=8% Similarity=-0.002 Sum_probs=81.0
Q ss_pred hhhhhHhhhccccccCcCCC--------------CCCCCCchhhccccccccCCCCccccccchhhhccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD--------------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDC 387 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~--------------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l 387 (644)
+.+..++ +.++.++..++. ....+...++.++...|.|++|.| ++.||+...... +.+
T Consensus 536 ~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~d~~G~I-~f~EF~~l~~~~------~~l 607 (714)
T 3bow_A 536 RLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKL-GLKEFYILWTKI------QKY 607 (714)
T ss_dssp HHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCCSSCSSB-CHHHHHHHHHHH------HHH
T ss_pred HHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCCCCCCcC-cHHHHHHHHHHH------HHH
Confidence 3455566 666665554442 123445567889999999999999 999999887542 678
Q ss_pred ccccccccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 388 SRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 388 ~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+.+|+.+++ |.+++++.+|+..+.+..|.... .+++ ++..-| | .|+.|++.||-
T Consensus 608 ~~~F~~~D~-----d~dG~Is~~El~~~L~~~G~~ls~~~~~~----l~~~~D-d--~dG~Isf~EF~ 663 (714)
T 3bow_A 608 QKIYREIDV-----DRSGTMNSYEMRKALEEAGFKLPCQLHQV----IVARFA-D--DELIIDFDNFV 663 (714)
T ss_dssp HHHHHHHCT-----TCCSSEEHHHHHHHHHHTTEECCHHHHHH----HHHHHS-C--TTCEECHHHHH
T ss_pred HHHHHHhCC-----CCCCeECHHHHHHHHHHcCCCCCHHHHHH----HHHHhC-C--CCCeEcHHHHH
Confidence 899999988 99999999999999876664332 2222 355556 6 78899888885
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.47 E-value=0.14 Score=44.06 Aligned_cols=54 Identities=7% Similarity=0.009 Sum_probs=42.5
Q ss_pred hhhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhc
Q 006460 321 LENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDS 375 (644)
Q Consensus 321 le~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~ 375 (644)
.+.++.++.+..+.++..++. .-.-+..+++.++...|.|++|.| ||.||+..+
T Consensus 39 ~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I-~~~EF~~~m 98 (100)
T 2lv7_A 39 REAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQV-DFEEFVTLL 98 (100)
T ss_dssp HHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSB-CHHHHHHHT
T ss_pred HHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeE-eHHHHHHHh
Confidence 345777888888888777763 234466788999999999999999 999998643
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=85.21 E-value=0.2 Score=59.37 Aligned_cols=91 Identities=9% Similarity=-0.013 Sum_probs=53.4
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQP 425 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (644)
+...++.++...|.|++|.| +|.||+...... ..++.+|+..+. |.++.++.+|+.++.+..+.++..
T Consensus 772 s~~~~~~l~~~~D~d~dG~I-s~~EF~~l~~~~------~~l~~~F~~~D~-----d~dG~Is~~El~~~l~~~g~~ls~ 839 (900)
T 1qxp_A 772 GIDTCRSMVAVMDSDTTGKL-GFEEFKYLWNNI------KKWQGIYKRFET-----DRSGTIGSNELPGAFEAAGFHLNQ 839 (900)
T ss_dssp CHHHHHHHHHHHCCSSSSSB-CSHHHHHHHHHH------HHHSSCC----C-----CSCC-------CCTTGGGTCCCCS
T ss_pred CHHHHHHHHHHHCCCCCCeE-CHHHHHHHHHHH------HHHHHHHHHhCC-----CCCCccCHHHHHHHHHhcCCCCCH
Confidence 34566888999999999999 999998775332 367789988877 889999999999998877754421
Q ss_pred ccccccccccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
++++ .++..-| + .|+.|++.||-
T Consensus 840 -~~~~-~l~~~~d-d--~dg~Is~~EF~ 862 (900)
T 1qxp_A 840 -HIYS-MIIRRYS-D--ETGNMDFDNFI 862 (900)
T ss_dssp -CCCC------------CCSCCCHHHHH
T ss_pred -HHHH-HHHHHhc-C--CCCeECHHHHH
Confidence 1111 1244445 5 68888888875
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=83.88 E-value=0.029 Score=52.14 Aligned_cols=88 Identities=7% Similarity=-0.026 Sum_probs=57.6
Q ss_pred cccccccCCCCccccccchhhhccccccccccccccccc--ccccCCccCCCCchhhhhhhhhhhccccccCc--ccccc
Q 006460 353 NLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDK--QAHFNGSTGSDLTSEITANSQNEIQEPADAHV--QPAEE 428 (644)
Q Consensus 353 ~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 428 (644)
.|...|.|++|.| ++.| .....-.....+.+.+.++| .+++. |.+++++.+++...+...+... ..+++
T Consensus 70 ~f~~~D~d~dg~I-~~~E-~~~~~~~~~~~~~~~~~~~f~~~~fD~-----d~~G~I~~~E~~~~l~~~g~~~~~~~~~~ 142 (186)
T 2hps_A 70 LAPGVRISVEEAA-VNAT-DSLLKMKGEEKAMAVIQSLIMYDCIDT-----DKDGYVSLPEFKAFLQAVGPDLTDDKAIT 142 (186)
T ss_dssp CCTTCEEEHHHHH-HHHH-HHHHHCCTHHHHHTTHHHHHHHHHHCT-----TCSSEEEHHHHHHHHHHHCTTCCHHHHHH
T ss_pred HHHhcCCCCCCcc-cHHH-HHHHHhcCChHHHHHHHHHHHHHHccC-----CCCCcCCHHHHHHHHHHhCCCCCHHHHHH
Confidence 3688899999999 9999 22111111112234555566 66555 8899999999999976666322 22222
Q ss_pred cccccccccCCCCCchhhhhhhhcc
Q 006460 429 IDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
++..-|.+ .|+.|++.||.
T Consensus 143 ----~~~~~D~d--~dG~i~~~ef~ 161 (186)
T 2hps_A 143 ----CFNTLDFN--KNGQISRDEFL 161 (186)
T ss_dssp ----HHHHHCTT--CSSEEEHHHHH
T ss_pred ----HHHHHcCC--CCCcCcHHHHH
Confidence 36677777 89999888886
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=83.84 E-value=0.16 Score=44.44 Aligned_cols=59 Identities=10% Similarity=0.054 Sum_probs=49.4
Q ss_pred ccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 384 TSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 384 ~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
...++.+|+.+++ |.+++++.+++..+.+..++....++++ +...|.+ .|+.|++.||-
T Consensus 21 ~~~~~~~F~~~D~-----d~dG~Is~~el~~~l~~~gl~~~el~~i----~~~~D~d--~dG~I~~~EF~ 79 (110)
T 1iq3_A 21 REYYVNQFRSLQP-----DPSSFISGSVAKNFFTKSKLSIPELSYI----WELSDAD--CDGALTLPEFC 79 (110)
T ss_dssp HHHHHHHHHHHCC-----SSSSEEEHHHHHHHCCSSSCSSCCHHHH----HHHHCSS--SCSEEEHHHHH
T ss_pred HHHHHHHHHHHCC-----CCCCeEcHHHHHHHHHHcCCCHHHHHHH----HHHHcCC--CCCcCcHHHHH
Confidence 3578889999998 8899999999999988777665566665 8888888 89999999985
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=81.67 E-value=0.17 Score=44.22 Aligned_cols=43 Identities=9% Similarity=0.026 Sum_probs=32.5
Q ss_pred CchhhccccccccCCCCccccccchhhhcccccccccccccccc
Q 006460 347 STSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRD 390 (644)
Q Consensus 347 s~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~a 390 (644)
..+++.++..+|.|++|.| ||.||+..........++++|..+
T Consensus 61 ~~ev~~li~~~D~d~dG~I-df~EF~~~~~~~~~~~~~ek~~~~ 103 (106)
T 2h2k_A 61 VGSLDEKMKSLDVNQDSEL-KFNEYWRLIGELAKEIRKKKDLKI 103 (106)
T ss_dssp CCCHHHHHHHHCTTCSSSE-EHHHHHHHHHHHHHHHHHHC----
T ss_pred HHHHHHHHHHHCCCCCCCC-cHHHHHHHHHHHHHHhhHHHHHHh
Confidence 3678999999999999999 999999988766555555555443
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=81.50 E-value=0.11 Score=42.83 Aligned_cols=68 Identities=9% Similarity=0.021 Sum_probs=44.4
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccccc---cccccccccc
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQT---ETSDCSRDKQ 392 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~---~~~~l~~af~ 392 (644)
++.++.+..+.++..++. ..+.+...++.++...|.|++|.| +|.||+........-. ..+.+++||+
T Consensus 15 F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~dg~i-~~~eF~~~~~~~~~~~~~~~~~~l~~aF~ 91 (92)
T 2kn2_A 15 FKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQV-NYEEFVKMMMTVRGGGGGNGWSRLRRKFS 91 (92)
T ss_dssp HHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCCSSE-EHHHHHHHHHHHTTTCCCHHHHHHHHHHT
T ss_pred HHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcE-eHHHHHHHHHhccCCCCCchHHHHHHHhc
Confidence 444555555554444331 223456678899999999999999 9999998775543321 3355677774
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=81.50 E-value=0.1 Score=42.33 Aligned_cols=66 Identities=8% Similarity=0.035 Sum_probs=43.7
Q ss_pred hhhhHhhhccccccCcCCC-----CCCCCCchhhccccccccCCCCccccccchhhhccccccccccccccccc
Q 006460 323 NVRSVAKNIAVQLNNLPLD-----DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDK 391 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~-----~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af 391 (644)
.++.++.+..+.++..++. ....+...++.++...|.|++|.| +|.||+........+. ..+..||
T Consensus 16 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~D~~~dg~i-~~~eF~~~~~~~~~~~--~~~~~aF 86 (86)
T 2opo_A 16 IFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEIDTDGDGFI-SFDEFTDFARANRGLV--KDVSKIF 86 (86)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHCTTCSSEE-CHHHHHHHHHHCTTTH--HHHHHHC
T ss_pred HHHHHCCCCCCCcCHHHHHHHHHHcCCCCHHHHHHHHHHhCCCCCCcC-cHHHHHHHHHHCccHH--HHHHHhC
Confidence 3455666666655554442 114455678899999999999999 9999998886654433 3344444
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.77 E-value=0.25 Score=42.38 Aligned_cols=58 Identities=9% Similarity=0.031 Sum_probs=46.7
Q ss_pred cccccccccccCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 385 SDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 385 ~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..|+.+|+.+++ |.+|+++.+|+.++++..|..+. .+++ ++...|.| .|+.|++.||-
T Consensus 36 ~el~~~F~~~D~-----d~~G~I~~~El~~~l~~lg~~~~~~ei~~----l~~~~D~d--~dG~I~~~EF~ 95 (100)
T 2lv7_A 36 EEIREAFKVFDR-----DGNGFISKQELGTAMRSLGYMPNEVELEV----IIQRLDMD--GDGQVDFEEFV 95 (100)
T ss_dssp HHHHHHHHHTCS-----SCSSCBCHHHHHHHHHHHTCCCCTTTHHH----HHHHHCSS--CSSSBCHHHHH
T ss_pred HHHHHHHHHHcC-----CCCCcCCHHHHHHHHHHhCCCCCHHHHHH----HHHHHCCC--CCCeEeHHHHH
Confidence 357889999999 99999999999999887775543 2233 47888888 89999998884
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.70 E-value=0.18 Score=55.37 Aligned_cols=62 Identities=13% Similarity=0.032 Sum_probs=16.6
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEE------EEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVL------KKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWV 82 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAi------K~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~ 82 (644)
.++|| ||.||++.......+||+ |..............+.+|..+++.++|||+++.+.+-.
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 34555 999999988765568888 665543333344456888999999999999999988643
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=80.66 E-value=0.17 Score=59.23 Aligned_cols=84 Identities=1% Similarity=-0.109 Sum_probs=47.6
Q ss_pred cccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc-ccC-----------cc
Q 006460 357 KKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA-DAH-----------VQ 424 (644)
Q Consensus 357 ~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----------~~ 424 (644)
.|.|++|.| ||.||+..... +..++.++.+|+.+.+ |..+++|.+++.+.++.. +.. ..
T Consensus 195 ~D~d~~g~i-df~EF~~~~~~---l~~r~el~~aF~~fD~-----d~~g~Is~~eL~~fL~~~Qge~~~~~~~~~~~t~e 265 (799)
T 2zkm_X 195 NDAINPEDF-PEPVYKSFLMS---LCPRPEIDEIFTSYHA-----KAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPD 265 (799)
T ss_dssp TCEECGGGC-CHHHHHHHHHH---HSCCHHHHTTCC-------------CCCHHHHHHHHHHTCC---------------
T ss_pred cccCCCCcC-CHHHHHHHHHH---ccCHHHHHHHHHHhcc-----CCCCeEcHHHHHHHHHHhcCCcccccccccCCCHH
Confidence 567899999 99999998754 4467889999998876 788999999999886433 221 11
Q ss_pred cccccccccccccCCC--CCchhhhhhhhcc
Q 006460 425 PAEEIDVETVKSKDQN--PFSDRVIEEADIE 453 (644)
Q Consensus 425 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 453 (644)
.+++ ++...|.+ ...|+.|++.+|-
T Consensus 266 e~~~----iI~~~d~d~~~~~dg~is~eeF~ 292 (799)
T 2zkm_X 266 QVQG----LIDKYEPSGINAQRGQLSPEGMV 292 (799)
T ss_dssp CHHH----HHHHHCCC--------CCHHHHH
T ss_pred HHHH----HHHHhhcccccccCCccchhhhh
Confidence 2222 24444443 2256778877773
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=80.48 E-value=0.096 Score=45.12 Aligned_cols=96 Identities=9% Similarity=-0.028 Sum_probs=63.5
Q ss_pred hhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc-ccCcccccc
Q 006460 350 TEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA-DAHVQPAEE 428 (644)
Q Consensus 350 ~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 428 (644)
....|...|.|++|+| ++.||..+......-.++..+...|+.... |..+.++.++........ ........+
T Consensus 2 l~~~F~~~D~~~~g~i-~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~-----~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 75 (134)
T 1jfj_A 2 AEALFKEIDVNGDGAV-SYEEVKAFVSKKRAIKNEQLLQLIFKSIDA-----DGNGEIDQNEFAKFYGSIQGQDLSDDKI 75 (134)
T ss_dssp HHHHHHHHCTTCSSEE-EHHHHHHHHHTTCCSSHHHHHHHHHHHHCS-----SCCSEEEHHHHHHHTTCSSCCSSHHHHH
T ss_pred HHHHHHHHCCCCCCcC-CHHHHHHHHHHcCCCCCHHHHHHHHHHHcC-----CCCCeEcHHHHHHHHHHhcccccCCCHH
Confidence 3467888999999999 999999877554455567778888887766 778889999988876311 000100000
Q ss_pred cccccccccCCCCCchhhhhhhhcc
Q 006460 429 IDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.=..+...-|.+ .|+.|+..||.
T Consensus 76 ~~~~~f~~~D~d--~~G~i~~~e~~ 98 (134)
T 1jfj_A 76 GLKVLYKLMDVD--GDGKLTKEEVT 98 (134)
T ss_dssp HHHHHHHHHCCS--SSSEEEHHHHH
T ss_pred HHHHHHHHHCCC--CCCccCHHHHH
Confidence 001235555666 78888777775
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=80.07 E-value=0.19 Score=43.07 Aligned_cols=59 Identities=8% Similarity=-0.017 Sum_probs=48.2
Q ss_pred ccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 384 TSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 384 ~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+.++.+|+..++ |.+++++.+++.+..+..++....++++ +...|.+ .|+.|++.||-
T Consensus 10 ~~~~~~~F~~~D~-----d~dG~Is~~el~~~l~~~~l~~~~l~~i----~~~~D~d--~dG~i~~~EF~ 68 (99)
T 1qjt_A 10 NPVYEKYYRQVEA-----GNTGRVLALDAAAFLKKSGLPDLILGKI----WDLADTD--GKGVLSKQEFF 68 (99)
T ss_dssp CTHHHHHHHHHCC-----TTSSCCCSHHHHHHHHTSSSCHHHHHHH----HHHHCCS--SSSSCCSHHHH
T ss_pred HHHHHHHHHHHCC-----CCCCcCCHHHHHHHHHHcCCCHHHHHHH----HHHHCCC--CCCcCCHHHHH
Confidence 3578889999988 8899999999999987777655555554 7778888 89999998886
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 644 | ||||
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-85 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-77 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-76 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-76 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-75 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-74 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-73 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-72 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-72 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-72 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-71 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-71 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-70 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-69 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-66 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-63 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-62 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-62 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-62 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-62 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-61 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-60 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-59 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-59 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-59 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-58 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-58 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-57 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-57 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-56 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-56 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-55 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-54 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-53 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-51 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-22 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (678), Expect = 7e-85
Identities = 104/267 (38%), Positives = 150/267 (56%), Gaps = 9/267 (3%)
Query: 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL 69
S+ EDYEV+ IG G++G + K + K V K++ TE K+ + E++L+ +L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 70 NNPYIVKYKDAWVDKGN-CVCIVTGYCEGGDMAEIIKKAR--GACFPEEKLCKWLTQLLL 126
+P IV+Y D +D+ N + IV YCEGGD+A +I K EE + + +TQL L
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 127 AVDYLH-----SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTPNY 180
A+ H + VLHRDLK +N+FL +++LGDFGLA++LN A + VGTP Y
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSS 240
M PE + + Y KSDIWSLGC ++E+ A P F A L KI +P YS
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 241 TMKQIIKSMLRKNPEHRPTASDLLRHP 267
+ +II ML HRP+ ++L +P
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENP 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 2e-78
Identities = 69/260 (26%), Positives = 127/260 (48%), Gaps = 6/260 (2%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLN 70
LED+E+ +G+G FG +L K + LK + A+ + + +E+++ S L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+P I++ + D V ++ Y G + ++K F E++ ++T+L A+ Y
Sbjct: 65 HPNILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSY 121
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIP 190
HS RV+HRD+K N+ L ++++ DFG + +++ GT +Y+ PE++
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRM 180
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
+ K D+WSLG +E +P F A +I+R P + + +I +L
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLL 239
Query: 251 RKNPEHRPTASDLLRHPHLQ 270
+ NP RP ++L HP +
Sbjct: 240 KHNPSQRPMLREVLEHPWIT 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 247 bits (632), Expect = 5e-77
Identities = 72/317 (22%), Positives = 132/317 (41%), Gaps = 12/317 (3%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
L+ Y++ E++G GAFG V + + K + +++K T +E+ +S L +
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRH 82
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P +V DA+ D + ++ + GG++ E + E++ +++ Q+ + ++
Sbjct: 83 PTLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHM 140
Query: 132 HSNRVLHRDLKCSNIFLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI 189
H N +H DLK NI T ++L DFGL L+ + GT + PE+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY---SSTMKQII 246
P GY +D+WS+G + + + F + + + + + S K I
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQPYLLRCQN---PSSVYLPIKPTNIMKEKTRKSPSSK 303
+ +L +P R T L HP L P ++ PSS Y I+ + K P
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPP 320
Query: 304 HNSRKDKGEREAAAPNQ 320
+ P +
Sbjct: 321 LGRISNYSSLRKHRPQE 337
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 246 bits (628), Expect = 2e-76
Identities = 74/307 (24%), Positives = 142/307 (46%), Gaps = 13/307 (4%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
S + Y+++E++G GAFG + K + +V K I +K T E+ ++++
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQ 82
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
L++P ++ DA+ DK + ++ + GG++ + I E ++ ++ Q +
Sbjct: 83 LHHPKLINLHDAFEDKYE-MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGL 140
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
++H + ++H D+K NI +++ DFGLA LN +++ T + PE++
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY---SSTMK 243
P G+ +D+W++G + + + F D + + R + S K
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 244 QIIKSMLRKNPEHRPTASDLLRHPHLQPYL--LRCQNPSSVYLPIKPTNIMKEKTRKSPS 301
IK++L+K P R T D L HP L+ L + PSS Y I+ +KEK P+
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ--KIKEKYADWPA 318
Query: 302 SKHNSRK 308
+ +
Sbjct: 319 PQPAIGR 325
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 2e-76
Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 12/266 (4%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ +E+I ++G GAFG + +K K I ++E+ + E+D+++ ++P
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHP 69
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IVK DA+ + N + I+ +C GG + ++ + E ++ Q L A++YLH
Sbjct: 70 NIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH 127
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL-NTEDLASSVVGTPNYMCPELLA---- 187
N+++HRDLK NI T D DI+L DFG++ T S +GTP +M PE++
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 188 -DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV--YSSTMKQ 244
D PY YK+D+WSLG + E+A +P + ++ KI +S L +SS K
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 245 IIKSMLRKNPEHRPTASDLLRHPHLQ 270
+K L KN + R T S LL+HP +
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 8e-75
Identities = 66/268 (24%), Positives = 126/268 (47%), Gaps = 10/268 (3%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+ED+++++ +G GA+G L ++++ + +K + + K+ +E+ + LN+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNH 62
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
+VK+ +GN + YC GG++ + I+ G PE ++ QL+ V YL
Sbjct: 63 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYL 119
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL---NTEDLASSVVGTPNYMCPELLAD 188
H + HRD+K N+ L + +++++ DFGLA + N E L + + GT Y+ PELL
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 189 IPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV--YSSTMKQI 245
+ D+WS G + + A + + P + + + L S +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 246 IKSMLRKNPEHRPTASDLLRHPHLQPYL 273
+ +L +NP R T D+ + L
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKPL 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 238 bits (608), Expect = 2e-74
Identities = 79/278 (28%), Positives = 134/278 (48%), Gaps = 20/278 (7%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-------AKQTEKFKRTALQEMDL 65
E+YE E +GRG +HK K+Y +K I + A++ ++ + L+E+D+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 66 ISKLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
+ K++ P I++ KD + +V + G++ + + + E++ K + L
Sbjct: 63 LRKVSGHPNIIQLKDTYETN-TFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRAL 119
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE 184
L + LH ++HRDLK NI L D +I+L DFG + L+ + V GTP+Y+ PE
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 185 LLA------DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---SPLP 235
++ YG + D+WS G M+ + A P F ++ I + SP
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 236 IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273
YS T+K ++ L P+ R TA + L HP Q Y+
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 2e-73
Identities = 74/264 (28%), Positives = 130/264 (49%), Gaps = 12/264 (4%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
+ +IGRG+F + L + +++ K T+ ++ +E +++ L +P I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 75 VKYKDAW---VDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
V++ D+W V C+ +VT G + +K+ + + L W Q+L + +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFL 128
Query: 132 HSN--RVLHRDLKCSNIFLT-KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD 188
H+ ++HRDLKC NIF+T +++GD GLA L A +V+GTP +M PE+ +
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE 187
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI--VYSSTMKQII 246
Y D+++ G CM E+A + + A I + S + P V +K+II
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQ 270
+ +R+N + R + DLL H Q
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 236 bits (602), Expect = 4e-73
Identities = 80/308 (25%), Positives = 151/308 (49%), Gaps = 18/308 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA-KQTEKFKRTALQEMDLISKLNN 71
+ + + +IG G+FGA + + +KK+ + KQ+ + + ++E+ + KL +
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P ++Y+ ++ + +V YC G + + E ++ L + YL
Sbjct: 75 PNTIQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYL 131
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA---D 188
HS+ ++HRD+K NI L++ ++LGDFG A ++ A+S VGTP +M PE++ +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDE 188
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL-PIVYSSTMKQIIK 247
Y K D+WSLG E+A +P + + I ++ L +S + +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 248 SMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKHNSR 307
S L+K P+ RPT+ LL+H ++LR + P+ + I+ T K+ R+ + ++
Sbjct: 249 SCLQKIPQDRPTSEVLLKH----RFVLRERPPTVIMDLIQRT---KDAVRELDNLQYRKM 301
Query: 308 KDKGEREA 315
K +EA
Sbjct: 302 KKILFQEA 309
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 4e-72
Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 49/304 (16%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN 70
K +D+E I ++G G G F V HK K I L + + ++E+ ++ + N
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECN 62
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+PYIV + A+ G + I + +GG + +++KKA PE+ L K ++ + Y
Sbjct: 63 SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTY 119
Query: 131 LHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI 189
L ++++HRD+K SNI + +I+L DFG++ L + +A+S VGT +YM PE L
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGT 178
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPD------------------------------- 218
Y +SDIWS+G + E+A + PD
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 219 -----------MAGLINKINRSSISPLP-IVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+ L++ I LP V+S + + L KNP R L+ H
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 267 PHLQ 270
++
Sbjct: 299 AFIK 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 4e-72
Identities = 72/261 (27%), Positives = 132/261 (50%), Gaps = 9/261 (3%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ Y E+IG+GA G + + ++ ++++ L +Q +K + E+ ++ + NP
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNP 77
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IV Y D+++ + +V Y GG + +++ + C E ++ + L A+++LH
Sbjct: 78 NIVNYLDSYLVGDE-LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH 133
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-TEDLASSVVGTPNYMCPELLADIPY 191
SN+V+HRD+K NI L D ++L DFG + + S++VGTP +M PE++ Y
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 192 GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPI--VYSSTMKQIIKSM 249
G K DIWSLG E+ +P + + + I + L S+ + +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 250 LRKNPEHRPTASDLLRHPHLQ 270
L + E R +A +LL+H L+
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 6e-72
Identities = 65/310 (20%), Positives = 126/310 (40%), Gaps = 19/310 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E Y + E +GRG FG + +K Y+ K +++ + +E+ +++ +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHR 61
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
I+ +++ + ++ + G D+ E I E ++ ++ Q+ A+ +LH
Sbjct: 62 NILHLHESFESMEE-LVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH 119
Query: 133 SNRVLHRDLKCSNIFLTKDND--IRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIP 190
S+ + H D++ NI I++ +FG A+ L D + P Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY---SSTMKQIIK 247
+D+WSLG ++ + + F A +I I + + + S +
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 248 SMLRKNPEHRPTASDLLRHPHLQPYLLRCQNP---------SSVYLPIKPTNIMKEKTRK 298
+L K + R TAS+ L+HP L+ + R L K N++ R
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARI 299
Query: 299 SPSSKHNSRK 308
S S+K
Sbjct: 300 SCGGAIRSQK 309
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 231 bits (591), Expect = 1e-71
Identities = 80/296 (27%), Positives = 139/296 (46%), Gaps = 10/296 (3%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ Y+ + +G GAF L K +K +K I K E + + E+ ++ K+ +P
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLHKIKHP 67
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
IV D + G+ + ++ GG++ + I + + E + + Q+L AV YLH
Sbjct: 68 NIVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLH 124
Query: 133 SNRVLHRDLKCSNIFLT---KDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADI 189
++HRDLK N+ +D+ I + DFGL+K+ + + S+ GTP Y+ PE+LA
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI---SPLPIVYSSTMKQII 246
PY D WS+G + + P F + A L +I ++ SP S + K I
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244
Query: 247 KSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSS 302
+ ++ K+PE R T L+HP + +N N K K +++ ++
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNA 300
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 2e-71
Identities = 76/284 (26%), Positives = 137/284 (48%), Gaps = 17/284 (5%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLIS 67
K + ED++ + +G G+F L ++Y +K + E +E D++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
+L++P+ VK + D + Y + G++ + I+K F E + +++ A
Sbjct: 64 RLDHPFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSA 120
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPE 184
++YLH ++HRDLK NI L +D I++ DFG AK+L+ E A+S VGT Y+ PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244
LL + SD+W+LGC ++++ A P FRA + + KI + P + +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 239
Query: 245 IIKSMLRKNPEHRPTASDLLRHPHLQ--PYL-------LRCQNP 279
+++ +L + R ++ + L+ P+ L Q P
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 283
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 9e-70
Identities = 61/265 (23%), Positives = 115/265 (43%), Gaps = 17/265 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
V ++IG G+FG + +K + + T + + E+ ++ K +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
I+ + + IVT +CEG + + F KL Q +DYLH
Sbjct: 65 NILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH 121
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELL--- 186
+ ++HRDLK +NIFL +D +++GDFGLA + + + G+ +M PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI-----NRSSISPLPIVYSST 241
PY ++SD+++ G ++E+ Q + + I + +S +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 242 MKQIIKSMLRKNPEHRPTASDLLRH 266
MK+++ L+K + RP +L
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 7e-69
Identities = 53/256 (20%), Positives = 118/256 (46%), Gaps = 9/256 (3%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+++ ++++ IG+G FG L ++ K +K I+ + F E ++++L +
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA----EASVMTQLRH 59
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
+V+ V++ + IVT Y G + + ++ + + L K+ + A++YL
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPY 191
N +HRDL N+ +++DN ++ DFGL K ++ + + PE L + +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKF 177
Query: 192 GYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
KSD+WS G ++EI + + + + ++ ++ + P + +++K+
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 251 RKNPEHRPTASDLLRH 266
+ RP+ L
Sbjct: 238 HLDAAMRPSFLQLREQ 253
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 4e-66
Identities = 76/320 (23%), Positives = 143/320 (44%), Gaps = 22/320 (6%)
Query: 9 KSKLEDYEVIEQ-IGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLIS 67
+ ++DY+V Q +G G G + +K ++K+ LK ++ + A +E++L
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHW 59
Query: 68 KLNN-PYIVKYKDAWVD---KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ 123
+ + P+IV+ D + + C+ IV +GG++ I+ F E + + +
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDND---IRLGDFGLAKLLNTEDLASSVVGTPNY 180
+ A+ YLHS + HRD+K N+ T ++L DFG AK + + ++ TP Y
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 179
Query: 181 MCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD----MAGLINKINRSSI---SP 233
+ PE+L Y D+WSLG M+ + P F + G+ +I +P
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMK 293
S +K +I+++L+ P R T ++ + HP + Q P +K
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 299
Query: 294 EKTRKSPSSKHNSRKDKGER 313
E ++ +S + + E+
Sbjct: 300 EDVKEEMTSALATMRVDYEQ 319
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 4e-65
Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 16/309 (5%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIR--LAKQTEKFKRTALQEMDLISKL 69
+ED+ + + +G+G+FG FL K + + +K ++ + + + T +++ L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
+P++ + K N + V Y GGD+ I+ F + + +++L +
Sbjct: 61 EHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQ 117
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPNYMCPELLAD 188
+LHS +++RDLK NI L KD I++ DFG+ K D ++ GTP+Y+ PE+L
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 189 IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248
Y + D WS G ++E+ Q F D L + I + P K ++
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAKDLLVK 236
Query: 249 MLRKNPEHRPTA-SDLLRHPHLQPY---LLRCQNPSSVYLP-----IKPTNIMKEKTRKS 299
+ + PE R D+ +HP + L + + P +N KE +
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEK 296
Query: 300 PSSKHNSRK 308
P R
Sbjct: 297 PRLSFADRA 305
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-63
Identities = 60/264 (22%), Positives = 112/264 (42%), Gaps = 11/264 (4%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E +++E++G G FG ++ + K +K + KQ L E +L+ +L +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQ 68
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+V+ + + I+T Y E G + + +K G KL Q+ + ++
Sbjct: 69 RLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL--NTEDLASSVVGTPNYMCPELLADIP 190
+HRDL+ +NI ++ ++ DFGLA+L+ N + PE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 191 YGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249
+ KSD+WS G + EI H + + +I + R P + Q+++
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246
Query: 250 LRKNPEHRPTASDLLRHPHLQPYL 273
++ PE RPT L L+ +
Sbjct: 247 WKERPEDRPTFDYLRS--VLEDFF 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-62
Identities = 65/277 (23%), Positives = 133/277 (48%), Gaps = 15/277 (5%)
Query: 8 SKSKLED-YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK----QTEKFKRTALQE 62
+ ++D Y+ E++G G F K +Y K I+ + + + +E
Sbjct: 4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 63 MDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLT 122
+ ++ ++ +P ++ + + +K + V ++ GG++ + + + EE+ ++L
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKE--SLTEEEATEFLK 120
Query: 123 QLLLAVDYLHSNRVLHRDLKCSNIFLTKDND----IRLGDFGLAKLLNTEDLASSVVGTP 178
Q+L V YLHS ++ H DLK NI L N I++ DFGLA ++ + ++ GTP
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180
Query: 179 NYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY 238
++ PE++ P G ++D+WS+G + + + F + ++ + +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 239 ---SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
S+ K I+ +L K+P+ R T D L+HP ++P
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-62
Identities = 56/257 (21%), Positives = 113/257 (43%), Gaps = 9/257 (3%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+D ++++G G FG + + +K I+ +E ++E ++ L++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHE 59
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+V+ + + I+T Y G + +++ R F ++L + + A++YL
Sbjct: 60 KLVQLYGVCTKQRP-IFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE 117
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS--VVGTPNYMCPELLADIP 190
S + LHRDL N + +++ DFGL++ + ++ SS + PE+L
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 191 YGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249
+ KSDIW+ G M+EI + + + + I + P + S + I+ S
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237
Query: 250 LRKNPEHRPTASDLLRH 266
+ + RPT LL +
Sbjct: 238 WHEKADERPTFKILLSN 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 206 bits (526), Expect = 1e-62
Identities = 65/277 (23%), Positives = 121/277 (43%), Gaps = 18/277 (6%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLNN 71
+ YE+ E +G G L + +K +R + F +E + LN+
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 72 PYIVKYKDAWVDK---GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
P IV D + G IV Y +G + +I+ ++ + + A+
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQAL 124
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL----NTEDLASSVVGTPNYMCPE 184
++ H N ++HRD+K +NI ++ N +++ DFG+A+ + N+ ++V+GT Y+ PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV---YSST 241
+SD++SLGC ++E+ +P F + + R P S+
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 242 MKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQN 278
+ ++ L KNPE+R + +R L+R N
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRAD-----LVRVHN 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-62
Identities = 80/317 (25%), Positives = 139/317 (43%), Gaps = 19/317 (5%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLIS 67
K + D++ ++ +G+G FG LV K + Y +K +R + + E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
+P++ K A+ + +C V Y GG++ + R F EE+ + +++ A
Sbjct: 61 NTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSA 117
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPNYMCPELL 186
++YLHS V++RD+K N+ L KD I++ DFGL K ++ + GTP Y+ PE+L
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
D YG D W LG M+E+ + F D L I I P S K ++
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLL 236
Query: 247 KSMLRKNPEHRP-----TASDLLRHPHLQPY---LLRCQNPSSVYLP-----IKPTNIMK 293
+L+K+P+ R A +++ H + + + P +
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 296
Query: 294 EKTRKSPSSKHNSRKDK 310
E T +S + R D
Sbjct: 297 EFTAQSITITPPDRYDS 313
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 207 bits (528), Expect = 3e-62
Identities = 65/265 (24%), Positives = 132/265 (49%), Gaps = 12/265 (4%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLISKLN 70
L+D++++ +G G+FG L+ + + Y +K ++ K E ++S +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+P+I++ + D + ++ Y EGG++ +++ + FP + ++ LA++Y
Sbjct: 63 HPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEY 119
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIP 190
LHS +++RDLK NI L K+ I++ DFG AK + D+ ++ GTP+Y+ PE+++ P
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKP 177
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSML 250
Y D WS G ++E+ A F + KI + + P ++ +K ++ ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLI 236
Query: 251 RKNPEHR-----PTASDLLRHPHLQ 270
++ R D+ HP +
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 8e-62
Identities = 58/275 (21%), Positives = 117/275 (42%), Gaps = 17/275 (6%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIER--KKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
LED +++G G FG +++++ K +K ++ K L E +++ +
Sbjct: 9 TLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
L+NPYIV+ + +V E G + + +++ R ++ + + + Q+ + +
Sbjct: 65 LDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGM 120
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL----NTEDLASSVVGTPNYMCPE 184
YL + +HRDL N+ L + ++ DFGL+K L N + + PE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243
+ + KSD+WS G M+E ++ Q +R + + + + P M
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 240
Query: 244 QIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQN 278
++ + E+RP + + L+ Y N
Sbjct: 241 DLMNLCWTYDVENRPGFAAVEL--RLRNYYYDVVN 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 9e-62
Identities = 53/268 (19%), Positives = 115/268 (42%), Gaps = 15/268 (5%)
Query: 11 KLEDYEVIE-QIGRGAFGAAFLVLHKIERKK--YVLKKIRLAKQTEKFKRTALQEMDLIS 67
K ++ + + ++G G FG+ ++++ +K+ +K ++ + + ++E ++
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM-MREAQIMH 64
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
+L+NPYIV+ + + +V GG + + + R P + + L Q+ +
Sbjct: 65 QLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMG 121
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED----LASSVVGTPNYMCP 183
+ YL +HRDL N+ L + ++ DFGL+K L +D S+ + P
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242
E + + +SD+WS G M+E ++ Q ++ ++ I + P +
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 241
Query: 243 KQIIKSMLRKNPEHRPTASDL---LRHP 267
++ E RP + +R
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-61
Identities = 80/291 (27%), Positives = 130/291 (44%), Gaps = 32/291 (10%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+E+++ +E+IG G +G + +K+ + LKKIRL +TE TA++E+ L+ +LN+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
P IVK D + +V + D+ + + + P + +L QLL + +
Sbjct: 61 PNIVKLLDVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPNYMCPELLADIP 190
HS+RVLHRDLK N+ + + I+L DFGLA+ + V T Y PE+L
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 191 Y-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY----------- 238
Y DIWSLGC E+ + F + +I R+ +P +V+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 239 -----------------SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
+ ++ ML +P R +A L HP Q
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-61
Identities = 81/299 (27%), Positives = 131/299 (43%), Gaps = 36/299 (12%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYV-LKKIRLAKQTEKFKRTALQEMDLISKL-- 69
+ YE + +IG GA+G F ++V LK++R+ E + ++E+ ++ L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 70 -NNPYIVKYKDAWV----DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
+P +V+ D D+ + +V + + + + K P E + + QL
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE 184
L +D+LHS+RV+HRDLK NI +T I+L DFGLA++ + + +SVV T Y PE
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY------ 238
+L Y D+WS+GC E+ +P FR + KI P +
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 239 --------------------SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQ 277
K ++ L NP R +A L HP+ Q L RC+
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD-LERCK 303
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 4e-61
Identities = 58/276 (21%), Positives = 114/276 (41%), Gaps = 14/276 (5%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E + ++G+G FG ++ + +K ++ + + LQE ++ KL +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHE 72
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+V+ ++ + IVT Y G + + +K G +L Q+ + Y+
Sbjct: 73 KLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--ASSVVGTPNYMCPELLADIP 190
+HRDL+ +NI + ++ ++ DFGLA+L+ + + PE
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 191 YGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249
+ KSD+WS G + E+ + + +++++ R P P ++ ++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250
Query: 250 LRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLP 285
RK PE RPT L L+ Y + Y P
Sbjct: 251 WRKEPEERPTFEYLQA--FLEDYF---TSTEPQYQP 281
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 4e-61
Identities = 61/257 (23%), Positives = 121/257 (47%), Gaps = 9/257 (3%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ +++IG G FG L + K +K IR +E+ ++E +++ KL++P
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHP 60
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+V+ +++ +C+V + E G +++ ++ + F E L + + YL
Sbjct: 61 KLVQLYGVCLEQAP-ICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS--VVGTPNYMCPELLADIP 190
V+HRDL N + ++ I++ DFG+ + + + SS + PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 191 YGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249
Y KSD+WS G M+E+ + + + + ++ I+ P + S+ + QI+
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 250 LRKNPEHRPTASDLLRH 266
++ PE RP S LLR
Sbjct: 239 WKERPEDRPAFSRLLRQ 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-60
Identities = 60/296 (20%), Positives = 113/296 (38%), Gaps = 39/296 (13%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKY----VLKKIRLAKQTEKFKRTALQEMDLISK 68
E+ E + +G GAFG K V K+ K + + E+ ++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 69 LNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARG------------------ 109
L + IV A G + ++ YC GD+ ++ R
Sbjct: 97 LGSHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 110 ---ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166
E L + Q+ +++L +HRDL N+ +T +++ DFGLA+ +
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 167 TED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGL 222
++ + + +M PE L + Y KSD+WS G ++EI + + +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 223 INKINRSSISP-LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQ 277
K+ ++ P + + I++S + RP+ +L L CQ
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF-------LGCQ 324
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 200 bits (508), Expect = 7e-60
Identities = 71/289 (24%), Positives = 118/289 (40%), Gaps = 34/289 (11%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+E Y +E+IG G +G + + + + LKKIRL K+ E T ++E+ ++ +L +
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
IVK D K +V + + + G +L QLL + Y
Sbjct: 60 SNIVKLYDVIHTKKRL-VLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYC 116
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS-SVVGTPNYMCPELLA-DI 189
H RVLHRDLK N+ + ++ ++++ DFGLA+ + T Y P++L
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 190 PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY----------- 238
Y DIWS+GC E+ P F A + +I R +P +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 239 -----------------SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270
+ ++ ML+ +P R TA L H + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (509), Expect = 7e-60
Identities = 61/289 (21%), Positives = 121/289 (41%), Gaps = 16/289 (5%)
Query: 3 TENGDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ--TEKFKRTAL 60
+ + ++ + IG G FG K+ K+ + I+ K TEK +R L
Sbjct: 16 VREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL 75
Query: 61 QEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKW 120
E ++ + ++P ++ + V I+T + E G + +++ G +L
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKSTP-VMIITEFMENGSLDSFLRQNDGQF-TVIQLVGM 133
Query: 121 LTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV------ 174
L + + YL +HRDL NI + + ++ DFGL++ L + +
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 175 VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISP 233
+ PE + + SD+WS G M+E+ ++ + + +IN I + P
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSV 282
P+ S + Q++ +K+ HRP ++ L + +NP+S+
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN--TLDKMI---RNPNSL 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 7e-60
Identities = 63/259 (24%), Positives = 113/259 (43%), Gaps = 8/259 (3%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKLN 70
E E+ IG G FG ++ + I+ K ++ + LQE + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 71 NPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+P+IVK + N V I+ C G++ ++ + + L + QL A+ Y
Sbjct: 67 HPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 123
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--ASSVVGTPNYMCPELLAD 188
L S R +HRD+ N+ ++ ++ ++LGDFGL++ + AS +M PE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 189 IPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247
+ SD+W G CM+EI H F+ +I +I P+P T+ ++
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243
Query: 248 SMLRKNPEHRPTASDLLRH 266
+P RP ++L
Sbjct: 244 KCWAYDPSRRPRFTELKAQ 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-59
Identities = 60/299 (20%), Positives = 126/299 (42%), Gaps = 18/299 (6%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK----KYVLKKIRLAKQTEKFKRTALQEMDLI 66
K +++ I+ +G GAFG + L E + +K++R A + K + L E ++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVM 65
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
+ ++NP++ + + V ++T G + + +++ + L W Q+
Sbjct: 66 ASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAK 122
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCP 183
++YL R++HRDL N+ + +++ DFGLAKLL E+ A +M
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242
E + Y ++SD+WS G ++E+ + + + + + + P P + + +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPS 301
I+ + + RP +L+ + YL I+ M + +
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIE------FSKMARDPQRYLVIQGDERMHLPSPTDSN 295
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-59
Identities = 65/279 (23%), Positives = 120/279 (43%), Gaps = 19/279 (6%)
Query: 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE----KFKRTALQEMDLISKL 69
Y+V +G G FG+ + + + +K + + ++ E+ L+ K+
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 70 NNPY--IVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
++ + +++ D + + V I+ D+ + I + EE + Q+L A
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 122
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
V + H+ VLHRD+K NI + + +++L DFG LL + GT Y PE +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWI 181
Query: 187 ADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245
Y G + +WSLG ++++ F +I R + SS + +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQV-FFRQRVSSECQHL 234
Query: 246 IKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYL 284
I+ L P RPT ++ HP +Q LL Q + ++L
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLL-PQETAEIHL 272
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 200 bits (509), Expect = 5e-59
Identities = 67/289 (23%), Positives = 128/289 (44%), Gaps = 19/289 (6%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLA----KQTEKFKRTALQEMDLIS 67
+ D+ V IGRG FG + K Y +K + KQ E + L+S
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
+ P+IV A+ + + GGD+ + + F E + + +++L
Sbjct: 63 TGDCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILG 119
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA 187
++++H+ V++RDLK +NI L + +R+ D GLA ++ + VGT YM PE+L
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQ 178
Query: 188 D-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL--INKINRSSISPLPIVYSSTMKQ 244
+ Y +D +SLGC +F++ FR I+++ + LP +S ++
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 245 IIKSMLRKNPEHRPT-----ASDLLRHPHLQPY---LLRCQNPSSVYLP 285
+++ +L+++ R A ++ P + ++ Q +P
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 287
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 8e-59
Identities = 72/303 (23%), Positives = 123/303 (40%), Gaps = 46/303 (15%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
+ YE + +IG+G FG F H+ +K LKK+ + + E F TAL+E+ ++ L +
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 72 PYIVKYKDAWVDKG-------NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQL 124
+V + K + +V +CE + F ++ + + L
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQML 126
Query: 125 LLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA-----SSVVGTPN 179
L + Y+H N++LHRD+K +N+ +T+D ++L DFGLA+ + + ++ V T
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 180 YMCPELLA-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP--- 235
Y PELL + YG D+W GC M E+ P + + I++ S P
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 236 ----------------------------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
V +I +L +P R + D L H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 268 HLQ 270
Sbjct: 307 FFW 309
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (505), Expect = 1e-58
Identities = 69/266 (25%), Positives = 128/266 (48%), Gaps = 12/266 (4%)
Query: 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-QTEKFKRTALQEMDLI 66
+ ++L+ ++ I+ +G G+FG LV HK Y +K + K K L E ++
Sbjct: 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
+N P++VK + ++ D N ++ G + + + R F E + Q++L
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVL 152
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
+YLHS +++RDLK N+ + + I++ DFG AK + ++ GTP + PE++
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEII 210
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
Y D W+LG ++E+AA P F A + KI + P +SS +K ++
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLL 269
Query: 247 KSMLRKNPEHR-----PTASDLLRHP 267
+++L+ + R +D+ H
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHK 295
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-58
Identities = 69/297 (23%), Positives = 122/297 (41%), Gaps = 35/297 (11%)
Query: 16 EVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEK---FKRTALQEMDLISKLNNP 72
E ++ +G G F + K + +KKI+L ++E RTAL+E+ L+ +L++P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 73 YIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
I+ DA+ K N + +V + E I + + ++ L ++YLH
Sbjct: 61 NIIGLLDAFGHKSN-ISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLH 117
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLASSVVGTPNYMCPELLADI-P 190
+ +LHRDLK +N+ L ++ ++L DFGLAK + + V T Y PELL
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 191 YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVY------------ 238
YG D+W++GC + E+ P + +I + +P +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 239 ---------------SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQNPS 280
+ +I+ + NP R TA+ L+ +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-58
Identities = 52/273 (19%), Positives = 110/273 (40%), Gaps = 20/273 (7%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYV--LKKIRLAKQTEKFKRTALQEMDLISKL 69
D + + IG G FG K + + +K+++ + + E++++ KL
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKL 67
Query: 70 NN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKK--------------ARGACFPE 114
+ P I+ A +G + + Y G++ + ++K + +
Sbjct: 68 GHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 115 EKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSV 174
++L + + +DYL + +HRDL NI + ++ ++ DFGL++ +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 175 VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISP 233
+M E L Y SD+WS G ++EI + + A L K+ +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
P+ + +++ R+ P RP+ + +L
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (497), Expect = 3e-58
Identities = 48/259 (18%), Positives = 118/259 (45%), Gaps = 9/259 (3%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRL-AKQTEKFKRTALQEMDLISKL 69
+ D + ++G G +G + + K +K ++ + E+F + E ++ ++
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEI 70
Query: 70 NNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
+P +V+ + I+T + G++ + +++ L TQ+ A++
Sbjct: 71 KHPNLVQLLGVCTREPPF-YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 130 YLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASS--VVGTPNYMCPELLA 187
YL +HRDL N + +++ +++ DFGL++L+ + + + PE LA
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 188 DIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246
+ KSD+W+ G ++EIA + + D++ + + + P + +++
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249
Query: 247 KSMLRKNPEHRPTASDLLR 265
++ + NP RP+ +++ +
Sbjct: 250 RACWQWNPSDRPSFAEIHQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-58
Identities = 54/264 (20%), Positives = 112/264 (42%), Gaps = 13/264 (4%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKK---YVLKKIRLAK-QTEKFKRTALQEMDLI 66
+D ++E++G G+FG K +K ++ + ++E++ +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 67 SKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLL 126
L++ +++ + + +VT G + + ++K +G F L ++ Q+
Sbjct: 66 HSLDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAE 122
Query: 127 AVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED----LASSVVGTPNYMC 182
+ YL S R +HRDL N+ L + +++GDFGL + L D + +
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 183 PELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSIS-PLPIVYSS 240
PE L + + SD W G ++E+ + Q + + + +++KI++ P P
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242
Query: 241 TMKQIIKSMLRKNPEHRPTASDLL 264
+ ++ PE RPT L
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 5e-58
Identities = 52/284 (18%), Positives = 106/284 (37%), Gaps = 33/284 (11%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIER-----KKYVLKKIRLAKQTEKFKRTALQEMDLIS 67
+ E + IG GAFG F +K ++ + + + +E L++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMA 71
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGAC---------------- 111
+ +NP IVK +C++ Y GD+ E ++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 112 ------FPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165
+ Q+ + YL + +HRDL N + ++ +++ DFGL++ +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 166 NTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQ-PAFRAPDMAG 221
+ D + +M PE + Y +SD+W+ G ++EI ++ +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 222 LINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
+I + +I P + +++ K P RP+ + R
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 76/326 (23%), Positives = 135/326 (41%), Gaps = 47/326 (14%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y + IG GA+G + + + +KKI + + + + L+E+ ++ + + I
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENI 68
Query: 75 VKYKDAWVDK----GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDY 130
+ D V +VT + G D+ +++K + +C +L Q+L + Y
Sbjct: 69 IGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKY 124
Query: 131 LHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL----NTEDLASSVVGTPNYMCPELL 186
+HS VLHRDLK SN+ L D+++ DFGLA++ + + V T Y PE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 187 A-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI------------------- 226
Y DIWS+GC + E+ +++P F +N I
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 227 -----------NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLR 275
N+ + L S ++ ML NP R L HP+L+ Y
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 276 CQNP---SSVYLPIKPTNIMKEKTRK 298
P + ++ ++ KEK ++
Sbjct: 305 SDEPIAEAPFKFDMELDDLPKEKLKE 330
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-57
Identities = 73/292 (25%), Positives = 133/292 (45%), Gaps = 34/292 (11%)
Query: 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN 71
++ YE +E+IG G +G F ++ + LK++RL E +AL+E+ L+ +L +
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 72 PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYL 131
IV+ D +V +C+ + + E + +L QLL + +
Sbjct: 61 KNIVRLHDVLHSDKKL-TLVFEFCD--QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 132 HSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-LASSVVGTPNYMCPELLADIP 190
HS VLHRDLK N+ + ++ +++L +FGLA+ S+ V T Y P++L
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 191 -YGYKSDIWSLGCCMFEIA-AHQPAFRAPDMAGLINKINRSSISPLPIVY---------- 238
Y D+WS GC E+A A +P F D+ + +I R +P +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 239 ------------------SSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272
++T + +++++L+ NP R +A + L+HP+ +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-56
Identities = 74/316 (23%), Positives = 128/316 (40%), Gaps = 52/316 (16%)
Query: 4 ENGDSK-SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQE 62
E GDS + L+ Y+ ++ IG GA G + + +KK+ Q + + A +E
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 63 MDLISKLNNPYIVKYKDAWVDKG-----NCVCIVTGYCEGGDMAEIIKKARGACFPEEKL 117
+ L+ +N+ I+ + + + V +V + I E++
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERM 121
Query: 118 CKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGT 177
L Q+L + +LHS ++HRDLK SNI + D +++ DFGLA+ T + + V T
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 178 PNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV 237
Y PE++ + Y DIWS+GC M E+ H+ F D NK+ +P P
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 238 Y-----------------------------------------SSTMKQIIKSMLRKNPEH 256
+S + ++ ML +P
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 257 RPTASDLLRHPHLQPY 272
R + D L+HP++ +
Sbjct: 302 RISVDDALQHPYINVW 317
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-56
Identities = 62/335 (18%), Positives = 112/335 (33%), Gaps = 42/335 (12%)
Query: 6 GDSKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDL 65
G + + Y + IG G+FG + + +KK+ + KR +E+ +
Sbjct: 13 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQI 66
Query: 66 ISKLNNPYIVKYKDAWVDKG-----NCVCIVTGYCEGGDMAEIIKKAR-GACFPEEKLCK 119
+ KL++ IV+ + + G + +V Y +R P +
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 120 WLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTEDLASSVVGTP 178
++ QL ++ Y+HS + HRD+K N+ L D ++L DFG AK L + S + +
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 179 NYMCP-ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIV 237
Y P + Y D+WS GC + E+ QP F + +I + +P
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 238 Y----------------------------SSTMKQIIKSMLRKNPEHRPTASDLLRHPHL 269
+ +L P R T + H
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 270 QPYLLRCQNPSSVYLPIKPTNIMKEKTRKSPSSKH 304
+ N ++ +P
Sbjct: 307 DELRDPNVKLPNGRDTPALFNFTTQELSSNPPLAT 341
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 4e-55
Identities = 50/274 (18%), Positives = 90/274 (32%), Gaps = 27/274 (9%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y + +IG G+FG +L ++ +K + + + E + +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI----ESKIYKMMQGGVG 64
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
+ +G+ +V +R F + + Q++ ++Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK 122
Query: 135 RVLHRDLKCSNIFLT---KDNDIRLGDFGLAKLLNTEDL--------ASSVVGTPNYMCP 183
+HRD+K N + K N + + DFGLAK ++ GT Y
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 184 ELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS-------ISPLPI 236
I + D+ SLG + ++ A K R S I L
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 237 VYSSTMKQIIKSMLRKNPEHRPTAS---DLLRHP 267
Y S + + +P S L R+
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-54
Identities = 68/304 (22%), Positives = 132/304 (43%), Gaps = 42/304 (13%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
Y ++ +G GA+GA + K +KK+ Q+E F + A +E+ L+ + +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 73 YIVKYKDAWVDKG-----NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
++ D + +V + G D+ +++K + E+++ + Q+L
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQMLKG 133
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPE-LL 186
+ Y+H+ ++HRDLK N+ + +D ++++ DFGLA+ ++E + V T Y PE +L
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVIL 191
Query: 187 ADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP------------- 233
+ Y DIWS+GC M E+ + F+ D + +I + + +P
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 234 -----------------LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRC 276
+ S +++ ML + E R TA + L HP+ +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 277 QNPS 280
P
Sbjct: 312 DEPQ 315
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 7e-54
Identities = 72/302 (23%), Positives = 132/302 (43%), Gaps = 27/302 (8%)
Query: 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIER---KKYVLKKIRLAK--QTEKFKRTALQEM 63
K +E++E+++ +G GA+G FLV K Y +K ++ A Q K E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 64 DLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQ 123
++ + + + ++ Y GG++ + + F E ++ ++ +
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGE 137
Query: 124 LLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL--ASSVVGTPNYM 181
++LA+++LH +++RD+K NI L + + L DFGL+K ++ A GT YM
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 182 CPELLADIPYGY--KSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPI 236
P+++ G+ D WSLG M+E+ F +I+R + P P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 237 VYSSTMKQIIKSMLRKNPEHRP-----TASDLLRHPHLQPY----LLRCQNPSSVYLPIK 287
S+ K +I+ +L K+P+ R A ++ H Q L + P+ P K
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA----PFK 313
Query: 288 PT 289
P
Sbjct: 314 PV 315
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 3e-53
Identities = 56/278 (20%), Positives = 111/278 (39%), Gaps = 24/278 (8%)
Query: 13 EDYEVIEQIGRGAFGAAFL-----VLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLIS 67
+ ++ + +GRGAFG + + +K ++ + + + LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 68 KLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGAC--------------FP 113
++ +V A G + ++ +C+ G+++ ++ R
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 114 EEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED---L 170
E L + Q+ +++L S + +HRDL NI L++ N +++ DFGLA+ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA--HQPAFRAPDMAGLINKINR 228
+M PE + D Y +SD+WS G ++EI + P ++
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252
Query: 229 SSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+ P + M Q + P RPT S+L+ H
Sbjct: 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 182 bits (462), Expect = 9e-53
Identities = 67/299 (22%), Positives = 125/299 (41%), Gaps = 51/299 (17%)
Query: 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL 69
+DY+++ ++GRG + F ++ +K V+K ++ K+ +K KR E+ ++ L
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-KKIKR----EIKILENL 86
Query: 70 N-NPYIVKYKDAWVDK-GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLA 127
P I+ D D +V + D ++ + + + ++ ++L A
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKA 141
Query: 128 VDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELL 186
+DY HS ++HRD+K N+ + ++ +RL D+GLA+ + + V + + PELL
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
Query: 187 ADIP-YGYKSDIWSLGCCMFEIAAHQPAFRA-----------------PDMAGLINKIN- 227
D Y Y D+WSLGC + + + F D+ I+K N
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 228 -------------------RSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHP 267
R S + S + +LR + + R TA + + HP
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-52
Identities = 50/257 (19%), Positives = 102/257 (39%), Gaps = 11/257 (4%)
Query: 19 EQIGRGAFGA---AFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIV 75
E IGRG FG L+ + ++ +K + + + L E ++ ++P ++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF-LTEGIIMKDFSHPNVL 91
Query: 76 KYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR 135
+ +V Y + GD+ I+ + L + Q+ + +L S +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 136 VLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS-----SVVGTPNYMCPELLADIP 190
+HRDL N L + +++ DFGLA+ + ++ S +M E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210
Query: 191 YGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249
+ KSD+WS G ++E+ P + + + + + P + +++
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270
Query: 250 LRKNPEHRPTASDLLRH 266
E RP+ S+L+
Sbjct: 271 WHPKAEMRPSFSELVSR 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 3e-52
Identities = 59/282 (20%), Positives = 110/282 (39%), Gaps = 28/282 (9%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK-------KYVLKKIRLAKQTEKFKRTALQEM 63
+ + + +G GAFG L K K +K ++ TEK + EM
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEM 69
Query: 64 DLISKLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGAC----------- 111
+++ + I+ A + ++ Y G++ E ++ R
Sbjct: 70 EMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 112 ---FPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168
+ L Q+ ++YL S + +HRDL N+ +T+DN +++ DFGLA+ ++
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 169 DLASS---VVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLIN 224
D +M PE L D Y ++SD+WS G ++EI + + L
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 225 KINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
+ P ++ + +++ P RPT L+
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-52
Identities = 56/262 (21%), Positives = 113/262 (43%), Gaps = 12/262 (4%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKI----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISK 68
+ IG G FG + + K + +K ++ A TEK + L E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQ 65
Query: 69 LNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
++ I++ + + I+T Y E G + + +++ G F +L L + +
Sbjct: 66 FSHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGM 123
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLA----SSVVGTPNYMCPE 184
YL + +HRDL NI + + ++ DFGL+++L + A S + PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 185 LLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243
++ + SD+WS G M+E+ + + + ++ IN P P+ S +
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243
Query: 244 QIIKSMLRKNPEHRPTASDLLR 265
Q++ ++ RP +D++
Sbjct: 244 QLMMQCWQQERARRPKFADIVS 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-52
Identities = 58/280 (20%), Positives = 111/280 (39%), Gaps = 29/280 (10%)
Query: 13 EDYEVIEQIGRGAFGAAFLV-----LHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLIS 67
+ +G GAFG + +K ++ + + + + E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL-MSELKVLS 81
Query: 68 KLNN-PYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGAC--------------- 111
L N IV A G ++T YC GD+ +++ R +
Sbjct: 82 YLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 112 -FPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED- 169
E L + Q+ + +L S +HRDL NI LT ++ DFGLA+ + +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 170 --LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKI 226
+ + +M PE + + Y ++SD+WS G ++E+ + + + K+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 227 NRSSISPL-PIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
+ L P + M I+K+ +P RPT +++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-51
Identities = 52/273 (19%), Positives = 118/273 (43%), Gaps = 19/273 (6%)
Query: 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK-----KYVLKKIRLAKQTEKFKRTALQEMDL 65
E + ++G+G+FG + + K K + +K + A + + + L E +
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASV 76
Query: 66 ISKLNNPYIVKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGAC--------FPEEKL 117
+ + N ++V+ V +G ++ GD+ ++ R A K+
Sbjct: 77 MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 118 CKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL---ASSV 174
+ ++ + YL++N+ +HRDL N + +D +++GDFG+ + + D
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 175 VGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISP 233
+ +M PE L D + SD+WS G ++EIA + ++ ++ + +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255
Query: 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266
P + ++++ + NP+ RP+ +++
Sbjct: 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 176 bits (446), Expect = 6e-51
Identities = 45/271 (16%), Positives = 87/271 (32%), Gaps = 26/271 (9%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y+V +IG G+FG F + + ++ +K + + + L++
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEY-RTYKLLAGCTGIPN 65
Query: 75 VKYKDAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSN 134
V Y + +G +V G E + G F + + Q+L V +H
Sbjct: 66 VYY---FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 135 RVLHRDLKCSNIFLTK-----DNDIRLGDFGLAKLLNTED--------LASSVVGTPNYM 181
+++RD+K N + + N I + DFG+ K ++ GT YM
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 182 CPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINR-------SSISPL 234
+ D+ +LG ++ A K R + + L
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265
+ + + + P L
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-49
Identities = 63/321 (19%), Positives = 130/321 (40%), Gaps = 42/321 (13%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
E Y+ + +G GA+G+ + +KK+ Q+ + +E+ L+ + +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 73 YIVKYKDAWVDKGNCV----CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAV 128
++ D + + + + G D+ I+K + ++ + + Q+L +
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 129 DYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLAD 188
Y+HS ++HRDLK SN+ + +D ++++ DFGLA+ + E + V T Y PE++ +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 192
Query: 189 -IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI--------------------- 226
+ Y DIWS+GC M E+ + F D + I
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 227 ---------NRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLLRCQ 277
+ + + + I + +++ ML + + R TA+ L H + Y
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY--HDP 310
Query: 278 NPSSVYLPIKPTNIMKEKTRK 298
+ V P + ++
Sbjct: 311 DDEPVADPYDQSFESRDLLID 331
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-48
Identities = 57/296 (19%), Positives = 106/296 (35%), Gaps = 51/296 (17%)
Query: 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNP 72
+ E IG+G FG + + ++ +K ++ F+ E+ L +
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREA---EIYQTVMLRHE 57
Query: 73 YIVKYKDAWVDKGN---CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVD 129
I+ + A + +V+ Y E G + + + + E + K +
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 114
Query: 130 YLHS--------NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN-----TEDLASSVVG 176
+LH + HRDLK NI + K+ + D GLA + + + VG
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 177 TPNYMCPELLAD------IPYGYKSDIWSLGCCMFEIAAHQPAF---------------R 215
T YM PE+L D ++DI+++G +EIA
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 216 APDMAGLINKINRSSISP-LPIVYSST-----MKQIIKSMLRKNPEHRPTASDLLR 265
P + + + + P +P + S M +I++ N R TA + +
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (361), Expect = 2e-38
Identities = 64/339 (18%), Positives = 119/339 (35%), Gaps = 72/339 (21%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
Y ++ ++G G F +L + +K +R K + A E+ L+ ++N+
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADN 71
Query: 75 VKYKDAWVD-------------KGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWL 121
K + ++ G ++ +IKK P + +
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 122 TQLLLAVDYLHSNR-VLHRDLKCSNIFLTKD----NDIRLGDFGLAKLLNTEDLASSVVG 176
QLLL +DY+H ++H D+K N+ + N I++ L ++ ++ +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 177 TPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAP------------------- 217
T Y PE+L P+G +DIWS C +FE+ F
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 218 ------------------DMAGLINKINRSSISPLPIV----------YSSTMKQIIKSM 249
+ GL+ I++ PL V + + + M
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 250 LRKNPEHRPTASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288
L+ +P R A L+ HP L+ L + +P +
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTL----GMEEIRVPDRE 346
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.4 bits (226), Expect = 8e-22
Identities = 31/204 (15%), Positives = 66/204 (32%), Gaps = 26/204 (12%)
Query: 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYI 74
+ + +G G A F + + V+K ++ + K + DL +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 75 VKYKDAWVDKGNCVCIVT--GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLH 132
+ + + K + + + + E+I E + L +L V +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 133 SNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLA-DI-- 189
++H DL N+ ++ + I + DF + V E+L D+
Sbjct: 121 HRGIVHGDLSQYNVLVS-EEGIWIIDFPQS------------VEVGEEGWREILERDVRN 167
Query: 190 -------PYGYKSDIWSLGCCMFE 206
Y + DI S + +
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 644 | |||
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.12 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.4 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 96.85 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 96.68 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 96.37 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 96.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.85 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 95.82 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.66 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 95.63 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 95.54 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 95.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.24 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 95.11 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 95.06 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 94.41 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 94.4 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 94.39 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 94.37 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 94.34 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 94.21 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 94.06 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 94.04 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 94.02 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 94.01 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 93.78 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 93.63 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 93.34 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 93.33 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 92.59 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 92.36 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 92.23 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 92.18 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 91.84 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 91.7 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 91.63 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 90.6 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 90.23 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 90.1 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 89.95 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 89.66 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 88.99 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 88.86 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 88.79 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 88.54 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 88.38 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 87.73 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 87.41 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 87.15 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 87.05 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 87.03 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 86.28 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 85.44 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 85.23 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 84.51 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 84.06 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 83.11 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 82.06 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 80.46 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-59 Score=478.71 Aligned_cols=259 Identities=39% Similarity=0.700 Sum_probs=226.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-CceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-GNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-~~~~~ 89 (644)
+.++|++++.||+|+||.||+|.++.+|+.||+|++......+...+.+.+|+++|++++|||||+++++|.+. +..+|
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 56899999999999999999999999999999999988776676778899999999999999999999998753 45689
Q ss_pred EEEeccCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 90 IVTGYCEGGDMAEIIKKA--RGACFPEEKLCKWLTQLLLAVDYLHSNR-----VLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~--~~~~l~e~~i~~i~~QIL~gL~yLHs~g-----IIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
||||||+||+|.+++.+. .+..+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999999753 3457999999999999999999999976 999999999999999999999999999
Q ss_pred cccccc-cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHH
Q 006460 163 KLLNTE-DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSST 241 (644)
Q Consensus 163 ~~~~~~-~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~ 241 (644)
+.+... ......+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+......++|..+|++
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 241 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 876543 3445688999999999999999999999999999999999999999999999999999888888888999999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhhCCCC
Q 006460 242 MKQIIKSMLRKNPEHRPTASDLLRHPHL 269 (644)
Q Consensus 242 l~dLI~~~L~~dP~~RpTa~eiL~hp~f 269 (644)
+.+||.+||+.||.+|||++|+|+|||+
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=474.18 Aligned_cols=256 Identities=27% Similarity=0.511 Sum_probs=232.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
.+++|++++.||+|+||.||+|.++.+++.||+|++.+.... ......+.+|+++|++++|||||+++++|.+ +..+|
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~ 82 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVY 82 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEE
Confidence 478999999999999999999999999999999999765322 2235678899999999999999999999876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
||||||+||+|.+++.... .+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||++......
T Consensus 83 ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred EEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999999998643 5999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
.....+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+++..+.+... .+|..+|+++++||.+|
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRL 238 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCccCCHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999999998888876654 46788999999999999
Q ss_pred hccCCCCCCCHHHHhhCCCCch
Q 006460 250 LRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 250 L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
|..||.+|||++|+|+||||+.
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=472.76 Aligned_cols=257 Identities=23% Similarity=0.452 Sum_probs=219.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
++++|++++.||+|+||.||+|.++.+|+.||+|++...... ...+.+.+|+++|++++|||||+++++|.+ ++.+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEE
Confidence 478999999999999999999999999999999999765433 234678899999999999999999999887 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc--
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-- 168 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-- 168 (644)
|||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 vmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 9999999999999864 446999999999999999999999999999999999999999999999999999876432
Q ss_pred -cccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHh-ccCCCCCCccccHHHHH
Q 006460 169 -DLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL-INKIN-RSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 169 -~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el-~~~i~-~~~~~~~p~~~s~~l~d 244 (644)
......+||+.|||||++.+..| +.++|||||||++|+|++|++||........ ...+. .......+..+++++.+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 23456789999999999988876 6789999999999999999999976553322 22222 22333334568999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
||.+||..||.+|||++|+|+||||+.
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=481.16 Aligned_cols=262 Identities=28% Similarity=0.529 Sum_probs=236.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
..+++|++++.||+|+||.||+|+++.+|+.||+|++++.... ....+.+.+|+.+|++++|||||+++++|.+ ...+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~ 80 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-cccc
Confidence 4678999999999999999999999999999999999865322 2235678899999999999999999999877 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT- 167 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~- 167 (644)
|+|||||+||+|.+++.... .+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999999998743 599999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIK 247 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~ 247 (644)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..++...+..... .+|..+|+++++||.
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli~ 237 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLA 237 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHH
Confidence 3455678999999999999999999999999999999999999999999999998888877664 578889999999999
Q ss_pred HHhccCCCCCCC-----HHHHhhCCCCchhhhh
Q 006460 248 SMLRKNPEHRPT-----ASDLLRHPHLQPYLLR 275 (644)
Q Consensus 248 ~~L~~dP~~RpT-----a~eiL~hp~f~~~~~~ 275 (644)
+||++||.+|++ ++++++||||+...+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred hhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 999999999994 9999999999875444
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=472.85 Aligned_cols=253 Identities=29% Similarity=0.568 Sum_probs=226.9
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
-++|+++++||+|+||.||+|.++.+|+.||+|++....... .+.+.+|+++|++++|||||+++++|.+ ++.+|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV-GDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEE
Confidence 458999999999999999999999999999999998654332 3568899999999999999999999887 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-cc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~ 170 (644)
||||+||+|.+++... .+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.+... ..
T Consensus 96 mEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 9999999999988652 4999999999999999999999999999999999999999999999999999876543 34
Q ss_pred cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC--CCCCccccHHHHHHHHH
Q 006460 171 ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI--SPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~--~~~p~~~s~~l~dLI~~ 248 (644)
....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+....+..+..... .+.|..+++++++||.+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 5567899999999999999999999999999999999999999999887777666654433 33567789999999999
Q ss_pred HhccCCCCCCCHHHHhhCCCCc
Q 006460 249 MLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
||..||.+|||+.|+|+||||+
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhC
Confidence 9999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-57 Score=470.30 Aligned_cols=257 Identities=28% Similarity=0.496 Sum_probs=211.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
.-+.|++.+.||+|+||.||+|.++.+++.||||++....... ....+.+|+++|++|+|||||+++++|.+ +..+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEE
Confidence 3467999999999999999999999999999999997654332 24567899999999999999999999876 567999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc---CCCCeEEeccCccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT---KDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~---~~g~vKL~DFGls~~~~~ 167 (644)
|||||+||+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+. .++.+||+|||+++....
T Consensus 85 vmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999999975 44699999999999999999999999999999999999995 478899999999998776
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---CCCccccHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---PLPIVYSSTMKQ 244 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---~~p~~~s~~l~d 244 (644)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+....++...+...... +.+..+|+++.+
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 66677789999999999999999999999999999999999999999999988888888766543 334568999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
||.+||.+||.+|||+.|+|+||||+.
T Consensus 243 li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999964
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=457.93 Aligned_cols=252 Identities=28% Similarity=0.569 Sum_probs=221.1
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC---CceEEEE
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK---GNCVCIV 91 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~---~~~~~LV 91 (644)
|++.++||+|+||.||+|.++.++..||+|++..........+.+.+|+++|++|+|||||+++++|.+. ...+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4788899999999999999999999999999988766666677899999999999999999999998652 4678999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCcEEEc-CCCCeEEeccCcccccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNR--VLHRDLKCSNIFLT-KDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~g--IIHRDLKPeNILL~-~~g~vKL~DFGls~~~~~~ 168 (644)
||||+||+|.+++.+.. .+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 99999999999998643 5999999999999999999999998 99999999999997 478999999999986543
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhccCCC-CCCccccHHHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD-MAGLINKINRSSIS-PLPIVYSSTMKQII 246 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~-~~el~~~i~~~~~~-~~p~~~s~~l~dLI 246 (644)
......+||+.|||||++.+ .|+.++|||||||++|+|++|++||.... ...+...+.....+ .++..+++++.+||
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 34557799999999999876 69999999999999999999999997654 45555666544332 34556789999999
Q ss_pred HHHhccCCCCCCCHHHHhhCCCCc
Q 006460 247 KSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
.+||..||++|||++|+|+||||+
T Consensus 247 ~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-57 Score=469.37 Aligned_cols=260 Identities=28% Similarity=0.512 Sum_probs=229.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
.-++|++++.||+|+||.||+|.++.+++.||||++..... .+...+.+.+|+++|++++|||||+++++|.+ ++.+|
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ 84 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLY 84 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEE
Confidence 45789999999999999999999999999999999976432 12234678899999999999999999999876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
||||||+||+|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.+...
T Consensus 85 ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999999988643 5999999999999999999999999999999999999999999999999999876432
Q ss_pred --cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 169 --DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 169 --~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
....+.+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+..++...+..... .+|..+++++++||
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLV 241 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCCTTCCHHHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-CCCccCCHHHHHHH
Confidence 234567899999999999999999999999999999999999999999999998888877654 46788999999999
Q ss_pred HHHhccCCCCCCCHHH------HhhCCCCchhhh
Q 006460 247 KSMLRKNPEHRPTASD------LLRHPHLQPYLL 274 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~e------iL~hp~f~~~~~ 274 (644)
.+||+.||.+|||++| +++||||+...|
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred HHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 9999999999999987 688999986543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-57 Score=466.62 Aligned_cols=254 Identities=33% Similarity=0.563 Sum_probs=225.7
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
+.|++++.||+|+||.||+|.++.++..||+|++...... ..+.+.+|+++|++|+|||||+++++|.+ .+.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--GGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEE
Confidence 5799999999999999999999999999999999765322 24568899999999999999999999887 45699999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-ccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLA 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~ 171 (644)
|||+||+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 999999999998764 346999999999999999999999999999999999999999999999999999865432 234
Q ss_pred ccccCCCCCCChhhhc-----CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC--CCCccccHHHHH
Q 006460 172 SSVVGTPNYMCPELLA-----DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS--PLPIVYSSTMKQ 244 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~-----~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~--~~p~~~s~~l~d 244 (644)
.+.+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+.+..+.+..+.....+ ..+..+|+++.+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 5678999999999984 456899999999999999999999999998888888887766543 345678999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
||.+||+.||.+|||+.|+|+||||+
T Consensus 248 li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccC
Confidence 99999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-56 Score=469.78 Aligned_cols=259 Identities=25% Similarity=0.546 Sum_probs=233.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
.+++|++++.||+|+||.||+|+++.+|+.||||+++..... ....+.+.+|+.+|++++|||||+++++|.+ ...+|
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ 80 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIF 80 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeee
Confidence 368999999999999999999999999999999999765322 2235678899999999999999999999876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
+|||||.||+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++....
T Consensus 81 ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp EEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 999999999999998864 4589999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSM 249 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~ 249 (644)
...+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+..... .+|..+++++.++|.+|
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHH
T ss_pred ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHH
Confidence 34568999999999999999999999999999999999999999999999999888877654 46778899999999999
Q ss_pred hccCCCCCC-----CHHHHhhCCCCchhhhh
Q 006460 250 LRKNPEHRP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 250 L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
|.+||.+|+ |++++|+||||+.+.|.
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred hhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 999999996 99999999999876554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-57 Score=472.28 Aligned_cols=259 Identities=31% Similarity=0.523 Sum_probs=219.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCI 90 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~L 90 (644)
+-++|+++++||+|+||.||+|.++.+|+.||+|+++.... ......+.+|+++|++++|||||+++++|.+ ...+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-SSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEE
Confidence 45789999999999999999999999999999999976532 3445778999999999999999999999877 456999
Q ss_pred EEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 91 VTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 91 VmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
|||||.||+|.+++.+.. .+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.+.. .
T Consensus 82 VmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~ 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-S 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-H
T ss_pred EEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-C
Confidence 999999999999998643 59999999999999999999997 5999999999999999999999999999987654 3
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH---------------------------
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL--------------------------- 222 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el--------------------------- 222 (644)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+....
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 45678999999999999999999999999999999999999999976543221
Q ss_pred ---------------HHHHhccCCCCCC-ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhhh
Q 006460 223 ---------------INKINRSSISPLP-IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYLL 274 (644)
Q Consensus 223 ---------------~~~i~~~~~~~~p-~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~~ 274 (644)
...+.....+..+ ..+|.++.+||.+||+.||.+|||++|+|+||||+...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 1111111222222 236889999999999999999999999999999986543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=461.93 Aligned_cols=259 Identities=24% Similarity=0.442 Sum_probs=230.8
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH----HHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE----KFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
-++|++++.||+|+||.||+|+++.+|+.||||++.+..... ...+.+.+|+++|++|+|||||+++++|.+ ...
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~ 87 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTD 87 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCE
Confidence 357999999999999999999999999999999997653221 134678899999999999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC----CeEEeccCccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN----DIRLGDFGLAK 163 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g----~vKL~DFGls~ 163 (644)
+|||||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999998643 599999999999999999999999999999999999999776 49999999999
Q ss_pred ccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC---CccccH
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL---PIVYSS 240 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~---p~~~s~ 240 (644)
.........+..||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+........ +..+|.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 88766667778999999999999999999999999999999999999999999999998888877654422 245789
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.+++||++||..||.+|||++++|+||||++..
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999998543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.3e-56 Score=472.85 Aligned_cols=259 Identities=25% Similarity=0.454 Sum_probs=233.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+++|++++.||+|+||.||+|.++.+|+.||||++..... ...+.+.+|+++|++|+|||||+++++|.+ ++.+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch--hhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEE
Confidence 467899999999999999999999999999999999976543 335678899999999999999999999877 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC--CCCeEEeccCccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK--DNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~--~g~vKL~DFGls~~~~~ 167 (644)
||||||+||+|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+++.+..
T Consensus 100 ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999999998643 346999999999999999999999999999999999999964 57899999999998877
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC---CCccccHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP---LPIVYSSTMKQ 244 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~---~p~~~s~~l~d 244 (644)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..+....... .+..+|+++++
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 666777899999999999999999999999999999999999999999999999888887665432 22457999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
||.+||+.||.+|||++|+|+||||+..
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-56 Score=476.35 Aligned_cols=260 Identities=25% Similarity=0.456 Sum_probs=234.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
+..+++|++++.||+|+||.||+|.++.+|+.||+|+++.... .....+.+|+++|++|+|||||+++++|.+ +..+
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~ 101 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEM 101 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEE
Confidence 3567889999999999999999999999999999999976543 234678899999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEc--CCCCeEEeccCcccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLT--KDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~--~~g~vKL~DFGls~~~~ 166 (644)
|||||||+||+|.+++... +..+++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||++..+.
T Consensus 102 ~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 9999999999999887643 44699999999999999999999999999999999999998 56899999999999887
Q ss_pred cccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC---CCccccHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP---LPIVYSSTMK 243 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~---~p~~~s~~l~ 243 (644)
......+..||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..+....... .+..+++++.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 7777777899999999999999999999999999999999999999999999999888887765432 3356899999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+||.+||++||.+|||+.|+|+||||+..
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-56 Score=472.13 Aligned_cols=260 Identities=27% Similarity=0.498 Sum_probs=233.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
..+++|++++.||+|+||.||+|.++.+|+.||||++.+.... ....+.+.+|+++|+.++|||||+++++|.+ ...+
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~ 116 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNL 116 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-cccc
Confidence 3478999999999999999999999999999999999764322 2234678899999999999999999999876 5679
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+||||+.||+|..++.... .+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.+..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 99999999999999997653 599999999999999999999999999999999999999999999999999987654
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
...+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+...++..+..... ..|..+++++.+||++
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHH
T ss_pred -ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999999888888877654 4577899999999999
Q ss_pred HhccCCCCCC-----CHHHHhhCCCCchhhhh
Q 006460 249 MLRKNPEHRP-----TASDLLRHPHLQPYLLR 275 (644)
Q Consensus 249 ~L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~ 275 (644)
||.+||.+|+ |+++|++||||+...|.
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 9999999994 99999999999875443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-55 Score=460.85 Aligned_cols=251 Identities=27% Similarity=0.511 Sum_probs=224.1
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
.|+++++||+|+||.||+|+++.+++.||||++..... .....+.+.+|+++|++|+|||||+++++|.+ +..+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEEE
Confidence 49999999999999999999999999999999987643 34456779999999999999999999999877 56799999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDLAS 172 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~~~ 172 (644)
|||.||+|..++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++..... ..
T Consensus 95 E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---AN 169 (309)
T ss_dssp ECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BC
T ss_pred EecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CC
Confidence 99999999877654 34699999999999999999999999999999999999999999999999999987544 34
Q ss_pred cccCCCCCCChhhhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC-CccccHHHHHHHHH
Q 006460 173 SVVGTPNYMCPELLAD---IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL-PIVYSSTMKQIIKS 248 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~---~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~-p~~~s~~l~dLI~~ 248 (644)
..+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+....+.+..+.....+.. +..+|+++.+||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 5789999999999864 4589999999999999999999999999888888777776655443 45689999999999
Q ss_pred HhccCCCCCCCHHHHhhCCCCc
Q 006460 249 MLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
||..||.+|||++++|+||||.
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHH
T ss_pred HCcCChhHCcCHHHHHhCHHhc
Confidence 9999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.3e-55 Score=449.53 Aligned_cols=259 Identities=30% Similarity=0.514 Sum_probs=231.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc-------HHHHHHHHHHHHHHHhcC-CCCcceeeeEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT-------EKFKRTALQEMDLISKLN-NPYIVKYKDAWV 82 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~-------~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~ 82 (644)
+.++|++.+.||+|+||.||+|+++.+++.||||+++..... ....+.+.+|+.+|++|+ |||||+++++|.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 468999999999999999999999999999999999765321 334567899999999997 999999999987
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
+ +..+|||||||+||+|.++++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~-~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 81 T-NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp C-SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred c-CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence 6 56799999999999999999864 35999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccCCCCCCChhhhcC------CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC---C
Q 006460 163 KLLNTEDLASSVVGTPNYMCPELLAD------IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS---P 233 (644)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APEvl~~------~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~---~ 233 (644)
+.+.........+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+||.+.+.......+...... +
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 98877666677899999999998853 45789999999999999999999999999988888887765432 2
Q ss_pred CCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 234 LPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 234 ~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.+..+|+++++||.+||+.||.+|||++|+|+||||+.|
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 334689999999999999999999999999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.6e-55 Score=466.56 Aligned_cols=261 Identities=24% Similarity=0.454 Sum_probs=221.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc----HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT----EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~----~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
.+++|++++.||+|+||.||+|+++.+|+.||||++.+.... ........+++++++.++|||||+++++|.+ ..
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~ 80 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PD 80 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CC
Confidence 378999999999999999999999999999999999754321 2222333445777888899999999999876 56
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|||||||+||+|.+++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.+.
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 799999999999999999864 358999999999999999999999999999999999999999999999999998766
Q ss_pred cccccccccCCCCCCChhhhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH--HHHhccCCCCCCccccHHHH
Q 006460 167 TEDLASSVVGTPNYMCPELLA-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLI--NKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~-~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~--~~i~~~~~~~~p~~~s~~l~ 243 (644)
.. .....+||+.|+|||++. +..|+.++|||||||+||+|++|++||.+....... ...........|..+|++++
T Consensus 159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 53 355678999999999986 457899999999999999999999999875533222 22223344456778999999
Q ss_pred HHHHHHhccCCCCCCC-----HHHHhhCCCCchhhhh
Q 006460 244 QIIKSMLRKNPEHRPT-----ASDLLRHPHLQPYLLR 275 (644)
Q Consensus 244 dLI~~~L~~dP~~RpT-----a~eiL~hp~f~~~~~~ 275 (644)
+||.+||.+||.+||| ++++++||||+...|.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 9999999999999999 7999999999876544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=460.01 Aligned_cols=259 Identities=25% Similarity=0.475 Sum_probs=229.1
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHH-hcCCCCcceeeeEEEeCCceEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLIS-KLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~-~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
+++|++++.||+|+||.||+|.++.+++.||||++++... .....+.+.+|..++. .++|||||+++++|.+ +..+|
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~y 79 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLF 79 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCcee
Confidence 5899999999999999999999999999999999976432 1122345667777765 6899999999999876 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE- 168 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~- 168 (644)
||||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 80 ivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999999998643 5899999999999999999999999999999999999999999999999999865433
Q ss_pred cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 169 DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 169 ~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+...+...+.... ..+|..+|+++.+||++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHH
Confidence 33455789999999999999999999999999999999999999999999999988887664 45788899999999999
Q ss_pred HhccCCCCCCCHH-HHhhCCCCchhhh
Q 006460 249 MLRKNPEHRPTAS-DLLRHPHLQPYLL 274 (644)
Q Consensus 249 ~L~~dP~~RpTa~-eiL~hp~f~~~~~ 274 (644)
||.+||.+|||+. ++++||||+.+.+
T Consensus 237 ~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred hcccCCCCCcCHHHHHHhCchhccCCH
Confidence 9999999999995 8999999987543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-55 Score=459.79 Aligned_cols=258 Identities=22% Similarity=0.372 Sum_probs=231.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+++|++++.||+|+||.||+|.++.+++.||+|+++..... ...+.+|+++|+.++|||||+++++|.+ +..+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFES-MEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEE
Confidence 4689999999999999999999999999999999999765432 3457899999999999999999999877 56799
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC--CCeEEeccCccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD--NDIRLGDFGLAKLLNT 167 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~--g~vKL~DFGls~~~~~ 167 (644)
||||||+||+|.+++... +..+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 78 lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999999999753 3469999999999999999999999999999999999999854 4799999999998776
Q ss_pred ccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC---ccccHHHHH
Q 006460 168 EDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP---IVYSSTMKQ 244 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p---~~~s~~l~d 244 (644)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..+......... ..+|+++++
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 66667788999999999999999999999999999999999999999999999999888776554222 357999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 245 IIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
||.+||.+||.+|||+.|+|+||||+..
T Consensus 237 li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=445.75 Aligned_cols=259 Identities=31% Similarity=0.504 Sum_probs=218.6
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+++|+++++||+|+||.||+|.++.+|+.||+|+++.....+.....+.+|+++|++++|||||+++++|.+ +..+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEE
Confidence 589999999999999999999999999999999997765544556788999999999999999999999887 5679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc-ccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT-EDL 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~-~~~ 170 (644)
||||.+ .+..++.......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.... ...
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 999954 566666555566799999999999999999999999999999999999999999999999999987643 234
Q ss_pred cccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-----------------
Q 006460 171 ASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----------------- 232 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~----------------- 232 (644)
.....||+.|+|||++....+ +.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 556789999999998877664 88999999999999999999999998877766665321100
Q ss_pred CC-----------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 233 PL-----------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 233 ~~-----------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.. ...++.++.+||++||..||.+|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00 11357899999999999999999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=457.46 Aligned_cols=254 Identities=26% Similarity=0.490 Sum_probs=216.8
Q ss_pred CCCCCeEEEE-EeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEe---C
Q 006460 10 SKLEDYEVIE-QIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVD---K 84 (644)
Q Consensus 10 ~~~~~Y~i~~-~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d---~ 84 (644)
..+++|++++ .||+|+||.||+|.++.+++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ .
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 4689999986 599999999999999999999999999653 3456799987655 89999999999865 2
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC---CCCeEEeccCc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK---DNDIRLGDFGL 161 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~---~g~vKL~DFGl 161 (644)
+.++|||||||+||+|.+++.......+++.+++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 467999999999999999998654567999999999999999999999999999999999999985 45799999999
Q ss_pred ccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHh----ccCCCCCC--
Q 006460 162 AKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKIN----RSSISPLP-- 235 (644)
Q Consensus 162 s~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~----~~~~~~~p-- 235 (644)
++...........+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.........+. .... .+|
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-~~~~~ 239 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNP 239 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-SCCTT
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-CCCCc
Confidence 998777667778899999999999999999999999999999999999999998766444333322 2221 122
Q ss_pred --ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 236 --IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 236 --~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..+|+++.+||++||++||.+|||+.|+|+||||+.
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 357999999999999999999999999999999963
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=443.14 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=219.9
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecC-CeEEEEEEEecccccHHHHHHHHHHHHHHHhc---CCCCcceeeeEEEe----C
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIE-RKKYVLKKIRLAKQTEKFKRTALQEMDLISKL---NNPYIVKYKDAWVD----K 84 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~t-g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HPNIVkl~~~~~d----~ 84 (644)
++|+++++||+|+||.||+|.+..+ ++.||||+++.....+.....+.+|+.+|+.| +|||||+++++|.. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 7999999999999999999999766 67799999976544333334456777777766 79999999999863 2
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...+|++||||.++.+.... ......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 35789999999876665443 34556799999999999999999999999999999999999999999999999999988
Q ss_pred cccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC-------------
Q 006460 165 LNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI------------- 231 (644)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~------------- 231 (644)
..........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 7766677788999999999999999999999999999999999999999999988877776543110
Q ss_pred -------------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 232 -------------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 232 -------------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
..++..+++.+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 1123446889999999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=443.94 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=211.9
Q ss_pred EEEEEeccCCCeEEEEEEEecCCeEEEEEEEeccccc---HHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 16 EVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQT---EKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 16 ~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
+.+++||+|+||.||+|.++.+|+.||||+++..... +...+.+.+|+.+|++++|||||+++++|.+ +..+||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCceeehh
Confidence 3578999999999999999999999999999765432 2234578899999999999999999999876 45699999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc-ccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE-DLA 171 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~-~~~ 171 (644)
|||.|+++..++. .+..+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 80 E~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 80 DFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp ECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 9998877766553 3456999999999999999999999999999999999999999999999999999876543 334
Q ss_pred ccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-----------------
Q 006460 172 SSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP----------------- 233 (644)
Q Consensus 172 ~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~----------------- 233 (644)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+....+.+..+......+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 56789999999998865 468999999999999999999999999999888777765321100
Q ss_pred -----C-----CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 234 -----L-----PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 234 -----~-----p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
. ...+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0 1235789999999999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-53 Score=436.40 Aligned_cols=252 Identities=19% Similarity=0.362 Sum_probs=225.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
...++|++.++||+|+||.||+|.++.+++.||||+++..... .+.+.+|+++|++|+|||||+++++|.+ +..+|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee-CCeeE
Confidence 4567999999999999999999999999999999999765433 3568899999999999999999999876 45689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
||||||++|+|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999999999987666789999999999999999999999999999999999999999999999999998765432
Q ss_pred c--cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 170 L--ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 170 ~--~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG-~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
. .....||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+...+...+......+.|..+++++.+||
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 249 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHH
Confidence 2 2334588999999999999999999999999999999995 566777788888888877777788889999999999
Q ss_pred HHHhccCCCCCCCHHHHhh
Q 006460 247 KSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~ 265 (644)
.+||..||.+|||+++|++
T Consensus 250 ~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 250 RACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-53 Score=431.82 Aligned_cols=256 Identities=21% Similarity=0.398 Sum_probs=226.1
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 8 SKSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 8 ~~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
-....++|++.++||+|+||.||+|.++ ++..||||+++..... .+.+.+|+++|++++|||||++++++.+ ..
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~ 81 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ--EP 81 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc--CC
Confidence 3456689999999999999999999975 6788999999765443 3568899999999999999999998654 34
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|||||||++|+|.+++.......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 78999999999999987655445699999999999999999999999999999999999999999999999999997654
Q ss_pred cc--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 168 ED--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 168 ~~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
.. ......||+.|+|||++.+..|+.++|||||||++|||+| |.+||......+++..+......+.|..+++++.+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 241 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence 32 3345679999999999998899999999999999999998 57788888888899999888888888899999999
Q ss_pred HHHHHhccCCCCCCCHHHHhh--CCCC
Q 006460 245 IIKSMLRKNPEHRPTASDLLR--HPHL 269 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~--hp~f 269 (644)
||.+||..||.+|||+++|++ |+||
T Consensus 242 li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 242 LMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 999999999999999999987 5555
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=426.05 Aligned_cols=249 Identities=23% Similarity=0.449 Sum_probs=213.7
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
-++|+++++||+|+||.||+|.++ ++..||||+++..... .+.+.+|++++++++|||||+++++|.+. ..+|+|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccC-CceEEE
Confidence 368999999999999999999876 5678999999765544 35688999999999999999999998764 558999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
||||++|+|.+++... ...+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999999999998753 45689999999999999999999999999999999999999999999999999987654332
Q ss_pred -cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 171 -ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 171 -~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
.....||+.|+|||++.+..|+.++|||||||++|||++ |.+||......++...+........|..+++++.+||.+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 234678999999999999999999999999999999998 688888888888999988887778888999999999999
Q ss_pred HhccCCCCCCCHHHHhhC
Q 006460 249 MLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~h 266 (644)
||..||.+|||+++|++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=434.36 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=213.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccH----HHHHHHHHHHHHHHhcC--CCCcceeeeEEEeCC
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTE----KFKRTALQEMDLISKLN--NPYIVKYKDAWVDKG 85 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~--HPNIVkl~~~~~d~~ 85 (644)
-++|++.+.||+|+||.||+|.++.+++.||||++....... ....++.+|+.+|++++ |||||+++++|.+ .
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~ 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-P 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-S
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-C
Confidence 368999999999999999999999999999999997643211 11234567999999996 8999999999876 5
Q ss_pred ceEEEEEeccCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCC-CCeEEeccCccc
Q 006460 86 NCVCIVTGYCEG-GDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKD-NDIRLGDFGLAK 163 (644)
Q Consensus 86 ~~~~LVmEy~~G-gsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~-g~vKL~DFGls~ 163 (644)
+.+|+||||+.+ +++.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 679999999976 6888888764 359999999999999999999999999999999999999855 789999999998
Q ss_pred ccccccccccccCCCCCCChhhhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 164 LLNTEDLASSVVGTPNYMCPELLADIPY-GYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y-s~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
.... ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.... .+.+.. ..++..+|+++
T Consensus 160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~-~~~~~~~s~~~ 231 (273)
T d1xwsa_ 160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQRVSSEC 231 (273)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC-CCCSSCCCHHH
T ss_pred eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc-cCCCCCCCHHH
Confidence 7544 34567889999999999987665 678999999999999999999997632 222332 34677889999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 243 KQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
++||.+||..||.+|||++|+|+||||+..
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-52 Score=431.85 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=214.7
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+++|+++++||+|+||.||+|.++ +++.||||+++.....+...+.+.+|+.+|++++|||||+++++|.. .+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEE
Confidence 589999999999999999999985 78999999997765554456788999999999999999999999876 4569999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-c
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-L 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~ 170 (644)
|+|+.++.+..+... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++....... .
T Consensus 79 ~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 999977766666543 4569999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCC------------------
Q 006460 171 ASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSI------------------ 231 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~------------------ 231 (644)
.....|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3456799999999998764 469999999999999999999999998887777666532110
Q ss_pred ----------CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCc
Q 006460 232 ----------SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQ 270 (644)
Q Consensus 232 ----------~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~ 270 (644)
...+..+++.+.+||++||++||++|||+.|+|+||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 012234688999999999999999999999999999996
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=431.29 Aligned_cols=248 Identities=21% Similarity=0.369 Sum_probs=214.9
Q ss_pred EEeccCCCeEEEEEEEec--CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEEeccC
Q 006460 19 EQIGRGAFGAAFLVLHKI--ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVTGYCE 96 (644)
Q Consensus 19 ~~LG~G~fG~Vyla~~k~--tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVmEy~~ 96 (644)
++||+|+||.||+|.++. +++.||||+++.........+.+.+|+++|++++|||||+++++|.. + ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C-CEEEEEEcCC
Confidence 479999999999998754 45789999997665555566789999999999999999999998754 3 4789999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc----ccc
Q 006460 97 GGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED----LAS 172 (644)
Q Consensus 97 GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~----~~~ 172 (644)
||+|.+++.. ...+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.... ...
T Consensus 91 ~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 91 LGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp TEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 9999999976 3469999999999999999999999999999999999999999999999999998764332 223
Q ss_pred cccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHHHhc
Q 006460 173 SVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKSMLR 251 (644)
Q Consensus 173 ~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~ 251 (644)
...||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..++...+..+...+.|..+|.++.+||.+||.
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~ 248 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcC
Confidence 4578999999999999999999999999999999997 899999999999999998888888899999999999999999
Q ss_pred cCCCCCCCHHHHh---hCCCCc
Q 006460 252 KNPEHRPTASDLL---RHPHLQ 270 (644)
Q Consensus 252 ~dP~~RpTa~eiL---~hp~f~ 270 (644)
.||.+|||+++|+ +|+|++
T Consensus 249 ~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 249 YDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp SSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999984 555543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-52 Score=432.53 Aligned_cols=254 Identities=22% Similarity=0.400 Sum_probs=213.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCe---EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERK---KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
...++|++.+.||+|+||.||+|.++.+++ .||+|.+.... .....+.+.+|+++|++|+|||||+++++|.. +.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-ST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CC
Confidence 446889999999999999999999987764 57888776543 34456789999999999999999999999866 45
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+|||||+||+|.+++... ...+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 689999999999999988753 4469999999999999999999999999999999999999999999999999998765
Q ss_pred cccc------cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCcccc
Q 006460 167 TEDL------ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYS 239 (644)
Q Consensus 167 ~~~~------~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s 239 (644)
.... .....||+.|||||++.+..|+.++|||||||++|||++ |.+||.+....++...+......+.|..++
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 4322 122457899999999999999999999999999999997 899999999999999998888788888999
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
..+.+||.+||..||.+|||+.+|+++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=439.21 Aligned_cols=257 Identities=25% Similarity=0.450 Sum_probs=217.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC-----
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----- 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----- 85 (644)
.-++|+++++||+|+||.||+|.++.+|+.||||+++.....+...+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 458999999999999999999999999999999999877667777788999999999999999999999987643
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
..+||||||| |.+|..+++. ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 2579999999 7788888764 35999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC--------------
Q 006460 166 NTEDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS-------------- 230 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~-------------- 230 (644)
.. .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+..+....
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 172 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred CC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 54 34668899999999998764 56899999999999999999999999887666554433211
Q ss_pred ----------------CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 231 ----------------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 231 ----------------~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.......+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 1112234688999999999999999999999999999998643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8e-52 Score=424.70 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=214.0
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC---ce
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG---NC 87 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~---~~ 87 (644)
-++|++.+.||+|+||.||+|.++.+++.||||+++.... .......+.+|+++|++++|||||++++++...+ ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999999999999999986543 3455678999999999999999999999987643 35
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|||||||+|++|..++.... .+++.+++.|+.||+.||.|||++|||||||||+|||++.++.++|+|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 899999999999999987643 599999999999999999999999999999999999999999999999999876533
Q ss_pred c----cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC---CCccccH
Q 006460 168 E----DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP---LPIVYSS 240 (644)
Q Consensus 168 ~----~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~---~p~~~s~ 240 (644)
. ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+......+ .+..+|+
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 2 23455789999999999999999999999999999999999999999998888777665544322 3456899
Q ss_pred HHHHHHHHHhccCCCCCC-CHHHHhhCCCC
Q 006460 241 TMKQIIKSMLRKNPEHRP-TASDLLRHPHL 269 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~Rp-Ta~eiL~hp~f 269 (644)
++.+||.+||.+||.+|| |+++++ |+|+
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~-~~l~ 272 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMR-ADLV 272 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHH-HHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHH-HHHH
Confidence 999999999999999999 555554 5554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=433.59 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=214.5
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-------
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK------- 84 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~------- 84 (644)
+++|+++++||+|+||+||+|+++.+|+.||||++......+....++.+|+++|++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 7999999999999999999999999999999999977665555567789999999999999999999997542
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...+|+|||||.++.+..+.. ....+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 246899999997766554432 345699999999999999999999999999999999999999999999999999976
Q ss_pred cccc-----cccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCCC---
Q 006460 165 LNTE-----DLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPLP--- 235 (644)
Q Consensus 165 ~~~~-----~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~p--- 235 (644)
+... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.........+......+.+
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 5432 234456899999999998765 6899999999999999999999999988877776665432211111
Q ss_pred ----------------------------ccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCch
Q 006460 236 ----------------------------IVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQP 271 (644)
Q Consensus 236 ----------------------------~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~ 271 (644)
...++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 013667889999999999999999999999999973
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=429.48 Aligned_cols=255 Identities=20% Similarity=0.366 Sum_probs=222.8
Q ss_pred CCCCeEEEEE-eccCCCeEEEEEEEecC--CeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCce
Q 006460 11 KLEDYEVIEQ-IGRGAFGAAFLVLHKIE--RKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNC 87 (644)
Q Consensus 11 ~~~~Y~i~~~-LG~G~fG~Vyla~~k~t--g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~ 87 (644)
.-++|.+.+. ||+|+||.||+|.++.+ +..||||+++... .....+.+.+|+++|++++|||||++++++.. ..
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EA 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SS
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--Ce
Confidence 3467889884 99999999999987644 5579999997654 34456789999999999999999999998754 34
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
+|||||||+||+|.+++... ...+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 89999999999999998643 34699999999999999999999999999999999999999999999999999987654
Q ss_pred cc----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHH
Q 006460 168 ED----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTM 242 (644)
Q Consensus 168 ~~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l 242 (644)
.. ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+....++...+..+...+.|..+|+++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 241 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 241 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 32 2234578999999999998899999999999999999998 999999988888999998888888899999999
Q ss_pred HHHHHHHhccCCCCCCCHHHH---hhCCCC
Q 006460 243 KQIIKSMLRKNPEHRPTASDL---LRHPHL 269 (644)
Q Consensus 243 ~dLI~~~L~~dP~~RpTa~ei---L~hp~f 269 (644)
.+||.+||..||.+|||+.+| |+|+|+
T Consensus 242 ~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999999988 556655
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-52 Score=435.38 Aligned_cols=254 Identities=21% Similarity=0.344 Sum_probs=215.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCe-----EEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERK-----KYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~-----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~ 84 (644)
..++|++.++||+|+||.||+|.+..+++ .||+|.+..... ......+.+|+.+|+++ +|||||+++++|.+.
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 34799999999999999999999987653 689998865432 33456788999999998 899999999998764
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARG---------------------ACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKC 143 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~---------------------~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKP 143 (644)
..+|||||||+||+|.++|..... ..+++..++.|+.||+.||.|||++|||||||||
T Consensus 114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 114 -GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp -SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred -CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 568999999999999999975432 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCh
Q 006460 144 SNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDM 219 (644)
Q Consensus 144 eNILL~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~ 219 (644)
+|||++.++.+||+|||+|+...... ...+..||+.|||||++.+..|+.++|||||||+||||++ |.+||.+.+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998754432 2345678999999999999999999999999999999997 8999988665
Q ss_pred HHH-HHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 220 AGL-INKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 220 ~el-~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
... ...+......+.|..+|+++.+||.+||+.||.+|||+++|++|
T Consensus 273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444 44445555567788899999999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=428.43 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=211.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
....++|++.++||+|+||.||+|.++ ..||||+++.........+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~ 78 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQL 78 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSC
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEE
Confidence 355789999999999999999999753 369999998766555567789999999999999999999997643 458
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|||||||+||+|.+++... ...+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999999999753 346999999999999999999999999999999999999999999999999999876432
Q ss_pred ---cccccccCCCCCCChhhhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHhccCCC----CCCcc
Q 006460 169 ---DLASSVVGTPNYMCPELLAD---IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGL-INKINRSSIS----PLPIV 237 (644)
Q Consensus 169 ---~~~~~~~GT~~Y~APEvl~~---~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el-~~~i~~~~~~----~~p~~ 237 (644)
.......||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+...... ...+...... ..+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 23456789999999999864 3589999999999999999999999988665544 3444444332 24556
Q ss_pred ccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 238 YSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 238 ~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+++++.+||.+||..||.+|||+.+|+++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=420.45 Aligned_cols=249 Identities=21% Similarity=0.360 Sum_probs=224.8
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
-++|++.++||+|+||.||+|+++ ++..||||+++...... +.+.+|+.++++++|||||+++++|.+. ..+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCS-SSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEE
Confidence 368999999999999999999984 78899999998765443 4688999999999999999999998764 569999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc-
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL- 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~- 170 (644)
|||+++|+|..++... ...+++..+++++.||++||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 78 ~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999999998754 34589999999999999999999999999999999999999999999999999987654432
Q ss_pred -cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 171 -ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 171 -~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
.....||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+....++...+......+.|..++.++.+||.+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 234678999999999999999999999999999999998 899999999999999998888888899999999999999
Q ss_pred HhccCCCCCCCHHHHhhC
Q 006460 249 MLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~h 266 (644)
||+.||.+|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=435.01 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=209.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----C
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-----G 85 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-----~ 85 (644)
.+++|+++++||+|+||+||+|+++.+|+.||||++...........++.+|+.+|++++|||||+++++|... .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 46899999999999999999999999999999999987766666677899999999999999999999998643 3
Q ss_pred ceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccc
Q 006460 86 NCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLL 165 (644)
Q Consensus 86 ~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~ 165 (644)
.++|+|||||.|+.+ ..+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++..
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~----~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSEEHH-HHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ceeEEEEeccchHHH-Hhh----hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 689999999966544 443 235899999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCCC-----------
Q 006460 166 NTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISPL----------- 234 (644)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~~----------- 234 (644)
.........+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+.......+......+.
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 776667778899999999999999999999999999999999999999998887666555432111100
Q ss_pred ------------------------------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 235 ------------------------------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 235 ------------------------------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
+...++++.+||++||.+||.+|||++|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 01236789999999999999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=433.09 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=215.1
Q ss_pred CeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC-----CceE
Q 006460 14 DYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK-----GNCV 88 (644)
Q Consensus 14 ~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~-----~~~~ 88 (644)
+|+.+++||+|+||+||+|+++.+|+.||||++..... .+.+|+++|++|+|||||+++++|... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 79999999999999999999999999999999976542 234699999999999999999998643 3468
Q ss_pred EEEEeccCCCCHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-CeEEeccCcccccc
Q 006460 89 CIVTGYCEGGDMAEIIKK-ARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLN 166 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~-~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-~vKL~DFGls~~~~ 166 (644)
|||||||.++.+..+... .....+++..++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999976544443332 2355799999999999999999999999999999999999999875 89999999999877
Q ss_pred cccccccccCCCCCCChhhhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccC---------------
Q 006460 167 TEDLASSVVGTPNYMCPELLAD-IPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSS--------------- 230 (644)
Q Consensus 167 ~~~~~~~~~GT~~Y~APEvl~~-~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~--------------- 230 (644)
......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||...+..+.+..+....
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 7677778899999999998765 568999999999999999999999999888777665553210
Q ss_pred ----CC---------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchhh
Q 006460 231 ----IS---------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPYL 273 (644)
Q Consensus 231 ----~~---------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~~ 273 (644)
.+ .....+++++.+||.+||.+||.+|||+.|+|+||||+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00 01234688999999999999999999999999999998654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=419.00 Aligned_cols=258 Identities=27% Similarity=0.475 Sum_probs=222.4
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEE
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LV 91 (644)
+++|+++++||+|+||+||+|+++.+++.||||+++..........++.+|+.+|+.++|||||+++++|.+ ...+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEE
Confidence 589999999999999999999999999999999998776666677889999999999999999999998876 5678999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc-c
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED-L 170 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~-~ 170 (644)
++++.|++|..++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... .
T Consensus 80 ~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999999988887764 4568999999999999999999999999999999999999999999999999998765433 3
Q ss_pred cccccCCCCCCChhhhcCCC-CCcccchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHhccC------------------
Q 006460 171 ASSVVGTPNYMCPELLADIP-YGYKSDIWSLGCCMFEIAAHQPA-FRAPDMAGLINKINRSS------------------ 230 (644)
Q Consensus 171 ~~~~~GT~~Y~APEvl~~~~-ys~ksDIWSLGvILyeLltG~~P-F~~~~~~el~~~i~~~~------------------ 230 (644)
.....+++.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 44556789999999987665 69999999999999999998877 56666666666553211
Q ss_pred ----------CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 231 ----------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 231 ----------~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
....+..+++.+.+||.+||+.||.+|||++|+|+||||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 111223468899999999999999999999999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=420.45 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=213.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCC---eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIER---KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
...++|++.+.||+|+||.||+|.+..++ ..||+|.++... .....+.+.+|+++|++++|||||++++++.+ .
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~ 80 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE--N 80 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 34579999999999999999999987654 568888876543 34456789999999999999999999998753 4
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 689999999999999988754 4569999999999999999999999999999999999999999999999999998765
Q ss_pred ccc--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHH
Q 006460 167 TED--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMK 243 (644)
Q Consensus 167 ~~~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~ 243 (644)
... ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+....++...+......+.|..+|+++.
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 432 2344678999999999999999999999999999999997 8999999999999999988888888999999999
Q ss_pred HHHHHHhccCCCCCCCHHHHhhC
Q 006460 244 QIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 244 dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+||.+||..||.+|||+.+|++|
T Consensus 240 ~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 240 SLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=414.56 Aligned_cols=254 Identities=21% Similarity=0.366 Sum_probs=216.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCC----eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIER----KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
....+.|++.+.||+|+||.||+|.++.++ ..||||++.... .+.....+.+|+++|++|+|||||++++++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 455678999999999999999999988765 479999996554 344456789999999999999999999998764
Q ss_pred CceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
...++|||||.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 82 -~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 -KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred -CceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 5589999999999999988764 45699999999999999999999999999999999999999999999999999987
Q ss_pred ccccc----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCcccc
Q 006460 165 LNTED----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYS 239 (644)
Q Consensus 165 ~~~~~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s 239 (644)
+.... ......||+.|||||++.+..|+.++|||||||++|||++ |.+||......+++..+..+...+.|..++
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence 64432 1223568999999999999999999999999999999998 567777788888888888888888888999
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 240 STMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 240 ~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
..+.+||.+||..||.+|||+.+|++
T Consensus 240 ~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=432.59 Aligned_cols=277 Identities=26% Similarity=0.450 Sum_probs=228.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEe---cCCeEEEEEEEecccc--cHHHHHHHHHHHHHHHhcCC-CCcceeeeEEE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHK---IERKKYVLKKIRLAKQ--TEKFKRTALQEMDLISKLNN-PYIVKYKDAWV 82 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k---~tg~~vAiK~i~~~~~--~~~~~~~~~rEi~iL~~L~H-PNIVkl~~~~~ 82 (644)
+..+++|++++.||+|+||.||+|.+. .+|+.||+|++++... .....+.+.+|+++|++++| |||+++++++.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 456799999999999999999999984 4689999999865432 22234567889999999976 89999999887
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcc
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLA 162 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls 162 (644)
+ ...+|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 ~-~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 100 T-ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp E-TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred c-CCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 7 457999999999999999998754 4889999999999999999999999999999999999999999999999999
Q ss_pred cccccc--cccccccCCCCCCChhhhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH---hccCCCCCC
Q 006460 163 KLLNTE--DLASSVVGTPNYMCPELLADI--PYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKI---NRSSISPLP 235 (644)
Q Consensus 163 ~~~~~~--~~~~~~~GT~~Y~APEvl~~~--~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i---~~~~~~~~p 235 (644)
+.+... ....+..|++.|+|||.+.+. .|+.++|||||||+||+|++|..||.+.........+ ......+.|
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence 875432 334567899999999998764 4688999999999999999999999776543332222 223445677
Q ss_pred ccccHHHHHHHHHHhccCCCCCC-----CHHHHhhCCCCchhhhhcCCCCCcccCCCc
Q 006460 236 IVYSSTMKQIIKSMLRKNPEHRP-----TASDLLRHPHLQPYLLRCQNPSSVYLPIKP 288 (644)
Q Consensus 236 ~~~s~~l~dLI~~~L~~dP~~Rp-----Ta~eiL~hp~f~~~~~~~~~~~~~~~p~~p 288 (644)
..+++++.+||.+||.+||.+|| |++|+|+||||+.+.+..........|++|
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p 314 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP 314 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCC
Confidence 78999999999999999999999 589999999998766554444445555554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-51 Score=420.42 Aligned_cols=256 Identities=21% Similarity=0.374 Sum_probs=220.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 9 KSKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 9 ~~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
....++|++.+.||+|+||.||+|.++.+ ..||||++...... .+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~ 86 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPI 86 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec--CCe
Confidence 35678999999999999999999998755 57999999766544 3568899999999999999999998754 347
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
|+|||||.+|+|..++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 89999999999999987655556999999999999999999999999999999999999999999999999999876443
Q ss_pred c--ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHH
Q 006460 169 D--LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQI 245 (644)
Q Consensus 169 ~--~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dL 245 (644)
. ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||......+++..+......+.+..+++++.+|
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 246 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHH
Confidence 3 2334678999999999999999999999999999999998 567778888888888888887778899999999999
Q ss_pred HHHHhccCCCCCCCHHHHhh--CCCCc
Q 006460 246 IKSMLRKNPEHRPTASDLLR--HPHLQ 270 (644)
Q Consensus 246 I~~~L~~dP~~RpTa~eiL~--hp~f~ 270 (644)
|.+||..||++|||+++|+. ++||.
T Consensus 247 i~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 247 MCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 99999999999999999987 67774
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.2e-51 Score=426.20 Aligned_cols=252 Identities=24% Similarity=0.449 Sum_probs=213.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeC-CceE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDK-GNCV 88 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~-~~~~ 88 (644)
..++|+++++||+|+||+||+|+++.+++.||||+++... .+.+.+|+.+|+++. ||||++++++|... ...+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 4578999999999999999999999999999999997543 356788999999995 99999999998753 4579
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC-CeEEeccCccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN-DIRLGDFGLAKLLNT 167 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g-~vKL~DFGls~~~~~ 167 (644)
|+|||||.+++|..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999987653 2499999999999999999999999999999999999999765 599999999998777
Q ss_pred ccccccccCCCCCCChhhhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhc-------------c---
Q 006460 168 EDLASSVVGTPNYMCPELLADI-PYGYKSDIWSLGCCMFEIAAHQPAFRAPDM-AGLINKINR-------------S--- 229 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~-~ys~ksDIWSLGvILyeLltG~~PF~~~~~-~el~~~i~~-------------~--- 229 (644)
.......+||+.|+|||++.+. .|+.++|||||||++|+|++|..||..... ......+.. .
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 6667788999999999998765 479999999999999999999999976542 222111110 0
Q ss_pred --------------------CCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 230 --------------------SISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 230 --------------------~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
........+++++.+||++||++||.+|||++|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0011223468899999999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=424.34 Aligned_cols=250 Identities=22% Similarity=0.412 Sum_probs=216.5
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCe----EEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERK----KYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~ 88 (644)
.+|++++.||+|+||.||+|.+..+|+ +||+|+++... .....+.+.+|+++|++++|||||+++++|.+. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Ce
Confidence 679999999999999999999988876 57888776432 233456789999999999999999999998763 36
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
+++|+|+.+++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 7889999999999988764 456999999999999999999999999999999999999999999999999999876443
Q ss_pred cc---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHH
Q 006460 169 DL---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQ 244 (644)
Q Consensus 169 ~~---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~d 244 (644)
.. .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..++...+..+...+.|..++.++.+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 22 234568999999999999999999999999999999998 89999998888888888888878888899999999
Q ss_pred HHHHHhccCCCCCCCHHHHhhC
Q 006460 245 IIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 245 LI~~~L~~dP~~RpTa~eiL~h 266 (644)
||.+||..||.+|||+.+|+.|
T Consensus 245 li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=426.26 Aligned_cols=255 Identities=28% Similarity=0.498 Sum_probs=211.4
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC----ceE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG----NCV 88 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~----~~~ 88 (644)
++|+++++||+|+||+||+|.++.+|+.||||+++... .....+.+++|+.+|++|+|||||++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 57999999999999999999999999999999997654 3455678899999999999999999999986532 335
Q ss_pred EEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccc
Q 006460 89 CIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTE 168 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~ 168 (644)
||+| |+.||+|.+++... .+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++......
T Consensus 87 ~l~~-~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVT-HLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEE-ECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEE-eecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 5555 55599999999753 4999999999999999999999999999999999999999999999999999865443
Q ss_pred c----ccccccCCCCCCChhhhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCC-----------
Q 006460 169 D----LASSVVGTPNYMCPELLA-DIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSIS----------- 232 (644)
Q Consensus 169 ~----~~~~~~GT~~Y~APEvl~-~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~----------- 232 (644)
. .....+||+.|+|||++. +..|+.++||||+||++|+|++|.+||.+.+..+...........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 245578999999999884 456799999999999999999999999888765554443221100
Q ss_pred -------------------CCCccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 233 -------------------PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 233 -------------------~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
.....++.++.+||.+||++||.+|||+.++|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0122457899999999999999999999999999999754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=416.78 Aligned_cols=249 Identities=21% Similarity=0.400 Sum_probs=216.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~ 89 (644)
..+++|+++++||+|+||.||+|.+ .|..||+|+++.... .+.+.+|+++|++++|||||++++++.+....+|
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 4678999999999999999999987 477999999976543 3567899999999999999999999877656689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccccc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~ 169 (644)
|||||+++|+|.+++.......+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999999999997655446899999999999999999999999999999999999999999999999999875443
Q ss_pred ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccCCCCCCccccHHHHHHHHH
Q 006460 170 LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSSISPLPIVYSSTMKQIIKS 248 (644)
Q Consensus 170 ~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI~~ 248 (644)
.....+|+.|+|||++.+..|+.++|||||||++|||++ |++||...+..++...+.....++.|..+++++.+||.+
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 445678999999999998899999999999999999998 899999999999999998888888999999999999999
Q ss_pred HhccCCCCCCCHHHHhhC
Q 006460 249 MLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 249 ~L~~dP~~RpTa~eiL~h 266 (644)
||..||.+|||+.+++++
T Consensus 236 cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcccCHhHCcCHHHHHHH
Confidence 999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=428.50 Aligned_cols=256 Identities=24% Similarity=0.411 Sum_probs=215.9
Q ss_pred CCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC----Cce
Q 006460 12 LEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK----GNC 87 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~----~~~ 87 (644)
-++|+++++||+|+||+||+|+++.+|+.||||+++.........+.+.+|+++|++|+|||||+++++|... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 3689999999999999999999999999999999987766666677899999999999999999999998632 223
Q ss_pred EEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCccccccc
Q 006460 88 VCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNT 167 (644)
Q Consensus 88 ~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~ 167 (644)
.+++|+|+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc
Confidence 4556667779999999853 3599999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccCCCCCCChhhhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHhccCCCC-------------
Q 006460 168 EDLASSVVGTPNYMCPELLADIP-YGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKINRSSISP------------- 233 (644)
Q Consensus 168 ~~~~~~~~GT~~Y~APEvl~~~~-ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~~~~~~~------------- 233 (644)
...+..||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+......+
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 345678999999999877654 6899999999999999999999999988776666653321111
Q ss_pred ---------C--------CccccHHHHHHHHHHhccCCCCCCCHHHHhhCCCCchh
Q 006460 234 ---------L--------PIVYSSTMKQIIKSMLRKNPEHRPTASDLLRHPHLQPY 272 (644)
Q Consensus 234 ---------~--------p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~hp~f~~~ 272 (644)
. ...+++++++||.+||..||.+|||+.|+|+||||+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0 12468899999999999999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-50 Score=414.32 Aligned_cols=255 Identities=22% Similarity=0.392 Sum_probs=211.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecC-----CeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIE-----RKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~t-----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~ 84 (644)
..++|++.++||+|+||.||+|.+... ++.||+|+++.... ....+.+.+|+.++.++ +|||||.+++++.+.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 457899999999999999999998654 46899999875443 33456778888888877 689999999998877
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK 150 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~ 150 (644)
+..+++|||||+||+|.+++.... ...+++..+..|+.||+.||.|||++|||||||||+||||+.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 778999999999999999997643 235889999999999999999999999999999999999999
Q ss_pred CCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhC-CCCCCCCC-hHHHHHH
Q 006460 151 DNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPD-MAGLINK 225 (644)
Q Consensus 151 ~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG-~~PF~~~~-~~el~~~ 225 (644)
++.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.. ...+...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999998654332 23456899999999999999999999999999999999986 57887765 4455566
Q ss_pred HhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 226 INRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 226 i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
+......+.|..+++++.+||.+||..||.+|||+.+|++|
T Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66777777888899999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=418.48 Aligned_cols=255 Identities=20% Similarity=0.369 Sum_probs=222.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeE--EEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeCCc
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKK--YVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~--vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~~~ 86 (644)
..+++|++.++||+|+||.||+|.++.++.. ||||++..... ....+.+.+|+++|+++ +|||||+++++|.+ +.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CC
Confidence 5678999999999999999999999999875 56676654332 23456789999999999 79999999999887 45
Q ss_pred eEEEEEeccCCCCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCC
Q 006460 87 CVCIVTGYCEGGDMAEIIKKA--------------RGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDN 152 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~--------------~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g 152 (644)
.+|+|||||+||+|.++|... ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 699999999999999999743 235799999999999999999999999999999999999999999
Q ss_pred CeEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHhccCC
Q 006460 153 DIRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSI 231 (644)
Q Consensus 153 ~vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG-~~PF~~~~~~el~~~i~~~~~ 231 (644)
.+||+|||+++............||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..++...+..+..
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 9999999999876655555567899999999999999999999999999999999996 578999999999999988878
Q ss_pred CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 232 SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 232 ~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
.+.|..+++++.+||.+||..||++|||+.+|+++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88888999999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-49 Score=411.38 Aligned_cols=254 Identities=21% Similarity=0.350 Sum_probs=223.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEec-----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKI-----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...++|++++.||+|+||.||+|+++. ++..||||++.... .....+.+.+|+.+|++++||||++++++|..
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~- 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV- 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc-
Confidence 345789999999999999999999864 46789999987543 34456789999999999999999999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR----------------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLK 142 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~----------------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLK 142 (644)
....++||||+.+|+|.+++.... ...+++..+..|+.||+.||.|||++||||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 456899999999999999997532 1247899999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhC-CCCCCCCC
Q 006460 143 CSNIFLTKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPD 218 (644)
Q Consensus 143 PeNILL~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG-~~PF~~~~ 218 (644)
|+||||+.++.+||+|||+++.+.... ...+..||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998654432 23456789999999999999999999999999999999998 47899999
Q ss_pred hHHHHHHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 219 MAGLINKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 219 ~~el~~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
..++...+.....++.|..+++++.+||.+||..+|.+|||+.+|++
T Consensus 248 ~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999988888889999999999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=408.23 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=220.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecCC-------eEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEE
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIER-------KKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWV 82 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~tg-------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~ 82 (644)
..++|++++.||+|+||.||+|++..++ ..||+|+++... .......+.+|+.++.++ +|||||+++++|.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 4589999999999999999999987654 479999997654 344456788999999988 7999999999987
Q ss_pred eCCceEEEEEeccCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE
Q 006460 83 DKGNCVCIVTGYCEGGDMAEIIKKAR--------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL 148 (644)
Q Consensus 83 d~~~~~~LVmEy~~GgsL~~~L~~~~--------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL 148 (644)
+ +..+|+|||||++|+|.++|.... ...+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 90 ~-~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 90 Q-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp S-SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred c-CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 6 456999999999999999997542 2358999999999999999999999999999999999999
Q ss_pred cCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 006460 149 TKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLIN 224 (644)
Q Consensus 149 ~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~ 224 (644)
+.++.+||+|||+++...... ......||+.|+|||.+.+..|+.++|||||||++|||++ |.+||.+.....+..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 999999999999999765432 2344678999999999999999999999999999999997 799999999999999
Q ss_pred HHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 225 KINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 225 ~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.+......+.|..+++++.+||.+||+.||.+|||+.+|++
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 98888888889999999999999999999999999999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=407.14 Aligned_cols=252 Identities=21% Similarity=0.362 Sum_probs=208.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEecC-C--eEEEEEEEecccc-cHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCc
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHKIE-R--KKYVLKKIRLAKQ-TEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGN 86 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k~t-g--~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~ 86 (644)
..++|++++.||+|+||.||+|.+... + ..||||++..... .....+.+.+|+++|++++|||||++++++.+ .
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~ 83 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--P 83 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--c
Confidence 457899999999999999999987644 2 4689999876532 23445789999999999999999999998854 3
Q ss_pred eEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccc
Q 006460 87 CVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLN 166 (644)
Q Consensus 87 ~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~ 166 (644)
.+++|||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 5789999999999999887643 459999999999999999999999999999999999999999999999999999764
Q ss_pred ccc----ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHhccC-CCCCCccccH
Q 006460 167 TED----LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGLINKINRSS-ISPLPIVYSS 240 (644)
Q Consensus 167 ~~~----~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el~~~i~~~~-~~~~p~~~s~ 240 (644)
... ......|++.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+....+.+.. ..+.+..+|+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence 332 2334567889999999999999999999999999999998 899999999999888886554 4566778999
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 241 TMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 241 ~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
++.+||.+||..||.+|||+.+|++
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=404.25 Aligned_cols=254 Identities=20% Similarity=0.361 Sum_probs=225.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEec-----CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeC
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKI-----ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDK 84 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~ 84 (644)
...++|++.++||+|+||.||+|.++. ++..||||+++... .......+.+|+.++++++|||||+++++|..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~- 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ- 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-
Confidence 456899999999999999999998864 35789999997654 34445678999999999999999999999866
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEE
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR--------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRL 156 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~--------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL 156 (644)
...+++|||||.+|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 456899999999999999987542 124688999999999999999999999999999999999999999999
Q ss_pred eccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHhccCCC
Q 006460 157 GDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAH-QPAFRAPDMAGLINKINRSSIS 232 (644)
Q Consensus 157 ~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG-~~PF~~~~~~el~~~i~~~~~~ 232 (644)
+|||+++.+.... ......||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..+.+..+..+...
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999998764432 23445789999999999999999999999999999999998 5899999999999999888888
Q ss_pred CCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 233 PLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 233 ~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
+.|..++..+.+||.+||+.||.+|||+.+|++
T Consensus 255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888999999999999999999999999999997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=400.59 Aligned_cols=249 Identities=19% Similarity=0.293 Sum_probs=210.9
Q ss_pred EEEEEeccCCCeEEEEEEEecCC---eEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 16 EVIEQIGRGAFGAAFLVLHKIER---KKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 16 ~i~~~LG~G~fG~Vyla~~k~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
.+.++||+|+||+||+|.+..++ ..||||+++... .....+.+.+|+++|++|+|||||++++++.+.+..+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 34678999999999999987653 368999986543 44556789999999999999999999999887777899999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEeccCcccccccccc--
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGDFGLAKLLNTEDL-- 170 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~DFGls~~~~~~~~-- 170 (644)
|||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999998753 44678889999999999999999999999999999999999999999999999987644322
Q ss_pred ---cccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCC-CCCChHHHHHHHhccCCCCCCccccHHHHHHH
Q 006460 171 ---ASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAF-RAPDMAGLINKINRSSISPLPIVYSSTMKQII 246 (644)
Q Consensus 171 ---~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF-~~~~~~el~~~i~~~~~~~~p~~~s~~l~dLI 246 (644)
.....||+.|+|||.+.+..|+.++|||||||++|||++|..|| ...+..++...+..+.....|..+++++.+||
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHH
Confidence 22356899999999999999999999999999999999965555 44555566777777777778888999999999
Q ss_pred HHHhccCCCCCCCHHHHhhC
Q 006460 247 KSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 247 ~~~L~~dP~~RpTa~eiL~h 266 (644)
.+||..||++|||+.||++|
T Consensus 268 ~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 268 LKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=398.93 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=218.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEEEEe-----cCCeEEEEEEEecccccHHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeC
Q 006460 11 KLEDYEVIEQIGRGAFGAAFLVLHK-----IERKKYVLKKIRLAKQTEKFKRTALQEMDLISKL-NNPYIVKYKDAWVDK 84 (644)
Q Consensus 11 ~~~~Y~i~~~LG~G~fG~Vyla~~k-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HPNIVkl~~~~~d~ 84 (644)
..++|++.++||+|+||.||+|.+. .+++.||||+++.... ......+.+|+.+++++ +|||||++++++.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~- 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTI- 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-
Confidence 3489999999999999999999875 3567899999976543 34456789999999999 69999999999876
Q ss_pred CceEEEEEeccCCCCHHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEE
Q 006460 85 GNCVCIVTGYCEGGDMAEIIKKAR----------------GACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFL 148 (644)
Q Consensus 85 ~~~~~LVmEy~~GgsL~~~L~~~~----------------~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL 148 (644)
...+|||||||+||+|.+++.... ...+++..+..|+.||+.||.|||++|||||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 456899999999999999998643 2258899999999999999999999999999999999999
Q ss_pred cCCCCeEEeccCccccccccc---ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHH-H
Q 006460 149 TKDNDIRLGDFGLAKLLNTED---LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAA-HQPAFRAPDMAGL-I 223 (644)
Q Consensus 149 ~~~g~vKL~DFGls~~~~~~~---~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLlt-G~~PF~~~~~~el-~ 223 (644)
+.++.+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++ |.+||......+. .
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999999765432 2344678999999999999999999999999999999998 7788877666544 4
Q ss_pred HHHhccCCCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 224 NKINRSSISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 224 ~~i~~~~~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
..+........|..++..+.+||.+||+.||.+|||+.+|++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 445556666677788999999999999999999999999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-46 Score=387.52 Aligned_cols=251 Identities=19% Similarity=0.248 Sum_probs=203.7
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCCceEEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKGNCVCIVT 92 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~~~~~LVm 92 (644)
++|++++.||+|+||.||+|+++.+++.||||++...... ..+.+|+++++.+.|+|+|..+..+...+..+++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4799999999999999999999999999999998765432 346779999999998887777666666678899999
Q ss_pred eccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC---CCCeEEeccCccccccccc
Q 006460 93 GYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK---DNDIRLGDFGLAKLLNTED 169 (644)
Q Consensus 93 Ey~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~---~g~vKL~DFGls~~~~~~~ 169 (644)
||+ +++|...+... ...+++..+..++.||+.||.|||++|||||||||+|||++. +..+||+|||+++.+....
T Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999 66777776653 456999999999999999999999999999999999999864 4569999999998764332
Q ss_pred --------ccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHh-------ccCCCCC
Q 006460 170 --------LASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMAGLINKIN-------RSSISPL 234 (644)
Q Consensus 170 --------~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~el~~~i~-------~~~~~~~ 234 (644)
.....+||+.|||||++.+..|+.++|||||||++|||++|.+||...........+. .......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 2345689999999999999999999999999999999999999998765443322221 1112223
Q ss_pred CccccHHHHHHHHHHhccCCCCCCCHHHH---hhCCCC
Q 006460 235 PIVYSSTMKQIIKSMLRKNPEHRPTASDL---LRHPHL 269 (644)
Q Consensus 235 p~~~s~~l~dLI~~~L~~dP~~RpTa~ei---L~hp~f 269 (644)
+..+|+++.+||.+||..+|.+||++.+| |+|+|.
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 45688999999999999999999999755 555543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.3e-45 Score=378.10 Aligned_cols=246 Identities=17% Similarity=0.220 Sum_probs=205.4
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeCCceEEEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN-PYIVKYKDAWVDKGNCVCIV 91 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H-PNIVkl~~~~~d~~~~~~LV 91 (644)
++|++.++||+|+||.||+|.+..+|+.||||++...... ..+.+|+++++.|.| +||+.+++++.. +...|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEE
Confidence 5899999999999999999999999999999998665432 245678899999975 899999988766 6679999
Q ss_pred EeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcC-----CCCeEEeccCcccccc
Q 006460 92 TGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTK-----DNDIRLGDFGLAKLLN 166 (644)
Q Consensus 92 mEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~-----~g~vKL~DFGls~~~~ 166 (644)
|||+ |++|.+++... +..+++..+..++.|++.||.|||++|||||||||+|||++. ++.+||+|||+++.+.
T Consensus 80 me~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9999 88999998764 456999999999999999999999999999999999999974 5689999999998754
Q ss_pred cc--------cccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHhc----cCC
Q 006460 167 TE--------DLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPD---MAGLINKINR----SSI 231 (644)
Q Consensus 167 ~~--------~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~---~~el~~~i~~----~~~ 231 (644)
.. ......+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.. .......+.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 32 12345689999999999999999999999999999999999999997644 2233333322 122
Q ss_pred CCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 232 SPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 232 ~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
..++..+|+++.+|+..|+..+|++||+++.+.+
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 2234567899999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=382.60 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=195.6
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcceeeeEEEeCC---ceEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIVKYKDAWVDKG---NCVC 89 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIVkl~~~~~d~~---~~~~ 89 (644)
.+|.+.++||+|+||.||+|++ +|+.||||+++..... .....+|+..+.+++|||||++++++.+.+ ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5799999999999999999985 6889999999654321 112234555566789999999999998654 3689
Q ss_pred EEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCccccCCCCcEEEcCCCCeEEeccCc
Q 006460 90 IVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS--------NRVLHRDLKCSNIFLTKDNDIRLGDFGL 161 (644)
Q Consensus 90 LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs--------~gIIHRDLKPeNILL~~~g~vKL~DFGl 161 (644)
+|||||++|+|.+++++. .+++..++.++.|++.||.|||+ +|||||||||+||||+.++.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999999863 48999999999999999999996 5999999999999999999999999999
Q ss_pred cccccccc-----ccccccCCCCCCChhhhcCCC------CCcccchhhHHHHHHHHHhCCCCCCCC-------------
Q 006460 162 AKLLNTED-----LASSVVGTPNYMCPELLADIP------YGYKSDIWSLGCCMFEIAAHQPAFRAP------------- 217 (644)
Q Consensus 162 s~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~------ys~ksDIWSLGvILyeLltG~~PF~~~------------- 217 (644)
++...... .....+||+.|+|||++.+.. |+.++|||||||+||||++|.+||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98764332 234568999999999987643 577999999999999999998877431
Q ss_pred --ChHHHHHHHhccCC-CCCCcc-----ccHHHHHHHHHHhccCCCCCCCHHHHhhC
Q 006460 218 --DMAGLINKINRSSI-SPLPIV-----YSSTMKQIIKSMLRKNPEHRPTASDLLRH 266 (644)
Q Consensus 218 --~~~el~~~i~~~~~-~~~p~~-----~s~~l~dLI~~~L~~dP~~RpTa~eiL~h 266 (644)
........+..... +..|.. ....+.+|+.+||+.||.+|||+.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22333333333332 333333 23468999999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-44 Score=376.95 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=200.3
Q ss_pred CCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-----------CCCcceeeeEE
Q 006460 13 EDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-----------NPYIVKYKDAW 81 (644)
Q Consensus 13 ~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HPNIVkl~~~~ 81 (644)
++|+++++||+|+||.||+|+++.+|+.||||+++... ...+.+.+|+++|+.+. |||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 36999999999999999999999999999999997543 33456788999988875 57899999988
Q ss_pred EeC-CceEEEEEeccCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcEEEcCCCC-----
Q 006460 82 VDK-GNCVCIVTGYCEGG-DMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHS-NRVLHRDLKCSNIFLTKDND----- 153 (644)
Q Consensus 82 ~d~-~~~~~LVmEy~~Gg-sL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs-~gIIHRDLKPeNILL~~~g~----- 153 (644)
... ....+++|.++.++ .............+++..++.++.||+.||.|||+ +||+||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 643 34566666665444 44444445556679999999999999999999998 89999999999999986653
Q ss_pred -eEEeccCcccccccccccccccCCCCCCChhhhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCChH------HHHHHH
Q 006460 154 -IRLGDFGLAKLLNTEDLASSVVGTPNYMCPELLADIPYGYKSDIWSLGCCMFEIAAHQPAFRAPDMA------GLINKI 226 (644)
Q Consensus 154 -vKL~DFGls~~~~~~~~~~~~~GT~~Y~APEvl~~~~ys~ksDIWSLGvILyeLltG~~PF~~~~~~------el~~~i 226 (644)
++|+|||.+..... .....+||+.|+|||++.+..|+.++||||+||++++|++|+.||...... ..+...
T Consensus 170 ~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 99999999986543 346678999999999999999999999999999999999999999754321 111110
Q ss_pred hc--------------------------cC---------------CCCCCccccHHHHHHHHHHhccCCCCCCCHHHHhh
Q 006460 227 NR--------------------------SS---------------ISPLPIVYSSTMKQIIKSMLRKNPEHRPTASDLLR 265 (644)
Q Consensus 227 ~~--------------------------~~---------------~~~~p~~~s~~l~dLI~~~L~~dP~~RpTa~eiL~ 265 (644)
.. .. ....+...++++.+||.+||.+||.+|||+.|+|+
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00 00112334678999999999999999999999999
Q ss_pred CCCCch
Q 006460 266 HPHLQP 271 (644)
Q Consensus 266 hp~f~~ 271 (644)
||||+.
T Consensus 328 Hp~f~~ 333 (362)
T d1q8ya_ 328 HPWLKD 333 (362)
T ss_dssp CGGGTT
T ss_pred CcccCC
Confidence 999984
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.7e-24 Score=208.54 Aligned_cols=164 Identities=18% Similarity=0.188 Sum_probs=122.8
Q ss_pred eEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccc----------------cHHHHHHHHHHHHHHHhcCCCCcceee
Q 006460 15 YEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQ----------------TEKFKRTALQEMDLISKLNNPYIVKYK 78 (644)
Q Consensus 15 Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~----------------~~~~~~~~~rEi~iL~~L~HPNIVkl~ 78 (644)
|.+.++||+|+||.||+|.+. +|+.||||+++.... .......+.+|+..|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999874 789999998754211 011233456789999999999999988
Q ss_pred eEEEeCCceEEEEEeccCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcEEEcCCCCeEEec
Q 006460 79 DAWVDKGNCVCIVTGYCEGGDMAEIIKKARGACFPEEKLCKWLTQLLLAVDYLHSNRVLHRDLKCSNIFLTKDNDIRLGD 158 (644)
Q Consensus 79 ~~~~d~~~~~~LVmEy~~GgsL~~~L~~~~~~~l~e~~i~~i~~QIL~gL~yLHs~gIIHRDLKPeNILL~~~g~vKL~D 158 (644)
++ . . .+++|||+++..+.. +++..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|
T Consensus 81 ~~--~-~--~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 81 AW--E-G--NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EE--E-T--TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred Ee--c-C--CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEE
Confidence 64 2 2 269999998765432 4556678899999999999999999999999999999854 599999
Q ss_pred cCcccccccccccccccCCCCCCCh------hhhcCCCCCcccchhhHHH
Q 006460 159 FGLAKLLNTEDLASSVVGTPNYMCP------ELLADIPYGYKSDIWSLGC 202 (644)
Q Consensus 159 FGls~~~~~~~~~~~~~GT~~Y~AP------Evl~~~~ys~ksDIWSLGv 202 (644)
||++.....+... .|... +.+ ...|+.++|+||+.-
T Consensus 146 FG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 146 FPQSVEVGEEGWR-------EILERDVRNIITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp CTTCEETTSTTHH-------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHH
T ss_pred CCCcccCCCCCcH-------HHHHHHHHHHHHHH-cCCCCCcccHHHHHH
Confidence 9999765433211 11111 111 356889999999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.12 E-value=4.4e-06 Score=81.03 Aligned_cols=89 Identities=12% Similarity=0.065 Sum_probs=60.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeCCceE
Q 006460 10 SKLEDYEVIEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLN-NPYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 10 ~~~~~Y~i~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HPNIVkl~~~~~d~~~~~ 88 (644)
..++.|+..+..+.|+.+.||++. ..+..+++|+........ ...+.+|..+|+.|. +=-+.+++.+..+ +...
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEec-CCce
Confidence 456789988886666667999874 456678889876543211 223566888887774 3234556665444 4568
Q ss_pred EEEEeccCCCCHHHH
Q 006460 89 CIVTGYCEGGDMAEI 103 (644)
Q Consensus 89 ~LVmEy~~GgsL~~~ 103 (644)
|+||++++|.++...
T Consensus 86 ~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 86 NLLMSEADGVLCSEE 100 (263)
T ss_dssp EEEEECCSSEEHHHH
T ss_pred EEEEEeccccccccc
Confidence 999999999877543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.58 E-value=7.9e-05 Score=77.60 Aligned_cols=79 Identities=13% Similarity=0.098 Sum_probs=48.2
Q ss_pred EEEeccCCCeEEEEEEEecCCeEEEEEEEeccc-c-c---HHHHHHHHHHHHHHHhcC-C-C-CcceeeeEEEeCCceEE
Q 006460 18 IEQIGRGAFGAAFLVLHKIERKKYVLKKIRLAK-Q-T---EKFKRTALQEMDLISKLN-N-P-YIVKYKDAWVDKGNCVC 89 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~tg~~vAiK~i~~~~-~-~---~~~~~~~~rEi~iL~~L~-H-P-NIVkl~~~~~d~~~~~~ 89 (644)
.+.||.|....||++....+++.+++|.-.... . . .....+..+|...|+.+. + | .+.+++. .+... .+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~-~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM-AV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT-TE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC-CE
Confidence 567999999999999988888899999754321 0 0 011234556888887663 2 3 3444543 34443 56
Q ss_pred EEEeccCCCC
Q 006460 90 IVTGYCEGGD 99 (644)
Q Consensus 90 LVmEy~~Ggs 99 (644)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 8999997754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.40 E-value=0.00015 Score=69.42 Aligned_cols=145 Identities=16% Similarity=0.093 Sum_probs=81.9
Q ss_pred CCCeEEEEEeccCC-CeEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC--CCcceeeeEEEeCCceE
Q 006460 12 LEDYEVIEQIGRGA-FGAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN--PYIVKYKDAWVDKGNCV 88 (644)
Q Consensus 12 ~~~Y~i~~~LG~G~-fG~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--PNIVkl~~~~~d~~~~~ 88 (644)
+..+.+.. +..|. -+.||++.. ..+..+++|....... ..+.+|+..|+.|.. -.+.+++.+..+ +...
T Consensus 10 l~g~~~~~-~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~ 81 (255)
T d1nd4a_ 10 LFGYDWAQ-QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTE-AGRD 81 (255)
T ss_dssp TTTCEEEE-CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCE
T ss_pred ccCCceEE-cCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeeccc-ccce
Confidence 34455543 44454 468898864 4566788887655432 234567777776632 235556665444 4568
Q ss_pred EEEEeccCCCCHHH--------------HHHHhcC-----CCCC--HHHHHH-H---H----------------HHHHHH
Q 006460 89 CIVTGYCEGGDMAE--------------IIKKARG-----ACFP--EEKLCK-W---L----------------TQLLLA 127 (644)
Q Consensus 89 ~LVmEy~~GgsL~~--------------~L~~~~~-----~~l~--e~~i~~-i---~----------------~QIL~g 127 (644)
++||++++|.++.. .+.+... ..+. ...... . . ......
T Consensus 82 ~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 82 WLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp EEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred EEEEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 89999998865421 1111110 0000 000000 0 0 011223
Q ss_pred HHHHHHC-------CCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 128 VDYLHSN-------RVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 128 L~yLHs~-------gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
+..+... .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 3444432 279999999999999766677999998754
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=96.85 E-value=6.2e-05 Score=64.68 Aligned_cols=85 Identities=13% Similarity=0.063 Sum_probs=63.2
Q ss_pred cCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccccccccc-cccccc
Q 006460 359 VDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDV-ETVKSK 437 (644)
Q Consensus 359 ~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 437 (644)
+|++|.| ||.||+..+-- +..+++.++.+|+..+. |.+|+++.+|+.++..-.+.....+-+..| .+++.-
T Consensus 18 ~d~dG~i-df~EF~~~~~~--~~~~~~~~~~~F~~~D~-----d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~ 89 (109)
T d1pvaa_ 18 VKAEGSF-NHKKFFALVGL--KAMSANDVKKVFKAIDA-----DASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAA 89 (109)
T ss_dssp TCSTTCC-CHHHHHHHHTC--TTSCHHHHHHHHHHHCT-----TCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHH
T ss_pred cCCCCCC-cHHHHHHHHHH--ccCCHHHHHHHhhCccC-----CCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHH
Confidence 5788999 99999876532 23356789999999999 999999999999987654332223322222 247888
Q ss_pred CCCCCchhhhhhhhcc
Q 006460 438 DQNPFSDRVIEEADIE 453 (644)
Q Consensus 438 ~~~~~~~~~~~~~~~~ 453 (644)
|.| .|++|++.||.
T Consensus 90 D~d--~dG~I~~~EF~ 103 (109)
T d1pvaa_ 90 DKD--GDGKIGIDEFE 103 (109)
T ss_dssp CTT--CSSSBCHHHHH
T ss_pred CCC--CcCcEeHHHHH
Confidence 888 99999999986
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=96.68 E-value=8.7e-05 Score=63.70 Aligned_cols=85 Identities=8% Similarity=0.041 Sum_probs=61.7
Q ss_pred cCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccccccccc-cccccc
Q 006460 359 VDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDV-ETVKSK 437 (644)
Q Consensus 359 ~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 437 (644)
++.+|.| ||.||+... . .+..+++.++.+|+..++ |.+|+++.+||..++.-.+..-..+.+..| ++++.-
T Consensus 18 ~~~~G~i-df~eF~~~~-~-~~~~~~~~l~~~F~~~D~-----d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~ 89 (109)
T d5pala_ 18 FKDPGTF-DYKRFFHLV-G-LKGKTDAQVKEVFEILDK-----DQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAG 89 (109)
T ss_dssp TCSTTCC-CHHHHHHHH-T-CTTCCHHHHHHHHHHHCT-----TCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHH
T ss_pred cCCCCcC-cHHHHHHHH-H-hcCCCHHHHHHHHhhhcC-----CCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHh
Confidence 4677999 999998654 3 234467899999999999 999999999999886433222122222111 247888
Q ss_pred CCCCCchhhhhhhhcc
Q 006460 438 DQNPFSDRVIEEADIE 453 (644)
Q Consensus 438 ~~~~~~~~~~~~~~~~ 453 (644)
|.| .|+.|++.||-
T Consensus 90 D~d--~dG~I~~~EF~ 103 (109)
T d5pala_ 90 DSD--HDGKIGADEFA 103 (109)
T ss_dssp CTT--CSSSEEHHHHH
T ss_pred CCC--CCCCEeHHHHH
Confidence 888 99999998885
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=96.37 E-value=0.00017 Score=66.75 Aligned_cols=119 Identities=10% Similarity=0.083 Sum_probs=93.1
Q ss_pred hhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccC
Q 006460 323 NVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFN 396 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~ 396 (644)
.++.++.+..+.++..++. ....+....+.++...|.+++|+| +|.+|+...........++.++.+|.....
T Consensus 15 ~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d~~~~g~i-~~~ef~~~~~~~~~~~~~e~l~~aF~~~D~ 93 (182)
T d1s6ia_ 15 LFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTI-DYGEFIAATVHLNKLEREENLVSAFSYFDK 93 (182)
T ss_dssp HHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEE-CHHHHHHHHTTSSSSCCCCSTHHHHHHTTT
T ss_pred HHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhhccccccc-hHHHHHHHHHhhcccccHHHHHHHHHHHhh
Confidence 3455566666555554441 123345667899999999999999 999999999888888889999999998888
Q ss_pred CccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 397 GSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.+++++..++.+++.-.++.-..+++ +++.-|.+ .|+.|++.||.
T Consensus 94 -----d~~G~i~~~el~~~l~~~gl~~~ev~~----~f~~~D~d--~DG~Is~~EF~ 139 (182)
T d1s6ia_ 94 -----DGSGYITLDEIQQACKDFGLDDIHIDD----MIKEIDQD--NDGQIDYGEFA 139 (182)
T ss_dssp -----TCSSEEEHHHHHHTTTTTTCCTTHHHH----HHHHHCSS--SSSEEETTHHH
T ss_pred -----cCCCccchhhhhhhhhhcCccHHHHHH----HHHHhhcC--CCCeEeHHHHH
Confidence 889999999999998766654444443 37788888 89999999997
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=96.01 E-value=8.2e-05 Score=64.29 Aligned_cols=116 Identities=9% Similarity=-0.024 Sum_probs=81.8
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccc---cccccccccccccc
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERST---QTETSDCSRDKQAH 394 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~---~~~~~~l~~af~~~ 394 (644)
++.++.+.++.++..++. ..+.....++.++...|.+++|+| ++.||+........ ...+..++.+|++.
T Consensus 6 F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i-~~~Ef~~~~~~~~~~~~~~~~~~~~~~F~~~ 84 (134)
T d1jfja_ 6 FKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEI-DQNEFAKFYGSIQGQDLSDDKIGLKVLYKLM 84 (134)
T ss_dssp HHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEE-EHHHHHHHTTCSSCCSSHHHHHHHHHHHHHH
T ss_pred HHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhhcccccc-ccccccccccccccccccccccccccccccc
Confidence 455566666555554442 233455677889999999999999 99999876543222 22345678899888
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+ |.+++++.+++...++..+. ..+.+ .+...|.| .|+.|.+.||-
T Consensus 85 D~-----~~~g~i~~~el~~~~~~~~~--~~~~~----~~~~~D~d--~dG~is~~EF~ 130 (134)
T d1jfja_ 85 DV-----DGDGKLTKEEVTSFFKKHGI--EKVAE----QVMKADAN--GDGYITLEEFL 130 (134)
T ss_dssp CC-----SSSSEEEHHHHHHHHTTTTC--HHHHH----HHHHHHCS--SSSEEEHHHHH
T ss_pred cc-----ccCCcccHHHHHHHHHhcCc--HHHHH----HHHHHCCC--CCCCCCHHHHH
Confidence 77 88899999999999765542 23333 47778888 89999888874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.85 E-value=0.019 Score=58.74 Aligned_cols=74 Identities=20% Similarity=0.212 Sum_probs=48.1
Q ss_pred EEEeccCCCeEEEEEEEec-------CCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCCCCcc-eeeeEEEeCCceEE
Q 006460 18 IEQIGRGAFGAAFLVLHKI-------ERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNNPYIV-KYKDAWVDKGNCVC 89 (644)
Q Consensus 18 ~~~LG~G~fG~Vyla~~k~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HPNIV-kl~~~~~d~~~~~~ 89 (644)
++.|+.|-.-.+|++.... .+..|++++.... ... ....+|..+++.+.-.+++ ++++++ .+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~---idr~~E~~i~~~ls~~gl~Pkll~~~--~~---g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE---SHLVAESVIFTLLSERHLGPKLYGIF--SG---G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH---HHHHHHHHHHHHHHHTTSSSCEEEEE--TT---E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chh---hHHHHHHHHHHHHHhCCCCCeEEEEc--CC---c
Confidence 4678889999999998753 2456777776532 222 2345788888888533444 565543 23 4
Q ss_pred EEEeccCCCCH
Q 006460 90 IVTGYCEGGDM 100 (644)
Q Consensus 90 LVmEy~~GgsL 100 (644)
+|++|++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987543
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.82 E-value=0.00047 Score=64.27 Aligned_cols=99 Identities=10% Similarity=0.015 Sum_probs=74.5
Q ss_pred CchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccc
Q 006460 347 STSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPA 426 (644)
Q Consensus 347 s~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (644)
....+.+|...|.|++|.| ||.||+.+.........++.++.+|+.++. |+++.++.+++.+..+.........
T Consensus 62 ~~~~~~if~~~D~~~~G~I-~f~EF~~~~~~~~~~~~~~~l~~~F~~~D~-----d~~G~is~~E~~~~~~~~~~~~~~~ 135 (201)
T d1omra_ 62 KAYAQHVFRSFDANSDGTL-DFKEYVIALHMTSAGKTNQKLEWAFSLYDV-----DGNGTISKNEVLEIVTAIFKMISPE 135 (201)
T ss_dssp HHHHHHHHHTTTSCSSSEE-EHHHHHHHHHHHHSSCGGGSHHHHHHHHCT-----TCSSSBCHHHHHHHHHHHHTTSCHH
T ss_pred HHHHHHHHHHhccCCCCeE-eehhHHHHHHhhcccchHHHHHHHHHHHcc-----CCCCccCHHHHHHHHHHHHhhcChh
Confidence 3445789999999999999 999999988777777788899999999998 9999999999988765433322111
Q ss_pred ------------cccccccccccCCCCCchhhhhhhhcc
Q 006460 427 ------------EEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 427 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
++.-=.+.+.-|.| -|+.|++.||-
T Consensus 136 ~~~~~~~~~~~~~~~~~~if~~~D~d--~dG~Is~~EF~ 172 (201)
T d1omra_ 136 DTKHLPEDENTPEKRAEKIWGFFGKK--DDDKLTEKEFI 172 (201)
T ss_dssp HHTTSCGGGSSHHHHHHHHHHHTTCC--TTCCBCHHHHH
T ss_pred hhhhhhhhhccHHHHHHHHHHHhCCC--CCCCCcHHHHH
Confidence 11101235566777 88999888874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.66 E-value=0.025 Score=56.27 Aligned_cols=68 Identities=19% Similarity=0.278 Sum_probs=41.4
Q ss_pred eEEEEEEEecCCeEEEEEEEecccccHHHHHHHHHHHHHHHhcCC---C--Ccceee-eEEEeCCceEEEEEeccCCC
Q 006460 27 GAAFLVLHKIERKKYVLKKIRLAKQTEKFKRTALQEMDLISKLNN---P--YIVKYK-DAWVDKGNCVCIVTGYCEGG 98 (644)
Q Consensus 27 G~Vyla~~k~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H---P--NIVkl~-~~~~d~~~~~~LVmEy~~Gg 98 (644)
-.||++.. .+|..|++|+.+...... +.+..|...|..|.. | ..+..- +.....+...+.+++++.|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 57999865 467889999997764432 345567777777631 1 111111 11112245678899999773
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=95.63 E-value=0.00076 Score=57.34 Aligned_cols=94 Identities=7% Similarity=0.043 Sum_probs=67.5
Q ss_pred chhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccccc
Q 006460 348 TSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAE 427 (644)
Q Consensus 348 ~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (644)
.++..++...+.+ |.| ||.||+....-. ..+.+.++.+|+..++ |.+++++.+++....+..+....++.
T Consensus 8 ~di~~~~~~~~~~--gsi-~~~eF~~~~~l~--~~~~~~l~~~F~~~D~-----d~~G~I~~~el~~~l~~l~~~~~~~~ 77 (107)
T d2pvba_ 8 ADVAAALAACSAA--DSF-KHKEFFAKVGLA--SKSLDDVKKAFYVIDQ-----DKSGFIEEDELKLFLQNFSPSARALT 77 (107)
T ss_dssp HHHHHHHHHTCST--TCC-CHHHHHHHHTGG--GSCHHHHHHHHHHHCT-----TCSSSBCHHHHHTGGGGTCTTSCCCC
T ss_pred HHHHHHHHhccCC--CCc-CHHHHHHHHhcc--cCCHHHHHHHHHhhcc-----CCCCcCcHHHHHHHHHHhhcccccCC
Confidence 4455555555444 568 999999876532 2356789999999999 99999999999998766554333333
Q ss_pred cccc-ccccccCCCCCchhhhhhhhcc
Q 006460 428 EIDV-ETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 428 ~~~~-~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+..+ ++++..|.+ .|+.|++.||.
T Consensus 78 ~~~~~~l~~~~D~d--~dG~I~~~EF~ 102 (107)
T d2pvba_ 78 DAETKAFLADGDKD--GDGMIGVDEFA 102 (107)
T ss_dssp HHHHHHHHHHHCTT--CSSSBCHHHHH
T ss_pred HHHHHHHHHHhCCC--CCCcEeHHHHH
Confidence 2222 247888999 99999998885
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.54 E-value=0.00047 Score=60.77 Aligned_cols=120 Identities=7% Similarity=0.058 Sum_probs=79.4
Q ss_pred hhhhHhhhccccccCcCCC------CCCCCCchhhccccccccC--CCCccccccchhhhccc---cccccccccccccc
Q 006460 323 NVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVD--PTSYTMEVSSSINDSKE---RSTQTETSDCSRDK 391 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D--~nG~i~d~~efi~a~~d---~s~~~~~~~l~~af 391 (644)
.+..++.+..+.++..++. .-..+...+...+...+.| ++|.| +|.||+..... .....+.+.+..||
T Consensus 9 ~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d~~~~g~i-~~~eF~~~~~~~~~~~~~~~~~~l~~aF 87 (145)
T d2mysc_ 9 AFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAI-TFEEFLPMLQAAANNKDQGTFEDFVEGL 87 (145)
T ss_pred HHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhcccccCcc-chhHHHHHHhhhhhccccchHHHHHHHH
Confidence 3555666666666665552 1122445566777766666 46889 99999776543 23344666788999
Q ss_pred ccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 392 QAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+..++ |.+|+++.+++.+++...|.... +..++-+-..|.+ .|+.|+|.||-
T Consensus 88 ~~~D~-----d~~G~I~~~el~~~l~~~g~~~~---~~e~~~l~~~~~d--~dG~I~y~eF~ 139 (145)
T d2mysc_ 88 RVFDK-----EGNGTVMGAELRHVLATLGEKMT---EEEVEELMKGQED--SNGCINYEAFV 139 (145)
T ss_pred HHhhc-----CCCCEEcHHHHHHHHHHhCCCCC---HHHHHHHHhhcCC--CCCeEEHHHHH
Confidence 99988 99999999999999866664332 2222222234666 78999998874
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=95.35 E-value=0.001 Score=61.58 Aligned_cols=101 Identities=14% Similarity=0.002 Sum_probs=77.1
Q ss_pred CCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccC--
Q 006460 345 TSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAH-- 422 (644)
Q Consensus 345 ~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 422 (644)
..+..++.+|...|.|++|+| |+.||+.+......-..++.++.+|+.++. |.++.++.+|+..........
T Consensus 60 ~~~~~~~~if~~~D~~~~G~I-~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D~-----d~dG~is~~E~~~~~~~~~~~~~ 133 (190)
T d1fpwa_ 60 SPEDFANHLFTVFDKDNNGFI-HFEEFITVLSTTSRGTLEEKLSWAFELYDL-----NHDGYITFDEMLTIVASVYKMMG 133 (190)
T ss_dssp CCSHHHHHHHHTCCSSCSSEE-CHHHHHHHHHHHSCCCSTHHHHHHHHHHCS-----SCSSEEEHHHHHHHHHHHHTTSC
T ss_pred ChHHHHHHHHHHhCcCCCCcc-cHHHHHHHHHHHccCchHHHHHHHHHHhcc-----CCCCcCcHHHHHHHHHHHHHhcc
Confidence 345557889999999999999 999999998766666778899999999988 999999999998875332211
Q ss_pred --------cccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 --------VQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
-..+++.--.+.+..|.| .|+.|++.||.
T Consensus 134 ~~~~~~~~~~~~~~~v~~if~~~D~d--~dG~Is~~EF~ 170 (190)
T d1fpwa_ 134 SMVTLNEDEATPEMRVKKIFKLMDKN--EDGYITLDEFR 170 (190)
T ss_dssp STTSSSCCCCCHHHHHHHHHHHHTTT--CSSEEEHHHHH
T ss_pred cccCCCchhhhHHHHHHHHHHHhCCC--CCCcCcHHHHH
Confidence 111122212356777888 99999999987
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.24 E-value=0.034 Score=54.44 Aligned_cols=31 Identities=35% Similarity=0.344 Sum_probs=27.0
Q ss_pred CCCccccCCCCcEEEcCCCCeEEeccCcccc
Q 006460 134 NRVLHRDLKCSNIFLTKDNDIRLGDFGLAKL 164 (644)
Q Consensus 134 ~gIIHRDLKPeNILL~~~g~vKL~DFGls~~ 164 (644)
.|+||+|+.+.||+++.+...-|+||+.++.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999877778999998753
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.11 E-value=0.00063 Score=62.82 Aligned_cols=102 Identities=11% Similarity=0.004 Sum_probs=75.1
Q ss_pred CCCCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccccc--
Q 006460 344 PTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADA-- 421 (644)
Q Consensus 344 ~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 421 (644)
+.+...++.+|...|.|++|.| ||.||+.+.........++.++.+|+.++. |..+.++.+++.........
T Consensus 54 ~~~~~~~~~lf~~~D~d~dG~I-~f~Ef~~~l~~~~~~~~~~~~~~~F~~~D~-----d~~g~i~~~E~~~~~~~~~~~~ 127 (189)
T d1jbaa_ 54 EEATQYVEAMFRAFDTNGDNTI-DFLEYVAALNLVLRGTLEHKLKWTFKIYDK-----DRNGCIDRQELLDIVESIYKLK 127 (189)
T ss_dssp STTHHHHHHHHHHHCCSSSSEE-CHHHHHHHHHHHSSCCCTHHHHHHHHHHCS-----SCSSCBCHHHHHHHHHHHHHHH
T ss_pred CccHHHHHHHHHHhccCCCCeE-eehhHHHHHHhhcccchHHHHHHHHhhhcc-----CCCCcccHhHHHHHHHHHHHhh
Confidence 3445667899999999999999 999999999887777778889999999888 88899999998876432110
Q ss_pred -------------CcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 422 -------------HVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 422 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.....++.--.+.+.-|.| .|+.|++.||-
T Consensus 128 ~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d--~dG~Is~~EF~ 170 (189)
T d1jbaa_ 128 KACSVEVEAEQQGKLLTPEEVVDRIFLLVDEN--GDGQLSLNEFV 170 (189)
T ss_dssp HHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCS--CCSCBCHHHHH
T ss_pred ccccccchhhhhccccchHHHHHHHHHHhCCC--CCCcEeHHHHH
Confidence 0001111101246667777 88999888886
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.06 E-value=0.00066 Score=59.99 Aligned_cols=121 Identities=10% Similarity=0.051 Sum_probs=81.2
Q ss_pred hhhhHhhhccccccCcCCCCC---CCCCchhhccccccccCCCCccccccchhhhcccc-cccccccccccccccccCCc
Q 006460 323 NVRSVAKNIAVQLNNLPLDDK---PTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQAHFNGS 398 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~~~---~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~~~~~~ 398 (644)
.+..++.+..+.++..++... .......+..+...+.+.+|.| +|.+|+.....+ +....++.+..||+..++
T Consensus 12 ~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~g~i-~~~eF~~~~~~~~~~~~~~~~l~~aF~~fD~-- 88 (145)
T d2mysb_ 12 AFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEASGPI-NFTVFLTMFGEKLKGADPEDVIMGAFKVLDP-- 88 (145)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHHHHHHHHHhccCce-eechhhhhhhhcccccchHHHHHHHHHhhhh--
Confidence 355566666666555554211 0011112234455666788999 999999987664 334456679999999988
Q ss_pred cCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 399 TGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.+++++.+++.+++...|..... +|+ -+++..-|.+ .|+.|+|.+|-
T Consensus 89 ---~~~g~I~~~el~~~l~~~g~~ls~-~e~-~~~~~~~d~d--~dg~I~y~eF~ 136 (145)
T d2mysb_ 89 ---DGKGSIKKSFLEELLTTGGGRFTP-EEI-KNMWAAFPPD--VAGNVDYKNIC 136 (145)
T ss_pred ---cccchhhHHHHHHHHHHcCCCCCH-HHH-HHHHHHhCCC--CCCeEeHHHHH
Confidence 999999999999998777754322 111 1347777888 89999998885
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.41 E-value=0.0013 Score=58.83 Aligned_cols=122 Identities=12% Similarity=0.116 Sum_probs=90.9
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccc----cccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERS----TQTETSDCSRDK 391 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s----~~~~~~~l~~af 391 (644)
+.++.++.+..+.++..++. ........+..++...|.+++|.+ ++.||+...+... ....++.++.+|
T Consensus 24 ~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~e~~~~~~~~~~~~~~~~~~~~~~~aF 102 (162)
T d1topa_ 24 AAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI-DFEEFLVMMVRQMKEDAKGKSEEELANCF 102 (162)
T ss_dssp HHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEE-EHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheeccCCCCCe-eeehhhhhhhhhhhhhcccCcHHHHHHHH
Confidence 44667788888888877762 334456677889999999999999 9999988876543 233556778899
Q ss_pred ccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 392 QAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+..+. |.+++++.+++.+++...+..... +++ -.++..-|.+ .|+.|.+.||.
T Consensus 103 ~~~D~-----d~~G~Is~~e~~~~l~~~~~~~~~-~~~-~~l~~~~D~d--~dG~Is~~EF~ 155 (162)
T d1topa_ 103 RIFDK-----NADGFIDIEELGEILRATGEHVTE-EDI-EDLMKDSDKN--NDGRIDFDEFL 155 (162)
T ss_dssp HHHCT-----TCSSCBCHHHHHHHHHTTTCCCCH-HHH-HHHHHHHCTT--CSSSBCHHHHH
T ss_pred HHHCC-----CCCCCCcHHHHHHHHHhhCCCCCH-HHH-HHHHHHhCCC--CCCcEEHHHHH
Confidence 99888 999999999999998777655432 221 1246677777 88999888875
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.40 E-value=0.0029 Score=53.58 Aligned_cols=86 Identities=10% Similarity=0.075 Sum_probs=63.1
Q ss_pred ccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccccccccc-ccccc
Q 006460 358 KVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDV-ETVKS 436 (644)
Q Consensus 358 d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 436 (644)
+++..|.+ +|.+|+....-.. .+.+.++.+|...++ |.+|+++.+++.+.....+....++.+..+ .++..
T Consensus 17 ~~~~~~s~-~~~~F~~~~~~~~--~~~~~l~~~F~~~D~-----d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~ 88 (108)
T d1rroa_ 17 ECQDPDTF-EPQKFFQTSGLSK--MSASQVKDIFRFIDN-----DQSGYLDGDELKYFLQKFQSDARELTESETKSLMDA 88 (108)
T ss_dssp HTCSTTCC-CHHHHHHHHSGGG--SCHHHHHHHHHHHCT-----TCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHH
T ss_pred hcccCCCc-cHHHHHHHHccCc--CCHHHHHHHHhhhcC-----CCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHH
Confidence 44566777 8999987654322 355789999999999 999999999999997655443333322222 24788
Q ss_pred cCCCCCchhhhhhhhcc
Q 006460 437 KDQNPFSDRVIEEADIE 453 (644)
Q Consensus 437 ~~~~~~~~~~~~~~~~~ 453 (644)
.|.| .|+.|++.||.
T Consensus 89 ~D~d--~dG~I~~~EF~ 103 (108)
T d1rroa_ 89 ADND--GDGKIGADEFQ 103 (108)
T ss_dssp HCCS--SSSSEEHHHHH
T ss_pred hCCC--CCCeEeHHHHH
Confidence 8999 99999999986
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=94.39 E-value=0.00063 Score=59.70 Aligned_cols=120 Identities=11% Similarity=0.112 Sum_probs=87.3
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccc-ccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERS-TQTETSDCSRDKQAH 394 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s-~~~~~~~l~~af~~~ 394 (644)
+.+..++.+..+.++..++. ....+...+..++...|.+++|.| +|.||+......- .....+.++.+|+..
T Consensus 13 ~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i-~~~ef~~~~~~~~~~~~~~~~~~~~F~~~ 91 (146)
T d1exra_ 13 EAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI-DFPEFLSLMARKMKEQDSEEELIEAFKVF 91 (146)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSE-EHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCCCCCCcc-cHHHHHHHHHHHhhccChHHHHHHHHHHh
Confidence 34566677777766655552 223345667889999999999999 9999998764322 233567888899988
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. |.+++++.+++...+...+..+. .++ .+++.-|.+ .|+.|++.||-
T Consensus 92 D~-----d~~G~i~~~e~~~~l~~~~~~~~~~~~~----~i~~~~D~d--~dG~i~~~eF~ 141 (146)
T d1exra_ 92 DR-----DGNGLISAAELRHVMTNLGEKLTDDEVD----EMIREADID--GDGHINYEEFV 141 (146)
T ss_dssp ST-----TCSSCBCHHHHHHHHHHTTCCCCHHHHH----HHHHHHCSS--SSSSBCHHHHH
T ss_pred CC-----CCCCcCCHHHHHHHHHHHhhcCCHHHHH----HHHHHhCCC--CCCeEeHHHHH
Confidence 88 89999999999999877775443 222 347777888 88999888774
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.37 E-value=0.0021 Score=55.77 Aligned_cols=119 Identities=9% Similarity=0.023 Sum_probs=77.0
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhcccccccc--CCCCccccccchhhhcccc---cccccccccccccc
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKV--DPTSYTMEVSSSINDSKER---STQTETSDCSRDKQ 392 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~--D~nG~i~d~~efi~a~~d~---s~~~~~~~l~~af~ 392 (644)
+..++.+..+.++..++. .-..+..++...+...+. +++|.| ||.+|+...... ......+.+..||+
T Consensus 6 F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~~~~~~~~~i-~~~ef~~~~~~~~~~~~~~~~~~l~~aF~ 84 (139)
T d1w7jb1 6 FELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRV-DFETFLPMLQAVAKNRGQGTYEDYLEGFR 84 (139)
T ss_dssp HHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEE-EHHHHHHHHHHHCC--------CCHHHHH
T ss_pred HHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHhcccccCCce-eeeccchhhHhhhhhccccHHHHHHHhhh
Confidence 455666666666665542 122334556667666664 467889 999997766433 23345567889999
Q ss_pred cccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 393 AHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..++ |.+++++.+++.+++...|... .+..++.+...|.+ .|+.|+|.||-
T Consensus 85 ~~D~-----d~~G~I~~~el~~~l~~~g~~~---~~~e~~~l~~~~~d--~dg~I~~~eF~ 135 (139)
T d1w7jb1 85 VFDK-----EGNGKVMGAELRHVLTTLGEKM---TEEEVETVLAGHED--SNGCINYEAFL 135 (139)
T ss_dssp TTCT-----TSSSEEEHHHHHHHHHHSSSCC---CHHHHHHHHTTCCC--TTSEEEHHHHH
T ss_pred hccC-----CCCCeEeHHHHHHHHHHhCCCC---CHHHHHHHHhhCCC--CCCeEeHHHHH
Confidence 9998 9999999999999986666433 23334445555666 78999998885
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.34 E-value=0.0013 Score=59.99 Aligned_cols=100 Identities=13% Similarity=-0.001 Sum_probs=76.0
Q ss_pred CchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccc-ccCc--
Q 006460 347 STSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA-DAHV-- 423 (644)
Q Consensus 347 s~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-- 423 (644)
...++.++...|.+++|+| +|.||+.+....+....++.++-+|+.++. |..+.++.+++....... ....
T Consensus 58 ~~~~~~lf~~~d~~~~g~i-~~~eFl~~~~~~~~~~~~~~~~~~f~~~D~-----d~dg~i~~~E~~~~~~~~~~~~~~~ 131 (181)
T d1bjfa_ 58 SKFAEHVFRTFDANGDGTI-DFREFIIALSVTSRGKLEQKLKWAFSMYDL-----DGNGYISKAEMLEIVQAIYKMVSSV 131 (181)
T ss_dssp HHHHHHHHHHHCSSCSSEE-EHHHHHHHHHHHTSSCHHHHHHHHHHHHCT-----TCSSCEEHHHHHHHHHHHHTTCCCT
T ss_pred HHHHHHHHHhcCCCCCCcE-eHHHHHHHHHHHhhhchHHHHHHHHHHhcc-----CCCCeecHHHHHHHHHHHhhhcccc
Confidence 3456889999999999999 999999999888888888899999999988 889999999988885422 1111
Q ss_pred -------ccccccccccccccCCCCCchhhhhhhhccc
Q 006460 424 -------QPAEEIDVETVKSKDQNPFSDRVIEEADIEG 454 (644)
Q Consensus 424 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (644)
...++.==.++...|.| .||+|++.||.+
T Consensus 132 ~~~~~~~~~~~~~~~~if~~~D~d--~dG~Is~~EF~~ 167 (181)
T d1bjfa_ 132 MKMPEDESTPEKRTEKIFRQMDTN--RDGKLSLEEFIR 167 (181)
T ss_dssp TTSCGGGSSHHHHHHHHHHHSCTT--CSSEECHHHHHH
T ss_pred ccCCcccccHHHHHHHHHHHhCCC--CCCcEeHHHHHH
Confidence 11111101236777888 999999999973
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=94.21 E-value=0.0015 Score=60.15 Aligned_cols=91 Identities=7% Similarity=-0.038 Sum_probs=72.0
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQP 425 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (644)
+...+..++...|.|++|.| +|.||+..... ...+..+|+.+++ |.+++++.+++.++.+..+.....
T Consensus 59 s~~~~~~l~~~~D~d~~G~I-~~~EF~~~~~~------~~~~~~~F~~~D~-----d~sG~I~~~El~~~l~~~g~~~~~ 126 (186)
T d1df0a1 59 SIETCKIMVDMLDEDGSGKL-GLKEFYILWTK------IQKYQKIYREIDV-----DRSGTMNSYEMRKALEEAGFKLPC 126 (186)
T ss_dssp CHHHHHHHHHHHCCSSSSEE-CHHHHHHHHHH------HHHHHHHHHHHCT-----TCCSCEEGGGHHHHHHHTTEECCH
T ss_pred CHHHHHHHHHHHcCCCCCcc-cHHHHHHHHHh------HHHHHHHHHhhCC-----CCCCcccHHHHHHHHHHHHhcccH
Confidence 44556888899999999999 99999987644 2567889999999 999999999999998777765442
Q ss_pred ccccccccccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.-++.+...|.+ -|+.|++.||-
T Consensus 127 ---~~~~~~~~~d~d--~dg~I~f~eFi 149 (186)
T d1df0a1 127 ---QLHQVIVARFAD--DELIIDFDNFV 149 (186)
T ss_dssp ---HHHHHHHHHHCC--STTEECHHHHH
T ss_pred ---HHHHHHHHHHcC--CCCeEeHHHHH
Confidence 223456667777 78999888873
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.06 E-value=0.0021 Score=59.13 Aligned_cols=96 Identities=9% Similarity=0.017 Sum_probs=67.7
Q ss_pred hhccccccccC-CCCccccccchhhhccccc-ccccccccccccccccCCccCCCCchhhhhhhhhhhcccc-----c--
Q 006460 350 TEDNLETKKVD-PTSYTMEVSSSINDSKERS-TQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA-----D-- 420 (644)
Q Consensus 350 ~ed~~~~~d~D-~nG~i~d~~efi~a~~d~s-~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-- 420 (644)
++.++...|.+ ++|.| ++.|||.+.-..+ .-..++.++.||+.++. |.+|+++.++|.+..... +
T Consensus 59 ~~rif~~fd~~~~~g~I-~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~-----d~~G~I~~~el~~~l~~~~~~~~~~~ 132 (180)
T d1xo5a_ 59 KERICRVFSTSPAKDSL-SFEDFLDLLSVFSDTATPDIKSHYAFRIFDF-----DDDGTLNREDLSRLVNCLTGEGEDTR 132 (180)
T ss_dssp HHHHHHHHCCSTTCCEE-CHHHHHHHHHHHSTTSCHHHHHHHHHHHHCT-----TCSSSBCHHHHHHHHHHHC------C
T ss_pred HHHHHHhccCCCCCCcC-cHHHHHHHHHHHhhcCCHHHHHHHhhccccC-----CCCCeeeHHHHHHHHHHHHhcccccc
Confidence 56778888887 57999 9999998864433 22446789999999998 999999999999975432 1
Q ss_pred cCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 421 AHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.....+++.=-.+...-|.| .|+.|.+.||.
T Consensus 133 ~~~~~~~~~v~~~~~~~D~d--~dG~Is~~EF~ 163 (180)
T d1xo5a_ 133 LSASEMKQLIDNILEESDID--RDGTINLSEFQ 163 (180)
T ss_dssp CCCTTHHHHHHHHHHHHCTT--CSSSBCHHHHH
T ss_pred ccHHHHHHHHHHHHHHhCCC--CCCcCcHHHHH
Confidence 11222222201135566878 89999988886
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=94.04 E-value=0.0028 Score=58.95 Aligned_cols=91 Identities=9% Similarity=-0.062 Sum_probs=68.4
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQP 425 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (644)
+...++.++...|.|++|.| +|.||...... ...++.+|+.+++ |.+|.++.+|+..+....|.++.
T Consensus 61 s~e~~~~li~~~D~d~~G~i-~~~EF~~l~~~------~~~~~~~F~~~D~-----d~sG~i~~~El~~~l~~~g~~~~- 127 (188)
T d1qxpa2 61 SLESCRSMVNLMDRDGNGKL-GLVEFNILWNR------IRNYLTIFRKFDL-----DKSGSMSAYEMRMAIEAAGFKLP- 127 (188)
T ss_dssp CHHHHHHHHHHHCC--CCCC-CSSSHHHHHHH------HHHHHHHHGGGCT-----TCCSCCBHHHHHHHHHHTTEECC-
T ss_pred CHHHHHHHHHHhcCCCCCcc-cHHHHHHHHhh------hHHHHHHHHHhCC-----CCCCEECHHHHHHHHHHhhhcCC-
Confidence 44556888999999999999 99999876532 2578889999999 99999999999999887776653
Q ss_pred ccccccccccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+.-++.+-..+.+ .|+.|++.+|-
T Consensus 128 --~~~~~~l~~~~~~--~dg~i~f~eFi 151 (188)
T d1qxpa2 128 --CQLHQVIVARFAD--DELIIDFDNFV 151 (188)
T ss_dssp --HHHHHHHHHHTSC--SSSBCCHHHHH
T ss_pred --HHHHHHHHHHhcC--CCCcCCHHHHH
Confidence 2223445555655 78888887773
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=94.02 E-value=0.0032 Score=53.37 Aligned_cols=92 Identities=8% Similarity=0.058 Sum_probs=65.3
Q ss_pred hhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccccccc
Q 006460 350 TEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEI 429 (644)
Q Consensus 350 ~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (644)
++..+.+ ++.+|.| ||.||+....-++ .+++.++.+|...++ |.+++++.+++.....-.+.....+.+.
T Consensus 11 i~~~~~~--~~~~~~i-~f~eF~~~~~~~~--~~~~~~~~~F~~~D~-----d~~G~I~~~El~~~l~~l~~~~~~~~~~ 80 (109)
T d1rwya_ 11 IKKAIGA--FTAADSF-DHKKFFQMVGLKK--KSADDVKKVFHILDK-----DKSGFIEEDELGSILKGFSSDARDLSAK 80 (109)
T ss_dssp HHHHHHT--TCSTTCC-CHHHHHHHHTGGG--SCHHHHHHHHHHHST-----TCSSEECHHHHHTHHHHHCTTCCCCCHH
T ss_pred HHHHHHh--cccCCCc-CHHHHHHHHcccc--CCHHHHHHHhhcccC-----CCCCcCcHHHHHHHHHHhccccccCCHH
Confidence 3344443 3566888 9999988764333 356889999999999 9999999999999875444333333222
Q ss_pred c-cccccccCCCCCchhhhhhhhcc
Q 006460 430 D-VETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 430 ~-~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
. -.++..-|.| .|++|++.||-
T Consensus 81 e~~~~~~~~D~d--~dG~i~~~EF~ 103 (109)
T d1rwya_ 81 ETKTLMAAGDKD--GDGKIGVEEFS 103 (109)
T ss_dssp HHHHHHHHHCTT--CSSSEEHHHHH
T ss_pred HHHHHHHHhCCC--CCCeEeHHHHH
Confidence 1 1357788888 99999998885
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=94.01 E-value=0.0012 Score=58.11 Aligned_cols=113 Identities=5% Similarity=0.011 Sum_probs=74.1
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccc-cccccccccccccccccC
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKER-STQTETSDCSRDKQAHFN 396 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~-s~~~~~~~l~~af~~~~~ 396 (644)
+..++.+..+.++..++. .-..+..+++..+ -+++|.| +|.+|+.....+ ....+++.+..||+..++
T Consensus 13 F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~----~~~~~~i-~~~eF~~~~~~~~~~~~~~~~l~~aF~~~D~ 87 (142)
T d1wdcb_ 13 FSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAML----KEAPGPL-NFTMFLSIFSDKLSGTDSEETIRNAFAMFDE 87 (142)
T ss_dssp HHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHH----TTSSSCC-CHHHHHHHHHHHTCSCCCHHHHHHHHHTTCT
T ss_pred HHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHH----HhccCcc-ccccccccccccccccchhhhHHHhhhhhcc
Confidence 334455555555444441 1122334444444 3677999 999999987654 333457889999999998
Q ss_pred CccCCCCchhhhhhhhhhhccccccCcc--cccccccccccccCCCCCchhhhhhhhcc
Q 006460 397 GSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.+++++.+++.+++.-.|.... .+++ ++..-|.+ ++.|+|.||-
T Consensus 88 -----d~~G~I~~~el~~~l~~~g~~lt~~e~~~----l~~~~d~~---~G~I~y~eF~ 134 (142)
T d1wdcb_ 88 -----QETKKLNIEYIKDLLENMGDNFNKDEMRM----TFKEAPVE---GGKFDYVKFT 134 (142)
T ss_dssp -----TCCSCEEHHHHHHHHHHSSSCCCHHHHHH----HHHHCCEE---TTEECHHHHH
T ss_pred -----cCCCcccHHHHHHHHHHccccCCHHHHHH----HHHHhCCC---CCEEcHHHHH
Confidence 99999999999999876664332 2333 35555544 5889998885
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=93.78 E-value=0.0046 Score=54.71 Aligned_cols=96 Identities=8% Similarity=-0.014 Sum_probs=67.4
Q ss_pred chhhccccccccCCCCccccccchhhhcccc--cccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccc
Q 006460 348 TSTEDNLETKKVDPTSYTMEVSSSINDSKER--STQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQP 425 (644)
Q Consensus 348 ~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~--s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (644)
.+++.+ ...+.+++|.| +|.||+...... ....+.+.+..||+..++ |.+++++.+++..++...|..+.
T Consensus 45 ~e~~~~-~~~~~~~~~~i-~~~eFl~~~~~~~~~~~~~~~~l~~aF~~~D~-----~~~G~I~~~el~~~l~~~g~~ls- 116 (152)
T d1wdcc_ 45 EDVFAV-GGTHKMGEKSL-PFEEFLPAYEGLMDCEQGTFADYMEAFKTFDR-----EGQGFISGAELRHVLTALGERLS- 116 (152)
T ss_dssp HHHHHT-TCCSSTTSCEE-CHHHHHHHHHHHTTSCCCCHHHHHHHHHTTCS-----SSSSEEEHHHHHHHHHHSSSCCC-
T ss_pred hhhhhh-hhhhccccccc-cccccccccccccccchhHHHhhhhhhhcccc-----ccCccchHHHHHHHHHHcCCCCC-
Confidence 344444 44677888999 999999866432 334566779999999998 99999999999999877665443
Q ss_pred ccccccc-cccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVE-TVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+..++ +++..|.+.-.++.|+|.+|-
T Consensus 117 --~~e~~~l~~~~d~~~d~~G~I~y~eF~ 143 (152)
T d1wdcc_ 117 --DEDVDEIIKLTDLQEDLEGNVKYEDFV 143 (152)
T ss_dssp --HHHHHHHHHHHTCCCCTTSEEEHHHHH
T ss_pred --HHHHHHHHHHhccCCCCCCEEEHHHHH
Confidence 22222 255545442256789998885
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=93.63 E-value=0.0028 Score=51.60 Aligned_cols=55 Identities=9% Similarity=0.119 Sum_probs=43.4
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKE 377 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d 377 (644)
..++.++++..+.++..++. ....+..++++++..+|.|++|+| +|.|||++++|
T Consensus 27 ~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I-~~~EFl~am~h 87 (87)
T d1s6ja_ 27 ELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTI-DYGEFIAATVH 87 (87)
T ss_dssp THHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEE-CHHHHTTCCCC
T ss_pred HHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeE-eHHHHHHHHcC
Confidence 34677777777777766663 233466788999999999999999 99999999876
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=93.34 E-value=0.0023 Score=58.51 Aligned_cols=98 Identities=8% Similarity=-0.021 Sum_probs=70.5
Q ss_pred chhhccccccccCCCCccccccchhhhccccc-ccccccccccccccccCCccCCCCchhhhhhhhhhhcccc----ccC
Q 006460 348 TSTEDNLETKKVDPTSYTMEVSSSINDSKERS-TQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPA----DAH 422 (644)
Q Consensus 348 ~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s-~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 422 (644)
...+.++...|.|++|.| +|.||+.+..... ....++.++.+|+.++. |++|.++.+++.+..... +..
T Consensus 54 ~~~~~lf~~~d~~~dg~I-~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~-----d~~G~Is~~e~~~~~~~~~~~~~~~ 127 (183)
T d2zfda1 54 LFADRVFDLFDTKHNGIL-GFEEFARALSVFHPNAPIDDKIHFSFQLYDL-----KQQGFIERQEVKQMVVATLAESGMN 127 (183)
T ss_dssp HHHHHHHHHHCSSCSSSB-CHHHHHHHHHHTSTTSCHHHHHHHHHHHHCT-----TSSSSEEHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHccCCCCcC-cHHHHHHHHHhhhccCcHHHHHHHhhccccc-----CCCCCccHHHHHHHHHHHHhhhhcc
Confidence 356789999999999999 9999998763332 33446789999999998 999999999999875432 111
Q ss_pred c--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 V--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
. ..+++.=-.+....|.+ .|+.|++.||.
T Consensus 128 ~~~~~~~~~~~~if~~~D~d--~dG~Is~~EF~ 158 (183)
T d2zfda1 128 LKDTVIEDIIDKTFEEADTK--HDGKIDKEEWR 158 (183)
T ss_dssp CCHHHHHHHHHHHHHHHCSS--CSSEECHHHHH
T ss_pred cchHHHHHHHHHHHHHhCCC--CCCeEcHHHHH
Confidence 1 11111111245667888 99999999996
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.33 E-value=0.002 Score=59.23 Aligned_cols=99 Identities=14% Similarity=-0.005 Sum_probs=73.3
Q ss_pred chhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhcccccc------
Q 006460 348 TSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADA------ 421 (644)
Q Consensus 348 ~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 421 (644)
..++.++...|.+++|.| |+.||+.+.........++.++.+|+.++. |..+.++.+|+.........
T Consensus 60 ~~~~~if~~~d~~~dg~I-~~~EF~~~l~~~~~~~~~e~l~~~F~~~D~-----d~dG~i~~~El~~~~~~~~~~~~~~~ 133 (187)
T d1g8ia_ 60 KFATFVFNVFDENKDGRI-EFSEFIQALSVTSRGTLDEKLRWAFKLYDL-----DNDGYITRNEMLDIVDAIYQMVGNTV 133 (187)
T ss_dssp HHHHHHHHHHCTTCSSEE-EHHHHHHHHHHHHHCCHHHHHHHHHHHHCT-----TCSSEEEHHHHHHHHHHHHHHC----
T ss_pred HHHHHHHHHhCcCCCCCC-cHHHHHHHHHHhccCchhhhHHHHHHHHhc-----CCCCeEcHHHHHHHHHHHhhhhcccc
Confidence 345778899999999999 999999988776666677889999999998 99999999999887432110
Q ss_pred ----CcccccccccccccccCCCCCchhhhhhhhccc
Q 006460 422 ----HVQPAEEIDVETVKSKDQNPFSDRVIEEADIEG 454 (644)
Q Consensus 422 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (644)
.....++.==.+.+.-|.| .||+|++.||.+
T Consensus 134 ~~~~~~~~~~~~v~~if~~~D~d--~dG~Is~~EF~~ 168 (187)
T d1g8ia_ 134 ELPEEENTPEKRVDRIFAMMDKN--ADGKLTLQEFQE 168 (187)
T ss_dssp -CCGGGSSHHHHHHHHHHHHCSS--CSSEEEHHHHHH
T ss_pred cCchhhccHHHHHHHHHHHhCCC--CCCcEeHHHHHH
Confidence 0111111101246777888 899999988873
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.59 E-value=0.0035 Score=54.16 Aligned_cols=120 Identities=8% Similarity=0.111 Sum_probs=86.8
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccc-cccccccccccccccC
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERST-QTETSDCSRDKQAHFN 396 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~-~~~~~~l~~af~~~~~ 396 (644)
+..++.+..+.++..++. ....+......++...|.+++|.| ++.||+........ ....+.+..+|....+
T Consensus 12 F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i-~~~ef~~~~~~~~~~~~~~~~l~~~f~~~d~ 90 (141)
T d2obha1 12 FDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKM-NFGDFLTVMTQKMSEKDTKEEILKAFKLFDD 90 (141)
T ss_dssp HHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEE-EHHHHHHHHHHHHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhccCCCCee-chHHHHHHHHHHHhhhccHHHHHHHHHHhcc
Confidence 455666777776666552 234455667788899999999999 99999988754322 3346778899998888
Q ss_pred CccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 397 GSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+.++.++.+++++++...+..+..- |+ -.++..-|.| .||.|++.||-
T Consensus 91 -----~~~G~i~~~el~~~l~~~g~~l~~~-e~-~~l~~~~D~d--~dG~i~~~EF~ 138 (141)
T d2obha1 91 -----DETGKISFKNLKRVAKELGENLTDE-EL-QEMIDEADRD--GDGEVSEQEFL 138 (141)
T ss_dssp -----TCSSSBCHHHHHHHHHHTTCCCCHH-HH-HHHHHHHCTT--SSSSBCHHHHH
T ss_pred -----cCCCCccHHHHHHHHHHhCCCCCHH-HH-HHHHHHHCCC--CCCCEeHHHHH
Confidence 8899999999999987776544321 11 1246777777 88999888874
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.36 E-value=0.0049 Score=54.46 Aligned_cols=120 Identities=10% Similarity=0.087 Sum_probs=80.4
Q ss_pred hhhHhhh-ccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcc----cccccccccccccccc
Q 006460 324 VRSVAKN-IAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSK----ERSTQTETSDCSRDKQ 392 (644)
Q Consensus 324 ~~~~~~n-~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~----d~s~~~~~~~l~~af~ 392 (644)
+..++.. ..+.++..++. ....+...+..++...+.++.|.+ .+.+|..... ......+++.++.+|+
T Consensus 20 F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~ 98 (156)
T d1dtla_ 20 FDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTV-DFDEFLVMMVRSMKDDSKGKSEEELSDLFR 98 (156)
T ss_dssp HHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSB-CHHHHHHHHHHHHC-----CHHHHHHHHHH
T ss_pred HHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhhccCCCcc-chhhhhhhhhhcccccccccHHHHHHHHHH
Confidence 4455555 34555554431 233455667888889999999998 7777775433 2333456678889999
Q ss_pred cccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 393 AHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..++ |.+++++.+++.+++...+.....- |+ -.++..-|.+ .|+.|++.||-
T Consensus 99 ~~D~-----d~~G~I~~~e~~~~~~~~~~~ls~~-e~-~~i~~~~D~d--~dG~I~~~eF~ 150 (156)
T d1dtla_ 99 MFDK-----NADGYIDLEELKIMLQATGETITED-DI-EELMKDGDKN--NDGRIDYDEFL 150 (156)
T ss_dssp HHCT-----TCSSEEEHHHHGGGGTTC--CCCHH-HH-HHHHHHHCTT--SSSEEEHHHHH
T ss_pred HhCc-----CCCCcCcHHHHHHHHhhcCCCCCHH-HH-HHHHHHhCCC--CCCeEeHHHHH
Confidence 9999 9999999999999987776544321 11 2347777888 89999998874
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=92.23 E-value=0.0035 Score=56.81 Aligned_cols=101 Identities=9% Similarity=-0.046 Sum_probs=72.5
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccC---
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAH--- 422 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 422 (644)
.+..++.++...|.|++|+| ++.||+.+..-.+....++.++.+|+.++. |..+.++.+++...+......
T Consensus 49 ~~~~~~~lf~~~D~~~~g~I-~~~EFl~~~~~~~~~~~~~~~~~~f~~~D~-----~~~g~i~~~e~~~~~~~~~~~~~~ 122 (178)
T d1s6ca_ 49 ASTYAHYLFNAFDTTQTGSV-KFEDFVTALSILLRGTVHEKLRWTFNLYDI-----NKDGYINKEEMMDIVKAIYDMMGK 122 (178)
T ss_dssp CHHHHHHHHHHHCTTCSSCE-EHHHHHHHHHHHHHCCHHHHHHHHHHHHCT-----TCSSCEEHHHHHHHHHHHHHHTC-
T ss_pred HHHHHHHHHHHHCCCCCCcc-cHHHHHHHHHHHhccchHHHHHHHHHhhcc-----CCCCeecHHHHHHHHHHHHhhccc
Confidence 34456889999999999999 999999988766666777889999999877 888899988887654221110
Q ss_pred -------cccccccccccccccCCCCCchhhhhhhhccc
Q 006460 423 -------VQPAEEIDVETVKSKDQNPFSDRVIEEADIEG 454 (644)
Q Consensus 423 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (644)
....++.--.+.+.-|.| .||.|.+.||..
T Consensus 123 ~~~~~~~~~~~~~~~~~if~~~D~d--~DG~Is~~EF~~ 159 (178)
T d1s6ca_ 123 YTYPVLKEDTPRQHVDVFFQKMDKN--KDGIVTLDEFLE 159 (178)
T ss_dssp ----------CHHHHHHHHHHHCTT--CSSEECHHHHHH
T ss_pred ccccCCcHHHHHHHHHHHHHHhCCC--CCCcEeHHHHHH
Confidence 011111101245666778 999999999983
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.18 E-value=0.0061 Score=55.36 Aligned_cols=86 Identities=10% Similarity=-0.026 Sum_probs=64.7
Q ss_pred chhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccc--
Q 006460 348 TSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQP-- 425 (644)
Q Consensus 348 ~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 425 (644)
..+..++...|.|++|.| +|.||+..... ...++.+|+.+++ |.+++++.+|+.++....|..+..
T Consensus 40 ~~~~~li~~~D~~~~G~i-~~~EF~~l~~~------~~~~~~~F~~fD~-----d~sG~I~~~El~~~l~~~G~~l~~~~ 107 (165)
T d1k94a_ 40 ETCRIMIAMLDRDHTGKM-GFNAFKELWAA------LNAWKENFMTVDQ-----DGSGTVEHHELRQAIGLMGYRLSPQT 107 (165)
T ss_dssp HHHHHHHHHHCTTCSSCB-CHHHHHHHHHH------HHHHHHHHHHHCT-----TCCSBCCHHHHHHHHHHTTCCCCHHH
T ss_pred HHHHHHHHHhCCCCCCcC-cHHHHHHHhhc------cchhHHHHHHhCC-----CCCCeEcHHHHHHHHHHhhhcCCHHH
Confidence 446778888999999999 99999886532 3578899999999 999999999999998877765432
Q ss_pred ccccccccccccCCCCCchhhhhhhhcc
Q 006460 426 AEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+++. +..-|. |++|++.||-
T Consensus 108 ~~~l----~~~~d~----~g~i~~~eFi 127 (165)
T d1k94a_ 108 LTTI----VKRYSK----NGRIFFDDYV 127 (165)
T ss_dssp HHHH----HHHHCB----TTBCBHHHHH
T ss_pred HHHH----HHHcCC----CCcCcHHHHH
Confidence 2222 333343 4778777773
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.84 E-value=0.003 Score=56.71 Aligned_cols=124 Identities=9% Similarity=0.033 Sum_probs=83.5
Q ss_pred hhhhhHhhhccccccCcCCCCC--CCCCchhhccccccccCCCCccccccchhhhccccccc-ccccccccccccccCCc
Q 006460 322 ENVRSVAKNIAVQLNNLPLDDK--PTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQ-TETSDCSRDKQAHFNGS 398 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~~~--~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~-~~~~~l~~af~~~~~~~ 398 (644)
..++.++++..+.++..++..- ......++.++...|.+++|+| +|.||+........- ...+.+..+|.....
T Consensus 20 ~~F~~~D~d~~G~I~~~E~~~~~~~~~~~~~~~l~~~~d~~~~g~i-~~~EFl~~~~~~~~~~~~~~~~~~~f~~~d~-- 96 (165)
T d1auib_ 20 KRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQRVIDIFDTDGNGEV-DFKEFIEGVSQFSVKGDKEQKLRFAFRIYDM-- 96 (165)
T ss_dssp HHHHHHCTTCCSEECHHHHTTSHHHHTCTTHHHHHHHHCTTCSSSE-EHHHHHHHHGGGCTTCCHHHHHHHHHHHHCT--
T ss_pred HHHHHHCCCCCCCCcHHHHHHhhhccCCHHHHHHHHHHccccchhh-hhhhhhhhccccccchhhHHHHHHHHHHhcc--
Confidence 4456677777777776665321 1223346789999999999999 999999887664332 233457778887777
Q ss_pred cCCCCchhhhhhhhhhhcccc-ccCc--ccccccccccccccCCCCCchhhhhhhhcc
Q 006460 399 TGSDLTSEITANSQNEIQEPA-DAHV--QPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|.+++++.+++.+..... +... .+.++.=-.++...|.+ .|+.|++.||.
T Consensus 97 ---d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~--~dG~Is~~EF~ 149 (165)
T d1auib_ 97 ---DKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKD--GDGRISFEEFC 149 (165)
T ss_dssp ---TCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTT--SSSSEEHHHHH
T ss_pred ---cccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCC--CCCcEeHHHHH
Confidence 889999999999875332 2111 11122101356677888 89999988886
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=91.70 E-value=0.011 Score=51.71 Aligned_cols=120 Identities=12% Similarity=0.088 Sum_probs=78.2
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhcccc-ccccCCCCccccccchhhhcccc------cccccccccccc
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLE-TKKVDPTSYTMEVSSSINDSKER------STQTETSDCSRD 390 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~-~~d~D~nG~i~d~~efi~a~~d~------s~~~~~~~l~~a 390 (644)
++.++.+..+.++..++. .-..+..+++.++. ..+.+.+|+| ++.+|+...... ..-...+.+..|
T Consensus 8 F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~~~~~~~~~i-~~~ef~~~~~~~~~~~~~~~~~~~~~l~~~ 86 (146)
T d1m45a_ 8 FTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSL-TLDQITGLIEVNEKELDATTKAKTEDFVKA 86 (146)
T ss_dssp HHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEE-EHHHHHHHHHHTHHHHHGGGCCCTHHHHHH
T ss_pred HHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhcccccccccccc-ccchhhhhhhhhcccccccccchHHHHHHH
Confidence 555666666666655542 11223455667664 4556667888 899998875332 222345678889
Q ss_pred cccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 391 KQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 391 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|+..+. |.+++++.+++.+++.-.|..+.. +|+ -+++..-|.+ .|+.|+|.||-
T Consensus 87 F~~~D~-----~~~G~I~~~el~~~l~~~g~~l~~-~ei-~~l~~~~D~d--~dG~I~y~eF~ 140 (146)
T d1m45a_ 87 FQVFDK-----ESTGKVSVGDLRYMLTGLGEKLTD-AEV-DELLKGVEVD--SNGEIDYKKFI 140 (146)
T ss_dssp HHTTCS-----SSSSEEEHHHHHHHHHHSTTCCCH-HHH-HHHHTTCCCC--TTSEEEHHHHH
T ss_pred HHhhcc-----ccccccchhhhhhhhcccCCcchH-HHH-HHHHHHhCCC--CCCcEEHHHHH
Confidence 998888 889999999999998766654321 111 2357778888 99999998884
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=91.63 E-value=0.0061 Score=55.69 Aligned_cols=117 Identities=11% Similarity=-0.007 Sum_probs=81.1
Q ss_pred hhhhhhHhhhccccccCcCCC-------CCCCCCchhhccccccccCCCCccccccchhhhccccccccccccccccccc
Q 006460 321 LENVRSVAKNIAVQLNNLPLD-------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQA 393 (644)
Q Consensus 321 le~~~~~~~n~~~q~~~~~~~-------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~ 393 (644)
...+..++.+..+.++..++. ..+.+....+.++...|.|++|.| +|.||+...... ..++.+|+.
T Consensus 22 ~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i-~~~EFl~~~~~~------~~~~~~f~~ 94 (181)
T d1hqva_ 22 WNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGV-NFSEFTGVWKYI------TDWQNVFRT 94 (181)
T ss_dssp HHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSB-CHHHHHHHHHHH------HHHHHHHHH
T ss_pred HHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccch-hhhHHHhhhhhc------ccccccccc
Confidence 345677777777777766652 223455677889999999999999 999999876542 456778888
Q ss_pred ccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 394 HFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
..+ +.++.++.+++.+++.-.+.+... ++. -+++...|.+ .|+.|.+.||-
T Consensus 95 ~D~-----~~~G~i~~~el~~~l~~~~~~l~~-e~~-~~~~~~~d~~--~dg~Is~~eF~ 145 (181)
T d1hqva_ 95 YDR-----DNSGMIDKNELKQALSGFGYRLSD-QFH-DILIRKFDRQ--GRGQIAFDDFI 145 (181)
T ss_dssp HCT-----TCCSSBCHHHHHHHHHHHTBCCCH-HHH-HHHHHHHCSS--CSSCBCHHHHH
T ss_pred ccc-----cccchhhhHHHHHHHHHcCCcchh-HHH-HHHHHHhCCC--CCCcCcHHHHH
Confidence 777 788999999999986554433211 111 1235666666 77888776663
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=90.60 E-value=0.0074 Score=55.17 Aligned_cols=116 Identities=11% Similarity=0.028 Sum_probs=82.1
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccccccccccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHF 395 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~ 395 (644)
+.+..++.+..+.++..++. .-..+...++.++...|.|++|.| +|.||+..... ...++.+|+.++
T Consensus 22 ~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d~d~~~~i-~~~ef~~~~~~------~~~~~~~F~~~D 94 (182)
T d1y1xa_ 22 EWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEI-TFDEFKDLHHF------ILSMREGFRKRD 94 (182)
T ss_dssp HHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSB-CHHHHHHHHHH------HHHHHHHHHHHC
T ss_pred HHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhccccccccccc-ccccccccccc------ccccccchhccc
Confidence 34566777777777666652 123455667888999999999999 99999876533 245667787776
Q ss_pred CCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 396 NGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
. +.++.++.+++.+.+...|..... +++ -.+++..|.+ .|+.|++.||-
T Consensus 95 ~-----~~~g~I~~~el~~~l~~~g~~ls~-~e~-~~i~~~~d~~--~dg~I~~~eF~ 143 (182)
T d1y1xa_ 95 S-----SGDGRLDSNEVRAALLSSGYQVSE-QTF-QALMRKFDRQ--RRGSLGFDDYV 143 (182)
T ss_dssp T-----TSSSCBCHHHHHHHHHTTSCCCCH-HHH-HHHHHHHCTT--CSSSBCHHHHH
T ss_pred c-----ccchhhhhHHHHHHHHHhCCchhH-HHH-HHHHhhcccC--CCCCcCHHHHH
Confidence 6 778999999999987666543321 111 1247888888 89999888775
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=90.23 E-value=0.012 Score=46.84 Aligned_cols=54 Identities=6% Similarity=0.043 Sum_probs=40.0
Q ss_pred hhhhHhhhccccccCcCCC-----CCCCCCchhhccccccccCCCCccccccchhhhccc
Q 006460 323 NVRSVAKNIAVQLNNLPLD-----DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKE 377 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~-----~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d 377 (644)
.++.++.+..+.++..++. -...+..+++.++..+|.|++|.| ||.||+..+..
T Consensus 11 ~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~ei~~~~~~~D~d~~G~I-~~~EF~~~~~~ 69 (81)
T d2opoa1 11 IFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEIDTDGDGFI-SFDEFTDFARA 69 (81)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHCTTCSSEE-CHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeE-eHHHHHHHHHH
Confidence 3556677777666665552 112356678999999999999999 99999987644
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=90.10 E-value=0.013 Score=51.11 Aligned_cols=89 Identities=12% Similarity=0.119 Sum_probs=62.4
Q ss_pred ccccccCCCCccccccchhhhccccccc---ccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccc
Q 006460 354 LETKKVDPTSYTMEVSSSINDSKERSTQ---TETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEID 430 (644)
Q Consensus 354 ~~~~d~D~nG~i~d~~efi~a~~d~s~~---~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (644)
+...+.+++|.| +|.+|+.....+... .+.+.+..||+..+. |.+|+++.+++.+++.-.|..+.. +|++
T Consensus 43 i~~~~~~~~~~i-~~~eF~~~~~~~~~~~~~~~~~~l~~aF~~~D~-----d~~G~I~~~el~~~l~~~g~~lt~-~e~~ 115 (140)
T d1ggwa_ 43 ITEIESTLPAEV-DMEQFLQVLNRPNGFDMPGDPEEFVKGFQVFDK-----DATGMIGVGELRYVLTSLGEKLSN-EEMD 115 (140)
T ss_dssp HHHHHTTSCSSE-EHHHHHHHHCTTSSSSSSCCHHHHHHHHHTTCS-----SCSSCCCHHHHHHHHHHHHSCSCH-HHHH
T ss_pred hhhhhccccccc-cchhhhhhhhhhhhcchhhHHHHHHHHHHHHhc-----cCCCcchHHHHHHHHHHcCCCCCH-HHHH
Confidence 455677889999 999999877544332 344568899999988 999999999999998666643322 1111
Q ss_pred cccccccCCCCCchhhhhhhhcc
Q 006460 431 VETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+++..|.+ |+.|+|.||-
T Consensus 116 -~l~~~~d~~---dG~I~y~eF~ 134 (140)
T d1ggwa_ 116 -ELLKGVPVK---DGMVNYHDFV 134 (140)
T ss_dssp -HHHHHTTCS---SCCSTTTHHH
T ss_pred -HHHHhhCCC---CCEEeHHHHH
Confidence 135555533 7889888774
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=89.95 E-value=0.019 Score=43.66 Aligned_cols=62 Identities=11% Similarity=0.145 Sum_probs=49.8
Q ss_pred cccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 383 ETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 383 ~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
|++.++.||+.+++ |.+|+++.+++..+++..|..+..- |+ -.++..-|.+ .|+.|++.||-
T Consensus 1 Seeel~~aF~~fD~-----d~~G~I~~~el~~~l~~lg~~~~~~-e~-~~l~~~~D~d--~~g~I~~~eF~ 62 (65)
T d1fw4a_ 1 SEEEIREAFRVFDK-----DGNGYISAAELRHVMTNLGEKLTDE-EV-DEMIREADID--GDGQVNYEEFV 62 (65)
T ss_dssp CCHHHHHHHHHHCT-----TCSSEECHHHHHHHHHHTTCCCCHH-HH-HHHHHTTCTT--CSSSEEHHHHH
T ss_pred CHHHHHHHHHHHcC-----CCCCcCCHHHHHHHHHHhCCCCCHH-HH-HHHHHHcCCC--CCCcEeHHHHH
Confidence 56789999999999 9999999999999988887665442 11 1247778888 89999998874
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=89.66 E-value=0.031 Score=45.05 Aligned_cols=78 Identities=6% Similarity=0.018 Sum_probs=56.2
Q ss_pred CCCccccccchhhhc-ccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcc--ccccccccccccc
Q 006460 361 PTSYTMEVSSSINDS-KERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQ--PAEEIDVETVKSK 437 (644)
Q Consensus 361 ~nG~i~d~~efi~a~-~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 437 (644)
.+|.| |..+..++- +...+ + ..|+.+|..++. |.+++++.+++..+.+-.|..+. .+++ ++...
T Consensus 2 ~~g~i-d~~~~~ma~~l~~~~-i--~~l~~~F~~~D~-----d~~G~I~~~el~~~l~~lg~~~s~~e~~~----l~~~~ 68 (87)
T d1s6ja_ 2 SSGHI-DDDDKHMAERLSEEE-I--GGLKELFKMIDT-----DNSGTITFDELKDGLKRVGSELMESEIKD----LMDAA 68 (87)
T ss_dssp CSSSS-SSHHHHSSSSSCSSS-T--TTTTTHHHHHCT-----TCSSCEEHHHHHHHHHTTTSSCCHHHHHH----HHHHH
T ss_pred CCCcc-CchHHHHHhhCCHHH-H--HHHHHHHHHHcC-----CCCCcCcHHHHHHHHHHcCCCCCHHHHHH----HHHHc
Confidence 45778 555544442 22111 1 247889999988 89999999999999888776654 3333 48888
Q ss_pred CCCCCchhhhhhhhcc
Q 006460 438 DQNPFSDRVIEEADIE 453 (644)
Q Consensus 438 ~~~~~~~~~~~~~~~~ 453 (644)
|.+ .|+.|++.||-
T Consensus 69 D~d--~~g~I~~~EFl 82 (87)
T d1s6ja_ 69 DID--KSGTIDYGEFI 82 (87)
T ss_dssp CTT--CSSEECHHHHT
T ss_pred CCC--CCCeEeHHHHH
Confidence 999 89999999885
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=88.99 E-value=0.0068 Score=52.94 Aligned_cols=121 Identities=12% Similarity=0.093 Sum_probs=83.8
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcccccccc-cccccccccccc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQT-ETSDCSRDKQAH 394 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~-~~~~l~~af~~~ 394 (644)
+.++.++.+..+.++..++. ........+...+...+.++.|.+ ++.+|+.......... +++.+..||+..
T Consensus 14 ~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~aF~~~ 92 (146)
T d1lkja_ 14 EAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQI-EFSEFLALMSRQLKSNDSEQELLEAFKVF 92 (146)
T ss_dssp HHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCSSSCCEE-EHHHHHHHHHHHTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhccCCcccc-cHHHHHHHHHHhhccccHHHHHHHHHHHh
Confidence 34556666666666655552 223344556777777888888888 8999998876644433 467888999999
Q ss_pred cCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 395 FNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+. |.+++++.+++..++...|.+...- ++ -+++..-| + .|++|++.||-
T Consensus 93 D~-----d~~G~I~~~el~~~l~~~g~~~~~~-~~-~~~~~~~d-d--~dG~I~~~eF~ 141 (146)
T d1lkja_ 93 DK-----NGDGLISAAELKHVLTSIGEKLTDA-EV-DDMLREVS-D--GSGEINIQQFA 141 (146)
T ss_dssp CS-----SSSCEEEHHHHHHHHHHHTCSCCHH-HH-HHHHHHHC-C--SSSEEEHHHHH
T ss_pred CC-----CCCCcCcHHHHHHHHHHcCCcccHH-HH-HHHHHhcc-C--CCCeEeHHHHH
Confidence 98 9999999999999987776544221 11 12355555 6 68999988874
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=88.86 E-value=0.038 Score=36.72 Aligned_cols=30 Identities=10% Similarity=0.044 Sum_probs=27.0
Q ss_pred cccccccccccccCCccCCCCchhhhhhhhhhhcc
Q 006460 383 ETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQE 417 (644)
Q Consensus 383 ~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (644)
|++.++.||+.+++ |++++|+++||..+..
T Consensus 1 seeel~eAF~~FDk-----Dg~G~Is~~EL~~vm~ 30 (33)
T d2hf5a1 1 SEEEIREAFRVFDK-----DGNGYISAAELRHVMT 30 (33)
T ss_dssp CHHHHHHHHHHHSS-----SCCSCBCHHHHHHHTT
T ss_pred CHHHHHHHHHHhCC-----CCCCcCcHHHHHHHHH
Confidence 46789999999999 9999999999998864
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=88.79 E-value=0.026 Score=50.36 Aligned_cols=90 Identities=1% Similarity=-0.131 Sum_probs=64.7
Q ss_pred ccccccccCCCCccccccchhhhcccccccc---------cccccccccccccCCccCCCCchhhhhhhhhhhccccccC
Q 006460 352 DNLETKKVDPTSYTMEVSSSINDSKERSTQT---------ETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAH 422 (644)
Q Consensus 352 d~~~~~d~D~nG~i~d~~efi~a~~d~s~~~---------~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (644)
..+...|.+++|.| ++.+|+.+........ ....+..+|+..+. |.+++++.+|+...++..++.
T Consensus 64 ~~~~~~d~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~~G~Is~~E~~~~l~~~~l~ 137 (185)
T d2sasa_ 64 DLKGRADINKDDVV-SWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDV-----SGDGIVDLEEFQNYCKNFQLQ 137 (185)
T ss_dssp HHHHHHCTTCSSCE-EHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCT-----TSSSCCCHHHHHHHTTSSCCC
T ss_pred HHHHHhCcCCCCcE-eeeHhhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHcc-----CCCccCCHHHHHHHHHHcCCC
Confidence 44567788889999 8999987764322111 11236678888887 999999999999998877654
Q ss_pred cccccccccccccccCCCCCchhhhhhhhcc
Q 006460 423 VQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
-..+.. +...-|.| .|+.|++.||.
T Consensus 138 ~~~~~~----~f~~~D~d--~dG~i~~~EF~ 162 (185)
T d2sasa_ 138 CADVPA----VYNVITDG--GKVTFDLNRYK 162 (185)
T ss_dssp CSSHHH----HHHHHHTT--TTSCCSHHHHH
T ss_pred HHHHHH----HHHHcCCC--CCCCCcHHHHH
Confidence 333332 37778888 89999988886
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=88.54 E-value=0.019 Score=48.54 Aligned_cols=96 Identities=10% Similarity=0.036 Sum_probs=64.7
Q ss_pred hhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCccccccc
Q 006460 350 TEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEI 429 (644)
Q Consensus 350 ~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (644)
.|.+|...|.|++|+| ++.||..+........+++.++..|+..+. +.++.++.+|..............-.+.
T Consensus 2 ae~~F~~~D~d~dG~i-s~~E~~~~l~~~~~~~~~~~~~~~~~~~D~-----~~~g~i~~~Ef~~~~~~~~~~~~~~~~~ 75 (134)
T d1jfja_ 2 AEALFKEIDVNGDGAV-SYEEVKAFVSKKRAIKNEQLLQLIFKSIDA-----DGNGEIDQNEFAKFYGSIQGQDLSDDKI 75 (134)
T ss_dssp HHHHHHHHCTTCSSEE-EHHHHHHHHHTTCCSSHHHHHHHHHHHHCS-----SCCSEEEHHHHHHHTTCSSCCSSHHHHH
T ss_pred HHHHHHHHcCCCcCCC-cHHHHHHHHHHcCCCCCHHHHHHHHHHhhh-----cccccccccccccccccccccccccccc
Confidence 3678999999999999 999998877665666677788888887766 7788999999988753222111110111
Q ss_pred cc-ccccccCCCCCchhhhhhhhcc
Q 006460 430 DV-ETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 430 ~~-~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+ ..-+.-|++ .|+.|...++.
T Consensus 76 ~~~~~F~~~D~~--~~g~i~~~el~ 98 (134)
T d1jfja_ 76 GLKVLYKLMDVD--GDGKLTKEEVT 98 (134)
T ss_dssp HHHHHHHHHCCS--SSSEEEHHHHH
T ss_pred cccccccccccc--cCCcccHHHHH
Confidence 11 124555666 67777655554
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=88.38 E-value=0.009 Score=58.31 Aligned_cols=121 Identities=7% Similarity=0.000 Sum_probs=75.4
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhccccccccc--------------
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTE-------------- 383 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~-------------- 383 (644)
+..++.++.+.++..++. ....+..++..++...|.|++|.| ||.||+........+..
T Consensus 128 F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i-~~~ef~~~~~~~~~~~~~F~~~d~d~~~~i~ 206 (321)
T d1ij5a_ 128 FLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTKGRM-SYITLVAVANDLAALVADFRKIDTNSNGTLS 206 (321)
T ss_dssp HTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHCCSSTH-HHHHHTTSHHHHHTSCCCHHHHCTTCCSEEC
T ss_pred HHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHhhcCCccc-cchhhhhhhhhhhhhhHHHHHHhhcccccch
Confidence 444555555555544442 123455678899999999999999 99999865433222111
Q ss_pred ccc---------------------------------------------cccccccccCCccCCCCchhhhhhhhhhhccc
Q 006460 384 TSD---------------------------------------------CSRDKQAHFNGSTGSDLTSEITANSQNEIQEP 418 (644)
Q Consensus 384 ~~~---------------------------------------------l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (644)
... +..+|...+. |.+|+++-+++.+.+.-
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~F~~~D~-----d~~G~Is~~E~~~~l~~ 281 (321)
T d1ij5a_ 207 RKEFREHFVRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLLVLRILYAFADF-----DKSGQLSKEEVQKVLED 281 (321)
T ss_dssp HHHHHHHHHHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHHHHHTCS-----SSCSSEEHHHHHHHHHH
T ss_pred hHHHhhhhhcccccchHHHHHHHHhhhcccccccccccccchhhhhhHHHHHHHHHhc-----CCCCCCcHHHHHHHHHH
Confidence 110 1113444343 78899999999999876
Q ss_pred cccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 419 ADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+.....-++. -.+++.-|.| .||.|+|.||-
T Consensus 282 ~~~~~~~~~~~-~~l~~~~D~d--~dG~Is~~EF~ 313 (321)
T d1ij5a_ 282 AHIPESARKKF-EHQFSVVDVD--DSKSLSYQEFV 313 (321)
T ss_dssp TTCCGGGCSTH-HHHHHHHTTT--TCSEECHHHHH
T ss_pred cCCCcCcHHHH-HHHHHHhCCC--CCCcCcHHHHH
Confidence 66421111111 1247888888 89999998885
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=87.73 E-value=0.032 Score=42.49 Aligned_cols=58 Identities=10% Similarity=-0.055 Sum_probs=29.9
Q ss_pred hhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhh
Q 006460 350 TEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQN 413 (644)
Q Consensus 350 ~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~ 413 (644)
+...|...|.|++|+| +..||..+......-.+++.++..|+..+. |.++.++-+|..
T Consensus 3 ~r~~F~~~D~d~~G~I-~~~El~~~l~~lg~~~~~~~i~~~~~~~D~-----d~dg~I~~~EF~ 60 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKL-SLDEFREVALAFSPYFTQEDIVKFFEEIDV-----DGNGELNADEFT 60 (67)
T ss_dssp HHHHHHHHCTTSSSCE-EHHHHHHHHHHTCTTSCHHHHHHHHHHHCC-----SSSSEECHHHHH
T ss_pred HHHHHHHHCCCCcCcC-cHHHHHHHHHHhccccchHHHHHHHHHhCC-----CCCCeEeHHHHH
Confidence 3445555666666666 666665555444444455555555544443 444444444433
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.41 E-value=0.041 Score=49.33 Aligned_cols=66 Identities=3% Similarity=-0.111 Sum_probs=53.3
Q ss_pred CCchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCc
Q 006460 346 SSTSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHV 423 (644)
Q Consensus 346 ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (644)
+...+..++...|.|++|+| +|.||+...... ..+..+|+.++. |.+++++.+|+.++....+...
T Consensus 45 ~~~~v~~l~~~~D~d~~G~I-~f~EF~~~~~~~------~~~~~~f~~~D~-----d~sG~i~~~El~~~l~~~g~~l 110 (172)
T d1juoa_ 45 NLETCRLMVSMLDRDMSGTM-GFNEFKELWAVL------NGWRQHFISFDT-----DRSGTVDPQELQKALTTMGFRL 110 (172)
T ss_dssp CHHHHHHHHHHHCTTCSSCE-EHHHHHHHHHHH------HHHHHHHHTTCT-----TCCSEECHHHHHHHHHHTTCCC
T ss_pred CHHHHHHHHHHHCCCCCCce-ehHHHHHHHHhh------hhhhHHHHHhCc-----CCCCcCCHHHHHHHHHHHHHhh
Confidence 34567888999999999999 999999776432 456778988888 8999999999999976666443
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=87.15 E-value=0.02 Score=51.48 Aligned_cols=90 Identities=9% Similarity=-0.034 Sum_probs=68.1
Q ss_pred CchhhccccccccCCCCccccccchhhhcccccccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccc
Q 006460 347 STSTEDNLETKKVDPTSYTMEVSSSINDSKERSTQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPA 426 (644)
Q Consensus 347 s~~~ed~~~~~d~D~nG~i~d~~efi~a~~d~s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (644)
......++...|.|++|.| +|.||+..... ...+..+|+.++. |.++.++.+++.+++...+..+.
T Consensus 46 ~~~~~~l~~~~d~d~~g~i-~~~ef~~~~~~------~~~~~~~f~~~D~-----d~~G~I~~~el~~~L~~~g~~~~-- 111 (173)
T d1alva_ 46 IDTCRSMVAVMDSDTTGKL-GFEEFKYLWNN------IKKWQAIYKQFDV-----DRSGTIGSSELPGAFEAAGFHLN-- 111 (173)
T ss_dssp HHHHHHHHHHHCTTCSSSB-CHHHHHHHHHH------HHHHHHHHHHHCT-----TCCSSBCTTTHHHHHHHHTCCCC--
T ss_pred HHHHHHHHHHhccCCCCcc-cchhhhhhhhh------hhHHHHHHHHhcc-----CCCCeecHHHHHHHHHHHHHhhH--
Confidence 3456788899999999999 99999876533 2567778888777 88999999999999877775443
Q ss_pred cccccccccccCCCCCchhhhhhhhcc
Q 006460 427 EEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+.-++.+..-|.| .|+.|++.||-
T Consensus 112 -~~~~~~~~~~d~d--~~G~i~~~EF~ 135 (173)
T d1alva_ 112 -EHLYSMIIRRYSD--EGGNMDFDNFI 135 (173)
T ss_dssp -HHHHHHHHHHHTC--SSSCBCHHHHH
T ss_pred -HHHHHHhhccccC--CCCeEeHHHHH
Confidence 2224455556666 78889888874
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=87.05 E-value=0.03 Score=44.43 Aligned_cols=66 Identities=15% Similarity=0.179 Sum_probs=51.7
Q ss_pred cccccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 379 STQTETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 379 s~~~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+.-.+++.|+.+|+.++. |.+|+++.+++..+++..|..+.. +|++ .++...|.+ .|+.|++.||-
T Consensus 9 ~~~~~ee~l~~~F~~~D~-----d~~G~I~~~el~~~l~~~g~~~~~-~ev~-~~~~~~D~d--~dg~I~~~EF~ 74 (81)
T d1fi5a_ 9 SKGKTEEELSDLFRMFDK-----NADGYIDLEELKIMLQATGETITE-DDIE-ELMKDGDKN--NDGRIDYDEFL 74 (81)
T ss_dssp CCCCCHHHHHHHHHHHCS-----SCSSEECHHHHHHHHHTSSSCCCH-HHHH-HHHHHHCSS--SSSSEEHHHHH
T ss_pred hcCCCHHHHHHHHHHHcC-----CCCCcccHHHHHHHHHhcCCCCCH-HHHH-HHHHHHCCC--CCCcEeHHHHH
Confidence 444567889999999999 999999999999998877755432 1221 247788888 89999998885
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=87.03 E-value=0.027 Score=44.07 Aligned_cols=63 Identities=17% Similarity=0.192 Sum_probs=50.5
Q ss_pred ccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 382 TETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 382 ~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
.+++.+..+|+..+. +.+++++..++..+++..|..+..-+ + -++++..|.+ .|++|++.||-
T Consensus 6 ~~eeel~~~F~~fD~-----~~~G~I~~~el~~~l~~lg~~~~~~e-~-~~~~~~~D~d--~dg~I~~~EF~ 68 (75)
T d1jc2a_ 6 KSEEELANCFRIFDK-----NADGFIDIEELGEILRATGEHVIEED-I-EDLMKDSDKN--NDGRIDFDEFL 68 (75)
T ss_dssp CCHHHHHHHHHHHCC-----STTSSEEHHHHHHHHHHSSSCCCHHH-H-HHHHHHHCSS--SCSEECHHHHH
T ss_pred CcHHHHHHHHHHHcC-----CCcCeEcHHHHHHHHHhcCCCccHHH-H-HHHHHHhCCC--CCCcEeHHHHH
Confidence 466789999999998 99999999999999988886553321 1 1248888888 89999998884
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=86.28 E-value=0.042 Score=41.06 Aligned_cols=48 Identities=13% Similarity=0.126 Sum_probs=35.5
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchh
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSI 372 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi 372 (644)
++.++.+..+.++..++. ..+.+...++.++..+|.|++|.| +|.|||
T Consensus 7 F~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I-~~~eFl 60 (61)
T d2fcea1 7 FQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEI-DYKKFI 60 (61)
T ss_dssp HHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEE-CHHHHH
T ss_pred HHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcE-eHHHhc
Confidence 455556666555555542 345677888999999999999999 999997
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=85.44 E-value=0.059 Score=41.19 Aligned_cols=62 Identities=15% Similarity=0.169 Sum_probs=47.8
Q ss_pred ccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 384 TSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 384 ~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
++.++++|+..++ |.+++++.+++..+....|.+...-+|+. .+++..|.| .|+.|++.||-
T Consensus 1 eeel~~~F~~~D~-----d~~G~I~~~el~~~l~~~g~~~~s~~e~~-~~~~~~D~d--~dG~i~~~EF~ 62 (68)
T d1c7va_ 1 EEEILRAFKVFDA-----NGDGVIDFDEFKFIMQKVGEEPLTDAEVE-EAMKEADED--GNGVIDIPEFM 62 (68)
T ss_dssp CHHHHHHHHHHSC-----SGGGEECHHHHHHHSSTTTTCCCCHHHHH-HHHHHHCSS--GGGSEEHHHHH
T ss_pred CHHHHHHHHHHcC-----CCcCeEcHHHHHHHHHHhCCCCCCHHHHH-HHHHHhCCC--CCCcEeHHHHH
Confidence 3568889999998 99999999999999888876532112221 248889999 99999998885
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=85.23 E-value=0.05 Score=42.40 Aligned_cols=67 Identities=7% Similarity=0.049 Sum_probs=47.4
Q ss_pred ccccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccccccccCCCCCchhhhhhhhcc
Q 006460 382 TETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVETVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 382 ~~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (644)
-+++.++.+|+.+.... +.+++|+.+++.++++-.|.....-++.=-++++..|.| .|+.|++.||.
T Consensus 2 ~s~eel~~~F~~fd~~~---~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d--~dG~I~f~EF~ 68 (76)
T d1qx2a_ 2 KSPEEIKGAFEVFAAKE---GDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKN--GDGEVSFEEFL 68 (76)
T ss_dssp CCHHHHHHHHHHHHTSS---SCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTT--CSSEECHHHHH
T ss_pred cCHHHHHHHHHHHcccC---CCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcC--CCCcCcHHHHH
Confidence 35678889998764411 237899999999998766654432211112358999999 89999999985
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=84.51 E-value=0.063 Score=47.46 Aligned_cols=84 Identities=13% Similarity=0.028 Sum_probs=61.0
Q ss_pred ccCCCCccccccchhhhcccccccc-----cccccccccccccCCccCCCCchhhhhhhhhhhccccccCcccccccccc
Q 006460 358 KVDPTSYTMEVSSSINDSKERSTQT-----ETSDCSRDKQAHFNGSTGSDLTSEITANSQNEIQEPADAHVQPAEEIDVE 432 (644)
Q Consensus 358 d~D~nG~i~d~~efi~a~~d~s~~~-----~~~~l~~af~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (644)
+.+++|.| ++.||+.......... ....+..+|+..+. |.+++++.+|+...+.-.+.....+..
T Consensus 63 ~~~~~~~i-~~~ef~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~-----d~dG~Is~~E~~~~l~~~~~~~~~~~~---- 132 (174)
T d2scpa_ 63 AVAGGKGI-DETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDT-----NEDNNISRDEYGIFFGMLGLDKTMAPA---- 132 (174)
T ss_dssp GTTTTSCE-EHHHHHHHHHHHTSCGGGTHHHHTHHHHHHHHHCT-----TCSSSEEHHHHHHHHHHTTCCGGGHHH----
T ss_pred ccCCCCcC-cHHHHHHHHHhhhcchhhHHHHHHHHHHHHHHHCC-----CccccCCHHHHHHHHHHHhhhhHHHHH----
Confidence 55677888 8999988764432221 23356678888887 999999999999987666654444443
Q ss_pred cccccCCCCCchhhhhhhhcc
Q 006460 433 TVKSKDQNPFSDRVIEEADIE 453 (644)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~ 453 (644)
+.+..|.| .|+.|++.||-
T Consensus 133 ~f~~~D~d--~dG~Is~~Ef~ 151 (174)
T d2scpa_ 133 SFDAIDTN--NDGLLSLEEFV 151 (174)
T ss_dssp HHHHHCTT--CSSEECHHHHH
T ss_pred HHhhcCCC--CCCcEeHHHHH
Confidence 37788888 99999988875
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.06 E-value=0.062 Score=43.83 Aligned_cols=52 Identities=8% Similarity=-0.103 Sum_probs=39.5
Q ss_pred hhhhHhhhccccccCcCCC----CCCCCCchhhccccccccCCCCccccccchhhhc
Q 006460 323 NVRSVAKNIAVQLNNLPLD----DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDS 375 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~----~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~ 375 (644)
.++.++.+..+.++..++. ...-.....+.+++.+|.|++|+| |+.||++++
T Consensus 15 ~F~~~D~d~~G~is~~e~~~~l~~~~l~~~~l~~i~~~~D~d~dG~l-~~~EF~~am 70 (95)
T d1c07a_ 15 IFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKL-SKDQFALAF 70 (95)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSE-ETTTHHHHH
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHhcCCCHHHHHHHHHHhCCCCCCeE-cHHHHHHHH
Confidence 4666777777777666552 222345567899999999999999 999999886
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=83.11 E-value=0.058 Score=41.25 Aligned_cols=52 Identities=8% Similarity=0.136 Sum_probs=37.8
Q ss_pred hhhhHhhhccccccCcCCC-------CCCCCCchhhccccccccCCCCccccccchhhhc
Q 006460 323 NVRSVAKNIAVQLNNLPLD-------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDS 375 (644)
Q Consensus 323 ~~~~~~~n~~~q~~~~~~~-------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~ 375 (644)
.++.++.+..+.++..++. ..+.+...+++++..+|.|++|.| +|.||+..+
T Consensus 7 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i-~~~EF~~~m 65 (68)
T d1c7va_ 7 AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVI-DIPEFMDLI 65 (68)
T ss_dssp HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSE-EHHHHHHHH
T ss_pred HHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcE-eHHHHHHHH
Confidence 3555666666655554442 234567888999999999999999 999999643
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=82.06 E-value=0.056 Score=41.01 Aligned_cols=51 Identities=12% Similarity=-0.027 Sum_probs=37.5
Q ss_pred hhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhc
Q 006460 324 VRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDS 375 (644)
Q Consensus 324 ~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~ 375 (644)
++.++.+..+.++..++. ....+..+++.++...|.|++|.| +|.||+...
T Consensus 7 F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I-~~~EF~~~m 63 (67)
T d1tiza_ 7 FEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGEL-NADEFTSCI 63 (67)
T ss_dssp HHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEE-CHHHHHHHH
T ss_pred HHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeE-eHHHHHHHH
Confidence 455556666555555542 234456788999999999999999 999999765
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=80.46 E-value=0.072 Score=42.04 Aligned_cols=54 Identities=6% Similarity=0.005 Sum_probs=42.1
Q ss_pred hhhhhHhhhccccccCcCCC------CCCCCCchhhccccccccCCCCccccccchhhhcc
Q 006460 322 ENVRSVAKNIAVQLNNLPLD------DKPTSSTSTEDNLETKKVDPTSYTMEVSSSINDSK 376 (644)
Q Consensus 322 e~~~~~~~n~~~q~~~~~~~------~~~~ss~~~ed~~~~~d~D~nG~i~d~~efi~a~~ 376 (644)
+.++.++++..+.++..++. ..+-+..+++.++...|.|++|.| +|.||+..+.
T Consensus 18 ~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I-~~~eF~~~m~ 77 (81)
T d1avsa_ 18 AAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI-DFEEFLVMMV 77 (81)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSE-EHHHHHHHHH
T ss_pred HHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeE-eHHHHHHHHH
Confidence 34666788877777776662 334566778999999999999999 9999998663
|